PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Beaudoin, J; Ioannoni, R; Lopez-Maury, L; Bahler, J; Ait-Mohand, S; Guerin, B; Dodani, SC; Chang, CJ; Labbe, S				Beaudoin, Jude; Ioannoni, Raphael; Lopez-Maury, Luis; Baehler, Juerg; Ait-Mohand, Samia; Guerin, Brigitte; Dodani, Sheel C.; Chang, Christopher J.; Labbe, Simon			Mfc1 Is a Novel Forespore Membrane Copper Transporter in Meiotic and Sporulating Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING FACTOR PHP4; FISSION YEAST; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; MOLECULAR-MECHANISMS; IRON-DEFICIENCY; MEIOSIS; PROTEIN; CTR1; IDENTIFICATION	To gain insight in the molecular basis of copper homeostasis during meiosis, we have used DNA microarrays to analyze meiotic gene expression in the model yeast Schizosaccharomyces pombe. Profiling data identified a novel meiosis-specific gene, termed mfc1(+), that encodes a putative major facilitator super-family-type transporter. Although Mfc1 does not exhibit any significant sequence homology with the copper permease Ctr4, it contains four putative copper-binding motifs that are typically found in members of the copper transporter family of copper transporters. Similarly to the ctr4(+) gene, the transcription of mfc1(+) was induced by low concentrations of copper. However, its temporal expression profile during meiosis was distinct to ctr4(+). Whereas Ctr4 was observed at the plasma membrane shortly after induction of meiosis, Mfc1 appeared later in precursor vesicles and, subsequently, at the forespore membrane of ascospores. Using the fluorescent copper-binding tracker Coppersensor-1 (CS1), labile cellular copper was primarily detected in the forespores in an mfc1(+)/mfc1(+) strain, whereas an mfc1 Delta/mfc1 Delta mutant exhibited an intracellular dispersed punctate distribution of labile copper ions. In addition, the copper amine oxidase Cao1, which localized primarily in the forespores of asci, was fully active in mfc1(+)/mfc1(+) cells, but its activity was drastically reduced in an mfc1 Delta/mfc1 Delta strain. Furthermore, our data showed that meiotic cells that express the mfc1(+) gene have a distinct developmental advantage over mfc1 Delta/mfc1 Delta mutant cells when copper is limiting. Taken together, the data reveal that Mfc1 serves to transport copper for accurate and timely meiotic differentiation under copper-limiting conditions.	[Labbe, Simon] Univ Sherbrooke, Fac Med, Dept Biochim, Sherbrooke, PQ J1H 5N4, Canada; [Guerin, Brigitte] Univ Sherbrooke, Dept Med Nucl & Radiobiol, Fac Med & Sci Sante, Sherbrooke, PQ J1H 5N4, Canada; [Ait-Mohand, Samia; Guerin, Brigitte] Univ Sherbrooke, Ctr Imagerie Mol Sherbrooke, Sherbrooke, PQ J1H 5N4, Canada; [Lopez-Maury, Luis; Baehler, Juerg] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Dodani, Sheel C.; Chang, Christopher J.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Chang, Christopher J.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; University of London; University College London; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Labbe, S (corresponding author), Univ Sherbrooke, Fac Med, Dept Biochim, 3001,12E Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	Simon.Labbe@USherbrooke.ca	Bahler, Jurg/B-4572-2009; Lopez-Maury, Luis/B-3715-2015	Bahler, Jurg/0000-0003-4036-1532; Lopez-Maury, Luis/0000-0002-3510-0621; Labbe, Simon/0000-0002-4947-523X	National Institutes of Health, NIGMS [GM-79465]; Canadian Institutes of Health Research [MOP-3645, MOP-114986]; Foundation of Stars for Children's Health Research; Cancer Research UK [CUK C9546/A6517]; Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079465] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Foundation of Stars for Children's Health Research; Cancer Research UK(Cancer Research UK); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-79465 from NIGMS (to C. J. C.). This work was also supported by Grants MOP-3645 and MOP-114986 from the Canadian Institutes of Health Research, by a grant from the Foundation of Stars for Children's Health Research (to S. L.), and by Cancer Research UK Grant CUK C9546/A6517 (to J. B.).; Recipient of a studentship from the Natural Sciences and Engineering Research Council of Canada.	Aller SG, 2006, P NATL ACAD SCI USA, V103, P3627, DOI 10.1073/pnas.0509929103; BAHLER J, 1991, CURR GENET, V19, P445, DOI 10.1007/BF00312735; Beaudoin J, 2006, MICROBIOL-SGM, V152, P209, DOI 10.1099/mic.0.28392-0; Beaudoin J, 2003, J BIOL CHEM, V278, P14565, DOI 10.1074/jbc.M300861200; Beaudoin J, 2001, J BIOL CHEM, V276, P15472, DOI 10.1074/jbc.M011256200; Beaudoin J, 2011, MICROBIOL-SGM, V157, P1021, DOI 10.1099/mic.0.046854-0; Bellemare DR, 2002, J BIOL CHEM, V277, P46676, DOI 10.1074/jbc.M206444200; Bezanilla M, 1997, MOL BIOL CELL, V8, P2693, DOI 10.1091/mbc.8.12.2693; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Cobine PA, 2006, BBA-MOL CELL RES, V1763, P759, DOI 10.1016/j.bbamcr.2006.03.002; COTTAREL G, 1993, CURR GENET, V23, P547, DOI 10.1007/BF00312650; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; De Feo CJ, 2009, P NATL ACAD SCI USA, V106, P4237, DOI 10.1073/pnas.0810286106; Doll E, 2008, GENETICS, V180, P727, DOI 10.1534/genetics.108.092619; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Glerum DM, 1996, J BIOL CHEM, V271, P14504, DOI 10.1074/jbc.271.24.14504; HALLIWELL B, 1992, FEBS LETT, V307, P108, DOI 10.1016/0014-5793(92)80911-Y; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Harigaya Y, 2007, CHROMOSOME RES, V15, P523, DOI 10.1007/s10577-007-1151-0; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Ioannoni R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011964; KEENEY JB, 1994, GENETICS, V136, P849; Kim AM, 2011, ACS CHEM BIOL, V6, P716, DOI 10.1021/cb200084y; Kim AM, 2010, NAT CHEM BIOL, V6, P674, DOI [10.1038/NCHEMBIO.419, 10.1038/nchembio.419]; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Kim J, 1998, GENETICS, V149, P795; Knight SAB, 1996, GENE DEV, V10, P1917, DOI 10.1101/gad.10.15.1917; Kuo YM, 2006, J NUTR, V136, P21, DOI 10.1093/jn/136.1.21; Labbe S, 1999, J BIOL CHEM, V274, P36252, DOI 10.1074/jbc.274.51.36252; Laliberte J, 2004, J BIOL CHEM, V279, P28744, DOI 10.1074/jbc.M403426200; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Lee J, 2002, J BIOL CHEM, V277, P40253, DOI 10.1074/jbc.M208002200; Lin SJ, 1997, J BIOL CHEM, V272, P9215; Loidl J, 2009, METHODS MOL BIOL, V558, P15, DOI 10.1007/978-1-60761-103-5_2; Lyne R, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-27; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Maeda Y, 2009, BIOSCI BIOTECH BIOCH, V73, P339, DOI 10.1271/bbb.80575; Marston AL, 2004, NAT REV MOL CELL BIO, V5, P983, DOI 10.1038/nrm1526; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Mata J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r217; Matsuyama A, 2000, GENETICS, V155, P539; Mercier A, 2008, EUKARYOT CELL, V7, P493, DOI 10.1128/EC.00446-07; Mercier A, 2006, EUKARYOT CELL, V5, P1866, DOI 10.1128/EC.00199-06; Miller EW, 2006, NAT PROTOC, V1, P824, DOI 10.1038/nprot.2006.140; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nakamura T, 2008, MOL BIOL CELL, V19, P3544, DOI 10.1091/mbc.E08-04-0414; Nevitt T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001322; Nose Y, 2006, TRENDS BIOCHEM SCI, V31, P604, DOI 10.1016/j.tibs.2006.09.003; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Peter C, 2008, EUKARYOT CELL, V7, P1781, DOI 10.1128/EC.00230-08; Puig S, 2002, CURR OPIN CHEM BIOL, V6, P171, DOI 10.1016/S1367-5931(02)00298-3; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Sabatinos SA, 2010, METHOD ENZYMOL, V470, P759, DOI 10.1016/S0076-6879(10)70032-X; Siam R, 2004, METHODS, V33, P189, DOI 10.1016/j.ymeth.2003.11.013; Steiger D, 2010, J BIOL CHEM, V285, P17089, DOI 10.1074/jbc.M109.090282; Turski ML, 2009, J BIOL CHEM, V284, P717, DOI 10.1074/jbc.R800055200; Yamamoto M, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P297; Zeng L, 2006, J AM CHEM SOC, V128, P10, DOI 10.1021/ja055064u; Zhou H, 2001, J BIOL CHEM, V276, P20529, DOI 10.1074/jbc.M102004200	64	31	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34356	34372		10.1074/jbc.M111.280396	http://dx.doi.org/10.1074/jbc.M111.280396			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21828039	Green Published, hybrid			2022-12-25	WOS:000295159200064
J	Lv, ZM; Wang, Q; Wan, Q; Lin, JG; Hu, MS; Liu, YX; Wang, R				Lv, Zhi-Mei; Wang, Qun; Wan, Qiang; Lin, Jian-Gong; Hu, Meng-Si; Liu, You-Xia; Wang, Rong			The Role of the p38 MAPK Signaling Pathway in High Glucose-Induced Epithelial-Mesenchymal Transition of Cultured Human Renal Tubular Epithelial Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SNAIL; ACTIVATED-PROTEIN KINASE; HUMAN MESANGIAL CELLS; E-CADHERIN; TRANSFORMING GROWTH-FACTOR-BETA-1; GENE-EXPRESSION; GROWTH; INDUCTION; 12-LIPOXYGENASE; CANCER	Background: Epithelial-mesenchymal transition of tubular epithelial cells, which is characterized by a loss of epithelial cell characteristics and a gain of ECM-producing myofibroblast characteristics, is an essential mechanism that is involved in tubulointerstitial fibrosis, an important component of the renal injury that is associated with diabetic nephropathy. Under diabetic conditions, p38 MAPK activation has been reported in glomeruli and mesangial cells; however, studies on p38 MAPK in TECs are lacking. In this study, the role of p38 MAPK in AP-1 activation and in the EMT in the human proximal tubular epithelial cell line (HK-2) under high glucose concentration conditions is investigated. Methodology/Principal Findings: A vector for small interfering RNA that targets p38 MAPK was constructed; the cells were then either transfected with p38 siRNA or pretreated with a chemical inhibitor of AP-1 and incubated with low glucose plus TGF-beta 1 or high glucose for 48 h. Cells that were not transfected or pretreated and were exposed to low glucose with or without TGF-beta 1 or high glucose for 48 h were considered to be the controls. We found that high glucose induced an increase in TGF-beta 1. And high glucose-induced p38 MAPK activation was inhibited by p38 siRNA (P<0.05). A significant decline in E-cadherin and CK expression and a notable increase in vimentin and alpha-SMA were detected when exposed to low glucose with TGF-beta 1 or high glucose, and a significant raise of secreted fibronectin were detected when exposed to high glucose; whereas these changes were reversed when the cells were treated with p38 siRNA or AP-1 inhibitor (P<0.05). AP-1 activity levels and Snail expression were up-regulated under high glucose conditions but were markedly down-regulated through knockdown of p38 MAPK with p38 siRNA or pretreatment with AP-1 inhibitor (P<0.05). Conclusion: This study suggests that p38 MAPK may play an important role in the high glucose-induced EMT by activating AP-1 in tubular epithelial cells.	[Lv, Zhi-Mei; Wang, Qun; Wan, Qiang; Lin, Jian-Gong; Hu, Meng-Si; Liu, You-Xia; Wang, Rong] Shandong Univ, Prov Hosp, Dept Nephrol, Jinan 250100, Peoples R China	Shandong University	Lv, ZM (corresponding author), Shandong Univ, Prov Hosp, Dept Nephrol, Jinan 250100, Peoples R China.	sdwangrong@sina.cn	wang, qinghong/M-7969-2017	Lv, Zhimei/0000-0001-5128-4734	National Natural Science Foundation of China [30971381]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by National Natural Science Foundation of China (Grant 30971381). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves CC, 2009, FRONT BIOSCI-LANDMRK, V14, P3041, DOI 10.2741/3433; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bode AM, 2001, CANCER RES, V61, P850; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; CANO E, 1995, TRENDS BIOCHEM SCI, V20, P117, DOI 10.1016/S0968-0004(00)88978-1; CESAR C, 2007, ANNU REV GENET, V41, P41; Duyndam MCA, 2003, J BIOL CHEM, V278, P6885, DOI 10.1074/jbc.M206320200; ESTER P, 1999, J CELL SCI, V112, P4557; FATIMA MG, 2001, ONCOGENE, V20, P2378; Gruden G, 2000, DIABETES, V49, P655, DOI 10.2337/diabetes.49.4.655; Guo YS, 2001, J BIOL CHEM, V276, P22941, DOI 10.1074/jbc.M101801200; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; HISAYO F, 2004, AM J PHYSIOL-RENAL, V286, P120; HUGHES P, 1995, PHARMACOL REV, V47, P133; JIRI Z, 2001, P NATL ACAD SCI USA, V98, P6686; JOHN MK, 1996, J BIOL CHEM, V271, P24313; Jung Young D., 2001, Angiogenesis, V4, P155, DOI 10.1023/A:1012291524723; JUNGHEE J, 2005, BIOCHEM BIOPH RES CO, V331, P1421; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kang SW, 2001, KIDNEY INT, V59, P1354, DOI 10.1046/j.1523-1755.2001.0590041354.x; KATHLEEN MM, 2000, CYTOKINE GRWOTH FACT, V11, P23; KOH O, 2000, CELL SIGNAL, V12, P1; MARIA P, 2002, KIDNEY INT, V62, P137; MASAYUKI I, 2002, J CLIN INVEST, V110, P341; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mezzano SA, 2001, KIDNEY INT, V60, P1366, DOI 10.1046/j.1523-1755.2001.00941.x; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; NEIL AB, 2001, J BIOL CHEM, V276, P46707; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443; PAIVI JM, 1994, J CELL BIOL, V127, P2021; Palmer HG, 2004, NAT MED, V10, P917, DOI 10.1038/nm1095; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pena C, 2005, HUM MOL GENET, V14, P3361, DOI 10.1093/hmg/ddi366; Reddy MA, 2002, AM J PHYSIOL-RENAL, V283, pF985, DOI 10.1152/ajprenal.00181.2002; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; SHIBY P, 2009, CANC PREV RES, V2, P650; Strutz F, 2000, NEPHROL DIAL TRANSPL, V15, P1729, DOI 10.1093/ndt/15.11.1729; Tanaka T, 2000, J MOL CELL CARDIOL, V32, P1955, DOI 10.1006/jmcc.2000.1228; Tokuda H, 2003, AM J PHYSIOL-ENDOC M, V284, pE1202, DOI 10.1152/ajpendo.00300.2002; TOMLINSON DR, 2003, DIABETOLOGIA, V46, P1271; Touyz RM, 2001, J HYPERTENS, V19, P553, DOI 10.1097/00004872-200103001-00006; Tsai PW, 2003, J BIOL CHEM, V278, P5750, DOI 10.1074/jbc.M204863200; Wilmer WA, 2001, KIDNEY INT, V60, P858, DOI 10.1046/j.1523-1755.2001.060003858.x; WOLFRAM J, 2001, ONCOGENE, V20, P2401; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Zeisberg M, 2004, J MOL MED, V82, P175, DOI 10.1007/s00109-003-0517-9; Zeisberg M, 2000, J NEPHROL, V13, pS111; Zheng GP, 2009, AM J PATHOL, V175, P580, DOI 10.2353/ajpath.2009.080983	50	96	110	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22806	10.1371/journal.pone.0022806	http://dx.doi.org/10.1371/journal.pone.0022806			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829520	Green Published, gold, Green Submitted			2022-12-25	WOS:000293286500032
J	Whitehead, RN; Overton, TW; Kemp, CL; Webber, MA				Whitehead, Rebekah N.; Overton, Tim W.; Kemp, Caroline L.; Webber, Mark A.			Exposure of Salmonella enterica Serovar Typhimurium to High Level Biocide Challenge Can Select Multidrug Resistant Mutants in a Single Step	PLOS ONE			English	Article							MULTIPLE ANTIBIOTIC-RESISTANCE; TOLC EFFLUX PUMP; ESCHERICHIA-COLI; EXPRESSION; VIRULENCE; RAMA; DISINFECTANTS; SYSTEMS; GENES; PLAYS	Background: Biocides are crucial to the prevention of infection by bacteria, particularly with the global emergence of multiply antibiotic resistant strains of many species. Concern has been raised regarding the potential for biocide exposure to select for antibiotic resistance due to common mechanisms of resistance, notably efflux. Methodology/Principal Findings: Salmonella enterica serovar Typhimurium was challenged with 4 biocides of differing modes of action at both low and recommended-use concentration. Flow cytometry was used to investigate the physiological state of the cells after biocide challenge. After 5 hours exposure to biocide, live cells were sorted by FACS and recovered. Cells recovered after an exposure to low concentrations of biocide had antibiotic resistance profiles similar to wild-type cells. Live cells were recovered after exposure to two of the biocides at in-use concentration for 5 hours. These cells were multi-drug resistant and accumulation assays demonstrated an efflux phenotype of these mutants. Gene expression analysis showed that the AcrEF multidrug efflux pump was de-repressed in mutants isolated from high-levels of biocide. Conclusions/Significance: These data show that a single exposure to the working concentration of certain biocides can select for mutant Salmonella with efflux mediated multidrug resistance and that flow cytometry is a sensitive tool for identifying biocide tolerant mutants. The propensity for biocides to select for MDR mutants varies and this should be a consideration when designing new biocidal formulations.	[Whitehead, Rebekah N.; Kemp, Caroline L.; Webber, Mark A.] Univ Birmingham, Sch Immun & Infect, Antimicrobial Agents Res Grp, Birmingham, W Midlands, England; [Overton, Tim W.] Univ Birmingham, Sch Chem Engn, Birmingham B15 2TT, W Midlands, England	University of Birmingham; University of Birmingham	Whitehead, RN (corresponding author), Univ Birmingham, Sch Immun & Infect, Antimicrobial Agents Res Grp, Birmingham, W Midlands, England.	r.n.whitehead@bham.ac.uk; m.a.webber@bham.ac.uk	Overton, Tim W/F-3284-2011	Overton, Tim W/0000-0003-3050-2549; Webber, Mark/0000-0001-9169-7592	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/G012016/1, BB/FO11237/1]; Biotechnology and Biological Sciences Research Council [BB/G012016/1] Funding Source: researchfish; BBSRC [BB/G012016/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by Biotechnology and Biological Sciences Research Council (BBSRC) grant BB/G012016/1. Purchase of the FACSAria II instrument was facilitated by BBSRC REI grant BB/FO11237/1 (www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Bailey AM, 2008, ANTIMICROB AGENTS CH, V52, P3604, DOI 10.1128/AAC.00661-08; Bailey AM, 2010, J BACTERIOL, V192, P1607, DOI 10.1128/JB.01517-09; Bailey AM, 2009, J ANTIMICROB CHEMOTH, V64, P973, DOI 10.1093/jac/dkp320; Blair JMA, 2009, J ANTIMICROB CHEMOTH, V64, P965, DOI 10.1093/jac/dkp311; Blair JMA, 2009, CURR OPIN MICROBIOL, V12, P512, DOI 10.1016/j.mib.2009.07.003; Buckley AM, 2006, CELL MICROBIOL, V8, P847, DOI 10.1111/j.1462-5822.2005.00671.x; Chubiz LM, 2011, J BACTERIOL, V193, P2252, DOI 10.1128/JB.01382-10; Eaves DJ, 2004, ANTIMICROB AGENTS CH, V48, P1145, DOI 10.1128/AAC.48.4.1145-1150.2004; Horiyama T, 2010, J ANTIMICROB CHEMOTH, V65, P1372, DOI 10.1093/jac/dkq160; Karatzas KAG, 2008, APPL ENVIRON MICROB, V74, P1508, DOI 10.1128/AEM.01931-07; Karatzas KAG, 2007, J ANTIMICROB CHEMOTH, V60, P947, DOI 10.1093/jac/dkm314; Ma D, 1996, MOL MICROBIOL, V19, P101, DOI 10.1046/j.1365-2958.1996.357881.x; MILLER PF, 1994, ANTIMICROB AGENTS CH, V38, P1773, DOI 10.1128/AAC.38.8.1773; Nikaido E, 2011, MICROBIOL-SGM, V157, P648, DOI 10.1099/mic.0.045757-0; Nikaido H, 1996, J BACTERIOL, V178, P5853, DOI 10.1128/jb.178.20.5853-5859.1996; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; Nishino K, 2006, MOL MICROBIOL, V59, P126, DOI 10.1111/j.1365-2958.2005.04940.x; Randall LP, 2007, J ANTIMICROB CHEMOTH, V60, P1273, DOI 10.1093/jac/dkm359; Randall LP, 2002, RES VET SCI, V72, P87, DOI 10.1053/rvsc.2001.0537; Ricci V, 2009, J ANTIMICROB CHEMOTH, V64, P654, DOI 10.1093/jac/dkp234; Rosenberg EY, 2003, MOL MICROBIOL, V48, P1609, DOI 10.1046/j.1365-2958.2003.03531.x; Russell AD, 2003, LANCET INFECT DIS, V3, P794, DOI 10.1016/S1473-3099(03)00833-8; Veiga DFT, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-101; Webber MA, 2010, METHODS MOL BIOL, V642, P173, DOI 10.1007/978-1-60327-279-7_13; Webber MA, 2009, J BACTERIOL, V191, P4276, DOI 10.1128/JB.00363-09; WRAY C, 1978, RES VET SCI, V25, P139, DOI 10.1016/S0034-5288(18)32968-0; Zhang DF, 2011, CURR MICROBIOL, V62, P777, DOI 10.1007/s00284-010-9786-z	28	47	47	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22833	10.1371/journal.pone.0022833	http://dx.doi.org/10.1371/journal.pone.0022833			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829527	Green Published, Green Submitted, gold			2022-12-25	WOS:000293286500035
J	Galli, A; Barbic, F; Borella, M; Costantino, G; Perego, F; Dipaola, F; Casella, F; Duca, PG; Diedrich, A; Raj, S; Robertson, D; Porta, A; Furlan, R				Galli, Andrea; Barbic, Franca; Borella, Marta; Costantino, Giorgio; Perego, Francesca; Dipaola, Franca; Casella, Francesco; Duca, Pier Giorgio; Diedrich, Andre; Raj, Satish; Robertson, David; Porta, Alberto; Furlan, Raffaello		STePS Investigators	Influence of Climate on Emergency Department Visits for Syncope: Role of Air Temperature Variability	PLOS ONE			English	Article							ORTHOSTATIC TOLERANCE; HEAT ACCLIMATION; HOSPITAL ADMISSIONS; CROSS-TOLERANCE; HUMANS; MORTALITY; RESPONSES; PATTERNS; STRESS; POPULATION	Background: Syncope is a clinical event characterized by a transient loss of consciousness, estimated to affect 6.2/1000 person-years, resulting in remarkable health care and social costs. Human pathophysiology suggests that heat may promote syncope during standing. We tested the hypothesis that the increase of air temperatures from January to July would be accompanied by an increased rate of syncope resulting in a higher frequency of Emergency Department (ED) visits. We also evaluated the role of maximal temperature variability in affecting ED visits for syncope. Methodology/Principal Findings: We included 770 of 2775 consecutive subjects who were seen for syncope at four EDs between January and July 2004. This period was subdivided into three epochs of similar length: 23 January-31 March, 1 April-31 May and 1 June-31 July. Spectral techniques were used to analyze oscillatory components of day by day maximal temperature and syncope variability and assess their linear relationship. There was no correlation between daily maximum temperatures and number of syncope. ED visits for syncope were lower in June and July when maximal temperature variability declined although the maximal temperatures themselves were higher. Frequency analysis of day by day maximal temperature variability showed a major non-random fluctuation characterized by a similar to 23-day period and two minor oscillations with similar to 3- and similar to 7-day periods. This latter oscillation was correlated with a similar similar to 7-day fluctuation in ED visits for syncope. Conclusions/Significance: We conclude that ED visits for syncope were not predicted by daily maximal temperature but were associated with increased temperature variability. A similar to 7-day rhythm characterized both maximal temperatures and ED visits for syncope variability suggesting that climate changes may have a significant effect on the mode of syncope occurrence.	[Galli, Andrea] Vimercate Hosp, Emergency Dept, Milan, Italy; [Barbic, Franca; Furlan, Raffaello] Bolognini Hosp, Neurosci Res Assoc, Bergamo, Italy; [Borella, Marta; Costantino, Giorgio; Perego, Francesca; Casella, Francesco] L Sacco Hosp Vialba, Milan, Italy; [Dipaola, Franca] Sesto S Giovanni Hosp, Milan, Italy; [Duca, Pier Giorgio] Inst Clin Sci L Sacco, Milan, Italy; [Diedrich, Andre; Raj, Satish; Robertson, David] Vanderbilt Univ, Div Clin Pharmacol, Dept Med, Auton Dysfunct Ctr, Nashville, TN USA; [Porta, Alberto] Galeazzi Orthopaed Inst, Dept Technol Hlth, Milan, Italy; [Porta, Alberto; Furlan, Raffaello] Univ Milan, Milan, Italy	Ospedale di Vimercate; University of Milan; Luigi Sacco Hospital; Vanderbilt University; IRCCS Istituto Ortopedico Galeazzi; University of Milan	Galli, A (corresponding author), Vimercate Hosp, Emergency Dept, Milan, Italy.	raffaello.furlan@unimi.it	Perego, Francesca/K-8990-2016; Barbic, Franca/GLV-2669-2022; Barbic, Franca/S-2183-2019; Porta, Alberto/K-4390-2016; Furlan, Raffaello/AAH-3167-2021; costantino, giorgio/AAC-6441-2022; Dipaola, Franca/F-5081-2018; Duca, Piergiorgio/S-7525-2017	Perego, Francesca/0000-0003-3973-6931; Barbic, Franca/0000-0002-8283-1988; Porta, Alberto/0000-0002-6720-9824; Furlan, Raffaello/0000-0001-5209-6786; costantino, giorgio/0000-0002-6391-3849; Dipaola, Franca/0000-0002-1557-8935; Raj, Satish/0000-0002-5890-3785; Duca, Piergiorgio/0000-0003-4499-8805				Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; Anderson CH, 2010, EUR J EMERG MED, V17, P240, DOI 10.1097/MEJ.0b013e328331ddf9; Appenzeller O, 2005, AUTON NEUROSCI-BASIC, V117, P115, DOI 10.1016/j.autneu.2004.10.003; Beggs Paul J, 2008, N S W Public Health Bull, V19, P132; Bromage TG, 2009, CALCIFIED TISSUE INT, V84, P388, DOI 10.1007/s00223-009-9221-2; Costantino G, 2008, J AM COLL CARDIOL, V51, P276, DOI 10.1016/j.jacc.2007.08.059; Crandall CG, 2008, J PHYSIOL-LONDON, V586, P293, DOI 10.1113/jphysiol.2007.143057; Furlan R, 2000, CIRCULATION, V101, P886, DOI 10.1161/01.CIR.101.8.886; Horowitz M, 2004, J APPL PHYSIOL, V97, P1496, DOI 10.1152/japplphysiol.00306.2004; Josseran L, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-14; Keller DM, 2009, J PHYSIOL-LONDON, V587, P1131, DOI 10.1113/jphysiol.2008.165118; Knowlton K, 2009, ENVIRON HEALTH PERSP, V117, P61, DOI 10.1289/ehp.11594; Kovats RS, 2004, OCCUP ENVIRON MED, V61, P893, DOI 10.1136/oem.2003.012047; LEVINE BD, 1991, CIRCULATION, V84, P1016, DOI 10.1161/01.CIR.84.3.1016; Linares C, 2008, EUR J PUBLIC HEALTH, V18, P317, DOI 10.1093/eurpub/ckm108; LIND AR, 1968, J APPL PHYSIOL, V25, P268, DOI 10.1152/jappl.1968.25.3.268; Lipp A, 2005, NEUROLOGY, V65, P905, DOI 10.1212/01.wnl.0000176060.90959.36; Lu CC, 2003, CIRCULATION, V108, P2660, DOI 10.1161/01.CIR.0000101966.24899.CB; Massimini M, 2000, J PHYSIOL-LONDON, V526, P387, DOI 10.1111/j.1469-7793.2000.t01-1-00387.x; Meendering JR, 2005, AM J PHYSIOL-HEART C, V289, pH631, DOI 10.1152/ajpheart.00029.2005; Michelozzi P, 2009, AM J RESP CRIT CARE, V179, P383, DOI 10.1164/rccm.200802-217OC; Mosqueda-Garcia R, 2000, CIRCULATION, V102, P2898; Moya A, 2009, EUR HEART J, V30, P2631, DOI 10.1093/eurheartj/ehp298; Nordkamp LRAO, 2009, AM J EMERG MED, V27, P271, DOI 10.1016/j.ajem.2008.02.022; O'Neill MS, 2005, J URBAN HEALTH, V82, P191, DOI 10.1093/jurban/jti043; PALUS M, DETECTING PHASE SYNC, V235, P341; Porta A, 2002, BIOL CYBERN, V86, P241, DOI 10.1007/s00422-001-0292-z; PORTA A, IMPLICIT EXPLICIT MO, V94, P805; Schroeder C, 2002, CIRCULATION, V106, P2806, DOI 10.1161/01.CIR.0000038921.64575.D0; SHVARTZ E, 1975, J APPL PHYSIOL, V39, P590, DOI 10.1152/jappl.1975.39.4.590; SHVARTZ E, 1970, J APPL PHYSIOL, V28, P428, DOI 10.1152/jappl.1970.28.4.428; Soteriades ES, 2002, NEW ENGL J MED, V347, P878, DOI 10.1056/NEJMoa012407; STEADMAN RG, 2001, ASSESSMENT SULTRIN 1, V18, P861; Tetievsky A, 2008, PHYSIOL GENOMICS, V34, P78, DOI 10.1152/physiolgenomics.00215.2007; Theiler James, TESTING NONLINEARITY, V58, P77; van Dijk N, 2007, EUROPACE, V9, P823, DOI 10.1093/europace/eum104; Wilson TE, 2002, J APPL PHYSIOL, V93, P85, DOI 10.1152/japplphysiol.01043.2001; Wilson TE, 2006, AM J PHYSIOL-REG I, V291, pR1443, DOI 10.1152/ajpregu.00712.2005; Wolf K, 2009, CIRCULATION, V120, P735, DOI 10.1161/CIRCULATIONAHA.108.815860; WU JY, 1990, PROG CLIN BIOL RES, V341, P643	40	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22719	10.1371/journal.pone.0022719	http://dx.doi.org/10.1371/journal.pone.0022719			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818372	gold, Green Published			2022-12-25	WOS:000293282700065
J	Mallet, P; Mourdi, N; Dubus, JC; Bavoux, F; Boyer-Gervoise, MJ; Jean-Pastor, MJ; Chalumeau, M				Mallet, Pauline; Mourdi, Nadjette; Dubus, Jean-Christophe; Bavoux, Francoise; Boyer-Gervoise, Marie-Jose; Jean-Pastor, Marie-Josephe; Chalumeau, Martin			Respiratory Paradoxical Adverse Drug Reactions Associated with Acetylcysteine and Carbocysteine Systemic Use in Paediatric Patients: A National Survey	PLOS ONE			English	Article							CHILDREN; INFANTS; FRANCE; LABEL	Objective: To report pediatric cases of paradoxical respiratory adverse drug reactions (ADRs) after exposure to oral mucolytic drugs (carbocysteine, acetylcysteine) that led to the withdrawal of licenses for these drugs for infants in France and then Italy. Design: The study followed the recommendations of the European guidelines of pharmacovigilance for medicines used in the paediatric population. Setting: Cases voluntarily reported by physicians from 1989 to 2008 were identified in the national French pharmacovigilance public database and in drug company databases. Patients: The definition of paradoxical respiratory ADRs was based on the literature. Exposure to mucolytic drugs was arbitrarily defined as having received mucolytic drugs for at least 2 days (> 200 mg) and at least until the day before the first signs of the suspected ADR. Results: The non-exclusive paradoxical respiratory ADRs reported in 59 paediatric patients (median age 5 months, range 3 weeks to 34 months, 98% younger than 2 years old) were increased bronchorrhea or mucus vomiting (n = 27), worsening of respiratory distress during respiratory tract infection (n = 35), dyspnoea (n = 18), cough aggravation or prolongation (n = 11), and bronchospasm (n = 1). Fifty-one (86%) children required hospitalization or extended hospitalization because of the ADR; one patient died of pulmonary oedema after mucus vomiting. Conclusion: Parents, physicians, pharmacists, and drug regulatory agencies should know that the benefit risk ratio of mucolytic drugs is at least null and most probably negative in infants according to available evidence.	[Mallet, Pauline; Chalumeau, Martin] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Dept Pediat, Paris, France; [Mallet, Pauline; Bavoux, Francoise] Univ Paris 05, Cochin St Vincent de Paul Hosp, AP HP, Reg Pharmacovigilance Ctr, Paris, France; [Mallet, Pauline; Bavoux, Francoise] Univ Paris 05, Cochin St Vincent de Paul Hosp, AP HP, Dept Clin Pharmacol, Paris, France; [Mourdi, Nadjette; Chalumeau, Martin] Hop St Vincent de Paul, Inserm U953, F-75674 Paris, France; [Dubus, Jean-Christophe] CHU Timone Enfants, CNRS URMITE 6236, Unite Pneumol & Med Infantile, Marseille, France; [Boyer-Gervoise, Marie-Jose; Jean-Pastor, Marie-Josephe] Salvator Hosp, Assistance Publ Hop Marseille, Reg Pharmacovigilance Ctr, Marseille, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Mallet, P (corresponding author), Univ Paris 05, Hop Necker Enfants Malad, AP HP, Dept Pediat, Paris, France.	martin.chalumeau@nck.aphp.fr	Dubus, Jean-Christophe/P-8242-2016; Chalumeau, Martin/F-4293-2017	Chalumeau, Martin/0000-0001-8175-3706				*AFSS, 2010, MED MUC MUC HEL CONT; *AFSS, DECL EFF IND SUC ETR; Begaud B, 2002, JAMA-J AM MED ASSOC, V288, P1588, DOI 10.1001/jama.288.13.1588; *BLOG PHARHAMSTER, AFSS INT MUC CHEZ MO; Bricks LF, 1996, REV SAUDE PUBL, V30, P527, DOI 10.1590/S0034-89101996000600006; Bucheler R, 2002, BRIT MED J, V324, P1311, DOI 10.1136/bmj.324.7349.1311; Cazzato T, 2001, EUR J CLIN PHARMACOL, V57, P611, DOI 10.1007/s002280100356; Chalumeau M, 2002, ARCH PEDIATRIE, V9, P1128, DOI 10.1016/S0929-693X(02)00091-X; Chalumeau M, 2000, ARCH DIS CHILD, V83, P502, DOI 10.1136/adc.83.6.502; COLLET JP, 1991, EUR J CLIN PHARMACOL, V41, P489, DOI 10.1007/BF00626376; *COMM MED PROD HUM, 2005, GUID COND PHARM MED; David M, 2010, ARCH PEDIATRIE, V17, P125, DOI 10.1016/j.arcped.2009.10.022; Duijvestijn Y C, 1997, Ned Tijdschr Geneeskd, V141, P826; Duijvestijn YCM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003124.pub3; HARRIS RL, 1967, J AMER MED ASSOC, V201, P953, DOI 10.1001/jama.201.12.953; *J OFF REP FRANC, 2005, ARR 28 AVR 2005 REL; JEAN R, 1982, EFFICACY EXPECTORATI; Kelly WN, 2007, PHARMACOEPIDEM DR S, V16, P581, DOI 10.1002/pds.1399; MEDICI TC, 1979, J INT MED RES, V7, P434, DOI 10.1177/030006057900700518; *MICR, 2010, DRUGD; Mourdi N, 2010, ARCH PEDIATRIE, V17, P735, DOI 10.1016/S0929-693X(10)70084-1; SANZ EJ, 1988, EUR J CLIN PHARMACOL, V34, P495, DOI 10.1007/BF01046708; WHO Multicentre Growth Reference Study Group, 2007, WHO CHILD GROWTH STA, DOI 10.1093/tropej/fmn002; Wohl M., 1998, KENDIGS DISORDERS RE, V5th, P19; 1987, ETUDE TOLERANCE CLIN; 2008, FDA RECOMMENDS OVER; 2009, DICT VIDAL 2010; 2000, ACETYLCYSTEINE AM HO, P472; 2000, ACETYLCYSTEINE DRUG, P677	29	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22792	10.1371/journal.pone.0022792	http://dx.doi.org/10.1371/journal.pone.0022792			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818391	Green Submitted, gold, Green Published			2022-12-25	WOS:000293282700077
J	Romano, A; Rubolini, D; Caprioli, M; Boncoraglio, G; Ambrosini, R; Saino, N				Romano, Andrea; Rubolini, Diego; Caprioli, Manuela; Boncoraglio, Giuseppe; Ambrosini, Roberto; Saino, Nicola			Sex-Related Effects of an Immune Challenge on Growth and Begging Behavior of Barn Swallow Nestlings	PLOS ONE			English	Article							FAULT-BARS; TRADE-OFFS; NATURAL-SELECTION; MOUTH COLORATION; BROOD SIZE; IMMUNOCOMPETENCE; NEED; SUSCEPTIBILITY; ACTIVATION; SIGNALS	Parent-offspring conflicts lead the offspring to evolve reliable signals of individual quality, including parasite burden, which may allow parents to adaptively modulate investment in the progeny. Sex-related variation in offspring reproductive value, however, may entail differential investment in sons and daughters. Here, we experimentally manipulated offspring condition in the barn swallow (Hirundo rustica) by subjecting nestlings to an immune challenge (injection with bacterial lipopolysaccharide, LPS) that simulates a bacterial infection, and assessed the effects on growth, feather quality, expression of morphological (gape coloration) and behavioral (posture) begging displays involved in parent-offspring communication, as well as on food allocation by parents. Compared to sham-injected controls, LPS-treated chicks suffered a depression of body mass and a reduction of palate color saturation. In addition, LPS treatment resulted in lower feather quality, with an increase in the occurrence of fault bars on wing feathers. The color of beak flanges, feather growth and the intensity of postural begging were affected by LPS treatment only in females, suggesting that chicks of either sex are differently susceptible to the immune challenge. However, irrespective of the effects of LPS, parents equally allocated food among control and challenged offspring both under normal food provisioning and after a short period of food deprivation of the chicks. These results indicate that bacterial infection and the associated immune response entail different costs to offspring of either sex, but a decrease in nestling conditions does not affect parental care allocation, possibly because the barn swallow adopts a brood-survival strategy. Finally, we showed that physiological stress induced by pathogens impairs plumage quality, a previously neglected major negative impact of bacterial infection which could severely affect fitness, particularly among long-distance migratory birds.	[Romano, Andrea; Rubolini, Diego; Caprioli, Manuela; Saino, Nicola] Univ Milan, Dipartimento Biol, Milan, Italy; [Boncoraglio, Giuseppe] Univ Cambridge, Dept Zool, Cambridge, England; [Ambrosini, Roberto] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy	University of Milan; University of Cambridge; University of Milano-Bicocca	Romano, A (corresponding author), Univ Milan, Dipartimento Biol, Milan, Italy.	andrea.romano@unimi.it	Romano, Andrea/A-2780-2017; Romano, Andrea/B-3930-2012; Rubolini, Diego/F-2851-2011; Ambrosini, Roberto/F-3188-2012	Romano, Andrea/0000-0002-0945-6018; Rubolini, Diego/0000-0003-2703-5783; Ambrosini, Roberto/0000-0002-7148-1468; Saino, Nicola/0000-0002-0230-3967	Universita degli Studi di Milano; Marie Curie Intra-European Fellowship [PIEF-GA-2009-252120]	Universita degli Studi di Milano; Marie Curie Intra-European Fellowship(European Commission)	Funding was provided by the Universita degli Studi di Milano. GB was funded by a Marie Curie Intra-European Fellowship PIEF-GA-2009-252120. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alvarez C, 2004, AM NAT, V164, P651, DOI 10.1086/424971; Armenta JK, 2008, J EXP BIOL, V211, P2423, DOI 10.1242/jeb.013094; Berthouly A, 2008, FUNCT ECOL, V22, P854, DOI 10.1111/j.1365-2435.2008.01439.x; Bertrand S, 2006, FUNCT ECOL, V20, P1022, DOI 10.1111/j.1365-2435.2006.01191.x; Bize P, 2005, FUNCT ECOL, V19, P405, DOI 10.1111/j.1365-2435.2005.00995.x; Bliese P. D., 2000, MULTILEVEL THEORY RE, P349; Boncoraglio G, 2008, J EVOLUTION BIOL, V21, P256, DOI 10.1111/j.1420-9101.2007.01441.x; Boncoraglio G, 2008, BEHAV ECOL SOCIOBIOL, V62, P729, DOI 10.1007/s00265-007-0498-8; Boncoraglio G, 2009, P ROY SOC B-BIOL SCI, V276, P2117, DOI 10.1098/rspb.2009.0085; Bonisoli-Alquati A, 2011, P ROY SOC B-BIOL SCI, V278, P1273, DOI 10.1098/rspb.2010.1741; Bonneaud C, 2003, AM NAT, V161, P367, DOI 10.1086/346134; BONSER RHC, 1995, CONDOR, V97, P590, DOI 10.2307/1369048; Brommer JE, 2004, P ROY SOC B-BIOL SCI, V271, pS110, DOI 10.1098/rsbl.2003.0103; Chin EH, 2005, J AVIAN BIOL, V36, P549, DOI 10.1111/j.0908-8857.2005.03496.x; Christe P, 1996, BEHAV ECOL, V7, P127, DOI 10.1093/beheco/7.2.127; Dai B., 2008, IME4 LINEAR MIXED EF; DesRochers DW, 2009, COMP BIOCHEM PHYS A, V152, P46, DOI 10.1016/j.cbpa.2008.08.034; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; Ewen JG, 2008, OECOLOGIA, V157, P361, DOI 10.1007/s00442-008-1073-3; Faivre B, 2003, SCIENCE, V300, P103, DOI 10.1126/science.1081802; Ferrari RP, 2006, J EVOLUTION BIOL, V19, P981, DOI 10.1111/j.1420-9101.2005.01030.x; GODFRAY HCJ, 1995, AM NAT, V146, P1, DOI 10.1086/285784; GODFRAY HCJ, 1995, NATURE, V376, P133, DOI 10.1038/376133a0; Gotmark F, 1997, P ROY SOC B-BIOL SCI, V264, P959, DOI 10.1098/rspb.1997.0132; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Hardy I.C.W, 2002, SEX RATIOS CONCEPTS; JENNI L, 1989, BIRD STUDY, V36, P1, DOI 10.1080/00063658909476996; Kilner R, 1997, P ROY SOC B-BIOL SCI, V264, P963, DOI 10.1098/rspb.1997.0133; Kilner R, 1997, TRENDS ECOL EVOL, V12, P11, DOI 10.1016/S0169-5347(96)10061-6; Lee KA, 2005, OECOLOGIA, V145, P244, DOI 10.1007/s00442-005-0113-5; Lessells CM, 2002, PHILOS T R SOC B, V357, P381, DOI 10.1098/rstb.2001.0928; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Loye J.E., 1991, BIRD PARASITE INTERA; MACHMER MM, 1992, ARDEA, V80, P261; Mock D. W., 1997, EVOLUTION SIBLING RI; Moller Anders Pape, 1997, P105; Moller AP, 2009, BIOL J LINN SOC, V97, P334, DOI 10.1111/j.1095-8312.2009.01204.x; Moller AP, 2000, AVIAN POULT BIOL REV, V11, P137; Moller AP., 1994, SEXUAL SELECTION BAR; Moreno-Rueda G, 2010, J EVOLUTION BIOL, V23, P2229, DOI 10.1111/j.1420-9101.2010.02090.x; Nager RG, 2000, BEHAV ECOL SOCIOBIOL, V48, P452, DOI 10.1007/s002650000262; Ottosson U, 1997, BEHAV ECOL SOCIOBIOL, V41, P381, DOI 10.1007/s002650050399; Owen-Ashley NT, 2007, J ORNITHOL, V148, pS583, DOI 10.1007/s10336-007-0197-2; Owen-Ashley NT, 2006, HORM BEHAV, V49, P15, DOI 10.1016/j.yhbeh.2005.04.009; Potti J, 1996, P ROY SOC B-BIOL SCI, V263, P9, DOI 10.1098/rspb.1996.0002; REDONDO T, 1992, ETHOLOGY, V92, P193; Riddle O, 1908, BIOL BULL-US, V14, P328, DOI 10.2307/1535869; Romero LM, 2005, COMP BIOCHEM PHYS A, V142, P65, DOI 10.1016/j.cbpa.2005.07.014; Royle NJ, 2002, TRENDS ECOL EVOL, V17, P434, DOI 10.1016/S0169-5347(02)02565-X; Saino N, 2003, BEHAV ECOL, V14, P16, DOI 10.1093/beheco/14.1.16; Saino N, 2000, P ROY SOC B-BIOL SCI, V267, P57, DOI 10.1098/rspb.2000.0966; Saino N, 2000, AM NAT, V156, P637, DOI 10.1086/316996; Saino N, 2008, EVOL ECOL, V22, P659, DOI 10.1007/s10682-007-9189-1; Saino N, 2008, ANIM BEHAV, V75, P1375, DOI 10.1016/j.anbehav.2007.09.011; Sarasola JH, 2006, J AVIAN BIOL, V37, P29, DOI 10.1111/j.2006.0908-8857.03693.x; Schielzeth H, 2009, BEHAV ECOL, V20, P416, DOI 10.1093/beheco/arn145; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; SLAGSVOLD T, 1982, ORNIS SCAND, V13, P165, DOI 10.2307/3676294; Soler JJ, 2003, P ROY SOC B-BIOL SCI, V270, P241, DOI 10.1098/rspb.2002.2217; Stearns S.C., 1992, pi; Swaddle JP, 1996, J AVIAN BIOL, V27, P103, DOI 10.2307/3677139; TRIVERS RL, 1974, AM ZOOL, V14, P249; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Tschirren B, 2003, J ANIM ECOL, V72, P839, DOI 10.1046/j.1365-2656.2003.00755.x; Wright J, 2002, EVOLUTION BEGGING; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006; Zuur Alain F., 2009, P1	67	37	37	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22805	10.1371/journal.pone.0022805	http://dx.doi.org/10.1371/journal.pone.0022805			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818393	Green Published, Green Submitted, gold			2022-12-25	WOS:000293282700078
J	Sun, Y; Wang, F; Li, S				Sun, Yan; Wang, Fei; Li, Shu			Higher Height, Higher Ability: Judgment Confidence as a Function of Spatial Height Perception	PLOS ONE			English	Article							SPACE; MIND	Based on grounded cognition theories, the current study showed that judgments about ability were regulated by the subjects' perceptions of their spatial height. In Experiment 1, we found that after seeing the ground from a higher rather than lower floor, people had higher expectations about their performance on a knowledge test and assigned themselves higher rank positions in a peer comparison evaluation. In Experiment 2, we examined the boundary conditions of the spatial height effects and showed that it could still occur even if we employed photos rather than actual building floors to manipulate the perceptions of spatial heights. In addition, Experiment 2 excluded processing style as an explanation for these observations. In Experiment 3, we investigated a potential mechanism for the spatial height effect by manipulating the scale direction in the questionnaire. Consequently, consistent with our representational dependence account, the effect of spatial heights on ability judgments was eliminated when the mental representation of ability was disturbed by a reverse physical representation. These results suggest that people's judgments about their ability are correlated with their spatial perception.	[Sun, Yan; Wang, Fei; Li, Shu] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Wang, Fei] Xiamen Univ, Sch Journalism & Commun, Xiamen, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Xiamen University	Sun, Y (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	suny@psych.ac.cn; lishu@psych.ac.cn		li, shu/0000-0003-4402-1674	National Basic Research Program of China (973 Program) [2011CB711000]; National Natural Science Foundation of China [70871110, 71001098]; Special Fund for Beijing Key Discipline Construction; IPCAS [Y0CX073S01]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Beijing Key Discipline Construction; IPCAS(Chinese Academy of Sciences)	This research was supported by the National Basic Research Program of China (973 Program, No. 2011CB711000), the National Natural Science Foundation of China (Nos. 70871110, 71001098), the Special Fund for Beijing Key Discipline Construction, and the Young Scientist Project of IPCAS (No. Y0CX073S01). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Boroditsky L, 2002, PSYCHOL SCI, V13, P185, DOI 10.1111/1467-9280.00434; Casasanto D, 2008, COGNITION, V106, P579, DOI 10.1016/j.cognition.2007.03.004; Casasanto D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011805; Ijzerman H, 2010, J EXP SOC PSYCHOL, V46, P867, DOI 10.1016/j.jesp.2010.07.015; Judge TA, 2004, J APPL PSYCHOL, V89, P428, DOI 10.1037/0021-9010.89.3.428; Lakoff G., 2003, METAPHORS WE LIVE; Lakoff George., 1999, PHILOS FLESH EMBODIE; Landau MJ, 2010, PSYCHOL BULL, V136, P1045, DOI 10.1037/a0020970; Meier BP, 2007, J PERS SOC PSYCHOL, V93, P699, DOI 10.1037/0022-3514.93.5.699; Moore DA, 2008, PSYCHOL REV, V115, P502, DOI 10.1037/0033-295X.115.2.502; Proffitt DR, 2006, CURR DIR PSYCHOL SCI, V15, P131, DOI 10.1111/j.0963-7214.2006.00422.x; Sanna LJ, 2011, J EXP SOC PSYCHOL, V47, P472, DOI 10.1016/j.jesp.2010.12.013; Schubert TW, 2005, J PERS SOC PSYCHOL, V89, P1, DOI 10.1037/0022-3514.89.1.1; Semin GR, 2008, EMBODIED GROUNDING: SOCIAL, COGNITIVE, AFFECTIVE, AND NEUROSCIENTIFIC APPROACHES, P1; SUN Y, J BEHAV DEC IN PRESS; Sun Y, 2010, JUDGM DECIS MAK, V5, P151; Williams LE, 2008, SCIENCE, V322, P606, DOI 10.1126/science.1162548; WILSON PR, 1968, J SOC PSYCHOL, V74, P97, DOI 10.1080/00224545.1968.9919806; Young TJ, 1996, PERCEPT MOTOR SKILL, V82, P1002, DOI 10.1177/003151259608200301; Zhong CB, 2008, PSYCHOL SCI, V19, P838, DOI 10.1111/j.1467-9280.2008.02165.x; Zhong CB, 2006, SCIENCE, V313, P1451, DOI 10.1126/science.1130726	23	10	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22125	10.1371/journal.pone.0022125	http://dx.doi.org/10.1371/journal.pone.0022125			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	799JJ	21818299	Green Submitted, Green Published, gold			2022-12-25	WOS:000293282700016
J	Zhang, PJ; Zhu, XY; Huang, F; Liu, Y; Zhang, JM; Lu, YB; Ruan, YM				Zhang, Pengjun; Zhu, Xiaoyun; Huang, Fang; Liu, Yong; Zhang, Jinming; Lu, Yaobin; Ruan, Yongming			Suppression of Jasmonic Acid-Dependent Defense in Cotton Plant by the Mealybug Phenacoccus solenopsis	PLOS ONE			English	Article							SALICYLIC-ACID; GOSSYPIUM-HIRSUTUM; INDUCED RESISTANCE; INVASIVE PEST; APHID; ARABIDOPSIS; RESPONSES; TOMATO; ACCUMULATION; EXPRESSION	The solenopsis mealybug, Phenacoccus solenopsis, has been recently recognized as an aggressively invasive pest in China, and is now becoming a serious threat to the cotton industry in the country. Thus, it is necessary to investigate the molecular mechanisms employed by cotton for defending against P. solenopsis before the pest populations reach epidemic levels. Here, we examined the effects of exogenous jasmonic acid (JA), salicylic acid (SA), and herbivory treatments on feeding behavior and on development of female P. solenopsis. Further, we compared the volatile emissions of cotton plants upon JA, SA, and herbivory treatments, as well as the time-related changes in gossypol production and defense-related genes. Female adult P. solenopsis were repelled by leaves from JA-treated plant, but were not repelled by leaves from SA-treated plants. In contrast, females were attracted by leaves from plants pre-infested by P. solenopsis. The diverse feeding responses by P. solenopsis were due to the difference in volatile emission of plants from different treatments. Furthermore, we show that JA-treated plants slowed P. solenopsis development, but plants pre-infested by P. solenopsis accelerated its development. We also show that P. solenopsis feeding inhibited the JA-regulated gossypol production, and prevented the induction of JA-related genes. We conclude that P. solenopsis is able to prevent the activation of JA-dependent defenses associated with basal resistance to mealybugs.	[Zhang, Pengjun; Zhu, Xiaoyun; Huang, Fang; Liu, Yong; Zhang, Jinming; Lu, Yaobin] Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Inst Plant Protect & Microbiol, Hangzhou, Zhejiang, Peoples R China; [Zhu, Xiaoyun] Nanjing Agr Univ, Dept Plant Protect, Nanjing, Peoples R China; [Ruan, Yongming] Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua, Peoples R China	Zhejiang Academy of Agricultural Sciences; Nanjing Agricultural University; Zhejiang Normal University	Zhang, PJ (corresponding author), Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Inst Plant Protect & Microbiol, Hangzhou, Zhejiang, Peoples R China.	Luybcn@163.com			Special Fund for Agro-scientific Research in the Public Interest of China [201103026, 200803025]; Zhejiang Provincial Natural Science Foundation of China [R3100692]; Science and Technology Project of Zhejiang Province [2010C32064]; ZAAS	Special Fund for Agro-scientific Research in the Public Interest of China; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Science and Technology Project of Zhejiang Province; ZAAS	This study was funded by Special Fund for Agro-scientific Research in the Public Interest of China (201103026; 200803025), Zhejiang Provincial Natural Science Foundation of China under Grant No. R3100692, Science and Technology Project of Zhejiang Province (2010C32064), and International Cooperation Project of ZAAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas Ghulam, 2005, Pakistan Entomologist, V27, P83; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; BELL E, 1995, P NATL ACAD SCI USA, V92, P8675, DOI 10.1073/pnas.92.19.8675; Bruinsma M, 2007, J CHEM ECOL, V33, P655, DOI 10.1007/s10886-006-9245-2; Charleston K, 2010, BEATSHEET; Cooper WR, 2005, ENTOMOL EXP APPL, V115, P107, DOI 10.1111/j.1570-7458.2005.00289.x; de Ilarduya OM, 2003, MOL PLANT MICROBE IN, V16, P699, DOI 10.1094/MPMI.2003.16.8.699; Dicke M, 1999, J CHEM ECOL, V25, P1907, DOI 10.1023/A:1020942102181; Du L, 2004, J ECON ENTOMOL, V97, P1278, DOI 10.1603/0022-0493-97.4.1278; Dutt U., 2007, MEALY BUG INFESTATIO; Ellis C, 2002, MOL PLANT MICROBE IN, V15, P1025, DOI 10.1094/MPMI.2002.15.10.1025; Fidantsef AL, 1999, PHYSIOL MOL PLANT P, V54, P97, DOI 10.1006/pmpp.1998.0192; Hodgson C, 2008, ZOOTAXA, P1; Hudspeth RL, 1996, PLANT MOL BIOL, V31, P911, DOI 10.1007/BF00019478; Kempema LA, 2007, PLANT PHYSIOL, V143, P849, DOI 10.1104/pp.106.090662; Li Q, 2006, MOL PLANT MICROBE IN, V19, P655, DOI 10.1094/MPMI-19-0655; Li Y, 2008, NEW PHYTOL, V179, P185, DOI 10.1111/j.1469-8137.2008.02443.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marmey P, 2007, PLANT PHYSIOL BIOCH, V45, P596, DOI 10.1016/j.plaphy.2007.05.002; Mewis I, 2005, PLANT PHYSIOL, V138, P1149, DOI 10.1104/pp.104.053389; Mohase L, 2002, J PLANT PHYSIOL, V159, P585, DOI 10.1078/0176-1617-0633; Moran PJ, 2001, PLANT PHYSIOL, V125, P1074, DOI 10.1104/pp.125.2.1074; Muhammad A., 2007, MEALYBUG COTTON CROP; Muhammad Yousuf, 2007, Pakistan Entomologist, V29, P49; Nagrare VS, 2009, B ENTOMOL RES, V99, P537, DOI 10.1017/S0007485308006573; Opitz S, 2008, J CHEM ECOL, V34, P508, DOI 10.1007/s10886-008-9453-z; Pegadaraju V, 2005, PLANT PHYSIOL, V139, P1927, DOI 10.1104/pp.105.070433; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; STIPANOVIC RD, 1988, J AGR FOOD CHEM, V36, P509, DOI 10.1021/jf00081a026; Thaler JS, 1999, ENVIRON ENTOMOL, V28, P30, DOI 10.1093/ee/28.1.30; Thaler JS, 1999, NATURE, V399, P686, DOI 10.1038/21420; Thompson GA, 2006, J EXP BOT, V57, P755, DOI 10.1093/jxb/erj135; Tinsley J.B., 1898, CAN ENTOMOL, V30, P47, DOI [DOI 10.4039/ENT3047-2, 10.4039/Ent3047-2]; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; Wang Yan-Ping, 2009, Chinese Bulletin of Entomology, V46, P101; Wang YP, 2010, AGR FOREST ENTOMOL, V12, P403, DOI 10.1111/j.1461-9563.2010.00490.x; Williams D., 1992, MEALYBUGS CENTRAL S; Wu San-An, 2009, Chinese Bulletin of Entomology, V46, P159; Zarate SI, 2007, PLANT PHYSIOL, V143, P866, DOI 10.1104/pp.106.090035; Zhang PJ, 2008, OECOLOGIA, V157, P83, DOI 10.1007/s00442-008-1060-8; Zhang PJ, 2009, P NATL ACAD SCI USA, V106, P21202, DOI 10.1073/pnas.0907890106; Zhen XH, 2004, J PLANT PHYSIOL, V161, P1367, DOI 10.1016/j.jplph.2004.04.007; Zhu-Salzman K, 2004, PLANT PHYSIOL, V134, P420, DOI 10.1104/pp.103.028324; Zhu-Salzman Keyan, 2005, Insect Science, V12, P3, DOI 10.1111/j.1672-9609.2005.00002.x	44	38	44	5	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22378	10.1371/journal.pone.0022378	http://dx.doi.org/10.1371/journal.pone.0022378			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818315	Green Published, Green Submitted, gold			2022-12-25	WOS:000293282700026
J	Martinez, JM; Poulton, NJ; Stepanauskas, R; Sieracki, ME; Wilson, WH				Martinez, Joaquin Martinez; Poulton, Nicole J.; Stepanauskas, Ramunas; Sieracki, Michael E.; Wilson, William H.			Targeted Sorting of Single Virus-Infected Cells of the Coccolithophore Emiliania huxleyi	PLOS ONE			English	Article							VIRAL-INFECTION; FLOW-CYTOMETRY; ALGAL VIRUS; PHYTOPLANKTON; AMPLIFICATION; DEATH	Discriminating infected from healthy cells is the first step to understanding the mechanisms and ecological implications of viral infection. We have developed a method for detecting, sorting, and performing molecular analysis of individual, infected cells of the important microalga Emiliania huxleyi, based on known physiological responses to viral infection. Of three fluorescent dyes tested, FM 1-43 (for detecting membrane blebbing) gave the most unequivocal and earliest separation of cells. Furthermore, we were able to amplify the genomes of single infected cells using Multiple Displacement Amplification. This novel method to reliably discriminate infected from healthy cells in cultures will allow researchers to answer numerous questions regarding the mechanisms and implications of viral infection of E. huxleyi. The method may be transferable to other virus-host systems.	[Martinez, Joaquin Martinez; Poulton, Nicole J.; Stepanauskas, Ramunas; Sieracki, Michael E.; Wilson, William H.] Bigelow Lab Ocean Sci, W Boothbay Harbor, ME USA	Bigelow Laboratory for Ocean Sciences	Martinez, JM (corresponding author), Bigelow Lab Ocean Sci, W Boothbay Harbor, ME USA.	jmartinez@bigelow.org; wwilson@bigelow.org		Sieracki, Michael/0000-0001-7959-1832; Poulton, Nicole/0000-0003-3020-4509; Stepanauskas, Ramunas/0000-0003-4458-3108	National Science Foundation [EF-0723730, OCE-821374, OCE-1019242, EF-0633142, MCB-738232]	National Science Foundation(National Science Foundation (NSF))	This research was supported by National Science Foundation grants EF-0723730 to WHW, OCE-821374, OCE-1019242, EF-0633142 and MCB-738232 to RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Bidle KD, 2004, NAT REV MICROBIOL, V2, P643, DOI 10.1038/nrmicro956; BRATBAK G, 1993, MAR ECOL PROG SER, V93, P39, DOI 10.3354/meps093039; Brown CM, 2006, J MAR BIOL ASSOC UK, V86, P491, DOI 10.1017/S0025315406013397; Brussaard CPD, 2004, APPL ENVIRON MICROB, V70, P1506, DOI 10.1128/AEM.70.3.1506-1513.2004; Brussaard CPD, 2001, AQUAT MICROB ECOL, V26, P157, DOI 10.3354/ame026157; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Evans C, 2006, J PHYCOL, V42, P1040, DOI 10.1111/j.1529-8817.2006.00256.x; Guillard R.R., 1975, CULTURE MARINE INVER, P29, DOI 10.1007/978-1-4615-8714-9_3.; HOLLIGAN PM, 1993, GLOBAL BIOGEOCHEM CY, V7, P879, DOI 10.1029/93GB01731; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Lane N, 2008, NATURE, V453, P583, DOI 10.1038/453583a; Mackinder LCM, 2009, J GEN VIROL, V90, P2306, DOI 10.1099/vir.0.011635-0; Marie D, 1999, CURRENT PROTOCOLS CY; Martinez JM, 2007, APPL ENVIRON MICROB, V73, P554, DOI 10.1128/AEM.00864-06; Raghunathan A, 2005, APPL ENVIRON MICROB, V71, P3342, DOI 10.1128/AEM.71.6.3342-3347.2005; SALIN ML, 1988, PHYSIOL PLANTARUM, V72, P681, DOI 10.1111/j.1399-3054.1988.tb09182.x; Schroeder DC, 2005, J PHYCOL, V41, P874, DOI 10.1111/j.1529-8817.2005.04188.x; Schroeder DC, 2002, ARCH VIROL, V147, P1685, DOI 10.1007/s00705-002-0841-3; SEATON GGR, 1995, PLANT PHYSIOL, V108, P1431, DOI 10.1104/pp.108.4.1431; Simo R, 2001, TRENDS ECOL EVOL, V16, P287, DOI 10.1016/S0169-5347(01)02152-8; SOGIN ML, 1987, ANN NY ACAD SCI, V503, P125, DOI 10.1111/j.1749-6632.1987.tb40603.x; Stepanauskas R, 2007, P NATL ACAD SCI USA, V104, P9052, DOI 10.1073/pnas.0700496104; SUTTLE CA, 1992, MAR ECOL PROG SER, V87, P105, DOI 10.3354/meps087105; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; VANETTEN JL, 1991, MICROBIOL REV, V55, P586, DOI 10.1128/MMBR.55.4.586-620.1991; Wilson WH, 2005, SCIENCE, V309, P1090, DOI 10.1126/science.1113109; Wilson WH, 2002, J MAR BIOL ASSOC UK, V82, P369, DOI 10.1017/S002531540200560X; Wommack KE, 2010, MANUAL AQUATIC VIRAL, P110; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214	30	18	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e22520	10.1371/journal.pone.0022520	http://dx.doi.org/10.1371/journal.pone.0022520			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21818332	Green Submitted, Green Published, gold			2022-12-25	WOS:000293175100031
J	Frieden, BR; Gatenby, RA				Frieden, B. Roy; Gatenby, Robert A.			Information Dynamics in Living Systems: Prokaryotes, Eukaryotes, and Cancer	PLOS ONE			English	Article							BREAST-CANCER; SCREENING-PROGRAM	Background: Living systems use information and energy to maintain stable entropy while far from thermodynamic equilibrium. The underlying first principles have not been established. Findings: We propose that stable entropy in living systems, in the absence of thermodynamic equilibrium, requires an information extremum (maximum or minimum), which is invariant to first order perturbations. Proliferation and death represent key feedback mechanisms that promote stability even in a non-equilibrium state. A system moves to low or high information depending on its energy status, as the benefit of information in maintaining and increasing order is balanced against its energy cost. Prokaryotes, which lack specialized energy-producing organelles (mitochondria), are energy-limited and constrained to an information minimum. Acquisition of mitochondria is viewed as a critical evolutionary step that, by allowing eukaryotes to achieve a sufficiently high energy state, permitted a phase transition to an information maximum. This state, in contrast to the prokaryote minima, allowed evolution of complex, multicellular organisms. A special case is a malignant cell, which is modeled as a phase transition from a maximum to minimum information state. The minimum leads to a predicted power-law governing the in situ growth that is confirmed by studies measuring growth of small breast cancers. Conclusions: We find living systems achieve a stable entropic state by maintaining an extreme level of information. The evolutionary divergence of prokaryotes and eukaryotes resulted from acquisition of specialized energy organelles that allowed transition from information minima to maxima, respectively. Carcinogenesis represents a reverse transition: of an information maximum to minimum. The progressive information loss is evident in accumulating mutations, disordered morphology, and functional decline characteristics of human cancers. The findings suggest energy restriction is a critical first step that triggers the genetic mutations that drive somatic evolution of the malignant phenotype.	[Frieden, B. Roy] Univ Arizona, Coll Opt Sci, Tucson, AZ 85721 USA; [Gatenby, Robert A.] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Radiol, Tampa, FL 33682 USA; [Gatenby, Robert A.] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Integrated Math Oncol, Tampa, FL 33682 USA	University of Arizona; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Frieden, BR (corresponding author), Univ Arizona, Coll Opt Sci, Tucson, AZ 85721 USA.	robert.gatenby@moffitt.org			National Cancer Institute [1U54CA143970-01]; NATIONAL CANCER INSTITUTE [U54CA143970] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by the National Cancer Institute grant 1U54CA143970-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURHENNE LJW, 1992, AM J ROENTGENOL, V158, P45, DOI 10.2214/ajr.158.1.1307850; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; DEKONING HJ, 1995, INT J CANCER, V60, P777, DOI 10.1002/ijc.2910600608; DEPRIT A, 1966, ASTRON J, V71, P94, DOI 10.1086/109861; FAGERBERG G, 1985, ACTA ONCOL, V24, P465, DOI 10.3109/02841868509134418; Fisher R.A., 1922, PHILOS T ROYAL SOC A, V222, P309, DOI [10.1098/rsta.1922.0009, DOI 10.1098/RSTA.1922.0009]; Frank SA, 2009, J EVOLUTION BIOL, V22, P231, DOI 10.1111/j.1420-9101.2008.01647.x; Frieden BR, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.066117; Frieden BR, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.036101; Frieden BR, 2001, J THEOR BIOL, V208, P49, DOI 10.1006/jtbi.2000.2199; Frieden BR, 2004, SCI FISHER INFORM; FRIEDEN BR, 2007, EXPLORATORY DATA ANA, P1; FRIEDEN BR, 2001, PROBABILITY STAT OPT; Gatenby RA, 2004, MUTAT RES-FUND MOL M, V568, P259, DOI 10.1016/j.mrfmmm.2004.04.018; Gatenby RA, 2002, CANCER RES, V62, P3675; Gatenby RA, 2008, NAT REV CANCER, V8, P56, DOI 10.1038/nrc2255; Gatenby RA, 2007, B MATH BIOL, V69, P635, DOI 10.1007/s11538-006-9141-5; Gatenby RA, 2010, NAT REV CANCER, V10, P526, DOI 10.1038/nrc2892; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hart D, 1998, BRIT J CANCER, V78, P382, DOI 10.1038/bjc.1998.503; HAYES W, 1993, MLH DELBRUCK BIOGRAP, V62; Isidoro A, 2005, CARCINOGENESIS, V26, P2095, DOI 10.1093/carcin/bgi188; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486; Loeb LA, 2010, SEMIN CANCER BIOL, V20, P279, DOI 10.1016/j.semcancer.2010.10.006; PEER PGM, 1994, J NATL CANCER I, V86, P436, DOI 10.1093/jnci/86.6.436; Rao C.R, 1973, LINEAR STAT INFERENC, V2; Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490; TABAR L, 1992, RADIOL CLIN N AM, V30, P187; THOMAS BA, 1984, RECENT RES CANCER, V90, P195; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309	32	31	33	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22085	10.1371/journal.pone.0022085	http://dx.doi.org/10.1371/journal.pone.0022085			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21818295	Green Published, gold, Green Submitted			2022-12-25	WOS:000292929500038
J	Zhu, G; Wang, Y; Huang, B; Liang, J; Ding, Y; Xu, A; Wu, W				Zhu, G.; Wang, Y.; Huang, B.; Liang, J.; Ding, Y.; Xu, A.; Wu, W.			A Rac1/PAK1 cascade controls beta-catenin activation in colon cancer cells	ONCOGENE			English	Article						colon cancer; beta-catenin; PAK1; Rac1; phosphorylation	WNT SIGNALING PATHWAY; COLORECTAL-CANCER; PHOSPHORYLATION; PAK; EXPRESSION; KINASES; RAC1; LOCALIZATION; PROGRESSION; INHIBITION	P21-activated kinase 1 (PAK1) is associated with colon cancer progression and metastasis, whereas the molecular mechanism remains elusive. Here, we show that down-regulation of PAK1 in colon cancer cells reduces total beta-catenin level, as well as cell proliferation. Mechanistically, PAK1 directly phosphorylates beta-catenin proteins at Ser675 site and this leads to more stable and transcriptional active beta-catenin. Corroborating these results, PAK1 is required for full Wnt signaling, and superactivation of beta-catenin is achieved by simultaneous knockdown of adenomatous polyposis coli protein and activation of PAK1. Moreover, we show that Rac1 functions upstream of PAK1 in colon cancer cells and contributes to beta-catenin phosphorylation and accumulation. We conclude that a Rac1/PAK1 cascade controls beta-catenin S675 phosphorylation and full activation in colon cancer cells. Supporting this conclusion, overexpression of PAK1 is observed in 70% of colon cancer samples and is correlated with massive beta-catenin accumulation. Oncogene (2012) 31, 1001-1012; doi:10.1038/onc.2011.294; published online 8 August 2011	[Zhu, G.; Wang, Y.; Huang, B.; Liang, J.; Ding, Y.; Wu, W.] Tsinghua Univ, Prot Sci Lab, Minist Educ, Sch Life Sci, Beijing 100084, Peoples R China; [Xu, A.] Beijing Friendship Hosp, Beijing, Peoples R China	Tsinghua University; Capital Medical University	Wu, W (corresponding author), Tsinghua Univ, Prot Sci Lab, Minist Educ, Sch Life Sci, Qinghuayuan 1, Beijing 100084, Peoples R China.	wwu@mail.tsinghua.edu.cn			National Natural Science Foundation of China [30730048, 30921004]; Major Science Programs of China [2006CB943402, 2011CB943803]; Tsinghua University [2010THZ0]; Bayer Healthcare	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Science Programs of China; Tsinghua University; Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals)	We thank Drs Ye-Guang Chen, Jonathan Chernoff, Raymond Habas, Alan Hall, Tianhui Hu, Edward Leof, Chaojun Li, Randy Moon, Christof Niehrs, Roel Nusse and Thomas Rudel for reagents. This work was supported by grants to WW from the National Natural Science Foundation of China (No. 30730048, 30921004), the Major Science Programs of China (2006CB943402, 2011CB943803), Tsinghua University Initiative Scientific Research Program (2010THZ0) and Bayer Healthcare.	Anderson CB, 2002, P NATL ACAD SCI USA, V99, P8683, DOI 10.1073/pnas.122235399; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Balasenthil S, 2004, J BIOL CHEM, V279, P1422, DOI 10.1074/jbc.M309937200; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Bikkavilli RK, 2008, J CELL SCI, V121, P234, DOI 10.1242/jcs.021964; Billin AN, 2000, MOL CELL BIOL, V20, P6882, DOI 10.1128/MCB.20.18.6882-6890.2000; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Carter JH, 2004, CLIN CANCER RES, V10, P3448, DOI 10.1158/1078-0432.CCR-03-0210; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Esufali S, 2004, ONCOGENE, V23, P8260, DOI 10.1038/sj.onc.1208007; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Galisteo ML, 1996, J BIOL CHEM, V271, P20997, DOI 10.1074/jbc.271.35.20997; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; He H, 2008, BBA-MOL CELL RES, V1783, P1943, DOI 10.1016/j.bbamcr.2008.04.016; Hendriksen J, 2008, J CELL SCI, V121, P1793, DOI 10.1242/jcs.025536; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Huynh N, 2010, BBA-MOL CELL RES, V1803, P1106, DOI 10.1016/j.bbamcr.2010.05.007; Ilyas M, 1997, P NATL ACAD SCI USA, V94, P10330, DOI 10.1073/pnas.94.19.10330; Jacobs T, 2007, J NEUROSCI, V27, P8604, DOI 10.1523/JNEUROSCI.0765-07.2007; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Lee SH, 2007, CANCER RES, V67, P11045, DOI 10.1158/0008-5472.CAN-07-0986; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu WG, 1997, CURR BIOL, V7, P85, DOI 10.1016/S0960-9822(06)00052-2; Lu ZM, 2004, CELL CYCLE, V3, P571; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Molli PR, 2009, ONCOGENE, V28, P2545, DOI 10.1038/onc.2009.119; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Nheu T, 2004, CELL CYCLE, V3, P71; Phelps RA, 2009, CELL, V137, P623, DOI 10.1016/j.cell.2009.02.037; Polakis P, 2000, GENE DEV, V14, P1837; Polakis P, 2002, CURR BIOL, V12, pR499, DOI 10.1016/S0960-9822(02)00969-7; Rennefahrt UEE, 2007, J BIOL CHEM, V282, P15667, DOI 10.1074/jbc.M700253200; Rong R, 2004, ONCOGENE, V23, P8447, DOI 10.1038/sj.onc.1207794; Segditsas S, 2008, EXP MOL PATHOL, V85, P201, DOI 10.1016/j.yexmp.2008.09.006; Sun J, 2009, ONCOGENE, V28, P3132, DOI 10.1038/onc.2009.167; Tang Y, 1997, MOL CELL BIOL, V17, P4454, DOI 10.1128/MCB.17.8.4454; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Valentini AM, 2003, CURR PHARM DESIGN, V9, P1932, DOI 10.2174/1381612033454216; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Wang RA, 2002, EMBO J, V21, P5437, DOI 10.1093/emboj/cdf543; Wang Y, 2010, J BIOL CHEM, V285, P10890, DOI 10.1074/jbc.M109.058347; Wang Z, 2010, ONCOGENE, V29, P3362, DOI 10.1038/onc.2010.95; Wells CM, 2010, BIOCHEM J, V425, P465, DOI 10.1042/BJ20091173; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Xiao GH, 2002, J BIOL CHEM, V277, P883, DOI 10.1074/jbc.C100553200; Xing Y, 2004, MOL CELL, V15, P523, DOI 10.1016/j.molcel.2004.08.001	54	153	159	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2012	31	8					1001	1012		10.1038/onc.2011.294	http://dx.doi.org/10.1038/onc.2011.294			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	898BG	21822311				2022-12-25	WOS:000300709700006
J	Wu, K; Yan, H; Fang, L; Wang, XJ; Pfleger, C; Jiang, XJ; Huang, L; Pan, ZQ				Wu, Kenneth; Yan, Hua; Fang, Lei; Wang, Xinjiang; Pfleger, Cathie; Jiang, Xuejun; Huang, Lan; Pan, Zhen-Qiang			Mono-ubiquitination Drives Nuclear Export of the Human DCN1-like Protein hDCNL1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL CONTROL; CULLIN NEDDYLATION; C-TERMINUS; LIGASE; NEDD8; SCF; CONJUGATION; COMPLEX; ACTIVATION; DOMAIN	Conjugation of Nedd8 to a cullin protein, termed neddylation, is an evolutionarily conserved process that functions to activate the cullin-RING family E3 ubiquitin ligases, leading to increased proteasomal degradation of a wide range of substrate proteins. Recent emerging evidence demonstrates that cellular neddylation requires the action of Dcn1, which, in humans, consists of five homologues designated as hDCNL1-5. Here we revealed a previously unknown mechanism that regulates hDCNL1. In cultured mammalian cells ectopically expressed hDCNL1 was mono-ubiquitinated predominantly at K143, K149, and K171. Using a classical chromatographic purification strategy, we identified Nedd4-1 as an E3 ligase that can catalyze mono-ubiquitination of hDCNL1 in a reconstituted ubiquitination system. In addition, the hDCNL1 N-terminal ubiquitin-binding domain is necessary and sufficient to mediate mono-ubiquitination. Finally, fluorescence microscopic and subcellular fractionation analyses revealed a role for mono-ubiquitination in driving nuclear export of hDCNL1. Taken together, these results suggest a mono-ubiquitination-mediated mechanism that governs nuclear-cytoplasmic trafficking of hDCNL1, thereby regulating hDCNL1-dependent activation of the cullin-RING E3 ubiquitin ligases in selected cellular compartments.	[Wu, Kenneth; Yan, Hua; Pfleger, Cathie; Pan, Zhen-Qiang] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Fang, Lei; Huang, Lan] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Fang, Lei; Huang, Lan] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Wang, Xinjiang; Jiang, Xuejun] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA	Icahn School of Medicine at Mount Sinai; University of California System; University of California Irvine; University of California System; University of California Irvine; Memorial Sloan Kettering Cancer Center	Pan, ZQ (corresponding author), Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA.	zhen-qiang.pan@mssm.edu	Yan, Hua/E-5305-2011; Huang, Lan/C-3618-2011	Fang, Lei/0000-0002-2582-4845	NIH-NCI [1 R24 CA095823-01]; NSF [DBI-9724504]; Public Health Service [CA140451, GM74830, GM61051, CA095634]; NCI, National Institutes of Health; American Cancer Society [ACS-RSG-07-081-01-MGO-01]; Geoffrey Beene Cancer Research fund; NATIONAL CANCER INSTITUTE [R01CA095634, R24CA095823, R01CA140451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074830, R01GM061051] Funding Source: NIH RePORTER	NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NSF(National Science Foundation (NSF)); Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Geoffrey Beene Cancer Research fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Hurwitz for regents. Fluorescent microscopy was performed at the MSSM-Microscopy Shared Research Facility, supported with funding from NIH-NCI shared resources grant (1 R24 CA095823-01) and NSF major research instrumentation grant (DBI-9724504).; This study was supported by Public Health Service Grants CA140451 (to C. P.), GM74830 (to L. H.), as well as GM61051 and CA095634 (to Z.-Q. P.). This work was also supported by a post-doctoral training grant from NCI, National Institutes of Health (to K. W.) and by American Cancer Society Fund (ACS-RSG-07-081-01-MGO-01) and Geoffrey Beene Cancer Research fund (to X. J.).	Anan T, 1998, GENES CELLS, V3, P751, DOI 10.1046/j.1365-2443.1998.00227.x; Boh BK, 2011, J MOL BIOL, V409, P136, DOI 10.1016/j.jmb.2011.03.023; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Dharmasiri S, 2003, EMBO J, V22, P1762, DOI 10.1093/emboj/cdg190; Dias DC, 2002, P NATL ACAD SCI USA, V99, P16601, DOI 10.1073/pnas.252646399; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Fang L, 2008, J PROTEOME RES, V7, P4914, DOI 10.1021/pr800574c; French ME, 2009, J BIOL CHEM, V284, P12071, DOI 10.1074/jbc.M901106200; Huang DT, 2004, ONCOGENE, V23, P1958, DOI 10.1038/sj.onc.1207393; Huang GC, 2011, J BIOL CHEM, V286, P10297, DOI 10.1074/jbc.M110.203729; Jones J, 2008, J PROTEOME RES, V7, P1274, DOI 10.1021/pr700749v; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kamura T, 1999, GENE DEV, V13, P2928, DOI 10.1101/gad.13.22.2928; Kurz T, 2005, NATURE, V435, P1257, DOI 10.1038/nature03662; Kurz T, 2008, MOL CELL, V29, P23, DOI 10.1016/j.molcel.2007.12.012; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Ma T, 2008, CANCER SCI, V99, P2128, DOI 10.1111/j.1349-7006.2008.00929.x; Meyer-Schaller N, 2009, P NATL ACAD SCI USA, V106, P12365, DOI 10.1073/pnas.0812528106; Morimoto M, 2003, BIOCHEM BIOPH RES CO, V301, P392, DOI 10.1016/S0006-291X(02)03051-6; Ogunjimi AA, 2010, J BIOL CHEM, V285, P6308, DOI 10.1074/jbc.M109.044537; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Sarkaria I, 2006, CANCER RES, V66, P9437, DOI 10.1158/0008-5472.CAN-06-2074; Scott DC, 2010, MOL CELL, V39, P784, DOI 10.1016/j.molcel.2010.08.030; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Sorokin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1439, DOI 10.1134/S0006297907130032; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; Villa C, 2009, EUR J NEUROL, V16, P870, DOI 10.1111/j.1468-1331.2009.02611.x; Wang XJ, 2008, BIOCHEM J, V414, P221, DOI 10.1042/BJ20080674; Woelk T, 2006, NAT CELL BIOL, V8, P1246, DOI 10.1038/ncb1484; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200; Wu K, 2002, J BIOL CHEM, V277, P516, DOI 10.1074/jbc.M108008200; Wu K, 2003, J BIOL CHEM, V278, P28882, DOI 10.1074/jbc.M302888200; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Yamoah K, 2008, P NATL ACAD SCI USA, V105, P12230, DOI 10.1073/pnas.0806155105; Yang XY, 2007, J BIOL CHEM, V282, P24490, DOI 10.1074/jbc.C700038200	40	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34060	34070		10.1074/jbc.M111.273045	http://dx.doi.org/10.1074/jbc.M111.273045			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21813641	Green Published, hybrid			2022-12-25	WOS:000295159200038
J	Nagase, L; Murata-Kamiya, N; Hatakeyama, M				Nagase, Lisa; Murata-Kamiya, Naoko; Hatakeyama, Masanori			Potentiation of Helicobacter pylori CagA Protein Virulence through Homodimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHATASE; PHOSPHORYLATION SITES; BIOLOGICAL-ACTIVITY; ONCOGENIC DRIVER; KINASE; CELLS; DIVERSITY; ACTIVATION; POLARITY; CANCER	Chronic infection with Helicobacter pylori cagA-positive strains is associated with atrophic gastritis, peptic ulceration, and gastric carcinoma. The cagA gene product, CagA, is delivered into gastric epithelial cells via type IV secretion, where it undergoes tyrosine phosphorylation at the EPIYA motifs. Tyrosine-phosphorylated CagA binds and aberrantly activates the oncogenic tyrosine phosphatase SHP2, which mediates induction of elongated cell morphology (hummingbird phenotype) that reflects CagA virulence. CagA also binds and inhibits the polarity-regulating kinase partitioning-defective 1 (PAR1)/microtubule affinity-regulating kinase (MARK) via the CagA multimerization (CM) sequence independently of tyrosine phosphorylation. Because PAR1 exists as a homodimer, two CagA proteins appear to be passively dimerized through complex formation with a PAR1 dimer in cells. Interestingly, a CagA mutant that lacks the CM sequence displays a reduced SHP2 binding activity and exhibits an attenuated ability to induce the hummingbird phenotype, indicating that the CagA-PAR1 interaction also influences the morphological transformation. Here we investigated the role of CagA dimerization in induction of the hummingbird phenotype with the use of a chemical dimerizer, coumermycin. We found that CagA dimerization markedly stabilizes the CagA-SHP2 complex and thereby potentiates SHP2 deregulation, causing an increase in the number of hummingbird cells. Protrusions of hummingbird cells induced by chemical dimerization of CagA are further elongated by simultaneous inhibition of PAR1. This study revealed a role of the CM sequence in amplifying the magnitude of SHP2 deregulation by CagA, which, in conjunction with the CM sequence-mediated inhibition of PAR1, evokes morphological transformation that reflects in vivo CagA virulence.	[Nagase, Lisa; Murata-Kamiya, Naoko; Hatakeyama, Masanori] Univ Tokyo, Div Microbiol, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Hatakeyama, M (corresponding author), Univ Tokyo, Div Microbiol, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	mhata@m.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Grants-in-Aid for Scientific Research [22240085, 22114001, 22114002] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for scientific research on innovative areas from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Argent RH, 2004, GASTROENTEROLOGY, V127, P514, DOI 10.1053/j.gastro.2004.06.006; Argent RH, 2008, J MED MICROBIOL, V57, P1062, DOI 10.1099/jmm.0.2008/001818-0; Azuma T, 2004, J INFECT DIS, V189, P820, DOI 10.1086/381782; Backert S, 2005, TRENDS MICROBIOL, V13, P476, DOI 10.1016/j.tim.2005.08.002; Basso D, 2008, GASTROENTEROLOGY, V135, P91, DOI 10.1053/j.gastro.2008.03.041; Batista SA, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-61; Ebneth A, 1999, CELL MOTIL CYTOSKEL, V44, P209, DOI 10.1002/(SICI)1097-0169(199911)44:3<209::AID-CM6>3.0.CO;2-4; Farrar MA, 2000, J BIOL CHEM, V275, P31318, DOI 10.1074/jbc.M003399200; Farrar MA, 1996, NATURE, V383, P178, DOI 10.1038/383178a0; GILBERT EJ, 1994, MOL MICROBIOL, V12, P365, DOI 10.1111/j.1365-2958.1994.tb01026.x; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Hatakeyama M, 2008, ONCOGENE, V27, P7047, DOI 10.1038/onc.2008.353; Hatakeyama M, 2011, CANCER SCI, V102, P36, DOI 10.1111/j.1349-7006.2010.01743.x; Higashi H, 2005, J BIOL CHEM, V280, P23130, DOI 10.1074/jbc.M503583200; Higashi H, 2002, P NATL ACAD SCI USA, V99, P14428, DOI 10.1073/pnas.222375399; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Higuchi M, 2004, CANCER SCI, V95, P442, DOI 10.1111/j.1349-7006.2004.tb03229.x; Li X, 1998, J EXP MED, V188, P1385, DOI 10.1084/jem.188.7.1385; Lu HS, 2008, CANCER SCI, V99, P2004, DOI 10.1111/j.1349-7006.2008.00950.x; Lu HS, 2009, J BIOL CHEM, V284, P23024, DOI 10.1074/jbc.M109.001008; Miura M, 2009, INT J CANCER, V125, P2497, DOI 10.1002/ijc.24740; Mizuguchi R, 1998, J BIOL CHEM, V273, P32297, DOI 10.1074/jbc.273.48.32297; Mohi MG, 2007, CURR OPIN GENET DEV, V17, P23, DOI 10.1016/j.gde.2006.12.011; Mohi MG, 1998, MOL BIOL CELL, V9, P3299, DOI 10.1091/mbc.9.12.3299; Murata-Kamiya N, 2010, CELL HOST MICROBE, V7, P399, DOI 10.1016/j.chom.2010.04.005; Naito M, 2006, GASTROENTEROLOGY, V130, P1181, DOI 10.1053/j.gastro.2005.12.038; Nesic D, 2010, NAT STRUCT MOL BIOL, V17, P130, DOI 10.1038/nsmb.1705; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; Ren SM, 2006, J BIOL CHEM, V281, P32344, DOI 10.1074/jbc.M606172200; Saadat I, 2007, NATURE, V447, P330, DOI 10.1038/nature05765; Saito Y, 2010, J EXP MED, V207, P2157, DOI 10.1084/jem.20100602; Schmidt HMA, 2009, HELICOBACTER, V14, P256, DOI 10.1111/j.1523-5378.2009.00684.x; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Takahashi A, 2011, MOL CELL, V43, P45, DOI 10.1016/j.molcel.2011.05.014; Tartaglia M, 2005, EUR J MED GENET, V48, P81, DOI 10.1016/j.ejmg.2005.03.001; Tegtmeyer N, 2011, FEBS J, V278, P1190, DOI 10.1111/j.1742-4658.2011.08035.x; Tsutsumi R, 2006, MOL CELL BIOL, V26, P261, DOI 10.1128/MCB.26.1.261-276.2006; Wen SC, 2009, CANCER LETT, V282, P1, DOI 10.1016/j.canlet.2008.11.016	39	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33622	33631		10.1074/jbc.M111.258673	http://dx.doi.org/10.1074/jbc.M111.258673			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21813645	Green Published, hybrid			2022-12-25	WOS:000294968800078
J	Johnson, C; Kannan, TR; Baseman, JB				Johnson, Coreen; Kannan, T. R.; Baseman, Joel B.			Cellular Vacuoles Induced by Mycoplasma pneumoniae CARDS Toxin Originate from Rab9-Associated Compartments	PLOS ONE			English	Article							HELICOBACTER-PYLORI VACA; TRANS-GOLGI; VACUOLATING CYTOTOXIN; PHAGOSOME MATURATION; BINDING-PROTEIN; ORGAN-CULTURE; RAB GTPASES; CELLS; ENDOSOMES; REPLICATION	Recently, we identified an ADP-ribosylating and vacuolating cytotoxin in Mycoplasma pneumoniae designated Community Acquired Respiratory Distress Syndrome (CARDS) toxin. In this study we show that vacuoles induced by recombinant CARDS (rCARDS) toxin are acidic and derive from the endocytic pathway as determined by the uptake of neutral red and the fluid-phase marker, Lucifer yellow, respectively. Also, we demonstrate that the formation of rCARDS toxin-associated cytoplasmic vacuoles is inhibited by the vacuolar ATPase inhibitor, bafilomycin A1, and the ionophore, monensin. To examine the ontogeny of these vacuoles, we analyzed the distribution of endosomal and lysosomal membrane markers during vacuole formation and observed the enrichment of the late endosomal GTPase, Rab9, around rCARDS toxin-induced vacuoles. Immunogold-labeled Rab9 and overexpression of green fluorescent-tagged Rab9 further confirmed vacuolar association. The late endosomal-and lysosomal-associated membrane proteins, LAMP1 and LAMP2, also localized to the vacuolar membranes, while the late endosomal protein, Rab7, and early endosomal markers, Rab5 and EEA1, were excluded. HeLa cells expressing dominant-negative (DN) Rab9 exhibited markedly reduced vacuole formation in the presence of rCARDS toxin, in contrast to cells expressing DN-Rab7, highlighting the importance of Rab9 function in rCARDS toxin-induced vacuolation. Our findings reveal the unique Rab9-association with rCARDS toxin-induced vacuoles and its possible relationship to the characteristic histopathology that accompanies M. pneumoniae infection.	[Johnson, Coreen; Kannan, T. R.; Baseman, Joel B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Johnson, C (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA.	baseman@uthsca.edu			National Institute of Allergy and Infectious Diseases [U19AI070412]; The Kleberg Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070412] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); The Kleberg Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by an award number U19AI070412 from the National Institute of Allergy and Infectious Diseases and The Kleberg Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; Baseman J B, 1993, Subcell Biochem, V20, P243; BASEMAN JB, 1982, J BACTERIOL, V151, P1514, DOI 10.1128/JB.151.3.1514-1522.1982; BASEMAN JB, 1995, MICROB PATHOGENESIS, V19, P105, DOI 10.1006/mpat.1995.0050; Baseman JB, 1996, AM J RESP CRIT CARE, V154, pS137, DOI 10.1164/ajrccm/154.4_Pt_2.S137; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Brurnell JH, 2007, MICROBIOL MOL BIOL R, V71, P636, DOI 10.1128/MMBR.00023-07; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; BURGESS TL, 1987, ANNU REV CELL BIOL, V3, P243, DOI 10.1146/annurev.cellbio.3.1.243; CATRENICH CE, 1992, J MED MICROBIOL, V37, P389, DOI 10.1099/00222615-37-6-389; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; CLAGUE MJ, 1994, J BIOL CHEM, V269, P21; Cognet I, 2003, J IMMUNOL METHODS, V272, P199, DOI 10.1016/S0022-1759(02)00506-9; COHEN G, 1967, ANN NY ACAD SCI, V143, P85, DOI 10.1111/j.1749-6632.1967.tb27648.x; COLLIER AM, 1971, P SOC EXP BIOL MED, V136, P569, DOI 10.3181/00379727-136-35313; Cover TL, 2005, NAT REV MICROBIOL, V3, P320, DOI 10.1038/nrmicro1095; COVER TL, 1991, INFECT IMMUN, V59, P1264, DOI 10.1128/IAI.59.4.1264-1270.1991; COVER TL, 1992, J BIOL CHEM, V267, P10570; COVER TL, 1992, HUM PATHOL, V23, P1004, DOI 10.1016/0046-8177(92)90261-Z; Dallo SF, 2000, MICROB PATHOGENESIS, V29, P301, DOI 10.1006/mpat.2000.0395; Dallo SF, 2002, MOL MICROBIOL, V46, P1041, DOI 10.1046/j.1365-2958.2002.03207.x; DEBERNARD M, 1995, J BIOL CHEM, V270, P23937, DOI 10.1074/jbc.270.41.23937; DEBRABANDER M, 1988, CELL MOTIL CYTOSKEL, V9, P30, DOI 10.1002/cm.970090105; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; GRUENBERG J, 1989, ANNU REV CELL BIOL, V5, P453; Hardy RD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007562; HU PC, 1975, INFECT IMMUN, V11, P704, DOI 10.1128/IAI.11.4.704-710.1975; HU PC, 1976, INFECT IMMUN, V14, P217, DOI 10.1128/IAI.14.1.217-224.1976; Kannan TR, 2006, P NATL ACAD SCI USA, V103, P6724, DOI 10.1073/pnas.0510644103; Kannan TR, 2005, INFECT IMMUN, V73, P2828, DOI 10.1128/IAI.73.5.2828-2834.2005; Kraft M, 1998, AM J RESP CRIT CARE, V158, P998, DOI 10.1164/ajrccm.158.3.9711092; Krause DC, 2004, MOL MICROBIOL, V51, P917, DOI 10.1046/j.1365-2958.2003.03899.x; Li Y, 2004, MOL BIOL CELL, V15, P1946, DOI 10.1091/mbc.e03-08-0618; LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; MERESSE S, 1995, J CELL SCI, V108, P3349; MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z; Morinaga N, 2007, INFECT IMMUN, V75, P488, DOI 10.1128/IAI.01336-06; MUIR MT, 2010, CHEST; MURPHY GF, 1980, VIRCHOWS ARCH A, V389, P93, DOI 10.1007/BF00428670; Murray JL, 2005, J VIROL, V79, P11742, DOI 10.1128/JVI.79.18.11742-11751.2005; Papini E, 1997, EMBO J, V16, P15, DOI 10.1093/emboj/16.1.15; PAPINI E, 1994, P NATL ACAD SCI USA, V91, P9720, DOI 10.1073/pnas.91.21.9720; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; RIEDERER MA, 1994, J CELL BIOL, V125, P573, DOI 10.1083/jcb.125.3.573; RIEZMAN H, 1985, CELL, V40, P1001, DOI 10.1016/0092-8674(85)90360-5; Rohrer J, 1996, J CELL BIOL, V132, P565, DOI 10.1083/jcb.132.4.565; Sandvig K, 2000, EMBO J, V19, P5943, DOI 10.1093/emboj/19.22.5943; SEGGEV JS, 1986, ANN ALLERGY, V57, P263; Smith AC, 2007, J CELL BIOL, V176, P263, DOI 10.1083/jcb.200611056; Smith DC, 2006, TRAFFIC, V7, P379, DOI 10.1111/j.1600-0854.2006.00391.x; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Techasaensiri C, 2010, AM J RESP CRIT CARE, V182, P797, DOI 10.1164/rccm.201001-0080OC; Terebiznik MR, 2006, INFECT IMMUN, V74, P6599, DOI 10.1128/IAI.01085-06; Via LE, 1997, J BIOL CHEM, V272, P13326, DOI 10.1074/jbc.272.20.13326; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004	56	27	31	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22877	10.1371/journal.pone.0022877	http://dx.doi.org/10.1371/journal.pone.0022877			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829543	gold, Green Published, Green Submitted			2022-12-25	WOS:000293286500043
J	Khong, FL; Zhang, Y; Edgley, AJ; Qi, WE; Connelly, KA; Woodman, OL; Krum, H; Kelly, DJ				Khong, Fay Lin; Zhang, Yuan; Edgley, Amanda J.; Qi, Weier; Connelly, Kim A.; Woodman, Owen L.; Krum, Henry; Kelly, Darren J.			3 ',4 '-Dihydroxyflavonol Antioxidant Attenuates Diastolic Dysfunction and Cardiac Remodeling in Streptozotocin-Induced Diabetic m(Ren2)27 Rats	PLOS ONE			English	Article							TAIL-CUFF METHOD; HEART-FAILURE; OXIDATIVE STRESS; NADPH OXIDASE; SUPEROXIDE-DISMUTASE; EJECTION FRACTION; THIOREDOXIN; CARDIOMYOPATHY; COMPLICATIONS; MECHANISMS	Background: Diabetic cardiomyopathy (DCM) is an increasingly recognized cause of chronic heart failure amongst diabetic patients. Both increased reactive oxygen species (ROS) generation and impaired ROS scavenging have been implicated in the pathogenesis of hyperglycemia-induced left ventricular dysfunction, cardiac fibrosis, apoptosis and hypertrophy. We hypothesized that 3',4'-dihydroxyflavonol (DiOHF), a small highly lipid soluble synthetic flavonol, may prevent DCM by scavenging ROS, thus preventing ROS-induced cardiac damage. Methodology/Principal Findings: Six week old homozygous Ren-2 rats were randomized to receive either streptozotocin or citrate buffer, then further randomized to receive either DiOHF (1 mg/kg/day) by oral gavage or vehicle for six weeks. Cardiac function was assessed via echocardiography and left ventricular cardiac catheterization before the animals were sacrificed and hearts removed for histological and molecular analyses. Diabetic Ren-2 rats showed evidence of diastolic dysfunction with prolonged deceleration time, reduced E/A ratio, and increased slope of end-diastolic pressure volume relationship (EDPVR) in association with marked interstitial fibrosis and oxidative stress (all P<0.05 vs control Ren-2). Treatment with DiOHF prevented the development of diastolic dysfunction and was associated with reduced oxidative stress and interstitial fibrosis (all P<0.05 vs untreated diabetic Ren-2 rats). In contrast, few changes were seen in nondiabetic treated animals compared to untreated counterparts. Conclusions: Inhibition of ROS production and action by DiOHF improved diastolic function and reduced myocyte hypertrophy as well as collagen deposition. These findings suggest the potential clinical utility of antioxidative compounds such as flavonols in the prevention of diabetes-associated cardiac dysfunction.	[Khong, Fay Lin; Zhang, Yuan; Edgley, Amanda J.; Qi, Weier; Connelly, Kim A.; Kelly, Darren J.] Univ Melbourne, Dept Med, St Vincents Hosp Fitzroy, Melbourne, Vic, Australia; [Kelly, Darren J.] St Vincents Hosp Fitzroy, St Vincents Inst Med Res, Melbourne, Vic, Australia; [Woodman, Owen L.] Univ Bundoora, Sch Med Sci, Royal Melbourne Inst Technol, Melbourne, Vic, Australia; [Connelly, Kim A.] St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [Krum, Henry] Monash Univ, Dept Epidemiol & Prevent Med, Fac Med Nursing & Hlth Sci, Ctr Cardiovasc Res & Educ CCRE Therapeut, Melbourne, Vic 3004, Australia; [Krum, Henry] Monash Univ, Dept Med, Fac Med Nursing & Hlth Sci, Ctr Cardiovasc Res & Educ CCRE Therapeut, Melbourne, Vic 3004, Australia	St Vincent's Hospital Melbourne; University of Melbourne; St Vincent's Hospital Melbourne; St. Vincent's Institute of Medical Research; Royal Melbourne Institute of Technology (RMIT); University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Monash University; Monash University	Khong, FL (corresponding author), Univ Melbourne, Dept Med, St Vincents Hosp Fitzroy, Melbourne, Vic, Australia.	dkelly@medstv.unimelb.edu.au	Connelly, Kim A/S-5160-2017; Woodman, Owen L/H-7297-2019	Connelly, Kim A/0000-0002-1031-3137; Woodman, Owen L/0000-0003-3759-1396; Edgley, Amanda/0000-0001-9672-4836; Kelly, Darren/0000-0003-4850-3929	Melbourne International Research Scholarship; Melbourne International Fee Remission Scholarship	Melbourne International Research Scholarship; Melbourne International Fee Remission Scholarship	FL Khong is a recipient of Melbourne International Research Scholarship and Melbourne International Fee Remission Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani A, 2009, J AM SOC NEPHROL, V20, P730, DOI 10.1681/ASN.2008020142; Ago T, 2006, J MOL CELL CARDIOL, V41, P762, DOI 10.1016/j.yjmcc.2006.08.006; Aliciguzel Y, 2003, J LAB CLIN MED, V142, P172, DOI 10.1016/S0022-2143(03)00110-0; Alvarez B, 2004, FREE RADICAL BIO MED, V37, P813, DOI 10.1016/j.freeradbiomed.2004.06.006; Beckman JA, 2003, AM J PHYSIOL-HEART C, V285, pH2392, DOI 10.1152/ajpheart.00403.2003; Bell DSH, 2003, DIABETES CARE, V26, P2433, DOI 10.2337/diacare.26.8.2433; Bollano E, 2007, INT J CARDIOL, V114, P195, DOI 10.1016/j.ijcard.2006.01.027; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; BUNAG RD, 1973, J APPL PHYSIOL, V34, P279, DOI 10.1152/jappl.1973.34.2.279; Burda S, 2001, J AGR FOOD CHEM, V49, P2774, DOI 10.1021/jf001413m; Burns AT, 2007, ECHOCARDIOGR-J CARD, V24, P697, DOI 10.1111/j.1540-8175.2007.00466.x; Ceriello A, 2003, DIABETES CARE, V26, P1589, DOI 10.2337/diacare.26.5.1589; Chen JQ, 2009, AM J PHYSIOL-ENDOC M, V296, pE1133, DOI 10.1152/ajpendo.90944.2008; Connelly KA, 2007, CARDIOVASC RES, V76, P280, DOI 10.1016/j.cardiores.2007.06.022; Connelly KA, 2009, CIRC-HEART FAIL, V2, P129, DOI 10.1161/CIRCHEARTFAILURE.108.765750; Dhalla NS, 1998, CARDIOVASC RES, V40, P239, DOI 10.1016/S0008-6363(98)00186-2; Dworakowski R, 2006, BIOCHEM SOC T, V34, P960, DOI 10.1042/BST0340960; Fang ZY, 2004, ENDOCR REV, V25, P543, DOI 10.1210/er.2003-0012; Fang ZY, 2003, J AM COLL CARDIOL, V41, P611, DOI 10.1016/S0735-1097(02)02869-3; Francis G, 2001, HEART, V85, P247, DOI 10.1136/heart.85.3.247; Galderisi M, 2006, J AM COLL CARDIOL, V48, P1548, DOI 10.1016/j.jacc.2006.07.033; Giacchetti G, 2005, TRENDS ENDOCRIN MET, V16, P120, DOI 10.1016/j.tem.2005.02.003; Gilbert RE, 2006, CLIN J AM SOC NEPHRO, V1, P193, DOI 10.2215/CJN.00540705; Grassi D, 2009, CURR PHARM DESIGN, V15, P1072, DOI 10.2174/138161209787846982; Hayat SA, 2004, CLIN SCI, V107, P539, DOI 10.1042/CS20040057; Heymes C, 2003, J AM COLL CARDIOL, V41, P2164, DOI 10.1016/S0735-1097(03)00471-6; KANNEL WB, 1979, CIRCULATION, V59, P8, DOI 10.1161/01.CIR.59.1.8; Kawasaki D, 2007, CIRC J, V71, P524, DOI 10.1253/circj.71.524; KOMAJDA M, 2010, CIRC HEART IN PRESS; Limaye PV, 2003, MOL CELL BIOCHEM, V243, P147, DOI 10.1023/A:1021620414979; LOPEZ B, 2001, HYPERTENSION, V38; MacDonald MR, 2008, EUR HEART J, V29, P1377, DOI 10.1093/eurheartj/ehn153; Martos R, 2007, CIRCULATION, V115, P888, DOI 10.1161/CIRCULATIONAHA.106.638569; Massie BM, 2008, NEW ENGL J MED, V359, P2456, DOI 10.1056/NEJMoa0805450; Maurer MS, 2004, J AM COLL CARDIOL, V44, P1543, DOI 10.1016/j.jacc.2004.07.034; Murdoch CE, 2006, CURR OPIN PHARMACOL, V6, P148, DOI 10.1016/j.coph.2005.10.008; Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418; Ommen SR, 2000, CIRCULATION, V102, P1788; Pacher P, 2006, CURR OPIN PHARMACOL, V6, P136, DOI 10.1016/j.coph.2006.01.001; PFEFFER JM, 1971, J LAB CLIN MED, V78, P957; Pietta PG, 2000, J NAT PROD, V63, P1035, DOI 10.1021/np9904509; Poirier P, 2001, DIABETES CARE, V24, P5, DOI 10.2337/diacare.24.1.5; Privratsky JR, 2003, HYPERTENSION, V42, P206, DOI 10.1161/01.HYP.0000082814.62655.85; Qi W, 2007, AM J PATHOL, V171, P744, DOI 10.2353/ajpath.2007.060813; RUBLER S, 1972, AM J CARDIOL, V30, P595, DOI 10.1016/0002-9149(72)90595-4; Schulze PC, 2004, J BIOL CHEM, V279, P30369, DOI 10.1074/jbc.M400549200; Semeniuk LM, 2002, AM J PHYSIOL-HEART C, V283, pH976, DOI 10.1152/ajpheart.00088.2002; Tan SM, 2010, AM J PHYSIOL-HEART C, V298, pH1415, DOI 10.1152/ajpheart.01048.2009; TAN SM, 2010, NEPHROL DIA IN PRESS; van Heerebeek L, 2006, CIRCULATION, V113, P1966, DOI 10.1161/CIRCULATIONAHA.105.587519; van Heerebeek L, 2008, CIRCULATION, V117, P43, DOI 10.1161/CIRCULATIONAHA.107.728550; Wang S, 2004, BRIT J PHARMACOL, V142, P443, DOI 10.1038/sj.bjp.0705815; White V, 2010, FREE RADICAL RES, V44, P1407, DOI 10.3109/10715762.2010.512039; Wold LE, 2005, ACTA PHARMACOL SIN, V26, P908, DOI 10.1111/j.1745-7254.2005.00146.x; Woodman OL, 2004, CLIN EXP PHARMACOL P, V31, P786, DOI 10.1111/j.1440-1681.2004.04072.x; Xia ZY, 2006, EUR J PHARMACOL, V544, P118, DOI 10.1016/j.ejphar.2006.06.033; YAMAKURA F, BIOCH BIOPHYSICA ACT, V1804, P318; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7	58	20	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22777	10.1371/journal.pone.0022777	http://dx.doi.org/10.1371/journal.pone.0022777			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829510	Green Published, gold			2022-12-25	WOS:000293284600044
J	Ghosh, A; Manrique-Hoyos, N; Voigt, A; Schulz, JB; Kreutzfeldt, M; Merkler, D; Simons, M				Ghosh, Aniket; Manrique-Hoyos, Natalia; Voigt, Aaron; Schulz, Joerg B.; Kreutzfeldt, Mario; Merkler, Doron; Simons, Mikael			Targeted Ablation of Oligodendrocytes Triggers Axonal Damage	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; MOUSE MODEL; NEURODEGENERATIVE DISEASE; DEFECTIVE GLIA; CELL-DEATH; DEMYELINATION; DROSOPHILA; MYELIN; REMYELINATION	Glial dysfunction has been implicated in a number of neurodegenerative diseases. In this study we investigated the consequences of glial and oligodendrocyte ablation on neuronal integrity and survival in Drosophila and adult mice, respectively. Targeted genetic ablation of glia was achieved in the adult Drosophila nervous system using the GAL80-GAL4 system. In mice, oligodendrocytes were depleted by the injection of diphtheria toxin in MOGi-Cre/iDTR double transgenic animals. Acute depletion of oligodendrocytes induced axonal injury, but did not cause neuronal cell death in mice. Ablation of glia in adult flies triggered neuronal apoptosis and resulted in a marked reduction in motor performance and lifespan. Our study shows that the targeted depletion of glia triggers secondary neurotoxicity and underscores the central contribution of glia to neuronal homeostasis. The models used in this study provide valuable systems for the investigation of therapeutic strategies to prevent axonal or neuronal damage.	[Ghosh, Aniket; Manrique-Hoyos, Natalia; Simons, Mikael] Max Planck Inst Expt Med, D-37075 Gottingen, Germany; [Simons, Mikael] Univ Gottingen, Dept Neurol, D-37075 Gottingen, Germany; [Voigt, Aaron; Schulz, Joerg B.] Rhein Westfal TH Aachen, Sch Med, Aachen, Germany; [Kreutzfeldt, Mario; Merkler, Doron] Univ Gottingen, Dept Neuropathol, Univ Med Ctr, Gottingen, Germany; [Kreutzfeldt, Mario; Merkler, Doron] Univ Hosp Geneva, Div Clin Pathol, Dept Pathol & Immunol, Geneva Fac Med, Geneva, Switzerland; [Voigt, Aaron; Schulz, Joerg B.] Univ Hosp, Dept Neurol, Aachen, Germany; [Voigt, Aaron; Schulz, Joerg B.] Univ Hosp, JARA Brain, Aachen, Germany	Max Planck Society; University of Gottingen; RWTH Aachen University; University of Gottingen; University of Geneva; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital	Ghosh, A (corresponding author), Max Planck Inst Expt Med, Hermann Rein Str 3, D-37075 Gottingen, Germany.	msimons@gwdg.de	Merkler, Doron/N-9157-2016; Schulz, Jörg B/D-9786-2012	Merkler, Doron/0000-0002-0247-2007; Schulz, Jörg B/0000-0002-8903-0593; Manrique Hoyos, Natalia/0000-0002-2478-7456; Ghosh, Aniket/0000-0002-3771-6390; Simons, Mikael/0000-0001-5329-192X; Kreutzfeldt, Mario/0000-0003-0335-2733	ERC [204034]	ERC(European Research Council (ERC)European Commission)	Funding was provided by an ERC Starging Grant "Myelin'' No 204034 (http://erc.europa.eu/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas O, 2007, ARCH NEUROL-CHICAGO, V64, P185, DOI 10.1001/archneur.64.2.185; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Booth GE, 2000, DEVELOPMENT, V127, P237; BRAND AH, 1993, DEVELOPMENT, V118, P401; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; BUCHANAN RL, 1993, NEURON, V10, P839, DOI 10.1016/0896-6273(93)90200-B; Colodner KJ, 2010, J NEUROSCI, V30, P16102, DOI 10.1523/JNEUROSCI.2491-10.2010; Edenfeld G, 2005, CURR OPIN NEUROBIOL, V15, P34, DOI 10.1016/j.conb.2005.01.007; Edgar JM, 2010, EMBO MOL MED, V2, P42, DOI 10.1002/emmm.200900057; Edwards TN, 2010, PROG NEUROBIOL, V90, P471, DOI 10.1016/j.pneurobio.2010.01.001; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Griffiths I, 1998, SCIENCE, V280, P1610, DOI 10.1126/science.280.5369.1610; Harrington EP, 2010, ANN NEUROL, V68, P703, DOI 10.1002/ana.22090; HIDALGO A, 2010, GLIA; Hiremath MM, 1998, J NEUROIMMUNOL, V92, P38, DOI 10.1016/S0165-5728(98)00168-4; Hovelmeyer N, 2005, J IMMUNOL, V175, P5875, DOI 10.4049/jimmunol.175.9.5875; Howell OW, 2010, J NEUROPATH EXP NEUR, V69, P1017, DOI 10.1097/NEN.0b013e3181f3a5b1; Inagaki HK, 2010, NAT PROTOC, V5, P20, DOI 10.1038/nprot.2009.196; Kassmann CM, 2007, NAT GENET, V39, P969, DOI 10.1038/ng2070; Kiryu-Seo S, 2010, J NEUROSCI, V30, P6658, DOI 10.1523/JNEUROSCI.5265-09.2010; Kuhlmann T, 2002, BRAIN, V125, P2202, DOI 10.1093/brain/awf235; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Lassmann H, 2010, EXP NEUROL, V225, P2, DOI 10.1016/j.expneurol.2009.10.009; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; Lucchinetti CF, 2005, NEUROL CLIN, V23, P77, DOI 10.1016/j.ncl.2004.09.002; Magliozzi R, 2010, ANN NEUROL, V68, P477, DOI 10.1002/ana.22230; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Mason JL, 2001, NEUROPATH APPL NEURO, V27, P50, DOI 10.1046/j.0305-1846.2001.00301.x; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Merkler D, 2005, NMR BIOMED, V18, P395, DOI 10.1002/nbm.972; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Pereira JA, 2010, J NEUROSCI, V30, P6763, DOI 10.1523/JNEUROSCI.0801-10.2010; Piaton G, 2010, J NEUROCHEM, V114, P1243, DOI 10.1111/j.1471-4159.2010.06831.x; Pohl HBF, 2011, J NEUROSCI, V31, P1069, DOI 10.1523/JNEUROSCI.5035-10.2011; Sepp KJ, 2001, DEV BIOL, V238, P47, DOI 10.1006/dbio.2001.0411; Shin JY, 2005, J CELL BIOL, V171, P1001, DOI 10.1083/jcb.200508072; Simons M, 2006, J CELL SCI, V119, P4381, DOI 10.1242/jcs.03242; Stirling DP, 2010, TRENDS MOL MED, V16, P160, DOI 10.1016/j.molmed.2010.02.002; Taveggia C, 2010, NAT REV NEUROL, V6, P276, DOI 10.1038/nrneurol.2010.37; Traka M, 2010, BRAIN, V133, P3017, DOI 10.1093/brain/awq247; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Waxman SG, 2008, NAT CLIN PRACT NEURO, V4, P159, DOI 10.1038/ncpneuro0735; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; Wilkins A, 2010, J NEUROPATH EXP NEUR, V69, P1256, DOI 10.1097/NEN.0b013e3181ffc317; XIONG WC, 1995, NEURON, V14, P581, DOI 10.1016/0896-6273(95)90314-3; Yazawa I, 2005, NEURON, V45, P847, DOI 10.1016/j.neuron.2005.01.032; Yin XH, 1998, J NEUROSCI, V18, P1953, DOI 10.1523/jneurosci.18-06-01953.1998; Zoller I, 2008, J NEUROSCI, V28, P9741, DOI 10.1523/JNEUROSCI.0458-08.2008	51	40	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22735	10.1371/journal.pone.0022735	http://dx.doi.org/10.1371/journal.pone.0022735			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818378	gold, Green Submitted, Green Published			2022-12-25	WOS:000293282700068
J	Karama, S; Armony, J; Beauregard, M				Karama, Sherif; Armony, Jorge; Beauregard, Mario			Film Excerpts Shown to Specifically Elicit Various Affects Lead to Overlapping Activation Foci in a Large Set of Symmetrical Brain Regions in Males	PLOS ONE			English	Article							SELF-INDUCED SADNESS; FUNCTIONAL NEUROANATOMY; FACIAL EXPRESSIONS; PREFRONTAL CORTEX; BASIC EMOTIONS; FMRI; METAANALYSIS; MODULATION; IMITATION; HAPPINESS	While the limbic system theory continues to be part of common scientific parlance, its validity has been questioned on multiple grounds. Nonetheless, the issue of whether or not there exists a set of brain areas preferentially dedicated to emotional processing remains central within affective neuroscience. Recently, a widespread neural reference space for emotion which includes limbic as well as other regions was characterized in a large meta-analysis. As methodologically heterogeneous studies go into such meta-analyses, showing in an individual study in which all parameters are kept constant, the involvement of overlapping areas for various emotion conditions in keeping with the neural reference space for emotion, would serve as valuable confirmatory evidence. Here, using fMRI, 20 young adult men were scanned while viewing validated neutral and effective emotion-eliciting short film excerpts shown to quickly and specifically elicit disgust, amusement, or sexual arousal. Each emotion-specific run included, in random order, multiple neutral and emotion condition blocks. A stringent conjunction analysis revealed a large overlap across emotion conditions that fit remarkably well with the neural reference space for emotion. This overlap included symmetrical bilateral activation of the medial prefrontal cortex, the anterior cingulate, the temporo-occipital junction, the basal ganglia, the brainstem, the amygdala, the hippocampus, the thalamus, the subthalamic nucleus, the posterior hypothalamus, the cerebellum, as well as the frontal operculum extending towards the anterior insula. This study clearly confirms for the visual modality, that processing emotional stimuli leads to widespread increases in activation that cluster within relatively confined areas, regardless of valence.	[Karama, Sherif] McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ, Canada; [Karama, Sherif; Armony, Jorge] McGill Univ, Dept Neurol & Neurosurg, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Karama, Sherif; Beauregard, Mario] Univ Montreal, Ctr Rech Sci Neurol, Montreal, PQ H3C 3J7, Canada	McGill University; McGill University; Universite de Montreal	Karama, S (corresponding author), McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ, Canada.	sherif.karama@mail.mcgill.ca	Karama, Sherif/AAT-2683-2021	Lauwereyns, Jan/0000-0003-0551-2550	Universite de Montreal; Fonds de Recherche en Sante du Quebec; Departement de radiologie, Faculte de medecine, Universite de Montreal	Universite de Montreal; Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Departement de radiologie, Faculte de medecine, Universite de Montreal	This work was supported by studentships from the MD/PhD program of Universite de Montreal and from the Fonds de Recherche en Sante du Quebec to S.K., and by a grant from the Departement de radiologie, Faculte de medecine, Universite de Montreal to M.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral DG, 2003, ANN NY ACAD SCI, V1000, P337, DOI 10.1196/annals.1280.015; Barbas H, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-25; BARRETT LF, 2006, CURRENT DIRECTIONS P, V15; Beauregard M, 1998, NEUROREPORT, V9, P3253, DOI 10.1097/00001756-199810050-00022; Benedetti F, 2005, J NEUROSCI, V25, P10390, DOI 10.1523/JNEUROSCI.3458-05.2005; Birn RM, 2009, NEUROIMAGE, V47, P1092, DOI 10.1016/j.neuroimage.2009.05.030; Calder AJ, 2001, NAT REV NEUROSCI, V2, P352, DOI 10.1038/35072584; Chaminade T, 2005, NEUROPSYCHOLOGIA, V43, P115, DOI 10.1016/j.neuropsychologia.2004.04.026; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dalgleish T, 2004, NAT REV NEUROSCI, V5, P583, DOI 10.1038/nrn1432; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Damasio AR, 1998, BRAIN RES REV, V26, P83, DOI 10.1016/S0165-0173(97)00064-7; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Derntl B, 2009, PSYCHONEUROENDOCRINO, V34, P687, DOI 10.1016/j.psyneuen.2008.11.007; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Friston KJ, 1999, NEUROIMAGE, V10, P607, DOI 10.1006/nimg.1999.0498; Friston KJ, 2000, NEUROIMAGE, V12, P196, DOI 10.1006/nimg.2000.0609; Friston KJ, 2005, NEUROIMAGE, V25, P661, DOI 10.1016/j.neuroimage.2005.01.013; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; George MS, 1996, BIOL PSYCHIAT, V40, P859, DOI 10.1016/0006-3223(95)00572-2; Goldin PR, 2005, NEUROIMAGE, V27, P26, DOI 10.1016/j.neuroimage.2005.03.018; Gupta SK, 2000, J CLIN PHARMACOL, V40, P731, DOI 10.1177/00912700022009486; Gur RC, 2002, NEUROIMAGE, V16, P651, DOI 10.1006/nimg.2002.1097; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2005, CURR OPIN NEUROBIOL, V15, P632, DOI 10.1016/j.conb.2005.10.010; Iacoboni M, 2006, NAT REV NEUROSCI, V7, P942, DOI 10.1038/nrn2024; Kober H, 2008, NEUROIMAGE, V42, P998, DOI 10.1016/j.neuroimage.2008.03.059; Koski L, 2002, CEREB CORTEX, V12, P847, DOI 10.1093/cercor/12.8.847; Lane RD, 1997, AM J PSYCHIAT, V154, P926; LEDOUX J, 2002, SYNAPTIC SELF VIKING; LeDoux JE., 1991, CONCEPTS NEUROSCIENC, V2, P169; Levesque J, 2003, NEUROSCIENCE, V121, P545, DOI 10.1016/S0306-4522(03)00528-1; LOVICK TA, 1992, EXP BRAIN RES, V89, P133; MACLEAN PD, 1955, ARCH NEURO PSYCHIATR, V73, P130, DOI 10.1001/archneurpsyc.1955.02330080008004; Manuck SB, 2010, PSYCHONEUROENDOCRINO, V35, P94, DOI 10.1016/j.psyneuen.2009.04.013; Murphy FC, 2003, COGN AFFECT BEHAV NE, V3, P207, DOI 10.3758/CABN.3.3.207; Nelson SM, 2010, BRAIN STRUCT FUNCT, V214, P669, DOI 10.1007/s00429-010-0260-2; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliveri M, 2003, EXP BRAIN RES, V149, P214, DOI 10.1007/s00221-002-1346-8; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Panksepp J, 2005, CONSCIOUS COGN, V14, P30, DOI 10.1016/j.concog.2004.10.004; Panksepp J, 2007, PERSPECT PSYCHOL SCI, V2, P281, DOI 10.1111/j.1745-6916.2007.00045.x; Pelletier M, 2003, NEUROREPORT, V14, P1111, DOI 10.1097/00001756-200306110-00003; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Posner J, 2009, HUM BRAIN MAPP, V30, P883, DOI 10.1002/hbm.20553; Reiman EM, 1997, AM J PSYCHIAT, V154, P918; Reinders AATS, 2005, EUR J NEUROSCI, V22, P524, DOI 10.1111/j.1460-9568.2005.04212.x; Rottenberg J., 2007, HDB EMOTION ELICITAT; SAPER CB, 1976, BRAIN RES, V117, P305, DOI 10.1016/0006-8993(76)90738-1; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Sewards TV, 2003, BRAIN RES BULL, V61, P25, DOI 10.1016/S0361-9230(03)00069-8; Simpson JR, 2000, J COGNITIVE NEUROSCI, V12, P157, DOI 10.1162/089892900564019; Smith AM, 1999, NEUROIMAGE, V9, P526, DOI 10.1006/nimg.1999.0435; SNIDER RS, 1976, J NEUROSCI RES, V2, P133, DOI 10.1002/jnr.490020204; Sprengelmeyer R, 1998, P ROY SOC B-BIOL SCI, V265, P1927, DOI 10.1098/rspb.1998.0522; Toro R, 2008, CEREB CORTEX, V18, P2553, DOI 10.1093/cercor/bhn014; Trautmann SA, 2009, BRAIN RES, V1284, P100, DOI 10.1016/j.brainres.2009.05.075; VALENSTEIN ES, 1968, SCIENCE, V159, P1119, DOI 10.1126/science.159.3819.1119; VANWINGEN GA, 2011, NEUROSCIENCE; Wager TD, 2003, NEUROIMAGE, V19, P513, DOI 10.1016/S1053-8119(03)00078-8; Wager TD, 2004, NEUROIMAGE, V22, P1679, DOI 10.1016/j.neuroimage.2004.03.052; Wager TD, 2008, HDB EMOTIONS; Zarahn E, 1997, NEUROIMAGE, V6, P122, DOI 10.1006/nimg.1997.0279	69	29	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22343	10.1371/journal.pone.0022343	http://dx.doi.org/10.1371/journal.pone.0022343			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818311	Green Published, gold			2022-12-25	WOS:000293282700023
J	Keebaugh, AC; Mitchell, HA; Gaval-Cruz, M; Freeman, KG; Edwards, GL; Weinshenker, D; Thomas, JW				Keebaugh, Alaine C.; Mitchell, Heather A.; Gaval-Cruz, Meriem; Freeman, Kimberly G.; Edwards, Gaylen L.; Weinshenker, David; Thomas, James W.			PRTFDC1 Is a Genetic Modifier of HPRT-Deficiency in the Mouse	PLOS ONE			English	Article							LESCH-NYHAN SYNDROME; BACILLUS-SUBTILIS; MODEL; MICE; DISEASE; PHOSPHORIBOSYLTRANSFERASE; PROTEIN; DOPAMINE	Lesch-Nyhan disease (LND) is a severe X-linked neurological disorder caused by a deficiency of hypoxanthine phosphoribosyltransferase (HPRT). In contrast, HPRT-deficiency in the mouse does not result in the profound phenotypes such as self-injurious behavior observed in humans, and the genetic basis for this phenotypic disparity between HPRT-deficient humans and mice is unknown. To test the hypothesis that HPRT deficiency is modified by the presence/absence of phosphoribosyltransferase domain containing 1 (PRTFDC1), a paralog of HPRT that is a functional gene in humans but an inactivated pseudogene in mice, we created transgenic mice that express human PRTFDC1 in wild-type and HPRT-deficient backgrounds. Male mice expressing PRTFDC1 on either genetic background were viable and fertile. However, the presence of PRTFDC1 in the HPRT-deficient, but not wild-type mice, increased aggression as well as sensitivity to a specific amphetamine-induced stereotypy, both of which are reminiscent of the increased aggressive and self-injurious behavior exhibited by patients with LND. These results demonstrate that PRTFDC1 is a genetic modifier of HPRT-deficiency in the mouse and could therefore have important implications for unraveling the molecular etiology of LND.	[Keebaugh, Alaine C.] Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Mitchell, Heather A.; Gaval-Cruz, Meriem; Weinshenker, David; Thomas, James W.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA; [Freeman, Kimberly G.; Edwards, Gaylen L.] Univ Georgia, Dept Physiol & Pharmacol, Atlanta, GA USA	Emory University; University System of Georgia; University of Georgia	Keebaugh, AC (corresponding author), Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA.	jthomas@genetics.emory.edu	Weinshenker, David/V-3998-2019		National Institutes of Health [1R21NS060935]; National Institutes of Health (NIH)/National Institute on Drug Abuse (NIDA) [DA017963, DA25040]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS060935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017963, F31DA025040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH)/National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	A.C.K., H.A.M., D.W. and J.W.T. were supported by a grant from the National Institutes of Health (1R21NS060935). This work was also supported in part by the National Institutes of Health (NIH)/National Institute on Drug Abuse (NIDA) (DA017963 to D.W., DA25040 to M.G.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSELL JD, 1991, DEVELOPMENT, V112, P489; BREESE GR, 1984, J PHARMACOL EXP THER, V231, P343; Cai LY, 2007, LIFE SCI, V80, P1458, DOI 10.1016/j.lfs.2007.01.015; Chandrasekharan K, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000692; Engle SJ, 1996, HUM MOL GENET, V5, P1607, DOI 10.1093/hmg/5.10.1607; FINGER S, 1988, J NEUROL SCI, V86, P203, DOI 10.1016/0022-510X(88)90099-8; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Jinnah H, 2001, METABOLIC MOL BASES, P2537; JINNAH HA, 1994, J NEUROSCI, V14, P1164; JINNAH HA, 1991, BEHAV NEUROSCI, V105, P1004, DOI 10.1037/0735-7044.105.6.1004; Keebaugh AC, 2007, GENOMICS, V89, P134, DOI 10.1016/j.ygeno.2006.07.003; KUEHN MR, 1987, NATURE, V326, P295, DOI 10.1038/326295a0; LESCH M, 1964, AM J MED, V36, P561, DOI 10.1016/0002-9343(64)90104-4; Marino MD, 2005, BEHAV BRAIN RES, V161, P197, DOI 10.1016/j.bbr.2005.02.005; MAROTTI KR, 1993, NATURE, V364, P73, DOI 10.1038/364073a0; Mikolaenko I, 2005, NEUROBIOL DIS, V20, P479, DOI 10.1016/j.nbd.2005.04.005; Rommelfanger KS, 2007, P NATL ACAD SCI USA, V104, P13804, DOI 10.1073/pnas.0702753104; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Schretlen DJ, 2005, DEV MED CHILD NEUROL, V47, P673, DOI 10.1017/S0012162205001374; Sinha SC, 2003, J BACTERIOL, V185, P4087, DOI 10.1128/JB.185.14.4087-4098.2003; Suzuki E, 2007, ONCOGENE, V26, P7921, DOI 10.1038/sj.onc.1210589; Tomchick DR, 1998, STRUCTURE, V6, P337, DOI 10.1016/S0969-2126(98)00036-7; Visser JE, 2000, BRAIN RES REV, V32, P449, DOI 10.1016/S0165-0173(99)00094-6; Weinshenker D, 2002, P NATL ACAD SCI USA, V99, P13873, DOI 10.1073/pnas.212519999; Welin M, 2010, FEBS J, V277, P4920, DOI 10.1111/j.1742-4658.2010.07897.x	26	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22381	10.1371/journal.pone.0022381	http://dx.doi.org/10.1371/journal.pone.0022381			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818316	gold, Green Submitted, Green Published			2022-12-25	WOS:000293282700027
J	Geng, EH; Glidden, DV; Bwana, MB; Musinguzi, N; Emenyonu, N; Muyindike, W; Christopoulos, KA; Neilands, TB; Yiannoutsos, CT; Deeks, SG; Bangsberg, DR; Martin, JN				Geng, Elvin H.; Glidden, David V.; Bwana, Mwebesa Bosco; Musinguzi, Nicolas; Emenyonu, Nneka; Muyindike, Winnie; Christopoulos, Katerina A.; Neilands, Torsten B.; Yiannoutsos, Constantin T.; Deeks, Steven G.; Bangsberg, David R.; Martin, Jeffrey N.			Retention in Care and Connection to Care among HIV-Infected Patients on Antiretroviral Therapy in Africa: Estimation via a Sampling-Based Approach	PLOS ONE			English	Article							PATIENTS LOST; FOLLOW-UP; PROGRAMS; MORTALITY; OUTCOMES	Introduction: Current estimates of retention among HIV-infected patients on antiretroviral therapy (ART) in Africa consider patients who are lost to follow-up (LTF) as well as those who die shortly after their last clinic visit to be no longer in care and to represent limitations in access to care. Yet many lost patients may have "silently" transferred and deaths shortly after the last clinic visit more likely represent limitations in clinical care rather than access to care after initial linkage. Methods: We evaluated HIV-infected adults initiating ART from 1/1/2004 to 9/30/2007 at a clinic in rural Uganda. A representative sample of lost patients was tracked in the community to obtain updated information about care at other ART sites. Updated outcomes were incorporated with probability weights to obtain "corrected" estimates of retention for the entire clinic population. We used the competing risks approach to estimate "connection to care"-the percentage of patients accessing care over time (including those who died while in care). Results: Among 3,628 patients, 829 became lost, 128 were tracked and in 111, updated information was obtained. Of 111, 79 (71%) were alive and 35/48 (73%) of patients interviewed in person were in care and on ART. Patient retention for the clinic population assuming lost patients were not in care was 82.3%, 68.9%, and 60.1% at 1, 2 and 3 years. Incorporating updated care information from the sample of lost patients increased estimates of patient retention to 85.8% to 90.9%, 78.9% to 86.2% and 75.8% to 84.7% at the same time points. Conclusions: Accounting for "silent transfers" and early deaths increased estimates of patient retention and connection to care substantially. Deaths soon after the last clinic visit (potentially reflecting limitations in clinical effectiveness) and disconnection from care among patient who were alive each accounted for approximately half of failures of retention.	[Geng, Elvin H.; Christopoulos, Katerina A.; Deeks, Steven G.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div HIV AIDS, San Francisco, CA 94143 USA; [Glidden, David V.; Martin, Jeffrey N.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Bwana, Mwebesa Bosco; Musinguzi, Nicolas; Emenyonu, Nneka; Muyindike, Winnie] Mbarara Univ Sci & Technol, Dept Med, Mbarara, Uganda; [Neilands, Torsten B.] Univ Calif San Francisco, Ctr AIDS Prevent Studies, Dept Med, San Francisco, CA USA; [Yiannoutsos, Constantin T.] Indiana Univ, Dept Med, Div Biostat, Indianapolis, IN USA; [Emenyonu, Nneka; Bangsberg, David R.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA; [Geng, Elvin H.; Glidden, David V.; Bwana, Mwebesa Bosco; Musinguzi, Nicolas; Emenyonu, Nneka; Muyindike, Winnie; Yiannoutsos, Constantin T.; Bangsberg, David R.; Martin, Jeffrey N.] E Africa Int Epidemiol Databases Evaluate AIDS Ie, Eldoret, Kenya	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Mbarara University of Science & Technology; University of California System; University of California San Francisco; Indiana University System; Indiana University-Purdue University Indianapolis; Harvard University; Harvard Medical School; Massachusetts General Hospital	Geng, EH (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div HIV AIDS, San Francisco, CA 94143 USA.	genge@php.ucsf.edu	Glidden, David/AAD-4730-2020; Muyindike, Winnie/W-2892-2019	Glidden, David/0000-0001-5888-1419	National Institutes of Health [K23 AI084544, U01 AI069911, R01 MH054907, P30 AI027763]; United States President's Emergency Plan for AIDS Relief (PEPFAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, K23AI084544, U01AI069911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054907, K23MH092220, K24MH087227] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding was provided by the National Institutes of Health (K23 AI084544, U01 AI069911, R01 MH054907, P30 AI027763) and the United States President's Emergency Plan for AIDS Relief (PEPFAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Coviello V, 2004, STATA J, V4, P103, DOI 10.1177/1536867X0400400201; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Frangakis CE, 2001, BIOMETRICS, V57, P333, DOI 10.1111/j.0006-341X.2001.00333.x; Geng EH, 2008, JAMA-J AM MED ASSOC, V300, P506, DOI 10.1001/jama.300.5.506; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Hare CB, 2008, CLIN INFECT DIS, V47, P421, DOI 10.1086/589867; *ICAP, 2009, ICAP NEWS        OCT; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Liechty CA, 2007, TROP MED INT HEALTH, V12, P929, DOI 10.1111/j.1365-3156.2007.01874.x; Longley N, 2008, CLIN INFECT DIS, V47, P1556, DOI 10.1086/593194; Losina E, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000173; MAKADZANGE A, 2009, E EARLY VS DELAYED A; Moore D, 2007, AIDS, V21, P713, DOI 10.1097/QAD.0b013e328013f632; Navario P, 2009, LANCET, V374, P184, DOI 10.1016/S0140-6736(09)61312-X; PRENTICE RL, 1978, BIOMETRICS, V34, P541, DOI 10.2307/2530374; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Satagopan JM, 2004, BRIT J CANCER, V91, P1229, DOI 10.1038/sj.bjc.6602102; van Oosterhout JJ, 2005, TROP MED INT HEALTH, V10, P464, DOI 10.1111/j.1365-3156.2005.01409.x; Wools-Kaloustian K, 2006, AIDS, V20, P41, DOI 10.1097/01.aids.0000196177.65551.ea; UGANDA DISTRICTS INF	22	72	72	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e21797	10.1371/journal.pone.0021797	http://dx.doi.org/10.1371/journal.pone.0021797			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21818265	Green Published, gold, Green Submitted			2022-12-25	WOS:000293175100008
J	Mani, J; Guttinger, A; Schimanski, B; Heller, M; Acosta-Serrano, A; Pescher, P; Spath, G; Roditi, I				Mani, Jan; Guettinger, Andreas; Schimanski, Bernd; Heller, Manfred; Acosta-Serrano, Alvaro; Pescher, Pascale; Spaeth, Gerald; Roditi, Isabel			Alba-Domain Proteins of Trypanosoma brucei Are Cytoplasmic RNA-Binding Proteins That Interact with the Translation Machinery	PLOS ONE			English	Article							3 UNTRANSLATED REGION; BLOOD-STREAM FORMS; ARCHAEBACTERIUM SULFOLOBUS-ACIDOCALDARIUS; PROCYCLIN EXPRESSION SITE; METHIONYL-TRANSFER-RNA; MESSENGER-RNA; GENE-EXPRESSION; SURFACE PROTEIN; RIBONUCLEASE-P; INSECT FORMS	Trypanosoma brucei and related pathogens transcribe most genes as polycistronic arrays that are subsequently processed into monocistronic mRNAs. Expression is frequently regulated post-transcriptionally by cis-acting elements in the untranslated regions (UTRs). GPEET and EP procyclins are the major surface proteins of procyclic (insect midgut) forms of T. brucei. Three regulatory elements common to the 3' UTRs of both mRNAs regulate mRNA turnover and translation. The glycerol-responsive element (GRE) is unique to the GPEET 3' UTR and regulates its expression independently from EP. A synthetic RNA encompassing the GRE showed robust sequence-specific interactions with cytoplasmic proteins in electromobility shift assays. This, combined with column chromatography, led to the identification of 3 Alba-domain proteins. RNAi against Alba3 caused a growth phenotype and reduced the levels of Alba1 and Alba2 proteins, indicative of interactions between family members. Tandem-affinity purification and co-immunoprecipitation verified these interactions and also identified Alba4 in sub-stoichiometric amounts. Alba proteins are cytoplasmic and are recruited to starvation granules together with poly(A) RNA. Concomitant depletion of all four Alba proteins by RNAi specifically reduced translation of a reporter transcript flanked by the GPEET 3' UTR. Pulldown of tagged Alba proteins confirmed interactions with poly(A) binding proteins, ribosomal protein P0 and, in the case of Alba3, the cap-binding protein eIF4E4. In addition, Alba2 and Alba3 partially cosediment with polyribosomes in sucrose gradients. Alba-domain proteins seem to have exhibited great functional plasticity in the course of evolution. First identified as DNA-binding proteins in Archaea, then in association with nuclear RNase MRP/P in yeast and mammalian cells, they were recently described as components of a translationally silent complex containing stage-regulated mRNAs in Plasmodium. Our results are also consistent with stage-specific regulation of translation in trypanosomes, but most likely in the context of initiation.	[Mani, Jan; Guettinger, Andreas; Schimanski, Bernd; Roditi, Isabel] Univ Bern, Inst Cell Biol, Bern, Switzerland; [Heller, Manfred] Univ Bern, Dept Clin Res, Bern, Switzerland; [Acosta-Serrano, Alvaro] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Pescher, Pascale; Spaeth, Gerald] Inst Pasteur, Dept Parasitol & Mycol, Paris, France	University of Bern; University of Bern; Liverpool School of Tropical Medicine; University of Liverpool; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Mani, J (corresponding author), Univ Bern, Inst Cell Biol, Bern, Switzerland.	isabel.roditi@izb.unibe.ch	Späth, Gerald/B-1393-2014; Acosta-Serrano, Alvaro/L-5503-2015	Acosta-Serrano, Alvaro/0000-0002-2576-7959; Roditi, Isabel/0000-0003-2812-6513; Spaeth, Gerald/0000-0002-0256-2029; Pescher, Pascale/0000-0003-2796-7855; Heller, Manfred/0000-0002-6364-7325	Swiss National Science Foundation; Howard Hughes Medical Institute; Canton of Bern	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Canton of Bern(Japanese Urological Association)	This research was funded by the Swiss National Science Foundation, the Howard Hughes Medical Institute and the Canton of Bern. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Serrano A, 2001, P NATL ACAD SCI USA, V98, P1513, DOI 10.1073/pnas.041611698; Alsford S, 2007, MOL MICROBIOL, V63, P724, DOI 10.1111/j.1365-2958.2006.05553.x; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Aphasizhev R, 2003, RNA, V9, P62, DOI 10.1261/rna.2134303; Aravind L, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r64; Archer SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000565; Arhin GK, 2005, MOL BIOCHEM PARASIT, V144, P104, DOI 10.1016/j.molbiopara.2005.06.006; Arhin GK, 2004, EUKARYOT CELL, V3, P893, DOI 10.1128/EC.3.4.893-899.2004; BARBU V, 1989, NUCLEIC ACIDS RES, V17, P7115, DOI 10.1093/nar/17.17.7115; Bell SD, 2002, SCIENCE, V296, P148, DOI 10.1126/science.1070506; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; BRUN R, 1979, ACTA TROP, V36, P289; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Burkard G, 2007, MOL BIOCHEM PARASIT, V153, P220, DOI 10.1016/j.molbiopara.2007.02.008; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Cassola A, 2007, MOL MICROBIOL, V65, P655, DOI 10.1111/j.1365-2958.2007.05833.x; Chanez AL, 2006, J CELL SCI, V119, P2968, DOI 10.1242/jcs.03023; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; De Gaudenzi J, 2005, EUKARYOT CELL, V4, P2106, DOI 10.1128/EC.4.12.2106-2114.2005; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Engstler M, 2004, GENE DEV, V18, P2798, DOI 10.1101/gad.323404; Esakova O, 2010, RNA, V16, P1725, DOI 10.1261/rna.2214510; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Fernandez-Moya SM, 2010, WIRES RNA, V1, P34, DOI 10.1002/wrna.6; Fetzer CP, 2002, NUCLEIC ACIDS RES, V30, P4380, DOI 10.1093/nar/gkf579; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fluck C, 2003, MOL BIOCHEM PARASIT, V127, P93, DOI 10.1016/S0166-6851(02)00310-9; Forterre P, 1999, MOL MICROBIOL, V32, P669, DOI 10.1046/j.1365-2958.1999.01366.x; Fragoso CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007074; Freire ER, 2011, MOL BIOCHEM PARASIT, V176, P25, DOI 10.1016/j.molbiopara.2010.11.011; Furger A, 1997, MOL CELL BIOL, V17, P4372, DOI 10.1128/MCB.17.8.4372; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; GROTE M, 1986, BIOCHIM BIOPHYS ACTA, V873, P405, DOI 10.1016/0167-4838(86)90090-7; Guo R, 2003, MOL MICROBIOL, V50, P1605, DOI 10.1046/j.1365-2958.2003.03793.x; Haile S, 2007, CURR OPIN MICROBIOL, V10, P569, DOI 10.1016/j.mib.2007.10.001; Hands-Taylor KLD, 2010, NUCLEIC ACIDS RES, V38, P4052, DOI 10.1093/nar/gkq141; HEHL A, 1994, P NATL ACAD SCI USA, V91, P370, DOI 10.1073/pnas.91.1.370; Hotz HR, 1997, NUCLEIC ACIDS RES, V25, P3017, DOI 10.1093/nar/25.15.3017; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jarrous N, 2007, NUCLEIC ACIDS RES, V35, P3519, DOI 10.1093/nar/gkm071; Jelinska C, 2005, STRUCTURE, V13, P963, DOI 10.1016/j.str.2005.04.016; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Kolev NG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001090; KRAMER S, 2010, TRENDS PARASITOL; Kramer S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-283; Kramer S, 2010, J CELL SCI, V123, P699, DOI 10.1242/jcs.058511; Lai LB, 2010, FEBS LETT, V584, P287, DOI 10.1016/j.febslet.2009.11.048; LERAY D, 1977, ANN SOC BELG MED TR, V57, P369; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; LURZ R, 1986, EMBO J, V5, P3715, DOI 10.1002/j.1460-2075.1986.tb04705.x; Mair GR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000767; MATTHEWS KR, 1994, GENE DEV, V8, P491, DOI 10.1101/gad.8.4.491; Morales MA, 2010, P NATL ACAD SCI USA, V107, P8381, DOI 10.1073/pnas.0914768107; Morris JC, 2002, EMBO J, V21, P4429, DOI 10.1093/emboj/cdf474; Muller M, 2010, MOL MICROBIOL, V77, P471, DOI 10.1111/j.1365-2958.2010.07226.x; Nett IRE, 2009, MOL CELL PROTEOMICS, V8, P1527, DOI 10.1074/mcp.M800556-MCP200; Nett IRE, 2009, EUKARYOT CELL, V8, P617, DOI 10.1128/EC.00366-08; Nilsson D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001037; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Paterou A, 2006, J BIOL CHEM, V281, P39002, DOI 10.1074/jbc.M604280200; PAYS E, 1990, EMBO J, V9, P3145, DOI 10.1002/j.1460-2075.1990.tb07512.x; Perederina A, 2007, RNA, V13, P1648, DOI 10.1261/rna.654407; Perederina A, 2010, EMBO J, V29, P761, DOI 10.1038/emboj.2009.396; Rigden DJ, 2008, BIOINFORMATICS, V24, P1793, DOI 10.1093/bioinformatics/btn314; RODITI I, 1989, J CELL BIOL, V108, P737, DOI 10.1083/jcb.108.2.737; Roditi I, 1998, MOL BIOCHEM PARASIT, V91, P117, DOI 10.1016/S0166-6851(97)00195-3; Rosenblad MA, 2006, NUCLEIC ACIDS RES, V34, P5145, DOI 10.1093/nar/gkl626; Ruepp S, 1997, J CELL BIOL, V137, P1369, DOI 10.1083/jcb.137.6.1369; Salavati R, 2001, MOL BIOCHEM PARASIT, V115, P109, DOI 10.1016/S0166-6851(01)00273-0; Schimanski B, 2005, EUKARYOT CELL, V4, P1942, DOI 10.1128/EC.4.11.1942-1950.2005; Schumacher MA, 2006, CELL, V126, P701, DOI 10.1016/j.cell.2006.06.047; Schurch N, 1997, MOL BIOCHEM PARASIT, V89, P109, DOI 10.1016/S0166-6851(97)00107-2; SCHURCH N, 1994, MOL CELL BIOL, V14, P3668, DOI 10.1128/MCB.14.6.3668; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Siegel TN, 2010, NUCLEIC ACIDS RES, V38, P4946, DOI 10.1093/nar/gkq237; Tan THP, 2002, P NATL ACAD SCI USA, V99, P1152, DOI 10.1073/pnas.022522299; Thomas M.G., 2010, CELL SIGNAL; Urwyler S, 2005, PLOS PATHOG, V1, P225, DOI 10.1371/journal.ppat.0010022; VANHAMME L, 1995, NUCLEIC ACIDS RES, V23, P1862, DOI 10.1093/nar/23.11.1862; Vassella E, 1996, MOL BIOCHEM PARASIT, V82, P91, DOI 10.1016/0166-6851(96)02727-2; Vassella E, 2000, GENE DEV, V14, P615; Vassella E, 2004, MOL BIOL CELL, V15, P3986, DOI 10.1091/mbc.E04-04-0341; Vassella E, 2001, J MOL BIOL, V312, P597, DOI 10.1006/jmbi.2001.5004; VASSELLA E, 1994, NUCLEIC ACIDS RES, V22, P1359, DOI 10.1093/nar/22.8.1359; Vondruskova E, 2005, J BIOL CHEM, V280, P2429, DOI 10.1074/jbc.M405933200; Walker SC, 2006, CRIT REV BIOCHEM MOL, V41, P77, DOI 10.1080/10409230600602634; Walrad P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000317; Wardleworth BN, 2002, EMBO J, V21, P4654, DOI 10.1093/emboj/cdf465; Welting TJM, 2007, RNA, V13, P65, DOI 10.1261/rna.237807; Welting TJM, 2006, RNA, V12, P1373, DOI 10.1261/rna.2293906; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Xiao SH, 2002, ANNU REV BIOCHEM, V71, P165, DOI 10.1146/annurev.biochem.71.110601.135352	94	82	82	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22463	10.1371/journal.pone.0022463	http://dx.doi.org/10.1371/journal.pone.0022463			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811616	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000292956800061
J	van Gameren-Oosterom, HBM; Fekkes, M; Buitendijk, SE; Mohangoo, AD; Bruil, J; Van Wouwe, JP				van Gameren-Oosterom, Helma B. M.; Fekkes, Minne; Buitendijk, Simone E.; Mohangoo, Ashna D.; Bruil, Jeanet; Van Wouwe, Jacobus P.			Development, Problem Behavior, and Quality of Life in a Population Based Sample of Eight-Year-Old Children with Down Syndrome	PLOS ONE			English	Article							DISORDERS; ADOLESCENTS; COMORBIDITY; PREVALENCE; HEALTH; CARE	Objective: Children with Down syndrome (DS) have delayed psychomotor development. We investigated levels of development, problem behavior, and Health-Related Quality of Life (HRQoL) in a population sample of Dutch eight-year-old children with DS. Developmental outcomes were compared with normative data of eight-year-old children from the general population. Method: Over a three-year-period all parents with an eight-year-old child with DS were approached by the national parent organization. Developmental skills were assessed by means of the McCarthy Scales of Children's Ability. To measure emotional and behavioral problems we used the Child Behavior Checklist. HRQoL was assessed with the TNO-AZL Children's Quality of Life questionnaire. Analyses of variance were applied to compare groups. Results: A total of 337 children participated. Mean developmental age was substantially lower than mean calendar age (3.9 years, SD 0.87 and 8.1 years, SD 0.15 respectively). Mean developmental age was significantly lower among boys than girls (3.6 (SD 0.85) and 4.2 years (SD 0.82) respectively; p < 0.001). Compared with the general population, children with DS had more emotional and behavioral problems (p, 0.001). However on the anxious/depressed scale, they scored significantly more favorably (p < 0.001). Significantly lower HRQoL scores for the scales gross motor skills, autonomy, social functioning and cognitive functioning were found (p-values, 0.001). Hardly any differences were observed for the scales physical complaints, positive and negative emotions. Conclusion: Eight-year-old children with DS have an average developmental delay of four years, more often have emotional and behavioral problems, and have a less favorable HRQoL compared with children from the general population.	[van Gameren-Oosterom, Helma B. M.; Fekkes, Minne; Buitendijk, Simone E.; Mohangoo, Ashna D.; Bruil, Jeanet; Van Wouwe, Jacobus P.] Netherlands Org Appl Sci Res TNO, Dept Child Hlth, Leiden, Netherlands	Netherlands Organization Applied Science Research	van Gameren-Oosterom, HBM (corresponding author), Netherlands Org Appl Sci Res TNO, Dept Child Hlth, Leiden, Netherlands.	helma.vangameren@tno.nl	Van Wouwe, Jacobus P/D-5549-2018	Van Wouwe, Jacobus P/0000-0001-9273-6258; Hindori-Mohangoo, Ashna/0000-0003-2364-2893	Netherlands Organization for Health Research and Development (ZonMw) [2200.0061]	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This study was financially supported by grant # 2200.0061 from the Netherlands Organization for Health Research and Development (ZonMw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, MANUAL CBCL 4 18; [Anonymous], 1991, MANUAL CHILD BEHAV C; ANTHONY S, 2005, TNORAPPORTKVLJPB2005; Buckley Sue, 2006, Downs Syndr Res Pract, V9, P54, DOI 10.3104/reports.295; Capone G, 2006, AM J MED GENET C, V142C, P158, DOI 10.1002/ajmg.c.30097; CARR J, 1988, J CHILD PSYCHOL PSYC, V29, P407, DOI 10.1111/j.1469-7610.1988.tb00734.x; Chapman RS, 2000, MENT RETARD DEV D R, V6, P84, DOI 10.1002/1098-2779(2000)6:2<84::AID-MRDD2>3.0.CO;2-P; Coe DA, 1999, J AUTISM DEV DISORD, V29, P149, DOI 10.1023/A:1023044711293; Cohen J., 1997, STAT POWER ANAL BEHA; Cunniff C, 2001, PEDIATRICS, V107, P442; Davis AS, 2008, SCHOOL PSYCHOL QUART, V23, P271, DOI 10.1037/1045-3830.23.2.271; de Ruiter KP, 2007, J CHILD PSYCHOL PSYC, V48, P498, DOI 10.1111/j.1469-7610.2006.01712.x; DEGRAAF G, 2006, DOWN UP, V76, P37; Dekker MC, 2002, J CHILD PSYCHOL PSYC, V43, P1087, DOI 10.1111/1469-7610.00235; Dykens EM, 2007, MENT RETARD DEV D R, V13, P272, DOI 10.1002/mrdd.20159; Dykens EM, 1997, AM J MENT RETARD, V102, P228, DOI 10.1352/0895-8017(1997)102<0228:MBICWP>2.0.CO;2; GATH A, 1986, BRIT J PSYCHIAT, V149, P156, DOI 10.1192/bjp.149.2.156; JARROLD, 1999, DOWNS SYNDROME RES P, V6, P61; Kent L, 1999, DEV MED CHILD NEUROL, V41, P153, DOI 10.1017/S001216229900033X; McCarthy D., 1972, MANUAL MCCARTHY SCAL; MOHANGOO AD, 2009, TNORAPPORTKVLPZ20091; MYERS BA, 1991, J NERV MENT DIS, V179, P609, DOI 10.1097/00005053-199110000-00004; Noterdaeme M, 1999, Z KINDER JUG-PSYCH, V27, P183, DOI 10.1024//1422-4917.27.3.183; PUESCHEL SM, 1991, J MENT DEFIC RES, V35, P502; Reijneveld SA, 2005, SOC PSYCH PSYCH EPID, V40, P18, DOI 10.1007/s00127-005-0850-0; Roizen NJ, 2003, LANCET, V361, P1281, DOI 10.1016/S0140-6736(03)12987-X; Schieve LA, 2009, PEDIATRICS, V123, pE253, DOI 10.1542/peds.2008-1440; Shin M, 2009, PEDIATRICS, V124, P1565, DOI 10.1542/peds.2009-0745; Silverman W, 2007, MENT RETARD DEV D R, V13, P228, DOI 10.1002/mrdd.20156; Stores R, 1998, J INTELL DISABIL RES, V42, P228, DOI 10.1046/j.1365-2788.1998.00123.x; Tennant PWG, 2010, LANCET, V375, P649, DOI 10.1016/S0140-6736(09)61922-X; Turner S, 2003, BRIT J EDUC PSYCHOL, V73, P563, DOI 10.1348/000709903322591244; Van der Meulen B. F., 1985, MOS 2 5 8 5 MCCARTHY; van Trotsenburg ASP, 2006, PEDIATRICS, V118, P1633, DOI 10.1542/peds.2006-1136; Van Wouwe JP, 2001, NED TIJDSCHR GENEES, V145, P1617; Verrips EGH, 1999, EUR J PUBLIC HEALTH, V9, P188, DOI 10.1093/eurpub/9.3.188; Vogels T, 1998, QUAL LIFE RES, V7, P457, DOI 10.1023/A:1008848218806; Weijerman ME, 2008, J PEDIATR-US, V152, P15, DOI 10.1016/j.jpeds.2007.09.045; Weijerman ME, 2010, EUR J PEDIATR, V169, P1195, DOI 10.1007/s00431-010-1200-0	39	74	74	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e21879	10.1371/journal.pone.0021879	http://dx.doi.org/10.1371/journal.pone.0021879			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	795FA	21814560	Green Submitted, Green Published, gold			2022-12-25	WOS:000292956800013
J	Sharp, ER; Willberg, CB; Kuebler, PJ; Abadi, J; Fennelly, GJ; Dobroszycki, J; Wiznia, AA; Rosenberg, MG; Nixon, DF				Sharp, Elizabeth R.; Willberg, Christian B.; Kuebler, Peter J.; Abadi, Jacob; Fennelly, Glenn J.; Dobroszycki, Joanna; Wiznia, Andrew A.; Rosenberg, Michael G.; Nixon, Douglas F.			Immunodominance of HIV-1 Specific CD8+T-Cell Responses Is Related to Disease Progression Rate in Vertically Infected Adolescents	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL RESPONSES; LONG-TERM NONPROGRESSORS; CLASS-I ALLELES; LOW VIRAL LOAD; LYMPHOCYTE RESPONSES; SET-POINT; HLA; TYPE-1; GAG	Background: HIV-1 vertically infected children in the USA are living into adolescence and beyond with the widespread use of antiretroviral drugs. These patients exhibit striking differences in the rate of HIV-1 disease progression which could provide insights into mechanisms of control. We hypothesized that differences in the pattern of immunodomination including breadth, magnitude and polyfunctionality of HIV-1 specific CD8+ T cell response could partially explain differences in progression rate. Methodology/Principal Findings: In this study, we mapped, quantified, and assessed the functionality of these responses against individual HIV-1 Gag peptides in 58 HIV-1 vertically infected adolescents. Subjects were divided into two groups depending upon the rate of disease progression: adolescents with a sustained CD4%>= 25 were categorized as having no immune suppression (NS), and those with CD4%<= 15 categorized as having severe immune suppression (SS). We observed differences in the area of HIV-1-Gag to which the two groups made responses. In addition, subjects who expressed the HLA-B*57 or B*42 alleles were highly likely to restrict their immunodominant response through these alleles. There was a significantly higher frequency of naive CD8+ T cells in the NS subjects (p = 0.0066) compared to the SS subjects. In contrast, there were no statistically significant differences in any other CD8+ T cell subsets. The differentiation profiles and multifunctionality of Gag-specific CD8+ T cells, regardless of immunodominance, also failed to demonstrate meaningful differences between the two groups. Conclusions/Significance: Together, these data suggest that, at least in vertically infected adolescents, the region of HIV-1-Gag targeted by CD8+ T cells and the magnitude of that response relative to other responses may have more importance on the rate of disease progression than their qualitative effector functions.	[Sharp, Elizabeth R.; Willberg, Christian B.; Kuebler, Peter J.; Nixon, Douglas F.] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94143 USA; [Abadi, Jacob; Fennelly, Glenn J.; Dobroszycki, Joanna; Wiznia, Andrew A.; Rosenberg, Michael G.] Jacobi Med Ctr, Bronx, NY USA	University of California System; University of California San Francisco; Jacobi Medical Center	Sharp, ER (corresponding author), Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94143 USA.	douglas.nixon@ucsf.edu	Nixon, Douglas/AAU-5734-2020	Nixon, Douglas/0000-0002-2801-1786; Willberg, Christian/0000-0001-5299-9344	NIH [AI060379]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, R21AI060379, R01AI060379] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by a grant from the NIH AI060379. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000321; Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Altfeld M, 2003, AIDS, V17, P2581, DOI 10.1097/00002030-200312050-00005; Altfeld M, 2006, PLOS MED, V3, P1851, DOI 10.1371/journal.pmed.0030403; [Anonymous], 1994, MMWR Recomm Rep, V43, P1; Bansal A, 2007, AIDS, V21, P2387, DOI 10.1097/QAD.0b013e3282f13823; Barouch DH, 2003, J VIROL, V77, P7367, DOI 10.1128/JVI.77.13.7367-7375.2003; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; Brumme ZL, 2008, AIDS, V22, P1277, DOI 10.1097/QAD.0b013e3283021a8c; Cao JH, 2003, J VIROL, V77, P6867, DOI 10.1128/JVI.77.12.6867-6878.2003; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Carrington M, 2002, AIDS, V16, pS105, DOI 10.1097/00002030-200216004-00015; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Chandwani R, 2004, SCAND J IMMUNOL, V59, P109, DOI 10.1111/j.0300-9475.2004.01365.x; Crawford H, 2009, J EXP MED, V206, P909, DOI 10.1084/jem.20081984; Daucher M, 2008, J VIROL, V82, P4102, DOI 10.1128/JVI.02212-07; Edwards BH, 2002, J VIROL, V76, P2298, DOI 10.1128/JVI.76.5.2298-2305.2002; Frahm N, 2006, NAT IMMUNOL, V7, P173, DOI 10.1038/ni1281; Frahm N, 2004, J VIROL, V78, P2187, DOI 10.1128/JVI.78.5.2187-2200.2004; Frahm N, 2008, AIDS, V22, P447, DOI 10.1097/QAD.0b013e3282f42412; Geldmacher C, 2007, J VIROL, V81, P2440, DOI 10.1128/JVI.01847-06; Goulder PJR, 2000, J VIROL, V74, P5679, DOI 10.1128/JVI.74.12.5679-5690.2000; Harrer T, 1996, J IMMUNOL, V156, P2616; Hel Z, 2002, J IMMUNOL, V169, P4778, DOI 10.4049/jimmunol.169.9.4778; Hess C, 2004, LANCET, V363, P863, DOI 10.1016/S0140-6736(04)15735-8; Huang SH, 2008, J IMMUNOL, V181, P8103, DOI 10.4049/jimmunol.181.11.8103; Jennes W, 2002, J IMMUNOL METHODS, V270, P99, DOI 10.1016/S0022-1759(02)00275-2; Jin X, 2000, MOL MED, V6, P803, DOI 10.1007/BF03402195; Jordan KA, 2006, VIROLOGY, V347, P117, DOI 10.1016/j.virol.2005.12.002; JULG B, J VIROL, V84, P5540; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Lichterfeld M, 2005, TRENDS IMMUNOL, V26, P166, DOI 10.1016/j.it.2005.01.003; Maiers M, 2007, HUM IMMUNOL, V68, P779, DOI 10.1016/j.humimm.2007.04.005; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Migueles SA, 2003, J VIROL, V77, P6889, DOI 10.1128/JVI.77.12.6889-6898.2003; Miura T, 2009, J VIROL, V83, P2743, DOI 10.1128/JVI.02265-08; Northfield JW, 2007, J VIROL, V81, P5759, DOI 10.1128/JVI.00045-07; O'Brien SJ, 2001, TRENDS MOL MED, V7, P379, DOI 10.1016/S1471-4914(01)02131-1; RINALDO C, 1995, J VIROL, V69, P5838, DOI 10.1128/JVI.69.9.5838-5842.1995; RIVIERE Y, 1995, AIDS RES HUM RETROV, V11, P903, DOI 10.1089/aid.1995.11.903; Saah AJ, 1998, AIDS, V12, P2107, DOI 10.1097/00002030-199816000-00005; Sandberg JK, 2003, J IMMUNOL, V170, P4403, DOI 10.4049/jimmunol.170.8.4403; Schneidewind A, 2009, J VIROL, V83, P8616, DOI 10.1128/JVI.00730-09; Sharp ER, 2005, J INFECT DIS, V192, P1772, DOI 10.1086/462423; STREECK HAG, 2007, IMMUNODOMINATION HLA; Streeck H, 2007, J VIROL, V81, P7725, DOI 10.1128/JVI.00708-07; Streeck H, 2009, J VIROL, V83, P7641, DOI 10.1128/JVI.00182-09; Wang YYE, 2009, J VIROL, V83, P1845, DOI 10.1128/JVI.01061-08; Willberg CB, 2007, CLIN VACCINE IMMUNOL, V14, P785, DOI 10.1128/CVI.00048-07; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Yu XG, 2002, J VIROL, V76, P8690, DOI 10.1128/JVI.76.17.8690-8701.2002	53	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e21135	10.1371/journal.pone.0021135	http://dx.doi.org/10.1371/journal.pone.0021135			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21818255	gold, Green Published, Green Submitted			2022-12-25	WOS:000292929500004
J	Soye, KJ; Trottier, C; Richardson, CD; Ward, BJ; Miller, WH				Soye, Kaitlin J.; Trottier, Claire; Richardson, Chris D.; Ward, Brian J.; Miller, Wilson H.			RIG-I Is Required for the Inhibition of Measles Virus by Retinoids	PLOS ONE			English	Article							INTERFERON REGULATORY FACTOR-1; ACID-INDUCED DIFFERENTIATION; INDUCIBLE GENE-I; RAR-ALPHA; VITAMIN-A; NUCLEAR-LOCALIZATION; TRANSCRIPTION FACTOR; V-PROTEIN; EXPRESSION; RECEPTOR	Vitamin A can significantly decrease measles-associated morbidity and mortality. Vitamin A can inhibit the replication of measles virus (MeV) in vitro through an RAR alpha- and type I interferon (IFN)-dependent mechanism. Retinoid-induced gene I (RIG-I) expression is induced by retinoids, activated by MeV RNA and is important for IFN signaling. We hypothesized that RIG-I is central to retinoid-mediated inhibition of MeV in vitro. We demonstrate that RIG-I expression is increased in cells treated with retinoids and infected with MeV. The central role of RIG-I in the retinoid-anti-MeV effect was demonstrated in the Huh-7/7.5 model; the latter cells having non-functional RIG-I. RAR-dependent retinoid signaling was required for the induction of RIG-I by retinoids and MeV. Retinoid signaling was also found to act in combination with IFN to induce high levels of RIG-I expression. RIG-I promoter activation required both retinoids and MeV, as indicated by markers of active chromatin. IRF-1 is known to be regulated by retinoids and MeV, but we found recruitment of IRF-1 to the RIG-I promoter by retinoids alone. Using luciferase expression constructs, we further demonstrated that the IRF-1 response element of RIG-I was required for RIG-I activation by retinoids or IFN. These results reveal that retinoid treatment and MeV infection induces significant RIG-I. RIG-I is required for the retinoid-MeV antiviral response. The induction is dependent on IFN, retinoids and IRF-1.	[Soye, Kaitlin J.; Trottier, Claire; Ward, Brian J.] McGill Univ, Dept Infect Dis, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Soye, Kaitlin J.; Trottier, Claire; Miller, Wilson H.] McGill Univ, SMBD Jewish Gen Hosp, Lady Davis Inst Med Res, Segal Canc Ctr, Montreal, PQ, Canada; [Richardson, Chris D.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada	McGill University; Lady Davis Institute; McGill University; Dalhousie University	Soye, KJ (corresponding author), McGill Univ, Dept Infect Dis, Ctr Hlth, Res Inst, Montreal, PQ, Canada.	brian.ward@mcgill.ca; wmiller@ldi.jgh.mcgill.ca			Canadian Institute of Health Research (CIHR)	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work is funded by a Canadian Institute of Health Research (CIHR) grant to BJW and to WHM. WHM is a Chercheur National de la Fonds de la Recherche en Sante du Quebec (FRSQ). KJS is supported by a CIHR Doctoral Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AABY P, 1985, MED HYPOTHESES, V18, P93, DOI 10.1016/0306-9877(85)90042-8; [Anonymous], 1988, Int Nurs Rev, V35, P21; Arany I, 2002, CLIN DIAGN LAB IMMUN, V9, P1102, DOI 10.1128/CDLI.9.5.1102-1106.2002; Balmer JE, 2005, J STEROID BIOCHEM, V96, P347, DOI 10.1016/j.jsbmb.2005.05.005; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Chen QY, 2005, P NATL ACAD SCI USA, V102, P14142, DOI 10.1073/pnas.0505018102; D'Souza RM, 2002, J TROP PEDIATRICS, V48, P323, DOI 10.1093/tropej/48.6.323; Dabbagh A., 2008, Morbidity and Mortality Weekly Report, V57, P1303; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Dimberg A, 2000, BLOOD, V96, P2870; Ertesvag A, 2002, J IMMUNOL, V169, P5555, DOI 10.4049/jimmunol.169.10.5555; Ertesvag A, 2009, IMMUNOLOGY, V126, P514, DOI 10.1111/j.1365-2567.2008.02913.x; Feigelstock DA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-44; Fontana JM, 2008, VIROLOGY, V374, P71, DOI 10.1016/j.virol.2007.12.031; Geissmann F, 2003, J EXP MED, V198, P623, DOI 10.1084/jem.20030390; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Gianni M, 1997, BLOOD, V89, P1001, DOI 10.1182/blood.V89.3.1001; HARRIS P, 1985, J LEUKOCYTE BIOL, V37, P407, DOI 10.1002/jlb.37.4.407; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Huiming YM, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001479.pub3; Ikegame S, 2010, J VIROL, V84, P372, DOI 10.1128/JVI.01690-09; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; KASTNER P, 1992, EMBO J, V11, P629, DOI 10.1002/j.1460-2075.1992.tb05095.x; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; Kroger A, 2002, J INTERF CYTOK RES, V22, P5, DOI 10.1089/107999002753452610; LANOTTE M, 1991, BLOOD, V77, P1080; Lin RT, 1999, MOL CELL BIOCHEM, V191, P169, DOI 10.1023/A:1006850009017; Liu TX, 2000, BLOOD, V96, P1496, DOI 10.1182/blood.V96.4.1496.h8001496_1496_1504; Lou YJ, 2009, CANCER RES, V69, P3673, DOI 10.1158/0008-5472.CAN-08-4922; Luo XM, 2006, EXP BIOL MED, V231, P619; Luo XM, 2005, J BIOL CHEM, V280, P36228, DOI 10.1074/jbc.M505749200; Matikainen S, 1996, BLOOD, V88, P114; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Naniche D, 2000, J VIROL, V74, P7478, DOI 10.1128/JVI.74.16.7478-7484.2000; Negishi H, 2006, P NATL ACAD SCI USA, V103, P15136, DOI 10.1073/pnas.0607181103; Ohno S, 2004, J GEN VIROL, V85, P2991, DOI 10.1099/vir.0.80308-0; PANDOLFI PP, 1991, ONCOGENE, V6, P1285; Pelicano L, 1999, ONCOGENE, V18, P3944, DOI 10.1038/sj.onc.1202802; Pelicano L, 1997, ONCOGENE, V15, P2349, DOI 10.1038/sj.onc.1201410; Percario ZA, 1999, CELL GROWTH DIFFER, V10, P263; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; PINE R, 1990, MOL CELL BIOL, V10, P2448, DOI 10.1128/MCB.10.6.2448; Plumet S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000279; Rodeheffer C, 2007, J NUTR, V137, P1916, DOI 10.1093/jn/137.8.1916; SCHLEE M, 2010, MOL THER; Shao WL, 1997, BLOOD, V89, P4282, DOI 10.1182/blood.V89.12.4282; Siren J, 2006, MICROBES INFECT, V8, P2013, DOI 10.1016/j.micinf.2006.02.028; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Su ZZ, 2007, J CELL PHYSIOL, V213, P502, DOI 10.1002/jcp.21128; THANOS D, 1993, COLD SPRING HARB SYM, V58, P73, DOI 10.1101/SQB.1993.058.01.011; Toma S, 1998, INT J CANCER, V78, P86, DOI 10.1002/(SICI)1097-0215(19980925)78:1<86::AID-IJC14>3.0.CO;2-3; TROTTIER C, 2009, FASEB J; Trottier C, 2008, ANTIVIR RES, V80, P45, DOI 10.1016/j.antiviral.2008.04.003; WATANABE N, 1991, NUCLEIC ACIDS RES, V19, P4421, DOI 10.1093/nar/19.16.4421; Witcher M, 2008, NUCLEIC ACIDS RES, V36, P435, DOI 10.1093/nar/gkm1058; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	61	23	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22323	10.1371/journal.pone.0022323	http://dx.doi.org/10.1371/journal.pone.0022323			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21811588	Green Submitted, Green Published, gold			2022-12-25	WOS:000292929500054
J	Li, CH; Li, M; Chen, P; Narayan, S; Matschinsky, FM; Bennett, MJ; Stanley, CA; Smith, TJ				Li, Changhong; Li, Ming; Chen, Pan; Narayan, Srinivas; Matschinsky, Franz M.; Bennett, Michael J.; Stanley, Charles A.; Smith, Thomas J.			Green Tea Polyphenols Control Dysregulated Glutamate Dehydrogenase in Transgenic Mice by Hijacking the ADP Activation Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-SECRETION; REGULATORY MUTATIONS; ACTIVE-SITE; MECHANISM; (-)-EPIGALLOCATECHIN-3-GALLATE; HYPERINSULINISM; CRYSTALLOGRAPHY; CELLS; HYPERAMMONEMIA; METABOLISM	Glutamate dehydrogenase (GDH) catalyzes the oxidative deamination of L-glutamate and, in animals, is extensively regulated by a number of metabolites. Gain of function mutations in GDH that abrogate GTP inhibition cause the hyperinsulinism/hyperammonemia syndrome (HHS), resulting in increased pancreatic beta-cell responsiveness to leucine and susceptibility to hypoglycemia following high protein meals. We have previously shown that two of the polyphenols from green tea (epigallocatechin gallate (EGCG) and epicatechin gallate (ECG)) inhibit GDH in vitro and that EGCG blocks GDH-mediated insulin secretion in wild type rat islets. Using structural and site-directed mutagenesis studies, we demonstrate that ECG binds to the same site as the allosteric regulator, ADP. Perifusion assays using pancreatic islets from transgenic mice expressing a human HHS form of GDH demonstrate that the hyperresponse to glutamine caused by dysregulated GDH is blocked by the addition of EGCG. As observed in HHS patients, these transgenic mice are hypersensitive to amino acid feeding, and this is abrogated by oral administration of EGCG prior to challenge. Finally, the low basal blood glucose level in the HHS mouse model is improved upon chronic administration of EGCG. These results suggest that this common natural product or some derivative thereof may prove useful in controlling this genetic disorder. Of broader clinical implication is that other groups have shown that restriction of glutamine catabolism via these GDH inhibitors can be useful in treating various tumors. This HHS transgenic mouse model offers a highly useful means to test these agents in vivo.	[Li, Ming; Smith, Thomas J.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Li, Changhong; Chen, Pan; Stanley, Charles A.] Childrens Hosp Philadelphia, Div Endocrinol, Philadelphia, PA 19104 USA; [Narayan, Srinivas; Bennett, Michael J.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Matschinsky, Franz M.] Univ Penn, Diabet Res Ctr, Philadelphia, PA 19104 USA; Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	Donald Danforth Plant Science Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Smith, TJ (corresponding author), Donald Danforth Plant Sci Ctr, 975 N Warson Rd, St Louis, MO 63132 USA.	tsmith@danforthcenter.org	Smith, Thomas J/K-9086-2013	Smith, Thomas J/0000-0003-3528-6793; STANLEY, CHARLES/0000-0003-4881-9392	National Institutes of Health [DK072171, DK53012, DK19525]; American Diabetes Association [1-05-RA-128]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525, R01DK072171, R01DK053012] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK072171 (to T. J. S.), DK53012 (to C. A. S.), and DK19525 (for the islet biology and radioimmunoassay cores). This work was also supported by American Diabetes Association Research Award 1-05-RA-128 (to C. A. S.).	Allen A, 2004, BIOCHEMISTRY-US, V43, P14431, DOI 10.1021/bi048817i; Bahi-Buisson N, 2008, DEV MED CHILD NEUROL, V50, P945, DOI 10.1111/j.1469-8749.2008.03114.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAKER PJ, 1992, PROTEINS, V12, P75, DOI 10.1002/prot.340120109; Banerjee S, 2003, BIOCHEMISTRY-US, V42, P3446, DOI 10.1021/bi0206917; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; DEAN JLE, 1994, BIOCHEM J, V301, P13, DOI 10.1042/bj3010013; Di Gangi IM, 2010, ANAL CHIM ACTA, V677, P140, DOI 10.1016/j.aca.2010.08.011; EARHART RH, 1990, INVEST NEW DRUG, V8, P113; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAHIEN LA, 1981, ARCH BIOCHEM BIOPHYS, V212, P247, DOI 10.1016/0003-9861(81)90364-7; Fang J, 2002, BIOCHEM J, V363, P81, DOI 10.1042/0264-6021:3630081; Feng WY, 2006, CURR DRUG METAB, V7, P755, DOI 10.2174/138920006778520552; FRIEDEN C, 1965, J BIOL CHEM, V240, P2028; FRIEDEN C, 1963, BIOCHEM BIOPH RES CO, V10, P410, DOI 10.1016/0006-291X(63)90547-3; GEORGE A, 1980, BIOCHEMISTRY-US, V19, P6057, DOI 10.1021/bi00567a017; Hong J, 2002, CANCER RES, V62, P7241; Hou Z, 2005, CANCER RES, V65, P8049, DOI 10.1158/0008-5472.CAN-05-0480; Hsu BYL, 2001, J PEDIATR-US, V138, P383, DOI 10.1067/mpd.2001.111818; HUDSON RC, 1993, COMP BIOCHEM PHYS B, V106, P767, DOI 10.1016/0305-0491(93)90031-Y; IWATSUBO M, 1967, B SOC CHIM BIOL, V49, P1563; Katpally U, 2007, J VIROL, V81, P6307, DOI 10.1128/JVI.00441-07; KOBERSTEIN R, 1973, EUR J BIOCHEM, V36, P545, DOI 10.1111/j.1432-1033.1973.tb02942.x; Li CH, 2006, J BIOL CHEM, V281, P10214, DOI 10.1074/jbc.M512792200; Li CH, 2004, J BIOL CHEM, V279, P13393, DOI 10.1074/jbc.M311502200; Li CH, 2003, J BIOL CHEM, V278, P2853, DOI 10.1074/jbc.M210577200; Li CH, 2006, J BIOL CHEM, V281, P15064, DOI 10.1074/jbc.M600994200; Li CH, 2010, J BIOL CHEM, V285, P31806, DOI 10.1074/jbc.M110.123638; Li M, 2007, BIOCHEMISTRY-US, V46, P15089, DOI 10.1021/bi7018783; Li M, 2009, J BIOL CHEM, V284, P22988, DOI 10.1074/jbc.M109.020222; Mochizuki M, 2002, BBA-GEN SUBJECTS, V1569, P35, DOI 10.1016/S0304-4165(01)00230-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peterson PE, 1999, STRUCTURE, V7, P769, DOI 10.1016/S0969-2126(99)80101-4; Sang SM, 2005, J AGR FOOD CHEM, V53, P9478, DOI 10.1021/jf0519055; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Smith CA, 1996, ACTA CRYSTALLOGR A, V52, pC226, DOI 10.1107/S0108767396090319; Smith TJ, 2011, EXPERT OPIN DRUG DIS, V6, P589, DOI 10.1517/17460441.2011.570750; Smith TJ, 2008, TRENDS BIOCHEM SCI, V33, P557, DOI 10.1016/j.tibs.2008.07.007; Smith TJ, 1999, ADV VIRUS RES, V52, P1, DOI 10.1016/S0065-3527(08)60297-3; Smith TJ, 2002, J MOL BIOL, V318, P765, DOI 10.1016/S0022-2836(02)00161-4; Smith TJ, 2001, J MOL BIOL, V307, P707, DOI 10.1006/jmbi.2001.4499; SMITH TJ, 1986, SCIENCE, V233, P1286, DOI 10.1126/science.3018924; Stanley C A, 1976, Adv Pediatr, V23, P315; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; STILLMAN TJ, 1993, J MOL BIOL, V234, P1131, DOI 10.1006/jmbi.1993.1665; Yang CD, 2009, CANCER RES, V69, P7986, DOI 10.1158/0008-5472.CAN-09-2266; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641; YIELDING KL, 1961, P NATL ACAD SCI USA, V47, P983, DOI 10.1073/pnas.47.7.983	49	53	55	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34164	34174		10.1074/jbc.M111.268599	http://dx.doi.org/10.1074/jbc.M111.268599			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21813650	Green Published, hybrid			2022-12-25	WOS:000295159200047
J	Richter, D; Katz, B; Oberacker, T; Tzarfaty, V; Belusic, G; Minke, B; Huber, A				Richter, David; Katz, Ben; Oberacker, Tina; Tzarfaty, Vered; Belusic, Gregor; Minke, Baruch; Huber, Armin			Translocation of the Drosophila Transient Receptor Potential-like (TRPL) Channel Requires Both the N- and C-terminal Regions Together with Sustained Ca2+ Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBCELLULAR TRANSLOCATION; LIGHT RESPONSE; ACTIVATION; PHOTORECEPTORS; TRAFFICKING; ADAPTATION; CALCIUM; PATHWAY; INSULIN; PROTEIN	In Drosophila photoreceptors the transient receptor potential-like (TRPL), but not the TRP channels undergo light-dependent translocation between the rhabdomere and cell body. Here we studied which of the TRPL channel segments are essential for translocation and why the TRP channels are required for inducing TRPL translocation. We generated transgenic flies expressing chimeric TRP and TRPL proteins that formed functional light-activated channels. Translocation was induced only in chimera containing both the N- and C-terminal segments of TRPL. Using an inactive trp mutation and overexpressing the Na+/Ca2+ exchanger revealed that the essential function of the TRP channels in TRPL translocation is to enhance Ca2+-influx. These results indicate that motifs present at both the N and C termini as well as sustained Ca2+ entry are required for proper channel translocation.	[Richter, David; Oberacker, Tina; Huber, Armin] Univ Hohenheim, Dept Biosensor, Inst Physiol, D-70599 Stuttgart, Germany; [Katz, Ben; Tzarfaty, Vered; Minke, Baruch] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Med Neurobiol, IL-91120 Jerusalem, Israel; [Katz, Ben; Tzarfaty, Vered; Minke, Baruch] Hebrew Univ Jerusalem, Hadassah Med Sch, Kuhne Minerva Ctr Studies Visual Transduct, IL-91120 Jerusalem, Israel; [Belusic, Gregor] Univ Ljubljana, Dept Biol, Biotech Fac, Ljubljana 1000, Slovenia	University Hohenheim; Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of Ljubljana	Huber, A (corresponding author), Univ Hohenheim, Dept Biosensor, Inst Physiol, August von Hartmann Str 3, D-70599 Stuttgart, Germany.	Armin.Huber@uni-hohenheim.de	Huber, Armin/GYU-6322-2022	Belusic, Gregor/0000-0003-3571-1948; Huber, Armin/0000-0003-3977-089X	National Institutes of Health [EY 03529]; Deutsche Forschungsgemeinschaft [Hu 839/2-5]; German-Israeli Foundation for Scientific Research and Development [I-1001-96.13/2008]; Israel Science Foundation (ISF); NATIONAL EYE INSTITUTE [R01EY003529] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); Israel Science Foundation (ISF)(Israel Science Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by grants from the National Institutes of Health (EY 03529) (to B. M.), Deutsche Forschungsgemeinschaft (Hu 839/2-5) (to A. H.), the German-Israeli Foundation for Scientific Research and Development (I-1001-96.13/2008) (to B. M. and A. H.), and the Israel Science Foundation (ISF) (to B. M.).	Bahner M, 2002, NEURON, V34, P83, DOI 10.1016/S0896-6273(02)00630-X; Becker D, 2008, MOL MEMBR BIOL, V25, P139, DOI 10.1080/09687680701635237; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Boels K, 2001, J CELL SCI, V114, P3599; Cerny AC, 2011, ADV EXP MED BIOL, V704, P545, DOI 10.1007/978-94-007-0265-3_30; Chorna-Ornan I, 2005, J CELL BIOL, V171, P143, DOI 10.1083/jcb.200503014; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Cronin MA, 2006, J CELL SCI, V119, P2935, DOI 10.1242/jcs.03049; Deen PMT, 1997, J AM SOC NEPHROL, V8, P1493; Fushimi K, 1997, J BIOL CHEM, V272, P14800, DOI 10.1074/jbc.272.23.14800; Gkika D, 2006, EMBO J, V25, P4707, DOI 10.1038/sj.emboj.7601357; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; Huber A., 2004, INVERTEBRATE PHOTOTR; Kanzaki M, 1999, NAT CELL BIOL, V1, P165, DOI 10.1038/11086; Katsura T, 1997, AM J PHYSIOL-RENAL, V272, pF816; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; Lambers TT, 2007, MOL CELL BIOL, V27, P1486, DOI 10.1128/MCB.01468-06; Meyer NE, 2008, FLY, V2, P36, DOI 10.4161/fly.5773; Meyer NE, 2006, J CELL SCI, V119, P2592, DOI 10.1242/jcs.02986; Minke B, 2002, PHYSIOL REV, V82, P429, DOI 10.1152/physrev.00001.2002; Minke B, 2006, CELL CALCIUM, V40, P261, DOI 10.1016/j.ceca.2006.05.002; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; Oberegelsbacher C, 2011, EUR J CELL BIOL, V90, P620, DOI 10.1016/j.ejcb.2011.02.003; OTOUSA JE, 1992, VISUAL NEUROSCI, V8, P385, DOI 10.1017/S0952523800004910; Pak W. L., 1979, NEUROGENETICS GENETI; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; PERETZ A, 1994, J GEN PHYSIOL, V104, P1057, DOI 10.1085/jgp.104.6.1057; PERETZ A, 1994, NEURON, V12, P1257, DOI 10.1016/0896-6273(94)90442-1; Phelps CB, 2007, J BIOL CHEM, V282, P36474, DOI 10.1074/jbc.M707205200; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Reuss H, 1997, NEURON, V19, P1249, DOI 10.1016/S0896-6273(00)80416-X; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Scott K, 1997, CELL, V91, P375, DOI 10.1016/S0092-8674(00)80421-3; Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8; Toro CA, 2011, CURR PHARM BIOTECHNO, V12, P12; van Balkom BWM, 2004, AM J PHYSIOL-CELL PH, V286, pC372, DOI 10.1152/ajpcell.00271.2003; Van Buren JJ, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-17; Wang T, 2005, J CELL BIOL, V171, P685, DOI 10.1083/jcb.200508030; Wang T, 2005, NEURON, V45, P367, DOI 10.1016/j.neuron.2004.12.046; Yang ZH, 1998, NEURON, V21, P215, DOI 10.1016/S0896-6273(00)80528-0; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893	46	15	15	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34234	34243		10.1074/jbc.M111.278564	http://dx.doi.org/10.1074/jbc.M111.278564			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21816824	hybrid, Green Published			2022-12-25	WOS:000295159200053
J	Lamers, ML; Almeida, MES; Vicente-Manzanares, M; Horwitz, AF; Santos, MF				Lamers, Marcelo L.; Almeida, Maira E. S.; Vicente-Manzanares, Miguel; Horwitz, Alan F.; Santos, Marinilce F.			High Glucose-Mediated Oxidative Stress Impairs Cell Migration	PLOS ONE			English	Article							FOCAL ADHESIONS; NADPH OXIDASES; DIABETIC-RATS; RAC; RHO; ACTIVATION; INHIBITION; PROTEIN; GROWTH; DYNAMICS	Deficient wound healing in diabetic patients is very frequent, but the cellular and molecular causes are poorly defined. In this study, we evaluate the hypothesis that high glucose concentrations inhibit cell migration. Using CHO.K1 cells, NIH-3T3 fibroblasts, mouse embryonic fibroblasts and primary skin fibroblasts from control and diabetic rats cultured in 5 mM D-glucose (low glucose, LG), 25 mM D-glucose (high glucose, HG) or 25 mM L-glucose medium (osmotic control - OC), we analyzed the migration speed, protrusion stability, cell polarity, adhesion maturation and the activity of the small Rho GTPase Rac1. We also analyzed the effects of reactive oxygen species by incubating cells with the antioxidant N-Acetyl-Cysteine (NAC). We observed that HG conditions inhibited cell migration when compared to LG or OC. This inhibition resulted from impaired cell polarity, protrusion destabilization and inhibition of adhesion maturation. Conversely, Rac1 activity, which promotes protrusion and blocks adhesion maturation, was increased in HG conditions, thus providing a mechanistic basis for the HG phenotype. Most of the HG effects were partially or completely rescued by treatment with NAC. These findings demonstrate that HG impairs cell migration due to an increase in oxidative stress that causes polarity loss, deficient adhesion and protrusion. These alterations arise, in large part, from increased Rac1 activity and may contribute to the poor wound healing observed in diabetic patients.	[Lamers, Marcelo L.] Univ Fed Rio Grande do Sul, Dept Morphol Sci, Inst Basic Hlth Sci, Porto Alegre, RS, Brazil; [Lamers, Marcelo L.; Almeida, Maira E. S.; Santos, Marinilce F.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil; [Vicente-Manzanares, Miguel; Horwitz, Alan F.] Univ Virginia, Dept Cell Biol, Charlottesville, VA USA	Universidade Federal do Rio Grande do Sul; Universidade de Sao Paulo; University of Virginia	Lamers, ML (corresponding author), Univ Fed Rio Grande do Sul, Dept Morphol Sci, Inst Basic Hlth Sci, Porto Alegre, RS, Brazil.	mfsantos@usp.br	Almeida, Maira/F-7175-2013; Vicente-Manzanares, Miguel/H-1010-2018; Bustelo, Xose R./A-9526-2010; Santos, Marinilce F/G-9548-2011; LAMERS, MARCELO/A-5291-2013	Vicente-Manzanares, Miguel/0000-0001-5943-3220; Bustelo, Xose R./0000-0001-9398-6072; Santos, Marinilce F/0000-0002-3257-3327; LAMERS, MARCELO/0000-0001-5296-5662	NIH [GM23244]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES [5181062]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [06/57508-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [478606/2010-9, 480092/2010-9]; Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul - FAPERGS [0903698]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM023244, R01GM023244] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul - FAPERGS(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by the following agencies/grants: NIH (GM23244), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES (#5181062), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (06/57508-2), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (478606/2010-9; 480092/2010-9), Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul - FAPERGS (0903698). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Braiman-Wiksman L, 2007, TOXICOL PATHOL, V35, P767, DOI 10.1080/01926230701584189; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Chiarugi P, 2003, J CELL BIOL, V161, P933, DOI 10.1083/jcb.200211118; Chiarugi P, 2007, ANTIOXID REDOX SIGN, V9, P1, DOI 10.1089/ars.2007.9.1; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Demidenko ZN, 2009, AGING-US, V1, P1008, DOI 10.18632/aging.100115; Demidenko ZN, 2009, CELL CYCLE, V8, P1896, DOI 10.4161/cc.8.12.8809; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Glaven JA, 1999, J BIOL CHEM, V274, P2279, DOI 10.1074/jbc.274.4.2279; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hinz B, 1999, EXP CELL RES, V251, P234, DOI 10.1006/excr.1999.4541; Kolavennu V, 2008, DIABETES, V57, P714, DOI 10.2337/db07-1241; Korotchkina LG, 2010, AGING-US, V2, P344, DOI 10.18632/aging.100160; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Lan CCE, 2008, BRIT J DERMATOL, V159, P1103, DOI 10.1111/j.1365-2133.2008.08789.x; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lerman OZ, 2003, AM J PATHOL, V162, P303, DOI 10.1016/S0002-9440(10)63821-7; Li JM, 2010, DIABETES, V59, P2033, DOI 10.2337/db09-1800; Lin GR, 2007, CARDIOVASC RES, V75, P51, DOI 10.1016/j.cardiores.2007.03.009; Liu L, 2010, J BIOL CHEM, V285, P38362, DOI 10.1074/jbc.M110.141168; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Miyano K, 2007, BIOCHIMIE, V89, P1133, DOI 10.1016/j.biochi.2007.05.003; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Pan Y, 2009, AGING-US, V1, P131, DOI 10.18632/aging.100016; Pani G, 2010, AGING-US, V2, P514, DOI 10.18632/aging.100182; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Paravicini TM, 2008, DIABETES CARE, V31, pS170, DOI 10.2337/dc08-s247; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Peng FF, 2008, DIABETES, V57, P1683, DOI 10.2337/db07-1149; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; SANDERS DA, 1990, CELL GROWTH DIFFER, V1, P251; Shen E, 2009, DIABETES, V58, P2386, DOI 10.2337/db08-0617; Shiga N, 2005, CIRC RES, V96, P1014, DOI 10.1161/01.RES.0000165483.34603.91; Tang JP, 2006, ACTA PHARMACOL SIN, V27, P543, DOI 10.1111/j.1745-7254.2006.00325.x; Terada LS, 2006, J CELL BIOL, V174, P615, DOI 10.1083/jcb.200605036; Ueda S, 2008, BIOL CELL, V100, P645, DOI 10.1042/BC20070160; Vecchione C, 2006, CIRC RES, V98, P218, DOI 10.1161/01.RES.0000200440.18768.30; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wu RF, 2005, J CELL BIOL, V171, P893, DOI 10.1083/jcb.200507004; Yach D, 2006, NAT MED, V12, P62, DOI 10.1038/nm0106-62	46	107	111	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22865	10.1371/journal.pone.0022865	http://dx.doi.org/10.1371/journal.pone.0022865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826213	Green Published, gold, Green Submitted			2022-12-25	WOS:000293558900039
J	Mori, M; Sriwanthana, B; Wichukchinda, N; Boonthimat, C; Tsuchiya, N; Miura, T; Pathipvanich, P; Ariyoshi, K; Sawanpanyalert, P				Mori, Masahiko; Sriwanthana, Busarawan; Wichukchinda, Nuanjun; Boonthimat, Chetsada; Tsuchiya, Naho; Miura, Toshiyuki; Pathipvanich, Panita; Ariyoshi, Koya; Sawanpanyalert, Pathom			Unique CRF01_AE Gag CTL Epitopes Associated with Lower HIV-Viral Load and Delayed Disease Progression in a Cohort of HIV-Infected Thais	PLOS ONE			English	Article							T-CELL RESPONSES; CLASS-I; TYPE-1; LYMPHOCYTES; PROTEINS; SELECT; INDIVIDUALS; RECOGNITION; DIVERSE; IMPACT	Cytotoxic T Lymphocytes (CTLs) play a central role in controlling HIV-replication. Although numerous CTL epitopes have been described, most are in subtype B or C infection. Little is known about CTL responses in CRF01_AE infection. Gag CTL responses were investigated in a cohort of 137 treatment-naive HIV-1 infected Thai patients with high CD4+ T cell counts, using gIFN Enzyme-Linked Immunospot (ELISpot) assays with 15-mer overlapping peptides (OLPs) derived from locally dominant CRF01_AE Gag sequences. 44 OLPs were recognized in 112 (81.8%) individuals. Both the breadth and magnitude of the CTL response, particularly against the p24 region, positively correlated with CD4+ T cell count and inversely correlated with HIV viral load. The breadth of OLP response was also associated with slower progression to antiretroviral therapy initiation. Statistical analysis and single peptide ELISpot assay identified at least 17 significant associations between reactive OLP and HLA in 12 OLP regions; 6 OLP-HLA associations (35.3%) were not compatible with previously reported CTL epitopes, suggesting that these contained new CTL Gag epitopes. A substantial proportion of CTL epitopes in CRF01_AE infection differ from subtype B or C. However, the pattern of protective CTL responses is similar; Gag CTL responses, particularly against p24, control viral replication and slow clinical progression.	[Mori, Masahiko; Tsuchiya, Naho; Ariyoshi, Koya] Nagasaki Univ, Inst Trop Med NEKKEN, Dept Clin Med, Nagasaki 852, Japan; [Mori, Masahiko] JFAP, Tokyo, Japan; [Sriwanthana, Busarawan; Wichukchinda, Nuanjun; Boonthimat, Chetsada; Sawanpanyalert, Pathom] Minist Publ Hlth, Dept Med Sci, Natl Inst Hlth, Nonthaburi, Thailand; [Tsuchiya, Naho; Ariyoshi, Koya] Nagasaki Univ, Global COE Program, Nagasaki 852, Japan; [Miura, Toshiyuki] Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Tokyo, Japan; [Pathipvanich, Panita] Lampang Hosp, Day Care Ctr, Lampang, Thailand	Nagasaki University; Ministry of Public Health - Thailand; Nagasaki University; University of Tokyo	Mori, M (corresponding author), Nagasaki Univ, Inst Trop Med NEKKEN, Dept Clin Med, Nagasaki 852, Japan.	kari@nagasaki-u.ac.jp			Japan Ministry of Health, Labour and Welfare; Japan Foundation for AIDS Prevention; Nagasaki University; Ministry of Public Health, Thailand	Japan Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Foundation for AIDS Prevention; Nagasaki University; Ministry of Public Health, Thailand	This study was mainly supported by the Japan Ministry of Health, Labour and Welfare; the Japan Foundation for AIDS Prevention and gCOE program, Nagasaki University; and partly by the Ministry of Public Health, Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Brumme Z, 2009, CLIN INFECT DIS, V49, P956, DOI 10.1086/605503; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; Dong T, 2004, J EXP MED, V200, P1547, DOI 10.1084/jem.20032044; Dorrell L, 2001, EUR J IMMUNOL, V31, P1747, DOI 10.1002/1521-4141(200106)31:6<1747::AID-IMMU1747>3.3.CO;2-C; Ferrari G, 1997, P NATL ACAD SCI USA, V94, P1396, DOI 10.1073/pnas.94.4.1396; Geels MJ, 2005, J VIROL, V79, P11247, DOI 10.1128/JVI.79.17.11247-11258.2005; Geldmacher C, 2007, J VIROL, V81, P2440, DOI 10.1128/JVI.01847-06; Gesprasert G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011179; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Gudmundsdotter L, 2008, VACCINE, V26, P5182, DOI 10.1016/j.vaccine.2008.03.094; Julg B, 2010, J VIROL, V84, P5540, DOI 10.1128/JVI.02031-09; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kaslow RA, 2005, J INFECT DIS, V191, pS68, DOI 10.1086/425269; Kern F, 1999, J VIROL, V73, P8179, DOI 10.1128/JVI.73.10.8179-8184.1999; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Lieberman J, 1997, AIDS RES HUM RETROV, V13, P383, DOI 10.1089/aid.1997.13.383; Malhotra U, 2007, VACCINE, V25, P381, DOI 10.1016/j.vaccine.2006.07.045; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Masemola A, 2004, J VIROL, V78, P3233, DOI 10.1128/JVI.78.7.3233-3243.2004; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Meyer-Olson D, 2006, BLOOD, V107, P2373, DOI 10.1182/blood-2005-04-1636; Miura T, 2009, J VIROL, V83, P2743, DOI 10.1128/JVI.02265-08; Novitsky V, 2003, J VIROL, V77, P882, DOI 10.1128/JVI.77.2.882-890.2003; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; Seth A, 2000, AIDS RES HUM RETROV, V16, P337, DOI 10.1089/088922200309214; Streeck H, 2009, NAT PROTOC, V4, P461, DOI 10.1038/nprot.2009.7; Tenzer S, 2009, NAT IMMUNOL, V10, P636, DOI 10.1038/ni.1728; Thakar MR, 2005, J INFECT DIS, V192, P749, DOI 10.1086/432547; Yokomaku Y, 2004, J VIROL, V78, P1324, DOI 10.1128/JVI.78.3.1324-1332.2004; Yu XG, 2005, AIDS, V19, P1449, DOI 10.1097/01.aids.0000183126.32077.c8; Yusim K, 2002, J VIROL, V76, P8757, DOI 10.1128/JVI.76.17.8757-8768.2002; Zuniga R, 2006, J VIROL, V80, P3122, DOI 10.1128/JVI.80.6.3122-3125.2006	37	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22680	10.1371/journal.pone.0022680	http://dx.doi.org/10.1371/journal.pone.0022680			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826201	Green Published, Green Submitted, gold			2022-12-25	WOS:000293558900027
J	Gassmann, AJ; Petzold-Maxwell, JL; Keweshan, RS; Dunbar, MW				Gassmann, Aaron J.; Petzold-Maxwell, Jennifer L.; Keweshan, Ryan S.; Dunbar, Mike W.			Field-Evolved Resistance to Bt Maize by Western Corn Rootworm	PLOS ONE			English	Article							TRANSGENIC CROPS; INSECT RESISTANCE; CHRYSOMELIDAE POPULATIONS; COLEOPTERA; EVOLUTION; COTTON; SUPPRESSION; ADAPTATION; BOLLWORM; ECOLOGY	Background: Crops engineered to produce insecticidal toxins derived from the bacterium Bacillus thuringiensis (Bt) are planted on millions of hectares annually, reducing the use of conventional insecticides and suppressing pests. However, the evolution of resistance could cut short these benefits. A primary pest targeted by Bt maize in the United States is the western corn rootworm Diabrotica virgifera virgifera (Coleoptera: Chrysomelidae). Methodology/Principal Findings: We report that fields identified by farmers as having severe rootworm feeding injury to Bt maize contained populations of western corn rootworm that displayed significantly higher survival on Cry3Bb1 maize in laboratory bioassays than did western corn rootworm from fields not associated with such feeding injury. In all cases, fields experiencing severe rootworm feeding contained Cry3Bb1 maize. Interviews with farmers indicated that Cry3Bb1 maize had been grown in those fields for at least three consecutive years. There was a significant positive correlation between the number of years Cry3Bb1 maize had been grown in a field and the survival of rootworm populations on Cry3Bb1 maize in bioassays. However, there was no significant correlation among populations for survival on Cry34/35Ab1 maize and Cry3Bb1 maize, suggesting a lack of cross resistance between these Bt toxins. Conclusions/Significance: This is the first report of field-evolved resistance to a Bt toxin by the western corn rootworm and by any species of Coleoptera. Insufficient planting of refuges and non-recessive inheritance of resistance may have contributed to resistance. These results suggest that improvements in resistance management and a more integrated approach to the use of Bt crops may be necessary.	[Gassmann, Aaron J.; Petzold-Maxwell, Jennifer L.; Keweshan, Ryan S.; Dunbar, Mike W.] Iowa State Univ, Dept Entomol, Ames, IA 50011 USA	Iowa State University	Gassmann, AJ (corresponding author), Iowa State Univ, Dept Entomol, Ames, IA 50011 USA.	aaronjg@iastate.edu			United States Department of Agriculture; College of Agriculture and Life Sciences at Iowa State University; Dow; Monsanto; Pioneer; Syngenta; Bayer CropScience	United States Department of Agriculture(United States Department of Agriculture (USDA)); College of Agriculture and Life Sciences at Iowa State University; Dow; Monsanto; Pioneer; Syngenta(Syngenta); Bayer CropScience(Bayer AG)	This research was supported through the Biotechnology Risk Assessment Grant program of the United States Department of Agriculture, and through the College of Agriculture and Life Sciences at Iowa State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Aaron Gassmann has received research funding, not related to this project, from Dow, Monsanto, Pioneer, Syngenta, and Bayer CropScience. Aaron Gassmann has filed a provisional patent for the seedling based assay described in this manuscript. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Bagla P, 2010, SCIENCE, V327, P1439, DOI 10.1126/science.327.5972.1439; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; CAPRIO MA, 1992, J ECON ENTOMOL, V85, P611, DOI 10.1093/jee/85.3.611; Carriere Y, 2003, P NATL ACAD SCI USA, V100, P1519, DOI 10.1073/pnas.0436708100; Carriere Y, 2010, EVOL APPL, V3, P561, DOI 10.1111/j.1752-4571.2010.00129.x; Cattaneo MG, 2006, P NATL ACAD SCI USA, V103, P7571, DOI 10.1073/pnas.0508312103; Coates BS, 2009, J HERED, V100, P556, DOI 10.1093/jhered/esp028; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; Downes S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012567; *ENV PROT AG, 2009, PEST FACT SHEET; *ENV PROT AG, 2003, BIOP REG ACT DOC EV; *ENV PROT AG, 2010, BIOP REG ACT DOC; Gassmann AJ, 2009, ANNU REV ENTOMOL, V54, P147, DOI 10.1146/annurev.ento.54.110807.090518; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Gray ME, 2009, ANNU REV ENTOMOL, V54, P303, DOI 10.1146/annurev.ento.54.110807.090434; Huang JK, 2005, SCIENCE, V308, P688, DOI 10.1126/science.1108972; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; Jaffe G., 2009, COMPLANCENCY FARM SI; Jaffe K, 1997, J THEOR BIOL, V188, P289, DOI 10.1006/jtbi.1997.0472; Kim KS, 2005, ENVIRON ENTOMOL, V34, P494, DOI 10.1603/0046-225X-34.2.494; Levine Eli, 2002, American Entomologist, V48, P94; Meihls LN, 2008, P NATL ACAD SCI USA, V105, P19177, DOI 10.1073/pnas.0805565105; Meinke LJ, 1998, J ECON ENTOMOL, V91, P594, DOI 10.1093/jee/91.3.594; Metcalf R. L., 1986, ECOLOGICAL THEORY IN, P251; Nowatzki TM, 2008, J APPL ENTOMOL, V132, P177, DOI 10.1111/j.1439-0418.2008.01270.x; Oleson JD, 2005, J ECON ENTOMOL, V98, P1, DOI 10.1603/0022-0493-98.1.1; Onstad DW, 2010, J ECON ENTOMOL, V103, P849, DOI 10.1603/EC09199; Parimi S, 2006, CROP PROT, V25, P269, DOI 10.1016/j.cropro.2005.04.017; Pedigo LP., 2009, ENTOMOLOGY PEST MANA; Roush RT, 1998, PHILOS T R SOC B, V353, P1777, DOI 10.1098/rstb.1998.0330; Roush RT, 1997, PESTIC SCI, V51, P328, DOI 10.1002/(SICI)1096-9063(199711)51:3&lt;328::AID-PS650&gt;3.0.CO;2-B; Sisterson MS, 2005, J ECON ENTOMOL, V98, P1751, DOI 10.1603/0022-0493-98.6.1751; Sokal R. R., 2012, BIOMETRY; Spencer JL, 2003, J ECON ENTOMOL, V96, P1738, DOI 10.1603/0022-0493-96.6.1738; Spencer JL, 2009, AGR FOREST ENTOMOL, V11, P9, DOI 10.1111/j.1461-9563.2008.00399.x; STERN VERNON M., 1959, HILGARDIA, V29, P81; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Tabashnik BE, 2004, J EVOLUTION BIOL, V17, P904, DOI 10.1111/j.1420-9101.2004.00695.x; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2010, NAT BIOTECHNOL, V28, P1304, DOI 10.1038/nbt.1704; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; Walters FS, 2008, APPL ENVIRON MICROB, V74, P367, DOI 10.1128/AEM.02165-07; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550	44	447	464	4	181	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22629	10.1371/journal.pone.0022629	http://dx.doi.org/10.1371/journal.pone.0022629			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829470	gold, Green Submitted, Green Published			2022-12-25	WOS:000293286500015
J	Bacher, N; Graulich, E; Jonuleit, H; Grabbe, S; Steinbrink, K				Bacher, Nicole; Graulich, Edith; Jonuleit, Helmut; Grabbe, Stephan; Steinbrink, Kerstin			Interferon-alpha Abrogates Tolerance Induction by Human Tolerogenic Dendritic Cells	PLOS ONE			English	Article							REGULATORY T-CELLS; IFN-ALPHA; SUPPRESSOR ACTIVITY; IN-VITRO; CD4(+); EXPRESSION; MELANOMA; IL-10; DIFFERENTIATION; INTERLEUKIN-12	Background: Administration of interferon-alpha (IFN-alpha) represents an approved adjuvant therapy as reported for malignancies like melanoma and several viral infections. In malignant diseases, tolerance processes are critically involved in tumor progression. In this study, the effect of IFN-alpha on tolerance induction by human tolerogenic dendritic cells (DC) was analyzed. We focussed on tolerogenic IL-10-modulated DC (IL-10 DC) that are known to induce anergic regulatory T cells (iTregs). Methodology/Principal Findings: IFN-alpha promoted an enhanced maturation of IL-10 DC as demonstrated by upregulation of the differentiation marker CD83 as well as costimulatory molecules. IFN-alpha treatment resulted in an increased capacity of DC to stimulate T cell activation compared to control tolerogenic DC. We observed a strengthened T cell proliferation and increased IFN-gamma production of CD4(+) and CD8(+) T cells stimulated by IFN-alpha-DC, demonstrating a restoration of the immunogenic capacity of tolerogenic DC in the presence of IFN-alpha. Notably, restimulation experiments revealed that IFN-alpha treatment of tolerogenic DC abolished the induction of T cell anergy and suppressor function of iTregs. In contrast, IFN-alpha Conclusions/Significance: IFN-alpha inhibits the induction of T cell tolerance by reversing the tolerogenic function of human DC.	[Bacher, Nicole; Graulich, Edith; Jonuleit, Helmut; Grabbe, Stephan; Steinbrink, Kerstin] Johannes Gutenberg Univ Mainz, Dept Dermatol, Univ Med Ctr Mainz, Mainz, Germany	Johannes Gutenberg University of Mainz	Bacher, N (corresponding author), Johannes Gutenberg Univ Mainz, Dept Dermatol, Univ Med Ctr Mainz, Mainz, Germany.	nicole.bacher@unimedizin-mainz.de; kerstin.steinbrink@unimedizin-mainz.de	Grabe, Stephan/AAJ-4578-2021; Jonuleit, Helmut/D-8059-2011	Grabe, Stephan/0000-0002-6863-8719; Jonuleit, Helmut/0000-0002-5672-9365	German Research Foundation [52/TPA7]; DFG [STE791/4-5, STE/5-1]; Foundation Rhineland-Palatinate	German Research Foundation(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Foundation Rhineland-Palatinate	This work was supported by the German Research Foundation (Transregio 52/TPA7, DFG STE791/4-5, STE/5-1) and the Foundation Rhineland-Palatinate to KS and intramural grants to NB (MAIFOR) and KS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler HS, 2007, BLOOD, V109, P4351, DOI 10.1182/blood-2006-09-047563; Adler HS, 2010, J IMMUNOL, V184, P6025, DOI 10.4049/jimmunol.0901327; Belardelli F, 2002, CYTOKINE GROWTH F R, V13, P119, DOI 10.1016/S1359-6101(01)00022-3; Bogdan C, 2004, IMMUNOL REV, V202, P33, DOI 10.1111/j.0105-2896.2004.00207.x; Carbonneil C, 2004, INT IMMUNOL, V16, P1037, DOI 10.1093/intimm/dxh106; Commins S, 2008, J ALLERGY CLIN IMMUN, V121, P1108, DOI 10.1016/j.jaci.2008.02.026; Cousens LP, 1997, P NATL ACAD SCI USA, V94, P634, DOI 10.1073/pnas.94.2.634; Dondi E, 2004, J IMMUNOL, V173, P3740, DOI 10.4049/jimmunol.173.6.3740; Enk AH, 1997, INT J CANCER, V73, P309, DOI 10.1002/(SICI)1097-0215(19971104)73:3<309::AID-IJC1>3.0.CO;2-3; Fortis C, 1996, CANCER LETT, V104, P1, DOI 10.1016/0304-3835(96)04213-9; Garbe C, 2009, CLIN DERMATOL, V27, P3, DOI 10.1016/j.clindermatol.2008.09.001; Garbe C, 2010, EUR J CANCER, V46, P270, DOI 10.1016/j.ejca.2009.10.032; Gimeno R, 2005, MOL CELL BIOL, V25, P5456, DOI 10.1128/MCB.25.13.5456-5465.2005; Gogas H, 2006, NEW ENGL J MED, V354, P709, DOI 10.1056/NEJMoa053007; Golding A, 2010, IMMUNOLOGY, V131, P107, DOI 10.1111/j.1365-2567.2010.03280.x; Gregori S, 2010, BLOOD, V116, P935, DOI 10.1182/blood-2009-07-234872; GUTTERMAN JU, 1994, P NATL ACAD SCI USA, V91, P1198, DOI 10.1073/pnas.91.4.1198; Jonuleit H, 2002, J EXP MED, V196, P255, DOI 10.1084/jem.20020394; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; KRAUZE MT, 2011, SEMIN IMMUNOPAT 0131; Kubsch S, 2003, EUR J IMMUNOL, V33, P1988, DOI 10.1002/eji.200323600; Levings MK, 2001, J IMMUNOL, V166, P5530, DOI 10.4049/jimmunol.166.9.5530; Limmroth V, 2007, J NEUROL, V254, P67, DOI 10.1007/s00415-006-0281-1; Manicassamy S, 2011, IMMUNOL REV, V241, P206, DOI 10.1111/j.1600-065X.2011.01015.x; Moschella F, 2003, CLIN CANCER RES, V9, P2022; Muthuswamy R, 2008, CANCER RES, V68, P5972, DOI 10.1158/0008-5472.CAN-07-6818; Pace L, 2010, J IMMUNOL, V184, P5969, DOI 10.4049/jimmunol.0900526; Parlato S, 2001, BLOOD, V98, P3022, DOI 10.1182/blood.V98.10.3022; Romerio F, 2002, FASEB J, V16, P1680, DOI 10.1096/fj.02-0120fje; Santini SM, 2000, J EXP MED, V191, P1777, DOI 10.1084/jem.191.10.1777; Santini SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017364; Sato T, 1996, CLIN CANCER RES, V2, P1383; Shibuya H, 2005, J ALLERGY CLIN IMMUN, V116, P205, DOI 10.1016/j.jaci.2005.03.016; Shibuya H, 2003, CLIN EXP IMMUNOL, V132, P216, DOI 10.1046/j.1365-2249.2003.02128.x; Smyth MJ, 2004, IMMUNOL REV, V202, P275, DOI 10.1111/j.0105-2896.2004.00199.x; Steinbrink K, 1997, J IMMUNOL, V159, P4772; Steinbrink K, 1999, BLOOD, V93, P1634, DOI 10.1182/blood.V93.5.1634.405k11_1634_1642; Steinbrink K, 2002, BLOOD, V99, P2468, DOI 10.1182/blood.V99.7.2468; Stewart TJ, 2008, ONCOGENE, V27, P5894, DOI 10.1038/onc.2008.268; Tamir A, 2005, CLIN EXP IMMUNOL, V142, P471, DOI 10.1111/j.1365-2249.2005.02933.x; Trepiakas R, 2009, VACCINE, V27, P2213, DOI 10.1016/j.vaccine.2009.02.015; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Xu ML, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/832454; Yan B, 2008, ARTHRITIS RHEUM-US, V58, P801, DOI 10.1002/art.23268; Zagury D, 1998, P NATL ACAD SCI USA, V95, P3851, DOI 10.1073/pnas.95.7.3851; Zella D, 2000, J IMMUNOL, V164, P2296, DOI 10.4049/jimmunol.164.5.2296	46	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22763	10.1371/journal.pone.0022763	http://dx.doi.org/10.1371/journal.pone.0022763			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818385	Green Submitted, Green Published, gold			2022-12-25	WOS:000293282700072
J	Herbach, N; Bergmayr, M; Goke, B; Wolf, E; Wanke, R				Herbach, Nadja; Bergmayr, Martina; Goeke, Burkhard; Wolf, Eckhard; Wanke, Ruediger			Postnatal Development of Numbers and Mean Sizes of Pancreatic Islets and Beta-Cells in Healthy Mice and GIPR(dn) Transgenic Diabetic Mice	PLOS ONE			English	Article							DEPENDENT INSULINOTROPIC POLYPEPTIDE; GLUCAGON-LIKE PEPTIDE-1; ENDOCRINE PANCREAS; LINEAR CORRELATION; GLUCOSE-INFUSION; PROGENITOR CELLS; ADULT PANCREAS; PROTEIN-KINASE; RAT PANCREAS; MASS	The aim of this study was to examine postnatal islet and beta-cell expansion in healthy female control mice and its disturbances in diabetic GIPR(dn) transgenic mice, which exhibit an early reduction of beta-cell mass. Pancreata of female control and GIPR(dn) transgenic mice, aged 10, 45, 90 and 180 days were examined, using state-of-the-art quantitative-stereological methods. Total islet and beta-cell volumes, as well as their absolute numbers increased significantly until 90 days in control mice, and remained stable thereafter. The mean islet volumes of controls also increased slightly but significantly between 10 and 45 days of age, and then remained stable until 180 days. The total volume of isolated betac-ells, an indicator of islet neogenesis, and the number of proliferating (BrdU-positive) islet cells were highest in 10-day-old controls and declined significantly between 10 and 45 days. In GIPR(dn) transgenic mice, the numbers of islets and beta-cells were significantly reduced from 10 days of age onwards vs. controls, and no postnatal expansion of total islet and beta-cell volumes occurred due to a reduction in islet neogenesis whereas early islet-cell proliferation and apoptosis were unchanged as compared to control mice. Insulin secretion in response to pharmacological doses of GIP was preserved in GIPR(dn) transgenic mice, and serum insulin to pancreatic insulin content in response to GLP-1 and arginine was significantly higher in GIPR(dn) transgenic mice vs. controls. We could show that the increase in islet number is mainly responsible for expansion of islet and beta-cell mass in healthy control mice. GIPR(dn) transgenic mice show a disturbed expansion of the endocrine pancreas, due to perturbed islet neogenesis.	[Herbach, Nadja; Bergmayr, Martina; Wanke, Ruediger] Ludwig Maximilians Univ Munchen, Ctr Clin Vet Med, Inst Vet Pathol, Munich, Germany; [Goeke, Burkhard] Ludwig Maximilians Univ Munchen, Dept Internal Med 2, Univ Clin Grosshadern, Munich, Germany; [Wolf, Eckhard] Ludwig Maximilians Univ Munchen, Chair Mol Anim Breeding & Biotechnol, Munich, Germany; [Wolf, Eckhard] Ludwig Maximilians Univ Munchen, Gene Ctr, Lab Funct Genome Anal LAFUGA, Munich, Germany	University of Munich; University of Munich; University of Munich; University of Munich	Herbach, N (corresponding author), Ludwig Maximilians Univ Munchen, Ctr Clin Vet Med, Inst Vet Pathol, Munich, Germany.	herbach@patho.vetmed.uni-muenchen.de		Wolf, Eckhard/0000-0002-0430-9510; Herbach, Nadja/0000-0001-5893-0356; Wanke, Rudiger/0000-0002-0153-224X				Ablamunits V, 2007, ANN NY ACAD SCI, V1103, P19, DOI 10.1196/annals.1394.006; Ahren B, 2005, CURR MOL MED, V5, P275, DOI 10.2174/1566524053766004; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bernard C, 1998, DIABETES, V47, P1058, DOI 10.2337/diabetes.47.7.1058; Bernard C, 1999, FASEB J, V13, P1195, DOI 10.1096/fasebj.13.10.1195; Bock T, 2005, DIABETES, V54, P133, DOI 10.2337/diabetes.54.1.133; Bonner-Weir S, 2006, NAT CLIN PRACT ENDOC, V2, P240, DOI 10.1038/ncpendmet0186; Bonner-Weir S, 2000, ENDOCRINOLOGY, V141, P1926, DOI 10.1210/en.141.6.1926; BONNERWEIR S, 1989, DIABETES, V38, P49, DOI 10.2337/diabetes.38.1.49; Bouwens L, 2005, PHYSIOL REV, V85, P1255, DOI 10.1152/physrev.00025.2004; Bouwens L, 1998, DIABETOLOGIA, V41, P629, DOI 10.1007/s001250050960; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; CREUTZFELDT W, 1992, DIABETES METAB REV, V8, P149, DOI 10.1002/dmr.5610080206; De Leon DD, 2003, DIABETES, V52, P365, DOI 10.2337/diabetes.52.2.365; Del Prato S, 2009, DIABETIC MED, V26, P1185, DOI 10.1111/j.1464-5491.2009.02847.x; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Dor Y, 2008, CELL, V132, P183, DOI 10.1016/j.cell.2008.01.004; Ehses JA, 2003, ENDOCRINOLOGY, V144, P4433, DOI 10.1210/en.2002-0068; FEHMANN HC, 1995, ENDOCR REV, V16, P390, DOI 10.1210/er.16.3.390; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; FINEGOOD DT, 1995, DIABETES, V44, P249, DOI 10.2337/diabetes.44.3.249; Flock G, 2007, DIABETES, V56, P3006, DOI 10.2337/db07-0697; Granger A, 2009, J INTERN MED, V266, P325, DOI 10.1111/j.1365-2796.2009.02156.x; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Guiot Y, 2001, DIABETES, V50, pS188, DOI 10.2337/diabetes.50.2007.S188; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Herbach N, 2005, REGUL PEPTIDES, V125, P103, DOI 10.1016/j.regpep.2004.08.021; Herbach N, 2008, REGUL PEPTIDES, V146, P260, DOI 10.1016/j.regpep.2007.10.005; Herbach N, 2007, DIABETES, V56, P1268, DOI 10.2337/db06-0658; Howard CV, 2005, UNBIASED STEREOLOGY; Inuwa IM, 2005, J ANAT, V206, P185, DOI 10.1111/j.1469-7580.2005.00367.x; Jo JH, 2007, BIOPHYS J, V93, P2655, DOI 10.1529/biophysj.107.104125; Kaiser N, 2003, J PEDIATR ENDOCR MET, V16, P5, DOI 10.1515/JPEM.2003.16.1.5; Kassem SA, 2000, DIABETES, V49, P1325, DOI 10.2337/diabetes.49.8.1325; Kim SJ, 2005, J BIOL CHEM, V280, P22297, DOI 10.1074/jbc.M500540200; KLOPPEL G, 1985, SURV SYN PATHOL RES, V4, P110; Ling Z, 2001, VIRCHOWS ARCH, V438, P382, DOI 10.1007/s004280000374; Lipsett M, 2002, DIABETES, V51, P1834, DOI 10.2337/diabetes.51.6.1834; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Montanya E, 2000, DIABETES, V49, P1341, DOI 10.2337/diabetes.49.8.1341; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Pamir N, 2003, AM J PHYSIOL-ENDOC M, V284, pE931, DOI 10.1152/ajpendo.00270.2002; Peng SW, 2009, ENDOCRINOLOGY, V150, P3058, DOI 10.1210/en.2008-1731; Pospisilik JA, 2003, DIABETES, V52, P741, DOI 10.2337/diabetes.52.3.741; RAHIER J, 1983, DIABETOLOGIA, V24, P366; Rankin MM, 2009, DIABETES, V58, P1365, DOI 10.2337/db08-1198; Renner S, 2010, DIABETES, V59, P1228, DOI 10.2337/db09-0519; Rukstalis JM, 2009, ISLETS, V1, P177, DOI 10.4161/isl.1.3.9877; Sakuraba H, 2002, DIABETOLOGIA, V45, P85, DOI 10.1007/s125-002-8248-z; SCAGLIA L, 1995, ENDOCRINOLOGY, V136, P5461, DOI 10.1210/en.136.12.5461; Scaglia L, 1997, ENDOCRINOLOGY, V138, P1736, DOI 10.1210/en.138.4.1736; Seymour PA, 2004, J ANAT, V204, P103, DOI 10.1111/j.1469-7580.2004.00265.x; Skau M, 2001, DIABETES, V50, P1763, DOI 10.2337/diabetes.50.8.1763; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Trudeau JD, 2000, DIABETES, V49, P1, DOI 10.2337/diabetes.49.1.1; Trumper A, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740233; Trumper A, 2001, MOL ENDOCRINOL, V15, P1559, DOI 10.1210/me.15.9.1559; Weibel E., 1979, STEREOLOGICAL METHOD; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Weir GC, 2001, DIABETES, V50, pS154, DOI 10.2337/diabetes.50.2007.S154; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015	63	29	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e22814	10.1371/journal.pone.0022814	http://dx.doi.org/10.1371/journal.pone.0022814			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21818396	Green Published, Green Submitted, gold			2022-12-25	WOS:000293175100051
J	Oberg, AI; Yassin, K; Csikasz, RI; Dehvari, N; Shabalina, IG; Hutchinson, DS; Wilcke, M; Ostenson, CG; Bengtsson, T				Oberg, Anette I.; Yassin, Kamal; Csikasz, Robert I.; Dehvari, Nodi; Shabalina, Irina G.; Hutchinson, Dana S.; Wilcke, Mona; Ostenson, Claes-Goran; Bengtsson, Tore			Shikonin Increases Glucose Uptake in Skeletal Muscle Cells and Improves Plasma Glucose Levels in Diabetic Goto-Kakizaki Rats	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; TRANSPORT; CALCIUM; CA2+; MITOCHONDRIA; EXERCISE; AMPK	Background: There is considerable interest in identifying compounds that can improve glucose homeostasis. Skeletal muscle, due to its large mass, is the principal organ for glucose disposal in the body and we have investigated here if shikonin, a naphthoquinone derived from the Chinese plant Lithospermum erythrorhizon, increases glucose uptake in skeletal muscle cells. Methodology/Principal Findings: Shikonin increases glucose uptake in L6 skeletal muscle myotubes, but does not phosphorylate Akt, indicating that in skeletal muscle cells its effect is medaited via a pathway distinct from that used for insulin-stimulated uptake. Furthermore we find no evidence for the involvement of AMP-activated protein kinase in shikonin induced glucose uptake. Shikonin increases the intracellular levels of calcium in these cells and this increase is necessary for shikonin-mediated glucose uptake. Furthermore, we found that shikonin stimulated the translocation of GLUT4 from intracellular vesicles to the cell surface in L6 myoblasts. The beneficial effect of shikonin on glucose uptake was investigated in vivo by measuring plasma glucose levels and insulin sensitivity in spontaneously diabetic Goto-Kakizaki rats. Treatment with shikonin (10 mg/kg intraperitoneally) once daily for 4 days significantly decreased plasma glucose levels. In an insulin sensitivity test (s.c. injection of 0.5 U/kg insulin), plasma glucose levels were significantly lower in the shikonin-treated rats. In conclusion, shikonin increases glucose uptake in muscle cells via an insulin-independent pathway dependent on calcium. Conclusions/Significance: Shikonin increases glucose uptake in skeletal muscle cells via an insulin-independent pathway dependent on calcium. The beneficial effects of shikonin on glucose metabolism, both in vitro and in vivo, show that the compound possesses properties that make it of considerable interest for developing novel treatment of type 2 diabetes.	[Oberg, Anette I.; Csikasz, Robert I.; Dehvari, Nodi; Shabalina, Irina G.; Bengtsson, Tore] Stockholm Univ, Wenner Gren Inst, Dept Physiol, Arrhenius Labs F3, S-10691 Stockholm, Sweden; [Yassin, Kamal; Ostenson, Claes-Goran] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Hutchinson, Dana S.] Monash Univ, Dept Pharmacol, Parkville, Vic, Australia; [Hutchinson, Dana S.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia; [Wilcke, Mona] Glucox Biotech AB, Stockholm, Sweden	Stockholm University; Karolinska Institutet; Monash University; Monash University	Oberg, AI (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Physiol, Arrhenius Labs F3, S-10691 Stockholm, Sweden.	tore.bengtsson@wgi.su.se	Shabalina, Irina/AAC-3720-2019; Hutchinson, Dana/K-3795-2012; Shabalina, Irina G/A-4225-2011	Shabalina, Irina/0000-0002-2915-6450; Shabalina, Irina G/0000-0002-2915-6450; Hutchinson, Dana/0000-0001-9947-0106; Dehvari, Nodi/0000-0002-2186-8023	Swedish Research Council; Swedish Diabetes Association; Novonordiskfonden; Magn. Bergvall foundation; Carl Tryggers foundation; National Health and Medical Research Council (NHMRC) [545952]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Association; Novonordiskfonden(Novo Nordisk Foundation); Magn. Bergvall foundation; Carl Tryggers foundation; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	These studies were supported by grants from the Swedish Research Council (CGO, TB) and Swedish Diabetes Association (CGO), Novonordiskfonden (TB), Magn. Bergvall foundation (TB) and Carl Tryggers foundation (TB). Dr Dana Hutchinson is supported by a National Health and Medical Research Council (NHMRC) Career Development Award (545952). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELHALIM SM, 1994, DIABETES, V43, P281, DOI 10.2337/diabetes.43.2.281; Bruton JD, 1999, P NATL ACAD SCI USA, V96, P3281, DOI 10.1073/pnas.96.6.3281; Chen X, 2002, PHYTOTHER RES, V16, P199, DOI 10.1002/ptr.1100; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hutchinson DS, 2008, PHARMACOL THERAPEUT, V119, P291, DOI 10.1016/j.pharmthera.2008.05.008; Hutchinson DS, 2007, CELL SIGNAL, V19, P1610, DOI 10.1016/j.cellsig.2007.02.006; Hutchinson DS, 2006, DIABETES, V55, P682, DOI 10.2337/diabetes.55.03.06.db05-0901; Hutchinson DS, 2005, ENDOCRINOLOGY, V146, P901, DOI 10.1210/en.2004-1083; Kamei R, 2002, BIOCHEM BIOPH RES CO, V292, P642, DOI 10.1006/bbrc.2002.6714; Klip A, 2009, APPL PHYSIOL NUTR ME, V34, P481, DOI 10.1139/H09-047; Lanner JT, 2008, CURR OPIN PHARMACOL, V8, P339, DOI 10.1016/j.coph.2008.01.006; Lee H, 2010, PHYTOTHER RES, V24, P344, DOI 10.1002/ptr.2942; Lindquist JM, 2000, J BIOL CHEM, V275, P22670, DOI 10.1074/jbc.M909093199; Merlin J, 2010, CELL SIGNAL, V22, P1104, DOI 10.1016/j.cellsig.2010.03.004; Merry TL, 2009, IUBMB LIFE, V61, P479, DOI 10.1002/iub.179; MITSUMOTO Y, 1991, BIOCHEM BIOPH RES CO, V175, P652, DOI 10.1016/0006-291X(91)91615-J; Nevzorova J, 2006, BRIT J PHARMACOL, V147, P446, DOI 10.1038/sj.bjp.0706626; Nigorikawa K, 2006, MOL PHARMACOL, V70, P1143, DOI 10.1124/mol.106.025809; Niu WY, 2010, AM J PHYSIOL-ENDOC M, V298, pE1058, DOI 10.1152/ajpendo.00773.2009; OSTENSON CG, 1993, DIABETOLOGIA, V36, P3, DOI 10.1007/BF00399086; Papageorgiou VP, 1999, ANGEW CHEM INT EDIT, V38, P270, DOI 10.1002/(SICI)1521-3773(19990201)38:3<270::AID-ANIE270>3.0.CO;2-0; Rose AJ, 2005, PHYSIOLOGY, V20, P260, DOI 10.1152/physiol.00012.2005; SCHUDT C, 1976, EUR J BIOCHEM, V68, P103, DOI 10.1111/j.1432-1033.1976.tb10768.x; Shabalina IG, 2010, BBA-BIOENERGETICS, V1797, P968, DOI 10.1016/j.bbabio.2010.02.033; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Tanishita T, 1997, J BIOCHEM, V122, P90; Witczak CA, 2007, DIABETES, V56, P1403, DOI 10.2337/db06-1230; Witczak CA, 2010, AM J PHYSIOL-ENDOC M, V298, pE1150, DOI 10.1152/ajpendo.00659.2009; Wright DC, 2004, DIABETES, V53, P330, DOI 10.2337/diabetes.53.2.330; YOUN JH, 1991, AM J PHYSIOL, V260, pC555, DOI 10.1152/ajpcell.1991.260.3.C555	32	28	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e22510	10.1371/journal.pone.0022510	http://dx.doi.org/10.1371/journal.pone.0022510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21818330	gold, Green Submitted, Green Published			2022-12-25	WOS:000293175100029
J	Hu, Y; Zhang, L; Zhao, L; Li, J; He, SB; Zhou, K; Yang, F; Huang, M; Jiang, L; Li, LJ				Hu, Yong; Zhang, Lu; Zhao, Lin; Li, Jun; He, Shibin; Zhou, Kun; Yang, Fei; Huang, Min; Jiang, Li; Li, Lijia			Trichostatin A Selectively Suppresses the Cold-Induced Transcription of the ZmDREB1 Gene in Maize	PLOS ONE			English	Article							GLOBAL HISTONE ACETYLATION; DNA METHYLATION; ARABIDOPSIS-THALIANA; LOW-TEMPERATURE; ABSCISIC-ACID; EXPRESSION; DEACETYLATION; REPRESSION; RESPONSES; DROUGHT	Post-translational modifications of histone proteins play a crucial role in responding to environmental stresses. Histone deacetylases (HDACs) catalyze the removal of an acetyl group from histones and are generally believed to be a transcriptional repressor. In this paper, we report that cold treatment highly induces the up-regulation of HDACs, leading to global deacetylation of histones H3 and H4. Treatment of maize with the HDAC inhibitor trichostatin A (TSA) under cold stress conditions strongly inhibits induction of the maize cold-responsive genes ZmDREB1 and ZmCOR413. However, upregulation of the ZmICE1 gene in response to cold stress is less affected. The expression of drought and salt induced genes, ZmDBF1 and rab17, is almost unaffected by TSA treatment. Thus, these observations show that HDACs may selectively activate transcription. The time course of TSA effects on the expression of ZmDREB1 and ZmCOR413 genes indicates that HDACs appear to directly activate the ZmDREB1 gene, which in turn modulates ZmCOR413 expression. After cold treatment, histone hyperacetylation and DNA demethylation occurs in the ICE1 binding region, accompanied by an increase in accessibility to micrococcal nuclease (MNase). The two regions adjacent to the ICE1 binding site remain hypoacetylated and methylated. However, during cold acclimation, TSA treatment increases the acetylation status and accessibility of MNase and decreases DNA methylation at these two regions. However, TSA treatment does not affect histone hyperacetylation and DNA methylation levels at the ICE1 binding regions of the ZmDREB1 gene. Altogether, our findings indicate that HDACs positively regulate the expression of the cold-induced ZmDREB1 gene through histone modification and chromatin conformational changes and that this activation is both gene and site selective.	[Hu, Yong; Zhang, Lu; Zhao, Lin; Li, Jun; He, Shibin; Zhou, Kun; Yang, Fei; Huang, Min; Jiang, Li; Li, Lijia] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China	Wuhan University	Hu, Y (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China.	ljli@whu.edu.cn			NSFC [30870261, 30771204]; National Genetically Modified Organism Breeding Major Project [200908010-008B]; Research Fund for the Doctoral Program of Higher Education [20090141110031]	NSFC(National Natural Science Foundation of China (NSFC)); National Genetically Modified Organism Breeding Major Project; Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP))	This work was supported by the NSFC (nos. 30870261 and 30771204), the National Genetically Modified Organism Breeding Major Project (no. 200908010-008B), and the Research Fund for the Doctoral Program of Higher Education (no. 20090141110031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Bernatavichute YV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003156; Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; Bode KA, 2007, IMMUNOLOGY, V122, P596, DOI 10.1111/j.1365-2567.2007.02678.x; Breton G, 2003, PLANT PHYSIOL, V132, P64, DOI 10.1104/pp.102.015255; Chang S, 2005, J BIOL CHEM, V280, P796, DOI 10.1074/jbc.M409053200; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Chiurazzi P, 1999, HUM MOL GENET, V8, P2317, DOI 10.1093/hmg/8.12.2317; Chung HR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015754; Demetriou K, 2009, PHYSIOL PLANTARUM, V136, P358, DOI 10.1111/j.1399-3054.2009.01236.x; Durcova-Hills G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003531; Haring M, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-11; Kadosh D, 1998, GENE DEV, V12, P797, DOI 10.1101/gad.12.6.797; Katan-Khaykovich Y, 2002, GENE DEV, V16, P743, DOI 10.1101/gad.967302; Kizis D, 2002, PLANT J, V30, P679, DOI 10.1046/j.1365-313X.2002.01325.x; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuo MH, 2000, MOL CELL, V6, P1309, DOI 10.1016/S1097-2765(00)00129-5; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Lee SC, 2005, MOL CELLS, V19, P212; Li LJ, 2005, CYTOM PART A, V63A, P114, DOI 10.1002/cyto.a.20111; Li Y, 2005, PLANT J, V41, P346, DOI 10.1111/j.1365-313X.2004.02301.x; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Lo AWI, 2001, GENOME RES, V11, P448, DOI 10.1101/gr.GR-1676R; Lopez-Soto A, 2009, ONCOGENE, V28, P2370, DOI 10.1038/onc.2009.117; Nguyen HT, 2009, PLANT PHYSIOL BIOCH, V47, P116, DOI 10.1016/j.plaphy.2008.10.010; Niogret MF, 1996, PLANT J, V9, P549, DOI 10.1046/j.1365-313X.1996.09040549.x; Qin F, 2004, PLANT CELL PHYSIOL, V45, P1042, DOI 10.1093/pcp/pch118; Rao SH, 2001, J IMMUNOL, V167, P4494, DOI 10.4049/jimmunol.167.8.4494; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; RISTIC Z, 1993, PROTOPLASMA, V172, P111, DOI 10.1007/BF01379368; Rossi V, 2007, PLANT CELL, V19, P1145, DOI 10.1105/tpc.106.042549; Selker EU, 1998, P NATL ACAD SCI USA, V95, P9430, DOI 10.1073/pnas.95.16.9430; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Song CP, 2005, PLANT CELL, V17, P2384, DOI 10.1105/tpc.105.033043; Sridha S, 2006, PLANT J, V46, P124, DOI 10.1111/j.1365-313X.2006.02678.x; Steward N, 2002, J BIOL CHEM, V277, P37741, DOI 10.1074/jbc.M204050200; Stockinger EJ, 2001, NUCLEIC ACIDS RES, V29, P1524, DOI 10.1093/nar/29.7.1524; Tai HH, 2005, PLANT MOL BIOL, V59, P909, DOI 10.1007/s11103-005-2081-x; Tanaka M, 2008, PLANT PHYSIOL, V146, P149, DOI 10.1104/pp.107.111674; Tariq M, 2003, P NATL ACAD SCI USA, V100, P8823, DOI 10.1073/pnas.1432939100; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; TUBEROSA R, 2005, QTLS GENES TOLERANCE, P253; van Buuren ML, 2002, PLANT MOL BIOL, V48, P741, DOI 10.1023/A:1014890008579; Vlachonasios KE, 2003, PLANT CELL, V15, P626, DOI 10.1105/tpc.007922; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127; Wu KQ, 2003, PLANT J, V34, P241, DOI 10.1046/j.1365-313X.2003.01714.x; Yang F, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-178; Zarka DG, 2003, PLANT PHYSIOL, V133, P910, DOI 10.1104/pp.103.027169; Zhao J, 2001, J BIOL CHEM, V276, P22772, DOI 10.1074/jbc.M101756200; Zhou CH, 2005, PLANT CELL, V17, P1196, DOI 10.1105/tpc.104.028514; Zhu J, 2008, P NATL ACAD SCI USA, V105, P4945, DOI 10.1073/pnas.0801029105	52	79	92	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22132	10.1371/journal.pone.0022132	http://dx.doi.org/10.1371/journal.pone.0022132			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811564	Green Published, Green Submitted, gold			2022-12-25	WOS:000292956800023
J	Leidenfrost, S; Boelhauve, M; Reichenbach, M; Gungor, T; Reichenbach, HD; Sinowatz, F; Wolf, E; Habermann, FA				Leidenfrost, Sandra; Boelhauve, Marc; Reichenbach, Myriam; Guengoer, Tuna; Reichenbach, Horst-Dieter; Sinowatz, Fred; Wolf, Eckhard; Habermann, Felix A.			Cell Arrest and Cell Death in Mammalian Preimplantation Development: Lessons from the Bovine Model	PLOS ONE			English	Article							IN-VIVO; GENE-EXPRESSION; RNA EXPRESSION; APOPTOSIS; CASPASE; OOCYTES; EMBRYOS; BLASTOCYSTS; MATURATION; SURVIVAL	Background: The causes, modes, biological role and prospective significance of cell death in preimplantation development in humans and other mammals are still poorly understood. Early bovine embryos represent a very attractive experimental model for the investigation of this fundamental and important issue. Methods and Findings: To obtain reference data on the temporal and spatial occurrence of cell death in early bovine embryogenesis, three-dimensionally preserved embryos of different ages and stages of development up to hatched blastocysts were examined in toto by confocal laser scanning microscopy. In parallel, transcript abundance profiles for selected apoptosis-related genes were analyzed by real-time reverse transcriptase-polymerase chain reaction. Our study documents that in vitro as well as in vivo, the first four cleavage cycles are prone to a high failure rate including different types of permanent cell cycle arrest and subsequent non-apoptotic blastomere death. In vitro produced and in vivo derived blastocysts showed a significant incidence of cell death in the inner cell mass (ICM), but only in part with morphological features of apoptosis. Importantly, transcripts for CASP3, CASP9, CASP8 and FAS/FASLG were not detectable or found at very low abundances. Conclusions: In vitro and in vivo, errors and failures of the first and the next three cleavage divisions frequently cause immediate embryo death or lead to aberrant subsequent development, and are the main source of developmental heterogeneity. A substantial occurrence of cell death in the ICM even in fast developing blastocysts strongly suggests a regular developmentally controlled elimination of cells, while the nature and mechanisms of ICM cell death are unclear. Morphological findings as well as transcript levels measured for important apoptosis-related genes are in conflict with the view that classical caspase-mediated apoptosis is the major cause of cell death in early bovine development.	[Leidenfrost, Sandra; Sinowatz, Fred; Habermann, Felix A.] Univ Munich, Inst Anat Histol & Embryol, Dept Vet Sci, Munich, Germany; [Boelhauve, Marc; Reichenbach, Myriam; Guengoer, Tuna; Wolf, Eckhard] Univ Munich, Gene Ctr, Dept Vet Sci, Chair Mol Anim Breeding & Biotechnol, Munich, Germany; [Boelhauve, Marc; Reichenbach, Myriam; Guengoer, Tuna; Wolf, Eckhard] Univ Munich, Gene Ctr, Lab Funct Genome Anal LAFUGA, Munich, Germany; [Reichenbach, Horst-Dieter] Bavarian State Inst Agr, Inst Anim Breeding, Biotechnol Unit, Poing, Germany; [Boelhauve, Marc] S Westphalia Univ Appl Sci, Soest, Germany	University of Munich; University of Munich; University of Munich	Leidenfrost, S (corresponding author), Univ Munich, Inst Anat Histol & Embryol, Dept Vet Sci, Munich, Germany.	f.habermann@lmu.de	Sinowatz, Fred/V-1575-2019	Boelhauve, Marc/0000-0002-7961-9425; Wolf, Eckhard/0000-0002-0430-9510; Habermann, Felix/0000-0003-2916-3463	Deutsche Forschungsgemeinschaft (DFG) [FOR 478, GRK 1029, FOR 1041]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (DFG; grant numbers FOR 478, GRK 1029, FOR 1041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badr H, 2007, ZYGOTE, V15, P355, DOI 10.1017/S0967199407004315; Bettegowda A, 2006, MOL REPROD DEV, V73, P267, DOI 10.1002/mrd.20333; Bettegowda A, 2008, REPROD FERT DEVELOP, V20, P45, DOI 10.1071/RD07156; Bettegowda A, 2007, FRONT BIOSCI-LANDMRK, V12, P3713, DOI 10.2741/2346; Betts DH, 2001, THERIOGENOLOGY, V55, P171, DOI 10.1016/S0093-691X(00)00453-2; BilodeauGoeseels S, 1997, BIOL REPROD, V56, P1323, DOI 10.1095/biolreprod56.5.1323; Boelhauve M, 2005, BIOL REPROD, V73, P737, DOI 10.1095/biolreprod.105.041103; Brevini TAL, 2007, REPROD FERT DEVELOP, V19, P35, DOI 10.1071/RD06119; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Crosier AE, 2001, BIOL REPROD, V64, P1375, DOI 10.1095/biolreprod64.5.1375; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; Diskin MG, 2006, ANIM REPROD SCI, V96, P297, DOI 10.1016/j.anireprosci.2006.08.008; Draker R, 2009, BIOCHEM CELL BIOL, V87, P19, DOI 10.1139/O08-117; Dubrez-Daloz L, 2008, CELL CYCLE, V7, P1036, DOI 10.4161/cc.7.8.5783; Exley GE, 1999, BIOL REPROD, V61, P231, DOI 10.1095/biolreprod61.1.231; Fabian D, 2005, THERIOGENOLOGY, V64, P221, DOI 10.1016/j.theriogenology.2004.11.022; Fan TJ, 2005, ACTA BIOCH BIOPH SIN, V37, P719, DOI 10.1111/j.1745-7270.2005.00108.x; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Galluzzi L, 2007, CELL DEATH DIFFER, V14, P1237, DOI 10.1038/sj.cdd.4402148; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gjorret JO, 2007, MOL REPROD DEV, V74, P961, DOI 10.1002/mrd.20714; Gjorret JO, 2003, BIOL REPROD, V69, P1193, DOI 10.1095/biolreprod.102.013243; Goossens K, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-27; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Hardy K, 2003, BIOL REPROD, V68, P1165, DOI 10.1095/biolreprod.102.010090; Jakobsen AS, 2006, MOL REPROD DEV, V73, P196, DOI 10.1002/mrd.20389; Jurisicova A, 2003, MOL HUM REPROD, V9, P133, DOI 10.1093/molehr/gag016; Knijn HM, 2003, BIOL REPROD, V69, P1371, DOI 10.1095/biolreprod.103.017251; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Laurincik J, 2003, MOL REPROD DEV, V65, P73, DOI 10.1002/mrd.10294; LEIBFRIED L, 1979, J ANIM SCI, V48, P76; Lonergan P, 2007, Soc Reprod Fertil Suppl, V64, P315; Malhi PS, 2005, BIOL REPROD, V73, P45, DOI 10.1095/biolreprod.104.038745; Memili E, 1998, MOL REPROD DEV, V51, P36, DOI 10.1002/(SICI)1098-2795(199809)51:1&lt;36::AID-MRD4&gt;3.0.CO;2-X; Paula-Lopes FF, 2007, BIOL REPROD, V76, P532, DOI 10.1095/biolreprod.106.054551; Pomar FJR, 2005, THERIOGENOLOGY, V63, P2254, DOI 10.1016/j.theriogenology.2004.10.015; Pradelli LA, 2010, CELL MOL LIFE SCI, V67, P1589, DOI 10.1007/s00018-010-0285-y; Robert C, 2002, BIOL REPROD, V67, P1465, DOI 10.1095/biolreprod.102.006320; Robertson I., 1998, MANUAL INT EMBRYO TR, P103; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Sartori R, 2010, REPROD FERT DEVELOP, V22, P151, DOI 10.1071/RD09221; Vandaele L, 2008, ANIM REPROD SCI, V106, P168, DOI 10.1016/j.anireprosci.2007.12.016; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Wang J, 2000, J CELL SCI, V113, P753; Wrenzycki C, 2005, REPROD FERT DEVELOP, V17, P23, DOI 10.1071/RD04109; Yuan JY, 2006, MOL CELL, V23, P1, DOI 10.1016/j.molcel.2006.06.008	49	39	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22121	10.1371/journal.pone.0022121	http://dx.doi.org/10.1371/journal.pone.0022121			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811561	Green Published, gold, Green Submitted			2022-12-25	WOS:000292956800022
J	Diaz-Sanchez, V; Estrada, AF; Trautmann, D; Limon, MC; Al-Babili, S; Avalos, J				Diaz-Sanchez, Violeta; Estrada, Alejandro F.; Trautmann, Danika; Limon, M. Carmen; Al-Babili, Salim; Avalos, Javier			Analysis of al-2 Mutations in Neurospora	PLOS ONE			English	Article							CAROTENOID BIOSYNTHETIC GENE; PHYTOENE SYNTHASE; FUNCTIONAL-CHARACTERIZATION; LYCOPENE CYCLASE; BETA-CAROTENE; BLUE-LIGHT; IDENTIFICATION; SEQUENCE; CRASSA; CLEAVAGE	The orange pigmentation of the fungus Neurospora crassa is due to the accumulation of the xanthophyll neurosporaxanthin and precursor carotenoids. Two key reactions in the synthesis of these pigments, the formation of phytoene from geranylgeranyl pyrophosphate and the introduction of beta cycles in desaturated carotenoid products, are catalyzed by two domains of a bifunctional protein, encoded by the gene al-2. We have determined the sequence of nine al-2 mutant alleles and analyzed the carotenoid content in the corresponding strains. One of the mutants is reddish and it is mutated in the cyclase domain of the protein, and the remaining eight mutants are albino and harbor different mutations on the phytoene synthase (PS) domain. Some of the mutations are expected to produce truncated polypeptides. A strain lacking most of the PS domain contained trace amounts of a carotenoid-like pigment, tentatively identified as the squalene desaturation product diapolycopene. In support, trace amounts of this compound were also found in a knock-out mutant for gene al-2, but not in that for gene al-1, coding for the carotene desaturase. The cyclase activity of the AL-2 enzyme from two albino mutants was investigated by heterologous expression in an appropriately engineered E. coli strain. One of the AL-2 enzymes, predictably with only 20% of the PS domain, showed full cyclase activity, suggesting functional independence of both domains. However, the second mutant showed no cyclase activity, indicating that some alterations in the phytoene synthase segment affect the cyclase domain. Expression experiments showed a diminished photoinduction of al-2 transcripts in the al-2 mutants compared to the wild type strain, suggesting a synergic effect between reduced expression and impaired enzymatic activities in the generation of their albino phenotypes.	[Diaz-Sanchez, Violeta; Estrada, Alejandro F.; Limon, M. Carmen; Avalos, Javier] Univ Seville, Fac Biol, Dept Genet, Seville, Spain; [Trautmann, Danika; Al-Babili, Salim] Univ Freiburg, Fac Biol, Freiburg, Germany	University of Sevilla; University of Freiburg	Diaz-Sanchez, V (corresponding author), Univ Seville, Fac Biol, Dept Genet, Seville, Spain.	avalos@us.es	del Carmen Limón Mirón, María/E-6582-2010; Avalos, Javier/B-4218-2011	del Carmen Limón Mirón, María/0000-0002-9982-6480; Avalos, Javier/0000-0001-5484-2893; Al-Babili, Salim/0000-0003-4823-2882	European Union; Spanish Ministerio de Ciencia y Tecnologia [BIO2006-01323, BIO2009-11131]; Andalusian Government [P07-CVI-02813]; Deutsche Forschungsgemeinschaft (DFG) [AL 892/1-4]	European Union(European Commission); Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Andalusian Government; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the European Union (European Regional Development Fund), the Spanish Ministerio de Ciencia y Tecnologia {projects BIO2006-01323 and BIO2009-11131), the Andalusian Government (project P07-CVI-02813) and the Deutsche Forschungsgemeinschaft (DFG, Grant AL 892/1-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida ERA, 2008, CURR GENET, V53, P129, DOI 10.1007/s00294-007-0170-x; Arrach N, 2002, MOL GENET GENOMICS, V266, P914, DOI 10.1007/s00438-001-0626-5; Arrach N, 2001, P NATL ACAD SCI USA, V98, P1687, DOI 10.1073/pnas.021555298; Auldridge ME, 2006, CURR OPIN PLANT BIOL, V9, P315, DOI 10.1016/j.pbi.2006.03.005; Avalos J., 2004, Handbook of fungal biotechnology, P367; BEJARANO ER, 1992, FEBS LETT, V306, P209, DOI 10.1016/0014-5793(92)81002-4; Limon MC, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-40; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Corrochano LM, 2007, PHOTOCH PHOTOBIO SCI, V6, P725, DOI 10.1039/b702155k; Davis R.H., 1970, 789 METHODS ENZYMOLO, VVolume 17, P79, DOI DOI 10.1016/0076-6879(71)17168-6; Domenech CE, 1996, EUR J BIOCHEM, V239, P720, DOI 10.1111/j.1432-1033.1996.0720u.x; Estrada AF, 2008, MOL MICROBIOL, V69, P1207, DOI 10.1111/j.1365-2958.2008.06349.x; Estrada AF, 2008, FUNGAL GENET BIOL, V45, P1497, DOI 10.1016/j.fgb.2008.09.001; Fraser PD, 2004, PROG LIPID RES, V43, P228, DOI 10.1016/j.plipres.2003.10.002; GOLDIE AH, 1973, BIOCHEM GENET, V10, P275, DOI 10.1007/BF00485705; Hausmann A, 2000, FUNGAL GENET BIOL, V30, P147, DOI 10.1006/fgbi.2000.1212; Lee PC, 2003, CHEM BIOL, V10, P453, DOI 10.1016/S1074-5521(03)00103-0; Linden H, 1997, FUNGAL GENET BIOL, V22, P141, DOI 10.1006/fgbi.1997.1013; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Mark Manuel, 2009, Nucl Recept Signal, V7, pe002, DOI 10.1621/nrs.07002; McCluskey K, 2003, ADV APPL MICROBIOL, V52, P245, DOI 10.1016/S0065-2164(03)01010-4; MEHTA BJ, 1995, APPL MICROBIOL BIOT, V42, P836, DOI 10.1007/s002530050339; NELSON MA, 1989, MOL CELL BIOL, V9, P1271, DOI 10.1128/MCB.9.3.1271; Neudert U, 1998, BBA-LIPID LIPID MET, V1392, P51, DOI 10.1016/S0005-2760(98)00017-4; Prado-Cabrero A, 2007, MOL MICROBIOL, V64, P448, DOI 10.1111/j.1365-2958.2007.05665.x; Raisig A, 1999, J BACTERIOL, V181, P6184, DOI 10.1128/JB.181.19.6184-6187.1999; Rao AV, 2007, PHARMACOL RES, V55, P207, DOI 10.1016/j.phrs.2007.01.012; Rodriguez-Ortiz R, 2009, APPL ENVIRON MICROB, V75, P405, DOI 10.1128/AEM.01089-08; Saelices L, 2007, MOL GENET GENOMICS, V278, P527, DOI 10.1007/s00438-007-0269-2; SANDMANN G, 1993, J PHOTOCH PHOTOBIO B, V18, P245, DOI 10.1016/1011-1344(93)80071-G; Sandmann G, 2002, MYCOTA 10 IND APPL, P247; SCHMIDHAUSER TJ, 1994, J BIOL CHEM, V269, P12060; SCHMIDHAUSER TJ, 1990, MOL CELL BIOL, V10, P5064, DOI 10.1128/MCB.10.10.5064; Sestak Z., 2004, CAROTENOIDS, V42, DOI 10.1023/b:phot.0000040641.40049.19,2; Takaichi S, 1997, ARCH MICROBIOL, V168, P277, DOI 10.1007/s002030050499; Telfer A, 2005, PHOTOCH PHOTOBIO SCI, V4, P950, DOI 10.1039/b507888c; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TORRESMARTINEZ S, 1980, GENET RES, V36, P299, DOI 10.1017/S0016672300019911; Velayos A, 2000, EUR J BIOCHEM, V267, P5509, DOI 10.1046/j.1432-1327.2000.01612.x; Verdoes JC, 1999, MOL GEN GENET, V262, P453, DOI 10.1007/s004380051105; von Lintig J, 2004, J NUTR, V134, p251S, DOI 10.1093/jn/134.1.251S; Walter MH, 2010, PLANTA, V232, P1, DOI 10.1007/s00425-010-1156-3	42	16	16	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e21948	10.1371/journal.pone.0021948	http://dx.doi.org/10.1371/journal.pone.0021948			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21818281	Green Published, gold, Green Submitted			2022-12-25	WOS:000292929500021
J	Viranaicken, W; Gasmi, L; Chaumet, A; Durieux, C; Georget, V; Denoulet, P; Larcher, JC				Viranaicken, Wildriss; Gasmi, Laila; Chaumet, Alexandre; Durieux, Christiane; Georget, Virginie; Denoulet, Philippe; Larcher, Jean-Christophe			L-Ilf3 and L-NF90 Traffic to the Nucleolus Granular Component: Alternatively-Spliced Exon 3 Encodes a Nucleolar Localization Motif	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; DEPENDENT PROTEIN-KINASE; GENE-EXPRESSION; NUCLEAR FACTOR-90; MESSENGER-RNA; INTRACELLULAR-DISTRIBUTION; BINDING; NF90; TRANSLATION; ILF3	Ilf3 and NF90, two proteins containing double-stranded RNA-binding domains, are generated by alternative splicing and involved in several functions. Their heterogeneity results from posttranscriptional and posttranslational modifications. Alternative splicing of exon 3, coding for a 13 aa N-terminal motif, generates for each protein a long and short isoforms. Subcellular fractionation and localization of recombinant proteins showed that this motif acts as a nucleolar localization signal. Deletion and substitution mutants identified four arginines, essential for nucleolar targeting, and three histidines to stabilize the proteins within the nucleolus. The short isoforms are never found in the nucleoli, whereas the long isoforms are present in the nucleoplasm and the nucleoli. For Ilf3, only the posttranslationally-unmodified long isoform is nucleolar, suggesting that this nucleolar targeting is abrogated by posttranslational modifications. Confocal microscopy and FRAP experiments have shown that the long Ilf3 isoform localizes to the granular component of the nucleolus, and that L-Ilf3 and L-NF90 exchange rapidly between nucleoli. The presence of this 13 aminoacid motif, combined with posttranslational modifications, is responsible for the differences in Ilf3 and NF90 isoforms subcellular localizations. The protein polymorphism of Ilf3/NF90 and the various subcellular localizations of their isoforms may partially explain the various functions previously reported for these proteins.	[Viranaicken, Wildriss; Gasmi, Laila; Chaumet, Alexandre; Denoulet, Philippe; Larcher, Jean-Christophe] Univ Paris 06, UMR 7622, Lab Biol Dev, Paris, France; [Viranaicken, Wildriss; Gasmi, Laila; Chaumet, Alexandre; Denoulet, Philippe; Larcher, Jean-Christophe] CNRS, UMR 7622, Lab Biol Dev, Paris, France; [Durieux, Christiane] Univ Paris 07, CNRS, UMR7592, Inst Jacques Monod, Paris, France; [Georget, Virginie] Univ Paris 06, IFR 83, Inst Biol Integrat, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite	Viranaicken, W (corresponding author), GRI CYROI Univ Reunion, St Clotilde, Reunion, France.	jclarche@snv.jussieu.fr	Durieux, Christiane/M-9530-2018; Georget, Virginie/AAQ-1843-2020	Chaumet, Alexandre/0000-0002-6864-5468	Centre National de la Recherche Scientifique; Ministere de l'Enseignement superieur et de la Recherche [n<SUP>o</SUP>04 5 495]; Federation pour la Recherche sur le Cerveau; Ministere de l'Enseignement superieur et de la Recherche; Centre National de la Recherche Scientifique; Ministere de l'Enseignement superieur et de la Recherche [n<SUP>o</SUP>04 5 495]; Federation pour la Recherche sur le Cerveau; Ministere de l'Enseignement superieur et de la Recherche	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Enseignement superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Federation pour la Recherche sur le Cerveau; Ministere de l'Enseignement superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Enseignement superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Federation pour la Recherche sur le Cerveau; Ministere de l'Enseignement superieur et de la Recherche(Estonian Research CouncilEuropean Commission)	This work was supported by the Centre National de la Recherche Scientifique and the Ministere de l'Enseignement superieur et de la Recherche. J.-C. L. and C. D. were supported by the Ministere de l'Enseignement superieur et de la Recherche (ACI BCMS 2004, decision n<SUP>o</SUP>04 5 495) and the "Federation pour la Recherche sur le Cerveau". W. V. and A. C. hold fellowships from the Ministere de l'Enseignement superieur et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Brownawell AM, 2002, J CELL BIOL, V156, P53, DOI 10.1083/jcb.200110082; Buaas FW, 1999, MAMM GENOME, V10, P451, DOI 10.1007/s003359901022; Chauvin C, 2005, MOL CELL BIOL, V25, P5801, DOI 10.1128/MCB.25.14.5801-5811.2005; CORTHESY B, 1994, J BIOL CHEM, V269, P20682; Duchange N, 2000, GENE, V261, P345, DOI 10.1016/S0378-1119(00)00495-9; HATANAKA M, 1990, BIOESSAYS, V12, P143, DOI 10.1002/bies.950120310; Horke S, 2004, J BIOL CHEM, V279, P26563, DOI 10.1074/jbc.M401017200; Isken O, 2003, EMBO J, V22, P5655, DOI 10.1093/emboj/cdg562; Kiebler MA, 2005, TRENDS BIOCHEM SCI, V30, P228, DOI 10.1016/j.tibs.2005.03.005; Kuwano Y, 2010, NUCLEIC ACIDS RES, V38, P225, DOI 10.1093/nar/gkp861; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larcher JC, 2004, FASEB J, V18, P1761, DOI 10.1096/fj.04-1763fje; LARCHER JC, 1992, DEV BIOL, V154, P195, DOI 10.1016/0012-1606(92)90059-P; LEUNG AK, 2006, J CELL BIOL, V166, P787; Liao HJ, 1998, P NATL ACAD SCI USA, V95, P8514, DOI 10.1073/pnas.95.15.8514; Louvet E, 2005, EXP CELL RES, V304, P457, DOI 10.1016/j.yexcr.2004.11.018; Louvet E, 2006, MOL BIOL CELL, V17, P2537, DOI 10.1091/mbc.E05-10-0923; Macchi P, 2004, J BIOL CHEM, V279, P31440, DOI 10.1074/jbc.C400226200; Negi SS, 2006, J CELL SCI, V119, P3676, DOI 10.1242/jcs.03090; Nie YZ, 2005, MOL CELL BIOL, V25, P6956, DOI 10.1128/MCB.25.16.6956-6963.2005; OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3; Parker LM, 2001, J BIOL CHEM, V276, P32522, DOI 10.1074/jbc.M104408200; Parrott AM, 2005, J MOL BIOL, V348, P281, DOI 10.1016/j.jmb.2005.02.047; Parrott AM, 2007, NUCLEIC ACIDS RES, V35, P6249, DOI 10.1093/nar/gkm668; Patel RC, 1999, J BIOL CHEM, V274, P20432, DOI 10.1074/jbc.274.29.20432; Pei Y, 2008, J IMMUNOL, V180, P222, DOI 10.4049/jimmunol.180.1.222; Rabut G., 2005, LIVE CELL IMAGING LA, P101; Reichman TW, 2003, J MOL BIOL, V332, P85, DOI 10.1016/S0022-2836(03)00885-4; Reichman TW, 2003, RNA, V9, P543, DOI 10.1261/rna.2181103; Reichman TW, 2002, MOL CELL BIOL, V22, P343, DOI 10.1128/MCB.22.1.343-356.2002; Sansam CL, 2003, P NATL ACAD SCI USA, V100, P14018, DOI 10.1073/pnas.2336131100; Saunders LR, 2001, J BIOL CHEM, V276, P32300, DOI 10.1074/jbc.M104207200; SCOTT SS, 2010, NUCLEIC ACIDS RES, V38, P7388; Shi LF, 2005, J BIOL CHEM, V280, P18981, DOI 10.1074/jbc.M411034200; Shim J, 2002, MOL CELL, V10, P1331, DOI 10.1016/S1097-2765(02)00730-X; Song ZY, 2005, ONCOGENE, V24, P2723, DOI 10.1038/sj.onc.1208097; STJOHNSTON D, 1992, P NATL ACAD SCI USA, V89, P10979, DOI 10.1073/pnas.89.22.10979; Tang J, 2000, J BIOL CHEM, V275, P19866, DOI 10.1074/jbc.M000023200; Ting NSY, 1998, J BIOL CHEM, V273, P2136, DOI 10.1074/jbc.273.4.2136; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Viranaicken W, 2006, GENOMICS, V88, P622, DOI 10.1016/j.ygeno.2006.08.006; Weber JD, 2000, MOL CELL BIOL, V20, P2517, DOI 10.1128/MCB.20.7.2517-2528.2000; Xu YH, 2005, MOL GENET METAB, V84, P252, DOI 10.1016/j.ymgme.2004.10.005; Xu YH, 1999, MOL GENET METAB, V68, P441, DOI 10.1006/mgme.1999.2934; Xu YH, 2000, MOL GENET METAB, V70, P106, DOI 10.1006/mgme.2000.3010; Xu YH, 2003, MOL GENET METAB, V80, P426, DOI 10.1016/j.ymgme.2003.09.006	47	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22296	10.1371/journal.pone.0022296	http://dx.doi.org/10.1371/journal.pone.0022296			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21811582	Green Published, Green Submitted, gold			2022-12-25	WOS:000292929500050
J	Liu, XF; Xiang, L; Zhang, Y; Becker, KG; Bera, TK; Pastan, I				Liu, X-F; Xiang, L.; Zhang, Y.; Becker, K. G.; Bera, T. K.; Pastan, I.			CAPC negatively regulates NF-kappa B activation and suppresses tumor growth and metastasis	ONCOGENE			English	Article						CAPC; tumor growth; NF-kappa B; cytokines	BREAST-CANCER CELLS; COLORECTAL-CANCER; CYSTATIN SN; INFLAMMATION; PROTEIN; PATHWAY; GENES	CAPC, also known as LRRC26, is expressed in normal prostate and salivary gland. We developed a mAb to CAPC and used it to characterize the protein and study its function. CAPC protein was detected in normal prostate and salivary gland, in several human breast cancer cell lines and in the prostate cancer cell line LNCaP. Knockdown of CAPC by siRNA in LNCaP cells enhanced anchorage-independent growth in soft agar. Conversely, overexpression of CAPC in MDA-231 breast cancer cells and A431 epidermoid cancer cells inhibited growth in soft agar and tumorigenesis in nude mice, and suppressed the metastasis of MDA-231 cells to the lung. Overexpression of CAPC downregulated NF-kappa B activity and its target genes, including GM-CSF (CSF2), CXCL1, IL8 and LTB1. It also suppressed genes encoding the serine protease mesotrypsin (PRSS3) and cystatin SN (CST1). CAPC expressing tumors showed a decrease in the number of proliferating cells and a large increase in ECM. The role of CAPC in the suppression of tumor growth and metastasis may be through its alteration of the tumor microenvironment. Oncogene (2012) 31, 1673-1682; doi:10.1038/onc.2011.355; published online 8 August 2011	[Liu, X-F; Xiang, L.; Bera, T. K.; Pastan, I.] NCI, Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Zhang, Y.; Becker, K. G.] NIA, Gene Express & Genom Unit, Res Resources Branch, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Pastan, I (corresponding author), NCI, Mol Biol Lab, Ctr Canc Res, NIH, 37 Convent Dr,Room 5106, Bethesda, MD 20892 USA.	pastani@mail.nih.gov	pastan, ira/P-9319-2019	pastan, ira/0000-0002-9223-0270; Becker, Kevin/0000-0002-6794-6656	NIH, National Cancer Institute, Center for Cancer Research; National Institute on Aging; NATIONAL CANCER INSTITUTE [ZIABC010298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZICAG000616] Funding Source: NIH RePORTER	NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The CAPC antibody was provided by BD BioSciences Pharmingen as an outcome of Antibody Co-development Collaboration between the NCI and BD BioSciences. We thank William H Wood III (National Institute on Aging) and the Confocal Core Facility members (Center for Cancer Research, NIH) for technical assistance. This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research, and in part by the National Institute on Aging.	American Cancer Society, 2009, CANC FACTS FIG 2009; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Basbaum CB, 1996, CURR OPIN CELL BIOL, V8, P731, DOI 10.1016/S0955-0674(96)80116-5; Chatterjee Sabarni K, 2005, Future Oncol, V1, P37, DOI 10.1517/14796694.1.1.37; Choi EH, 2009, CLIN CHIM ACTA, V406, P45, DOI 10.1016/j.cca.2009.05.008; Dixit V, 2002, CELL, V111, P615, DOI 10.1016/S0092-8674(02)01166-2; Egland KA, 2006, P NATL ACAD SCI USA, V103, P5929, DOI 10.1073/pnas.0601296103; Egland KA, 2003, P NATL ACAD SCI USA, V100, P1099, DOI 10.1073/pnas.0337425100; Friedl P, 2008, CANCER RES, V68, P7247, DOI 10.1158/0008-5472.CAN-08-0784; Hockla A, 2010, BREAST CANCER RES TR, V124, P27, DOI 10.1007/s10549-009-0699-0; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Lee CH, 2007, BIOFACTORS, V29, P19, DOI 10.1002/biof.5520290103; Lee M, 2004, CHEM SOC REV, V33, P401, DOI 10.1039/b209224g; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; Loza MJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001035; Nam JS, 2006, CANCER RES, V66, P7176, DOI 10.1158/0008-5472.CAN-06-0825; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Pacifico F, 2006, BIOCHEM PHARMACOL, V72, P1142, DOI 10.1016/j.bcp.2006.07.032; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Porta C, 2009, IMMUNOBIOLOGY, V214, P761, DOI 10.1016/j.imbio.2009.06.014; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Wang SL, 2009, CELL MOL IMMUNOL, V6, P327, DOI 10.1038/cmi.2009.43; Wu Y, 2009, CELL CYCLE, V8, P3267, DOI 10.4161/cc.8.20.9699; Yan JS, 2010, NATURE, V466, P513, DOI 10.1038/nature09162; Yoneda K, 2009, INT J ONCOL, V35, P33, DOI 10.3892/ijo_00000310	27	23	23	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2012	31	13					1673	1682		10.1038/onc.2011.355	http://dx.doi.org/10.1038/onc.2011.355			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	918EF	21822313	Green Accepted			2022-12-25	WOS:000302231400006
J	Mukerjee, R; Chang, JR; Del Valle, L; Bagashev, A; Gayed, MM; Lyde, RB; Hawkins, BJ; Brailoiu, E; Cohen, E; Power, C; Azizi, SA; Gelman, BB; Sawaya, BE				Mukerjee, Ruma; Chang, J. Robert; Del Valle, Luis; Bagashev, Asen; Gayed, Monika M.; Lyde, Randolph B.; Hawkins, Brian J.; Brailoiu, Eugen; Cohen, Eric; Power, Chris; Azizi, S. Ausim; Gelman, Benjamin B.; Sawaya, Bassel E.			Deregulation of microRNAs by HIV-1 Vpr Protein Leads to the Development of Neurocognitive Disorders	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NEURONAL INJURY; RECEPTOR; BRAIN; EXPRESSION; APOPTOSIS; INVOLVEMENT; DEATH; STEM; P53	Studies have shown that HIV-infected patients develop neurocognitive disorders characterized by neuronal dysfunction. The lack of productive infection of neurons by HIV suggests that viral and cellular proteins, with neurotoxic activities, released from HIV-1-infected target cells can cause this neuronal deregulation. The viral protein R (Vpr), a protein encoded by HIV-1, has been shown to alter the expression of various important cytokines and inflammatory proteins in infected and uninfected cells; however the mechanisms involved remain unclear. Using a human neuronal cell line, we found that Vpr can be taken up by neurons causing: (i) deregulation of calcium homeostasis, (ii) endoplasmic reticulum-calcium release, (iii) activation of the oxidative stress pathway, (iv) mitochondrial dysfunction and v-synaptic retraction. In search for the cellular factors involved, we performed microRNAs and gene array assays using human neurons (primary cultures or cell line, SH-SY5Y) that we treated with recombinant Vpr proteins. Interestingly, Vpr deregulates the levels of several microRNAs (e. g. miR-34a) and their target genes (e. g. CREB), which could lead to neuronal dysfunctions. Therefore, we conclude that Vpr plays a major role in neuronal dysfunction through deregulating microRNAs and their target genes, a phenomenon that could lead to the development of neurocognitive disorders.	[Mukerjee, Ruma; Chang, J. Robert; Bagashev, Asen; Gayed, Monika M.; Lyde, Randolph B.; Azizi, S. Ausim; Sawaya, Bassel E.] Temple Univ, Sch Med, Mol Studies Neurodegenerat Dis Lab, Dept Neurol, 3420 N Broad St MRB 719, Philadelphia, PA 19140 USA; [Brailoiu, Eugen] Temple Univ, Sch Med, Mol Studies Neurodegenerat Dis Lab, Dept Pharmacol, Philadelphia, PA 19140 USA; [Del Valle, Luis] Louisiana State Univ, Sch Med, Stanley S Scott Canc Ctr, Dept Med,Sect Hematol Oncol, New Orleans, LA 70112 USA; [Del Valle, Luis] Louisiana State Univ, Sch Med, Stanley S Scott Canc Ctr, Dept Pathol, New Orleans, LA 70112 USA; [Hawkins, Brian J.] Univ Washington, Mitochondria & Metab Ctr, Seattle, WA 98109 USA; [Cohen, Eric] Univ Montreal, IRCM, Quebec City, PQ, Canada; [Cohen, Eric] Univ Montreal, Dept Microbiol & Immunol, Quebec City, PQ, Canada; [Power, Chris] Univ Alberta, Dept Med Neurol Med Microbiol & Immunol, Edmonton, AB T6G 2S2, Canada; [Power, Chris] Univ Alberta, Dept Psychiat, Edmonton, AB T6G 2S2, Canada; [Gelman, Benjamin B.] Univ Texas, Med Branch, Texas NeuroAIDS Res Ctr, Dept Pathol & Neurosci, Galveston, TX 77555 USA; [Gelman, Benjamin B.] Univ Texas, Med Branch, Texas NeuroAIDS Res Ctr, Dept Cell Biol, Galveston, TX 77555 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Louisiana State University System; Louisiana State University System; University of Washington; University of Washington Seattle; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; University of Alberta; University of Alberta; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Sawaya, BE (corresponding author), Temple Univ, Sch Med, Mol Studies Neurodegenerat Dis Lab, Dept Neurol, 3420 N Broad St MRB 719, Philadelphia, PA 19140 USA.	sawaya@temple.edu	Power, Christopher/C-7181-2013; Bagashev, Asen/D-2913-2011; Del Valle, Luis/J-4085-2015	Bagashev, Asen/0000-0001-9900-8106; Del Valle, Luis/0000-0003-3894-9206; Azizi, Sayed/0000-0002-0888-5013; Power, Christopher/0000-0002-5131-9711	National Institutes of Health [R01-NS059327]; Harvard Catalyst; Harvard Clinical and Translational Science Center (National Institutes of Health, Harvard University and its affiliated academic health care centers) [UL1 RR 025758]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL094536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH083545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059327] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Catalyst; Harvard Clinical and Translational Science Center (National Institutes of Health, Harvard University and its affiliated academic health care centers)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NINDS, R01-NS059327 (to B. E. S.). This work was also conducted with support from Harvard Catalyst, The Harvard Clinical and Translational Science Center (National Institutes of Health Award UL1 RR 025758 and financial contributions from Harvard University and its affiliated academic health care centers).	Ando H, 2006, MOL CELL, V22, P795, DOI 10.1016/j.molcel.2006.05.017; Anthony IC, 2008, INT REV PSYCHIATR, V20, P15, DOI 10.1080/09540260701862037; Aquaro Stefano, 2008, Recent Pat CNS Drug Discov, V3, P23; Barbato C, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/871313; Boehning D, 2005, P NATL ACAD SCI USA, V102, P1466, DOI 10.1073/pnas.0409650102; Brailoiu GC, 2011, J BIOL CHEM, V286, P29166, DOI 10.1074/jbc.M110.217463; Bushati N, 2008, CURR OPIN NEUROBIOL, V18, P292, DOI 10.1016/j.conb.2008.07.001; Carter CC, 2011, CELL HOST MICROBE, V9, P223, DOI 10.1016/j.chom.2011.02.005; Cheng XD, 2007, DNA CELL BIOL, V26, P116, DOI 10.1089/dna.2006.0541; Das AT, 2004, J VIROL, V78, P2601, DOI 10.1128/JVI.78.5.2601-2605.2004; Dickie P, 2004, VIROLOGY, V322, P69, DOI 10.1016/j.virol.2004.01.026; Eacker SM, 2009, NAT REV NEUROSCI, V10, P837, DOI 10.1038/nrn2726; Ellis R, 2007, NAT REV NEUROSCI, V8, P33, DOI 10.1038/nrn2040; Everall I, 2009, J NEUROVIROL, V15, P360, DOI 10.3109/13550280903131915; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Guessous F, 2010, CELL CYCLE, V9, P1031, DOI 10.4161/cc.9.6.10987; Han Y, 2007, NAT MED, V13, P1138, DOI 10.1038/nm1007-1138; Henklein P, 2000, J BIOL CHEM, V275, P32016, DOI 10.1074/jbc.M004044200; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Houzet L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-118; Jacquot G, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-84; Jones GJ, 2007, J NEUROSCI, V27, P3703, DOI 10.1523/JNEUROSCI.5522-06.2007; Kaul M, 2008, FRONT BIOSCI-LANDMRK, V13, P2484, DOI 10.2741/2860; Kaul M, 2006, CURR HIV RES, V4, P307, DOI 10.2174/157016206777709384; Kim AH, 2010, SCHIZOPHR RES, V124, P183, DOI 10.1016/j.schres.2010.07.002; Kitayama H, 2008, J VIROL, V82, P2528, DOI 10.1128/JVI.02094-07; Kriz J, 2000, BRAIN RES, V885, P32, DOI 10.1016/S0006-8993(00)02899-7; Lau P, 2010, SEMIN CELL DEV BIOL, V21, P768, DOI 10.1016/j.semcdb.2010.01.009; Mattson MP, 2003, NAT CELL BIOL, V5, P1041, DOI 10.1038/ncb1203-1041; Moser JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013445; Nitahara-Kasahara Y, 2007, J VIROL, V81, P5284, DOI 10.1128/JVI.01928-06; Pandey RC, 2009, CURR HIV RES, V7, P114, DOI 10.2174/157016209787581508; Poluektova L, 2005, GLIA, V52, P344, DOI 10.1002/glia.20253; Roggli E, 2010, DIABETES, V59, P978, DOI 10.2337/db09-0881; Rom I, 2009, BRAIN RES, V1275, P81, DOI 10.1016/j.brainres.2009.03.024; Rossbach M, 2010, CURR MOL MED, V10, P361, DOI 10.2174/156652410791317048; Sabbah EN, 2005, J NEUROVIROL, V11, P489, DOI 10.1080/13550280500384941; Sawaya BE, 1998, J BIOL CHEM, V273, P20052, DOI 10.1074/jbc.273.32.20052; Schipper HM, 2007, GENE REGUL SYST BIO, V1, P263; Singh SK, 2007, PHARMACOGENOMICS, V8, P971, DOI 10.2217/14622416.8.8.971; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Sonntag KC, 2010, BRAIN RES, V1338, P48, DOI 10.1016/j.brainres.2010.03.106; Stallings RL, 2009, CURR PHARM DESIGN, V15, P456, DOI 10.2174/138161209787315837; Sun FN, 2010, MOL CELL PROTEOMICS, V9, P963, DOI 10.1074/mcp.R900003-MCP200; Vivithanaporn P, 2010, NEUROLOGY, V75, P1150, DOI 10.1212/WNL.0b013e3181f4d5bb; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Wheeler EDA, 2006, J NEUROVIROL, V12, P200, DOI 10.1080/13550280600827377; Yamaguchi A, 1999, J CELL BIOL, V147, P1195, DOI 10.1083/jcb.147.6.1195; Yamakage M, 2002, CAN J ANAESTH, V49, P151, DOI 10.1007/BF03020488; Yamakuchi M, 2009, CELL CYCLE, V8, P712, DOI 10.4161/cc.8.5.7753; Zhao RY, 2007, ADV PHARMACOL, V55, P233, DOI 10.1016/S1054-3589(07)55007-6; Zhou R, 2009, NEUROPSYCHOPHARMACOL, V34, P1395, DOI 10.1038/npp.2008.131; Zieg J, 2008, CELL, V134, DOI 10.1016/j.cell.2008.09.010	54	35	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34976	34985		10.1074/jbc.M111.241547	http://dx.doi.org/10.1074/jbc.M111.241547			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21816823	Green Published, hybrid			2022-12-25	WOS:000295406300051
J	Low, LY; Yang, C; Perego, M; Osterman, A; Liddington, R				Low, Lieh Yoon; Yang, Chen; Perego, Marta; Osterman, Andrei; Liddington, Robert			Role of Net Charge on Catalytic Domain and Influence of Cell Wall Binding Domain on Bactericidal Activity, Specificity, and Host Range of Phage Lysins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDOGLYCAN RECOGNITION PROTEINS; LACTOCOCCUS-LACTIS PHAGES; MAJOR PHYSIOLOGICAL-ROLE; LYTIC ENZYME CPL-1; BACILLUS-ANTHRACIS; CRYSTAL-STRUCTURE; STREPTOCOCCUS-PNEUMONIAE; TEICHOIC-ACID; BACTERIOPHAGE ENDOLYSINS; ANTIBACTERIAL PROPERTIES	The recombinant lysins of lytic phages, when applied externally to Gram-positive bacteria, can be efficient bactericidal agents, typically retaining high specificity. Their development as novel antibacterial agents offers many potential advantages over conventional antibiotics. Protein engineering could exploit this potential further by generating novel lysins fit for distinct target populations and environments. However, access to the peptidoglycan layer is controlled by a variety of secondary cell wall polymers, chemical modifications, and (in some cases) S-layers and capsules. Classical lysins require a cell wall-binding domain (CBD) that targets the catalytic domain to the peptidoglycan layer via binding to a secondary cell wall polymer component. The cell walls of Gram-positive bacteria generally have a negative charge, and we noticed a correlation between (positive) charge on the catalytic domain and bacteriolytic activity in the absence of the CBD (nonclassical behavior). We investigated a physical basis for this correlation by comparing the structures and activities of pairs of lysins where the lytic activity of one of each pair was CBD-independent. We found that by engineering a reversal of sign of the net charge of the catalytic domain, we could either eliminate or create CBD dependence. We also provide evidence that the S-layer of Bacillus anthracis acts as a molecular sieve that is chiefly size-dependent, favoring catalytic domains over full-length lysins. Our work suggests a number of facile approaches for fine-tuning lysin activity, either to enhance or reduce specificity/host range and/or bactericidal potential, as required.	[Low, Lieh Yoon; Yang, Chen; Osterman, Andrei; Liddington, Robert] Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; [Perego, Marta] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; Scripps Research Institute	Liddington, R (corresponding author), Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	liehyoon@gmail.com; rlidding@sanfordburnham.org			National Institutes of Health, NIAID [AI055789, AI055860]; United States Army Medical Research and Materiel Command [DAMD17-03-2-0038]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI055789, R01AI055860] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI055789 and AI055860 from NIAID. This work was also supported by United States Army Medical Research and Materiel Command Grant DAMD17-03-2-0038.	Alcantara EH, 2007, J BIOCHEM MOL BIOL, V40, P539; Becker SC, 2009, GENE, V443, P32, DOI 10.1016/j.gene.2009.04.023; Beers SA, 2002, J BIOL CHEM, V277, P1788, DOI 10.1074/jbc.M109777200; Bernhardt TG, 2002, RES MICROBIOL, V153, P493, DOI 10.1016/S0923-2508(02)01330-X; Bhavsar AP, 2004, J BACTERIOL, V186, P7865, DOI 10.1128/JB.186.23.7865-7873.2004; Blackburn NT, 2001, J MOL EVOL, V52, P78, DOI 10.1007/s002390010136; BRAU B, 1991, APPL MICROBIOL BIOT, V34, P481; Briers Y, 2009, BIOCHEM BIOPH RES CO, V383, P187, DOI 10.1016/j.bbrc.2009.03.161; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buckland AG, 2000, BBA-MOL CELL BIOL L, V1488, P71, DOI 10.1016/S1388-1981(00)00111-6; Buckland AG, 2000, BBA-MOL CELL BIOL L, V1484, P195, DOI 10.1016/S1388-1981(00)00018-4; Claus H, 2005, CAN J MICROBIOL, V51, P731, DOI 10.1139/W05-093; DeLano W.L., 2005, PYMOL MOL GRAPHICS S; Demchick P, 1996, J BACTERIOL, V178, P768, DOI 10.1128/jb.178.3.768-773.1996; DIAZ E, 1990, P NATL ACAD SCI USA, V87, P8125, DOI 10.1073/pnas.87.20.8125; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; Djurkovic S, 2005, ANTIMICROB AGENTS CH, V49, P1225, DOI 10.1128/AAC.49.3.1225-1228.2005; Donovan DM, 2006, FEMS MICROBIOL LETT, V265, P133, DOI 10.1111/j.1574-6968.2006.00483.x; Donovan DM, 2006, APPL ENVIRON MICROB, V72, P5108, DOI 10.1128/AEM.03065-05; Dziarski R, 2010, INNATE IMMUN-LONDON, V16, P168, DOI 10.1177/1753425910366059; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ETIENNETOUMELIN I, 1995, J BACTERIOL, V177, P614, DOI 10.1128/jb.177.3.614-620.1995; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fischetti VA, 2005, TRENDS MICROBIOL, V13, P491, DOI 10.1016/j.tim.2005.08.007; Fischetti VA, 2010, INT J MED MICROBIOL, V300, P357, DOI 10.1016/j.ijmm.2010.04.002; Fischetti VA, 2008, CURR OPIN MICROBIOL, V11, P393, DOI 10.1016/j.mib.2008.09.012; Foreman-Wykert AK, 1999, J CLIN INVEST, V103, P715, DOI 10.1172/JCI5468; Fouet A, 2009, MOL ASPECTS MED, V30, P374, DOI 10.1016/j.mam.2009.07.001; GARCIA P, 1990, GENE, V86, P81, DOI 10.1016/0378-1119(90)90116-9; GROMAN NB, 1962, J BACTERIOL, V84, P596, DOI 10.1128/JB.84.3.596-597.1962; GROMAN NB, 1963, J BACTERIOL, V86, P187, DOI 10.1128/JB.86.2.187-194.1963; Guan RJ, 2006, PROTEIN SCI, V15, P1199, DOI 10.1110/ps.062077606; Guan RJ, 2007, TRENDS MICROBIOL, V15, P127, DOI 10.1016/j.tim.2007.01.006; Hermoso JA, 2003, STRUCTURE, V11, P1239, DOI 10.1016/j.str.2003.09.005; Hermoso JA, 2007, CURR OPIN MICROBIOL, V10, P461, DOI 10.1016/j.mib.2007.08.002; HUDSON IRB, 1994, J HOSP INFECT, V27, P81, DOI 10.1016/0195-6701(94)90001-9; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kerff F, 2010, J MOL BIOL, V397, P249, DOI 10.1016/j.jmb.2009.12.038; Kern J, 2010, J MOL BIOL, V401, P757, DOI 10.1016/j.jmb.2010.06.059; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; Koch AL, 2003, TRENDS MICROBIOL, V11, P166, DOI 10.1016/S0966-842X(03)00063-5; Koprivnjak T, 2008, INFECT IMMUN, V76, P2169, DOI 10.1128/IAI.01705-07; Korndorfer IP, 2006, J MOL BIOL, V364, P678, DOI 10.1016/j.jmb.2006.08.069; KOZACK RE, 1995, BIOPHYS J, V68, P807, DOI 10.1016/S0006-3495(95)80257-2; Kumar S, 2005, J BIOL CHEM, V280, P37005, DOI 10.1074/jbc.M506385200; Lambert PA, 2002, J APPL MICROBIOL, V92, p46S, DOI 10.1046/j.1365-2672.92.5s1.7.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leoff C, 2008, J BIOL CHEM, V283, P29812, DOI 10.1074/jbc.M803234200; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Liu C, 2000, J BIOL CHEM, V275, P24490, DOI 10.1074/jbc.M001239200; Loeffler JM, 2001, SCIENCE, V294, P2170, DOI 10.1126/science.1066869; Loeffler JM, 2003, INFECT IMMUN, V71, P6199, DOI 10.1128/IAI.71.11.6199-6204.2003; Loessner MJ, 1997, J BACTERIOL, V179, P2845, DOI 10.1128/jb.179.9.2845-2851.1997; Loessner MJ, 2002, MOL MICROBIOL, V44, P335, DOI 10.1046/j.1365-2958.2002.02889.x; Loessner MJ, 2005, CURR OPIN MICROBIOL, V8, P480, DOI 10.1016/j.mib.2005.06.002; LONGCHAMP PF, 1994, MICROBIOL-UK, V140, P1855, DOI 10.1099/13500872-140-8-1855; Lopez R, 1997, MICROB DRUG RESIST, V3, P199, DOI 10.1089/mdr.1997.3.199; Low LY, 2005, J BIOL CHEM, V280, P35433, DOI 10.1074/jbc.M502723200; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Meroueh SO, 2006, P NATL ACAD SCI USA, V103, P4404, DOI 10.1073/pnas.0510182103; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oyston PCF, 2009, J MED MICROBIOL, V58, P977, DOI 10.1099/jmm.0.011122-0; Pastagia M, 2011, ANTIMICROB AGENTS CH, V55, P738, DOI 10.1128/AAC.00890-10; PEREGO M, 1995, J BIOL CHEM, V270, P15598, DOI 10.1074/jbc.270.26.15598; Perez-Dorado I, 2007, J BIOL CHEM, V282, P24990, DOI 10.1074/jbc.M704317200; Peschel A, 2002, TRENDS MICROBIOL, V10, P179, DOI 10.1016/S0966-842X(02)02333-8; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Porter CJ, 2007, J MOL BIOL, V366, P540, DOI 10.1016/j.jmb.2006.11.056; Rashel M, 2007, J INFECT DIS, V196, P1237, DOI 10.1086/521305; Roy H, 2009, IUBMB LIFE, V61, P940, DOI 10.1002/iub.240; Saha S, 2009, CELL HOST MICROBE, V5, P137, DOI 10.1016/j.chom.2008.12.010; SANZ JM, 1992, BIOCHEMISTRY-US, V31, P8495, DOI 10.1021/bi00151a016; SANZ JM, 1992, MOL MICROBIOL, V6, P921, DOI 10.1111/j.1365-2958.1992.tb01542.x; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schuch R, 2002, NATURE, V418, P884, DOI 10.1038/nature01026; Scott JR, 2006, ANNU REV MICROBIOL, V60, P397, DOI 10.1146/annurev.micro.60.080805.142256; Severin A, 2004, MICROB DRUG RESIST, V10, P77, DOI 10.1089/1076629041310082; Spinelli S, 2006, J BIOL CHEM, V281, P14256, DOI 10.1074/jbc.M600666200; SRISODSUK M, 1993, J BIOL CHEM, V268, P20756; Sugahara K, 2007, GENE, V404, P41, DOI 10.1016/j.gene.2007.08.023; Swaminathan CP, 2006, P NATL ACAD SCI USA, V103, P684, DOI 10.1073/pnas.0507656103; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Ton-That H, 2004, BBA-MOL CELL RES, V1694, P269, DOI 10.1016/j.bbamcr.2004.04.014; Tremblay DM, 2006, J BACTERIOL, V188, P2400, DOI 10.1128/JB.188.7.2400-2410.2006; Turner MS, 2004, FEMS MICROBIOL LETT, V238, P9, DOI 10.1016/j.femsle.2004.07.008; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Witzenrath M, 2009, CRIT CARE MED, V37, P642, DOI 10.1097/CCM.0b013e31819586a6; Yoong P, 2004, J BACTERIOL, V186, P4808, DOI 10.1128/JB.186.14.4808-4812.2004; Young R, 2000, TRENDS MICROBIOL, V8, P120, DOI 10.1016/S0966-842X(00)01705-4; YOUNG R, 1995, FEMS MICROBIOL REV, V17, P191, DOI 10.1016/0168-6445(94)00079-4	93	96	100	1	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34391	34403		10.1074/jbc.M111.244160	http://dx.doi.org/10.1074/jbc.M111.244160			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21816821	hybrid, Green Published			2022-12-25	WOS:000295159200067
J	Qian, YF; Shi, L; Tien, M				Qian, Yufeng; Shi, Liang; Tien, Ming			SO2907, a Putative TonB-dependent Receptor, Is Involved in Dissimilatory Iron Reduction by Shewanella oneidensis Strain MR-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL-CATALYZED OXIDATION; EXTRACELLULAR ELECTRON-TRANSFER; MEMBRANE CYTOCHROMES MTRC; AMINO-ACID-RESIDUES; ANAEROBIC RESPIRATION; TETRAHEME CYTOCHROME; ESCHERICHIA-COLI; PROTEINS; BINDING; OUTER	Shewanella oneidensis strain MR-1 utilizes soluble and insoluble ferric ions as terminal electron acceptors during anaerobic respiration. The components of respiratory metabolism are localized in the membrane fractions which include the outer membrane and cytoplasmic membrane. Many of the biological components that interact with the various iron forms are proposed to be localized in these membrane fractions. To identify the iron-binding proteins acting either as an iron transporter or as a terminal iron reductase, we used metal-catalyzed oxidation reactions. This system catalyzed the oxidation of amino acids in close proximity to the iron binding site. The carbonyl groups formed from this oxidation can then be labeled with fluoresceinamine (FLNH2). The peptide harboring the FLNH2 can then be proteolytically digested, purified by HPLC and then identified by MALDI-TOF tandem MS. A predominant peptide was identified to be part of SO2907 that encodes a putative TonB-dependent receptor. Compared with wild type (wt), the so2907 gene deletion (Delta SO2907) mutant has impaired ability to reduce soluble Fe(III), but retains the same ability to respire oxygen or fumarate as the wt. The Delta SO2907 mutant was also impacted in reduction of insoluble iron. Iron binding assays using isothermal titration calorimetry and fluorescence tryptophan quenching demonstrated that a truncated form of heterologous-expressed SO2907 that contains the Fe(III) binding site, is capable of binding soluble Fe(III) forms with K-d of approximate 50 mu M. To the best of our knowledge, this is the first report of the physiological role of SO2907 in Fe(III) reduction by MR-1.	[Qian, Yufeng; Tien, Ming] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Shi, Liang] Pacific NW Natl Lab, Richland, WA 99352 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Tien, M (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	mxt3@psu.edu	Qian, Yufeng/F-3699-2012	Qian, Yufeng/0000-0002-9901-6154	NSF Environmental Molecular Sciences Institute through the Penn State Center for environmental Kinetics Analysis [CHE-0431328]; DOE [ER64399 0013153]	NSF Environmental Molecular Sciences Institute through the Penn State Center for environmental Kinetics Analysis; DOE(United States Department of Energy (DOE))	This work was supported by the NSF Environmental Molecular Sciences Institute program (CHE-0431328) through the Penn State Center for environmental Kinetics Analysis and by DOE Grant ER64399 0013153.	Ali FE, 2004, J INORG BIOCHEM, V98, P173, DOI 10.1016/j.jinorgbio.2003.10.002; AMICI A, 1989, J BIOL CHEM, V264, P3341; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56; CAMPBELL JA, 1994, ANAL CHEM, V66, pA1208, DOI 10.1021/ac00096a711; CLIMENT I, 1989, ANAL BIOCHEM, V182, P226, DOI 10.1016/0003-2697(89)90584-8; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; Fredrickson JK, 2004, GEOCHIM COSMOCHIM AC, V68, P3171, DOI 10.1016/j.gca.2003.10.024; Fredrickson JK, 2000, GEOCHIM COSMOCHIM AC, V64, P3085, DOI 10.1016/S0016-7037(00)00397-5; Gescher JS, 2008, MOL MICROBIOL, V68, P706, DOI 10.1111/j.1365-2958.2008.06183.x; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; Gralnick JA, 2007, MOL MICROBIOL, V65, P1, DOI 10.1111/j.1365-2958.2007.05778.x; Jones ME, 2010, ENVIRON MICROBIOL, V12, P938, DOI 10.1111/j.1462-2920.2009.02137.x; Lies DP, 2005, APPL ENVIRON MICROB, V71, P4414, DOI 10.1128/AEM.71.8.4414-4426.2005; Lower BH, 2007, J BACTERIOL, V189, P4944, DOI 10.1128/JB.01518-06; Madigan M. T., 2000, BROCK BIOL MICROORGA; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; MYERS CR, 1988, SCIENCE, V240, P1319, DOI 10.1126/science.240.4857.1319; Nancharaiah YV, 2006, WATER RES, V40, P1539, DOI 10.1016/j.watres.2006.02.006; Nealson K. H., 1997, GEOMICROBIOLOGY INTE; NEALSON KH, 1994, ANNU REV MICROBIOL, V48, P311, DOI 10.1146/annurev.mi.48.100194.001523; Newton SMC, 1999, MOL MICROBIOL, V32, P1153, DOI 10.1046/j.1365-2958.1999.01424.x; PEALING SL, 1995, BIOCHEMISTRY-US, V34, P6153, DOI 10.1021/bi00018a018; Perozzo R, 2004, J RECEPT SIG TRANSD, V24, P1, DOI 10.1081/RRS-120037896; PERRY AJ, 1973, J MATER SCI, V8, P904, DOI 10.1007/BF02397923; Postle K, 1999, NAT STRUCT BIOL, V6, P3, DOI 10.1038/4869; Postle K, 2003, MOL MICROBIOL, V49, P869, DOI 10.1046/j.1365-2958.2003.03629.x; Postle K, 2007, BIOMETALS, V20, P453, DOI 10.1007/s10534-006-9071-6; Qian YF, 2011, BIOCHEMISTRY-US, V50, P6217, DOI 10.1021/bi2005015; Ruebush SS, 2006, APPL ENVIRON MICROB, V72, P2925, DOI 10.1128/AEM.72.4.2925-2935.2006; Schwalb C, 2003, BIOCHEMISTRY-US, V42, P9491, DOI 10.1021/bi034456f; STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053; STADTMAN ER, 1991, J BIOL CHEM, V266, P2005; STADTMAN ER, 1990, FREE RADICAL BIO MED, V9, P315, DOI 10.1016/0891-5849(90)90006-5; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Taillefert M, 2007, J INORG BIOCHEM, V101, P1760, DOI 10.1016/j.jinorgbio.2007.07.020; Temple A, 2006, J AM SOC MASS SPECTR, V17, P1172, DOI 10.1016/j.jasms.2006.04.030; Tiedje JM, 2002, NAT BIOTECHNOL, V20, P1093, DOI 10.1038/nbt1102-1093; von Canstein H, 2008, APPL ENVIRON MICROB, V74, P615, DOI 10.1128/AEM.01387-07; Wade R, 2000, FEMS MICROBIOL LETT, V184, P143, DOI 10.1111/j.1574-6968.2000.tb09005.x; Wang ZM, 2008, APPL ENVIRON MICROB, V74, P6746, DOI 10.1128/AEM.01454-08; Weber KA, 2006, NAT REV MICROBIOL, V4, P752, DOI 10.1038/nrmicro1490; WINZOR DJ, 1995, QUANTITATIVE CHARACT; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3	45	7	8	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33973	33980		10.1074/jbc.M111.262113	http://dx.doi.org/10.1074/jbc.M111.262113			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21813652	Green Published, hybrid			2022-12-25	WOS:000295159200029
J	Fauchald, P; Skov, H; Skern-Mauritzen, M; Johns, D; Tveraa, T				Fauchald, Per; Skov, Henrik; Skern-Mauritzen, Mette; Johns, David; Tveraa, Torkild			Wasp-Waist Interactions in the North Sea Ecosystem	PLOS ONE			English	Article							HERRING CLUPEA-HARENGUS; CONTINUOUS PLANKTON RECORDS; SPRAT SPRATTUS-SPRATTUS; CENTRAL BALTIC SEA; TROPHIC CASCADES; POPULATION-DYNAMICS; CALANOID COPEPODS; ATLANTIC OCEAN; REGIME SHIFTS; BOTTOM-UP	Background: In a "wasp-waist'' ecosystem, an intermediate trophic level is expected to control the abundance of predators through a bottom-up interaction and the abundance of prey through a top-down interaction. Previous studies suggest that the North Sea is mainly governed by bottom-up interactions driven by climate perturbations. However, few studies have investigated the importance of the intermediate trophic level occupied by small pelagic fishes. Methodology/Principal Findings: We investigated the numeric interactions among 10 species of seabirds, two species of pelagic fish and four groups of zooplankton in the North Sea using decadal-scale databases. Linear models were used to relate the time series of zooplankton and seabirds to the time series of pelagic fish. Seabirds were positively related to herring (Clupea harengus), suggesting a bottom-up interaction. Two groups of zooplankton; Calanus helgolandicus and krill were negatively related to sprat (Sprattus sprattus) and herring respectively, suggesting top-down interactions. In addition, we found positive relationships among the zooplankton groups. Para/pseudocalanus was positively related to C. helgolandicus and C. finmarchicus was positively related to krill. Conclusion/Significance: Our results indicate that herring was important in regulating the abundance of seabirds through a bottom-up interaction and that herring and sprat were important in regulating zooplankton through top-down interactions. We suggest that the positive relationships among zooplankton groups were due to selective foraging and switching in the two clupeid fishes. Our results suggest that "wasp-waist'' interactions might be more important in the North Sea than previously anticipated. Fluctuations in the populations of pelagic fish due to harvesting and depletion of their predators might accordingly have profound consequences for ecosystem dynamics through trophic cascades.	[Fauchald, Per; Tveraa, Torkild] Norwegian Inst Nat Res NINA, Dept Arct Ecol, Fram Ctr, Tromso, Norway; [Skov, Henrik] DHI, Horsholm, Denmark; [Skern-Mauritzen, Mette] Inst Marine Res, N-5024 Bergen, Norway; [Johns, David] Sir Alister Hardy Fdn Ocean Sci, Plymouth, Devon, England	Norwegian Institute Nature Research; Institute of Marine Research - Norway	Fauchald, P (corresponding author), Norwegian Inst Nat Res NINA, Dept Arct Ecol, Fram Ctr, Tromso, Norway.	per.fauchald@nina.no	Fauchald, Per/AAV-4242-2021; Skern-Mauritzen, Mette/ABA-8173-2020	Johns, David/0000-0003-3270-6764; Tveraa, Torkild/0000-0002-7501-3696	Norwegian Research Council [173348, 172532]; DHI; Natural Environment Research Council [SAH01001] Funding Source: researchfish; NERC [SAH01001] Funding Source: UKRI	Norwegian Research Council(Research Council of NorwayEuropean Commission); DHI; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The research was supported by the Norwegian Research Council through the project #173348 to PF and MS-M and the project #172532 to PF. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Henrik Skov is an employee of DHI and was supported by internal research funds from DHI. He contributed to the design of experiments and wrote the manuscript.	AEBISCHER NJ, 1990, NATURE, V347, P753, DOI 10.1038/347753a0; Alheit J, 1997, FISH OCEANOGR, V6, P130, DOI 10.1046/j.1365-2419.1997.00035.x; Alheit J, 2005, ICES J MAR SCI, V62, P1205, DOI 10.1016/j.icesjms.2005.04.024; Bakun A, 2006, PROG OCEANOGR, V68, P271, DOI 10.1016/j.pocean.2006.02.004; Barrett RT, 2007, ICES J MAR SCI, V64, P1675, DOI 10.1093/icesjms/fsm152; Barry SC, 2002, ECOL MODEL, V157, P179, DOI 10.1016/S0304-3800(02)00194-1; Beaugrand G, 2004, PROG OCEANOGR, V60, P245, DOI 10.1016/j.pocean.2004.02.018; Beaugrand G, 2004, MAR ECOL PROG SER, V284, P35, DOI 10.3354/meps284035; CAIRNS D K, 1987, Biological Oceanography, V5, P261; Camphuysen K, 1999, ARDEA, V87, P177; Casini M, 2006, OIKOS, V112, P638, DOI 10.1111/j.0030-1299.2006.13860.x; Casini M, 2004, ICES J MAR SCI, V61, P1267, DOI 10.1016/j.icesjms.2003.12.011; Casini M, 2009, P NATL ACAD SCI USA, V106, P197, DOI 10.1073/pnas.0806649105; Chase JM, 2002, ECOL LETT, V5, P302, DOI 10.1046/j.1461-0248.2002.00315.x; Cury P, 2000, ICES J MAR SCI, V57, P603, DOI 10.1006/jmsc.2000.0712; Dalpadado P, 2000, ICES J MAR SCI, V57, P843, DOI 10.1006/jmsc.2000.0573; Davis, INTRO TIME SERIES FO; DUNNET GM, 1990, NETH J SEA RES, V26, P387, DOI 10.1016/0077-7579(90)90097-Z; Edwards M, 2002, MAR ECOL PROG SER, V239, P1, DOI 10.3354/meps239001; Fauchald P, 2011, ECOLOGY, V92, P228, DOI 10.1890/10-0818.1; Fauchald P, 2010, ECOLOGY, V91, P2191, DOI 10.1890/09-1500.1; Fox CJ, 2000, FISH OCEANOGR, V9, P33; Frank KT, 2007, TRENDS ECOL EVOL, V22, P236, DOI 10.1016/j.tree.2007.03.002; Frank KT, 2006, ECOL LETT, V9, P1096, DOI 10.1111/j.1461-0248.2006.00961.x; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; FRANSZ HG, 1991, NETH J SEA RES, V28, P1, DOI 10.1016/0077-7579(91)90003-J; Fraser HM, 2007, ICES J MAR SCI, V64, P1800, DOI 10.1093/icesjms/fsm145; Frederiksen M, 2005, MAR ECOL PROG SER, V300, P201, DOI 10.3354/meps300201; Frederiksen M, 2007, MAR ECOL PROG SER, V337, P279, DOI 10.3354/meps337279; Frederiksen M, 2006, J ANIM ECOL, V75, P1259, DOI 10.1111/j.1365-2656.2006.01148.x; Garthe S, 1996, MAR ECOL PROG SER, V136, P1, DOI 10.3354/meps136001; GIBSON RN, 1990, MAR BIOL, V107, P357, DOI 10.1007/BF01319837; Heath MR, 2005, ICES J MAR SCI, V62, P1233, DOI 10.1016/j.icesjms.2005.04.010; ICES, 2004, MAN INT BOTT TRAWL S; ICES [International Council for the Exploration of the Seas], 2008, ICES ADV; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kirby RR, 2009, P ROY SOC B-BIOL SCI, V276, P4095, DOI 10.1098/rspb.2009.1320; Kirby RR, 2009, ECOSYSTEMS, V12, P548, DOI 10.1007/s10021-009-9241-9; LAST JM, 1989, J FISH BIOL, V34, P489, DOI 10.1111/j.1095-8649.1989.tb03330.x; Letessier TB, 2009, MAR BIOL, V156, P2539, DOI 10.1007/s00227-009-1278-y; LINDLEY JA, 1982, MAR BIOL, V71, P7, DOI 10.1007/BF00396986; LINDLEY JA, 1977, J BIOGEOGR, V4, P121, DOI 10.2307/3038157; LINDLEY JA, 1982, MAR BIOL, V66, P37, DOI 10.1007/BF00397252; Link JS, 2009, FISH FISH, V10, P58, DOI 10.1111/j.1467-2979.2008.00295.x; Mackinson S, 2009, ECOL MODEL, V220, P2972, DOI 10.1016/j.ecolmodel.2008.10.021; Mackinson S., 2007, CEFAS SCI SERIES TEC, V142, P196; Maes J, 2005, HYDROBIOLOGIA, V540, P225, DOI 10.1007/s10750-004-7146-3; Mitchell P. Ian, 2006, P765; Mollmann C, 2008, ICES J MAR SCI, V65, P302, DOI 10.1093/icesjms/fsm197; Mollmann C, 2004, J FISH BIOL, V65, P1563, DOI 10.1111/j.0022-1112.2004.00566.x; Mollmann C, 2002, J PLANKTON RES, V24, P959, DOI 10.1093/plankt/24.10.959; MURDOCH WW, 1975, ECOLOGY, V56, P1094, DOI 10.2307/1936149; Osterblom H, 2006, MAR ECOL PROG SER, V323, P233, DOI 10.3354/meps323233; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Petrie B, 2009, FISH OCEANOGR, V18, P83, DOI 10.1111/j.1365-2419.2009.00500.x; Pinhiero J., 2009, NLME LINEAR NONLINEA, P1; R Development Core Team, 2009, R FDN STAT COMP; Reid PC, 2000, ICES J MAR SCI, V57, P495, DOI 10.1006/jmsc.2000.0740; Reid PC, 2003, FISH OCEANOGR, V12, P260, DOI 10.1046/j.1365-2419.2003.00252.x; Richardson AJ, 2006, PROG OCEANOGR, V68, P27, DOI 10.1016/j.pocean.2005.09.011; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Skov H, 2000, J AVIAN BIOL, V31, P135, DOI 10.1034/j.1600-048X.2000.310205.x; STRONG DR, 1992, ECOLOGY, V73, P747, DOI 10.2307/1940154; Swain DP, 2000, CAN J FISH AQUAT SCI, V57, P1321, DOI 10.1139/cjfas-57-7-1321; TASKER ML, 1984, AUK, V101, P567, DOI 10.1093/auk/101.3.567; Walters C, 2001, CAN J FISH AQUAT SCI, V58, P39, DOI 10.1139/cjfas-58-1-39; Welsh AH, 1996, ECOL MODEL, V88, P297, DOI 10.1016/0304-3800(95)00113-1; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zuur Alain F., 2009, P1	69	48	48	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22729	10.1371/journal.pone.0022729	http://dx.doi.org/10.1371/journal.pone.0022729			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829494	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000293284600034
J	Pedigo, A; Seaver, W; Odoi, A				Pedigo, Ashley; Seaver, William; Odoi, Agricola			Identifying Unique Neighborhood Characteristics to Guide Health Planning for Stroke and Heart Attack: Fuzzy Cluster and Discriminant Analyses Approaches	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; QUALITY-OF-CARE; CARDIOVASCULAR-DISEASE; SOCIOECONOMIC CONTEXT; INFLUENTIAL SUBSETS; UNITED-STATES; SOCIAL-CLASS; SURVIVAL; ASSOCIATION; DEPRIVATION	Background: Socioeconomic, demographic, and geographic factors are known determinants of stroke and myocardial infarction (MI) risk. Clustering of these factors in neighborhoods needs to be taken into consideration during planning, prioritization and implementation of health programs intended to reduce disparities. Given the complex and multidimensional nature of these factors, multivariate methods are needed to identify neighborhood clusters of these determinants so as to better understand the unique neighborhood profiles. This information is critical for evidence-based health planning and service provision. Therefore, this study used a robust multivariate approach to classify neighborhoods and identify their socio-demographic characteristics so as to provide information for evidence-based neighborhood health planning for stroke and MI. Methods and Findings: The study was performed in East Tennessee Appalachia, an area with one of the highest stroke and MI risks in USA. Robust principal component analysis was performed on neighborhood (census tract) socioeconomic and demographic characteristics, obtained from the US Census, to reduce the dimensionality and influence of outliers in the data. Fuzzy cluster analysis was used to classify neighborhoods into Peer Neighborhoods (PNs) based on their socioeconomic and demographic characteristics. Nearest neighbor discriminant analysis and decision trees were used to validate PNs and determine the characteristics important for discrimination. Stroke and MI mortality risks were compared across PNs. Four distinct PNs were identified and their unique characteristics and potential health needs described. The highest risk of stroke and MI mortality tended to occur in less affluent PNs located in urban areas, while the suburban most affluent PNs had the lowest risk. Conclusions: Implementation of this multivariate strategy provides health planners useful information to better understand and effectively plan for the unique neighborhood health needs and is important in guiding resource allocation, service provision, and policy decisions to address neighborhood health disparities and improve population health.	[Pedigo, Ashley; Odoi, Agricola] Univ Tennessee, Dept Comparat Med, Knoxville, TN 37996 USA; [Seaver, William] Univ Tennessee, Dept Stat Operat & Business Sci, Knoxville, TN USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Tennessee System; University of Tennessee Knoxville	Pedigo, A (corresponding author), Univ Tennessee, Dept Comparat Med, Knoxville, TN 37996 USA.	aodoi@utk.edu	Odoi, Agricola/I-9532-2019	Odoi, Agricola/0000-0001-5050-6737	American Heart Association [0865290E]	American Heart Association(American Heart Association)	This study was funded by the American Heart Association (http://www.heart.org). The grant number is 0865290E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HP, 2007, CIRCULATION, V115, pE478, DOI 10.1161/CIRCULATIONAHA.107.181486; Alazraqui M, 2007, REV PANAM SALUD PUBL, V21, P1, DOI 10.1590/S1020-49892007000100001; Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; Baldwin LM, 2004, J RURAL HEALTH, V20, P99, DOI 10.1111/j.1748-0361.2004.tb00015.x; Bezdek JC, 1981, PATTERN RECOGNITION, DOI 10.1007/978-1-4757-0450-1; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; BROOKS T, 2008, US CENSUS BUREAU AM, P1; CASPER ML, 1999, WOMEN HEART DIS ATLA; Centers for Disease Control and Prevention, 2007, MMWR-MORBID MORTAL W, V56, P471; Centers for Disease Control and Prevention National Center for Health Statistics, 2009, COMPR MORT FIL 1999; Chaix B, 2007, EPIDEMIOLOGY, V18, P104, DOI 10.1097/01.ede.0000249573.22856.9a; Cooper R, 2000, CIRCULATION, V102, P3137; Diez-Roux AV, 1998, AM J PUBLIC HEALTH, V88, P216, DOI 10.2105/AJPH.88.2.216; Dunn J. C., 1974, Journal of Cybernetics, V4, P1, DOI 10.1080/01969727408546062; Edgington E. S., 1995, RANDOMIZATION TESTS; Environmental Systems Research Institute, 2008, ARCGIS 9 3; FRENETTE M, 2004, LONG PEOPLE LIVE LOW; Gerber Y, 2008, MAYO CLIN PROC, V83, P663, DOI 10.4065/83.6.663; Glymour MM, 2007, STROKE, V38, P2415, DOI 10.1161/STROKEAHA.107.482059; Harris C., 2005, Morbidity and Mortality Weekly Report, V54, P477; Hart CL, 2000, AM J PUBLIC HEALTH, V90, P1788, DOI 10.2105/AJPH.90.11.1788; HINTZE J, 2007, MULTIVARIATE ANAL CL; HINTZE J., 2007, NCSS 2007; HOLMSTRAND P, 2009, BATCH GEOCODE; Howard G, 1997, STROKE, V28, P936, DOI 10.1161/01.STR.28.5.936; HOWARD G, 1995, STROKE, V26, P1759, DOI 10.1161/01.STR.26.10.1759; HOWARD G, 1999, NAT C CVD PREV BETH; Jackson JE, 2003, USERS GUIDE PRINCIPA; Jneid H, 2008, CIRCULATION, V118, P2803, DOI 10.1161/CIRCULATIONAHA.108.789800; Johnson D., 1998, APPL MULTIVARIATE ME; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; Kaufman L., 2005, FINDING GROUPS DATA; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Krieger N, 1997, ANNU REV PUBL HEALTH, V18, P341, DOI 10.1146/annurev.publhealth.18.1.341; Lattin L., 2003, ANAL MULTIVARIATE DA; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Lovasi GS, 2008, HEALTH PLACE, V14, P453, DOI 10.1016/j.healthplace.2007.09.004; MOREWITZ SJ, 2006, CARDIOVASCULAR DIS C, P139; ODOI A, 2005, INT J HEALTH GEOGR, V4, P1; Pickett KE, 2001, J EPIDEMIOL COMMUN H, V55, P111, DOI 10.1136/jech.55.2.111; ROSAMOND W, 2008, HEART DIS STROKE STA, pE25; Rose KM, 2009, ANN EPIDEMIOL, V19, P867, DOI 10.1016/j.annepidem.2009.07.092; Rosvall M, 2008, EUR J PUBLIC HEALTH, V18, P533, DOI 10.1093/eurpub/ckn059; Sampson RJ, 2002, ANNU REV SOCIOL, V28, P443, DOI 10.1146/annurev.soc.28.110601.141114; *SAS I INC, 2007, SAS ONLINEDOCH 9 2; SAS Institute Inc, 2007, SAS VERS 9 2; Schuurman N, 2007, J URBAN HEALTH, V84, P591, DOI 10.1007/s11524-007-9193-3; Seaver B, 2004, J PROD ANAL, V21, P201, DOI 10.1023/B:PROD.0000016873.63406.90; Seaver B, 1999, TECHNOMETRICS, V41, P340, DOI 10.2307/1271350; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; *SPSS, 2002, ANSW TREE 3 1; StataCorp, 2009, STAT STAT SOFTW REL, V11; Statistics Canada, 2007, 2006 CENS DICT; TOFLER GH, 1993, AM J CARDIOL, V71, P1031, DOI 10.1016/0002-9149(93)90568-W; Tonne C, 2005, CIRCULATION, V111, P3063, DOI 10.1161/CIRCULATIONAHA.104.496174; TRIANTIS K, 2010, USING MULTIVARIATE M, P39; *US BUR CENS, 2001, CENS TRACT BLOCK NUM; *US BUR CENS, 1994, GEOGR AR REF MAN CEN; *US BUR CENS, 2009, AM FACT FIND, DOI DOI 10.1016/J.HEALTHPLACE.2007.09.004; *US BUR CENS, 2010, CENS BUR INF QUAL GU, DOI DOI 10.1016/J.ANNEPIDEM.2009.07.092	61	12	12	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22693	10.1371/journal.pone.0022693	http://dx.doi.org/10.1371/journal.pone.0022693			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	799KC	21829481	gold, Green Published			2022-12-25	WOS:000293284600026
J	Peris-Bondia, F; Latorre, A; Artacho, A; Moya, A; D'Auria, G				Peris-Bondia, Francesc; Latorre, Amparo; Artacho, Alejandro; Moya, Andres; D'Auria, Giuseppe			The Active Human Gut Microbiota Differs from the Total Microbiota	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; IN-SITU HYBRIDIZATION; TARGETED OLIGONUCLEOTIDE PROBES; FLOW-CYTOMETRY; SP NOV.; BACTERIAL COMMUNITIES; PROTEOME ANALYSIS; GEN. NOV.; DIVERSITY; CELL	The human gut microbiota is considered one of the most fascinating reservoirs of microbial diversity hosting between 400 to 1000 bacterial species distributed among nine phyla with Firmicutes, Bacteroidetes and Actinobacteria representing around 75 % of the diversity. One of the most intriguing issues relates to understanding which microbial groups are active players in the maintenance of the microbiota homeostasis. Here, we describe the diversity of active microbial fractions compared with the whole community from raw human fecal samples. We studied four healthy volunteers by 16S rDNA gene pyrosequencing. The fractions were obtained by cell sorting based on bacterial RNA concentration. Bacterial families were observed to appear or disappear on applying a cell sorting method in which flow cytometry was used to evaluate the active cells by pyronin-Y staining of RNA. This method was able to detect active bacteria, indicating that the active players differed from that observed in raw fecal material. Generally, observations showed that in the active fractions, the number of reads related to Bacteroidetes decreased whereas several families from Clostridiales ( Firmicutes) were more highly represented. Moreover, a huge number of families appeared as part of the active fraction when cell sorting was applied, indicating reads that are simply statistically hidden by the total reads.	[Peris-Bondia, Francesc; Latorre, Amparo; Artacho, Alejandro; Moya, Andres; D'Auria, Giuseppe] Univ Valencia, Joint Unit Res Genom & Hlth, Ctr Publ Hlth Res CSISP, Cavanilles Inst Biodivers & Evolutionary Biol, Valencia, Spain; [Peris-Bondia, Francesc; Latorre, Amparo; Moya, Andres; D'Auria, Giuseppe] Ctr Invest Red Epidemiol & Salud Publ CIBEResp, Barcelona, Spain	University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Peris-Bondia, F (corresponding author), Univ Valencia, Joint Unit Res Genom & Hlth, Ctr Publ Hlth Res CSISP, Cavanilles Inst Biodivers & Evolutionary Biol, Valencia, Spain.	dauria_giu@gva.es	Guan, Xiaokang/A-6675-2012; Latorre, Amparo/E-4997-2015; D'Auria, Giuseppe/E-6583-2010; Artacho, Alejandro/Z-4613-2019; Moya, Andrés/A-8190-2008	Latorre, Amparo/0000-0002-9146-7284; Moya, Andrés/0000-0002-2867-1119; D'Auria, Giuseppe/0000-0003-0672-2541	Miguel Servet, Instituto de Salud Carlos III, Spain [CP09/00049]; Spanish Ministery for Science and Innovation (MCINN) [SAF2009-13032-C02-01, BFU2008-04501-E]; Conselleria D'Educacio Generalitat Valenciana, Spain; University of Valencia	Miguel Servet, Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Spanish Ministery for Science and Innovation (MCINN); Conselleria D'Educacio Generalitat Valenciana, Spain(Center for Forestry Research & Experimentation (CIEF)); University of Valencia	This work was funded by grant CP09/00049 Miguel Servet, Instituto de Salud Carlos III, Spain to GD; by projects SAF2009-13032-C02-01 from the Spanish Ministery for Science and Innovation (MCINN), BFU2008-04501-E from Spanish Ministery for Science and Innovation (MCINN) in the frame of ERA-Net PathoGenoMics and Prometeo/2009/092 from Conselleria D'Educacio Generalitat Valenciana, Spain, to AM. FPB is recipient of a fellowship from the University of Valencia. FCM-FACS experiments were carried out using facilities at the Servei Central de Suport a la Investigacio Experimental (SCSIE), University of Valencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Ben-Amor K, 2005, APPL ENVIRON MICROB, V71, P4679, DOI 10.1128/AEM.71.8.4679-4689.2005; Burtscher C, 2003, APPL ENVIRON MICROB, V69, P4618, DOI 10.1128/AEM.69.8.4618-4627.2003; Campieri M, 2001, GUT, V48, P132, DOI 10.1136/gut.48.1.132; Collado Maria Carmen, 2007, Curr Issues Intest Microbiol, V8, P9; Collins SM, 2009, DIGEST LIVER DIS, V41, P850, DOI 10.1016/j.dld.2009.07.023; Comalada M, 2006, J CANCER RES CLIN, V132, P487, DOI 10.1007/s00432-006-0092-x; Cordova-Kreylos AL, 2006, APPL ENVIRON MICROB, V72, P3357, DOI 10.1128/AEM.72.5.3357-3366.2006; Daffonchio D, 2006, NATURE, V440, P203, DOI 10.1038/nature04418; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Devillard E, 2007, J BACTERIOL, V189, P2566, DOI 10.1128/JB.01359-06; Duncan SH, 2002, INT J SYST EVOL MICR, V52, P2141, DOI [10.1099/ijs.0.02241-0, 10.1099/00207713-52-6-2141]; Durban A, 2011, MICROB ECOL, V61, P123, DOI 10.1007/s00248-010-9738-y; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Ellis B., FLOWVIZ VISUALIZATIO; Franks AH, 1998, APPL ENVIRON MICROB, V64, P3336; Furrie E, 2006, GUT, V55, P141, DOI 10.1136/gut.2005.081695; Garnova ES, 2003, EXTREMOPHILES, V7, P213, DOI 10.1007/s00792-002-0312-5; Gentile G, 2006, ENVIRON MICROBIOL, V8, P2150, DOI 10.1111/j.1462-2920.2006.01097.x; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Guarner F, 2003, BEST PRACT RES CL GA, V17, P793, DOI 10.1016/S1521-6918(03)00068-4; Harmsen HJM, 2002, APPL ENVIRON MICROB, V68, P2982, DOI 10.1128/AEM.68.6.2982-2990.2002; Hattori M, 2009, DNA RES, V16, P1, DOI 10.1093/dnares/dsn033; Heine F, 2009, CYTOM PART A, V75A, P140, DOI 10.1002/cyto.a.20661; Hold GL, 2002, FEMS MICROBIOL ECOL, V39, P33, DOI 10.1111/j.1574-6941.2002.tb00904.x; HOLDEMAN LV, 1974, INT J SYST BACTERIOL, V24, P260, DOI 10.1099/00207713-24-2-260; Hsiao WWL, 2009, DRUG DISCOV TODAY, V14, P331, DOI 10.1016/j.drudis.2009.03.001; Gosalbes MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017447; JOSEPHSON KL, 1993, APPL ENVIRON MICROB, V59, P3513, DOI 10.1128/AEM.59.10.3513-3515.1993; Kang S, 2010, INFLAMM BOWEL DIS, V16, P2034, DOI 10.1002/ibd.21319; Keller M, 2008, CURR OPIN MICROBIOL, V11, P195, DOI 10.1016/j.mib.2008.05.003; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Lay C, 2005, APPL ENVIRON MICROB, V71, P4153, DOI 10.1128/AEM.71.7.4153-4155.2005; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Louis P, 2004, J BACTERIOL, V186, P2099, DOI 10.1128/JB.186.7.2099-2106.2004; Macfarlane S, 2007, J APPL MICROBIOL, V102, P1187, DOI 10.1111/j.1365-2672.2007.03287.x; MAHONY DE, 1977, APPL ENVIRON MICROB, V34, P419, DOI 10.1128/AEM.34.4.419-423.1977; McHugh IOL, 2007, CYTOM PART A, V71A, P1019, DOI 10.1002/cyto.a.20488; Meier H, 1999, SYST APPL MICROBIOL, V22, P186, DOI 10.1016/S0723-2020(99)80065-4; Muller S, 2010, FEMS MICROBIOL REV, V34, P554, DOI 10.1111/j.1574-6976.2010.00214.x; Nebe-von-Caron G, 2000, J MICROBIOL METH, V42, P97, DOI 10.1016/S0167-7012(00)00181-0; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; O'Sullivan LA, 2002, APPL ENVIRON MICROB, V68, P201, DOI 10.1128/AEM.68.1.201-210.2002; Oksanen J., 2010, VEGAN COMMUNITY ECOL, P17; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Podar M, 2007, APPL ENVIRON MICROB, V73, P3205, DOI 10.1128/AEM.02985-06; Price LB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006462; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rochet V, 2004, J MICROBIOL METH, V59, P263, DOI 10.1016/j.mimet.2004.07.012; SANZ Y, 2008, INTERDISCIP PERSPECT, P29101, DOI DOI 10.1155/2008/829101; Scheppach W, 2004, CURR OPIN CLIN NUTR, V7, P563, DOI 10.1097/00075197-200409000-00009; Shiratori H, 2009, INT J SYST EVOL MICR, V59, P1764, DOI 10.1099/ijs.0.003483-0; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Song L, 2009, INT J SYST EVOL MICR, V59, P295, DOI 10.1099/ijs.0.000349-0; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; STARK PL, 1982, J MED MICROBIOL, V15, P189, DOI 10.1099/00222615-15-2-189; Stepanauskas R, 2007, P NATL ACAD SCI USA, V104, P9052, DOI 10.1073/pnas.0700496104; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Tamboli CP, 2004, GUT, V53, P1, DOI 10.1136/gut.53.1.1; Tan HT, 2008, MOL CELL PROTEOMICS, V7, P1174, DOI 10.1074/mcp.M700483-MCP200; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wasilewska Jolanta, 2009, Pol Merkur Lekarski, V27, P40; Weller R, 2000, SYST APPL MICROBIOL, V23, P107, DOI 10.1016/S0723-2020(00)80051-X; Whitehead TR, 2004, INT J SYST EVOL MICR, V54, P241, DOI 10.1099/ijs.0.02719-0; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P4225, DOI 10.1128/AEM.68.9.4225-4232.2002; Zoetendal Erwin G, 2004, Curr Issues Intest Microbiol, V5, P31; [No title captured]; [No title captured]	73	71	75	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22448	10.1371/journal.pone.0022448	http://dx.doi.org/10.1371/journal.pone.0022448			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829462	gold, Green Published, Green Submitted			2022-12-25	WOS:000293284600014
J	Bastianelli, G; Bouillon, A; Nguyen, C; Crublet, E; Petres, S; Gorgette, O; Le-Nguyen, D; Barale, JC; Nilges, M				Bastianelli, Giacomo; Bouillon, Anthony; Nguyen, Christophe; Crublet, Elodie; Petres, Stephane; Gorgette, Olivier; Le-Nguyen, Dung; Barale, Jean-Christophe; Nilges, Michael			Computational Reverse-Engineering of a Spider-Venom Derived Peptide Active Against Plasmodium falciparum SUB1	PLOS ONE			English	Article							SUBTILISIN-LIKE PROTEASE-1; FREE-ENERGY CALCULATIONS; MOLECULAR-DYNAMICS; PROTEIN STRUCTURES; MALARIA PARASITES; DRUG DESIGN; IN-VITRO; PREDICTION; MODEL; RECOGNITION	Background: Psalmopeotoxin I (PcFK1), a protein of 33 aminoacids derived from the venom of the spider Psalmopoeus Cambridgei, is able to inhibit the growth of Plasmodium falciparum malaria parasites with an IC50 in the low micromolar range. PcFK1 was proposed to act as an ion channel inhibitor, although experimental validation of this mechanism is lacking. The surface loops of PcFK1 have some sequence similarity with the parasite protein sequences cleaved by PfSUB1, a subtilisin-like protease essential for egress of Plasmodium falciparum merozoites and invasion into erythrocytes. As PfSUB1 has emerged as an interesting drug target, we explored the hypothesis that PcFK1 targeted PfSUB1 enzymatic activity. Findings: Molecular modeling and docking calculations showed that one loop could interact with the binding site of PfSUB1. The calculated free energy of binding averaged -5.01 kcal/mol, corresponding to a predicted low-medium micromolar constant of inhibition. PcFK1 inhibited the enzymatic activity of the recombinant PfSUB1 enzyme and the in vitro P. falciparum culture in a range compatible with our bioinformatics analysis. Using contact analysis and free energy decomposition we propose that residues A14 and Q15 are important in the interaction with PfSUB1. Conclusions: Our computational reverse engineering supported the hypothesis that PcFK1 targeted PfSUB1, and this was confirmed by experimental evidence showing that PcFK1 inhibits PfSUB1 enzymatic activity. This outlines the usefulness of advanced bioinformatics tools to predict the function of a protein structure. The structural features of PcFK1 represent an interesting protein scaffold for future protein engineering.	[Bastianelli, Giacomo; Nilges, Michael] Dept Biol Struct & Chim, Unite Bioinformat Struct, Paris, France; [Bastianelli, Giacomo; Nilges, Michael] CNRS, URA2185, Paris, France; [Bouillon, Anthony; Gorgette, Olivier; Barale, Jean-Christophe] Dept Parasitol & Mycol, Unite Immunol Mol Parasites, Paris, France; [Bouillon, Anthony; Gorgette, Olivier; Barale, Jean-Christophe] CNRS, URA2581, Paris, France; [Nguyen, Christophe; Le-Nguyen, Dung] CNRS BioRad, CNRS, UMR3145, SYSDIAG, Montpellier, France; [Crublet, Elodie; Petres, Stephane] Inst Pasteur, Paris, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Bastianelli, G (corresponding author), Dept Biol Struct & Chim, Unite Bioinformat Struct, Paris, France.	nilges@pasteur.fr	Nilges, Michael/E-4803-2011	Nilges, Michael/0000-0002-1451-8092; petres, stephane/0000-0002-4716-565X	European Commission [MEST-CT-05-020311]; Sanofi-Aventis; French Ministry of Research; Institut Carnot-Pasteur Maladies Infectieuses	European Commission(European CommissionEuropean Commission Joint Research Centre); Sanofi-Aventis(Sanofi-Aventis); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Institut Carnot-Pasteur Maladies Infectieuses	This work was partly supported by MEST-CT-05-020311, a Marie Curie Early Stage Research Training Fellowship (EIMID) of the Framework Program 6 by the European Commission. AB is a fellow of the "Direction Generale pour l'Armement" from the French Ministry of Defense. This work was also partly supported by the "Fond dedie: combattre les maladies parasitaires" granted by Sanofi-Aventis and the French Ministry of Research and the Institut Carnot-Pasteur Maladies Infectieuses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Bates PA, 2001, PROTEINS, P39; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bougdour A, 2009, J EXP MED, V206, P953, DOI 10.1084/jem.20082826; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Case D, 2006, AMBER 9; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Choi SJ, 2004, FEBS LETT, V572, P109, DOI 10.1016/j.febslet.2004.07.019; Christ CD, 2010, J COMPUT CHEM, V31, P1569, DOI 10.1002/jcc.21450; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Dagan A, 2002, ANTIMICROB AGENTS CH, V46, P1059, DOI 10.1128/AAC.46.4.1059-1066.2002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Egan TJ, 2007, CURR OPIN INFECT DIS, V20, P598, DOI 10.1097/QCO.0b013e3282f1673a; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Ghosh JK, 1997, J BIOL CHEM, V272, P31609, DOI 10.1074/jbc.272.50.31609; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hyde JE, 2007, FEBS J, V274, P4688, DOI 10.1111/j.1742-4658.2007.05999.x; Jean L, 2003, J BIOL CHEM, V278, P28572, DOI 10.1074/jbc.M303827200; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karanicolas J, 2009, CURR OPIN STRUC BIOL, V19, P458, DOI 10.1016/j.sbi.2009.07.005; Keizer DW, 2003, BIOCHEMISTRY-US, V42, P9915, DOI 10.1021/bi034376b; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kormos BL, 2007, J MOL BIOL, V371, P1405, DOI 10.1016/j.jmb.2007.06.003; Koussis K, 2009, EMBO J, V28, P725, DOI 10.1038/emboj.2009.22; Krowarsch D, 2003, CELL MOL LIFE SCI, V60, P2427, DOI 10.1007/s00018-003-3120-x; Kumar A, 2003, CURR MED CHEM, V10, P1137, DOI 10.2174/0929867033457494; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Lepsik M, 2004, PROTEINS, V57, P279, DOI 10.1002/prot.20192; Li QG, 2007, CYTOM PART A, V71A, P297, DOI 10.1002/cyto.a.20380; Lippow SM, 2007, CURR OPIN BIOTECH, V18, P305, DOI 10.1016/j.copbio.2007.04.009; LUND O, 2002, CASP5 METHODS ABSTRA, P102; Mandell DJ, 2009, NAT CHEM BIOL, V5, P797, DOI 10.1038/nchembio.251; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Otlewski J, 2005, EMBO J, V24, P1303, DOI 10.1038/sj.emboj.7600611; Pimentel C, 2006, PROTEIN SCI, V15, P628, DOI 10.1110/ps.051860606; Pontius J, 1996, J MOL BIOL, V264, P121, DOI 10.1006/jmbi.1996.0628; Prasad JC, 2003, BIOINFORMATICS, V19, P1682, DOI 10.1093/bioinformatics/btg211; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salmon BL, 2001, P NATL ACAD SCI USA, V98, P271, DOI 10.1073/pnas.011413198; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tsui V, 2001, BIOPOLYMERS, V56, P275, DOI 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E; Vajda S, 2009, CURR OPIN STRUC BIOL, V19, P164, DOI 10.1016/j.sbi.2009.02.008; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Winzeler EA, 2008, NATURE, V455, P751, DOI 10.1038/nature07361; Withers-Martinez C, 2002, J BIOL CHEM, V277, P29698, DOI 10.1074/jbc.M203088200; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049; Zhong HZ, 2005, PROTEINS, V58, P222, DOI 10.1002/prot.20275; Zhu S, 2002, J MED CHEM, V45, P3491, DOI 10.1021/jm020104f	58	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e21812	10.1371/journal.pone.0021812	http://dx.doi.org/10.1371/journal.pone.0021812			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818266	Green Submitted, Green Published, gold			2022-12-25	WOS:000293282700009
J	Campo, JJ; Whitman, TJ; Freilich, D; Burgess, TH; Martin, GJ; Doolan, DL				Campo, Joseph J.; Whitman, Timothy J.; Freilich, Daniel; Burgess, Timothy H.; Martin, Gregory J.; Doolan, Denise L.			Toward a Surrogate Marker of Malaria Exposure: Modeling Longitudinal Antibody Measurements under Outbreak Conditions	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM ANTIGENS; LIVER-STAGE ANTIGEN-1; CIRCUMSPOROZOITE PROTEIN; RESPONSES; TRANSMISSION; AREA; REINFECTION; PREVALENCE; TRAVELERS; CHILDREN	Background: Biomarkers of exposure to Plasmodium falciparum would be a useful tool for the assessment of malaria burden and analysis of intervention and epidemiological studies. Antibodies to pre-erythrocytic antigens represent potential surrogates of exposure. Methods and Findings: In an outbreak cohort of U.S. Marines deployed to Liberia, we modeled pre- and post-deployment IgG against P. falciparum sporozoites by immunofluorescence antibody test, and both IgG and IgM against the P. falciparum circumsporozoite protein by enzyme-linked immunosorbant assay. Modeling seroconversion thresholds by a fixed ratio, linear regression or nonlinear regression produced sensitivity for identification of exposed U.S. Marines between 58-70% and specificities between 87-97%, compared with malaria-naive U.S. volunteers. Exposure was predicted in 30-45% of the cohort. Conclusion: Each of the three models tested has merits in different studies, but further development and validation in endemic populations is required. Overall, these models provide support for an antibody-based surrogate marker of exposure to malaria.	[Campo, Joseph J.; Freilich, Daniel; Burgess, Timothy H.; Doolan, Denise L.] USN, Med Res Ctr, Silver Spring, MD 20910 USA; [Campo, Joseph J.] Univ Barcelona, Hosp Clin, CRESIB, Barcelona Ctr Int Hlth Res, Barcelona, Spain; [Whitman, Timothy J.; Burgess, Timothy H.; Martin, Gregory J.] Natl Naval Med Ctr, Dept Infect Dis, Bethesda, MD USA; [Doolan, Denise L.] Queensland Inst Med Res, Div Immunol, Brisbane, Qld 4006, Australia; [Doolan, Denise L.] Univ Queensland, Sch Med, Brisbane, Qld, Australia	United States Department of Defense; United States Navy; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Walter Reed National Military Medical Center; QIMR Berghofer Medical Research Institute; University of Queensland	Campo, JJ (corresponding author), USN, Med Res Ctr, Silver Spring, MD 20910 USA.	joe.campo@cresib.cat; Denise.Doolan@qimr.edu.au	Doolan, Denise L/F-1969-2015; Martin, Gregory/CAG-8518-2022	Doolan, Denise/0000-0001-7354-8817	US Army Medical Research and Materiel Command [6000.RAD1.F.A0309]	US Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This work was supported by funds allocated to the Naval Medical Research Center by the US Army Medical Research and Materiel Command (work unit 6000.RAD1.F.A0309). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpogheneta OJ, 2008, INFECT IMMUN, V76, P1748, DOI 10.1128/IAI.01333-07; Bejon P, 2009, INFECT IMMUN, V77, P1917, DOI 10.1128/IAI.01358-08; Branch OH, 1998, AM J TROP MED HYG, V58, P211, DOI 10.4269/ajtmh.1998.58.211; Cohen J, 2010, HUM VACCINES, V6, P90, DOI 10.4161/hv.6.1.9677; Dow Geoffrey S, 2008, Ther Clin Risk Manag, V4, P803; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; DRUILHE P, 1986, INFECT IMMUN, V53, P393, DOI 10.1128/IAI.53.2.393-397.1986; Jelinek T, 1996, J INFECT DIS, V174, P1376, DOI 10.1093/infdis/174.6.1376; John CC, 2003, INFECT IMMUN, V71, P4320, DOI 10.1128/IAI.71.8.4320-4325.2003; Kinyanjui SM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-82; Kolodny N, 2001, J CHROMATOGR B, V762, P77, DOI 10.1016/S0378-4347(01)00340-1; Luty AJF, 2000, AM J TROP MED HYG, V62, P566, DOI 10.4269/ajtmh.2000.62.566; Noland GS, 2008, INFECT IMMUN, V76, P5721, DOI 10.1128/IAI.00591-08; NUSSENZWEIG V, 1989, ADV IMMUNOL, V45, P283, DOI 10.1016/S0065-2776(08)60695-1; Orlandi-Pradines E, 2006, AM J TROP MED HYG, V74, P979; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Stewart L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006083; Torres KJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-173; Weiss GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015983; Weiss GE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000912; Weiss GE, 2009, J IMMUNOL, V183, P2176, DOI 10.4049/jimmunol.0901297; Whitman TJ, 2010, AM J TROP MED HYG, V83, P258, DOI 10.4269/ajtmh.2010.09-0774; Wipasa J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000770; Zhou Z, 2002, AM J TROP MED HYG, V66, P7, DOI 10.4269/ajtmh.2002.66.7	24	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e21826	10.1371/journal.pone.0021826	http://dx.doi.org/10.1371/journal.pone.0021826			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818270	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000293282700010
J	Ramscar, M; Dye, M; Popick, HM; O'Donnell-McCarthy, F				Ramscar, Michael; Dye, Melody; Popick, Hanna Muenke; O'Donnell-McCarthy, Fiona			The Enigma of Number: Why Children Find the Meanings of Even Small Number Words Hard to Learn and How We Can Help Them Do Better	PLOS ONE			English	Article							NUMERICAL COMPETENCE; DISCRIMINATION; PREDICTION; SYSTEMS; ACQUISITION; LANGUAGE; INFANCY; SPEECH; SENSE; CUES	Although number words are common in everyday speech, learning their meanings is an arduous, drawn-out process for most children, and the source of this delay has long been the subject of inquiry. Children begin by identifying the few small numerosities that can be named without counting, and this has prompted further debate over whether there is a specific, capacity-limited system for representing these small sets, or whether smaller and larger sets are both represented by the same system. Here we present a formal, computational analysis of number learning that offers a possible solution to both puzzles. This analysis indicates that once the environment and the representational demands of the task of learning to identify sets are taken into consideration, a continuous system for learning, representing and discriminating set-sizes can give rise to effective discontinuities in processing. At the same time, our simulations illustrate how typical prenominal linguistic constructions ("there are three balls") structure information in a way that is largely unhelpful for discrimination learning, while suggesting that postnominal constructions ("balls, there are three") will facilitate such learning. A training-experiment with three-year olds confirms these predictions, demonstrating that rapid, significant gains in numerical understanding and competence are possible given appropriately structured postnominal input. Our simulations and results reveal how discrimination learning tunes children's systems for representing small sets, and how its capacity-limits result naturally out of a mixture of the learning environment and the increasingly complex task of discriminating and representing ever-larger number sets. They also explain why children benefit so little from the training that parents and educators usually provide. Given the efficacy of our intervention, the ease with which it can be implemented, and the large body of research showing how early numerical ability predicts later educational outcomes, this simple discovery may have far-reaching consequences.	[Ramscar, Michael; Dye, Melody; Popick, Hanna Muenke; O'Donnell-McCarthy, Fiona] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University	Ramscar, M (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	michael.ramscar@gmail.com		Dye, Melody/0000-0002-4777-0761	National Science Foundation [0547775]	National Science Foundation(National Science Foundation (NSF))	This material is based upon work supported by the National Science Foundation under Grant No. 0547775 to MR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin D. A., 1995, JOINT ATTENTION ITS, P131; Benford F, 1938, P AM PHILOS SOC, V78, P551, DOI DOI 10.2307/984802; Bloom P, 1997, J CHILD LANG, V24, P511, DOI 10.1017/S0305000997003188; Booth JL, 2008, CHILD DEV, V79, P1016, DOI 10.1111/j.1467-8624.2008.01173.x; Brannon EM, 2001, COGNITIVE PSYCHOL, V43, P53, DOI 10.1006/cogp.2001.0756; Carpenter M, 1998, MONOGR SOC RES CHILD, V63, pV; Clark, 2009, 1 LANGUAGE ACQUISITI, DOI [10.1017/CBO9780511806698, DOI 10.1017/CBO9780511806698]; Clements DH, 2007, J RES MATH EDUC, V38, P136, DOI 10.2307/30034954; Cordes S, 2001, PSYCHON B REV, V8, P698, DOI 10.3758/BF03196206; Dahan D, 2005, PSYCHON B REV, V12, P453, DOI 10.3758/BF03193787; DARWIN CH, 1877, KOSMOS, V1, P367; DAVIES M, 2010, DIACRONIA LENGUAS IB, P137; Davies M, 2009, INT J CORPUS LINGUIS, V14, P159, DOI 10.1075/ijcl.14.2.02dav; ELMAN JL, 1990, COGNITIVE SCI, V14, P179, DOI 10.1207/s15516709cog1402_1; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Fernald A, 2006, DEV PSYCHOL, V42, P98, DOI 10.1037/0012-1649.42.1.98; Fernald A, 2010, COGNITIVE PSYCHOL, V60, P190, DOI 10.1016/j.cogpsych.2009.12.002; Fuson K. C., 1988, CHILDRENS COUNTING C; GALLISTEL CR, 2003, BEHAV PROCESS, V61, P1234; Gelman R, 2004, SCIENCE, V306, P441, DOI 10.1126/science.1105144; Gentner D., 2001, LANG ACQUIS, P215, DOI [10.1017/CBO9780511620669.010, DOI 10.1017/CBO9780511620669.010]; Huang YT, 2010, PSYCHOL SCI, V21, P600, DOI 10.1177/0956797610363552; Jevons W.S., 1871, NATURE, V3, P281, DOI [10.1038/003281a0, DOI 10.1038/003281A0]; Jordan NC, 2010, LEARN INDIVID DIFFER, V20, P82, DOI 10.1016/j.lindif.2009.07.004; Jordan NC, 2009, DEV PSYCHOL, V45, P850, DOI 10.1037/a0014939; Kamide Y, 2003, J MEM LANG, V49, P133, DOI 10.1016/S0749-596X(03)00023-8; Kamin L. J., 1969, PUNISHMENT AVERSIVE, P279, DOI DOI 10.2105/AJPH.2006.090910; KAUFMAN EL, 1949, AM J PSYCHOL, V62, P498, DOI 10.2307/1418556; Landau Barbara., 1985, LANGUAGE EXPERIENCE; Lipton JS, 2004, INFANCY, V5, P271, DOI 10.1207/s15327078in0503_2; Mix KS, 2002, PSYCHOL BULL, V128, P278, DOI 10.1037//0033-2909.128.2.278; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Niv Y, 2008, TRENDS COGN SCI, V12, P265, DOI 10.1016/j.tics.2008.03.006; Niv Y, 2009, J MATH PSYCHOL, V53, P139, DOI 10.1016/j.jmp.2008.12.005; RAMSCAR M, 2009, P 31 ANN C COGN SCI; RAMSCAR M, 2011, P 33 M COGN SCI SOC; Ramscar M, 2010, COGNITIVE SCI, V34, P909, DOI 10.1111/j.1551-6709.2009.01092.x; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; RESCORLA RA, 1988, AM PSYCHOL, V43, P151, DOI 10.1037/0003-066X.43.3.151; RESCORLA RA, 1968, J COMP PHYSIOL PSYCH, V66, P1, DOI 10.1037/h0025984; Revkin SK, 2008, PSYCHOL SCI, V19, P607, DOI 10.1111/j.1467-9280.2008.02130.x; RICE N, 1980, COGNITION LANGUAGE; Roberson D, 2004, J EXP PSYCHOL GEN, V133, P554, DOI 10.1037/0096-3445.133.4.554; Roberts S, 2000, PSYCHOL REV, V107, P358, DOI 10.1037/0033-295X.107.2.358; ROSENBLATT F, 1959, MECHANISATION THOUGH, P419; Rowe ML, 2008, J CHILD LANG, V35, P185, DOI 10.1017/S0305000907008343; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; SONNENSCHEIN S, 1982, J PSYCHOLINGUIST RES, V11, P115, DOI 10.1007/BF01068215; Spivey MJ, 2001, PSYCHOL SCI, V12, P282, DOI 10.1111/1467-9280.00352; TANENHAUS MK, 1995, SCIENCE, V268, P1632, DOI 10.1126/science.7777863; Thorpe K, 2006, COGNITION, V100, P389, DOI 10.1016/j.cognition.2005.04.009; Triesch J, 2006, DEVELOPMENTAL SCI, V9, P125, DOI 10.1111/j.1467-7687.2006.00470.x; Van de Walle GA, 2000, J COGN DEV, V1, P249, DOI 10.1207/S15327647JCD0103_1; Vetter P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003269; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Wilson E.O., 1975, P1; Wynn K, 1998, TRENDS COGN SCI, V2, P296, DOI 10.1016/S1364-6613(98)01203-0; WYNN K, 1992, COGNITIVE PSYCHOL, V24, P220, DOI 10.1016/0010-0285(92)90008-P; WYNN K, 1990, COGNITION, V36, P155, DOI 10.1016/0010-0277(90)90003-3; Xu F, 2005, DEVELOPMENTAL SCI, V8, P88, DOI 10.1111/j.1467-7687.2005.00395.x; Xu F, 2003, COGNITION, V89, pB15, DOI 10.1016/S0010-0277(03)00050-7; Xu F, 2000, COGNITION, V74, pB1, DOI 10.1016/S0010-0277(99)00066-9	65	40	40	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22501	10.1371/journal.pone.0022501	http://dx.doi.org/10.1371/journal.pone.0022501			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	799JJ	21818329	Green Published, Green Submitted, gold			2022-12-25	WOS:000293282700034
J	Clare, EL				Clare, Elizabeth L.			Cryptic Species? Patterns of Maternal and Paternal Gene Flow in Eight Neotropical Bats	PLOS ONE			English	Article							COMMON VAMPIRE BAT; MITOCHONDRIAL-DNA; COMPARATIVE PHYLOGEOGRAPHY; MOLECULAR PHYLOGENY; DESMODUS-ROTUNDUS; SPECIATION; DIVERSIFICATION; HYBRIDIZATION; SUBSTITUTIONS; DICLIDURINI	Levels of sequence divergence at mitochondrial loci are frequently used in phylogeographic analysis and species delimitation though single marker systems cannot assess bi-parental gene flow. In this investigation I compare the phylogeographic patterns revealed through the maternally inherited mitochondrial COI region and the paternally inherited 7 th intron region of the Dby gene on the Y-chromosome in eight common Neotropical bat species. These species are diverse and include members of two families from the feeding guilds of sanguivores, nectarivores, frugivores, carnivores and insectivores. In each case, the currently recognized taxon is comprised of distinct, substantially divergent intraspecific mitochondrial lineages suggesting cryptic species complexes. In Chrotopterus auritus, and Saccopteryx bilineata I observed congruent patterns of divergence in both genetic regions suggesting a cessation of gene flow between intraspecific groups. This evidence supports the existence of cryptic species complexes which meet the criteria of the genetic species concept. In Glossophaga soricina two intraspecific groups with largely sympatric South American ranges show evidence for incomplete lineage sorting or frequent hybridization while a third group with a Central American distribution appears to diverge congruently at both loci suggesting speciation. Within Desmodus rotundus and Trachops cirrhosus the paternally inherited region was monomorphic and thus does not support or refute the potential for cryptic speciation. In Uroderma bilobatum, Micronycteris megalotis and Platyrrhinus helleri the gene regions show conflicting patterns of divergence and I cannot exclude ongoing gene flow between intraspecific groups. This analysis provides a comprehensive comparison across taxa and employs both maternally and paternally inherited gene regions to validate patterns of gene flow. I present evidence for previously unrecognized species meeting the criteria of the genetic species concept but demonstrate that estimates of mitochondrial diversity alone do not accurately represent gene flow in these species and that contact/ hybrid zones must be explored to evaluate reproductive isolation.	Univ Guelph, Dept Integrat Biol, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada	University of Guelph	Clare, EL (corresponding author), Univ Guelph, Dept Integrat Biol, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada.	elclare.evol.biology@gmail.com		Clare, Elizabeth/0000-0002-6563-3365	Natural Sciences and Engineering Research Council; Genome Canada through Ontario Genomics Institute; Ontario Ministry of 400 Research and Innovation	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Genome Canada through Ontario Genomics Institute(Genome Canada); Ontario Ministry of 400 Research and Innovation	This research was supported by a Natural Sciences and Engineering Research Council of 398 Canada Canadian Graduate Scholarship to ELC. Additional funding for this research was 399 provided by Genome Canada through the Ontario Genomics Institute and the Ontario Ministry of 400 Research and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez J., 1991, Mammalian Species, P1; BAKER RJ, 1972, OCCAS PAPERS MUS TEX, V7, P1; BAKER RJ, 2002, OCCASIONAL PAPERS MU, V217, P1, DOI [DOI 10.5962/BHL.TITLE.156831, 10.5962/bhl.title.156831]; Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; Barquez Ruben M., 2001, Acta Zoologica Mexicana Nueva Serie, V82, P29; Berthier P, 2006, P ROY SOC B-BIOL SCI, V273, P3101, DOI 10.1098/rspb.2006.3680; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Borisenko AV, 2008, MOL ECOL RESOUR, V8, P471, DOI 10.1111/j.1471-8286.2007.01998.x; Bradley RD, 2001, J MAMMAL, V82, P960, DOI 10.1644/1545-1542(2001)082<0960:ATOTGS>2.0.CO;2; CLARE EL, 2011, PLOS ONE IN PRESS; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cognato AI, 2006, J ECON ENTOMOL, V99, P1037, DOI 10.1603/0022-0493-99.4.1037; Coyne JA, 2004, SPECIATION; CRACRAFT J, 1988, EVOLUTION, V42, P603, DOI 10.1111/j.1558-5646.1988.tb04164.x; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Ditchfield AD, 2000, MOL ECOL, V9, P1307, DOI 10.1046/j.1365-294x.2000.01013.x; Gavrilets Sergey, 2004, P1; Gregory-Wodzicki KM, 2000, GEOL SOC AM BULL, V112, P1091, DOI 10.1130/0016-7606(2000)112<1091:UHOTCA>2.0.CO;2; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hoffmann FG, 2003, MOL ECOL, V12, P3403, DOI 10.1046/j.1365-294X.2003.02009.x; Hoffmann FG, 2003, MOL ECOL, V12, P2981, DOI 10.1046/j.1365-294X.2003.01959.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KOOPMAN KF, 1981, SPECIAL PUBLICATION, V6, P273; KRAUSZ C, 1999, FRONT BIOSCI, V4, P1; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lim BK, 2003, ACTA CHIROPTEROL, V5, P15, DOI 10.3161/001.005.0102; Lim BK, 2001, BIODIVERS CONSERV, V10, P613, DOI 10.1023/A:1016660123189; Lim BK, 2007, MOL PHYLOGENET EVOL, V45, P777, DOI 10.1016/j.ympev.2007.09.003; Lim BK, 2008, BIOL J LINN SOC, V93, P189; Mao XG, 2010, MOL ECOL, V19, P1352, DOI 10.1111/j.1365-294X.2010.04560.x; Martins FM, 2007, J ZOOL SYST EVOL RES, V45, P372, DOI 10.1111/j.1439-0469.2007.00419.x; Martins FM, 2009, BMC EVOL BIOL, V9, DOI [10.1186/1471-2148-9-36, 10.1186/1471-2148-9-294]; Mayr E., 1942, P1; Medellin R.A., 1989, Mammalian Species, P1; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Simmons Nancy B., 1998, Bulletin of the American Museum of Natural History, V237, P1; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Swofford DL, 2001, PAUP PHYLOGENETIC AN; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Voigt CC, 2006, J MAMMAL, V87, P1, DOI 10.1644/05-MAMM-F-276R1.1; Webb N. J., 1995, Australian Mammalogy, V18, P19; WILLIG MR, 1989, J BIOGEOGR, V16, P189, DOI 10.2307/2845093	52	48	53	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e21460	10.1371/journal.pone.0021460	http://dx.doi.org/10.1371/journal.pone.0021460			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21814545	gold, Green Submitted, Green Published			2022-12-25	WOS:000293175100003
J	Ramirez, C; Sierra, S; Tercero, I; Vazquez, JA; Pineda, A; Manrique, T; Burgos, JS				Ramirez, Carlos; Sierra, Saleta; Tercero, Inmaculada; Antonio Vazquez, Jose; Pineda, Antonia; Manrique, Tatiana; Burgos, Javier S.			ApoB100/LDLR-/- Hypercholesterolaemic Mice as a Model for Mild Cognitive Impairment and Neuronal Damage	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; RECEPTOR-KNOCKOUT MICE; A-BETA ACCUMULATION; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; CHOLESTEROL LEVELS; LEARNING-DEFICITS; AMYLOID PLAQUES; VASCULAR RISK; GRIP-STRENGTH	Recent clinical findings support the notion that the progressive deterioration of cholesterol homeostasis is a central player in Alzheimer's disease (AD). Epidemiological studies suggest that high midlife plasma total cholesterol levels are associated with an increased risk of AD. This paper reports the plasma cholesterol concentrations, cognitive performance, locomotor activity and neuropathological signs in a murine model (transgenic mice expressing apoB100 but knockout for the LDL receptor [ LDLR]) of human familial hypercholesterolaemia (FH). From birth, these animals have markedly elevated LDL-cholesterol and apolipoprotein B100 (apoB100) levels. These transgenic mice were confirmed to have higher plasma cholesterol concentrations than wild-type mice, an effect potentiated by aging. Further, 3-month-old transgenic mice showed cholesterol (total and fractions) concentrations considerably higher than those of 18-month-old wild-type mice. The hypercholesterolaemia of the transgenic mice was associated with a clear locomotor deficit (as determined by rotarod, grip strength and open field testing) and impairment of the episodic-like memory (determined by the integrated memory test). This decline in locomotor activity and cognitive status was associated with neuritic dystrophy and/or the disorganization of the neuronal microtubule network, plus an increase in astrogliosis and lipid peroxidation in the brain regions associated with AD, such as the motor and lateral entorhinal cortex, the amygdaloid basal nucleus, and the hippocampus. Aortic atherosclerotic lesions were positively correlated with age, although potentiated by the transgenic genotype, while cerebral beta-amyloidosis was positively correlated with genetic background rather than with age. These findings confirm hypercholesterolaemia as a key biomarker for monitoring mild cognitive impairment, and shows these transgenic mice can be used as a model for cognitive and psycho-motor decline.	[Ramirez, Carlos; Sierra, Saleta; Tercero, Inmaculada; Antonio Vazquez, Jose; Pineda, Antonia; Manrique, Tatiana; Burgos, Javier S.] Neuron BPh, BioPharma Div, Granada, Spain		Ramirez, C (corresponding author), Neuron BPh, BioPharma Div, Granada, Spain.	jburgos@neuronbp.com	Manrique-Zuluaga, Tatiana/K-3215-2016; Burgos, Javier S/ABA-9183-2021	Manrique-Zuluaga, Tatiana/0000-0002-8333-772X; Burgos, Javier S/0000-0002-1652-4234; Ramirez Moreno, Carlos/0000-0001-6558-595X	Agencia de Innovacion y Desarrollo de Andalucia of the Andalusian Regional Government; CDTI of the Ministerio de Ciencia e Innovacion; Torres Quevedo program; NEURON BPh	Agencia de Innovacion y Desarrollo de Andalucia of the Andalusian Regional Government; CDTI of the Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)); Torres Quevedo program; NEURON BPh	This work was funded by grants from the Agencia de Innovacion y Desarrollo de Andalucia of the Andalusian Regional Government, the CDTI of the Ministerio de Ciencia e Innovacion, and by funds from the Torres Quevedo program (CR, SS, TM and JSB). NEURON BPh provided financial resources. All authors are employees of NEURON BPh and contributed to all aspects of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bereczki E, 2008, J PROTEOME RES, V7, P2246, DOI 10.1021/pr7006329; Bodovitz S, 1996, J BIOL CHEM, V271, P4436; Bouet V, 2007, EXP NEUROL, V203, P555, DOI 10.1016/j.expneurol.2006.09.006; Breslow JL, 1996, SCIENCE, V272, P685, DOI 10.1126/science.272.5262.685; Buchman AS, 2007, NEUROEPIDEMIOLOGY, V29, P66, DOI 10.1159/000109498; Burgess BL, 2006, NEUROBIOL DIS, V24, P114, DOI 10.1016/j.nbd.2006.06.007; Cankurtaran M, 2005, ARCH GERONTOL GERIAT, V41, P31, DOI 10.1016/j.archger.2004.10.008; Cao DF, 2006, NEUROBIOL AGING, V27, P1632, DOI 10.1016/j.neurobiolaging.2005.09.011; Caramelli P, 1999, ACTA NEUROL SCAND, V100, P61, DOI 10.1111/j.1600-0404.1999.tb00724.x; Civeira F, 2004, ATHEROSCLEROSIS, V173, P55, DOI 10.1016/j.atherosclerosis.2003.11.010; Cole GM, 1999, J NEUROSCI RES, V57, P504, DOI 10.1002/(SICI)1097-4547(19990815)57:4<504::AID-JNR10>3.0.CO;2-H; Dere E, 2005, NEUROBIOL LEARN MEM, V84, P214, DOI 10.1016/j.nlm.2005.07.002; Dickstein DL, 2010, MT SINAI J MED, V77, P82, DOI 10.1002/msj.20155; Duyckaerts C, 2008, ACTA NEUROPATHOL, V115, P5, DOI 10.1007/s00401-007-0312-8; Ellis RJ, 1996, NEUROLOGY, V46, P1592, DOI 10.1212/WNL.46.6.1592; Ferrer I, 2004, BRAIN PATHOL, V14, P11, DOI 10.1111/j.1750-3639.2004.tb00493.x; Ghribi O, 2006, J NEUROCHEM, V99, P438, DOI 10.1111/j.1471-4159.2006.04079.x; Gopalraj RK, 2005, NEUROBIOL AGING, V26, P1, DOI 10.1016/j.neurobiolaging.2004.09.001; Gottlieb M, 2006, NEUROBIOL DIS, V23, P374, DOI 10.1016/j.nbd.2006.03.017; Greenwood CE, 1996, BEHAV NEUROSCI, V110, P451, DOI 10.1037/0735-7044.110.3.451; Harris-White M. E., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P469, DOI 10.2174/156800705774322102; Hofman A, 1997, LANCET, V349, P151, DOI 10.1016/S0140-6736(96)09328-2; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Jellinger KA, 2007, ACTA NEUROPATHOL, V113, P349, DOI 10.1007/s00401-006-0185-2; KAWAI M, 1990, AM J PATHOL, V137, P1435; Kuo YM, 1998, BIOCHEM BIOPH RES CO, V252, P711, DOI 10.1006/bbrc.1998.9652; Lalonde R, 2008, J NEUROSCI METH, V171, P48, DOI 10.1016/j.jneumeth.2008.02.003; Leduc V, 2010, TRENDS MOL MED, V16, P469, DOI 10.1016/j.molmed.2010.07.008; Li L, 2003, AM J PATHOL, V163, P2155, DOI 10.1016/S0002-9440(10)63572-9; Mielke MM, 2005, NEUROLOGY, V64, P1689, DOI 10.1212/01.WNL.0000161870.78572.A5; Mizoguchi T, 2004, J LIPID RES, V45, P396, DOI 10.1194/jlr.D300024-JLR200; Mulder M, 2004, NEUROBIOL DIS, V16, P212, DOI 10.1016/j.nbd.2004.01.015; Nimpf J, 2000, BBA-MOL CELL BIOL L, V1529, P287, DOI 10.1016/S1388-1981(00)00155-4; Pappolla MA, 2003, NEUROLOGY, V61, P199, DOI 10.1212/01.WNL.0000070182.02537.84; Poirier J, 2003, TRENDS MOL MED, V9, P94, DOI 10.1016/S1471-4914(03)00007-8; Powell-Braxton L, 1998, NAT MED, V4, P934, DOI 10.1038/nm0898-934; Prasanthi JRP, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-1; Ramirez C, 2011, J ALZHEIMERS DIS, V24, P161, DOI 10.3233/JAD-2010-101653; Refolo LM, 2000, NEUROBIOL DIS, V7, P321, DOI 10.1006/nbdi.2000.0304; Reitz C, 2010, ARCH NEUROL-CHICAGO, V67, P1491, DOI 10.1001/archneurol.2010.297; Sabbagh M, 2004, J ALZHEIMERS DIS, V6, P585; SELKOE DJ, 1987, SCIENCE, V235, P873, DOI 10.1126/science.3544219; Shie FS, 2002, NEUROREPORT, V13, P455, DOI 10.1097/00001756-200203250-00019; Shobab LA, 2005, LANCET NEUROL, V4, P841, DOI 10.1016/S1474-4422(05)70248-9; SPARKS DL, 1994, EXP NEUROL, V126, P88, DOI 10.1006/exnr.1994.1044; Stewart R, 2001, J AM GERIATR SOC, V49, P263, DOI 10.1046/j.1532-5415.2001.4930263.x; Suryadevara Vana, 2003, J Gerontol A Biol Sci Med Sci, V58, pM859; Thirumangalakudi L, 2008, J NEUROCHEM, V106, P475, DOI 10.1111/j.1471-4159.2008.05415.x; TOYOKUNI S, 1995, FEBS LETT, V359, P189, DOI 10.1016/0014-5793(95)00033-6; Walz W, 1998, NEUROSCI LETT, V257, P127, DOI 10.1016/S0304-3940(98)00813-1; Whitmer RA, 2005, NEUROLOGY, V64, P277, DOI 10.1212/01.WNL.0000149519.47454.F2; Zadroniak A, 2009, PHARMACOL REP, V61, P737, DOI 10.1016/S1734-1140(09)70128-8; Zambon D, 2010, AM J MED, V123, P267, DOI 10.1016/j.amjmed.2009.08.015	53	24	24	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e22712	10.1371/journal.pone.0022712	http://dx.doi.org/10.1371/journal.pone.0022712			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21829488	Green Published, gold, Green Submitted			2022-12-25	WOS:000293175100042
J	Du, HY; Hu, ZD; Bazzoli, A; Zhang, Y				Du, Hongying; Hu, Zhide; Bazzoli, Andrea; Zhang, Yang			Prediction of Inhibitory Activity of Epidermal Growth Factor Receptor Inhibitors Using Grid Search-Projection Pursuit Regression Method	PLOS ONE			English	Article							TYROSINE KINASE INHIBITORS; BINDING-SITE INHIBITORS; SUPPORT VECTOR MACHINES; IN-VITRO; QSAR; EGFR; POTENT; DERIVATIVES; DESIGN; CANCER	The epidermal growth factor receptor (EGFR) protein tyrosine kinase (PTK) is an important protein target for anti-tumor drug discovery. To identify potential EGFR inhibitors, we conducted a quantitative structure-activity relationship (QSAR) study on the inhibitory activity of a series of quinazoline derivatives against EGFR tyrosine kinase. Two 2D-QSAR models were developed based on the best multi-linear regression (BMLR) and grid-search assisted projection pursuit regression (GS-PPR) methods. The results demonstrate that the inhibitory activity of quinazoline derivatives is strongly correlated with their polarizability, activation energy, mass distribution, connectivity, and branching information. Although the present investigation focused on EGFR, the approach provides a general avenue in the structure-based drug development of different protein receptor inhibitors.	[Du, Hongying; Bazzoli, Andrea; Zhang, Yang] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Du, Hongying] Lanzhou Univ, Dept Publ Hlth, Lanzhou 730000, Peoples R China; [Hu, Zhide] Lanzhou Univ, Dept Chem, Lanzhou 730000, Peoples R China	University of Michigan System; University of Michigan; Lanzhou University; Lanzhou University	Du, HY (corresponding author), Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.	zhng@umich.edu			Alfred P. Sloan Foundation; NSF [DBI 1027394]; National Institute of General Medical Sciences [GM083107, GM084222]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084222, R01GM083107] Funding Source: NIH RePORTER	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NSF(National Science Foundation (NSF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by the Alfred P. Sloan Foundation (http://www.sloan.org/), a NSF Career Award (DBI 1027394; http://www.nsf.gov), and the National Institute of General Medical Sciences (GM083107, GM084222; http://www.nigms.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouzid K, 2008, BIOORGAN MED CHEM, V16, P7543, DOI 10.1016/j.bmc.2008.07.038; [Anonymous], R PROJECT STAT COMPU; [Anonymous], 2000, HYPERCHEM REL 6 0 WI; Basak SC, 2008, J COMPUT AID MOL DES, V22, P339, DOI 10.1007/s10822-008-9202-y; BIRATTARI M, 2003, R MANUALS; Boschelli Diane H., 1999, Drugs of the Future, V24, P515, DOI 10.1358/dof.1999.024.05.858622; Bridges AJ, 1999, CURR MED CHEM, V6, P825; Bridges AJ, 1996, J MED CHEM, V39, P267, DOI 10.1021/jm9503613; Consonni V, 2002, J CHEM INF COMP SCI, V42, P682, DOI 10.1021/ci015504a; DAMSTRUP L, 1992, CANCER RES, V52, P3089; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ding K, 2006, J MED CHEM, V49, P3432, DOI 10.1021/jm051122a; DONOHO D, 1985, ANN STAT, V13, P496, DOI 10.1214/aos/1176349526; Du HY, 2008, EUR J MED CHEM, V43, P2861, DOI 10.1016/j.ejmech.2008.02.012; Du HY, 2008, J AGR FOOD CHEM, V56, P10785, DOI 10.1021/jf8022194; FRIEDMAN JH, 1981, J AM STAT ASSOC, V76, P817, DOI 10.2307/2287576; Fukui K, 1975, REACTIVITY STRUCTURE, V1; GROSS ME, 1991, CANCER RES, V51, P1452; Hansch C, 2009, MOL PHARMACEUT, V6, P849, DOI 10.1021/mp800138w; HSUAN JJ, 1993, ANTICANCER RES, V13, P2521; HUBER PJ, 1985, ANN STAT, V13, P435, DOI 10.1214/aos/1176349519; Katritzky A. R., 1995, CODESSA TRAINING MAN; KATRITZKY AR, 1995, CODESSA VERSION 2 0; Klutchko SR, 1998, J MED CHEM, V41, P3276, DOI 10.1021/jm9802259; La Motta C, 2009, J MED CHEM, V52, P964, DOI 10.1021/jm800829v; LI N, 2010, PLOS ONE, V5; Liu FP, 2006, CHEMOMETR INTELL LAB, V81, P120, DOI 10.1016/j.chemolab.2005.10.004; Liu HX, 2007, BIOORGAN MED CHEM, V15, P5251, DOI 10.1016/j.bmc.2007.05.016; Ma XH, 2010, MOL PHARMACEUT, V7, P1545, DOI 10.1021/mp100179t; Mandal AS, 2009, EUR J MED CHEM, V44, P1509, DOI 10.1016/j.ejmech.2008.07.020; *MDL INF SYST INC, 1990, ISIS DRAW2 3; Nunez MB, 2004, BIOORG MED CHEM LETT, V14, P5611, DOI 10.1016/j.bmcl.2004.08.066; Pasha FA, 2010, J MOL MODEL, V16, P263, DOI 10.1007/s00894-009-0534-x; Pawar VG, 2010, J MED CHEM, V53, P2892, DOI 10.1021/jm901877j; Puzyn T., 2010, RECENT ADV QSAR STUD; Rewcastle GW, 1997, J MED CHEM, V40, P1820, DOI 10.1021/jm960879m; Rewcastle GW, 1996, J MED CHEM, V39, P1823, DOI 10.1021/jm9508651; REWCASTLE GW, 1995, J MED CHEM, V38, P3482, DOI 10.1021/jm00018a008; Shi WM, 2007, EUR J MED CHEM, V42, P81, DOI 10.1016/j.ejmech.2006.08.001; Solca FF, 2004, J PHARMACOL EXP THER, V311, P502, DOI 10.1124/jpet.104.069138; SOLER C, 1994, J BIOL CHEM, V269, P12320; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; STROUF O, 1986, CHEM PATTERN RECOGNI; Szantai-Kis C, 2006, CURR MED CHEM, V13, P277, DOI 10.2174/092986706775476098; Thompson AM, 1997, J MED CHEM, V40, P3915, DOI 10.1021/jm970366v; THOMPSON AM, 1995, J MED CHEM, V38, P3780, DOI 10.1021/jm00019a007; Todeschini R., 2008, HDB MOL DESCRIPTORS; Todeschini R, 2006, DRAGONS SOFTWARE CAL; Toyoshima E, 2001, LUNG CANCER-J IASLC, V31, P193, DOI 10.1016/S0169-5002(00)00184-7; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; van der Veeken J, 2009, CURR CANCER DRUG TAR, V9, P748; Vema A, 2003, BIOORGAN MED CHEM, V11, P4643, DOI 10.1016/S0968-0896(03)00482-6; Verbeek BS, 1998, FEBS LETT, V425, P145, DOI 10.1016/S0014-5793(98)00224-5; Verma RP, 2010, EUR J MED CHEM, V45, P1470, DOI 10.1016/j.ejmech.2009.12.054; Voldborg BR, 1997, ANN ONCOL, V8, P1197, DOI 10.1023/A:1008209720526; Weast R.C, 1974, HDB CHEM PHYSICS, pF; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; Wissner A, 2003, J MED CHEM, V46, P49, DOI 10.1021/jm020241c; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	59	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22367	10.1371/journal.pone.0022367	http://dx.doi.org/10.1371/journal.pone.0022367			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811593	gold, Green Submitted, Green Published			2022-12-25	WOS:000292956800049
J	Malashchenko, T; Shilnikov, A; Cymbalyuk, G				Malashchenko, Tatiana; Shilnikov, Andrey; Cymbalyuk, Gennady			Six Types of Multistability in a Neuronal Model Based on Slow Calcium Current	PLOS ONE			English	Article							HEART INTERNEURONS; BISTABILITY; LEECH; MEMBRANE; OSCILLATIONS; SEROTONIN; NETWORKS; DYNAMICS	Background: Multistability of oscillatory and silent regimes is a ubiquitous phenomenon exhibited by excitable systems such as neurons and cardiac cells. Multistability can play functional roles in short-term memory and maintaining posture. It seems to pose an evolutionary advantage for neurons which are part of multifunctional Central Pattern Generators to possess multistability. The mechanisms supporting multistability of bursting regimes are not well understood or classified. Methodology/Principal Findings: Our study is focused on determining the bio-physical mechanisms underlying different types of co-existence of the oscillatory and silent regimes observed in a neuronal model. We develop a low-dimensional model typifying the dynamics of a single leech heart interneuron. We carry out a bifurcation analysis of the model and show that it possesses six different types of multistability of dynamical regimes. These types are the co-existence of 1) bursting and silence, 2) tonic spiking and silence, 3) tonic spiking and subthreshold oscillations, 4) bursting and subthreshold oscillations, 5) bursting, subthreshold oscillations and silence, and 6) bursting and tonic spiking. These first five types of multistability occur due to the presence of a separating regime that is either a saddle periodic orbit or a saddle equilibrium. We found that the parameter range wherein multistability is observed is limited by the parameter values at which the separating regimes emerge and terminate. Conclusions: We developed a neuronal model which exhibits a rich variety of different types of multistability. We described a novel mechanism supporting the bistability of bursting and silence. This neuronal model provides a unique opportunity to study the dynamics of networks with neurons possessing different types of multistability.	[Malashchenko, Tatiana; Cymbalyuk, Gennady] Georgia State Univ, Dept Phys & Astron, Atlanta, GA 30303 USA; [Shilnikov, Andrey; Cymbalyuk, Gennady] Georgia State Univ, Inst Neurosci, Atlanta, GA 30303 USA; [Shilnikov, Andrey] Georgia State Univ, Dept Math & Stat, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Malashchenko, T (corresponding author), Georgia State Univ, Dept Phys & Astron, Atlanta, GA 30303 USA.	gcymbalyuk@gsu.edu	shilnikov, andrey/AAX-5100-2020; Cymbalyuk, Gennady/A-2308-2014	shilnikov, andrey/0000-0002-4879-4327; Cymbalyuk, Gennady/0000-0002-1889-5397	Georgia State University; National Science Foundation [PHY-0750456]	Georgia State University; National Science Foundation(National Science Foundation (NSF))	The authors acknowledge the support of the Brains and Behavior program at Georgia State University and of National Science Foundation PHY-0750456. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkowitz A, 2008, J NEUROPHYSIOL, V99, P2887, DOI 10.1152/jn.90235.2008; Briggman KL, 2008, ANNU REV NEUROSCI, V31, P271, DOI 10.1146/annurev.neuro.31.060407.125552; Butera RJ, 1998, CHAOS, V8, P274, DOI 10.1063/1.166358; CALABRESE RL, 1995, J NEUROBIOL, V27, P390, DOI 10.1002/neu.480270311; CANAVIER CC, 1994, J NEUROPHYSIOL, V72, P872, DOI 10.1152/jn.1994.72.2.872; Channell P, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.134101; Cymbalyuk G, 2005, J COMPUT NEUROSCI, V18, P255, DOI 10.1007/s10827-005-0354-7; Cymbalyuk GS, 2002, J NEUROSCI, V22, P10580; Cymbalyuk GS, 2001, NEUROCOMPUTING, V38, P159, DOI 10.1016/S0925-2312(01)00414-3; Durstewitz D, 2006, NEUROSCIENCE, V139, P119, DOI 10.1016/j.neuroscience.2005.06.094; Fall CP, 2006, J COMPUT NEUROSCI, V20, P97, DOI 10.1007/s10827-006-4791-8; Frohlich F, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.031922; GETTING PA, 1989, ANNU REV NEUROSCI, V12; Gutkin BS, 2009, NATURWISSENSCHAFTEN, V96, P1091, DOI 10.1007/s00114-009-0570-5; GUTTMAN R, 1980, J PHYSIOL-LONDON, V305, P377, DOI 10.1113/jphysiol.1980.sp013370; Heyward P, 2001, J NEUROSCI, V21, P5311, DOI 10.1523/JNEUROSCI.21-14-05311.2001; Hill AAV, 2001, J COMPUT NEUROSCI, V10, P281, DOI 10.1023/A:1011216131638; HOUNSGAARD J, 1989, J PHYSIOL-LONDON, V414, P265, DOI 10.1113/jphysiol.1989.sp017687; Hughes SW, 1999, J PHYSIOL-LONDON, V517, P805, DOI 10.1111/j.1469-7793.1999.0805s.x; Lechner HA, 1996, J NEUROPHYSIOL, V75, P957, DOI 10.1152/jn.1996.75.2.957; Loewenstein Y, 2005, NAT NEUROSCI, V8, P202, DOI 10.1038/nn1393; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; MARDER E, 1994, CURR BIOL, V4, P752, DOI 10.1016/S0960-9822(00)00169-X; Marder E, 1996, P NATL ACAD SCI USA, V93, P13481, DOI 10.1073/pnas.93.24.13481; Nadim F, 1999, P NATL ACAD SCI USA, V96, P8206, DOI 10.1073/pnas.96.14.8206; Olypher A, 2006, J NEUROPHYSIOL, V96, P2857, DOI 10.1152/jn.00582.2006; Perrier JF, 2000, BRAIN RES BULL, V53, P529, DOI 10.1016/S0361-9230(00)00386-5; Ramirez JM, 2004, CURR OPIN NEUROBIOL, V14, P665, DOI 10.1016/j.conb.2004.10.011; RINZEL J, 1978, FED PROC, V37, P2793; SCHMIDT J, 1992, J EXP BIOL, V171, P329; Shilnikov A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.048101; SHILNIKOV A, 2005, PHYS REV E, V71, P1; SHILNIKOV AL, 2008, INT J BIFURCAT CHAOS, V18, P1; Shilnikov A, 2008, CHAOS, V18, DOI 10.1063/1.2959850; Shilnikov L.P., 1998, METHODS QUALITATIV 1; Shilnikov LP, 2001, METHODS QUALITATIV 2; Smith JC, 2009, PHILOS T R SOC B, V364, P2577, DOI 10.1098/rstb.2009.0081; TERMAN D, 1992, J NONLINEAR SCI, V2, P135, DOI 10.1007/BF02429854; Venugopal S, 2007, J COMPUT NEUROSCI, V22, P223, DOI 10.1007/s10827-006-0009-3; WANG XJ, 1994, NEUROSCIENCE, V59, P21, DOI 10.1016/0306-4522(94)90095-7; Williams SR, 2002, J PHYSIOL-LONDON, V539, P469, DOI 10.1113/jphysiol.2001.013136	41	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e21782	10.1371/journal.pone.0021782	http://dx.doi.org/10.1371/journal.pone.0021782			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21814554	Green Published, gold, Green Submitted			2022-12-25	WOS:000292956800009
J	Dai, Y; Chen, S; Wang, L; Pei, XY; Funk, VL; Kramer, LB; Dent, P; Grant, S				Dai, Yun; Chen, Shuang; Wang, Li; Pei, Xin-Yan; Funk, Vanessa L.; Kramer, Lora B.; Dent, Paul; Grant, Steven			Disruption of I kappa B Kinase (IKK)-mediated RelA Serine 536 Phosphorylation Sensitizes Human Multiple Myeloma Cells to Histone Deacetylase (HDAC) Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; IKK-BETA; TRANSCRIPTIONAL ACTIVITY; DEPENDENT TRANSCRIPTION; SIGNALING PATHWAY; DOWN-REGULATION; LEUKEMIA-CELLS; ACTIVATION; P65; ACETYLATION	Post-translational modifications of RelA play an important role in regulation of NF-kappa B activation. We previously demonstrated that in malignant hematopoietic cells, histone deacetylase inhibitors (HDACIs) induced RelA hyperacetylation and NF-kappa B activation, attenuating lethality. We now present evidence that I kappa B kinase(IKK) beta-mediatedRelASer-536phosphorylation plays a significant functional role in promoting RelA acetylation, inducing NF-kappa B activation, and limiting HDACI lethality in human multiple myeloma (MM) cells. Immunoblot profiling revealed that although basal RelA phosphorylation varied in MM cells, Ser-536 phosphorylation correlated with IKK activity. Exposure to the pan-HDACIs vorinostat or LBH-589 induced phosphorylation of IKK alpha/beta(Ser-180/Ser-181) and RelA (Ser-536) in MM cells, including cells expressing an I kappa B alpha "super-repressor," accompanied by increased RelA nuclear translocation, acetylation, DNA binding, and transactivation activity. These events were substantially blocked by either pan-IKK or IKK beta-selective inhibitors, resulting in marked apoptosis. Consistent with these events, inhibitory peptides targeting either the NF-kappa B essential modulator (NEMO) binding domain for IKK complex formation or RelA phosphorylation sites also significantly increased HDACI lethality. Moreover, IKK beta knockdown by shRNA prevented Ser-536 phosphorylation and significantly enhanced HDACI susceptibility. Finally, introduction of a nonphosphorylatable RelA mutant S536A, which failed to undergo acetylation in response to HDACIs, impaired NF-kappa B activation and increased cell death. These findings indicate that HDACIs induce Ser-536 phosphorylation of the NF-kappa B subunit RelA through an IKK beta-dependent mechanism, an action that is functionally involved in activation of the cytoprotective NF-kappa B signaling cascade primarily through facilitation of RelA acetylation rather than nuclear translocation.	[Dai, Yun; Chen, Shuang; Wang, Li; Pei, Xin-Yan; Funk, Vanessa L.; Kramer, Lora B.; Grant, Steven] Virginia Commonwealth Univ, Massey Canc Ctr, Dept Med, Richmond, VA 23298 USA; [Dent, Paul; Grant, Steven] Virginia Commonwealth Univ, Massey Canc Ctr, Dept Biochem, Richmond, VA 23298 USA; [Grant, Steven] Virginia Commonwealth Univ, Massey Canc Ctr, Dept Pharmacol, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Grant, S (corresponding author), 234 Goodwin,401 Coll St, Richmond, VA 23298 USA.	stgrant@vcu.edu	Dai, Yun/AAG-4040-2019	Dai, Yun/0000-0003-2285-0818	National Institutes of Health, NCI [CA 93738, CA100866, 1 P50 CA130805-01, 1 P50 CA142509-01]; Leukemia and Lymphoma Society of America [6181-10]; V Foundation; Multiple Myeloma Research Foundation; NATIONAL CANCER INSTITUTE [P50CA130805, P50CA142509, R01CA150214, R01CA100866, R01CA093738, R01CA141703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052825] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society); V Foundation; Multiple Myeloma Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA 93738, CA100866, 1 P50 CA130805-01, and 1 P50 CA142509-01 from NCI. This work was also supported by Grant 6181-10 from the Leukemia and Lymphoma Society of America and grants from the V Foundation and the Multiple Myeloma Research Foundation.	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Atadja P, 2009, CANCER LETT, V280, P233, DOI 10.1016/j.canlet.2009.02.019; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bednarski BK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006992; Bohuslav J, 2004, J BIOL CHEM, V279, P26115, DOI 10.1074/jbc.M313509200; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Buss H, 2004, J BIOL CHEM, V279, P49571, DOI 10.1074/jbc.C400442200; Chavey C, 2008, MOL PHARMACOL, V74, P1359, DOI 10.1124/mol.108.047332; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen LF, 2003, J MOL MED, V81, P549, DOI 10.1007/s00109-003-0469-0; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Dai Y, 2005, MOL CELL BIOL, V25, P5429, DOI 10.1128/MCB.25.13.5429-5444.2005; Dai Y, 2002, BLOOD, V100, P3333, DOI 10.1182/blood-2002-03-0940; Demchenko YN, 2010, ONCOTARGET, V1, P59, DOI 10.18632/oncotarget.109; Demchenko YN, 2010, BLOOD, V115, P3541, DOI 10.1182/blood-2009-09-243535; Dickinson M, 2010, INVEST NEW DRUG, V28, pS3, DOI 10.1007/s10637-010-9596-y; Dimopoulos MA, 2011, EUR J HAEMATOL, V86, P1, DOI 10.1111/j.1600-0609.2010.01542.x; Gilmore TD, 2007, CANCER CELL, V12, P95, DOI 10.1016/j.ccr.2007.07.010; Grant S, 2007, NAT REV DRUG DISCOV, V6, P21, DOI 10.1038/nrd2227; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Haller D, 2002, J BIOL CHEM, V277, P38168, DOI 10.1074/jbc.M205737200; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Hideshima T, 2006, CLIN CANCER RES, V12, P5887, DOI 10.1158/1078-0432.CCR-05-2501; Hoberg JE, 2006, MOL CELL BIOL, V26, P457, DOI 10.1128/MCB.26.2.457-471.2006; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Jeong SJ, 2005, J BIOL CHEM, V280, P10326, DOI 10.1074/jbc.M412643200; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Kim YK, 2006, CELL DEATH DIFFER, V13, P2033, DOI 10.1038/sj.cdd.4401915; Klein B, 2010, BLOOD, V115, P3422, DOI 10.1182/blood-2010-01-264796; Konopleva MY, 2011, J CLIN ONCOL, V29, P591, DOI 10.1200/JCO.2010.31.0904; Mattioli I, 2006, J BIOL CHEM, V281, P6175, DOI 10.1074/jbc.M508045200; Mattioli I, 2004, J IMMUNOL, V172, P6336, DOI 10.4049/jimmunol.172.10.6336; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Mayo MW, 2003, J BIOL CHEM, V278, P18980, DOI 10.1074/jbc.M211695200; Mitsiades CS, 2009, SEMIN HEMATOL, V46, P166, DOI 10.1053/j.seminhematol.2009.02.003; Moreno R, 2010, NUCLEIC ACIDS RES, V38, P6029, DOI 10.1093/nar/gkq439; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Neumann M, 2007, FASEB J, V21, P2642, DOI 10.1096/fj.06-7615rev; Oakley F, 2009, GASTROENTEROLOGY, V136, P2334, DOI 10.1053/j.gastro.2009.02.081; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Orian A, 2000, EMBO J, V19, P2580, DOI 10.1093/emboj/19.11.2580; Podolin PL, 2005, J PHARMACOL EXP THER, V312, P373, DOI 10.1124/jpet.104.074484; Rosato RR, 2010, J BIOL CHEM, V285, P10064, DOI 10.1074/jbc.M109.095208; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Schmitz ML, 2004, CHEMBIOCHEM, V5, P1348, DOI 10.1002/cbic.200400144; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; Takada Y, 2004, J BIOL CHEM, V279, P15096, DOI 10.1074/jbc.M311192200; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wan FY, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000067; Wang JL, 2007, CANCER CELL, V12, P239, DOI 10.1016/j.ccr.2007.07.002; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Xiao GT, 2004, J BIOL CHEM, V279, P30099, DOI 10.1074/jbc.M401428200; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630; Yang JM, 2001, J BIOL CHEM, V276, P47828, DOI 10.1074/jbc.M106103200; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	68	29	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34036	34050		10.1074/jbc.M111.284216	http://dx.doi.org/10.1074/jbc.M111.284216			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21816815	Green Published, hybrid			2022-12-25	WOS:000295159200036
J	Ding, L; Forsburg, SL				Ding, Lin; Forsburg, Susan L.			Schizosaccharomyces pombe Minichromosome Maintenance-binding Protein (MCM-BP) Antagonizes MCM Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORIGIN RECOGNITION COMPLEX; REPLICATION FACTOR MCM4; DNA-DAMAGE CHECKPOINT; XENOPUS EGG EXTRACTS; FISSION YEAST; S-PHASE; CELL-CYCLE; DORMANT ORIGINS; SACCHAROMYCES-CEREVISIAE; NUCLEAR-LOCALIZATION	The minichromosome maintenance (MCM) complex, a replicative helicase, is a heterohexamer essential for DNA duplication and genome stability. We identified Schizosaccharomyces pombe mcb1(+) (Mcm-binding protein 1), an apparent orthologue of the human MCM-binding protein that associates with a subset of MCM complex proteins. mcb1(+) is an essential gene. Deletion of mcb1(+) caused cell cycle arrest after several generations with a cdc phenotype and disrupted nuclear structure. Mcb1 is an abundant protein, constitutively present across the cell cycle. It is widely distributed in cytoplasm and nucleoplasm and bound to chromatin. Co-immunoprecipitation suggested that Mcb1 interacts robustly with Mcm3-7 but not Mcm2. Overproduction of Mcb1 disrupted the association of Mcm2 with other MCM proteins, resulting in inhibition of DNA replication, DNA damage, and activation of the checkpoint kinase Chk1. Thus, Mcb1 appears to antagonize the function of MCM helicase.	[Ding, Lin; Forsburg, Susan L.] Univ So Calif, Mol & Computat Biol Program, Los Angeles, CA 90089 USA	University of Southern California	Forsburg, SL (corresponding author), Univ So Calif, Mol & Computat Biol Program, 1050 Childs Way,RRI 201, Los Angeles, CA 90089 USA.	forsburg@usc.edu		Forsburg, Susan L/0000-0002-4895-8598	National Institutes of Health [R01 GM059321]; University of Southern California Keck School of Medicine; University of Southern California; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059321] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Southern California Keck School of Medicine; University of Southern California; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM059321 (to S. L. F.) and the National Institutes of Health Cellular, Biochemical, and Molecular Sciences Training Program at the University of Southern California Keck School of Medicine (to L. D.).; Supported by a University of Southern California college doctoral fellowship.	Adachi Y, 1997, GENES CELLS, V2, P467, DOI 10.1046/j.1365-2443.1997.1350333.x; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bailis JM, 2008, MOL CELL BIOL, V28, P1724, DOI 10.1128/MCB.01717-07; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Bauerschmidt C, 2007, GENES CELLS, V12, P745, DOI 10.1111/j.1365-2443.2007.01090.x; Blow JJ, 2009, EMBO REP, V10, P406, DOI 10.1038/embor.2009.5; Bochman ML, 2010, NUCLEIC ACIDS RES, V38, P6078, DOI 10.1093/nar/gkq422; Bochman ML, 2009, MICROBIOL MOL BIOL R, V73, P652, DOI 10.1128/MMBR.00019-09; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Braun KA, 2007, MOL BIOL CELL, V18, P1447, DOI 10.1091/mbc.E06-09-0792; Catlett MG, 2003, MOL BIOL CELL, V14, P4707, DOI 10.1091/mbc.E03-05-0288; Chuang CH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001110; COXON A, 1992, NUCLEIC ACIDS RES, V20, P5571, DOI 10.1093/nar/20.21.5571; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; Edwards MC, 2002, J BIOL CHEM, V277, P33049, DOI 10.1074/jbc.M204438200; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; FORSBURG SL, 1994, J CELL SCI, V107, P2779; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Forsburg SL, 1997, GENETICS, V147, P1025; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Gomez EB, 2002, GENETICS, V160, P1305; Gozuacik D, 2003, NUCLEIC ACIDS RES, V31, P570, DOI 10.1093/nar/gkg136; Grallert B, 1996, GENE DEV, V10, P2644, DOI 10.1101/gad.10.20.2644; HARTWELL L, 1994, COLD SPRING HARB SYM, V59, P259, DOI 10.1101/SQB.1994.059.01.030; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Hingorani MM, 1998, CURR BIOL, V8, pR83, DOI 10.1016/S0960-9822(98)70052-1; Hyrien O, 2003, BIOESSAYS, V25, P116, DOI 10.1002/bies.10208; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kearsey SE, 2000, EMBO J, V19, P1681, DOI 10.1093/emboj/19.7.1681; KEENEY JB, 1994, GENETICS, V136, P849; KELLY TJ, 1993, COLD SPRING HARB SYM, V58, P637, DOI 10.1101/SQB.1993.058.01.071; KELLY TJ, 1993, CELL, V74, P371, DOI 10.1016/0092-8674(93)90427-R; Krude T, 1996, J CELL SCI, V109, P309; Labib K, 1999, NAT CELL BIOL, V1, P415, DOI 10.1038/15649; Laskey RA, 2003, EMBO REP, V4, P26, DOI 10.1038/sj.embor.embor706; Lee JK, 2000, J BIOL CHEM, V275, P18871, DOI 10.1074/jbc.M001118200; Lee JK, 2001, P NATL ACAD SCI USA, V98, P54, DOI 10.1073/pnas.98.1.54; Lei M, 1996, MOL CELL BIOL, V16, P5081; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Liang DT, 1999, J CELL SCI, V112, P559; Liang DT, 2001, GENETICS, V159, P471; Lutzmann M, 2005, GENE, V362, P51, DOI 10.1016/j.gene.2005.07.031; MADINE MA, 1995, CURR BIOL, V5, P1270, DOI 10.1016/S0960-9822(95)00253-3; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Mason JA, 1997, NUCLEIC ACIDS RES, V25, P4700, DOI 10.1093/nar/25.22.4700; Matsuo Y, 2006, BIOSCI BIOTECH BIOCH, V70, P1992, DOI 10.1271/bbb.60087; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; MIYAKE S, 1993, MOL BIOL CELL, V4, P1003, DOI 10.1091/mbc.4.10.1003; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MuziFalconi M, 1995, P NATL ACAD SCI USA, V92, P12475, DOI 10.1073/pnas.92.26.12475; Namdar M, 2006, EXP CELL RES, V312, P3360, DOI 10.1016/j.yexcr.2006.07.001; Nguyen VQ, 2000, CURR BIOL, V10, P195, DOI 10.1016/S0960-9822(00)00337-7; Nishiyama A, 2011, GENE DEV, V25, P165, DOI 10.1101/gad.614411; Pasion SG, 1999, MOL BIOL CELL, V10, P4043, DOI 10.1091/mbc.10.12.4043; Radcliffe P, 1998, MOL BIOL CELL, V9, P1757, DOI 10.1091/mbc.9.7.1757; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Sabatinos SA, 2010, METHOD ENZYMOL, V470, P759, DOI 10.1016/S0076-6879(10)70032-X; Sabatinos Sarah A., 2009, V521, P449, DOI [10.1007/978-1-60327-815-7_25, 10.1007/978-1-60327-817-5_25]; SAKA Y, 1993, CELL, V74, P383, DOI 10.1016/0092-8674(93)90428-S; Sakwe AM, 2007, MOL CELL BIOL, V27, P3044, DOI 10.1128/MCB.02384-06; SAZER S, 1990, J CELL SCI, V97, P509; Schwacha A, 2001, MOL CELL, V8, P1093, DOI 10.1016/S1097-2765(01)00389-6; Sherman DA, 1998, NUCLEIC ACIDS RES, V26, P3955, DOI 10.1093/nar/26.17.3955; Sherman DA, 1998, MOL BIOL CELL, V9, P1833, DOI 10.1091/mbc.9.7.1833; Shultz RW, 2007, PLANT PHYSIOL, V144, P1697, DOI 10.1104/pp.107.101105; Sible JC, 1998, CURR BIOL, V8, P347, DOI 10.1016/S0960-9822(98)70136-8; TAKAHASHI K, 1994, MOL BIOL CELL, V5, P1145, DOI 10.1091/mbc.5.10.1145; Takahashi N, 2008, EMBO J, V27, P1840, DOI 10.1038/emboj.2008.107; Takahashi N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000817; Walworth NC, 1996, SCIENCE, V271, P353, DOI 10.1126/science.271.5247.353; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108; Yin L, 2008, MOL BIOL CELL, V19, P4374, DOI 10.1091/mbc.E08-01-0020; Yoshida K, 2005, BIOCHEM BIOPH RES CO, V331, P669, DOI 10.1016/j.bbrc.2005.03.222	77	17	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					32918	32930		10.1074/jbc.M111.282541	http://dx.doi.org/10.1074/jbc.M111.282541			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21813639	Green Published, hybrid			2022-12-25	WOS:000294968800010
J	Kigoshi, Y; Tsuruta, F; Chiba, T				Kigoshi, Yu; Tsuruta, Fuminori; Chiba, Tomoki			Ubiquitin Ligase Activity of Cul3-KLHL7 Protein Is Attenuated by Autosomal Dominant Retinitis Pigmentosa Causative Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CUL3-BASED E3 LIGASE; MYOSIN-VIIA; DOMAIN PROTEINS; RETINAL FASCIN; SCF; INSIGHTS; KEAP1; DEGRADATION; ACTIVATION; COMPLEXES	Substrate-specific protein degradation mediated by the ubiquitin proteasome system (UPS) is crucial for the proper function of the cell. Proteins are specifically recognized and ubiquitinated by the ubiquitin ligases (E3s) and are then degraded by the proteasome. BTB proteins act as the substrate recognition subunit that recruits their cognate substrates to the Cullin 3-based multisubunit E3s. Recently, it was reported that missense mutations in KLHL7, a BTB-Kelch protein, are related to autosomal dominant retinitis pigmentosa (adRP). However, the involvement of KLHL7 in the UPS and the outcome of the adRP causative mutations were unknown. In this study, we show that KLHL7 forms a dimer, assembles with Cul3 through its BTB and BACK domains, and exerts E3 activity. Lys-48-linked but not Lys-63-linked polyubiquitin chain co-localized with KLHL7, which increased upon proteasome inhibition suggesting that KLHL7 mediates protein degradation via UPS. An adRP-causative missense mutation in the BACK domain of KLHL7 attenuated only the Cul3 interaction but not dimerization. Nevertheless, the incorporation of the mutant as a heterodimer in the Cul3-KLHL7 complex diminished the E3 ligase activity. Together, our results suggest that KLHL7 constitutes a Cul3-based E3 and that the disease-causing mutation inhibits ligase activity in a dominant negative manner, which may lead to the inappropriate accumulation of the substrates targeted for proteasomal degradation.	[Kigoshi, Yu; Tsuruta, Fuminori; Chiba, Tomoki] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan	University of Tsukuba	Chiba, T (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan.	tchiba@biol.tsukuba.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan; Grants-in-Aid for Scientific Research [23770218] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Science, Sports, and Culture of Japan (to T.C.).	Bomont P, 2000, NAT GENET, V26, P370, DOI 10.1038/81701; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cirak S, 2010, BRAIN, V133, P2123, DOI 10.1093/brain/awq108; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; Dias DC, 2002, P NATL ACAD SCI USA, V99, P16601, DOI 10.1073/pnas.252646399; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; ElAmraoui A, 1996, HUM MOL GENET, V5, P1171, DOI 10.1093/hmg/5.8.1171; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Friedman JS, 2009, AM J HUM GENET, V84, P792, DOI 10.1016/j.ajhg.2009.05.007; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hugosson T, 2010, ARCH OPHTHALMOL-CHIC, V128, P772, DOI 10.1001/archophthalmol.2010.98; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jackson PK, 2002, MOL CELL, V9, P923, DOI 10.1016/S1097-2765(02)00538-5; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kubota H, 2009, J BIOCHEM, V146, P609, DOI 10.1093/jb/mvp139; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; Liu Q, 2004, J NEUROSCI, V24, P6427, DOI 10.1523/JNEUROSCI.1335-04.2004; Merlet J, 2009, CELL MOL LIFE SCI, V66, P1924, DOI 10.1007/s00018-009-8712-7; Ogura T, 2010, P NATL ACAD SCI USA, V107, P2842, DOI 10.1073/pnas.0914036107; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Olzmann JA, 2008, AUTOPHAGY, V4, P85, DOI 10.4161/auto.5172; Patton EE, 1998, GENE DEV, V12, P692, DOI 10.1101/gad.12.5.692; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Saishin Y, 2000, INVEST OPHTH VIS SCI, V41, P2087; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Sumara I, 2007, DEV CELL, V12, P887, DOI 10.1016/j.devcel.2007.03.019; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Tubb BE, 2000, GENOMICS, V65, P146, DOI 10.1006/geno.2000.6156; Udovichenko IP, 2002, J CELL SCI, V115, P445; Weil D, 1996, P NATL ACAD SCI USA, V93, P3232, DOI 10.1073/pnas.93.8.3232; Willems AR, 1996, CELL, V86, P453, DOI 10.1016/S0092-8674(00)80118-X; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Williams DS, 2002, VISION RES, V42, P455, DOI 10.1016/S0042-6989(01)00228-0; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhuang M, 2009, MOL CELL, V36, P39, DOI 10.1016/j.molcel.2009.09.022	47	47	50	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33613	33621		10.1074/jbc.M111.245126	http://dx.doi.org/10.1074/jbc.M111.245126			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21828050	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000294968800077
J	Lee, J; Di Jeso, B; Arvan, P				Lee, Jaemin; Di Jeso, Bruno; Arvan, Peter			Maturation of Thyroglobulin Protein Region I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLINESTERASE-LIKE DOMAIN; HEREDITARY CONGENITAL GOITER; ENDOPLASMIC-RETICULUM; MOLECULAR CHAPERONE; TRANSPORT; HYPOTHYROIDISM; AGGREGATION; MUTATIONS; EVOLUTION; SEQUENCE	In vertebrates, the thyroglobulin (Tg) gene product must be exported to the lumen of thyroid follicles for thyroid hormone synthesis. In toto, Tg is composed of multiple type-1 repeats connected by linker and hinge (altogether considered as "region I," nearly 1,200 residues); regions II-III (similar to 720 residues); and cholinesterase-like (ChEL) domain (similar to 570 residues). Regions II-III and ChEL rapidly acquire competence for secretion, yet regions I-II-III require 20 min to become a partially mature disulfide isomer; stabilization of a fully oxidized form requires ChEL. Transition from partially mature to mature Tg occurs as a discrete "jump" in mobility by nonreducing SDS-PAGE, suggesting formation of at most a few final pairings of Cys residues that may be separated by significant intervening primary sequence. Using two independent approaches, we have investigated which portion of Tg is engaged in this late stage of its maturation. First, we demonstrate that this event is linked to oxidation involving region I. Introduction of the Tg-C1245R mutation in the hinge (identical to that causing human goitrous hypothyroidism) inhibits this maturation, although the Cys-1245 partner remains unidentified. Second, we find that Tg truncated after its fourth type-1 repeat is a fully independent secretory protein. Together, the data indicate that final acquisition of secretory competence includes conformational maturation in the interval between linker and hinge segments of region I.	Univ Michigan, Med Ctr, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Di Jeso, Bruno] Univ Lecce, Dipartimento Sci & Tecnol Biol & Ambientali, Fac Sci MFN, I-73100 Lecce, Italy	University of Michigan System; University of Michigan; University of Salento	Arvan, P (corresponding author), Univ Michigan, Div Metab Endocrinol & Diabet, 1000 Wall St,Rm 5112, Ann Arbor, MI 48105 USA.	parvan@umich.edu	Lee, Jaemin/AAP-4875-2021	Lee, Jaemin/0000-0002-0224-7141; di jeso, bruno/0000-0001-8713-5984	National Institutes of Health [R01-DK40344, 5P60 DK20572];  [P30 CA46592]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040344, P30DK020572, P60DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-DK40344 (to P. A.).; We gratefully acknowledge the University of Michigan Diabetes Research and Training Center Cell and Molecular Biology Core (supported by Grant NIH5P60 DK20572) and the University of Michigan Cancer Center Core laboratories (supported by Grant P30 CA46592).	Arvan P, 1997, THYROID, V7, P89, DOI 10.1089/thy.1997.7.89; Aryan P, 2004, THYROID, P77; Baryshev M, 2004, J MOL ENDOCRINOL, V32, P903, DOI 10.1677/jme.0.0320903; CHRISTOPHE D, 1990, TRENDS ENDOCRIN MET, V1, P351, DOI 10.1016/1043-2760(90)90083-F; Citterio CE, 2011, CLIN ENDOCRINOL, V74, P534, DOI 10.1111/j.1365-2265.2010.03932.x; DEVIJLDER JJM, 1978, ENDOCRINOLOGY, V102, P1214, DOI 10.1210/endo-102-4-1214; Di Jeso B, 2005, MOL CELL BIOL, V25, P9793, DOI 10.1128/MCB.25.22.9793-9805.2005; Di Jeso B, 2003, BIOCHEM J, V370, P449, DOI 10.1042/BJ20021257; Dunn AD, 1998, J BIOL CHEM, V273, P25223, DOI 10.1074/jbc.273.39.25223; Fujikawa T, 2010, CELL STRESS CHAPERON, V15, P193, DOI 10.1007/s12192-009-0133-x; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Hall N, 2002, NATURE, V419, P527, DOI 10.1038/nature01095; Hishinuma A, 1999, J CLIN ENDOCR METAB, V84, P1438, DOI 10.1210/jc.84.4.1438; Hishinuma A, 2006, J CLIN ENDOCR METAB, V91, P3100, DOI 10.1210/jc.2005-2702; Kim PS, 2008, MOL ENDOCRINOL, V22, P477, DOI 10.1210/me.2007-0183; KIM PS, 1991, J BIOL CHEM, V266, P12412; KIM PS, 1993, AM J PHYSIOL, V265, pC704, DOI 10.1152/ajpcell.1993.265.3.C704; Kim PS, 1996, J CELL BIOL, V133, P517, DOI 10.1083/jcb.133.3.517; KIM PS, 1995, J CELL BIOL, V128, P29, DOI 10.1083/jcb.128.1.29; KIM PS, 1992, J CELL BIOL, V118, P541, DOI 10.1083/jcb.118.3.541; LAMAS L, 1977, ENDOCRINOLOGY, V100, P1129; Lee J, 2008, J CLIN INVEST, V118, P2950, DOI 10.1172/JCI35164; Lee J, 2011, J BIOL CHEM, V286, P26327, DOI 10.1074/jbc.M111.242099; Lee J, 2009, J BIOL CHEM, V284, P12752, DOI 10.1074/jbc.M806898200; MARRIQ C, 1991, MOL CELL ENDOCRINOL, V81, P155, DOI 10.1016/0303-7207(91)90214-D; MERCKEN L, 1985, NATURE, V316, P647, DOI 10.1038/316647a0; Mihelic M, 2007, BIOL CHEM, V388, P1123, DOI 10.1515/BC.2007.155; Molina F, 1996, EUR J BIOCHEM, V240, P125, DOI 10.1111/j.1432-1033.1996.0125h.x; Muresan Z, 1997, J BIOL CHEM, V272, P26095, DOI 10.1074/jbc.272.42.26095; Muresan Z, 1998, MOL ENDOCRINOL, V12, P458, DOI 10.1210/me.12.3.458; Park YN, 2004, J BIOL CHEM, V279, P17085, DOI 10.1074/jbc.M314042200; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Targovnik HM, 2010, MOL CELL ENDOCRINOL, V322, P44, DOI 10.1016/j.mce.2010.01.009; Taurog A, 1999, BIOCHIMIE, V81, P557, DOI 10.1016/S0300-9084(99)80110-2; Turakulov Ia Kh, 1976, Biokhimiia, V41, P1004; van de Graaf SAR, 1999, J CLIN ENDOCR METAB, V84, P2537, DOI 10.1210/jc.84.7.2537; VANVOORTHUIZEN WF, 1978, ENDOCRINOLOGY, V103, P2105, DOI 10.1210/endo-103-6-2105; VEENBOER GJM, 1993, ENDOCRINOLOGY, V132, P377, DOI 10.1210/en.132.1.377; Vono J, 1996, THYROID, V6, P11, DOI 10.1089/thy.1996.6.11; Vono-Toniolo J, 2005, THYROID, V15, P1021, DOI 10.1089/thy.2005.15.1021; Wang XF, 2010, J BIOL CHEM, V285, P17564, DOI 10.1074/jbc.M110.111641; Xiao S, 1996, ARCH BIOCHEM BIOPHYS, V334, P284, DOI 10.1006/abbi.1996.0457	42	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33045	33052		10.1074/jbc.M111.281337	http://dx.doi.org/10.1074/jbc.M111.281337			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21816825	Green Published, hybrid			2022-12-25	WOS:000294968800023
J	Sohail, A; Marco, M; Zhao, HR; Shi, QC; Merriman, S; Mobashery, S; Fridman, R				Sohail, Anjum; Marco, Marta; Zhao, Huiren; Shi, Qicun; Merriman, Scott; Mobashery, Shahriar; Fridman, Rafael			Characterization of the Dimerization Interface of Membrane Type 4 (MT4)-Matrix Metalloproteinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; RICH LIPID RAFTS; MATRIX-METALLOPROTEINASE; EXPRESSION ANALYSIS; MMP25; PROTEINS; MT4-MMP; IDENTIFICATION; METASTASIS; INHIBITOR	MT4-MMP (MMP17) belongs to a unique subset of membrane type-matrix metalloproteinases that are anchored to the cell surface via a glycosylphosphatidylinositol moiety. However, little is known about its biochemical properties. Here, we report that MT4-MMP is displayed on the cell surface as a mixed population of monomeric, dimeric, and oligomeric forms. Sucrose gradient fractionation demonstrated that these forms of MT4-MMP are all present in lipid rafts. Mutational and computational analyses revealed that Cys(564), which is present within the stem region, mediates MT4-MMP homodimerization by forming a disulfide bond. Substitution of Cys(564) results in a more rapid MT4-MMP turnover, when compared with the wild-type enzyme, consistent with a role for dimerization in protein stability. Expression of MT4-MMP in Madin-Darby canine kidney cells enhanced cell migration and invasion of Matrigel, a process that requires catalytic activity. However, a serine substitution at Cys(564) did not reduce MT4-MMP-stimulated cell invasion of Matrigel suggesting that homodimerization is not required for this process. Deglycosylation studies showed that MT4-MMP is modified by N-glycosylation. Moreover, inhibition of N-glycosylation by tunicamycin diminished the extent of MT4-MMP dimerization suggesting that N-glycans may confer stability to the dimeric form. Taken together, the data presented here provide a new insight into the characteristics of MT4-MMP and highlight the common and distinct properties of the glycosylphosphatidylinositol-anchored membrane type-matrix metalloproteinases.	[Fridman, Rafael] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA; [Sohail, Anjum; Marco, Marta; Zhao, Huiren; Merriman, Scott; Fridman, Rafael] Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48201 USA; [Shi, Qicun; Mobashery, Shahriar] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Shi, Qicun; Mobashery, Shahriar] Univ Notre Dame, Walther Canc Res Ctr, Notre Dame, IN 46556 USA	Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; University of Notre Dame; University of Notre Dame; Walther Cancer Institute	Fridman, R (corresponding author), Wayne State Univ, Sch Med, Dept Pathol, 540 E Canfield Ave, Detroit, MI 48201 USA.	rfridman@med.wayne.edu		Sohail, Anjum/0000-0001-5567-9645	National Institutes of Health [CA-61986-16, CA-122417]; NATIONAL CANCER INSTITUTE [R01CA122417, R01CA061986] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA-61986-16 (to R. F.) and CA-122417 (to S. M.).	Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Caiolfa VR, 2007, J CELL BIOL, V179, P1067, DOI 10.1083/jcb.200702151; Chabottaux V, 2006, CANCER RES, V66, P5165, DOI 10.1158/0008-5472.CAN-05-3012; Chabottaux V, 2009, J CELL MOL MED, V13, P4002, DOI 10.1111/j.1582-4934.2009.00764.x; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P211, DOI 10.1021/bi00699a001; Clements KM, 2011, ANN RHEUM DIS, V70, P683, DOI 10.1136/ard.2010.130757; Cunningham O, 2003, EMBO J, V22, P5994, DOI 10.1093/emboj/cdg588; English WR, 2000, J BIOL CHEM, V275, P14046, DOI 10.1074/jbc.275.19.14046; English WR, 2001, FEBS LETT, V491, P137, DOI 10.1016/S0014-5793(01)02150-0; Funatsu N, 2004, CEREB CORTEX, V14, P1031, DOI 10.1093/cercor/bhh063; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; Gauthier MC, 2003, INT J BIOCHEM CELL B, V35, P1667, DOI 10.1016/S1357-2725(03)00136-5; Hegedus L, 2008, J CELL PHYSIOL, V216, P480, DOI 10.1002/jcp.21417; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Huang CH, 2009, NEOPLASIA, V11, P1371, DOI 10.1593/neo.91326; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kajita M, 1999, FEBS LETT, V457, P353, DOI 10.1016/S0014-5793(99)01065-0; Kim JY, 2004, ENDOCRINOLOGY, V145, P613, DOI 10.1210/en.2003-0772; Kinoh H, 1999, CYTOGENET CELL GENET, V87, P97, DOI 10.1159/000015402; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nie J, 2004, EXP CELL RES, V296, P145, DOI 10.1016/j.yexcr.2004.02.008; Nuttall RK, 2004, FEBS LETT, V563, P129, DOI 10.1016/S0014-5793(04)00281-9; Olson MW, 1997, J BIOL CHEM, V272, P29975, DOI 10.1074/jbc.272.47.29975; Onufriev A, 2000, J PHYS CHEM B, V104, P3712, DOI 10.1021/jp994072s; Paladino S, 2007, TRAFFIC, V8, P251, DOI 10.1111/j.1600-0854.2006.00522.x; Patwari P, 2005, OSTEOARTHR CARTILAGE, V13, P269, DOI 10.1016/j.joca.2004.10.023; Plaisier M, 2006, MOL HUM REPROD, V12, P11, DOI 10.1093/molehr/gah257; Puente XS, 1996, CANCER RES, V56, P944; Rikimaru A, 2007, GENES CELLS, V12, P1091, DOI 10.1111/j.1365-2443.2007.01110.x; Rizki A, 2008, CANCER RES, V68, P1378, DOI 10.1158/0008-5472.CAN-07-2225; Rowe RG, 2009, ANNU REV CELL DEV BI, V25, P567, DOI 10.1146/annurev.cellbio.24.110707.175315; Sohail A, 2008, CANCER METAST REV, V27, P289, DOI 10.1007/s10555-008-9129-8; Srichai MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017099; Sun Q, 2007, J BIOL CHEM, V282, P21998, DOI 10.1074/jbc.M701737200; Wu YI, 2004, J BIOL CHEM, V279, P8278, DOI 10.1074/jbc.M311870200; Zhang WL, 2007, BIOCHEMISTRY-US, V46, P10113, DOI 10.1021/bi700777x; Zhao HR, 2008, J BIOL CHEM, V283, P35023, DOI 10.1074/jbc.M806553200; Zhuang LY, 2002, CANCER RES, V62, P2227; Zucker S, 2003, CURR TOP DEV BIOL, V54, P1, DOI 10.1016/S0070-2153(03)54004-2	40	19	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33178	33189		10.1074/jbc.M111.253369	http://dx.doi.org/10.1074/jbc.M111.253369			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21828052	hybrid, Green Published			2022-12-25	WOS:000294968800037
J	Bruna, EM; Izzo, TJ; Inouye, BD; Uriarte, M; Vasconcelos, HL				Bruna, Emilio M.; Izzo, Thiago J.; Inouye, Brian D.; Uriarte, Maria; Vasconcelos, Heraldo L.			Asymmetric Dispersal and Colonization Success of Amazonian Plant-Ants Queens	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; SPECIES COEXISTENCE; SEED DISPERSAL; MUTUALISM; PATTERNS; COMPETITION; DYNAMICS; CECROPIA; CONSEQUENCES; RECRUITMENT	Background: The dispersal ability of queens is central to understanding ant life-history evolution, and plays a fundamental role in ant population and community dynamics, the maintenance of genetic diversity, and the spread of invasive ants. In tropical ecosystems, species from over 40 genera of ants establish colonies in the stems, hollow thorns, or leaf pouches of specialized plants. However, little is known about the relative dispersal ability of queens competing for access to the same host plants. Methodology/Principal Findings: We used empirical data and inverse modeling-a technique developed by plant ecologists to model seed dispersal-to quantify and compare the dispersal kernels of queens from three Amazonian ant species that compete for access to host-plants. We found that the modal colonization distance of queens varied 8-fold, with the generalist ant species (Crematogaster laevis) having a greater modal distance than two specialists (Pheidole minutula, Azteca sp.) that use the same host-plants. However, our results also suggest that queens of Azteca sp. have maximal distances that are four-sixteen times greater than those of its competitors. Conclusions/Significance: We found large differences between ant species in both the modal and maximal distance ant queens disperse to find vacant seedlings used to found new colonies. These differences could result from interspecific differences in queen body size, and hence wing musculature, or because queens differ in their ability to identify potential host plants while in flight. Our results provide support for one of the necessary conditions underlying several of the hypothesized mechanisms promoting coexistence in tropical plant-ants. They also suggest that for some ant species limited dispersal capability could pose a significant barrier to the rescue of populations in isolated forest fragments. Finally, we demonstrate that inverse models parameterized with field data are an excellent means of quantifying the dispersal of ant queens.	[Bruna, Emilio M.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32610 USA; [Bruna, Emilio M.] Univ Florida, Ctr Latin Amer Studies, Gainesville, FL USA; [Izzo, Thiago J.] Univ Fed Mato Grosso, Dept Bot & Ecol, Cuiaba, Mato Grosso, Brazil; [Inouye, Brian D.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Uriarte, Maria] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY USA; [Vasconcelos, Heraldo L.] Univ Fed Uberlandia, Inst Biol, BR-38400 Uberlandia, MG, Brazil; [Bruna, Emilio M.; Izzo, Thiago J.; Inouye, Brian D.; Uriarte, Maria; Vasconcelos, Heraldo L.] Inst Nacl de Pesquisas da Amazonia, Biol Dynam Forest Fragments Project, Manaus, Amazonas, Brazil; [Bruna, Emilio M.; Izzo, Thiago J.; Inouye, Brian D.; Uriarte, Maria; Vasconcelos, Heraldo L.] Smithsonian Trop Res Inst, Manaus, Amazonas, Brazil	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Universidade Federal de Mato Grosso; State University System of Florida; Florida State University; Columbia University; Universidade Federal de Uberlandia; Institute Nacional de Pesquisas da Amazonia; Smithsonian Institution; Smithsonian Tropical Research Institute	Bruna, EM (corresponding author), Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32610 USA.	embruna@ufl.edu	Uriarte, Maria/L-8944-2013; Izzo, Thiago/K-7405-2012; Bruna, Emilio M/H-2769-2012; Bruna, Elena/C-4939-2014; Vasconcelos, Heraldo L/C-3353-2013	Izzo, Thiago/0000-0002-4613-3787; Bruna, Emilio M/0000-0003-3381-8477; Bruna, Elena/0000-0001-5427-1461; Vasconcelos, Heraldo L/0000-0001-6969-7131	US National Science Foundation [DEB-0453631, DEB-0452720]; University of Florida	US National Science Foundation(National Science Foundation (NSF)); University of Florida(University of Florida)	This research was supported by Grants DEB-0453631 and DEB-0452720 from the US National Science Foundation (http://nsf.gov). Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernays E. A., 1994, Host-plant selection by phytophagous insects.; BIERREGAARD RO, LESSONS AMAZONIA ECO; Blatrix R, 2010, SIGNAL COMMUN PLANTS, P127, DOI 10.1007/978-3-642-12162-3_9; Brouat C, 2001, P ROY SOC B-BIOL SCI, V268, P2131, DOI 10.1098/rspb.2001.1763; Bruna EM, 2005, BIOL CONSERV, V124, P209, DOI 10.1016/j.biocon.2005.01.026; Bruna EM, 2004, OECOLOGIA, V138, P558, DOI 10.1007/s00442-003-1455-5; Canham CD, 2006, ECOL APPL, V16, P62, DOI 10.1890/04-0657; Clark JS, 1999, ECOLOGY, V80, P1475, DOI 10.2307/176541; Clark JS, 1998, ECOL MONOGR, V68, P213, DOI 10.1890/0012-9615(1998)068[0213:SASSOR]2.0.CO;2; Darvill B, 2010, MOL ECOL, V19, P53, DOI 10.1111/j.1365-294X.2009.04423.x; Dattilo W, 2009, BIOTROPICA, V41, P642, DOI 10.1111/j.1744-7429.2009.00518.x; Debout GDG, 2009, OIKOS, V118, P873, DOI 10.1111/j.1600-0706.2009.16317.x; Edwards DP, 2006, INSECT SOC, V53, P172, DOI 10.1007/s00040-006-0855-z; FEARNSIDE PM, 2002, LESSONS AMAZONIA ECO, P291; Fonseca CR, 1996, J ANIM ECOL, V65, P339, DOI 10.2307/5880; Fonseca CR, 1999, J TROP ECOL, V15, P807, DOI 10.1017/S0266467499001194; Frederickson ME, 2006, OECOLOGIA, V149, P418, DOI 10.1007/s00442-006-0460-x; GREENE DF, 1992, AM NAT, V139, P825, DOI 10.1086/285359; Greene DF, 2002, DISPERSAL ECOLOGY, P3; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Holldobler B., 1990, pi; Izzo TJ, 2009, INSECT SOC, V56, P341, DOI 10.1007/s00040-009-0029-x; Lapola DM, 2005, SOCIOBIOLOGY, V46, P433; LONGINO JT, 1991, J NAT HIST, V25, P1571, DOI 10.1080/00222939100770981; LONGINO JT, 1989, BIOTROPICA, V21, P126, DOI 10.2307/2388703; MARKIN G P, 1971, Journal of the Georgia Entomological Society, V6, P145; Michelanceli FA, 2000, SYST BOT, V25, P211, DOI 10.2307/2666640; Nathan R, 2002, NATURE, V418, P409, DOI 10.1038/nature00844; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Palmer TM, 2003, AM NAT, V162, pS63, DOI 10.1086/378682; Palmer TM, 2000, OECOLOGIA, V123, P425, DOI 10.1007/s004420051030; Palmer TM, 2010, P NATL ACAD SCI USA, V107, P17234, DOI 10.1073/pnas.1006872107; Pinto SRR, 2010, TROP CONSERV SCI, V3, P389, DOI 10.1177/194008291000300404; R Core Development Team, 2008, R LANG ENV STAT COMP; RIBBENS E, 1994, ECOLOGY, V75, P1794, DOI 10.2307/1939638; SIMBERLOFF DS, 1969, ECOLOGY, V50, P278, DOI 10.2307/1934856; Stanton ML, 1999, NATURE, V401, P578, DOI 10.1038/44119; Stanton ML, 2002, ECOL MONOGR, V72, P347, DOI 10.1890/0012-9615(2002)072[0347:CCTOIA]2.0.CO;2; STEEL RG, 1961, BIOMETRICS, V17, P539, DOI 10.2307/2527854; Suni SS, 2010, HEREDITY, V104, P168, DOI 10.1038/hdy.2009.124; Tackenberg O, 2003, ECOL MONOGR, V73, P173, DOI 10.1890/0012-9615(2003)073[0173:MLDOPD]2.0.CO;2; Trager MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014308; Turke M, 2010, ECOL ENTOMOL, V35, P662, DOI 10.1111/j.1365-2311.2010.01222.x; Vasconcelos HL, 2000, BIOTROPICA, V32, P100, DOI 10.1111/j.1744-7429.2000.tb00452.x; VASCONCELOS HL, 1991, OECOLOGIA, V87, P295, DOI 10.1007/BF00325269; VASCONCELOS HL, 1993, OECOLOGIA, V95, P439, DOI 10.1007/BF00321000; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P7411, DOI 10.1073/pnas.0502264102; Yu DW, 2004, J ANIM ECOL, V73, P1102, DOI 10.1111/j.0021-8790.2004.00877.x; Yu DW, 2001, AM NAT, V158, P49, DOI 10.1086/320865; Yu DW, 2001, ECOLOGY, V82, P1761, DOI 10.1890/0012-9658(2001)082[1761:AEMOSC]2.0.CO;2; Yu DW, 1997, ECOL MONOGR, V67, P273, DOI 10.1890/0012-9615(1997)067[0273:ESOSSI]2.0.CO;2	51	20	20	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22937	10.1371/journal.pone.0022937	http://dx.doi.org/10.1371/journal.pone.0022937			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826219	Green Published, gold			2022-12-25	WOS:000293558900045
J	Chentouf, M; Dubois, G; Jahannaut, C; Castex, F; Lajoix, AD; Gross, R; Peraldi-Roux, S				Chentouf, Myriam; Dubois, Gregor; Jahannaut, Celine; Castex, Francoise; Lajoix, Anne Dominique; Gross, Rene; Peraldi-Roux, Sylvie			Excessive Food Intake, Obesity and Inflammation Process in Zucker fa/fa Rat Pancreatic Islets	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; BETA-CELL; INSULIN-SECRETION; SIGNAL-TRANSDUCTION; INTERLEUKIN-1; INHIBITION; LANGERHANS; ACTIVATION; PATHWAY; GLUCOSE	Inappropriate food intake-related obesity and more importantly, visceral adiposity, are major risk factors for the onset of type 2 diabetes. Evidence is emerging that nutriment-induced beta-cell dysfunction could be related to indirect induction of a state of low grade inflammation. Our aim was to study whether hyperphagia associated obesity could promote an inflammatory response in pancreatic islets leading to beta-cell dysfunction. In the hyperphagic obese insulin resistant male Zucker rat, we measured the level of circulating pro-inflammatory cytokines and estimated their production as well as the expression of their receptors in pancreatic tissue and beta-cells. Our main findings concern intra-islet pro-inflammatory cytokines from fa/fa rats: IL-1 beta, IL-6 and TNF alpha expressions were increased; IL-1R1 was also over-expressed with a cellular redistribution also observed for IL-6R. To get insight into the mechanisms involved in phenotypic alterations, abArrays were used to determine the expression profile of proteins implicated in different membrane receptors signaling, apoptosis and cell cycle pathways. Despite JNK overexpression, cell viability was unaffected probably because of decreases in cleaved caspase3 as well as in SMAC/DIABLO and APP, involved in the induction and amplification of apoptosis. Concerning beta-cell proliferation, decreases in important cell cycle regulators (Cyclin D1, p35) and increased expression of SMAD4 probably contribute to counteract and restrain hyperplasia in fa/fa rat islets. Finally and probably as a result of IL-1 beta and IL-1R1 increased expressions with sub-cellular redistribution of the receptor, islets from fa/fa rats were found more sensitive to both stimulating and inhibitory concentrations of the cytokine; this confers some physiopathological relevance to a possible autocrine regulation of beta-cell function by IL-1 beta. These results support the hypothesis that pancreatic islets from prediabetic fa/fa rats undergo an inflammatory process. That the latter could contribute to beta-cell hyperactivity/proliferation and possibly lead to progressive beta-cell failure in these animals, deserves further investigations.	[Chentouf, Myriam; Jahannaut, Celine; Castex, Francoise; Lajoix, Anne Dominique; Gross, Rene; Peraldi-Roux, Sylvie] Fac Pharm Montpellier, Ctr Natl Rech Sci Format Rech Evolut 3400, Ctr Pharmacol & Innovat Diabete, F-34060 Montpellier, France; [Dubois, Gregor] Fac Pharm Montpellier, Inst Rech Dev, Unite Mixte Rech, F-34060 Montpellier, France	Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Chentouf, M (corresponding author), Fac Pharm Montpellier, Ctr Natl Rech Sci Format Rech Evolut 3400, Ctr Pharmacol & Innovat Diabete, F-34060 Montpellier, France.	sylvie.roux@univ-montp1.fr		Gross, Rene/0000-0001-5884-3607	Alfediam-BD	Alfediam-BD	The work was supported by Alfediam-BD grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENDTZEN K, 1986, SCIENCE, V232, P1545, DOI 10.1126/science.3086977; Boni-Schnetzler M, 2008, J CLIN ENDOCR METAB, V93, P4065, DOI 10.1210/jc.2008-0396; BORG LAH, 1990, IMMUNOL LETT, V26, P253, DOI 10.1016/0165-2478(90)90155-J; Buckingham RE, 1998, DIABETES, V47, P1326, DOI 10.2337/diabetes.47.8.1326; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; CAMPBELL IL, 1989, J IMMUNOL, V143, P1188; Chandrasekar B, 2003, BIOCHEM J, V373, P547, DOI 10.1042/BJ20030207; Chen AR, 2005, OBES RES, V13, P1311, DOI 10.1038/oby.2005.159; Choi SE, 2004, TRANSPL IMMUNOL, V13, P43, DOI 10.1016/j.trim.2004.04.001; CORBETT JA, 1993, P NATL ACAD SCI USA, V90, P1731, DOI 10.1073/pnas.90.5.1731; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Donath MY, 2005, DIABETES, V54, pS108, DOI 10.2337/diabetes.54.suppl_2.S108; Donath MY, 2003, J MOL MED-JMM, V81, P455, DOI 10.1007/s00109-003-0450-y; EIZIRIK DL, 1995, MOL CELL ENDOCRINOL, V111, P159, DOI 10.1016/0303-7207(95)03561-K; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Ellingsgaard H, 2008, P NATL ACAD SCI USA, V105, P13163, DOI 10.1073/pnas.0801059105; HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271; Jia DM, 2005, METABOLISM, V54, P619, DOI 10.1016/j.metabol.2004.12.005; Kristiansen OP, 2005, DIABETES, V54, pS114, DOI 10.2337/diabetes.54.suppl_2.S114; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Lee Yong-Ho, 2005, Curr Diab Rep, V5, P70; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Maedler K, 2008, DIABETES OBES METAB, V10, P408, DOI 10.1111/j.1463-1326.2007.00718.x; Maedler K, 2006, DIABETES, V55, P2713, DOI 10.2337/db05-1430; Maedler K, 2009, EXPERT OPIN BIOL TH, V9, P1177, DOI 10.1517/14712590903136688; MANDRUPPOULSEN T, 1985, ALLERGY, V40, P424, DOI 10.1111/j.1398-9995.1985.tb02681.x; MandrupPoulsen T, 1996, DIABETOLOGIA, V39, P1005, DOI 10.1007/BF00400649; McGillicuddy FC, 2009, J BIOL CHEM, V284, P31936, DOI 10.1074/jbc.M109.061655; MINE T, 2004, DIABETES S2, V53, pA2475; Nunez G, 1998, ONCOGENE, V17, P3237, DOI 10.1038/sj.onc.1202581; SANDLER S, 1991, AUTOIMMUNITY, V10, P241, DOI 10.3109/08916939109001895; Sjoholm A, 2006, DIABETES-METAB RES, V22, P4, DOI 10.1002/dmrr.568; SOUTHERN C, 1990, FEBS LETT, V276, P42, DOI 10.1016/0014-5793(90)80502-A; SPINAS GA, 1988, ACTA ENDOCRINOL-COP, V119, P307, DOI 10.1530/acta.0.1190307; Wang XQ, 2009, NEUROSCI LETT, V450, P122, DOI 10.1016/j.neulet.2008.11.051; WELSH N, 1991, ENDOCRINOLOGY, V129, P3167, DOI 10.1210/endo-129-6-3167; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; ZAWALICH WS, 1986, DIABETES, V35, P1119, DOI 10.2337/diabetes.35.10.1119	38	23	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22954	10.1371/journal.pone.0022954	http://dx.doi.org/10.1371/journal.pone.0022954			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826222	Green Published, gold, Green Submitted			2022-12-25	WOS:000293558900048
J	Chiang, CY; Liu, SJ; Tsai, JP; Li, YS; Chen, MY; Liu, HH; Chong, P; Leng, CH; Chen, HW				Chiang, Chen-Yi; Liu, Shih-Jen; Tsai, Jy-Ping; Li, Yi-Shiuan; Chen, Mei-Yu; Liu, Hsueh-Hung; Chong, Pele; Leng, Chih-Hsiang; Chen, Hsin-Wei			A Novel Single-Dose Dengue Subunit Vaccine Induces Memory Immune Responses	PLOS ONE			English	Article							DOMAIN-III PROTEIN; NF-KAPPA-B; ENVELOPE PROTEIN; NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODY; VIRUS-VACCINE; NONHUMAN-PRIMATES; CRYSTAL-STRUCTURE; E-GLYCOPROTEIN; CELL-CULTURE	To protect against dengue viral infection, a novel lipidated dengue subunit vaccine was rationally designed to contain the consensus amino acid sequences derived from four serotypes of dengue viruses. We found that the lipidated consensus dengue virus envelope protein domain III (LcED III) is capable of activating antigen-presenting cells and enhancing cellular and humoral immune responses. A single-dose of LcED III immunization in mice without extra adjuvant formulation is sufficient to elicit neutralizing antibodies against all four serotypes of dengue viruses. In addition, strong memory responses were elicited in mice immunized with a single-dose of LcED III. Quick, anamnestic neutralizing antibody responses to a live dengue virus challenge were elicited at week 28 post-immunization. These results demonstrate the promising possibility of a future successful tetravalent vaccine against dengue viral infections that utilizes one-dose vaccination with LcED III.	[Chiang, Chen-Yi; Liu, Shih-Jen; Tsai, Jy-Ping; Li, Yi-Shiuan; Chen, Mei-Yu; Liu, Hsueh-Hung; Chong, Pele; Leng, Chih-Hsiang; Chen, Hsin-Wei] Natl Hlth Res Inst, Vaccine Res & Dev Ctr, Zhunan, Miaoli, Taiwan; [Liu, Shih-Jen; Chong, Pele; Leng, Chih-Hsiang; Chen, Hsin-Wei] China Med Univ, Grad Inst Immunol, Taichung, Taiwan	National Health Research Institutes - Taiwan; China Medical University Taiwan	Chiang, CY (corresponding author), Natl Hlth Res Inst, Vaccine Res & Dev Ctr, Zhunan, Miaoli, Taiwan.	leoleng@nhri.org.tw; chenhw@nhri.org.tw	Leng, Chih-Hsiang/E-3874-2010; Liu, Shih-Jen/E-3942-2010; Liu, Shih-Jen/AAV-1931-2021; Chong, Pele/E-3855-2010; Chen, Hsin-Wei/ABA-7436-2021; Chen, Hsin-Wei/C-3304-2009	Liu, Shih-Jen/0000-0002-8736-1452; Chen, Hsin-Wei/0000-0002-3207-2397; 	National Health Research Institutes [98A1-VC-PP-07-014, 99A1-VC-PP-07-014]	National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan)	This study was supported by grants 98A1-VC-PP-07-014 and 99A1-VC-PP-07-014 from the National Health Research Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angsubhakorn Subhkij, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P554; Babu JP, 2008, VACCINE, V26, P4655, DOI 10.1016/j.vaccine.2008.07.006; Bernardo L, 2008, ARCH VIROL, V153, P849, DOI 10.1007/s00705-008-0050-9; Blaney JE, 2008, VACCINE, V26, P817, DOI 10.1016/j.vaccine.2007.11.082; Block OKT, 2010, VACCINE, V28, P8085, DOI 10.1016/j.vaccine.2010.10.004; Brandler S, 2010, VACCINE, V28, P6730, DOI 10.1016/j.vaccine.2010.07.073; Bray M, 1996, J VIROL, V70, P4162, DOI 10.1128/JVI.70.6.4162-4166.1996; Chambers TJ, 1997, VACCINE, V15, P1494, DOI 10.1016/S0264-410X(97)00195-3; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Chen HW, 2009, VACCINE, V27, P1400, DOI 10.1016/j.vaccine.2008.12.043; Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; Clements DE, 2010, VACCINE, V28, P2705, DOI 10.1016/j.vaccine.2010.01.022; Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001; EDELMAN R, 1994, J INFECT DIS, V170, P1448, DOI 10.1093/infdis/170.6.1448; GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55; Guzman MG, 2010, EXPERT REV VACCINES, V9, P137, DOI [10.1586/erv.09.139, 10.1586/ERV.09.139]; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Hermida L, 2006, VACCINE, V24, P3165, DOI 10.1016/j.vaccine.2006.01.036; Hiramatsu K, 1996, VIROLOGY, V224, P437, DOI 10.1006/viro.1996.0550; HOKE CH, 1990, AM J TROP MED HYG, V43, P219, DOI 10.4269/ajtmh.1990.43.219; Hung JJ, 2004, J VIROL, V78, P378, DOI 10.1128/JVI.78.1.378-388.2004; Khanam S, 2006, VACCINE, V24, P6513, DOI 10.1016/j.vaccine.2006.06.031; Khanam S, 2009, VACCINE, V27, P6011, DOI 10.1016/j.vaccine.2009.07.073; Kinney RM, 1997, VIROLOGY, V230, P300, DOI 10.1006/viro.1997.8500; Konishi E, 2006, VACCINE, V24, P2200, DOI 10.1016/j.vaccine.2005.11.002; Lazo L, 2007, VACCINE, V25, P1064, DOI 10.1016/j.vaccine.2006.09.068; Leng CH, 2010, MOL IMMUNOL, V47, P2015, DOI 10.1016/j.molimm.2010.04.012; Leng CH, 2009, MICROBES INFECT, V11, P288, DOI 10.1016/j.micinf.2008.12.004; Men RH, 1996, J VIROL, V70, P3930, DOI 10.1128/JVI.70.6.3930-3937.1996; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005; Mota J, 2005, VACCINE, V23, P3469, DOI 10.1016/j.vaccine.2004.12.028; Nayak V, 2009, J VIROL, V83, P4338, DOI 10.1128/JVI.02574-08; Putnak JR, 2005, VACCINE, V23, P4442, DOI 10.1016/j.vaccine.2005.03.042; Putnak R, 1996, AM J TROP MED HYG, V55, P504; Raviprakash K, 2003, VIROLOGY, V315, P345, DOI 10.1016/S0042-6822(03)00542-7; Roehrig JT, 1998, VIROLOGY, V246, P317, DOI 10.1006/viro.1998.9200; ROEHRIG JT, 1994, VIROLOGY, V198, P31, DOI 10.1006/viro.1994.1005; Shimizu T, 2008, INFECT IMMUN, V76, P3672, DOI 10.1128/IAI.00257-08; Tawaratsumida K, 2009, J BIOL CHEM, V284, P9147, DOI 10.1074/jbc.M900429200; Thakran S, 2008, J BIOL CHEM, V283, P3751, DOI 10.1074/jbc.M706854200; Thullier P, 2001, J GEN VIROL, V82, P1885, DOI 10.1099/0022-1317-82-8-1885; TRIRAWATANAPONG T, 1992, GENE, V116, P139, DOI 10.1016/0378-1119(92)90509-N; Valdes I, 2009, VACCINE, V27, P995, DOI 10.1016/j.vaccine.2008.11.106; Vaughn DW, 1996, VACCINE, V14, P329, DOI 10.1016/0264-410X(95)00167-Y; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690	46	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e23319	10.1371/journal.pone.0023319	http://dx.doi.org/10.1371/journal.pone.0023319			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826249	gold, Green Published, Green Submitted			2022-12-25	WOS:000293558900075
J	Latzin, P; Frey, U; Armann, J; Kieninger, E; Fuchs, O; Roosli, M; Schaub, B				Latzin, Philipp; Frey, Urs; Armann, Jakob; Kieninger, Elisabeth; Fuchs, Oliver; Roeoesli, Martin; Schaub, Bianca			Exposure to Moderate Air Pollution during Late Pregnancy and Cord Blood Cytokine Secretion in Healthy Neonates	PLOS ONE			English	Article							BIRTH COHORT; ORGANIC-COMPOUNDS; IMMUNE-RESPONSES; MATERNAL SMOKING; ASTHMA; CHILDREN; CELLS; PM10; MACROPHAGES; DISEASE	Background/Objectives: Ambient air pollution can alter cytokine concentrations as shown in vitro and following short-term exposure to high air pollution levels in vivo. Exposure to pollution during late pregnancy has been shown to affect fetal lymphocytic immunophenotypes. However, effects of prenatal exposure to moderate levels of air pollutants on cytokine regulation in cord blood of healthy infants are unknown. Methods: In a birth cohort of 265 healthy term-born neonates, we assessed maternal exposure to particles with an aerodynamic diameter of 10 mu m or less (PM(10)), as well as to indoor air pollution during the last trimester, specifically the last 21, 14, 7, 3 and 1 days of pregnancy. As a proxy for traffic-related air pollution, we determined the distance of mothers' homes to major roads. We measured cytokine and chemokine levels (MCP-1, IL-6, IL-10, IL-1 beta, TNF-alpha and GM-CSF) in cord blood serum using LUMINEX technology. Their association with pollution levels was assessed using regression analysis, adjusted for possible confounders. Results: Mean (95%-CI) PM(10) exposure for the last 7 days of pregnancy was 18.3 (10.3-38.4 mu g/m(3)). PM(10) exposure during the last 3 days of pregnancy was significantly associated with reduced IL-10 and during the last 3 months of pregnancy with increased IL-1 beta levels in cord blood after adjustment for relevant confounders. Maternal smoking was associated with reduced IL-6 levels. For the other cytokines no association was found. Conclusions: Our results suggest that even naturally occurring prenatal exposure to moderate amounts of indoor and outdoor air pollution may lead to changes in cord blood cytokine levels in a population based cohort.	[Latzin, Philipp; Frey, Urs; Kieninger, Elisabeth; Fuchs, Oliver] Univ Bern, Inselspital, Dept Paediat, Div Resp Med, CH-3010 Bern, Switzerland; [Frey, Urs; Fuchs, Oliver] Univ Basel, Univ Childrens Hosp UKBB, Basel, Switzerland; [Armann, Jakob; Schaub, Bianca] Univ Munich, Univ Childrens Hosp Munich, Dept Allergy & Pulm, Munich, Germany; [Roeoesli, Martin] Univ Basel, Swiss Trop & Publ Hlth Inst, Basel, Switzerland	University of Bern; University Hospital of Bern; University of Basel; University of Munich; University of Basel; Swiss Tropical & Public Health Institute	Latzin, P (corresponding author), Univ Bern, Inselspital, Dept Paediat, Div Resp Med, CH-3010 Bern, Switzerland.	Bianca.Schaub@med.uni-muenchen.de	Röösli, Martin/A-2658-2008; Schaub, Bianca/B-9935-2019; Latzin, Philipp/F-2206-2017	Röösli, Martin/0000-0002-7475-1531; Schaub, Bianca/0000-0003-1652-8873; Latzin, Philipp/0000-0002-5239-1571	OMNIBUS; MUG; SNF [3200-052197.97/1]; Swiss Federal Office of Public Health	OMNIBUS; MUG; SNF; Swiss Federal Office of Public Health	This work was supported by Stiftung OMNIBUS, MUG (BS), SNF grant 3200-052197.97/1 (to PL, OF and UF) and Swiss Federal Office of Public Health (Anti-Tobacco Fund to UF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandrini F, 2009, AM J RESP CRIT CARE, V179, P984, DOI 10.1164/rccm.200807-1061OC; Alfaro-Moreno E, 2008, EUR RESPIR J, V32, P1184, DOI 10.1183/09031936.00044008; Bayer-Oglesby L, 2006, AM J EPIDEMIOL, V164, P1190, DOI 10.1093/aje/kwj338; Brauer M, 2007, EUR RESPIR J, V29, P879, DOI 10.1183/09031936.00083406; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Brown DM, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-29; Charpin D, 2009, B ACAD NAT MED PARIS, V193, P1317, DOI 10.1016/S0001-4079(19)32470-7; FUCHS O, 2011, INT J EPIDEMIOL 0113; GEHRING U, 2009, AM J RESP CRIT CARE; Gilliland F, 2005, ENVIRON HEALTH PERSP, V113, P1447, DOI 10.1289/ehp.7673; Glinianaia SV, 2004, ENVIRON HEALTH PERSP, V112, P1365, DOI 10.1289/ehp.6857; Gold DR, 2006, J ALLERGY CLIN IMMUN, V117, P931, DOI 10.1016/j.jaci.2005.12.1322; Herberth G, 2009, PEDIAT ALLERG IMM-UK, V20, P563, DOI 10.1111/j.1399-3038.2008.00819.x; HERR CE, ENV HLTH, V9, P46; HERR CE, PEDIAT ALLERGY IMMUN, V22, P75; Hertz-Picciotto I, 2005, ENVIRON HEALTH PERSP, V113, P1391, DOI 10.1289/ehp.7610; Hertz-Picciotto I, 2008, BASIC CLIN PHARMACOL, V102, P146, DOI 10.1111/j.1742-7843.2007.00190.x; Ishii H, 2004, AM J PHYSIOL-LUNG C, V287, pL176, DOI 10.1152/ajplung.00290.2003; Jerrett M, 2008, ENVIRON HEALTH PERSP, V116, P1433, DOI 10.1289/ehp.10968; Kim H, 2009, CURR ALLERGY ASTHM R, V9, P128, DOI 10.1007/s11882-009-0019-0; Kramer U, 2009, J DERMATOL SCI, V56, P99, DOI 10.1016/j.jdermsci.2009.07.014; Latzin P, 2009, EUR RESPIR J, V33, P594, DOI 10.1183/09031936.00084008; Le Souef PN, 2006, EUR RESPIR J, V28, P675, DOI 10.1183/09031936.06.00101206; Lehmann I, 2002, ENVIRON TOXICOL, V17, P203, DOI 10.1002/tox.10055; Lundborg M, 2007, ENVIRON RES, V104, P250, DOI 10.1016/j.envres.2007.01.002; Ly NP, 2007, PEDIATRICS, V119, pE171, DOI 10.1542/peds.2006-0524; McConnell R, 2006, ENVIRON HEALTH PERSP, V114, P766, DOI 10.1289/ehp.8594; McCreanor J, 2007, NEW ENGL J MED, V357, P2348, DOI 10.1056/NEJMoa071535; MIYAKE Y, 2009, PEDIAT ALLERGY IMMUN; Noakes PS, 2006, EUR RESPIR J, V28, P721, DOI 10.1183/09031936.06.00050206; Peters JL, 2009, J ALLERGY CLIN IMMUN, V123, P1041, DOI 10.1016/j.jaci.2009.02.027; RAMIEZ EM, 2006, REV ALERG MEX, V53, P3; Roosli M, 2008, BIOELECTROMAGNETICS, V29, P471, DOI 10.1002/bem.20417; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; Schaub B, 2008, J ALLERGY CLIN IMMUN, V121, P1491, DOI 10.1016/j.jaci.2008.04.010; Schaub Bianca, 2009, J Allergy Clin Immunol, V123, P774, DOI 10.1016/j.jaci.2009.01.056; Schmid JMP, 2007, PEDIATR RES, V61, P462, DOI 10.1203/pdr.0b013e3180332d02; van Eeden SF, 2002, J TOXICOL ENV HEAL A, V65, P1597, DOI 10.1080/00984100290071685; van Eeden SF, 2001, AM J RESP CRIT CARE, V164, P826, DOI 10.1164/ajrccm.164.5.2010160; Wang Lei, 2007, Birth Defects Research, V81, P144, DOI 10.1002/bdrc.20097; Willwerth BM, 2006, ANN ALLERG ASTHMA IM, V96, P445, DOI 10.1016/S1081-1206(10)60912-X; Wright RJ, 2010, AM J RESP CRIT CARE, V182, P25, DOI 10.1164/rccm.200904-0637OC	42	53	53	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e23130	10.1371/journal.pone.0023130	http://dx.doi.org/10.1371/journal.pone.0023130			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826232	Green Published, Green Submitted, gold			2022-12-25	WOS:000293558900058
J	Liu, WH; Tao, KS; You, N; Liu, ZC; Zhang, HT; Dou, KF				Liu, Wei-hui; Tao, Kai-shan; You, Nan; Liu, Zheng-cai; Zhang, Hong-tao; Dou, Ke-feng			Differences in the Properties and Mirna Expression Profiles between Side Populations from Hepatic Cancer Cells and Normal Liver Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; EMBRYONIC STEM-CELLS; HEPATOCELLULAR-CARCINOMA; STEM/PROGENITOR CELLS; OVARIAN-CANCER; FETAL LIVER; MICRORNA SIGNATURES; PANCREATIC-CANCER; CYCLE REGULATION; BREAST-CANCER	Aims: Because hepatic cancer stem cells (HCSCs) are believed to derive from the conversion of hepatic normal stem cells (HNSCs), the identification of the differences that distinguish HCSCs from HNSCs is important. Methods: The HCC model was established in F344 rats by DEN induction. Using FACS analysis, side population cells from HCC (SP-HCCs) were isolated from the epithelial-like cells of HCC tissues, and the side population cells from normal liver (SP-NLCs) were isolated from syngeneic normal liver cells. The expression of stem cell markers was detected in both freshly isolated and amplified subpopulations. After induction with HGF, the differentiation of each subpopulation was analyzed by detection of early and late liver markers. In vivo, the biological characteristics of SP-HCCs and SP-NLCs were analyzed by repairing injured livers or forming tumors in nude mice. In addition, the expression of miRNAs was examined in both populations by miRNA array and QRT-PCR. Results: SP-NLCs and SP-HCCs were 4.30 +/- 0.011% and 2.100 +/- 0.010% of the whole population, respectively. Both SP-NLCs and SP-HCCs displayed greater expression of stem cell markers (CD133 and EpCAM) than NSP-NLCs and NSP-HCCs, respectively (P < 0.01), both after fresh isolation and amplification. Upon HGF induction, SP-NLCs generated many ALB positive cells and few CK-7 positive cells, but NSP-NLCs could generate only ALB positive cells. In contrast, SP-HCCs gave rise to only AFP positive cells. As few as 5x10(5) SP-NLCs were capable of repairing liver injury, while the same number of NSP-NLCs could not repair the liver. Furthermore, only 1x10(4) SP-HCCs were necessary to initiate a tumor, while NSP-HCCs could not form a tumor. Compared to SP-NLCs, 68 up-regulated and 10 down-regulated miRNAs were present in SP-HCCs (P, 0.01). Conclusion: Based on the decisive roles of some miRNAs in the genesis of HCSCs, miRNAs may contribute to the different characteristics that distinguish SP-HCCs from SP-NLCs.	[Liu, Wei-hui] Gen Hosp Chengdu Army Reg, PLA Ctr Gen Surg, Chengdu, Sichuan Prov, Peoples R China; [Liu, Wei-hui; Tao, Kai-shan; You, Nan; Liu, Zheng-cai; Zhang, Hong-tao; Dou, Ke-feng] Fourth Mil Med Univ, Xijing Hosp, Dept Hepatobiliary Surg, Xian 710032, Shaanxi Prov, Peoples R China	Air Force Military Medical University	Liu, WH (corresponding author), Gen Hosp Chengdu Army Reg, PLA Ctr Gen Surg, Chengdu, Sichuan Prov, Peoples R China.	doukf2008@yahoo.cn			National Natural Science Foundation of China [30772102]; Nature Science Foundation of Shaanxi Province [2007K09-05(7)]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Shaanxi Province	This study was supported by the National Natural Science Foundation of China (No. 30772102) and Nature Science Foundation of Shaanxi Province (No. 2007K09-05(7)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2010, CANCER RES, V70, P3606, DOI 10.1158/0008-5472.CAN-09-4598; Alison MR, 2005, CELL PROLIFERAT, V38, P407, DOI 10.1111/j.1365-2184.2005.00354.x; Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Arends B, 2009, STEM CELLS DEV, V18, P343, DOI 10.1089/scd.2008.0022; Bandi N, 2009, CANCER RES, V69, P5553, DOI 10.1158/0008-5472.CAN-08-4277; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Beheshti B, 2003, NEOPLASIA, V5, P53, DOI 10.1016/S1476-5586(03)80017-9; Bendoraite A, 2010, GYNECOL ONCOL, V116, P117, DOI 10.1016/j.ygyno.2009.08.009; Bhattacharya R, 2009, CANCER RES, V69, P9090, DOI 10.1158/0008-5472.CAN-09-2552; Bottoni A, 2007, J CELL PHYSIOL, V210, P370, DOI 10.1002/jcp.20832; Cai KM, 2010, INT J MOL MED, V25, P565, DOI 10.3892/ijmm_00000378; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; CANNELL IG, 2010, CELL CYCLE IN PRESS, V9; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chiba T, 2007, GASTROENTEROLOGY, V133, P937, DOI 10.1053/j.gastro.2007.06.016; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; DeSano JT, 2009, AAPS J, V11, P682, DOI 10.1208/s12248-009-9147-7; Fiume L, 2005, J HEPATOL, V43, P645, DOI 10.1016/j.jhep.2005.02.045; Folini M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-12; Forbes SJ, 2006, HEPATOLOGY, V44, P23, DOI 10.1002/hep.21275; Goodell Margaret A, 2005, Curr Protoc Cytom, VChapter 9, DOI 10.1002/0471142956.cy0918s34; Gregory PA, 2011, MOL BIOL CELL, V22, P1686, DOI 10.1091/mbc.E11-02-0103; Gunaratne PH, 2009, CURR STEM CELL RES T, V4, P168, DOI 10.2174/157488809789057400; Guo CJ, 2009, J HEPATOL, V50, P766, DOI 10.1016/j.jhep.2008.11.025; Hadnagy A, 2006, EXP CELL RES, V312, P3701, DOI 10.1016/j.yexcr.2006.08.030; HAGMAN Z, 2010, INT J CANC IN PRESS; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Herr I, 2007, INT J CANCER, V121, P1875, DOI 10.1002/ijc.23041; HOHNE MW, 1993, MOL CARCINOGEN, V7, P180, DOI 10.1002/mc.2940070308; Hussain SZ, 2005, DIGEST DIS SCI, V50, P1755, DOI 10.1007/s10620-005-2933-x; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Ji JF, 2009, HEPATOLOGY, V50, P472, DOI 10.1002/hep.22989; Johnnidis Jonathan B., 2008, V430, P183, DOI 10.1007/978-1-59745-182-6_13; Kaddar T, 2009, BIOL CELL, V101, P511, DOI 10.1042/BC20080213; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Meeson AP, 2004, STEM CELLS, V22, P1305, DOI 10.1634/stemcells.2004-0077; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Mirnezami AHF, 2009, EJSO-EUR J SURG ONC, V35, P339, DOI 10.1016/j.ejso.2008.06.006; Moriarty CH, 2010, J BIOL CHEM, V285, P20541, DOI 10.1074/jbc.M110.121012; Nava S, 2005, DIFFERENTIATION, V73, P249, DOI 10.1111/j.1432-0436.2005.00019.x; O'Hara SP, 2010, J BIOL CHEM, V285, P216, DOI 10.1074/jbc.M109.041640; Oertel M, 2006, GASTROENTEROLOGY, V130, P507, DOI 10.1053/j.gastro.2005.10.049; Oertel M, 2008, GASTROENTEROLOGY, V134, P823, DOI 10.1053/j.gastro.2008.01.007; OKUDA K, 1984, HEPATOLOGY, V4, pS3, DOI 10.1002/hep.1840040703; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Pogribny IP, 2007, MUTAT RES-FUND MOL M, V619, P30, DOI 10.1016/j.mrfmmm.2006.12.006; Riggi N, 2010, GENE DEV, V24, P916, DOI 10.1101/gad.1899710; Rogler CE, 2009, GASTROENTEROLOGY, V136, P770, DOI 10.1053/j.gastro.2009.01.022; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; SASAKI Y, 1992, SURGERY, V112, P515; Sengupta S, 2009, STEM CELLS, V27, P1524, DOI 10.1002/stem.84; SHI L, 2010, BRAIN RES IN PRESS; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Spaderna Simone, 2009, Gastroenterology, V136, P1835, DOI 10.1053/j.gastro.2009.03.009; Sui WG, 2008, TRANSPL IMMUNOL, V19, P81, DOI 10.1016/j.trim.2008.01.007; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; TRICHOPOULOS D, 1987, INT J CANCER, V39, P283, DOI 10.1002/ijc.2910390303; Uchida N, 2001, J CLIN INVEST, V108, P1071, DOI 10.1172/JCI13297; Voorhoeve PM, 2007, BBA-REV CANCER, V1775, P274, DOI 10.1016/j.bbcan.2006.11.003; Wang YM, 2009, CANCER RES, V69, P4093, DOI 10.1158/0008-5472.CAN-09-0309; Wang YL, 2009, CURR OPIN MOL THER, V11, P292; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Xia HP, 2010, BIOCHEM BIOPH RES CO, V391, P535, DOI 10.1016/j.bbrc.2009.11.093; Yang N, 2008, CANCER RES, V68, P10307, DOI 10.1158/0008-5472.CAN-08-1954; Yui S, 2010, GASTROENTEROLOGY, V138, pS116; Zender L, 2005, COLD SH Q B, V70, P251, DOI 10.1101/sqb.2005.70.059; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zheng L, 2010, J GASTROEN HEPATOL, V25, P156, DOI 10.1111/j.1440-1746.2009.05949.x; Zhu H, 2008, BIOCHEM PHARMACOL, V76, P582, DOI 10.1016/j.bcp.2008.06.007	77	22	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e23311	10.1371/journal.pone.0023311	http://dx.doi.org/10.1371/journal.pone.0023311			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826246	Green Submitted, Green Published, gold			2022-12-25	WOS:000293558900072
J	Schmidt, H; Mesters, JR; Wu, J; Woodard, RW; Hilgenfeld, R; Mamat, U				Schmidt, Helgo; Mesters, Jeroen R.; Wu, Jing; Woodard, Ronald W.; Hilgenfeld, Rolf; Mamat, Uwe			Evidence for a Two-Metal-Ion Mechanism in the Cytidyltransferase KdsB, an Enzyme Involved in Lipopolysaccharide Biosynthesis	PLOS ONE			English	Article							CMP-2-KETO-3-DEOXY-MANNO-OCTONIC ACID SYNTHETASE; CMP-KDO SYNTHETASE; ESCHERICHIA-COLI; NEISSERIA-MENINGITIDIS; 8-PHOSPHATE SYNTHASE; CATALYTIC MECHANISM; CYTIDYLYLTRANSFERASE; COMPLEXES; PURIFICATION; POLYMERASES	Lipopolysaccharide (LPS) is located on the surface of Gram-negative bacteria and is responsible for maintaining outer membrane stability, which is a prerequisite for cell survival. Furthermore, it represents an important barrier against hostile environmental factors such as antimicrobial peptides and the complement cascade during Gram-negative infections. The sugar 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo) is an integral part of LPS and plays a key role in LPS functionality. Prior to its incorporation into the LPS molecule, Kdo has to be activated by the CMP-Kdo synthetase (CKS). Based on the presence of a single Mg2+ ion in the active site, detailed models of the reaction mechanism of CKS have been developed previously. Recently, a two-metal-ion hypothesis suggested the involvement of two Mg2+ ions in Kdo activation. To further investigate the mechanistic aspects of Kdo activation, we kinetically characterized the CKS from the hyperthermophilic organism Aquifex aeolicus. In addition, we determined the crystal structure of this enzyme at a resolution of 2.10 angstrom and provide evidence that two Mg2+ ions are part of the active site of the enzyme.	[Schmidt, Helgo; Mesters, Jeroen R.; Hilgenfeld, Rolf] Univ Lubeck, Inst Biochem, Ctr Struct & Cell Biol Med, Lubeck, Germany; [Wu, Jing; Woodard, Ronald W.] Univ Michigan, Coll Pharm, Dept Med Chem, Ann Arbor, MI 48109 USA; [Hilgenfeld, Rolf] DESY, Lab Struct Biol Infect & Inflammat, D-2000 Hamburg, Germany; [Hilgenfeld, Rolf] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 200031, Peoples R China; [Mamat, Uwe] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Struct Biochem, Borstel, Germany	University of Lubeck; University of Michigan System; University of Michigan; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Forschungszentrum Borstel	Schmidt, H (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	hilgenfeld@biochem.uni-luebeck.de; umamat@fz-borstel.de	Hilgenfeld, Rolf/C-9675-2011	Mesters, Jeroen/0000-0001-8532-6699; Woodard, Ronald/0000-0002-7472-3653	Deutsche Forschungsgemeinschaft (DFG) [MA 1408/2-1, ME 2741/1-1, EXC 306]; EC [LSH2005-037793]; National Institutes of Health [AI1061531]; Chinese Academy of Sciences [2010T1S6]; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); EC(European CommissionEuropean Commission Joint Research Centre); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Academy of Sciences(Chinese Academy of Sciences); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) (grant MA 1408/2-1 to UM, and grant ME 2741/1-1 to JRM and RH), the OptiCryst project of the EC (LSH2005-037793; www.opticryst.org), and the National Institutes of Health grant AI1061531 (to RWW). RH is supported by a Chinese Academy of Sciences Visiting Professorship for Senior International Scientists, grant no. 2010T1S6, by the DFG Cluster of Excellence "Inflammation at Interfaces" (EXC 306), as well as by the Fonds der Chemischen Industrie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badger J, 2005, PROTEINS, V60, P787, DOI 10.1002/prot.20541; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; Castro C, 2009, NAT STRUCT MOL BIOL, V16, P212, DOI 10.1038/nsmb.1540; DOTSON GD, 1993, BIOCHEMISTRY-US, V32, P12392, DOI 10.1021/bi00097a017; EDWARDS U, 1992, FEMS MICROBIOL LETT, V96, P161; FINKE A, 1989, J BACTERIOL, V171, P3074, DOI 10.1128/jb.171.6.3074-3079.1989; GABRIEL O, 1982, METHOD ENZYMOL, V83, P332; GHALAMBOR MA, 1966, J BIOL CHEM, V241, P3216; HAMMOND SM, 1987, NATURE, V327, P730, DOI 10.1038/327730a0; Heyes DJ, 2009, J BIOL CHEM, V284, P35514, DOI 10.1074/jbc.M109.056630; Holst O, 2002, TRENDS GLYCOSCI GLYC, V14, P87, DOI 10.4052/tigg.14.87; Horsfall LE, 2010, FEBS J, V277, P2779, DOI 10.1111/j.1742-4658.2010.07696.x; Jelakovic S, 2002, BIOCHEMISTRY-US, V41, P1174, DOI 10.1021/bi0119060; Jelakovic S, 2001, J MOL BIOL, V312, P143, DOI 10.1006/jmbi.2001.4948; Jelakovic S, 1996, FEBS LETT, V391, P157, DOI 10.1016/0014-5793(96)00724-7; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kapitonov D, 1999, GLYCOBIOLOGY, V9, P961, DOI 10.1093/glycob/9.10.961; KOHLBRENNER WE, 1985, J BIOL CHEM, V260, P4695; Krapp S, 2003, J MOL BIOL, V334, P625, DOI 10.1016/j.jmb.2003.09.080; Lin CH, 1997, BIOCHEMISTRY-US, V36, P780, DOI 10.1021/bi962055c; Mamat U, 2009, J BIOL CHEM, V284, P22248, DOI 10.1074/jbc.M109.033308; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Meredith TC, 2003, J BIOL CHEM, V278, P32771, DOI 10.1074/jbc.M303661200; Mosimann SC, 2001, J BIOL CHEM, V276, P8190, DOI 10.1074/jbc.M007235200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Radaev S, 2000, J BIOL CHEM, V275, P9476, DOI 10.1074/jbc.275.13.9476; RAY PH, 1981, J BACTERIOL, V145, P1273, DOI 10.1128/JB.145.3.1273-1280.1981; RAY PH, 1982, METHOD ENZYMOL, V83, P535; Roberts IS, 1996, ANNU REV MICROBIOL, V50, P285, DOI 10.1146/annurev.micro.50.1.285; ROSENOW C, 1995, FEMS MICROBIOL LETT, V125, P159, DOI 10.1016/0378-1097(94)00492-A; Royo J, 2000, J BIOL CHEM, V275, P24993, DOI 10.1074/jbc.M905750199; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Tzeng YL, 2002, J BIOL CHEM, V277, P24103, DOI 10.1074/jbc.M200931200; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wu J, 2003, J BIOL CHEM, V278, P18117, DOI 10.1074/jbc.M301983200; Yoon HJ, 2008, ACTA CRYSTALLOGR D, V64, P1292, DOI 10.1107/S0907444908036342	41	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e23231	10.1371/journal.pone.0023231	http://dx.doi.org/10.1371/journal.pone.0023231			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826242	Green Submitted, Green Published, gold			2022-12-25	WOS:000293558900068
J	Xu, CX; Zhao, L; Pan, X; Samaj, J				Xu, Chunxiang; Zhao, Lu; Pan, Xiao; Samaj, Jozef			Developmental Localization and Methylesterification of Pectin Epitopes during Somatic Embryogenesis of Banana (Musa spp. AAA)	PLOS ONE			English	Article							MATRIX SURFACE NETWORK; MONOCLONAL-ANTIBODIES; CELL-WALLS; PLANT-REGENERATION; POLYSACCHARIDES; ESTERIFICATION; CALLUS; DIFFERENTIATION; CONSEQUENCES; SUSPENSIONS	Background: The plant cell walls play an important role in somatic embryogenesis and plant development. Pectins are major chemical components of primary cell walls while homogalacturonan (HG) is the most abundant pectin polysaccharide. Developmental regulation of HG methyl-esterification degree is important for cell adhesion, division and expansion, and in general for proper organ and plant development. Methodology/Principal Findings: Developmental localization of pectic homogalacturonan (HG) epitopes and the (1 -> 4)-beta-D-galactan epitope of rhamnogalacturonan I (RG-I) and degree of pectin methyl-esterification (DM) were studied during somatic embryogenesis of banana (Musa spp. AAA). Histological analysis documented all major developmental stages including embryogenic cells (ECs), pre-globular, globular, pear-shaped and cotyledonary somatic embryos. Histochemical staining of extracellularly secreted pectins with ruthenium red showed the most intense staining at the surface of preglobular, globular and pear-shaped somatic embryos. Biochemical analysis revealed developmental regulation of galacturonic acid content and DM in diverse embryogenic stages. Immunodots and immunolabeling on tissue sections revealed developmental regulation of highly methyl-esterified HG epitopes recognized by JIM7 and LM20 antibodies during somatic embryogenesis. Cell walls of pre-globular/globular and late-stage embryos contained both low methyl-esterified HG epitopes as well as partially and highly methyl-esterified ones. Extracellular matrix which covered surface of early developing embryos contained pectin epitopes recognized by 2F4, LM18, JIM5, JIM7 and LM5 antibodies. De-esterification of cell wall pectins by NaOH caused a decrease or an elimination of immunolabeling in the case of highly methyl-esterified HG epitopes. However, immunolabeling of some low methyl-esterified epitopes appeared stronger after this base treatment. Conclusions/Significance: These data suggest that both low-and highly-methyl-esterified HG epitopes are developmentally regulated in diverse embryogenic stages during somatic embryogenesis. This study provides new information about pectin composition, HG methyl-esterification and developmental localization of pectin epitopes during somatic embryogenesis of banana.	[Xu, Chunxiang; Zhao, Lu; Pan, Xiao] S China Agr Univ, Coll Hort, Guangzhou, Guangdong, Peoples R China; [Samaj, Jozef] Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, Dept Cell Biol, CR-77147 Olomouc, Czech Republic; [Samaj, Jozef] Slovak Acad Sci, Inst Plant Genet & Biotechnol, Nitra, Slovakia	South China Agricultural University; Palacky University Olomouc; Slovak Academy of Sciences	Xu, CX (corresponding author), S China Agr Univ, Coll Hort, Guangzhou, Guangdong, Peoples R China.	jozef.samaj@upol.cz	Samaj, Jozef/AAD-4206-2022	Samaj, Jozef/0000-0003-4750-2123; Xu, Chunxiang/0000-0002-5722-668X	Centre of the Region Hana for Biotechnological and Agricultural Research, Faculty of Science, Palacky University, Olomouc, Czech Republic [ED0007/01/01]; Key Technologies Research and Development Program of Guangdong Province [2010B020305004]; 863 Program [SQ2010AA1000687012]; Guangdong '211' Project [5300-K201088]; NSF [DBI-0421683, RCN-0090281]	Centre of the Region Hana for Biotechnological and Agricultural Research, Faculty of Science, Palacky University, Olomouc, Czech Republic(Czech Republic Government); Key Technologies Research and Development Program of Guangdong Province; 863 Program(National High Technology Research and Development Program of China); Guangdong '211' Project; NSF(National Science Foundation (NSF))	This work was supported by grants Nr. ED0007/01/01 Centre of the Region Hana for Biotechnological and Agricultural Research, Faculty of Science, Palacky University, Olomouc, Czech Republic as well as by Key Technologies Research and Development Program of Guangdong Province (2010B020305004), the 863 Program (SQ2010AA1000687012) and Guangdong '211' Project (5300-K201088). Development and distribution of CCRCM34 and CCRCM38 antibodies was supported in part by NSF grants DBI-0421683 and RCN-0090281. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barany I, 2010, J EXP BOT, V61, P1159, DOI 10.1093/jxb/erp392; [徐春香 Xu Chunxiang], 2004, [植物生理学通讯, Plant Physiology Communications], V40, P293; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; Chapman A, 2000, CAN J BOT, V78, P824, DOI 10.1139/cjb-78-6-824; Clausen MH, 2003, CARBOHYD RES, V338, P1797, DOI 10.1016/S0008-6215(03)00272-6; Dhed'a D., 1991, Fruits (Paris), V46, P125; Eder M, 2008, J MICROSC-OXFORD, V231, P201, DOI 10.1111/j.1365-2818.2008.02036.x; Hoenemann C, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-77; Iwai H, 1999, PLANT CELL REP, V18, P561, DOI 10.1007/s002990050622; JARVIS MC, 1988, PLANT PHYSIOL, V88, P309, DOI 10.1104/pp.88.2.309; Jones L, 1997, PLANT PHYSIOL, V113, P1405, DOI 10.1104/pp.113.4.1405; KIKUCHI A, 1995, PLANT CELL REP, V14, P279, DOI 10.1007/BF00232028; KLAVONS JA, 1986, J AGR FOOD CHEM, V34, P597, DOI 10.1021/jf00070a004; Knox JP, 2008, CURR OPIN PLANT BIOL, V11, P308, DOI 10.1016/j.pbi.2008.03.001; KNOX JP, 1990, PLANTA, V181, P512, DOI 10.1007/BF00193004; Konieczny R, 2005, PLANT CELL TISS ORG, V83, P201, DOI 10.1007/s11240-005-5771-9; Konieczny R, 2007, PLANT CELL REP, V26, P355, DOI 10.1007/s00299-006-0222-6; LINERS F, 1989, PLANT PHYSIOL, V91, P1419, DOI 10.1104/pp.91.4.1419; LINERS F, 1994, PLANTA, V192, P545, DOI 10.1007/BF00203593; LINERS F, 1992, PROTOPLASMA, V170, P10, DOI 10.1007/BF01384453; Louvet R, 2011, PHYTOCHEMISTRY, V72, P59, DOI 10.1016/j.phytochem.2010.10.008; LUFT JH, 1971, ANAT REC, V171, P347, DOI 10.1002/ar.1091710302; Marry M, 2006, PHYSIOL PLANTARUM, V126, P243, DOI 10.1111/j.1399-3054.2006.00591.x; Mastroberti Alexandra Antunes, 2008, Braz. J. Bot., V31, P1, DOI 10.1590/S0100-84042008000100002; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Pan X, 2011, PHYSIOL PLANTARUM, V142, P372, DOI 10.1111/j.1399-3054.2011.01478.x; Pattathil S, 2010, PLANT PHYSIOL, V153, P514, DOI 10.1104/pp.109.151985; Popielarska-Konieczna M, 2008, PLANT CELL REP, V27, P1137, DOI 10.1007/s00299-008-0534-9; Ramirez C, 2004, EUR J CELL BIOL, V83, P213, DOI 10.1078/0171-9335-00368; Ramirez C, 2003, ACTA BIOL CRACOV BOT, V45, P53; Ramirez C, 2001, INT J DEV BIOL, V45, pS57; Samaj J, 1999, J MICROSC-OXFORD, V193, P150, DOI 10.1046/j.1365-2818.1999.00441.x; Samaj J, 2006, PLANT CELL MONOGR, V2, P35, DOI 10.1007/7089_024; SHEVELL DE, 1994, CELL, V77, P1051, DOI 10.1016/0092-8674(94)90444-8; Sobry S, 2005, PROTOPLASMA, V225, P15, DOI 10.1007/s00709-005-0089-3; Solis MT, 2008, PLANT SCI, V174, P597, DOI 10.1016/j.plantsci.2008.03.014; Strosse H, 2006, PLANT SCI, V170, P104, DOI 10.1016/j.plantsci.2005.08.007; Verdeil JL, 2001, ANN BOT-LONDON, V88, P9, DOI 10.1006/anbo.2001.1408; Verhertbruggen Y, 2009, CARBOHYD RES, V344, P1858, DOI 10.1016/j.carres.2008.11.010; Vitha S, 2000, HISTOCHEM J, V32, P457, DOI 10.1023/A:1004171431449; Wietholter N, 2003, CARBOHYD RES, V338, P423, DOI 10.1016/S0008-6215(02)00498-6; Willats WGT, 2001, PLANT MOL BIOL, V47, P9, DOI 10.1023/A:1010662911148; Willats WGT, 2000, CARBOHYD RES, V327, P309, DOI 10.1016/S0008-6215(00)00039-2; Wolf S, 2009, MOL PLANT, V2, P851, DOI 10.1093/mp/ssp066; Xu C.X., 2008, INT J PLANT DEV BIOL, V2, P52; Xu CX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-38; Xu CX, 2005, J HORTIC SCI BIOTECH, V80, P523	48	35	36	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22992	10.1371/journal.pone.0022992	http://dx.doi.org/10.1371/journal.pone.0022992			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826225	Green Published, Green Submitted, gold			2022-12-25	WOS:000293558900051
J	Zhao, SL; Hong, J; Xie, ZQ; Tang, JT; Su, WY; Du, W; Chen, YX; Lu, R; Sun, DF; Fang, JY				Zhao, Shu-Liang; Hong, Jie; Xie, Zuo-Quan; Tang, Jie-Ting; Su, Wen-Yu; Du, Wan; Chen, Ying-Xuan; Lu, Rong; Sun, Dan-Feng; Fang, Jing-Yuan			TRAPPC4-ERK2 Interaction Activates ERK1/2, Modulates Its Nuclear Localization and Regulates Proliferation and Apoptosis of Colorectal Cancer Cells	PLOS ONE			English	Article							SPONDYLOEPIPHYSEAL DYSPLASIA TARDA; TRAPP COMPLEX; MAP KINASE; PROTEIN; GOLGI; SYNDECANS; TRANSPORT; GENE; PHOSPHORYLATION; ARCHITECTURE	The trafficking protein particle complex 4 (TRAPPC4) is implicated in vesicle-mediated transport, but its association with disease has rarely been reported. We explored its potential interaction with ERK2, part of the ERK1/2 complex in the Extracellular Signal-regulated Kinase/Mitogen-activated Protein Kinase (ERK-MAPK) pathway, by a yeast two-hybrid screen and confirmed by co-immunoprecipitation (Co-IP) and glutathione S-transferase (GST) pull-down. Further investigation found that when TRAPPC4 was depleted, activated ERK1/2 specifically decreased in the nucleus, which was accompanied with cell growth suppression and apoptosis in colorectal cancer (CRC) cells. Overexpression of TRAPPC4 promoted cell viability and caused activated ERK1/2 to increase overall, but especially in the nucleus. TRAPPC4 was expressed more highly in the nucleus of CRC cells than in normal colonic epithelium or adenoma which corresponded with nuclear staining of pERK1/2. We demonstrate here that TRAPPC4 may regulate cell proliferation and apoptosis in CRC by interaction with ERK2 and subsequently phosphorylating ERK1/2 as well as modulating the subcellular location of pERK1/2 to activate the relevant signaling pathway.	[Zhao, Shu-Liang; Hong, Jie; Tang, Jie-Ting; Su, Wen-Yu; Du, Wan; Chen, Ying-Xuan; Lu, Rong; Sun, Dan-Feng; Fang, Jing-Yuan] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Shanghai Inst Digest Dis,Dept Gastroenterol, Shanghai 200030, Peoples R China; [Xie, Zuo-Quan] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Div Antitumor Pharmacol, Shanghai 200031, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Zhao, SL (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Shanghai Inst Digest Dis,Dept Gastroenterol, Shanghai 200030, Peoples R China.	jingyuanfang@yahoo.com			National Natural Science Foundation of Key Program [30830055]; National Natural Science Foundation of Youth Program [31000634]; Shanghai Commission for Science and Technology [10ZR1419000]; Shanghai Health Bureau for youth [2009032]; Shanghai Jiao-Tong University School of Medicine Foundation for Science and Technology [09XJ21065]	National Natural Science Foundation of Key Program; National Natural Science Foundation of Youth Program; Shanghai Commission for Science and Technology; Shanghai Health Bureau for youth; Shanghai Jiao-Tong University School of Medicine Foundation for Science and Technology	This work was supported by grants from the National Natural Science Foundation of Key Program (No. 30830055) to J-YF (http://www.nsfc.gov.cn/Portal0/default106.htm) and by the grants from the National Natural Science Foundation of Youth Program to S-LZ (No. 31000634) (http://www.nsfc.gov.cn/Portal0/default106.htm), Shanghai Commission for Science and Technology to S-LZ (No. 10ZR1419000) (http://www.stcsm.gov.cn/structure/index.htm), Shanghai Health Bureau for youth to S-LZ (No. 2009032) (http://wsj.sh.gov.cn/website/), Shanghai Jiao-Tong University School of Medicine Foundation for Science and Technology to S-LZ (09XJ21065) (http://www.shsmu.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; Cai HQ, 2005, J CELL BIOL, V171, P823, DOI 10.1083/jcb.200505145; Calvert PM, 2002, ANN INTERN MED, V137, P603, DOI 10.7326/0003-4819-137-7-200210010-00012; Cao XC, 2000, J CELL BIOL, V149, P55, DOI 10.1083/jcb.149.1.55; Carey DJ, 1997, BIOCHEM J, V327, P1; Chen CH, 2005, EMBO J, V24, P294, DOI 10.1038/sj.emboj.7600510; Chiari R, 1999, CANCER RES, V59, P5785; Ethell IM, 2000, J CELL BIOL, V151, P53, DOI 10.1083/jcb.151.1.53; Fang JY, 2001, J VIROL, V75, P9753, DOI 10.1128/JVI.75.20.9753-9761.2001; Fang JY, 2005, LANCET ONCOL, V6, P322, DOI 10.1016/S1470-2045(05)70168-6; Formstecher E, 2001, DEV CELL, V1, P239, DOI 10.1016/S1534-5807(01)00035-1; Gecz J, 2000, GENOMICS, V69, P242, DOI 10.1006/geno.2000.6326; Gedeon AK, 1999, NAT GENET, V22, P400, DOI 10.1038/11976; Gellad ZF, 2010, GASTROENTEROLOGY, V138, P2177, DOI 10.1053/j.gastro.2010.01.056; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; Glading A, 2007, CANCER RES, V67, P1536, DOI 10.1158/0008-5472.CAN-06-1378; Jedd G, 1997, J CELL BIOL, V137, P563, DOI 10.1083/jcb.137.3.563; Jones S, 2000, MOL BIOL CELL, V11, P4403, DOI 10.1091/mbc.11.12.4403; Kim YG, 2006, CELL, V127, P817, DOI 10.1016/j.cell.2006.09.029; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kummel D, 2008, FEBS LETT, V582, P3729, DOI 10.1016/j.febslet.2008.09.056; Loh E, 2005, J CELL SCI, V118, P1209, DOI 10.1242/jcs.01723; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; Rojo F, 2007, CLIN CANCER RES, V13, P81, DOI 10.1158/1078-0432.CCR-06-1560; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Sacher M, 2001, MOL CELL, V7, P433, DOI 10.1016/S1097-2765(01)00190-3; Sacher M, 2008, TRAFFIC, V9, P2032, DOI 10.1111/j.1600-0854.2008.00833.x; SEGEV N, 1991, SCIENCE, V252, P1553, DOI 10.1126/science.1904626; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; Uyama N, 2006, GUT, V55, P1276, DOI 10.1136/gut.2005.078865; Wang W, 2000, J CELL BIOL, V151, P289, DOI 10.1083/jcb.151.2.289; Wang YY, 2005, P NATL ACAD SCI USA, V102, P1104, DOI 10.1073/pnas.0408831102; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zimmermann P, 1999, FASEB J, V13, pS91; Zuber J, 2000, NAT GENET, V24, P144, DOI 10.1038/72799	36	20	22	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e23262	10.1371/journal.pone.0023262	http://dx.doi.org/10.1371/journal.pone.0023262			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826244	Green Published, Green Submitted, gold			2022-12-25	WOS:000293558900070
J	Bramley, JR; Wiles, EM; Sollars, PJ; Pickard, GE				Bramley, Jayne R.; Wiles, Erin M.; Sollars, Patricia J.; Pickard, Gary E.			Carbenoxolone Blocks the Light-Evoked Rise in Intracellular Calcium in Isolated Melanopsin Ganglion Cell Photoreceptors	PLOS ONE			English	Article							SYNAPTIC-TRANSMISSION; AII AMACRINE; RAT; PROJECTIONS; DIVERSITY; PHOTOTRANSDUCTION	Background: Retinal ganglion cells expressing the photopigment melanopsin are intrinsically photosensitive (ipRGCs). These ganglion cell photoreceptors send axons to several central targets involved in a variety of functions. Within the retina ipRGCs provide excitatory drive to dopaminergic amacrine cells via glutamatergic signals and ipRGCs are coupled to wide-field GABAergic amacrine cells via gap junctions. However, the extent to which ipRGCs are coupled to other retinal neurons in the ganglion cell layer via gap junctions is unclear. Carbenoxolone, a widely employed gap junction inhibitor, greatly reduces the number of retinal neurons exhibiting non-rod, non-cone mediated light-evoked Ca2+ signals suggesting extensive intercellular coupling between ipRGCs and non-ipRGCs in the ganglion cell layer. However, carbenoxolone may directly inhibit light-evoked Ca2+ signals in ipRGCs independent of gap junction blockade. Methodology/Principal Findings: To test the possibility that carbenoxolone directly inhibits light-evoked Ca2+ responses in ipRGCs, the light-evoked rise in intracellular Ca2+ ([Ca2+](i)) was examined using fura-2 imaging in isolated rat ipRGCs maintained in short-term culture in the absence and presence of carbenoxolone. Carbenoxolone at 50 and 100 mu M concentrations completely abolished the light-evoked rise in [Ca2+](i) in isolated ipRGCs. Recovery from carbenoxolone inhibition was variable. Conclusions/Significance: We demonstrate that the light-evoked rise in [Ca2+](i) in isolated mammalian ganglion cell photoreceptors is inhibited by carbenoxolone. Since the light-evoked increase in [Ca2+](i) in isolated ipRGCs is almost entirely due to Ca2+ entry via L-type voltage-gated calcium channels and carbenoxolone does not inhibit light-evoked action potential firing in ipRGCs in situ, carbenoxolone may block the light-evoked increase in [Ca2+](i) in ipRGCs by blocking L-type voltage-gated Ca2+ channels. The ability of carbenoxolone to block evoked Ca2+ responses must be taken into account when interpreting the effects of this pharmacological agent on retinal or other neuronal circuits, particularly if a change in [Ca2+](i) is the output being measured.	[Bramley, Jayne R.; Wiles, Erin M.; Sollars, Patricia J.; Pickard, Gary E.] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68583 USA	University of Nebraska System; University of Nebraska Lincoln	Bramley, JR (corresponding author), Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68583 USA.	gpickard2@unl.edu			National Institutes of Health [R01 EY017809]; NATIONAL EYE INSTITUTE [R01EY017809] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health grant R01 EY017809 to PJS and GEP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Brown TM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000558; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; DAVIDSON JS, 1988, J PHARMACOL EXP THER, V246, P1104; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Gooley JJ, 2003, J NEUROSCI, V23, P7093, DOI 10.1523/JNEUROSCI.23-18-07093.2003; Graham DM, 2008, J NEUROPHYSIOL, V99, P2522, DOI 10.1152/jn.01066.2007; Harks EGA, 2001, J PHARMACOL EXP THER, V298, P1033; Hartwick ATE, 2008, J PHYSIOL-LONDON, V586, P3425, DOI 10.1113/jphysiol.2008.154609; Hartwick ATE, 2007, J NEUROSCI, V27, P13468, DOI 10.1523/JNEUROSCI.3626-07.2007; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Kamasawa N, 2006, NEUROSCIENCE, V142, P1093, DOI 10.1016/j.neuroscience.2006.08.020; Liu XX, 2010, J NEUROSCI, V30, P4197, DOI 10.1523/JNEUROSCI.4187-09.2010; Morin LP, 2003, J COMP NEUROL, V465, P401, DOI 10.1002/cne.10881; Muller LPD, 2010, J COMP NEUROL, V518, P4813, DOI 10.1002/cne.22490; Pan F, 2007, VISUAL NEUROSCI, V24, P609, DOI 10.1017/S0952523807070472; Perez-Leighton CE, 2011, EUR J NEUROSCI, V33, P856, DOI 10.1111/j.1460-9568.2010.07583.x; Sekaran S, 2005, CURR BIOL, V15, P1099, DOI 10.1016/j.cub.2005.05.053; Sekaran S, 2003, CURR BIOL, V13, P1290, DOI 10.1016/S0960-9822(03)00510-4; Sollars PJ, 2003, VISUAL NEUROSCI, V20, P601, DOI 10.1017/S0952523803206027; Sterling P., 2004, SYNAPTIC ORG BRAIN, P217; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Tovar KR, 2009, J NEUROPHYSIOL, V102, P974, DOI 10.1152/jn.00060.2009; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; Vaney DI, 2002, PROG BRAIN RES, V136, P239; Veruki ML, 2010, J NEUROPHYSIOL, V103, P1456, DOI 10.1152/jn.01105.2009; Veruki ML, 2009, J NEUROPHYSIOL, V101, P2339, DOI 10.1152/jn.00112.2009; Vessey JP, 2004, J NEUROPHYSIOL, V92, P1252, DOI 10.1152/jn.00148.2004; Warren EJ, 2006, EUR J NEUROSCI, V23, P2477, DOI 10.1111/j.1460-9568.2006.04777.x; Weng SJ, 2009, J BIOL RHYTHM, V24, P391, DOI 10.1177/0748730409343767; Wilson JM, 2007, J NEUROPHYSIOL, V98, P2370, DOI 10.1152/jn.00338.2007; Zhang DQ, 2008, P NATL ACAD SCI USA, V105, P14181, DOI 10.1073/pnas.0803893105	33	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22721	10.1371/journal.pone.0022721	http://dx.doi.org/10.1371/journal.pone.0022721			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829491	Green Published, gold			2022-12-25	WOS:000293286500022
J	Gaffey, MF; Venkatesh, S; Dhingra, N; Khera, A; Kumar, R; Arora, P; Nagelkerke, N; Jha, P				Gaffey, Michelle F.; Venkatesh, Srinivasan; Dhingra, Neeraj; Khera, Ajay; Kumar, Rajesh; Arora, Paul; Nagelkerke, Nico; Jha, Prabhat			Male Use of Female Sex Work in India: A Nationally Representative Behavioural Survey	PLOS ONE			English	Article							HIV-INFECTION; SOUTH-INDIA; PREVENTION; POPULATION; HIV/AIDS; SPREAD; WOMEN; DETERMINANTS; TRANSMISSION; PERSPECTIVE	Heterosexual transmission of HIV in India is driven by the male use of female sex workers (FSW), but few studies have examined the factors associated with using FSW. This nationally representative study examined the prevalence and correlates of FSW use among 31,040 men aged 15-49 years in India in 2006. Nationally, about 4% of men used FSW in the previous year, representing about 8.5 million FSW clients. Unmarried men were far more likely than married men to use FSW overall (PR = 8.0), but less likely than married men to use FSW among those reporting at least one non-regular partner (PR = 0.8). More than half of all FSW clients were married. FSW use was higher among men in the high-HIV states than in the low-HIV states (PR = 2.7), and half of all FSW clients lived in the high-HIV states. The risk of FSW use rose sharply with increasing number of non-regular partners in the past year. Given the large number of men using FSW, interventions for the much smaller number of FSW remains the most efficient strategy for curbing heterosexual HIV transmission in India.	[Gaffey, Michelle F.; Arora, Paul; Nagelkerke, Nico; Jha, Prabhat] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada; [Gaffey, Michelle F.; Arora, Paul; Nagelkerke, Nico; Jha, Prabhat] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Venkatesh, Srinivasan; Dhingra, Neeraj] Natl AIDS Control Org, New Delhi, India; [Khera, Ajay] Minist Hlth & Family Welf, New Delhi, India; [Kumar, Rajesh] Postgrad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh 160012, India	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Gaffey, MF (corresponding author), Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada.	jhap@smh.ca			Fogarty International Centre of the US National Institutes of Health [R01 TW05991-01]; Canadian Institute of Health Research (CIHR) [IEG-53506]; Li Ka Shing Knowledge Institute; Keenan Research Centre at St Michael's Hospital, University of Toronto; FOGARTY INTERNATIONAL CENTER [R01TW005991] Funding Source: NIH RePORTER	Fogarty International Centre of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Li Ka Shing Knowledge Institute(University of Toronto); Keenan Research Centre at St Michael's Hospital, University of Toronto; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	External funding is from the Fogarty International Centre of the US National Institutes of Health (grant R01 TW05991-01), Canadian Institute of Health Research (CIHR; IEG-53506), and Li Ka Shing Knowledge Institute and Keenan Research Centre at St Michael's Hospital, University of Toronto (unrestricted support). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora P, 2005, NATL COMMISSION MACR; Arora P, 2008, LANCET, V372, P289, DOI 10.1016/S0140-6736(08)61105-8; Basu I, 2004, JAIDS-J ACQ IMM DEF, V36, P845, DOI 10.1097/00126334-200407010-00012; Blanchard JF, 2007, SEX TRANSM INFECT, V83, pI30, DOI 10.1136/sti.2006.023572; Brewer DD, 2000, P NATL ACAD SCI USA, V97, P12385, DOI 10.1073/pnas.210392097; Buve A, 2001, AIDS, V15, pS117, DOI 10.1097/00002030-200108004-00013; Buzdugan R, 2010, INT J EPIDEMIOL, V39, P439, DOI 10.1093/ije/dyp351; Chattopadhyay A, 2004, AIDS PATIENT CARE ST, V18, P159, DOI 10.1089/108729104322994847; Claeson M, 2008, HEALTH AFFAIR, V27, P1091, DOI 10.1377/hlthaff.27.4.1091; Dandona L, 2008, INT J EPIDEMIOL, V37, P1274, DOI 10.1093/ije/dyn161; *FAM HLTH INT, 2000, BEHAV SURV SURV BSS; Fenton KA, 2001, SEX TRANSM INFECT, V77, P84, DOI 10.1136/sti.77.2.84; Gangakhedkar RR, 1997, JAMA-J AM MED ASSOC, V278, P2090, DOI 10.1001/jama.278.23.2090; Hernandez AL, 2006, AIDS BEHAV, V10, pS5, DOI 10.1007/s10461-006-9129-z; *IND AIDS IN, 2008, BUS HIV PREV SCAL; Jha P, 2001, SCIENCE, V292, P224, DOI 10.1126/science.1058187; Jha P, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c621; Kaul R, 2002, J ACQ IMMUN DEF SYND, V30, P69, DOI 10.1097/00042560-200205010-00009; Kumar R, 2006, LANCET, V367, P1164, DOI 10.1016/S0140-6736(06)68435-3; Lenka Satya Ranjan, 2011, Indian J Public Health, V55, P30, DOI 10.4103/0019-557X.82542; Nagelkerke NJD, 2002, B WORLD HEALTH ORGAN, V80, P89; *NAT AIDS CONTR OR, 2001, NAT BAS GEN POP BEHA; *NAT AIDS CONTR OR, 2006, NAT BEHAV SURV SURV; National AIDS Control Organisation, 2007, ANN REP 2006; National AIDS Control Organisation, 2006, NAT BEH SURV SURV 20; National AIDS Control Organisation, 2006, STRAT IMPL PLAN NAT; Newmann S, 2000, INT J STD AIDS, V11, P250, DOI 10.1258/0956462001915796; Nnko S, 2004, SOC SCI MED, V59, P299, DOI 10.1016/j.socscimed.2003.10.031; Ramesh BA, 2008, AIDS, V22, pS35, DOI 10.1097/01.aids.0000343762.54831.5c; *REG GEN IND, 2006, CENS IND 2001 POP PO; *REG GEN IND, 2007, SAMPL REG SYST STAT; Ruxrungtham K, 2004, LANCET, V364, P69, DOI 10.1016/S0140-6736(04)16593-8; Sarkar K, 2006, J INFECTION, V53, P255, DOI 10.1016/j.jinf.2005.11.009; Schneider JA, 2007, AIDS CARE, V19, P1171, DOI 10.1080/09540120701336392; Shahmanesh M, 2009, SEX TRANSM INFECT, V85, P50, DOI 10.1136/sti.2008.030767; Talukdar A, 2008, AIDS BEHAV, V12, P613, DOI 10.1007/s10461-007-9338-0; Venkataramana CBS, 2001, TROP MED INT HEALTH, V6, P1040, DOI 10.1046/j.1365-3156.2001.00814.x; Wellings K, 2006, LANCET, V368, P1706, DOI 10.1016/S0140-6736(06)69479-8	38	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22704	10.1371/journal.pone.0022704	http://dx.doi.org/10.1371/journal.pone.0022704			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	799KV	21829486	gold, Green Published, Green Submitted			2022-12-25	WOS:000293286500019
J	Spektor, TM; Congdon, LM; Veerappan, CS; Rice, JC				Spektor, Tanya M.; Congdon, Lauren M.; Veerappan, Chendhore S.; Rice, Judd C.			The UBC9 E2 SUMO Conjugating Enzyme Binds the PR-Set7 Histone Methyltransferase to Facilitate Target Gene Repression	PLOS ONE			English	Article							TRANSCRIPTIONAL REPRESSION; SUBSTRATE RECOGNITION; FUNCTIONAL-ANALYSIS; SILENT CHROMATIN; DNA-DAMAGE; H4 LYS-20; MONOMETHYLATION; SET8; METHYLATION; SUMOYLATION	PR-Set7/Set8/KMT5a is a chromatin-modifying enzyme that specifically monomethylates lysine 20 of histone H4 (H4K20me1). In this study we attempted to identify PR-Set7-interacting proteins reasoning that these proteins would provide important insights into the role of PR-Set7 in transcriptional regulation. Using an unbiased yeast two-hybrid approach, we discovered that PR-Set7 interacts with the UBC9 E2 SUMO conjugating enzyme. This interaction was confirmed in human cells and we demonstrated that PR-Set7 was preferentially modified with SUMO1 in vivo. Further in vitro studies revealed that UBC9 directly binds PR-Set7 proximal to the catalytic SET domain. Two putative SUMO consensus sites were identified in this region and both were capable of being SUMOylated in vitro. The absence of either or both SUMO sites did not perturb nuclear localization of PR-Set7. By employing whole genome expression arrays, we identified a panel of genes whose expression was significantly altered in the absence of PR-Set7. The vast majority of these genes displayed increased expression strongly suggesting that PR-Set7 predominantly functions as a transcriptional repressor. Importantly, the reduction of UBC9 resulted in the consistent derepression of several of these newly identified genes regulated by PR-Set7. Our findings indicate that direct interaction with UBC9 facilitates the repressive effects of PR-Set7 at specific target genes, most likely by SUMOylating PR-Set7.	[Spektor, Tanya M.; Congdon, Lauren M.; Veerappan, Chendhore S.; Rice, Judd C.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA	University of Southern California	Spektor, TM (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA.	juddrice@usc.edu			Pew Charitable Trusts; National Institutes of Health [GM075094]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075094] Funding Source: NIH RePORTER	Pew Charitable Trusts; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Pew Charitable Trusts and the National Institutes of Health (GM075094). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Congdon LM, 2010, J CELL BIOCHEM, V110, P609, DOI 10.1002/jcb.22570; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; Fernandez-Miranda G, 2010, J CELL SCI, V123, P2823, DOI 10.1242/jcs.065565; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Houston SI, 2008, J BIOL CHEM, V283, P19478, DOI 10.1074/jbc.M710579200; Huen MSY, 2008, J BIOL CHEM, V283, P11073, DOI 10.1074/jbc.C700242200; Kalakonda N, 2008, ONCOGENE, V27, P4293, DOI 10.1038/onc.2008.67; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Kim JH, 2006, NAT CELL BIOL, V8, P631, DOI 10.1038/ncb1415; Kirsh O, 2002, EMBO J, V21, P2682, DOI 10.1093/emboj/21.11.2682; Lin DH, 2002, J BIOL CHEM, V277, P21740, DOI 10.1074/jbc.M108418200; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011; Oda H, 2009, MOL CELL BIOL, V29, P2278, DOI 10.1128/MCB.01768-08; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Sakaguchi A, 2007, J CELL BIOL, V176, P155, DOI 10.1083/jcb.200607178; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Shin JA, 2005, MOL CELL, V19, P817, DOI 10.1016/j.molcel.2005.08.021; Sims JK, 2008, MOL CELL BIOL, V28, P4459, DOI 10.1128/MCB.00410-08; Sims JK, 2006, J BIOL CHEM, V281, P12760, DOI 10.1074/jbc.M513462200; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Talasz H, 2005, J BIOL CHEM, V280, P38814, DOI 10.1074/jbc.M505563200; Tardat M, 2010, NAT CELL BIOL, V12, P1086, DOI 10.1038/ncb2113; Tatham MH, 2003, BIOCHEMISTRY-US, V42, P3168, DOI 10.1021/bi026861x; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Wu SM, 2010, GENE DEV, V24, P2531, DOI 10.1101/gad.1984210; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; Yang ML, 2006, J BIOL CHEM, V281, P8264, DOI 10.1074/jbc.M510364200; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104; Zeng L, 2008, NAT STRUCT MOL BIOL, V15, P626, DOI 10.1038/nsmb.1416	40	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22785	10.1371/journal.pone.0022785	http://dx.doi.org/10.1371/journal.pone.0022785			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829513	Green Published, gold, Green Submitted			2022-12-25	WOS:000293286500028
J	van Eersel, J; Ke, YD; Gladbach, A; Bi, M; Gotz, J; Kril, JJ; Ittner, LM				van Eersel, Janet; Ke, Yazi D.; Gladbach, Amadeus; Bi, Mian; Goetz, Juergen; Kril, Jillian J.; Ittner, Lars M.			Cytoplasmic Accumulation and Aggregation of TDP-43 upon Proteasome Inhibition in Cultured Neurons	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; DNA-BINDING PROTEIN-43; ALZHEIMERS-DISEASE; TARDBP MUTATIONS; ANIMAL-MODELS; PICKS-DISEASE; P301L TAU; DEMENTIA; UBIQUITIN	Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) are characterized by intraneuronal deposition of the nuclear TAR DNA-binding protein 43 (TDP-43) caused by unknown mechanisms. Here, we studied TDP-43 in primary neurons under different stress conditions and found that only proteasome inhibition by MG-132 or lactacystin could induce significant cytoplasmic accumulation of TDP-43, a histopathological hallmark in disease. This cytoplasmic accumulation was accompanied by phosphorylation, ubiquitination and aggregation of TDP-43, recapitulating major features of disease. Proteasome inhibition produced similar effects in both hippocampal and cortical neurons, as well as in immortalized motor neurons. To determine the contribution of TDP-43 to cell death, we reduced TDP-43 expression using small interfering RNA (siRNA), and found that reduced levels of TDP-43 dose-dependently rendered neurons more vulnerable to MG-132. Taken together, our data suggests a role for the proteasome in subcellular localization of TDP-43, and possibly in disease.	[van Eersel, Janet; Ke, Yazi D.; Gladbach, Amadeus; Bi, Mian; Ittner, Lars M.] Univ Sydney, Brain & Mind Res Inst, Lab Translat Neurodegenerat, Sydney, NSW 2006, Australia; [Goetz, Juergen] Univ Sydney, Brain & Mind Res Inst, Alzheimers & Parkinsons Dis Lab, Sydney, NSW 2006, Australia; [Kril, Jillian J.] Univ Sydney, Discipline Med, Sydney, NSW 2006, Australia; [Kril, Jillian J.] Univ Sydney, Discipline Pathol, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney; University of Sydney	van Eersel, J (corresponding author), Univ Sydney, Brain & Mind Res Inst, Lab Translat Neurodegenerat, Sydney, NSW 2006, Australia.	littner@med.usyd.edu.au	van Eersel, Janet/AAZ-4197-2020; Ke, Yazi/ABC-3052-2020; Gotz, Jurgen/C-2448-2014	van Eersel, Janet/0000-0002-1354-6171; Ke, Yazi/0000-0002-1423-0451; Ittner, Lars/0000-0001-6738-3825; Bi, Mian/0000-0002-4383-3606; Gotz, Jurgen/0000-0001-8501-7896; Kril, Jillian/0000-0001-9407-8674	National Health and Medical Research Council (NHMRC); Australian Research Council (ARC)	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council)	The research has been supported by the National Health and Medical Research Council (NHMRC) and the Australian Research Council (ARC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Benajiba L, 2009, ANN NEUROL, V65, P470, DOI 10.1002/ana.21612; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Chio A, 2010, ARCH NEUROL-CHICAGO, V67, P1002, DOI 10.1001/archneurol.2010.173; Cruts M, 2008, TRENDS GENET, V24, P186, DOI 10.1016/j.tig.2008.01.004; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; DAOUD H, 2008, J MED GENET; Deng HX, 2010, ANN NEUROL, V67, P739, DOI 10.1002/ana.22051; Deroo BJ, 2002, MOL CELL BIOL, V22, P4113, DOI 10.1128/MCB.22.12.4113-4123.2002; Dormann D, 2009, J NEUROCHEM, V110, P1082, DOI 10.1111/j.1471-4159.2009.06211.x; Fath T, 2009, NAT PROTOC, V4, P78, DOI 10.1038/nprot.2008.199; Gitcho MA, 2009, ACTA NEUROPATHOL, V118, P633, DOI 10.1007/s00401-009-0571-7; Gotz J, 2004, MOL PSYCHIATR, V9, P664, DOI 10.1038/sj.mp.4001508; Gotz J, 2001, J BIOL CHEM, V276, P529, DOI 10.1074/jbc.M006531200; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Graham A, 2005, BRAIN, V128, P597, DOI 10.1093/brain/awh348; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Iguchi Y, 2009, J BIOL CHEM, V284, P22059, DOI 10.1074/jbc.M109.012195; Inukai Y, 2008, FEBS LETT, V582, P2899, DOI 10.1016/j.febslet.2008.07.027; Ittner LM, 2008, P NATL ACAD SCI USA, V105, P15997, DOI 10.1073/pnas.0808084105; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Ittner LM, 2009, J BIOL CHEM, V284, P20909, DOI 10.1074/jbc.M109.014472; Ittner LM, 2005, BIOCHEMISTRY-US, V44, P5749, DOI 10.1021/bi048111o; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Kovacs GG, 2009, MOVEMENT DISORD, V24, P1843, DOI 10.1002/mds.22697; Krupka N, 2010, PLASMID, V63, P155, DOI 10.1016/j.plasmid.2010.01.002; Kuehnlein P, 2008, ARCH NEUROL-CHICAGO, V65, P1185, DOI 10.1001/archneur.65.9.1185; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Liscic RM, 2007, ARCH NEUROL-CHICAGO, V64, P535, DOI 10.1001/archneur.64.4.535; Mackenzie IRA, 2010, ACTA NEUROPATHOL, V119, P1, DOI 10.1007/s00401-009-0612-2; Mackenzie IRA, 2005, J NEUROPATH EXP NEUR, V64, P730, DOI 10.1097/01.jnen.0000174335.27708.0a; Mattsson K, 2001, P NATL ACAD SCI USA, V98, P1012, DOI 10.1073/pnas.031566998; Mayer RJ, 1996, ADV EXP MED BIOL, V389, P261; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishimoto Y, 2010, J BIOL CHEM, V285, P608, DOI 10.1074/jbc.M109.022012; Nonaka T, 2009, FEBS LETT, V583, P394, DOI 10.1016/j.febslet.2008.12.031; Pickering-Brown SM, 2007, EXP NEUROL, V206, P1, DOI 10.1016/j.expneurol.2007.03.017; Ratnavalli E, 2002, NEUROLOGY, V58, P1615, DOI 10.1212/WNL.58.11.1615; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Salomon D, 1997, J CELL BIOL, V139, P1325, DOI 10.1083/jcb.139.5.1325; Santiago-Josefat B, 2001, MOL CELL BIOL, V21, P1700, DOI 10.1128/MCB.21.5.1700-1709.2001; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; Spillantini MG, 1998, AM J PATHOL, V153, P1359, DOI 10.1016/S0002-9440(10)65721-5; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Strong MJ, 2005, J NEUROPATH EXP NEUR, V64, P649, DOI 10.1097/01.jnen.0000173889.71434.ea; SUZUKI H, 2011, J BIOL CHEM; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; van Eersel J, 2009, J NEURAL TRANSM, V116, P1243, DOI 10.1007/s00702-009-0293-y; Wang XJ, 2010, NEUROSCI LETT, V469, P112, DOI 10.1016/j.neulet.2009.11.055; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Winton MJ, 2008, FEBS LETT, V582, P2252, DOI 10.1016/j.febslet.2008.05.024; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhao JH, 2003, J CELL SCI, V116, P4011, DOI 10.1242/jcs.00700	72	71	71	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22850	10.1371/journal.pone.0022850	http://dx.doi.org/10.1371/journal.pone.0022850			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829535	Green Published, gold, Green Submitted			2022-12-25	WOS:000293286500039
J	Harrison, NC; del Corral, RD; Vasiev, B				Harrison, Nigel C.; Diez del Corral, Ruth; Vasiev, Bakhtier			Coordination of Cell Differentiation and Migration in Mathematical Models of Caudal Embryonic Axis Extension	PLOS ONE			English	Article							PRIMITIVE STREAK; NEURONAL DIFFERENTIATION; RETINOID PATHWAYS; OPPOSING FGF; NEURAL PLATE; STEM-CELLS; BODY; SIMULATION; SEGMENTATION; NODE	Vertebrate embryos display a predominant head-to-tail body axis whose formation is associated with the progressive development of post-cranial structures from a pool of caudal undifferentiated cells. This involves the maintenance of active FGF signaling in this caudal region as a consequence of the restricted production of the secreted factor FGF8. FGF8 is transcribed specifically in the caudal precursor region and is down-regulated as cells differentiate and the embryo extends caudally. We are interested in understanding the progressive down-regulation of FGF8 and its coordination with the caudal movement of cells which is also known to be FGF-signaling dependent. Our study is performed using mathematical modeling and computer simulations. We use an individual-based hybrid model as well as a caricature continuous model for the simulation of experimental observations (ours and those known from the literature) in order to examine possible mechanisms that drive differentiation and cell movement during the axis elongation. Using these models we have identified a possible gene regulatory network involving self-repression of a caudal morphogen coupled to directional domain movement that may account for progressive down-regulation of FGF8 and conservation of the FGF8 domain of expression. Furthermore, we have shown that chemotaxis driven by molecules, such as FGF8 secreted in the stem zone, could underlie the migration of the caudal precursor zone and, therefore, embryonic axis extension. These mechanisms may also be at play in other developmental processes displaying a similar mode of axis extension coupled to cell differentiation.	[Harrison, Nigel C.; Vasiev, Bakhtier] Univ Liverpool, Dept Math Sci, Liverpool L69 3BX, Merseyside, England; [Diez del Corral, Ruth] CSIC, Inst Cajal, Madrid, Spain	University of Liverpool; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Harrison, NC (corresponding author), Univ Liverpool, Dept Math Sci, Liverpool L69 3BX, Merseyside, England.	r.diez@cajal.csic.es; bnvasiev@liverpool.ac.uk	Vasiev, Bakhtier/D-8006-2011; DIEZ DEL CORRAL, RUTH/K-7974-2014	Vasiev, Bakhtier/0000-0002-3452-7885; DIEZ DEL CORRAL, RUTH/0000-0003-2649-7214	Biotechnology and Biological Sciences Research Council (BBSRC) [94/E18787]; Spanish Ministry of Science [BFU-2005-02972]; Wellcome Trust [069142]; Liverpool University	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Wellcome Trust(Wellcome Trust); Liverpool University	Biotechnology and Biological Sciences Research Council (BBSRC) Grant 94/E18787; Spanish Ministry of Science grant (BFU-2005-02972); Wellcome Trust Research Training Fellowship in Mathematical Biology Ref: 069142; Liverpool University RCMM fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker RE, 2007, MATH BIOSCI, V209, P30, DOI 10.1016/j.mbs.2007.01.006; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Benazeraf B, 2010, NATURE, V466, P248, DOI 10.1038/nature09151; Brown JM, 2000, CURR BIOL, V10, P869, DOI 10.1016/S0960-9822(00)00601-1; Cambray N, 2007, DEVELOPMENT, V134, P2829, DOI 10.1242/dev.02877; Catala M, 1996, DEVELOPMENT, V122, P2599; Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.0.CO;2-5; Chen N, 2007, COMPUT PHYS COMMUN, V176, P670, DOI 10.1016/j.cpc.2007.03.007; Chuai M, 2009, CURR OPIN GENET DEV, V19, P343, DOI 10.1016/j.gde.2009.06.007; Chuai ML, 2009, HFSP J, V3, P71, DOI 10.2976/1.3103933; Davis GK, 2002, ANNU REV ENTOMOL, V47, P669, DOI 10.1146/annurev.ento.47.091201.145251; Diez del Corral R, 2003, NEURON, V40, P65; Diez del Corral R, 2004, BIOESSAYS, V26, P857, DOI 10.1002/bies.20080; Diez del Corral R, 2002, DEVELOPMENT, V129, P1681; Dubrulle J, 2004, NATURE, V427, P419, DOI 10.1038/nature02216; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; GLAZIER JA, 1993, PHYS REV E, V47, P2128, DOI 10.1103/PhysRevE.47.2128; Goldbeter A, 2007, DEV DYNAM, V236, P1495, DOI 10.1002/dvdy.21193; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; GRIMA R, 2005, PHYS REV LETT, V95, P4; KELLER EF, 1971, J THEOR BIOL, V30, P235, DOI 10.1016/0022-5193(71)90051-8; Long TA, 2006, CURR OPIN CELL BIOL, V18, P710, DOI 10.1016/j.ceb.2006.09.004; Maree AFM, 2001, P NATL ACAD SCI USA, V98, P3879, DOI 10.1073/pnas.061535198; Mathis L, 2000, DEVELOPMENT, V127, P1277; Mathis L, 2001, NAT CELL BIOL, V3, P559, DOI 10.1038/35078535; MEINHARDT H, 2009, COLD SPRING HARBOR P, V1; Meinhardt H, 2008, CURR TOP DEV BIOL, V81, P1, DOI 10.1016/S0070-2153(07)81001-5; Merks RMH, 2005, PHYSICA A, V352, P113, DOI 10.1016/j.physa.2004.12.028; Merks RMH, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000163; Olivera-Martinez I, 2007, DEVELOPMENT, V134, P2125, DOI 10.1242/dev.000216; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Psychoyos D, 1996, DEVELOPMENT, V122, P1523; Roszko I, 2007, DEV BIOL, V304, P232, DOI 10.1016/j.ydbio.2006.12.050; SCHWANK G, COLD SPRING HARB PER, V2; SELLECK MAJ, 1991, DEVELOPMENT, V112, P615; Standley HJ, 2002, INT J DEV BIOL, V46, P279; Starruss J, 2007, J STAT PHYS, V128, P269, DOI 10.1007/s10955-007-9298-9; Tautz D, 2004, DEV CELL, V7, P301, DOI 10.1016/j.devcel.2004.08.008; Towers M, 2009, DEVELOPMENT, V136, P179, DOI 10.1242/dev.024158; Vasiev B, 1997, J THEOR BIOL, V184, P441, DOI 10.1006/jtbi.1996.0282; Vasiev B, 2003, J THEOR BIOL, V223, P347, DOI 10.1016/S0022-5193(03)00103-6; Vasiev B, 1999, BIOPHYS J, V76, P595, DOI 10.1016/S0006-3495(99)77228-0; Vasiev B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010571; Vasiev BN, 2004, PHYS LETT A, V323, P194, DOI 10.1016/j.physleta.2004.01.068; VASIEV BN, 1994, PHYS REV LETT, V73, P3173, DOI 10.1103/PhysRevLett.73.3173; Voiculescu O, 2007, NATURE, V449, P1049, DOI 10.1038/nature06211; Wahl MB, 2007, DEVELOPMENT, V134, P4033, DOI 10.1242/dev.009167; Weigel D, 2002, NATURE, V415, P751, DOI 10.1038/415751a; Wilson V, 2009, DEVELOPMENT, V136, P1591, DOI 10.1242/dev.021246; Yamanaka Y, 2007, DEV CELL, V13, P884, DOI 10.1016/j.devcel.2007.10.016; Yin C, 2008, J CELL BIOL, V180, P221, DOI 10.1083/jcb.200704150; Yin CY, 2009, CURR TOP DEV BIOL, V89, P163, DOI 10.1016/S0070-2153(09)89007-8; Zajac M, 2003, J THEOR BIOL, V222, P247, DOI 10.1016/S0022-5193(03)00033-X	53	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22700	10.1371/journal.pone.0022700	http://dx.doi.org/10.1371/journal.pone.0022700			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829483	gold, Green Published			2022-12-25	WOS:000293284600028
J	Songhet, P; Barthel, M; Stecher, B; Muller, AJ; Kremer, M; Hansson, GC; Hardt, WD				Songhet, Pascal; Barthel, Manja; Stecher, Baerbel; Mueller, Andreas J.; Kremer, Marcus; Hansson, Gunnar C.; Hardt, Wolf-Dietrich			Stromal IFN-gamma R-Signaling Modulates Goblet Cell Function During Salmonella Typhimurium Infection	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; MUCIN GENE-EXPRESSION; POLYMERIC IMMUNOGLOBULIN RECEPTOR; INNATE IMMUNE-RESPONSE; INTERFERON-GAMMA; SEROTYPE TYPHIMURIUM; S.-TYPHIMURIUM; INTESTINAL INFLAMMATION; MOLECULAR-CLONING; EARLY-PHASE	Enteropathogenic bacteria are a frequent cause of diarrhea worldwide. The mucosal defenses against infection are not completely understood. We have used the streptomycin mouse model for Salmonella Typhimurium diarrhea to analyze the role of interferon gamma receptor (IFN-gamma R)-signaling in mucosal defense. IFN-gamma is known to contribute to acute S. Typhimurium diarrhea. We have compared the acute mucosal inflammation in IFN-gamma R(-/) (-)mice and wild type animals. IFN-gamma R(-/-) mice harbored increased pathogen loads in the mucosal epithelium and the lamina propria. Surprisingly, the epithelium of the IFN-gamma R(-/-) mice did not show the dramatic "loss" of mucus-filled goblet cell vacuoles, a hallmark of the wild type mucosal infection. Using bone marrow chimeric mice we established that IFN-gamma R-signaling in stromal cells (e. g. goblet cells, enterocytes) controlled mucus excretion/vacuole loss by goblet cells. In contrast, IFN-gamma R-signaling in bone marrow-derived cells (e.g. macrophages, DCs, PMNs) was required for restricting pathogen growth in the gut tissue. Thus IFN-gamma R-signaling influences different mucosal responses to infection, including not only pathogen restriction in the lamina propria, but, as shown here, also goblet cell function.	[Songhet, Pascal; Barthel, Manja; Stecher, Baerbel; Mueller, Andreas J.; Hardt, Wolf-Dietrich] ETH, Inst Microbiol D BIOL, Zurich, Switzerland; [Kremer, Marcus] Tech Univ Munich, Inst Allgemeine Pathol & Pathol Anat, Munich, Germany; [Hansson, Gunnar C.] Univ Gothenburg, Dept Med Biochem, Gothenburg, Sweden	Swiss Federal Institutes of Technology Domain; ETH Zurich; Technical University of Munich; University of Gothenburg	Songhet, P (corresponding author), ETH, Inst Microbiol D BIOL, Zurich, Switzerland.	hardt@micro.biol.ethz.ch	Hansson, Gunnar C./AAF-7324-2019; Stecher, Bärbel/A-2911-2015; Stecher, Barbel/B-9940-2019; Hansson, Gunnar C/A-1236-2009	Hansson, Gunnar C./0000-0002-1900-1869; Stecher, Bärbel/0000-0002-7445-5193; Hansson, Gunnar C/0000-0002-1900-1869; Muller, Andreas/0000-0002-0281-6383; Hardt, Wolf-Dietrich/0000-0002-9892-6420	Swiss National Science Foundation [310000-113623/1, 310030-132997]; European Union [INCO-CT-2006-032296]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095473] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants to WDH from the Swiss National Science Foundation (310000-113623/1 and 310030-132997) and from the European Union (SavinMucoPath INCO-CT-2006-032296). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2008, NATURE, V454, P987, DOI 10.1038/nature07067; ALTMEYER M, 2010, INFECT IMMUN; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bao S, 2000, IMMUNOLOGY, V99, P464, DOI 10.1046/j.1365-2567.2000.00955.x; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Berg RE, 2006, CURR OPIN IMMUNOL, V18, P338, DOI 10.1016/j.coi.2006.03.010; Bergstrom KSB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000902; Bustarnante J, 2008, CURR OPIN IMMUNOL, V20, P39, DOI 10.1016/j.coi.2007.10.005; CHARBONNEAU H, 1988, P NATL ACAD SCI USA, V85, P7182, DOI 10.1073/pnas.85.19.7182; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Fernandez MI, 2003, INT J MED MICROBIOL, V293, P55, DOI 10.1078/1438-4221-00244; FORSTNER G, 1995, ANNU REV PHYSIOL, V57, P585, DOI 10.1146/annurev.ph.57.030195.003101; Foster N, 2003, INFECT IMMUN, V71, P4733, DOI 10.1128/IAI.71.8.4733-4741.2003; Godinez I, 2008, INFECT IMMUN, V76, P2008, DOI 10.1128/IAI.01691-07; Godinez I, 2009, INFECT IMMUN, V77, P387, DOI 10.1128/IAI.00933-08; Grassl GA, 2008, CURR OPIN GASTROEN, V24, P22, DOI 10.1097/MOG.0b013e3282f21388; GUM JR, 1994, J BIOL CHEM, V269, P2440; HANSSON GC, 1994, BIOCHEM BIOPH RES CO, V198, P181, DOI 10.1006/bbrc.1994.1026; Hapfelmeier S, 2005, J IMMUNOL, V174, P1675, DOI 10.4049/jimmunol.174.3.1675; Hapfelmeier S, 2004, INFECT IMMUN, V72, P795, DOI 10.1128/IAI.72.2.795-809.2004; Hapfelmeier S, 2008, J EXP MED, V205, P437, DOI 10.1084/jem.20070633; Harrington L, 2007, FEMS IMMUNOL MED MIC, V51, P372, DOI 10.1111/j.1574-695X.2007.00313.x; Hess J, 1996, J IMMUNOL, V156, P3321; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Horsnell WGC, 2007, PLOS PATHOG, V3, P46, DOI 10.1371/journal.ppat.0030001; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; JARRY A, 1994, EUR J PHARM-MOLEC PH, V267, P95, DOI 10.1016/0922-4106(94)90229-1; Johansson M.E., 2010, P NATL ACAD SCI US; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kaetzel CS, 2005, IMMUNOL REV, V206, P83, DOI 10.1111/j.0105-2896.2005.00278.x; KAGAYA K, 1989, INFECT IMMUN, V57, P609, DOI 10.1128/IAI.57.2.609-615.1989; Knight PA, 2008, PARASITOLOGY, V135, P655, DOI 10.1017/S0031182008004319; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; MANTLE M, 1989, INFECT IMMUN, V57, P3292, DOI 10.1128/IAI.57.11.3292-3299.1989; Mastroeni P, 1999, INFECT IMMUN, V67, P478, DOI 10.1128/IAI.67.2.478-483.1999; MCCOOL DJ, 1995, BIOCHEM J, V312, P125, DOI 10.1042/bj3120125; McDermott JR, 2005, J IMMUNOL, V175, P3207, DOI 10.4049/jimmunol.175.5.3207; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; Muller AJ, 2009, CELL HOST MICROBE, V6, P125, DOI 10.1016/j.chom.2009.07.007; MUOTIALA A, 1990, MICROB PATHOGENESIS, V8, P135, DOI 10.1016/0882-4010(90)90077-4; MURRAY HW, 1985, J IMMUNOL, V134, P1619; NATHAN CF, 1984, J EXP MED, V160, P600, DOI 10.1084/jem.160.2.600; NAUCIEL C, 1992, INFECT IMMUN, V60, P450, DOI 10.1128/IAI.60.2.450-454.1992; Nava P, 2010, IMMUNITY, V32, P392, DOI 10.1016/j.immuni.2010.03.001; Nutten S, 2002, MICROBES INFECT, V4, P1121, DOI 10.1016/S1286-4579(02)01636-2; Pie S, 1996, INFECT IMMUN, V64, P849, DOI 10.1128/IAI.64.3.849-854.1996; Piskurich JF, 1997, MOL IMMUNOL, V34, P75, DOI 10.1016/S0161-5890(96)00079-X; Pron B, 1998, INFECT IMMUN, V66, P747, DOI 10.1128/IAI.66.2.747-755.1998; Rabsch W, 2001, MICROBES INFECT, V3, P237, DOI 10.1016/S1286-4579(01)01375-2; RAMARATHINAM L, 1991, MICROB PATHOGENESIS, V11, P347, DOI 10.1016/0882-4010(91)90020-B; Rhee SJ, 2005, J IMMUNOL, V175, P1127, DOI 10.4049/jimmunol.175.2.1127; Salzman NH, 2007, SEMIN IMMUNOL, V19, P70, DOI 10.1016/j.smim.2007.04.002; Santos RL, 2009, TRENDS MICROBIOL, V17, P498, DOI 10.1016/j.tim.2009.08.008; Seregni E, 1997, TUMORI J, V83, P625, DOI 10.1177/030089169708300301; Shekels LL, 2001, DIGEST DIS SCI, V46, P1757, DOI 10.1023/A:1010622125040; Silva-Herzog E, 2008, CELL MICROBIOL, V10, P2151, DOI 10.1111/j.1462-5822.2008.01192.x; Stecher B, 2005, INFECT IMMUN, V73, P3228, DOI 10.1128/IAI.73.6.3228-3241.2005; Stecher B, 2010, CURR OPIN MICROBIOL; Stecher B, 2008, CELL MICROBIOL, V10, P1166, DOI 10.1111/j.1462-5822.2008.01118.x; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Theodoropoulos G, 2007, J CELL BIOCHEM, V102, P1103, DOI 10.1002/jcb.21539; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Van Klinken BJW, 1999, AM J PHYSIOL-GASTR L, V276, pG115, DOI 10.1152/ajpgi.1999.276.1.G115; Vieira MAM, 2010, INFECT IMMUN, V78, P927, DOI 10.1128/IAI.01115-09; Winter SE, 2009, INFECT IMMUN, V77, P1904, DOI 10.1128/IAI.01341-08; Yang H, 2002, ANN SURG, V236, P226, DOI 10.1097/00000658-200208000-00011	67	67	69	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22459	10.1371/journal.pone.0022459	http://dx.doi.org/10.1371/journal.pone.0022459			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829463	Green Submitted, Green Published, gold			2022-12-25	WOS:000293284600015
J	Yuan, DJ; Tu, LL; Zhang, XL				Yuan, Daojun; Tu, Lili; Zhang, Xianlong			Generation, Annotation and Analysis of First Large-Scale Expressed Sequence Tags from Developing Fiber of Gossypium barbadense L.	PLOS ONE			English	Article							COTTON FIBER; GENE-EXPRESSION; MOLECULAR CHARACTERIZATION; CELL ELONGATION; INDOLE-3-BUTYRIC ACID; FUNCTIONAL GENOMICS; REDOX HOMEOSTASIS; YIELD THRESHOLD; ARABIDOPSIS; STRESS	Background: Cotton fiber is the world's leading natural fiber used in the manufacture of textiles. Gossypium is also the model plant in the study of polyploidization, evolution, cell elongation, cell wall development, and cellulose biosynthesis. G. barbadense L. is an ideal candidate for providing new genetic variations useful to improve fiber quality for its superior properties. However, little is known about fiber development mechanisms of G. barbadense and only a few molecular resources are available in GenBank. Methodology and Principal Findings: In total, 10,979 high-quality expressed sequence tags (ESTs) were generated from a normalized fiber cDNA library of G. barbadense. The ESTs were clustered and assembled into 5852 unigenes, consisting of 1492 contigs and 4360 singletons. The blastx result showed 2165 unigenes with significant similarity to known genes and 2687 unigenes with significant similarity to genes of predicted proteins. Functional classification revealed that unigenes were abundant in the functions of binding, catalytic activity, and metabolic pathways of carbohydrate, amino acid, energy, and lipids. The function motif/domain-related cytoskeleton and redox homeostasis were enriched. Among the 5852 unigenes, 282 and 736 unigenes were identified as potential cell wall biosynthesis and transcription factors, respectively. Furthermore, the relationships among cotton species or between cotton and other model plant systems were analyzed. Some putative species-specific unigenes of G. barbadense were highlighted. Conclusions/Significance: The ESTs generated in this study are from the first large-scale EST project for G. barbadense and significantly enhance the number of G. barbadense ESTs in public databases. This knowledge will contribute to cotton improvements by studying fiber development mechanisms of G. barbadense, establishing a breeding program using marker-assisted selection, and discovering candidate genes related to important agronomic traits of cotton through oligonucleotide array. Our work will also provide important resources for comparative genomics, polyploidization, and genome evolution among Gossypium species.	[Yuan, Daojun; Tu, Lili; Zhang, Xianlong] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University	Yuan, DJ (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China.	xlzhang@mail.hzau.edu.cn	Yuan, Daojun/D-5555-2011; Yuan, Daojun/R-6048-2016	Yuan, Daojun/0000-0001-6007-5571; Zhang, Xianlong/0000-0002-7703-524X	Ministry of Agriculture, China; National Basic Research Program of China (973 Program) [2010CB126001]; National Natural Science Foundation [30871560]	Ministry of Agriculture, China(Ministry of Agriculture & Rural Affairs); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was financially supported by the Ministry of Agriculture, China, the National Basic Research Program of China (973 Program) (http://www.973.gov.cn/, No. 2010CB126001) and the National Natural Science Foundation (http://www.nsfc.gov.cn/, No. 30871560). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ghazi Y, 2009, PLANT CELL PHYSIOL, V50, P1364, DOI 10.1093/pcp/pcp084; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; An CF, 2007, MOL GENET GENOMICS, V278, P539, DOI 10.1007/s00438-007-0270-9; Arpat AB, 2004, PLANT MOL BIOL, V54, P911, DOI 10.1007/s11103-004-0392-y; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P229, DOI [10.1007/BF02672073, DOI 10.1007/BF02672073]; BASRA AS, 1984, INT REV CYTOL, V89, P65, DOI 10.1016/S0074-7696(08)61300-5; Basu D, 2005, PLANT CELL, V17, P502, DOI 10.1105/tpc.104.027987; Bluthgen Nils, 2005, Genome Inform, V16, P106; Chaudhary B, 2008, EVOL DEV, V10, P567, DOI 10.1111/j.1525-142X.2008.00272.x; Chaudhary B, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-378; Chi JN, 2008, GENES GENET SYST, V83, P383, DOI 10.1266/ggs.83.383; Clark G, 2010, PLANT PHYSIOL, V152, P1073, DOI 10.1104/pp.109.147637; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Davies RT, 1999, PLANT CELL, V11, P365, DOI 10.1105/tpc.11.3.365; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Feng JX, 2004, ACTA BIOCH BIOPH SIN, V36, P51, DOI 10.1093/abbs/36.1.51; Finkemeier I, 2005, J BIOL CHEM, V280, P12168, DOI 10.1074/jbc.M413189200; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Girke T, 2004, PLANT PHYSIOL, V136, P3003, DOI 10.1104/pp.104.049965; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Guo AY, 2008, NUCLEIC ACIDS RES, V36, pD966, DOI 10.1093/nar/gkm841; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; He XC, 2008, J EXP BOT, V59, P2687, DOI 10.1093/jxb/ern127; Hovav R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040025; Hovav R, 2008, PLANTA, V227, P319, DOI 10.1007/s00425-007-0619-7; Huang GQ, 2008, PHYSIOL PLANTARUM, V134, P348, DOI 10.1111/j.1399-3054.2008.01139.x; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Ishida K, 2008, PLANT CELL PHYSIOL, V49, P47, DOI 10.1093/pcp/pcm165; Jakoby MJ, 2008, PLANT PHYSIOL, V148, P1583, DOI 10.1104/pp.108.126979; Jansson S, 2007, ANNU REV PLANT BIOL, V58, P435, DOI 10.1146/annurev.arplant.58.032806.103956; Jin LG, 2010, J INTEGR PLANT BIOL, V52, P485, DOI 10.1111/j.1744-7909.2010.00914.x; John ME, 1996, P NATL ACAD SCI USA, V93, P12768, DOI 10.1073/pnas.93.23.12768; Kim HJ, 2001, PLANT PHYSIOL, V127, P1361, DOI 10.1104/pp.010724; Kuhl JC, 2004, PLANT CELL, V16, P114, DOI 10.1105/tpc.017202; Labarga A, 2007, NUCLEIC ACIDS RES, V35, pW6, DOI 10.1093/nar/gkm291; Li HB, 2007, NEW PHYTOL, V175, P462, DOI 10.1111/j.1469-8137.2007.02120.x; Li L, 2007, J EXP BOT, V58, P3227, DOI 10.1093/jxb/erm167; Li XB, 2005, PLANT CELL, V17, P859, DOI 10.1105/tpc.104.029629; Li XB, 2002, PLANT PHYSIOL, V130, P666, DOI 10.1104/pp.005538; Li XB, 2010, J EXP BOT, V61, P41, DOI 10.1093/jxb/erp280; Li YJ, 2010, PLANT CELL REP, V29, P193, DOI 10.1007/s00299-009-0812-1; Liu DQ, 2008, PLANT MOL BIOL REP, V26, P98, DOI 10.1007/s11105-008-0026-7; Mei WQ, 2009, J GENET GENOMICS, V36, P141, DOI 10.1016/S1673-8527(08)60101-0; Moons A, 1998, PLANT J, V15, P89, DOI 10.1046/j.1365-313X.1998.00185.x; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Okamoto-Nakazato A, 2001, PLANT CELL PHYSIOL, V42, P952, DOI 10.1093/pcp/pce121; Okamoto-Nakazato A, 2000, PLANT CELL ENVIRON, V23, P155, DOI 10.1046/j.1365-3040.2000.00526.x; Oliveira EJ, 2006, GENET MOL BIOL, V29, P294, DOI 10.1590/S1415-47572006000200018; Parkinson J, 2003, BIOINFORMATICS, V19, P390, DOI 10.1093/bioinformatics/btf870; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Qin YM, 2007, PLANT CELL, V19, P3692, DOI 10.1105/tpc.107.054437; Rapp RA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-139; Ruan YL, 2004, PLANT PHYSIOL, V136, P4104, DOI 10.1104/pp.104.051540; Ruan YL, 2001, PLANT CELL, V13, P47, DOI 10.1105/tpc.13.1.47; Rudd S, 2003, TRENDS PLANT SCI, V8, P321, DOI 10.1016/S1360-1385(03)00131-6; Saha MC, 2006, THEOR APPL GENET, V113, P1449, DOI 10.1007/s00122-006-0391-2; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Smart LB, 1998, PLANT PHYSIOL, V116, P1539, DOI 10.1104/pp.116.4.1539; Song WQ, 2009, J EXP BOT, V60, P1839, DOI 10.1093/jxb/erp057; Squirrell J, 2003, MOL ECOL, V12, P1339, DOI 10.1046/j.1365-294X.2003.01825.x; Strader Lucia C, 2010, Plant Physiol, V153, P1577, DOI 10.1104/pp.110.157461; Titiz O, 2006, PLANT J, V48, P933, DOI 10.1111/j.1365-313X.2006.02928.x; Tu LL, 2007, PLANT CELL REP, V26, P1309, DOI 10.1007/s00299-007-0337-4; Udall JA, 2006, GENOME RES, V16, P441, DOI 10.1101/gr.4602906; Ulloa M, 2006, GENET RESOUR CROP EV, V53, P653, DOI 10.1007/s10722-004-2988-0; Wang HY, 2009, PLANT BIOTECHNOL J, V7, P13, DOI 10.1111/j.1467-7652.2008.00367.x; Wang HY, 2005, PLANTA, V222, P594, DOI 10.1007/s00425-005-0005-2; Wang JA, 2010, PLANT CELL PHYSIOL, V51, P1276, DOI 10.1093/pcp/pcq086; Weber H, 2004, PLANT J, V37, P877, DOI 10.1111/j.1365-313X.2003.02013.x; Wilkins TA, 2005, PHYSIOL PLANTARUM, V124, P295, DOI 10.1111/j.1399-3054.2005.00514.x; Xiao YH, 2010, J PLANT PHYSIOL, V167, P829, DOI 10.1016/j.jplph.2010.01.003; Xu WL, 2007, GENE, V389, P27, DOI 10.1016/j.gene.2006.09.014; Yang SS, 2006, PLANT J, V47, P761, DOI 10.1111/j.1365-313X.2006.02829.x; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; YU S, 2010, INT COTT IN GEN ICGI; Yu Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-15; Zhang DY, 2010, J PLANT PHYSIOL, V167, P393, DOI 10.1016/j.jplph.2009.10.005; Zhang H, 2011, NUCLEIC ACIDS RES, V39, pD1114, DOI 10.1093/nar/gkq1141; Zhang Li-Da, 2003, Acta Genetica Sinica, V30, P147; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zolman BK, 2007, PLANT MOL BIOL, V64, P59, DOI 10.1007/s11103-007-9134-2	83	21	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22758	10.1371/journal.pone.0022758	http://dx.doi.org/10.1371/journal.pone.0022758			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829504	Green Published, Green Submitted, gold			2022-12-25	WOS:000293284600040
J	Pereira, MG; Nakayasu, ES; Sant'Anna, C; De Cicco, NNT; Atella, GC; de Souza, W; Almeida, IC; Cunha-e-Silva, N				Pereira, Miria G.; Nakayasu, Ernesto S.; Sant'Anna, Celso; De Cicco, Nuccia N. T.; Atella, Georgia C.; de Souza, Wanderley; Almeida, Igor C.; Cunha-e-Silva, Narcisa			Trypanosoma cruzi Epimastigotes Are Able to Store and Mobilize High Amounts of Cholesterol in Reservosome Lipid Inclusions	PLOS ONE			English	Article							PROCYCLIC FORM; LIVING CELLS; FOAM CELL; TRAFFICKING; DIFFERENTIATION; ORGANELLES; PROTEIN; ABCA1; LDL; BIOSYNTHESIS	Background: Reservosomes are lysosome-related organelles found in Trypanosoma cruzi epimastigotes. They represent the last step in epimastigote endocytic route, accumulating a set of proteins and enzymes related to protein digestion and lipid metabolism. The reservosome matrix contains planar membranes, vesicles and lipid inclusions. Some of the latter may assume rectangular or sword-shaped crystalloid forms surrounded by a phospholipid monolayer, resembling the cholesterol crystals in foam cells. Methodology/Principal Findings: Using Nile Red fluorimetry and fluorescence microscopy, as well as electron microscopy, we have established a direct correlation between serum concentration in culture medium and the presence of crystalloid lipid inclusions. Starting from a reservosome purified fraction, we have developed a fractionation protocol to isolate lipid inclusions. Gas-chromatography mass-spectrometry (GC-MS) analysis revealed that lipid inclusions are composed mainly by cholesterol and cholesterol esters. Moreover, when the parasites with crystalloid lipid-loaded reservosomes were maintained in serum free medium for 48 hours the inclusions disappeared almost completely, including the sword shaped ones. Conclusions/Significance: Taken together, our results suggest that epimastigote forms of T. cruzi store high amounts of neutral lipids from extracellular medium, mostly cholesterol or cholesterol esters inside reservosomes. Interestingly, the parasites are able to disassemble the reservosome cholesterol crystalloid inclusions when submitted to serum starvation.	[Pereira, Miria G.; Sant'Anna, Celso; de Souza, Wanderley; Cunha-e-Silva, Narcisa] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; [Nakayasu, Ernesto S.; Almeida, Igor C.] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; [Sant'Anna, Celso; de Souza, Wanderley] Inst Nacl Metrol Normatizacao & Qualidade Ind, Rio De Janeiro, Brazil; [De Cicco, Nuccia N. T.; Atella, Georgia C.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil; [Pereira, Miria G.; Sant'Anna, Celso; de Souza, Wanderley; Cunha-e-Silva, Narcisa] Inst Nacl Ciencia & Tecnol Biol Estruct & Bioimag, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; University of Texas System; University of Texas El Paso; Universidade Federal do Rio de Janeiro	Pereira, MG (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil.	narcisa@biof.ufrj.br	Almeida, Igor C./AAF-9409-2019; Atella, Georgia/AAK-7897-2020; Pereira, Miria G/AAJ-9998-2021; Cunha-e-Silva, Narcisa L/Q-2902-2018; Nakayasu, Ernesto S./AAJ-8374-2020	Almeida, Igor C./0000-0002-2443-8213; Cunha-e-Silva, Narcisa L/0000-0003-4863-4945; Nakayasu, Ernesto S./0000-0002-4056-2695; Pereira, Miria G/0000-0001-9103-0448	CNPq; FAPERJ; NIH [SO6GM00812, 2G12RR008124-16A1, 2G12RR008124-16A1S1]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR008124] Funding Source: NIH RePORTER	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by Brazilian agencies CNPq and FAPERJ, as well as by NIH grants SO6GM00812, 2G12RR008124-16A1, and 2G12RR008124-16A1S1. The authors are grateful to the Biomolecule Analysis Core Facility/BBRC/UTEP, supported by NIH grants 2G12RR008124-16A1 and 2G12RR008124-16A1S1 for the access to the GC-MS instrument. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida IC, 2000, EMBO J, V19, P1476, DOI 10.1093/emboj/19.7.1476; Bastin P, 1996, MOL BIOCHEM PARASIT, V76, P43, DOI 10.1016/0166-6851(95)02537-5; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bobryshev YV, 2006, MICRON, V37, P208, DOI 10.1016/j.micron.2005.10.007; BRONIA DH, 1986, EXP PARASITOL, V61, P151, DOI 10.1016/0014-4894(86)90147-5; CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93; CARREIRO IAP, 2000, EUR J CELL BIOL, V79, P858; Cavelier C, 2006, BBA-MOL CELL BIOL L, V1761, P655, DOI 10.1016/j.bbalip.2006.04.012; CHAM BE, 1976, J LIPID RES, V17, P176; CHAPMAN MJ, 1981, J LIPID RES, V22, P339; COPPENS I, 1988, P NATL ACAD SCI USA, V85, P6753, DOI 10.1073/pnas.85.18.6753; Cunha-e-Silva N, 2006, PARASITOL RES, V99, P325, DOI 10.1007/s00436-006-0190-3; Cunha-e-Silva NL, 2002, FEMS MICROBIOL LETT, V214, P7, DOI 10.1111/j.1574-6968.2002.tb11317.x; de Souza W, 2009, PROG HISTOCHEM CYTO, V44, P67, DOI 10.1016/j.proghi.2009.01.001; DESOUZA W, 2009, INTERDISCIPL PERSPEC; Devlin C, 2010, TRAFFIC, V11, P601, DOI 10.1111/j.1600-0854.2010.01046.x; ESTEVES MG, 1989, FEMS MICROBIOL LETT, V59, P31; Figueiredo RCBQ, 2000, J PARASITOL, V86, P1213, DOI 10.1645/0022-3395(2000)086[1213:DOTCEM]2.0.CO;2; FlorinChristensen M, 1997, MOL BIOCHEM PARASIT, V88, P25, DOI 10.1016/S0166-6851(97)00056-X; Fridberg A, 2008, J CELL SCI, V121, P522, DOI 10.1242/jcs.016741; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Green HP, 2003, J BIOL CHEM, V278, P422, DOI 10.1074/jbc.M207215200; Hao MM, 2002, J BIOL CHEM, V277, P609, DOI 10.1074/jbc.M108861200; Holtta-Vuori M, 2008, TRAFFIC, V9, P1839, DOI 10.1111/j.1600-0854.2008.00801.x; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Ikonen E, 2006, PHYSIOL REV, V86, P1237, DOI 10.1152/physrev.00022.2005; ISOLA ELD, 1986, EXP PARASITOL, V62, P329, DOI 10.1016/0014-4894(86)90039-1; KLINKNER AM, 1995, J HISTOCHEM CYTOCHEM, V43, P1071, DOI 10.1177/43.10.7560885; LAZARDI K, 1990, ANTIMICROB AGENTS CH, V34, P2097, DOI 10.1128/AAC.34.11.2097; Lee MGS, 1999, MOL BIOCHEM PARASIT, V100, P153, DOI 10.1016/S0166-6851(99)00009-2; Liendo A, 1999, MOL BIOCHEM PARASIT, V104, P81, DOI 10.1016/S0166-6851(99)00129-2; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu JY, 2000, J BIOL CHEM, V275, P12032, DOI 10.1074/jbc.275.16.12032; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Maldonado RA, 2006, J PARASITOL, V92, P1064, DOI 10.1645/GE-845R.1; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Martin S, 2008, METHOD ENZYMOL, V438, P109, DOI 10.1016/S0076-6879(07)38008-7; Mesmin B, 2009, BBA-MOL CELL BIOL L, V1791, P636, DOI 10.1016/j.bbalip.2009.03.002; Mobius W, 2003, TRAFFIC, V4, P222; Neufeld EB, 2004, J BIOL CHEM, V279, P15571, DOI 10.1074/jbc.M314160200; Neufeld EB, 2001, J BIOL CHEM, V276, P27584, DOI 10.1074/jbc.M103264200; Pernet F, 2006, J CHROMATOGR A, V1137, P127, DOI 10.1016/j.chroma.2006.10.059; Sant'Anna C, 2004, MICROSC MICROANAL, V10, P637, DOI 10.1017/S1431927604040863; Sant'Anna C, 2008, HISTOCHEM CELL BIOL, V130, P1187, DOI 10.1007/s00418-008-0486-8; Sant'Anna C, 2008, MICROSC RES TECHNIQ, V71, P599, DOI 10.1002/jemt.20592; Sant'Anna C, 2009, PROTEOMICS, V9, P1782, DOI 10.1002/pmic.200800730; SOARES MJ, 1991, PARASITOL RES, V77, P461, DOI 10.1007/BF00928410; SOARES MJ, 1989, PARASITOL RES, V75, P522, DOI 10.1007/BF00931160; SOARES MJ, 1988, J SUBMICR CYTOL PATH, V20, P349; Soccio RE, 2004, ARTERIOSCL THROM VAS, V24, P1150, DOI 10.1161/01.ATV.0000131264.66417.d5; Sugii S, 2003, J BIOL CHEM, V278, P27180, DOI 10.1074/jbc.M300542200; TANGIRALA RK, 1994, J LIPID RES, V35, P93; Torres C, 2004, MOL MICROBIOL, V54, P632, DOI 10.1111/j.1365-2958.2004.04304.x; TURRENS JF, 1980, MEDICINA-BUENOS AIRE, V40, P137; URBINA JA, 1993, ANTIMICROB AGENTS CH, V37, P580, DOI 10.1128/AAC.37.3.580; Urbina JA, 2009, MEM I OSWALDO CRUZ, V104, P311, DOI 10.1590/S0074-02762009000900041; Villasuso AL, 2005, BBA-MOL CELL BIOL L, V1735, P185, DOI 10.1016/j.bbalip.2005.06.004	57	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22359	10.1371/journal.pone.0022359	http://dx.doi.org/10.1371/journal.pone.0022359			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818313	Green Published, gold, Green Submitted			2022-12-25	WOS:000293282700024
J	Wang, XC; Brown, PM; Zhang, YN; Song, LP				Wang, Xiaochun; Brown, Peter M.; Zhang, Yanni; Song, Laiping			Imprint of the Atlantic Multidecadal Oscillation on Tree-Ring Widths in Northeastern Asia since 1568	PLOS ONE			English	Article							CLIMATE VARIABILITY; RAINFALL; DROUGHT; PACIFIC; CYCLES	We present a new tree-ring reconstruction of the Atlantic Multidecadal Oscillation (AMO) spanning 1568-2007 CE from northeast Asia. Comparison of the instrumental AMO index, an existing tree-ring based AMO reconstruction, and this new record show strongly similar annual to multidecadal patterns of variation over the last 440 years. Warm phases of the AMO are related to increases in growth of Scots pine trees and moisture availability in northeast China and central eastern Siberia. Multi-tape method (MTM) and cross-wavelet analyses indicate that robust multidecadal (similar to 64-128 years) variability is present throughout the new proxy record. Our results have important implications concerning the influence of North Atlantic sea surface temperatures on East Asian climate, and provide support for the possibility of an AMO signature on global multidecadal climate variability.	[Wang, Xiaochun; Song, Laiping] NE Forestry Univ, Coll Forestry, Harbin, Heilongjiang, Peoples R China; [Brown, Peter M.] Rocky Mt Tree Ring Res, Ft Collins, CO USA; [Zhang, Yanni] NE Forestry Univ, Coll Landscape Architecture, Harbin, Heilongjiang, Peoples R China	Northeast Forestry University - China; Northeast Forestry University - China	Wang, XC (corresponding author), NE Forestry Univ, Coll Forestry, Harbin, Heilongjiang, Peoples R China.	wangxc-cf@nefu.edu.cn	Wang, Xiaochun/AAW-9444-2020	Wang, Xiaochun/0000-0002-8897-5077	National Natural Science Foundation of China [30970481]; Fundamental Research Funds for the Central Universities [DL10CA07]; Ministry of Finance [201104006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Ministry of Finance	This research was supported by the National Natural Science Foundation of China (Grant No. 30970481), the Fundamental Research Funds for the Central Universities (Grant No. DL10CA07) and the Special Fund Projects of Ministry of Finance (Grant No. 201104006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	D'Arrigo R, 2006, INT J CLIMATOL, V26, P1607, DOI 10.1002/joc.1326; Dai A, 2004, J HYDROMETEOROL, V5, P1117, DOI 10.1175/JHM-386.1; Delworth TL, 2000, CLIM DYNAM, V16, P661, DOI 10.1007/s003820000075; Enfield DB, 2001, GEOPHYS RES LETT, V28, P2077, DOI 10.1029/2000GL012745; Feng S, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032484; Folland CK, 2001, J CLIMATE, V14, P1937, DOI 10.1175/1520-0442(2001)014&lt;1937:PONBRA&gt;2.0.CO;2; Fortin D, 2009, CLIM DYNAM, V33, P427, DOI 10.1007/s00382-008-0422-6; Goswami BN, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024803; Gray ST, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019932; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Hubeny JB, 2006, GEOLOGY, V34, P569, DOI 10.1130/G22671.1; Kaplan A, 1998, J GEOPHYS RES-OCEANS, V103, P18567, DOI 10.1029/97JC01734; Kerr RA, 2000, SCIENCE, V288, P1984, DOI 10.1126/science.288.5473.1984; Kitzberger T, 2007, P NATL ACAD SCI USA, V104, P543, DOI 10.1073/pnas.0606078104; Knight JR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026242; Knight JR, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024233; Kravtsov S, 2008, J CLIMATE, V21, P1104, DOI 10.1175/2007JCLI1874.1; Li SL, 2007, ADV ATMOS SCI, V24, P126, DOI 10.1007/s00376-007-0126-6; Lu RY, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027655; Mann ME, 1996, CLIMATIC CHANGE, V33, P409, DOI 10.1007/BF00142586; McCabe GJ, 2004, P NATL ACAD SCI USA, V101, P4136, DOI 10.1073/pnas.0306738101; Poore RZ, 2009, GEO-MAR LETT, V29, P477, DOI 10.1007/s00367-009-0154-6; Rigling A, 2001, CAN J FOREST RES, V31, P18, DOI 10.1139/cjfr-31-1-18; Shanahan TM, 2009, SCIENCE, V324, P377, DOI 10.1126/science.1166352; Sutton RT, 2005, SCIENCE, V309, P115, DOI 10.1126/science.1109496; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Wang SW, 2004, ADV ATMOS SCI, V21, P307, DOI 10.1007/BF02915560; Wang YM, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010929; Zhang R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026267; Zhang R, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028683	30	30	36	5	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22740	10.1371/journal.pone.0022740	http://dx.doi.org/10.1371/journal.pone.0022740			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818380	Green Submitted, gold, Green Published			2022-12-25	WOS:000293282700070
J	Whyteside, G; Alcocer, MJC; Kumita, JR; Dobson, CM; Lazarou, M; Pleass, RJ; Archer, DB				Whyteside, Graham; Alcocer, Marcos J. C.; Kumita, Janet R.; Dobson, Christopher M.; Lazarou, Maria; Pleass, Richard J.; Archer, David B.			Native-State Stability Determines the Extent of Degradation Relative to Secretion of Protein Variants from Pichia pastoris	PLOS ONE			English	Article							HUMAN LYSOZYME; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; AMYLOIDOGENIC VARIANTS; ASPERGILLUS-NIGER; MUTATIONS; SEQUENCE; GENOME; FRAGMENTS; MECHANISM	We have investigated the relationship between the stability and secreted yield of a series of mutational variants of human lysozyme (HuL) in Pichia pastoris. We show that genes directly involved in the unfolded protein response (UPR), ER-associated degradation (ERAD) and ER-phagy are transcriptionally up-regulated more quickly and to higher levels in response to expression of more highly-destabilised HuL variants and those variants are secreted to lower yield. We also show that the less stable variants are retained within the cell and may also be targeted for degradation. To explore the relationship between stability and secretion further, two different single-chain-variable-fragment (scFv) antibodies were also expressed in P. pastoris, but only one of the scFvs gave rise to secreted protein. The non-secreted scFv was detected within the cell and the UPR indicators were pronounced, as they were for the poorly-secreted HuL variants. The non-secreted scFv was modified by changing either the framework regions or the linker to improve the predicted stability of the scFv and secretion was then achieved and the levels of UPR indicators were lowered Our data support the hypothesis that less stable proteins are targeted for degradation over secretion and that this accounts for the decrease in the yields observed. We discuss the secretion of proteins in relation to lysozyme amyloidosis, in particular, and optimised protein secretion, in general.	[Whyteside, Graham; Lazarou, Maria; Pleass, Richard J.; Archer, David B.] Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England; [Alcocer, Marcos J. C.] Univ Nottingham, Sch Biosci, Loughborough, Notts, England; [Kumita, Janet R.; Dobson, Christopher M.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Lazarou, Maria; Pleass, Richard J.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	University of Nottingham; University of Nottingham; University of Cambridge; Liverpool School of Tropical Medicine; University of Liverpool	Whyteside, G (corresponding author), Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England.	david.archer@nottingham.ac.uk	Alcocer, Marcos J C/F-3218-2012; Pleass, Richard/N-7831-2019; Kumita, Janet/AAO-5254-2021; Pleass, Richard J/L-4148-2015	Pleass, Richard/0000-0001-7438-8296; Pleass, Richard J/0000-0001-7438-8296; Alcocer, Marcos/0000-0002-6828-2855	BBSRC [BB/F004389/1, BB/E019927/1]; Marie-Curie Excellence grant; MRC; BBSRC [BB/H003843/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H003843/1, BB/E019927/1, BB/F004389/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Marie-Curie Excellence grant(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding was provided by the BBSRC (BRIC : BB/F004389/1 [GW, MJCA, DBA] and BB/E019927/1 [JRK, CMD]). RJP and ML were supported by a Marie-Curie Excellence grant and the MRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; ARCHER DB, 1990, BIO-TECHNOL, V8, P741, DOI 10.1038/nbt0890-741; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; De Schutter K, 2009, NAT BIOTECHNOL, V27, P561, DOI 10.1038/nbt.1544; Demain Arnold L., 2008, V65; Dumoulin M, 2005, J MOL BIOL, V346, P773, DOI 10.1016/j.jmb.2004.11.020; Dumoulin M, 2006, ACCOUNTS CHEM RES, V39, P603, DOI 10.1021/ar050070g; FELGENHAUER M, 1990, NUCLEIC ACIDS RES, V18, P4927, DOI 10.1093/nar/18.16.4927; Gasser B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-179; Gonzalez TN, 1999, EMBO J, V18, P3119, DOI 10.1093/emboj/18.11.3119; Graf A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-390; Guillemette T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-158; HARFORD N, 1987, POSTGRAD MED J, V63, P65; Idiris A, 2010, APPL MICROBIOL BIOT, V86, P403, DOI 10.1007/s00253-010-2447-0; Idiris A, 2010, APPL MICROBIOL BIOT, V85, P667, DOI 10.1007/s00253-009-2151-0; KOHNO K, 1993, MOL CELL BIOL, V13, P877, DOI 10.1128/MCB.13.2.877; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Kruse KB, 2006, AUTOPHAGY, V2, P135, DOI 10.4161/auto.2.2.2388; Kumita JR, 2006, FEBS J, V273, P711, DOI 10.1111/j.1742-4658.2005.05099.x; Lazarou M, 2009, INFECT IMMUN, V77, P5659, DOI 10.1128/IAI.00167-09; Leber JH, 2004, PLOS BIOL, V2, P1197, DOI 10.1371/journal.pbio.0020235; Mattanovich D, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-53; MCBRIDE JS, 1987, MOL BIOCHEM PARASIT, V23, P71, DOI 10.1016/0166-6851(87)90189-7; Monsellier E, 2006, J MOL BIOL, V362, P580, DOI 10.1016/j.jmb.2006.07.044; Niwa M, 2005, GENOME BIOL, V6; Patil CK, 2004, PLOS BIOL, V2, P1208, DOI 10.1371/journal.pbio.0020246; Payne T, 2008, FEBS LETT, V582, P503, DOI 10.1016/j.febslet.2008.01.009; PEPYS MB, 1993, NATURE, V362, P553, DOI 10.1038/362553a0; Schmidt FR, 2004, APPL MICROBIOL BIOT, V65, P363, DOI 10.1007/s00253-004-1656-9; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; STEIPE B, 1994, J MOL BIOL, V240, P188, DOI 10.1006/jmbi.1994.1434; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Wain R, 2005, J MOL BIOL, V351, P662, DOI 10.1016/j.jmb.2005.06.035; Worn A, 2001, J MOL BIOL, V305, P989, DOI 10.1006/jmbi.2000.4265; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200	37	38	41	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22692	10.1371/journal.pone.0022692	http://dx.doi.org/10.1371/journal.pone.0022692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818368	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000293282700061
J	Yang, J; Chen, YW				Yang, Jing; Chen, Yingwu			Fast Computing Betweenness Centrality with Virtual Nodes on Large Sparse Networks	PLOS ONE			English	Article							COMPLEX; DYNAMICS	Betweenness centrality is an essential index for analysis of complex networks. However, the calculation of betweenness centrality is quite time-consuming and the fastest known algorithm uses O(N(M + N log N)) time and O(N + M) space for weighted networks, where N and M are the number of nodes and edges in the network, respectively. By inserting virtual nodes into the weighted edges and transforming the shortest path problem into a breadth-first search (BFS) problem, we propose an algorithm that can compute the betweenness centrality in O((w) over bar(D) over barN(2)) time for integer-weighted networks, where (w) over bar is the average weight of edges and (D) over bar is the average degree in the network. Considerable time can be saved with the proposed algorithm when (w) over bar < log N/<(D)over bar> + 1, indicating that it is suitable for lightly weighted large sparse networks. A similar concept of virtual node transformation can be used to calculate other shortest path based indices such as closeness centrality, graph centrality, stress centrality, and so on. Numerical simulations on various randomly generated networks reveal that it is feasible to use the proposed algorithm in large network analysis.	[Yang, Jing; Chen, Yingwu] Natl Univ Def Technol, Dept Informat Syst & Management, Changsha, Hunan, Peoples R China	National University of Defense Technology - China	Yang, J (corresponding author), Natl Univ Def Technol, Dept Informat Syst & Management, Changsha, Hunan, Peoples R China.	jing_edu@sohu.com			National Science Foundation [70971131]	National Science Foundation(National Science Foundation (NSF))	This work is funded by the National Science Foundation (no. 70971131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; BADER DA, APPROXIMATING CENTRA; Bader DA, 2006, PROC INT CONF PARAL, P539, DOI 10.1109/ICPP.2006.57; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Dijkstra E. W., 1959, NUMER MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; FREDMAN ML, 1987, J ACM, V34, P596, DOI 10.1145/28869.28874; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; HAGE P, 1995, SOC NETWORKS, V17, P57, DOI 10.1016/0378-8733(94)00248-9; Holme Petter, 2002, Phys Rev E Stat Nonlin Soft Matter Phys, V65, P066109; Jiang Karl, 2009, Proceedings of the 2009 International Conference on Parallel Processing (ICPP 2009), P542, DOI 10.1109/ICPP.2009.76; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Panzarasa P, 2009, J AM SOC INF SCI TEC, V60, P911, DOI 10.1002/asi.21015; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Puzis R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.056709; SABIDUSSI G, 1966, PSYCHOMETRIKA, V31, P581, DOI 10.1007/BF02289527; Schwartz N, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.015104; Scott J., 2000, SOCIAL STRUCTURE, V2nd; SHIMBEL ALFONSO, 1953, BULL MATH BIOPHYS, V15, P501, DOI 10.1007/BF02476438; SKVORETZ J, 2003, COMPLEXITY, P47; TAN G, 2009, J SUPERCOMPUT, P1; Tan Guangming, 2009, P INT C PAR PROC, P340; Tu DB, 2009, 2009 IEEE INTERNATIONAL SYMPOSIUM ON PARALLEL AND DISTRIBUTED PROCESSING WITH APPLICATIONS, PROCEEDINGS, P182, DOI 10.1109/ISPA.2009.18; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yook SH, 2002, P NATL ACAD SCI USA, V99, P13382, DOI 10.1073/pnas.172501399; [No title captured]	34	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22557	10.1371/journal.pone.0022557	http://dx.doi.org/10.1371/journal.pone.0022557			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818337	Green Submitted, Green Published, gold			2022-12-25	WOS:000293282700038
J	Valastyan, JS; Lindquist, S				Valastyan, Julie S.; Lindquist, Susan			TorsinA and the TorsinA-Interacting Protein Printor Have No Impact on Endoplasmic Reticulum Stress or Protein Trafficking in Yeast	PLOS ONE			English	Article							DYSTONIA-ASSOCIATED PROTEIN; ALPHA-SYNUCLEIN; EXPRESSION; CLONING; CELLS; GENE; TRANSFORMATION; LOCALIZATION; REVEALS	Early-onset torsion dystonia is a severe, life-long disease that leads to loss of motor control and involuntary muscle contractions. While the molecular etiology of the disease is not fully understood, a mutation in an AAA+ ATPase, torsinA, has been linked to disease onset. Previous work on torsinA has shown that it localizes to the endoplasmic reticulum, where there is evidence that it plays roles in protein trafficking, and potentially also protein folding. Given the high level of evolutionary conservation among proteins involved in these processes, the ability of human such proteins to function effectively in yeast, as well as the previous successes achieved in examining other proteins involved in complex human diseases in yeast, we hypothesized that Saccharomyces cerevisiae might represent a useful model system for studying torsinA function and the effects of its mutants. Since torsinA is proposed to function in protein homeostasis, we tested cells for their ability to respond to various stressors, using a fluorescent reporter to measure the unfolded protein response, as well as their rate of protein secretion. TorsinA did not impact these processes, even after co-expression of its recently identified interacting partner, printor. In light of these findings, we propose that yeast may lack an additional cofactor necessary for torsinA function or proteins required for essential post-translational modifications of torsinA. Alternatively, torsinA may not function in endoplasmic reticulum protein homeostasis. The strains and assays we describe may provide useful tools for identifying and investigating these possibilities and are freely available.	[Valastyan, Julie S.; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Valastyan, Julie S.; Lindquist, Susan] MIT, Dept Biol, Cambridge, MA USA; [Lindquist, Susan] MIT, Howard Hughes Med Inst, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Valastyan, JS (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lindquist_admin@wi.mit.edu			Howard Hughes Medical Institute (HHMI); Bachmann-Strauss Dystonia and Parkinson Foundation	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Bachmann-Strauss Dystonia and Parkinson Foundation	This work was supported by Howard Hughes Medical Institute (HHMI) (http://www.hhmi.org/) and the Bachmann-Strauss Dystonia and Parkinson Foundation (http://www.dystonia-parkinsons.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; Bharadwaj P, 2008, J ALZHEIMERS DIS, V13, P147; BRESSMAN SB, 1994, ANN NEUROL, V36, P771, DOI 10.1002/ana.410360514; BURDETTE AJ, 2010, CELL STRESS CHAPERON; Caine J, 2007, FEMS YEAST RES, V7, P1230, DOI 10.1111/j.1567-1364.2007.00285.x; Cao SS, 2005, J NEUROSCI, V25, P3801, DOI 10.1523/JNEUROSCI.5157-04.2005; Chen P, 2010, HUM MOL GENET, V19, P3502, DOI 10.1093/hmg/ddq266; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Giles LM, 2008, HUM MOL GENET, V17, P2712, DOI 10.1093/hmg/ddn173; Giles LM, 2009, J BIOL CHEM, V284, P21765, DOI 10.1074/jbc.M109.004838; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Gordon KL, 2011, NEUROCHEM RES, V36, P452, DOI 10.1007/s11064-010-0363-4; Granata A, 2008, J BIOL CHEM, V283, P7568, DOI 10.1074/jbc.M704097200; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Hewett J, 2003, J NEUROSCI RES, V72, P158, DOI 10.1002/jnr.10567; Hewett JW, 2007, P NATL ACAD SCI USA, V104, P7271, DOI 10.1073/pnas.0701185104; Khurana V, 2010, NAT REV NEUROSCI, V11, P436, DOI 10.1038/nrn2809; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Kustedjo K, 2000, J BIOL CHEM, V275, P27933; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Liu ZH, 2003, BIOCHEM J, V374, P117, DOI 10.1042/BJ20030258; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; Middendorp O, 2004, BIOL CHEM, V385, P481, DOI 10.1515/BC.2004.056; Mori K, 2009, J BIOCHEM, V146, P743, DOI 10.1093/jb/mvp166; Nagase T, 2000, DNA RES, V7, P65, DOI 10.1093/dnares/7.1.65; Naismith TV, 2004, P NATL ACAD SCI USA, V101, P7612, DOI 10.1073/pnas.0308760101; NISHIKAWA S, 1993, P NATL ACAD SCI USA, V90, P8179, DOI 10.1073/pnas.90.17.8179; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; Perrin V, 2007, MOL THER, V15, P903, DOI 10.1038/mt.sj.6300141; Piper PW, 2003, GENE, V302, P165, DOI 10.1016/S0378-1119(02)01102-2; Pogulis R J, 1996, Methods Mol Biol, V57, P167; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Ronicke V, 1997, METHOD ENZYMOL, V283, P313; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Shashidharan P, 2000, BRAIN RES, V877, P379, DOI 10.1016/S0006-8993(00)02702-5; Shashidharan P, 2000, BRAIN RES, V853, P197, DOI 10.1016/S0006-8993(99)02232-5; Su LHJ, 2010, DIS MODEL MECH, V3, P194, DOI 10.1242/dmm.004267; TOKUNAGA M, 1992, J BIOL CHEM, V267, P17553; Torres GE, 2004, P NATL ACAD SCI USA, V101, P15650, DOI 10.1073/pnas.0308088101; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Yeger-Lotem E, 2009, NAT GENET, V41, P316, DOI 10.1038/ng.337; Zhu L, 2008, MOL BIOL CELL, V19, P3599, DOI 10.1091/mbc.E08-01-0015	53	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e22744	10.1371/journal.pone.0022744	http://dx.doi.org/10.1371/journal.pone.0022744			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21818381	Green Submitted, Green Published, gold			2022-12-25	WOS:000293175100046
J	Zheng, SH; Huang, JH; Zhou, KW; Zhang, CX; Xiang, QL; Tan, Z; Wang, TH; Fu, XD				Zheng, Shuhui; Huang, Jinghe; Zhou, Kewen; Zhang, Chengxi; Xiang, Qiuling; Tan, Zhi; Wang, Tinghuai; Fu, Xiaodong			17 beta-Estradiol Enhances Breast Cancer Cell Motility and Invasion via Extra-Nuclear Activation of Actin-Binding Protein Ezrin	PLOS ONE			English	Article							FOCAL ADHESION KINASE; ESTROGEN-RECEPTOR; IN-VIVO; ERM PROTEINS; EZRIN/RADIXIN/MOESIN PROTEINS; ENDOTHELIAL-CELLS; TYROSINE KINASES; CARCINOMA CELLS; GROWTH-FACTOR; SRC KINASE	Estrogen promotes breast cancer metastasis. However, the detailed mechanism remains largely unknown. The actin binding protein ezrin is a key component in tumor metastasis and its over-expression is positively correlated to the poor outcome of breast cancer. In this study, we investigate the effects of 17 beta-estradiol (E2) on the activation of ezrin and its role in estrogen-dependent breast cancer cell movement. In T47-D breast cancer cells, E2 rapidly enhances ezrin phosphorylation at Thr(567) in a time-and concentration-dependent manner. The signalling cascade implicated in this action involves estrogen receptor (ER) interaction with the non-receptor tyrosine kinase c-Src, which activates the phosphatidylinositol-3 kinase/Akt pathway and the small GTPase RhoA/Rho-associated kinase (ROCK-2) complex. E2 enhances the horizontal cell migration and invasion of T47-D breast cancer cells in three-dimensional matrices, which is reversed by transfection of cells with specific ezrin siRNAs. In conclusion, E2 promotes breast cancer cell movement and invasion by the activation of ezrin. These results provide novel insights into the effects of estrogen on breast cancer progression and highlight potential targets to treat endocrine-sensitive breast cancers.	[Zheng, Shuhui; Huang, Jinghe; Zhou, Kewen; Xiang, Qiuling; Tan, Zhi; Wang, Tinghuai; Fu, Xiaodong] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Physiol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Chengxi] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Cardiovasc Internal Med, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zheng, SH (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Physiol, Guangzhou 510275, Guangdong, Peoples R China.	wangth@mail.sysu.edu.cn; fuxiaod@mail.sysu.edu.cn		Fu, Xiaodong/0000-0003-2754-8976	Ministry of Education of China [20090171120052]; Scientific Research Foundation for Returned Scholars, Ministry of Education of China [4115015]	Ministry of Education of China(Ministry of Education, China); Scientific Research Foundation for Returned Scholars, Ministry of Education of China(Scientific Research Foundation for the Returned Overseas Chinese ScholarsMinistry of Education, China)	This work has been supported by the Doctoral Fund of Ministry of Education of China (To XD Fu, No: 20090171120052) and by the Scientific Research Foundation for Returned Scholars, Ministry of Education of China (to XD Fu, Grant No: 4115015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Applanat MP, 2008, ADV EXP MED BIOL, V617, P437, DOI 10.1007/978-0-387-69080-3_42; Bendrik C, 2009, J IMMUNOL, V182, P371, DOI 10.4049/jimmunol.182.1.371; BERRYMAN M, 1993, J CELL SCI, V105, P1025; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Bruce B, 2007, CLIN EXP METASTAS, V24, P69, DOI 10.1007/s10585-006-9050-x; Cant SH, 2005, MOL BIOL CELL, V16, P3088, DOI 10.1091/mbc.E04-10-0877; Chambliss KL, 2010, J CLIN INVEST, V120, P2319, DOI 10.1172/JCI38291; Chan TO, 2002, CANCER CELL, V1, P181, DOI 10.1016/S1535-6108(02)00033-8; CHIEN EJ, 1991, MOL CELL ENDOCRINOL, V81, P53, DOI 10.1016/0303-7207(91)90204-6; Chuan YC, 2006, J BIOL CHEM, V281, P29938, DOI 10.1074/jbc.M602237200; Croft DR, 2004, CANCER RES, V64, P8994, DOI 10.1158/0008-5472.CAN-04-2052; Cui YZ, 2010, CANCER INVEST, V28, P242, DOI 10.3109/07357900903124498; Elliott BE, 2005, BREAST CANCER RES, V7, pR365, DOI 10.1186/bcr1006; Etique N, 2006, ONCOL REP, V15, P603; Fadiel A, 2008, MATURITAS, V60, P31, DOI 10.1016/j.maturitas.2008.03.007; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Fu XD, 2008, IUBMB LIFE, V60, P502, DOI 10.1002/iub.80; Fu XD, 2008, MOL HUM REPROD, V14, P225, DOI 10.1093/molehr/gan010; Fu XD, 2007, SEMIN REPROD MED, V25, P178, DOI 10.1055/s-2007-973430; Fu XD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002790; Gautreau A, 1999, P NATL ACAD SCI USA, V96, P7300, DOI 10.1073/pnas.96.13.7300; Giretti MS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002238; Greger JG, 2007, MOL CELL BIOL, V27, P1904, DOI 10.1128/MCB.01732-06; GREM JL, 1995, MOL PHARMACOL, V48, P305; Hebert M, 2008, J IMMUNOL, V181, P5963, DOI 10.4049/jimmunol.181.9.5963; Heiska L, 2005, J BIOL CHEM, V280, P10244, DOI 10.1074/jbc.M411353200; Ivetic A, 2004, IMMUNOLOGY, V112, P165, DOI 10.1111/j.1365-2567.2004.01882.x; Janni W, 2010, CANCER TREAT REV, V36, P249, DOI 10.1016/j.ctrv.2009.12.010; Ju XM, 2007, P NATL ACAD SCI USA, V104, P7438, DOI 10.1073/pnas.0605874104; Kang YK, 2010, MOL CARCINOGEN, V49, P798, DOI 10.1002/mc.20653; Kedrin D, 2007, J MAMMARY GLAND BIOL, V12, P143, DOI 10.1007/s10911-007-9046-4; Kim C, 2009, CANCER RES TREAT, V41, P138, DOI 10.4143/crt.2009.41.3.138; Kobel M, 2006, MODERN PATHOL, V19, P581, DOI 10.1038/modpathol.3800567; Koga F, 2006, P NATL ACAD SCI USA, V103, P11318, DOI 10.1073/pnas.0604705103; Lee JH, 2004, J CELL BIOL, V167, P327, DOI 10.1083/jcb.200403091; Levin ER, 2009, TRENDS ENDOCRIN MET, V20, P477, DOI 10.1016/j.tem.2009.06.009; Li JJ, 2010, ONCOL REP, V24, P965, DOI 10.3892/or_00000943; Li Q, 2008, CANCER LETT, V261, P55, DOI 10.1016/j.canlet.2007.11.018; Lin Y, 2004, INT J CANCER, V109, P507, DOI 10.1002/ijc.11724; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; Matsui T, 1999, CURR BIOL, V9, P1259, DOI 10.1016/S0960-9822(99)80508-9; Migliaccio A, 2006, ANN NY ACAD SCI, V1089, P194, DOI 10.1196/annals.1386.006; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; Oesterreich S, 2003, CANCER RES, V63, P5203; Planas-Silva MD, 2006, BIOCHEM BIOPH RES CO, V341, P73, DOI 10.1016/j.bbrc.2005.12.164; Prag S, 2007, MOL BIOL CELL, V18, P2935, DOI 10.1091/mbc.E06-11-1031; Quang CT, 2000, EMBO J, V19, P4565, DOI 10.1093/emboj/19.17.4565; Rahman MA, 2010, J BIOL CHEM, V285, P3806, DOI 10.1074/jbc.M109.059782; Raz L, 2008, NEUROSIGNALS, V16, P140, DOI 10.1159/000111559; Rebillard A, 2010, EUR J CANCER, V46, P1445, DOI 10.1016/j.ejca.2010.01.034; Ren L, 2009, ONCOGENE, V28, P792, DOI 10.1038/onc.2008.437; Revelli A, 1998, ENDOCR REV, V19, P3, DOI 10.1210/er.19.1.3; Russo J, 2006, J STEROID BIOCHEM, V102, P89, DOI 10.1016/j.jsbmb.2006.09.004; Sanchez AM, 2010, MOL ENDOCRINOL, V24, P2114, DOI 10.1210/me.2010-0252; Sandilands E, 2007, EMBO REP, V8, P1162, DOI 10.1038/sj.embor.7401097; Sarrio D, 2006, BREAST CANCER RES TR, V98, P71, DOI 10.1007/s10549-005-9133-4; SCHWARTZALBIEZ R, 1995, EUR J CELL BIOL, V67, P189; Simoncini T, 2006, MOL ENDOCRINOL, V20, P1756, DOI 10.1210/me.2005-0259; Song J, 2005, CANCER LETT, V220, P57, DOI 10.1016/j.canlet.2004.04.024; Srivastava J, 2005, MOL BIOL CELL, V16, P1481, DOI 10.1091/mbc.e04-08-0721; Takei Hiroyuki, 2002, Breast Cancer, V9, P39, DOI 10.1007/BF02967545; Verkooijen HM, 2009, MATURITAS, V64, P80, DOI 10.1016/j.maturitas.2009.07.015; Wang Q, 2003, J BIOL CHEM, V278, P47731, DOI 10.1074/jbc.M308466200; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Yonemura S, 2002, J CELL SCI, V115, P2569	66	51	58	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e22439	10.1371/journal.pone.0022439	http://dx.doi.org/10.1371/journal.pone.0022439			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21818323	Green Published, Green Submitted, gold			2022-12-25	WOS:000293175100026
J	Aghcheli, K; Marjani, HA; Nasrollahzadeh, D; Islami, F; Shakeri, R; Sotoudeh, M; Abedi-Ardekani, B; Ghavamnasiri, MR; Razaei, E; Khalilipour, E; Mohtashami, S; Makhdoomi, Y; Rajabzadeh, R; Merat, S; Sotoudehmanesh, R; Semnani, S; Malekzadeh, R				Aghcheli, Karim; Marjani, Haji-Amin; Nasrollahzadeh, Dariush; Islami, Farhad; Shakeri, Ramin; Sotoudeh, Masoud; Abedi-Ardekani, Behnoush; Ghavamnasiri, Mohammad-Reza; Razaei, Ezzatollah; Khalilipour, Elias; Mohtashami, Samira; Makhdoomi, Yasha; Rajabzadeh, Rabea; Merat, Shahin; Sotoudehmanesh, Rasoul; Semnani, Shahryar; Malekzadeh, Reza			Prognostic Factors for Esophageal Squamous Cell Carcinoma-A Population-Based Study in Golestan Province, Iran, a High Incidence Area	PLOS ONE			English	Article							CANCER INCIDENCE; COMPUTED-TOMOGRAPHY; HIGH-RISK; SURVIVAL; PATTERNS; TOBACCO; ANGIOGENESIS; DISPARITIES; MORTALITY; HISTOLOGY	Golestan Province in northern Iran is an area with a high incidence of esophageal squamous cell carcinoma (ESCC). We aimed to investigate prognostic factors for ESCC and survival of cases in Golestan, on which little data were available. We followed-up 426 ESCC cases participating in a population-based case-control study. Data were analyzed using the Kaplan-Meier method and the Cox proportional hazard models. Median survival was 7 months. Age at diagnosis was inversely associated with survival, but the association was disappeared with adjustment for treatment. Residing in urban areas (hazard ratio, HR = 0.70; 95% CI 0.54-0.90) and being of non-Turkmen ethnic groups (HR = 0.76; 95% CI 0.61-0.96) were associated with better prognosis. In contrast to other types of tobacco use, nass (a smokeless tobacco product) chewing was associated with a slightly poorer prognosis even in models adjusted for other factors including stage of disease and treatment (HR = 1.38; 95% CI 0.99-1.92). Opium use was associated with poorer prognosis in crude analyses but not in adjusted models. Almost all of potentially curative treatments were associated with longer survival. Prognosis of ESCC in Golestan is very poor. Easier access to treatment facilities may improve the prognosis of ESCC in Golestan. The observed association between nass chewing and poorer prognosis needs further investigations; this association may suggest a possible role for ingestion of nass constituents in prognosis of ESCC.	[Aghcheli, Karim; Marjani, Haji-Amin; Nasrollahzadeh, Dariush; Islami, Farhad; Shakeri, Ramin; Sotoudeh, Masoud; Abedi-Ardekani, Behnoush; Khalilipour, Elias; Rajabzadeh, Rabea; Merat, Shahin; Sotoudehmanesh, Rasoul; Malekzadeh, Reza] Univ Tehran Med Sci, Shariati Hosp, Digest Dis Res Ctr, Tehran, Iran; [Nasrollahzadeh, Dariush] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Islami, Farhad] Int Agcy Res Canc, F-69372 Lyon, France; [Ghavamnasiri, Mohammad-Reza; Razaei, Ezzatollah; Mohtashami, Samira; Makhdoomi, Yasha] Mashhad Univ Med Sci, Omid Hosp, Dept Oncol, Mashhad, Iran; [Semnani, Shahryar] Golestan Univ Med Sci, Golestan Res Ctr Gastroenterol & Hepatol, Gorgan, Iran	Tehran University of Medical Sciences; Karolinska Institutet; World Health Organization; International Agency for Research on Cancer (IARC); Mashhad University Medical Science; Golestan University of Medical Sciences	Aghcheli, K (corresponding author), Univ Tehran Med Sci, Shariati Hosp, Digest Dis Res Ctr, Tehran, Iran.	malek@ams.ac.ir	Merat, Shahin/A-5478-2009; Abedi-Ardekani, Behnoush/O-7829-2016; Malekzadeh, Reza/U-1382-2017; Semnani, Shahryar/N-2270-2016; Pour, Elias Khalili/AAT-5270-2021	Abedi-Ardekani, Behnoush/0000-0002-0980-0587; Malekzadeh, Reza/0000-0002-9820-6335; Semnani, Shahryar/0000-0002-8768-6142; Pour, Elias Khalili/0000-0001-8123-4375; , Ramin/0000-0003-0487-3629; Malekzadeh, Reza/0000-0003-1043-3814; Islami, Farhad/0000-0002-7357-5994	Digestive Disease Research Center of Tehran University of Medical Sciences	Digestive Disease Research Center of Tehran University of Medical Sciences(Tehran University of Medical Sciences)	This study was funded by Digestive Disease Research Center of Tehran University of Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah M, 2010, J DIGEST DIS, V11, P28, DOI 10.1111/j.1751-2980.2009.00410.x; Abnet CC, 2004, CANCER EPIDEM BIOMAR, V13, P1068; Alidina A, 2004, ANN ONCOL, V15, P118, DOI 10.1093/annonc/mdh014; *AM JOINT COMM CAN, 2002, AJCC CANC STAG MAN; Baastrup R, 2008, EUR J CANCER, V44, P1962, DOI 10.1016/j.ejca.2008.06.013; BLOT WJ, 2006, CANC EPIDEMIOLOGY PR, P697, DOI DOI 10.1093/ACPROF:OSO/9780195149616.003.0036; Boffetta P, 2008, LANCET ONCOL, V9, P667, DOI 10.1016/S1470-2045(08)70173-6; Cescon DW, 2009, CLIN CANCER RES, V15, P3103, DOI 10.1158/1078-0432.CCR-08-3120; COOKMOZAFFARI PJ, 1979, BRIT J CANCER, V39, P293, DOI 10.1038/bjc.1979.54; Dubecz A, 2010, J AM COLL SURGEONS, V211, P754, DOI 10.1016/j.jamcollsurg.2010.07.029; Faivre J, 1998, EUR J CANCER, V34, P2167, DOI 10.1016/S0959-8049(98)00329-3; GAUR P, 2010, CANCER; Greenstein AJ, 2008, ANN SURG ONCOL, V15, P881, DOI 10.1245/s10434-007-9664-5; Gupta K, 2002, CANCER RES, V62, P4491; Hajian-Tilaki KO, 2001, BRIT J CANCER, V85, P1671, DOI 10.1054/bjoc.2001.2153; Islami F, 2004, BRIT J CANCER, V90, P1402, DOI 10.1038/sj.bjc.6601737; Jeffreys M, 2005, AM J PUBLIC HEALTH, V95, P834, DOI 10.2105/AJPH.2004.053678; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Klint A, 2010, ACTA ONCOL, V49, P578, DOI 10.3109/02841861003739330; Kranzfelder M, 2010, J AM COLL SURGEONS, V210, P351, DOI 10.1016/j.jamcollsurg.2009.12.010; Lin CS, 2009, ANN THORAC SURG, V87, P1056, DOI 10.1016/j.athoracsur.2008.11.051; Malthaner R, 2010, CLIN ONCOL-UK, V22, P250, DOI 10.1016/j.clon.2010.02.005; Nasrollahzadeh D, 2008, BRIT J CANCER, V98, P1857, DOI 10.1038/sj.bjc.6604369; Peyre CG, 2008, ANN SURG, V248, P979, DOI 10.1097/SLA.0b013e3181904f3c; Pourshams A, 2010, INT J EPIDEMIOL, V39, P52, DOI 10.1093/ije/dyp161; Rouvelas I, 2005, LANCET ONCOL, V6, P864, DOI 10.1016/S1470-2045(05)70347-8; Salek R, 2009, ONCOLOGY-BASEL, V77, P172, DOI 10.1159/000231887; Samadi F, 2007, ARCH IRAN MED, V10, P32; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; Semnani S, 2006, CANCER DETECT PREV, V30, P14, DOI 10.1016/j.cdp.2005.11.002; Shimada Y, 1999, BRIT J CANCER, V80, P1281, DOI 10.1038/sj.bjc.6690499; Shitara K, 2010, CANCER SCI, V101, P1001, DOI 10.1111/j.1349-7006.2009.01466.x; Singleton PA, 2006, MICROVASC RES, V72, P3, DOI 10.1016/j.mvr.2006.04.004; Steevens J, 2010, EUR J GASTROEN HEPAT, V22, P669, DOI 10.1097/MEG.0b013e32832ca091; Steyerberg EW, 2007, J CLIN ONCOL, V25, P2389, DOI 10.1200/JCO.2006.09.7931; Stockeld D, 2007, ACTA ONCOL, V46, P1075, DOI 10.1080/02841860701426807; Sundelof M, 2008, EUR J CANCER, V44, P1566, DOI 10.1016/j.ejca.2008.04.002; THOMPSON WM, 1983, AM J ROENTGENOL, V141, P951, DOI 10.2214/ajr.141.5.951; Trivers KF, 2008, INT J CANCER, V123, P1422, DOI 10.1002/ijc.23691; Trivers KF, 2005, CLIN GASTROENTEROL H, V3, P225, DOI 10.1016/S1542-3565(04)00613-5; van Vliet EPM, 2008, BRIT J CANCER, V98, P547, DOI 10.1038/sj.bjc.6604200; Wallace MB, 2002, ANN THORAC SURG, V74, P1026, DOI 10.1016/S0003-4975(02)03875-4; Wang LS, 1999, AM J GASTROENTEROL, V94, P1933; Yeole Balkrishna Bhika, 2004, Asian Pac J Cancer Prev, V5, P175	46	41	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22152	10.1371/journal.pone.0022152	http://dx.doi.org/10.1371/journal.pone.0022152			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811567	Green Submitted, Green Published, gold			2022-12-25	WOS:000292956800026
J	Goossens, P; Vergouwe, MN; Gijbels, MJJ; Curfs, DMJ; van Woezik, JHG; Hoeksema, MA; Xanthoulea, S; Leenen, PJM; Rupec, RA; Hofker, MH; de Winther, MPJ				Goossens, Pieter; Vergouwe, Monique N.; Gijbels, Marion J. J.; Curfs, Danielle M. J.; van Woezik, Johannes H. G.; Hoeksema, Marten A.; Xanthoulea, Sofia; Leenen, Pieter J. M.; Rupec, Rudolf A.; Hofker, Marten H.; de Winther, Menno P. J.			Myeloid I kappa B alpha Deficiency Promotes Atherogenesis by Enhancing Leukocyte Recruitment to the Plaques	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; INFLAMMATORY RESPONSE; ATHEROSCLEROTIC LESION; TRANSCRIPTION FACTORS; TARGET GENES; MICE; ACTIVATION; CELLS; MACROPHAGES; PATHWAY	Activation of the transcription factor NF-kappa B appears to be involved in different stages of atherogenesis. In this paper we investigate the role of NF-kappa B inhibitor I kappa B alpha in atherosclerosis. Myeloid-specific deletion of I kappa B alpha results in larger and more advanced lesions in LDL-R-deficient mice without affecting the compositional phenotype of the plaques or systemic inflammatory markers in the plasma. We show that I kappa B alpha-deleted macrophages display enhanced adhesion to an in vitro endothelial cell layer, coinciding with an increased expression of the chemokine CCL5. Also, in vivo we found that I kappa B alpha(del) mice had more leukocytes adhering to the luminal side of the endothelial cell layers that cover the atherosclerotic plaques. Moreover, we introduce ER-MP58 in this paper as a new immunohistochemical tool for quantifying newly recruited myeloid cells in the atherosclerotic lesion. This staining confirms that in I kappa B alpha(del) mice more leukocytes are attracted to the plaques. In conclusion, we show that I kappa B alpha deletion in myeloid cells promotes atherogenesis, probably through an induced leukocyte recruitment to plaques.	[Goossens, Pieter; Vergouwe, Monique N.; Gijbels, Marion J. J.; Curfs, Danielle M. J.; van Woezik, Johannes H. G.; Hoeksema, Marten A.; Xanthoulea, Sofia; de Winther, Menno P. J.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Mol Genet, Maastricht, Netherlands; [Gijbels, Marion J. J.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Pathol, Maastricht, Netherlands; [Leenen, Pieter J. M.] Erasmus Univ, Dept Immunol, Med Ctr, NL-3000 DR Rotterdam, Netherlands; [Rupec, Rudolf A.] Univ Munich, Dept Dermatol, D-8000 Munich, Germany; [Hofker, Marten H.] Univ Groningen, Univ Med Ctr Groningen, Med Biol Sect, Dept Pathol & Med Biol, Groningen, Netherlands	Maastricht University; Maastricht University; Erasmus University Rotterdam; Erasmus MC; University of Munich; University of Groningen	Goossens, P (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Mol Genet, Maastricht, Netherlands.	dewinther@maastrichtuniversity.nl	de Winther, Menno/E-8721-2012; Leenen, Pieter JM/I-5839-2013	Leenen, Pieter JM/0000-0001-9860-2920; Goossens, Pieter/0000-0002-7269-6372; Hoeksema, Marten/0000-0001-5981-121X; xanthoulea, sofia/0000-0003-4700-3404; de Winther, Menno/0000-0002-4038-6636	Netherlands Heart Foundation [2005B175]; Netherlands Organization for Scientific Research (ZonMW) [VIDI 917-66-329]; European Union [MEST-CT-2005-020706/CADRE2]; European Vascular Genomics Network (EVGN)	Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands Organization for Scientific Research (ZonMW)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); European Union(European Commission); European Vascular Genomics Network (EVGN)	This work was supported by the Netherlands Heart Foundation (grant no. 2005B175), Netherlands Organization for Scientific Research (ZonMW VIDI 917-66-329 to MPJdW), the European Union (Marie-Curie MEST-CT-2005-020706/CADRE2 to PG) and the European Vascular Genomics Network (EVGN). MPJdW is an established investigator of the Netherlands Heart Foundation (2007T067 and 2009T034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; Brand K, 1996, J CLIN INVEST, V97, P1715, DOI 10.1172/JCI118598; Brand K, 1997, ARTERIOSCL THROM VAS, V17, P1901, DOI 10.1161/01.ATV.17.10.1901; Chan J, 1998, BLOOD, V92, P1423, DOI 10.1182/blood.V92.4.1423.416k31_1423_1431; Cook AD, 2003, J IMMUNOL, V171, P4816, DOI 10.4049/jimmunol.171.9.4816; de Winther MPJ, 2005, ARTERIOSCL THROM VAS, V25, P904, DOI 10.1161/01.ATV.0000160340.72641.87; Gareus R, 2008, CELL METAB, V8, P372, DOI 10.1016/j.cmet.2008.08.016; Gerondakis S, 2006, ONCOGENE, V25, P6781, DOI 10.1038/sj.onc.1209944; Goossens P, 2010, CELL METAB, V12, P142, DOI 10.1016/j.cmet.2010.06.008; Hajra L, 2000, P NATL ACAD SCI USA, V97, P9052, DOI 10.1073/pnas.97.16.9052; Kanters E, 2003, J CLIN INVEST, V112, P1176, DOI 10.1172/JCI18580; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Klement JF, 1996, MOL CELL BIOL, V16, P2341; LEENEN PJM, 1994, J IMMUNOL METHODS, V174, P5, DOI 10.1016/0022-1759(94)90005-1; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Monaco C, 2004, P NATL ACAD SCI USA, V101, P5634, DOI 10.1073/pnas.0401060101; Natoli G, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.11pe1; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Rebholz B, 2007, IMMUNITY, V27, P296, DOI 10.1016/j.immuni.2007.05.024; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Rupec RA, 2005, IMMUNITY, V22, P479, DOI 10.1016/j.immuni.2005.02.009; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Tergaonkar V, 2005, NAT CELL BIOL, V7, P921, DOI 10.1038/ncb1296; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wiesner P, 2010, CIRC RES, V107, P56, DOI 10.1161/CIRCRESAHA.110.218420; Wolfrum S, 2007, P NATL ACAD SCI USA, V104, P18601, DOI 10.1073/pnas.0709011104; Xanthoulea S, 2005, CURR OPIN LIPIDOL, V16, P536, DOI 10.1097/01.mol.0000180167.15820.ae; Yamamoto T, 1996, AM J PATHOL, V149, P1271; Zernecke A, 2008, ARTERIOSCL THROM VAS, V28, P1897, DOI 10.1161/ATVBAHA.107.161174; Zernecke A, 2010, CARDIOVASC RES, V86, P192, DOI 10.1093/cvr/cvp391	32	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22327	10.1371/journal.pone.0022327	http://dx.doi.org/10.1371/journal.pone.0022327			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21814576	Green Published, Green Submitted, gold			2022-12-25	WOS:000292956800043
J	Soudja, SM; Henri, S; Mello, M; Chasson, L; Mas, A; Wehbe, M; Auphan-Anezin, N; Leserman, L; Van den Eynde, B; Schmitt-Verhulst, AM				Soudja, Saidi M.; Henri, Sandrine; Mello, Marielle; Chasson, Lionel; Mas, Amandine; Wehbe, Maria; Auphan-Anezin, Nathalie; Leserman, Lee; Van den Eynde, Benoit; Schmitt-Verhulst, Anne-Marie			Disrupted Lymph Node and Splenic Stroma in Mice with Induced Inflammatory Melanomas Is Associated with Impaired Recruitment of T and Dendritic Cells	PLOS ONE			English	Article							FIBROBLASTIC RETICULAR CELLS; STEADY-STATE; MONOCLONAL-ANTIBODY; ANTITUMOR IMMUNITY; SUPPRESSOR-CELLS; LANGERHANS CELLS; MIGRATION; CHEMOKINE; EXPRESSION; CANCER	Migration of dendritic cells (DC) from the tumor environment to the T cell cortex in tumor-draining lymph nodes (TDLN) is essential for priming naive T lymphocytes (TL) to tumor antigen (Ag). We used a mouse model of induced melanoma in which similar oncogenic events generate two phenotypically distinct melanomas to study the influence of tumor-associated inflammation on secondary lymphoid organ (SLO) organization. One tumor promotes inflammatory cytokines, leading to mobilization of immature myeloid cells (iMC) to the tumor and SLO; the other does not. We report that inflammatory tumors induced alterations of the stromal cell network of SLO, profoundly altering the distribution of TL and the capacity of skin-derived DC and TL to migrate or home to TDLN. These defects, which did not require tumor invasion, correlated with loss of fibroblastic reticular cells in T cell zones and in impaired production of CCL21. Infiltrating iMC accumulated in the TDLN medulla and the splenic red pulp. We propose that impaired function of the stromal cell network during chronic inflammation induced by some tumors renders spleens non-receptive to TL and TDLN non-receptive to TL and migratory DC, while the entry of iMC into these perturbed SLO is enhanced. This could constitute a mechanism by which inflammatory tumors escape immune control. If our results apply to inflammatory tumors in general, the demonstration that SLO are poorly receptive to CCR7-dependent migration of skin-derived DC and naive TL may constitute an obstacle for proposed vaccination or adoptive TL therapies of their hosts.	[Soudja, Saidi M.; Henri, Sandrine; Mello, Marielle; Chasson, Lionel; Mas, Amandine; Wehbe, Maria; Auphan-Anezin, Nathalie; Leserman, Lee; Schmitt-Verhulst, Anne-Marie] Univ Aix Marseille 2, CIML, UMR6546, Marseille, France; [Soudja, Saidi M.; Henri, Sandrine; Mello, Marielle; Chasson, Lionel; Mas, Amandine; Wehbe, Maria; Auphan-Anezin, Nathalie; Leserman, Lee; Schmitt-Verhulst, Anne-Marie] INSERM, UMR631, F-13258 Marseille, France; [Soudja, Saidi M.; Henri, Sandrine; Mello, Marielle; Chasson, Lionel; Mas, Amandine; Wehbe, Maria; Auphan-Anezin, Nathalie; Leserman, Lee; Schmitt-Verhulst, Anne-Marie] CNRS, UMR6102, Marseille, France; [Van den Eynde, Benoit] Catholic Univ Louvain, Ludwig Inst Canc Res, B-1200 Brussels, Belgium; [Van den Eynde, Benoit] Catholic Univ Louvain, Duve Inst, B-1200 Brussels, Belgium	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain	Soudja, SM (corresponding author), Univ Aix Marseille 2, CIML, UMR6546, Marseille, France.	verhulst@ciml.univ-mrs.fr	AUPHAN-ANEZIN, Nathalie/E-7790-2018; Henri, Sandrine/O-3045-2016	AUPHAN-ANEZIN, Nathalie/0000-0002-1967-5206; MELLO, Marielle/0000-0002-5454-3559; HENRI, Sandrine/0000-0002-8980-9193; Schmitt-Verhulst, Anne-Marie/0000-0002-1296-2739; Wehbe, Maria/0000-0003-2900-2811	Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; Institut National du Cancer (INCA); INCA PROCAN program; European Communities [LSHC-CT-2006-518234]; Association pour la Recherche sur le Cancer	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National du Cancer (INCA)(Institut National du Cancer (INCA) France); INCA PROCAN program; European Communities(European Commission); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This study was supported by the Institut National de la Sante et de la Recherche Medicale and Centre National de la Recherche Scientifique, and by grants from the Institut National du Cancer (INCA), the INCA PROCAN program (to A-MS-V) and the European Communities ( Integrated project Cancerimmunotherapy LSHC-CT-2006-518234 to A-MS-V and to BVdE). SMS and MW received doctoral fellowships from the Association pour la Recherche sur le Cancer. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Bajenoff M, 2008, J IMMUNOL, V181, P3947, DOI 10.4049/jimmunol.181.6.3947; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Boissonnas A, 2010, IMMUNITY, V32, P266, DOI 10.1016/j.immuni.2009.11.015; Britschgi MR, 2010, EUR J IMMUNOL, V40, P1266, DOI 10.1002/eji.200939921; Carriere V, 2005, CANCER RES, V65, P11639, DOI 10.1158/0008-5472.CAN-05-1190; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Cyster JG, 2000, IMMUNOL REV, V176, P181; Cyster JG, 2003, IMMUNOL REV, V195, P5, DOI 10.1034/j.1600-065X.2003.00075.x; FARR AG, 1992, J EXP MED, V176, P1477, DOI 10.1084/jem.176.5.1477; Flaishon L, 2008, BLOOD, V112, P5016, DOI 10.1182/blood-2007-12-129122; Flavell RA, 2010, NAT REV IMMUNOL, V10, P554, DOI 10.1038/nri2808; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Ginhoux F, 2007, J EXP MED, V204, P3133, DOI 10.1084/jem.20071733; Gounaris E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002916; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Hanson EM, 2009, J IMMUNOL, V183, P937, DOI 10.4049/jimmunol.0804253; Henri S, 2001, J IMMUNOL, V167, P741, DOI 10.4049/jimmunol.167.2.741; Henri S, 2010, IMMUNOL CELL BIOL, V88, P366, DOI 10.1038/icb.2010.34; Hinrichs CS, 2009, P NATL ACAD SCI USA, V106, P17469, DOI 10.1073/pnas.0907448106; Huijbers IJ, 2006, CANCER RES, V66, P3278, DOI 10.1158/0008-5472.CAN-05-3216; Ishida T, 1998, J IMMUNOL, V161, P4842; Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254; KRAAL G, 1986, IMMUNOLOGY, V58, P665; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Mueller SN, 2007, SCIENCE, V317, P670, DOI 10.1126/science.1144830; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Nolte MA, 2003, J EXP MED, V198, P505, DOI 10.1084/jem.20021801; Norbury CC, 2002, NAT IMMUNOL, V3, P265, DOI 10.1038/ni762; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Poulin LF, 2007, J EXP MED, V204, P3119, DOI 10.1084/jem.20071724; Shanker A, 2007, J IMMUNOL, V179, P6651, DOI 10.4049/jimmunol.179.10.6651; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Soudja SM, 2010, CANCER RES, V70, P3515, DOI 10.1158/0008-5472.CAN-09-4354; St John AL, 2009, NAT MED, V15, P1259, DOI 10.1038/nm.2036; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Takeuchi H, 2004, CLIN CANCER RES, V10, P2351, DOI 10.1158/1078-0432.CCR-03-0195; Thompson ED, 2010, J EXP MED, V207, P1791, DOI 10.1084/jem.20092454; VANVLIET E, 1986, J HISTOCHEM CYTOCHEM, V34, P883, DOI 10.1177/34.7.3519751; Villablanca EJ, 2010, NAT MED, V16, P98, DOI 10.1038/nm.2074; Xue Y, 2008, P NATL ACAD SCI USA, V105, P18513, DOI 10.1073/pnas.0807967105; Zhao F, 2009, CLIN CANCER RES, V15, P4382, DOI 10.1158/1078-0432.CCR-09-0399	49	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22639	10.1371/journal.pone.0022639	http://dx.doi.org/10.1371/journal.pone.0022639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811640	Green Published, gold, Green Submitted			2022-12-25	WOS:000292956800077
J	Bronmark, C; Lakowitz, T; Hollander, J				Bronmark, Christer; Lakowitz, Thomas; Hollander, Johan			Predator-Induced Morphological Plasticity Across Local Populations of a Freshwater Snail	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; GENE FLOW; ADAPTIVE DIVERGENCE; TRAIT COMPENSATION; EVOLUTION; SHAPE; SIZE; RISK; FISH	The expression of anti-predator adaptations may vary on a spatial scale, favouring traits that are advantageous in a given predation regime. Besides, evolution of different developmental strategies depends to a large extent on the grain of the environment and may result in locally canalized adaptations or, alternatively, the evolution of phenotypic plasticity as different predation regimes may vary across habitats. We investigated the potential for predator-driven variability in shell morphology in a freshwater snail, Radix balthica, and whether found differences were a specialized ecotype adaptation or a result of phenotypic plasticity. Shell shape was quantified in snails from geographically separated pond populations with and without molluscivorous fish. Subsequently, in a common garden experiment we investigated reaction norms of snails from populations' with/without fish when exposed to chemical cues from tench (Tinca tinca), a molluscivorous fish. We found that snails from fish-free ponds had a narrow shell with a well developed spire, whereas snails that coexisted with fish had more rotund shells with a low spire, a shell morphology known to increase survival rate from shell-crushing predators. The common garden experiment mirrored the results from the field survey and showed that snails had similar reaction norms in response to chemical predator cues, i.e. the expression of shell shape was independent of population origin. Finally, we found significant differences for the trait means among populations, within each pond category (fish/fish free), suggesting a genetic component in the determination of shell morphology that has evolved independently across ponds.	[Bronmark, Christer; Lakowitz, Thomas; Hollander, Johan] Lund Univ, Dept Biol, Aquat Ecol Unit, Lund, Sweden	Lund University	Bronmark, C (corresponding author), Lund Univ, Dept Biol, Aquat Ecol Unit, Lund, Sweden.	christer.bronmark@limnol.lu.se		Hollander, Johan/0000-0002-4207-2956	Swedish Research Council [621-2006-4113]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by grant 621-2006-4113 from the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auld JR, 2010, BIOL LETTERS, V6, P222, DOI 10.1098/rsbl.2009.0726; Bilton DT, 2001, ANNU REV ECOL SYST, V32, P159, DOI 10.1146/annurev.ecolsys.32.081501.114016; BRONMARK C, 1986, OECOLOGIA, V69, P268, DOI 10.1007/BF00377633; BRONMARK C, 1985, OIKOS, V45, P26, DOI 10.2307/3565218; Bronmark C, 1996, OECOLOGIA, V108, P534, DOI 10.1007/BF00333731; BRONMARK C, 1992, ECOLOGY, V73, P1662, DOI 10.2307/1940018; BRONMARK C, 1992, SCIENCE, V258, P1348, DOI 10.1126/science.258.5086.1348; BRONMARK C, 1992, OECOLOGIA, V91, P526, DOI 10.1007/BF00650326; Crispo E, 2008, J EVOLUTION BIOL, V21, P1460, DOI 10.1111/j.1420-9101.2008.01592.x; CROWL TA, 1990, SCIENCE, V247, P949, DOI 10.1126/science.247.4945.949; DeWitt TJ, 1999, ANIM BEHAV, V58, P397, DOI 10.1006/anbe.1999.1158; DeWitt TJ, 2000, EVOL ECOL RES, V2, P129; Diamond J.M., 1975, P342; *EK, 2002, BIOL MANGF DAMM; Evanno G, 2006, J EVOLUTION BIOL, V19, P1071, DOI 10.1111/j.1420-9101.2006.01098.x; GLOER P, 2002, SUSSWASSERGASTROPODE; Hansson LA, 2005, FRESHWATER BIOL, V50, P705, DOI 10.1111/j.1365-2427.2005.01352.x; Hendry AP, 2004, EVOLUTION, V58, P2319; Hollander J, 2006, J EVOLUTION BIOL, V19, P1861, DOI 10.1111/j.1420-9101.2006.01171.x; Hollander J, 2008, EVOLUTION, V62, P1381, DOI 10.1111/j.1558-5646.2008.00365.x; Hollander J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-333; Hoverman JT, 2007, OECOLOGIA, V154, P551, DOI 10.1007/s00442-007-0847-3; Hoverman JT, 2007, ECOLOGY, V88, P693, DOI 10.1890/05-1697; Hoverman JT, 2005, OECOLOGIA, V144, P481, DOI 10.1007/s00442-005-0082-8; HUBENDICK B, 1951, KONGLIGA SVENSKA VET, V4; Iwata H, 2002, J HERED, V93, P384, DOI 10.1093/jhered/93.5.384; KATS LB, 1988, ECOLOGY, V69, P1865, DOI 10.2307/1941163; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; LAM PKS, 1988, J MOLLUS STUD, V54, P197, DOI 10.1093/mollus/54.2.197; Langerhans RB, 2002, EVOL ECOL RES, V4, P857; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; LEVINS RICHARD, 1968; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lind MI, 2007, J EVOLUTION BIOL, V20, P1288, DOI 10.1111/j.1420-9101.2007.01353.x; Nosil P, 2004, EVOLUTION, V58, P102, DOI 10.1111/j.0014-3820.2004.tb01577.x; Nystrom P, 1999, OIKOS, V85, P545, DOI 10.2307/3546704; PALMER AR, 1979, EVOLUTION, V33, P697, DOI 10.1111/j.1558-5646.1979.tb04722.x; Pigliucci M., 2001, SYN ECO EVO; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; R Core Team, 2022, R LANG ENV STAT COMP; Relyea RA, 2007, OECOLOGIA, V152, P389, DOI 10.1007/s00442-007-0675-5; Rundle SD, 2001, P ROY SOC B-BIOL SCI, V268, P1463, DOI 10.1098/rspb.2001.1682; Sultan SE, 2002, AM NAT, V160, P271, DOI 10.1086/341015; TOLLRIAN R, 1999, ECOLOGY EVOLUTION IN; Trussell GC, 2000, EVOL ECOL RES, V2, P803; Turner AM, 2003, ECOLOGY, V84, P616, DOI 10.1890/0012-9658(2003)084[0616:SATSOP]2.0.CO;2; VANTIENDEREN PH, 1991, EVOLUTION, V45, P1317, DOI [10.1111/j.1558-5646.1991.tb02638.x, 10.2307/2409882]; VIA S, 1985, EVOLUTION, V39, P505, DOI [10.2307/2408649, 10.1111/j.1558-5646.1985.tb00391.x]; Wullschleger EB, 1998, J MOLLUS STUD, V64, P402, DOI 10.1093/mollus/64.3.402; Wullschleger EB, 2002, J MOLLUS STUD, V68, P1, DOI 10.1093/mollus/68.1.1	50	54	57	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e21773	10.1371/journal.pone.0021773	http://dx.doi.org/10.1371/journal.pone.0021773			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21818264	Green Published, gold, Green Submitted			2022-12-25	WOS:000292929500008
J	Diwakar, S; Lombardo, P; Solinas, S; Naldi, G; D'Angelo, E				Diwakar, Shyam; Lombardo, Paola; Solinas, Sergio; Naldi, Giovanni; D'Angelo, Egidio			Local Field Potential Modeling Predicts Dense Activation in Cerebellar Granule Cells Clusters under LTP and LTD Control	PLOS ONE			English	Article							TERM SYNAPTIC PLASTICITY; GOLGI CELLS; NEUROTRANSMITTER RELEASE; INTRINSIC EXCITABILITY; NEURONAL EXCITABILITY; SPATIAL-ORGANIZATION; RECEPTIVE-FIELDS; PURKINJE-CELLS; MOSSY FIBERS; IN-SITU	Local field-potentials (LFPs) are generated by neuronal ensembles and contain information about the activity of single neurons. Here, the LFPs of the cerebellar granular layer and their changes during long-term synaptic plasticity (LTP and LTD) were recorded in response to punctate facial stimulation in the rat in vivo. The LFP comprised a trigeminal (T) and a cortical (C) wave. T and C, which derived from independent granule cell clusters, co-varied during LTP and LTD. To extract information about the underlying cellular activities, the LFP was reconstructed using a repetitive convolution (ReConv) of the extracellular potential generated by a detailed multicompartmental model of the granule cell. The mossy fiber input patterns were determined using a Blind Source Separation (BSS) algorithm. The major component of the LFP was generated by the granule cell spike Na+ current, which caused a powerful sink in the axon initial segment with the source located in the soma and dendrites. Reproducing the LFP changes observed during LTP and LTD required modifications in both release probability and intrinsic excitability at the mossy fiber-granule cells relay. Synaptic plasticity and Golgi cell feed-forward inhibition proved critical for controlling the percentage of active granule cells, which was 11% in standard conditions but ranged from 3% during LTD to 21% during LTP and raised over 50% when inhibition was reduced. The emerging picture is that of independent (but neighboring) trigeminal and cortical channels, in which synaptic plasticity and feed-forward inhibition effectively regulate the number of discharging granule cells and emitted spikes generating "dense" activity clusters in the cerebellar granular layer.	[Diwakar, Shyam; Lombardo, Paola; D'Angelo, Egidio] Univ Pavia, Dept Physiol, I-27100 Pavia, Italy; [Diwakar, Shyam] Consorzio Interuniv Sci Fis Mat CNISM, Pavia, Italy; [Solinas, Sergio; D'Angelo, Egidio] Fdn Ist Neurol Nazl IRCCS C Mondino, Brain Connect Ctr, Pavia, Italy; [Naldi, Giovanni] Dept Math, Milan, Italy; [Diwakar, Shyam] Amrita Vishwa Vidyapeetham Amrita Univ, Amrita Sch Biotechnol, Kollam, Kerala, India	University of Pavia; IRCCS Fondazione Casimiro Mondino; Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Amritapuri	Diwakar, S (corresponding author), Univ Pavia, Dept Physiol, Via Palestro 3, I-27100 Pavia, Italy.	dangelo@unipv.it	Diwakar, Shyam/C-2455-2015; Naldi, Giovanni/F-2935-2012; D'Angelo, Egidio/AAC-3846-2022; Solinas, Sergio/A-8598-2010	Diwakar, Shyam/0000-0003-1546-0184; D'Angelo, Egidio/0000-0002-6007-7187; Naldi, Giovanni/0000-0001-9191-6003; Solinas, Sergio/0000-0002-8605-8515	European Union [FP6-IST028056, FP7-ITN238686, FP7-ICT270434]	European Union(European Commission)	This work was supported by the European Union (SENSOPAC, FP6-IST028056; CEREBNET FP7-ITN238686, REALNET FP7-ICT270434) to ED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Andreescu CE, 2011, NEUROSCIENCE, V176, P274, DOI 10.1016/j.neuroscience.2010.12.024; ANGELAKI DE, 1994, J NEUROPHYSIOL, V72, P1443, DOI 10.1152/jn.1994.72.3.1443; Antic SD, 2003, J PHYSIOL-LONDON, V550, P35, DOI 10.1113/jphysiol.2002.033746; Armano S, 2000, J NEUROSCI, V20, P5208, DOI 10.1523/JNEUROSCI.20-14-05208.2000; Bedard C, 2004, BIOPHYS J, V86, P1829, DOI 10.1016/S0006-3495(04)74250-2; BOWER JM, 1983, J NEUROPHYSIOL, V49, P745, DOI 10.1152/jn.1983.49.3.745; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; CARDOSO JF, 1993, IEE PROC-F, V140, P362, DOI 10.1049/ip-f-2.1993.0054; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Cichocki A., 2012, ADAPTIVE BLIND SIGNA, DOI DOI 10.1002/0470845899; D'Angelo E, 1999, J NEUROPHYSIOL, V81, P277, DOI 10.1152/jn.1999.81.1.277; D'Angelo E, 1998, J NEUROPHYSIOL, V80, P493, DOI 10.1152/jn.1998.80.2.493; D'Angelo E, 2011, BRAIN RES REV, V66, P5, DOI 10.1016/j.brainresrev.2010.10.002; D'Angelo E, 2009, NEUROSCIENCE, V162, P805, DOI 10.1016/j.neuroscience.2009.01.048; D'Angelo E, 2001, J NEUROSCI, V21, P759, DOI 10.1523/JNEUROSCI.21-03-00759.2001; D'Angelo E, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00131; D'Angelo E, 2008, FRONT NEUROSCI-SWITZ, V2, P35, DOI 10.3389/neuro.01.008.2008; D'Angelo E, 2009, TRENDS NEUROSCI, V32, P30, DOI 10.1016/j.tins.2008.09.007; D'Errico A, 2009, J PHYSIOL-LONDON, V587, P5843, DOI 10.1113/jphysiol.2009.177162; DANGELO E, 1995, J PHYSIOL-LONDON, V484, P397, DOI 10.1113/jphysiol.1995.sp020673; Daoudal G, 2003, LEARN MEMORY, V10, P456, DOI 10.1101/lm.64103; Debanne D, 1996, REV NEUROSCIENCE, V7, P29; Dieudonne S, 1998, J PHYSIOL-LONDON, V510, P845, DOI 10.1111/j.1469-7793.1998.845bj.x; Diwakar S, 2009, J NEUROPHYSIOL, V101, P519, DOI 10.1152/jn.90382.2008; Dover K, 2010, J PHYSIOL-LONDON, V588, P3695, DOI 10.1113/jphysiol.2010.192559; Dugue GP, 2009, NEURON, V61, P126, DOI 10.1016/j.neuron.2008.11.028; ECCLES JC, 1967, EXP BRAIN RES, V3, P58; Eccles JC, 1967, CEREBELLUM NEURAL MA; Forti L, 2006, J PHYSIOL-LONDON, V574, P711, DOI 10.1113/jphysiol.2006.110858; Gall D, 2005, J NEUROSCI, V25, P4813, DOI 10.1523/JNEUROSCI.0410-05.2005; Gall D, 2003, J NEUROSCI, V23, P9320; Gold C, 2006, J NEUROPHYSIOL, V95, P3113, DOI 10.1152/jn.00979.2005; Gold C, 2007, J COMPUT NEUROSCI, V23, P39, DOI 10.1007/s10827-006-0018-2; Goldfarb M, 2007, NEURON, V55, P449, DOI 10.1016/j.neuron.2007.07.006; HABERLY LB, 1973, J NEUROPHYSIOL, V36, P789, DOI 10.1152/jn.1973.36.4.789; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; Harmsen JJ, 2003, PROC SPIE, V5020, P131, DOI 10.1117/12.476813; HARVEY RJ, 1991, PROG NEUROBIOL, V36, P437, DOI 10.1016/0301-0082(91)90012-P; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Holtzman T, 2006, J PHYSIOL-LONDON, V574, P491, DOI 10.1113/jphysiol.2006.108282; Hubbard JI., 1969, ELECTROPHYSIOLOGICAL; Ito M, 2006, PROG NEUROBIOL, V78, P272, DOI 10.1016/j.pneurobio.2006.02.006; Jorntell H, 2006, J NEUROSCI, V26, P11786, DOI 10.1523/JNEUROSCI.2939-06.2006; Kanichay RT, 2008, J NEUROSCI, V28, P8955, DOI 10.1523/JNEUROSCI.5469-07.2008; KASE M, 1980, J PHYSIOL-LONDON, V300, P539, DOI 10.1113/jphysiol.1980.sp013178; Koch Christof, 1999, P1; Lopez-Aguado L, 2001, NEUROSCIENCE, V108, P249, DOI 10.1016/S0306-4522(01)00417-1; Lu H, 2005, J NEUROPHYSIOL, V94, P1849, DOI 10.1152/jn.01275.2004; Magistretti J, 2006, J PHYSIOL-LONDON, V573, P83, DOI 10.1113/jphysiol.2006.106682; Mapelli J, 2007, J NEUROSCI, V27, P1285, DOI 10.1523/JNEUROSCI.4873-06.2007; Mapelli J, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00014; Mapelli J, 2010, J NEUROPHYSIOL, V103, P250, DOI 10.1152/jn.00642.2009; Mapelli L, 2009, J NEUROPHYSIOL, V101, P3089, DOI 10.1152/jn.91190.2008; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Morissette J, 1996, EXP BRAIN RES, V109, P240; Nieus T, 2006, J NEUROPHYSIOL, V95, P686, DOI 10.1152/jn.00696.2005; RALL W, 1968, J NEUROPHYSIOL, V31, P884, DOI 10.1152/jn.1968.31.6.884; Rancz EA, 2007, NATURE, V450, P1245, DOI 10.1038/nature05995; Roggeri L, 2008, J NEUROSCI, V28, P6354, DOI 10.1523/JNEUROSCI.5709-07.2008; Saviane C, 2006, NATURE, V439, P983, DOI 10.1038/nature04509; Schweighofer N, 2001, NEUROSCIENCE, V103, P35, DOI 10.1016/S0306-4522(00)00548-0; SHAMBES GM, 1978, BRAIN BEHAV EVOLUT, V15, P94, DOI 10.1159/000123774; SHEPHERD GM, 1970, J NEUROPHYSIOL, V33, P643, DOI 10.1152/jn.1970.33.5.643; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; Sola E, 2004, J PHYSIOL-LONDON, V557, P843, DOI 10.1113/jphysiol.2003.060285; Solinas S, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00012; Solinas S, 2007, FRONT CELL NEUROSCI, V1, DOI 10.3389/neuro.03.002.2007; Solinas S, 2007, FRONT CELL NEUROSCI, V1, DOI 10.3389/neuro.03.004.2007; Soman K.P., 2006, INSIGHT DATA MINING; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Sultan F, 2003, J PHYSIOL-PARIS, V97, P591, DOI 10.1016/j.jphysparis.2004.01.016; Tahon K, 2011, J NEUROPHYSIOL, V105, P1327, DOI 10.1152/jn.00317.2010; THACH WT, 1967, J NEUROPHYSIOL, V30, P675, DOI 10.1152/jn.1967.30.4.675; VANKAN PLE, 1993, J NEUROPHYSIOL, V69, P74, DOI 10.1152/jn.1993.69.1.74; Vervaeke K, 2010, NEURON, V67, P435, DOI 10.1016/j.neuron.2010.06.028; Volny-Luraghi A, 2002, NEUROSCIENCE, V113, P363, DOI 10.1016/S0306-4522(02)00196-3; Vos BP, 1999, EUR J NEUROSCI, V11, P2621, DOI 10.1046/j.1460-9568.1999.00678.x; WELSH JP, 1995, NATURE, V374, P453, DOI 10.1038/374453a0; Wu HS, 1999, J COMP NEUROL, V411, P97, DOI 10.1002/(SICI)1096-9861(19990816)411:1<97::AID-CNE8>3.0.CO;2-O	81	48	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e21928	10.1371/journal.pone.0021928	http://dx.doi.org/10.1371/journal.pone.0021928			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21818278	Green Published, Green Submitted, gold			2022-12-25	WOS:000292929500019
J	Ghosh, A; Dowd, SE; Zurek, L				Ghosh, Anuradha; Dowd, Scot E.; Zurek, Ludek			Dogs Leaving the ICU Carry a Very Large Multi-Drug Resistant Enterococcal Population with Capacity for Biofilm Formation and Horizontal Gene Transfer	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; ANTIMICROBIAL RESISTANCE; ANTIBIOTIC-RESISTANCE; BACTERIAL DIVERSITY; VIRULENCE DETERMINANTS; STAPHYLOCOCCUS-AUREUS; SPECIES DISTRIBUTION; FECAL ENTEROCOCCI; SURFACE PROTEIN; FAECIUM	The enterococcal community from feces of seven dogs treated with antibiotics for 2-9 days in the veterinary intensive care unit (ICU) was characterized. Both, culture-based approach and culture-independent 16S rDNA amplicon 454 pyrosequencing, revealed an abnormally large enterococcal community: 1.4 +/- 0.8x10(8) CFU gram(-1) of feces and 48.9 +/- 11.5% of the total 16,228 sequences, respectively. The diversity of the overall microbial community was very low which likely reflects a high selective antibiotic pressure. The enterococcal diversity based on 210 isolates was also low as represented by Enterococcus faecium (54.6%) and Enterococcus faecalis (45.4%). E. faecium was frequently resistant to enrofloxacin (97.3%), ampicillin (96.5%), tetracycline (84.1%), doxycycline (60.2%), erythromycin (53.1%), gentamicin (48.7%), streptomycin (42.5%), and nitrofurantoin (26.5%). In E. faecalis, resistance was common to tetracycline (59.6%), erythromycin (56.4%), doxycycline (53.2%), and enrofloxacin (31.9%). No resistance was detected to vancomycin, tigecycline, linezolid, and quinupristin/dalfopristin in either species. Many isolates carried virulence traits including gelatinase, aggregation substance, cytolysin, and enterococcal surface protein. All E. faecalis strains were biofilm formers in vitro and this phenotype correlated with the presence of gelE and/or esp. In vitro intra-species conjugation assays demonstrated that E. faecium were capable of transferring tetracycline, doxycycline, streptomycin, gentamicin, and erythromycin resistance traits to human clinical strains. Multi-locus variable number tandem repeat analysis (MLVA) and pulsed-field gel electrophoresis (PFGE) of E. faecium strains showed very low genotypic diversity. Interestingly, three E. faecium clones were shared among four dogs suggesting their nosocomial origin. Furthermore, multi-locus sequence typing (MLST) of nine representative MLVA types revealed that six sequence types (STs) originating from five dogs were identical or closely related to STs of human clinical isolates and isolates from hospital outbreaks. It is recommended to restrict close physical contact between pets released from the ICU and their owners to avoid potential health risks.	[Ghosh, Anuradha; Zurek, Ludek] Kansas State Univ, Coll Vet Med, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA; [Dowd, Scot E.] Med Biofilm Res Inst, Lubbock, TX USA; [Zurek, Ludek] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA	Kansas State University; Kansas State University	Ghosh, A (corresponding author), Kansas State Univ, Coll Vet Med, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA.	lzurek@vet.k-state.edu	Dowd, Scot E/M-5386-2017; Zurek, Ludek/O-4813-2018	Dowd, Scot E/0000-0002-6296-1427; Zurek, Ludek/0000-0002-4912-3138	Kansas State University	Kansas State University	This study was funded by Ludek Zurek's (Principal Investigator) Kansas State University operational funds not linked to any specific funding agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amachawadi RG, 2010, FOODBORNE PATHOG DIS, V7, P1089, DOI 10.1089/fpd.2010.0540; Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Arias CA, 2008, EXPERT REV ANTI-INFE, V6, P637, DOI 10.1586/14787210.6.5.637; Arias CA, 2009, ANTIMICROB AGENTS CH, V53, P4240, DOI 10.1128/AAC.00242-09; Austin DJ, 1999, P NATL ACAD SCI USA, V96, P6908, DOI 10.1073/pnas.96.12.6908; Bell J. A., 2008, INTERDISCIP PERSPECT, DOI [10.1155/2008/149694, DOI 10.1155/2008/149694.PMID:19282974]; BENTORCHA F, 1991, ANTIMICROB AGENTS CH, V35, P808, DOI 10.1128/AAC.35.5.808; Biavasco F, 2007, APPL ENVIRON MICROB, V73, P3307, DOI 10.1128/AEM.02239-06; Black DM, 2009, J VET EMERG CRIT CAR, V19, P489, DOI 10.1111/j.1476-4431.2009.00463.x; Boerlin P, 2001, VET MICROBIOL, V82, P347, DOI 10.1016/S0378-1135(01)00396-0; Butaye P, 2001, ANTIMICROB AGENTS CH, V45, P1374, DOI 10.1128/AAC.45.5.1374-1378.2001; CHOW JW, 1993, ANTIMICROB AGENTS CH, V37, P2474, DOI 10.1128/AAC.37.11.2474; Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI, V30, P76; Clinical and Laboratory Standards Institute, 2008, M27A3 CLSI, V28, P1; Clooten J, 2008, VET MICROBIOL, V129, P209, DOI 10.1016/j.vetmic.2007.11.013; Coburn PS, 2007, MOL MICROBIOL, V63, P530, DOI 10.1111/j.1365-2958.2006.05520.x; Coque TM, 1996, ANTIMICROB AGENTS CH, V40, P2605, DOI 10.1128/AAC.40.11.2605; Damborg P, 2008, VET MICROBIOL, V132, P190, DOI 10.1016/j.vetmic.2008.04.026; Damborg P, 2009, APPL ENVIRON MICROB, V75, P2360, DOI 10.1128/AEM.02035-08; De Graef EM, 2005, J APPL MICROBIOL, V99, P348, DOI 10.1111/j.1365-2672.2005.02588.x; De Leener E, 2005, MICROB DRUG RESIST, V11, P395, DOI 10.1089/mdr.2005.11.395; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; DEVRIESE LA, 1992, J APPL BACTERIOL, V73, P421, DOI 10.1111/j.1365-2672.1992.tb04998.x; Devriese LA, 1996, ANTIMICROB AGENTS CH, V40, P2285, DOI 10.1128/AAC.40.10.2285; DEVRIESE LA, 1987, INT J SYST BACTERIOL, V37, P257, DOI 10.1099/00207713-37-3-257; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Dzidic S, 2003, ACTA PHARMACOL SIN, V24, P519; Eaton TJ, 2001, APPL ENVIRON MICROB, V67, P1628, DOI 10.1128/AEM.67.4.1628-1635.2001; El Amin N, 1999, ANTIMICROB AGENTS CH, V43, P947, DOI 10.1128/AAC.43.4.947; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Frank LA, 2009, VET DERMATOL, V20, P496, DOI 10.1111/j.1365-3164.2009.00826.x; Freitas AR, 2009, APPL ENVIRON MICROB, V75, P4904, DOI 10.1128/AEM.02945-08; Galloway-Pena JR, 2009, J INFECT DIS, V200, P1566, DOI 10.1086/644790; Gilmore MS, 2002, ENTEROCOCCI: PATHOGENESIS, MOLECULAR BIOLOGY, AND ANTIBIOTIC RESISTANCE, P301; Guardabassi L, 2004, J ANTIMICROB CHEMOTH, V54, P321, DOI 10.1093/jac/dkh332; Guardabassi L, 2004, VET MICROBIOL, V98, P23, DOI 10.1016/j.vetmic.2003.09.021; Haas W, 2002, NATURE, V415, P84, DOI 10.1038/415084a; Hancock LE, 2004, J BACTERIOL, V186, P5629, DOI 10.1128/JB.186.17.5629-5639.2004; Heikens E, 2007, J BACTERIOL, V189, P8233, DOI 10.1128/JB.01205-07; Herrero IA, 2004, J CLIN MICROBIOL, V42, P1384, DOI 10.1128/JCM.42.3.1384-1385.2004; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Ike Y, 1998, J BACTERIOL, V180, P4886, DOI 10.1128/JB.180.18.4886-4892.1998; Jackson CR, 2010, J APPL MICROBIOL, V108, P2171, DOI 10.1111/j.1365-2672.2009.04619.x; Jackson CR, 2009, J APPL MICROBIOL, V107, P1269, DOI 10.1111/j.1365-2672.2009.04310.x; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Kim SY, 2007, MICROBIOL IMMUNOL, V51, P919, DOI 10.1111/j.1348-0421.2007.tb03983.x; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; LANDMAN D, 1993, ANTIMICROB AGENTS CH, V37, P1904, DOI 10.1128/AAC.37.9.1904; Loeffler A, 2005, J ANTIMICROB CHEMOTH, V56, P692, DOI 10.1093/jac/dki312; Macovei L, 2007, APPL ENVIRON MICROB, V73, P6740, DOI 10.1128/AEM.01444-07; Macovei L, 2006, APPL ENVIRON MICROB, V72, P4028, DOI 10.1128/AEM.00034-06; Macovei L, 2009, ENVIRON MICROBIOL, V11, P1540, DOI 10.1111/j.1462-2920.2009.01881.x; Manian FA, 2003, CLIN INFECT DIS, V36, pE26, DOI 10.1086/344772; Manson JM, 2003, J CLIN MICROBIOL, V41, P3331, DOI 10.1128/JCM.41.7.3331-3333.2003; Mentula S, 2005, APPL ENVIRON MICROB, V71, P4169, DOI 10.1128/AEM.71.8.4169-4175.2005; Middelbos IS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009768; Murray BE, 2000, NEW ENGL J MED, V342, P710, DOI 10.1056/NEJM200003093421007; Nakayama J, 2001, MOL MICROBIOL, V41, P145, DOI 10.1046/j.1365-2958.2001.02486.x; Nannini EC, 2003, ANTIMICROB AGENTS CH, V47, P529, DOI 10.1128/AAC.47.2.529-532.2003; Ogeer-Gyles JS, 2006, J VET EMERG CRIT CAR, V16, P1, DOI 10.1111/j.1476-4431.2005.00162.x; Ossiprandi MC, 2008, COMP IMMUNOL MICROB, V31, P1, DOI 10.1016/j.cimid.2007.08.003; Pelz RK, 2002, INTENS CARE MED, V28, P692, DOI 10.1007/s00134-002-1276-8; Poeta P, 2006, INT J ANTIMICROB AG, V27, P131, DOI 10.1016/j.ijantimicag.2005.09.018; Prescott JF, 2002, CAN VET J, V43, P107; Qi C, 2006, J CLIN MICROBIOL, V44, P1098, DOI 10.1128/JCM.44.3.1098-1100.2006; Rice LB, 2001, ANTIMICROB AGENTS CH, V45, P1480, DOI 10.1128/AAC.45.5.1480-1486.2001; Roberts RR, 2009, CLIN INFECT DIS, V49, P1175, DOI 10.1086/605630; Samuelsson A, 2003, J HOSP INFECT, V54, P188, DOI 10.1016/S0195-6701(03)00122-1; Sandoe JAT, 2003, J MED MICROBIOL, V52, P547, DOI 10.1099/jmm.0.05201-0; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Schlievert PM, 1998, INFECT IMMUN, V66, P218, DOI 10.1128/IAI.66.1.218-223.1998; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sghir A, 2000, APPL ENVIRON MICROB, V66, P2263, DOI 10.1128/AEM.66.5.2263-2266.2000; Shankar N, 2004, INT J MED MICROBIOL, V293, P609, DOI 10.1078/1438-4221-00301; Simjee S, 2002, J CLIN MICROBIOL, V40, P4659, DOI 10.1128/JCM.40.12.4659-4665.2002; Simpson JM, 2002, MICROB ECOL, V44, P186, DOI 10.1007/s00248-002-0001-z; Suchodolski JS, 2008, FEMS MICROBIOL ECOL, V66, P567, DOI 10.1111/j.1574-6941.2008.00521.x; Suchodolski JS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-210; Takeuchi K, 2005, FEMS MICROBIOL LETT, V243, P347, DOI 10.1016/j.femsle.2004.12.022; Teixeira LCRS, 2010, ISME J, V4, P989, DOI 10.1038/ismej.2010.35; Tendolkar PM, 2006, J BACTERIOL, V188, P2063, DOI 10.1128/JB.188.6.2063-2072.2006; Tendolkar PM, 2004, INFECT IMMUN, V72, P6032, DOI 10.1128/IAI.72.10.6032-6039.2004; Top J, 2004, J CLIN MICROBIOL, V42, P4503, DOI 10.1128/JCM.42.10.4503-4511.2004; Top J, 2008, FEMS IMMUNOL MED MIC, V52, P297, DOI 10.1111/j.1574-695X.2008.00383.x; Umber JK, 2009, VET CLIN N AM-SMALL, V39, P279, DOI 10.1016/j.cvsm.2008.10.016; Valdezate S, 2009, J ANTIMICROB CHEMOTH, V63, P17, DOI 10.1093/jac/dkn449; vanBelkum A, 1996, LANCET, V348, P1038, DOI 10.1016/S0140-6736(05)64973-2; Vankerckhoven V, 2004, J CLIN MICROBIOL, V42, P4473, DOI 10.1128/JCM.42.10.4473-4479.2004; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Warburton PJ, 2007, J ANTIMICROB CHEMOTH, V60, P973, DOI 10.1093/jac/dkm331; Wassenberg MWM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011562; Willems RJL, 2005, EMERG INFECT DIS, V11, P821, DOI 10.3201/1106.041204; Willems RJL, 2000, J INFECT DIS, V182, P816, DOI 10.1086/315752; Willems RJL, 2009, FUTURE MICROBIOL, V4, P1125, DOI [10.2217/fmb.09.82, 10.2217/FMB.09.82]; Wolfs TFW, 2001, CLIN INFECT DIS, V32, pE97, DOI 10.1086/319224	95	36	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22451	10.1371/journal.pone.0022451	http://dx.doi.org/10.1371/journal.pone.0022451			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21811613	Green Published, gold, Green Submitted			2022-12-25	WOS:000292929500068
J	Lihoreau, M; Rivault, C				Lihoreau, Mathieu; Rivault, Colette			Local Enhancement Promotes Cockroach Feeding Aggregations	PLOS ONE			English	Article							BLATTELLA-GERMANICA L.; CUTICULAR HYDROCARBONS; DICTYOPTERA; INFORMATION; CHOICE	Communication and learning from each other are part of the success of animal societies. Social insects invest considerable effort into signalling to their nestmates the locations of the most profitable resources in their environment. Growing evidence also indicates that insects glean such information through cues inadvertently provided by their conspecifics. Here, we investigate social information use in the foraging decisions by gregarious cockroaches (Blattella germanica L.). Individual cockroaches given a simultaneous choice in a Y-olfactometer between the odour of feeding conspecifics and the mixed odour of food plus non-feeding conspecifics showed a preference for the arm scented with the odour of feeding conspecifics. Social information (the presence of feeding conspecifics) was produced by cockroaches of all age classes and perceived at short distance in the olfactometer arms, suggesting the use of inadvertently provided cues rather than signals. We discuss the nature of these cues and the role of local enhancement (the selection of a location based on cues associated with the presence of conspecifics) in the formation of feeding aggregations in B. germanica. Similar cue-mediated recruitments could underpin a wide range of collective behaviours in group-living insects.	[Lihoreau, Mathieu; Rivault, Colette] Univ Rennes 1, Ctr Natl Rech Sci, Unite Mixte Rech 6552, Rennes, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Lihoreau, M (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	mathieu.lihoreau@sydney.edu.au	Lihoreau, Mathieu/H-7623-2013	Lihoreau, Mathieu/0000-0002-2463-2040	French Ministry for Research	French Ministry for Research(Ministry of Research, France)	This work was funded by a Ph.D. grant from the French Ministry for Research to ML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell W. J., 2007, COCKROACHES ECOLOGY; Coolen I, 2005, CURR BIOL, V15, P1931, DOI 10.1016/j.cub.2005.09.015; COOPER RA, 1992, J ECON ENTOMOL, V85, P838, DOI 10.1093/jee/85.3.838; Costa J., 2006, OTHER INSECT SOC; D'Adamo P, 2000, INSECT SOC, V47, P289, DOI 10.1007/PL00001717; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Dambach M, 1999, J INSECT PHYSIOL, V45, P423, DOI 10.1016/S0022-1910(98)00141-3; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Dawkins R., 1978, P282; Durier V, 1999, ANIM LEARN BEHAV, V27, P108, DOI 10.3758/BF03199436; Durier V, 2001, ANIM BEHAV, V62, P681, DOI 10.1006/anbe.2001.1807; FITZGERALD DT, 1995, TENT CATERPILLARS; Franks NR, 2006, NATURE, V439, P153, DOI 10.1038/439153a; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Gruter C, 2009, TRENDS ECOL EVOL, V24, P242, DOI 10.1016/j.tree.2008.12.007; Holldobler B., 1990, pi; Holldobler B., 2009, SUPERORGANISM; Jeanson R, 2006, J EXP BIOL, V209, P4768, DOI 10.1242/jeb.02562; Laland KN, 2008, CURR BIOL, V18, pR366, DOI 10.1016/j.cub.2008.02.049; Leadbeater E, 2005, CURR BIOL, V15, pR447, DOI 10.1016/j.cub.2005.06.011; Leadbeater E, 2007, CURR BIOL, V17, pR703, DOI 10.1016/j.cub.2007.06.012; Lihoreau M, 2009, BEHAV ECOL, V20, P46, DOI 10.1093/beheco/arn113; Lihoreau M, 2008, ANIM BEHAV, V75, P1965, DOI 10.1016/j.anbehav.2007.12.006; Lihoreau M, 2010, BEHAV ECOL SOCIOBIOL, V64, P1577, DOI 10.1007/s00265-010-0971-7; Lihoreau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003365; Lihoreau M, 2009, BEHAV PROCESS, V82, P81, DOI 10.1016/j.beproc.2009.03.008; Mery F, 2009, CURR BIOL, V19, P730, DOI 10.1016/j.cub.2009.02.064; Mistal C, 2000, CAN ENTOMOL, V132, P867, DOI 10.4039/Ent132867-6; R Development Core Team, 2009, R FDN STAT COMP; Raubenheimer D, 2006, ANIM BEHAV, V71, P1253, DOI 10.1016/j.anbehav.2005.07.024; RIVAULT C, 1992, BEHAV PROCESS, V26, P91, DOI 10.1016/0376-6357(92)90005-X; Rust MK, 1995, UNDERSTANDING CONTRO; Said I, 2005, J INSECT PHYSIOL, V51, P1384, DOI 10.1016/j.jinsphys.2005.09.001; Slaa EJ, 2003, ECOL ENTOMOL, V28, P369, DOI 10.1046/j.1365-2311.2003.00512.x; Sumpter DJT, 2009, PHILOS T R SOC B, V364, P743, DOI 10.1098/rstb.2008.0204; Thorpe W H., 1964, LEARNING INSTINCT AN, V2nd; Tregenza T., 1995, Advances in Ecological Research, V26, P253, DOI 10.1016/S0065-2504(08)60067-7; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Wijenberg R, 2008, ENTOMOL EXP APPL, V129, P124, DOI 10.1111/j.1570-7458.2008.00758.x; Worden BD, 2005, BIOL LETT-UK, V1, P504, DOI 10.1098/rsbl.2005.0368	40	15	15	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22048	10.1371/journal.pone.0022048	http://dx.doi.org/10.1371/journal.pone.0022048			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21811557	Green Submitted, Green Published, gold			2022-12-25	WOS:000292929500032
J	Nishimura, N; Heins, DC; Andersen, RO; Barber, I; Cresko, WA				Nishimura, Nicole; Heins, David C.; Andersen, Ryan O.; Barber, Iain; Cresko, William A.			Distinct Lineages of Schistocephalus Parasites in Threespine and Ninespine Stickleback Hosts Revealed by DNA Sequence Analysis	PLOS ONE			English	Article							GASTEROSTEUS-ACULEATUS; 3-SPINED STICKLEBACK; INTERMEDIATE HOST; GENETIC ARCHITECTURE; PARALLEL EVOLUTION; PELVIC REDUCTION; HYBRID ZONE; SOLIDUS; COMPLEX; SPECIFICITY	Parasitic interactions are often part of complex networks of interspecific relationships that have evolved in biological communities. Despite many years of work on the evolution of parasitism, the likelihood that sister taxa of parasites can co-evolve with their hosts to specifically infect two related lineages, even when those hosts occur sympatrically, is still unclear. Furthermore, when these specific interactions occur, the molecular and physiological basis of this specificity is still largely unknown. The presence of these specific parasitic relationships can now be tested using molecular markers such as DNA sequence variation. Here we test for specific parasitic relationships in an emerging host-parasite model, the stickleback-Schistocephalus system. Threespine and ninespine stickleback fish are intermediate hosts for Schistocephalus cestode parasites that are phenotypically very similar and have nearly identical life cycles through plankton, stickleback, and avian hosts. We analyzed over 2000 base pairs of COX1 and NADH1 mitochondrial DNA sequences in 48 Schistocephalus individuals collected from threespine and ninespine stickleback hosts from disparate geographic regions distributed across the Northern Hemisphere. Our data strongly support the presence of two distinct clades of Schistocephalus, each of which exclusively infects either threespine or ninespine stickleback. These clades most likely represent different species that diverged soon after the speciation of their stickleback hosts. In addition, genetic structuring exists among Schistocephalus taken from threespine stickleback hosts from Alaska, Oregon and Wales, although it is much less than the divergence between hosts. Our findings emphasize that biological communities may be even more complex than they first appear, and beg the question of what are the ecological, physiological, and genetic factors that maintain the specificity of the Schistocephalus parasites and their stickleback hosts.	[Nishimura, Nicole; Cresko, William A.] Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA; [Heins, David C.] Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA; [Andersen, Ryan O.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; [Barber, Iain] Univ Leicester, Dept Biol, Coll Med Biol Sci & Psychol, Leicester, Leics, England	University of Oregon; Tulane University; University of Oregon; University of Leicester	Nishimura, N (corresponding author), Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA.	wcresko@uoregon.edu	Barber, Iain/B-8872-2008; Cresko, William/H-4010-2014	Barber, Iain/0000-0003-3955-6674; Cresko, William/0000-0002-3496-8074	United States National Science Foundation [IOS NSF DEB-0919090]; United States National Institutes of Health [1R24GM079486-01A1]; University of Oregon; Newcomb College Institute; UK NERC [NE/F019440/1]; NERC [NE/F019440/1] Funding Source: UKRI; Natural Environment Research Council [NE/F019440/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM079486] Funding Source: NIH RePORTER	United States National Science Foundation(National Science Foundation (NSF)); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Oregon; Newcomb College Institute; UK NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants IOS NSF DEB-0919090 to WAC from the United States National Science Foundation, grant 1R24GM079486-01A1 from the United States National Institutes of Health to WAC, as well as startup funds from the University of Oregon to WAC. DCH was supported by the Newcomb College Institute. IB is in receipt of grant funding from the UK NERC (NE/F019440/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARME C, 1967, PARASITOLOGY, V57, P301, DOI 10.1017/S0031182000072103; Barber I, 2004, BEHAVIOUR, V141, P1425, DOI 10.1163/1568539042948231; Barber I, 2010, PARASITOLOGY, V137, P411, DOI 10.1017/S0031182009991466; Barber I, 2000, REV FISH BIOL FISHER, V10, P131, DOI 10.1023/A:1016658224470; Barber Iain, 2007, P271; Barber I, 2008, BEHAVIOUR, V145, P647, DOI 10.1163/156853908792451403; Bell M.A., 1994, EVOLUTIONARY BIOL TH; BELL MA, 1976, SYST ZOOL, V25, P211, DOI 10.2307/2412489; Blasco-Costa I, 2010, PARASITOLOGY, V137, P287, DOI 10.1017/S0031182009991375; Bouzid W, 2008, INT J PARASITOL, V38, P1465, DOI 10.1016/j.ijpara.2008.03.008; BRATEN T, 1966, PARASITOLOGY, V56, pP5, DOI 10.1017/S0031182000071687; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Choisy M, 2003, AM NAT, V162, P172, DOI 10.1086/375681; Chubb JC, 2006, SYST PARASITOL, V65, P161, DOI 10.1007/s11230-006-9047-5; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Copp GH, 2003, ANN ZOOL FENN, V40, P341; Cresko WA, 2004, P NATL ACAD SCI USA, V101, P6050, DOI 10.1073/pnas.0308479101; Cresko WA, 2008, SCIENCE, V322, P204, DOI 10.1126/science.1165663; Cresko WA, 2007, GENETICA, V129, P105, DOI 10.1007/s10709-006-0036-z; DARTNALL HJ, 1973, J FISH BIOL, V5, P505, DOI 10.1111/j.1095-8649.1973.tb04480.x; Dubinina M. N., 1959, Zoologicheskii Zhurnal, V38, P1498; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Franz K, 2002, PARASITOLOGY, V125, P187, DOI 10.1017/S0031182002001932; Gibson G, 2005, SCIENCE, V307, P1890, DOI 10.1126/science.1109835; GILES N, 1983, ANIM BEHAV, V31, P1192, DOI 10.1016/S0003-3472(83)80025-6; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hammerschmidt K, 2005, P ROY SOC B-BIOL SCI, V272, P2511, DOI 10.1098/rspb.2005.3241; Hammerschmidt K, 2009, EVOLUTION, V63, P1976, DOI 10.1111/j.1558-5646.2009.00687.x; Harmon LJ, 2009, NATURE, V458, P1167, DOI 10.1038/nature07974; Heins DC, 2008, BEHAVIOUR, V145, P625, DOI 10.1163/156853908792451412; Heins DC, 2010, J PARASITOL, V96, P206, DOI 10.1645/GE-2162.1; Heins DC, 2004, CAN J ZOOL, V82, P1731, DOI 10.1139/Z04-171; Hoffman GL., 1999, PARASITES N AM FRESH, V2nd Edn., DOI p.335; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Hudson PJ, 2006, TRENDS ECOL EVOL, V21, P381, DOI 10.1016/j.tree.2006.04.007; Hung GC, 1999, INT J PARASITOL, V29, P285, DOI 10.1016/S0020-7519(98)00203-3; Hunt G, 2008, EVOLUTION, V62, P700, DOI 10.1111/j.1558-5646.2007.00310.x; HYSLOP EJ, 1983, PARASITOLOGY, V87, pR30; Kimmel CB, 2005, P NATL ACAD SCI USA, V102, P5791, DOI 10.1073/pnas.0408533102; Kuris AM, 2008, NATURE, V454, P515, DOI 10.1038/nature06970; Kurtz J, 2006, J HELMINTHOL, V80, P199, DOI 10.1079/JOH2006349; Kurtz J, 2004, P ROY SOC B-BIOL SCI, V271, P197, DOI 10.1098/rspb.2003.2567; LAFFERTY KD, 2008, J FISH BIOL; Lafferty KD, 2008, ECOL LETT, V11, P533, DOI 10.1111/j.1461-0248.2008.01174.x; Lafferty KD, 2006, P NATL ACAD SCI USA, V103, P11211, DOI 10.1073/pnas.0604755103; Lafferty KD, 2009, PHILOS T R SOC B, V364, P1659, DOI 10.1098/rstb.2008.0220; LESTER RJG, 1971, CAN J ZOOLOG, V49, P361, DOI 10.1139/z71-052; LOBUE CP, 1993, AM NAT, V142, P725, DOI 10.1086/285568; Logan FJ, 2004, PARASITOL RES, V94, P10, DOI 10.1007/s00436-004-1164-y; MARCOGLIESE DJ, 1992, J FISH BIOL, V41, P399, DOI 10.1111/j.1095-8649.1992.tb02668.x; McKinnon JS, 2002, TRENDS ECOL EVOL, V17, P480, DOI 10.1016/S0169-5347(02)02579-X; McManus DP, 1996, INT J PARASITOL, V26, P687, DOI 10.1016/0020-7519(96)82612-9; Milinski M., 1990, P95; Miller CT, 2007, CELL, V131, P1179, DOI 10.1016/j.cell.2007.10.055; Miura O, 2005, INT J PARASITOL, V35, P793, DOI 10.1016/j.ijpara.2005.02.014; Miya M, 2003, MOL PHYLOGENET EVOL, V26, P121, DOI 10.1016/S1055-7903(02)00332-9; Moore J., 2000, PARASITES BEHAV ANIM; MOULIA C, 1993, PARASITOLOGY, V106, P387, DOI 10.1017/S0031182000067135; MOULIA C, 1995, HEREDITY, V74, P48, DOI 10.1038/hdy.1995.6; Ness JH, 1999, OIKOS, V85, P127, DOI 10.2307/3546798; Olson PD, 2002, J HELMINTHOL, V76, P171, DOI 10.1079/JOH2001101; ORR TSC, 1969, PARASITOLOGY, V59, P683, DOI 10.1017/S0031182000031206; ORTI G, 1994, EVOLUTION, V48, P608, DOI 10.1111/j.1558-5646.1994.tb01348.x; Overli O, 2001, P ROY SOC B-BIOL SCI, V268, P1411, DOI 10.1098/rspb.2001.1668; Peichel CL, 2001, NATURE, V414, P901, DOI 10.1038/414901a; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ross JA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000391; SAGE RD, 1986, NATURE, V324, P60, DOI 10.1038/324060a0; SAGE RD, 1986, CURR TOP MICROBIOL, V127, P75; Scharsack JP, 2007, P ROY SOC B-BIOL SCI, V274, P1523, DOI 10.1098/rspb.2007.0210; Scharsack JP, 2007, P ROY SOC B-BIOL SCI, V274, P3151, DOI 10.1098/rspb.2007.1148; Scharsack JP, 2004, DIS AQUAT ORGAN, V59, P141, DOI 10.3354/dao059141; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Shapiro MD, 2006, P NATL ACAD SCI USA, V103, P13753, DOI 10.1073/pnas.0604706103; Shapiro MD, 2009, CURR BIOL, V19, P1140, DOI 10.1016/j.cub.2009.05.029; SMYTH J. D., 1956, EXPTL PARASITOL, V5, P519, DOI 10.1016/0014-4894(56)90026-1; SMYTH JD, 1990, INT J PARASITOL, V20, P411, DOI 10.1016/0020-7519(90)90190-X; SMYTH JD, 1954, EXP PARASITOL, V3, P64, DOI 10.1016/0014-4894(54)90019-3; SMYTH JD, 1946, J EXP BIOL, V23, P47; SMYTH JD, 1950, J PARASITOL, V36, P371, DOI 10.2307/3273473; Smyth JD, 1994, INTRO ANIMAL PARASIT; Stefka J, 2009, MOL ECOL, V18, P1187, DOI 10.1111/j.1365-294X.2008.04074.x; THOMAS LJ, 1947, J PARASITOL, V33, P107, DOI 10.2307/3273532; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; Wedekind C, 1996, PARASITOLOGY, V112, P371, DOI 10.1017/S0031182000066609; Wegner KM, 2006, MOL ECOL, V15, P1153, DOI 10.1111/j.1365-294X.2006.02855.x; Wegner KM, 2003, J EVOLUTION BIOL, V16, P224, DOI 10.1046/j.1420-9101.2003.00519.x; WHEELER A, 1969, P613; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569; Wootton R. J., 1984, FUNCTIONAL BIOL STIC; Wootton R.J., 1976, BIOL STICKLEBACKS	92	32	32	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22505	10.1371/journal.pone.0022505	http://dx.doi.org/10.1371/journal.pone.0022505			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21811623	Green Published, Green Submitted, gold			2022-12-25	WOS:000292929500074
J	Simon-Areces, J; Dopazo, A; Dettenhofer, M; Rodriguez-Tebar, A; Garcia-Segura, LM; Arevalo, MA				Simon-Areces, Julia; Dopazo, Ana; Dettenhofer, Markus; Rodriguez-Tebar, Alfredo; Miguel Garcia-Segura, Luis; Arevalo, Maria-Angeles			Formin1 Mediates the Induction of Dendritogenesis and Synaptogenesis by Neurogenin3 in Mouse Hippocampal Neurons	PLOS ONE			English	Article							LIMB DEFORMITY; ARP2/3 COMPLEX; ACTIN; NUCLEATION; MECHANISM; PROFILIN; GROWTH; NEURITOGENESIS; POLYMERIZATION; LOCALIZATION	Neurogenin3, a proneural transcription factor controlled by Notch receptor, has been recently shown to regulate dendritogenesis and synaptogenesis in mouse hippocampal neurons. However, little is known about the molecular mechanisms involved in these actions of Ngn3. We have used a microarray analysis to identify Ngn3 regulated genes related with cytoskeleton dynamics. One of such genes is Fmn1, whose protein, Formin1, is associated with actin and microtubule cytoskeleton. Overexpression of the Fmn1 isoform-Ib in cultured mouse hippocampal neurons induced an increase in the number of primary dendrites and in the number of glutamatergic synaptic inputs at 4 days in vitro. The same changes were provoked by overexpression of Ngn3. In addition downregulation of Fmn1 by the use of Fmn1-siRNAs impaired such morphological and synaptic changes induced by Ngn3 overexpression in neurons. These results reveal a previously unknown involvement of Formin1 in dendritogenesis and synaptogenesis and indicate that this protein is a key component of the Ngn3 signaling pathway that controls neuronal differentiation.	[Simon-Areces, Julia; Miguel Garcia-Segura, Luis; Arevalo, Maria-Angeles] CSIC, Inst Cajal, Lab Neuroact Steroids, E-28002 Madrid, Spain; [Dopazo, Ana] CNIC, Genom Unit, Madrid, Spain; [Dettenhofer, Markus] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Rodriguez-Tebar, Alfredo] Consejo Super Invest Cient CABIMER CSIC, Ctr Andaluz Biol Mol & Med Regenerat, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Centro Nacional de Investigaciones Cardiovasculares (CNIC); Harvard University; Harvard Medical School; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER)	Simon-Areces, J (corresponding author), CSIC, Inst Cajal, Lab Neuroact Steroids, E-28002 Madrid, Spain.	arevalo@cajal.csic.es	Garcia-Segura, Luis M/U-3711-2017; Dettenhofer, Markus/ABB-9840-2021; Dopazo, Ana/N-1159-2014; Arevalo, Maria-Angeles/J-7000-2014	Garcia-Segura, Luis M/0000-0002-2450-2916; Dettenhofer, Markus/0000-0003-1972-7026; Dopazo, Ana/0000-0002-4910-1684; Arevalo, Maria-Angeles/0000-0002-4303-9576	Ministerio de Ciencia e Innovacion, Spain [BFU2008-02950-C03-01]; Comunidad de Madrid [CCG08-CSIC/SAL-3617]	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid(Comunidad de Madrid)	This work has been supported by Ministerio de Ciencia e Innovacion, Spain (BFU2008-02950-C03-01) http://www.micinn.es, and by Comunidad de Madrid (CCG08-CSIC/SAL-3617) http://www.madrid.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Arakawa Y, 2003, J CELL BIOL, V161, P381, DOI 10.1083/jcb.200210149; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; CHAN DC, 1995, DEVELOPMENT, V121, P3151; Dent EW, 2007, NAT CELL BIOL, V9, P1347, DOI 10.1038/ncb1654; Dettenhofer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002497; Diez D, 2007, BIOINFORMATICS, V23, P1168, DOI 10.1093/bioinformatics/btm072; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; FIFKOVA E, 1982, J CELL BIOL, V95, P345, DOI 10.1083/jcb.95.1.345; GENTLEMAN R, 2007, GENEFILTER METHODS F; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gupton SL, 2010, DEV CELL, V18, P725, DOI [10.1016/j.devcel.2010.02.017, 10.1016/j.devce1.2010.02.017]; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; JACKSONGRUSBY L, 1992, GENE DEV, V6, P29, DOI 10.1101/gad.6.1.29; KESSELS MM, 2010, EUR J CELL IN PRESS; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Korobova F, 2008, MOL BIOL CELL, V19, P1561, DOI 10.1091/mbc.E07-09-0964; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Lee J, 2003, DEV BIOL, V253, P84, DOI 10.1006/dbio.2002.0868; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Liu Y, 2002, GLIA, V40, P25, DOI 10.1002/glia.10111; Ma WX, 2009, MOL CELL NEUROSCI, V40, P187, DOI 10.1016/j.mcn.2008.10.006; MAAS RL, 1990, NATURE, V346, P853, DOI 10.1038/346853a0; Matusek T, 2008, J NEUROSCI, V28, P13310, DOI 10.1523/JNEUROSCI.2727-08.2008; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Ruiz-Palmero I, 2011, J NEUROENDOCRINOL, V23, P355, DOI 10.1111/j.1365-2826.2011.02110.x; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Salama-Cohen P, 2006, J NEUROCHEM, V97, P1269, DOI 10.1111/j.1471-4159.2006.03783.x; Salomon SN, 2008, NEUROSCI LETT, V447, P62, DOI 10.1016/j.neulet.2008.09.051; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Simon-Areces J, 2010, J COMP NEUROL, V518, P1814, DOI 10.1002/cne.22304; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Strasser GA, 2004, NEURON, V43, P81, DOI 10.1016/j.neuron.2004.05.015; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Trevino V, 2007, MOL MED, V13, P527, DOI 10.2119/2006-00107.Trevino; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; WOYCHIK RP, 1990, NATURE, V346, P850, DOI 10.1038/346850a0; WynshawBoris A, 1997, MOL MED, V3, P372, DOI 10.1007/BF03401684; You JJ, 2010, J BIOL CHEM, V285, P11652, DOI 10.1074/jbc.M109.051094; Zallen JA, 2002, J CELL BIOL, V156, P689, DOI 10.1083/jcb.200109057; Zhou F, 2006, EXP CELL RES, V312, P1119, DOI 10.1016/j.yexcr.2005.12.035; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019	46	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e21825	10.1371/journal.pone.0021825	http://dx.doi.org/10.1371/journal.pone.0021825			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21818269	Green Published, Green Submitted, gold			2022-12-25	WOS:000292929500012
J	Tejiokem, MC; Faye, A; Penda, IC; Guemkam, G; Ndongo, FA; Chewa, G; Rekacewicz, C; Rousset, D; Kfutwah, A; Boisier, P; Warszawski, J				Tejiokem, Mathurin C.; Faye, Albert; Penda, Ida C.; Guemkam, Georgette; Ndongo, Francis Ateba; Chewa, Gisele; Rekacewicz, Claire; Rousset, Dominique; Kfutwah, Anfumbom; Boisier, Pascal; Warszawski, Josiane		ARNS 12140-PEDIACAM Study Grp	Feasibility of Early Infant Diagnosis of HIV in Resource-Limited Settings: The ANRS 12140-PEDIACAM Study in Cameroon	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TO-CHILD TRANSMISSION; EARLY ANTIRETROVIRAL THERAPY; POLYMERASE-CHAIN-REACTION; FOLLOW-UP; INFECTED INFANTS; EXPOSED INFANTS; RURAL MALAWI; PREVENTION; PROGRAM	Background: Early infant diagnosis (EID) of HIV is a key-point for the implementation of early HAART, associated with lower mortality in HIV-infected infants. We evaluated the EID process of HIV according to national recommendations, in urban areas of Cameroon. Methods/Findings: The ANRS12140-Pediacam study is a multisite cohort in which infants born to HIV-infected mothers were included before the 8(th) day of life and followed. Collection of samples for HIV DNA/RNA-PCR was planned at 6 weeks together with routine vaccination. The HIV test result was expected to be available at 10 weeks. A positive or indeterminate test result was confirmed by a second test on a different sample. Systematic HAART was offered to HIV-infected infants identified. The EID process was considered complete if infants were tested and HIV results provided to mothers/family before 7 months of age. During 2007-2009, 1587 mother-infant pairs were included in three referral hospitals; most infants (n = 1423, 89.7%) were tested for HIV, at a median age of 1.5 months (IQR, 1.4-1.6). Among them, 51 (3.6%) were HIV-infected. Overall, 1331 (83.9%) completed the process by returning for the result before 7 months (median age: 2.5 months (IQR, 2.4-3.0)). Incomplete process, that is test not performed, or result of test not provided or provided late to the family, was independently associated with late HIV diagnosis during pregnancy (adjusted odds ratio (aOR) = 1.8, 95% CI: 1.1 to 2.9, p = 0.01), absence of PMTCT prophylaxis (aOR = 2.4, 95% CI: 1.4 to 4.3, p = 0.002), and emergency caesarean section (aOR = 2.5, 95% CI: 1.5 to 4.3, p = 0.001). Conclusions: In urban areas of Cameroon, HIV-infected women diagnosed sufficiently early during pregnancy opt to benefit from EID whatever their socio-economic, marital or disclosure status. Reduction of non optimal diagnosis process should focus on women with late HIV diagnosis during pregnancy especially if they did not receive any PMTCT, or if complications occurred at delivery.	[Tejiokem, Mathurin C.; Rousset, Dominique; Kfutwah, Anfumbom; Boisier, Pascal] Ctr Pasteur Cameroun, Yaounde, Cameroon; [Tejiokem, Mathurin C.; Warszawski, Josiane] Univ Paris 11, Paris, France; [Faye, Albert] Hop Robert Debre, Assistance Publ Hop Paris, Serv Pediat Gen, F-75019 Paris, France; [Faye, Albert] Univ Paris Diderot, UFR Med, Paris, France; [Penda, Ida C.] Hop Laquintinie, Douala, Cameroon; [Penda, Ida C.] Univ Douala, Douala, Cameroon; [Guemkam, Georgette; Ndongo, Francis Ateba] Fdn Chantal Biya, Ctr Mere & Enfant, Yaounde, Cameroon; [Chewa, Gisele] Ctr Hosp Essos, Yaounde, Cameroon; [Rekacewicz, Claire] Agence Natl Rech Sida & Hepatites Virales, Paris, France; [Rousset, Dominique] Inst Pasteur, Paris, France; [Warszawski, Josiane] Hop Bicetre, Assistance Publ Hop Paris, Serv Epidemiol & Sante Publ, Paris, France; [Warszawski, Josiane] INSERM, CESP U1018, Equipe VIH & IST 4, Paris, France	Centre Pasteur du Cameroun; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm)	Tejiokem, MC (corresponding author), Ctr Pasteur Cameroun, Yaounde, Cameroon.	tejiokem@pasteur-yaounde.org	Barre-Sinoussi, Françoise/G-8355-2011; Pouillot, Regis/E-8103-2010; Rousset, Dominique/S-5400-2019; BOISIER, PASCAL/A-2922-2009	Pouillot, Regis/0000-0002-6107-5212; Rousset, Dominique/0000-0002-1473-3147; Baril, Laurence/0000-0003-2346-883X; Penda, Calixte Ida/0000-0002-1070-2108	French National Agency for Research on AIDS and Viral Hepatitis (ANRS)	French National Agency for Research on AIDS and Viral Hepatitis (ANRS)(ANRSFrench National Research Agency (ANR))	This prospective study is sponsored by the French National Agency for Research on AIDS and Viral Hepatitis (ANRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahoua L, 2010, J TROP PEDIATRICS, V56, P43, DOI 10.1093/tropej/fmp054; Bwirire LD, 2008, T ROY SOC TROP MED H, V102, P1195, DOI 10.1016/j.trstmh.2008.04.002; Chiappini E, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-140; Creek T, 2008, PEDIATR INFECT DIS J, V27, P22, DOI 10.1097/INF.0b013e3181469050; Creek TL, 2007, AM J OBSTET GYNECOL, V197, pS64, DOI 10.1016/j.ajog.2007.03.002; Faye A, 2004, CLIN INFECT DIS, V39, P1692, DOI 10.1086/425739; Goetghebuer T, 2009, AIDS, V23, P597, DOI 10.1097/QAD.0b013e328326ca37; Institut national de la statistique et ORC Macro, 2004, ENQ DEM SANT CAM; Ioannidis JPA, 1999, INT J EPIDEMIOL, V28, P769, DOI 10.1093/ije/28.4.769; Jones SA, 2005, AIDS CARE, V17, P466, DOI 10.1080/09540120412331319723; Kaplan R, 2008, AIDS, V22, P1679, DOI 10.1097/QAD.0b013e32830ebcee; Lanoy E, 2006, J CLIN EPIDEMIOL, V59, P829, DOI 10.1016/j.jclinepi.2005.11.024; Manzi M, 2005, TROP MED INT HEALTH, V10, P1242, DOI 10.1111/j.1365-3156.2005.01526.x; McCoy D, 2002, INTERIM FINDINGS NAT; *MIN SANT PUBL CAM, 2009, 4 MIN SANT PUBL CAM; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Nuwagaba-Biribonwoha H, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-44; Nyandiko WM, 2010, JAIDS-J ACQ IMM DEF, V54, P42, DOI 10.1097/QAI.0b013e3181d8ad51; Rollins N, 2009, AIDS, V23, P1851, DOI 10.1097/QAD.0b013e32832d84fd; Rouet F, 2005, J CLIN MICROBIOL, V43, P2709, DOI 10.1128/JCM.43.6.2709-2717.2005; Sherman GG, 2005, PEDIATR INFECT DIS J, V24, P993, DOI 10.1097/01.inf.0000187036.73539.8d; Tchendjou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010411; Tejiokem MC, 2004, MED MALADIES INFECT, V34, pS57, DOI 10.1016/S0399-077X(04)90019-4; UNAIDS, 2010, UNAIDS REP GLOB AIDS; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; *WHO, 2008, WHO TECHN REF GROUP; World Health Organization, 2010, UN ACC SCAL PRIOR HI; World Health Organization, 2010, ANT THER HIV INF INF	28	43	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e21840	10.1371/journal.pone.0021840	http://dx.doi.org/10.1371/journal.pone.0021840			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21818273	Green Published, Green Submitted, gold			2022-12-25	WOS:000292929500014
J	Viblanc, VA; Mathien, A; Saraux, C; Viera, VM; Groscolas, R				Viblanc, Vincent A.; Mathien, Adeline; Saraux, Claire; Viera, Vanessa M.; Groscolas, Rene			It Costs to Be Clean and Fit: Energetics of Comfort Behavior in Breeding-Fasting Penguins	PLOS ONE			English	Article							DOUBLY LABELED WATER; TICKS IXODES-URIAE; KING PENGUINS; HEART-RATE; APTENODYTES-PATAGONICUS; GROOMING BEHAVIORS; OXYGEN-CONSUMPTION; ENERGY-EXPENDITURE; SEABIRD; SUMMER	Background: Birds may allocate a significant part of time to comfort behavior (e. g., preening, stretching, shaking, etc.) in order to eliminate parasites, maintain plumage integrity, and possibly reduce muscular ankylosis. Understanding the adaptive value of comfort behavior would benefit from knowledge on the energy costs animals are willing to pay to maintain it, particularly under situations of energy constraints, e. g., during fasting. We determined time and energy devoted to comfort activities in freely breeding king penguins (Aptenodytes patagonicus), seabirds known to fast for up to one month during incubation shifts ashore. Methodology/Principal Findings: A time budget was estimated from focal and scan sampling field observations and the energy cost of comfort activities was calculated from the associated increase in heart rate (HR) during comfort episodes, using previously determined equations relating HR to energy expenditure. We show that incubating birds spent 22% of their daily time budget in comfort behavior (with no differences between day and night) mainly devoted to preening (73%) and head/body shaking (16%). During comfort behavior, energy expenditure averaged 1.24 times resting metabolic rate (RMR) and the corresponding energy cost (i.e., energy expended in excess to RMR) was 58 kJ/hr. Energy expenditure varied greatly among various types of comfort behavior, ranging from 1.03 (yawning) to 1.78 (stretching) times RMR. Comfort behavior contributed 8.8-9.3% to total daily energy expenditure and 69.4-73.5% to energy expended daily for activity. About half of this energy was expended caring for plumage. Conclusion/Significance: This study is the first to estimate the contribution of comfort behavior to overall energy budget in a free-living animal. It shows that although breeding on a tight energy budget, king penguins devote a substantial amount of time and energy to comfort behavior. Such findings underline the importance of comfort behavior for the fitness of colonial seabirds.	[Viblanc, Vincent A.; Mathien, Adeline; Saraux, Claire; Viera, Vanessa M.; Groscolas, Rene] Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, Dept Ecol Physiol & Ethol, Strasbourg, France; [Viblanc, Vincent A.; Mathien, Adeline; Saraux, Claire; Viera, Vanessa M.; Groscolas, Rene] Ctr Natl Rech Sci, Unite Mixte Rech 7178, Strasbourg, France; [Saraux, Claire] AgroParisTech, Ecole Natl Genie Rural Eaux & Forets, Paris, France; [Viera, Vanessa M.] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Viera, Vanessa M.] Univ Laval, Ctr Etud Nord, Quebec City, PQ G1K 7P4, Canada	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); AgroParisTech; Laval University; Laval University	Viblanc, VA (corresponding author), Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, Dept Ecol Physiol & Ethol, Strasbourg, France.	vincent.viblanc@iphc.cnrs.fr; rene.groscolas@c-strasbourg.fr	saraux, claire/AAX-8709-2020; Viblanc, Vincent Alexandre/A-7455-2014	saraux, claire/0000-0001-5061-4009; Viblanc, Vincent Alexandre/0000-0002-4953-659X	French Polar Institute (Institut Paul Emile Victor - IPEV) [119]; Centre National Francais pour la Recherche Scientifique (CNRS-INEE); French Ministere de l'Education Nationale, de la Recherche et de la Technologie; Fondation Universite Laval; National Sciences and Engineering and Research Council of Canada; Fonds Richard-Bernard	French Polar Institute (Institut Paul Emile Victor - IPEV); Centre National Francais pour la Recherche Scientifique (CNRS-INEE); French Ministere de l'Education Nationale, de la Recherche et de la Technologie; Fondation Universite Laval; National Sciences and Engineering and Research Council of Canada; Fonds Richard-Bernard	This research was funded by project no. 119 of the French Polar Institute (Institut Paul Emile Victor - IPEV, URL: http://www.institut-polaire.fr/) and by the Centre National Francais pour la Recherche Scientifique (CNRS-INEE, URL:http://www.cnrs.fr/). Logistic support was provided by Terres Australes et Antarctiques Francaises (TAAF, URL: http://www.taaf.fr/spip/). VAV was the recipient of a fellowship from the French Ministere de l'Education Nationale, de la Recherche et de la Technologie. VMV was supported by scholarships from the Fondation Universite Laval, the National Sciences and Engineering and Research Council of Canada, and the Fonds Richard-Bernard under the supervision of SD Cote. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINLEY DG, 1974, BEHAVIOUR, V50, P16, DOI 10.1163/156853974X00020; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Ballinger GA, 2004, ORGAN RES METHODS, V7, P127, DOI 10.1177/1094428104263672; Barron DG, 2010, METHODS ECOL EVOL, V1, P180, DOI 10.1111/j.2041-210X.2010.00013.x; Basibuyuk HH, 1999, ZOOL J LINN SOC-LOND, V125, P349, DOI 10.1111/j.1096-3642.1999.tb00597.x; Bevan RM, 1995, PHILOS T R SOC B, V350, P119, DOI 10.1098/rstb.1995.0146; BOOTH DT, 1993, P ROY SOC B-BIOL SCI, V253, P125, DOI 10.1098/rspb.1993.0091; Bost CA, 1997, MAR ECOL PROG SER, V150, P21, DOI 10.3354/meps150021; Bshary R, 2002, ANIM BEHAV, V63, P557, DOI 10.1006/anbe.2001.1923; Butler PJ, 2004, FUNCT ECOL, V18, P168, DOI 10.1111/j.0269-8463.2004.00821.x; CHALLET E, 1994, J ZOOL, V233, P669, DOI 10.1111/j.1469-7998.1994.tb05373.x; Charrassin JB, 1998, OECOLOGIA, V114, P194, DOI 10.1007/s004420050436; Cote SD, 2000, ANIM BEHAV, V59, P813, DOI 10.1006/anbe.1999.1384; COTGREAVE P, 1994, BEHAVIOUR, V131, P171, DOI 10.1163/156853994X00424; Delius J D., 1970, Revue Comport. Anim., V4, P3; Delord K, 2004, POLAR BIOL, V27, P793, DOI 10.1007/s00300-004-0651-z; Eckstein RA, 2000, APPL ANIM BEHAV SCI, V68, P141, DOI 10.1016/S0168-1591(00)00095-2; Fahlman A, 2004, AM J PHYSIOL-REG I, V287, pR870, DOI 10.1152/ajpregu.00651.2003; Froget G, 2002, J EXP BIOL, V205, P2511; Froget G, 2001, J EXP BIOL, V204, P2133; Gauthier-Clerc M, 2001, ANIM BEHAV, V62, P661, DOI 10.1006/anbe.2001.1803; Gauthier-Clerc M, 1998, COLON WATERBIRD, V21, P229, DOI 10.2307/1521910; Giorgi MS, 2001, P ROY SOC B-BIOL SCI, V268, P2071, DOI 10.1098/rspb.2001.1686; Green JA, 2001, J EXP BIOL, V204, P673; Green JA, 2011, COMP BIOCHEM PHYS A, V158, P287, DOI 10.1016/j.cbpa.2010.09.011; GROSCOLAS R, 1978, COMP BIOCHEM PHYS A, V61, P287, DOI 10.1016/0300-9629(78)90111-1; Groscolas R, 2010, J EXP BIOL, V213, P153, DOI 10.1242/jeb.033720; Groscolas R., 1990, P269; Groscolas R, 2000, AM J PHYSIOL-REG I, V279, pR2104, DOI 10.1152/ajpregu.2000.279.6.R2104; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; Halsey LG, 2007, ZOOLOGY, V110, P81, DOI 10.1016/j.zool.2006.09.001; HART BL, 1992, ANIM BEHAV, V44, P1073, DOI 10.1016/S0003-3472(05)80319-7; Hawlena H, 2007, ETHOLOGY, V113, P394, DOI 10.1111/j.1439-0310.2007.01332.x; JOUVENTIN P, 1994, MAR ECOL PROG SER, V106, P11, DOI 10.3354/meps106011; Lenouvel P, 2009, ANIM BEHAV, V77, P1253, DOI 10.1016/j.anbehav.2009.02.007; Mangin S, 2003, J AVIAN BIOL, V34, P30, DOI 10.1034/j.1600-048X.2003.02916.x; MCKINNEY F, 1965, BEHAVIOUR, V25, P120, DOI 10.1163/156853965X00138; MOLLER AP, 1994, OECOLOGIA, V98, P263, DOI 10.1007/BF00324213; Mooring MS, 2004, BIOL J LINN SOC, V81, P17, DOI 10.1111/j.1095-8312.2004.00273.x; Palestis BG, 1998, ANIM BEHAV, V56, P1107, DOI 10.1006/anbe.1998.0907; Piersma T, 2003, J EXP BIOL, V206, P3361, DOI 10.1242/jeb.00545; Putz K, 1998, ECOLOGY, V79, P1905, DOI 10.2307/176698; Robin JP, 2001, J AVIAN BIOL, V32, P303, DOI 10.1111/j.0908-8857.2001.320403.x; Rovero F, 2000, ANIM BEHAV, V59, P705, DOI 10.1006/anbe.1999.1353; SCHINO G, 1988, AM J PRIMATOL, V16, P43, DOI 10.1002/ajp.1350160106; Schino G, 2008, BIOL LETTERS, V4, P9, DOI 10.1098/rsbl.2007.0506; Schmid I, 1997, APPL ANIM BEHAV SCI, V55, P103, DOI 10.1016/S0168-1591(97)00039-7; Schmidt M, 2005, J EXP BIOL, V208, P233, DOI 10.1242/jeb.01357; Schmidt-Nielsen K., 1979, ANIMAL PHYSL ADAPTAT; SIMMONS KEL, 1985, DICT BIRDS, P101; SMITH IP, 1993, ANIM BEHAV, V45, P375, DOI 10.1006/anbe.1993.1042; Stearns S.C., 1992, pi; Stonehouse B, 1960, SCI REPT FALKLAND IS, V23, P1; Sumana A, 2004, ETHOLOGY, V110, P825, DOI 10.1111/j.1439-0310.2004.01024.x; VIERA VM, 2010, THESIS U LAVAL QUEBE; Walther BA, 2005, BEHAV ECOL, V16, P89, DOI 10.1093/beheco/arh135; Walther Bruno A., 2003, Lundiana, V4, P149; WEIMERSKIRCH H, 1992, IBIS, V134, P107, DOI 10.1111/j.1474-919X.1992.tb08387.x; Williams T.D., 1995, PENGUINS; Zar JH, 1999, BIOSTATISTICAL ANAL; Zheng BY, 2000, STAT MED, V19, P1265, DOI 10.1002/(SICI)1097-0258(20000530)19:10<1265::AID-SIM486>3.3.CO;2-L	61	22	22	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e21110	10.1371/journal.pone.0021110	http://dx.doi.org/10.1371/journal.pone.0021110			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21818253	gold, Green Published, Green Submitted			2022-12-25	WOS:000292929500002
J	Zhou, LP; Wang, YP; Li, Y; Yap, PT; Shen, DG				Zhou, Luping; Wang, Yaping; Li, Yang; Yap, Pew-Thian; Shen, Dinggang		Alzheimer's Dis Neuroimaging Initi	Hierarchical Anatomical Brain Networks for MCI Prediction: Revisiting Volumetric Measures	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; PRODROMAL ALZHEIMERS-DISEASE; PATTERN-CLASSIFICATION; MRI; ATROPHY; SEGMENTATION; DIAGNOSIS	Owning to its clinical accessibility, T1-weighted MRI (Magnetic Resonance Imaging) has been extensively studied in the past decades for prediction of Alzheimer's disease (AD) and mild cognitive impairment (MCI). The volumes of gray matter (GM), white matter (WM) and cerebrospinal fluid (CSF) are the most commonly used measurements, resulting in many successful applications. It has been widely observed that disease-induced structural changes may not occur at isolated spots, but in several inter-related regions. Therefore, for better characterization of brain pathology, we propose in this paper a means to extract inter-regional correlation based features from local volumetric measurements. Specifically, our approach involves constructing an anatomical brain network for each subject, with each node representing a Region of Interest (ROI) and each edge representing Pearson correlation of tissue volumetric measurements between ROI pairs. As second order volumetric measurements, network features are more descriptive but also more sensitive to noise. To overcome this limitation, a hierarchy of ROIs is used to suppress noise at different scales. Pairwise interactions are considered not only for ROIs with the same scale in the same layer of the hierarchy, but also for ROIs across different scales in different layers. To address the high dimensionality problem resulting from the large number of network features, a supervised dimensionality reduction method is further employed to embed a selected subset of features into a low dimensional feature space, while at the same time preserving discriminative information. We demonstrate with experimental results the efficacy of this embedding strategy in comparison with some other commonly used approaches. In addition, although the proposed method can be easily generalized to incorporate other metrics of regional similarities, the benefits of using Pearson correlation in our application are reinforced by the experimental results. Without requiring new sources of information, our proposed approach improves the accuracy of MCI prediction from 80.83% (of conventional volumetric features) to 84.35% (of hierarchical network features), evaluated using data sets randomly drawn from the ADNI (Alzheimer's Disease Neuroimaging Initiative) dataset.	[Zhou, Luping; Wang, Yaping; Li, Yang; Yap, Pew-Thian; Shen, Dinggang] Univ N Carolina, BRIC, Chapel Hill, NC USA; [Alzheimer's Dis Neuroimaging Initi] Univ Calif Los Angeles, Dept Neurol, Alzheimers Dis Neuroimaging Initiat, Los Angeles, CA 90024 USA; [Zhou, Luping; Wang, Yaping; Li, Yang; Yap, Pew-Thian; Shen, Dinggang] Univ N Carolina, Dept Radiol, IDEA Lab, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Los Angeles; University of North Carolina; University of North Carolina Chapel Hill	Zhou, LP (corresponding author), Univ N Carolina, Dept Radiol, IDEA Lab, Chapel Hill, NC 27515 USA.	dgshen@med.unc.edu	Yap, Pew-Thian/G-3292-2012; Shen, Dinggang/ABF-6812-2020; Zhou, Luping/AAD-6045-2020	Shen, Dinggang/0000-0002-7934-5698; 	NIH [EB006733, EB008374, EB009634, MH088520]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009634, R01EB008374, R01EB006733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC1MH088520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U19AG010483, U01AG024904] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by NIH grants EB006733, EB008374, EB009634 and MH088520. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Both the normal control and MCI subjects used in this study were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) (www.loni.ucla.eduADNI). The ADNI investigators contributed to the design and implementation of ADNI and/or provided data but did not participate in the analysis or writing of this report. The complete listing of ADNI investigators is available at http://www.loni.ucla.edu/ADNI/Collaboration/ADNI_Manuscript_Citations.pdf. The following statements were cited from ADNI: Data collection and sharing for ADNI was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott, AstraZeneca AB, Bayer Schering Pharma AG, Bristol-Myers Squibb, Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare, GlaxoSmithKline, Innogenetics, Johnson and Johnson, Eli Lilly and Co., Medpace, Inc., Merck and Co., Inc., Novartis AG, Pfizer Inc, F. Hoffman-La Roche, Schering-Plough, Synarc, Inc., as well as non-profit partners the Alzheimer's Association and Alzheimer's Drug Discovery Foundation, with participation from the U. S. Food and Drug Administration. Private sector contributions to ADNI are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bozzali M, 2002, J NEUROL NEUROSUR PS, V72, P742, DOI 10.1136/jnnp.72.6.742; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Chetelat G, 2003, NEUROIMAGE, V18, P525, DOI 10.1016/S1053-8119(02)00026-5; Chupin M, 2009, HIPPOCAMPUS, V19, P579, DOI 10.1002/hipo.20626; Colliot O, 2008, RADIOLOGY, V248, P194, DOI 10.1148/radiol.2481070876; Convit A, 1997, NEUROBIOL AGING, V18, P131, DOI 10.1016/S0197-4580(97)00001-8; Copenhaver BR, 2006, PSYCHIAT RES-NEUROIM, V147, P93, DOI 10.1016/j.pscychresns.2006.01.015; Cuingnet R, 2011, NEUROIMAGE, V56, P766, DOI 10.1016/j.neuroimage.2010.06.013; Davatzikos C, 2008, NEUROBIOL AGING, V29, P514, DOI 10.1016/j.neurobiolaging.2006.11.010; Dickerson BC, 2009, CEREB CORTEX, V19, P497, DOI 10.1093/cercor/bhn113; Fan Y., 2005, P 8 INT C MED IM COM, P1; Fan Y, 2008, NEUROIMAGE, V41, P277, DOI 10.1016/j.neuroimage.2008.02.043; Fan Y, 2008, NEUROIMAGE, V39, P1731, DOI 10.1016/j.neuroimage.2007.10.031; Fan Y, 2007, IEEE T MED IMAGING, V26, P93, DOI 10.1109/TMI.2006.886812; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jack CR, 1997, NEUROLOGY, V49, P786, DOI 10.1212/WNL.49.3.786; Jack CR, 1998, NEUROLOGY, V51, P993, DOI 10.1212/WNL.51.4.993; Kabani N., 1998, NEUROIMAGE, V7, pS7; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Lao ZQ, 2004, NEUROIMAGE, V21, P46, DOI 10.1016/j.neuroimage.2003.09.027; Lerch JP, 2008, NEUROBIOL AGING, V29, P23, DOI 10.1016/j.neurobiolaging.2006.09.013; LONG X, 2010, P COMP VIS PATT REC; Magnin B, 2009, NEURORADIOLOGY, V51, P73, DOI 10.1007/s00234-008-0463-x; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Pengas G, 2010, NEUROBIOL AGING, V31, P25, DOI 10.1016/j.neurobiolaging.2008.03.014; Rosipal R, 2006, LECT NOTES COMPUT SC, V3940, P34, DOI 10.1007/11752790_2; Shen DG, 2003, NEUROIMAGE, V18, P28, DOI 10.1006/nimg.2002.1301; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Thompson PM, 2003, J NEUROSCI, V23, P994; Thompson PM, 2004, NEUROIMAGE, V23, pS2, DOI 10.1016/j.neuroimage.2004.07.071; Thompson PM, 2001, CEREB CORTEX, V11, P1, DOI 10.1093/cercor/11.1.1; Wold S., 1993, 3D QSAR DRUG DESIGN, P523, DOI DOI 10.1007/0-306-46858-1; ZHOU L, 2011, P COMP VIS IN PRESS	37	64	67	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e21935	10.1371/journal.pone.0021935	http://dx.doi.org/10.1371/journal.pone.0021935			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21818280	Green Submitted, Green Published, gold			2022-12-25	WOS:000292929500020
J	Bielnicki, JA; Shkumatov, AV; Derewenda, U; Somlyo, AV; Svergun, DI; Derewenda, ZS				Bielnicki, Jakub A.; Shkumatov, Alexander V.; Derewenda, Urszula; Somlyo, Avril V.; Svergun, Dmitri I.; Derewenda, Zygmunt S.			Insights into the Molecular Activation Mechanism of the RhoA-specific Guanine Nucleotide Exchange Factor, PDZRhoGEF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; LEUKEMIA-ASSOCIATED RHO; PDZ-RHOGEF; SOLUTION SCATTERING; STRUCTURAL-CHARACTERIZATION; TRANSCRIPTIONAL REPRESSION; BIOLOGICAL MACROMOLECULES; CA2+ SENSITIZATION; CRYSTAL-STRUCTURE; DOMAIN	PDZRhoGEF (PRG) belongs to a small family of RhoA-specific nucleotide exchange factors that mediates signaling through select G-protein-coupled receptors via G alpha(12/13) and activates RhoA by catalyzing the exchange of GDP to GTP. PRG is a multidomain protein composed of PDZ, regulators of G-protein signaling-like (RGSL), Dbl-homology (DH), and pleckstrin-homology (PH) domains. It is autoinhibited in cytosol and is believed to undergo a conformational rearrangement and translocation to the membrane for full activation, although the molecular details of the regulation mechanism are not clear. It has been shown recently that the main autoregulatory elements of PDZRhoGEF, the autoinhibitory "activation box" and the "GEF switch," which is required for full activation, are located directly upstream of the catalytic DH domain and its RhoA binding surface, emphasizing the functional role of the RGSL-DH linker. Here, using a combination of biophysical and biochemical methods, we show that the mechanism of PRG regulation is yet more complex and may involve an additional autoinhibitory element in the form of a molten globule region within the linker between RGSL and DH domains. We propose a novel, two-tier model of autoinhibition where the activation box and the molten globule region act synergistically to impair the ability of RhoA to bind to the catalytic DH-PH tandem. The molten globule region and the activation box become less ordered in the PRG-RhoA complex and dissociate from the RhoA-binding site, which may constitute a critical step leading to PRG activation.	[Shkumatov, Alexander V.; Svergun, Dmitri I.] DESY, European Mol Biol Lab, EMBL, Hamburg Outstn, D-22603 Hamburg, Germany; [Bielnicki, Jakub A.; Derewenda, Urszula; Somlyo, Avril V.; Derewenda, Zygmunt S.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA	European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Virginia	Svergun, DI (corresponding author), DESY, European Mol Biol Lab, EMBL, Hamburg Outstn, Notkestr 85, D-22603 Hamburg, Germany.	svergun@embl-hamburg.de; zsd4n@virginia.edu		Svergun, Dmitri/0000-0003-0830-5696	National Institutes of Health [R01 GM086457]; Human Frontier Science Program Research [RGP 55/2006]; BMBF (Bundesministerium fur Bildung und Forschung) [05K10YEA]; EU [261572]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program Research(Human Frontier Science Program); BMBF (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); EU(European Commission); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM086457. This work was also supported by Human Frontier Science Program Research Grant RGP 55/2006.; Supported by BMBF (Bundesministerium fur Bildung und Forschung) Research Grant SYNC-LIFE (Contract 05K10YEA) and EU FP7 e-Infrastructure grant WeNMR (Contract 261572). To whom correspondence may be addressed. Tel.: 49-40-89902-125; Fax: 49-40-89902-149; E-mail: svergun@embl-hamburg.de.; Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. W-31-109-Eng-38.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bernado P, 2010, EUR BIOPHYS J BIOPHY, V39, P769, DOI 10.1007/s00249-009-0549-3; Bhattacharya M, 2004, BIOCHEM SOC T, V32, P1040, DOI 10.1042/BST0321040; Bondos SE, 2003, ANAL BIOCHEM, V316, P223, DOI 10.1016/S0003-2697(03)00059-9; Chen Z, 2005, NAT STRUCT MOL BIOL, V12, P191, DOI 10.1038/nsmb888; Chen Z, 2001, NAT STRUCT BIOL, V8, P805, DOI 10.1038/nsb0901-805; Chen Z, 2011, PROTEIN SCI, V20, P107, DOI 10.1002/pro.542; Chikumi H, 2004, ONCOGENE, V23, P233, DOI 10.1038/sj.onc.1207012; Chikumi H, 2002, J BIOL CHEM, V277, P12463, DOI 10.1074/jbc.M108504200; Cierpicki T, 2009, PROTEIN SCI, V18, P2067, DOI 10.1002/pro.219; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Derewenda U, 2004, STRUCTURE, V12, P1955, DOI 10.1016/j.str.2004.09.003; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Erickson JW, 2004, BIOCHEMISTRY-US, V43, P837, DOI 10.1021/bi036026v; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Fukuhara S, 2001, ONCOGENE, V20, P1661, DOI 10.1038/sj.onc.1204182; Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Gong MC, 1996, P NATL ACAD SCI USA, V93, P1340, DOI 10.1073/pnas.93.3.1340; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; HARDING SE, 1995, BIOPHYS CHEM, V55, P69, DOI 10.1016/0301-4622(94)00143-8; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Jachimska B, 2008, LANGMUIR, V24, P6866, DOI 10.1021/la800548p; Jaiswal M, 2011, J BIOL CHEM, V286, P18202, DOI 10.1074/jbc.M111.226431; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kristelly R, 2004, J BIOL CHEM, V279, P47352, DOI 10.1074/jbc.M406056200; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Longenecker K, 1999, ACTA CRYSTALLOGR D, V55, P1503, DOI 10.1107/S090744499900801X; Longenecker KL, 2001, STRUCTURE, V9, P559, DOI 10.1016/S0969-2126(01)00620-7; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Murayama K, 2007, J BIOL CHEM, V282, P4238, DOI 10.1074/jbc.C600234200; Mylonas E, 2008, BIOCHEMISTRY-US, V47, P10345, DOI 10.1021/bi800900d; Newman J, 2005, ACTA CRYSTALLOGR D, V61, P490, DOI 10.1107/S0907444905002726; Oleksy A, 2004, ACTA CRYSTALLOGR D, V60, P740, DOI 10.1107/S0907444904002318; Papoian GA, 2008, P NATL ACAD SCI USA, V105, P14237, DOI 10.1073/pnas.0807977105; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Porod G, 1982, GEN THEORY SMALL ANG, P17; PTITSYN OB, 1994, FEBS LETT, V341, P15, DOI 10.1016/0014-5793(94)80231-9; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Romero P, 1997, 1997 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS, VOLS 1-4, P90, DOI 10.1109/ICNN.1997.611643; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Round AR, 2008, J APPL CRYSTALLOGR, V41, P913, DOI 10.1107/S0021889808021018; Rubinstein M, 2003, POLYM PHYS; Shankaranarayanan A, 2010, CELL SIGNAL, V22, P1114, DOI 10.1016/j.cellsig.2010.03.006; Shkumatov AV, 2011, PROTEINS, V79, P2122, DOI 10.1002/prot.23033; Snowden AW, 2000, MOL CELL BIOL, V20, P2676, DOI 10.1128/MCB.20.8.2676-2686.2000; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Taya S, 2001, J CELL BIOL, V155, P809, DOI 10.1083/jcb.200106139; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Unneberg P, 2001, PROTEINS, V42, P460, DOI 10.1002/1097-0134(20010301)42:4<460::AID-PROT50>3.0.CO;2-U; Verstraete K, 2011, BLOOD, V118, P60, DOI 10.1182/blood-2011-01-329532; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Woods VL, 2001, J CELL BIOCHEM, V84, P89, DOI 10.1002/jcb.10069; Yamada T, 2005, J BIOL CHEM, V280, P19358, DOI 10.1074/jbc.M414561200; Yu BK, 2010, CELL, V140, P246, DOI 10.1016/j.cell.2009.12.033; Zheng MY, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-36; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9; Zurdo J, 1997, BIOCHEMISTRY-US, V36, P9625, DOI 10.1021/bi9702400; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	72	20	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35163	35175		10.1074/jbc.M111.270918	http://dx.doi.org/10.1074/jbc.M111.270918			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21816819	hybrid, Green Published			2022-12-25	WOS:000295406300069
J	Nagele, E; Han, M; DeMarshall, C; Belinka, B; Nagele, R				Nagele, Eric; Han, Min; DeMarshall, Cassandra; Belinka, Benjamin; Nagele, Robert			Diagnosis of Alzheimer's Disease Based on Disease-Specific Autoantibody Profiles in Human Sera	PLOS ONE			English	Article							ASSOCIATION WORKGROUPS; NATIONAL INSTITUTE; DEMENTIA; RECOMMENDATIONS; GUIDELINES	After decades of Alzheimer's disease (AD) research, the development of a definitive diagnostic test for this disease has remained elusive. The discovery of blood-borne biomarkers yielding an accurate and relatively non-invasive test has been a primary goal. Using human protein microarrays to characterize the differential expression of serum autoantibodies in AD and non-demented control (NDC) groups, we identified potential diagnostic biomarkers for AD. The differential significance of each biomarker was evaluated, resulting in the selection of only 10 autoantibody biomarkers that can effectively differentiate AD sera from NDC sera with a sensitivity of 96.0% and specificity of 92.5%. AD sera were also distinguishable from sera obtained from patients with Parkinson's disease and breast cancer with accuracies of 86% and 92%, respectively. Results demonstrate that serum autoantibodies can be used effectively as highly-specific and accurate biomarkers to diagnose AD throughout the course of the disease.	[Nagele, Eric; Belinka, Benjamin] Durin Technol Inc, New Brunswick, NJ USA; [Han, Min; DeMarshall, Cassandra] Univ Med & Dent New Jersey, Sch Osteopath Med, Grad Sch Biomed Sci, Stratford, NJ 08084 USA; [Han, Min; Nagele, Robert] Univ Med & Dent New Jersey, Sch Osteopath Med, New Jersey Inst Successful Aging, Stratford, NJ 08084 USA	Rowan University; Rowan University School of Osteopathic Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rowan University; Rowan University School of Osteopathic Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center	Nagele, E (corresponding author), Durin Technol Inc, New Brunswick, NJ USA.	nagelero@umdnj.edu		Han, Min/0000-0002-8350-687X; Han, Min/0000-0002-7348-9121	Foundation Venture Capital Group, L.L.C, an affiliate of the New Jersey Health Foundation; Durin	Foundation Venture Capital Group, L.L.C, an affiliate of the New Jersey Health Foundation; Durin	The authors gratefully acknowledge financial support from the Foundation Venture Capital Group, L.L.C, an affiliate of the New Jersey Health Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MH and CD have no competing interests. EPN is a paid consultant for Durin Technologies. BB is CEO of Durin Technologies and receives a salary from Durin. He also owns stock in Durin. RGN is Founder of Durin Technologies and has stock interest. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aarsland D, 2010, BRAIN PATHOL, V20, P633, DOI 10.1111/j.1750-3639.2009.00369.x; Aretouli E, 2010, ARCH CLIN NEUROPSYCH, V25, P396, DOI 10.1093/arclin/acq038; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; CHENG F, 2010, J CHEM NEUR IN PRESS; Clifford PM, 2007, BRAIN RES, V1142, P223, DOI 10.1016/j.brainres.2007.01.070; Dekosky ST, 2003, SCIENCE, V302, P830, DOI 10.1126/science.1090349; Di Domenico F, 2011, J PROTEOMICS, V74, P1091, DOI 10.1016/j.jprot.2011.03.033; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Dickson DW, 1997, NEUROBIOL AGING, V18, pS21, DOI 10.1016/S0197-4580(97)00065-1; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Haggerty T, 2011, EUR J NEUROSCI, V33, P1598, DOI 10.1111/j.1460-9568.2011.07660.x; Jobst K A, 1998, Int Psychogeriatr, V10, P271, DOI 10.1017/S1041610298005389; Levin EC, 2010, BRAIN RES, V1345, P221, DOI 10.1016/j.brainres.2010.05.038; Lopponen M, 2003, AGE AGEING, V32, P606, DOI 10.1093/ageing/afg097; Lubomirski M, 2007, J COMPUT BIOL, V14, P350, DOI 10.1089/cmb.2006.0116; Mayeux R, 1998, NEW ENGL J MED, V338, P506, DOI 10.1056/NEJM199802193380804; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Morris JC, 2005, ALZ DIS ASSOC DIS, V19, P163; NAGELE RG, 2011, J ALZHEIMER IN PRESS; Ranginwala NA, 2008, AM J GERIAT PSYCHIAT, V16, P384, DOI 10.1097/JGP.0b013e3181629971; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Strobel G, 2009, J ALZHEIMERS DIS, V18, P625, DOI [10.3233/JAD-2009-1250, 10.3233/JAD-2009-1234]; Thies W, 2011, ALZHEIMERS DEMENT, V7, P175, DOI [10.1016/j.jalz.2011.02.004, 10.1016/j.jalz.2011.02.002]; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299	25	108	115	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e23112	10.1371/journal.pone.0023112	http://dx.doi.org/10.1371/journal.pone.0023112			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826230	gold, Green Submitted, Green Published			2022-12-25	WOS:000293558900056
J	Young, CD; Lewis, AS; Rudolph, MC; Ruehle, MD; Jackman, MR; Yun, UJ; Ilkun, O; Pereira, R; Abel, ED; Anderson, SM				Young, Christian D.; Lewis, Andrew S.; Rudolph, Michael C.; Ruehle, Marisa D.; Jackman, Matthew R.; Yun, Ui J.; Ilkun, Olesya; Pereira, Renata; Abel, E. Dale; Anderson, Steven M.			Modulation of Glucose Transporter 1 (GLUT1) Expression Levels Alters Mouse Mammary Tumor Cell Growth In Vitro and In Vivo	PLOS ONE			English	Article							HUMAN BREAST-CARCINOMA; GLUCOSE TRANSPORTERS; GENE-EXPRESSION; MESSENGER-RNA; DIFFERENTIAL EXPRESSION; AEROBIC GLYCOLYSIS; PYRUVATE-KINASE; SUGAR-TRANSPORT; CANCER-CELLS; C-MYC	Tumor cells exhibit an altered metabolism characterized by elevated aerobic glycolysis and lactate secretion which is supported by an increase in glucose transport and consumption. We hypothesized that reducing or eliminating the expression of the most prominently expressed glucose transporter(s) would decrease the amount of glucose available to breast cancer cells thereby decreasing their metabolic capacity and proliferative potential. Of the 12 GLUT family glucose transporters expressed in mice, GLUT1 was the most abundantly expressed at the RNA level in the mouse mammary tumors from MMTV-c-ErbB2 mice and cell lines examined. Reducing GLUT1 expression in mouse mammary tumor cell lines using shRNA or Cre/Lox technology reduced glucose transport, glucose consumption, lactate secretion and lipid synthesis in vitro without altering the concentration of ATP, as well as reduced growth on plastic and in soft agar. The growth of tumor cells with reduced GLUT1 expression was impaired when transplanted into the mammary fat pad of athymic nude mice in vivo. Overexpression of GLUT1 in a cell line with low levels of endogenous GLUT1 increased glucose transport in vitro and enhanced growth in nude mice in vivo as compared to the control cells with very low levels of GLUT1. These studies demonstrate that GLUT1 is the major glucose transporter in mouse mammary carcinoma models overexpressing ErbB2 or PyVMT and that modulation of the level of GLUT1 has an effect upon the growth of mouse mammary tumor cell lines in vivo.	[Young, Christian D.; Lewis, Andrew S.; Rudolph, Michael C.; Ruehle, Marisa D.; Anderson, Steven M.] Univ Colorado, Sch Med, Dept Pathol, Aurora, CO 80045 USA; [Jackman, Matthew R.] Univ Colorado, Sch Med, Dept Med, Div Endocrinol Metab & Diabet, Aurora, CO USA; [Yun, Ui J.; Ilkun, Olesya; Pereira, Renata; Abel, E. Dale] Univ Utah, Sch Med, Div Endocrinol Metab & Diabet, Program Mol Med, Salt Lake City, UT USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Utah System of Higher Education; University of Utah	Young, CD (corresponding author), Univ Colorado, Sch Med, Dept Pathol, Anshutz Med Campus, Aurora, CO 80045 USA.	steve.anderson@ucdenver.edu		Abel, E. Dale/0000-0001-5290-0738; Ruehle, Marisa/0000-0001-7457-8532	Susan G. Komen Foundation [BCTR0600727]; Public Health Service [PO1-HD38129]; Department of Defense (DoD) [W81XWH-06-1-0423, W81XWH-08-1-0596]; Cancer League of Colorado; American Heart Association; American Diabetes Association [RO1HL070070];  [5P30CA046934-22]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD038129] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA046934, R01CA138482] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK091317] Funding Source: NIH RePORTER	Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Department of Defense (DoD)(United States Department of Defense); Cancer League of Colorado; American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	SA is supported by BCTR0600727 from the Susan G. Komen Foundation and PO1-HD38129 from the Public Health Service. CY was supported by W81XWH-06-1-0423 predoctoral award from the Department of Defense (DoD) Breast Cancer Research Program and a grant from the Cancer League of Colorado. MCR is supported by W81XWH-08-1-0596 predoctoral award from the DoD Breast Cancer Research Program. The Small Animal Imaging Core of the University of Colorado Cancer Center is supported by 5P30CA046934-22. RP is supported by a post-doctoral fellowship from the American Heart Association and EA by an American Diabetes Association Research Award, RO1HL070070. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amann T, 2009, AM J PATHOL, V174, P1544, DOI 10.2353/ajpath.2009.080596; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; BOADO RJ, 1994, MOL BRAIN RES, V27, P51, DOI 10.1016/0169-328X(94)90183-X; Borowsky AD, 2005, CLIN EXP METASTAS, V22, P47, DOI 10.1007/s10585-005-2908-5; Bos R, 2002, J CLIN ONCOL, V20, P379, DOI 10.1200/JCO.20.2.379; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; DeBerardinis RJ, 2006, J BIOL CHEM, V281, P37372, DOI 10.1074/jbc.M608372200; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; FLIER JS, 1987, SCIENCE, V235, P1492, DOI 10.1126/science.3103217; Godoy A, 2006, J CELL PHYSIOL, V207, P614, DOI 10.1002/jcp.20606; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Hiyoshi Y, 2009, ONCOLOGY-BASEL, V76, P286, DOI 10.1159/000207505; KAESTNER KH, 1989, P NATL ACAD SCI USA, V86, P3150, DOI 10.1073/pnas.86.9.3150; Kang SS, 2002, JPN J CANCER RES, V93, P1123, DOI 10.1111/j.1349-7006.2002.tb01214.x; Kim A, 2005, BREAST CANCER RES, V7, pR708, DOI 10.1186/bcr1281; Kim JW, 2007, MOL CELL BIOL, V27, P7381, DOI 10.1128/MCB.00440-07; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; Manolescu AR, 2007, PHYSIOLOGY, V22, P234, DOI 10.1152/physiol.00011.2007; Marcotte R, 2008, J MAMMARY GLAND BIOL, V13, P323, DOI 10.1007/s10911-008-9087-3; MARTIN GS, 1971, P NATL ACAD SCI USA, V68, P2739, DOI 10.1073/pnas.68.11.2739; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Noguchi Y, 2000, CANCER LETT, V154, P175, DOI 10.1016/S0304-3835(00)00392-X; Onetti R, 1997, FEBS LETT, V407, P267, DOI 10.1016/S0014-5793(97)00340-2; Orlicky DJ, 2001, J LIPID RES, V42, P460; Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200; Rastogi S, 2007, CANCER LETT, V257, P244, DOI 10.1016/j.canlet.2007.07.021; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Reske SN, 1997, J NUCL MED, V38, P1344; Rogers S, 2003, CANCER LETT, V193, P225, DOI 10.1016/S0304-3835(03)00010-7; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Scheepers A, 2004, JPEN-PARENTER ENTER, V28, P364, DOI 10.1177/0148607104028005364; Schwartzenberg-Bar-Yoseph F, 2004, CANCER RES, V64, P2627, DOI 10.1158/0008-5472.CAN-03-0846; Semenza G L, 2001, Novartis Found Symp, V240, P251; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Sun QA, 2011, P NATL ACAD SCI USA, V108, P4129, DOI 10.1073/pnas.1014769108; Tran A, 2005, J NUCL MED, V46, P1455; WARBURG O, 1930, METABOLISM TUMORS; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; Welm AL, 2005, P NATL ACAD SCI USA, V102, P4324, DOI 10.1073/pnas.0500470102; Welm AL, 2007, P NATL ACAD SCI USA, V104, P7570, DOI 10.1073/pnas.0702095104; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Wood IS, 2003, BRIT J NUTR, V89, P3, DOI 10.1079/BJN2002763; Younes M, 1995, ANTICANCER RES, V15, P2895; Younes M, 1997, CANCER-AM CANCER SOC, V80, P1046, DOI 10.1002/(SICI)1097-0142(19970915)80:6<1046::AID-CNCR6>3.0.CO;2-7; Young CD, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2132; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Zhao FQ, 2007, CURR GENOMICS, V8, P113, DOI 10.2174/138920207780368187; Zhao YX, 2008, J BIOL CHEM, V283, P36344, DOI 10.1074/jbc.M803580200	55	51	52	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e23205	10.1371/journal.pone.0023205	http://dx.doi.org/10.1371/journal.pone.0023205			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826239	Green Submitted, Green Published, gold			2022-12-25	WOS:000293558900065
J	Goker, M; Scheuner, C; Klenk, HP; Stielow, JB; Menzel, W				Goeker, Markus; Scheuner, Carmen; Klenk, Hans-Peter; Stielow, J. Benjamin; Menzel, Wulf			Codivergence of Mycoviruses with Their Hosts	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; PHYLOGENETIC ANALYSES; GENOME; SEQUENCE; FUNGUS; TREES; HYPOVIRULENCE; HISTORY; CLASSIFICATION; ENDORNAVIRUS	Background: The associations between pathogens and their hosts are complex and can result from any combination of evolutionary events such as codivergence, switching, and duplication of the pathogen. Mycoviruses are RNA viruses which infect fungi and for which natural vectors are so far unknown. Thus, lateral transfer might be improbable and codivergence their dominant mode of evolution. Accordingly, mycoviruses are a suitable target for statistical tests of virus-host codivergence, but inference of mycovirus phylogenies might be difficult because of low sequence similarity even within families. Methodology: We analyzed here the evolutionary dynamics of all mycovirus families by comparing virus and host phylogenies. Additionally, we assessed the sensitivity of the co-phylogenetic tests to the settings for inferring virus trees from their genome sequences and approximate, taxonomy-based host trees. Conclusions: While sequence alignment filtering modes affected branch support, the overall results of the co-phylogenetic tests were significantly influenced only by the number of viruses sampled per family. The trees of the two largest families, Partitiviridae and Totiviridae, were significantly more similar to those of their hosts than expected by chance, and most individual host-virus links had a significant positive impact on the global fit, indicating that codivergence is the dominant mode of virus diversification. However, in this regard mycoviruses did not differ from closely related viruses sampled from non-fungus hosts. The remaining virus families were either dominated by other evolutionary modes or lacked an apparent overall pattern. As this negative result might be caused by insufficient taxon sampling, the most parsimonious hypothesis still is that host-parasite evolution is basically the same in all mycovirus families. This is the first study of mycovirus-host codivergence, and the results shed light not only on how mycovirus biology affects their co-phylogenetic relationships, but also on their presumable host range itself.	[Goeker, Markus; Scheuner, Carmen; Klenk, Hans-Peter; Stielow, J. Benjamin; Menzel, Wulf] DSMZ German Collect Microorganisms & Cell Culture, Braunschweig, Germany	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)	Goker, M (corresponding author), DSMZ German Collect Microorganisms & Cell Culture, Braunschweig, Germany.	markus.goeker@dsmz.de	Göker, Markus/AAX-6258-2021	Göker, Markus/0000-0002-5144-6200	Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH	Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH	Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH funded this research through the employment of Markus Goker, Carmen Scheuner, Hans-Peter Klenk, J. Benjamin Stielow and Wulf Menzel, who contributed to all aspects of the study. There are no external funders who could have had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Rwahnih M, 2011, ARCH VIROL, V156, P397, DOI 10.1007/s00705-010-0869-8; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSON I, 2011, PLOS ONE IN PRESS; [Anonymous], 2012, BIOMETRY PRINCIPLES; [Anonymous], [No title captured]; Auch AF, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-350; Bamford DH, 2005, CURR OPIN STRUC BIOL, V15, P655, DOI 10.1016/j.sbi.2005.10.012; Begerow D., 2004, Frontiers in Basidiomycote mycology, P81; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Buneman P., 1974, J COMBINAT THEORY B, V17, P48, DOI [10.1016/0095-8956(74)90047-1, DOI 10.1016/0095-8956(74)90047-1]; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Castro M, 2003, FEMS MICROBIOL LETT, V228, P87, DOI 10.1016/S0378-1097(03)00755-9; Charleston MA, 1998, MATH BIOSCI, V149, P191, DOI 10.1016/S0025-5564(97)10012-8; CHIBA S, 2009, J VIROL, V83; CHUNGCHAU H, 2008, J GEN VIROL, V89, P3156; Cole TE, 2000, VIROLOGY, V268, P239, DOI 10.1006/viro.1999.0097; CRAWLEY MJ, 2007, R BOOK, DOI DOI 10.1080/10635150490522304; Deng F, 2006, EUR J PLANT PATHOL, V114, P127, DOI 10.1007/s10658-005-8913-3; Deng F, 2004, PHYTOPATHOLOGY, V94, P917, DOI 10.1094/PHYTO.2004.94.9.917; Dennehy JJ, 2006, AM NAT, V167, P429, DOI 10.1086/499381; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fahrenholz H., 1913, Zoologischer Anzeiger Leipzig, V41; Faraway J.J., 2002, PRACTICAL REGRESSION; FARRIS JS, 1972, AM NAT, V106, P645, DOI 10.1086/282802; FAUQUET CM, 8 INT COMM TAX VIR; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Ghabrial SA, 1998, VIRUS GENES, V16, P119, DOI 10.1023/A:1007966229595; Ghabrial SA, 2009, ANNU REV PHYTOPATHOL, V47, P353, DOI 10.1146/annurev-phyto-080508-081932; Gottschling M, 2011, MOL BIOL EVOL, V28, P2101, DOI 10.1093/molbev/msr030; Hess PN, 2007, BIOL J LINN SOC, V92, P669, DOI 10.1111/j.1095-8312.2007.00864.x; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Hillman BI, 2004, J VIROL, V78, P892, DOI 10.1128/JVI.78.2.892-898.2004; Holmes EC, 2007, CURR TOP MICROBIOL, V315, P51; Horiuchi H, 2004, VIRUS GENES, V29, P365, DOI 10.1007/s11262-004-7441-0; Horiuchi H, 2003, GENES GENET SYST, V78, P229, DOI 10.1266/ggs.78.229; Johnson KP, 2003, SYST BIOL, V52, P37, DOI 10.1080/10635150390132704; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Kazmierczak P, 1996, J VIROL, V70, P1137, DOI 10.1128/JVI.70.2.1137-1142.1996; KLASSEN GJ, 1992, J PARASITOL, V78, P573, DOI 10.2307/3283532; Klenk HP, 2010, SYST APPL MICROBIOL, V33, P175, DOI 10.1016/j.syapm.2010.03.003; Lee MSY, 2001, TRENDS ECOL EVOL, V16, P681, DOI 10.1016/S0169-5347(01)02313-8; Leebens-Mack J, 2005, MOL BIOL EVOL, V22, P1948, DOI 10.1093/molbev/msi191; Legendre P, 2002, SYST BIOL, V51, P217, DOI 10.1080/10635150252899734; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; LIN D, 1998, P ICML 1998 15 INT C; MEDINA, 2003, INT J ASTROBIOL, V2, P203, DOI DOI 10.1093/MOLBEV/MSI191; Meier-Kolthoff JP, 2007, BIOINFORMATICS, V23, P898, DOI 10.1093/bioinformatics/btm027; Melzer MS, 2002, PHYTOPATHOLOGY, V92, P780, DOI 10.1094/PHYTO.2002.92.7.780; Mindell DP, 2004, ASSEMBLING THE TREE OF LIFE, P107; Nobiron I, 2008, VIROLOGY, V371, P350, DOI 10.1016/j.virol.2007.09.022; NUSS D, 2006, NATURE REV, V3, P632; Osche G, 1966, HDB BIOL, V2, P817; Page RDM, 2003, TANGLED TREES: PHYLOGENY, COSPECIATION AND COEVOLUTION, P1; PAGE RDM, 1994, CLADISTICS, V10, P155, DOI 10.1006/clad.1994.1010; Page RDM, 1998, TRENDS ECOL EVOL, V13, P356, DOI 10.1016/S0169-5347(98)01438-4; Park Y, 2006, PHYTOPATHOLOGY, V96, P468, DOI 10.1094/PHYTO-96-0468; Pearson MN, 2009, MOL PLANT PATHOL, V10, P115, DOI 10.1111/j.1364-3703.2008.00503.x; Philippe H, 2005, ANNU REV ECOL EVOL S, V36, P541, DOI 10.1146/annurev.ecolsys.35.112202.130205; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Reimann-Philipp U, 1998, METH MOL B, V81, P521; Rodriguez-Cousino N, 2011, APPL ENVIRON MICROB, V77, P1822, DOI 10.1128/AEM.02501-10; Ronquist F, 2003, TANGLED TREES: PHYLOGENY, COSPECIATION AND COEVOLUTION, P22; Ronquist F, 1995, CLADISTICS, V11, P73, DOI 10.1111/j.1096-0031.1995.tb00005.x; Sasaki A, 2005, ARCH VIROL, V150, P1069, DOI 10.1007/s00705-005-0494-0; Smart CD, 1999, VIROLOGY, V265, P66, DOI 10.1006/viro.1999.0039; Spring S, 2010, ARCHAEA, V2010, DOI 10.1155/2010/690737; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stamatakis A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-405; Steenkamp ET, 2006, MOL BIOL EVOL, V23, P93, DOI 10.1093/molbev/msj011; Stevens J, 2004, BRIEF BIOINFORM, V5, P339, DOI 10.1093/bib/5.4.339; Stielow B, 2011, ARCH VIROL, V156, P1107, DOI 10.1007/s00705-011-0998-8; Stielow B, 2011, ARCH VIROL, V156, P343, DOI 10.1007/s00705-010-0875-x; Stielow B, 2010, ARCH VIROL, V155, P2075, DOI 10.1007/s00705-010-0824-8; Stockinger H, 2009, INT J GRID HIGH PERF, V1, P39, DOI 10.4018/jghpc.2009010104; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Taylor DJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-88; Thines M, 2006, MYCOL RES, V110, P646, DOI 10.1016/j.mycres.2006.04.001; Thompson JD, 2003, BIOINFORMATICS, V19, P1155, DOI 10.1093/bioinformatics/btg133; Timm RM, 1983, COEVOLUTION, P225, DOI DOI 10.14411/FP.2015.036; TIPPER DJ, 1991, MOL MICROBIOL, V5, P2331, DOI 10.1111/j.1365-2958.1991.tb02078.x; Urayama S, 2010, PLANT CELL PHYSIOL, V51, P58, DOI 10.1093/pcp/pcp167; van Diepeningen AD, 2006, FUNGAL GENET BIOL, V43, P446, DOI 10.1016/j.fgb.2006.01.014; VANDERLENDE TR, 1994, J GEN VIROL, V75, P2533, DOI 10.1099/0022-1317-75-9-2533; Wilkinson M, 1996, MOL BIOL EVOL, V13, P437, DOI 10.1093/oxfordjournals.molbev.a025604; Wu MD, 2007, PHYTOPATHOLOGY, V97, P1590, DOI 10.1094/PHYTO-97-12-1590; Wu MD, 2010, VIROLOGY, V406, P117, DOI 10.1016/j.virol.2010.07.010; Xie J, 2006, J GEN VIROL, V87, P241, DOI 10.1099/vir.0.81522-0; Yaegashi H, 2011, VIROLOGY, V409, P280, DOI 10.1016/j.virol.2010.10.014	91	33	34	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22252	10.1371/journal.pone.0022252	http://dx.doi.org/10.1371/journal.pone.0022252			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829452	gold, Green Published, Green Submitted			2022-12-25	WOS:000293286500009
J	Bendris, N; Lemmers, B; Blanchard, JM; Arsic, N				Bendris, Nawal; Lemmers, Benedicte; Blanchard, Jean-Marie; Arsic, Nikola			Cyclin A2 Mutagenesis Analysis: A New Insight into CDK Activation and Cellular Localization Requirements	PLOS ONE			English	Article							PROTEIN-KINASES; SOMATIC-CELLS; PROGRESSION; COMPLEX; GENE; E2F	Cyclin A2 is essential at two critical points in the somatic cell cycle: during S phase, when it activates CDK2, and during the G2 to M transition when it activates CDK1. Based on the crystal structure of Cyclin A2 in association with CDKs, we generated a panel of mutants to characterize the specific amino acids required for partner binding, CDK activation and subcellular localization. We find that CDK1, CDK2, p21, p27 and p107 have overlapping but distinct requirements for association with this protein. Our data highlight the crucial importance of the N-terminal alpha helix, in conjunction with the alpha 3 helix within the cyclin box, in activating CDK. Several Cyclin A2 mutants selectively bind to either CDK1 or CDK2. We demonstrate that association of Cyclin A2 to proteins such as CDK2 that was previously suggested as crucial is not a prerequisite for its nuclear localization, and we propose that the whole protein structure is involved.	[Bendris, Nawal; Lemmers, Benedicte; Blanchard, Jean-Marie; Arsic, Nikola] Univ Montpellier 1, Univ Montpellier 2, CNRS, Inst Genet Mol Montpellier, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Bendris, N (corresponding author), Univ Montpellier 1, Univ Montpellier 2, CNRS, Inst Genet Mol Montpellier, Montpellier, France.	jean-marie.blanchard@igmm.cnrs.fr; nikola.arsic@igmm.cnrs.fr			ANR [BLANC06-3_142605]; Marie Curie [MIRG-CT-2006-044922]; French Ministry of Education and Research; Fondation Pour La Recherche Medicale	ANR(French National Research Agency (ANR)); Marie Curie(European Commission); French Ministry of Education and Research; Fondation Pour La Recherche Medicale(Fondation pour la Recherche Medicale)	This work and NA were supported by grants from ANR (BLANC06-3_142605) and Marie Curie reintegration programme (MIRG-CT-2006-044922). NB was supported by fellowships from the French Ministry of Education and Research and the Fondation Pour La Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARLAT I, 1995, ONCOGENE, V11, P1309; BROWN NR, 1995, STRUCTURE, V3, P1235, DOI 10.1016/S0969-2126(01)00259-3; Coisy M, 2004, MOL CELL, V15, P43, DOI 10.1016/j.molcel.2004.06.022; Coisy-Quivy M, 2006, CANCER RES, V66, P5069, DOI 10.1158/0008-5472.CAN-05-0596; Fajas L, 2001, MOL CELL BIOL, V21, P2956, DOI 10.1128/MCB.21.8.2956-2966.2001; Fung TK, 2007, MOL BIOL CELL, V18, P1861, DOI 10.1091/mbc.E06-12-1092; Gallant P, 1995, J CELL SCI, P21; Goda T, 2001, J BIOL CHEM, V276, P15415, DOI 10.1074/jbc.M011101200; Huet X, 1996, MOL CELL BIOL, V16, P3789; Jackman M, 2002, MOL BIOL CELL, V13, P1030, DOI 10.1091/mbc.01-07-0361; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Kalaszczynska I, 2009, CELL, V138, P352, DOI 10.1016/j.cell.2009.04.062; Lukas C, 1999, NATURE, V401, P815, DOI 10.1038/44611; MARIDOR G, 1993, J CELL SCI, V106, P535; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Murphy M, 1997, NAT GENET, V15, P83, DOI 10.1038/ng0197-83; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; Philip A, 2000, J BIOL CHEM, V275, P5911, DOI 10.1074/jbc.275.8.5911; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; Sorensen CS, 2001, MOL CELL BIOL, V21, P3692, DOI 10.1128/MCB.21.11.3692-3703.2001; Tsang WY, 2007, J CELL BIOL, V178, P621, DOI 10.1083/jcb.200701166; Yam CH, 2002, CELL MOL LIFE SCI, V59, P1317, DOI 10.1007/s00018-002-8510-y	23	44	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22879	10.1371/journal.pone.0022879	http://dx.doi.org/10.1371/journal.pone.0022879			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829545	Green Published, gold, Green Submitted			2022-12-25	WOS:000293284600062
J	Valkonen, JK; Nokelainen, O; Mappes, J				Valkonen, Janne K.; Nokelainen, Ossi; Mappes, Johanna			Antipredatory Function of Head Shape for Vipers and Their Mimics	PLOS ONE			English	Article							PSYCHOLOGY; ARANEAE; NATRIX	Most research into the adaptive significance of warning signals has focused on the colouration and patterns of prey animals. However, behaviour, odour and body shape can also have signal functions and thereby reduce predators' willingness to attack defended prey. European vipers all have a distinctive triangular head shape; and they are all venomous. Several nonvenomous snakes, including the subfamily Natricinae, commonly flatten their heads (also known as head triangulation) when disturbed. The adaptive significance of this potential behavioural mimicry has never been investigated. We experimentally tested if the triangular head shape typical of vipers offers protection against predation. We compared the predation pressure of free-ranging predators on artificial snakes with triangular-shaped heads against the pressure on replicas with narrow heads. Snakes of both head types had either zigzag patterned bodies, typical of European vipers, or plain (patternless) bodies. Plain snakes with narrower Colubrid-like heads suffered significantly higher predation by raptors than snakes with triangular-shaped heads. Head shape did not, however, have an additive effect on survival in zigzag-patterned snakes, suggesting that species which differ from vipers in colouration and pattern would benefit most from behavioural mimicry. Our results demonstrate that the triangular head shape typical of vipers can act as a warning signal to predators. We suggest that head-shape mimicry may be a more common phenomenon among more diverse taxa than is currently recognised.	[Valkonen, Janne K.; Nokelainen, Ossi; Mappes, Johanna] Univ Jyvaskyla, Dept Biol & Environm Sci, Ctr Excellence Evolutionary Res, Jyvaskyla, Finland	University of Jyvaskyla	Valkonen, JK (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Ctr Excellence Evolutionary Res, Jyvaskyla, Finland.	janne.k.valkonen@jyu.fi	Mappes, Johanna/AAZ-3627-2021	Valkonen, Janne/0000-0002-2177-6612; Nokelainen, Ossi/0000-0002-0278-6698; Mappes, Johanna/0000-0002-1117-5629	Spanish Ministry of Science and Innovation; ICTS Donana Scientific Reserve [ICTS-2009-39]; Centre of Excellence in Evolutionary Research; Academy of Finland [SA-21000004745]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ICTS Donana Scientific Reserve; Centre of Excellence in Evolutionary Research; Academy of Finland(Academy of Finland)	This study was funded by the Spanish Ministry of Science and Innovation (www.micinn.es), ICTS Donana Scientific Reserve (ICTS-2009-39) (www.csic.es) and the Centre of Excellence in Evolutionary Research, by the Academy of Finland (project number SA-21000004745) (www.jyu.fi/bioenv/en/divisions/eko/coeevolution). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREN C, 1981, BIOL J LINN SOC, V15, P235, DOI 10.1111/j.1095-8312.1981.tb00761.x; ARNOLD EN, 1978, FIELD FUIDE REPTILES; Bates HW., 1862, T LINN SOC LOND, V23, P495, DOI [DOI 10.1111/J.1096-3642.1860.TB00146.X, 10.1111/j.1096-3642.1860.tb00146.x]; Berenbaum May R., 1995, Journal of the Lepidopterists' Society, V49, P386; BRODIE ED, 1995, FUNCT ECOL, V9, P186; Ceccarelli FS, 2008, J ARACHNOL, V36, P344, DOI 10.1636/CSt07-114.1; Cott H. B., 1940, ADAPTIVE COLOURATION; DESMEDT J, 2001, EUROPAISCHEN VIPERN; GREENE HW, 1977, CELL MOL LIFE SCI, V35, P747, DOI DOI 10.1007/BF01968221; HAILEY A, 1986, J ZOOL, V208, P541; Lawson R, 2005, MOL PHYLOGENET EVOL, V37, P581, DOI 10.1016/j.ympev.2005.07.016; MADSEN T, 1987, OIKOS, V48, P265, DOI 10.2307/3565512; MATTISON C, 1995, ENCY SNAKES BLANDFOR; MULLER F, 1897, P ENTHOMOLOG SOC LON, pR20; Niskanen M, 2005, J ANIM ECOL, V74, P1091, DOI 10.1111/j.1365-2656.2005.01008.x; Norman MD, 2001, P ROY SOC B-BIOL SCI, V268, P1755, DOI 10.1098/rspb.2001.1708; Pfennig DW, 2001, NATURE, V410, P323, DOI 10.1038/35066628; Poulton EB, 1890, COLOURS ANIMALS THEI; Rangen SA, 2000, AUK, V117, P136, DOI 10.1642/0004-8038(2000)117[0136:VAOAOA]2.0.CO;2; REISKIND J, 1977, BIOTROPICA, V9, P1, DOI 10.2307/2387854; Rowe C, 1999, ANIM BEHAV, V58, P921, DOI 10.1006/anbe.1999.1242; Ruxton GD, 2004, AVOIDING ATTACK EVOL; SPEED MP, 1993, ANIM BEHAV, V45, P571, DOI 10.1006/anbe.1993.1067; Valkonen J, 2011, EVOL ECOL, V25, P1047, DOI 10.1007/s10682-011-9463-0; Wuster W, 2004, P ROY SOC B-BIOL SCI, V271, P2495, DOI 10.1098/rspb.2004.2894; Young BA, 1999, J ZOOL, V248, P169	26	53	56	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22272	10.1371/journal.pone.0022272	http://dx.doi.org/10.1371/journal.pone.0022272			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818305	Green Published, Green Submitted, gold			2022-12-25	WOS:000293282700020
J	Tolambiya, A; Thomas, E; Chiovetto, E; Berret, B; Pozzo, T				Tolambiya, Arvind; Thomas, Elizabeth; Chiovetto, Enrico; Berret, Bastien; Pozzo, Thierry			An Ensemble Analysis of Electromyographic Activity during Whole Body Pointing with the Use of Support Vector Machines	PLOS ONE			English	Article							MOVEMENTS; COORDINATION; POSTURE; HUMANS; CLASSIFICATION; EQUILIBRIUM; DIAGNOSIS; PATTERNS; ARM	We explored the use of support vector machines (SVM) in order to analyze the ensemble activities of 24 postural and focal muscles recorded during a whole body pointing task. Because of the large number of variables involved in motor control studies, such multivariate methods have much to offer over the standard univariate techniques that are currently employed in the field to detect modifications. The SVM was used to uncover the principle differences underlying several variations of the task. Five variants of the task were used. An unconstrained reaching, two constrained at the focal level and two at the postural level. Using the electromyographic (EMG) data, the SVM proved capable of distinguishing all the unconstrained from the constrained conditions with a success of approximately 80% or above. In all cases, including those with focal constraints, the collective postural muscle EMGs were as good as or better than those from focal muscles for discriminating between conditions. This was unexpected especially in the case with focal constraints. In trying to rank the importance of particular features of the postural EMGs we found the maximum amplitude rather than the moment at which it occurred to be more discriminative. A classification using the muscles one at a time permitted us to identify some of the postural muscles that are significantly altered between conditions. In this case, the use of a multivariate method also permitted the use of the entire muscle EMG waveform rather than the difficult process of defining and extracting any particular variable. The best accuracy was obtained from muscles of the leg rather than from the trunk. By identifying the features that are important in discrimination, the use of the SVM permitted us to identify some of the features that are adapted when constraints are placed on a complex motor task.	[Tolambiya, Arvind; Pozzo, Thierry] Univ Bourgogne, IUF, F-21078 Dijon, France; [Tolambiya, Arvind; Thomas, Elizabeth; Pozzo, Thierry] INSERM, U887, F-21078 Dijon, France; [Chiovetto, Enrico] Univ Clin Tubingen, Ctr Integrat Neurosci, Hertie Inst Clin Brain Res, Dept Cognit Neurol,Sect Computat Sensomotor, Tubingen, Germany; [Berret, Bastien; Pozzo, Thierry] Italian Inst Technol, Genoa, Italy	Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Istituto Italiano di Tecnologia - IIT	Tolambiya, A (corresponding author), Univ Bourgogne, IUF, Campus Univ,BP 27877, F-21078 Dijon, France.	Elizabeth.Thomas@u-bourgogne.fr	Berret, Bastien/AAA-4287-2020	Berret, Bastien/0000-0002-0779-7724; Pozzo, Thierry/0000-0002-0585-7965	Conseil Regional of Bourgogne [08 HCP 60];  [ANR-10-ORAR-006-03]	Conseil Regional of Bourgogne; 	This research was supported by the postdoctoral grant no08 HCP 60 from the Conseil Regional of Bourgogne (http://www.cr-bourgogne.fr/) to Arvind Tolambiya. Elizabeth Thomas was supported by the ANR-10-ORAR-006-03. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bear M.F., 2007, NEUROSCIENCE, Vthird; Begg R, 2005, J BIOMECH, V38, P401, DOI 10.1016/j.jbiomech.2004.05.002; Berret B, 2009, J NEUROSCI, V29, P191, DOI 10.1523/JNEUROSCI.3426-08.2009; Bosco G, 1997, J NEUROPHYSIOL, V78, P1421, DOI 10.1152/jn.1997.78.3.1421; Carletta J, 1996, COMPUT LINGUIST, V22, P249; Chan KL, 2002, IEEE T BIO-MED ENG, V49, P963, DOI 10.1109/TBME.2002.802012; Cherkassky V, 1998, LEARNING DATA CONCEP; Cheron G, 1997, ELECTROMYOGR MOTOR C, V105, P58, DOI 10.1016/S0924-980X(96)96544-3; Chiovetto E, 2010, NEUROSCIENCE, V170, P1223, DOI 10.1016/j.neuroscience.2010.07.006; CORDO PJ, 1982, J NEUROPHYSIOL, V47, P287, DOI 10.1152/jn.1982.47.2.287; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; David A, 2005, PATTERN RECOGN LETT, V26, P1029, DOI 10.1016/j.patrec.2004.09.048; Fautrelle L, 2010, EXP BRAIN RES, V203, P147, DOI 10.1007/s00221-010-2219-1; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Ghazanfar AA, 2000, J NEUROSCI, V20, P3761, DOI 10.1523/JNEUROSCI.20-10-03761.2000; GRIMM LG, 1994, READING UNDERSTANDIN; Hart CB, 2010, J NEUROSCI, V30, P1322, DOI 10.1523/JNEUROSCI.5894-08.2010; Hinton P., 1995, STAT EXPLAINED GUIDE; Horak F, 1996, HDB PHYSL; Howell D. C., 2013, STAT METHODS PSYCHOL; HUFSCHMIDT HJ, 1954, NATURE, V174, P607, DOI 10.1038/174607a0; Ivanenko YP, 2005, J NEUROSCI, V25, P7238, DOI 10.1523/JNEUROSCI.1327-05.2005; Kaminski TR, 2007, GAIT POSTURE, V26, P256, DOI 10.1016/j.gaitpost.2006.09.006; Kaminski TR, 2001, EXP BRAIN RES, V136, P439, DOI 10.1007/s002210000604; Kandell E.R., 2000, PRINCIPLES NEURAL SC; Kendall FP, 1993, MUSCLES TESTING FUNC; MASSION J, 1992, PROG NEUROBIOL, V38, P35, DOI 10.1016/0301-0082(92)90034-C; Nair SS, 2010, IEEE T NEUR SYS REH, V18, P174, DOI 10.1109/TNSRE.2009.2032638; Nicolelis MAL, 2009, NAT REV NEUROSCI, V10, P530, DOI 10.1038/nrn2653; Papaxanthis C, 2005, NEUROSCIENCE, V135, P371, DOI 10.1016/j.neuroscience.2005.06.063; Poppele R, 2003, TRENDS NEUROSCI, V26, P269, DOI 10.1016/S0166-2236(03)00073-0; Pozzo T, 2002, EXP BRAIN RES, V144, P343, DOI 10.1007/s00221-002-1052-6; Rencher AC, 2002, METHODS MULTIVARIATE; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Schmidt RA, 2005, MOTOR CONTROL LEARNI; Shadmehr R., 2005, COMPUTATIONAL NEUROB; SOECHTING JF, 1992, ANNU REV NEUROSCI, V15, P167, DOI 10.1146/annurev.ne.15.030192.001123; Stapley PJ, 1999, EXP BRAIN RES, V129, P134, DOI 10.1007/s002210050944; Theodoridis S., 2003, PATTERN RECOGNITION; Thomas E, 2001, J COGNITIVE NEUROSCI, V13, P190, DOI 10.1162/089892901564252; Thomas JS, 2005, J NEUROPHYSIOL, V93, P352, DOI 10.1152/jn.00582.2004; Tolambiya A, 2010, NEUROCOMPUTING, V73, P1417, DOI 10.1016/j.neucom.2009.12.006; Tolambiya A, 2010, SOFT COMPUT, V14, P129, DOI 10.1007/s00500-009-0439-8; Vapnik V., 1995, NATURE STAT LEARNING, V38, P409; Vapnik V., 1998, STAT LEARNING THEORY; Wang Z, 2007, NEUROIMAGE, V36, P1139, DOI 10.1016/j.neuroimage.2007.03.072; Winter D, 2005, BIOMECHANICS MOTOR C; Winter DA., 1987, BIOMECHANICS MOTOR C	48	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e20732	10.1371/journal.pone.0020732	http://dx.doi.org/10.1371/journal.pone.0020732			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21814541	Green Published, gold, Green Submitted			2022-12-25	WOS:000293175100001
J	Moon, S; Ceyhan, E; Gurkan, UA; Demirci, U				Moon, SangJun; Ceyhan, Elvan; Gurkan, Umut Atakan; Demirci, Utkan			Statistical Modeling of Single Target Cell Encapsulation	PLOS ONE			English	Article							STEM-CELLS; DROPLET; EPITAXY	High throughput drop-on-demand systems for separation and encapsulation of individual target cells from heterogeneous mixtures of multiple cell types is an emerging method in biotechnology that has broad applications in tissue engineering and regenerative medicine, genomics, and cryobiology. However, cell encapsulation in droplets is a random process that is hard to control. Statistical models can provide an understanding of the underlying processes and estimation of the relevant parameters, and enable reliable and repeatable control over the encapsulation of cells in droplets during the isolation process with high confidence level. We have modeled and experimentally verified a microdroplet-based cell encapsulation process for various combinations of cell loading and target cell concentrations. Here, we explain theoretically and validate experimentally a model to isolate and pattern single target cells from heterogeneous mixtures without using complex peripheral systems.	[Moon, SangJun; Demirci, Utkan] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Bioengn,Demirci Bioacoust MEMS Med BAMM Lab, Boston, MA 02115 USA; [Ceyhan, Elvan] Koc Univ, Fac Sci, Dept Math, Istanbul, Turkey; [Gurkan, Umut Atakan; Demirci, Utkan] MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Koc University; Harvard University; Massachusetts Institute of Technology (MIT)	Moon, S (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Bioengn,Demirci Bioacoust MEMS Med BAMM Lab, Boston, MA 02115 USA.	udemirci@rics.bwh.harvard.edu	Gurkan, Umut A./Z-2496-2019	Gurkan, Umut A./0000-0002-0331-9960	NIH [R01AI081534, R21AI087107]; Wallace H. Coulter Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI087107, R01AI081534] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wallace H. Coulter Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Dr. Demirci would like to thank the Wallace H. Coulter Foundation for the Young Investigator in Bioengineering Award, and the following grants which have partially supported this study: NIH (R01AI081534) and NIH (R21AI087107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate AR, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026310; Abate AR, 2009, LAB CHIP, V9, P2628, DOI 10.1039/b909386a; Baret JC, 2009, LAB CHIP, V9, P1850, DOI 10.1039/b902504a; Bhattacharyya G.K., 1997, STAT CONCEPTS METHOD; Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181; Boland Thomas, 2006, Biotechnology Journal, V1, P910, DOI 10.1002/biot.200600081; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Clausell-Tormos J, 2008, CHEM BIOL, V15, P427, DOI 10.1016/j.chembiol.2008.04.004; Demirci U, 2007, LAB CHIP, V7, P1428, DOI 10.1039/b705809h; Demirci U, 2007, LAB CHIP, V7, P1139, DOI 10.1039/b704965j; Demirci U, 2006, J MICROELECTROMECH S, V15, P957, DOI 10.1109/JMEMS.2006.878879; Goldmann T, 2000, J BIOCHEM BIOPH METH, V42, P105, DOI 10.1016/S0165-022X(99)00049-4; Grinstead C. M., 1997, INTRO PROBABILITY; Hong JW, 2004, NAT BIOTECHNOL, V22, P435, DOI 10.1038/nbt951; Khalil S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3128729; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Liberski A, 2009, CHEM COMMUN, P7509, DOI 10.1039/b914279g; Love JC, 2006, NAT BIOTECHNOL, V24, P703, DOI 10.1038/nbt1210; Marcus JS, 2006, ANAL CHEM, V78, P3084, DOI 10.1021/ac0519460; Marques de Sa J., 2007, APPL STAT USING SPSS, V2; Mazutis L, 2009, LAB CHIP, V9, P2902, DOI 10.1039/b907753g; Moon S, 2010, TISSUE ENG PART C-ME, V16, P157, DOI [10.1089/ten.tec.2009.0179, 10.1089/ten.TEC.2009.0179]; Moon S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017455; Moon S, 2009, BIOSENS BIOELECTRON, V24, P3208, DOI 10.1016/j.bios.2009.03.037; Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Rane TD, 2010, LAB CHIP, V10, P161, DOI 10.1039/b917503b; Ross Sheldon, 2008, 1 COURSE PROBABILITY; Slack JMW, 2008, SCIENCE, V322, P1498, DOI 10.1126/science.1162782; Song YS, 2010, P NATL ACAD SCI USA, V107, P4596, DOI 10.1073/pnas.0914059107; Sun W, 2004, BIOTECHNOL APPL BIOC, V39, P29, DOI 10.1042/BA20030108; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; VARDEMAN SB, 1998, STAT QUALITY ASSURAN; Villani S, 2008, ACTA BIOMATER, V4, P943, DOI 10.1016/j.actbio.2008.01.007; Walker A, 2008, NAT REV MICROBIOL, V6, P176, DOI 10.1038/nrmicro1862; Xu F, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/1/014105; Xu F, 2010, BIOFABRICATION, DOI [10.1088/1758-5082/1082/1081/014105, DOI 10.1088/1758-5082/1082/1081/014105]; XU F, 2011, PLOS ONE, V6, P12; Xu F, 2011, BIOTECHNOL J, V6, P204, DOI 10.1002/biot.201000340; Zipori D, 2005, STEM CELLS, V23, P719, DOI 10.1634/stemcells.2005-0030	40	29	30	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e21580	10.1371/journal.pone.0021580	http://dx.doi.org/10.1371/journal.pone.0021580			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21814548	Green Published, gold, Green Submitted			2022-12-25	WOS:000292956800005
J	Maynou, F; Sbrana, M; Sartor, P; Maravelias, C; Kavadas, S; Damalas, D; Cartes, JE; Osio, G				Maynou, Francesc; Sbrana, Mario; Sartor, Paolo; Maravelias, Christos; Kavadas, Stefanos; Damalas, Dimitros; Cartes, Joan E.; Osio, Giacomo			Estimating Trends of Population Decline in Long-Lived Marine Species in the Mediterranean Sea Based on Fishers' Perceptions	PLOS ONE			English	Article							COMMON DOLPHINS; CONSERVATION; EXTINCTION; SHARKS; RESOURCES; ABUNDANCE; HISTORY; CATCHES; WATERS; GULF	We conducted interviews of a representative sample of 106 retired fishers in Italy, Spain and Greece, asking specific questions about the trends they perceived in dolphin and shark abundances between 1940 and 1999 (in three 20 year periods) compared to the present abundance. The large marine fauna studied were not target species of the commercial fleet segment interviewed (trawl fishery). The fishers were asked to rank the perceived abundance in each period into qualitative ordinal classes based on two indicators: frequency of sightings and frequency of catches (incidental or intentional) of each taxonomic group. The statistical analysis of the survey results showed that both incidental catches and the sighting frequency of dolphins have decreased significantly over the 60+ years of the study period (except for in Greece due to the recent population increase). This shows that fishers' perceptions are in agreement with the declining population trends detected by scientists. Shark catches were also perceived to have diminished since the early 1940s for all species. Other long-lived Mediterranean marine fauna (monk seals, whales) were at very low levels in the second half of the 20(th) century and no quantitative data could be obtained. Our study supports the results obtained in the Mediterranean and other seas that show the rapid disappearance (over a few decades) of marine fauna. We show that appropriately designed questionnaires help provide a picture of animal abundance in the past through the valuable perceptions of fishers. This information can be used to complement scientific sources or in some cases be taken as the only information source for establishing population trends in the abundance of sensitive species.	[Maynou, Francesc; Cartes, Joan E.] CSIC, Inst Ciencies Mar, Barcelona, Spain; [Sbrana, Mario; Sartor, Paolo; Osio, Giacomo] Consorzio Ctr Interuniv Biol Marina & Ecol Applic, Livorno, Italy; [Maravelias, Christos; Kavadas, Stefanos; Damalas, Dimitros] Hellen Ctr Marine Res, Anavissos, Attica, Greece	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Hellenic Centre for Marine Research	Maynou, F (corresponding author), CSIC, Inst Ciencies Mar, Barcelona, Spain.	maynouf@icm.csic.es	Maynou, Francesc/A-6433-2011; Maravelias, Christos/W-4151-2019	Maynou, Francesc/0000-0001-7200-6485; Sbrana, Mario/0000-0002-9562-8372; Maravelias, Christos/0000-0002-2440-3707; Kavadas, Stefanos/0000-0003-3473-9084; SARTOR, PAOLO/0000-0001-7239-8255	European Commission [MARE/2008/11: Lot 4]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The data acquisition was supported by the European Commission through project EVOMED ("The 20th Century evolution of Mediterranean exploited demersal resources under increasing fishing disturbance and environmental change", n<SUP>o</SUP> MARE/2008/11: Lot 4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2001, INT STAT REV, V69, P345, DOI 10.2307/1403450; AGUILAR A, 2008, IUCN 2010 IUCN RED L; Ainsworth CH, 2005, LOW WAKE FI, V21, P289; Aldebert Y, 1997, VIE MILIEU, V47, P275; Bearzi G, 2004, AQUAT CONSERV, V14, P363, DOI 10.1002/aqc.626; Bearzi G, 2003, MAMMAL REV, V33, P224, DOI 10.1046/j.1365-2907.2003.00032.x; Caminas JA, 1997, COLLECTIVE VOLUMES S, V46, P446; Canadas A, 2002, DEEP-SEA RES PT I, V49, P2053, DOI 10.1016/S0967-0637(02)00123-1; Cartes JE, 2011, PROG OCEANOGR, V91, P286, DOI 10.1016/j.pocean.2011.01.004; Casey JM, 1998, SCIENCE, V281, P690, DOI 10.1126/science.281.5377.690; Coelho R, 2008, J FISH BIOL, V73, P1419, DOI 10.1111/j.1095-8649.2008.02021.x; Di Natale A., 1995, COLLECTIVE VOLUME SC, V44, P255; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; Dulvy NK, 2004, ANIM CONSERV, V7, P365, DOI 10.1017/S1367943004001519; Dulvy NK, 2003, FISH FISH, V4, P25, DOI 10.1046/j.1467-2979.2003.00105.x; Faber G. L., 1883; Ferretti F, 2008, CONSERV BIOL, V22, P952, DOI 10.1111/j.1523-1739.2008.00938.x; Forcada J, 2004, MAR ECOL PROG SER, V275, P275, DOI 10.3354/meps275275; Forcada J, 1998, J SEA RES, V39, P313, DOI 10.1016/S1385-1101(97)00063-4; FORCADA J, 1994, MAR MAMMAL SCI, V10, P137, DOI 10.1111/j.1748-7692.1994.tb00256.x; Fortibuoni T, 2009, ALTRO MARE; Fortibuoni T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015502; Frantzis A., 2003, Journal of Cetacean Research and Management, V5, P219; Frechette GR, 2001, STATA TECHNICAL B, V159, P23; Johannes RE, 1998, TRENDS ECOL EVOL, V13, P243, DOI 10.1016/S0169-5347(98)01384-6; JOHNSON WM, 1999, MONK SEALS ANTIQUITY, V35; JOHNSON WM, 2004, MONK SEALS POST CLAS, V39; Lavides MN, 2009, ENVIRON CONSERV, V36, P235, DOI 10.1017/S0376892909990385; LEVIMORENOS D, 1906, ESTRATTO ANN AGRICOL, V241; Lopez A, 2003, BIOL CONSERV, V111, P25, DOI 10.1016/S0006-3207(02)00244-6; Mackinson S, 1998, REV FISH BIOL FISHER, V8, P481, DOI 10.1023/A:1008847106984; Myers RA, 2005, PHILOS T R SOC B, V360, P13, DOI 10.1098/rstb.2004.1573; Neis B, 1999, CAN J FISH AQUAT SCI, V56, P1949, DOI 10.1139/cjfas-56-10-1949; Notarbartolo di Sciara, 2002, CETACEANS MEDITERRAN; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; REEVES RR, 1995, WHALES WHALING OCEAN, P82; Rochet MJ, 2008, ICES J MAR SCI, V65, P1057, DOI 10.1093/icesjms/fsn062; Rosenberg AA, 2005, FRONT ECOL ENVIRON, V3, P84, DOI 10.2307/3868514; Sadovy Y, 2003, FISH FISH, V4, P86, DOI 10.1046/j.1467-2979.2003.00104.x; Saenz-Arroyo A, 2005, P ROY SOC B-BIOL SCI, V272, P1957, DOI 10.1098/rspb.2005.3175; Sarda F, 1998, FISH RES, V36, P149, DOI 10.1016/S0165-7836(98)00102-7; Serena F., 2005, FAO SPECIES IDENTIFI; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Tudela S, 2005, BIOL CONSERV, V121, P65, DOI 10.1016/j.biocon.2004.04.010; Vacchi M., 2000, Biologia Marina Mediterranea, V7, P296; Walker PA, 1996, ICES J MAR SCI, V53, P1085, DOI 10.1006/jmsc.1996.0135; Watson R, 2006, FISH RES, V79, P103, DOI 10.1016/j.fishres.2006.01.013	47	71	73	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e21818	10.1371/journal.pone.0021818	http://dx.doi.org/10.1371/journal.pone.0021818			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21818268	gold, Green Published			2022-12-25	WOS:000292929500011
J	Waiczies, H; Lepore, S; Janitzek, N; Hagen, U; Seifert, F; Ittermann, B; Purfurst, B; Pezzutto, A; Paul, F; Niendorf, T; Waiczies, S				Waiczies, Helmar; Lepore, Stefano; Janitzek, Nicole; Hagen, Ulrike; Seifert, Frank; Ittermann, Bernd; Purfuerst, Bettina; Pezzutto, Antonio; Paul, Friedemann; Niendorf, Thoralf; Waiczies, Sonia			Perfluorocarbon Particle Size Influences Magnetic Resonance Signal and Immunological Properties of Dendritic Cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-ALPHA; T-CELLS; TRACKING; MOUSE; PHAGOCYTOSIS; MIGRATION; THERAPY; ANTIGEN	The development of cellular tracking by fluorine ((19)F) magnetic resonance imaging (MRI) has introduced a number of advantages for following immune cell therapies in vivo. These include improved signal selectivity and a possibility to correlate cells labeled with fluorine-rich particles with conventional anatomic proton ((1)H) imaging. While the optimization of the cellular labeling method is clearly important, the impact of labeling on cellular dynamics should be kept in mind. We show by (19)F MR spectroscopy (MRS) that the efficiency in labeling cells of the murine immune system (dendritic cells) by perfluoro-15-crown-5-ether (PFCE) particles increases with increasing particle size (560>365>245>130 nm). Dendritic cells (DC) are professional antigen presenting cells and with respect to impact of PFCE particles on DC function, we observed that markers of maturation for these cells (CD80, CD86) were also significantly elevated following labeling with larger PFCE particles (560 nm). When labeled with these larger particles that also gave an optimal signal in MRS, DC presented whole antigen more robustly to CD8+ T cells than control cells. Our data suggest that increasing particle size is one important feature for optimizing cell labeling by PFCE particles, but may also present possible pitfalls such as alteration of the immunological status of these cells. Therefore depending on the clinical scenario in which the (19)F-labeled cellular vaccines will be applied (cancer, autoimmune disease, transplantation), it will be interesting to monitor the fate of these cells in vivo in the relevant preclinical mouse models.	[Waiczies, Helmar; Lepore, Stefano; Hagen, Ulrike; Paul, Friedemann; Niendorf, Thoralf; Waiczies, Sonia] Max Delbruck Ctr Mol Med, Expt & Clin Res Ctr, Berlin, Germany; [Waiczies, Helmar; Lepore, Stefano; Hagen, Ulrike; Paul, Friedemann; Niendorf, Thoralf; Waiczies, Sonia] Fac Med Charite, Berlin, Germany; [Waiczies, Helmar; Lepore, Stefano; Hagen, Ulrike; Niendorf, Thoralf; Waiczies, Sonia] Max Delbruck Ctr Mol Med, Berlin Ultrahigh Field Facil, Berlin, Germany; [Waiczies, Helmar; Seifert, Frank; Ittermann, Bernd] Phys Tech Bundesanstalt, Berlin, Germany; [Pezzutto, Antonio] Charite, Dept Hematol & Oncol, Berlin, Germany; [Paul, Friedemann] Charite, NeuroCure Clin Res Ctr, Berlin, Germany; [Paul, Friedemann] Charite, Clin & Expt Multiple Sclerosis Res Ctr, Berlin, Germany; [Waiczies, Sonia] Univ Malta, Dept Anat, Msida, Malta	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Physikalisch-Technische Bundesanstalt (PTB); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Malta	Waiczies, H (corresponding author), Max Delbruck Ctr Mol Med, Expt & Clin Res Ctr, Berlin, Germany.	sonia.waiczies@charite.de	Niendorf, Thoralf/H-7738-2013; Paul, Friedemann/ABF-9415-2020; Waiczies, Sonia/H-4181-2012	Niendorf, Thoralf/0000-0001-7584-6527; Waiczies, Sonia/0000-0002-9916-9572; Pezzutto, Antonio/0000-0002-3246-4470; paul, friedemann/0000-0002-6378-0070; Waiczies, Helmar/0000-0001-6651-4790	Deutsche Forschungsgemeinschaft (DFG) [WA 2804, Exc. 257]; Experimental and Clinical Research Center	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Experimental and Clinical Research Center	This work was funded by the Deutsche Forschungsgemeinschaft to S. W. (DFG WA 2804) and F. P. (DFG Exc. 257) and a university grant to S. W. from the Experimental and Clinical Research Center, a cooperation of the Max Delbruck Center for Molecular Medicine and Charite Medical Faculty in Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Ahrens ET, 2005, NAT BIOTECHNOL, V23, P983, DOI 10.1038/nbt1121; AUSTYN JM, 1988, J EXP MED, V167, P646, DOI 10.1084/jem.167.2.646; Banchereau J, 2001, CELL, V106, P271, DOI 10.1016/S0092-8674(01)00448-2; BENDIX I, 2010, EUR J IMMUNOL; Borriello F, 1997, IMMUNITY, V6, P303, DOI 10.1016/S1074-7613(00)80333-7; BROOKS RA, 1989, MAGNET RESON MED, V12, P241, DOI 10.1002/mrm.1910120210; Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103; de Vries IJM, 2005, NAT BIOTECHNOL, V23, P1407, DOI 10.1038/nbt1154; Dobrovolskaia MA, 2007, NAT NANOTECHNOL, V2, P469, DOI 10.1038/nnano.2007.223; HOLLAND GN, 1977, J MAGN RESON, V28, P133, DOI 10.1016/0022-2364(77)90263-3; LAUTERBUR PC, 1973, NATURE, V242, P190, DOI 10.1038/242190a0; LIU MS, 1977, RADIOLOGY, V122, P71, DOI 10.1148/122.1.71; Mackensen A, 1999, CANCER IMMUNOL IMMUN, V48, P118, DOI 10.1007/s002620050555; Menges M, 2002, J EXP MED, V195, P15, DOI 10.1084/jem.20011341; Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]; Partlow KC, 2007, FASEB J, V21, P1647, DOI 10.1096/fj.06-6505com; Pelkmans L, 2005, BBA-MOL CELL RES, V1746, P295, DOI 10.1016/j.bbamcr.2005.06.009; ROAKE JA, 1995, J EXP MED, V181, P2237, DOI 10.1084/jem.181.6.2237; Ruiz-Cabello J, 2008, MAGN RESON MED, V60, P1506, DOI 10.1002/mrm.21783; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; SHASTRI N, 1993, J IMMUNOL, V150, P2724; Sommermeyer D, 2006, EUR J IMMUNOL, V36, P3052, DOI 10.1002/eji.200636539; Srinivas M, 2007, MAGN RESON MED, V58, P725, DOI 10.1002/mrm.21352; van Zlverden M, 2000, TOXICOLOGY, V152, P69, DOI 10.1016/S0300-483X(00)00293-6; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317	26	43	43	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e21981	10.1371/journal.pone.0021981	http://dx.doi.org/10.1371/journal.pone.0021981			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21811551	Green Published, Green Accepted, gold			2022-12-25	WOS:000292929500025
J	Moore, AE; Young, LE; Dixon, DA				Moore, A. E.; Young, L. E.; Dixon, D. A.			A common single-nucleotide polymorphism in cyclooxygenase-2 disrupts microRNA-mediated regulation	ONCOGENE			English	Article						COX-2; post-transcriptional regulation; microRNA; SNP; polymorphism	GENETIC POLYMORPHISMS; CANCER; RISK; EXPRESSION; ASSOCIATION; CELLS	Elevated expression of the prostaglandin synthase cyclooxygenase-2 (COX-2) is commonly observed in many chronic inflammatory diseases and cancer. However, the mechanisms allowing for pathogenic COX-2 overexpression are largely unknown. The gene for COX-2 (PTGS2) carries a common single-nucleotide polymorphism (SNP) at position 8473 (T8473C), in exon 10 that is associated with diseases in which COX-2 overexpression is a contributing factor. We demonstrate that the T8473C SNP resides within a region that targets COX-2 mRNA for degradation through microRNA-mediated regulation. miR-542-3p was identified to bind transcripts derived from the 8473T allele and promote mRNA decay. By contrast, the presence of the variant 8473C allele interfered with miR-542-3p binding, allowing for mRNA stabilization, and this effect was rescued using a mutated miR-542-3p at the respective 8473 site. Colon cancer cells and tissue displayed COX-2 mRNA levels that were dependent on T8473C allele dosage, and allele-specific expression of COX-2 was observed to be a contributing factor promoting COX-2 overexpression. These findings provide a novel molecular explanation underlying disease susceptibility associated with COX-2 T8473C SNP, and identify it as a potential marker for identifying cancer patients best served through selective COX-2 inhibition. Oncogene (2012) 31, 1592-1598; doi:10.1038/onc.2011.349; published online 8 August 2011	[Dixon, D. A.] Univ S Carolina, Dept Biol Sci, Jones PSC, Columbia, SC 29208 USA; Univ S Carolina, Ctr Colon Canc Res, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Dixon, DA (corresponding author), Univ S Carolina, Dept Biol Sci, Jones PSC, 712 Main St,Room 614, Columbia, SC 29208 USA.	ddixon@biol.sc.edu			National Institutes of Health [R01CA134609]; American Cancer Society [RSG-06-122-01-CNE]; NATIONAL CANCER INSTITUTE [R01CA134609] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (R01CA134609) and American Cancer Society (RSG-06-122-01-CNE).	Abdelmohsen K, 2008, P NATL ACAD SCI USA, V105, P20297, DOI 10.1073/pnas.0809376106; Ali IU, 2005, BRIT J CANCER, V93, P953, DOI 10.1038/sj.bjc.6602806; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Birkenkamp-Demtroder K, 2005, GUT, V54, P374, DOI 10.1136/gut.2003.036848; Campa D, 2004, CARCINOGENESIS, V25, P229, DOI 10.1093/carcin/bgh008; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Dimberg J, 1999, GUT, V45, P730, DOI 10.1136/gut.45.5.730; Dixon DA, 2000, J BIOL CHEM, V275, P11750, DOI 10.1074/jbc.275.16.11750; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Ferguson HR, 2008, CANCER EPIDEM BIOMAR, V17, P727, DOI 10.1158/1055-9965.EPI-07-2570; Gong ZH, 2009, INT J COLORECTAL DIS, V24, P647, DOI 10.1007/s00384-009-0656-8; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Langsenlehner U, 2006, CLIN CANCER RES, V12, P1392, DOI 10.1158/1078-0432.CCR-05-2055; Menter DG, 2010, CLIN CANCER RES, V16, P1384, DOI 10.1158/1078-0432.CCR-09-0788; Nasir Aejaz, 2004, Clin Colorectal Cancer, V3, P243, DOI 10.3816/CCC.2004.n.005; Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541; Ozhan G, 2010, PANCREAS, V39, P371, DOI 10.1097/MPA.0b013e3181bae9ca; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Sanduja S, 2009, AGING-US, V1, P803, DOI 10.18632/aging.100086; Shen J, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1629; Siezen CLE, 2005, CARCINOGENESIS, V26, P449, DOI 10.1093/carcin/bgh336; Vogel U, 2008, MUTAT RES-FUND MOL M, V639, P89, DOI 10.1016/j.mrfmmm.2007.11.004; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421; Young LE, 2010, CURR COLORECT CANC R, V6, P60, DOI 10.1007/s11888-010-0044-3; Young LE, 2009, GASTROENTEROLOGY, V136, P1669, DOI 10.1053/j.gastro.2009.01.010	27	39	39	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2012	31	12					1592	1598		10.1038/onc.2011.349	http://dx.doi.org/10.1038/onc.2011.349			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	916VT	21822307	Green Accepted			2022-12-25	WOS:000302132000011
J	Carayon, K; Chaoui, K; Ronzier, E; Lazar, I; Bertrand-Michel, J; Roques, V; Balor, S; Terce, F; Lopez, A; Salome, L; Joly, E				Carayon, Kevin; Chaoui, Karima; Ronzier, Elsa; Lazar, Ikrame; Bertrand-Michel, Justine; Roques, Veronique; Balor, Stephanie; Terce, Francois; Lopez, Andre; Salome, Laurence; Joly, Etienne			Proteolipidic Composition of Exosomes Changes during Reticulocyte Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DERIVED EXOSOMES; IN-VITRO; MEMBRANE MICRODOMAINS; TRANSFERRIN RECEPTOR; LIPIDS; VESICLES; PHOSPHOLIPIDS; BIOGENESIS; PROTEOMICS; PROTEINS	During the orchestrated process leading to mature erythrocytes, reticulocytes must synthesize large amounts of hemoglobin, while eliminating numerous cellular components. Exosomes are small secreted vesicles that play an important role in this process of specific elimination. To understand the mechanisms of proteolipidic sorting leading to their biogenesis, we have explored changes in the composition of exosomes released by reticulocytes during their differentiation, in parallel to their physical properties. By combining proteomic and lipidomic approaches, we found dramatic alterations in the composition of the exosomes retrieved over the course of a 7-day in vitro differentiation protocol. Our data support a previously proposed model, whereby in reticulocytes the biogenesis of exosomes involves several distinct mechanisms for the preferential recruitment of particular proteins and lipids and suggest that the respective prominence of those pathways changes over the course of the differentiation process.	[Carayon, Kevin; Chaoui, Karima; Ronzier, Elsa; Lazar, Ikrame; Lopez, Andre; Salome, Laurence] CNRS, Inst Pharmacol & Struct Biol, F-31077 Toulouse, France; [Carayon, Kevin; Chaoui, Karima; Ronzier, Elsa; Lazar, Ikrame; Lopez, Andre; Salome, Laurence; Joly, Etienne] Univ Toulouse 3, Univ Toulouse, F-31077 Toulouse, France; [Bertrand-Michel, Justine; Roques, Veronique; Terce, Francois] CHU Purpan, INSERM CPTP U563, F-31024 Toulouse 3, France; [Balor, Stephanie] CNRS, Inst Explorat Fonct Genomes, IFR109, Batiment Inst Biol Cellulaire & Genet, F-31062 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS)	Carayon, K (corresponding author), CNRS, Inst Pharmacol & Struct Biol, 205 Route Narbonne, F-31077 Toulouse, France.	kevin.carayon@ipbs.fr; atnjoly@mac.com	Joly, Etienne/A-5644-2009; Tercé, François/M-5863-2018	Joly, Etienne/0000-0002-7264-2681; Tercé, François/0000-0003-4488-2167; Lazar, Ikrame/0000-0003-4062-3627; SALOME, Laurence/0000-0001-9667-4154	CNRS; Agence Nationale de la Recherche (Agence Nationale de la Recherche/INCa Programme Plates-Formes Technologiques du Vivant); Fondation pour la Recherche Medicale; Region Midi-Pyrenees	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (Agence Nationale de la Recherche/INCa Programme Plates-Formes Technologiques du Vivant)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie)	This work was supported in part by the CNRS (PEPS 2009 Program).; Supported by a postdoctoral grant from CNRS. To whom correspondence may be addressed: Institute of Pharmacology and Structural Biology; 205 Route de Narbonne, F-31077 Toulouse, France. Tel.: 33-561-17-58-70; Fax: 33-561-17-59-94; E-mail: kevin.carayon@ipbs.fr.; We are thankful to S. Powis, A. Saoudi, and I. Bernard-Cadenat for the gifts of antibody reagents and to members of the O. Cuvillier and M-L. Maddelein teams for providing us with materials and reagents for the Western blot analyses. We gratefully acknowledge L. Kaddoum, B. Monsarrat, M. Record, C. Thery, and M. Vidal for helpful discussions and technical advice, as well as the anonymous referees for their helpful suggestions. This work benefited from the assistance of the electron microscopy facility of the IFR 109 and of the TRI Imaging platform of Toulouse. The IPBS proteomic platform was supported by grants from the Agence Nationale de la Recherche (Agence Nationale de la Recherche/INCa Programme Plates-Formes Technologiques du Vivant), the Fondation pour la Recherche Medicale (Programme Grands Equipements), and the Region Midi-Pyrenees. Institut de Pharmacologie et de Biologie Structurale belongs to the CNRS Consortium CellTiss.	Amigorena S, 2000, MEDICINA-BUENOS AIRE, V60, P51; APOVO M, 1994, BBA-MOL BASIS DIS, V1225, P255, DOI 10.1016/0925-4439(94)90003-5; Bagatolli LA, 2010, PROG LIPID RES, V49, P378, DOI 10.1016/j.plipres.2010.05.001; BARRANS A, 1994, J BIOL CHEM, V269, P11572; Barres C, 2010, BLOOD, V115, P696, DOI 10.1182/blood-2009-07-231449; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Blanc L, 2010, CURR OPIN HEMATOL, V17, P177, DOI 10.1097/MOH.0b013e328337b4e3; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bouyssie D, 2007, MOL CELL PROTEOMICS, V6, P1621, DOI 10.1074/mcp.T600069-MCP200; Brittain JE, 2008, TRANSFUS CLIN BIOL, V15, P19, DOI 10.1016/j.tracli.2008.03.013; Chasis JA, 2008, BLOOD, V112, P470, DOI 10.1182/blood-2008-03-077883; Criswell KA, 2000, J APPL TOXICOL, V20, P25, DOI 10.1002/(SICI)1099-1263(200001/02)20:1<25::AID-JAT624>3.0.CO;2-7; De Franceschi L, 2009, MEDITERR J HEMATOL I, V1, DOI [10.4084/MJHID.2009.024, 10.4084/MMID.2009.024]; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; Destainville Nicolas, 2008, J Chem Biol, V1, P37, DOI 10.1007/s12154-008-0005-3; FLANAGAN J P, 1970, Ohio Journal of Science, V70, P300; FOLCH J, 1951, J BIOL CHEM, V191, P833; Geminard C, 2004, TRAFFIC, V5, P181, DOI 10.1111/j.1600-0854.2004.0167.x; GRONOWICZ G, 1984, J CELL SCI, V71, P177; Hanson PI, 2009, CURR OPIN CELL BIOL, V21, P568, DOI 10.1016/j.ceb.2009.06.002; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; Joly E, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-3; Kakhniashvili DG, 2005, EXP BIOL MED, V230, P787, DOI 10.1177/153537020523001102; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Koury MJ, 2005, BLOOD, V105, P2168, DOI 10.1182/blood-2004-02-0616; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, V3rd, P353; Laulagnier K, 2005, BLOOD CELL MOL DIS, V35, P116, DOI 10.1016/j.bcmd.2005.05.010; Laulagnier K, 2004, BIOCHEM J, V380, P161, DOI 10.1042/BJ20031594; LEBORGNE N, 1992, PLANT PHYSIOL, V100, P246, DOI 10.1104/pp.100.1.246; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lynch S, 2009, J IMMUNOL, V183, P1884, DOI 10.4049/jimmunol.0900798; Mairhofer M, 2002, BLOOD, V100, P897, DOI 10.1182/blood.V100.3.897; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; MEL HC, 1977, BLOOD, V49, P1001; Mouton-Barbosa E, 2010, MOL CELL PROTEOMICS, V9, P1006, DOI 10.1074/mcp.M900513-MCP200; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Schroeder F, 2001, EXP BIOL MED, V226, P873, DOI 10.1177/153537020122601002; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Subra C, 2007, BIOCHIMIE, V89, P205, DOI 10.1016/j.biochi.2006.10.014; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Meer G, 2011, J CELL SCI, V124, P5, DOI 10.1242/jcs.071233; van Meer G, 2010, EMBO REP, V11, P331, DOI 10.1038/embor.2010.60; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; VIDAL M, 1989, J CELL PHYSIOL, V140, P455, DOI 10.1002/jcp.1041400308; Vidal M, 2010, TRANSFUS CLIN BIOL, V17, P131, DOI 10.1016/j.tracli.2010.05.004; Vieu C, 2002, J LIPID RES, V43, P510; Woodman PG, 2008, CURR OPIN CELL BIOL, V20, P408, DOI 10.1016/j.ceb.2008.04.001; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200; YAO JK, 1985, ANAL BIOCHEM, V150, P111, DOI 10.1016/0003-2697(85)90447-6; ZAK B, 1954, AM J CLIN PATHOL, V24, P1307, DOI 10.1093/ajcp/24.11_ts.1307; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	60	130	136	3	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34426	34439		10.1074/jbc.M111.257444	http://dx.doi.org/10.1074/jbc.M111.257444			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21828046	hybrid, Green Published			2022-12-25	WOS:000295159200070
J	Della-Maria, J; Zhou, Y; Tsai, MS; Kuhnlein, J; Carney, JP; Paull, TT; Tomkinson, AE				Della-Maria, Julie; Zhou, Yi; Tsai, Miaw-Sheue; Kuhnlein, Jeff; Carney, James P.; Paull, Tanya T.; Tomkinson, Alan E.			Human Mre11/Human Rad50/Nbs1 and DNA Ligase III alpha/XRCC1 Protein Complexes Act Together in an Alternative Nonhomologous End Joining Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; V(D)J RECOMBINATION; POLY(ADP-RIBOSE) POLYMERASE; CHROMOSOMAL TRANSLOCATIONS; BACKUP PATHWAYS; HUMAN-CELLS; III-ALPHA; REPAIR; MRE11; ATM	Recent studies have implicated a poorly defined alternative pathway of nonhomologous end joining (alt-NHEJ) in the generation of large deletions and chromosomal translocations that are frequently observed in cancer cells. Here, we describe an interaction between two factors, hMre11/hRad50/Nbs1 (MRN) and DNA ligase III alpha/XRCC1, that have been linked with alt-NHEJ. Expression of DNA ligase III alpha and the association between MRN and DNA ligase III alpha/XRCC1 are altered in cell lines defective in the major NHEJ pathway. Most notably, DNA damage induced the association of these factors in DNA ligase IV-deficient cells. MRN interacts with DNA ligase III alpha/XRCC1, stimulating intermolecular ligation, and together these proteins join incompatible DNA ends in a reaction that mimics alt-NHEJ. Thus, our results provide novel mechanistic insights into the alt-NHEJ pathway that not only contributes to genome instability in cancer cells but may also be a therapeutic target.	[Della-Maria, Julie; Carney, James P.; Tomkinson, Alan E.] Univ Maryland, Sch Med, Dept Radiat Oncol, Radiat Oncol Res Lab, Baltimore, MD 21201 USA; [Della-Maria, Julie; Carney, James P.; Tomkinson, Alan E.] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Tsai, Miaw-Sheue] Univ Calif Berkeley, Ernest Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Zhou, Yi; Kuhnlein, Jeff; Paull, Tanya T.] Univ Texas Austin, Howard Hughes Med Inst, Austin, TX 78712 USA; [Zhou, Yi; Kuhnlein, Jeff; Paull, Tanya T.] Univ Texas Austin, Dept Mol Genet & Microbiol, Austin, TX 78712 USA; [Tomkinson, Alan E.] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA; [Tomkinson, Alan E.] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of New Mexico; University of New Mexico	Tomkinson, AE (corresponding author), 1 Univ New Mexico, Canc Res Facil, 915 Camino Salud, Albuquerque, NM 87131 USA.	atomkinson@salud.unm.edu	Classen, Scott/AAY-8176-2020; Zhou, Yi/P-1039-2015	Zhou, Yi/0000-0002-1650-4591; Paull, Tanya/0000-0002-2991-651X	National Institutes of Health (NIH) from the NIEHS [ES012512]; NIH from the NCI [CA92584]; NIH [CA094008]; NATIONAL CANCER INSTITUTE [P01CA092584, R01CA094008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012512] Funding Source: NIH RePORTER	National Institutes of Health (NIH) from the NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH from the NCI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant ES012512 from the NIEHS (to A. E. T.), NIH Program Project Grant CA92584 from the NCI (to A. E. T. and T. T. P.), and NIH Grant CA094008 (to T. T. P.).	Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bentley DJ, 2002, J CELL SCI, V115, P1551; Boboila C, 2010, P NATL ACAD SCI USA, V107, P3034, DOI 10.1073/pnas.0915067107; Bressan DA, 1998, GENETICS, V150, P591; Brown ML, 2002, P NATL ACAD SCI USA, V99, P4532, DOI 10.1073/pnas.072495299; Cahill D, 2007, MUTAGENESIS, V22, P269, DOI 10.1093/mutage/gem011; Chen L, 2001, MOL CELL, V8, P1105, DOI 10.1016/S1097-2765(01)00388-4; Chen X, 2008, CANCER RES, V68, P3169, DOI 10.1158/0008-5472.CAN-07-6636; Cheng WH, 2004, J BIOL CHEM, V279, P21169, DOI 10.1074/jbc.M312770200; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; Deriano L, 2009, MOL CELL, V34, P13, DOI 10.1016/j.molcel.2009.03.009; Dinkelmann M, 2009, NAT STRUCT MOL BIOL, V16, P808, DOI 10.1038/nsmb.1639; Fattah F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000855; Ferguson DO, 2000, P NATL ACAD SCI USA, V97, P6630, DOI 10.1073/pnas.110152897; Gao YK, 2011, NATURE, V471, P240, DOI 10.1038/nature09773; Gatei M, 2000, NAT GENET, V25, P115, DOI 10.1038/75508; Grawunder U, 1998, MOL CELL, V2, P477, DOI 10.1016/S1097-2765(00)80147-1; Guirouilh-Barbat J, 2007, P NATL ACAD SCI USA, V104, P20902, DOI 10.1073/pnas.0708541104; Haber JE, 2008, P NATL ACAD SCI USA, V105, P405, DOI 10.1073/pnas.0711334105; Hopkins BB, 2008, CELL, V135, P250, DOI 10.1016/j.cell.2008.09.054; HUSAIN I, 1995, J BIOL CHEM, V270, P9683, DOI 10.1074/jbc.270.16.9683; IKEJIMA M, 1990, J BIOL CHEM, V265, P21907; Krejci L, 2001, MOL CELL BIOL, V21, P966, DOI 10.1128/MCB.21.3.966-976.2001; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2010, EMBO J, V29, P574, DOI 10.1038/emboj.2009.372; LEESMILLER SP, 1995, SCIENCE, V267, P1183, DOI 10.1126/science.7855602; Liang L, 2008, NUCLEIC ACIDS RES, V36, P3297, DOI 10.1093/nar/gkn184; Lieber MR, 2010, NAT STRUCT MOL BIOL, V17, P393, DOI 10.1038/nsmb0410-393; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Mackey ZB, 1999, J BIOL CHEM, V274, P21679, DOI 10.1074/jbc.274.31.21679; Mackey ZB, 1997, MOL CELL BIOL, V17, P989, DOI 10.1128/MCB.17.2.989; Mari PO, 2006, P NATL ACAD SCI USA, V103, P18597, DOI 10.1073/pnas.0609061103; Nicolette ML, 2010, NAT STRUCT MOL BIOL, V17, P1478, DOI 10.1038/nsmb.1957; Nussenzweig A, 2007, CELL, V131, P223, DOI 10.1016/j.cell.2007.10.005; O'Driscoll M, 2001, MOL CELL, V8, P1175, DOI 10.1016/S1097-2765(01)00408-7; Okano S, 2005, NUCLEIC ACIDS RES, V33, P422, DOI 10.1093/nar/gki190; Okano S, 2003, MOL CELL BIOL, V23, P3974, DOI 10.1128/MCB.23.11.3974-3981.2003; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Paull TT, 2000, P NATL ACAD SCI USA, V97, P6409, DOI 10.1073/pnas.110144297; Rass E, 2009, NAT STRUCT MOL BIOL, V16, P819, DOI 10.1038/nsmb.1641; Sallmyr A, 2008, BLOOD, V112, P1413, DOI 10.1182/blood-2007-07-104257; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Sharpless NE, 2001, MOL CELL, V8, P1187, DOI 10.1016/S1097-2765(01)00425-7; Simsek D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002080; Simsek D, 2011, NATURE, V471, P245, DOI 10.1038/nature09794; Simsek D, 2010, NAT STRUCT MOL BIOL, V17, P410, DOI 10.1038/nsmb.1773; Soulas-Sprauel P, 2007, J EXP MED, V204, P1717, DOI 10.1084/jem.20070255; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Tsuchida R, 2002, RADIAT RES, V158, P195, DOI 10.1667/0033-7587(2002)158[0195:DOAGMI]2.0.CO;2; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Vijayakumar S, 2009, MOL CELL BIOL, V29, P2042, DOI 10.1128/MCB.01732-08; Wang HC, 2005, CANCER RES, V65, P4020, DOI 10.1158/0008-5472.CAN-04-3055; Wang JH, 2009, NATURE, V460, P231, DOI 10.1038/nature08159; Wang JH, 2008, J EXP MED, V205, P3079, DOI 10.1084/jem.20082271; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Xie AY, 2009, NAT STRUCT MOL BIOL, V16, P814, DOI 10.1038/nsmb.1640; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020; Zhang Y, 2007, NAT STRUCT MOL BIOL, V14, P639, DOI 10.1038/nsmb1261; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	65	93	94	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33845	33853		10.1074/jbc.M111.274159	http://dx.doi.org/10.1074/jbc.M111.274159			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21816818	hybrid, Green Published			2022-12-25	WOS:000295159200016
J	Shumay, E; Chen, J; Fowler, JS; Volkow, ND				Shumay, Elena; Chen, John; Fowler, Joanna S.; Volkow, Nora D.			Genotype and Ancestry Modulate Brain's DAT Availability in Healthy Humans	PLOS ONE			English	Article							DOPAMINE TRANSPORTER GENE; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; STRIATAL D2 RECEPTORS; VARIABLE NUMBER; TANDEM REPEATS; IN-VIVO; ADHD; VNTR; POLYMORPHISMS	The dopamine transporter (DAT) is a principal regulator of dopaminergic neurotransmission and its gene (the SLC6A3) is a strong biological candidate gene for various behavioral- and neurological disorders. Intense investigation of the link between the SLC6A3 polymorphisms and behavioral phenotypes yielded inconsistent and even contradictory results. Reliance on objective brain phenotype measures, for example, those afforded by brain imaging, might critically improve detection of DAT genotype-phenotype association. Here, we tested the relationship between the DAT brain availability and the SLC6A3 genotypes using an aggregate sample of 95 healthy participants of several imaging studies. These studies employed positron emission tomography (PET) with [C-11] cocaine wherein the DAT availability was estimated as Bmax/Kd; while the genotype values were obtained on two repeat polymorphisms -3-UTR- and intron 8-VNTRs. The main findings are the following: 1) both polymorphisms analyzed as single genetic markers and in combination (haplotype) modulate DAT density in midbrain; 2) ethnic background and age influence the strength of these associations; and 3) age-related changes in DAT availability differ in the 3-UTR and intron8 - genotype groups.	[Shumay, Elena; Fowler, Joanna S.] Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA; [Chen, John] SUNY Stony Brook, Dept Prevent Med, Stony Brook, NY 11794 USA; [Volkow, Nora D.] Natl Inst Drug Abuse, NIH, Bethesda, MD USA	United States Department of Energy (DOE); Brookhaven National Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Shumay, E (corresponding author), Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA.	eshumay@bnl.gov			National Institute on Drug Abuse [KO1 DA025280-01A1, K05 DA20001]; National Institutes of Health, NIDA; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA025280, K05DA020001] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institutes of Health, NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was performed at Brookhaven National Laboratory with infrastructure support from the Department of Energy, Office of Biological and Environmental Research and funded by the National Institute on Drug Abuse, grants KO1 DA025280-01A1 (ES), K05 DA20001 (JSF) and National Institutes of Health Intramural Research Program, NIDA (NDV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Arias-Carrion Oscar, 2010, Int Arch Med, V3, P24, DOI 10.1186/1755-7682-3-24; Asherson P, 2007, AM J PSYCHIAT, V164, P674, DOI 10.1176/appi.ajp.164.4.674; Ball EV, 2005, HUM MUTAT, V26, P205, DOI 10.1002/humu.20212; Ballon N, 2007, AM J MED GENET B, V144B, P1034, DOI 10.1002/ajmg.b.30540; BANNON MJ, 1992, P NATL ACAD SCI USA, V89, P7095, DOI 10.1073/pnas.89.15.7095; Bannon MJ, 1997, NEUROLOGY, V48, P969, DOI 10.1212/WNL.48.4.969; Benedek G, 2010, GENES IMMUN, V11, P423, DOI 10.1038/gene.2010.20; Brookes KJ, 2008, AM J MED GENET B, V147B, P1519, DOI 10.1002/ajmg.b.30782; Brookes KJ, 2007, AM J MED GENET B, V144B, P1070, DOI 10.1002/ajmg.b.30572; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Caspi A, 2008, ARCH GEN PSYCHIAT, V65, P203, DOI 10.1001/archgenpsychiatry.2007.24; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; COHEN ME, 1983, COMMUNITY DENT ORAL, V11, P102, DOI 10.1111/j.1600-0528.1983.tb01364.x; D'Souza UM, 2008, PROG BRAIN RES, V172, P73, DOI 10.1016/S0079-6123(08)00904-7; Drgon T, 2006, CELL MOL NEUROBIOL, V26, P875, DOI 10.1007/s10571-006-9014-3; Elena SF, 2003, SCIENCE, V302, P2074, DOI 10.1126/science.1093165; Epstein LH, 2002, OBES RES, V10, P1232, DOI 10.1038/oby.2002.168; Eriksen J, 2010, J NEUROCHEM, V113, P27, DOI 10.1111/j.1471-4159.2010.06599.x; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Fondon JW, 2008, TRENDS NEUROSCI, V31, P328, DOI 10.1016/j.tins.2008.03.006; Fowler JS, 2008, NEUROIMAGE, V43, P756, DOI 10.1016/j.neuroimage.2008.07.020; Fowler JS, 2001, NUCL MED BIOL, V28, P561, DOI 10.1016/S0969-8051(01)00211-6; Fuchs SC, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-1; Fuke S, 2005, J BIOCHEM, V137, P205, DOI 10.1093/jb/mvi020; Genro JP, 2008, AM J MED GENET B, V147B, P1568, DOI 10.1002/ajmg.b.30863; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Greenwood TA, 2003, GENOMICS, V82, P511, DOI 10.1016/S0888-7543(03)00142-3; Guindalini C, 2006, P NATL ACAD SCI USA, V103, P4552, DOI 10.1073/pnas.0504789103; Guindalini C, 2010, PSYCHIAT RES, V179, P238, DOI 10.1016/j.psychres.2009.07.017; Guo G, 2007, EUR J HUM GENET, V15, P279, DOI 10.1038/sj.ejhg.5201763; Heinz A, 2000, NEUROPSYCHOPHARMACOL, V22, P133, DOI 10.1016/S0893-133X(99)00099-8; Hill M, 2010, PHARMACOGENOMICS J, V10, P442, DOI 10.1038/tpj.2009.66; Jacobsen LK, 2000, AM J PSYCHIAT, V157, P1700, DOI 10.1176/appi.ajp.157.10.1700; JULIA PG, 2008, AM J MED GENET B, V147, P1568; Kang AM, 1999, BIOL PSYCHIAT, V46, P151, DOI 10.1016/S0006-3223(99)00101-8; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Khusnutdinova E. K., 2003, Genetika, V39, P1550; Lafuente A, 2007, SCHIZOPHR RES, V90, P115, DOI 10.1016/j.schres.2006.09.031; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Martin GM, 2002, NEUROBIOL AGING, V23, P647, DOI 10.1016/S0197-4580(01)00341-4; Martinez D, 2001, NEUROPSYCHOPHARMACOL, V24, P553, DOI 10.1016/S0893-133X(00)00216-5; Mattei J, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-45; Michelhaugh SK, 2001, J NEUROCHEM, V79, P1033, DOI 10.1046/j.1471-4159.2001.00647.x; Mill J, 2002, AM J MED GENET, V114, P975, DOI 10.1002/ajmg.b.10948; Monuteaux MC, 2009, J AM ACAD CHILD PSY, V48, P757, DOI 10.1097/CHI.0b013e3181a5661b; Ritz BR, 2009, ENVIRON HEALTH PERSP, V117, P964, DOI 10.1289/ehp.0800277; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Rommelse NNJ, 2008, AM J MED GENET B, V147B, P1536, DOI 10.1002/ajmg.b.30848; Shohamy D, 2010, TRENDS COGN SCI, V14, P464, DOI 10.1016/j.tics.2010.08.002; Shumay E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011067; Smith Y, 2000, TRENDS NEUROSCI, V23, pS28, DOI 10.1016/S1471-1931(00)00023-9; Swanson JM, 2007, NEUROPSYCHOL REV, V17, P39, DOI 10.1007/s11065-007-9019-9; Tan IKL, 2010, GENOME RES, V20, P1629, DOI 10.1101/gr.101881.109; van de Giessen EM, 2009, J NUCL MED, V50, P45, DOI 10.2967/jnumed.108.053652; van Dyck CH, 2002, AM J GERIAT PSYCHIAT, V10, P36, DOI 10.1176/appi.ajgp.10.1.36; Vandenbergh DJ, 2000, MOL PSYCHIATR, V5, P283, DOI 10.1038/sj.mp.4000701; VANDENBERGH DJ, 1992, GENOMICS, V14, P1104, DOI 10.1016/S0888-7543(05)80138-7; Vernier P, 2004, ANN NY ACAD SCI, V1035, P231, DOI 10.1196/annals.1332.015; Volkow ND, 2005, BIOL PSYCHIAT, V57, P1410, DOI 10.1016/j.biopsych.2004.11.006; Volkow ND, 2002, SYNAPSE, V43, P181, DOI 10.1002/syn.10038; Volkow ND, 1996, J NUCL MED, V37, P554; Volkow ND, 2008, NEUROIMAGE, V42, P1537, DOI 10.1016/j.neuroimage.2008.06.002; Volkow ND, 2007, ARCH NEUROL-CHICAGO, V64, P1575, DOI 10.1001/archneur.64.11.1575; Volkow ND, 2007, ARCH GEN PSYCHIAT, V64, P932, DOI 10.1001/archpsyc.64.8.932; Volkow ND, 2007, NEUROIMAGE, V34, P1182, DOI 10.1016/j.neuroimage.2006.10.014; Volkow ND, 2009, NEUROIMAGE, V45, P1232, DOI 10.1016/j.neuroimage.2009.01.003; Volkow ND, 2009, JAMA-J AM MED ASSOC, V301, P1148, DOI 10.1001/jama.2009.351; Wang GJ, 2004, BRAIN, V127, P2452, DOI 10.1093/brain/awh269; Yang BR, 2007, AM J MED GENET B, V144B, P541, DOI 10.1002/ajmg.b.30453	70	48	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22754	10.1371/journal.pone.0022754	http://dx.doi.org/10.1371/journal.pone.0022754			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826203	Green Submitted, gold, Green Published			2022-12-25	WOS:000293558900029
J	Dalkvist, T; Sibly, RM; Topping, CJ				Dalkvist, Trine; Sibly, Richard M.; Topping, Chris J.			How Predation and Landscape Fragmentation Affect Vole Population Dynamics	PLOS ONE			English	Article							DENSITY-DEPENDENCE; MICROTUS-AGRESTIS; CLETHRIONOMYS-RUFOCANUS; SMALL RODENTS; SMALL MAMMALS; FIELD VOLE; CYCLES; NORTHERN; ECOLOGY; CONNECTIVITY	Background: Microtine species in Fennoscandia display a distinct north-south gradient from regular cycles to stable populations. The gradient has often been attributed to changes in the interactions between microtines and their predators. Although the spatial structure of the environment is known to influence predator-prey dynamics of a wide range of species, it has scarcely been considered in relation to the Fennoscandian gradient. Furthermore, the length of microtine breeding season also displays a north-south gradient. However, little consideration has been given to its role in shaping or generating population cycles. Because these factors covary along the gradient it is difficult to distinguish their effects experimentally in the field. The distinction is here attempted using realistic agent-based modelling. Methodology/Principal Findings: By using a spatially explicit computer simulation model based on behavioural and ecological data from the field vole (Microtus agrestis), we generated a number of repeated time series of vole densities whose mean population size and amplitude were measured. Subsequently, these time series were subjected to statistical autoregressive modelling, to investigate the effects on vole population dynamics of making predators more specialised, of altering the breeding season, and increasing the level of habitat fragmentation. We found that fragmentation as well as the presence of specialist predators are necessary for the occurrence of population cycles. Habitat fragmentation and predator assembly jointly determined cycle length and amplitude. Length of vole breeding season had little impact on the oscillations. Significance: There is good agreement between our results and the experimental work from Fennoscandia, but our results allow distinction of causation that is hard to unravel in field experiments. We hope our results will help understand the reasons for cycle gradients observed in other areas. Our results clearly demonstrate the importance of landscape fragmentation for population cycling and we recommend that the degree of fragmentation be more fully considered in future analyses of vole dynamics.	[Dalkvist, Trine; Sibly, Richard M.; Topping, Chris J.] Roskilde Univ, CIPE, Roskilde, Denmark; [Dalkvist, Trine; Topping, Chris J.] Roskilde Univ, Dept Environm Social & Spatial Change, Roskilde, Denmark; [Dalkvist, Trine] Aarhus Univ, Natl Environm Res Inst, Dept Wildlife Ecol & Biodivers, Ronde, Denmark; [Sibly, Richard M.] Univ Reading, Sch Anim & Microbial Sci, Reading RG6 2AJ, Berks, England	Roskilde University; Roskilde University; Aarhus University; University of Reading	Dalkvist, T (corresponding author), Roskilde Univ, CIPE, Roskilde, Denmark.	dal@dmu.dk	Topping, Christopher J/A-9167-2009	Topping, Christopher J/0000-0003-0874-7603; Sibly, Richard/0000-0001-6828-3543	Danish Natural Science Research Council; Centre for Integrated Population Ecology (CIPE)	Danish Natural Science Research Council(Danish Natural Science Research Council); Centre for Integrated Population Ecology (CIPE)	This research has been sponsored by the Danish Natural Science Research Council and the Centre for Integrated Population Ecology (CIPE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrell J, 1998, OIKOS, V83, P507, DOI 10.2307/3546678; Begon M., 2009, ECOLOGY INDIVIDUALS; BJORNSTAD ON, 1995, P ROY SOC B-BIOL SCI, V262, P127, DOI 10.1098/rspb.1995.0186; Bonsall MB, 2002, J ANIM ECOL, V71, P1075, DOI 10.1046/j.1365-2656.2002.00670.x; Box G.E.P., 1976, TIME SERIES ANAL FOR; Brockhurst MA, 2006, J EVOLUTION BIOL, V19, P374, DOI 10.1111/j.1420-9101.2005.01026.x; Chase JM, 2002, ECOL LETT, V5, P302, DOI 10.1046/j.1461-0248.2002.00315.x; Cope DR, 2005, NONLINEAR ANAL-REAL, V6, P691, DOI 10.1016/j.nonrwa.2004.12.011; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Dalkvist T, 2009, ECOTOX ENVIRON SAFE, V72, P1663, DOI 10.1016/j.ecoenv.2008.10.002; DeAngelis DL, 2005, ANNU REV ECOL EVOL S, V36, P147, DOI 10.1146/annurev.ecolsys.36.102003.152644; Ellner SP, 2001, NATURE, V412, P538, DOI 10.1038/35087580; Elton C., 1942, VOLES MICE LEMMINGS; Elton CS, 1924, BR J EXP BIOL, V2, P119; ERLINGE S, 1983, J ANIM ECOL, V52, P705, DOI 10.2307/4449; Fahrig L, 2005, ECOSYSTEM FUNCTION IN HETEROGENEOUS LANDSCAPES, P95, DOI 10.1007/0-387-24091-8_6; Gilg O, 2003, SCIENCE, V302, P866, DOI 10.1126/science.1087509; Grimm V, 1999, ECOL MODEL, V115, P129, DOI 10.1016/S0304-3800(98)00188-4; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Gurevitch J, 2000, AM NAT, V155, P435, DOI 10.1086/303337; Hansen TF, 1999, AM NAT, V154, P129, DOI 10.1086/303229; HANSKI I, 1991, J ANIM ECOL, V60, P353, DOI 10.2307/5465; HANSKI I, 1994, TRENDS ECOL EVOL, V9, P131, DOI 10.1016/0169-5347(94)90177-5; Hanski I, 2001, ECOLOGY, V82, P1505, DOI 10.1890/0012-9658(2001)082[1505:SRDAP]2.0.CO;2; Hanski I, 1999, OIKOS, V87, P209, DOI 10.2307/3546736; Hanski I., 1999, METAPOPULATION ECOLO; HANSSON L, 1969, OIKOS, V20, P431, DOI 10.2307/3543207; HANSSON L, 1985, OECOLOGIA, V67, P394, DOI 10.1007/BF00384946; Hendrichsen Ditte K., 2009, BMC Ecology, V9, P10, DOI 10.1186/1472-6785-9-10; HORNFELDT B, 1994, ECOLOGY, V75, P791, DOI 10.2307/1941735; Huitu O, 2003, OECOLOGIA, V135, P209, DOI 10.1007/s00442-002-1171-6; Huitu O, 2008, OECOLOGIA, V155, P53, DOI 10.1007/s00442-007-0885-x; INNES DGL, 1994, MAMMAL REV, V24, P179, DOI 10.1111/j.1365-2907.1994.tb00142.x; JENSEN TS, 2001, GRAESNING EKSTENSIVT, V34, P107; Jiang L, 2003, ECOLOGY, V84, P2208, DOI 10.1890/02-0557; Kindlmann P, 2008, LANDSCAPE ECOL, V23, P879, DOI 10.1007/s10980-008-9245-4; Klemola T, 2003, ADV ECOL RES, V33, P75, DOI 10.1016/S0065-2504(03)33010-7; KORPIMAKI E, 1994, J ANIM ECOL, V63, P619, DOI 10.2307/5228; Korpimaki E, 2005, J ANIM ECOL, V74, P1150, DOI 10.1111/j.1365-2656.2005.01015.x; Korpimaki E, 1996, BIOSCIENCE, V46, P754, DOI 10.2307/1312851; Krebs CJ, 1996, J MAMMAL, V77, P8, DOI 10.2307/1382705; Lambin X, 2006, J ANIM ECOL, V75, P340, DOI 10.1111/j.1365-2656.2006.01051.x; Lenth R., 2019, Journal of Statistical Software, V60, P1; Leslie PH, 1940, J ANIM ECOL, V9, P27, DOI 10.2307/1425; Lima M, 2006, OIKOS, V112, P555, DOI 10.1111/j.0030-1299.2006.14439.x; MARTINSSON B, 1993, ANN ZOOL FENN, V30, P31; May RM, 1981, THEORETICAL ECOLOGY, P5; MURDOCH W W, 1975, P1; MURRAY JD, 2003, MATHEMATICAL BIOL, V1; MYLLYMAKI A, 1977, OIKOS, V29, P468, DOI 10.2307/3543588; NABENIELSEN J, 2010, PLOS ONE IN PRESS; NELSON J, 1991, OIKOS, V61, P73, DOI 10.2307/3545408; NORRDAHL K, 1995, BIOL REV, V70, P621, DOI 10.1111/j.1469-185X.1995.tb01654.x; Oli MK, 2003, TRENDS ECOL EVOL, V18, P105, DOI 10.1016/S0169-5347(03)00005-3; OSTFELD RS, 1995, ECOLOGY, V76, P521, DOI 10.2307/1941210; OSTFELD RS, 1993, NATURE, V366, P259, DOI 10.1038/366259a0; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; Royama T., 1992, ANAL POPULATION ECOL; Saitoh T, 2003, POPUL ECOL, V45, P165, DOI 10.1007/s10144-003-0164-6; Sibly RM, 2005, ECOTOXICOLOGY, V14, P863, DOI 10.1007/s10646-005-0033-5; Smith MJ, 2006, AM NAT, V167, P695, DOI 10.1086/503119; Stenseth NC, 1998, RES POPUL ECOL, V40, P85, DOI 10.1007/BF02765224; Stenseth NC, 1999, OIKOS, V87, P427, DOI 10.2307/3546809; Stenseth NC, 2002, P ROY SOC B-BIOL SCI, V269, P1853, DOI 10.1098/rspb.2002.2099; Stenseth NC, 2003, P NATL ACAD SCI USA, V100, P11478, DOI 10.1073/pnas.1935306100; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; Sundell J, 2006, MAMMAL REV, V36, P107, DOI 10.1111/j.1365-2907.2006.00083.x; Topping CJ, 2010, ECOL MODEL, V221, P245, DOI 10.1016/j.ecolmodel.2009.09.014; Topping CJ, 2010, ECOL MODEL, V221, P729, DOI 10.1016/j.ecolmodel.2009.11.004; Topping CJ, 2005, ECOTOXICOLOGY, V14, P925, DOI 10.1007/s10646-005-0027-3; Topping CJ, 2003, ECOL MODEL, V167, P65, DOI 10.1016/S0304-3800(03)00173-X; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; Turner MG, 2005, ANNU REV ECOL EVOL S, V36, P319, DOI 10.1146/annurev.ecolsys.36.102003.152614; VIITALA J, 1977, ANN ZOOL FENN, V14, P53; Ylonen H, 2003, EVOL ECOL, V17, P349, DOI 10.1023/A:1027390600748	76	19	20	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22834	10.1371/journal.pone.0022834	http://dx.doi.org/10.1371/journal.pone.0022834			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829528	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000293286500036
J	Niwa, A; Heike, T; Umeda, K; Oshima, K; Kato, I; Sakai, H; Suemori, H; Nakahata, T; Saito, MK				Niwa, Akira; Heike, Toshio; Umeda, Katsutsugu; Oshima, Koichi; Kato, Itaru; Sakai, Hiromi; Suemori, Hirofumi; Nakahata, Tatsutoshi; Saito, Megumu K.			A Novel Serum-Free Monolayer Culture for Orderly Hematopoietic Differentiation of Human Pluripotent Cells via Mesodermal Progenitors	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; DEFINITIVE HEMATOPOIESIS; IN-VITRO; HEMOANGIOGENIC PROGENITORS; EXTENSIVE CAPABILITY; ENDOTHELIAL-CELLS; COMMON PRECURSOR; PRIMITIVE STREAK; CD34(+) CELLS; CORD BLOOD	Elucidating the in vitro differentiation of human embryonic stem (ES) and induced pluripotent stem (iPS) cells is important for understanding both normal and pathological hematopoietic development in vivo. For this purpose, a robust and simple hematopoietic differentiation system that can faithfully trace in vivo hematopoiesis is necessary. In this study, we established a novel serum-free monolayer culture that can trace the in vivo hematopoietic pathway from ES/iPS cells to functional definitive blood cells via mesodermal progenitors. Stepwise tuning of exogenous cytokine cocktails induced the hematopoietic mesodermal progenitors via primitive streak cells. These progenitors were then differentiated into various cell lineages depending on the hematopoietic cytokines present. Moreover, single cell deposition assay revealed that common bipotential hemoangiogenic progenitors were induced in our culture. Our system provides a new, robust, and simple method for investigating the mechanisms of mesodermal and hematopoietic differentiation.	[Niwa, Akira; Oshima, Koichi; Kato, Itaru; Nakahata, Tatsutoshi; Saito, Megumu K.] Kyoto Univ, Ctr iPS Cell Res & Applicat, Clin Applicat Dept, Kyoto, Japan; [Niwa, Akira; Heike, Toshio; Umeda, Katsutsugu; Kato, Itaru; Nakahata, Tatsutoshi; Saito, Megumu K.] Kyoto Univ, Grad Sch Med, Dept Pediat, Kyoto, Japan; [Suemori, Hirofumi] Kyoto Univ, Inst Frontier Med Sci, Stem Cell Res Ctr, Lab Embryon Stem Cell Res, Kyoto, Japan; [Umeda, Katsutsugu] Univ Texas Hlth Sci Ctr, Inst Mol Med, Houston, TX USA; [Sakai, Hiromi] Waseda Biosci Res Inst Helios, Singapore, Singapore	Kyoto University; Kyoto University; Kyoto University; University of Texas System; University of Texas Health Science Center Houston	Niwa, A (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat, Clin Applicat Dept, Kyoto, Japan.	msaito@kuhp.kyoto-u.ac.jp	Sakai, Hiromi/J-2529-2019; Oshima, Koichi/AAT-5670-2020	Sakai, Hiromi/0000-0002-0681-3032; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan [22790979]; Grants-in-Aid for Scientific Research [22790979, 22249042] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (#22790979). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Choi K, 1998, DEVELOPMENT, V125, P725; Choi KD, 2009, J CLIN INVEST, V119, P2818, DOI 10.1172/JCI38591; Choi KD, 2009, STEM CELLS, V27, P559, DOI 10.1634/stemcells.2008-0922; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FLAMME I, 1995, DEV BIOL, V169, P699, DOI 10.1006/dbio.1995.1180; Fujimi A, 2008, INT J HEMATOL, V87, P339, DOI 10.1007/s12185-008-0062-y; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Garcia-Porrero JA, 1998, DEV COMP IMMUNOL, V22, P303, DOI 10.1016/S0145-305X(98)00006-8; Grigoriadis AE, 2010, BLOOD, V115, P2769, DOI 10.1182/blood-2009-07-234690; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Ji JF, 2008, STEM CELLS, V26, P2485, DOI 10.1634/stemcells.2008-0642; Ji P, 2008, NAT CELL BIOL, V10, P314, DOI 10.1038/ncb1693; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kennedy M, 1997, NATURE, V386, P488, DOI 10.1038/386488a0; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kitajima K, 2006, BLOOD, V107, P1857, DOI 10.1182/blood-2005-06-2527; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Ma F, 2008, P NATL ACAD SCI USA, V105, P13087, DOI 10.1073/pnas.0802220105; Martin R, 2004, DEVELOPMENT, V131, P693, DOI 10.1242/dev.00968; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Morishima T, 2011, J CELL PHYSIOL, V226, P1283, DOI 10.1002/jcp.22456; NAKAHATA T, 1982, J CLIN INVEST, V70, P1324, DOI 10.1172/JCI110734; NAKAHATA T, 1982, P NATL ACAD SCI-BIOL, V79, P3843, DOI 10.1073/pnas.79.12.3843; NAKAHATA T, 1982, BLOOD, V59, P857; Niwa A, 2009, J CELL PHYSIOL, V221, P367, DOI 10.1002/jcp.21864; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; RISAU W, 1995, FASEB J, V9, P926, DOI 10.1096/fasebj.9.10.7615161; RISAU W, 1986, DEV BIOL, V117, P537, DOI 10.1016/0012-1606(86)90321-0; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Shinoda G, 2007, BLOOD, V109, P2406, DOI 10.1182/blood-2006-06-031039; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Sumi T, 2008, DEVELOPMENT, V135, P2969, DOI 10.1242/dev.021121; Suwabe N, 1998, BLOOD, V92, P4108, DOI 10.1182/blood.V92.11.4108.423k29_4108_4118; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takayama N, 2008, BLOOD, V111, P5298, DOI 10.1182/blood-2007-10-117622; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Timmermans F, 2009, J IMMUNOL, V182, P6879, DOI 10.4049/jimmunol.0803670; UCHIDA T, 1985, J IMMUNOL METHODS, V77, P55, DOI 10.1016/0022-1759(85)90183-8; Umeda K, 2004, DEVELOPMENT, V131, P1869, DOI 10.1242/dev.01065; Umeda K, 2006, STEM CELLS, V24, P1348, DOI 10.1634/stemcells.2005-0165; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Wang LS, 2005, J EXP MED, V201, P1603, DOI 10.1084/jem.20041888; Wang LS, 2004, IMMUNITY, V21, P31, DOI 10.1016/j.immuni.2004.06.006; Wood HB, 1997, BLOOD, V90, P2300; Xu Y, 2008, NATURE, V453, P338, DOI 10.1038/nature07042; YAMAGUCHI TP, 1993, DEVELOPMENT, V118, P489	54	71	79	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22261	10.1371/journal.pone.0022261	http://dx.doi.org/10.1371/journal.pone.0022261			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818303	gold, Green Published, Green Submitted			2022-12-25	WOS:000293282700019
J	Osuala, K; Telusma, K; Khan, SM; Wu, SD; Shah, M; Baker, C; Alam, S; Abukenda, I; Fuentes, A; Seifein, HB; Ebert, SN				Osuala, Kingsley; Telusma, Kathleen; Khan, Saad M.; Wu, Shandong; Shah, Mubarak; Baker, Candice; Alam, Sabikha; Abukenda, Ibrahim; Fuentes, Aura; Seifein, Hani B.; Ebert, Steven N.			Distinctive Left-Sided Distribution of Adrenergic-Derived Cells in the Adult Mouse Heart	PLOS ONE			English	Article							PHENYLETHANOLAMINE-N-METHYLTRANSFERASE; CATECHOLAMINE-CONTAINING CELLS; STRESS TAKOTSUBO CARDIOMYOPATHY; CARDIAC EPINEPHRINE SYNTHESIS; RAT-HEART; GENE-EXPRESSION; SYNTHESIZING ENZYMES; EMOTIONAL-STRESS; 6-HYDROXYDOPAMINE; ARRANGEMENT	Adrenaline and noradrenaline are produced within the heart from neuronal and non-neuronal sources. These adrenergic hormones have profound effects on cardiovascular development and function, yet relatively little information is available about the specific tissue distribution of adrenergic cells within the adult heart. The purpose of the present study was to define the anatomical localization of cells derived from an adrenergic lineage within the adult heart. To accomplish this, we performed genetic fate-mapping experiments where mice with the cre-recombinase (Cre) gene inserted into the phenylethanolamine-n-methyltransferase (Pnmt) locus were cross-mated with homozygous Rosa26 reporter (R26R) mice. Because Pnmt serves as a marker gene for adrenergic cells, offspring from these matings express the beta-galactosidase (beta GAL) reporter gene in cells of an adrenergic lineage. beta GAL expression was found throughout the adult mouse heart, but was predominantly (89%) located in the left atrium (LA) and ventricle (LV) (p < 0.001 compared to RA and RV), where many of these cells appeared to have cardiomyocyte-like morphological and structural characteristics. The staining pattern in the LA was diffuse, but the LV free wall displayed intermittent non-random staining that extended from the apex to the base of the heart, including heavy staining of the anterior papillary muscle along its perimeter. Three-dimensional computer-aided reconstruction of XGAL+ staining revealed distribution throughout the LA and LV, with specific finger-like projections apparent near the mid and apical regions of the LV free wall. These data indicate that adrenergic-derived cells display distinctive left-sided distribution patterns in the adult mouse heart.	[Osuala, Kingsley; Telusma, Kathleen; Baker, Candice; Alam, Sabikha; Abukenda, Ibrahim; Fuentes, Aura; Ebert, Steven N.] Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32816 USA; [Khan, Saad M.; Wu, Shandong; Shah, Mubarak] Univ Cent Florida, Sch Elect Engn & Comp Sci, Coll Engn & Comp Sci, Orlando, FL 32816 USA; [Seifein, Hani B.] Florida Heart Grp, Orlando, FL USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida	Osuala, K (corresponding author), Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32816 USA.	Steven.Ebert@ucf.edu		Shah, Mubarak/0000-0001-6172-5572	National Institutes of Health [R01-HL078716]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078716] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the National Institutes of Health to SNE (R01-HL078716). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSSON T, 1979, ACTA PHYSIOL SCAND, V107, P149, DOI 10.1111/j.1748-1716.1979.tb06454.x; Akashi YJ, 2008, CIRCULATION, V118, P2754, DOI 10.1161/CIRCULATIONAHA.108.767012; Anderson RH, 2005, EUR J CARDIO-THORAC, V28, P517, DOI 10.1016/j.ejcts.2005.06.043; Anderson RH, 2006, ANAT REC PART A, V288A, P579, DOI 10.1002/ar.a.20330; COTTLE MKW, 1984, HISTOCHEM J, V16, P1137, DOI 10.1007/BF01003440; Ebert SN, 1996, J MOL CELL CARDIOL, V28, P1653, DOI 10.1006/jmcc.1996.0155; Ebert SN, 2004, DEV DYNAM, V231, P849, DOI 10.1002/dvdy.20188; Ebert SN, 2001, CIRC RES, V88, P117, DOI 10.1161/01.RES.88.1.117; Ebert SN, 2006, CARDIOVASC RES, V72, P364, DOI 10.1016/j.cardiores.2006.08.013; Ebert SN, 2008, ANN NY ACAD SCI, V1148, P317, DOI 10.1196/annals.1410.008; ELAYAN HH, 1990, CARDIOVASC RES, V24, P53, DOI 10.1093/cvr/24.1.53; ELLISON JP, 1974, J MOL CELL CARDIOL, V6, P17, DOI 10.1016/0022-2828(74)90003-0; FORSGREN S, 1990, HISTOCHEM J, V22, P667, DOI 10.1007/BF01047451; Goncalvesova E, 2005, TRANSPL P, V37, P1340, DOI 10.1016/j.transproceed.2004.11.052; Huang MH, 1996, J CLIN INVEST, V98, P1298, DOI 10.1172/JCI118916; Hurst RT, 2010, JACC-CARDIOVASC IMAG, V3, P641, DOI 10.1016/j.jcmg.2010.01.009; JACOBOWITZ D, 1967, J PHARMACOL EXP THER, V158, P227; Kassim Thaslim Ahamed, 2008, Endocr Pract, V14, P1137; KENNEDY B, 1995, J CLIN INVEST, V95, P2896, DOI 10.1172/JCI117996; KENNEDY B, 1991, CIRCULATION, V84, P891, DOI 10.1161/01.CIR.84.2.891; Kirby M. L., 1999, HEART DEV, P179; KIRBY ML, 1983, SCIENCE, V220, P1059, DOI 10.1126/science.6844926; Kloberg AJ, 2002, J EXP ZOOL, V292, P293, DOI 10.1002/jez.10049; Kocica Mladen J, 2007, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, P52, DOI 10.1053/j.pcsu.2007.01.006; Korlakunta HL, 2005, INT J CARDIOL, V102, P351, DOI 10.1016/j.ijcard.2004.05.070; Krizanova O, 2001, AM J PHYSIOL-HEART C, V281, pH1372, DOI 10.1152/ajpheart.2001.281.3.H1372; Kuroko Y, 2007, CARDIOVASC RES, V74, P438, DOI 10.1016/j.cardiores.2007.02.018; Kvetnansky R, 2004, ANN NY ACAD SCI, V1018, P405, DOI 10.1196/annals.1296.050; Lyon AR, 2008, NAT CLIN PRACT CARD, V5, P22, DOI 10.1038/ncpcardio1066; Nef HM, 2010, NAT REV CARDIOL, V7, P187, DOI 10.1038/nrcardio.2010.16; PAPKA RE, 1974, CELL TISSUE RES, V154, P471; Pfeifer K, 2004, ANN NY ACAD SCI, V1018, P418, DOI 10.1196/annals.1296.051; Prasad A, 2008, AM HEART J, V155, P408, DOI 10.1016/j.ahj.2007.11.008; Sato H, 1990, CLIN ASPECT MYOCARDI, P56; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; THOMAS SA, 1995, NATURE, V374, P643, DOI 10.1038/374643a0; Tillinger A, 2006, GEN PHYSIOL BIOPHYS, V25, P355; Tillinger A, 2006, STRESS, V9, P207, DOI 10.1080/10253890601069385; TORDA T, 1987, EUR J PHARMACOL, V141, P305, DOI 10.1016/0014-2999(87)90276-7; Torrent-Guasp F, 2001, Semin Thorac Cardiovasc Surg, V13, P301; Ueyama T, 2008, ANN NY ACAD SCI, V1148, P479, DOI 10.1196/annals.1410.079; Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046; Ziegler MG, 2002, ANN NY ACAD SCI, V971, P76, DOI 10.1111/j.1749-6632.2002.tb04437.x	43	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22811	10.1371/journal.pone.0022811	http://dx.doi.org/10.1371/journal.pone.0022811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818395	Green Submitted, Green Published, gold			2022-12-25	WOS:000293282700080
J	Pecchia, T; Gagliardo, A; Vallortigara, G				Pecchia, Tommaso; Gagliardo, Anna; Vallortigara, Giorgio			Stable Panoramic Views Facilitate Snap-Shot Like Memories for Spatial Reorientation in Homing Pigeons	PLOS ONE			English	Article							RECOGNITION	Following spatial disorientation, animals can reorient themselves by relying on geometric cues (metric and sense) specified both by the macroscopic surface layout of an enclosed space and prominent visual landmarks in arrays. Whether spatial reorientation in arrays of landmarks is based on explicit representation of the geometric cues is a matter of debate. Here we trained homing pigeons (Columba livia) to locate a food-reward in a rectangular array of four identical or differently coloured pipes provided with four openings, only one of which allowed the birds to have access to the reward. Pigeons were trained either with a stable or a variable position of the opening on pipes, so that they could view the array either from the same or a variable perspective. Explicit mapping of configural geometry would predict successful reorientation irrespective of access condition. In contrast, we found that a stable view of the array facilitated spatial learning in homing pigeons, likely through the formation of snapshot-like memories.	[Pecchia, Tommaso; Vallortigara, Giorgio] Univ Trento, Ctr Mind Brain Sci, Rovereto, Italy; [Gagliardo, Anna] Univ Pisa, Dept Biol, Pisa, Italy	University of Trento; University of Pisa	Pecchia, T (corresponding author), Univ Trento, Ctr Mind Brain Sci, Rovereto, Italy.	tommaso.pecchia@unitn.it						Biro D, 2003, ANIM BEHAV, V65, P115, DOI 10.1006/anbe.2002.2014; Biro D, 2004, P NATL ACAD SCI USA, V101, P17440, DOI 10.1073/pnas.0406984101; CARTWRIGHT BA, 1983, J COMP PHYSIOL, V151, P521, DOI 10.1007/BF00605469; Cheng K, 2006, BEHAV PROCESS, V72, P115, DOI 10.1016/j.beproc.2005.11.018; Cheng K, 2005, PSYCHON B REV, V12, P1, DOI 10.3758/BF03196346; Cheng K, 2008, TRENDS COGN SCI, V12, P355, DOI 10.1016/j.tics.2008.06.004; Dawkins MS, 2000, NATURE, V403, P652, DOI 10.1038/35001064; Gallistel C. R., 1990, ORG LEARNING; Gibson BM, 2007, J COMP PSYCHOL, V121, P130, DOI 10.1037/0735-7036.121.2.130; Kelly DM, 2010, ANIM COGN, V13, P453, DOI 10.1007/s10071-009-0296-y; Lee SA, 2011, PSYCHON B REV, V18, P192, DOI 10.3758/s13423-010-0035-z; Pearce JM, 2009, Q J EXP PSYCHOL, V62, P1665, DOI 10.1080/17470210902805589; Pecchia T, 2010, J EXP BIOL, V213, P2987, DOI 10.1242/jeb.043315; Vallortigara G, 2009, VIENNA SER THEOR BIO, P83; Wystrach A, 2009, CURR BIOL, V19, P61, DOI 10.1016/j.cub.2008.11.054	15	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22657	10.1371/journal.pone.0022657	http://dx.doi.org/10.1371/journal.pone.0022657			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818360	Green Published, Green Submitted, gold			2022-12-25	WOS:000293282700057
J	Scheffers, BR; Yong, DL; Harris, JBC; Giam, XL; Sodhi, NS				Scheffers, Brett R.; Yong, Ding Li; Harris, J. Berton C.; Giam, Xingli; Sodhi, Navjot S.			The World's Rediscovered Species: Back from the Brink?	PLOS ONE			English	Article							CONSERVATION; EXTINCTION; DRIVERS; SCIENCE	Each year, numerous species thought to have disappeared are rediscovered. Yet, do these rediscoveries represent the return of viable populations or the delayed extinction of doomed species? We document the number, distribution and conservation status of rediscovered amphibian, bird, and mammal species globally. Over the past 122 years, at least 351 species have been rediscovered, most occurring in the tropics. These species, on average, were missing for 61 years before being rediscovered (range of 3-331 years). The number of rediscoveries per year increased over time and the majority of these rediscoveries represent first documentations since their original description. Most rediscovered species have restricted ranges and small populations, and 92% of amphibians, 86% of birds, and 86% of mammals are highly threatened, independent of how long they were missing or when they were rediscovered. Under the current trends of widespread habitat loss, particularly in the tropics, most rediscovered species remain on the brink of extinction.	[Scheffers, Brett R.; Yong, Ding Li; Sodhi, Navjot S.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Harris, J. Berton C.] Univ Adelaide, Inst Environm, Adelaide, SA, Australia; [Harris, J. Berton C.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia; [Giam, Xingli] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	National University of Singapore; University of Adelaide; University of Adelaide; Princeton University	Scheffers, BR (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	schefbr0@gmail.com	Scheffers, Brett/L-2585-2014; Harris, J. Berton C./H-4752-2011	Scheffers, Brett/0000-0003-2423-3821; Yong, Ding Li/0000-0003-3115-6916; Giam, Xingli/0000-0002-5239-9477	Singapore International Graduate Award; Osprey Packs Inc.; Wildlife Reserves Singapore Conservation Fund; Loke Wan Tho Memorial Foundation; University of Adelaide;  [R154000479112]	Singapore International Graduate Award; Osprey Packs Inc.; Wildlife Reserves Singapore Conservation Fund; Loke Wan Tho Memorial Foundation; University of Adelaide; 	BRS is supported by the Singapore International Graduate Award, Osprey Packs Inc., and Wildlife Reserves Singapore Conservation Fund. JBCH is funded by the Loke Wan Tho Memorial Foundation and an EIRP scholarship at the University of Adelaide. Research was supported by grant number R154000479112. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WM, 2004, SCIENCE, V306, P1146, DOI 10.1126/science.1097920; [Anonymous], 2010, BBC NEWS; *BIRDL INT, 2009, QUEST LAUNCH FIND LO; Bradshaw CJA, 2009, FRONT ECOL ENVIRON, V7, P79, DOI 10.1890/070193; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Butchart S. H. M., 2006, Bulletin of the British Ornithologists' Club, V126, P7; Butchart S.H.M., 2005, BirdingASIA, V3, P41; Butchart Stuart, 2007, Bulletin of the African Bird Club, V14, P139; C?lix M., 2018, EUROPEAN RED LIST SA; Ceballos G, 2009, P NATL ACAD SCI USA, V106, P3841, DOI 10.1073/pnas.0812419106; Collar NJ, 1998, ORYX, V32, P239, DOI 10.1046/j.1365-3008.1998.d01-51.x; *CONS INT, 2010, SEARCH LOST AMPH; DIAMOND J M, 1987, Conservation Biology, V1, P77, DOI 10.1111/j.1523-1739.1987.tb00012.x; Fisher DO, 2011, BIOL CONSERV, V144, P1712, DOI 10.1016/j.biocon.2011.03.005; Fisher DO, 2011, P ROY SOC B-BIOL SCI, V278, P1090, DOI 10.1098/rspb.2010.1579; FISHER DO, 2010, GLOBAL ECOL BIOGEOGR, DOI DOI 10.1111/J.1466-8238.2010.00624.X; Giam XL, 2012, P ROY SOC B-BIOL SCI, V279, P67, DOI 10.1098/rspb.2011.0433; Gomez-Pompa A, 2004, BIOSCIENCE, V54, P217, DOI 10.1641/0006-3568(2004)054[0217:TROBSI]2.0.CO;2; Hansen MC, 2008, P NATL ACAD SCI USA, V105, P9439, DOI 10.1073/pnas.0804042105; Harris G, 2008, CONSERV BIOL, V22, P163, DOI 10.1111/j.1523-1739.2007.00798.x; Jackson JA, 2006, AUK, V123, P1, DOI 10.1642/0004-8038(2006)123[0001:IWCPHA]2.0.CO;2; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P554, DOI 10.1098/rspb.2010.1004; Ladle RJ, 2009, NATURE, V461, P723, DOI 10.1038/461723c; Lawler JJ, 2006, FRONT ECOL ENVIRON, V4, P473, DOI 10.1890/1540-9295(2006)4[473:CSAYRC]2.0.CO;2; Mace G.M., 2005, ECOSYSTEMS HUMAN WEL, P77; Peh KSH, 2011, BIOSCIENCE, V61, P27, DOI 10.1525/bio.2011.61.1.8; RAVEN PH, 1992, SCIENCE, V258, P1099, DOI 10.1126/science.258.5085.1099; Roedder Dennis, 2009, Diversity, V1, P52; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Scott JM, 2008, AVIAN CONSERV ECOL, V3; Smith P, 2010, PHILOS T R SOC B, V365, P2941, DOI 10.1098/rstb.2010.0127; Sodhi NS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001636; Sodhi NS, 2008, BIODIVERSITY AND HUMAN LIVELIHOODS IN PROTECTED AREAS: CASE STUDIES FROM THE MALAY ARCHIPELAGO, P1; Sodhi NS., 2007, TROPICAL CONSERVATIO; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V115, P1089, DOI 10.2307/4089533; Tobias JA, 2006, NEOTROP BIRDING, V1, P4; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Wilson D. E., MAMMAL SPECIES WORLD, V3rd	40	61	66	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22531	10.1371/journal.pone.0022531	http://dx.doi.org/10.1371/journal.pone.0022531			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818334	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000293282700036
J	Faunes, F; Sanchez, N; Moreno, M; Olivares, GH; Lee-Liu, D; Almonacid, L; Slater, AW; Norambuena, T; Taft, RJ; Mattick, JS; Melo, F; Larrain, J				Faunes, Fernando; Sanchez, Natalia; Moreno, Mauricio; Olivares, Gonzalo H.; Lee-Liu, Dasfne; Almonacid, Leonardo; Slater, Alex W.; Norambuena, Tomas; Taft, Ryan J.; Mattick, John S.; Melo, Francisco; Larrain, Juan			Expression of Transposable Elements in Neural Tissues during Xenopus Development	PLOS ONE			English	Article							SMALL RNAS; L1 RETROTRANSPOSITION; DNA TRANSPOSONS; NORTHERN BLOT; TC1 FAMILY; GENOME; DROSOPHILA; EVOLUTION; REPEAT; QUANTIFICATION	Transposable elements comprise a large proportion of animal genomes. Transposons can have detrimental effects on genome stability but also offer positive roles for genome evolution and gene expression regulation. Proper balance of the positive and deleterious effects of transposons is crucial for cell homeostasis and requires a mechanism that tightly regulates their expression. Herein we describe the expression of DNA transposons of the Tc1/mariner superfamily during Xenopus development. Sense and antisense transcripts containing complete Tc1-2_Xt were detected in Xenopus embryos. Both transcripts were found in zygotic stages and were mainly localized in Spemann's organizer and neural tissues. In addition, the Tc1-like elements Eagle, Froggy, Jumpy, Maya, Xeminos and TXr were also expressed in zygotic stages but not oocytes in X. tropicalis. Interestingly, although Tc1-2_Xt transcripts were not detected in Xenopus laevis embryos, transcripts from other two Tc1-like elements (TXr and TXz) presented a similar temporal and spatial pattern during X. laevis development. Deep sequencing analysis of Xenopus tropicalis gastrulae showed that PIWI-interacting RNAs (piRNAs) are specifically derived from several Tc1-like elements. The localized expression of Tc1-like elements in neural tissues suggests that they could play a role during the development of the Xenopus nervous system.	[Faunes, Fernando; Sanchez, Natalia; Moreno, Mauricio; Olivares, Gonzalo H.; Lee-Liu, Dasfne; Larrain, Juan] Pontificia Univ Catolica Chile, Ctr Aging & Regenerat & Millennium Nucleus Regene, Santiago, Chile; [Almonacid, Leonardo; Slater, Alex W.; Norambuena, Tomas; Melo, Francisco] Pontificia Univ Catolica Chile, Mol Bioinformat Lab, Millennium Inst Immunol & Immunotheraphy, Santiago, Chile; [Almonacid, Leonardo; Slater, Alex W.; Norambuena, Tomas; Melo, Francisco] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Genet Mol & Microbiol, Santiago, Chile; [Lee-Liu, Dasfne] Univ Chile, Fac Chem & Pharmaceut Sci, Santiago, Chile; [Taft, Ryan J.; Mattick, John S.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Universidad de Chile; University of Queensland	Faunes, F (corresponding author), Pontificia Univ Catolica Chile, Ctr Aging & Regenerat & Millennium Nucleus Regene, Alameda 340, Santiago, Chile.	jlarrain@bio.puc.cl	Melo, Francisco/M-3923-2014; Melo, Francisco/I-5139-2012; Taft, Ryan/B-2945-2010; Mattick, John/ABH-6130-2020; Mattick, John S/I-7789-2012; Faunes, Fernando/M-4146-2016	Mattick, John/0000-0002-7680-7527; Mattick, John S/0000-0002-7680-7527; Lee-Liu, Dasfne/0000-0003-1449-4104; Norambuena, Tomas/0000-0001-6477-0301; Olivares, Gonzalo/0000-0002-2784-0160; Slater, Alex W/0000-0002-5044-0931; Faunes, Fernando/0000-0003-2657-2552; Melo, Francisco/0000-0002-0424-5991	FONDECYT [1070357]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was funded by a grant from FONDECYT, #1070357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PP, 2008, SCIENCE, V319, P1787, DOI 10.1126/science.1155472; Arends HM, 2006, ARCH INSECT BIOCHEM, V63, P135, DOI 10.1002/arch.20149; Armisen J, 2009, GENOME RES, V19, P1766, DOI 10.1101/gr.093054.109; Avancini RMP, 1996, GENETICA, V98, P131, DOI 10.1007/BF00121361; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; BROOKMAN JJ, 1992, DEVELOPMENT, V116, P1185; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; de Boer JG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-422; De Robertis EM, 2000, NAT REV GENET, V1, P171, DOI 10.1038/35042039; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Faunes F, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r15; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; FINNEGAN DJ, 1989, TRENDS GENET, V5, P103, DOI 10.1016/0168-9525(89)90039-5; Girard A, 2008, TRENDS CELL BIOL, V18, P136, DOI 10.1016/j.tcb.2008.01.004; Gottgens B, 1999, GENE, V239, P373, DOI 10.1016/S0378-1119(99)00390-X; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Kimura M, 1998, J BIOCHEM-TOKYO, V124, P268, DOI 10.1093/oxfordjournals.jbchem.a022106; Krasnov A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-107; Lam WL, 1996, J MOL BIOL, V257, P359, DOI 10.1006/jmbi.1996.0168; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lau NC, 2009, EMBO J, V28, P2945, DOI 10.1038/emboj.2009.237; Le Rouzic A, 2007, P NATL ACAD SCI USA, V104, P19375, DOI 10.1073/pnas.0705238104; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lunyak VV, 2007, SCIENCE, V317, P248, DOI 10.1126/science.1140871; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959; Muotri AR, 2009, HIPPOCAMPUS, V19, P1002, DOI 10.1002/hipo.20564; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Nandi S, 2007, GENETICA, V131, P81, DOI 10.1007/s10709-006-9115-4; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Park EC, 2007, DEV DYNAM, V236, P1633, DOI 10.1002/dvdy.21167; PARKHURST SM, 1987, EMBO J, V6, P419, DOI 10.1002/j.1460-2075.1987.tb04771.x; Peaston AE, 2004, DEV CELL, V7, P597, DOI 10.1016/j.devcel.2004.09.004; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ro S, 2006, BIOCHEM BIOPH RES CO, V351, P756, DOI 10.1016/j.bbrc.2006.10.105; Robine N, 2009, CURR BIOL, V19, P2066, DOI 10.1016/j.cub.2009.11.064; Rouget C, 2010, NATURE, V467, P1128, DOI 10.1038/nature09465; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Sinzelle L, 2005, GENE, V349, P187, DOI 10.1016/j.gene.2004.12.023; Sinzelle L, 2009, CELL MOL LIFE SCI, V66, P1073, DOI 10.1007/s00018-009-8376-3; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Smit A. F. A., 1996, REPEATMASKER OPEN; Watanabe Toshiaki, 2008, V442, P173, DOI 10.1007/978-1-59745-191-8_13	49	15	15	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e22569	10.1371/journal.pone.0022569	http://dx.doi.org/10.1371/journal.pone.0022569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21818339	Green Published, Green Submitted, gold			2022-12-25	WOS:000293175100033
J	Bauerly, K; Harris, C; Chowanadisai, W; Graham, J; Havel, PJ; Tchaparian, E; Satre, M; Karliner, JS; Rucker, RB				Bauerly, Kathryn; Harris, Calliandra; Chowanadisai, Winyoo; Graham, James; Havel, Peter J.; Tchaparian, Eskouhie; Satre, Mike; Karliner, Joel S.; Rucker, Robert B.			Altering Pyrroloquinoline Quinone Nutritional Status Modulates Mitochondrial, Lipid, and Energy Metabolism in Rats	PLOS ONE			English	Article							MYOCARDIAL INFARCT SIZE; FATTY-ACID OXIDATION; SPHINGOSINE 1-PHOSPHATE; BINDING PROTEIN; GENE-EXPRESSION; GROWTH; SPHINGOLIPIDS; RESVERATROL; ANTIOXIDANT; PERFORMANCE	We have reported that pyrroloquinoline quinone (PQQ) improves reproduction, neonatal development, and mitochondrial function in animals by mechanisms that involve mitochondrial related cell signaling pathways. To extend these observations, the influence of PQQ on energy and lipid relationships and apparent protection against ischemia reperfusion injury are described herein. Sprague-Dawley rats were fed a nutritionally complete diet with PQQ added at either 0 (PQQ-) or 2 mg PQQ/Kg diet (PQQ+). Measurements included: 1) serum glucose and insulin, 2) total energy expenditure per metabolic body size (Wt(3/4)), 3) respiratory quotients (in the fed and fasted states), 4) changes in plasma lipids, 5) the relative mitochondrial amount in liver and heart, and 6) indices related to cardiac ischemia. For the latter, rats (PQQ- or PQQ+) were subjected to left anterior descending occlusions followed by 2 h of reperfusion to determine PQQ's influence on infarct size and myocardial tissue levels of malondialdehyde, an indicator of lipid peroxidation. Although no striking differences in serum glucose, insulin, and free fatty acid levels were observed, energy expenditure was lower in PQQ- vs. PQQ+ rats and energy expenditure (fed state) was correlated with the hepatic mitochondrial content. Elevations in plasma di- and triacylglyceride and beta-hydroxybutryic acid concentrations were also observed in PQQ- rats vs. PQQ+ rats. Moreover, PQQ administration (i.p. at 4.5 mg/kg BW for 3 days) resulted in a greater than 2-fold decrease in plasma triglycerides during a 6-hour fast than saline administration in a rat model of type 2 diabetes. Cardiac injury resulting from ischemia/reperfusion was more pronounced in PQQ- rats than in PQQ+ rats. Collectively, these data demonstrate that PQQ deficiency impacts a number of parameters related to normal mitochondrial function.	[Bauerly, Kathryn; Harris, Calliandra; Chowanadisai, Winyoo; Graham, James; Havel, Peter J.; Satre, Mike; Rucker, Robert B.] Univ Calif Davis, Davis, CA 95616 USA; [Tchaparian, Eskouhie] Amgen Inc, San Francisco, CA USA; [Karliner, Joel S.; Rucker, Robert B.] VA Med Ctr, San Francisco, CA USA	University of California System; University of California Davis; Amgen	Bauerly, K (corresponding author), Univ Calif Davis, Davis, CA 95616 USA.	rbrucker@ucdavis.edu		Graham, James/0000-0001-6507-8149; Havel, Peter/0000-0003-3652-8301	Mitsubishi Gas and Chemical Company	Mitsubishi Gas and Chemical Company	The work was funded in part by Mitsubishi Gas and Chemical Company (http://www.mgc.co.jp/eng/index.html), who also provided the compound. Additional funds for technical salaries were obtained from the Center for Health Related Research (Department of Nutrition, University of California Davis, Davis California, http://chnr.ucdavis.edu/) as a part of the CA Vitamin Settlement Fund, California State Attorney General's Office and the Charitable Leadership Foundation (http://www.charitableleadership.org/) as a grant/unrestricted gift. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Eskouhie Tchaparian is an employee of Amgen Inc. and played a role in study design, data collection, and preparation of the manuscript.	BASS NM, 1985, CHEM PHYS LIPIDS, V38, P95, DOI 10.1016/0009-3084(85)90060-X; Bauerly KA, 2006, BBA-GEN SUBJECTS, V1760, P1741, DOI 10.1016/j.bbagen.2006.07.009; Bebernitz GR, 2002, CURR PHARM DESIGN, V8, P1199, DOI 10.2174/1381612023394692; BELL GE, 1977, GROWTH, V41, P63; BERGMEYE.HU, 1965, ENZYMOL BIOL CLIN, V5, P65, DOI 10.1159/000457978; Binas B, 2007, MOL CELL BIOCHEM, V299, P75, DOI 10.1007/s11010-005-9043-0; Choi O, 2008, PLANT PHYSIOL, V146, P657, DOI 10.1104/pp.107.112748; Chowanadisai W, 2010, J BIOL CHEM, V285, P142, DOI 10.1074/jbc.M109.030130; Chung SW, 2010, ARCH BIOCHEM BIOPHYS, V501, P79, DOI 10.1016/j.abb.2010.05.003; Cummings BP, 2008, AM J PHYSIOL-REG I, V295, pR1782, DOI 10.1152/ajpregu.90635.2008; De Pauw A, 2009, AM J PATHOL, V175, P927, DOI 10.2353/ajpath.2009.081155; DUDLEY GA, 1987, J BIOL CHEM, V262, P9109; Erol E, 2003, FASEB J, V17, P347, DOI 10.1096/fj.03-0330fje; Fan Enguo, 2010, Recent Pat Cardiovasc Drug Discov, V5, P97; GEIGER O, 1987, ANAL BIOCHEM, V164, P418, DOI 10.1016/0003-2697(87)90513-6; Hao JJ, 2010, J NUTR BIOCHEM, V21, P634, DOI 10.1016/j.jnutbio.2009.03.012; Hara H, 2007, NEUROCHEM RES, V32, P489, DOI 10.1007/s11064-006-9257-x; Hirakawa A, 2009, BIOCHEM BIOPH RES CO, V378, P308, DOI 10.1016/j.bbrc.2008.11.045; HOLMAN RT, 1960, J NUTR, V70, P405, DOI 10.1093/jn/70.3.405; Hsu S, 2003, ANTICANCER RES, V23, P1533; Jump DB, 2005, J NUTR, V135, P2503, DOI 10.1093/jn/135.11.2503; Jump DB, 2008, CHEM PHYS LIPIDS, V153, P3, DOI 10.1016/j.chemphyslip.2008.02.007; Kosman V. M., 2007, Voprosy Pitaniya, V76, P62; KUMAZAWA T, 1995, BIOCHEM J, V307, P331, DOI 10.1042/bj3070331; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lahiri S, 2007, CELL MOL LIFE SCI, V64, P2270, DOI 10.1007/s00018-007-7076-0; Le HD, 2009, PROSTAG LEUKOTR ESS, V81, P165, DOI 10.1016/j.plefa.2009.05.020; Liu JK, 2009, ADV DRUG DELIVER REV, V61, P1343, DOI 10.1016/j.addr.2009.06.007; Liu SQ, 2005, MICROSURG, V25, P329, DOI 10.1002/micr.20126; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Misra HS, 2004, FEBS LETT, V578, P26, DOI 10.1016/j.febslet.2004.10.061; Mitchell AE, 1999, ANAL BIOCHEM, V269, P317, DOI 10.1006/abio.1999.4039; Miyauchi K, 1999, ANTIOXID REDOX SIGN, V1, P547, DOI 10.1089/ars.1999.1.4-547; Montoudis A, 2008, J LIPID RES, V49, P961, DOI 10.1194/jlr.M700363-JLR200; NAITO Y, 1993, LIFE SCI, V52, P1909, DOI 10.1016/0024-3205(93)90631-C; Nakamura MT, 2004, LIPIDS, V39, P1077, DOI 10.1007/s11745-004-1333-0; Nixon GF, 2009, BRIT J PHARMACOL, V158, P982, DOI 10.1111/j.1476-5381.2009.00281.x; Nunome K, 2008, BIOL PHARM BULL, V31, P1321, DOI 10.1248/bpb.31.1321; Ouchi A, 2009, J AGR FOOD CHEM, V57, P450, DOI 10.1021/jf802197d; Page MM, 2010, MECH AGEING DEV, V131, P242, DOI 10.1016/j.mad.2010.02.005; Rucker R, 2009, ALTERN MED REV, V14, P268; Shen WL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002328; Steinberg F, 2003, EXP BIOL MED, V228, P160, DOI 10.1177/153537020322800205; STEINBERG FM, 1994, J NUTR, V124, P744, DOI 10.1093/jn/124.5.744; Stites T, 2006, J NUTR, V136, P390, DOI 10.1093/jn/136.2.390; Tao R, 2007, BIOCHEM BIOPH RES CO, V363, P257, DOI 10.1016/j.bbrc.2007.08.041; Tchaparian E, 2010, BIOCHEM J, V429, P515, DOI 10.1042/BJ20091649; TERJUNG RL, 1985, J EXP BIOL, V115, P307; Vankoningsloo S, 2006, J CELL SCI, V119, P1266, DOI 10.1242/jcs.02848; Vessey DA, 2009, OXID MED CELL LONGEV, V2, P146, DOI 10.4161/oxim.2.3.8622; Vessey DA, 2009, AM J PHYSIOL-HEART C, V297, pH1429, DOI 10.1152/ajpheart.00358.2009; WILLIAMS RD, 1984, ARCH BIOCHEM BIOPHYS, V228, P282, DOI 10.1016/0003-9861(84)90069-9; Wong Alice, 2002, Methods Mol Biol, V197, P129, DOI 10.1385/1-59259-284-8:129; Yeh CC, 2009, AM J PHYSIOL-HEART C, V296, pH1193, DOI 10.1152/ajpheart.01032.2008; Zamora-Ros R, 2008, BRIT J NUTR, V100, P188, DOI 10.1017/S0007114507882997; Zhu BQ, 2006, J CARDIOVASC PHARM T, V11, P119, DOI 10.1177/1074248406288757; Zhu BQ, 2004, CARDIOVASC DRUG THER, V18, P421, DOI 10.1007/s10557-004-6219-x	57	50	58	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e21779	10.1371/journal.pone.0021779	http://dx.doi.org/10.1371/journal.pone.0021779			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21814553	Green Published, gold			2022-12-25	WOS:000292956800008
J	Nagasaka, Y; Shimoda, K; Fujii, N				Nagasaka, Yasuo; Shimoda, Kentaro; Fujii, Naotaka			Multidimensional Recording (MDR) and Data Sharing: An Ecological Open Research and Educational Platform for Neuroscience	PLOS ONE			English	Article							SOCIAL COGNITION; PARIETAL CORTEX; NEURONS; TETRODES; SPACE	Primate neurophysiology has revealed various neural mechanisms at the single-cell level and population level. However, because recording techniques have not been updated for several decades, the types of experimental design that can be applied in the emerging field of social neuroscience are limited, in particular those involving interactions within a realistic social environment. To address these limitations and allow more freedom in experimental design to understand dynamic adaptive neural functions, multidimensional recording (MDR) was developed. MDR obtains behavioral, neural, eye position, and other biological data simultaneously by using integrated multiple recording systems. MDR gives a wide degree of freedom in experimental design because the level of behavioral restraint is adjustable depending on the experimental requirements while still maintaining the signal quality. The biggest advantage of MDR is that it can provide a stable neural signal at higher temporal resolution at the network level from multiple subjects for months, which no other method can provide. Conventional event-related analysis of MDR data shows results consistent with previous findings, whereas new methods of analysis can reveal network mechanisms that could not have been investigated previously. MDR data are now shared in the public server Neurotycho.org. These recording and sharing methods support an ecological system that is open to everyone and will be a valuable and powerful research/educational platform for understanding the dynamic mechanisms of neural networks.	[Nagasaka, Yasuo; Shimoda, Kentaro; Fujii, Naotaka] RIKEN, BSI, Lab Adapt Intelligence, Saitama, Japan; [Shimoda, Kentaro] Nihon Univ, Sch Med, Dept Neurol Surg, Tokyo 173, Japan	RIKEN; Nihon University	Nagasaka, Y (corresponding author), RIKEN, BSI, Lab Adapt Intelligence, Saitama, Japan.	na@brain.riken.jp		Nagasaka, Yasuo/0000-0002-6492-2237	MEXT Japan	MEXT Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Strategic Research Program for Brain Sciences by MEXT Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Akil H, 2011, SCIENCE, V331, P708, DOI 10.1126/science.1199305; Aur D, 2006, J NEUROSCI METH, V157, P364, DOI 10.1016/j.jneumeth.2006.05.003; CACIOPPO JT, 2011, ANN NY ACAD SCI; Caggiano V, 2009, SCIENCE, V324, P403, DOI 10.1126/science.1166818; Chao Zenas C, 2010, Front Neuroeng, V3, P3, DOI 10.3389/fneng.2010.00003; EVARTS EV, 1968, ELECTROEN CLIN NEURO, V24, P83, DOI 10.1016/0013-4694(68)90070-9; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Frith CD, 2008, PHILOS T R SOC B, V363, P2033, DOI 10.1098/rstb.2008.0005; Fujii N, 2008, SOC NEUROSCI-UK, V3, P250, DOI 10.1080/17470910701434610; Fujii N, 2009, SOC NEUROSCI-UK, V4, P73, DOI 10.1080/17470910802046230; Fujii N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000397; Gardner D, 2003, NEUROINFORMATICS, V1, P289, DOI 10.1385/NI:1:3:289; Gould P, 2004, NATURE, V432, P137, DOI 10.1038/432137a; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; Hari R, 2009, PHYSIOL REV, V89, P453, DOI 10.1152/physrev.00041.2007; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; HUMPHREY NK, 1975, GROWING POINTS ETHOL, P303; Joshua M, 2007, J NEUROSCI METH, V163, P267, DOI 10.1016/j.jneumeth.2007.03.012; Lebedev MA, 2006, TRENDS NEUROSCI, V29, P536, DOI 10.1016/j.tins.2006.07.004; Matsuzawa T., 2001, PRIMATE ORIGINS HUMA; Nair DR, 2008, CLIN NEUROPHYSIOL, V119, P11, DOI 10.1016/j.clinph.2007.09.117; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Rubehn B, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/3/036003; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Supp GG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000684; Takahashi S, 2005, NEUROSCIENCE, V134, P301, DOI 10.1016/j.neuroscience.2005.03.031; Teeters JL, 2008, NEUROINFORMATICS, V6, P47, DOI 10.1007/s12021-008-9009-y	29	64	64	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22561	10.1371/journal.pone.0022561	http://dx.doi.org/10.1371/journal.pone.0022561			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811633	Green Published, gold, Green Submitted			2022-12-25	WOS:000292956800070
J	Romoser, A; Ritter, D; Majitha, R; Meissner, KE; McShane, M; Sayes, CM				Romoser, Amelia; Ritter, Dustin; Majitha, Ravish; Meissner, Kenith E.; McShane, Michael; Sayes, Christie M.			Mitigation of Quantum Dot Cytotoxicity by Microencapsulation	PLOS ONE			English	Article							IN-VITRO CYTOTOXICITY; NANOPARTICLES; CDSE; IMMOBILIZATION; POLYPYRROLE; SILICA; SYSTEM; PHASE; CELLS; SKIN	When CdSe/ZnS-polyethyleneimine (PEI) quantum dots (QDs) are microencapsulated in polymeric microcapsules, human fibroblasts are protected from acute cytotoxic effects. Differences in cellular morphology, uptake, and viability were assessed after treatment with either microencapsulated or unencapsulated dots. Specifically, QDs contained in microcapsules terminated with polyethylene glycol (PEG) mitigate contact with and uptake by cells, thus providing a tool to retain particle luminescence for applications such as extracellular sensing and imaging. The microcapsule serves as the "first line of defense'' for containing the QDs. This enables the individual QD coating to be designed primarily to enhance the function of the biosensor.	[Romoser, Amelia; Sayes, Christie M.] Texas A&M Univ, Interdisciplinary Program Toxicol, College Stn, TX 77843 USA; [Ritter, Dustin; Meissner, Kenith E.; McShane, Michael; Sayes, Christie M.] Texas A&M Univ, Dept Biomed Engn, College Stn, TX USA; [Majitha, Ravish; Meissner, Kenith E.; McShane, Michael; Sayes, Christie M.] Texas A&M Univ, Mat Sci & Engn Program, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Romoser, A (corresponding author), Texas A&M Univ, Interdisciplinary Program Toxicol, College Stn, TX 77843 USA.	csayes@cvm.tamu.edu	McShane, Mike/P-5261-2019; Sayes, Christie M/C-1333-2016; Sayes, Christie/AAO-9201-2020	McShane, Mike/0000-0001-6838-3982; Sayes, Christie M/0000-0002-5529-4101; 	Departments of Veterinary Physiology and Pharmacology and Biomedical Engineering at Texas AM University; DuPont Company; National Science Foundation; Texas A&M Dwight Look College of Engineering Barclay/Willson National Excellence	Departments of Veterinary Physiology and Pharmacology and Biomedical Engineering at Texas AM University; DuPont Company; National Science Foundation(National Science Foundation (NSF)); Texas A&M Dwight Look College of Engineering Barclay/Willson National Excellence	This work was supported by the Departments of Veterinary Physiology and Pharmacology and Biomedical Engineering at Texas A&M University. CMS acknowledges the DuPont Company's Young Professor Grant. DWR gratefully acknowledges support from the National Science Foundation Graduate Research Fellowship and the Texas A&M Dwight Look College of Engineering Barclay/Willson National Excellence Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEAGHA N, 2010, BIOL CHEM; ALMEIDA NF, 1993, BIOTECHNOL BIOENG, V42, P1037, DOI 10.1002/bit.260420904; Brunner TJ, 2006, ENVIRON SCI TECHNOL, V40, P4374, DOI 10.1021/es052069i; Caruso F, 1998, SCIENCE, V282, P1111, DOI 10.1126/science.282.5391.1111; Chang E, 2006, SMALL, V2, P1412, DOI 10.1002/smll.200600218; Choi J, 2010, ENVIRON HEALTH PERSP, V118, P589, DOI 10.1289/ehp.0901534; Das GK, 2010, J BIOMED MATER RES A, V93A, P337, DOI 10.1002/jbm.a.32533; Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334; Dobrovolskaia MA, 2008, MOL PHARMACEUT, V5, P487, DOI 10.1021/mp800032f; Duan HW, 2007, J AM CHEM SOC, V129, P3333, DOI 10.1021/ja068158s; Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194; Emerich DF, 2006, BIOMOL ENG, V23, P171, DOI 10.1016/j.bioeng.2006.05.026; Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994; Gerion D, 2001, J PHYS CHEM B, V105, P8861, DOI 10.1021/jp0105488; Ipe BI, 2005, SMALL, V1, P706, DOI 10.1002/smll.200500105; Jaiswal JK, 2003, NAT BIOTECHNOL, V21, P47, DOI 10.1038/nbt767; Kim S, 2003, J AM CHEM SOC, V125, P14652, DOI 10.1021/ja0368094; Kirchner C, 2005, TALANTA, V67, P486, DOI 10.1016/j.talanta.2005.06.042; LUNOV O, 2010, BIOMATERIALS, V31; Mahendra S, 2008, ENVIRON SCI TECHNOL, V42, P9424, DOI 10.1021/es8023385; MARCHESIELLO M, 1993, J ELECTROANAL CHEM, V358, P35, DOI 10.1016/0022-0728(93)80429-L; McNichols RJ, 2000, J BIOMED OPT, V5, P5, DOI 10.1117/1.429962; MCSHANE M, 2010, J MAT CHEM; McShane Michael J, 2002, Diabetes Technol Ther, V4, P533, DOI 10.1089/152091502760306625; MCSHANE MJ, 2006, TOPICS FLUORESCENCE; Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390; Moghimi SM, 1997, CLIN SCI, V93, P371, DOI 10.1042/cs0930371; Moghimi SM, 2003, PROG LIPID RES, V42, P463, DOI 10.1016/S0163-7827(03)00033-X; Nann T, 2005, CHEM COMMUN, P1735, DOI 10.1039/b414807j; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Oberdorster G, 2007, NANOTOXICOLOGY, V1, P2, DOI 10.1080/17435390701314761; PARTHASARATHY RV, 1994, NATURE, V369, P298, DOI 10.1038/369298a0; Parthasarathy RV, 1996, J APPL POLYM SCI, V62, P875, DOI 10.1002/(SICI)1097-4628(19961107)62:6<875::AID-APP3>3.0.CO;2-M; Peng ZA, 2001, J AM CHEM SOC, V123, P183, DOI 10.1021/ja003633m; Petrov AI, 2005, BIOTECHNOL PROGR, V21, P918, DOI 10.1021/bp0495825; Priester JH, 2009, ENVIRON SCI TECHNOL, V43, P2589, DOI 10.1021/es802806n; Przybytkowski E, 2009, FEBS J, V276, P6204, DOI 10.1111/j.1742-4658.2009.07324.x; Ryman-Rasmussen JP, 2007, NANO LETT, V7, P1344, DOI 10.1021/nl070375j; Semmler-Behnke M, 2007, ENVIRON HEALTH PERSP, V115, P728, DOI 10.1289/ehp.9685; Su YY, 2009, BIOMATERIALS, V30, P19, DOI 10.1016/j.biomaterials.2008.09.029; Volodkin DV, 2004, BIOMACROMOLECULES, V5, P1962, DOI 10.1021/bm049669e; Volodkin DV, 2004, LANGMUIR, V20, P3398, DOI 10.1021/la036177z; West JL, 2009, CANCER RES, V69, p484S; Xiao Yan, 2010, Journal of Nanobiotechnology, V8, P13, DOI 10.1186/1477-3155-8-13; Yu WW, 2006, BIOCHEM BIOPH RES CO, V348, P781, DOI 10.1016/j.bbrc.2006.07.160; Zhang LW, 2008, TOXICOL APPL PHARM, V228, P200, DOI 10.1016/j.taap.2007.12.022	47	27	28	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22079	10.1371/journal.pone.0022079	http://dx.doi.org/10.1371/journal.pone.0022079			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21814567	gold, Green Published			2022-12-25	WOS:000292956800021
J	Bhushan, L; Kandpal, RP				Bhushan, Lokesh; Kandpal, Raj P.			EphB6 Receptor Modulates Micro RNA Profile of Breast Carcinoma Cells	PLOS ONE			English	Article							MIR-23A-SIMILAR-TO-27A-SIMILAR-TO-24-2 CLUSTER; TRANSCRIPTION FACTORS; COLORECTAL-CANCER; GENE-EXPRESSION; TYROSINE KINASE; OVARIAN-CANCER; PATHWAY; PROLIFERATION; TUMORIGENESIS; INVASIVENESS	Breast carcinoma cells have a specific pattern of expression for Eph receptors and ephrin ligands. EphB6 has previously been characterized as a signature molecule for invasive breast carcinoma cells. The transcription of EphB6 is silenced in breast carcinoma cells and its re-expression leads to decreased invasiveness of MDA-MB-231 cells. Such differences in phenotypes of native and EphB6 expressing MDA-MB-231 cells relate to an altered profile of micro RNAs. Comparative hybridization of total RNA to slides containing all known miRNAs by using locked nucleic acid ( LNA) miRCURY platform yielded a significantly altered profile of miRNAs in MDA-MB-231 cells stably transfected with EphB6. After applying a threshold of change and a p-value of <0.001, the list of significantly altered miRNAs included miR-16, miR-23a, miR-24, miR-26a, miR-29a, miR-100, miRPlus-E1172 and miRPlus-E1258. The array-based changes were validated by real-time qPCR of miR-16, miR-23a, miR-24 and miR-100. Except miRPlus-E1172 and miRPlus-E1258, the remaining six miRNAs have been observed in a variety of cancers. The biological relevance of target mRNAs was predicted by using a common-target selection approach that allowed the identification of SMARCA5, SMARCC1, eIF2C2, eIF2C4, eIF4EBP2, FKABP5, FKBP1A, TRIB1, TRIB2, TRIB3, BMPR2, BMPR1A and BMPR1B as important targets of a subset of significantly altered miRNAs. Quantitative PCR revealed that the levels of SMARCC1, eIFC4, eIF4EB2, FKBP1a, FKBP5, TRIB1, TRIB3, BMPR1a and BMPR2 transcripts were significantly decreased in MDA-MB-231 cells transfected with EphB6. These observations confirm targeting of specific mRNAs by miR-100, miR-23a, miR-16 and miR-24, and suggest that the kinase-deficient EphB6 receptor is capable of initiating signal transduction from the cell surface to the nucleus resulting in the altered expression of a variety of genes involved in tumorigenesis and invasion. The alterations in miRNAs and their target mRNAs also suggest indirect involvement of EphB6 in PI3K/Akt/mTOR pathways.	[Bhushan, Lokesh; Kandpal, Raj P.] Western Univ Hlth Sci, Dept Basic Med Sci, Pomona, CA USA	Western University of Health Sciences	Bhushan, L (corresponding author), Western Univ Hlth Sci, Dept Basic Med Sci, Pomona, CA USA.	rkandpal@westernu.edu			Western University of Health Sciences	Western University of Health Sciences	This research was supported by startup funds from Western University of Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2009, BRIT J CANCER, V100, P511, DOI 10.1038/sj.bjc.6604884; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Chhabra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-232; Dalmay T, 2006, ONCOGENE, V25, P6170, DOI 10.1038/sj.onc.1209911; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fox BP, 2009, ONCOGENE, V28, P1706, DOI 10.1038/onc.2009.18; Fox B.P., 2008, OPEN PROTEOMICS J, V1, P79; Fox BP, 2006, BIOCHEM BIOPH RES CO, V340, P268, DOI 10.1016/j.bbrc.2005.11.174; Fox BP, 2004, BIOCHEM BIOPH RES CO, V318, P882, DOI 10.1016/j.bbrc.2004.04.102; Gebeshuber CA, 2009, EMBO REP, V10, P400, DOI 10.1038/embor.2009.9; Ghayad SE, 2010, RECENT PAT ANTI-CANC, V5, P29, DOI 10.2174/157489210789702208; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hassan MQ, 2010, P NATL ACAD SCI USA, V107, P19879, DOI 10.1073/pnas.1007698107; Jin GA, 2007, BLOOD, V109, P3998, DOI 10.1182/blood-2006-08-041202; Kandpal Raj P., 2010, Cancer Genomics & Proteomics, V7, P253; Khatua S, 2003, CANCER RES, V63, P1865; Kinyamu HK, 2008, MOL CARCINOGEN, V47, P845, DOI 10.1002/mc.20440; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Klein A, 2007, INT J CANCER, V121, P683, DOI 10.1002/ijc.22630; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Li L, 2011, BRIT J CANCER, V104, P19, DOI 10.1038/sj.bjc.6606014; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Miyoshi N, 2009, BRIT J CANCER, V101, P1664, DOI 10.1038/sj.bjc.6605361; Muniyappa MK, 2009, EUR J CANCER, V45, P3104, DOI 10.1016/j.ejca.2009.09.014; Nagaraja AK, 2010, MOL ENDOCRINOL, V24, P447, DOI 10.1210/me.2009-0295; Naylor TL, 2005, BREAST CANCER RES, V7, pR1186, DOI 10.1186/bcr1356; Okadome T, 1996, J BIOL CHEM, V271, P21687, DOI 10.1074/jbc.271.36.21687; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Puiffe ML, 2007, NEOPLASIA, V9, P820, DOI 10.1593/neo.07472; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Song GS, 2010, HEPATOLOGY, V51, P1735, DOI 10.1002/hep.23547; Stopka T, 2000, LEUKEMIA, V14, P1247, DOI 10.1038/sj.leu.2401807; Zanella F, 2010, ONCOGENE, V29, P2973, DOI 10.1038/onc.2010.58; Zhang XN, 2010, CANCER RES, V70, P7176, DOI 10.1158/0008-5472.CAN-10-0697; Zuo Z, 2011, BLOOD, V118, P413, DOI 10.1182/blood-2011-01-330704	41	31	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22484	10.1371/journal.pone.0022484	http://dx.doi.org/10.1371/journal.pone.0022484			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21811619	gold, Green Published, Green Submitted			2022-12-25	WOS:000292929500071
J	Ramella, NA; Rimoldi, OJ; Prieto, ED; Schinella, GR; Sanchez, SA; Jaureguiberry, MS; Vela, ME; Ferreira, ST; Tricerri, MA				Ramella, Nahuel A.; Rimoldi, Omar J.; Prieto, Eduardo D.; Schinella, Guillermo R.; Sanchez, Susana A.; Jaureguiberry, Maria S.; Vela, Maria E.; Ferreira, Sergio T.; Alejandra Tricerri, M.			Human Apolipoprotein A-I-Derived Amyloid: Its Association with Atherosclerosis	PLOS ONE			English	Article							REVERSE CHOLESTEROL TRANSPORT; DENSITY-LIPOPROTEIN DISKS; COLONY-STIMULATING FACTOR; HYDROSTATIC-PRESSURE; HUMAN NEUTROPHILS; TERMINAL DOMAIN; PRION PROTEIN; OLIGOMERS; FIBRILS; BETA	Amyloidoses constitute a group of diseases in which soluble proteins aggregate and deposit extracellularly in tissues. Nonhereditary apolipoprotein A-I (apoA-I) amyloid is characterized by deposits of nonvariant protein in atherosclerotic arteries. Despite being common, little is known about the pathogenesis and significance of apoA-I deposition. In this work we investigated by fluorescence and biochemical approaches the impact of a cellular microenvironment associated with chronic inflammation on the folding and pro-amyloidogenic processing of apoA-I. Results showed that mildly acidic pH promotes misfolding, aggregation, and increased binding of apoA-I to extracellular matrix elements, thus favoring protein deposition as amyloid like-complexes. In addition, activated neutrophils and oxidative/proteolytic cleavage of the protein give rise to pro amyloidogenic products. We conclude that, even though apoA-I is not inherently amyloidogenic, it may produce non hereditary amyloidosis as a consequence of the pro-inflammatory microenvironment associated to atherogenesis.	[Ramella, Nahuel A.; Rimoldi, Omar J.; Prieto, Eduardo D.; Jaureguiberry, Maria S.; Alejandra Tricerri, M.] Consejo Nacl Invest Cient & Tecn, CCT, Inst Invest Bioquim La Plata INIBIOLP, La Plata, Buenos Aires, Argentina; [Ramella, Nahuel A.; Rimoldi, Omar J.; Prieto, Eduardo D.; Schinella, Guillermo R.; Jaureguiberry, Maria S.; Alejandra Tricerri, M.] Univ Nacl La Plata, Fac Ciencias Med, La Plata, Buenos Aires, Argentina; [Sanchez, Susana A.] Univ Calif Irvine, Fluorescence Dynam Lab, Irvine, CA USA; [Sanchez, Susana A.] Ctr Nacl Invest Cardiovasc, Fdn CNIC Carlos III, Microscopy Unit, Madrid, Spain; [Vela, Maria E.] Univ Nacl La Plata, Inst Invest Fisicoquim Teor & Aplicadas INIFTA, CCT, CONICET, La Plata, Buenos Aires, Argentina; [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem, Program Biochem & Cellular Biophys, Rio De Janeiro, Brazil	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; University of California System; University of California Irvine; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; INIFTA; Universidade Federal do Rio de Janeiro	Ramella, NA (corresponding author), Consejo Nacl Invest Cient & Tecn, CCT, Inst Invest Bioquim La Plata INIBIOLP, La Plata, Buenos Aires, Argentina.	aletricerri@yahoo.com	Sánchez, Susana/HII-3113-2022; Neurociencia, Inct/I-1011-2013; Ferreira, Sergio/AAZ-1576-2020; Schinella, Guillermo/V-9937-2018	Ferreira, Sergio/0000-0001-7160-9866; Schinella, Guillermo/0000-0001-9541-9688; Ramella, Nahuel/0000-0002-6275-3193; Vela, Maria Elena/0000-0003-4502-5618	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina [2106-2008, 26228]; Universidad Nacional de La Plata [M126, M158]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 112-200801-00953]; National Institutes of Health, US [PHS 5 P41 RR-03155]; Instituto Nacional de Neurociencia Translacional; Conselho Nacional de Pesquisas; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003155] Funding Source: NIH RePORTER	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT); Universidad Nacional de La Plata(National University of La Plata); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National Institutes of Health, US(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Instituto Nacional de Neurociencia Translacional; Conselho Nacional de Pesquisas; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The work presented here was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina, grants # 2106-2008 to MAT and # 26228 to Horacio Garda, Universidad Nacional de La Plata (grants # M126 and M158 to MAT), and Consejo Nacional de Investigaciones Cientificas y Tecnicas, (PIP 112-200801-00953 to MAT and HG). SS acknowledges support from the National Institutes of Health (grant PHS 5 P41 RR-03155, US). STF is supported by grants from Instituto Nacional de Neurociencia Translacional, Conselho Nacional de Pesquisas and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreola A, 2003, J BIOL CHEM, V278, P2444, DOI 10.1074/jbc.M204801200; Benson MD, 2005, AMYLOID, V12, P75, DOI 10.1080/13506120500106925; Bergt C, 2001, EUR J BIOCHEM, V268, P3523, DOI 10.1046/j.1432-1327.2001.02253.x; Brouillette CG, 2001, BBA-MOL CELL BIOL L, V1531, P4, DOI 10.1016/S1388-1981(01)00081-6; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Chapeaurouge A, 2002, J BIOL CHEM, V277, P16478, DOI 10.1074/jbc.M105232200; Chen Y, 1999, METHODS, V19, P234, DOI 10.1006/meth.1999.0854; Coakley RJ, 2002, BLOOD, V100, P3383, DOI 10.1182/blood.V100.9.3383; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; Curtiss LK, 2006, ARTERIOSCL THROM VAS, V26, P12, DOI 10.1161/01.ATV.0000194291.94269.5a; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; Davidson WS, 1999, BIOCHEMISTRY-US, V38, P14387, DOI 10.1021/bi991428h; De Felice FG, 2004, FASEB J, V18, P1099, DOI 10.1096/fj.03-1072fje; Eberini I, 2002, BIOCHEM J, V362, P627, DOI 10.1042/0264-6021:3620627; Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882; Ferreira ST, 2006, CELL BIOCHEM BIOPHYS, V44, P539, DOI 10.1385/CBB:44:3:539; Gharavi NM, 2007, ARTERIOSCL THROM VAS, V27, P1346, DOI 10.1161/ATVBAHA.107.141283; Gongora L, 2002, LIFE SCI, V71, P2995, DOI 10.1016/S0024-3205(02)02167-7; Gursky O, 1996, P NATL ACAD SCI USA, V93, P2991, DOI 10.1073/pnas.93.7.2991; HAREL A, 1990, J NEUROCHEM, V55, P1237, DOI 10.1111/j.1471-4159.1990.tb03130.x; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Hill SE, 2009, BIOPHYS J, V96, P3781, DOI 10.1016/j.bpj.2009.01.044; Jaureguiberry MS, 2010, J MEMBRANE BIOL, V234, P183, DOI 10.1007/s00232-010-9245-6; Jerlich A, 2000, EUR J BIOCHEM, V267, P4137, DOI 10.1046/j.1432-1327.2000.01449.x; JOHNSON KH, 1992, AM J PATHOL, V141, P1013; JONAS A, 1989, J BIOL CHEM, V264, P4818; Kisilevsky R, 2000, J STRUCT BIOL, V130, P99, DOI 10.1006/jsbi.2000.4222; Lakowicz J.R., 2013, PRINCIPLES FLUORESCE; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Lindstedt L, 1999, J BIOL CHEM, V274, P22627, DOI 10.1074/jbc.274.32.22627; Liz MA, 2007, J LIPID RES, V48, P2385, DOI 10.1194/jlr.M700158-JLR200; Martins SM, 2006, J BIOL CHEM, V281, P26121, DOI 10.1074/jbc.M605367200; Martins SM, 2003, J BIOL CHEM, V278, P50449, DOI 10.1074/jbc.M307354200; Mucchiano GI, 2001, J PATHOL, V193, P270, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH753>3.0.CO;2-S; Mucchiano GI, 2001, AM J CLIN PATHOL, V115, P298; Munishkina LA, 2008, BIOCHEMISTRY-US, V47, P8993, DOI 10.1021/bi8008399; Navab M, 2006, NAT CLIN PRACT ENDOC, V2, P504, DOI 10.1038/ncpendmet0245; Nofer Jerzy-Roch, 2005, Expert Rev Cardiovasc Ther, V3, P1071, DOI 10.1586/14779072.3.6.1071; Obici L, 2006, AMYLOID, V13, P191, DOI 10.1080/13506120600960288; Paula-Lima AC, 2009, INT J BIOCHEM CELL B, V41, P1361, DOI 10.1016/j.biocel.2008.12.003; Rambaran RN, 2008, PRION, V2, P112, DOI 10.4161/pri.2.3.7488; Robinson JM, 2009, HISTOCHEM CELL BIOL, V131, P465, DOI 10.1007/s00418-009-0565-5; Ryan RO, 2003, PROTEIN EXPRES PURIF, V27, P98, DOI 10.1016/S1046-5928(02)00568-5; Rye KA, 2004, ARTERIOSCL THROM VAS, V24, P421, DOI 10.1161/01.ATV.0000104029.74961.f5; Saczynski JS, 2007, AM J EPIDEMIOL, V165, P985, DOI 10.1093/aje/kwm027; Sanchez SA, 2001, BIOCHEMISTRY-US, V40, P6903, DOI 10.1021/bi001599i; Sanchez SA, 2007, J LIPID RES, V48, P1689, DOI 10.1194/jlr.M600457-JLR200; Sandberg A, 2010, P NATL ACAD SCI USA, V107, P15595, DOI 10.1073/pnas.1001740107; Saraiva MJM, 2001, FEBS LETT, V498, P201, DOI 10.1016/S0014-5793(01)02480-2; Sebollela A, 2005, J BIOL CHEM, V280, P31949, DOI 10.1074/jbc.M505314200; Shao BH, 2008, P NATL ACAD SCI USA, V105, P12224, DOI 10.1073/pnas.0802025105; Shao BH, 2005, J BIOL CHEM, V280, P5983, DOI 10.1074/jbc.M411484200; Shin TM, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-16; Solomon A, 2006, ARTHRITIS RHEUM, V54, P3545, DOI 10.1002/art.22201; Thompson N. L., 1991, FLUORESCENCE CORRELA; Tricerri MA, 2001, BIOCHEMISTRY-US, V40, P5065, DOI 10.1021/bi002815q; Uversky VN, 2010, FEBS J, V277, P2940, DOI 10.1111/j.1742-4658.2010.07721.x; VANDERGOOT FG, 1991, NATURE, V354, P408, DOI 10.1038/354408a0; VOLLMER E, 1991, VIRCHOWS ARCH A, V419, P79, DOI 10.1007/BF01600220; Wettreich A, 1999, J BIOL CHEM, V274, P31468, DOI 10.1074/jbc.274.44.31468; WINROW VR, 1993, BRIT MED BULL, V49, P506, DOI 10.1093/oxfordjournals.bmb.a072627	61	46	47	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22532	10.1371/journal.pone.0022532	http://dx.doi.org/10.1371/journal.pone.0022532			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21811627	Green Published, gold			2022-12-25	WOS:000292929500075
J	Mannava, S; Omilian, AR; Wawrzyniak, JA; Fink, EE; Zhuang, D; Miecznikowski, JC; Marshall, JR; Soengas, MS; Sears, RC; Morrison, CD; Nikiforov, MA				Mannava, S.; Omilian, A. R.; Wawrzyniak, J. A.; Fink, E. E.; Zhuang, D.; Miecznikowski, J. C.; Marshall, J. R.; Soengas, M. S.; Sears, R. C.; Morrison, C. D.; Nikiforov, M. A.			PP2A-B56 alpha controls oncogene-induced senescence in normal and tumor human melanocytic cells	ONCOGENE			English	Article						senescence; PP2A; melanoma; C-MYC	C-MYC PROTEIN; BRAF MUTATIONS; PATHWAYS; PHOSPHORYLATION; PROLIFERATION; CIP2A; PP2A; IDENTIFICATION; SUPPRESSION; METABOLISM	Oncoprotein C-MYC is overexpressed in human metastatic melanomas and melanoma-derived cells where it is required for the suppression of oncogene-induced senescence (OIS). The genetic events that maintain high levels of C-MYC in melanoma cells and their role in OIS are unknown. Here we report that C-MYC in cells from several randomly chosen melanoma lines was upregulated at the protein level, and largely because of the increased protein stability. Of all known regulators of C-MYC stability, levels of B56 alpha subunit of the PP2A tumor suppressor complex were substantially suppressed in all human melanoma cells compared with normal melanocytes. Accordingly, immunohistochemical analysis revealed that the lowest and the highest amounts of PP2A-B56 alpha were predominantly detected in metastatic melanoma tissues and in primary melanomas from patients with good clinical outcome, respectively. Importantly, PP2A-B56 alpha overexpression suppressed C-MYC in melanoma cells and induced OIS, whereas depletion of PP2A-B56 alpha in normal human melanocytes upregulated C-MYC protein levels and suppressed BRAF(V600E)- and, less efficiently, NRAS(Q61R)-induced senescence. Our data reveal a mechanism of C-MYC overexpression in melanoma cells and identify a functional role for PP2A-B56 alpha in OIS of melanocytic cells. Oncogene (2012) 31, 1484-1492; doi:10.1038/onc.2011.339; published online 8 August 2011	[Mannava, S.; Wawrzyniak, J. A.; Fink, E. E.; Zhuang, D.; Nikiforov, M. A.] Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA; [Omilian, A. R.; Morrison, C. D.] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Miecznikowski, J. C.] Roswell Pk Canc Inst, Dept Biostat, Buffalo, NY 14263 USA; [Marshall, J. R.] Roswell Pk Canc Inst, Dept Canc Prevent & Populat Sci, Buffalo, NY 14263 USA; [Soengas, M. S.] Spanish Natl Canc Res Ctr, Mol Pathol Programme, Madrid, Spain; [Sears, R. C.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Centro Nacional de Investigaciones Oncologicas (CNIO); Oregon Health & Science University	Nikiforov, MA (corresponding author), Roswell Pk Canc Inst, Dept Cell Stress Biol, BLSC L3-317,Elm & Carlton Str, Buffalo, NY 14263 USA.	Mikhail.nikiforov@roswellpark.org	Soengas, Maria S/H-6455-2015	Soengas, Maria S/0000-0003-0612-6299; Fink, Emily/0000-0003-2738-5732	NIH [R01 CA120244, ACS RSG-10-121-01, 5P30CA016056-34]; NATIONAL CANCER INSTITUTE [R01CA120244, P30CA016056, R01CA100855, R01CA129040] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Dr Catherine Burkhart (Cleveland Biolabs) and Dr Shoshanna Zucker (Roswell Park Cancer Institute) for critical reading of the manuscript, Ms Carina Fung (University of Sydney) for the experimental help. This work was supported by the NIH R01 CA120244 and ACS RSG-10-121-01 grants to MAN. The work of JCM was supported in part by the NIH 5P30CA016056-34 grant.	Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Arnold HK, 2009, EMBO J, V28, P500, DOI 10.1038/emboj.2008.279; Arroyo JD, 2005, ONCOGENE, V24, P7746, DOI 10.1038/sj.onc.1209038; Bahram F, 2000, BLOOD, V95, P2104, DOI 10.1182/blood.V95.6.2104; Bansal R, 2010, CELL CYCLE, V9, P2782, DOI 10.4161/cc.9.14.12251; Bringold F, 2000, EXP GERONTOL, V35, P317, DOI 10.1016/S0531-5565(00)00083-8; Choi SH, 2010, GENE DEV, V24, P1236, DOI 10.1101/gad.1920310; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471; Eilers M, 1999, MOL CELLS, V9, P1; Grandori C, 2003, GENE DEV, V17, P1569, DOI 10.1101/gad.1100303; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Gregory MA, 2000, MOL CELL BIOL, V20, P2423, DOI 10.1128/MCB.20.7.2423-2435.2000; Haferkamp S, 2009, AGING-US, V1, P542, DOI 10.18632/aging.100051; Hann SR, 2006, SEMIN CANCER BIOL, V16, P288, DOI 10.1016/j.semcancer.2006.08.004; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Henriksson M, 1996, ADV CANCER RES, V68, P109, DOI 10.1016/S0065-230X(08)60353-X; Hydbring P, 2010, P NATL ACAD SCI USA, V107, P58, DOI 10.1073/pnas.0900121106; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Khanna A, 2009, JNCI-J NATL CANCER I, V101, P793, DOI 10.1093/jnci/djp103; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Larue L, 2006, FRONT BIOSCI-LANDMRK, V11, P733, DOI 10.2741/1831; LUTTERBACH B, 1994, MOL CELL BIOL, V14, P5510, DOI 10.1128/MCB.14.8.5510; Maldonado JL, 2003, J NATL CANCER I, V95, P1878, DOI 10.1093/jnci/djg123; Mannava S, 2008, CELL CYCLE, V7, P2392, DOI 10.4161/cc.6390; Meyer N, 2006, SEMIN CANCER BIOL, V16, P275, DOI 10.1016/j.semcancer.2006.07.011; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Newson R, 2006, STATA J, V2, P45; Nikiforov MA, 2003, J BIOL CHEM, V278, P11094, DOI 10.1074/jbc.M212298200; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Sablina AA, 2010, CANCER RES, V70, P10474, DOI 10.1158/0008-5472.CAN-10-2855; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; Shi YJ, 2008, CANCER RES, V68, P10215, DOI 10.1158/0008-5472.CAN-08-1066; Smalley KSM, 2005, SEMIN CANCER BIOL, V15, P451, DOI 10.1016/j.semcancer.2005.06.002; Vaarala MH, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-136; Wang H, 2008, ONCOGENE, V27, P1905, DOI 10.1038/sj.onc.1210823; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104; Zhuang D, 2008, ONCOGENE, V27, P6623, DOI 10.1038/onc.2008.258	47	28	32	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2012	31	12					1484	1492		10.1038/onc.2011.339	http://dx.doi.org/10.1038/onc.2011.339			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	916VT	21822300	Green Accepted			2022-12-25	WOS:000302132000002
J	Zakharian, E; Cao, C; Rohacs, T				Zakharian, Eleonora; Cao, Chike; Rohacs, Tibor			Intracellular ATP supports TRPV6 activity via lipid kinases and the generation of PtdIns(4,5)P-2	FASEB JOURNAL			English	Article						transient receptor potential channel; phosphoinositides	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; CALCIUM-CHANNEL; TRPM8 CHANNELS; VANILLOID RECEPTOR; CATION CHANNEL; ION CHANNELS; PHOSPHOINOSITIDES; DESENSITIZATION; FAMILY; PIP2	Transient receptor potential vanilloid 6 (TRPV6) channels play an important role in Ca2+ absorption in the intestines. Both phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P-2] and cytoplasmic ATP have been proposed to be important for maintaining TRPV6 activity. To evaluate whether PtdIns(4,5)P-2 and ATP affect channel activity directly or indirectly, we have used a dual approach, examining channel activity in excised patches and planar lipid bilayers. In excised inside-out patch-clamp measurements, ATP reactivated the human TRPV6 channels after current rundown only in the presence of Mg2+. The effect of MgATP was inhibited by 3 structurally different compounds that inhibit type III phosphatidylinositol 4-kinases (PI4Ks). PtdIns(4,5)P-2 also activated TRPV6 in excised patches, while its precursor PtdIns(4)P had only minimal effect. These data demonstrate that MgATP provides substrate for lipid kinases, allowing the resynthesis of PtdIns(4,5)P-2. To determine whether PtdIns(4,5)P-2 is a direct activator of TRPV6, we purified and reconstituted the channel protein in planar lipid bilayers. The reconstituted channel showed high activity in the presence of PtdIns(4,5)P-2, while PtdIns(4)P induced only minimal activity. Our data establish PtdIns(4,5)P-2 as a direct activator of TRPV6 and demonstrate that intracellular ATP regulates the channel indirectly as a substrate for type III PI4Ks.-Zakharian, E., Cao, C., Rohacs, T. Intracellular ATP supports TRPV6 activity via lipid kinases and the generation of PtdIns(4,5)P-2. FASEB J. 25, 3915-3928 (2011). www.fasebj.org	[Rohacs, Tibor] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Rohacs, T (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, 185 S Orange Ave,MSB H631, Newark, NJ 07103 USA.	tibor.rohacs@umdnj.edu			U.S. National Institutes of Health [NS-055159, GM-093290]; University of Medicine and Dentistry of New Jersey Foundation; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055159] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Medicine and Dentistry of New Jersey Foundation; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by U.S. National Institutes of Health grants NS-055159 and GM-093290 and by a grant from the University of Medicine and Dentistry of New Jersey Foundation (to T.R.) and by a Scientist Development grant from the American Heart Association (to E.Z). The authors thank Dr. Tamas Balla for insightful discussions and comments on the manuscript and Dr. Joshua Berlin for careful reading of and commenting on the manuscript. The clone for the human TRPV6 was generously provided by Dr. T. V. McDonald (Albert Einstein College of Medicine, New York, NY, USA).	Akey JM, 2006, HUM MOL GENET, V15, P2106, DOI 10.1093/hmg/ddl134; Al-Ansary D, 2010, FASEB J, V24, P425, DOI 10.1096/fj.09-141481; Balla A, 2008, BIOCHEMISTRY-US, V47, P1599, DOI 10.1021/bi7017927; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Balla T, 2001, CURR PHARM DESIGN, V7, P475, DOI 10.2174/1381612013397906; Bianco SDC, 2007, J BONE MINER RES, V22, P274, DOI 10.1359/JBMR.061110; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; D'Avanzo N, 2010, J BIOL CHEM, V285, P37129, DOI 10.1074/jbc.C110.186692; Daniels RL, 2009, J BIOL CHEM, V284, P1570, DOI 10.1074/jbc.M807270200; Derler I, 2006, J PHYSIOL-LONDON, V577, P31, DOI 10.1113/jphysiol.2006.118661; Grycova L, 2007, ARCH BIOCHEM BIOPHYS, V465, P389, DOI 10.1016/j.abb.2007.06.035; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Hilgemann DW, 1997, ANNU REV PHYSIOL, V59, P193, DOI 10.1146/annurev.physiol.59.1.193; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Hoenderop JGJ, 2003, J CLIN INVEST, V112, P1906, DOI 10.1172/JCI200319826; Hoenderop JGJ, 2001, J PHYSIOL-LONDON, V537, P747; Hughes DA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001686; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Korzeniowski MK, 2009, J BIOL CHEM, V284, P21027, DOI 10.1074/jbc.M109.012252; Kwak J, 2000, J NEUROSCI, V20, P8298, DOI 10.1523/JNEUROSCI.20-22-08298.2000; Leal-Pinto E, 2010, J BIOL CHEM, V285, P39790, DOI 10.1074/jbc.M110.151373; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Liu BY, 2005, J NEUROSCI, V25, P4835, DOI 10.1523/JNEUROSCI.1296-05.2005; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P1, DOI 10.1007/s00424-007-0311-6; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; Mercado J, 2010, J NEUROSCI, V30, P13338, DOI 10.1523/JNEUROSCI.2108-10.2010; Murata Y, 2007, J PHYSIOL-LONDON, V583, P875, DOI 10.1113/jphysiol.2007.134775; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; Niemeyer BA, 2001, P NATL ACAD SCI USA, V98, P3600, DOI 10.1073/pnas.051511398; Nilius B, 2008, EMBO J, V27, P2809, DOI 10.1038/emboj.2008.217; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Nilius B, 2010, PFLUG ARCH EUR J PHY, V460, P437, DOI 10.1007/s00424-010-0788-2; OROURKE B, 1993, BIOCHEM PHARMACOL, V46, P1103, DOI 10.1016/0006-2952(93)90456-7; Phelps CB, 2008, BIOCHEMISTRY-US, V47, P2476, DOI 10.1021/bi702109w; Phelps CB, 2010, J BIOL CHEM, V285, P731, DOI 10.1074/jbc.M109.052548; Rohacs T, 2002, METHOD ENZYMOL, V345, P71; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Rohacs T, 2009, CELL CALCIUM, V45, P554, DOI 10.1016/j.ceca.2009.03.011; Suchyna TM, 2009, BIOPHYS J, V97, P738, DOI 10.1016/j.bpj.2009.05.018; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Suzuki Y, 2008, HUM MOL GENET, V17, P1613, DOI 10.1093/hmg/ddn048; Thyagarajan B, 2008, J BIOL CHEM, V283, P14980, DOI 10.1074/jbc.M704224200; Thyagarajan B, 2009, MOL PHARMACOL, V75, P608, DOI 10.1124/mol.108.052449; Tominaga M, 2001, P NATL ACAD SCI USA, V98, P6951, DOI 10.1073/pnas.111025298; Toth B, 2006, J BIOL CHEM, V281, P36369, DOI 10.1074/jbc.M604935200; Toth B, 2010, J BIOL CHEM, V285, P30091, DOI 10.1074/jbc.M109.066464; Voets T, 2003, J GEN PHYSIOL, V121, P245, DOI 10.1085/jgp.20028752; Wu LJ, 2010, PHARMACOL REV, V62, P381, DOI 10.1124/pr.110.002725; Yao J, 2009, PLOS BIOL, V7, P350, DOI 10.1371/journal.pbio.1000046; Yue LX, 2001, NATURE, V410, P705, DOI 10.1038/35070596; Zakharian E, 2010, J NEUROSCI, V30, P12526, DOI 10.1523/JNEUROSCI.3189-10.2010; Zakharian E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005404	53	36	37	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	NOV	2011	25	11					3915	3928		10.1096/fj.11-184630	http://dx.doi.org/10.1096/fj.11-184630			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	844BT	21810903	Green Published			2022-12-25	WOS:000296723100016
J	Silkov, A; Yoon, Y; Lee, H; Gokhale, N; Adu-Gyamfi, E; Stahelin, RV; Cho, W; Murray, D				Silkov, Antonina; Yoon, Youngdae; Lee, Hunjoong; Gokhale, Nikhil; Adu-Gyamfi, Emmanuel; Stahelin, Robert V.; Cho, Wonhwa; Murray, Diana			Genome-wide Structural Analysis Reveals Novel Membrane Binding Properties of AP180 N-terminal Homology (ANTH) Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN ASSEMBLY PROTEIN; ALZHEIMERS-DISEASE; DIFFERENTIAL ROLES; PREDICTION; ELECTROSTATICS; RECOGNITION; DATABASE; PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE; PTDINS(4,5)P-2; ENDOCYTOSIS	An increasing number of cytosolic proteins are shown to interact with membrane lipids during diverse cellular processes, but computational prediction of these proteins and their membrane binding behaviors remains challenging. Here, we introduce a new combinatorial computation protocol for systematic and robust functional prediction of membrane-binding proteins through high throughput homology modeling and in-depth calculation of biophysical properties. The approach was applied to the genomic scale identification of the AP180 N-terminal homology (ANTH) domain, one of the modular lipid binding domains, and prediction of their membrane binding properties. Our analysis yielded comprehensive coverage of the ANTH domain family and allowed classification and functional annotation of proteins based on the differences in local structural and biophysical features. Our analysis also identified a group of plant ANTH domains with unique structural features that may confer novel functionalities. Experimental characterization of a representative member of this subfamily confirmed its unique membrane binding mechanism and unprecedented membrane deforming activity. Collectively, these studies suggest that our new computational approach can be applied to genome-wide functional prediction of other lipid binding domains.	[Yoon, Youngdae; Gokhale, Nikhil; Cho, Wonhwa] Univ Illinois, Dept Chem, Chicago, IL 60607 USA; [Silkov, Antonina; Lee, Hunjoong; Murray, Diana] Columbia Univ, Dept Pharmacol, New York, NY 11032 USA; [Adu-Gyamfi, Emmanuel; Stahelin, Robert V.] Univ Notre Dame, Dept Biochem, South Bend, IN 46617 USA; [Stahelin, Robert V.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, South Bend, IN 46617 USA; [Cho, Wonhwa] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang 790784, South Korea	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Columbia University; University of Notre Dame; Indiana University System; Indiana University South Bend; Pohang University of Science & Technology (POSTECH)	Cho, W (corresponding author), Univ Illinois, Dept Chem, Chicago, IL 60607 USA.	wcho@uic.edu; dm527@columbia.edu	Stahelin, Robert/L-3567-2019	Stahelin, Robert/0000-0001-5443-7863	National Institutes of Health [GM68849]; National Science Foundation [0618323]; National Research Foundation of Korea [R31-2008-000-10105-0]; Ministry of Education, Science and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068849] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM68849 (to W. C.). This work was also supported by National Science Foundation Grant 0618323 (to D. M.) and by the World Class University Program Grant R31-2008-000-10105-0 (to W. C.) from the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology.	AHLE S, 1986, EMBO J, V5, P3143, DOI 10.1002/j.1460-2075.1986.tb04621.x; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; BenTal N, 1996, BIOPHYS J, V71, P561, DOI 10.1016/S0006-3495(96)79280-9; Bhardwaj N, 2006, J MOL BIOL, V359, P486, DOI 10.1016/j.jmb.2006.03.039; Bhardwaj N, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S6; BRUNE D, 1994, P NATL ACAD SCI USA, V91, P2930, DOI 10.1073/pnas.91.8.2930; CHO W, 2006, SCI STKE, pPE7, DOI DOI 10.1126/STKE.3212006PE7; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Cho WW, 2001, ANAL BIOCHEM, V296, P153, DOI 10.1006/abio.2001.5225; Dreyling MH, 1996, P NATL ACAD SCI USA, V93, P4804, DOI 10.1073/pnas.93.10.4804; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Lee Hunjoong, 2010, Journal of Structural and Functional Genomics, V11, P51, DOI 10.1007/s10969-010-9086-7; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lin HH, 2006, J LIPID RES, V47, P824, DOI 10.1194/jlr.M500530-JLR200; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Mandell JG, 2001, PROTEIN ENG, V14, P105, DOI 10.1093/protein/14.2.105; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Medkova M, 1998, J BIOL CHEM, V273, P17544, DOI 10.1074/jbc.273.28.17544; Mirkovic N, 2007, PROTEINS, V66, P766, DOI 10.1002/prot.21191; Mishra SK, 2001, J BIOL CHEM, V276, P46230, DOI 10.1074/jbc.M108177200; MIYAZAWA S, 1985, MACROMOLECULES, V18, P534, DOI 10.1021/ma00145a039; Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841; Mulgrew-Nesbitt A, 2006, BBA-MOL CELL BIOL L, V1761, P812, DOI 10.1016/j.bbalip.2006.07.002; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; Park WS, 2008, MOL CELL, V30, P381, DOI 10.1016/j.molcel.2008.04.008; Petrey D, 2003, METHOD ENZYMOL, V374, P492, DOI 10.1016/S0076-6879(03)74021-X; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; Rao DS, 2002, J CLIN INVEST, V110, P351, DOI 10.1172/JCI200215529; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Stahelin RV, 2003, J BIOL CHEM, V278, P28993, DOI 10.1074/jbc.M302865200; Stahelin RV, 2001, BIOCHEMISTRY-US, V40, P4672, DOI 10.1021/bi0020325; Sun Y, 2005, MOL BIOL CELL, V16, P717, DOI 10.1091/mbc.E04-08-0740; Xiong WJ, 2010, PROTEIN J, V29, P427, DOI 10.1007/s10930-010-9269-x; Yao PJ, 1998, J NEUROSCI, V18, P2399; Yao PJ, 1998, NEUROSCI LETT, V252, P33, DOI 10.1016/S0304-3940(98)00547-3; Yao PJ, 1999, NEUROSCIENCE, V94, P389, DOI 10.1016/S0306-4522(99)00360-7; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; Zhang C, 1997, J MOL BIOL, V267, P707, DOI 10.1006/jmbi.1996.0859	45	17	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34155	34163		10.1074/jbc.M111.265611	http://dx.doi.org/10.1074/jbc.M111.265611			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21828048	Green Published, hybrid			2022-12-25	WOS:000295159200046
J	Jin, XG; Chen, SR; Cao, XH; Li, L; Pan, HL				Jin, Xiao-Gao; Chen, Shao-Rui; Cao, Xue-Hong; Li, Li; Pan, Hui-Lin			Nitric Oxide Inhibits Nociceptive Transmission by Differentially Regulating Glutamate and Glycine Release to Spinal Dorsal Horn Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; SUBSTANTIA-GELATINOSA NEURONS; AMINO-ACID ANTAGONISTS; REDOX MODULATORY SITE; CALCIUM-CHANNELS; NMDA RECEPTOR; LAMINA-II; PHARMACOLOGICAL INHIBITION; NEUROTRANSMITTER RELEASE; BACKGROUND ACTIVITY	Nitric oxide (NO) is involved in many physiological functions, but its role in pain signaling remains uncertain. Surprisingly, little is known about how endogenous NO affects excitatory and inhibitory synaptic transmission at the spinal level. Here we determined how NO affects excitatory and inhibitory synaptic inputs to dorsal horn neurons using whole-cell recordings in rat spinal cord slices. The NO precursor L-arginine or the NO donor SNAP significantly increased the frequency of glycinergic spontaneous and miniature inhibitory postsynaptic currents (IPSCs) of lamina II neurons. However, neither L-arginine nor SNAP had any effect on GABAergic IPSCs. L-arginine and SNAP significantly reduced the amplitude of monosynaptic excitatory postsynaptic currents (EPSCs) evoked from the dorsal root with an increase in paired-pulse ratio. Inhibition of the soluble guanylyl cyclase abolished the effect of L-arginine on glycinergic IPSCs but not on evoked monosynaptic EPSCs. Also, inhibition of protein kinase G blocked the increase in glycinergic sIPSCs by the cGMP analog 8-bromo-cGMP. The inhibitory effects of L-arginine on evoked EPSCs and high voltage-activated Ca2+ channels expressed in HEK293 cells and dorsal root ganglion neurons were abolished by blocking the S-nitrosylation reaction with N-ethylmaleimide. Intrathecal injection of L-arginine and SNAP significantly increased mechanical nociceptive thresholds. Our findings suggest that spinal endogenous NO enhances inhibitory glycinergic input to dorsal horn neurons through sGC-cGMP-protein kinase G. Furthermore, NO reduces glutamate release from primary afferent terminals through S-nitrosylation of voltage-activated Ca2+ channels. Both of these actions probably contribute to inhibition of nociceptive transmission by NO at the spinal level.	[Pan, Hui-Lin] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Unit 110, Houston, TX 77030 USA; [Pan, Hui-Lin] Univ Texas Houston, Grad Sch Biomed Sci, Program Neurosci, Houston, TX 77225 USA; [Pan, Hui-Lin] Univ Texas Houston, Grad Sch Biomed Sci, Program Expt Therapeut, Houston, TX 77225 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Pan, HL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Unit 110, 1515 Holcombe Blvd, Houston, TX 77030 USA.	huilinpan@mdanderson.org	Li, Li/K-9630-2013	Pan, Hui-Lin/0000-0001-8444-3770	National Institutes of Health [GM064830, NS073935]; N. G. and Helen T. Hawkins Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); N. G. and Helen T. Hawkins Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM064830 and NS073935 and the N. G. and Helen T. Hawkins Endowment (to H.-L. P.).	Aizenman E, 1999, BRIT J PHARMACOL, V126, P296, DOI 10.1038/sj.bjp.0702295; AKAIKE T, 1993, BIOCHEMISTRY-US, V32, P827, DOI 10.1021/bi00054a013; BERNARDI PS, 1995, J NEUROSCI, V15, P1363; Boettger MK, 2007, EUR J PAIN, V11, P810, DOI 10.1016/j.ejpain.2006.12.008; BOLOTINA VM, 1994, NATURE, V368, P850, DOI 10.1038/368850a0; Broillet MC, 1996, NEURON, V16, P377, DOI 10.1016/S0896-6273(00)80055-0; Butt E, 1995, BRIT J PHARMACOL, V116, P3110, DOI 10.1111/j.1476-5381.1995.tb15112.x; Chen SR, 2003, ANESTHESIOLOGY, V98, P217, DOI 10.1097/00000542-200301000-00033; Christopherson KS, 1999, J BIOL CHEM, V274, P27467, DOI 10.1074/jbc.274.39.27467; Chu YC, 2005, PAIN, V119, P113, DOI 10.1016/j.pain.2005.09.024; Ding JD, 2006, J COMP NEUROL, V495, P668, DOI 10.1002/cne.20901; Feil R, 2003, J CELL BIOL, V163, P295, DOI 10.1083/jcb.200306148; Gow AJ, 2004, AM J PHYSIOL-LUNG C, V287, pL262, DOI 10.1152/ajplung.00295.2003; Guan Y, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-29; Handy RLC, 1996, BRIT J PHARMACOL, V119, P423, DOI 10.1111/j.1476-5381.1996.tb16003.x; Head CA, 2010, AM J HEMATOL, V85, P800, DOI 10.1002/ajh.21832; Heinke B, 2004, J PHYSIOL-LONDON, V560, P249, DOI 10.1113/jphysiol.2004.070540; Hoheisel U, 2000, PAIN, V88, P249, DOI 10.1016/S0304-3959(00)00336-5; HOHEISEL U, 1995, NEUROSCI LETT, V188, P143, DOI 10.1016/0304-3940(95)11411-O; Hoheisel U, 2005, PAIN, V117, P358, DOI 10.1016/j.pain.2005.06.023; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Jeong HJ, 2003, J PHYSIOL-LONDON, V550, P373, DOI 10.1113/jphysiol.2003.041053; Jeong SW, 1998, NEURON, V21, P1201, DOI 10.1016/S0896-6273(00)80636-4; Lee EA, 2009, J NEUROCHEM, V109, P275, DOI 10.1111/j.1471-4159.2009.05960.x; LEI SZ, 1992, NEURON, V8, P1087, DOI 10.1016/0896-6273(92)90130-6; Li DP, 2002, J NEUROPHYSIOL, V88, P2664, DOI 10.1152/jn.00540.2002; Li DP, 2002, J PHYSIOL-LONDON, V543, P807, DOI 10.1113/jphysiol.2002.020644; Li K, 2010, NEUROSCI BULL, V26, P211, DOI 10.1007/s12264-010-0127-9; LIPTON SA, 1994, PROG BRAIN RES, V103, P359; Lu Y, 2003, J NEUROSCI, V23, P8752; MANZONI O, 1992, NEURON, V8, P653, DOI 10.1016/0896-6273(92)90087-T; McDavid S, 2006, J NEUROSCI, V26, P13373, DOI 10.1523/JNEUROSCI.3332-06.2006; Miyamoto T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007596; Nicholson R, 2004, NEUROSCI LETT, V359, P180, DOI 10.1016/j.neulet.2004.01.057; Pan YZ, 2004, J NEUROPHYSIOL, V91, P2413, DOI 10.1152/jn.01242.2003; Pehl U, 1997, NEUROSCIENCE, V77, P563, DOI 10.1016/S0306-4522(96)00495-2; Rudkouskaya A, 2010, FREE RADICAL BIO MED, V49, P757, DOI 10.1016/j.freeradbiomed.2010.05.032; Santos SFA, 2007, J PHYSIOL-LONDON, V581, P241, DOI 10.1113/jphysiol.2006.126912; Schmidtko A, 2008, J NEUROSCI, V28, P8568, DOI 10.1523/JNEUROSCI.2128-08.2008; SEKHAR KR, 1992, MOL PHARMACOL, V42, P103; Sorkin LS, 1998, PAIN, V77, P181, DOI 10.1016/S0304-3959(98)00094-3; Sousa AM, 2001, BRAIN RES, V897, P9, DOI 10.1016/S0006-8993(01)01995-3; Stuehr DJ, 1997, ANNU REV PHARMACOL, V37, P339, DOI 10.1146/annurev.pharmtox.37.1.339; Sun JH, 2006, CIRC RES, V98, P403, DOI 10.1161/01.RES.0000202707.79018.0a; Tanabe M, 2009, NEUROPHARMACOLOGY, V56, P702, DOI 10.1016/j.neuropharm.2008.12.003; Tao F, 2003, NEUROSCIENCE, V120, P847, DOI 10.1016/S0306-4522(03)00362-2; TERENGHI G, 1993, J NEUROL SCI, V118, P34, DOI 10.1016/0022-510X(93)90242-Q; Todd AJ, 1996, EUR J NEUROSCI, V8, P2492, DOI 10.1111/j.1460-9568.1996.tb01543.x; TODD AJ, 1990, J COMP NEUROL, V296, P496, DOI 10.1002/cne.902960312; UEDA H, 1990, J NEUROCHEM, V54, P841, DOI 10.1111/j.1471-4159.1990.tb02328.x; VALTSCHANOFF JG, 1992, NEUROSCI LETT, V148, P6, DOI 10.1016/0304-3940(92)90791-5; Valtschanoff JG, 2001, J NEUROSCI, V21, P1211; Wang XL, 2006, J PHYSIOL-LONDON, V571, P403, DOI 10.1113/jphysiol.2005.102905; WINSLOW JW, 1987, J BIOL CHEM, V262, P4501; Wu SY, 1996, J PHYSIOL-LONDON, V495, P479, DOI 10.1113/jphysiol.1996.sp021608; Wu ZZ, 2005, J BIOL CHEM, V280, P18142, DOI 10.1074/jbc.M501229200; Wu ZZ, 2004, NEUROSCI LETT, V368, P96, DOI 10.1016/j.neulet.2004.06.067; YAKSH TL, 1989, PAIN, V37, P111, DOI 10.1016/0304-3959(89)90160-7; Yuen KCJ, 2002, DIABETES CARE, V25, P1699, DOI 10.2337/diacare.25.10.1699; Zhang HM, 2005, J PHARMACOL EXP THER, V313, P697, DOI 10.1124/jpet.104.079939; Zhao YD, 2000, BIOCHEMISTRY-US, V39, P10848, DOI 10.1021/bi9929296; Zhou HY, 2008, J PHARMACOL EXP THER, V327, P375, DOI 10.1124/jpet.108.141226; Zhou HY, 2007, J NEUROPHYSIOL, V97, P871, DOI 10.1152/jn.00964.2006; Zhou HY, 2011, J PHARMACOL EXP THER, V336, P254, DOI 10.1124/jpet.110.173112; Zhou HY, 2010, J NEUROSCI, V30, P4460, DOI 10.1523/JNEUROSCI.5857-09.2010; ZHUO M, 1993, PAIN, V54, P71, DOI 10.1016/0304-3959(93)90101-T	66	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33190	33202		10.1074/jbc.M111.270967	http://dx.doi.org/10.1074/jbc.M111.270967			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21813646	Green Published, hybrid			2022-12-25	WOS:000294968800038
J	Lin, RK; Zhou, N; Lyu, YL; Tsai, YC; Lu, CH; Kerrigan, J; Chen, YT; Guan, Z; Hsieh, TS; Liu, LF				Lin, Ren-Kuo; Zhou, Nai; Lyu, Yi Lisa; Tsai, Yuan-Chin; Lu, Chang-Hsien; Kerrigan, John; Chen, Yu-tsung; Guan, Ziqiang; Hsieh, Tao-Shih; Liu, Leroy F.			Dietary Isothiocyanate-induced Apoptosis via Thiol Modification of DNA Topoisomerase II alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; GREEN TEA; KAPPA-B; MEDIATED APOPTOSIS; BETA-LAPACHONE; ATPASE DOMAIN; PREVENTION; SELENIUM; SULFORAPHANE; EXPRESSION	Studies in animal models have indicated that dietary isothiocyanates (ITCs) exhibit cancer preventive activities through carcinogen detoxification-dependent and -independent mechanisms. The carcinogen detoxification-independent mechanism of cancer prevention by ITCs has been attributed at least in part to their ability to induce apoptosis of transformed (initiated) cells (e. g. through suppression of I kappa B kinase and nuclear factor kappa B as well as other proposed mechanisms). In the current studies we show that ITC-induced apoptosis of oncogene-transformed cells involves thiol modification of DNA topoisomerase II (Top2) based on the following observations. 1) siRNA-mediated knockdown of Top2 alpha in both SV40-transformed MEFs and Ras-transformed human mammary epithelial MCF10A cells resulted in reduced ITC sensitivity. 2) ITCs, like some anticancer drugs and cancer-preventive dietary components, were shown to induce reversible Top2 alpha cleavage complexes in vitro. 3) ITC-induced Top2 alpha cleavage complexes were abolished by co-incubation with excess glutathione. In addition, proteomic analysis revealed that several cysteine residues on human Top2 alpha were covalently modified by benzyl-ITC, suggesting that ITC-induced Top2 alpha cleavage complexes may involve cysteine modification. Interestingly, consistent with the thiol modification mechanism for Top2 alpha cleavage complex induction, the thiol-reactive selenocysteine, but not the non-thiol-reactive selenomethionine, was shown to induce Top2 alpha cleavage complexes. In the aggregate, our results suggest that thiol modification of Top2 alpha may contribute to apoptosis induction in transformed cells by ITCs.	[Lin, Ren-Kuo; Zhou, Nai; Lyu, Yi Lisa; Tsai, Yuan-Chin; Kerrigan, John; Liu, Leroy F.] Univ Med & Dent New Jersey, Dept Pharmacol, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA; [Lin, Ren-Kuo; Zhou, Nai; Lyu, Yi Lisa; Tsai, Yuan-Chin; Kerrigan, John; Liu, Leroy F.] Univ Med & Dent New Jersey, Canc Inst New Jersey, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA; [Lu, Chang-Hsien] Chang Gung Mem Hosp, Dept Hematol & Oncol, Chia Yi Branch, Chiayi 61363, Taiwan; [Chen, Yu-tsung; Guan, Ziqiang; Hsieh, Tao-Shih] Duke Univ, Dept Biochem, Med Ctr, Durham, NC 27710 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Chang Gung Memorial Hospital; Duke University	Liu, LF (corresponding author), 675 Hoes Lane, Piscataway, NJ 08854 USA.	lliu@umdnj.edu	Wu, Wan-lin/G-8937-2012; Hsieh, Tao-shih/G-9305-2012	Liu, Leroy/0000-0001-9396-763X	National Institutes of Health [CA39662, CA102463]; NATIONAL CANCER INSTITUTE [R01CA102463, R01CA039662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA39662 and CA102463.	Asano T, 1996, ONCOL RES, V8, P101; Azarova AM, 2007, P NATL ACAD SCI USA, V104, P11014, DOI 10.1073/pnas.0704002104; Bandele OJ, 2008, CHEM RES TOXICOL, V21, P936, DOI 10.1021/tx700434v; Bandele OJ, 2007, BIOCHEMISTRY-US, V46, P6097, DOI 10.1021/bi7000664; Bender RP, 2007, BIOCHEMISTRY-US, V46, P2856, DOI 10.1021/bi062017l; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen G, 1999, ONCOGENE, V18, P7149, DOI 10.1038/sj.onc.1203149; Cheung KL, 2010, AAPS J, V12, P87, DOI 10.1208/s12248-009-9162-8; Chung FL, 2000, CARCINOGENESIS, V21, P2287, DOI 10.1093/carcin/21.12.2287; Clarke JD, 2008, CANCER LETT, V269, P291, DOI 10.1016/j.canlet.2008.04.018; Combs GF, 2001, NUTR CANCER, V40, P6, DOI 10.1207/S15327914NC401_4; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Frydman B, 1997, CANCER RES, V57, P620; Gasparian AV, 2002, MOL CANCER THER, V1, P1079; Genchi G, 2001, BBA-MOL CELL BIOL L, V1530, P146, DOI 10.1016/S1388-1981(00)00175-X; Giaccone G, 1995, BBA-GENE STRUCT EXPR, V1264, P337, DOI 10.1016/0167-4781(95)00171-9; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Herr I, 2010, CANCER TREAT REV, V36, P377, DOI 10.1016/j.ctrv.2010.01.002; Hu T, 2002, J BIOL CHEM, V277, P5944, DOI 10.1074/jbc.M111394200; Ip C, 1998, J NUTR, V128, P1845, DOI 10.1093/jn/128.11.1845; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; LIU LF, 1983, J BIOL CHEM, V258, P5365; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Lyu YL, 2007, CANCER RES, V67, P8839, DOI 10.1158/0008-5472.CAN-07-1649; Lyu YL, 2006, MOL CELL BIOL, V26, P7929, DOI 10.1128/MCB.00617-06; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Mi LX, 2011, CARCINOGENESIS, V32, P216, DOI 10.1093/carcin/bgq242; Mi LX, 2009, J BIOL CHEM, V284, P17039, DOI 10.1074/jbc.M901789200; Na HK, 2008, FOOD CHEM TOXICOL, V46, P1271, DOI 10.1016/j.fct.2007.10.006; Na HK, 2006, MOL CARCINOGEN, V45, P368, DOI 10.1002/mc.20225; Nakamura Y, 2010, BIOSCI BIOTECH BIOCH, V74, P242, DOI 10.1271/bbb.90731; Neder K, 1998, CELL MOL BIOL, V44, P465; Ogawa K, 1998, INT J CANCER, V76, P851; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Sahu RP, 2009, JNCI-J NATL CANCER I, V101, P176, DOI 10.1093/jnci/djn470; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schmidt BH, 2010, NATURE, V465, P641, DOI 10.1038/nature08974; Shishodia S, 2005, CANCER RES, V65, P9555, DOI 10.1158/0008-5472.CAN-05-1585; Singh AV, 2004, CARCINOGENESIS, V25, P83, DOI 10.1093/carcin/bgg178; Singh SV, 2005, J BIOL CHEM, V280, P19911, DOI 10.1074/jbc.M412443200; SMITH K, 1993, ONCOGENE, V8, P933; SOULE HD, 1990, CANCER RES, V50, P6075; Stan SD, 2008, J CELL BIOCHEM, V104, P339, DOI 10.1002/jcb.21623; Steinmetz KA, 1996, J AM DIET ASSOC, V96, P1027, DOI 10.1016/S0002-8223(96)00273-8; TEWEY KM, 1984, SCIENCE, V226, P466, DOI 10.1126/science.6093249; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Tsai Y.-C., 2011, PLOS ONE IN PRESS; Varis A, 2004, INT J CANCER, V109, P548, DOI 10.1002/ijc.20001; Wang HM, 2001, BIOCHEMISTRY-US, V40, P3316, DOI 10.1021/bi002786j; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang QJ, 1997, MOL CELL BIOL, V17, P389, DOI 10.1128/MCB.17.1.389; Warin R, 2009, CANCER RES, V69, P9473, DOI 10.1158/0008-5472.CAN-09-2960; Wei H, 2005, J BIOL CHEM, V280, P37041, DOI 10.1074/jbc.M506520200; WOESSNER RD, 1991, CELL GROWTH DIFFER, V2, P209; Xu CJ, 2006, CARCINOGENESIS, V27, P437, DOI 10.1093/carcin/bgi251; Yang FJ, 2001, MOL PHARMACOL, V60, P528; Zhang AL, 2006, J BIOL CHEM, V281, P35997, DOI 10.1074/jbc.M604149200; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; Zhou N, 2003, J BIOL CHEM, V278, P29532, DOI 10.1074/jbc.M301877200	63	38	38	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33591	33600		10.1074/jbc.M111.258137	http://dx.doi.org/10.1074/jbc.M111.258137			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21828038	Green Published, hybrid			2022-12-25	WOS:000294968800075
J	Hu, JH; Jiang, ZG				Hu, Junhua; Jiang, Zhigang			Climate Change Hastens the Conservation Urgency of an Endangered Ungulate	PLOS ONE			English	Article							GAZELLE PROCAPRA-PRZEWALSKII; SPECIES DISTRIBUTION; ENVELOPE MODELS; EXTINCTION RISK; COUPLED MODEL; QINGHAI-LAKE; RANGE SHIFTS; UNCERTAINTIES; PREDICTION; IMPACTS	Global climate change appears to be one of the main threats to biodiversity in the near future and is already affecting the distribution of many species. Currently threatened species are a special concern while the extent to which they are sensitive to climate change remains uncertain. Przewalski's gazelle (Procapra przewalskii) is classified as endangered and a conservation focus on the Qinghai-Tibetan Plateau. Using measures of species range shift, we explored how the distribution of Przewalski's gazelle may be impacted by projected climate change based on a maximum entropy approach. We also evaluated the uncertainty in the projections of the risks arising from climate change. Modeling predicted the Przewalski's gazelle would be sensitive to future climate change. As the time horizon increased, the strength of effects from climate change increased. Even assuming unlimited dispersal capacity of gazelles, a moderate decrease to complete loss of range was projected by 2080 under different thresholds for transforming the probability prediction to presence/absence data. Current localities of gazelles will undergo a decrease in their occurrence probability. Projections of the impacts of climate change were significantly affected by thresholds and general circulation models. This study suggests climate change clearly poses a severe threat and increases the extinction risk to Przewalski's gazelle. Our findings 1) confirm that endangered endemic species is highly vulnerable to climate change and 2) highlight the fact that forecasting impacts of climate change needs an assessment of the uncertainty. It is extremely important that conservation strategies consider the predicted geographical shifts and be planned with full knowledge of the reliability of projected impacts of climate change.	[Hu, Junhua; Jiang, Zhigang] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Hu, Junhua] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS	Hu, JH (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	jiangzg@ioz.ac.cn	hu, jh/B-4853-2010; Jiang, Zhigang/E-4598-2014	hu, jh/0000-0002-6669-8443; Jiang, Zhigang/0000-0003-2154-8588	National Natural Sciences Foundation of China [31070469]; Chinese Academy of Sciences [Y1B3021, KSCX2-EW-Z-4, KSCX2-EW-J-22]; Ministry of Science and Technology, China [2008BAC39B04]; SSC/IUCN	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology, China(Ministry of Science and Technology, China); SSC/IUCN	This work was supported by the National Natural Sciences Foundation of China (31070469), the Field Front Project of the Knowledge Innovation Program of the Chinese Academy of Sciences (Y1B3021), the Science and Technology Supporting Project, Ministry of Science and Technology, China (2008BAC39B04), the Sir Peter Scott Fund of SSC/IUCN (Population trends and habitat qualities of the critically endangered Przewalski's gazelle) and the Knowledge Innovation Project of Chinese Academy of Sciences (KSCX2-EW-Z-4; KSCX2-EW-J-22). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakaya HR, 2006, GLOBAL CHANGE BIOL, V12, P2037, DOI 10.1111/j.1365-2486.2006.01253.x; Anderson BJ, 2009, P ROY SOC B-BIOL SCI, V276, P1415, DOI 10.1098/rspb.2008.1681; Aranda SC, 2011, ECOGRAPHY, V34, P31, DOI 10.1111/j.1600-0587.2010.06134.x; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; ARAUJO MB, 2007, EVOLUTION, V22, P42, DOI DOI 10.1016/J.TREE.2006.09.010; Araujo MB, 2008, ECOGRAPHY, V31, P8, DOI 10.1111/j.2007.0906-7590.05318.x; Araujo MB, 2006, SCIENCE, V313, P1396, DOI 10.1126/science.1131758; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; Collins M, 2001, CLIM DYNAM, V17, P61, DOI 10.1007/s003820000094; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Dobrowski SZ, 2011, GLOBAL CHANGE BIOL, V17, P1022, DOI 10.1111/j.1365-2486.2010.02263.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; *EUR COMM JOINT RE, 2003, GLC GLOB LAND COV 20; Gordon HB, 1997, MON WEATHER REV, V125, P875, DOI 10.1175/1520-0493(1997)125<0875:TCCITC>2.0.CO;2; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Hu J, 2010, J ZOOL, V282, P54, DOI 10.1111/j.1469-7998.2010.00715.x; Hu JH, 2010, OECOLOGIA, V164, P555, DOI 10.1007/s00442-010-1732-z; Hu JH, 2010, EUR J WILDLIFE RES, V56, P551, DOI 10.1007/s10344-009-0346-4; *INT UN CONS NAT, 2012, IUCN RED LIST CAT CR; *IUCN SSC ANT SPEC, 2008, PROC PRZEW IUCN 2010; Jansson R, 2003, P ROY SOC B-BIOL SCI, V270, P583, DOI 10.1098/rspb.2002.2283; Jetz W, 2002, SCIENCE, V297, P1548, DOI 10.1126/science.1072779; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Jiang Z.G., 2004, CHINAS PRZEWALSKIS G; Jiang ZG, 2000, ORYX, V34, P129, DOI 10.1046/j.1365-3008.2000.00108.x; Jiang Zhigang, 1995, Acta Theriologica Sinica, V15, P241; Kim SJ, 2003, CLIM DYNAM, V20, P635, DOI 10.1007/s00382-002-0292-2; Klein JA, 2008, ECOSYSTEMS, V11, P775, DOI 10.1007/s10021-008-9160-1; Klein JA, 2007, ECOL APPL, V17, P541, DOI 10.1890/05-0685; Lawler JJ, 2006, GLOBAL CHANGE BIOL, V12, P1568, DOI 10.1111/j.1365-2486.2006.01191.x; Lawton J. H., 1995, EXTINCTION RATES; Lei RH, 2001, J ZOOL, V255, P175, DOI 10.1017/S0952836901001248; LI C, 2011, ORYX IN PRESS; Li CW, 2009, WILDLIFE RES, V36, P379, DOI 10.1071/WR08117; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Ma Rui-Jun, 2006, Acta Ecologica Sinica, V26, P3066; Mallon D.P., 2001, ANTELOPES 4, P231; Mallon DP, 2009, J APPL ECOL, V46, P516, DOI 10.1111/j.1365-2664.2009.01654.x; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Morueta-Holme N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010360; Moyes K, 2011, GLOBAL CHANGE BIOL, V17, P2455, DOI 10.1111/j.1365-2486.2010.02382.x; Nogues-Bravo D, 2008, PLOS BIOL, V6, P685, DOI 10.1371/journal.pbio.0060079; Ohlemuller R, 2008, BIOL LETTERS, V4, P568, DOI 10.1098/rsbl.2008.0097; Parra JL, 2008, GLOBAL CHANGE BIOL, V14, P2215, DOI 10.1111/j.1365-2486.2008.01649.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Penman TD, 2010, DIVERS DISTRIB, V16, P109, DOI 10.1111/j.1472-4642.2009.00619.x; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Schaller GB., 1998, WILDLIFE TIBETAN STE; Singh NJ, 2011, J APPL ECOL, V48, P35, DOI 10.1111/j.1365-2664.2010.01905.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2006, GLOBAL CHANGE BIOL, V12, P424, DOI 10.1111/j.1365-2486.2006.01115.x; Thuiller W, 2004, NATURE, V430, DOI 10.1038/nature02716; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; *USGS, 2009, HYDRO1K EV DER DAT; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WCS CIESIN, 2005, LAST WILD DAT VERS 2; Wiens JA, 2009, P NATL ACAD SCI USA, V106, P19729, DOI 10.1073/pnas.0901639106; Yang Ji, 2011, PLoS One, V6, pe20144, DOI 10.1371/journal.pone.0020144; Ye Runrong, 2006, Acta Theriologica Sinica, V26, P373	70	30	33	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22873	10.1371/journal.pone.0022873	http://dx.doi.org/10.1371/journal.pone.0022873			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826214	Green Submitted, gold, Green Published			2022-12-25	WOS:000293558900040
J	Jouneau, S; Bonizec, M; Belleguic, C; Desrues, B; Brinchault, G; Galaine, J; Gangneux, JP; Martin-Chouly, C				Jouneau, Stephane; Bonizec, Melanie; Belleguic, Chantal; Desrues, Benoit; Brinchault, Graziella; Galaine, Jeanne; Gangneux, Jean-Pierre; Martin-Chouly, Corinne			Anti-Inflammatory Effect of Fluvastatin on IL-8 Production Induced by Pseudomonas aeruginosa and Aspergillus fumigatus Antigens in Cystic Fibrosis	PLOS ONE			English	Article							WHOLE-BLOOD; PULMONARY INFLAMMATION; MEVALONATE PATHWAY; IN-VITRO; SIMVASTATIN; EXPRESSION; STATINS; REDUCTASE; CYTOKINES; DISEASE	Background: Early in life, patients with cystic fibrosis (CF) are infected with microorganisms including bacteria and fungi, particularly Pseudomonas aeruginosa and Aspergillus fumigatus. Since recent research has identified the anti-inflammatory properties of statins (besides their lipid-lowering effects), we investigated the effect of fluvastatin on the production of the potent neutrophil chemoattractant chemokine, IL-8, in whole blood from CF patients, stimulated by Pseudomonas aeruginosa (LPS) and Aspergillus fumigatus (AFA) antigens. Results: Whole blood from adult patients with CF and from healthy volunteers was collected at the Rennes University Hospital (France). Blood was pretreated for 1 h with fluvastatin (0-300 mu M) and incubated for 24 h with LPS (10 mu g/mL) and/or AFA (diluted 1/200). IL-8 protein levels, quantified by ELISA, were increased in a concentration-dependent manner when cells were stimulated by LPS or AFA. Fluvastatin strongly decreased the levels of IL-8, in a concentration-dependent manner, in whole blood from CF patients. However, its inhibitory effect was decreased or absent in whole blood from healthy subjects. Furthermore, the inhibition induced by fluvastatin in CF whole blood was reversed in the presence of intermediates within the cholesterol biosynthesis pathway, mevalonate, farnesyl pyprophosphate or geranylgeranyl pyrophosphate that activate small GTPases by isoprenylation. Conclusions: For the first time, the inhibitory effects of fluvastatin on CF systemic inflammation may reveal the important therapeutic potential of statins in pathological conditions associated with the over-production of pro-inflammatory cytokines and chemokines as observed during the manifestation of CF. The anti-inflammatory effect could be related to the modulation of the prenylation of signalling proteins.	[Jouneau, Stephane; Bonizec, Melanie; Galaine, Jeanne; Gangneux, Jean-Pierre; Martin-Chouly, Corinne] Univ Rennes 1, EA Signalisat & Reponse Agents Infect & Chim 4427, Inst Rech Sante Environm Travail, Inst Federatif Rech 140, Rennes, France; [Jouneau, Stephane; Belleguic, Chantal; Desrues, Benoit; Brinchault, Graziella] Ctr Hosp Univ Rennes, Hop Pontchaillou, Serv Pneumol, Rennes, France; [Gangneux, Jean-Pierre] Ctr Hosp Univ Rennes, Hop Pontchaillou, Serv Parasitol Mycol, Rennes, France	Universite de Rennes; CHU Rennes; Universite de Rennes; CHU Rennes; Universite de Rennes	Jouneau, S (corresponding author), Univ Rennes 1, EA Signalisat & Reponse Agents Infect & Chim 4427, Inst Rech Sante Environm Travail, Inst Federatif Rech 140, Rennes, France.	corinne.chouly@univ-rennes1.fr	MARTIN-CHOULY, Corinne AE/K-4288-2015; Gangneux, Jean-Pierre/J-2960-2015; Jouneau, Stephane/K-9956-2015	Desrues, Benoit/0000-0002-1748-1694; Galaine, Jeanne/0000-0001-7592-6447; Gangneux, Jean-Pierre/0000-0002-4974-5607; MARTIN-CHOULY, corinne/0000-0001-7493-0612	Vaincre la mucoviscidose; scientific council of the Faculty of Medicine, Rennes University, France	Vaincre la mucoviscidose; scientific council of the Faculty of Medicine, Rennes University, France	Support for this work is gratefully acknowledged from "Vaincre la mucoviscidose" and the scientific council of the Faculty of Medicine, Rennes 1 University, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augarten A, 2004, CLIN EXP MED, V4, P99, DOI 10.1007/s10238-004-0044-1; Bellanger AP, 2009, J MED MICROBIOL, V58, P174, DOI 10.1099/jmm.0.005488-0; Bjerre A, 2004, CRIT CARE MED, V32, P433, DOI 10.1097/01.CCM.0000104950.52577.97; Bjorkhem-Bergman L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010702; Cazalis J, 2008, J PERIODONTOL, V79, P1762, DOI [10.1902/jop.2008.080051, 10.1902/jop.2008.080051 ]; Chello M, 2007, ANN THORAC SURG, V83, P1374, DOI 10.1016/j.athoracsur.2006.10.065; CORSINI A, 1993, ATHEROSCLEROSIS, V101, P117, DOI 10.1016/0021-9150(93)90107-6; de Bont N, 1998, ATHEROSCLEROSIS, V139, P147, DOI 10.1016/S0021-9150(98)00074-4; Ehrenstein MR, 2005, NEW ENGL J MED, V352, P73, DOI 10.1056/NEJMe048326; ELBORN JS, 1994, PEDIATR PULM, V17, P411, DOI 10.1002/ppul.1950170615; Falagas ME, 2008, J ANTIMICROB CHEMOTH, V61, P774, DOI 10.1093/jac/dkn019; Ferro D, 2000, J AM COLL CARDIOL, V36, P427, DOI 10.1016/S0735-1097(00)00771-3; Fessler MB, 2005, AM J RESP CRIT CARE, V171, P606, DOI 10.1164/rccm.200406-729OC; Foldes G, 2008, INT J CARDIOL, V124, P80, DOI 10.1016/j.ijcard.2006.12.024; GILLIGAN PH, 1991, CLIN MICROBIOL REV, V4, P35, DOI 10.1128/CMR.4.1.35-51.1991; Goldman F, 1996, BLOOD, V88, P4611, DOI 10.1182/blood.V88.12.4611.bloodjournal88124611; Hartung T, 1999, CLIN PHARMACOL THER, V66, P415, DOI 10.1053/cp.1999.v66.a101210; Horn MP, 2008, J PHARMACOL EXP THER, V326, P135, DOI 10.1124/jpet.108.137927; Jacobson JR, 2005, AM J PHYSIOL-LUNG C, V288, pL1026, DOI 10.1152/ajplung.00354.2004; Johnson BA, 2003, AM J RESP CRIT CARE, V167, P1271, DOI 10.1164/rccm.200205-410OC; Keddissi JI, 2007, CHEST, V132, P1764, DOI 10.1378/chest.07-0298; Kiener PA, 2001, INT IMMUNOPHARMACOL, V1, P105, DOI 10.1016/S0162-3109(00)00272-1; Konstan MW, 2007, AM J RESP CRIT CARE, V176, P1084, DOI 10.1164/rccm.200702-181OC; Kreiselmeier NE, 2003, AM J PHYSIOL-LUNG C, V285, pL1286, DOI 10.1152/ajplung.00127.2003; KRONBORG G, 1993, PEDIATR PULM, V15, P292, DOI 10.1002/ppul.1950150506; Kuwahara I, 2006, AM J PHYSIOL-LUNG C, V291, pL407, DOI 10.1152/ajplung.00471.2005; Lands LC, 2007, J PEDIATR-US, V151, P249, DOI 10.1016/j.jpeds.2007.04.009; Langezaal I, 2001, TOXICOL IN VITRO, V15, P313, DOI 10.1016/S0887-2333(01)00028-5; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Lee LH, 2005, AM J RESP CRIT CARE, V172, P987, DOI 10.1164/rccm.200501-041OC; Leung BP, 2003, J IMMUNOL, V170, P1524, DOI 10.4049/jimmunol.170.3.1524; Lindholm MW, 2007, VASC PHARMACOL, V46, P91, DOI 10.1016/j.vph.2006.07.001; McKay A, 2004, J IMMUNOL, V172, P2903, DOI 10.4049/jimmunol.172.5.2903; Niwa S, 1996, INT J IMMUNOPHARMACO, V18, P669, DOI 10.1016/S0192-0561(96)00068-9; Nixon LS, 1998, AM J RESP CRIT CARE, V157, P1764, DOI 10.1164/ajrccm.157.6.9704086; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Ou XM, 2008, CHINESE MED J-PEKING, V121, P1680, DOI 10.1097/00029330-200809010-00018; Ouagued M, 2005, PULM PHARMACOL THER, V18, P49, DOI 10.1016/j.pupt.2004.09.031; Rowntree RK, 2003, ANN HUM GENET, V67, P471, DOI 10.1046/j.1469-1809.2003.00028.x; Sagel SD, 2002, CLIN REV ALLERG IMMU, V23, P41, DOI 10.1385/CRIAI:23:1:041; Sakoda K, 2006, J DENT RES, V85, P520, DOI 10.1177/154405910608500608; Schmitt-Grohe S, 2005, CYTOKINE, V29, P18, DOI 10.1016/j.cyto.2004.09.004; Shyamsundar M, 2009, AM J RESP CRIT CARE, V179, P1107, DOI 10.1164/rccm.200810-1584OC; Sturges NC, 2010, PEDIATR PULM, V45, P883, DOI 10.1002/ppul.21230; Svanborg C, 1999, CURR OPIN MICROBIOL, V2, P99, DOI 10.1016/S1369-5274(99)80017-4; Takano K, 2011, J PHARMACOL EXP THER, V336, P381, DOI 10.1124/jpet.110.171462; TERKELTAUB R, 1994, J LEUKOCYTE BIOL, V55, P749, DOI 10.1002/jlb.55.6.749; van Heeckeren AM, 2000, AM J RESP CRIT CARE, V161, P271, DOI 10.1164/ajrccm.161.1.9903019; Vandivier RW, 2009, AM J PHYSIOL-LUNG C, V297, pL677, DOI 10.1152/ajplung.00030.2009; Vaughan CJ, 1996, LANCET, V348, P1079, DOI 10.1016/S0140-6736(96)05190-2; Yao HW, 2006, CLIN EXP PHARMACOL P, V33, P793, DOI 10.1111/j.1440-1681.2006.04440.x; Zeki AA, 2009, AM J RESP CRIT CARE, V180, P731, DOI 10.1164/rccm.200901-0018OC; Zhao DZ, 2003, EXPERT OPIN THER TAR, V7, P583, DOI 10.1517/eott.7.5.583.22527	53	20	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22655	10.1371/journal.pone.0022655	http://dx.doi.org/10.1371/journal.pone.0022655			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826199	Green Published, gold			2022-12-25	WOS:000293558900025
J	Lagerholm, S; Park, HB; Luthman, H; Grynpas, M; McGuigan, F; Swanberg, M; Akesson, K				Lagerholm, Sofia; Park, Hee-Bok; Luthman, Holger; Grynpas, Marc; McGuigan, Fiona; Swanberg, Maria; Akesson, Kristina			Identification of Candidate Gene Regions in the Rat by Co-Localization of QTLs for Bone Density, Size, Structure and Strength	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; DEPENDENT DIABETES-MELLITUS; MITOCHONDRIAL-DNA; SEQUENCE-ANALYSIS; GENOME SCREEN; FRACTURE RISK; MIDDLE-AGE; SEX; BMD; ASSOCIATION	Susceptibility to osteoporotic fracture is influenced by genetic factors that can be dissected by whole-genome linkage analysis in experimental animal crosses. The aim of this study was to characterize quantitative trait loci (QTLs) for biomechanical and two-dimensional dual-energy X-ray absorptiometry (DXA) phenotypes in reciprocal F2 crosses between diabetic GK and normo-glycemic F344 rat strains and to identify possible co-localization with previously reported QTLs for bone size and structure. The biomechanical measurements of rat tibia included ultimate force, stiffness and work to failure while DXA was used to characterize tibial area, bone mineral content (BMC) and areal bone mineral density (aBMD). F2 progeny (108 males, 98 females) were genotyped with 192 genome-wide markers followed by sex- and reciprocal cross-separated whole-genome QTL analyses. Significant QTLs were identified on chromosome 8 (tibial area; logarithm of odds (LOD) = 4.7 and BMC; LOD = 4.1) in males and on chromosome 1 (stiffness; LOD = 5.5) in females. No QTLs showed significant sex-specific interactions. In contrast, significant cross-specific interactions were identified on chromosome 2 (aBMD; LOD = 4.7) and chromosome 6 (BMC; LOD = 4.8) for males carrying F344mtDNA, and on chromosome 15 (ultimate force; LOD = 3.9) for males carrying GKmtDNA, confirming the effect of reciprocal cross on osteoporosis-related phenotypes. By combining identified QTLs for biomechanical-, size- and qualitative phenotypes (pQCT and 3D CT) from the same population, overlapping regions were detected on chromosomes 1, 3, 4, 6, 8 and 10. These are strong candidate regions in the search for genetic risk factors for osteoporosis.	[Lagerholm, Sofia; McGuigan, Fiona; Swanberg, Maria; Akesson, Kristina] Lund Univ, Clin & Mol Osteoporosis Unit, Dept Clin Sci Malmo, Lund, Sweden; [Park, Hee-Bok; Luthman, Holger] Lund Univ, Med Genet Unit, Dept Clin Sci Malmo, Lund, Sweden; [Akesson, Kristina] Skane Univ Hosp Malmo, Dept Orthoped, Malmo, Sweden; [Grynpas, Marc] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Grynpas, Marc] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	Lund University; Lund University; Lund University; Skane University Hospital; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Lagerholm, S (corresponding author), Lund Univ, Clin & Mol Osteoporosis Unit, Dept Clin Sci Malmo, Lund, Sweden.	Kristina.Akesson@med.lu.se	Grynpas, Marc/ABG-7096-2020; Grynpas, Marc/E-4576-2013	Swanberg, Maria/0000-0002-1829-1008	Swedish Research Council [K2006-72X-09109-17-3, 2006-73X-14691-04-3]; Knut och Alice Wallenbergs Stiftelse; Malmo University Hospital Research Foundations; Medical Faculty of Lund University; Novo Nordisk Foundation; Svenska Diabetesforbundets Forskningsfond; Greta and Johan Kock Foundation; A Osterlund Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut och Alice Wallenbergs Stiftelse(Knut & Alice Wallenberg Foundation); Malmo University Hospital Research Foundations; Medical Faculty of Lund University; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Svenska Diabetesforbundets Forskningsfond; Greta and Johan Kock Foundation; A Osterlund Foundation	This study was supported by grants from the Swedish Research Council (http://www.vr.se) K2006-72X-09109-17-3, 2006-73X-14691-04-3, and a Linne grant to Lund University Diabetes Center, Knut och Alice Wallenbergs Stiftelse (http://www.wallenberg.com/kaw/), Malmo University Hospital Research Foundations (http://www.skane.se), the Medical Faculty of Lund University (http://www.med.lu.se/), Novo Nordisk Foundation (http://www.novonordiskfonden.dk/en/index.asp), Svenska Diabetesforbundets Forskningsfond (http://www.diabetesfonden.se/), Greta and Johan Kock Foundation (http://www.kockskastiftelsen.se/), and A Osterlund Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhyankar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008148; Ahmed LA, 2006, OSTEOPOROSIS INT, V17, P495, DOI 10.1007/s00198-005-0013-x; Alam I, 2006, BONE, V39, P93, DOI 10.1016/j.bone.2005.12.009; Alam I, 2005, J BONE MINER RES, V20, P1589, DOI 10.1359/JBMR.050512; Beamer WG, 2007, J BONE MINER RES, V22, P1187, DOI 10.1359/JBMR.070419; Bouxsein ML, 2004, J BONE MINER RES, V19, P587, DOI 10.1359/JBMR.0301255; Broman KW, 2006, GENETICS, V174, P2151, DOI 10.1534/genetics.106.061176; CHURCHILL GA, 1994, GENETICS, V138, P963; Edderkaoui B, 2004, J BONE MINER RES, V19, pS54; Galli J, 1996, NAT GENET, V12, P31, DOI 10.1038/ng0196-31; Holmberg AH, 2008, J CLIN ENDOCR METAB, V93, P815, DOI 10.1210/jc.2007-0843; Holmberg AH, 2006, OSTEOPOROSIS INT, V17, P1065, DOI 10.1007/s00198-006-0137-7; Ichikawa S, 2006, J BONE MINER RES, V21, P556, DOI 10.1359/JBMR.051212; Ioannidis JPA, 2004, JAMA-J AM MED ASSOC, V292, P2105, DOI 10.1001/jama.292.17.2105; Jamsa T, 1998, BONE, V23, P155, DOI 10.1016/S8756-3282(98)00076-3; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Klein RF, 2004, SCIENCE, V303, P229, DOI 10.1126/science.1090985; Koller DL, 2005, MAMM GENOME, V16, P578, DOI 10.1007/s00335-004-2459-0; Koller DL, 2001, J BONE MINER RES, V16, P985, DOI 10.1359/jbmr.2001.16.6.985; Lagerholm S, 2010, BONE, V47, P1039, DOI 10.1016/j.bone.2010.08.003; Lagerholm S, 2009, J BONE MINER RES, V24, P1066, DOI [10.1359/JBMR.081252, 10.1359/jbmr.081252]; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Langdahl BL, 2008, BONE, V42, P969, DOI 10.1016/j.bone.2007.11.007; Lynch M, GENETICS ANAL QUANTI; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Manly KF, 1999, MAMM GENOME, V10, P327, DOI 10.1007/s003359900997; Miao JM, 2005, DIABETES CARE, V28, P2850, DOI 10.2337/diacare.28.12.2850; Nagy TR, 2001, J BONE MINER RES, V16, P1682, DOI 10.1359/jbmr.2001.16.9.1682; Peacock M, 2002, ENDOCR REV, V23, P303, DOI 10.1210/er.23.3.303; Schlick NE, 2006, AM J PHYSIOL-CELL PH, V291, pC1183, DOI 10.1152/ajpcell.00234.2006; Stone KL, 2003, J BONE MINER RES, V18, P1947, DOI 10.1359/jbmr.2003.18.11.1947; Swanberg M, 2010, BONE, V47, P424, DOI 10.1016/j.bone.2010.05.009; Turner CH, 2002, OSTEOPOROSIS INT, V13, P97, DOI 10.1007/s001980200000; Turner CH, 2003, CALCIFIED TISSUE INT, V73, P297, DOI 10.1007/s00223-002-1062-1; Turner CH, 2001, J BONE MINER RES, V16, P1532, DOI 10.1359/jbmr.2001.16.8.1532; Urano T, 2005, J BONE MINER METAB, V23, P226, DOI 10.1007/s00774-004-0588-x; VANDAELE PLA, 1995, ANN INTERN MED, V122, P409, DOI 10.7326/0003-4819-122-6-199503150-00002; Volkman SK, 2004, J BONE MINER RES, V19, P1497, DOI 10.1359/JBMR.040506; Weiss LA, 2006, NAT GENET, V38, P218, DOI 10.1038/ng1726	39	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22462	10.1371/journal.pone.0022462	http://dx.doi.org/10.1371/journal.pone.0022462			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818327	Green Published, gold, Green Submitted			2022-12-25	WOS:000293282700032
J	Pathak, S; Ma, SB; Trinh, L; Eudy, J; Wagner, KU; Joshi, SS; Lu, RQ				Pathak, Simanta; Ma, Shibin; Trinh, Long; Eudy, James; Wagner, Kay-Uwe; Joshi, Shantaram S.; Lu, Runqing			IRF4 Is a Suppressor of c-Myc Induced B Cell Leukemia	PLOS ONE			English	Article							INTERFERON REGULATORY FACTOR-4; TUMOR-SUPPRESSOR; GENE-EXPRESSION; TRANSGENIC MICE; PROTEIN SLP-65; LYMPHOMAGENESIS; RECEPTOR; DIFFERENTIATION; PROLIFERATION; RECOMBINATION	Interferon regulatory factor 4 (IRF4) is a critical transcriptional regulator in B cell development and function. We have previously shown that IRF4, together with IRF8, orchestrates pre-B cell development by limiting pre-B cell expansion and by promoting pre-B cell differentiation. Here, we report that IRF4 suppresses c-Myc induced leukemia in E mu Myc mice. Our results show that c-Myc induced leukemia was greatly accelerated in the IRF4 heterozygous mice (IRF4(+/-) Myc); the average age of mortality in the IRF4(+/-) Myc mice was only 7 to 8 weeks but was 20 weeks in the control mice. Our results show that IRF4(+/-) Myc leukemic cells were derived from large pre-B cells and were hyperproliferative and resistant to apoptosis. Further analysis revealed that the majority of IRF4(+/-) Myc leukemic cells inactivated the wild-type IRF4 allele and contained defects in Arf-p53 tumor suppressor pathway. p27(kip) is part of the molecular circuitry that controls pre-B cell expansion. Our results show that expression of p27(kip) was lost in the IRF4(+/-) Myc leukemic cells and reconstitution of IRF4 expression in those cells induced p27(kip) and inhibited their expansion. Thus, IRF4 functions as a classical tumor suppressor to inhibit c-Myc induced B cell leukemia in E mu Myc mice.	[Pathak, Simanta; Ma, Shibin; Trinh, Long; Eudy, James; Joshi, Shantaram S.; Lu, Runqing] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68131 USA; [Wagner, Kay-Uwe] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Pathak, S (corresponding author), Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68131 USA.	rlu@unmc.edu	Joshi, Sudhanshu/L-2284-2019; Wagner, Kay-Uwe/B-6044-2009; Pathak, Simanta/E-8208-2012	Joshi, Sudhanshu/0000-0003-4748-5001; Wagner, Kay-Uwe/0000-0002-5081-0226	National Institutes of Health [AI-67891]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067891] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant AI-67891. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaviva J, 2008, BLOOD, V112, P3798, DOI 10.1182/blood-2007-10-117838; ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Bouchard C, 1999, EMBO J, V18, P5321, DOI 10.1093/emboj/18.19.5321; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Flemming A, 2003, NAT IMMUNOL, V4, P38, DOI 10.1038/ni862; Garrison SP, 2008, MOL CELL BIOL, V28, P5391, DOI 10.1128/MCB.00907-07; Gomez-del Arco P, 2004, MOL CELL BIOL, V24, P2797, DOI 10.1128/MCB.24.7.2797-2807.2004; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Hennighausen L, 1995, J CELL BIOCHEM, V59, P463, DOI 10.1002/jcb.240590407; Herzog S, 2009, NAT REV IMMUNOL, V9, P195, DOI 10.1038/nri2491; Huettner CS, 2000, NAT GENET, V24, P57, DOI 10.1038/71691; Jo SH, 2010, BLOOD, V116, P2759, DOI 10.1182/blood-2009-07-234559; Johnson K, 2008, IMMUNITY, V28, P335, DOI 10.1016/j.immuni.2007.12.019; Kaku H, 2009, J IMMUNOL, V183, P5575, DOI 10.4049/jimmunol.0901988; Kersseboom R, 2003, J EXP MED, V198, P91, DOI 10.1084/jem.20030615; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Lu RQ, 2003, GENE DEV, V17, P1703, DOI 10.1101/gad.1104803; Lu RQ, 2008, TRENDS IMMUNOL, V29, P487, DOI 10.1016/j.it.2008.07.006; Ma SB, 2008, BLOOD, V111, P1396, DOI 10.1182/blood-2007-08-110106; Ma SB, 2006, J IMMUNOL, V177, P7898, DOI 10.4049/jimmunol.177.11.7898; Ma SB, 2010, MOL CELL BIOL, V30, P4149, DOI 10.1128/MCB.00224-10; Martins CP, 2002, EMBO J, V21, P3739, DOI 10.1093/emboj/cdf364; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Pathak S, 2008, MOL CELL BIOL, V28, P2815, DOI 10.1128/MCB.01946-07; Perez-Roger I, 1999, EMBO J, V18, P5310, DOI 10.1093/emboj/18.19.5310; Refaeli Y, 2005, P NATL ACAD SCI USA, V102, P4097, DOI 10.1073/pnas.0409832102; Refaeli Y, 2008, PLOS BIOL, V6, P1208, DOI 10.1371/journal.pbio.0060152; Saito M, 2007, CANCER CELL, V12, P280, DOI 10.1016/j.ccr.2007.08.011; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Ta VBT, 2011, LEUKEMIA, V25, P48, DOI 10.1038/leu.2010.246; Teitell MA, 2009, ANNU REV PATHOL-MECH, V4, P175, DOI 10.1146/annurev.pathol.4.110807.092227; Wen RR, 2006, MOL CELL BIOL, V26, P9364, DOI 10.1128/MCB.00839-06; Young RM, 2009, BLOOD, V114, P5016, DOI 10.1182/blood-2008-12-196709	37	34	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22628	10.1371/journal.pone.0022628	http://dx.doi.org/10.1371/journal.pone.0022628			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818355	Green Published, gold, Green Submitted			2022-12-25	WOS:000293282700053
J	Wiswede, D; Taubner, S; Munte, TF; Roth, G; Struber, D; Wahl, K; Kramer, UM				Wiswede, Daniel; Taubner, Svenja; Muente, Thomas F.; Roth, Gerhard; Strueber, Daniel; Wahl, Klaus; Kraemer, Ulrike M.			Neurophysiological Correlates of Laboratory-Induced Aggression in Young Men with and without a History of Violence	PLOS ONE			English	Article							BARRATT IMPULSIVENESS SCALE; EVENT-RELATED POTENTIALS; REACTIVE AGGRESSION; ERROR-DETECTION; FUNCTIONAL-SIGNIFICANCE; TRYPTOPHAN DEPLETION; NEGATIVE AFFECT; ERP COMPONENTS; NEURAL SYSTEM; EYE-MOVEMENT	In order to further understand the mechanisms involved in planning an aggressive act, we conducted an event-related potential (ERP) study of young men with and without a history of violence. Participants completed a competitive reaction time task (based on the Taylor aggression paradigm) against a virtual opponent. In "passive" blocks, participants were punished by the opponent when losing the trial but could not punish, when winning, whereas in "active" blocks, participants were able to punish the opponent when winning, but were not punished when losing. Participants selected punishment strength in a decision phase prior to each reaction time task and were informed whether they had won or lost in the outcome phase. Additionally, a flanker task was conducted to assess basic performance monitoring. Violent participants selected stronger punishments, especially in "active" blocks. During the decision phase, a frontal P200 was more pronounced for violent participants, whereas non-violent participants showed an enhanced frontal negativity around 300 ms. The P200 might reflect the decision to approach the opponent at a very early state, the latter negativity could reflect inhibition processes, leading to a more considerate reaction in non-violent participants. During the outcome phase, a Feedback-Related Negativity was seen in both groups. This effect was most pronounced when losing entailed a subsequent inability to retaliate. The groups did not differ in the flanker task, indicating intact basic performance monitoring. Our data suggest that the planning of an aggressive act is associated with distinct brain activity and that such activity is differentially represented in violent and non-violent individuals.	[Wiswede, Daniel] Univ Jena, Dept Gen Psychol 2, Jena, Germany; [Taubner, Svenja] Univ Kassel, Dept Psychol, Kassel, Germany; [Muente, Thomas F.; Kraemer, Ulrike M.] Univ Lubeck, Dept Neurol, Lubeck, Germany; [Roth, Gerhard] Univ Bremen, Brain Res Inst, Bremen, Germany; [Strueber, Daniel] Carl von Ossietzky Univ Oldenburg, Dept Expt Psychol, Oldenburg, Germany; [Wahl, Klaus] Psychosocial Anal & Prevent Informat Syst, Munich, Germany	Friedrich Schiller University of Jena; Universitat Kassel; University of Lubeck; University of Bremen; Carl von Ossietzky Universitat Oldenburg	Wiswede, D (corresponding author), Univ Jena, Dept Gen Psychol 2, Jena, Germany.	daniel.wiswede@uni-jena.de	Münte, Thomas/C-2077-2014; Krämer, Ulrike/AAF-2966-2020; Taubner, Svenja/AAY-5144-2020; Krämer, Ulrike M./A-8871-2019	Taubner, Svenja/0000-0001-8058-762X; Krämer, Ulrike M./0000-0002-3841-1812; Wiswede, Daniel/0000-0002-2702-8316; Wahl, Klaus/0000-0002-1910-5019	German Federal Ministry of the Interior; Hanse Institute of Advanced Study Delmenhorst; Hamburg Foundation for the Promotion of Science and Culture; DFG [SFB 779/A5, KR 3691/1-1]	German Federal Ministry of the Interior; Hanse Institute of Advanced Study Delmenhorst; Hamburg Foundation for the Promotion of Science and Culture; DFG(German Research Foundation (DFG))	The study was financially supported by the German Federal Ministry of the Interior, the Hanse Institute of Advanced Study Delmenhorst, and Hamburg Foundation for the Promotion of Science and Culture. TFM is supported by the DFG (SFB 779/A5). UMK is supported by a fellowship from the DFG (KR 3691/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPERS GW, 2008, HOGREFE; Bertsch K, 2011, HORM BEHAV, V59, P428, DOI 10.1016/j.yhbeh.2010.12.010; Bertsch K, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.028.2009; Brazil IA, 2009, BIOL PSYCHIAT, V65, P137, DOI 10.1016/j.biopsych.2008.08.011; Bushman BJ, 2001, PSYCHOL REV, V108, P273, DOI 10.1037//0033-295X.108.1.273; Carretie L, 2005, NEUROIMAGE, V24, P615, DOI 10.1016/j.neuroimage.2004.09.009; Carretie L, 2001, INT J PSYCHOPHYSIOL, V41, P75, DOI 10.1016/S0167-8760(00)00195-1; CLEARE AJ, 1995, PSYCHOPHARMACOLOGY, V118, P72, DOI 10.1007/BF02245252; Coccaro EF, 2007, BIOL PSYCHIAT, V62, P168, DOI 10.1016/j.biopsych.2006.08.024; Edens JF, 2011, LAW HUMAN BEHAV, V35, P13, DOI 10.1007/s10979-010-9230-8; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Fukushima H, 2006, SOC COGN AFFECT NEUR, V1, P149, DOI 10.1093/scan/nsl020; Gao Y, 2009, BIOL PSYCHOL, V82, P199, DOI 10.1016/j.biopsycho.2009.06.006; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Giancola PR, 2008, AGGRESSIVE BEHAV, V34, P214, DOI 10.1002/ab.20235; Hajcak G, 2005, PSYCHOPHYSIOLOGY, V42, P161, DOI 10.1111/j.1469-8986.2005.00278.x; Heldmann M, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-33; HELMERS KF, 1995, PERS INDIV DIFFER, V19, P927, DOI 10.1016/S0191-8869(95)00107-7; Hoaken PNS, 2003, AGGRESSIVE BEHAV, V29, P15, DOI 10.1002/ab.10023; Itagaki S, 2008, NEUROREPORT, V19, P383, DOI 10.1097/WNR.0b013e3282f556e8; Joyce CA, 2004, PSYCHOPHYSIOLOGY, V41, P313, DOI 10.1111/j.1469-8986.2003.00141.x; Kierkels JJM, 2006, IEEE T BIO-MED ENG, V53, P246, DOI 10.1109/TBME.2005.862533; Kramer UM, 2008, J COGNITIVE NEUROSCI, V20, P1464, DOI 10.1162/jocn.2008.20103; Kramer UM, 2007, NEUROIMAGE, V38, P203, DOI 10.1016/j.neuroimage.2007.07.029; Kramer UM, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.046.2009; Kuepper Y, 2007, J INDIVID DIFFER, V28, P64, DOI [DOI 10.1027/1614-0001.28.2.64, 10.1027/1614-0001.28.2.64]; LeMarquand DG, 1998, NEUROPSYCHOPHARMACOL, V19, P333; Lilienfeld S.O., 2005, PSYCHOPATHIC PERSONA; Lilienfeld SO, 1996, J PERS ASSESS, V66, P488, DOI 10.1207/s15327752jpa6603_3; Lotze M, 2007, NEUROIMAGE, V34, P470, DOI 10.1016/j.neuroimage.2006.09.028; Marco-Pallares J, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-86; McCloskey MS, 2006, J PSYCHIATR RES, V40, P231, DOI 10.1016/j.jpsychires.2005.07.004; MILTNER WH, 2003, ERRORS CONFLICTS BRA, P549; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Morgan AB, 2000, CLIN PSYCHOL REV, V20, P113, DOI 10.1016/S0272-7358(98)00096-8; Munro GES, 2007, BIOL PSYCHOL, V76, P31, DOI 10.1016/j.biopsycho.2007.05.004; Overbeek TJM, 2005, J PSYCHOPHYSIOL, V19, P319, DOI 10.1027/0269-8803.19.4.319; PATRICK CJ, 2006, HDB PSYCHOPATHY; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Polich J., 2004, BRAINWAVES MIND RECE, P15; Preuss UW, 2003, FORTSCHR NEUROL PSYC, V71, P527; Qin JG, 2009, NEUROPSYCHOLOGIA, V47, P397, DOI 10.1016/j.neuropsychologia.2008.09.010; Raine A, 2006, AGGRESSIVE BEHAV, V32, P159, DOI 10.1002/ab.20115; Raine A, 1997, BIOL PSYCHIAT, V42, P495, DOI 10.1016/S0006-3223(96)00362-9; Rigoni D, 2010, BRAIN RES BULL, V81, P445, DOI 10.1016/j.brainresbull.2009.12.003; Roth G, 2009, PRAX KINDERPSYCHOL K, V58, P587, DOI 10.13109/prkk.2009.58.8.587; Schapkin SA, 2000, ACTA NEUROBIOL EXP, V60, P17; Siever LJ, 2008, AM J PSYCHIAT, V165, P429, DOI 10.1176/appi.ajp.2008.07111774; TAYLOR SP, 1967, J PERS, V35, P297, DOI 10.1111/j.1467-6494.1967.tb01430.x; Thomas SJ, 2007, INT J PSYCHOPHYSIOL, V63, P221, DOI 10.1016/j.ijpsycho.2006.10.002; Uzieblo K, 2010, ASSESSMENT, V17, P334, DOI 10.1177/1073191109356544; van Schie HT, 2004, NAT NEUROSCI, V7, P549, DOI 10.1038/nn1239; Wahlund K, 2009, INT J LAW PSYCHIAT, V32, P266, DOI 10.1016/j.ijlp.2009.04.007; Wiswede D, 2009, SOC COGN AFFECT NEUR, V4, P227, DOI 10.1093/scan/nsp015; Wiswede D, 2009, NEUROPSYCHOLOGIA, V47, P83, DOI 10.1016/j.neuropsychologia.2008.08.016; WOLFE BM, 1971, PSYCHON SCI, V24, P193, DOI 10.3758/BF03335564; Yeung N, 2005, CEREB CORTEX, V15, P535, DOI 10.1093/cercor/bhh153; Yeung N, 2004, J NEUROSCI, V24, P6258, DOI 10.1523/JNEUROSCI.4537-03.2004	61	19	20	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22599	10.1371/journal.pone.0022599	http://dx.doi.org/10.1371/journal.pone.0022599			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	795FA	21811638	gold, Green Published, Green Submitted			2022-12-25	WOS:000292956800075
J	David-Watine, B				David-Watine, Brigitte			Silencing Nuclear Pore Protein Tpr Elicits a Senescent-Like Phenotype in Cancer Cells	PLOS ONE			English	Article							ONCOGENE-INDUCED SENESCENCE; COMPLEX; SUMO; P53; EXPORT; ASSOCIATION; SUMOYLATION; LOCALIZATION; NUCLEOPORINS; ACTIVATION	Background: Tpr is a large coiled-coil protein located in the nuclear basket of the nuclear pore complex for which many different functions were proposed from yeast to human. Methodology/Principal Findings: Here we show that depletion of Tpr by RNA interference triggers G0-G1 arrest and ultimately induces a senescent-like phenotype dependent on the presence of p53. We also found that Tpr depletion impairs the NES [nuclear export sequence]-dependent nuclear export of proteins and causes partial co-depletion of Nup153. In addition Tpr depletion impacts on level and function of the SUMO-protease SENP2 thus affecting SUMOylation regulation at the nuclear pore and overall SUMOylation in the cell. Conclusions: Our data for the first time provide evidence that a nuclear pore component plays a role in controlling cellular senescence. Our findings also point to new roles for Tpr in the regulation of SUMO-1 conjugation at the nuclear pore and directly confirm Tpr involvement in the nuclear export of NES-proteins.	Inst Pasteur, CNRS, URA2582, Grp Biol Cellulaire Noyau E3, Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	David-Watine, B (corresponding author), Inst Pasteur, CNRS, URA2582, Grp Biol Cellulaire Noyau E3, Paris, France.	brigitte.david-watine@pasteur.fr	David-Watine, Brigitte/ABF-5621-2020; David-Watine, Brigitte/M-1476-2018; David-Watine, Brigitte/AAP-2758-2020	David-Watine, Brigitte/0000-0002-3292-0042; 	Institut Pasteur	Institut Pasteur(European Commission)	This work was supported by the Institut Pasteur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayaydin F, 2004, MOL BIOL CELL, V15, P5208, DOI 10.1091/mbc.E04-07-0589; Bangs P, 1998, J CELL BIOL, V143, P1801, DOI 10.1083/jcb.143.7.1801; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Ben-Efraim I, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-74; Bischof O, 2007, CELL CYCLE, V6, P677, DOI 10.4161/cc.6.6.4021; Braig M, 2006, CANCER RES, V66, P2881, DOI 10.1158/0008-5472.CAN-05-4006; Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884; Cordes VC, 1997, J CELL BIOL, V136, P515, DOI 10.1083/jcb.136.3.515; Cordes VC, 1998, EXP CELL RES, V245, P43, DOI 10.1006/excr.1998.4246; Cortes R, 2010, CARDIOVASC RES, V85, P464, DOI 10.1093/cvr/cvp336; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089; Desai SD, 2003, MOL CELL BIOL, V23, P2341, DOI 10.1128/MCB.23.7.2341-2350.2003; Dieppois G, 2006, MOL CELL BIOL, V26, P7858, DOI 10.1128/MCB.00870-06; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Evdokimov E, 2008, J CELL SCI, V121, P4106, DOI 10.1242/jcs.038570; Feuerbach F, 2002, NAT CELL BIOL, V4, P214, DOI 10.1038/ncb756; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Frosst P, 2002, J CELL BIOL, V156, P617, DOI 10.1083/jcb.200106046; Galy V, 2004, CELL, V116, P63, DOI 10.1016/S0092-8674(03)01026-2; Galy V, 2000, NATURE, V403, P108, DOI 10.1038/47528; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Hang J, 2002, J BIOL CHEM, V277, P19961, DOI 10.1074/jbc.M201799200; Hase ME, 2003, MOL BIOL CELL, V14, P1923, DOI 10.1091/mbc.E02-09-0620; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Hietanen S, 2000, P NATL ACAD SCI USA, V97, P8501, DOI 10.1073/pnas.97.15.8501; Inoue T, 2005, FEBS LETT, V579, P4978, DOI 10.1016/j.febslet.2005.08.006; Itahana Y, 2006, MOL CELL BIOL, V26, P4675, DOI 10.1128/MCB.01830-05; Jacob Y, 2007, PLANT PHYSIOL, V144, P1383, DOI 10.1104/pp.107.100735; Joseph J, 2002, J CELL BIOL, V156, P595, DOI 10.1083/jcb.200110109; Kohler A, 2010, MOL CELL, V38, P6, DOI 10.1016/j.molcel.2010.01.040; Krull S, 2004, MOL BIOL CELL, V15, P4261, DOI 10.1091/mbc.E04-03-0165; Krull S, 2010, EMBO J, V29, P1659, DOI 10.1038/emboj.2010.54; Kuznetsov NV, 2002, CHROMOSOMA, V111, P236, DOI 10.1007/s00412-002-0208-2; Lecane PS, 2003, PROSTATE, V54, P258, DOI 10.1002/pros.10197; Lee SH, 2008, GENE DEV, V22, P2926, DOI 10.1101/gad.1677208; Lee SH, 2002, J BIOL CHEM, V277, P23358, DOI 10.1074/jbc.M111559200; Levenson VV, 2000, CANCER RES, V60, P5027; Li TW, 2006, J BIOL CHEM, V281, P36221, DOI 10.1074/jbc.M608236200; Li TW, 2004, P NATL ACAD SCI USA, V101, P8551, DOI 10.1073/pnas.0402889101; Lince-Faria M, 2009, J CELL BIOL, V184, P647, DOI 10.1083/jcb.200811012; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Makhnevych T, 2009, MOL CELL, V33, P124, DOI 10.1016/j.molcel.2008.12.025; Meinecke I, 2007, P NATL ACAD SCI USA, V104, P5073, DOI 10.1073/pnas.0608773104; Meyer T, 2007, FEBS J, V274, P815, DOI 10.1111/j.1742-4658.2006.05626.x; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Nakano H, 2010, J BIOL CHEM, V285, P10841, DOI 10.1074/jbc.M110.105890; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Palancade B, 2008, TRENDS CELL BIOL, V18, P174, DOI 10.1016/j.tcb.2008.02.001; Palancade B, 2007, MOL BIOL CELL, V18, P2912, DOI 10.1091/mbc.E07-02-0123; Pichler A, 2002, TRAFFIC, V3, P381, DOI 10.1034/j.1600-0854.2002.30601.x; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Rosas-Acosta G, 2005, MOL CELL PROTEOMICS, V4, P56, DOI 10.1074/mcp.M400149-MCP200; Smart P, 1999, ONCOGENE, V18, P7378, DOI 10.1038/sj.onc.1203260; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Taddei A, 2004, EMBO J, V23, P1301, DOI 10.1038/sj.emboj.7600144; Van der Watt PJ, 2009, INT J CANCER, V124, P1829, DOI 10.1002/ijc.24146; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; Vomastek T, 2008, MOL CELL BIOL, V28, P6954, DOI 10.1128/MCB.00925-08; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Wild T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000522; Xylourgidis N, 2009, DEV CELL, V17, P617, DOI 10.1016/j.devcel.2009.10.015; Yamamoto H, 2003, EMBO J, V22, P2047, DOI 10.1093/emboj/cdg204; Yan JL, 2007, P NATL ACAD SCI USA, V104, P1841, DOI 10.1073/pnas.0605562104; Yates KE, 2008, AGING CELL, V7, P609, DOI 10.1111/j.1474-9726.2008.00411.x; Zhang H, 2002, MOL CELL BIOL, V22, P6498, DOI 10.1128/MCB.22.18.6498-6508.2002; Zhang XD, 2008, MOL CELL, V29, P729, DOI 10.1016/j.molcel.2008.01.013; Zhao XL, 2004, J CELL BIOL, V167, P605, DOI 10.1083/jcb.200405168; Zhu SS, 2009, MOL CELL, V33, P570, DOI 10.1016/j.molcel.2009.02.008	69	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22423	10.1371/journal.pone.0022423	http://dx.doi.org/10.1371/journal.pone.0022423			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21811608	Green Published, Green Submitted, gold			2022-12-25	WOS:000292929500065
J	Hendrata, M; Yang, Z; Lux, R; Shi, WY				Hendrata, Melisa; Yang, Zhe; Lux, Renate; Shi, Wenyuan			Experimentally Guided Computational Model Discovers Important Elements for Social Behavior in Myxobacteria	PLOS ONE			English	Article							FRUITING-BODY FORMATION; SURFACE-ASSOCIATED MORPHOGEN; MYXOCOCCUS-XANTHUS; GLIDING MOTILITY; 3-DIMENSIONAL MODEL; PILUS RETRACTION; CELL-MOVEMENT; AGGREGATION; PATTERNS; SPORULATION	Identifying essential factors in cellular interactions and organized movement of cells is important in predicting behavioral phenotypes exhibited by many bacterial cells. We chose to study Myxococcus xanthus, a soil bacterium whose individual cell behavior changes while in groups, leading to spontaneous formation of aggregation center during the early stage of fruiting body development. In this paper, we develop a cell-based computational model that solely relies on experimentally determined parameters to investigate minimal elements required to produce the observed social behaviors in M. xanthus. The model verifies previously known essential parameters and identifies one novel parameter, the active turning, which we define as the ability and tendency of a cell to turn to a certain angle without the presence of any obvious external factors. The simulation is able to produce both gliding pattern and spontaneous aggregation center formation as observed in experiments. The model is tested against several known M. xanthus mutants and our modification of parameter values relevant for the individual mutants produces good phenotypic agreements. This outcome indicates the strong predictive potential of our model for the social behaviors of uncharacterized mutants and their expected phenotypes during development.	[Hendrata, Melisa] Calif State Univ Los Angeles, Dept Math, Los Angeles, CA 90032 USA; [Yang, Zhe; Shi, Wenyuan] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Lux, Renate; Shi, Wenyuan] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA	California State University System; California State University Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Hendrata, M (corresponding author), Calif State Univ Los Angeles, Dept Math, Los Angeles, CA 90032 USA.	mhendra@calstatela.edu	SHI, wen/GPW-9531-2022					Berg, 2018, RANDOM WALKS BIOL; Berg H, 2005, CURR BIOL, V15, pR189, DOI 10.1016/j.cub.2005.03.003; BLACKHART BD, 1985, P NATL ACAD SCI USA, V82, P8767, DOI 10.1073/pnas.82.24.8767; BURCHARD RP, 1982, J BACTERIOL, V152, P495; Chavira M, 2007, J BACTERIOL, V189, P169, DOI 10.1128/JB.00792-06; Curtis PD, 2007, J BACTERIOL, V189, P9126, DOI 10.1128/JB.01008-07; HAGEN DC, 1978, DEV BIOL, V64, P284, DOI 10.1016/0012-1606(78)90079-9; Hendrata M, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.061902; HODGKIN J, 1979, MOL GEN GENET, V171, P177, DOI 10.1007/BF00270004; Holmes AB, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000686; Igoshin OA, 2004, P NATL ACAD SCI USA, V101, P15760, DOI 10.1073/pnas.0407111101; Igoshin OA, 2004, CURR BIOL, V14, pR459, DOI 10.1016/j.cub.2004.06.007; Igoshin OA, 2004, P NATL ACAD SCI USA, V101, P4256, DOI 10.1073/pnas.0400704101; Janetopoulos C, 2008, FEBS LETT, V582, P2075, DOI 10.1016/j.febslet.2008.04.035; Jelsbak L, 2002, P NATL ACAD SCI USA, V99, P2032, DOI 10.1073/pnas.042535699; KAISER D, 1979, P NATL ACAD SCI USA, V76, P5952, DOI 10.1073/pnas.76.11.5952; Kaiser D, 2003, NAT REV MICROBIOL, V1, P45, DOI 10.1038/nrmicro733; Kaiser D, 2004, J BACTERIOL, V186, P919, DOI 10.1128/JB.186.4.919-927.2004; Kaiser D, 2006, ANNU REV MICROBIOL, V60, P1, DOI 10.1146/annurev.micro.60.080805.142209; Kaiser D, 2008, ANNU REV GENET, V42, P109, DOI 10.1146/annurev.genet.42.110807.091615; KIM SK, 1990, CELL, V61, P19, DOI 10.1016/0092-8674(90)90211-V; Kruse T, 2001, MOL MICROBIOL, V40, P156, DOI 10.1046/j.1365-2958.2001.02365.x; Lux R., 2004, BIOFILMS, V1, P293; MCBRIDE MJ, 1993, J BACTERIOL, V175, P4936, DOI 10.1128/JB.175.15.4936-4940.1993; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Mignot T, 2007, CELL MOL LIFE SCI, V64, P2733, DOI 10.1007/s00018-007-7176-x; Mignot T, 2008, BIOESSAYS, V30, P733, DOI 10.1002/bies.20790; Mignot T, 2007, SCIENCE, V315, P853, DOI 10.1126/science.1137223; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; OCONNOR KA, 1989, J BACTERIOL, V171, P6013, DOI 10.1128/jb.171.11.6013-6024.1989; Pelling AE, 2006, CELL MOTIL CYTOSKEL, V63, P141, DOI 10.1002/cm.20112; SAGER B, 1993, P NATL ACAD SCI USA, V90, P3690, DOI 10.1073/pnas.90.8.3690; Shaulsky G, 2007, CURR BIOL, V17, pR684, DOI 10.1016/j.cub.2007.06.024; Shi WY, 2000, FEMS MICROBIOL LETT, V192, P211, DOI 10.1016/S0378-1097(00)00434-1; SHI WY, 1993, P NATL ACAD SCI USA, V90, P3378, DOI 10.1073/pnas.90.8.3378; Shi WY, 1996, P NATL ACAD SCI USA, V93, P4142, DOI 10.1073/pnas.93.9.4142; Skerker JM, 2001, P NATL ACAD SCI USA, V98, P6901, DOI 10.1073/pnas.121171698; Sliusarenko O, 2007, J BACTERIOL, V189, P611, DOI 10.1128/JB.01206-06; Sozinova O, 2005, P NATL ACAD SCI USA, V102, P11308, DOI 10.1073/pnas.0504259102; Sozinova O, 2006, P NATL ACAD SCI USA, V103, P17255, DOI 10.1073/pnas.0605555103; SPORMANN AM, 1995, J BACTERIOL, V177, P5846, DOI 10.1128/jb.177.20.5846-5852.1995; Sun H, 2000, CURR BIOL, V10, P1143, DOI 10.1016/S0960-9822(00)00705-3; VARON M, 1984, J BACTERIOL, V160, P1146, DOI 10.1128/JB.160.3.1146-1150.1984; Wolgemuth C, 2002, CURR BIOL, V12, P369, DOI 10.1016/S0960-9822(02)00716-9; Wu YL, 2009, P NATL ACAD SCI USA, V106, P1222, DOI 10.1073/pnas.0811662106; Wu YL, 2007, PLOS COMPUT BIOL, V3, P2546, DOI 10.1371/journal.pcbi.0030253; Yang ZM, 1998, MOL MICROBIOL, V30, P1123, DOI 10.1046/j.1365-2958.1998.01160.x; Zusman DR, 2007, NAT REV MICROBIOL, V5, P862, DOI 10.1038/nrmicro1770	49	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22169	10.1371/journal.pone.0022169	http://dx.doi.org/10.1371/journal.pone.0022169			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21811570	Green Published, Green Submitted, gold			2022-12-25	WOS:000292929500044
J	Abney, TM; Feng, Y; Pless, R; Okamoto, RJ; Genin, GM; Bayly, PV				Abney, Teresa M.; Feng, Yuan; Pless, Robert; Okamoto, Ruth J.; Genin, Guy M.; Bayly, Philip V.			Principal Component Analysis of Dynamic Relative Displacement Fields Estimated from MR Images	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; HEAD; MOTION; DEFORMATION; IMPACT; ACCELERATION; BIOMECHANICS; CYLINDER; STRAIN	Non-destructive measurement of acceleration-induced displacement fields within a closed object is a fundamental challenge. Inferences of how the brain deforms following skull impact have thus relied largely on indirect estimates and course-resolution cadaver studies. We developed a magnetic resonance technique to quantitatively identify the modes of displacement of an accelerating soft object relative to an object enclosing it, and applied it to study acceleration-induced brain deformation in human volunteers. We show that, contrary to the prevailing hypotheses of the field, the dominant mode of interaction between the brain and skull in mild head acceleration is one of sliding arrested by meninges.	[Abney, Teresa M.; Feng, Yuan; Okamoto, Ruth J.; Genin, Guy M.; Bayly, Philip V.] Washington Univ, Dept Mech Engn & Mat Sci, St Louis, MO 63130 USA; [Abney, Teresa M.; Genin, Guy M.] Washington Univ, Ctr Mat Innovat, St Louis, MO USA; [Pless, Robert] Washington Univ, Dept Comp Sci & Engn, St Louis, MO USA; [Bayly, Philip V.] Washington Univ, Dept Biomed Engn, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Abney, TM (corresponding author), Washington Univ, Dept Mech Engn & Mat Sci, St Louis, MO 63130 USA.	baylyp@seas.wustl.edu	Pless, Robert B/I-4698-2013; Feng, Yuan/C-7417-2011	Feng, Yuan/0000-0003-1902-3408; Bayly, Philip/0000-0003-4303-0704; Okamoto, Ruth/0000-0002-3085-3878	NIF [NS055951, HL079165]; NSF [0538541]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL079165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055951] Funding Source: NIH RePORTER	NIF(Department of Science & Technology (India)); NSF(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the NIF through grants NS055951 and HL079165, and by the NSF through grant 0538541 and a graduate fellowship to TMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXEL L, 1989, RADIOLOGY, V171, P841, DOI 10.1148/radiology.171.3.2717762; BAILY BN, 1989, MILD HEAD INJURY, P308; Bayly PV, 2008, J MECH PHYS SOLIDS, V56, P2036, DOI 10.1016/j.jmps.2007.10.012; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Bayly PV, 2004, J BIOMECH ENG-T ASME, V126, P523, DOI 10.1115/1.1785811; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Hardy Warren N., 2001, INVESTIGATION HEAD I; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; JACOBS N, 2008, FULLY AUTOMATIC GEOL, P1; Ji Songbai, 2004, Stapp Car Crash J, V48, P227; Ji SB, 2007, J BIOMECH, V40, P92, DOI 10.1016/j.jbiomech.2005.11.009; Ji SB, 2009, MED IMAGE ANAL, V13, P659, DOI 10.1016/j.media.2009.05.007; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Levchakov A, 2006, J NEUROTRAUM, V23, P1570, DOI 10.1089/neu.2006.23.1570; Massouros PG, 2008, P ROY SOC A-MATH PHY, V464, P207, DOI 10.1098/rspa.2007.0081; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Osman NF, 2000, IEEE T MED IMAGING, V19, P186, DOI 10.1109/42.845177; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; SIROVICH L, 1987, J OPT SOC AM A, V4, P519, DOI 10.1364/JOSAA.4.000519; SOEDEL W, 2004, VIBRATIONS SHELLS PL, V14, P366; Spaethling JM, 2007, PROG BRAIN RES, V161, P27, DOI 10.1016/S0079-6123(06)61003-0; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zou H, 2007, J BIOMECH, V40, P1183, DOI 10.1016/j.jbiomech.2006.06.018	27	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e22063	10.1371/journal.pone.0022063	http://dx.doi.org/10.1371/journal.pone.0022063			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21811560	gold, Green Published, Green Submitted			2022-12-25	WOS:000292811300038
J	Leis, O; Eguiara, A; Lopez-Arribillaga, E; Alberdi, MJ; Hernandez-Garcia, S; Elorriaga, K; Pandiella, A; Rezola, R; Martin, AG				Leis, O.; Eguiara, A.; Lopez-Arribillaga, E.; Alberdi, M. J.; Hernandez-Garcia, S.; Elorriaga, K.; Pandiella, A.; Rezola, R.; Martin, A. G.			Sox2 expression in breast tumours and activation in breast cancer stem cells	ONCOGENE			English	Article						Sox2; breast cancer; cancer stem cell; mammosphere	IN-VITRO PROPAGATION; SIDE POPULATION; SELF-RENEWAL; MOUSE; IDENTIFICATION; FIBROBLASTS; GENERATION; RESISTANCE; INDUCTION; PATHWAY	The cancer stem cell (CSC) model does not imply that tumours are generated from transformed tissue stem cells. The target of transformation could be a tissue stem cell, a progenitor cell, or a differentiated cell that acquires self-renewal ability. The observation that induced pluripotency reprogramming and cancer are related has lead to the speculation that CSCs may arise through a reprogramming-like mechanism. Expression of pluripotency genes (Oct4, Nanog and Sox2) was tested in breast tumours by immunohistochemistry and it was found that Sox2 is expressed in early stage breast tumours. However, expression of Oct4 or Nanog was not found. Mammosphere formation in culture was used to reveal stem cell properties, where expression of Sox2, but not Oct4 or Nanog, was induced. Over-expression of Sox2 increased mammosphere formation, effect dependent on continuous Sox2 expression; furthermore, Sox2 knockdown prevented mammosphere formation and delayed tumour formation in xenograft tumour initiation models. Induction of Sox2 expression was achieved through activation of the distal enhancer of Sox2 promoter upon sphere formation, the same element that controls Sox2 transcription in pluripotent stem cells. These findings suggest that reactivation of Sox2 represents an early step in breast tumour initiation, explaining tumour heterogeneity by placing the tumour-initiating event in any cell along the axis of mammary differentiation.Oncogene (2012) 31, 1354-1365; doi:10.1038/onc.2011.338; published online 8 August 2011	[Leis, O.; Eguiara, A.; Lopez-Arribillaga, E.; Martin, A. G.] Fdn Inbiomed, Regulat Cell Growth Lab, San Sebastian 20009, Gipuzkoa, Spain; [Alberdi, M. J.; Elorriaga, K.; Rezola, R.] Onkologikoa, Dept Pathol, San Sebastian, Spain; [Hernandez-Garcia, S.; Pandiella, A.] Inst Biol Mol & Celular Canc, Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC)	Martin, AG (corresponding author), Fdn Inbiomed, Regulat Cell Growth Lab, Paseo Mikeletegi 61, San Sebastian 20009, Gipuzkoa, Spain.	agmartin@inbiomed.org	Pandiella, Atanasio/O-5180-2014	Pandiella, Atanasio/0000-0002-4704-8971; Lopez-Arribillaga, Erika/0000-0002-9451-6635	Obra Social Kutxa; Fundacion Medica Mutua Madrilena; Gobierno Vasco [PI2010-25]; Instituto de Salud Carlos III Accion Estrategica en Salud [PI2010-01035]	Obra Social Kutxa; Fundacion Medica Mutua Madrilena(Instituto de Salud Carlos III); Gobierno Vasco(Basque Government); Instituto de Salud Carlos III Accion Estrategica en Salud	The Regulation of Cell Growth Laboratory is supported by grants from Obra Social Kutxa, Fundacion Medica Mutua Madrilena, Gobierno Vasco (Saiotek program and Consejeria de Educacion PI2010-25) and Instituto de Salud Carlos III Accion Estrategica en Salud (PI2010-01035). We thank Izaskun Beloqui, Andres Pavon and Maria Diaz for technical support. We thank the Flow Cytometry Unit at Inbiomed for extensive aid in flow cytometric analysis of fresh tumour cells. We thank our colleagues at Inbiomed for helpful discussion. We thank Dr R Sanchez-Pernaute and Dr L Vellon for critical reading of the manuscript.	Abraham BK, 2005, CLIN CANCER RES, V11, P1154; Akala OO, 2008, NATURE, V453, P228, DOI 10.1038/nature06869; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ambady S, 2010, INT J DEV BIOL, V54, P1743, DOI 10.1387/ijdb.103192sa; Ao A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018810; Callagy G, 2003, DIAGN MOL PATHOL, V12, P27, DOI 10.1097/00019606-200303000-00004; Cantz T, 2008, STEM CELLS, V26, P692, DOI 10.1634/stemcells.2007-0657; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Cirenajwis H, 2010, ANTI-CANCER DRUG, V21, P897, DOI 10.1097/CAD.0b013e32833f2f77; Comtesse N, 2005, P NATL ACAD SCI USA, V102, P9601, DOI 10.1073/pnas.0500404102; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Engelmann K, 2008, CANCER RES, V68, P2419, DOI 10.1158/0008-5472.CAN-07-2249; Farnie G, 2007, JNCI-J NATL CANCER I, V99, P616, DOI 10.1093/jnci/djk133; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Ghods AJ, 2007, STEM CELLS, V25, P1645, DOI 10.1634/stemcells.2006-0624; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gure AO, 2000, P NATL ACAD SCI USA, V97, P4198, DOI 10.1073/pnas.97.8.4198; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Iliopoulos D, 2011, P NATL ACAD SCI USA, V108, P1397, DOI 10.1073/pnas.1018898108; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Katoh M, 2011, CURR PHARM BIOTECHNO, V12, P160, DOI 10.2174/138920111794295710; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kondo T, 2004, GENE DEV, V18, P2963, DOI 10.1101/gad.309404; Lengerke C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-42; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Li XL, 2004, INT J ONCOL, V24, P257; Liu M, 2010, CANCER RES, V70, P10464, DOI 10.1158/0008-5472.CAN-10-0732; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Martin AG, 2001, J BIOL CHEM, V276, P15840, DOI 10.1074/jbc.M011313200; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Miyagi S, 2006, J BIOL CHEM, V281, P13374, DOI 10.1074/jbc.M512669200; Miyagi S, 2004, MOL CELL BIOL, V24, P4207, DOI 10.1128/MCB.24.10.4207-4220.2004; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Rodriguez-Pinilla SM, 2007, MODERN PATHOL, V20, P474, DOI 10.1038/modpathol.3800760; Sanada Y, 2006, PANCREAS, V32, P164, DOI 10.1097/01.mpa.0000202947.80117.a0; Sattler HP, 2000, PROSTATE, V45, P207, DOI 10.1002/1097-0045(20001101)45:3<207::AID-PROS2>3.0.CO;2-H; Shafee N, 2008, CANCER RES, V68, P3243, DOI 10.1158/0008-5472.CAN-07-5480; Sholl LM, 2010, AM J SURG PATHOL, V34, P1193, DOI 10.1097/PAS.0b013e3181e5e024; Simoes BM, 2011, BREAST CANCER RES TR, V129, P23, DOI 10.1007/s10549-010-1169-4; Suo GL, 2005, BIOCHEM BIOPH RES CO, V337, P1047, DOI 10.1016/j.bbrc.2005.09.157; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tanei T, 2009, CLIN CANCER RES, V15, P4234, DOI 10.1158/1078-0432.CCR-08-1479; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Yamanaka S, 2008, CELL PROLIFERAT, V41, P51, DOI 10.1111/j.1365-2184.2008.00493.x; Zappone MV, 2000, DEVELOPMENT, V127, P2367; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zhang JY, 2006, FEBS J, V273, P1723, DOI 10.1111/j.1742-4658.2006.05186.x; Zhou JB, 2008, BREAST CANCER RES TR, V111, P419, DOI 10.1007/s10549-007-9798-y	62	383	395	0	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2012	31	11					1354	1365		10.1038/onc.2011.338	http://dx.doi.org/10.1038/onc.2011.338			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	912FL	21822303				2022-12-25	WOS:000301780000003
J	Hashiguchi, T; Mizumoto, S; Nishimura, Y; Tamura, J; Yamada, S; Sugahara, K				Hashiguchi, Taishi; Mizumoto, Shuji; Nishimura, Yuko; Tamura, Jun-ichi; Yamada, Shuhei; Sugahara, Kazuyuki			Involvement of Human Natural Killer-1 (HNK-1) Sulfotransferase in the Biosynthesis of the GlcUA(3-O-sulfate)-Gal-Gal-Xyl Tetrasaccharide Found in alpha-Thrombomodulin from Human Urine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN SULFATE-K; 3-O-SULFATED GLUCURONIC-ACID; MONOCLONAL-ANTIBODY; SOLUBLE THROMBOMODULIN; CARBOHYDRATE EPITOPE; EXPRESSION CLONING; IGM PARAPROTEINS; DERMATAN SULFATE; NERVOUS-SYSTEM; OLIGOSACCHARIDES	Thrombomodulin (TM) is an integral membrane glycoprotein, which occurs as both a chondroitin sulfate (CS) proteoglycan (PG) form (beta-TM) and a non-PG form without a CS chain (alpha-TM) and hence is a part-time PG. An alpha-TM preparation isolated from human urine contained the glycosaminoglycan linkage region tetrasaccharide GlcUA beta 1-3Gal beta 1-3Gal beta 1-4xylose, and the nonreducing terminal GlcUA residue is 3-O-sulfated. Because the human natural killer-1 sulfotransferase (HNK-1ST) transfers a sulfate group from 3'-phosphoadenosine 5'-phosphosulfate to the C-3 position of the nonreducing terminal GlcUA residue in the HNK-1 antigen precursor trisaccharide, GlcUA beta 1-3Gal beta 1-4GlcNAc, the sulfotransferase activity toward the linkage region was investigated. In fact, the activity of HNK-1ST toward the linkage region was much higher than that toward the glucuronylneolactotetraosylceramide, the precursor of the HNK-1 epitope. HNK-1ST may be responsible for regulating the sorting of alpha- and beta-TM. Furthermore, HNK-1ST also transferred a sulfate group from 3'-phosphoadenosine 5'-phosphosulfate to the C-3 position of the nonreducing terminal GlcUA residue of a chondroitin chain. Intriguingly, the HNK-1 antibody recognized CS chains and the linkage region if they contained GlcUA(3-O-sulfate), suggesting that HNK-1ST not only synthesizes the HNK-1 epitope but may also be involved in the generation of part-time PGs.	[Hashiguchi, Taishi; Mizumoto, Shuji; Yamada, Shuhei; Sugahara, Kazuyuki] Hokkaido Univ, Lab Proteoglycan Signaling & Therapeut, Frontier Res Ctr Postgenom Sci & Technol, Grad Sch Life Sci,Kita Ku, Sapporo, Hokkaido 0010021, Japan; [Nishimura, Yuko; Tamura, Jun-ichi] Tottori Univ, Dept Reg Environm, Fac Reg Sci, Tottori 6808551, Japan	Hokkaido University; Tottori University	Yamada, S (corresponding author), Hokkaido Univ, Lab Proteoglycan Signaling & Therapeut, Frontier Res Ctr Postgenom Sci & Technol, Grad Sch Life Sci,Kita Ku, West 11,North 21, Sapporo, Hokkaido 0010021, Japan.	tjohej@sci.hokudai.ac.jp; k-sugar@sci.hokudai.ac.jp	Mizumoto, Shuji/F-8313-2018	Mizumoto, Shuji/0000-0002-4641-1505	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [23390016, 23790066, 12660098]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for Scientific Research (B) 23390016 (to K. S.), Young Scientists (B) 23790066 (to S. M.), and Scientific Research (C) 12660098 (to J. T.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	ABO T, 1981, J IMMUNOL, V127, P1024; ARIGA T, 1987, J BIOL CHEM, V262, P848; Bakker H, 1997, J BIOL CHEM, V272, P29942, DOI 10.1074/jbc.272.47.29942; Bao XF, 2005, J BIOL CHEM, V280, P9180, DOI 10.1074/jbc.M413423200; CHOU DKH, 1986, J BIOL CHEM, V261, P1717; Deepa SS, 2007, BIOCHEMISTRY-US, V46, P2453, DOI 10.1021/bi602374m; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Dudek AZ, 1997, J BIOL CHEM, V272, P31785, DOI 10.1074/jbc.272.50.31785; Fongmoon D, 2007, J BIOL CHEM, V282, P36895, DOI 10.1074/jbc.M707082200; FRANSSON LA, 1987, TRENDS BIOCHEM SCI, V12, P406, DOI 10.1016/0968-0004(87)90197-6; Hashiguchi T, 2010, GLYCOCONJUGATE J, V27, P49, DOI 10.1007/s10719-009-9253-x; Hiraoka N, 2000, J BIOL CHEM, V275, P20188, DOI 10.1074/jbc.M002443200; ILYAS AA, 1986, BRAIN RES, V385, P1, DOI 10.1016/0006-8993(86)91540-4; Kaneiwa T, 2010, GLYCOBIOLOGY, V20, P300, DOI 10.1093/glycob/cwp174; Kinoshita A, 1997, J BIOL CHEM, V272, P19656, DOI 10.1074/jbc.272.32.19656; Kinoshita A, 1999, ANAL BIOCHEM, V269, P367, DOI 10.1006/abio.1999.4027; Kitagawa H, 1997, GLYCOBIOLOGY, V7, P531, DOI 10.1093/glycob/7.4.531; KITAGAWA H, 1995, J BIOCHEM-TOKYO, V117, P1083, DOI 10.1093/oxfordjournals.jbchem.a124810; Kitagawa H, 1997, BIOCHEMISTRY-US, V36, P3998, DOI 10.1021/bi962740j; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Marcos I, 2002, J HUM GENET, V47, P677, DOI 10.1007/s100380200103; Mikami T, 2003, J BIOL CHEM, V278, P36115, DOI 10.1074/jbc.M306044200; Mitsumoto Y, 2000, GENOMICS, V65, P166, DOI 10.1006/geno.2000.6152; Morita I, 2008, J BIOCHEM, V143, P719, DOI 10.1093/jb/mvm221; Nadanaka S, 1998, J BIOL CHEM, V273, P33728, DOI 10.1074/jbc.273.50.33728; Nandini CD, 2006, ADV PHARMACOL, V53, P253, DOI 10.1016/S1054-3589(05)53012-6; NAWA K, 1990, BIOCHEM BIOPH RES CO, V171, P729, DOI 10.1016/0006-291X(90)91207-9; Ong E, 1998, J BIOL CHEM, V273, P5190, DOI 10.1074/jbc.273.9.5190; Plaas AHK, 1997, J BIOL CHEM, V272, P20603, DOI 10.1074/jbc.272.33.20603; SENO N, 1982, CARBOHYD RES, V103, P190; SHIODA Y, 1984, HISTOCHEM J, V16, P843, DOI 10.1007/BF01002790; Sugahara K, 1996, J BIOL CHEM, V271, P26745, DOI 10.1074/jbc.271.43.26745; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugahara K, 1996, GLYCOCONJUGATE J, V13, P609, DOI 10.1007/BF00731449; Sugahara K, 1996, EUR J BIOCHEM, V239, P865, DOI 10.1111/j.1432-1033.1996.0865u.x; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; SVENNERHOLM L, 1980, BIOCHIM BIOPHYS ACTA, V617, P97, DOI 10.1016/0005-2760(80)90227-1; Tagawa H, 2005, J BIOL CHEM, V280, P23876, DOI 10.1074/jbc.M501728200; Tamura J, 2010, CARBOHYD RES, V345, P2115, DOI 10.1016/j.carres.2010.06.019; VIEIRA RP, 1991, J BIOL CHEM, V266, P13530; Wakabayashi H, 1999, J BIOL CHEM, V274, P5436, DOI 10.1074/jbc.274.9.5436	41	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33003	33011		10.1074/jbc.M111.279174	http://dx.doi.org/10.1074/jbc.M111.279174			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21828042	Green Published, hybrid			2022-12-25	WOS:000294968800018
J	Kavitha, CV; Agarwal, C; Agarwal, R; Deep, G				Kavitha, Chandagirikoppal V.; Agarwal, Chapla; Agarwal, Rajesh; Deep, Gagan			Asiatic Acid Inhibits Pro-Angiogenic Effects of VEGF and Human Gliomas in Endothelial Cell Culture Models	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; BEVACIZUMAB PLUS IRINOTECAN; CENTELLA-ASIATICA; CYCLE ARREST; ANTIANGIOGENIC THERAPY; KINASE INHIBITORS; MALIGNANT GLIOMAS; PHASE-II; APOPTOSIS; GROWTH	Malignant gliomas are one of the most devastating and incurable tumors. Sustained excessive angiogenesis by glioma cells is the major reason for their uncontrolled growth and resistance toward conventional therapies resulting in high mortality. Therefore, targeting angiogenesis should be a logical strategy to prevent or control glioma cell growth. Earlier studies have shown that Asiatic Acid (AsA), a pentacyclic triterpenoid, is effective against glioma and other cancer cells; however, its efficacy against angiogenesis remains unknown. In the present study, we examined the anti-angiogenic efficacy of AsA using human umbilical vein endothelial cells (HUVEC) and human brain microvascular endothelial cells (HBMEC). Our results showed that AsA (5-20 mM) inhibits HUVEC growth and induces apoptotic cell death by activating caspases (3 and 9) and modulating the expression of apoptosis regulators Bad, survivin and pAkt-ser473. Further, AsA showed a dose-dependent inhibition of HUVEC migration, invasion and capillary tube formation, and disintegrated preformed capillary network. AsA also inhibited the VEGF-stimulated growth and capillary tube formation by HUVEC and HBMEC. Next, we analyzed the angiogenic potential of conditioned media collected from human glioma LN18 and U87-MG cells treated with either DMSO (control conditioned media, CCM) or AsA 20 mM (AsA20 conditioned media, AsA20CM). CCM from glioma cells significantly enhanced the capillary tube formation in both HUVEC and HBMEC, while capillary tube formation in both endothelial cell lines was greatly compromised in the presence of AsA20CM. Consistent with these results, VEGF expression was lesser in AsA20CM compared to CCM, and indeed AsA strongly inhibited VEGF level (both cellular and secreted) in glioma cells. AsA also showed dose-dependent anti-angiogenic efficacy in Matrigel plug assay, and inhibited the glioma cells potential to attract HUVEC/HBMEC. Overall, the present study clearly showed the strong anti-angiogenic potential of AsA and suggests its usefulness against malignant gliomas.	[Kavitha, Chandagirikoppal V.; Agarwal, Chapla; Agarwal, Rajesh; Deep, Gagan] Univ Colorado, Dept Pharmaceut Sci, Sch Pharm, Denver, CO 80202 USA; [Agarwal, Chapla; Agarwal, Rajesh; Deep, Gagan] Univ Colorado Canc Ctr, Aurora, CO USA	University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus	Kavitha, CV (corresponding author), Univ Colorado, Dept Pharmaceut Sci, Sch Pharm, Denver, CO 80202 USA.	Gagan.deep@ucdenver.edu	Deep, Gagan/H-1853-2012		Department of Pharmaceutical Sciences (DOPS); NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER	Department of Pharmaceutical Sciences (DOPS); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Department of Pharmaceutical Sciences (DOPS) Seed Grant to GD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal C, 2003, ONCOGENE, V22, P8271, DOI 10.1038/sj.onc.1207158; Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Boehm T, 1997, NATURE, V390, P404, DOI 10.1038/37126; Breen EC, 2007, J CELL BIOCHEM, V102, P1358, DOI 10.1002/jcb.21579; Bunpo P, 2004, FOOD CHEM TOXICOL, V42, P1987, DOI 10.1016/j.fct.2004.06.022; Bunpo P, 2005, J MED INVESTIG, V52, P65, DOI 10.2152/jmi.52.65; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cho CW, 2006, CELL BIOL TOXICOL, V22, P393, DOI 10.1007/s10565-006-0104-2; Dhanasekaran M, 2009, PHYTOTHER RES, V23, P14, DOI 10.1002/ptr.2405; FAN S, 2009, CANC LETT, V291, P158; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P23536, DOI 10.1074/jbc.M400554200; GRIMALDI R, 1990, J ETHNOPHARMACOL, V28, P235, DOI 10.1016/0378-8741(90)90033-P; Gu QY, 2004, RADIAT RES, V161, P692, DOI 10.1667/RR3158; Gurfinkel DM, 2006, APOPTOSIS, V11, P1463, DOI 10.1007/s10495-006-9086-z; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hsu YL, 2005, J PHARMACOL EXP THER, V313, P333, DOI 10.1124/jpet.104.078808; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; JUNCK L, NEUROLOGY, V76, P414; Kabbinavar F, 2003, J CLIN ONCOL, V21, P60, DOI 10.1200/JCO.2003.10.066; Khwaja A, 1999, NATURE, V401, P33, DOI 10.1038/43354; Kreisl TN, 2009, J CLIN ONCOL, V27, P740, DOI 10.1200/JCO.2008.16.3055; Krishnamurthy RG, 2009, J NEUROSCI RES, V87, P2541, DOI 10.1002/jnr.22071; Lee YS, 2003, EUR J PHARMACOL, V476, P173, DOI 10.1016/S0014-2999(03)02177-0; Lee YS, 2002, CANCER LETT, V186, P83, DOI 10.1016/S0304-3835(02)00260-4; Louis DN, 2002, CANCER CELL, V1, P125, DOI 10.1016/S1535-6108(02)00040-5; MATO L, 2009, EVID BASED COMPLEMEN; Omuro AMP, 2007, MOL CANCER THER, V6, P1909, DOI 10.1158/1535-7163.MCT-07-0047; ONISHI M, BRAIN TUMOR PATHOL, V28, P13; Park BC, 2005, CANCER LETT, V218, P81, DOI 10.1016/j.canlet.2004.06.039; Park BC, 2007, BIOL PHARM BULL, V30, P176, DOI 10.1248/bpb.30.176; Patan S, 2004, CANC TREAT, V117, P3; Preusser M, 2006, WIEN MED WOCHENSCHR, V156, P332, DOI 10.1007/s10354-006-0304-7; Saunders WB, 2006, J CELL BIOL, V175, P179, DOI 10.1083/jcb.200603176; Shinomol GK, 2008, NEUROTOXICOLOGY, V29, P948, DOI 10.1016/j.neuro.2008.09.009; SHINOMOL GK, PHYTOTHER RES, V24, P885; Singh R, 2008, BIOGERONTOLOGY, V9, P369, DOI 10.1007/s10522-008-9185-z; Singh RP, 2005, ONCOGENE, V24, P1188, DOI 10.1038/sj.onc.1208276; Skobe M, 1997, NAT MED, V3, P1222, DOI 10.1038/nm1197-1222; Takano S, 2010, J ONCOL, V2010, DOI 10.1155/2010/351908; Takano S, 2010, J NEURO-ONCOL, V99, P177, DOI 10.1007/s11060-010-0118-8; Tang XL, 2009, BIOL PHARM BULL, V32, P1399, DOI 10.1248/bpb.32.1399; Tortora G, 2004, CURR PHARM DESIGN, V10, P11, DOI 10.2174/1381612043453595; van Moorselaar RJA, 2002, MOL CELL ENDOCRINOL, V197, P239, DOI 10.1016/S0303-7207(02)00262-9; Whitacre CM, 1997, CANCER RES, V57, P2157; Zhao P, 2010, BIOCHEM BIOPH RES CO, V395, P219, DOI 10.1016/j.bbrc.2010.03.165; Zhong HZ, 2007, CURR TOP MED CHEM, V7, P1379	52	52	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22745	10.1371/journal.pone.0022745	http://dx.doi.org/10.1371/journal.pone.0022745			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826202	gold, Green Submitted, Green Published			2022-12-25	WOS:000293558900028
J	Pinske, C; Bonn, M; Kruger, S; Lindenstrauss, U; Sawers, RG				Pinske, Constanze; Boenn, Markus; Krueger, Sara; Lindenstrauss, Ute; Sawers, R. Gary			Metabolic Deficiences Revealed in the Biotechnologically Important Model Bacterium Escherichia coli BL21(DE3)	PLOS ONE			English	Article							PYRUVATE FORMATE-LYASE; B STRAINS REL606; NITRATE REDUCTASE; TRANSCRIPTIONAL REGULATION; HYDROGENASE ISOENZYMES; ANAEROBIC REGULATION; MOLYBDATE TRANSPORT; CRYSTAL-STRUCTURE; GENOME SEQUENCES; ACTIVE-SITE	The Escherichia coli B strain BL21(DE3) has had a profound impact on biotechnology through its use in the production of recombinant proteins. Little is understood, however, regarding the physiology of this important E. coli strain. We show here that BL21(DE3) totally lacks activity of the four [NiFe]-hydrogenases, the three molybdenum-and selenium-containing formate dehydrogenases and molybdenum-dependent nitrate reductase. Nevertheless, all of the structural genes necessary for the synthesis of the respective anaerobic metalloenzymes are present in the genome. However, the genes encoding the high-affinity molybdate transport system and the molybdenum-responsive transcriptional regulator ModE are absent from the genome. Moreover, BL21(DE3) has a nonsense mutation in the gene encoding the global oxygen-responsive transcriptional regulator FNR. The activities of the two hydrogen-oxidizing hydrogenases, therefore, could be restored to BL21(DE3) by supplementing the growth medium with high concentrations of Ni2+ (Ni2+-transport is FNR-dependent) or by introducing a wild-type copy of the fnr gene. Only combined addition of plasmid-encoded fnr and high concentrations of MoO42- ions could restore hydrogen production to BL21(DE3); however, to only 25-30% of a K-12 wildtype. We could show that limited hydrogen production from the enzyme complex responsible for formate-dependent hydrogen evolution was due solely to reduced activity of the formate dehydrogenase (FDH-H), not the hydrogenase component. The activity of the FNR-dependent formate dehydrogenase, FDH-N, could not be restored, even when the fnr gene and MoO42- were supplied; however, nitrate reductase activity could be recovered by combined addition of MoO42- and the fnr gene. This suggested that a further component specific for biosynthesis or activity of formate dehydrogenases H and N was missing. Re-introduction of the gene encoding ModE could only partially restore the activities of both enzymes. Taken together these results demonstrate that BL21(DE3) has major defects in anaerobic metabolism, metal ion transport and metalloprotein biosynthesis.	[Pinske, Constanze; Krueger, Sara; Lindenstrauss, Ute; Sawers, R. Gary] Univ Halle Wittenberg, Inst Microbiol, Halle, Saale, Germany; [Boenn, Markus] Univ Halle Wittenberg, Inst Comp Sci, Halle, Saale, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Pinske, C (corresponding author), Univ Halle Wittenberg, Inst Microbiol, Halle, Saale, Germany.	gary.sawers@mikrobiologie.uni-halle.de	Pinske, Constanze/N-1302-2017	Pinske, Constanze/0000-0001-6248-2437	Deutsche Forschungsgemeinschaft [SA 494/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (Grant SA 494/3-1) to RGS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAIBOU H, 1995, J BACTERIOL, V177, P7141, DOI 10.1128/jb.177.24.7141-7149.1995; Akhtar MK, 2008, APPL MICROBIOL BIOT, V78, P853, DOI 10.1007/s00253-008-1377-6; Anderson LA, 2000, J BACTERIOL, V182, P7035, DOI 10.1128/JB.182.24.7035-7043.2000; Andreini C, 2009, ACCOUNTS CHEM RES, V42, P1471, DOI 10.1021/ar900015x; BALBAS P, 1986, GENE, V50, P3, DOI 10.1016/0378-1119(86)90307-0; BALLANTINE SP, 1985, J BACTERIOL, V163, P454, DOI 10.1128/JB.163.2.454-459.1985; BEGG YA, 1977, FEMS MICROBIOL LETT, V2, P47, DOI 10.1111/j.1574-6968.1977.tb00905.x; BERG BL, 1990, GENETICS, V125, P691; BIRKMANN A, 1987, ARCH MICROBIOL, V148, P44, DOI 10.1007/BF00429646; BOCK A, 1991, MOL MICROBIOL, V5, P515, DOI 10.1111/j.1365-2958.1991.tb00722.x; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; Boyington JC, 1997, SCIENCE, V275, P1305, DOI 10.1126/science.275.5304.1305; BRONDSTED L, 1994, J BACTERIOL, V176, P5423; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Constantinidou C, 2006, J BIOL CHEM, V281, P4802, DOI 10.1074/jbc.M512312200; Cvetkovic A, 2010, NATURE, V466, P779, DOI 10.1038/nature09265; Daegelen P, 2009, J MOL BIOL, V394, P634, DOI 10.1016/j.jmb.2009.09.022; DARWIN A, 1993, J GEN MICROBIOL, V139, P1829, DOI 10.1099/00221287-139-8-1829; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Delbruck M, 1940, J GEN PHYSIOL, V23, P643, DOI 10.1085/jgp.23.5.643; ENOCH HG, 1975, J BIOL CHEM, V250, P6693; Forzi L, 2007, FEBS LETT, V581, P3317, DOI 10.1016/j.febslet.2007.06.028; Forzi L, 2007, BIOMETALS, V20, P565, DOI 10.1007/s10534-006-9048-5; GOODMAN TG, 1983, J CLIN MICROBIOL, V18, P825, DOI 10.1128/JCM.18.4.825-829.1983; GUEST JR, 1969, MOL GEN GENET, V105, P285, DOI 10.1007/BF00277583; Hall DR, 1999, EMBO J, V18, P1435, DOI 10.1093/emboj/18.6.1435; Hasona A, 1998, FEMS MICROBIOL LETT, V169, P111, DOI 10.1111/j.1574-6968.1998.tb13306.x; HAUSINGER RP, 1987, MICROBIOL REV, V51, P22, DOI 10.1128/MMBR.51.1.22-42.1987; Hesslinger C, 1998, MOL MICROBIOL, V27, P477, DOI 10.1046/j.1365-2958.1998.00696.x; Holt J. G., 1989, BERGEYS MANUAL SYSTE; Hube M, 2002, J BACTERIOL, V184, P3879, DOI 10.1128/JB.184.14.3879-3885.2002; JAMIESON DJ, 1984, J BACTERIOL, V160, P131, DOI 10.1128/JB.160.1.131-136.1984; Jeong H, 2009, J MOL BIOL, V394, P644, DOI 10.1016/j.jmb.2009.09.052; KAISER M, 1994, FEMS MICROBIOL LETT, V117, P163, DOI 10.1111/j.1574-6968.1994.tb06759.x; Kaluarachchi H, 2010, NAT PROD REP, V27, P681, DOI 10.1039/b906688h; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lenz O, 2007, FEBS LETT, V581, P3322, DOI 10.1016/j.febslet.2007.06.027; LESTER RL, 1971, J BACTERIOL, V105, P1006, DOI 10.1128/JB.105.3.1006-1014.1971; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luke I, 2008, ARCH MICROBIOL, V190, P685, DOI 10.1007/s00203-008-0420-4; LUTZ S, 1991, MOL MICROBIOL, V5, P123, DOI 10.1111/j.1365-2958.1991.tb01833.x; Magalon A, 2000, FEBS LETT, V473, P254, DOI 10.1016/S0014-5793(00)01542-8; Maier T, 1996, ARCH MICROBIOL, V165, P333, DOI 10.1007/s002030050335; MANDRANDBERTHELOT MA, 1978, FEMS MICROBIOL LETT, V4, P37; MANDRANDBERTHELOT MA, 1988, J GEN MICROBIOL, V134, P3129; MCDANIEL LE, 1969, APPL MICROBIOL, V17, P286, DOI 10.1128/AEM.17.2.286-290.1969; McNicholas PM, 2002, J BACTERIOL, V184, P3253, DOI 10.1128/JB.184.12.3253-3259.2002; Messenger SL, 2003, FEMS MICROBIOL LETT, V228, P81, DOI 10.1016/S0378-1097(03)00726-2; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; NAVARRO C, 1993, MOL MICROBIOL, V9, P1181, DOI 10.1111/j.1365-2958.1993.tb01247.x; Olson JW, 2002, SCIENCE, V298, P1788, DOI 10.1126/science.1077123; Paschos A, 2002, J BIOL CHEM, V277, P49945, DOI 10.1074/jbc.M204601200; Paschos A, 2001, FEBS LETT, V488, P9, DOI 10.1016/S0014-5793(00)02408-X; PINSENT J, 1954, BIOCHEM J, V57, P10, DOI 10.1042/bj0570010; Pinske C, 2010, INT J HYDROGEN ENERG, V35, P8938, DOI 10.1016/j.ijhydene.2010.06.030; Rangarajan ES, 2008, J BACTERIOL, V190, P1447, DOI 10.1128/JB.01610-07; Richard DJ, 1999, MICROBIOL-SGM, V145, P2903, DOI 10.1099/00221287-145-10-2903; Rolfe MD, 2011, J BIOL CHEM, V286, P10147, DOI 10.1074/jbc.M110.211144; ROSENTEL JK, 1995, J BACTERIOL, V177, P4857, DOI 10.1128/jb.177.17.4857-4864.1995; ROSSMANN R, 1991, MOL MICROBIOL, V5, P2807, DOI 10.1111/j.1365-2958.1991.tb01989.x; RUIZHERRERA J, 1969, J BACTERIOL, V99, P720, DOI 10.1128/JB.99.3.720-729.1969; Salmon K, 2003, J BIOL CHEM, V278, P29837, DOI 10.1074/jbc.M213060200; Sambrook J, 2001, MOL CLONING LAB MANU; SAUTER M, 1992, MOL MICROBIOL, V6, P1523, DOI 10.1111/j.1365-2958.1992.tb00873.x; SAWERS G, 1989, J BACTERIOL, V171, P2485, DOI 10.1128/jb.171.5.2485-2498.1989; SAWERS G, 1988, J BACTERIOL, V170, P5330, DOI 10.1128/jb.170.11.5330-5336.1988; Sawers G, 1999, CURR OPIN MICROBIOL, V2, P181, DOI 10.1016/S1369-5274(99)80032-0; SAWERS G, 1991, J BACTERIOL, V173, P4983, DOI 10.1128/jb.173.16.4983-4993.1991; SAWERS G, 1994, ANTON LEEUW INT J G, V66, P57, DOI 10.1007/BF00871633; Sawers R., 2004, FERMENTATIVE PYRUVAT; Sawers RG, 2005, J BACTERIOL, V187, P2609, DOI 10.1128/JB.187.8.2609-2617.2005; SAWERS RG, 1985, J BACTERIOL, V164, P1324, DOI 10.1128/JB.164.3.1324-1331.1985; Schindelin H, 2001, ADV PROTEIN CHEM, V58, P47; SCHLENSOG V, 1989, ARCH MICROBIOL, V152, P83, DOI 10.1007/BF00447016; SCHLINDWEIN C, 1990, J BACTERIOL, V172, P6112, DOI 10.1128/jb.172.10.6112-6121.1990; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Self WT, 2004, J BACTERIOL, V186, P580, DOI 10.1128/JB.186.2.580-587.2004; Self WT, 1999, MICROBIOL-UK, V145, P41, DOI 10.1099/13500872-145-1-41; SHAW DJ, 1982, J GEN MICROBIOL, V128, P2221; SPIRO S, 1991, TRENDS BIOCHEM SCI, V16, P310, DOI 10.1016/0968-0004(91)90125-F; Studier FW, 2009, J MOL BIOL, V394, P653, DOI 10.1016/j.jmb.2009.09.021; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Waegeman H, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-70; WAUGH R, 1986, BIOCHIMIE, V68, P157, DOI 10.1016/S0300-9084(86)81080-X; WU LF, 1989, MOL MICROBIOL, V3, P1709, DOI 10.1111/j.1365-2958.1989.tb00156.x; WU LF, 1986, BIOCHIMIE, V68, P167, DOI 10.1016/S0300-9084(86)81081-1; Zbell AL, 2009, APPL ENVIRON MICROB, V75, P1456, DOI 10.1128/AEM.02064-08; ZINONI F, 1987, P NATL ACAD SCI USA, V84, P3156, DOI 10.1073/pnas.84.10.3156	92	50	53	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22830	10.1371/journal.pone.0022830	http://dx.doi.org/10.1371/journal.pone.0022830			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826210	Green Submitted, Green Published, gold			2022-12-25	WOS:000293558900036
J	Woodward, HN; Rich, TH; Chinsamy, A; Vickers-Rich, P				Woodward, Holly N.; Rich, Thomas H.; Chinsamy, Anusuya; Vickers-Rich, Patricia			Growth Dynamics of Australia's Polar Dinosaurs	PLOS ONE			English	Article							SKELETOCHRONOLOGY; INDICATORS; HISTOLOGY; EVOLUTION; PATTERNS	Analysis of bone microstructure in ornithopod and theropod dinosaurs from Victoria, Australia, documents ontogenetic changes, providing insight into the dinosaurs' successful habitation of Cretaceous Antarctic environments. Woven-fibered bone tissue in the smallest specimens indicates rapid growth rates during early ontogeny. Later ontogeny is marked by parallel-fibered tissue, suggesting reduced growth rates approaching skeletal maturity. Bone microstructure similarities between the ornithopods and theropods, including the presence of LAGs in each group, suggest there is no osteohistologic evidence supporting the hypothesis that polar theropods hibernated seasonally. Results instead suggest high-latitude dinosaurs had growth trajectories similar to their lower-latitude relatives and thus, rapid early ontogenetic growth and the cyclical suspensions of growth inherent in the theropod and ornithopod lineages enabled them to successfully exploit polar regions.	[Woodward, Holly N.] Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA; [Rich, Thomas H.] Museum Victoria, Melbourne, Vic, Australia; [Chinsamy, Anusuya] Univ Cape Town, Dept Zool, Rhodes Gift, South Africa; [Rich, Thomas H.; Vickers-Rich, Patricia] Monash Univ, Sch Geosci, Clayton, Vic, Australia	Montana State University System; Montana State University Bozeman; Museum Victoria; University of Cape Town; Monash University	Woodward, HN (corresponding author), Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA.	holly.n.woodward@gmail.com	Ballard, HollyNoelle/AED-7676-2022	Ballard, HollyNoelle/0000-0003-0413-0681; Chinsamy-Turan, Anusuya/0000-0002-9786-5080	National Science Foundation through the East Asia and Pacific Summer Institutes	National Science Foundation through the East Asia and Pacific Summer Institutes	This research is supported by the National Science Foundation through the East Asia and Pacific Summer Institutes program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnolin FL, 2010, J SYST PALAEONTOL, V8, P257, DOI 10.1080/14772011003594870; [Anonymous], 1990, SKELETAL BIOMINERALI, DOI DOI 10.1029/SC005P0175; BUFFRENIL VD, 1980, ARCH ZOOL EXP GEN, V121, P63; Carrano MT, 2005, J VERTEBR PALEONTOL, V25, P835, DOI 10.1671/0272-4634(2005)025[0835:NIOSHA]2.0.CO;2; Castanet J., 1993, BONE, P245; Chinsamy A, 1998, J VERTEBR PALEONTOL, V18, P385, DOI 10.1080/02724634.1998.10011066; CHINSAMY A, 1990, Palaeontologia Africana, V27, P77; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; De Buffrenil V, 2000, J HERPETOL, V34, P414, DOI 10.2307/1565365; de Ricqles A, 2008, ANN PALEONTOL, V94, P57, DOI 10.1016/j.annpal.2008.03.002; de Ricqles Armand J., 2003, Annales de Paleontologie, V89, P67, DOI 10.1016/S0753-3969(03)00005-3; Erickson GM, 2005, TRENDS ECOL EVOL, V20, P677, DOI 10.1016/j.tree.2005.08.012; GREGORY RT, 1989, EARTH PLANET SC LETT, V92, P27, DOI 10.1016/0012-821X(89)90018-6; HALLAM A, 1985, J GEOL SOC LONDON, V142, P433, DOI 10.1144/gsjgs.142.3.0433; HEMELAAR ASM, 1980, NETH J ZOOL, V30, P129; Horner JR, 2009, J VERTEBR PALEONTOL, V29, P734, DOI 10.1671/039.029.0312; Horner JR, 1999, PALEOBIOLOGY, V25, P295, DOI 10.1017/S0094837300021308; HUTTON JM, 1986, COPEIA, P332, DOI 10.2307/1444994; Knoll F, 2010, GONDWANA RES, V17, P171, DOI 10.1016/j.gr.2009.03.010; LAMM ET, 2007, P MICR MICR 2007, P50; Lee AH, 2008, P NATL ACAD SCI USA, V105, P582, DOI 10.1073/pnas.0708903105; Martin AJ, 2009, CRETACEOUS RES, V30, P1223, DOI 10.1016/j.cretres.2009.06.003; Padian K, 2004, J VERTEBR PALEONTOL, V24, P555, DOI 10.1671/0272-4634(2004)024[0555:GISDAP]2.0.CO;2; RICH TH, 1994, RES EXPLOR, V10, P129; RICH TH, 1989, GEOLOGICAL SOC SPECI, V47, P121; Rich Thomas H., 1999, National Science Museum Monographs, V15, P167; RICH THV, 1989, NATL GEOGR RES, V5, P15; Schweitzer MH, 2007, BONE, V40, P1152, DOI 10.1016/j.bone.2006.10.029; SPICER RA, 1992, GEOL MAG, V129, P169, DOI 10.1017/S0016756800008268; TRUSLER P, 2010, ARTIST SCI BRINGING; Tutken T, 2004, PALAEOGEOGR PALAEOCL, V206, P217, DOI 10.1016/j.palaeo.2004.01.005; Varricchio David J., 1993, Journal of Vertebrate Paleontology, V13, P99; VEEVERS JJ, 1991, AUST J EARTH SCI, V38, P373, DOI 10.1080/08120099108727979; WAGSTAFF BE, 1989, NATL GEOGR RES, V5, P54	34	28	28	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e23339	10.1371/journal.pone.0023339	http://dx.doi.org/10.1371/journal.pone.0023339			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826250	Green Published, gold			2022-12-25	WOS:000293558900076
J	Flori, L; Gao, Y; Laloe, D; Lemonnier, G; Leplat, JJ; Teillaud, A; Cossalter, AM; Laffitte, J; Pinton, P; de Vaureix, C; Bouffaud, M; Mercat, MJ; Lefevre, F; Oswald, IP; Bidanel, JP; Rogel-Gaillard, C				Flori, Laurence; Gao, Yu; Laloe, Denis; Lemonnier, Gaetan; Leplat, Jean-Jacques; Teillaud, Angelique; Cossalter, Anne-Marie; Laffitte, Joelle; Pinton, Philippe; de Vaureix, Christiane; Bouffaud, Marcel; Mercat, Marie-Jose; Lefevre, Francois; Oswald, Isabelle P.; Bidanel, Jean-Pierre; Rogel-Gaillard, Claire			Immunity Traits in Pigs: Substantial Genetic Variation and Limited Covariation	PLOS ONE			English	Article							BLOOD-LYMPHOCYTES; LARGE WHITE; PARAMETERS; SELECTION; INNATE; RESPONSES; DEOXYNIVALENOL; INTERFERON; COMPETENCE; INGESTION	Background: Increasing robustness via improvement of resistance to pathogens is a major selection objective in livestock breeding. As resistance traits are difficult or impossible to measure directly, potential indirect criteria are measures of immune traits (ITs). Our underlying hypothesis is that levels of ITs with no focus on specific pathogens define an individual's immunocompetence and thus predict response to pathogens in general. Since variation in ITs depends on genetic, environmental and probably epigenetic factors, our aim was to estimate the relative importance of genetics. In this report, we present a large genetic survey of innate and adaptive ITs in pig families bred in the same environment. Methodology/Principal Findings: Fifty four ITs were studied on 443 Large White pigs vaccinated against Mycoplasma hyopneumoniae and analyzed by combining a principal component analysis (PCA) and genetic parameter estimation. ITs include specific and non specific antibodies, seric inflammatory proteins, cell subsets by hemogram and flow cytometry, ex vivo production of cytokines (IFN alpha, TNF alpha, IL6, IL8, IL12, IFN gamma, IL2, IL4, IL10), phagocytosis and lymphocyte proliferation. While six ITs had heritabilities that were weak or not significantly different from zero, 18 and 30 ITs had moderate (0.1<h2 <= 0.4) or high (h2>0.4) heritability values, respectively. Phenotypic and genetic correlations between ITs were weak except for a few traits that mostly include cell subsets. PCA revealed no cluster of innate or adaptive ITs. Conclusions/Significance: Our results demonstrate that variation in many innate and adaptive ITs is genetically controlled in swine, as already reported for a smaller number of traits by other laboratories. A limited redundancy of the traits was also observed confirming the high degree of complementarity between innate and adaptive ITs. Our data provide a genetic framework for choosing ITs to be included as selection criteria in multitrait selection programmes that aim to improve both production and health traits.	[Flori, Laurence; Gao, Yu; Laloe, Denis; Lemonnier, Gaetan; Leplat, Jean-Jacques; Teillaud, Angelique; Bidanel, Jean-Pierre; Rogel-Gaillard, Claire] INRA, UMR Genet Anim & Biol Integrat 1313, Jouy En Josas, France; [Flori, Laurence; Gao, Yu; Lemonnier, Gaetan; Leplat, Jean-Jacques; Teillaud, Angelique; Rogel-Gaillard, Claire] CEA, DSV, IRCM, SREIT,Lab Radiobiol & Etud Gnome, Jouy En Josas, France; [Flori, Laurence; Gao, Yu; Laloe, Denis; Lemonnier, Gaetan; Leplat, Jean-Jacques; Teillaud, Angelique; Bidanel, Jean-Pierre; Rogel-Gaillard, Claire] AgroParisTech, Lab Genet Anim & Biol Integrat, Jouy En Josas, France; [Cossalter, Anne-Marie; Laffitte, Joelle; Pinton, Philippe] INRA, Pharmacol Toxicol UR66, F-31931 Toulouse, France; [de Vaureix, Christiane; Lefevre, Francois] INRA, Virol & Immunol Mo UR892, Jouy En Josas, France; [Bouffaud, Marcel; Oswald, Isabelle P.] INRA, Stn Controle Performances, UE450, Le Rheu, France; [Mercat, Marie-Jose] IFIP, La Motte Au Vicomte, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; INRAE; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE	Flori, L (corresponding author), INRA, UMR Genet Anim & Biol Integrat 1313, Jouy En Josas, France.	claire.rogel-gaillard@jouy.inra.fr	OSWALD, Isabelle/GPP-1123-2022; Flori, Laurence/H-3683-2013; OSWALD, Isabelle P/A-8497-2013; Bidanel, Jean-Pierre/D-1234-2013; Laloe, Denis/O-7045-2019; Gao, Yu/B-9175-2012; Gao, Yu/AAU-9530-2021	OSWALD, Isabelle/0000-0001-9918-277X; OSWALD, Isabelle P/0000-0001-9918-277X; Bidanel, Jean-Pierre/0000-0001-9290-9550; Gao, Yu/0000-0002-4210-7338; ROGEL-GAILLARD, Claire/0000-0002-2174-1962; Laloe, Denis/0000-0001-8359-0760	Agence Nationale de la Recherche	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was funded by the Agence Nationale de la Recherche (IMMOPIG project, GENANIMAL 2007-2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accensi F, 2006, J ANIM SCI, V84, P1935, DOI 10.2527/jas.2005-355; Albers R, 2005, BRIT J NUTR, V94, P452, DOI 10.1079/BJN20051469; Bovenhuis H, 2002, POULTRY SCI, V81, P309, DOI 10.1093/ps/81.3.309; Calder PC, 2007, J NUTR, V137, p773S, DOI 10.1093/jn/137.3.773S; CHARLEY B, 1988, J VIROL, V62, P8, DOI 10.1128/JVI.62.1.8-11.1988; Chessel D., 2004, R NEWS, V4, P5, DOI DOI 10.2307/3780087; Clapperton M, 2008, ANIMAL, V2, P1575, DOI 10.1017/S1751731108002929; Clapperton M, 2007, VET IMMUNOL IMMUNOP, V119, P303, DOI 10.1016/j.vetimm.2007.05.008; Clapperton M, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-54; DEARCE HD, 1992, VET IMMUNOL IMMUNOP, V30, P319, DOI 10.1016/0165-2427(92)90102-V; DELIA D, 1984, EUR J IMMUNOL, V14, P720, DOI 10.1002/eji.1830140809; der Laan MHP, 2002, VET IMMUNOL IMMUNOP, V87, P199, DOI 10.1016/S0165-2427(02)00075-2; Edfors-Lilja I, 1998, J IMMUNOL, V161, P829; EDFORSLILJA I, 1994, VET IMMUNOL IMMUNOP, V40, P1, DOI 10.1016/0165-2427(94)90011-6; Flori Laurence, 2011, BMC Proc, V5 Suppl 4, pS32, DOI 10.1186/1753-6561-5-S4-S32; FRALEY C, 2007, J STAT SOFTW, V18, P1548; Gao Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-292; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Henryon M, 2006, ANIM SCI, V82, P597, DOI 10.1079/ASC200671; Hernandez A, 2003, GENET SEL EVOL, V35, pS67, DOI 10.1051/gse:2003017; JOLING P, 1993, VET QUART, V15, P9, DOI 10.1080/01652176.1993.9694360; Karin Meyer, 2007, Journal of Zhejiang University-Science B, V8, P815, DOI 10.1631/jzus.2007.B0815; KINDT JK, 2008, KUBY IMMUNOLOGY; Lu X, 2011, ANIM GENET, V42, P1, DOI 10.1111/j.1365-2052.2010.02071.x; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Magnusson U, 1998, VET IMMUNOL IMMUNOP, V61, P83, DOI 10.1016/S0165-2427(97)00132-3; Mallard B. A., 1992, Animal Biotechnology, V3, P257, DOI 10.1080/10495399209525776; MALLARD BA, 1998, AUSTR 6 WCGALP, V27, P257; Marin DE, 2007, MOL NUTR FOOD RES, V51, P1406, DOI 10.1002/mnfr.200700131; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Medzhitov R, 1998, SEMIN IMMUNOL, V10, P351, DOI 10.1006/smim.1998.0136; Minozzi G, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-5; NAGEL JE, 1982, CLIN EXP IMMUNOL, V49, P217; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.1093/biomet/58.3.545; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Pinton P, 2008, TOXICOL LETT, V177, P215, DOI 10.1016/j.toxlet.2008.01.015; Puel A, 1996, P NATL ACAD SCI USA, V93, P14742, DOI 10.1073/pnas.93.25.14742; Reddy NRJ, 2000, INFECT IMMUN, V68, P1150, DOI 10.1128/IAI.68.3.1150-1155.2000; Team RDC, 2009, LANG ENV STAT COMP; Tribout T, 2010, J ANIM SCI, V88, P2856, DOI 10.2527/jas.2009-2356; UDDIN MJ, 2011, INT J IMMUNOGENET; Wattrang E, 2005, ANIM GENET, V36, P337, DOI 10.1111/j.1365-2052.2005.01315.x; Welch BL, 1938, BIOMETRIKA, V29, P350, DOI 10.1093/biomet/29.3-4.350; Wilkie B, 1999, VET IMMUNOL IMMUNOP, V72, P231, DOI 10.1016/S0165-2427(99)00136-1; Wilkie B. N., 2000, BREEDING DIS RESISTA, P379; Wilkie BN, 1997, PROGRESS IN PIG SCIENCE, P29; Wimmers K, 2009, INT J IMMUNOGENET, V36, P141, DOI 10.1111/j.1744-313X.2009.00838.x	49	69	74	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22717	10.1371/journal.pone.0022717	http://dx.doi.org/10.1371/journal.pone.0022717			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829490	gold, Green Published			2022-12-25	WOS:000293286500021
J	Matthews, L; Johnson, J; Berry, A; Trebble, P; Cookson, A; Spiller, D; Rivers, C; Norman, M; White, M; Ray, D				Matthews, Laura; Johnson, James; Berry, Andrew; Trebble, Peter; Cookson, Ann; Spiller, Dave; Rivers, Caroline; Norman, Michael; White, Mike; Ray, David			Cell Cycle Phase Regulates Glucocorticoid Receptor Function	PLOS ONE			English	Article							HELA S3 CELLS; GENE-EXPRESSION; NUCLEAR TRANSLOCATION; PHOSPHORYLATION; SENSITIVITY; ACTIVATION; PROMOTER; GR; PHOSPHATASE; TRAFFICKING	The glucocorticoid receptor (GR) is a member of the nuclear hormone receptor superfamily of ligand-activated transcription factors. In contrast to many other nuclear receptors, GR is thought to be exclusively cytoplasmic in quiescent cells, and only translocate to the nucleus on ligand binding. We now demonstrate significant nuclear GR in the absence of ligand, which requires nuclear localisation signal 1 (NLS1). Live cell imaging reveals dramatic GR import into the nucleus through interphase and rapid exclusion of the GR from the nucleus at the onset of mitosis, which persists into early G(1). This suggests that the heterogeneity in GR distribution is reflective of cell cycle phase. The impact of cell cycle-driven GR trafficking on a panel of glucocorticoid actions was profiled. In G2/M-enriched cells there was marked prolongation of glucocorticoid-induced ERK activation. This was accompanied by DNA template-specific, ligand-independent GR transactivation. Using chimeric and domain-deleted receptors we demonstrate that this transactivation effect is mediated by the AF1 transactivation domain. AF-1 harbours multiple phosphorylation sites, which are consensus sequences for kinases including CDKs, whose activity changes during the cell cycle. In G2/M there was clear ligand independent induction of GR phosphorylation on residues 203 and 211, both of which are phosphorylated after ligand activation. Ligand-independent transactivation required induction of phospho-S211GR but not S203GR, thereby directly linking cell cycle driven GR modification with altered GR function. Cell cycle phase therefore regulates GR localisation and post-translational modification which selectively impacts GR activity. This suggests that cell cycle phase is an important determinant in the cellular response to Gc, and that mitotic index contributes to tissue Gc sensitivity.	[Matthews, Laura; Berry, Andrew; Trebble, Peter; Cookson, Ann; Ray, David] Univ Manchester, Dev Biomed Res Grp, Manchester, Lancs, England; [Johnson, James; Spiller, Dave; White, Mike] Univ Liverpool, Ctr Cell Imaging, Liverpool L69 3BX, Merseyside, England; [Spiller, Dave; White, Mike] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Rivers, Caroline; Norman, Michael] Univ Bristol, Div Med, Bristol, Avon, England	University of Manchester; University of Liverpool; University of Manchester; University of Bristol	Matthews, L (corresponding author), Univ Manchester, Dev Biomed Res Grp, Manchester, Lancs, England.	david.w.ray@manchester.ac.uk	Johnson, James R/A-8174-2012; Johnson, James R/D-9721-2014; Spiller, David G/I-3645-2012	Johnson, James R/0000-0002-8849-0993; Spiller, David Geoffrey/0000-0003-2502-6787; Ray, David/0000-0002-4739-6773; White, Michael/0000-0002-3617-3232	Wellcome Trust; NIHR Manchester Biomedical Research Centre; Neuroendocrinology Charitable Trust; Biotechnology and Biological Sciences Research Council; Society for Endocrinology; University of Manchester; Biotechnology and Biological Sciences Research Council [BB/H013725/2] Funding Source: researchfish; BBSRC [BB/H013725/2] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); NIHR Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Neuroendocrinology Charitable Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Society for Endocrinology; University of Manchester; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Wellcome Trust, the NIHR Manchester Biomedical Research Centre, the Neuroendocrinology Charitable Trust, the Biotechnology and Biological Sciences Research Council, the Society for Endocrinology, and the University of Manchester. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel GA, 2002, MOL ENDOCRINOL, V16, P1352, DOI 10.1210/me.16.6.1352; Berry A, 2010, FASEB J, V24, P1700, DOI 10.1096/fj.09-139998; Bodwell JE, 1998, J STEROID BIOCHEM, V65, P91, DOI 10.1016/S0960-0760(97)00185-4; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Carrigan A, 2007, J BIOL CHEM, V282, P10963, DOI 10.1074/jbc.M602931200; Chen WW, 2008, MOL ENDOCRINOL, V22, P1754, DOI 10.1210/me.2007-0219; Chen WW, 2006, MOL ENDOCRINOL, V20, P560, DOI 10.1210/me.2005-0318; CIDLOWSKI JA, 1977, NATURE, V266, P643, DOI 10.1038/266643a0; DISTELHORST CW, 1984, BLOOD, V63, P105; Donn R, 2007, CLIN ENDOCRINOL, V67, P342, DOI 10.1111/j.1365-2265.2007.02887.x; Donn R, 2007, FASEB J, V21, P402, DOI 10.1096/fj.06-7236com; Echeverria PC, 2009, MOL CELL BIOL, V29, P4788, DOI 10.1128/MCB.00649-09; Elsby LA, 2009, ARTHRITIS RHEUM-US, V60, P2220, DOI 10.1002/art.24659; Evans RM, 2005, MOL ENDOCRINOL, V19, P1429, DOI 10.1210/me.2005-0046; FANGER BO, 1986, ARCH BIOCHEM BIOPHYS, V249, P116, DOI 10.1016/0003-9861(86)90566-7; GRIFFIN MJ, 1969, J CELL BIOL, V40, P297, DOI 10.1083/jcb.40.2.297; Hache RJG, 1999, J BIOL CHEM, V274, P1432, DOI 10.1074/jbc.274.3.1432; HSU SC, 1995, J BIOL CHEM, V270, P3359, DOI 10.1074/jbc.270.7.3359; HSU SC, 1992, EMBO J, V11, P3457, DOI 10.1002/j.1460-2075.1992.tb05425.x; HU JM, 1994, MOL ENDOCRINOL, V8, P1709, DOI 10.1210/me.8.12.1709; Iniguez-Lluhi JA, 2000, MOL CELL BIOL, V20, P6040, DOI 10.1128/MCB.20.16.6040-6050.2000; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; Johnson TA, 2008, MOL BIOL CELL, V19, P3308, DOI 10.1091/mbc.E08-02-0123; Kayahara M, 2008, AM J PHYSIOL-ENDOC M, V295, pE1047, DOI 10.1152/ajpendo.90429.2008; Krstic MD, 1997, MOL CELL BIOL, V17, P3947, DOI 10.1128/MCB.17.7.3947; Luecke HF, 2005, GENE DEV, V19, P1116, DOI 10.1101/gad.1297105; Margolis RN, 2005, MOL ENDOCRINOL, V19, P2433, DOI 10.1210/me.2004-0461; MARTIN D, 1969, P NATL ACAD SCI USA, V62, P248, DOI 10.1073/pnas.62.1.248; Matthews JG, 2004, J ALLERGY CLIN IMMUN, V113, P1100, DOI 10.1016/j.jaci.2004.03.018; Matthews L, 2008, MOL ENDOCRINOL, V22, P1320, DOI 10.1210/me.2007-0154; Matthews L, 2009, ENDOCRINOLOGY, V150, P75, DOI 10.1210/en.2008-0196; McMaster A, 2008, NAT CLIN PRACT ENDOC, V4, P91, DOI 10.1038/ncpendmet0745; Miller AL, 2005, MOL ENDOCRINOL, V19, P1569, DOI 10.1210/me.2004-0528; Nagaich AK, 2004, ANN NY ACAD SCI, V1024, P213, DOI 10.1196/annals.1321.002; Oakley RH, 1999, STEROIDS, V64, P742, DOI 10.1016/S0039-128X(99)00059-8; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Rogatsky I, 1997, MOL CELL BIOL, V17, P3181, DOI 10.1128/MCB.17.6.3181; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Stavreva DA, 2004, MOL CELL BIOL, V24, P2682, DOI 10.1128/MCB.24.7.2682-2697.2004; Stevens A, 2004, J CLIN ENDOCR METAB, V89, P892, DOI 10.1210/jc.2003-031235; Usmani OS, 2005, AM J RESP CRIT CARE, V172, P704, DOI 10.1164/rccm.200408-1041OC; Verhoog NJD, 2011, J BIOL CHEM, V286, P19297, DOI 10.1074/jbc.M110.193672; Wang Z, 2002, J BIOL CHEM, V277, P26573, DOI 10.1074/jbc.M110530200; Wang Z, 2007, MOL ENDOCRINOL, V21, P625, DOI 10.1210/me.2005-0338; Waters CE, 2004, J ENDOCRINOL, V183, P375, DOI 10.1677/joe.1.05804	45	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22289	10.1371/journal.pone.0022289	http://dx.doi.org/10.1371/journal.pone.0022289			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829454	Green Published, Green Submitted, gold			2022-12-25	WOS:000293286500011
J	Bihani, SC; Das, A; Nilgiriwala, KS; Prashar, V; Pirocchi, M; Apte, SK; Ferrer, JL; Hosur, MV				Bihani, Subhash C.; Das, Amit; Nilgiriwala, Kayzad S.; Prashar, Vishal; Pirocchi, Michel; Apte, Shree Kumar; Ferrer, Jean-Luc; Hosur, Madhusoodan V.			X-Ray Structure Reveals a New Class and Provides Insight into Evolution of Alkaline Phosphatases	PLOS ONE			English	Article							ACTIVE-SITE; CRYSTAL-STRUCTURE; PHOSPHOGLYCERATE MUTASE; METAL SPECIFICITY; PROTEIN-STRUCTURE; TRANSITION-STATE; MECHANISM; SUPERFAMILY; SEQUENCE; PHENIX	The alkaline phosphatase (AP) is a bi-metalloenzyme of potential applications in biotechnology and bioremediation, in which phosphate monoesters are nonspecifically hydrolysed under alkaline conditions to yield inorganic phosphate. The hydrolysis occurs through an enzyme intermediate in which the catalytic residue is phosphorylated. The reaction, which also requires a third metal ion, is proposed to proceed through a mechanism of in-line displacement involving a trigonal bipyramidal transition state. Stabilizing the transition state by bidentate hydrogen bonding has been suggested to be the reason for conservation of an arginine residue in the active site. We report here the first crystal structure of alkaline phosphatase purified from the bacterium Sphingomonas. sp. Strain BSAR-1 (SPAP). The crystal structure reveals many differences from other APs: 1) the catalytic residue is a threonine instead of serine, 2) there is no third metal ion binding pocket, and 3) the arginine residue forming bidentate hydrogen bonding is deleted in SPAP. A lysine and an aspargine residue, recruited together for the first time into the active site, bind the substrate phosphoryl group in a manner not observed before in any other AP. These and other structural features suggest that SPAP represents a new class of APs. Because of its direct contact with the substrate phosphoryl group, the lysine residue is proposed to play a significant role in catalysis. The structure is consistent with a mechanism of in-line displacement via a trigonal bipyramidal transition state. The structure provides important insights into evolutionary relationships between members of AP superfamily.	[Bihani, Subhash C.; Das, Amit; Prashar, Vishal; Hosur, Madhusoodan V.] Bhabha Atom Res Ctr, Div Solid State Phys, Bombay 400085, Maharashtra, India; [Nilgiriwala, Kayzad S.; Apte, Shree Kumar] Bhabha Atom Res Ctr, Div Mol Biol, Bombay 400085, Maharashtra, India; [Pirocchi, Michel; Ferrer, Jean-Luc] CEA CNRS UJF, Inst Biol Struct JP Ebel, Grp Synchrotron, Grenoble, France	Bhabha Atomic Research Center (BARC); Bhabha Atomic Research Center (BARC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Bihani, SC (corresponding author), Bhabha Atom Res Ctr, Div Solid State Phys, Bombay 400085, Maharashtra, India.	hosur@barc.gov.in	Bihani, Subhash Chandra/G-1255-2010	Bihani, Subhash Chandra/0000-0002-0724-4919; Hosur, Madhusoodan/0000-0003-1012-0906; Nilgiriwala, Kayzad/0000-0002-5458-4916				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AKIYAMA Y, 1993, J BIOL CHEM, V268, P8146; COLEMAN JE, 1992, ANNU REV BIOPH BIOM, V21, P441, DOI 10.1146/annurev.biophys.21.1.441; de Backer M, 2002, J MOL BIOL, V318, P1265, DOI 10.1016/S0022-2836(02)00035-9; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Galperin MY, 1998, PROTEIN SCI, V7, P1829, DOI 10.1002/pro.5560070819; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Helland R, 2009, BBA-PROTEINS PROTEOM, V1794, P297, DOI 10.1016/j.bbapap.2008.09.020; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Holtz KM, 1999, J BIOL CHEM, V274, P8351, DOI 10.1074/jbc.274.13.8351; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jedrzejas MJ, 2000, EMBO J, V19, P1419, DOI 10.1093/emboj/19.7.1419; Jedrzejas MJ, 2000, PROG BIOPHYS MOL BIO, V73, P263, DOI 10.1016/S0079-6107(00)00007-9; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KIM EE, 1991, J MOL BIOL, V218, P449, DOI 10.1016/0022-2836(91)90724-K; KNOX JR, 1973, J MOL BIOL, V74, P533, DOI 10.1016/0022-2836(73)90045-4; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Le Du MH, 2001, J BIOL CHEM, V276, P9158, DOI 10.1074/jbc.M009250200; Le Du MH, 2002, J MOL BIOL, V316, P941, DOI 10.1006/jmbi.2001.5384; Murphy JE, 1997, NAT STRUCT BIOL, V4, P618, DOI 10.1038/nsb0897-618; Nilgiriwala KS, 2008, APPL ENVIRON MICROB, V74, P5516, DOI 10.1128/AEM.00107-08; Nilgiriwala KS, 2009, ACTA CRYSTALLOGR F, V65, P917, DOI 10.1107/S1744309109031133; O'Brien PJ, 2008, BIOCHEMISTRY-US, V47, P7663, DOI 10.1021/bi800545n; O'Brien PJ, 1999, J AM CHEM SOC, V121, P11022, DOI 10.1021/ja9932582; O'Donoghue P, 2003, MICROBIOL MOL BIOL R, V67, P550, DOI 10.1128/MMBR.67.4.550-573.2003; Olguin LF, 2008, J AM CHEM SOC, V130, P16547, DOI 10.1021/ja8047943; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Roberts E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-382; Roth M, 2002, ACTA CRYSTALLOGR D, V58, P805, DOI 10.1107/S0907444902003943; Stec B, 2000, J MOL BIOL, V299, P1303, DOI 10.1006/jmbi.2000.3799; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Tsuruta H, 2010, BIOSCI BIOTECH BIOCH, V74, P69, DOI 10.1271/bbb.90563; Wang E, 2007, J MOL BIOL, V366, P1318, DOI 10.1016/j.jmb.2006.11.079; Wang J, 2005, BIOCHEMISTRY-US, V44, P8378, DOI 10.1021/bi050155p; Wang J, 2006, PROTEIN SCI, V15, P2395, DOI 10.1110/ps.062351506; Wojciechowski CL, 2002, J BIOL CHEM, V277, P50476, DOI 10.1074/jbc.M209326200; Zalatan JG, 2006, BIOCHEMISTRY-US, V45, P9788, DOI 10.1021/bi060847t; Zalatan JG, 2008, J MOL BIOL, V384, P1174, DOI 10.1016/j.jmb.2008.09.059	43	16	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22767	10.1371/journal.pone.0022767	http://dx.doi.org/10.1371/journal.pone.0022767			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829507	Green Published, Green Submitted, gold			2022-12-25	WOS:000293284600042
J	Ellis, JJ; Kobe, B				Ellis, Jonathan J.; Kobe, Bostjan			Predicting Protein Kinase Specificity: Predikin Update and Performance in the DREAM4 Challenge	PLOS ONE			English	Article							SUBSTRATE-SPECIFICITY; PEPTIDE SPECIFICITY; LINEAR MOTIFS; RESOURCE; DOMAINS; SITES; YEAST; SMART	Predikin is a system for making predictions about protein kinase specificity. It was declared the "best performer" in the protein kinase section of the Peptide Recognition Domain specificity prediction category of the recent DREAM4 challenge (an independent test using unpublished data). In this article we discuss some recent improvements to the Predikin web server-including a more streamlined approach to substrate-to-kinase predictions and whole-proteome predictions-and give an analysis of Predikin's performance in the DREAM4 challenge. We also evaluate these improvements using a data set of yeast kinases that have been experimentally characterised, and we discuss the usefulness of Frobenius distance in assessing the predictive power of position weight matrices.	[Ellis, Jonathan J.] Univ Queensland, Sch Chem & Mol Biosci, Inst Mol Biosci, Brisbane, Qld, Australia; Univ Queensland, Ctr Infect Dis Res, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Ellis, JJ (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Inst Mol Biosci, Brisbane, Qld, Australia.	jonathan.ellis.research@gmail.com; b.kobe@uq.edu.au	Ellis, Jonathan J/F-2920-2010; Kobe, Bostjan/D-1292-2009	Ellis, Jonathan J/0000-0003-0410-5064; Kobe, Bostjan/0000-0001-9413-9166; Ellis, Jonathan/0000-0003-0218-546X	National Health and Medical Research Council (NHMRC); Australian Research Council (ARC)	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council)	This research was funded by the National Health and Medical Research Council (NHMRC) and the Australian Research Council (ARC). BK is an ARC Federation Fellow and an NHMRC Honorary Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Brinkworth RI, 2003, P NATL ACAD SCI USA, V100, P74, DOI 10.1073/pnas.0134224100; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Diella F, 2008, NUCLEIC ACIDS RES, V36, pD240, DOI 10.1093/nar/gkm772; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HUNTER T, 1991, METHOD ENZYMOL, V200, P3; Knuutila S, 1998, AM J PATHOL, V152, P1107; Kobe B, 2005, BBA-PROTEINS PROTEOM, V1754, P200, DOI 10.1016/j.bbapap.2005.07.036; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; Neduva V, 2005, FEBS LETT, V579, P3342, DOI 10.1016/j.febslet.2005.04.005; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Pinna LA, 1996, BBA-MOL CELL RES, V1314, P191, DOI 10.1016/S0167-4889(96)00083-3; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Saunders NFW, 2008, NUCLEIC ACIDS RES, V36, pW286, DOI 10.1093/nar/gkn279; Saunders NFW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-245; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Stolovitzky G, 2007, ANN NY ACAD SCI, V1115, P1, DOI 10.1196/annals.1407.021; Zhu GZ, 2005, CELL CYCLE, V4, P52, DOI 10.4161/cc.4.1.1353	24	34	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e21169	10.1371/journal.pone.0021169	http://dx.doi.org/10.1371/journal.pone.0021169			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829434	Green Published, gold, Green Submitted			2022-12-25	WOS:000293284600002
J	Feridooni, T; Hotchkiss, A; Remley-Carr, S; Saga, Y; Pasumarthi, KBS				Feridooni, Tiam; Hotchkiss, Adam; Remley-Carr, Sarah; Saga, Yumiko; Pasumarthi, Kishore B. S.			Cardiomyocyte Specific Ablation of p53 Is Not Sufficient to Block Doxorubicin Induced Cardiac Fibrosis and Associated Cytoskeletal Changes	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; MICROTUBULE-ASSOCIATED PROTEIN; INDUCED CARDIOTOXICITY; INDUCED APOPTOSIS; NITRIC-OXIDE; TUMOR-SUPPRESSOR; OXIDATIVE STRESS; ENDOTHELIAL-CELLS; GENE-EXPRESSION; TRANSGENIC MICE	Doxorubicin (Dox) is an anthracycline used to effectively treat several forms of cancer. Unfortunately, the use of Dox is limited due to its association with cardiovascular complications which are manifested as acute and chronic cardiotoxicity. The pathophysiological mechanism of Dox induced cardiotoxicity appears to involve increased expression of the tumor suppressor protein p53 in cardiomyocytes, followed by cellular apoptosis. It is not known whether downregulation of p53 expression in cardiomyocytes would result in decreased rates of myocardial fibrosis which occurs in response to cardiomyocyte loss. Further, it is not known whether Dox can induce perivascular necrosis and associated fibrosis in the heart. In this study we measured the effects of acute Dox treatment on myocardial and perivascular apoptosis and fibrosis in a conditional knockout (CKO) mouse model system which harbours inactive p53 alleles specifically in cardiomyocytes. CKO mice treated with a single dose of Dox (20 mg/kg), did not display lower levels of myocardial apoptosis or reactive oxygen and nitrogen species (ROS/RNS) compared to control mice with intact p53 alleles. Interestingly, CKO mice also displayed higher levels of interstitial and perivascular fibrosis compared to controls 3 or 7 days after Dox treatment. Additionally, the decrease in levels of the microtubule protein a-tubulin, which occurs in response to Dox treatment, was not prevented in CKO mice. Overall, these results indicate that selective loss of p53 in cardiomyocytes is not sufficient to prevent Dox induced myocardial ROS/RNS generation, apoptosis, interstitial fibrosis and perivascular fibrosis. Further, these results support a role for p53 independent apoptotic pathways leading to Dox induced myocardial damage and highlight the importance of vascular lesions in Dox induced cardiotoxicity.	[Feridooni, Tiam; Hotchkiss, Adam; Remley-Carr, Sarah; Pasumarthi, Kishore B. S.] Dalhousie Univ, Dept Pharmacol, Halifax, NS B3H 4H7, Canada; [Saga, Yumiko] Natl Inst Genet, Mammalian Dev Lab, Shizuoka, Japan	Dalhousie University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Feridooni, T (corresponding author), Dalhousie Univ, Dept Pharmacol, Halifax, NS B3H 4H7, Canada.	kpasumar@dal.ca		Pasumarthi, Kishore/0000-0001-9317-076X	Canadian Institutes of Health Research [MOP-62811]; Heart and Stroke Foundation of Nova Scotia; Canada Foundation for Innovation; Heart and Stroke Foundation; Dalhousie Medical Research Foundation; Nova Scotia Health Research Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Nova Scotia; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); Dalhousie Medical Research Foundation; Nova Scotia Health Research Foundation	This work was supported by grants from the Canadian Institutes of Health Research (MOP-62811), Heart and Stroke Foundation of Nova Scotia and Canada Foundation for Innovation. K. B. S. P. is the recipient of New Investigator Awards from the Heart and Stroke Foundation and Dalhousie Medical Research Foundation. A. H. is the recipient of a studentship from Nova Scotia Health Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambs S, 1998, P NATL ACAD SCI USA, V95, P8823, DOI 10.1073/pnas.95.15.8823; Bai P, 2004, ONCOL REP, V11, P505; Binaschi M, 2000, CANCER RES, V60, P3770; Binaschi M., 2001, Current Medicinal Chemistry - Anti-Cancer Agents, V1, P113, DOI 10.2174/1568011013354723; Bouska A, 2009, TRENDS BIOCHEM SCI, V34, P279, DOI 10.1016/j.tibs.2009.02.006; Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; CAULFIELD JB, 1988, AM J PATHOL, V133, P298; Chaiswing L, 2005, MOL CANCER THER, V4, P1056, DOI 10.1158/1535-7163.MCT-04-0322; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; Clementi ME, 2003, ANTICANCER RES, V23, P2445; CLEVELAND DW, 1981, CELL, V25, P537, DOI 10.1016/0092-8674(81)90072-6; Cooper G, 2006, AM J PHYSIOL-HEART C, V291, pH1003, DOI 10.1152/ajpheart.00132.2006; Dudnakova TV, 2003, J CARDIOVASC PHARM, V41, P788, DOI 10.1097/00005344-200305000-00017; Dunkern TR, 2003, DNA REPAIR, V2, P49, DOI 10.1016/S1568-7864(02)00185-4; EGHBALI M, 1990, MOL CELL BIOCHEM, V96, P1; Fajardo G, 2007, J AM COLL CARDIOL, V50, P537, DOI 10.1016/j.jacc.2007.04.052; Gaspard GJ, 2008, CLIN EXP PHARMACOL P, V35, P679, DOI 10.1111/j.1440-1681.2008.04930.x; Giannakakou P, 2000, NAT CELL BIOL, V2, P709, DOI 10.1038/35036335; Goetzenich A, 2009, J HEART LUNG TRANSPL, V28, P1087, DOI 10.1016/j.healun.2009.06.025; Green PS, 2002, BBA-MOL BASIS DIS, V1588, P94, DOI 10.1016/S0925-4439(02)00144-8; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kalyanaraman B, 2002, MOL CELL BIOCHEM, V234, P119, DOI 10.1023/A:1015976430790; KIM KK, 1994, J BIOL CHEM, V269, P22607; KLAPPACHER G, 1995, AM J CARDIOL, V75, P913, DOI 10.1016/S0002-9149(99)80686-9; Konishi M, 2011, CARDIOVASC RES, V89, P309, DOI 10.1093/cvr/cvq335; Li LH, 2006, CIRCULATION, V113, P535, DOI 10.1161/CIRCULATIONAHA.105.568402; Li LH, 2007, LAB INVEST, V87, P440, DOI 10.1038/labinvest.3700530; Lim CC, 2004, J BIOL CHEM, V279, P8290, DOI 10.1074/jbc.M308033200; Liu XW, 2004, AM J PHYSIOL-HEART C, V286, pH933, DOI 10.1152/ajpheart.00759.2003; Lorenzo E, 2002, J BIOL CHEM, V277, P10883, DOI 10.1074/jbc.M107442200; Ludke ARL, 2009, CAN J PHYSIOL PHARM, V87, P756, DOI 10.1139/Y09-059; Mailloux A, 2001, EUR J CELL BIOL, V80, P442, DOI 10.1078/0171-9335-00171; Miller FJ, 1998, CIRC RES, V82, P1298, DOI 10.1161/01.RES.82.12.1298; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Mukhopadhyay P, 2007, J AM COLL CARDIOL, V50, P528, DOI 10.1016/j.jacc.2007.03.057; Mukhopadhyay P, 2010, CARDIOVASC RES, V85, P773, DOI 10.1093/cvr/cvp369; Mukhopadhyay P, 2009, AM J PHYSIOL-HEART C, V296, pH1466, DOI 10.1152/ajpheart.00795.2008; Murphy M, 1996, GENE DEV, V10, P2971, DOI 10.1101/gad.10.23.2971; Nguyen HL, 1999, J CELL SCI, V112, P1813; Nithipongvanitch R, 2007, ANTIOXID REDOX SIGN, V9, P1001, DOI 10.1089/ars.2007.1632; Nithipongvanitch R, 2007, J HISTOCHEM CYTOCHEM, V55, P629, DOI 10.1369/jhc.6A7146.2007; Pasumarthi KBS, 2005, CIRC RES, V96, P110, DOI 10.1161/01.RES.0000152326.91223.4F; Picard F, 2006, CLIN RES CARDIOL, V95, P261, DOI 10.1007/s00392-006-0373-z; Pointon AV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012733; Popowich DA, 2010, AM J PHYSIOL-HEART C, V298, pH2192, DOI 10.1152/ajpheart.00535.2009; Pouillart P, 2004, CANCER TREAT REV, V30, P643, DOI 10.1016/j.ctrv.2004.06.002; Primeau AJ, 2005, CLIN CANCER RES, V11, P8782, DOI 10.1158/1078-0432.CCR-05-1664; RABKIN SW, 1987, J MOL CELL CARDIOL, V19, P1073, DOI 10.1016/S0022-2828(87)80352-8; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Saga Y, 1999, DEVELOPMENT, V126, P3437; SANCHEZQUINTANA D, 1994, BASIC RES CARDIOL, V89, P279; Sato H, 1997, J CELL BIOL, V139, P963, DOI 10.1083/jcb.139.4.963; Shacka JJ, 2006, CELL DEATH DIFFER, V13, P1506, DOI 10.1038/sj.cdd.4401831; Shirani J, 2000, J AM COLL CARDIOL, V35, P36, DOI 10.1016/S0735-1097(99)00492-1; Shizukuda Y, 2005, MOL CELL BIOCHEM, V273, P25, DOI 10.1007/s11010-005-5905-8; Simunek T, 2009, PHARMACOL REP, V61, P154; Song H, 1999, J HEART LUNG TRANSPL, V18, P744, DOI 10.1016/S1053-2498(98)00039-4; Spallarossa P, 2006, CARDIOVASC RES, V69, P736, DOI 10.1016/j.cardiores.2005.08.009; Spiel AO, 2008, CIRCULATION, V117, P1449, DOI 10.1161/CIRCULATIONAHA.107.722827; STRASSER A, 1994, CELL, V79, P329, DOI 10.1016/0092-8674(94)90201-1; Sun Q, 2009, J CELL SCI, V122, P1563, DOI 10.1242/jcs.047738; Takahashi M, 2003, AM J PHYSIOL-HEART C, V285, pH2072, DOI 10.1152/ajpheart.00396.2003; Takemura G, 2007, PROG CARDIOVASC DIS, V49, P330, DOI 10.1016/j.pcad.2006.10.002; Todorova VK, 2010, CANCER CHEMOTH PHARM, V66, P315, DOI 10.1007/s00280-009-1165-8; Tsang WP, 2003, LIFE SCI, V73, P2047, DOI 10.1016/S0024-3205(03)00566-6; Wouters KA, 2005, BRIT J HAEMATOL, V131, P561, DOI 10.1111/j.1365-2141.2005.05759.x; Yen HC, 1996, J CLIN INVEST, V98, P1253, DOI 10.1172/JCI118909; Yoshida M, 2009, J MOL CELL CARDIOL, V47, P698, DOI 10.1016/j.yjmcc.2009.07.024; Zhu WQ, 2009, CIRCULATION, V119, P99, DOI 10.1161/CIRCULATIONAHA.108.799700	69	44	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22801	10.1371/journal.pone.0022801	http://dx.doi.org/10.1371/journal.pone.0022801			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829519	Green Published, gold, Green Submitted			2022-12-25	WOS:000293284600049
J	Oberg, AI; Dehvari, N; Bengtsson, T				Oberg, Anette I.; Dehvari, Nodi; Bengtsson, Tore			beta-Adrenergic Inhibition of Contractility in L6 Skeletal Muscle Cells	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; LIGHT-CHAIN KINASE; CYCLIC-AMP; MYOSIN-II; EXTRACELLULAR CALCIUM; MORPHOLOGICAL-CHANGES; GLUCOSE-TRANSPORT; ENDOTHELIAL-CELLS; MDCK CELLS; ADHESION	The beta-adrenoceptors (beta-ARs) control many cellular processes. Here, we show that beta-ARs inhibit calcium depletion-induced cell contractility and subsequent cell detachment of L6 skeletal muscle cells. The mechanism underlying the cell detachment inhibition was studied by using a quantitative cell detachment assay. We demonstrate that cell detachment induced by depletion of extracellular calcium is due to myosin-and ROCK-dependent contractility. The beta-AR inhibition of L6 skeletal muscle cell detachment was shown to be mediated by the beta(2)-AR and increased cAMP but was surprisingly not dependent on the classical downstream effectors PKA or Epac, nor was it dependent on PKG, PI3K or PKC. However, inhibition of potassium channels blocks the beta(2)-AR mediated effects. Furthermore, activation of potassium channels fully mimicked the results of beta(2)-AR activation. In conclusion, we present a novel finding that beta(2)-AR signaling inhibits contractility and thus cell detachment in L6 skeletal muscle cells by a cAMP and potassium channel dependent mechanism.	[Oberg, Anette I.; Dehvari, Nodi; Bengtsson, Tore] Stockholm Univ, Dept Physiol, Wenner Gren Inst, S-10691 Stockholm, Sweden	Stockholm University	Oberg, AI (corresponding author), Stockholm Univ, Dept Physiol, Wenner Gren Inst, S-10691 Stockholm, Sweden.	tore.bengtsson@wgi.su.se		Dehvari, Nodi/0000-0002-2186-8023	Swedish Research Council; Novonordiskfonden; Magn.; Bergvall foundation; Carl Tryggers Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Novonordiskfonden(Novo Nordisk Foundation); Magn.; Bergvall foundation; Carl Tryggers Foundation	This study was funded by The Swedish Research Council (http://www.vr.se), Novonordiskfonden (TB) (http://www.novonordiskfonden.dk), Magn. Bergvall foundation (http://www.magnbergvallsstiftelse.nu), and the Carl Tryggers Foundation (http://www.carltryggersstiftelse.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Duck-Sun, 1995, Yonsei Medical Journal, V36, P232; Aslam M, 2010, CARDIOVASC RES, V87, P375, DOI 10.1093/cvr/cvq065; Bieger D, 2006, N-S ARCH PHARMACOL, V373, P186, DOI 10.1007/s00210-006-0060-7; Birukova AA, 2010, MICROVASC RES, V79, P128, DOI 10.1016/j.mvr.2009.11.007; BRITCH M, 1980, EXP CELL RES, V125, P221, DOI 10.1016/0014-4827(80)90206-2; Castillo AM, 1998, J MUSCLE RES CELL M, V19, P557, DOI 10.1023/A:1005316711538; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Delmotte P, 2010, FRONT BIOSCI-LANDMRK, V15, P750, DOI 10.2741/3644; Dong JM, 1998, J BIOL CHEM, V273, P22554, DOI 10.1074/jbc.273.35.22554; Enserink JM, 2004, J BIOL CHEM, V279, P44889, DOI 10.1074/jbc.M404599200; Essler M, 2000, J IMMUNOL, V164, P6543, DOI 10.4049/jimmunol.164.12.6543; Eto M, 1997, FEBS LETT, V410, P356, DOI 10.1016/S0014-5793(97)00657-1; Freund-Michel VC, 2010, EUR RESPIR J, V35, P647, DOI 10.1183/09031936.00034009; Frixione E, 2003, J MUSCLE RES CELL M, V24, P477, DOI 10.1023/A:1027329803686; Fujii K, 1999, HYPERTENSION, V34, P222, DOI 10.1161/01.HYP.34.2.222; Griffin MA, 2004, J CELL SCI, V117, P5855, DOI 10.1242/jcs.01496; HAMILTON KL, 1991, AM J PHYSIOL, V261, pF1055, DOI 10.1152/ajprenal.1991.261.6.F1055; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Ivanov AI, 2004, MOL BIOL CELL, V15, P2639, DOI 10.1091/mbc.E04-02-0163; Janssen LJ, 2004, AM J RESP CELL MOL, V30, P548, DOI 10.1165/rcmb.2003-0212OC; Kaneko K, 2002, PANCREAS, V24, P34, DOI 10.1097/00006676-200201000-00005; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Khuon S, 2010, J CELL SCI, V123, P431, DOI 10.1242/jcs.053793; Kitazawa T, 2004, J PHYSIOL-LONDON, V557, P515, DOI 10.1113/jphysiol.2004.064543; Kotlikoff MI, 1996, ANNU REV PHYSIOL, V58, P115, DOI 10.1146/annurev.ph.58.030196.000555; Lagunes R, 1999, J MUSCLE RES CELL M, V20, P761, DOI 10.1023/A:1005580425932; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Liu SJ, 2011, MOL BIOL REP, V38, P1363, DOI 10.1007/s11033-010-0238-4; Ma TY, 2000, MICROSC RES TECHNIQ, V51, P156, DOI 10.1002/1097-0029(20001015)51:2<156::AID-JEMT7>3.0.CO;2-J; Mammoto A, 2004, J BIOL CHEM, V279, P26323, DOI 10.1074/jbc.M402725200; MAZZANTI M, 1987, BIOPHYS J, V51, P115, DOI 10.1016/S0006-3495(87)83316-7; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Nagase I, 2001, FEBS LETT, V494, P175, DOI 10.1016/S0014-5793(01)02341-9; NAKASHIMA M, 1995, J PHARMACOL EXP THER, V272, P379; Nevzorova J, 2006, BRIT J PHARMACOL, V147, P446, DOI 10.1038/sj.bjp.0706626; Nevzorova J, 2002, BRIT J PHARMACOL, V137, P9, DOI 10.1038/sj.bjp.0704845; Parizi M, 2000, EXP CELL RES, V254, P210, DOI 10.1006/excr.1999.4754; Pelletier S, 2005, J CELL PHYSIOL, V204, P412, DOI 10.1002/jcp.20308; Polte TR, 2004, AM J PHYSIOL-CELL PH, V286, pC518, DOI 10.1152/ajpcell.00280.2003; Rangarajan S, 2003, J CELL BIOL, V160, P487, DOI 10.1083/jcb.200209105; Samarin SN, 2007, MOL BIOL CELL, V18, P3429, DOI 10.1091/mbc.E07-04-0315; SCHUBERT B, 1989, SCIENCE, V245, P516, DOI 10.1126/science.2547248; TANAKA E, 1995, CELL, V83, P171, DOI 10.1016/0092-8674(95)90158-2; Tanishita T, 1997, J BIOCHEM, V122, P90; TATE KM, 1991, EUR J BIOCHEM, V196, P357, DOI 10.1111/j.1432-1033.1991.tb15824.x; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Vishnubhotla R, 2007, LAB INVEST, V87, P1149, DOI 10.1038/labinvest.3700674; Wilhelm I, 2007, PHYS MED BIOL, V52, P6261, DOI 10.1088/0031-9155/52/20/012; Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010; Yamamoto DL, 2007, DIABETOLOGIA, V50, P158, DOI 10.1007/s00125-006-0484-0; Yoshioka K, 2007, MOL PHARMACOL, V71, P912, DOI 10.1124/mol.106.032599	53	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22304	10.1371/journal.pone.0022304	http://dx.doi.org/10.1371/journal.pone.0022304			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829455	gold, Green Published, Green Submitted			2022-12-25	WOS:000293284600009
J	Wang, C; Shangguan, L; Kibet, KN; Wang, XC; Han, J; Song, CN; Fang, JG				Wang, Chen; Shangguan, Lingfei; Kibet, Korir Nicholas; Wang, Xicheng; Han, Jian; Song, Changnian; Fang, Jinggui			Characterization of microRNAs Identified in a Table Grapevine Cultivar with Validation of Computationally Predicted Grapevine miRNAs by miR-RACE	PLOS ONE			English	Article							SMALL NONCODING RNAS; CONSERVED MICRORNAS; ANIMAL DEVELOPMENT; PLANT DEVELOPMENT; LAND PLANTS; TARGETS; GENES; ARABIDOPSIS; SEQUENCE; PCR	Background: Alignment analysis of the Vv-miRNAs identified from various grapevine cultivars indicates that over 30% orthologous Vv-miRNAs exhibit a 1-3 nucleotide discrepancy only at their ends, suggesting that this sequence discrepancy is not a random event, but might mainly derive from divergence of cultivars. With advantages of miR-RACE technology in determining precise sequences of potential miRNAs from bioinformatics prediction, the precise sequences of vv-miRNAs predicted computationally can be verified with miR-RACE in a different grapevine cultivar. This presents itself as a new approach for large scale discovery of precise miRNAs in different grapevine varieties. Methodology/Principal Findings: Among 88 unique sequences of Vv-miRNAs from bioinformatics prediction, 83 (96.3%) were successfully validated with MiR-RACE in grapevine cv. 'Summer Black'. All the validated sequences were identical to their corresponding ones obtained from deep sequencing of the small RNA library of 'Summer Black'. Quantitative RT-PCR analysis of the expressions levels of 10 Vv-miRNA/target gene pairs in grapevine tissues showed some negative correlation trends. Finally, comparison of Vv-miRNA sequences with their orthologs in Arabidopsis and study on the influence of divergent bases of the orthologous miRNAs on their targeting patterns in grapevine were also done. Conclusion: The validation of precise sequences of potential Vv-miRNAs from computational prediction in a different grapevine cultivar can be a new way to identify the orthologous Vv-miRNAs. Nucleotide discrepancy of orthologous Vv-miRNAs from different grapevine cultivars normally does not change their target genes. However, sequence variations of some orthologous miRNAs in grapevine and Arabidopsis can change their targeting patterns. These precise Vv-miRNAs sequences validated in our study could benefit some further study on grapevine functional genomics.	[Wang, Chen; Shangguan, Lingfei; Kibet, Korir Nicholas; Wang, Xicheng; Han, Jian; Song, Changnian; Fang, Jinggui] Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu Prov, Peoples R China	Nanjing Agricultural University	Wang, C (corresponding author), Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu Prov, Peoples R China.	fanggg@njau.edu.cn		Fang, Jinggui/0000-0003-1975-2715	NCET Program of China [NCET-08-079]; China Ministry of Education [109084]; Fundamental Research Funds for the Central Universities [KYJ200909]	NCET Program of China(Program for New Century Excellent Talents in University (NCET)); China Ministry of Education(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the NCET Program of China (grant no. NCET-08-0796), the Science & Technology Key Project of the China Ministry of Education (grant no. 109084), and the Fundamental Research Funds for the Central Universities (No. KYJ200909). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Axtell MJ, 2005, PLANT CELL, V17, P1658, DOI 10.1105/tpc.105.032185; Bartel B, 2003, PLANT PHYSIOL, V132, P709, DOI 10.1104/pp.103.023630; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; CAI B, 2008, ACTA AGR BOREALI S S, V23, P213; Carra A, 2009, PLANT J, V59, P750, DOI 10.1111/j.1365-313X.2009.03906.x; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chang S, 1993, PLANT MOL BIOL REP, V11, P113, DOI DOI 10.1007/BF02670468; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; De Felippes FF, 2008, RNA, V14, P2455, DOI 10.1261/rna.1149408; Elbashir S.M., 2001, GENE DEV, V16, P1616; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Floyd SK, 2004, NATURE, V428, P485, DOI 10.1038/428485a; Gleave AP, 2008, TREE GENET GENOMES, V4, P343, DOI 10.1007/s11295-007-0113-1; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Hunter C, 2003, CURR OPIN GENET DEV, V13, P372, DOI 10.1016/S0959-437X(03)00081-9; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Lai EC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-115; Laufs P, 2004, DEVELOPMENT, V131, P4311, DOI 10.1242/dev.01320; Lauter N, 2005, P NATL ACAD SCI USA, V102, P9412, DOI 10.1073/pnas.0503927102; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin SL, 2005, GENE, V356, P32, DOI 10.1016/j.gene.2005.04.036; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Mallory AC, 2004, CURR OPIN PLANT BIOL, V7, P120, DOI 10.1016/j.pbi.2004.01.006; Mica E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-109; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.0960-7412.2010.04208.x, 10.1111/j.1365-313X.2010.04208.x]; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Song CNA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010861; Song CN, 2009, PLANTA, V230, P671, DOI 10.1007/s00425-009-0971-x; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-25; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Wang Chen, 2010, Journal of Fruit Science, V27, P207; Wang JF, 2004, NUCLEIC ACIDS RES, V32, P1688, DOI 10.1093/nar/gkh332; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Yamaguchi A, 2009, DEV CELL, V17, P268, DOI 10.1016/j.devcel.2009.06.007; Yin ZJ, 2008, GENE, V414, P60, DOI 10.1016/j.gene.2008.02.007; YU HP, PHYSL PLANTARUM, V141, P56; Zhang BH, 2006, COMPUT BIOL CHEM, V30, P395, DOI 10.1016/j.compbiolchem.2006.08.006; Zhang BH, 2006, FEBS LETT, V580, P3753, DOI 10.1016/j.febslet.2006.05.063; Zhang BH, 2008, PLANTA, V229, P161, DOI 10.1007/s00425-008-0818-x; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang JG, 2008, GENE, V423, P1, DOI 10.1016/j.gene.2008.05.023	56	42	52	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e21259	10.1371/journal.pone.0021259	http://dx.doi.org/10.1371/journal.pone.0021259			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829435	gold, Green Submitted, Green Published			2022-12-25	WOS:000293284600003
J	Barocas, A; Ilany, A; Koren, L; Kam, M; Geffen, E				Barocas, Adi; Ilany, Amiyaal; Koren, Lee; Kam, Michael; Geffen, Eli			Variance in Centrality within Rock Hyrax Social Networks Predicts Adult Longevity	PLOS ONE			English	Article							REPRODUCTIVE SUCCESS; GROUP-SIZE; SURVIVAL; RECAPTURE; SELECTION; BONDS; MODEL	Background: In communal mammals the levels of social interaction among group members vary considerably. In recent years, biologists have realized that within-group interactions may affect survival of the group members. Several recent studies have demonstrated that the social integration of adult females is positively associated with infant survival, and female longevity is affected by the strength and stability of the individual social bonds. Our aim was to determine the social factors that influence adult longevity in social mammals. Methodology/Principal Findings: As a model system, we studied the social rock hyrax (Procavia capensis), a plural breeder with low reproductive skew, whose groups are mainly composed of females. We applied network theory using 11 years of behavioral data to quantify the centrality of individuals within groups, and found adult longevity to be inversely correlated to the variance in centrality. In other words, animals in groups with more equal associations lived longer. Individual centrality was not correlated with longevity, implying that social tension may affect all group members and not only the weakest or less connected ones. Conclusions/Significance: Our novel findings support previous studies emphasizing the adaptive value of social associations and the consequences of inequality among adults within social groups. However, contrary to previous studies, we suggest that it is not the number or strength of associations that an adult individual has (i.e. centrality) that is important, but the overall configuration of social relationships within the group (i.e. centrality SD) that is a key factor in influencing longevity.	[Barocas, Adi; Ilany, Amiyaal; Koren, Lee; Geffen, Eli] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Koren, Lee] Univ Calgary, Fac Vet Med, Dept Comparat Biol & Expt Med, Calgary, AB, Canada; [Kam, Michael] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Wyler Dept Dryland Agr, IL-84105 Beer Sheva, Israel	Tel Aviv University; University of Calgary; Ben Gurion University	Barocas, A (corresponding author), Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel.	geffene@post.tau.ac.il	Kam, Michael/Q-8764-2019	Kam, Michael/0000-0002-1062-7654; Ilany, Amiyaal/0000-0001-8089-569X	Israel Academy of Sciences and Humanities [ISF 577/99, 488/05, 461/09]	Israel Academy of Sciences and Humanities	This study was supported by three grants from the Israel Academy of Sciences and Humanities (ISF 577/99, 488/05, 461/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; ANDERSON DR, 1994, ECOLOGY, V75, P1780, DOI 10.2307/1939637; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Aviles L, 2004, AM NAT, V164, P132, DOI 10.1086/422263; Barker RJ, 1997, BIOMETRICS, V53, P666, DOI 10.2307/2533966; BAROCAS A, 2010, THESIS TEL AVIV U IS; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Bejder L, 1998, ANIM BEHAV, V56, P719, DOI 10.1006/anbe.1998.0802; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Borgatti S. P., 2002, UCINET WINDOWS SOFTW, V6; Cameron EZ, 2009, P NATL ACAD SCI USA, V106, P13850, DOI 10.1073/pnas.0900639106; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Clutton-Brock T.H., 1988, REPROD SUCCESS STUDI; Clutton-Brock TH, 2001, SCIENCE, V291, P478, DOI 10.1126/science.291.5503.478; Clutton-Brock TH, 1999, J ANIM ECOL, V68, P672, DOI 10.1046/j.1365-2656.1999.00317.x; Clutton-Brock T, 2009, PHILOS T R SOC B, V364, P3229, DOI 10.1098/rstb.2009.0120; Cooch E., 2001, GENTLE INTRO PROGRAM; Creel S, 1998, ANIM CONSERV, V1, P1, DOI 10.1111/j.1469-1795.1998.tb00220.x; Croft DP, 2008, EXPLORING ANIMAL SOCIAL NETWORKS, P1; DOREIAN P, 1974, J MATH SOCIOL, V3, P245, DOI 10.1080/0022250X.1974.9989837; ESTES RD, 1991, BEHAV GUIDE AFRICAN; Hall AJ, 2001, J ANIM ECOL, V70, P138; Hodge SJ, 2005, P ROY SOC B-BIOL SCI, V272, P2479, DOI 10.1098/rspb.2005.3255; HOECK HN, 1989, OECOLOGIA, V79, P353, DOI 10.1007/BF00384314; HOECK HN, 1982, Z TIERPSYCHOL, V59, P177; HOECK HN, 1982, Z TIERPSYCHOL, V59, P265; Hollister-Smith JA, 2007, ANIM BEHAV, V74, P287, DOI 10.1016/j.anbehav.2006.12.008; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; HOOGLAND JL, 1983, AM NAT, V121, P275, DOI 10.1086/284057; James R, 2009, BEHAV ECOL SOCIOBIOL, V63, P989, DOI 10.1007/s00265-009-0742-5; Kokko H, 1999, P ROY SOC B-BIOL SCI, V266, P571, DOI 10.1098/rspb.1999.0674; Koren L, 2006, HORM BEHAV, V49, P470, DOI 10.1016/j.yhbeh.2005.10.004; KOREN L, 2000, THESIS TEL AVIV U IS; Koren L, 2008, HORM BEHAV, V54, P212, DOI 10.1016/j.yhbeh.2008.02.020; Koren L, 2009, ANIM BEHAV, V77, P233, DOI 10.1016/j.anbehav.2008.09.031; Krause J, 2002, LIVING GROUPS; Krause J, 2009, BEHAV ECOL SOCIOBIOL, V63, P967, DOI 10.1007/s00265-009-0747-0; Lea AJ, 2010, P NATL ACAD SCI USA, V107, P21587, DOI 10.1073/pnas.1009882107; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; MANLY BFJ, 1994, RANDOMIZATION MONTE; Mosser A, 2009, ANIM BEHAV, V78, P359, DOI 10.1016/j.anbehav.2009.04.024; PACKER C, 1990, AM NAT, V136, P1, DOI 10.1086/285079; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Ramos-Fernandez G, 2009, BEHAV ECOL SOCIOBIOL, V63, P999, DOI 10.1007/s00265-009-0719-4; Randall JA, 2005, BEHAV ECOL, V16, P961, DOI 10.1093/beheco/ari078; SALE J B, 1970, Zoologica Africana, V5, P87; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; Schubert KA, 2007, BIOL J LINN SOC, V90, P85, DOI 10.1111/j.1095-8312.2007.00713.x; SCOTT J., 1991, SOCIAL NETWORK ANAL; Silk JB, 2003, SCIENCE, V302, P1231, DOI 10.1126/science.1088580; Silk JB, 2007, PHILOS T R SOC B, V362, P539, DOI 10.1098/rstb.2006.1994; Silk JB, 2010, CURR BIOL, V20, P1359, DOI 10.1016/j.cub.2010.05.067; STEPHENSON K, 1989, SOC NETWORKS, V11, P1, DOI 10.1016/0378-8733(89)90016-6; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y; Wittemyer G, 2007, ANIM BEHAV, V73, P671, DOI 10.1016/j.anbehav.2006.10.008; WRANGHAM RW, 1993, BEHAV ECOL SOCIOBIOL, V32, P199	59	85	85	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22375	10.1371/journal.pone.0022375	http://dx.doi.org/10.1371/journal.pone.0022375			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818314	Green Published, gold			2022-12-25	WOS:000293282700025
J	Zhang, JF; Tarbet, EB; Feng, TW; Shi, ZK; Van Kampen, KR; Tang, DCC				Zhang, Jianfeng; Tarbet, E. Bart; Feng, Tsungwei; Shi, Zhongkai; Van Kampen, Kent R.; Tang, De-chu C.			Adenovirus-Vectored Drug-Vaccine Duo as a Rapid-Response Tool for Conferring Seamless Protection against Influenza	PLOS ONE			English	Article							IMMUNE-RESPONSES; VIRUS; NASAL; H5N1; IMMUNOGENICITY; FORMULATIONS; IMMUNIZATION; REPLICATION; INTERFERON; ANTIBODIES	Few other diseases exert such a huge toll of suffering as influenza. We report here that intranasal (i.n.) administration of E1/E3-defective (Delta E1E3) adenovirus serotype 5 (Ad5) particles rapidly induced an anti-influenza state as a means of prophylactic therapy which persisted for several weeks in mice. By encoding an influenza virus (IFV) hemagglutinin (HA) HA1 domain, an Ad5-HA1 vector conferred rapid protection as a prophylactic drug followed by elicitation of sustained protective immunity as a vaccine for inducing seamless protection against influenza as a drug-vaccine duo (DVD) in a single package. Since Ad5 particles induce a complex web of host responses, which could arrest influenza by activating a specific arm of innate immunity to impede IFV growth in the airway, it is conceivable that this multi-pronged influenza DVD may escape the fate of drug resistance that impairs the current influenza drugs.	[Zhang, Jianfeng; Feng, Tsungwei; Shi, Zhongkai; Van Kampen, Kent R.; Tang, De-chu C.] Vaxin Inc, Birmingham, AL 35203 USA; [Tarbet, E. Bart] Utah State Univ, Inst Antiviral Res, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	Zhang, JF (corresponding author), Vaxin Inc, Birmingham, AL 35203 USA.	dechutang@gmail.com		Tarbet, Bart/0000-0002-4255-9094	National Institutes of Health [2-R44-AI-068285-02, 1-UC1-AI-067198-01, N01-AI-30063]; National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UC1AI067198, R29AI030063, R44AI068285] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants 2-R44-AI-068285-02 and 1-UC1-AI-067198-01; a National Institutes of Health contract N01-AI-30063; and a National Institute of Allergy and Infectious Diseases Non-Clinical Evaluation Agreement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnard Dale L., 2007, Antiviral Chemistry & Chemotherapy, V18, P125; CLEMENTS ML, 1986, J CLIN MICROBIOL, V24, P157, DOI 10.1128/JCM.24.1.157-160.1986; Couch RB, 2004, NEW ENGL J MED, V350, P860, DOI 10.1056/NEJMp048006; Croyle MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003548; Evans RK, 2004, J PHARM SCI-US, V93, P2458, DOI 10.1002/jps.20157; GAUSH CR, 1968, APPL MICROBIOL, V16, P588, DOI 10.1128/AEM.16.4.588-594.1968; Goodman AG, 2010, J VIROL, V84, P2027, DOI 10.1128/JVI.01595-09; Hartman ZC, 2008, VIRUS RES, V132, P1, DOI 10.1016/j.virusres.2007.10.005; Higashimoto Yuji, 2006, Inflammation & Allergy Drug Targets, V5, P229, DOI 10.2174/187152806779010927; Hoelscher MA, 2006, LANCET, V367, P475, DOI 10.1016/S0140-6736(06)68076-8; Ilyushina NA, 2010, J VIROL, V84, P8607, DOI 10.1128/JVI.00159-10; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Lemiale F, 2003, J VIROL, V77, P10078, DOI 10.1128/JVI.77.18.10078-10087.2003; Lynn Dwight E., 2001, Methods in Cell Science, V23, P221, DOI 10.1023/A:1016394421408; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Norton EB, 2010, J VIROL, V84, P2983, DOI 10.1128/JVI.01805-09; Poland GA, 2009, CLIN INFECT DIS, V48, P1254, DOI 10.1086/598989; Price GE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013162; Rhee EG, 2011, J VIROL, V85, P315, DOI 10.1128/JVI.01597-10; Schaack J, 2004, P NATL ACAD SCI USA, V101, P3124, DOI 10.1073/pnas.0303709101; Shi ZK, 2001, J VIROL, V75, P11474, DOI 10.1128/JVI.75.23.11474-11482.2001; Song KM, 2010, P NATL ACAD SCI USA, V107, P22213, DOI 10.1073/pnas.1015536108; Takahashi E, 2010, MICROBES INFECT, V12, P778, DOI 10.1016/j.micinf.2010.04.013; Tang DCC, 2009, EXPERT REV VACCINES, V8, P469, DOI [10.1586/erv.09.1, 10.1586/ERV.09.1]; Thiele AT, 2006, J VIROL, V80, P1826, DOI 10.1128/JVI.80.4.1826-1836.2006; Tumpey TM, 2007, J VIROL, V81, P10818, DOI 10.1128/JVI.01116-07; Tuvim MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004176; Van Kampen KR, 2005, VACCINE, V23, P1029, DOI 10.1016/j.vaccine.2004.07.043; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Yamaguchi T, 2010, P NATL ACAD SCI USA, V107, P17286, DOI 10.1073/pnas.1009823107; Zhu JA, 2008, MOL THER, V16, P1300, DOI 10.1038/mt.2008.88	32	17	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22605	10.1371/journal.pone.0022605	http://dx.doi.org/10.1371/journal.pone.0022605			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818346	Green Submitted, gold, Green Published			2022-12-25	WOS:000293282700047
J	Esposito, T; Magliocca, S; Formicola, D; Gianfrancesco, F				Esposito, Teresa; Magliocca, Sara; Formicola, Daniela; Gianfrancesco, Fernando			piR_015520 Belongs to Piwi-Associated RNAs Regulates Expression of the Human Melatonin Receptor 1A Gene	PLOS ONE			English	Article							PROTEIN; IDENTIFICATION; BIOGENESIS; DROSOPHILA; MICRORNAS; HOMOLOG; BIND	Piwi-associated RNAs (piRNAs) are a distinct class of 24- to 30-nucleotide-long RNAs produced by a Dicer-independent mechanism, and are associated with Piwi-class Argonaute proteins. In contrast to the several hundred species of microRNAs (miRNAs) identified thus far, piRNAs consist of more than 30,000 different species in humans. Studies in flies, fish and mice implicate these piRNAs in regulating germ line development, the silencing of selfish DNA elements, and maintaining germ line DNA integrity. Most piRNAs map to unique sites in the human genome, including intergenic, intronic, and exonic sequences. However, the role of piRNAs in humans remains to be elucidated. Here, we uncover an unexpected function of the piRNA pathway in humans. We show for the first time, that the piRNA_015520, located in intron 1 of the human Melatonin receptor 1A (MTNR1A) gene, is expressed in adult human tissues (testes and brain) and in the human cell line HEK 293. Although the role of piR_015520 expression in brain tissue remains unknown, the testes-specific expression is consistent with previous findings in several species. Surprisingly, in contrast to the mechanism known for miRNA-mediated modulation of gene expression, piRNA_015520 negatively regulates MTNR1A gene expression by binding to its genomic region. This finding suggests that changes in individual piRNA levels could influence both autoregulatory gene expression and the expression of the gene in which the piRNA is located. These findings offer a new perspective for piRNAs functioning as gene regulators in humans.	[Esposito, Teresa; Magliocca, Sara; Formicola, Daniela; Gianfrancesco, Fernando] Natl Res Council Italy, Inst Genet & Biophys Adriano Buzzati Traverso, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR)	Esposito, T (corresponding author), Natl Res Council Italy, Inst Genet & Biophys Adriano Buzzati Traverso, Naples, Italy.	teresa.esposito@igb.cnr.it	Formicola, Daniela/ABC-4081-2020; Esposito, Teresa/AAA-5488-2019; Gianfrancesco, Fernando/P-6853-2014; Formicola, Daniela/K-7005-2016	Esposito, Teresa/0000-0002-7879-8441; Gianfrancesco, Fernando/0000-0002-3812-2471; Formicola, Daniela/0000-0001-9128-9775	Italian Institute of Genetics and Biophysics, National Research Council of Italy	Italian Institute of Genetics and Biophysics, National Research Council of Italy(Consiglio Nazionale delle Ricerche (CNR))	The work was supported in part by grants from the Italian Institute of Genetics and Biophysics, National Research Council of Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	AIGNER A, 2011, J MOL MED       0114; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Betel D, 2007, PLOS COMPUT BIOL, V3, P2219, DOI 10.1371/journal.pcbi.0030222; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Dillon DC, 2002, AM J CLIN PATHOL, V118, P451; Esposito T, 2012, NEPHROL DIAL TRANSPL, V27, P210, DOI 10.1093/ndt/gfr216; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; GRANELLIPIPERNO A, 1990, J EXP MED, V172, P1869, DOI 10.1084/jem.172.6.1869; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai L, 2009, BREAST CANCER RES TR, V118, P293, DOI 10.1007/s10549-008-0220-1; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Rearick D, 2011, NUCLEIC ACIDS RES, V39, P2357, DOI 10.1093/nar/gkq1080; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Savaskan E, 2007, CURR ALZHEIMER RES, V4, P47, DOI 10.2174/156720507779939823	25	61	64	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e22727	10.1371/journal.pone.0022727	http://dx.doi.org/10.1371/journal.pone.0022727			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21818375	gold, Green Submitted, Green Published			2022-12-25	WOS:000293175100044
J	Lozano-Duran, R; Rosas-Diaz, T; Luna, AP; Bejarano, ER				Lozano-Duran, Rosa; Rosas-Diaz, Tabata; Luna, Ana P.; Bejarano, Eduardo R.			Identification of Host Genes Involved in Geminivirus Infection Using a Reverse Genetics Approach	PLOS ONE			English	Article							LEAF CURL VIRUS; REPLICATION PROTEIN INTERACTS; TOBACCO RATTLE VIRUS; NICOTIANA-BENTHAMIANA; ANTIOXIDANT SYSTEM; PLANT DEVELOPMENT; CELL-DEATH; EXPRESSION; STRESS; COMPLEX	Geminiviruses, like all viruses, rely on the host cell machinery to establish a successful infection, but the identity and function of these required host proteins remain largely unknown. Tomato yellow leaf curl Sardinia virus (TYLCSV), a monopartite geminivirus, is one of the causal agents of the devastating Tomato yellow leaf curl disease (TYLCD). The transgenic 2IRGFP N. benthamiana plants, used in combination with Virus Induced Gene Silencing (VIGS), entail an important potential as a tool in reverse genetics studies to identify host factors involved in TYLCSV infection. Using these transgenic plants, we have made an accurate description of the evolution of TYLCSV replication in the host in both space and time. Moreover, we have determined that TYLCSV and Tobacco rattle virus (TRV) do not dramatically influence each other when co-infected in N. benthamiana, what makes the use of TRV-induced gene silencing in combination with TYLCSV for reverse genetic studies feasible. Finally, we have tested the effect of silencing candidate host genes on TYLCSV infection, identifying eighteen genes potentially involved in this process, fifteen of which had never been implicated in geminiviral infections before. Seven of the analyzed genes have a potential anti-viral effect, whereas the expression of the other eleven is required for a full infection. Interestingly, almost half of the genes altering TYLCSV infection play a role in postranslational modifications. Therefore, our results provide new insights into the molecular mechanisms underlying geminivirus infections, and at the same time reveal the 2IRGFP/VIGS system as a powerful tool for functional reverse genetics studies.	[Lozano-Duran, Rosa; Rosas-Diaz, Tabata; Luna, Ana P.; Bejarano, Eduardo R.] Univ Malaga, Dept Biol Celular Genet & Fisiol, Malaga Consejo Super Invest Cient IHSM UMA CSIC, E-29071 Malaga, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM)	Lozano-Duran, R (corresponding author), Sainsbury Lab, Norwich Res Pk, Norwich, Norfolk, England.	Edu_rodri@uma.es	Bejarano, Eduardo R/K-5285-2014; Rosas, Tabata/A-8526-2019; Luna, Ana/AAS-1865-2021	Bejarano, Eduardo R/0000-0002-4806-253X; Rosas, Tabata/0000-0002-4338-6711; Luna, Ana/0000-0002-8230-3229	Spanish Ministerio de Ciencia y Tecnologia [AGL2007-66062-C02-02/AGR, GEN2006-27770-C2]; Spanish Ministerio de Educacion y Cultura; Fundacion Carolina; Junta de Andalucia	Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministerio de Educacion y Cultura(German Research Foundation (DFG)); Fundacion Carolina; Junta de Andalucia(Junta de Andalucia)	This research was supported by a grant from the Spanish Ministerio de Ciencia y Tecnologia (AGL2007-66062-C02-02/AGR and GEN2006-27770-C2). http://www.micinn.es/. R.L.D. was awarded a Predoctoral Fellowship from the Spanish Ministerio de Educacion y Cultura. T.R.D. was awarded a Fellowship from the Fundacion Carolina. A.P.L. was awarded a Predoctoral Fellowship from Junta de Andalucia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ach RA, 1997, MOL CELL BIOL, V17, P5077, DOI 10.1128/MCB.17.9.5077; Amari K, 2007, PHYSIOL PLANTARUM, V131, P302, DOI 10.1111/j.1399-3054.2007.00961.x; Andleeb S, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-373; Diaz-Pendon JA, 2010, MOL PLANT PATHOL, V11, P441, DOI [10.1111/j.1364-3703.2010.00618.x, 10.1111/J.1364-3703.2010.00618.X]; Aparicio F, 2005, PLANT PHYSIOL, V138, P529, DOI 10.1104/pp.104.058958; Asano T, 2002, PLANT J, V32, P401, DOI 10.1046/j.1365-313X.2002.01423.x; Ascencio-Ibanez JT, 2008, PLANT PHYSIOL, V148, P436, DOI 10.1104/pp.108.121038; Ausubel FM, 1998, CURRENT PROTOCOLS MO; Bennett T, 2010, PLANT CELL, V22, P640, DOI 10.1105/tpc.109.072272; BER R, 1990, ARCH VIROLOGY; Boudsocq M, 2004, J BIOL CHEM, V279, P41758, DOI 10.1074/jbc.M405259200; Burch-Smith TM, 2004, PLANT J, V39, P734, DOI 10.1111/j.1365-313X.2004.02158.x; Carvalho MF, 2006, PLANT PHYSIOL, V140, P1317, DOI 10.1104/pp.105.075556; Castillo AG, 2004, J VIROL, V78, P2758, DOI 10.1128/JVI.78.6.2758-2769.2004; Chen JC, 2004, PLANT MOL BIOL, V55, P521, DOI 10.1007/s11103-004-0590-7; Citovsky V, 2009, SEMIN CELL DEV BIOL, V20, P1048, DOI 10.1016/j.semcdb.2009.05.012; Clarke SF, 2002, PHYSIOL PLANTARUM, V114, P157, DOI 10.1034/j.1399-3054.2002.1140201.x; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; CZOSNEK H, 1988, PLANT DIS, V72, P949, DOI 10.1094/PD-72-0949; Maxwell Douglas P., 2007, P409, DOI 10.1007/978-1-4020-4769-5_24; Davis SJ, 1998, PLANT MOL BIOL, V36, P521, DOI 10.1023/A:1005991617182; DeYoung BJ, 2006, PLANT J, V45, P1, DOI 10.1111/j.1365-313X.2005.02592.x; DeYoung BJ, 2008, GENETICS, V180, P895, DOI 10.1534/genetics.108.091108; Diaz-Vivancos P, 2006, J EXP BOT, V57, P3813, DOI 10.1093/jxb/erl138; Diaz-Vivancos P, 2008, J EXP BOT, V59, P2147, DOI 10.1093/jxb/ern082; Dielen AS, 2010, MOL PLANT PATHOL, V11, P293, DOI 10.1111/j.1364-3703.2009.00596.x; Dogra SC, 2009, PLANT MOL BIOL, V71, P25, DOI 10.1007/s11103-009-9506-x; Dreher K, 2007, ANN BOT-LONDON, V99, P787, DOI 10.1093/aob/mcl255; Eini O, 2009, MOL PLANT MICROBE IN, V22, P737, DOI 10.1094/MPMI-22-6-0737; Ekengren SK, 2003, PLANT J, V36, P905, DOI 10.1046/j.1365-313X.2003.01944.x; ELMER JS, 1988, PLANT MOL BIOL, V10, P225, DOI 10.1007/BF00027399; Escaler M, 2000, VIROLOGY, V267, P318, DOI 10.1006/viro.1999.0119; Eybishtz A, 2010, PLANTA, V231, P537, DOI 10.1007/s00425-009-1072-6; Garcia-Marcos A, 2009, MOL PLANT MICROBE IN, V22, P1431, DOI 10.1094/MPMI-22-11-1431; Guerra-Peraza O, 2005, J GEN VIROL, V86, P1815, DOI 10.1099/vir.0.80920-0; Guo YF, 2010, PLANT J, V63, P889, DOI 10.1111/j.1365-313X.2010.04295.x; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Kjemtrup S, 1998, PLANT J, V14, P91, DOI 10.1046/j.1365-313X.1998.00101.x; Komatsu K, 2010, MOL PLANT MICROBE IN, V23, P283, DOI 10.1094/MPMI-23-3-0283; Kong LJ, 2000, EMBO J, V19, P3485, DOI 10.1093/emboj/19.13.3485; Kong LJ, 2002, PLANT CELL, V14, P1817, DOI 10.1105/tpc.003681; Krenz B, 2010, VIROLOGY, V401, P6, DOI 10.1016/j.virol.2010.02.011; La Camera S, 2005, PLANT J, V44, P810, DOI 10.1111/j.1365-313X.2005.02578.x; La Camera S, 2009, MOL PLANT MICROBE IN, V22, P469, DOI 10.1094/MPMI-22-4-0469; Lai JB, 2009, PLANT J, V57, P905, DOI 10.1111/j.1365-313X.2008.03737.x; Lampl N, 2010, J BIOL CHEM, V285, P13550, DOI 10.1074/jbc.M109.095075; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Lewis JD, 2010, P NATL ACAD SCI USA, V107, P2491, DOI 10.1073/pnas.0909080107; Liu EW, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-5; Liu FQ, 2004, PLANT CELL, V16, P5, DOI 10.1105/tpc.017772; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOZANODURAN R, 2011, PLANT SIGNA IN PRESS; LOZANODURAN R, 2011, PLANT CELL; Lois LM, 2010, BIOCHEM SOC T, V38, P60, DOI 10.1042/BST0380060; McGarry RC, 2003, PLANT CELL, V15, P1605, DOI 10.1105/tpc.012120; Morilla G, 2006, J VIROL, V80, P3624, DOI 10.1128/JVI.80.7.3624-3633.2006; Moriones E, 2000, VIRUS RES, V71, P123, DOI 10.1016/S0168-1702(00)00193-3; Mustafiz A, 2010, METHODS MOL BIOL, V639, P95, DOI 10.1007/978-1-60761-702-0_6; Noel LD, 2007, PLANT CELL, V19, P4061, DOI 10.1105/tpc.107.051896; Orzaez D, 2009, PLANT PHYSIOL, V150, P1122, DOI 10.1104/pp.109.139006; Peele C, 2001, PLANT J, V27, P357, DOI 10.1046/j.1365-313x.2001.01080.x; Piroux N, 2007, VIROLOGY, V362, P428, DOI 10.1016/j.virol.2006.12.034; Ratcliff F, 2001, PLANT J, V25, P237, DOI 10.1046/j.0960-7412.2000.00942.x; Rimmer J, 2006, ANN ROY COLL SURG, V88, P412, DOI 10.1308/rcsann.2006.88.4.412b; Rojas MR, 2005, ANNU REV PHYTOPATHOL, V43, P361, DOI 10.1146/annurev.phyto.43.040204.135939; Ruiz MT, 1998, PLANT CELL, V10, P937, DOI 10.1105/tpc.10.6.937; Sahu PP, 2010, MOL PLANT PATHOL, V11, P531, DOI [10.1111/J.1364-3703.2010.00630.X, 10.1111/j.1364-3703.2010.00630.x]; Sambrook J, 2001, MOL CLONING LAB MANU; Schwechheimer C, 2010, EUR J CELL BIOL, V89, P157, DOI 10.1016/j.ejcb.2009.11.021; Selth LA, 2005, PLANT CELL, V17, P311, DOI 10.1105/tpc.104.027235; Senthil-Kumar M, 2007, NEW PHYTOL, V176, P782, DOI 10.1111/j.1469-8137.2007.02225.x; Serino G, 2003, ANNU REV PLANT BIOL, V54, P165, DOI 10.1146/annurev.arplant.54.031902.134847; Shultz RW, 2007, PLANT PHYSIOL, V144, P1697, DOI 10.1104/pp.107.101105; Singh DK, 2007, NUCLEIC ACIDS RES, V35, P755, DOI 10.1093/nar/gkl1088; Song XS, 2009, PHYSIOL PLANTARUM, V135, P246, DOI 10.1111/j.1399-3054.2008.01189.x; Spitzer B, 2007, PLANT PHYSIOL, V145, P1241, DOI 10.1104/pp.107.105916; STANLEY J, 2005, VIRUS TAXONOMY, P301; Sun W, 2010, PLANT CELL PHYSIOL, V51, P997, DOI 10.1093/pcp/pcq056; Sung DY, 2001, PLANT PHYSIOL, V126, P789, DOI 10.1104/pp.126.2.789; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Thomas CL, 2001, PLANT J, V25, P417, DOI 10.1046/j.1365-313x.2001.00976.x; Trinks D, 2005, J VIROL, V79, P2517, DOI 10.1128/JVI.79.4.2517-2527.2005; Umezawa T, 2004, P NATL ACAD SCI USA, V101, P17306, DOI 10.1073/pnas.0407758101; Vilaine F, 2003, PLANT J, V36, P67, DOI 10.1046/j.1365-313X.2003.01855.x; Voinnet O, 1997, NATURE, V389, P553, DOI 10.1038/39215; Wang H, 2003, PLANT CELL, V15, P3020, DOI 10.1105/tpc.015180; Woodward AW, 2007, PLANT PHYSIOL, V144, P976, DOI 10.1104/PP.107.100404; Xie Q, 1999, PLANT MOL BIOL, V39, P647, DOI 10.1023/A:1006138221874; Yadav Sudesh Kumar, 2008, Drug Metabolism and Drug Interactions, V23, P51; Yang JM, 2011, PLANT PHYSIOL BIOCH, V49, P103, DOI 10.1016/j.plaphy.2010.10.004	90	48	48	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e22383	10.1371/journal.pone.0022383	http://dx.doi.org/10.1371/journal.pone.0022383			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21818318	Green Submitted, Green Published, gold			2022-12-25	WOS:000293175100023
J	Millucci, L; Paccagnini, E; Ghezzi, L; Bernardini, G; Braconi, D; Laschi, M; Consumi, M; Spreafico, A; Tanganelli, P; Lupetti, P; Magnani, A; Santucci, A				Millucci, Lia; Paccagnini, Eugenio; Ghezzi, Lorenzo; Bernardini, Giulia; Braconi, Daniela; Laschi, Marcella; Consumi, Marco; Spreafico, Adriano; Tanganelli, Piero; Lupetti, Pietro; Magnani, Agnese; Santucci, Annalisa			Different Factors Affecting Human ANP Amyloid Aggregation and Their Implications in Congestive Heart Failure	PLOS ONE			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; HUMAN FAILING HEARTS; AUGMENTED SYNTHESIS; PROTEINS; BINDING; IDENTIFICATION; POLYPEPTIDE; DISEASE; SYSTEM	Aims: Atrial Natriuretic Peptide (ANP)-containing amyloid is frequently found in the elderly heart. No data exist regarding ANP aggregation process and its link to pathologies. Our aims were: i) to experimentally prove the presumptive association of Congestive Heart Failure (CHF) and Isolated Atrial Amyloidosis (IAA); ii) to characterize ANP aggregation, thereby elucidating IAA implication in the CHF pathogenesis. Methods and Results: A significant prevalence (85%) of IAA was immunohistochemically proven ex vivo in biopsies from CHF patients. We investigated in vitro (using Congo Red, Thioflavin T, SDS-PAGE, transmission electron microscopy, infrared spectroscopy) ANP fibrillogenesis, starting from alpha-ANP as well as the ability of dimeric beta-ANP to promote amyloid formation. Different conditions were adopted, including those reproducing beta-ANP prevalence in CHF. Our results defined the uncommon rapidity of alpha-ANP self-assembly at acidic pH supporting the hypothesis that such aggregates constitute the onset of a fibrillization process subsequently proceeding at physiological pH. Interestingly, CHF-like conditions induced the production of the most stable and time-resistant ANP fibrils suggesting that CHF affected people may be prone to develop IAA. Conclusions: We established a link between IAA and CHF by ex vivo examination and assessed that beta-ANP is, in vitro, the seed of ANP fibrils. Our results indicate that beta-ANP plays a crucial role in ANP amyloid deposition under physiopathological CHF conditions. Overall, our findings indicate that early IAA-related ANP deposition may occur in CHF and suggest that these latter patients should be monitored for the development of cardiac amyloidosis.	[Millucci, Lia; Ghezzi, Lorenzo; Bernardini, Giulia; Braconi, Daniela; Laschi, Marcella; Santucci, Annalisa] Univ Siena, Dipartimento Biotecnol, I-53100 Siena, Italy; [Paccagnini, Eugenio; Lupetti, Pietro] Univ Siena, Dipartimento Biol Evolut, I-53100 Siena, Italy; [Consumi, Marco; Magnani, Agnese] Univ Siena, Dipartimento Farmaco Chim Tecnol, I-53100 Siena, Italy; [Spreafico, Adriano] Univ Siena, Dipartimento Med Clin & Sci Immunol, I-53100 Siena, Italy; [Tanganelli, Piero] Univ Siena, Dipartimento Patol Umana & Oncol, I-53100 Siena, Italy	University of Siena; University of Siena; University of Siena; University of Siena; University of Siena	Millucci, L (corresponding author), Univ Siena, Dipartimento Biotecnol, Via Laterina 8, I-53100 Siena, Italy.	santucci@unisi.it	Santucci, Annalisa/K-1932-2018; Spreafico, Adriano/K-2397-2018; spreafico, adriano/AAL-6492-2020; Magnani, Agnese/E-7999-2017; Consumi, Maco/AAI-4640-2020; Tanganelli, Piero/E-6806-2012; Bernardini, Giulia/ABG-2209-2020; Braconi, Daniela/J-9616-2018; Lupetti, Pietro/AAG-1721-2019	Santucci, Annalisa/0000-0001-6976-9086; Spreafico, Adriano/0000-0002-8047-8666; Magnani, Agnese/0000-0002-6960-9418; Consumi, Maco/0000-0002-7516-9105; Bernardini, Giulia/0000-0003-0016-0728; Braconi, Daniela/0000-0002-9657-4169; Paccagnini, Eugenio/0000-0002-9784-2057; Lupetti, Pietro/0000-0003-4316-9861	Fondazione MPS; TLS Orphan [0108]	Fondazione MPS; TLS Orphan	This work was supported by Fondazione MPS 2009-2011, TLS Orphan 0108. There are no relationships with industry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abassi Z, 2004, PHARMACOL THERAPEUT, V102, P223, DOI 10.1016/j.pharmthera.2004.04.004; AKIMOTO K, 1988, J CLIN ENDOCR METAB, V67, P93, DOI 10.1210/jcem-67-1-93; Bensimon M, 2004, ENDOCRINOLOGY, V145, P5313, DOI 10.1210/en.2004-0698; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CLERICO A, 1995, J ENDOCRINOL INVEST, V18, P194, DOI 10.1007/BF03347802; Cruz L, 2005, P NATL ACAD SCI USA, V102, P18258, DOI 10.1073/pnas.0509276102; Goetze JP, 2003, EUR HEART J, V24, P1471, DOI 10.1016/S0195-668X(03)00283-5; HERMANN R, 1981, BIOCHEMISTRY-US, V20, P5195, DOI 10.1021/bi00521a015; KAWAMURA S, 1995, PATHOL INT, V45, P335, DOI 10.1111/j.1440-1827.1995.tb03466.x; KAYE GC, 1986, J CLIN PATHOL, V39, P581, DOI 10.1136/jcp.39.5.581; Kholova I, 2005, J CLIN PATHOL, V58, P125, DOI 10.1136/jcp.2004.017293; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LOOI LM, 1993, HUM PATHOL, V24, P602; Maioli E, 2000, BBA-MOL BASIS DIS, V1500, P31, DOI 10.1016/S0925-4439(99)00083-6; Maioli E, 2001, BBA-MOL BASIS DIS, V1536, P123, DOI 10.1016/S0925-4439(01)00040-0; Muth E, 2004, BBA-PROTEINS PROTEOM, V1699, P263, DOI 10.1016/j.bbapap.2004.03.007; Necula M, 2003, J BIOL CHEM, V278, P46674, DOI 10.1074/jbc.M308231200; Otzen DE, 2010, CURR PROTEIN PEPT SC, V11, P355; PUCCI A, 1991, J PATHOL, V165, P235, DOI 10.1002/path.1711650307; Rocken C, 2002, CIRCULATION, V106, P2091, DOI 10.1161/01.CIR.0000034511.06350.DF; Steiner I, 2006, CARDIOVASC PATHOL, V15, P287, DOI 10.1016/j.carpath.2006.01.005; SUGAWARA A, 1988, BIOCHEM BIOPH RES CO, V150, P60, DOI 10.1016/0006-291X(88)90486-X; SUGAWARA A, 1988, J CLIN INVEST, V81, P1962, DOI 10.1172/JCI113544; Takemura G, 1998, J AM COLL CARDIOL, V31, P754, DOI 10.1016/S0735-1097(98)00045-X; TIMASHEFF SN, 1992, BIOCHEMISTRY-US, V31, P9857, DOI 10.1021/bi00156a001; Torricelli C, 2004, J MOL ENDOCRINOL, V33, P335, DOI 10.1677/jme.1.01530; Torricelli C, 2004, BIOCHEM BIOPH RES CO, V315, P16, DOI 10.1016/j.bbrc.2004.01.017; van Heerebeek L, 2006, CIRCULATION, V113, P1966, DOI 10.1161/CIRCULATIONAHA.105.587519; WEI CM, 1993, CIRCULATION, V88, P1016, DOI 10.1161/01.CIR.88.3.1016; Wozakowska-Kaplon Beata, 2008, Cardiol J, V15, P525; PROTPARAM EXPASY PRO	32	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e21870	10.1371/journal.pone.0021870	http://dx.doi.org/10.1371/journal.pone.0021870			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21814559	gold, Green Published, Green Submitted			2022-12-25	WOS:000293175100011
J	Lennartz, MR; Aggarwal, A; Michaud, TM; Feustel, PJ; Jones, DM; Brosnan, MJ; Keller, RS; Loegering, DJ; Kreienberg, PB				Lennartz, Michelle R.; Aggarwal, Ankur; Michaud, Tanya M.; Feustel, Paul J.; Jones, David M.; Brosnan, M. Julia; Keller, Rebecca S.; Loegering, Daniel J.; Kreienberg, Paul B.			Ligation of Macrophage Fc gamma Receptors Recapitulates the Gene Expression Pattern of Vulnerable Human Carotid Plaques	PLOS ONE			English	Article							E KNOCKOUT MICE; HUMAN ATHEROSCLEROTIC LESIONS; LOW-DENSITY-LIPOPROTEIN; MATRIX METALLOPROTEINASES; MEDIATED PHAGOCYTOSIS; SYMPTOMATIC PATIENTS; SURGERY-TRIAL; OXIDIZED LDL; ACTIVATION; INHIBITION	Stroke is a leading cause of death in the United States. As -60% of strokes result from carotid plaque rupture, elucidating the mechanisms that underlie vulnerability is critical for therapeutic intervention. We tested the hypothesis that stable and vulnerable human plaques differentially express genes associated with matrix degradation. Examination established that femoral, and the distal region of carotid, plaques were histologically stable while the proximal carotid plaque regions were vulnerable. Quantitative RT-PCR was used to compare expression of 22 genes among these tissues. Distal carotid and femoral gene expression was not significantly different, permitting the distal carotid segments to be used as a paired control for their corresponding proximal regions. Analysis of the paired plaques revealed differences in 16 genes that impact plaque stability: matrix metalloproteinases (MMP, higher in vulnerable), MMP modulators (inhibitors: lower, activators: higher in vulnerable), activating Fc receptors (Fc gamma R, higher in vulnerable) and Fc gamma R signaling molecules (higher in vulnerable). Surprisingly, the relative expression of smooth muscle cell and macrophage markers in the three plaque types was not significantly different, suggesting that macrophage distribution and/or activation state correlates with (in) stability. Immunohistochemistry revealed that macrophages and smooth muscle cells localize to distinct and non-overlapping regions in all plaques. MMP protein localized to macrophage-rich regions. In vitro, treatment of macrophages with immune complexes, but not oxidized low density lipoprotein, C-reactive protein, or TNF-alpha, induced a gene expression profile similar to that of the vulnerable plaques. That ligation of Fc gamma R recapitulates the pattern of gene expression in vulnerable plaques suggests that the Fc gamma R -> R macrophage activation pathway may play a greater role in human plaque vulnerability than previously appreciated.	[Lennartz, Michelle R.; Aggarwal, Ankur; Michaud, Tanya M.] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA; [Feustel, Paul J.] Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; [Jones, David M.] Albany Med Coll, Dept Pathol, Albany, NY 12208 USA; [Keller, Rebecca S.; Loegering, Daniel J.] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA; [Brosnan, M. Julia] Ordway Res Inst, Ctr Metab Dis, Albany, NY USA; [Kreienberg, Paul B.] Inst Vasc Hlth & Dis, Albany, NY USA	Albany Medical College; Albany Medical College; Albany Medical College; Albany Medical College; Ordway Research Institute	Lennartz, MR (corresponding author), Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA.	lennarm@mail.amc.edu	Feustel, Paul/AAW-5157-2021	Feustel, Paul/0000-0002-6963-4349	National Institutes of Health [GM090325, HL089730, HL095971]; The Albany Medical Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL089730, R21HL095971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Albany Medical Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was received from the National Institutes of Health [GM090325, HL089730, HL095971 to MRL]. Bridge funding was received from The Albany Medical Center [MRL]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branen L, 2004, ARTERIOSCL THROM VAS, V24, P2137, DOI 10.1161/01.ATV.0000143933.20616.1b; Calverley David C, 2004, Immun Ageing, V1, P4, DOI 10.1186/1742-4933-1-4; Cuaz-Perolin C, 2006, J VASC RES, V43, P493, DOI 10.1159/000095309; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Farrell B, 1998, LANCET, V351, P1379, DOI 10.1016/s0140-6736(97)09292-1; GALIS ZS, 1995, ANN NY ACAD SCI, V748, P501; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Hernandez-Vargas P, 2006, CIRC RES, V99, P1188, DOI 10.1161/01.RES.0000250556.07796.6c; Holvoet P, 1998, CIRCULATION, V98, P1487, DOI 10.1161/01.CIR.98.15.1487; Holvoet P, 2003, ARTERIOSCL THROM VAS, V23, P1444, DOI 10.1161/01.ATV.0000080379.05071.22; Kelly JA, 2010, CARDIOVASC RES, V85, P224, DOI 10.1093/cvr/cvp300; Larsen EC, 2002, J CELL BIOL, V159, P939, DOI 10.1083/jcb.200205140; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Loike JD, 2004, ARTERIOSCL THROM VAS, V24, P2051, DOI 10.1161/01.ATV.0000143858.15909.29; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Maxeiner H, 1998, J EXP MED, V188, P2257, DOI 10.1084/jem.188.12.2257; MENDEZFERNANDEZ YV, ATHEROSCLEROSIS, V214, P73; Mold C, 2001, J IMMUNOL, V166, P1200, DOI 10.4049/jimmunol.166.2.1200; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Orbe J, 2003, ATHEROSCLEROSIS, V170, P269, DOI 10.1016/S0021-9150(03)00251-X; Ranganathan AC, 2001, J BIOL CHEM, V276, P14264, DOI 10.1074/jbc.M100199200; RY HC, 1995, ARTERIOSCLER THROMB, V15, P1512; STEINBRECHER UP, 1984, P NATL ACAD SCI-BIOL, V81, P3883, DOI 10.1073/pnas.81.12.3883; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; van der Meer IM, 2004, THROMB HAEMOSTASIS, V92, P1273, DOI 10.1160/TH04-05-0268; Vemuganti R, 2005, NEUROSCIENCE, V131, P359, DOI 10.1016/j.neuroscience.2004.08.058; Virella G, 2008, ATHEROSCLEROSIS, V200, P239, DOI 10.1016/j.atherosclerosis.2008.03.025; WARLOW C, 1991, LANCET, V337, P1235, DOI 10.1016/0140-6736(91)92916-P; Zhao M, 2010, J IMMUNOL, V184, P2253, DOI 10.4049/jimmunol.0902654	29	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e21803	10.1371/journal.pone.0021803	http://dx.doi.org/10.1371/journal.pone.0021803			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21814555	Green Submitted, Green Published, gold			2022-12-25	WOS:000292956800010
J	Lu, YC; Wu, CC; Shen, WS; Yang, TH; Yeh, TH; Chen, PJ; Yu, IS; Lin, SW; Wong, JM; Chang, Q; Lin, X; Hsu, CJ				Lu, Ying-Chang; Wu, Chen-Chi; Shen, Wen-Sheng; Yang, Ting-Hua; Yeh, Te-Huei; Chen, Pei-Jer; Yu, I-Shing; Lin, Shu-Wha; Wong, Jau-Min; Chang, Qing; Lin, Xi; Hsu, Chuan-Jen			Establishment of a Knock-In Mouse Model with the SLC26A4 c.919-2A > G Mutation and Characterization of Its Pathology	PLOS ONE			English	Article							ENLARGED VESTIBULAR AQUEDUCT; GENOTYPE-PHENOTYPE CORRELATION; NONSYNDROMIC HEARING-LOSS; PENDRED-SYNDROME; INNER-EAR; MONDINI DYSPLASIA; PDS GENE; UNIQUE SPECTRUM; DEAFNESS; EXPRESSION	Recessive mutations in the SLC26A4 gene are a common cause of hereditary hearing impairment worldwide. Previous studies have demonstrated that different SLC26A4 mutations may have different pathogenetic mechanisms. In the present study, we established a knock-in mouse model (i.e., Slc26a4(tm1Dontuh/tm1Dontuh) mice) homozygous for the c. 919-2A. G mutation, which is a common mutation in East Asians. Mice were then subjected to audiologic assessment, a battery of vestibular evaluations, and inner ear morphological studies. All Slc26a4(tm1Dontuh/tm1Dontuh) mice revealed profound hearing loss, whereas 46% mice demonstrated pronounced head tilting and circling behaviors. There was a significant difference in the vestibular performance between wild-type and Slc26a4(tm1ontuh/tm1Dontuh) mice, especially those exhibiting circling behavior. Inner ear morphological examination of Slc26a4(tm1Dontuh/tm1Dontuh) mice revealed an enlarged endolymphatic duct, vestibular aqueduct and sac, atrophy of stria vascularis, deformity of otoconia in the vestibular organs, consistent degeneration of cochlear hair cells, and variable degeneration of vestibular hair cells. Audiologic and inner ear morphological features of Slc26a4(tm1Dontuh/tm1Dontuh) mice were reminiscent of those observed in humans. These features were also similar to those previously reported in both knock-out Slc26a4(-/-) mice and Slc26a4(loop/loop) mice with the Slc26a4 p.S408F mutation, albeit the severity of vestibular hair cell degeneration appeared different among the three mouse strains.	[Lu, Ying-Chang; Wong, Jau-Min] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan; [Lu, Ying-Chang; Wu, Chen-Chi; Shen, Wen-Sheng; Yang, Ting-Hua; Yeh, Te-Huei; Hsu, Chuan-Jen] Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan; [Wu, Chen-Chi; Chen, Pei-Jer] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Wu, Chen-Chi] Natl Taiwan Univ Hosp, Dept Med Genet, Taipei, Taiwan; [Yu, I-Shing; Lin, Shu-Wha] Natl Taiwan Univ, Res Ctr Med Excellence, Div Genom Med, Taipei 10764, Taiwan; [Chang, Qing; Lin, Xi] Emory Univ Sch Med, Dept Otolaryngol, Atlanta, GA USA; [Hsu, Chuan-Jen] Natl Taiwan Univ, Coll Med, Dept Otolaryngol, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Emory University; National Taiwan University	Lu, YC (corresponding author), Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan.	cjhsu@ntu.edu.tw	lin, xi/GZL-4959-2022	WU, CHEN-CHI/0000-0002-5047-2204; Chen, Pei-Jer/0000-0001-8316-3785; LIN, SHU-WHA/0000-0001-6748-5581	National Science Council of the Executive Yuan of the Republic of China [96-2314-B-002-174-MY3]	National Science Council of the Executive Yuan of the Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by research grants from the National Science Council of the Executive Yuan of the Republic of China (No. 96-2314-B-002-174-MY3). The funders had no role in study design, data collection and analysis decision to publish, or preparation of the manuscript.	Azaiez H, 2007, HUM GENET, V122, P451, DOI 10.1007/s00439-007-0415-2; Belyantseva IA, 2000, J NEUROSCI, V20, part. no.; Ben Rebeh I, 2010, CLIN GENET, V78, P74, DOI 10.1111/j.1399-0004.2009.01360.x; Bidart JM, 2000, J CLIN ENDOCR METAB, V85, P2028, DOI 10.1210/jc.85.5.2028; Choi BY, 2009, HUM MUTAT, V30, P599, DOI 10.1002/humu.20884; Dror AA, 2010, J BIOL CHEM, V285, P21724, DOI 10.1074/jbc.M110.120188; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Everett LA, 2001, HUM MOL GENET, V10, P153, DOI 10.1093/hmg/10.2.153; Everett LA, 1999, P NATL ACAD SCI USA, V96, P9727, DOI 10.1073/pnas.96.17.9727; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; JOHNSSON LG, 1972, LARYNGOSCOPE, V82, P1105, DOI 10.1288/00005537-197207000-00002; King KA, 2010, LARYNGOSCOPE, V120, P384, DOI 10.1002/lary.20722; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Li XC, 1998, NAT GENET, V18, P215, DOI 10.1038/ng0398-215; Nakaya K, 2007, AM J PHYSIOL-RENAL, V292, pF1314, DOI 10.1152/ajprenal.00432.2006; Park HJ, 2005, CLIN GENET, V67, P160, DOI 10.1111/j.1399-0004.2004.00386.x; Pryor SP, 2005, J MED GENET, V42, P159, DOI 10.1136/jmg.2004.024208; Royaux IE, 2003, JARO-J ASSOC RES OTO, V4, P394, DOI 10.1007/s10162-002-3052-4; Royaux IE, 2001, P NATL ACAD SCI USA, V98, P4221, DOI 10.1073/pnas.071516798; Scott DA, 2000, HUM MOL GENET, V9, P1709, DOI 10.1093/hmg/9.11.1709; Singh R, 2008, AM J PHYSIOL-RENAL, V294, pF139, DOI 10.1152/ajprenal.00433.2007; Snoeckx RL, 2005, AM J HUM GENET, V77, P945, DOI 10.1086/497996; Spicer SS, 2005, HEARING RES, V205, P225, DOI 10.1016/j.heares.2005.03.022; Su KY, 2007, J NEUROSCI, V27, P2513, DOI 10.1523/JNEUROSCI.4497-06.2007; Sugiura M, 2005, EUR ARCH OTO-RHINO-L, V262, P737, DOI 10.1007/s00405-004-0884-z; Suzuki H, 2007, ACTA OTO-LARYNGOL, V127, P1292, DOI 10.1080/00016480701258739; Tsukamoto K, 2003, EUR J HUM GENET, V11, P916, DOI 10.1038/sj.ejhg.5201073; Wang QJ, 2007, CLIN GENET, V72, P245, DOI 10.1111/j.1399-0004.2007.00862.x; Wangemann P, 2007, AM J PHYSIOL-RENAL, V292, pF1345, DOI 10.1152/ajprenal.00487.2006; Wangemann P, 2009, AM J PHYSIOL-RENAL, V297, pF1435, DOI 10.1152/ajprenal.00011.2009; Wu CC, 2005, AUDIOL NEURO-OTOL, V10, P234, DOI 10.1159/000085825; Wu CC, 2005, LARYNGOSCOPE, V115, P1060, DOI 10.1097/01.MLG.0000163339.61909.D0; Wu CC, 2005, LARYNGOSCOPE, V115, P132, DOI 10.1097/01.mlg.0000150691.85387.3f; Yang JJ, 2005, HEARING RES, V199, P22, DOI 10.1016/j.heares.2004.08.007; Zhou GW, 2008, LARYNGOSCOPE, V118, P2062, DOI 10.1097/MLG.0b013e31818208ad	35	37	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22150	10.1371/journal.pone.0022150	http://dx.doi.org/10.1371/journal.pone.0022150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811566	Green Published, gold, Green Submitted			2022-12-25	WOS:000292956800025
J	Bhojani, MS; Ranga, R; Luker, GD; Rehemtulla, A; Ross, BD; Van Dort, ME				Bhojani, Mahaveer S.; Ranga, Rajesh; Luker, Gary D.; Rehemtulla, Alnawaz; Ross, Brian D.; Van Dort, Marcian E.			Synthesis and Investigation of a Radioiodinated F3 Peptide Analog as a SPECT Tumor Imaging Radioligand	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; IN-VIVO; SURFACE; GROWTH; NUCLEOLIN; PROTEINS; NANOPARTICLES; ANGIOGENESIS; REAGENTS; NUCLEUS	A radioiodinated derivative of the tumor-homing F3 peptide, (N-(2-{3-[I-125]Iodobenzoyl} aminoethyl) maleimide-F3Cys peptide, [I-125]IBMF3 was developed for investigation as a SPECT tumor imaging radioligand. For this purpose, we custom synthesized a modified F3 peptide analog (F3Cys) incorporating a C-terminal cysteine residue for site-specific attachment of a radioiodinated maleimide conjugating group. Initial proof-of-concept Fluorescence studies conducted with AlexaFluor 532 C-5 maleimide-labeled F3Cys showed distinct membrane and nuclear localization of F3Cys in MDA-MB-435 cells. Additionally, F3Cys conjugated with NIR fluorochrome AlexaFluor 647 C-2 maleimide demonstrated high tumor specific uptake in melanoma cancer MDA-MB-435 and lung cancer A549 xenografts in nude mice whereas a similarly labeled control peptide did not show any tumor uptake. These results were also confirmed by ex vivo tissue analysis. No-carrier-added [I-125]IBMF3 was synthesized by a radioiododestannylation approach in 73% overall radiochemical yield. In vitro cell uptake studies conducted with [I-125]IBMF3 displayed a 5-fold increase in its cell uptake at 4 h when compared to controls. SPECT imaging studies with [I-125]IBMF3 in tumor bearing nude mice showed clear visualization of MDA-MB-435 xenografts on systemic administration. These studies demonstrate a potential utility of F3 peptide-based radioligands for tumor imaging with PET or SPECT techniques.	[Bhojani, Mahaveer S.; Ranga, Rajesh; Rehemtulla, Alnawaz] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Luker, Gary D.; Rehemtulla, Alnawaz; Ross, Brian D.; Van Dort, Marcian E.] Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA; [Luker, Gary D.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Bhojani, Mahaveer S.; Ranga, Rajesh; Luker, Gary D.; Rehemtulla, Alnawaz; Ross, Brian D.; Van Dort, Marcian E.] Univ Michigan, Ctr Mol Imaging, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Bhojani, MS (corresponding author), Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA.	mvandort@umich.edu		luker, gary/0000-0001-6832-2581	National Institutes of Health (NIH) [P50CA093990, R01CA136553, R01CA136829, PO1CA085878, P50 CADE97248, U24CA083099]; NATIONAL CANCER INSTITUTE [P01CA085878, R01CA136829, U24CA083099, R01CA136553, P50CA093990] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the following National Institutes of Health (NIH) research grants: P50CA093990 (BDR), R01CA136553 (GDL), R01CA136829 (GDL), PO1CA085878 (BDR), P50 CADE97248 (MSB) and U24CA083099 (BDR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jammaz I, 2002, APPL RADIAT ISOTOPES, V57, P743, DOI 10.1016/S0969-8043(02)00191-4; BHOJANI MS, 2010, MOL PHARM; Boeckler C, 1998, BIOORG MED CHEM LETT, V8, P2055, DOI 10.1016/S0960-894X(98)00360-6; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; BRINKLEY M, 1992, BIOCONJUGATE CHEM, V3, P2, DOI 10.1021/bc00013a001; Christian S, 2003, J CELL BIOL, V163, P871, DOI 10.1083/jcb.200304132; Dekker B, 2005, NUCL MED BIOL, V32, P241, DOI 10.1016/j.nucmedbio.2004.11.006; Derfus AM, 2007, BIOCONJUGATE CHEM, V18, P1391, DOI 10.1021/bc060367e; Destouches D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002518; Drecoll E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005715; GARG PK, 1989, NUCL MED BIOL, V16, P669, DOI 10.1016/0883-2897(89)90136-0; Ginisty H, 1999, J CELL SCI, V112, P761; HAH HJ, 2010, MACROMOL BIOSCI; Haubner R, 2001, J NUCL MED, V42, P326; Haubner R, 2006, EUR J NUCL MED MOL I, V33, pS54, DOI 10.1007/s00259-006-0136-0; HICKS RJ, 2010, MOL IMAGING PRINCIPL, P875; Kelloff G, 2005, CLIN CANCER RES, V11, P2785, DOI 10.1158/1078-0432.CCR-04-2626; Koziorowski J, 1998, APPL RADIAT ISOTOPES, V49, P955, DOI 10.1016/S0969-8043(97)10112-9; Makela AR, 2006, J VIROL, V80, P6603, DOI 10.1128/JVI.00528-06; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Orringer DA, 2009, NEUROSURGERY, V64, P965, DOI 10.1227/01.NEU.0000344150.81021.AA; Park JH, 2009, SMALL, V5, P694, DOI 10.1002/smll.200801789; Porkka K, 2002, P NATL ACAD SCI USA, V99, P7444, DOI 10.1073/pnas.062189599; Reddy GR, 2006, CLIN CANCER RES, V12, P6677, DOI 10.1158/1078-0432.CCR-06-0946; Said EA, 2002, J BIOL CHEM, V277, P37492, DOI 10.1074/jbc.M201194200; Shibata Y, 2002, MOL CELL BIOL, V22, P6788, DOI 10.1128/MCB.22.19.6788-6796.2002; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; van Schaijk FG, 2005, J NUCL MED, V46, P1016; WILBUR DS, 1992, BIOCONJUGATE CHEM, V3, P433, DOI 10.1021/bc00018a001; Winer I, 2010, CANCER RES, V70, P8674, DOI 10.1158/0008-5472.CAN-10-1917; Yu DH, 1998, BIOCHEM BIOPH RES CO, V247, P186, DOI 10.1006/bbrc.1998.8754	31	20	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22418	10.1371/journal.pone.0022418	http://dx.doi.org/10.1371/journal.pone.0022418			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21811604	gold, Green Published, Green Submitted			2022-12-25	WOS:000292929500062
J	Pinto, JPC; Kuipers, OP; Marreddy, RKR; Poolman, B; Kok, J				Pinto, Joao P. C.; Kuipers, Oscar P.; Marreddy, Ravi K. R.; Poolman, Bert; Kok, Jan			Efficient Overproduction of Membrane Proteins in Lactococcus lactis Requires the Cell Envelope Stress Sensor/Regulator Couple CesSR	PLOS ONE			English	Article							CONTROLLED GENE-EXPRESSION; COMPLETE GENOME SEQUENCE; DNA-MICROARRAY DATA; 2-COMPONENT SYSTEM; ESCHERICHIA-COLI; SUBSP CREMORIS; PLASMID; CLONING; IDENTIFICATION; CONSTRUCTION	Background: Membrane proteins comprise an important class of molecules whose study is largely frustrated by several intrinsic constraints, such as their hydrophobicity and added requirements for correct folding. Additionally, the complexity of the cellular mechanisms that are required to insert membrane proteins functionally in the membrane and to monitor their folding state makes it difficult to foresee the yields at which one can obtain them or to predict which would be the optimal production host for a given protein. Methods and Findings: We describe a rational design approach to improve the lactic acid bacterium Lactococcus lactis as a producer of membrane proteins. Our transcriptome data shows that the two-component system CesSR, which senses cell envelope stresses of different origins, is one of the major players when L. lactis is forced to overproduce the endogenous membrane protein BcaP, a branched-chain amino acid permease. Growth of the BcaP-producing L. lactis strain and its capability to produce membrane proteins are severely hampered when the CesSR system itself or particular members of the CesSR regulon are knocked out, notably the genes ftsH, oxaA2, llmg_2163 and rmaB. Overexpressing cesSR reduced the growth defect, thus directly improving the production yield of BcaP. Applying this rationale to eukaryotic proteins, some of which are notoriously more difficult to produce, such as the medically-important presenilin complex, we were able to significantly diminish the growth defect seen in the wild-type strain and improve the production yield of the presenilin variant PS1 Delta 9-H6 more than 4-fold. Conclusions: The results shed light into a key, and perhaps central, membrane protein quality control mechanism in L. lactis. Modulating the expression of CesSR benefited the production yields of membrane proteins from different origins. These findings reinforce L. lactis as a legitimate alternative host for the production of membrane proteins.	[Pinto, Joao P. C.; Kuipers, Oscar P.; Kok, Jan] Univ Groningen, Dept Mol Genet, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands; [Marreddy, Ravi K. R.; Poolman, Bert] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Netherlands Prote Ctr, Groningen, Netherlands; [Marreddy, Ravi K. R.; Poolman, Bert] Univ Groningen, Zernike Inst Adv Mat, Dept Biochem, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Pinto, JPC (corresponding author), Univ Groningen, Dept Mol Genet, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands.	jan.kok@rug.nl	Poolman, Bert/D-1882-2012; Kok, Jan/C-9972-2012; Kuipers, Oscar/B-6752-2009; Marreddy, RaviKanthReddy/Q-5680-2018; Institute, Zernike/W-7033-2019	Kuipers, Oscar/0000-0001-5596-7735; Marreddy, RaviKanthReddy/0000-0003-0425-406X; 	Netherlands Proteomics Centre (NPC); European Membrane Protein Consortium EDICT; Netherlands Science Foundation (NWO) [700-56-302]	Netherlands Proteomics Centre (NPC); European Membrane Protein Consortium EDICT; Netherlands Science Foundation (NWO)(Netherlands Organization for Scientific Research (NWO))	The research of RKRM and BP was supported by the Netherlands Proteomics Centre (NPC), the European Membrane Protein Consortium EDICT, and the Netherlands Science Foundation (NWO; Chemical Sciences Top Subsidy to BP; grant number 700-56-302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Belcheva A, 2008, J BIOL CHEM, V283, P12354, DOI 10.1074/jbc.M710010200; Bolotin A, 2001, GENOME RES, V11, P731, DOI 10.1101/gr.GR-1697R; BRISSETTE JL, 1991, J MOL BIOL, V220, P35, DOI 10.1016/0022-2836(91)90379-K; den Hengst CD, 2006, J BACTERIOL, V188, P3280, DOI 10.1128/JB.188.9.3280-3289.2006; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; GASSON MJ, 1983, J BACTERIOL, V154, P1; Geertsma ER, 2008, P NATL ACAD SCI USA, V105, P5722, DOI 10.1073/pnas.0802190105; Geertsma ER, 2007, NAT METHODS, V4, P705, DOI 10.1038/NMETH1073; Grisshammer R, 2006, CURR OPIN BIOTECH, V17, P337, DOI 10.1016/j.copbio.2006.06.001; Hoag Hannah, 2005, Nature, V437, P164, DOI 10.1038/nj7055-164a; Holo H, 1995, Methods Mol Biol, V47, P195; ISRAELSEN H, 1995, APPL ENVIRON MICROB, V61, P2540, DOI 10.1128/AEM.61.7.2540-2547.1995; JENSEN PR, 1993, APPL ENVIRON MICROB, V59, P4363, DOI 10.1128/AEM.59.12.4363-4366.1993; JOHANSEN E, 1992, PLASMID, V27, P200, DOI 10.1016/0147-619X(92)90022-3; Jordan S, 2006, J BACTERIOL, V188, P5153, DOI 10.1128/JB.00310-06; Kall L, 2005, BIOINFORMATICS, V21, pI251, DOI 10.1093/bioinformatics/bti1014; Katzen F, 2009, TRENDS BIOTECHNOL, V27, P455, DOI 10.1016/j.tibtech.2009.05.005; Kleerebezem M, 1997, APPL ENVIRON MICROB, V63, P4581, DOI 10.1128/AEM.63.11.4581-4584.1997; Krugel U, 2008, PLANT CELL, V20, P2497, DOI 10.1105/tpc.108.058271; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; Kunji ERS, 2003, BBA-BIOMEMBRANES, V1610, P97, DOI 10.1016/S0005-2736(02)00712-5; Kuroda M, 2003, MOL MICROBIOL, V49, P807, DOI 10.1046/j.1365-2958.2003.03599.x; Linares DM, 2010, J BACTERIOL, V192, P5806, DOI 10.1128/JB.00533-10; Linares DM, 2010, J MOL BIOL, V401, P45, DOI 10.1016/j.jmb.2010.06.002; Link AJ, 2008, PROTEIN SCI, V17, P1857, DOI 10.1110/ps.035980.108; Long AD, 2001, J BIOL CHEM, V276, P19937, DOI 10.1074/jbc.M010192200; MAGUIN E, 1992, J BACTERIOL, V174, P5633, DOI 10.1128/JB.174.17.5633-5638.1992; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; MARREDDY RKR, 2011, PLOS ONE; Martinez B, 2007, MOL MICROBIOL, V64, P473, DOI 10.1111/j.1365-2958.2007.05668.x; Mascher T, 2004, ANTIMICROB AGENTS CH, V48, P2888, DOI 10.1128/AAC.48.8.2888-2896.2004; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Monne M, 2005, PROTEIN SCI, V14, P3048, DOI 10.1110/ps.051689905; O'Connell-Motherway M, 2000, MICROBIOL-SGM, V146, P935, DOI 10.1099/00221287-146-4-935; PerezTur J, 1995, NEUROREPORT, V7, P297; POOLMAN B, 1983, EUR J BIOCHEM, V135, P41, DOI 10.1111/j.1432-1033.1983.tb07615.x; Saller MJ, 2009, J BACTERIOL, V191, P6749, DOI 10.1128/JB.00853-09; SAMBROOK J, 2000, MOL CLONING LAB MANU; Siezen RJ, 2010, J BACTERIOL, V192, P2649, DOI 10.1128/JB.00276-10; SIMON D, 1988, BIOCHIMIE, V70, P559, DOI 10.1016/0300-9084(88)90093-4; Solem C, 2008, APPL ENVIRON MICROB, V74, P4772, DOI 10.1128/AEM.00134-08; STEEN A, 2010, MOL CELL PROTEOMICS, DOI DOI 10.1074/MCP.M000052-MCP201; Suntharalingam P, 2009, J BACTERIOL, V191, P2973, DOI 10.1128/JB.01563-08; van Hijum Sacha A F T, 2003, Appl Bioinformatics, V2, P241; van Hijum SAFT, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-77; van Hijum SAFT, 2003, BIOINFORMATICS, V19, P1580, DOI 10.1093/bioinformatics/btg203; Veiga P, 2007, J BIOL CHEM, V282, P19342, DOI 10.1074/jbc.M611308200; Wagner S, 2008, P NATL ACAD SCI USA, V105, P14371, DOI 10.1073/pnas.0804090105; Wagner S, 2007, MOL CELL PROTEOMICS, V6, P1527, DOI 10.1074/mcp.M600431-MCP200; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Wegmann U, 2007, J BACTERIOL, V189, P3256, DOI 10.1128/JB.01768-06; Xu LY, 2009, BIOTECHNOL LETT, V31, P1775, DOI 10.1007/s10529-009-0075-5	54	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e21873	10.1371/journal.pone.0021873	http://dx.doi.org/10.1371/journal.pone.0021873			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21818275	gold, Green Published			2022-12-25	WOS:000292929500016
J	Saito, Y; Akiyama, M; Araki, Y; Sumioka, A; Shiono, M; Taru, H; Nakaya, T; Yamamoto, T; Suzuki, T				Saito, Yuhki; Akiyama, Mayu; Araki, Yoichi; Sumioka, Akio; Shiono, Maki; Taru, Hidenori; Nakaya, Tadashi; Yamamoto, Tohru; Suzuki, Toshiharu			Intracellular Trafficking of the Amyloid beta-Protein Precursor (APP) Regulated by Novel Function of X11-Like	PLOS ONE			English	Article							DISEASE PATHOGENESIS; ALZHEIMERS-DISEASE; MEMBRANE-PROTEINS; ADAPTER PROTEINS; TRANSGENIC MICE; PDZ DOMAINS; MOUSE-BRAIN; PHOSPHORYLATION; METABOLISM; TRANSPORT	Background: Amyloid beta (A beta), a causative peptide of Alzheimer's disease, is generated by intracellular metabolism of amyloid beta-protein precursor (APP). In general, mature APP (mAPP, N- and O-glycosylated form) is subject to successive cleavages by alpha- or beta-, and gamma-secretases in the late protein secretory pathway and/or at plasma membrane, while immature APP (imAPP, N-glycosylated form) locates in the early secretory pathway such as endoplasmic reticulum or cis-Golgi, in which imAPP is not subject to metabolic cleavages. X11-like (X11L) is a neural adaptor protein composed of a phosphotyrosine-binding (PTB) and two C-terminal PDZ domains. X11L suppresses amyloidogenic cleavage of mAPP by direct binding of X11L through its PTB domain, thereby generation of A beta lowers. X11L expresses another function in the regulation of intracellular APP trafficking. Methodology: In order to analyze novel function of X11L in intracellular trafficking of APP, we performed a functional dissection of X11L. Using cells expressing various domain-deleted X11L mutants, intracellular APP trafficking was examined along with analysis of APP metabolism including maturation (O-glycosylation), processing and localization of APP. Conclusions: X11L accumulates imAPP into the early secretory pathway by mediation of its C-terminal PDZ domains, without being bound to imAPP directly. With this novel function, X11L suppresses overall APP metabolism and results in further suppression of Ab generation. Interestingly some of the accumulated imAPP in the early secretory pathway are likely to appear on plasma membrane by unidentified mechanism. Trafficking of imAPP to plasma membrane is observed in other X11 family proteins, X11 and X11L2, but not in other APP-binding partners such as FE65 and JIP1. It is herein clear that respective functional domains of X11L regulate APP metabolism at multiple steps in intracellular protein secretory pathways.	[Saito, Yuhki; Akiyama, Mayu; Araki, Yoichi; Sumioka, Akio; Shiono, Maki; Nakaya, Tadashi; Yamamoto, Tohru; Suzuki, Toshiharu] Hokkaido Univ, Lab Neurosci, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido, Japan; [Taru, Hidenori] Hokkaido Univ, Lab Neuronal Cell Biol, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido, Japan; [Taru, Hidenori] Hokkaido Univ, Creat Res Inst Sousei, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Saito, Y (corresponding author), Hokkaido Univ, Lab Neurosci, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido, Japan.	tsuzuki@pharm.hokudai.ac.jp	Taru, Hidenori/B-7059-2009; Suzuki, Toshiharu/B-5342-2013; Yamamoto, Tohru/A-3801-2012	Yamamoto, Tohru/0000-0002-1652-0233	Ministry of Education, Culture, Sports, Science and Technology in Japan (MEXT) [YS 23790069, TS 2311370, TS2339001]; Grants-in-Aid for Scientific Research [23790070, 22590055, 23390017] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology in Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported, in part, by a Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology in Japan (MEXT) (YS 23790069, TS 2311370, TS2339001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTIN JG, 1995, ANAL BIOCHEM, V224, P382, DOI 10.1006/abio.1995.1054; Ando K, 2001, J BIOL CHEM, V276, P40353, DOI 10.1074/jbc.M104059200; Ando K, 1999, J NEUROSCI, V19, P4421; Araki Y, 2004, J BIOL CHEM, V279, P24343, DOI 10.1074/jbc.M401925200; Araki Y, 2003, J BIOL CHEM, V278, P49448, DOI 10.1074/jbc.M306024200; Araki Y, 2007, EMBO J, V26, P1475, DOI 10.1038/sj.emboj.7601609; Borg JP, 1998, J BIOL CHEM, V273, P14761, DOI 10.1074/jbc.273.24.14761; Cordy JM, 2003, P NATL ACAD SCI USA, V100, P11735, DOI 10.1073/pnas.1635130100; Foletti DL, 1999, NEURON, V23, P641, DOI 10.1016/S0896-6273(01)80022-2; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hase M, 2002, J NEUROCHEM, V81, P1223, DOI 10.1046/j.1471-4159.2002.00911.x; Hill K, 2003, J BIOL CHEM, V278, P36032, DOI 10.1074/jbc.M301632200; Horikoshi Y, 2004, BIOCHEM BIOPH RES CO, V319, P733, DOI 10.1016/j.bbrc.2004.05.051; Iijima K, 2000, J NEUROCHEM, V75, P1085, DOI 10.1046/j.1471-4159.2000.0751085.x; King GD, 2004, J NEUROCHEM, V88, P971, DOI 10.1046/j.1471-4159.2003.02234.x; Kondo M, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-35; Kyriazis GA, 2008, J BIOL CHEM, V283, P25492, DOI 10.1074/jbc.M802072200; Ladinsky MS, 2002, MOL BIOL CELL, V13, P2810, DOI 10.1091/mbc.01-12-0593; Lau KF, 2000, MOL CELL NEUROSCI, V16, P557, DOI 10.1006/mcne.2000.0898; Lee JH, 2004, J BIOL CHEM, V279, P49099, DOI 10.1074/jbc.M405602200; Lee JH, 2003, J BIOL CHEM, V278, P47025, DOI 10.1074/jbc.M300503200; Long JF, 2005, NAT STRUCT MOL BIOL, V12, P722, DOI 10.1038/nsmb958; MATLIN KS, 1983, CELL, V34, P233, DOI 10.1016/0092-8674(83)90154-X; McLoughlin DM, 1999, EUR J NEUROSCI, V11, P1988, DOI 10.1046/j.1460-9568.1999.00610.x; Mizumaru C, 2009, J NEUROCHEM, V111, P1213, DOI 10.1111/j.1471-4159.2009.06399.x; Okamoto M, 1997, J BIOL CHEM, V272, P31459, DOI 10.1074/jbc.272.50.31459; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; RANJAN PS, 2008, MOL BIOL CELL, V19, P51; Rogelj B, 2006, BRAIN RES REV, V52, P305, DOI 10.1016/j.brainresrev.2006.04.005; Saito Y, 2008, J BIOL CHEM, V283, P35763, DOI 10.1074/jbc.M801353200; Sakuma M, 2009, J NEUROCHEM, V109, P465, DOI 10.1111/j.1471-4159.2009.05988.x; Sakurai T, 2008, J CELL BIOL, V183, P339, DOI 10.1083/jcb.200804075; Sano Y, 2006, J BIOL CHEM, V281, P37853, DOI 10.1074/jbc.M609312200; Sastre M, 1998, J BIOL CHEM, V273, P22351, DOI 10.1074/jbc.273.35.22351; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Sumioka A, 2008, EXP CELL RES, V314, P1155, DOI 10.1016/j.yexcr.2007.12.006; Suzuki T, 2008, J BIOL CHEM, V283, P29633, DOI 10.1074/jbc.R800003200; Suzuki T, 2006, J BIOCHEM, V139, P949, DOI 10.1093/jb/mvj121; Tanahashi H, 1999, BIOCHEM BIOPH RES CO, V255, P663, DOI 10.1006/bbrc.1999.0265; Taru H, 2004, J BIOL CHEM, V279, P21628, DOI 10.1074/jbc.M312007200; Taru H, 2009, J ALZHEIMERS DIS, V18, P253, DOI 10.3233/JAD-2009-1148; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tomita S, 1999, J BIOL CHEM, V274, P2243, DOI 10.1074/jbc.274.4.2243; Tomita S, 2000, J BIOL CHEM, V275, P13056, DOI 10.1074/jbc.C000019200; Tomita S, 1998, J BIOL CHEM, V273, P6277, DOI 10.1074/jbc.273.11.6277; Vishnu S, 2006, DEV BIOL, V289, P296, DOI 10.1016/j.ydbio.2005.09.016; Yamayoshi S, 2010, J VIROL, V84, P4816, DOI 10.1128/JVI.00010-10; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	48	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22108	10.1371/journal.pone.0022108	http://dx.doi.org/10.1371/journal.pone.0022108			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21818298	Green Published, Green Submitted, gold			2022-12-25	WOS:000292929500040
J	Robertson, SL; Li, JH; Uzal, FA; McClane, BA				Robertson, Susan L.; Li, Jihong; Uzal, Francisco A.; McClane, Bruce A.			Evidence for a Prepore Stage in the Action of Clostridium perfringens Epsilon Toxin	PLOS ONE			English	Article							PORE FORMATION; MDCK CELLS; COMPLEX; FORMS; ENTEROTOXIN; PERMEABILITY; PROTOTOXIN; LETHALITY; MECHANISM; INSERTION	Clostridium perfringens epsilon toxin (ETX) rapidly kills MDCK II cells at 37 degrees C, but not 4 degrees C. The current study shows that, in MDCK II cells, ETX binds and forms an oligomeric complex equally well at 37 degrees C and 4 degrees C but only forms a pore at 37 degrees C. However, the complex formed in MDCK cells treated with ETX at 4 degrees C has the potential to form an active pore, since shifting those cells to 37 degrees C results in rapid cytotoxicity. Those results suggested that the block in pore formation at 4 degrees C involves temperature-related trapping of ETX in a prepore intermediate on the MDCK II cell plasma membrane surface. Evidence supporting this hypothesis was obtained when the ETX complex in MDCK II cells was shown to be more susceptible to pronase degradation when formed at 4 degrees C vs. 37 degrees C; this result is consistent with ETX complex formed at 4 degrees C remaining present in an exposed prepore on the membrane surface, while the ETX prepore complex formed at 37 degrees C is unaccessible to pronase because it has inserted into the plasma membrane to form an active pore. In addition, the ETX complex rapidly dissociated from MDCK II cells at 4 degrees C, but not 37 degrees C; this result is consistent with the ETX complex being resistant to dissociation at 37 degrees C because it has inserted into membranes, while the ETX prepore readily dissociates from cells at 4 degrees C because it remains on the membrane surface. These results support the identification of a prepore stage in ETX action and suggest a revised model for ETX cytotoxicity, i) ETX binds to an unidentified receptor, ii) ETX oligomerizes into a prepore on the membrane surface, and iii) the prepore inserts into membranes, in a temperature-sensitive manner, to form an active pore.	[Robertson, Susan L.; Li, Jihong; McClane, Bruce A.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA; [Uzal, Francisco A.] Univ Calif Davis, Sch Vet Med, Calif Anim Hlth & Food Safety Lab Syst, Davis, CA 95616 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Davis	Robertson, SL (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	bamcc@pitt.edu			National Institute of Allergy and Infectious Diseases [2U54AI057168-08, RO1 AI056177-08]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057168, R01AI056177] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this study was provided by grants 2U54AI057168-08 and RO1 AI056177-08 from the National Institute of Allergy and Infectious Diseases. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chassin C, 2007, AM J PHYSIOL-RENAL, V293, pF927, DOI 10.1152/ajprenal.00199.2007; Cole AR, 2004, NAT STRUCT MOL BIOL, V11, P797, DOI 10.1038/nsmb804; Colegio OR, 2003, AM J PHYSIOL-CELL PH, V284, pC1346, DOI 10.1152/ajpcell.00547.2002; HABEEB AFS, 1969, ARCH BIOCHEM BIOPHYS, V130, P430, DOI 10.1016/0003-9861(69)90055-1; HABEEB AFSA, 1975, BIOCHIM BIOPHYS ACTA, V412, P62, DOI 10.1016/0005-2795(75)90339-6; Iacovache I, 2008, BBA-BIOMEMBRANES, V1778, P1611, DOI 10.1016/j.bbamem.2008.01.026; Knapp O, 2010, TOXICON, V55, P61, DOI 10.1016/j.toxicon.2009.06.037; Knapp O, 2009, BBA-BIOMEMBRANES, V1788, P2584, DOI 10.1016/j.bbamem.2009.09.020; KokaiKun JF, 1997, CLIN INFECT DIS, V25, pS165, DOI 10.1086/516246; LINDSAY CD, 1995, TOXICOL IN VITRO, V9, P213, DOI 10.1016/0887-2333(95)00006-T; Lindsay CD, 1996, HUM EXP TOXICOL, V15, P904, DOI 10.1177/096032719601501107; Lonchamp E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013046; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mathur DD, 2010, APPL MICROBIOL BIOT, V88, P877, DOI 10.1007/s00253-010-2785-y; McClain MS, 2007, INFECT IMMUN, V75, P1785, DOI 10.1128/IAI.01643-06; MCCLANE BA, 1990, INFECT IMMUN, V58, P3109, DOI 10.1128/IAI.58.9.3109-3115.1990; McClane BA, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P698, DOI 10.1007/0-387-30744-3_22; Minami J, 1997, MICROBIOL IMMUNOL, V41, P527, DOI 10.1111/j.1348-0421.1997.tb01888.x; Miyata S, 2002, J BIOL CHEM, V277, P39463, DOI 10.1074/jbc.M206731200; Miyata S, 2001, J BIOL CHEM, V276, P13778, DOI 10.1074/jbc.M011527200; Nagahama M, 2006, BIOCHEMISTRY-US, V45, P296, DOI 10.1021/bi051805s; NAGAHAMA M, 1992, INFECT IMMUN, V60, P1237, DOI 10.1128/IAI.60.3.1237-1240.1992; NAGAHAMA M, 1991, TOXICON, V29, P211, DOI 10.1016/0041-0101(91)90105-Z; Nagahama M, 1998, J NAT TOXINS, V7, P291; NAGAHAMA M, 1993, TOXICON, V31, P427, DOI 10.1016/0041-0101(93)90178-L; PAYNE DW, 1994, FEMS MICROBIOL LETT, V116, P161, DOI 10.1016/0378-1097(94)90068-X; Pelish TM, 2009, J BIOL CHEM, V284, P29446, DOI 10.1074/jbc.M109.021782; Petit L, 1997, J BACTERIOL, V179, P6480, DOI 10.1128/jb.179.20.6480-6487.1997; Petit L, 2003, CELL MICROBIOL, V5, P155, DOI 10.1046/j.1462-5822.2003.00262.x; Petit L, 2001, J BIOL CHEM, V276, P15736, DOI 10.1074/jbc.M010412200; Robertson SL, 2010, INFECT IMMUN, V78, P505, DOI 10.1128/IAI.00778-09; Robertson SL, 2007, CELL MICROBIOL, V9, P2734, DOI 10.1111/j.1462-5822.2007.00994.x; SAKURAI J, 1983, INFECT IMMUN, V42, P1183, DOI 10.1128/IAI.42.3.1183-1186.1983; Sayeed S, 2005, INFECT IMMUN, V73, P7413, DOI 10.1128/IAI.73.11.7413-7421.2005; Sayeed S, 2007, INFECT IMMUN, V75, P2391, DOI 10.1128/IAI.02014-06; Sellman BR, 1997, MOL MICROBIOL, V23, P551, DOI 10.1046/j.1365-2958.1997.d01-1876.x; Shepard LA, 2000, BIOCHEMISTRY-US, V39, P10284, DOI 10.1021/bi000436r; Shortt SJ, 2000, HUM EXP TOXICOL, V19, P108, DOI 10.1191/096032700678815710; Smedley JG, 2007, INFECT IMMUN, V75, P2381, DOI 10.1128/IAI.01737-06; Soler-Jover A, 2004, J HISTOCHEM CYTOCHEM, V52, P931, DOI 10.1369/jhc.4A6254.2004; Songer J. G., 1997, The Clostridia: molecular biology and pathogenesis., P153, DOI 10.1016/B978-012595020-6/50012-7; Songer JG, 1996, CLIN MICROBIOL REV, V9, P216, DOI 10.1128/CMR.9.2.216; Tamai E, 2003, INFECT IMMUN, V71, P5371, DOI 10.1128/IAI.71.9.5371-5375.2003; Uzal FA, 2004, ANAEROBE, V10, P135, DOI 10.1016/j.anaerobe.2003.08.005; WIECKOWSKI EU, 1994, J BIOL CHEM, V269, P10838; Zitzer A, 2000, BBA-BIOMEMBRANES, V1509, P264, DOI 10.1016/S0005-2736(00)00303-5	46	43	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2011	6	7							e22053	10.1371/journal.pone.0022053	http://dx.doi.org/10.1371/journal.pone.0022053			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791QY	21814565	Green Published, gold, Green Accepted			2022-12-25	WOS:000292680900025
J	Borthwick, LA; Botha, P; Verdon, B; Brodlie, MJ; Gardner, A; Bourn, D; Johnson, GE; Gray, MA; Fisher, AJ				Borthwick, Lee A.; Botha, Phil; Verdon, Bernard; Brodlie, Malcolm J.; Gardner, Aaron; Bourn, David; Johnson, Gail E.; Gray, Mike A.; Fisher, Andrew J.			Is CFTR-delF508 Really Absent from the Apical Membrane of the Airway Epithelium?	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; DIFFERENT ANTIBODIES; WILD-TYPE; IMMUNOHISTOCHEMICAL LOCALIZATION; P-GLYCOPROTEIN; CFTR; CELLS; DELTA-F508-CFTR; EXPRESSION	Background: Understanding where mutant CFTR is localised in airway epithelia is essential in guiding the best therapeutic approach to correct the dysfunction of the CFTR protein. The widely held paradigm is that CF patients harbouring the commonest mutation, CFTR-delF508, trap CFTR within the endoplasmic reticulum and target it for degradation. However there are conflicting reports concerning expression and localisation of CFTR-delF508 in lung tissue. To attempt to resolve this fundamental issue we developed a novel approach to measure CFTR-delF508 in the lower airways of patients who have undergone lung transplantation for advanced CF. By sampling CF and non-CF epithelium simultaneously from the same individual, confounding factors of different airway microenvironments which may have influenced previous observations can be overcome. Methods: Epithelia sampled by bronchial brushing above (CF) and below (non-CF) the bronchial anastomosis were stained for CFTR and the localisation and level of expression assessed (n = 12). Results: There was no significant difference in the proportion of tall columnar cells showing CFTR immunostaining as a discrete band at the apical membrane in cells harbouring the CFTR-delF508 mutation compared to non-CF cells (p = 0.21, n = 12). However, the amount of CFTR expressed at the apical surface was reduced by similar to 50% in CF cells compared to non-CF cells (p = 0.04, n = 5). Conclusions: Our novel observation challenges the prevailing paradigm that CFTR is essentially absent from the apical membrane of respiratory cells harbouring the CFTR-delF508 mutation. Moreover, it raises the possibility that the new generation of CFTR potentiators may offer a realistic therapeutic option for CF patients.	[Borthwick, Lee A.; Botha, Phil; Brodlie, Malcolm J.; Gardner, Aaron; Johnson, Gail E.; Fisher, Andrew J.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Verdon, Bernard; Gray, Mike A.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Bourn, David] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Borthwick, LA (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	A.J.Fisher@newcastle.ac.uk	Gardner, Aaron/H-1511-2012; Fisher, Andrew J/A-2160-2012	Gardner, Aaron/0000-0001-8729-9823; Brodlie, Malcolm/0000-0003-4591-8299; Botha, Phil/0000-0002-8543-614X; Borthwick, Lee/0000-0003-2885-3382; GRAY, MICHAEL/0000-0002-6774-6283	Cystic Fibrosis Trust UK [PJ540]; Medical Research Council [G0800419] Funding Source: researchfish; MRC [G0800419] Funding Source: UKRI	Cystic Fibrosis Trust UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by an innovation grant from the Cystic Fibrosis Trust UK (PJ540) to MAG, PB and AJF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becq F, 1999, J BIOL CHEM, V274, P27415, DOI 10.1074/jbc.274.39.27415; Carvalho-Oliveira I, 2004, J HISTOCHEM CYTOCHEM, V52, P193, DOI 10.1177/002215540405200207; Cateni F, 2009, BIOORGAN MED CHEM, V17, P7894, DOI 10.1016/j.bmc.2009.10.028; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; CHOLON DM, AM J PHYSL LUNG CELL, V298, pL304; Claass A, 2000, J HISTOCHEM CYTOCHEM, V48, P831, DOI 10.1177/002215540004800611; Davidson H, 2009, MOL CELL PROBE, V23, P272, DOI 10.1016/j.mcp.2009.07.001; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Dormer RL, 2005, THORAX, V60, P55, DOI 10.1136/thx.2003.019778; Dormer RL, 2001, PFLUG ARCH EUR J PHY, V443, pS117; Doucet L, 2003, J HISTOCHEM CYTOCHEM, V51, P1191, DOI 10.1177/002215540305100909; ENGELHARDT JF, 1992, NAT GENET, V2, P240, DOI 10.1038/ng1192-240; Kalin N, 1999, J CLIN INVEST, V103, P1379, DOI 10.1172/JCI5731; Kong FS, 2006, CELL MICROBIOL, V8, P1121, DOI 10.1111/j.1462-5822.2006.00696.x; Kreda SM, 2005, MOL BIOL CELL, V16, P2154, DOI 10.1091/mbc.E04-11-1010; Loo TW, 1997, J BIOL CHEM, V272, P709, DOI 10.1074/jbc.272.2.709; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; MILLS AD, BIOORG MED CHEM LETT, V20, P87; Namkung W, 2005, GASTROENTEROLOGY, V129, P1979, DOI 10.1053/j.gastro.2005.08.049; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Ostedgaard LS, 2007, P NATL ACAD SCI USA, V104, P15370, DOI 10.1073/pnas.0706974104; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Penque D, 2000, LAB INVEST, V80, P857, DOI 10.1038/labinvest.3780090; PUCHELLE E, 1992, AM J RESP CELL MOL, V7, P485, DOI 10.1165/ajrcmb/7.5.485; Rab A, 2007, AM J PHYSIOL-CELL PH, V292, pC756, DOI 10.1152/ajpcell.00391.2006; Ramalho AS, 2002, AM J RESP CELL MOL, V27, P619, DOI 10.1165/rcmb.2001-0004OC; Rennolds J, 2008, BIOCHEM BIOPH RES CO, V366, P1025, DOI 10.1016/j.bbrc.2007.12.065; Rosenstein BJ, 1998, LANCET, V351, P277, DOI 10.1016/S0140-6736(97)09174-5; Swiatecka-Urban A, 2006, AM J PHYSIOL-CELL PH, V290, pC862, DOI 10.1152/ajpcell.00108.2005; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; Wang Y, 2007, MOL PHARMACOL, V71, P751, DOI 10.1124/mol.106.029926; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wellhauser L, 2009, MOL PHARMACOL, V75, P1430, DOI 10.1124/mol.109.055608; Zhang LQ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000155	35	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e23226	10.1371/journal.pone.0023226	http://dx.doi.org/10.1371/journal.pone.0023226			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826241	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000293558900067
J	Brady, N; Maguinness, C; Ni Choisdealbha, A				Brady, Nuala; Maguinness, Corrina; Ni Choisdealbha, Aine			My Hand or Yours? Markedly Different Sensitivity to Egocentric and Allocentric Views in the Hand Laterality Task	PLOS ONE			English	Article							EXTRASTRIATE BODY AREA; MENTAL ROTATION; MOTOR IMAGERY; REPRESENTATIONS; TRANSFORMATIONS; PERSPECTIVE; POSTURE; IDENTIFICATION; OBJECTS; SHAPE	In the hand laterality task participants judge the handedness of visually presented stimuli - images of hands shown in a variety of postures and views - and indicate whether they perceive a right or left hand. The task engages kinaesthetic and sensorimotor processes and is considered a standard example of motor imagery. However, in this study we find that while motor imagery holds across egocentric views of the stimuli (where the hands are likely to be one's own), it does not appear to hold across allocentric views (where the hands are likely to be another person's). First, we find that psychophysical sensitivity, d', is clearly demarcated between egocentric and allocentric views, being high for the former and low for the latter. Secondly, using mixed effects methods to analyse the chronometric data, we find high positive correlation between response times across egocentric views, suggesting a common use of motor imagery across these views. Correlations are, however, considerably lower between egocentric and allocentric views, suggesting a switch from motor imagery across these perspectives. We relate these findings to research showing that the extrastriate body area discriminates egocentric ('self') and allocentric ('other') views of the human body and of body parts, including hands.	[Brady, Nuala] Univ Coll Dublin, Sch Psychol, Dublin 2, Ireland; [Maguinness, Corrina; Ni Choisdealbha, Aine] Trinity Coll Dublin, Coll Green, Sch Psychol, Dublin, Ireland; [Maguinness, Corrina] Trinity Coll Dublin, Coll Green, Inst Neurosci, Dublin, Ireland	University College Dublin; Trinity College Dublin; Trinity College Dublin	Brady, N (corresponding author), Univ Coll Dublin, Sch Psychol, Dublin 2, Ireland.	nuala.brady@ucd.ie		Maguinness, Corrina/0000-0002-6200-4109; Brady, Nuala/0000-0002-9725-1441; Ni Choisdealbha, Aine/0000-0002-8740-167X				[Anonymous], 2010, R LANG ENV STAT COMP; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Chan AWY, 2004, NEUROREPORT, V15, P2407, DOI 10.1097/00001756-200410250-00021; COOPER LA, 1975, J EXP PSYCHOL HUMAN, V104, P48, DOI 10.1037/0096-1523.1.1.48; de Lange FP, 2006, NEUROIMAGE, V33, P609, DOI 10.1016/j.neuroimage.2006.07.017; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Ferri F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017927; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Ionta S, 2007, EXP BRAIN RES, V183, P1, DOI 10.1007/s00221-007-1020-2; Ionta S, 2009, EXP BRAIN RES, V195, P207, DOI 10.1007/s00221-009-1770-0; Kliegl R, 2010, VIS COGN, V18, P655, DOI 10.1080/13506280902986058; Kosslyn SM, 1998, PSYCHOPHYSIOLOGY, V35, P151, DOI 10.1017/S0048577298001516; Lorey B, 2009, EXP BRAIN RES, V194, P233, DOI 10.1007/s00221-008-1693-1; Macmillan NA, 1991, SIGNAL DETECTION THE; Myers A, 2008, NEUROIMAGE, V42, P1669, DOI 10.1016/j.neuroimage.2008.05.045; Ni Choisdealbha A, 2011, EXP BRAIN RES, V211, P73, DOI 10.1007/s00221-011-2652-9; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PARSONS LM, 1994, J EXP PSYCHOL HUMAN, V20, P709, DOI 10.1037/0096-1523.20.4.709; PARSONS LM, 1987, COGNITIVE PSYCHOL, V19, P178, DOI 10.1016/0010-0285(87)90011-9; Parsons LM, 1998, J NEUROSCI, V18, P6539; PARSONS LM, 1995, NATURE, V375, P54, DOI 10.1038/375054a0; Peelen MV, 2007, NAT REV NEUROSCI, V8, P636, DOI 10.1038/nrn2195; Pinheiro J, 2001, MIXED EFFECTS MODELS; Saxe R, 2006, CEREB CORTEX, V16, P178, DOI 10.1093/cercor/bhi095; Schwoebel J, 2005, J COGNITIVE NEUROSCI, V17, P543, DOI 10.1162/0898929053467587; SEKIYAMA K, 1982, PERCEPT PSYCHOPHYS, V32, P89, DOI 10.3758/BF03204268; Shenton JT, 2004, NEUROSCI LETT, V370, P19, DOI 10.1016/j.neulet.2004.07.053; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Sirigu A, 2001, J COGNITIVE NEUROSCI, V13, P910, DOI 10.1162/089892901753165827; Tao WD, 2009, NEUROREPORT, V20, P180, DOI 10.1097/WNR.0b013e32831c510a; ter Horst AC, 2010, EXP BRAIN RES, V203, P347, DOI 10.1007/s00221-010-2235-1; Thayer ZC, 2006, PSYCHOPHYSIOLOGY, V43, P401, DOI 10.1111/j.1469-8986.2006.00404.x; Urgesi C, 2007, NAT NEUROSCI, V10, P30, DOI 10.1038/nn1815; Vogt S, 2003, NEUROPSYCHOLOGIA, V41, P941, DOI 10.1016/S0028-3932(02)00319-6; Zacks J, 1999, NEUROPSYCHOLOGIA, V37, P1029, DOI 10.1016/S0028-3932(99)00012-3; Zacks J. M., 2000, Spatial Cognition and Computation, V2, P315, DOI 10.1023/A:1015584100204	36	39	39	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e23316	10.1371/journal.pone.0023316	http://dx.doi.org/10.1371/journal.pone.0023316			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	803CQ	21826247	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000293558900073
J	Ma, JC; Ibekwe, AM; Yi, X; Wang, HZ; Yamazaki, A; Crowley, DE; Yang, CH				Ma, Jincai; Ibekwe, A. Mark; Yi, Xuan; Wang, Haizhen; Yamazaki, Akihiro; Crowley, David E.; Yang, Ching-Hong			Persistence of Escherichia coli O157:H7 and Its Mutants in Soils	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; MANURE-AMENDED SOIL; SHIGA TOXIN; HEMORRHAGIC COLITIS; O157-H7 SURVIVAL; MULTIPLEX PCR; FRESH-WATER; COLONIZATION; MICROFLORA; INFECTION	The persistence of Shiga toxin-producing E. coli O157:H7 in the environment poses a serious threat to public health. However, the role of Shiga toxins and other virulence factors in the survival of E. coli O157: H7 is poorly defined. The aim of this study was to determine if the virulence factors, stx(1), stx(2), stx(1-2), and eae in E. coli O157: H7 EDL933 play any significant role in the growth of this pathogen in rich media and in soils. Isogenic deletion mutants that were missing one of four virulence factors, stx(1), stx(2), stx(1-2), and eae in E. coli O157:H7 EDL933 were constructed, and their growth in rich media and survival in soils with distinct texture and chemistry were characterized. The survival data were successfully analyzed using Double Weibull model, and the modeling parameters of the mutant strains were not significantly different from those of the wild type. The calculated T(d) (time needed to reach the detection limit, 100 CFU/g soil) for loamy sand, sandy loam, and silty clay was 32, 80, and 110 days, respectively. It was also found that T(d) was positively correlated with soil structure (e. g. clay content), and soil chemistry (e. g. total nitrogen, total carbon, and water extractable organic carbon). The results of this study showed that the possession of Shiga toxins and intimin in E. coli O157: H7 might not play any important role in its survival in soils. The double deletion mutant of E. coli O157: H7 (stx(1)(-) stx(2)(-)) may be a good substitute to use for the investigation of transport, fate, and survival of E. coli O157: H7 in the environment where the use of pathogenic strains are prohibited by law since the mutants showed the same characteristics in both culture media and environmental samples.	[Ma, Jincai; Ibekwe, A. Mark; Wang, Haizhen] ARS, US Salin Lab, USDA, Riverside, CA USA; [Ma, Jincai; Wang, Haizhen; Crowley, David E.] Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92521 USA; [Yi, Xuan; Yamazaki, Akihiro; Yang, Ching-Hong] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53201 USA; [Wang, Haizhen] Zhejiang Univ, Inst Soil & Water Resources & Environm Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Haizhen] Zhejiang Univ, Zhejiang Prov Key Lab Subtrop Soil & Plant Nutr, Hangzhou 310003, Zhejiang, Peoples R China	United States Department of Agriculture (USDA); University of California System; University of California Riverside; University of Wisconsin System; University of Wisconsin Milwaukee; Zhejiang University; Zhejiang University	Ma, JC (corresponding author), ARS, US Salin Lab, USDA, Riverside, CA USA.	Mark.Ibekwe@ars.usda.gov	Yamazaki, Akihiro/AAQ-1121-2021; MA, JINCAI/AAR-3734-2021; MA, JINCAI/D-1290-2013; Yamazaki, Akihiro/C-7418-2017; Crowley, David/C-1216-2014	Yamazaki, Akihiro/0000-0002-7848-2594; MA, JINCAI/0000-0002-0792-0251; MA, JINCAI/0000-0002-0792-0251; Yamazaki, Akihiro/0000-0002-7848-2594; Crowley, David/0000-0002-1805-8599; Ibekwe, Abasiofiok/0000-0003-3352-759X	National Research Initiative/National Institute of Food and Agriculture [2008-35201-18709]; United States Department of Agriculture-Agriculture Research Service	National Research Initiative/National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); United States Department of Agriculture-Agriculture Research Service(United States Department of Agriculture (USDA))	This research was supported by the National Research Initiative/National Institute of Food and Agriculture Agreement No. 2008-35201-18709 and the 206 Manure and Byproduct Utilization Project of the United States Department of Agriculture-Agriculture Research Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong GL, 1996, EPIDEMIOL REV, V18, P29, DOI 10.1093/oxfordjournals.epirev.a017914; Artz RRE, 2002, FEMS MICROBIOL LETT, V216, P117, DOI 10.1016/S0378-1097(02)01002-9; Avery LM, 2008, SCI TOTAL ENVIRON, V389, P378, DOI 10.1016/j.scitotenv.2007.08.049; BASHAN Y, 1986, APPL ENVIRON MICROB, V51, P1067, DOI 10.1128/AEM.51.5.1067-1071.1986; Besser RE, 1999, ANNU REV MED, V50, P355, DOI 10.1146/annurev.med.50.1.355; Bolton DJ, 1999, J APPL MICROBIOL, V86, P407, DOI 10.1046/j.1365-2672.1999.00677.x; BURTON GA, 1987, APPL ENVIRON MICROB, V53, P633, DOI 10.1128/AEM.53.4.633-638.1987; Campbell GR, 2001, J APPL MICROBIOL, V91, P1004, DOI 10.1046/j.1365-2672.2001.01465.x; CARTER AO, 1987, NEW ENGL J MED, V317, P1496, DOI 10.1056/NEJM198712103172403; Chapman PA, 1997, EPIDEMIOL INFECT, V119, P245, DOI 10.1017/S0950268897007826; Chase-Topping M, 2008, NAT REV MICROBIOL, V6, P904, DOI 10.1038/nrmicro2029; CIESLAK PR, 1993, LANCET, V342, P367, DOI 10.1016/0140-6736(93)91509-K; Coroller L., 2006, APPL ENVIRON MICROB, V72, P6439; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Franz E, 2008, CRIT REV MICROBIOL, V34, P143, DOI [10.1080/10408410802357432, 10.1080/10408410802357432 ]; Franz E, 2008, ENVIRON MICROBIOL, V10, P313, DOI 10.1111/j.1462-2920.2007.01453.x; Fratamico PM, 1997, J FOOD PROTECT, V60, P1167, DOI 10.4315/0362-028X-60.10.1167; Geeraerd AH, 2005, INT J FOOD MICROBIOL, V102, P95, DOI 10.1016/j.ijfoodmicro.2004.11.038; GRIFFIN PM, 1991, EPIDEMIOL REV, V13, P60, DOI 10.1093/oxfordjournals.epirev.a036079; HATTORI T, 1976, Critical Reviews in Microbiology, V4, P423, DOI 10.3109/10408417609102305; Jiang XP, 2002, APPL ENVIRON MICROB, V68, P2605, DOI 10.1128/AEM.68.5.2605-2609.2002; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; KARMALI MA, 1983, LANCET, V2, P1299; KLUTE A., 1996, AGRONOMY MONOGRAPHS, V9; KOLTER R, 1993, ANNU REV MICROBIOL, V47, P855, DOI 10.1146/annurev.micro.47.1.855; Kudva IT, 1997, J CLIN MICROBIOL, V35, P892, DOI 10.1128/JCM.35.4.892-899.1997; Kudva IT, 1998, APPL ENVIRON MICROB, V64, P3166; Lainhart W, 2009, J BACTERIOL, V191, P5116, DOI 10.1128/JB.00508-09; LALIBERTE P, 1982, APPL ENVIRON MICROB, V43, P623, DOI 10.1128/AEM.43.3.623-628.1982; Liang BC, 1998, BIOL FERT SOILS, V26, P88, DOI 10.1007/s003740050348; McGee P, 2002, J APPL MICROBIOL, V93, P706, DOI 10.1046/j.1365-2672.2002.01752.x; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; MORGAN GM, 1988, EPIDEMIOL INFECT, V101, P83, DOI 10.1017/S0950268800029241; Mubiru DN, 2000, J ENVIRON QUAL, V29, P1821, DOI 10.2134/jeq2000.00472425002900060012x; Nicholson FA, 2005, BIORESOURCE TECHNOL, V96, P135, DOI 10.1016/j.biortech.2004.02.030; O'Loughlin EV, 2001, MICROBES INFECT, V3, P493, DOI 10.1016/S1286-4579(01)01405-8; Paton AW, 1998, J CLIN MICROBIOL, V36, P598, DOI 10.1128/JCM.36.2.598-602.1998; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Ravva SV, 2006, J APPL MICROBIOL, V101, P891, DOI 10.1111/j.1365-2672.2006.02956.x; RICE DH, 1995, VET REC, V137, P524, DOI 10.1136/vr.137.20.524; RILEY L, 1983, NEW ENGL J MED, V308, P981; Ritchie JM, 2003, APPL ENVIRON MICROB, V69, P3359, DOI 10.1128/AEM.69.6.3359-3367.2003; Semenov AV, 2008, ENVIRON MICROBIOL, V10, P1450, DOI 10.1111/j.1462-2920.2007.01558.x; Topp E, 2003, FEMS MICROBIOL ECOL, V44, P303, DOI 10.1016/S0168-6496(03)00055-2; van Elsas JD, 2007, ISME J, V1, P204, DOI 10.1038/ismej.2007.21; van Elsas JD, 2011, ISME J, V5, P173, DOI 10.1038/ismej.2010.80; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; VANELSAS JD, 1986, FEMS MICROBIOL ECOL, V38, P151, DOI 10.1016/0378-1097(86)90046-7; vanVeen JA, 1997, MICROBIOL MOL BIOL R, V61, P121, DOI 10.1128/.61.2.121-135.1997; Vidovic S, 2007, CAN J MICROBIOL, V53, P822, DOI 10.1139/W07-041; Vital M, 2008, ENVIRON MICROBIOL, V10, P2387, DOI 10.1111/j.1462-2920.2008.01664.x; Wallace JS, 1997, J APPL MICROBIOL, V82, P399, DOI 10.1046/j.1365-2672.1997.00378.x; Watterworth L, 2006, WATER AIR SOIL POLL, V177, P367, DOI 10.1007/s11270-006-9179-x; Williams AP, 2008, FEMS MICROBIOL LETT, V287, P168, DOI 10.1111/j.1574-6968.2008.01310.x	55	33	33	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e23191	10.1371/journal.pone.0023191	http://dx.doi.org/10.1371/journal.pone.0023191			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826238	Green Submitted, gold, Green Published			2022-12-25	WOS:000293558900064
J	Nowakowski, TJ; Mysiak, KS; Pratt, T; Price, DJ				Nowakowski, Tomasz Jan; Mysiak, Karolina Sandra; Pratt, Thomas; Price, David Jonathan			Functional Dicer Is Necessary for Appropriate Specification of Radial Glia during Early Development of Mouse Telencephalon	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MESSENGER-RNA EXPRESSION; EMBRYONIC STEM-CELLS; CAJAL-RETZIUS CELLS; CEREBRAL-CORTEX; PROGENITOR CELLS; CORTICAL NEUROGENESIS; DEVELOPING NEOCORTEX; RIBONUCLEASE-III; ENZYME DICER	Early telencephalic development involves transformation of neuroepithelial stem cells into radial glia, which are themselves neuronal progenitors, around the time when the tissue begins to generate postmitotic neurons. To achieve this transformation, radial precursors express a specific combination of proteins. We investigate the hypothesis that micro RNAs regulate the ability of the early telencephalic progenitors to establish radial glia. We ablate functional Dicer, which is required for the generation of mature micro RNAs, by conditionally mutating the Dicer1 gene in the early embryonic telencephalon and analyse the molecular specification of radial glia as well as their progeny, namely postmitotic neurons and basal progenitors. Conditional mutation of Dicer1 from the telencephalon at around embryonic day 8 does not prevent morphological development of radial glia, but their expression of Nestin, Sox9, and ErbB2 is abnormally low. The population of basal progenitors, which are generated by the radial glia, is disorganised and expanded in Dicer1(-/-) dorsal telencephalon. While the proportion of cells expressing markers of postmitotic neurons is unchanged, their laminar organisation in the telencephalic wall is disrupted suggesting a defect in radial glial guided migration. We found that the laminar disruption could not be accounted for by a reduction of the population of Cajal Retzius neurons. Together, our data suggest novel roles for micro RNAs during early development of progenitor cells in the embryonic telencephalon.	[Nowakowski, Tomasz Jan; Mysiak, Karolina Sandra; Pratt, Thomas; Price, David Jonathan] Univ Edinburgh, Ctr Integrat Physiol, Dev Biol Lab, Edinburgh, Midlothian, Scotland	University of Edinburgh	Nowakowski, TJ (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Dev Biol Lab, Edinburgh, Midlothian, Scotland.	t.nowakowski@sms.ed.ac.uk	Nowakowski, Tomasz/P-7731-2014	Nowakowski, Tomasz/0000-0003-2345-4964; Mysiak, Karolina/0000-0002-4175-3581; Pratt, Thomas/0000-0002-7105-3527	Wellcome Trust; Medical Research Council; Biotechnology and Biological Sciences Research Council; MRC [G0800429] Funding Source: UKRI; Medical Research Council [G0800429] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	TJN is sponsored by the 4-year PhD studentship provided by the Wellcome Trust, KSM was a summer student funded by the Wellcome Trust Vacation Scholarship, and the laboratories of TP and DJP are funded by the Wellcome Trust, Medical Research Council and the Biotechnology and Biological Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara S, 1998, J NEUROSCI, V18, P7779; Andersson T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013453; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bielle F, 2005, NAT NEUROSCI, V8, P1002, DOI 10.1038/nn1511; Bobick BE, 2010, J CELL BIOCHEM, V109, P265, DOI 10.1002/jcb.22419; CAVINESS VS, 1976, J COMP NEUROL, V170, P435, DOI 10.1002/cne.901700404; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Collignon J, 1996, DEVELOPMENT, V122, P509; Davis N, 2011, DEVELOPMENT, V138, P127, DOI 10.1242/dev.053637; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Ding L, 2005, MOL CELL, V19, P437, DOI 10.1016/j.molcel.2005.07.013; Du Z, 2008, P NATL ACAD SCI USA, V105, P2391, DOI 10.1073/pnas.0711506105; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; Flammiger A, 2009, J INVEST DERMATOL, V129, P945, DOI 10.1038/jid.2008.316; Gan JH, 2006, CELL, V124, P355, DOI 10.1016/j.cell.2005.11.034; Georgi SA, 2010, J NEUROSCI, V30, P4048, DOI 10.1523/JNEUROSCI.4982-09.2010; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; GOTZ M, 1995, EXPERIENTIA, V51, P301; Grandjean V, 2009, DEVELOPMENT, V136, P3647, DOI 10.1242/dev.041061; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Guillemot F, 2005, CURR OPIN CELL BIOL, V17, P639, DOI 10.1016/j.ceb.2005.09.006; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; GUO XW, 1995, EMBO J, V14, P976, DOI 10.1002/j.1460-2075.1995.tb07078.x; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Hasling TA, 2003, EUR J NEUROSCI, V17, P467, DOI 10.1046/j.1460-9568.2003.02468.x; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Hevner RF, 2003, DEV BRAIN RES, V141, P39, DOI 10.1016/S0165-3806(02)00641-7; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kawase-Koga Y, 2010, J CELL SCI, V123, P586, DOI 10.1242/jcs.059659; Kawase-Koga Y, 2009, DEV DYNAM, V238, P2800, DOI 10.1002/dvdy.22109; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Kriegstein AR, 2003, GLIA, V43, P37, DOI 10.1002/glia.10250; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Maiorano NA, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-40; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Meier-Stiegen F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011481; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; Murakami S, 2000, P NATL ACAD SCI USA, V97, P1113, DOI 10.1073/pnas.97.3.1113; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Nakagawa A, 2010, SCIENCE, V328, P327, DOI 10.1126/science.1182374; Nicholson RH, 2002, MAMM GENOME, V13, P67, DOI 10.1007/s00335-001-2119-6; Nielsen JA, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-98; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; PARK D, 2010, STEM CELLS; Park D, 2009, BIOCHEM BIOPH RES CO, V382, P588, DOI 10.1016/j.bbrc.2009.03.074; Poche RA, 2008, J COMP NEUROL, V510, P237, DOI 10.1002/cne.21746; RUBENSTEIN JLR, 1994, CURR TOP DEV BIOL, V29, P1, DOI 10.1016/S0070-2153(08)60546-3; Rybak A, 2009, NAT CELL BIOL, V11, P1411, DOI 10.1038/ncb1987; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Schaefer A, 2008, DEV NEUROBIOL, V68, P590, DOI 10.1002/dneu.20601; Schmid RS, 2003, P NATL ACAD SCI USA, V100, P4251, DOI 10.1073/pnas.0630496100; Scott CE, 2010, NAT NEUROSCI, V13, P1181, DOI 10.1038/nn.2646; Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028; Shibata M, 2008, J NEUROSCI, V28, P10415, DOI 10.1523/JNEUROSCI.3219-08.2008; Stolt CC, 2010, INT J BIOCHEM CELL B, V42, P437, DOI 10.1016/j.biocel.2009.07.014; Stoykova A, 1996, DEVELOPMENT, V122, P3453; TAO W, 1992, NEURON, V8, P957, DOI 10.1016/0896-6273(92)90210-5; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; TOHYAMA T, 1992, LAB INVEST, V66, P303; Tonelli DD, 2008, DEVELOPMENT, V135, P3911, DOI 10.1242/dev.025080; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; VOIGT T, 1989, J COMP NEUROL, V289, P74, DOI 10.1002/cne.902890106; Walker JC, 2009, GENE DEV, V23, P1046, DOI 10.1101/gad.1777709; Wallace VA, 1999, DEVELOPMENT, V126, P2901; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Weimer JM, 2009, DEVELOPMENT, V136, P2965, DOI 10.1242/dev.036616; Woods A, 2005, J BIOL CHEM, V280, P11626, DOI 10.1074/jbc.M409158200; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yoshida M, 1997, DEVELOPMENT, V124, P101; Zhong WM, 2000, P NATL ACAD SCI USA, V97, P6844, DOI 10.1073/pnas.97.12.6844	83	37	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e23013	10.1371/journal.pone.0023013	http://dx.doi.org/10.1371/journal.pone.0023013			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826226	Green Submitted, Green Published, gold			2022-12-25	WOS:000293558900052
J	Perret, A; Lechaplais, C; Tricot, S; Perchat, N; Vergne, C; Pelle, C; Bastard, K; Kreimeyer, A; Vallenet, D; Zaparucha, A; Weissenbach, J; Salanoubat, M				Perret, Alain; Lechaplais, Christophe; Tricot, Sabine; Perchat, Nadia; Vergne, Carine; Pelle, Christine; Bastard, Karine; Kreimeyer, Annett; Vallenet, David; Zaparucha, Anne; Weissenbach, Jean; Salanoubat, Marcel			A Novel Acyl-CoA Beta-Transaminase Characterized from a Metagenome	PLOS ONE			English	Article							ESCHERICHIA-COLI; COENZYME; IDENTIFICATION; CLONING; BIOSYNTHESIS; FERMENTATION; TRANSFERASE; DEGRADATION; METABOLISM; REDUCTASE	Background: Bacteria are key components in all ecosystems. However, our knowledge of bacterial metabolism is based solely on the study of cultivated organisms which represent just a tiny fraction of microbial diversity. To access new enzymatic reactions and new or alternative pathways, we investigated bacterial metabolism through analyses of uncultivated bacterial consortia. Methodology/Principal Findings: We applied the gene context approach to assembled sequences of the metagenome of the anaerobic digester of a municipal wastewater treatment plant, and identified a new gene which may participate in an alternative pathway of lysine fermentation. Conclusions: We characterized a novel, unique aminotransferase that acts exclusively on Coenzyme A (CoA) esters, and proposed a variant route for lysine fermentation. Results suggest that most of the lysine fermenting organisms use this new pathway in the digester. Its presence in organisms representative of two distinct bacterial divisions indicate that it may also be present in other organisms.	[Perret, Alain; Lechaplais, Christophe; Tricot, Sabine; Perchat, Nadia; Vergne, Carine; Pelle, Christine; Bastard, Karine; Kreimeyer, Annett; Vallenet, David; Zaparucha, Anne; Weissenbach, Jean; Salanoubat, Marcel] Genoscope, Commissariat Energie Atom & Energies Alternat, Inst Genom, Evry, France; [Perret, Alain; Lechaplais, Christophe; Tricot, Sabine; Perchat, Nadia; Vergne, Carine; Pelle, Christine; Bastard, Karine; Kreimeyer, Annett; Vallenet, David; Zaparucha, Anne; Weissenbach, Jean; Salanoubat, Marcel] CNRS UMR 8030, Evry, France; [Perret, Alain; Lechaplais, Christophe; Tricot, Sabine; Perchat, Nadia; Vergne, Carine; Pelle, Christine; Bastard, Karine; Kreimeyer, Annett; Vallenet, David; Zaparucha, Anne; Weissenbach, Jean; Salanoubat, Marcel] Univ Evry, UEVE, Evry, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Perret, A (corresponding author), Genoscope, Commissariat Energie Atom & Energies Alternat, Inst Genom, Evry, France.	aperret@genoscope.cns.fr	Zaparucha, Anne/ADO-0726-2022	Zaparucha, Anne/0000-0003-2531-4148; Vallenet, David/0000-0001-6648-0332; PERRET, Alain/0000-0002-8896-1978; Karine, Bastard/0000-0003-4898-7871	Commissariat a l'Energie Atomique (CEA)	Commissariat a l'Energie Atomique (CEA)(French Atomic Energy Commission)	This work was supported by the Commissariat a l'Energie Atomique (CEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Angelidaki I, 2011, METHOD ENZYMOL, V494, P327, DOI 10.1016/B978-0-12-385112-3.00016-0; BARKER HA, 1978, J BIOL CHEM, V253, P1219; BARKER HA, 1982, J BACTERIOL, V152, P201; Battey JND, 2007, PROTEINS, V69, P68, DOI 10.1002/prot.21761; BROBST SW, 1994, CAN J CHEM, V72, P200, DOI 10.1139/v94-031; BUCKEL W, 1974, J BACTERIOL, V117, P1248, DOI 10.1128/JB.117.3.1248-1260.1974; CARY JW, 1990, APPL ENVIRON MICROB, V56, P1576, DOI 10.1128/AEM.56.6.1576-1583.1990; Chouari R, 2005, ENVIRON MICROBIOL, V7, P1104, DOI 10.1111/j.1462-2920.2005.00795.x; Chouari R, 2005, APPL ENVIRON MICROB, V71, P2145, DOI 10.1128/AEM.71.4.2145-2153.2005; Cowan DA, 2000, TRENDS BIOTECHNOL, V18, P14, DOI 10.1016/S0167-7799(99)01395-5; de Jong Rob N., 2006, Journal of Structural and Functional Genomics, V7, P109, DOI 10.1007/s10969-006-9014-z; de Melo-Minardi RC, 2010, BIOINFORMATICS, V26, P3075, DOI 10.1093/bioinformatics/btq595; DeLong EF, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000359; Ellrott K, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000798; Ettwig KF, 2010, NATURE, V464, P543, DOI 10.1038/nature08883; Galushko A, 1999, ENVIRON MICROBIOL, V1, P415; Herrmann G, 2008, J BACTERIOL, V190, P784, DOI 10.1128/JB.01422-07; Hugenholtz P, 2008, NATURE, V455, P481, DOI 10.1038/455481a; ILAG LL, 1992, BIOCHEMISTRY-US, V31, P7143, DOI 10.1021/bi00146a016; Kim J, 2007, APPL ENVIRON MICROB, V73, P1772, DOI 10.1128/AEM.02119-06; Kreimeyer A, 2007, J BIOL CHEM, V282, P7191, DOI 10.1074/jbc.M609829200; LERUD RF, 1971, J BACTERIOL, V106, P571, DOI 10.1128/JB.106.2.571-577.1971; Li F, 2008, J BACTERIOL, V190, P843, DOI 10.1128/JB.01417-07; Luer C, 2005, J BIOL CHEM, V280, P18568, DOI 10.1074/jbc.M500440200; McInerney MJ, 2009, CURR OPIN BIOTECH, V20, P623, DOI 10.1016/j.copbio.2009.10.001; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Pelletier E, 2008, J BACTERIOL, V190, P2572, DOI 10.1128/JB.01248-07; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Riviere D, 2009, ISME J, V3, P700, DOI 10.1038/ismej.2009.2; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; Sharon I, 2009, NATURE, V461, P258, DOI 10.1038/nature08284; STADTMAN TC, 1973, ADV ENZYMOL RAMB, V38, P413; STERN JR, 1956, J BIOL CHEM, V221, P33; STERN JR, 1956, J BIOL CHEM, V221, P15; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; Vallenet D, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap021; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; YUE S, 1987, J AM CHEM SOC, V109, P1253, DOI 10.1021/ja00238a050	40	12	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22918	10.1371/journal.pone.0022918	http://dx.doi.org/10.1371/journal.pone.0022918			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826218	Green Published, gold, Green Submitted			2022-12-25	WOS:000293558900044
J	Casey, T; Dover, H; Liesman, J; DeVries, L; Kiupel, M; VandeHaar, M; Plaut, K				Casey, Theresa; Dover, Heather; Liesman, James; DeVries, Lindsey; Kiupel, Matti; VandeHaar, Michael; Plaut, Karen			Transcriptome Analysis of Epithelial and Stromal Contributions to Mammogenesis in Three Week Prepartum Cows	PLOS ONE			English	Article							BOVINE MAMMARY-GLAND; MILK PROTEIN-SYNTHESIS; IGF-I AXIS; GENE-EXPRESSION; EXTRACELLULAR-MATRIX; SECRETORY ACTIVATION; MICROARRAY ANALYSIS; DRY PERIOD; PREPUBERTAL HEIFERS; INVOLUTION	Transcriptome analysis of bovine mammary development has provided insight into regulation of mammogenesis. However, previous studies primarily examined expression of epithelial and stromal tissues combined, and consequently did not account for tissue specific contribution to mammary development. Our objective was to identify differences in gene expression in epithelial and intralobular stromal compartments. Tissue was biopsied from non-lactating dairy cows 3 weeks prepartum, cut into explants and incubated for 2 hr with insulin and hydrocortisone. Epithelial and intralobular stromal tissues were isolated with laser capture microdissection. Global gene expression was measured with Bovine Affymetrix GeneChips, and data were preprocessed using RMA method. Moderated t-tests from gene-specific linear model analysis with cell type as a fixed effect showed more than 3,000 genes were differentially expressed between tissues (P<0.05; FDR<0.17). Analysis of epithelial and stromal transcriptomes using Database for Annotation, Visualization and Integrated Discovery (DAVID) and Ingenuity Pathways Analysis (IPA) showed that epithelial and stromal cells contributed distinct molecular signatures. Epithelial signatures were enriched with gene sets for protein synthesis, metabolism and secretion. Stromal signatures were enriched with genes that encoded molecules important to signaling, extracellular matrix composition and remodeling. Transcriptome differences also showed evidence for paracrine interactions between tissues in stimulation of IGF1 signaling pathway, stromal reaction, angiogenesis, neurogenesis, and immune response. Molecular signatures point to the dynamic role the stroma plays in prepartum mammogenesis and highlight the importance of examining the roles of cell types within the mammary gland when targeting therapies and studying mechanisms that affect milk production.	[Casey, Theresa; Plaut, Karen] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Dover, Heather; Liesman, James; DeVries, Lindsey; VandeHaar, Michael] Michigan State Univ, E Lansing, MI 48824 USA; [Kiupel, Matti] Diagnost Ctr Populat & Anim Hlth, Lansing, MI USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Michigan State University	Casey, T (corresponding author), Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA.	theresa-casey@purdue.edu	Casey, Theresa Marie/F-1171-2015; Kiupel, Matti/G-2827-2011	Casey, Theresa Marie/0000-0002-8835-3550; Kiupel, Matti/0000-0003-4429-9529	USDA Cooperative State Research, Education, and Extension Service [2006-35206-16719]	USDA Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This project was supported by National Research Initiative Competitive Grant no. 2006-35206-16719 from the USDA Cooperative State Research, Education, and Extension Service. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akers RM, 2000, J MAMMARY GLAND BIOL, V5, P43, DOI 10.1023/A:1009563115612; Anderson SM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1653; Auer H, 2003, NAT GENET, V35, P292, DOI 10.1038/ng1203-292; Bachman KC, 2003, J DAIRY SCI, V86, P3027, DOI 10.3168/jds.S0022-0302(03)73902-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry SDK, 2003, J DAIRY SCI, V86, P2864, DOI 10.3168/jds.S0022-0302(03)73883-1; Berry SDK, 2003, J ENDOCRINOL, V177, P295, DOI 10.1677/joe.0.1770295; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Capuco AV, 1999, J MAMMARY GLAND BIOL, V4, P137, DOI 10.1023/A:1018769022990; Capuco AV, 1997, J DAIRY SCI, V80, P477, DOI 10.3168/jds.S0022-0302(97)75960-5; Casey TM, 2008, BREAST CANCER RES TR, V110, P39, DOI 10.1007/s10549-007-9684-7; Casey TM, 2007, J MAMMARY GLAND BIOL, V12, P293, DOI 10.1007/s10911-007-9055-3; Connor EE, 2007, J DAIRY SCI, V90, pE55, DOI 10.3168/jds.2006-466; Connor EE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-362; Cui XG, 2005, BIOSTATISTICS, V6, P59, DOI 10.1093/biostatistics/kxh018; De Vries LD, 2010, J DAIRY SCI, V93, P2433, DOI 10.3168/jds.2009-2764; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; EDWARDS G, 1995, BIOCHEM SOC T, V23, P464, DOI 10.1042/bst0230464; Finucane KA, 2008, FUNCT INTEGR GENOMIC, V8, P251, DOI 10.1007/s10142-008-0074-y; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; HOLST BD, 1987, J DAIRY SCI, V70, P935, DOI 10.3168/jds.S0022-0302(87)80097-8; HOWLETT AR, 1993, EPITHELIAL CELL BIOL, V2, P79; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HURLEY WL, 1989, J DAIRY SCI, V72, P1637, DOI 10.3168/jds.S0022-0302(89)79276-6; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Joesting MS, 2008, DEV BIOL, V317, P161, DOI 10.1016/j.ydbio.2008.02.021; Lanigan F, 2007, CELL MOL LIFE SCI, V64, P3161, DOI 10.1007/s00018-007-7386-2; Li RW, 2006, PHYSIOL GENOMICS, V27, P42, DOI 10.1152/physiolgenomics.00032.2006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; Naylor MJ, 2005, MOL ENDOCRINOL, V19, P1868, DOI 10.1210/me.2004-0254; Noel A, 1998, J MAMMARY GLAND BIOL, V3, P215, DOI 10.1023/A:1018703208453; Norgaard JV, 2008, J DAIRY SCI, V91, P2319, DOI 10.3168/jds.2007-0767; Plath-Gabler A, 2001, J ENDOCRINOL, V168, P39, DOI 10.1677/joe.0.1680039; Rhoads RE, 2007, J MAMMARY GLAND BIOL, V12, P283, DOI 10.1007/s10911-007-9058-0; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; RONNOVJESSEN L, 1995, ORIGIN MYOFIBROBLAST, P859; SCHMIDHAUSER C, 1990, P NATL ACAD SCI USA, V87, P9118, DOI 10.1073/pnas.87.23.9118; Singh K, 2008, J DAIRY SCI, V91, P2236, DOI 10.3168/jds.2007-0900; SORDILLO LM, 1988, AM J VET RES, V49, P1112; STREULI CH, 1995, J BIOL CHEM, V270, P21639, DOI 10.1074/jbc.270.37.21639; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Tuxhorn JA, 2002, CANCER RES, V62, P3298; WILDE CJ, 1997, PROGRAMMED CELL DEAT, P943; Woodward TL, 1998, J MAMMARY GLAND BIOL, V3, P117, DOI 10.1023/A:1018738721656; Woodward TL, 2001, ENDOCRINOLOGY, V142, P3214, DOI 10.1210/en.142.7.3214; Wu H., 2003, ANAL GENE EXPRESSION, P313, DOI DOI 10.1007/0-387-21679-0_14	48	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22541	10.1371/journal.pone.0022541	http://dx.doi.org/10.1371/journal.pone.0022541			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829467	Green Published, gold, Green Submitted			2022-12-25	WOS:000293286500014
J	Zhao, YY; Xiong, Q; Xie, P				Zhao, Yanyan; Xiong, Qian; Xie, Ping			Analysis of MicroRNA Expression in Embryonic Developmental Toxicity Induced by MC-RR	PLOS ONE			English	Article							MICROCYSTIN-LR; GENE-EXPRESSION; NEGATIVE REGULATOR; RNA-INTERFERENCE; ZEBRAFISH; CYANOBACTERIA; DICER; TOXINS; LARVAE; FISH	As cynobacterial blooms frequently occur in fresh waters throughout the world, microcystins (MCs) have caused serious damage to both wildlife and human health. MCs are known to have developmental toxicity, however, the possible molecular mechanism is largely unknown. This is the first toxicological study to integrate post-transcriptomic, proteomic and bioinformatics analysis to explore molecular mechanisms for developmental toxicity of MCs in zebrafish. After being microinjected directly into embryos, MC-RR dose-dependently decreased survival rates and increased malformation rates of embryos, causing various embryo abnormalities including loss of vascular integrity and hemorrhage. Expressions of 31 microRNAs (miRNAs) and 78 proteins were significantly affected at 72 hours post-fertilisation (hpf). Expressions of miR-430 and miR-125 families were also significantly changed. The altered expressions of miR-31 and miR-126 were likely responsible for the loss of vascular integrity. MC-RR significantly reduced the expressions of a number of proteins involved in energy metabolism, cell division, protein synthesis, cytoskeleton maintenance, response to stress and DNA replication. Bioinformatics analysis shows that several aberrantly expressed miRNAs and proteins (involved in various molecular pathways) were predicted to be potential MC-responsive miRNA-target pairs, and that their aberrant expressions should be the possible molecular mechanisms for the various developmental defects caused by MC-RR.	[Zhao, Yanyan; Xiong, Qian; Xie, Ping] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol China, Donghu Expt Stn Lake Ecosys, Wuhan, Peoples R China; [Zhao, Yanyan; Xiong, Qian] Chinese Acad Sci, Grad Sch, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences	Zhao, YY (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol China, Donghu Expt Stn Lake Ecosys, Wuhan, Peoples R China.	xieping@ihb.ac.cn	zhao, yan/GWC-9174-2022; Qian, Xiong/R-8785-2018; Xiong, Qian/O-9468-2019; Xie, Ping/AAL-7532-2020; Xie, Huangming/B-2260-2012	Qian, Xiong/0000-0002-0547-039X; Xiong, Qian/0000-0002-0547-039X; 	National Basic Research Program of China (973 Program) [2008CB418101]; National Natural Science Foundation of China [31070457]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was jointly supported by the National Basic Research Program of China (973 Program; 2008CB418101) and the National Natural Science Foundation of China (31070457). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bu YZ, 2006, TOXICON, V48, P966, DOI 10.1016/j.toxicon.2006.07.038; CARMICHAEL WW, 1994, SCI AM, V270, P78, DOI 10.1038/scientificamerican0194-78; Carmichael WW, 1997, ADV BOT RES, V27, P211; Comte A, 2010, EVOL DEV, V12, P144, DOI 10.1111/j.1525-142X.2010.00400.x; Croce Jenifer C., 2008, V469, P3, DOI 10.1007/978-1-60327-469-2_1; Dietrich D, 2005, TOXICOL APPL PHARM, V203, P273, DOI 10.1016/j.taap.2004.09.005; Fastner J, 2002, ANAL BIOANAL CHEM, V374, P437, DOI 10.1007/s00216-002-1520-7; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; GAD S, 1988, STAT EXPT DESIGN TOX; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jacquet C, 2004, TOXICON, V43, P141, DOI 10.1016/j.toxicon.2003.11.010; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kloosterman WP, 2006, NUCLEIC ACIDS RES, V34, P2558, DOI 10.1093/nar/gkl278; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Liu YD, 2002, TOXICON, V40, P395, DOI 10.1016/S0041-0101(01)00173-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Oberemm A, 1999, ENVIRON TOXICOL, V14, P77, DOI 10.1002/(SICI)1522-7278(199902)14:1<77::AID-TOX11>3.0.CO;2-F; Palikova M, 2004, ACTA VET BRNO, V73, P253, DOI 10.2754/avb200473020253; Palikova M, 2003, ACTA VET BRNO, V72, P437, DOI 10.2754/avb200372030437; Pedrioli DML, 2010, MOL CELL BIOL, V30, P3620, DOI 10.1128/MCB.00185-10; Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030; Shi XJ, 2009, TOXICOL SCI, V110, P334, DOI 10.1093/toxsci/kfp111; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Wang PJ, 2005, TOXICON, V45, P303, DOI 10.1016/j.toxicon.2004.10.016; Wienholds E, 2003, NAT GENET, V35, P217, DOI 10.1038/ng1251; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006	37	16	17	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22676	10.1371/journal.pone.0022676	http://dx.doi.org/10.1371/journal.pone.0022676			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829477	gold, Green Published, Green Submitted			2022-12-25	WOS:000293286500017
J	Cho, KO; Kim, GW; Lee, OK				Cho, Kyung-Ok; Kim, Go-Woon; Lee, Ok-Kyung			Wolbachia Bacteria Reside in Host Golgi-Related Vesicles Whose Position Is Regulated by Polarity Proteins	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; CELL POLARITY; PLANAR POLARITY; DROSOPHILA-MELANOGASTER; TISSUE POLARITY; ASYMMETRIC LOCALIZATION; ANTERIOR LOCALIZATION; IMAGINAL DISCS; LOOP-TAIL; MEMBRANE	Wolbachia pipientis are intracellular symbiotic bacteria extremely common in various organisms including Drosophila melanogaster, and are known for their ability to induce changes in host reproduction. These bacteria are present in astral microtubule-associated vesicular structures in host cytoplasm, but little is known about the identity of these vesicles. We report here that Wolbachia are restricted only to a group of Golgi-related vesicles concentrated near the site of membrane biogenesis and minus-ends of microtubules. The Wolbachia vesicles were significantly mislocalized in mutant embryos defective in cell/planar polarity genes suggesting that cell/tissue polarity genes are required for apical localization of these Golgi-related vesicles. Furthermore, two of the polarity proteins, Van Gogh/Strabismus and Scribble, appeared to be present in these Golgi-related vesicles. Thus, establishment of polarity may be closely linked to the precise insertion of Golgi vesicles into the new membrane addition site.	[Cho, Kyung-Ok; Kim, Go-Woon; Lee, Ok-Kyung] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Cho, KO (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea.	kocho@kaist.ac.kr	Cho, Kyung-Ok/C-1705-2011	Cho, Kyung-Ok/0000-0002-0760-2560	Korea Advanced Institute of Science and Technology (KAIST) [G04080077]	Korea Advanced Institute of Science and Technology (KAIST)	This work was supported by a Korea Advanced Institute of Science and Technology (KAIST) internal grant G04080077. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Albertson R, 2009, J CELL SCI, V122, P4570, DOI 10.1242/jcs.054981; Axelrod JD, 2001, GENE DEV, V15, P1182; Bandi C, 1998, P ROY SOC B-BIOL SCI, V265, P2407, DOI 10.1098/rspb.1998.0591; Bastock R, 2003, DEVELOPMENT, V130, P3007, DOI 10.1242/dev.00526; Bellaiche Y, 2004, DEVELOPMENT, V131, P469, DOI 10.1242/dev.00928; Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; CALLAINI G, 1994, J CELL SCI, V107, P673; Cho KO, 2000, CELL, V103, P331, DOI 10.1016/S0092-8674(00)00124-0; Cho KO, 2004, GENE EXPR PATTERNS, V5, P167, DOI 10.1016/j.modgep.2004.08.008; Clark ME, 2005, GENETICS, V170, P1667, DOI 10.1534/genetics.104.038901; Clark ME, 2003, MECH DEVELOP, V120, P185, DOI 10.1016/S0925-4773(02)00424-0; Ferree PM, 2005, PLOS PATHOG, V1, P111, DOI 10.1371/journal.ppat.0010014; Garoff H, 1998, MICROBIOL MOL BIOL R, V62, P1171, DOI 10.1128/MMBR.62.4.1171-1190.1998; GILL SR, 1991, J CELL BIOL, V115, P1639, DOI 10.1083/jcb.115.6.1639; GONATAS JO, 1989, J BIOL CHEM, V264, P646; Gubb D, 1999, GENE DEV, V13, P2315, DOI 10.1101/gad.13.17.2315; HOLDEN PR, 1993, GENET RES, V62, P23, DOI 10.1017/S0016672300031529; Hong Y, 2001, NATURE, V414, P634, DOI 10.1038/414634a; Hunter C, 2000, J CELL BIOL, V150, P391, DOI 10.1083/jcb.150.2.391; Jenny A, 2003, EMBO J, V22, P4409, DOI 10.1093/emboj/cdg424; Kallay LM, 2006, J CELL BIOCHEM, V99, P647, DOI 10.1002/jcb.20992; Karcher RL, 2002, TRENDS CELL BIOL, V12, P21, DOI 10.1016/S0962-8924(01)02184-5; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Kondylis V, 2001, MOL BIOL CELL, V12, P2308, DOI 10.1091/mbc.12.8.2308; Kondylis V, 2009, FEBS LETT, V583, P3827, DOI 10.1016/j.febslet.2009.09.048; KOSE H, 1995, MECH DEVELOP, V51, P275, DOI 10.1016/0925-4773(95)00372-X; KREIS TE, 1990, CELL MOTIL CYTOSKEL, V15, P67, DOI 10.1002/cm.970150202; Lecuit T, 2000, J CELL BIOL, V150, P849, DOI 10.1083/jcb.150.4.849; Lee OK, 2003, NAT CELL BIOL, V5, P987, DOI 10.1038/ncb1055; Li KJ, 1996, CELL, V85, P585, DOI 10.1016/S0092-8674(00)81258-1; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; LOUIS C, 1989, J INVERTEBR PATHOL, V54, P39, DOI 10.1016/0022-2011(89)90137-7; Lowe M, 1998, CELL, V94, P783, DOI 10.1016/S0092-8674(00)81737-7; Marra P, 2007, MOL BIOL CELL, V18, P1595, DOI 10.1091/mbc.E06-10-0886; Merte J, 2010, NAT CELL BIOL, V12, P41, DOI 10.1038/ncb2002; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Murdoch JN, 2003, HUM MOL GENET, V12, P87, DOI 10.1093/hmg/ddg014; Murdoch JN, 2001, GENOMICS, V78, P55, DOI 10.1006/geno.2001.6638; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Perlman SJ, 2006, P ROY SOC B-BIOL SCI, V273, P2097, DOI 10.1098/rspb.2006.3541; Price MH, 2006, J CELL SCI, V119, P403, DOI 10.1242/jcs.02761; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Rawls AS, 2003, DEVELOPMENT, V130, P1877, DOI 10.1242/dev.00411; Rios RM, 2003, CURR OPIN CELL BIOL, V15, P60, DOI 10.1016/S0955-0674(02)00013-3; Roy CR, 2002, TRENDS MICROBIOL, V10, P418, DOI 10.1016/S0966-842X(02)02421-6; Salanueva IJ, 2003, J VIROL, V77, P1368, DOI 10.1128/JVI.77.2.1368-1381.2003; Sengupta D, 2009, J CELL BIOL, V186, P41, DOI 10.1083/jcb.200902110; Shimada Y, 2001, CURR BIOL, V11, P859, DOI 10.1016/S0960-9822(01)00233-0; Shimada Y, 2006, DEV CELL, V10, P209, DOI 10.1016/j.devcel.2005.11.016; Stanley H, 1997, P NATL ACAD SCI USA, V94, P14467, DOI 10.1073/pnas.94.26.14467; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Strutt D, 2002, CURR BIOL, V12, P813, DOI 10.1016/S0960-9822(02)00841-2; Strutt DI, 2001, MOL CELL, V7, P367, DOI 10.1016/S1097-2765(01)00184-8; Taylor J, 1998, GENETICS, V150, P199; THEURKAUF WE, 1992, DEVELOPMENT, V115, P923; Thomas GH, 1999, J CELL SCI, V112, P2843; Tree DRP, 2002, CELL, V109, P371, DOI 10.1016/S0092-8674(02)00715-8; Wansleeben C, 2010, DEVELOPMENT, V137, P1067, DOI 10.1242/dev.041434; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V262, P197, DOI 10.1098/rspb.1995.0196; Wolff T, 1998, DEVELOPMENT, V125, P1149; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; Yano H, 2005, P NATL ACAD SCI USA, V102, P13467, DOI 10.1073/pnas.0506681102	66	34	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22703	10.1371/journal.pone.0022703	http://dx.doi.org/10.1371/journal.pone.0022703			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829485	Green Published, gold, Green Submitted			2022-12-25	WOS:000293284600030
J	Walker, F; Zhang, HH; Odorizzi, A; Burgess, AW				Walker, Francesca; Zhang, Hui-Hua; Odorizzi, Annalisa; Burgess, Antony W.			LGR5 Is a Negative Regulator of Tumourigenicity, Antagonizes Wnt Signalling and Regulates Cell Adhesion in Colorectal Cancer Cell Lines	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; BETA-CATENIN; COLON-CANCER; STEM-CELLS; MARKER; IDENTIFICATION; EXPRESSION; TARGET; OVEREXPRESSION; INHIBITION	Background: LGR5 (Leucine-rich repeat-containing G-protein coupled receptor 5) is the most established marker for intestinal stem cells. Mouse models show that LGR5+ cells are the cells of origin of intestinal cancer, and LGR5 expression is elevated in human colorectal cancers, however very little is known about LGR5 function or its contribution to the stem cell phenotype and to colorectal cancer. Principal Findings: We have modulated the expression of LGR5 by RNAi (inhibitory RNAs) or overexpression in colorectal cancer cell lines. Paradoxically, ablation of LGR5 induces increased invasion and anchorage-independent growth, and enhances tumourigenicity in xenografts experiments. Conversely, overexpression of LGR5 augments cell adhesion, reduces clonogenicity and attenuates tumourigenicity. Expression profiling revealed enhanced wnt signalling and upregulation of EMT genes upon knockdown of LGR5, with opposite changes in LGR5 overexpressing cells. These findings suggest that LGR5 is important in restricting stem cells to their niche, and that loss of LGR5 concomitant with activated wnt signalling may contribute to the invasive phenotype of colorectal carcinomas.	[Walker, Francesca; Zhang, Hui-Hua; Odorizzi, Annalisa; Burgess, Antony W.] Ludwig Inst Canc Res, Epithelial Biochem Lab, Parkville, Vic, Australia	Ludwig Institute for Cancer Research	Walker, F (corresponding author), Ludwig Inst Canc Res, Epithelial Biochem Lab, Parkville, Vic, Australia.	Francesca.walker@ludwig.edu.au			NHMRC [487922]; Pezcoller Foundation, Trento, Italy; Victorian Government	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Pezcoller Foundation, Trento, Italy; Victorian Government	This project was partially funded by NHMRC Program Grant number 487922. Funding support for AO was also provided by the Pezcoller Foundation, Trento, Italy. This work was also supported by the Operational Infrastructure Support Program provided by the Victorian Government. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alison MR, 2011, J PATHOL, V223, P147, DOI 10.1002/path.2793; ANDREW SM, 1990, CANCER RES, V50, P5225; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Behrens J, 2005, BIOCHEM SOC T, V33, P672, DOI 10.1042/BST0330672; Brabletz T, 1999, AM J PATHOL, V155, P1033, DOI 10.1016/S0002-9440(10)65204-2; Carpentino JE, 2009, CANCER RES, V69, P8208, DOI 10.1158/0008-5472.CAN-09-1132; CHEN YS, 2010, MOL CELL PROTEOMICS; Chen Z, 2009, J ONCOL, V2009, DOI 10.1155/2009/894064; Chu P, 2009, INT J CANCER, V124, P1312, DOI 10.1002/ijc.24061; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; DasGupta R, 1999, DEVELOPMENT, V126, P4557; De Langhe SP, 2005, DEV BIOL, V277, P316, DOI 10.1016/j.ydbio.2004.09.023; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; Donnenberg VS, 2005, J CLIN PHARMACOL, V45, P872, DOI 10.1177/0091270005276905; Elsaba TMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010714; ESSERS MA, MOL ONCOL, V4, P443; Fan LF, 2010, INT J COLORECTAL DIS, V25, P17, DOI 10.1007/s00384-009-0791-2; Fan XS, 2010, INT J COLORECTAL DIS, V25, P583, DOI 10.1007/s00384-010-0903-z; Garcia MI, 2009, DEV BIOL, V331, P58, DOI 10.1016/j.ydbio.2009.04.020; Hlubek F, 2007, INT J CANCER, V121, P1941, DOI 10.1002/ijc.22916; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Howe LR, 2003, CANCER RES, V63, P1906; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Jordan CT, 2004, CURR OPIN CELL BIOL, V16, P708, DOI 10.1016/j.ceb.2004.09.002; Kayahara T, 2003, FEBS LETT, V535, P131, DOI 10.1016/S0014-5793(02)03896-6; Kratochwil K, 2002, GENE DEV, V16, P3173, DOI 10.1101/gad.1035602; Kremerskothen J, 2011, FASEB J, V25, P505, DOI 10.1096/fj.10-155598; Levin TG, 2010, GASTROENTEROLOGY, V139, P2072, DOI 10.1053/j.gastro.2010.08.053; Lewis A, 2010, GUT, V59, P1680, DOI 10.1136/gut.2009.193680; Li DW, 2010, J CANCER RES CLIN, V136, P997, DOI 10.1007/s00432-009-0745-7; McClanahan T, 2006, CANCER BIOL THER, V5, P419, DOI 10.4161/cbt.5.4.2521; McDonald T, 1998, BIOCHEM BIOPH RES CO, V247, P266, DOI 10.1006/bbrc.1998.8774; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Morita H, 2004, MOL CELL BIOL, V24, P9736, DOI 10.1128/MCB.24.22.9736-9743.2004; Nishimura S, 2003, DIGEST DIS SCI, V48, P1523, DOI 10.1023/A:1024763723240; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Potten CS, 2003, DIFFERENTIATION, V71, P28, DOI 10.1046/j.1432-0436.2003.700603.x; Rahmani M, 2005, J BIOL CHEM, V280, P13019, DOI 10.1074/jbc.M411766200; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rottiers P, 2009, J CELL SCI, V122, P4311, DOI 10.1242/jcs.057448; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schneikert J, 2007, GUT, V56, P417, DOI 10.1136/gut.2006.093310; Sun XF, 2009, ENDOCRINOLOGY, V150, P5065, DOI 10.1210/en.2009-0690; Sureban SM, 2008, GASTROENTEROLOGY, V134, P1448, DOI 10.1053/j.gastro.2008.02.057; Tago K, 2000, GENE DEV, V14, P1741; Taneyhill Lisa, 2004, BMC Developmental Biology, V4; ten Berge D, 2008, CELL STEM CELL, V3, P508, DOI 10.1016/j.stem.2008.09.013; Timmins Nicholas E., 2004, Angiogenesis, V7, P97, DOI 10.1007/s10456-004-8911-7; Todaro M, 2010, GASTROENTEROLOGY, V138, P2151, DOI 10.1053/j.gastro.2009.12.063; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; UCHIDA H, CANC SCI, V101, P1731; Uchida H, 2010, CANCER SCI, V101, P1731, DOI 10.1111/j.1349-7006.2010.01571.x; van den Brink GR, 2007, CANCER CELL, V11, P109, DOI 10.1016/j.ccr.2007.01.003; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; Van Goethem E, 2011, EUR J CELL BIOL, V90, P224, DOI 10.1016/j.ejcb.2010.07.011; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; WHITEHEAD RH, 1985, JNCI-J NATL CANCER I, V74, P759; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8; Xu LF, 2000, GENE DEV, V14, P585; Yamamoto Y, 2003, HEPATOLOGY, V37, P528, DOI 10.1053/jhep.2003.50029; Zhang HH, 2009, INT J CANCER, V125, P297, DOI 10.1002/ijc.24289	65	101	121	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22733	10.1371/journal.pone.0022733	http://dx.doi.org/10.1371/journal.pone.0022733			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829496	Green Published, gold			2022-12-25	WOS:000293284600036
J	Work, TM; Forsman, ZH; Szabo, Z; Lewis, TD; Aeby, GS; Toonen, RJ				Work, Thierry M.; Forsman, Zac H.; Szabo, Zoltan; Lewis, Teresa D.; Aeby, Greta S.; Toonen, Robert J.			Inter-Specific Coral Chimerism: Genetically Distinct Multicellular Structures Associated with Tissue Loss in Montipora capitata	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; GERM-CELL PARASITISM; WHITE SYNDROME; ALLORECOGNITION; CONSEQUENCES; MORTALITY; EVOLUTION; HYDROZOAN; DISEASE; LESIONS	Montipora white syndrome (MWS) results in tissue-loss that is often lethal to Montipora capitata, a major reef building coral that is abundant and dominant in the Hawai'ian Archipelago. Within some MWS-affected colonies in Kane'ohe Bay, Oahu, Hawai'i, we saw unusual motile multicellular structures within gastrovascular canals (hereafter referred to as invasive gastrovascular multicellular structure-IGMS) that were associated with thinning and fragmentation of the basal body wall. IGMS were in significantly greater densities in coral fragments manifesting tissue-loss compared to paired normal fragments. Mesenterial filaments from these colonies yielded typical M. capitata mitochondrial haplotypes (CO1, CR), while IGMS from the same colony consistently yielded distinct haplotypes previously only found in a different Montipora species (Montipora flabellata). Protein profiles showed consistent differences between paired mesenterial filaments and IGMS from the same colonies as did seven microsatellite loci that also exhibited an excess of alleles per locus inconsistent with a single diploid organism. We hypothesize that IGMS are a parasitic cellular lineage resulting from the chimeric fusion between M. capitata and M. flabellata larvae followed by morphological reabsorption of M. flabellata and subsequent formation of cell-lineage parasites. We term this disease Montiporaiasis. Although intra-specific chimerism is common in colonial animals, this is the first suspected inter-specific example and the first associated with tissue loss.	[Work, Thierry M.] US Geol Survey, Honolulu Field Stn, Natl Wildlife Hlth Ctr, Honolulu, HI USA; [Work, Thierry M.; Forsman, Zac H.; Szabo, Zoltan; Aeby, Greta S.; Toonen, Robert J.] Hawaii Inst Marine Biol, Kaneohe, HI USA; [Lewis, Teresa D.] US Fish & Wildlife Serv, Dexter Fish Hlth Unit, Dexter Natl Fish Hatchery & Technol Ctr, Dexter, NM USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service	Work, TM (corresponding author), US Geol Survey, Honolulu Field Stn, Natl Wildlife Hlth Ctr, Honolulu, HI USA.	thierry_work@usgs.gov	Work, Thierry M/F-1550-2015; Toonen, Rob/K-2891-2012; Toonen, Rob/V-6230-2019; Forsman, Zac/F-1266-2015	Work, Thierry M/0000-0002-4426-9090; Toonen, Rob/0000-0001-6339-4340; Toonen, Rob/0000-0001-6339-4340; Forsman, Zac/0000-0002-5837-3614	United States Geological Survey; Hawaii Institute of Marine Biology (HIMB) [1455]; School of Ocean and Earth Science Technology [8214]; National Oceanic and Atmospheric Administration National Marine Sanctuaries Partnership [2005-008/66882]; National Science Foundation [06-23678]	United States Geological Survey(United States Geological Survey); Hawaii Institute of Marine Biology (HIMB); School of Ocean and Earth Science Technology; National Oceanic and Atmospheric Administration National Marine Sanctuaries Partnership; National Science Foundation(National Science Foundation (NSF))	This project was funded in part by the United States Geological Survey (www.usgs.gov) and the Hawaii Institute of Marine Biology (HIMB) (http://www.hawaii.edu/himb/) HIMB contribution No. 1455 and School of Ocean and Earth Science Technology contribution No. 8214. ZHF, ZS and GSA were supported by a fellowship from the National Oceanic and Atmospheric Administration National Marine Sanctuaries Partnership MOA# 2005-008/66882, and DNA extraction and sequencing costs were supported by National Science Foundation OCE# 06-23678 to RJT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antonius A., 1981, P 4 INT COR REEF S M, V2, P3; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Barki Y, 2002, MAR ECOL PROG SER, V231, P91, DOI 10.3354/meps231091; CHADWICKFURMAN NE, 1995, P ROY SOC B-BIOL SCI, V262, P157, DOI 10.1098/rspb.1995.0190; Concepcion GT, 2010, CONSERV GENET RESOUR, V2, P11, DOI 10.1007/s12686-009-9118-4; CONCEPCION GT, 2009, MOL INSIGHTS CORAL C; CUNNINGHAM CW, 1993, BIOCHEM SYST ECOL, V21, P57, DOI 10.1016/0305-1978(93)90009-G; Denner EBM, 2003, INT J SYST EVOL MICR, V53, P1115, DOI 10.1099/ijs.0.02359-0; DRUMMOND AJ, 2009, GENEIOUS V4 7; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ENDEAN R, 1982, ENDEAVOUR, V6, P10, DOI 10.1016/0160-9327(82)90004-7; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Forsman ZH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015021; Frank U, 1997, P ROY SOC B-BIOL SCI, V264, P99, DOI 10.1098/rspb.1997.0015; Frias-Lopez J, 2002, APPL ENVIRON MICROB, V68, P2214, DOI 10.1128/AEM.68.5.2214-2228.2002; Grosberg RK, 1996, EVOLUTION, V50, P2221, DOI 10.1111/j.1558-5646.1996.tb03612.x; GROSBERG RK, 1986, NATURE, V322, P456, DOI 10.1038/322456a0; Hart MW, 1999, EVOLUTION, V53, P793, DOI 10.1111/j.1558-5646.1999.tb05373.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUGHES TP, 1980, SCIENCE, V209, P713, DOI 10.1126/science.209.4457.713; HYMAN LH, 1940, INVERTEBRATES PROTOZ; Jokiel Paul L., 2004, Pacific Science, V58, P159, DOI 10.1353/psc.2004.0018; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARCOTRIGIANO M, 1984, ANN BOT-LONDON, V54, P513, DOI 10.1093/oxfordjournals.aob.a086821; MCDOWELL EM, 1976, ARCH PATHOL LAB MED, V100, P405; PANCER Z, 1995, BIOL BULL, V189, P106, DOI 10.2307/1542460; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; Pineda-Krch M, 2004, J EVOLUTION BIOL, V17, P1167, DOI 10.1111/j.1420-9101.2004.00808.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Price P W, 1980, Monogr Popul Biol, V15, P1; Puill-Stephan E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007751; Raymundo L, 2008, CORAL DIS HDB GUIDEL, P17; Raymundo LJ, 2004, ECOL APPL, V14, P281, DOI 10.1890/02-5373; Rinkevich B, 2004, J EXP BIOL, V207, P3531, DOI 10.1242/jeb.01184; RINKEVICH B, 1992, OIKOS, V63, P119, DOI 10.2307/3545520; ROSSANT J, 1983, J EXP ZOOL, V228, P223, DOI 10.1002/jez.1402280208; SAMMARCO PW, 1982, MAR ECOL PROG SER, V10, P57, DOI 10.3354/meps010057; Santelices B, 2004, J EVOLUTION BIOL, V17, P1187, DOI 10.1111/j.1420-9101.2004.00813.x; SHENK MA, 1991, J EXP ZOOL, V257, P80, DOI 10.1002/jez.1402570111; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stoner DS, 1996, P NATL ACAD SCI USA, V93, P15254, DOI 10.1073/pnas.93.26.15254; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TURNER SJ, 1994, OCEANOGR MAR BIOL, V32, P461; van Oppen MJH, 2004, MAR BIOL, V144, P9, DOI 10.1007/s00227-003-1188-3; Weil E, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P465, DOI 10.1007/978-94-007-0114-4_27; Williams GJ, 2011, J INVERTEBR PATHOL, V106, P165, DOI 10.1016/j.jip.2010.08.002; Wilson ACC, 2004, BEHAV ECOL SOCIOBIOL, V57, P40, DOI 10.1007/s00265-004-0831-4; Work TM, 2006, DIS AQUAT ORGAN, V70, P155, DOI 10.3354/dao070155; Work TM, 2011, J INVERTEBR PATHOL, V107, P127, DOI 10.1016/j.jip.2011.03.009; Work TM, 2005, CORAL REEFS, V24, P384, DOI 10.1007/s00338-005-0018-0; ZOUROS E, 1992, NATURE, V359, P412, DOI 10.1038/359412a0; Zouros E, 2000, GENES GENET SYST, V75, P313, DOI 10.1266/ggs.75.313	56	23	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22869	10.1371/journal.pone.0022869	http://dx.doi.org/10.1371/journal.pone.0022869			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829541	gold, Green Published			2022-12-25	WOS:000293284600060
J	Woycicki, R; Witkowicz, J; Gawronski, P; Dabrowska, J; Lomsadze, A; Pawelkowicz, M; Siedlecka, E; Yagi, K; Plader, W; Seroczynska, A; Smiech, M; Gutman, W; Niemirowicz-Szczytt, K; Bartoszewski, G; Tagashira, N; Hoshi, Y; Borodovsky, M; Karpinski, S; Malepszy, S; Przybecki, Z				Woycicki, Rafal; Witkowicz, Justyna; Gawronski, Piotr; Dabrowska, Joanna; Lomsadze, Alexandre; Pawelkowicz, Magdalena; Siedlecka, Ewa; Yagi, Kohei; Plader, Wojciech; Seroczynska, Anna; Smiech, Mieczyslaw; Gutman, Wojciech; Niemirowicz-Szczytt, Katarzyna; Bartoszewski, Grzegorz; Tagashira, Norikazu; Hoshi, Yoshikazu; Borodovsky, Mark; Karpinski, Stanislaw; Malepszy, Stefan; Przybecki, Zbigniew			The Genome Sequence of the North-European Cucumber (Cucumis sativus L.) Unravels Evolutionary Adaptation Mechanisms in Plants	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; BAC LIBRARY; ARABIDOPSIS-THALIANA; SOMATIC EMBRYOGENESIS; CHROMOSOMAL REARRANGEMENTS; SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL GENOME; REGULATORY-ELEMENTS; EUKARYOTIC GENOMES; GENE PREDICTION	Cucumber (Cucumis sativus L.), a widely cultivated crop, has originated from Eastern Himalayas and secondary domestication regions includes highly divergent climate conditions e. g. temperate and subtropical. We wanted to uncover adaptive genome differences between the cucumber cultivars and what sort of evolutionary molecular mechanisms regulate genetic adaptation of plants to different ecosystems and organism biodiversity. Here we present the draft genome sequence of the Cucumis sativus genome of the North-European Borszczagowski cultivar (line B10) and comparative genomics studies with the known genomes of: C. sativus (Chinese cultivar - Chinese Long (line 9930)), Arabidopsis thaliana, Populus trichocarpa and Oryza sativa. Cucumber genomes show extensive chromosomal rearrangements, distinct differences in quantity of the particular genes (e. g. involved in photosynthesis, respiration, sugar metabolism, chlorophyll degradation, regulation of gene expression, photooxidative stress tolerance, higher non-optimal temperatures tolerance and ammonium ion assimilation) as well as in distributions of abscisic acid-, dehydration- and ethylene-responsive cis-regulatory elements (CREs) in promoters of orthologous group of genes, which lead to the specific adaptation features. Abscisic acid treatment of non-acclimated Arabidopsis and C. sativus seedlings induced moderate freezing tolerance in Arabidopsis but not in C. sativus. This experiment together with analysis of abscisic acid-specific CRE distributions give a clue why C. sativus is much more susceptible to moderate freezing stresses than A. thaliana. Comparative analysis of all the five genomes showed that, each species and/or cultivars has a specific profile of CRE content in promoters of orthologous genes. Our results constitute the substantial and original resource for the basic and applied research on environmental adaptations of plants, which could facilitate creation of new crops with improved growth and yield in divergent conditions.	[Woycicki, Rafal; Witkowicz, Justyna; Gawronski, Piotr; Dabrowska, Joanna; Pawelkowicz, Magdalena; Siedlecka, Ewa; Yagi, Kohei; Plader, Wojciech; Seroczynska, Anna; Smiech, Mieczyslaw; Gutman, Wojciech; Niemirowicz-Szczytt, Katarzyna; Bartoszewski, Grzegorz; Karpinski, Stanislaw; Malepszy, Stefan; Przybecki, Zbigniew] Warsaw Univ Life Sci SGGW, Dept Plant Genet Breeding & Biotechnol, Fac Hort & Landscape Architecture, Warsaw, Poland; [Lomsadze, Alexandre; Borodovsky, Mark] Georgia Inst Technol, Ctr Bioinformat & Computat Genom, Joint Wallace H Coulter Georgia Tech & Emory Dept, Sch Computat Sci & Engn, Atlanta, GA 30332 USA; [Tagashira, Norikazu] Hiroshima Jogakuin Univ, Dept Living Design & Informat Sci, Fac Human Dev, Higashi Ku, Hiroshima, Japan; [Hoshi, Yoshikazu] Tokai Univ, Dept Plant Sci, Kumamoto, Japan	Warsaw University of Life Sciences; University System of Georgia; Georgia Institute of Technology; Tokai University	Woycicki, R (corresponding author), Warsaw Univ Life Sci SGGW, Dept Plant Genet Breeding & Biotechnol, Fac Hort & Landscape Architecture, Warsaw, Poland.	rafalwoycicki@gmail.com; stanislaw_karpinski@sggw.pl; zbigniew_przybecki@sggw.pl	Bartoszewski, Grzegorz/B-2211-2012; Bartoszewski, Grzegorz/ACU-0775-2022; Woycicki, Rafal/P-4973-2019; Karpiński, Stanisław/ABE-1644-2021; Karpinski, Stanislaw/ABD-9543-2021; Woycicki, Rafal Kazimierz/D-1398-2011; Bartoszewski, Grzegorz/M-8458-2016	Bartoszewski, Grzegorz/0000-0002-6197-770X; Karpinski, Stanislaw/0000-0002-4328-1207; Bartoszewski, Grzegorz/0000-0002-6197-770X; Siedlecka, Ewa/0000-0002-7858-2843; Plader, Wojciech/0000-0002-5666-5269; Dabrowska-Bronk, Joanna/0000-0002-4924-6330; Woycicki, Rafal/0000-0001-7991-7150; Pawelkowicz, Magdalena/0000-0002-1621-8886; Gawronski, Piotr/0000-0002-9773-3109	Polish Ministry of Science and Higher Education [PZB-MNiSW-2/3/2006/36, PZB-MNiSW-2/3/2006, NN302429734, NN302363333]; Foundation for Polish Science [2008/1]; European Regional Development Fund; U.S. National Institutes of Health [GM47853]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R55GM047853] Funding Source: NIH RePORTER	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); European Regional Development Fund(European Commission); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been funded by grants from the Polish Ministry of Science and Higher Education: PZB-MNiSW-2/3/2006/36 (representing part of grant PZB-MNiSW-2/3/2006), NN302429734, NN302363333, Welcome 2008/1 - a project operated within the Foundation for Polish Science Welcome Program and co-financed by the European Regional Development Fund, and U.S. National Institutes of Health grant GM47853. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ammiraju JSS, 2006, GENOME RES, V16, P140, DOI 10.1101/gr.3766306; Antonov Ivan, 2010, Journal of Bioinformatics and Computational Biology, V8, P535, DOI 10.1142/S0219720010004847; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bartoszewski G, 2007, J APPL GENET, V48, P1, DOI 10.1007/BF03194652; Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Bloom AJ, 2002, P NATL ACAD SCI USA, V99, P1730, DOI 10.1073/pnas.022627299; Bloom AJ, 2010, SCIENCE, V328, P899, DOI 10.1126/science.1186440; Cavagnaro PF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-569; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Colson I, 2004, EMBO REP, V5, P392, DOI 10.1038/sj.embor.7400123; Coyle S, 2008, MOL BIOL EVOL, V25, P310, DOI 10.1093/molbev/msm256; CULLIS CA, 1987, AM NAT, V130, P62; Dalloul RA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000475; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Delker C, 2010, PLANT CELL, V22, P2184, DOI 10.1105/tpc.110.073957; DiGuistini S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r94; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Eck SH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r82; Farrer RA, 2009, FEMS MICROBIOL LETT, V291, P103, DOI 10.1111/j.1574-6968.2008.01441.x; Filipecki M, 2005, PLANT CELL TISS ORG, V82, P349, DOI 10.1007/s11240-005-2585-8; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Geisler M, 2006, PLANT J, V45, P384, DOI 10.1111/j.1365-313X.2005.02634.x; Goldberg SMD, 2006, P NATL ACAD SCI USA, V103, P11240, DOI 10.1073/pnas.0604351103; Grabowska A, 2009, J PLANT PHYSIOL, V166, P310, DOI 10.1016/j.jplph.2008.06.005; Guan Y, 2008, PROG NAT SCI, V18, P143, DOI 10.1016/j.pnsc.2007.10.001; Gutman W, 2008, CELL MOL BIOL LETT, V13, P74, DOI 10.2478/s11658-007-0038-6; Guzowska-Nowowiejska M, 2009, GENE, V434, P1, DOI 10.1016/j.gene.2008.12.017; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; Han YH, 2008, CYTOGENET GENOME RES, V122, P80, DOI 10.1159/000151320; Hanikenne M, 2008, NATURE, V453, P391, DOI 10.1038/nature06877; Havey MJ, 1997, J HERED, V88, P232, DOI 10.1093/oxfordjournals.jhered.a023094; Hong YS, 2003, MOL GENET GENOMICS, V268, P720, DOI 10.1007/s00438-003-0813-7; Hoshi Y, 1998, PLANT BREEDING, V117, P77, DOI 10.1111/j.1439-0523.1998.tb01452.x; Howarth KD, 2011, GENOME RES, V21, P525, DOI 10.1101/gr.114116.110; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Jacobs G, 2009, GENETICA, V135, P157, DOI 10.1007/s10709-008-9265-7; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Jaglo-Ottosen KR, 1998, SCIENCE, V280, P104, DOI 10.1126/science.280.5360.104; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kasprzak A, 2006, CELL MOL BIOL LETT, V11, P396, DOI 10.2478/s11658-006-0033-3; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kidd JM, 2010, CELL, V143, P837, DOI 10.1016/j.cell.2010.10.027; Kislyuk Andrey, 2009, Int J Bioinform Res Appl, V5, P458, DOI 10.1504/IJBRA.2009.027519; Koussevitzky S, 2007, SCIENCE, V316, P715, DOI 10.1126/science. 1140516; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lacombe E, 2008, PLANT SCI, V174, P634, DOI 10.1016/j.plantsci.2008.03.020; Ladyzynski M, 2002, EUPHYTICA, V125, P349, DOI 10.1023/A:1016017825907; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liang HY, 2007, TREE GENET GENOMES, V3, P215, DOI 10.1007/s11295-006-0057-x; Lomsadze A, 2005, NUCLEIC ACIDS RES, V33, P6494, DOI 10.1093/nar/gki937; MALEPSZY S, 1991, PLANT SCI, V80, P39, DOI 10.1016/0168-9452(91)90271-9; Malinowski R, 2004, PHYSIOL PLANTARUM, V120, P678, DOI 10.1111/j.0031-9317.2004.0289.x; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McCarthy FM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-229; McCourt P, 2008, CURR OPIN PLANT BIOL, V11, P474, DOI 10.1016/j.pbi.2008.06.014; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Muhlenbock P, 2008, PLANT CELL, V20, P2339, DOI 10.1105/tpc.108.059618; Muhlenbock P, 2007, PLANT CELL, V19, P3819, DOI 10.1105/tpc.106.048843; Nam YW, 2005, THEOR APPL GENET, V111, P150, DOI 10.1007/s00122-005-2007-7; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; Ouyang S, 2004, NUCLEIC ACIDS RES, V32, pD360, DOI 10.1093/nar/gkh099; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; PLADER W, 2009, N BIOTECHNOL 1, V25; Plader W, 2007, CELL MOL BIOL LETT, V12, P584, DOI 10.2478/s11658-007-0029-7; Przybecki Z, 2004, CELL MOL BIOL LETT, V9, P919; Przybecki Z, 2003, CELL MOL BIOL LETT, V8, P421; Quinn NL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-404; Ragu S, 2007, P NATL ACAD SCI USA, V104, P9747, DOI 10.1073/pnas.0703192104; Reinhardt JA, 2009, GENOME RES, V19, P294, DOI 10.1101/gr.083311.108; Ren Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005795; Rossel JB, 2007, PLANT CELL, V19, P4091, DOI 10.1105/tpc.106.045898; Rounsley S, 2009, RICE, V2, P35, DOI 10.1007/s12284-009-9025-z; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Schmid KJ, 2003, GENOME RES, V13, P1250, DOI 10.1101/gr.728603; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Sebastian P, 2010, P NATL ACAD SCI USA, V107, P14269, DOI 10.1073/pnas.1005338107; Seliverstov AV, 2009, RUSS J PLANT PHYSL+, V56, P838, DOI 10.1134/S1021443709060144; Shi BJ, 2009, THEOR APPL GENET, V119, P695, DOI 10.1007/s00122-009-1080-8; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Staub JE, 1999, GENET RESOUR CROP EV, V46, P297, DOI 10.1023/A:1008663225896; Sun S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005524; Swanson-Wagner RA, 2010, GENOME RES, V20, P1689, DOI 10.1101/gr.109165.110; Szechynska-Hebda M, 2010, PLANT CELL, V22, P2201, DOI 10.1105/tpc.109.069302; Ter-Hovhannisyan V, 2008, GENOME RES, V18, P1979, DOI 10.1101/gr.081612.108; Tirosh I, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100198; Tomkins J. P., 2002, Genetics and Molecular Research, V1, P306; Tuch BB, 2008, PLOS BIOL, V6, P352, DOI 10.1371/journal.pbio.0060038; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Walter NAR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-379; WARD BL, 1981, CELL, V25, P793, DOI 10.1016/0092-8674(81)90187-2; Wei CC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-327; Weirauch MT, 2010, TRENDS GENET, V26, P66, DOI 10.1016/j.tig.2009.12.002; Wheat CW, 2010, GENETICA, V138, P433, DOI 10.1007/s10709-008-9326-y; Wicker T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-275; Winters A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-94; Wirgin I, 2011, SCIENCE, V331, P1322, DOI 10.1126/science.1197296; Witkowicz J, 2003, CELL MOL BIOL LETT, V8, P375; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; WOYCICKI R, 2009, NATURE, DOI DOI 10.1038/NPRE.2009.3900.1; Wu CH, 2003, NUCLEIC ACIDS RES, V31, P345, DOI 10.1093/nar/gkg040; Wu FN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-182; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yamasaki S, 2010, J RADIAT RES, V51, P187, DOI 10.1269/jrr.09101; Yasuda M, 2008, PLANT CELL, V20, P1678, DOI 10.1105/tpc.107.054296; Yogeeswaran K, 2005, GENOME RES, V15, P505, DOI 10.1101/gr.3436305; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zhang X, 2004, PLANT J, V39, P905, DOI 10.1111/j.1365-313X.2004.02176.x; Zhao X, 2011, J GENET GENOMICS, V38, P39, DOI 10.1016/j.jcg.2010.12.005; Zharkikh A, 2008, J BIOTECHNOL, V136, P38, DOI 10.1016/j.jbiotec.2008.04.013; Zimin AV, 2008, BIOINFORMATICS, V24, P42, DOI 10.1093/bioinformatics/btm542; Ziolkowska A, 2005, PLANT CELL TISS ORG, V80, P329, DOI 10.1007/s11240-004-2107-0	123	82	88	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22728	10.1371/journal.pone.0022728	http://dx.doi.org/10.1371/journal.pone.0022728			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829493	Green Published, gold, Green Submitted			2022-12-25	WOS:000293284600033
J	Cheng, G; Liu, L; Wang, PH; Zhang, Y; Zhao, YO; Colpitts, TM; Feitosa, F; Anderson, JF; Fikrig, E				Cheng, Gong; Liu, Lei; Wang, Penghua; Zhang, Yue; Zhao, Yang O.; Colpitts, Tonya M.; Feitosa, Fabiana; Anderson, John F.; Fikrig, Erol			An In Vivo Transfection Approach Elucidates a Role for Aedes aegypti Thioester-Containing Proteins in Flaviviral Infection	PLOS ONE			English	Article							WEST NILE VIRUS; ANOPHELES-GAMBIAE; RNA INTERFERENCE; COMPLEMENT; MOSQUITOS; MALARIA; PLASMODIUM; EXPRESSION; PARASITES	Mosquitoes transmit pathogens that cause infectious diseases of global importance. Techniques to easily introduce genes into mosquitoes, however, limit investigations of the interaction between microbes and their arthropod vectors. We now show that a cationic liposome significantly enhances delivery and expression of plasmid DNA in Aedes aegypti and Anopheles gambiae mosquitoes. We then introduced the genes for Ae. aegypti thioester-containing proteins (AeTEPs), which are involved in the control of flaviviral infection, into mosquitoes using this technique. In vivo transfection of AeTEP-1 into Ae. aegypti significantly reduced dengue virus infection, suggesting that the approach can further our understanding of pathogen-mosquito interactions.	[Cheng, Gong; Liu, Lei; Wang, Penghua; Zhang, Yue; Zhao, Yang O.; Colpitts, Tonya M.; Feitosa, Fabiana; Fikrig, Erol] Yale Univ Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06511 USA; [Anderson, John F.] Connecticut Agr Expt Stn, Dept Entomol, New Haven, CT 06504 USA; [Fikrig, Erol] Howard Hughes Med Inst, Chevy Chase, MD USA	Yale University; Connecticut Agricultural Experiment Station; Howard Hughes Medical Institute	Cheng, G (corresponding author), Yale Univ Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06511 USA.	erol.fikrig@yale.edu	wang, Penghua/AAL-4011-2020; Liu, Lei/C-2725-2012	Colpitts, Tonya/0000-0003-3915-1554	Northeast Biodefense Center [U54-AI057158-Lipkin]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER	Northeast Biodefense Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	E. F. is an investigator with the Howard Hughes Medical Institute. G. C. is a James Hudson Brown-Alexander Brown Coxe Postdoctoral Fellow in Yale School of Medicine. P. W. is supported by a Career Development Award from Northeast Biodefense Center (U54-AI057158-Lipkin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation. of the manuscript.	Adelman ZN, 2002, MOL BIOCHEM PARASIT, V121, P1, DOI 10.1016/S0166-6851(02)00028-2; Anderson JF, 1999, SCIENCE, V286, P2331, DOI 10.1126/science.286.5448.2331; Avirutnan P, 2008, VACCINE, V26, pI100, DOI 10.1016/j.vaccine.2008.11.061; Baxter RHG, 2007, P NATL ACAD SCI USA, V104, P11615, DOI 10.1073/pnas.0704967104; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Blandin SA, 2009, SCIENCE, V326, P147, DOI 10.1126/science.1175241; Brackney DE, 2008, AM J TROP MED HYG, V79, P267, DOI 10.4269/ajtmh.2008.79.267; Cheng G, 2010, CELL, V142, P714, DOI 10.1016/j.cell.2010.07.038; Coleman Judy, 2007, J Vis Exp, P228, DOI 10.3791/228; Cummings KL, 2007, VIRAL IMMUNOL, V20, P505, DOI 10.1089/vim.2007.0061; Endo Y, 2006, IMMUNOBIOLOGY, V211, P283, DOI 10.1016/j.imbio.2006.01.003; Fradin MS, 1998, ANN INTERN MED, V128, P931, DOI 10.7326/0003-4819-128-11-199806010-00013; Goffin W, 2005, NUCLEIC ACIDS RES, V33, P4285, DOI 10.1093/nar/gki720; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Hoffman SL, 2002, NATURE, V415, P702, DOI 10.1038/415702a; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Isoe J, 2007, INSECT MOL BIOL, V16, P83, DOI 10.1111/j.1365-2583.2006.00704.x; Jansen CC, 2010, MICROBES INFECT, V12, P272, DOI 10.1016/j.micinf.2009.12.011; Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101; Lu YPE, 2001, J VIROL, V75, P8329, DOI 10.1128/JVI.75.17.8329-8339.2001; Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0; Moreira LA, 2002, INT J PARASITOL, V32, P1599, DOI 10.1016/S0020-7519(02)00188-1; MORRIS AC, 1995, AM J TROP MED HYG, V52, P456, DOI 10.4269/ajtmh.1995.52.456; NIR Y, 1968, AM J EPIDEMIOL, V87, P496, DOI 10.1093/oxfordjournals.aje.a120839; Parsons BD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008471; Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400; Sledz CA, 2004, BIOCHEM SOC T, V32, P952, DOI 10.1042/BST0320952; Turell MJ, 2000, AM J TROP MED HYG, V62, P413, DOI 10.4269/ajtmh.2000.62.413; Vanlandingham DL, 2007, AM J TROP MED HYG, V77, P925, DOI 10.4269/ajtmh.2007.77.925; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098	31	30	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22786	10.1371/journal.pone.0022786	http://dx.doi.org/10.1371/journal.pone.0022786			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818390	Green Published, gold, Green Submitted			2022-12-25	WOS:000293282700076
J	Goldberg, CS; Pilliod, DS; Arkle, RS; Waits, LP				Goldberg, Caren S.; Pilliod, David S.; Arkle, Robert S.; Waits, Lisette P.			Molecular Detection of Vertebrates in Stream Water: A Demonstration Using Rocky Mountain Tailed Frogs and Idaho Giant Salamanders	PLOS ONE			English	Article							BIODIVERSITY; ECOSYSTEM	Stream ecosystems harbor many secretive and imperiled species, and studies of vertebrates in these systems face the challenges of relatively low detection rates and high costs. Environmental DNA (eDNA) has recently been confirmed as a sensitive and efficient tool for documenting aquatic vertebrates in wetlands and in a large river and canal system. However, it was unclear whether this tool could be used to detect low-density vertebrates in fast-moving streams where shed cells may travel rapidly away from their source. To evaluate the potential utility of eDNA techniques in stream systems, we designed targeted primers to amplify a short, species-specific DNA fragment for two secretive stream amphibian species in the northwestern region of the United States (Rocky Mountain tailed frogs, Ascaphus montanus, and Idaho giant salamanders, Dicamptodon aterrimus). We tested three DNA extraction and five PCR protocols to determine whether we could detect eDNA of these species in filtered water samples from five streams with varying densities of these species in central Idaho, USA. We successfully amplified and sequenced the targeted DNA regions for both species from stream water filter samples. We detected Idaho giant salamanders in all samples and Rocky Mountain tailed frogs in four of five streams and found some indication that these species are more difficult to detect using eDNA in early spring than in early fall. While the sensitivity of this method across taxa remains to be determined, the use of eDNA could revolutionize surveys for rare and invasive stream species. With this study, the utility of eDNA techniques for detecting aquatic vertebrates has been demonstrated across the majority of freshwater systems, setting the stage for an innovative transformation in approaches for aquatic research.	[Goldberg, Caren S.; Waits, Lisette P.] Univ Idaho, Moscow, ID 83843 USA; [Pilliod, David S.; Arkle, Robert S.] US Geol Survey, Forest & Rangeland Ecosystem Sci Ctr, Boise, ID USA	Idaho; University of Idaho; United States Department of the Interior; United States Geological Survey	Goldberg, CS (corresponding author), Univ Idaho, Moscow, ID 83843 USA.	cgoldberg@vandals.uidaho.edu	Goldberg, Caren S/B-4075-2015; Pilliod, David/D-1782-2013	Pilliod, David/0000-0003-4207-3518; Waits, Lisette/0000-0002-1323-0812	United States Geological Survey Amphibian and Reptile Monitoring Initiative	United States Geological Survey Amphibian and Reptile Monitoring Initiative(United States Geological Survey)	Funding was provided by the United States Geological Survey Amphibian and Reptile Monitoring Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkle RS, 2010, FOREST ECOL MANAG, V259, P893, DOI 10.1016/j.foreco.2009.11.029; Bayley PB, 2001, T AM FISH SOC, V130, P620, DOI 10.1577/1548-8659(2001)130<0620:AATEPO>2.0.CO;2; BOHLIN T, 1989, HYDROBIOLOGIA, V173, P9, DOI 10.1007/BF00008596; Carstens BC, 2005, MOL ECOL, V14, P255, DOI 10.1111/j.1365-294X.2004.02404.x; Chadwick MA, 2006, ECOL APPL, V16, P1796, DOI 10.1890/1051-0761(2006)016[1796:UASEFB]2.0.CO;2; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; HILL WR, 1995, ECOLOGY, V76, P1297, DOI 10.2307/1940936; Hines, 2017, OCCUPANCY ESTIMATION; Jackson RB, 2001, ECOL APPL, V11, P1027, DOI 10.1890/1051-0761(2001)011[1027:WIACW]2.0.CO;2; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Lodge DM, 2000, FISHERIES, V25, P7, DOI 10.1577/1548-8446(2000)025<0007:NCTNAF>2.0.CO;2; Lohman K, 2002, INT VER THEOR ANGEW, V28, P802; Lohman K, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P651; Mehta SV, 2007, ECOL ECON, V61, P237, DOI 10.1016/j.ecolecon.2006.10.024; Meyer JL, 1999, J AM WATER RESOUR AS, V35, P1373, DOI 10.1111/j.1752-1688.1999.tb04222.x; Morton B, 1997, ZEBRA MUSSELS AND AQUATIC NUISANCE SPECIES, P1; NEHLSEN W, 1991, FISHERIES, V16, P4, DOI 10.1577/1548-8446(1991)016&lt;0004:PSATCS&gt;2.0.CO;2; Nielson M, 2001, EVOLUTION, V55, P147; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ricciardi A, 1999, CONSERV BIOL, V13, P1220, DOI 10.1046/j.1523-1739.1999.98380.x; Rothberg JM, 2008, NAT BIOTECHNOL, V26, P1117, DOI 10.1038/nbt1485; Ryu C, 2003, MICROBIOL IMMUNOL, V47, P693, DOI 10.1111/j.1348-0421.2003.tb03434.x; Scott Jr N. J., 1994, MEASURING MONITORING, P118; Snyder DE, 2003, REV FISH BIOL FISHER, V13, P445, DOI 10.1007/s11160-004-1095-9; Strayer DL, 2010, J N AM BENTHOL SOC, V29, P344, DOI 10.1899/08-171.1; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Valett HM, 2002, ECOLOGY, V83, P2888, DOI 10.1890/0012-9658(2002)083[2888:SNUFSA]2.0.CO;2; Waits LP, 2005, J WILDLIFE MANAGE, V69, P1419, DOI 10.2193/0022-541X(2005)69[1419:NGSTFW]2.0.CO;2; Whiles MR, 2006, FRONT ECOL ENVIRON, V4, P27, DOI 10.1890/1540-9295(2006)004[0027:TEOAPD]2.0.CO;2	31	296	322	6	258	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e22746	10.1371/journal.pone.0022746	http://dx.doi.org/10.1371/journal.pone.0022746			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21818382	Green Submitted, gold, Green Published			2022-12-25	WOS:000293175100047
J	Kollara, A; Ringuette, MJ; Brown, TJ				Kollara, Alexandra; Ringuette, Maurice J.; Brown, Theodore J.			Dynamic Distribution of Nuclear Coactivator 4 during Mitosis: Association with Mitotic Apparatus and Midbodies	PLOS ONE			English	Article							ANDROGEN RECEPTOR TRANSACTIVATION; COREGULATOR ARA70; PROSTATE-CANCER; CENTROSOME PROTEIN; OVARIAN-CANCER; EXPRESSION; RAN; CELLS; INTERACTS; ALIGNMENT	The cytoplasmic localization of Nuclear Receptor Coactivator 4 (NcoA4), also referred to as androgen receptor associated protein 70 (ARA70), indicates it may possess activities in addition to its role within the nucleus as a transcriptional enhancer. Towards identifying novel functions of NcoA4, we performed an in silico analysis of its amino acid sequence to identify potential functional domains and related proteins, and examined its subcellular distribution throughout the cell cycle. NcoA4 has no known or predicted functional or structural domains with the exception of an LxxLL and FxxLF nuclear receptor interaction motif and an N-terminal putative coiled-coil domain. Phylogenetic analysis indicated that NcoA4 has no paralogs and that a region referred to as ARA70-I family domain, located within the N-terminus and overlapping with the coiled-coil domain, is evolutionarily conserved in metazoans ranging from cnidarians to mammals. An adjacent conserved region, designated ARA70-II family domain, with no significant sequence similarity to the ARA70-I domain, is restricted to vertebrates. We demonstrate NcoA4 co-localizes with microtubules and microtubule organizing centers during prophase. Strong NcoA4 accumulation at the centrosomes was detected during interphase and telophase, with decreased levels at metaphase and anaphase. NcoA4 co-localized with tubulin and acetylated tubulin to the mitotic spindles during metaphase and anaphase, and to midbodies during telophase. Consistent with these observations, we demonstrated an interaction between NcoA4 and alpha-tubulin. Co-localization was not observed with microfilaments. These findings indicate a dynamic distribution of NcoA4 with components of the mitotic apparatus that is consistent with a potential non-transcriptional regulatory function(s) during cell division, which may be evolutionarily conserved.	[Kollara, Alexandra; Brown, Theodore J.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Obstet & Gynecol, Toronto, ON M5G 1X5, Canada; [Ringuette, Maurice J.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Kollara, A (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Obstet & Gynecol, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	brown@lunenfeld.ca	Brown, Theodore J./E-2192-2013	Brown, Theodore J./0000-0002-3074-4516	Natural Sciences and Engineering Research Council of Canada; Norm Hollend Fellowship in Oncology	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Norm Hollend Fellowship in Oncology	This work was funded by grants from the Natural Sciences and Engineering Research Council of Canada. Alexandra Kollara was funded in part by a Norm Hollend Fellowship in Oncology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaoutov A, 2005, CELL CYCLE, V4, P1161, DOI 10.4161/cc.4.9.1979; Arnaoutov A, 2003, DEV CELL, V5, P99, DOI 10.1016/S1534-5807(03)00194-1; Evangelou A, 2000, CANCER RES, V60, P929; Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003; FELSENSTEIN, 1989, CLADISTICS, V5, P164; Gao TS, 1999, MOL ENDOCRINOL, V13, P1645, DOI 10.1210/me.13.10.1645; Harada N, 2008, BIOCHEM BIOPH RES CO, V373, P373, DOI 10.1016/j.bbrc.2008.06.024; Heinlein CA, 2003, ENDOCRINE, V21, P139, DOI 10.1385/ENDO:21:2:139; Heinlein CA, 1999, J BIOL CHEM, V274, P16147, DOI 10.1074/jbc.274.23.16147; Hsiao PW, 1999, J BIOL CHEM, V274, P20229, DOI 10.1074/jbc.274.29.20229; Hu YC, 2004, J BIOL CHEM, V279, P33438, DOI 10.1074/jbc.M401781200; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Kawaguchi S, 2004, MOL BIOL CELL, V15, P37, DOI 10.1091/mbc.E03-03-0191; Keryer G, 2003, MOL BIOL CELL, V14, P4260, DOI 10.1091/mbc.E02-11-0773; Kollara A, 2001, BREAST CANCER RES TR, V67, P245, DOI 10.1023/A:1017938608460; Kollara A, 2006, BIOCHEM BIOPH RES CO, V346, P526, DOI 10.1016/j.bbrc.2006.05.148; Kollara A, 2010, J HISTOCHEM CYTOCHEM, V58, P595, DOI 10.1369/jhc.2010.955294; Lanzino M, 2005, J BIOL CHEM, V280, P20421, DOI 10.1074/jbc.M413576200; Leo C, 2000, GENE, V245, P1, DOI 10.1016/S0378-1119(00)00024-X; Ligr M, 2010, AM J PATHOL, V176, P1891, DOI 10.2353/ajpath.2010.090293; Magklara A, 2002, INT J CANCER, V100, P507, DOI 10.1002/ijc.10520; Peng Y, 2008, AM J PATHOL, V172, P225, DOI 10.2353/ajpath.2008.070065; Peng Y, 2008, APPL IMMUNOHISTO M M, V16, P7, DOI 10.1097/PAI.0b013e31802e91ea; Qutob MS, 2002, MOL CELL BIOL, V22, P6611, DOI 10.1128/MCB.22.18.6611-6626.2002; Salisbury JL, 2003, CURR BIOL, V13, pR88, DOI 10.1016/S0960-9822(03)00033-2; Shaw PA, 2001, GYNECOL ONCOL, V80, P132, DOI 10.1006/gyno.2000.6068; Silverman-Gavrila RV, 2006, MOL BIOL CELL, V17, P2069, DOI 10.1091/mbc.E05-10-0991; Thin TH, 2002, J BIOL CHEM, V277, P36499, DOI 10.1074/jbc.M202824200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ting HJ, 2005, ENDOCRINE, V26, P1, DOI 10.1385/ENDO:26:1:001; Wilde A, 2001, NAT CELL BIOL, V3, P221, DOI 10.1038/35060000; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Yeh SY, 1996, P NATL ACAD SCI USA, V93, P5517, DOI 10.1073/pnas.93.11.5517; Zhang YQ, 2004, MOL CELL BIOL, V24, P1044, DOI 10.1128/MCB.24.3.1044-1057.2004; Zheng PZ, 1998, P NATL ACAD SCI USA, V95, P14745, DOI 10.1073/pnas.95.25.14745; Zhou ZX, 2002, MOL ENDOCRINOL, V16, P287, DOI 10.1210/me.16.2.287; Zhu ML, 2010, CANCER RES, V70, P7992, DOI 10.1158/0008-5472.CAN-10-0585	37	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e22257	10.1371/journal.pone.0022257	http://dx.doi.org/10.1371/journal.pone.0022257			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21814571	Green Submitted, Green Published, gold			2022-12-25	WOS:000293175100017
J	McCaffery, JM; Jablonski, KA; Franks, PW; Dagogo-Jack, S; Wing, RR; Knowler, WC; Delahanty, L; Dabelea, D; Hamman, R; Shuldiner, AR; Florez, JC				McCaffery, Jeanne M.; Jablonski, Kathleen A.; Franks, Paul W.; Dagogo-Jack, Sam; Wing, Rena R.; Knowler, William C.; Delahanty, Linda; Dabelea, Dana; Hamman, Richard; Shuldiner, Alan R.; Florez, Jose C.		Diabet Prevention Program Res Grp	TCF7L2 Polymorphism, Weight Loss and Proinsulin: Insulin Ratio in the Diabetes Prevention Program	PLOS ONE			English	Article							VARIANTS; GENE; ASSOCIATION; SECRETION; GLUCOSE; RISK	Aims: TCF7L2 variants have been associated with type 2 diabetes, body mass index (BMI), and deficits in proinsulin processing and insulin secretion. Here we sought to test whether these effects were apparent in high-risk individuals and modify treatment responses. Methods: We examined the potential role of the TCF7L2 rs7903146 variant in predicting resistance to weight loss or a lack of improvement of proinsulin processing during 2.5-years of follow-up participants (N = 2,994) from the Diabetes Prevention Program (DPP), a randomized controlled trial designed to prevent or delay diabetes in high-risk adults. Results: We observed no difference in the degree of weight loss by rs7903146 genotypes. However, the T allele (conferring higher risk of diabetes) at rs7903146 was associated with higher fasting proinsulin at baseline (P, 0.001), higher baseline proinsulin: insulin ratio (p<0.0001) and increased proinsulin: insulin ratio over a median of 2.5 years of follow-up (P = 0.003). Effects were comparable across treatment arms. Conclusions: The combination of a lack of impact of the TCF7L2 genotypes on the ability to lose weight, but the presence of a consistent effect on the proinsulin: insulin ratio over the course of DPP, suggests that high-risk genotype carriers at this locus can successfully lose weight to counter diabetes risk despite persistent deficits in insulin production.	[McCaffery, Jeanne M.; Jablonski, Kathleen A.] George Washington Univ, Ctr Biostat, Rockville, MD USA; [McCaffery, Jeanne M.; Wing, Rena R.] Miriam Hosp, Weight Control & Diabet Res Ctr, Providence, RI 02906 USA; [McCaffery, Jeanne M.; Wing, Rena R.] Brown Med Sch, Providence, RI USA; [Franks, Paul W.] Lund Univ, Dept Genet & Mol Epidemiol, Malmo, Sweden; [Dagogo-Jack, Sam] Univ Tennessee, Coll Med, Div Endocrinol Diabet & Metab, Memphis, TN USA; [Knowler, William C.] NIDDK, Diabet Epidemiol & Clin Res Sect, Phoenix, AZ USA; [Delahanty, Linda; Dabelea, Dana] Massachusetts Gen Hosp, Ctr Diabet, Boston, MA 02114 USA; [Hamman, Richard] Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Shuldiner, Alan R.] Univ Maryland, Sch Med, Div Endocrinol Diabet & Metab, Baltimore, MD 21201 USA; [Shuldiner, Alan R.] Vet Adm Med Ctr, Geriatr Res & Educ Clin Ctr, Baltimore, MD 21218 USA; [Florez, Jose C.] Massachusetts Gen Hosp, Diabet Res Ctr, Diabet Unit, Boston, MA 02114 USA; [Florez, Jose C.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Florez, Jose C.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Florez, Jose C.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA	George Washington University; Lifespan Health Rhode Island; Miriam Hospital; Brown University; Lund University; University of Tennessee System; University of Tennessee Health Science Center; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Harvard University; Massachusetts General Hospital; Colorado School of Public Health; University System of Maryland; University of Maryland Baltimore; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	McCaffery, JM (corresponding author), George Washington Univ, Ctr Biostat, Rockville, MD USA.	dppmail@bsc.gwu.edu	de Bakker, Paul IW/B-8730-2009; Uwaifo, Gabriel I/M-2361-2016; Franks, Paul/AAA-3300-2020	de Bakker, Paul IW/0000-0001-7735-7858; Uwaifo, Gabriel I/0000-0002-6962-9304; McCaffery, Jeanne/0000-0002-2166-5840; Hill, James/0000-0003-4690-2264; Shuldiner, Alan/0000-0001-9921-4305; Franks, Paul/0000-0002-0520-7604	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health; NIDDK; Indian Health Service; Office of Research on Minority Health, the National Institute of Child Health and Human Development; National Institute on Aging; Centers for Disease Control and Prevention; American Diabetes Association; McKesson BioServices Corp.; Matthews Media Group, Inc.; Henry M. Jackson Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072041, P30DK017047, ZIADK069000] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Indian Health Service(United States Department of Health & Human Services); Office of Research on Minority Health, the National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)NIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); American Diabetes Association(American Diabetes Association); McKesson BioServices Corp.; Matthews Media Group, Inc.; Henry M. Jackson Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health provided funding to the clinical centers and the Coordinating Center for the design and conduct of the study; collection, management, analysis, and interpretation of the data. The Southwestern American Indian Centers were supported directly by the NIDDK and the Indian Health Service. The General Clinical Research Center Program, National Center for Research Resources, and the Department of Veterans Affairs supported data collection at many of the clinical centers. Funding for data collection and participant support was also provided by the Office of Research on Minority Health, the National Institute of Child Health and Human Development, the National Institute on Aging, the Centers for Disease Control and Prevention, and the American Diabetes Association. This research was also supported, in part, by the intramural research program of the NIDDK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Bristol-Myers Squibb and Parke-Davis provided medication; LifeScan Inc., Health O Meter, Hoechst Marion Roussel, Inc., Merck-Medco Managed Care, Inc., Merck and Co., Nike Sports Marketing, Slim Fast Foods Co. and Quaker Oats Co. donated materials, equipment, or medicines for concomitant conditions. McKesson BioServices Corp., Matthews Media Group, Inc., and the Henry M. Jackson Foundation provided support services under subcontract with the Coordinating Center. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	[Anonymous], 2000, Diabetes Care, V23, P1619; Bouchard C, 1997, J NUTR, V127, pS943, DOI 10.1093/jn/127.5.943S; Cauchi S, 2008, OBESITY, V16, P476, DOI 10.1038/oby.2007.77; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Fisher E, 2009, BRIT J NUTR, V101, P478, DOI 10.1017/S0007114508020369; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Fujimoto WY, 2000, DIABETES CARE, V23, pB11; Gonzalez-Sanchez JL, 2008, DIABETOLOGIA, V51, P1993, DOI 10.1007/s00125-008-1129-2; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Haupt A, 2010, DIABETES, V59, P747, DOI 10.2337/db09-1050; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; HOLM S, 1979, SCAND J STAT, V6, P65; Kirchhoff K, 2008, DIABETOLOGIA, V51, P597, DOI 10.1007/s00125-008-0926-y; Kitabchi AE, 2005, DIABETES, V54, P2404, DOI 10.2337/diabetes.54.8.2404; Loos RJF, 2007, DIABETES, V56, P1943, DOI 10.2337/db07-0055; Saxena R, 2006, DIABETES, V55, P2890, DOI 10.2337/db06-0381; Scott LJ, 2006, DIABETES, V55, P2649, DOI 10.2337/db06-0341; Shu L, 2008, DIABETES, V57, P645, DOI 10.2337/db07-0847; Stolerman ES, 2009, DIABETOLOGIA, V52, P614, DOI 10.1007/s00125-009-1266-2; Tang K, 1999, P NATL ACAD SCI USA, V96, P10016, DOI 10.1073/pnas.96.18.10016; Wang J, 2007, DIABETOLOGIA, V50, P1192, DOI 10.1007/s00125-007-0656-6; Xavier GD, 2009, DIABETES, V58, P894, DOI 10.2337/db08-1187	22	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e21518	10.1371/journal.pone.0021518	http://dx.doi.org/10.1371/journal.pone.0021518			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21814547	gold, Green Submitted, Green Published			2022-12-25	WOS:000293175100004
J	Schneider, TD; Arteaga-Salas, JM; Mentele, E; David, R; Nicetto, D; Imhof, A; Rupp, RAW				Schneider, Tobias D.; Arteaga-Salas, Jose M.; Mentele, Edith; David, Robert; Nicetto, Dario; Imhof, Axel; Rupp, Ralph A. W.			Stage-Specific Histone Modification Profiles Reveal Global Transitions in the Xenopus Embryonic Epigenome	PLOS ONE			English	Article							GENE-EXPRESSION PATTERNS; LYSINE 27 METHYLATION; STEM-CELLS; MASS-SPECTROMETRY; CHROMATIN SIGNATURES; DIFFERENTIATED CELLS; EPIGENETIC MARKING; MAMMALIAN GENOMES; H3 VARIANTS; ACETYLATION	Vertebrate embryos are derived from a transitory pool of pluripotent cells. By the process of embryonic induction, these precursor cells are assigned to specific fates and differentiation programs. Histone post-translational modifications are thought to play a key role in the establishment and maintenance of stable gene expression patterns underlying these processes. While on gene level histone modifications are known to change during differentiation, very little is known about the quantitative fluctuations in bulk histone modifications during development. To investigate this issue we analysed histones isolated from four different developmental stages of Xenopus laevis by mass spectrometry. In toto, we quantified 59 modification states on core histones H3 and H4 from blastula to tadpole stages. During this developmental period, we observed in general an increase in the unmodified states, and a shift from histone modifications associated with transcriptional activity to transcriptionally repressive histone marks. We also compared these naturally occurring patterns with the histone modifications of murine ES cells, detecting large differences in the methylation patterns of histone H3 lysines 27 and 36 between pluripotent ES cells and pluripotent cells from Xenopus blastulae. By combining all detected modification transitions we could cluster their patterns according to their embryonic origin, defining specific histone modification profiles (HMPs) for each developmental stage. To our knowledge, this data set represents the first compendium of covalent histone modifications and their quantitative flux during normogenesis in a vertebrate model organism. The HMPs indicate a stepwise maturation of the embryonic epigenome, which may be causal to the progressing restriction of cellular potency during development.	[Schneider, Tobias D.; Arteaga-Salas, Jose M.; Mentele, Edith; Nicetto, Dario; Imhof, Axel; Rupp, Ralph A. W.] Univ Munich, Adolf Butenandt Inst, Dept Mol Biol, Munich, Germany; [David, Robert] Univ Munich, Klinikum Grosshadern, Med Klin & Poliklin 1, D-8000 Munich, Germany; [Imhof, Axel] Ctr Integrated Prot Sci Munich, Munich, Germany	University of Munich; University of Munich; University of Munich	Schneider, TD (corresponding author), Univ Munich, Adolf Butenandt Inst, Dept Mol Biol, Munich, Germany.	Axel.Imhof@med.uni-muenchen.de; ralph.rupp@med.uni-muenchen.de	Imhof, Axel/AAU-5313-2021	Imhof, Axel/0000-0003-2993-8249; rupp, ralph/0000-0002-8068-9957	medical faculty/LMU Munich [61/2006]; European Union [LHSG-CT2006-037415]; Deutsche Forschungsgemeinschaft [SFBTR5/M4, SFBTR5/M5]	medical faculty/LMU Munich; European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding was provided by the FoFoLe-program "Molecular Medicine" of the medical faculty/LMU Munich to T. S. (project-# 61/2006), by grants from the European Union to A. I. (LHSG-CT2006-037415), and by the Deutsche Forschungsgemeinschaft to A. I. (SFBTR5/M4) and R. R. (SFBTR5/M5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkers RC, 2009, DEV CELL, V17, P425, DOI 10.1016/j.devcel.2009.08.005; Aldiri I, 2009, DEV DYNAM, V238, P3185, DOI 10.1002/dvdy.22120; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bell O, 2008, MOL CELL BIOL, V28, P3401, DOI 10.1128/MCB.00006-08; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Buszczak M, 2009, SCIENCE, V323, P248, DOI 10.1126/science.1165678; Chambeyron S, 2005, DEVELOPMENT, V132, P2215, DOI 10.1242/dev.01813; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Dahl JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009150; Dai B, 2007, STEM CELLS, V25, P2567, DOI 10.1634/stemcells.2007-0131; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; David R, 2008, NAT CELL BIOL, V10, P338, DOI 10.1038/ncb1696; De Robertis EM, 2009, MECH DEVELOP, V126, P925, DOI 10.1016/j.mod.2009.08.004; Fritsch E.F., 1989, MOL CLONING LAB MANU; Garcia BA, 2007, J BIOL CHEM, V282, P7641, DOI 10.1074/jbc.M607900200; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hake SB, 2006, P NATL ACAD SCI USA, V103, P6428, DOI 10.1073/pnas.0600803103; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; Jasencakova Z, 2010, MOL CELL, V37, P736, DOI 10.1016/j.molcel.2010.01.033; Jung HR, 2010, MOL CELL PROTEOMICS, V9, P838, DOI 10.1074/mcp.M900489-MCP200; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kurth T, 2005, DEV DYNAM, V233, P418, DOI 10.1002/dvdy.20342; Lee BM, 2009, J CELL BIOCHEM, V108, P22, DOI 10.1002/jcb.22250; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Maisonneuve C, 2009, DEVELOPMENT, V136, P3019, DOI 10.1242/dev.038174; Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI 10.1038/nbt.1684; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Neilson KA, 2011, PROTEOMICS, V11, P535, DOI 10.1002/pmic.201000553; Nicklay JJ, 2009, J BIOL CHEM, V284, P1075, DOI 10.1074/jbc.M807274200; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Pasini D, 2010, NUCLEIC ACIDS RES, V38, P4958, DOI 10.1093/nar/gkq244; Pauler FM, 2009, GENOME RES, V19, P221, DOI 10.1101/gr.080861.108; Phanstiel D, 2008, P NATL ACAD SCI USA, V105, P4093, DOI 10.1073/pnas.0710515105; PUDNEY M, 1973, EXPERIENTIA, V29, P466, DOI 10.1007/BF01926785; RAFFERTY KA, 1969, BIOL AMPHIBIAN TUMOR, P52; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Rugg-Gunn PJ, 2010, P NATL ACAD SCI USA, V107, P10783, DOI 10.1073/pnas.0914507107; RUPP RAW, 1991, CELL, V65, P927, DOI 10.1016/0092-8674(91)90545-A; Scharf AN, 2010, FEBS LETT; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Sharov AA, 2007, CELL STEM CELL, V1, P237, DOI 10.1016/j.stem.2007.08.015; Shechter D, 2009, J BIOL CHEM, V284, P1064, DOI 10.1074/jbc.M807273200; SHIMAMURA A, 1989, J BIOL CHEM, V264, P14524; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; SNAPE A, 1987, DEV BIOL, V119, P503, DOI 10.1016/0012-1606(87)90053-4; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Swigut T, 2007, CELL, V131, P29, DOI 10.1016/j.cell.2007.09.026; Szutorisz H, 2005, MOL CELL BIOL, V25, P1804, DOI 10.1128/MCB.25.5.1804-1820.2005; Taipale M, 2005, MOL CELL BIOL, V25, P6798, DOI 10.1128/MCB.25.15.6798-6810.2005; Thomas CE, 2006, J PROTEOME RES, V5, P240, DOI 10.1021/pr050266a; Tie F, 2009, DEVELOPMENT, V136, P3131, DOI 10.1242/dev.037127; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Villar-Garea A, 2008, CURR PROTOC PROTEIN; Wardle FC, 2004, DEVELOPMENT, V131, P4687, DOI 10.1242/dev.01340; WATERBORG JH, 1993, J BIOL CHEM, V268, P4918; WYLIE CC, 1987, DEV BIOL, V119, P496, DOI 10.1016/0012-1606(87)90052-2; Xie W, 2009, MOL CELL, V33, P417, DOI 10.1016/j.molcel.2009.02.004; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhang KL, 2002, MOL CELL PROTEOMICS, V1, P500, DOI 10.1074/mcp.M200031-MCP200	73	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22548	10.1371/journal.pone.0022548	http://dx.doi.org/10.1371/journal.pone.0022548			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21814581	Green Published, Green Submitted, gold			2022-12-25	WOS:000293097300063
J	Coll, M; Schmidt, A; Romanuk, T; Lotze, HK				Coll, Marta; Schmidt, Allison; Romanuk, Tamara; Lotze, Heike K.			Food-Web Structure of Seagrass Communities across Different Spatial Scales and Human Impacts	PLOS ONE			English	Article							NETWORK STRUCTURE; ECOSYSTEM; BIODIVERSITY; EUTROPHICATION; DEGRADATION; ROBUSTNESS; NUTRIENTS; GRADIENT	Seagrass beds provide important habitat for a wide range of marine species but are threatened by multiple human impacts in coastal waters. Although seagrass communities have been well-studied in the field, a quantification of their food-web structure and functioning, and how these change across space and human impacts has been lacking. Motivated by extensive field surveys and literature information, we analyzed the structural features of food webs associated with Zostera marina across 16 study sites in 3 provinces in Atlantic Canada. Our goals were to (i) quantify differences in food-web structure across local and regional scales and human impacts, (ii) assess the robustness of seagrass webs to simulated species loss, and (iii) compare food-web structure in temperate Atlantic seagrass beds with those of other aquatic ecosystems. We constructed individual food webs for each study site and cumulative webs for each province and the entire region based on presence/absence of species, and calculated 16 structural properties for each web. Our results indicate that food-web structure was similar among low impact sites across regions. With increasing human impacts associated with eutrophication, however, food-web structure show evidence of degradation as indicated by fewer trophic groups, lower maximum trophic level of the highest top predator, fewer trophic links connecting top to basal species, higher fractions of herbivores and intermediate consumers, and higher number of prey per species. These structural changes translate into functional changes with impacted sites being less robust to simulated species loss. Temperate Atlantic seagrass webs are similar to a tropical seagrass web, yet differed from other aquatic webs, suggesting consistent food-web characteristics across seagrass ecosystems in different regions. Our study illustrates that food-web structure and functioning of seagrass habitats change with human impacts and that the spatial scale of food-web analysis is critical for determining results.	[Coll, Marta; Schmidt, Allison; Romanuk, Tamara; Lotze, Heike K.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Coll, Marta] CSIC, ICM, Barcelona, Spain	Dalhousie University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Coll, M (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	martacoll@dal.ca	Coll, Marta/A-9488-2012; Romanuk, t N/C-6493-2008	Coll, Marta/0000-0001-6235-5868; Lotze, Heike/0000-0001-6258-1304	NSERC; NSERC PGSD; Killam Trusts; Spanish Ministry of Science and Technology; European Community [FP7-PEOPLE-2007-4-1-IOF]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC PGSD(Natural Sciences and Engineering Research Council of Canada (NSERC)); Killam Trusts; Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Community(European Commission)	This work was funded by an NSERC Discovery grant to HKL. AS was supported by NSERC PGSD and Killam Trusts Predoctoral Scholarships, and MC by a postdoctoral fellowship from the Spanish Ministry of Science and Technology, and the European Community Marie-Curie Program through the International Outgoing Fellowships (Call: FP7-PEOPLE-2007-4-1-IOF) to the ECOFUN project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Bascompte J, 2005, P NATL ACAD SCI USA, V102, P5443, DOI 10.1073/pnas.0501562102; Breitburg DL, 1999, LIMNOL OCEANOGR, V44, P837, DOI 10.4319/lo.1999.44.3_part_2.0837; Burkholder JM, 2007, J EXP MAR BIOL ECOL, V350, P46, DOI 10.1016/j.jembe.2007.06.024; CHRISTENSEN V, 1995, ECOL MODEL, V77, P3, DOI 10.1016/0304-3800(93)E0073-C; Christian RR, 1999, ECOL MODEL, V117, P99, DOI 10.1016/S0304-3800(99)00022-8; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cloern JE, 2001, MAR ECOL PROG SER, V210, P223, DOI 10.3354/meps210223; Coll M, 2008, ECOSYSTEMS, V11, P939, DOI 10.1007/s10021-008-9171-y; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; *DFO, 2005, WORKSH EC IMPL NUTR; DFO (Fisheries and Oceans Canada), 2009, 2009018 DFO CAN SCI; Duarte CM, 2002, ENVIRON CONSERV, V29, P192, DOI 10.1017/S0376892902000127; Duffy JE, 2006, MAR ECOL PROG SER, V311, P233, DOI 10.3354/meps311233; Dunne JA, 2004, MAR ECOL PROG SER, V273, P291, DOI 10.3354/meps273291; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Gloeckner DR, 2008, J EXP MAR BIOL ECOL, V357, P109, DOI 10.1016/j.jembe.2007.12.031; Green E. E. P., 2003, WORLD ATLAS SEAGRASS; Green E.P., 2000, COASTAL MANAGEMENT S; HAGERMAN L, 1996, EUTROPHICATION COAST, P155; HANSON AR, 2004, E CANADA TECHNICAL R, V412; Heck KL, 2003, MAR ECOL PROG SER, V253, P123, DOI 10.3354/meps253123; Hughes AR, 2004, MAR ECOL PROG SER, V282, P87, DOI 10.3354/meps282087; Lotze H. K., 2003, NUTR POLLUTION EUTRO; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Menge BA, 1997, LIMNOL OCEANOGR, V42, P57, DOI 10.4319/lo.1997.42.1.0057; MOORE KA, 2007, SEAGRASSES BIOL ECOL; ODUM EP, 1985, BIOSCIENCE, V35, P419, DOI 10.2307/1310021; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; Parsons L. S., 1993, MANAGEMENT MARINE FI, V36175; Patricio J, 2006, ECOL MODEL, V197, P21, DOI 10.1016/j.ecolmodel.2006.03.008; Pearson T.H., 1978, Oceanography and Marine Biology an Annual Review, V16, P229; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Romanuk TN, 2006, ECOGRAPHY, V29, P3, DOI 10.1111/j.2005.0906-7590.04181.x; ROTHSCHILD BJ, 1994, MAR ECOL PROG SER, V111, P29, DOI 10.3354/meps111029; Short F.T., 2003, WORLD ATLAS SEAGRASS, P207; Short FT, 1996, ESTUARIES, V19, P730, DOI 10.2307/1352532; Tewfik A, 2007, CAN J FISH AQUAT SCI, V64, P956, DOI 10.1139/F07-071; Thompson RM, 2005, ECOLOGY, V86, P1916, DOI 10.1890/04-1352; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Worm B, 2002, NATURE, V417, P848, DOI 10.1038/nature00830; Worm B, 2006, LIMNOL OCEANOGR, V51, P569, DOI 10.4319/lo.2006.51.1_part_2.0569; WYSMYK JKC, 2008, ATLANTIC CANADA HONO, P57	45	75	77	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22591	10.1371/journal.pone.0022591	http://dx.doi.org/10.1371/journal.pone.0022591			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811637	Green Published, Green Submitted, gold			2022-12-25	WOS:000292956800074
J	Liang, PP; Wang, ZQ; Yang, YH; Jia, XQ; Li, KC				Liang, Peipeng; Wang, Zhiqun; Yang, Yanhui; Jia, Xiuqin; Li, Kuncheng			Functional Disconnection and Compensation in Mild Cognitive Impairment: Evidence from DLPFC Connectivity Using Resting-State fMRI	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; VOXEL-BASED MORPHOMETRY; GRAY-MATTER LOSS; ALZHEIMERS-DISEASE; HUMAN BRAIN; DEFAULT MODE; PERSISTENT ACTIVITY; WORKING-MEMORY; TERM-MEMORY; NETWORKS	The known regional abnormality of the dorsolateral prefrontal cortex (DLPFC) and its role in various neural circuits in mild cognitive impairment (MCI) has given prominence to its importance in studies on the disconnection associated with MCI. The purpose of the current study was to examine the DLPFC functional connectivity patterns during rest in MCI patients and the impact of regional grey matter (GM) atrophy on the functional results. Structural and functional MRI data were collected from 14 MCI patients and 14 age, gender-matched healthy controls. We found that both the bilateral DLPFC showed reduced functional connectivity with the inferior parietal lobule (IPL), superior/medial frontal gyrus and sub-cortical regions (e. g., thalamus, putamen) in MCI patients when compared with healthy controls. Moreover, the DLPFC connectivity with the IPL and thalamus significantly correlated with the cognitive performance of patients as measured by mini-mental state examination (MMSE), clock drawing test (CDT), and California verbal learning test (CVLT) scores. When taking GM atrophy as covariates, these results were approximately consistent with those without correction, although there may be a decrease in the statistical power. These results suggest that the DLPFC disconnections may be the substrates of cognitive impairments in MCI patients. In addition, we also found enhanced functional connectivity between the left DLPFC and the right prefrontal cortex in MCI patients. This is consistent with previous findings of MCI-related increased activation during cognitive tasks, and may represent a compensatory mechanism in MCI patients. Together, the present study demonstrated the coexistence of functional disconnection and compensation in MCI patients using DLPFC functional connectivity analysis, and thus might provide insights into biological mechanism of the disease.	[Liang, Peipeng; Wang, Zhiqun; Yang, Yanhui; Jia, Xiuqin; Li, Kuncheng] Capital Med Univ, Xuanwu Hosp, Beijing, Peoples R China; [Liang, Peipeng] Beijing Univ Technol, Int WIC Inst, Beijing, Peoples R China; [Liang, Peipeng; Jia, Xiuqin; Li, Kuncheng] Beijing Municipal Lab Brain Informat, Beijing, Peoples R China	Capital Medical University; Beijing University of Technology	Liang, PP (corresponding author), Capital Med Univ, Xuanwu Hosp, Beijing, Peoples R China.	likuncheng1955@yahoo.com.cn	Liang, Peipeng/A-9502-2015; , xiuqin/T-8052-2018	Liang, Peipeng/0000-0003-3795-4134; , xiuqin/0000-0003-3920-2884	State Key Laboratory of Cognitive Neuroscience and Learning [CNKOPZD1001]; China Postdoctoral Science Foundation [201003142]; State Key Program of National Natural Science of China [30930029]; Capital Medical University [11JL24]	State Key Laboratory of Cognitive Neuroscience and Learning; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); Capital Medical University	This work was supported by Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning (No. CNKOPZD1001), China Postdoctoral Science Foundation funded project (No. 201003142), the State Key Program of National Natural Science of China (No. 30930029). and the Fund of Capital Medical University (No. 11JL24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bahar-Fuchs A, 2010, CHEM SENSES, V35, P855, DOI 10.1093/chemse/bjq094; Bai F, 2009, BRAIN RES, V1302, P167, DOI 10.1016/j.brainres.2009.09.028; Barbey A.K., 2009, ENCY NEUROSCIENCE, P8, DOI DOI 10.1016/B978-008045046-9.00435-6; Baron JC, 2001, NEUROIMAGE, V14, P298, DOI 10.1006/nimg.2001.0848; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bokde ALW, 2001, ARCH NEUROL-CHICAGO, V58, P480, DOI 10.1001/archneur.58.3.480; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; CASEY BJ, FRONTOSTRIA IN PRESS; Chetelat G, 2002, NEUROREPORT, V13, P1939; Clement F, 2010, BIOL PSYCHIAT, V68, P894, DOI 10.1016/j.biopsych.2010.02.004; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; DELACOSTE MC, 1993, NEUROBIOL AGING, V14, P1, DOI 10.1016/0197-4580(93)90015-4; Delbeuck X, 2003, NEUROPSYCHOL REV, V13, P79, DOI 10.1023/A:1023832305702; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Elgh E, 2003, INT PSYCHOGERIATR, V15, P121, DOI 10.1017/S1041610203008810; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fletcher PC, 1997, TRENDS NEUROSCI, V20, P213, DOI 10.1016/S0166-2236(96)01013-2; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Goel V, 2004, COGNITION, V93, pB109, DOI 10.1016/j.cognition.2004.03.001; Gomez-Isla T, 1997, CONNECTIONS COGNITIO, P149; Grady CL, 2003, J NEUROSCI, V23, P986, DOI 10.1523/jneurosci.23-03-00986.2003; Grady CL, 2001, BRAIN, V124, P739, DOI 10.1093/brain/124.4.739; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Heekeren HR, 2006, P NATL ACAD SCI USA, V103, P10023, DOI 10.1073/pnas.0603949103; Kaufmann L, 2008, CORTEX, V44, P1248, DOI 10.1016/j.cortex.2007.11.009; Kehagia AA, 2010, CURR OPIN NEUROBIOL, V20, P199, DOI 10.1016/j.conb.2010.01.007; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McCarthy G, 1996, CEREB CORTEX, V6, P600, DOI 10.1093/cercor/6.4.600; Murray LJ, 2007, J NEUROSCI, V27, P5515, DOI 10.1523/JNEUROSCI.0406-07.2007; Oakes TR, 2007, NEUROIMAGE, V34, P500, DOI 10.1016/j.neuroimage.2006.10.007; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Qi ZG, 2010, NEUROIMAGE, V50, P48, DOI 10.1016/j.neuroimage.2009.12.025; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rosano C, 2005, BIOL PSYCHIAT, V57, P761, DOI 10.1016/j.biopsych.2004.12.031; Rossi S, 2001, NAT NEUROSCI, V4, P948, DOI 10.1038/nn0901-948; Saykin AJ, 2004, BRAIN, V127, P1574, DOI 10.1093/brain/awh177; Schon K, 2005, J NEUROSCI, V25, P9112, DOI 10.1523/JNEUROSCI.1982-05.2005; Shi F, 2009, HIPPOCAMPUS, V19, P1055, DOI 10.1002/hipo.20573; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; Toro R, 2008, CEREB CORTEX, V18, P2553, DOI 10.1093/cercor/bhn014; van den Heuvel OA, 2003, NEUROIMAGE, V18, P367, DOI 10.1016/S1053-8119(02)00010-1; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Yang YH, 2009, SCI CHINA SER C, V52, P789, DOI 10.1007/s11427-009-0089-1; Zhou Y, 2007, NEUROSCI LETT, V417, P297, DOI 10.1016/j.neulet.2007.02.081; Zuo XN, 2010, J NEUROSCI, V30, P15034, DOI 10.1523/JNEUROSCI.2612-10.2010	55	112	115	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22153	10.1371/journal.pone.0022153	http://dx.doi.org/10.1371/journal.pone.0022153			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811568	gold, Green Submitted, Green Published			2022-12-25	WOS:000292956800027
J	Karpe, YA; Aher, PP; Lole, KS				Karpe, Yogesh A.; Aher, Pankaj P.; Lole, Kavita S.			NTPase and 5 '-RNA Triphosphatase Activities of Chikungunya Virus nsP2 Protein	PLOS ONE			English	Article							DUPLEX-UNWINDING ACTIVITIES; RNA HELICASE; BIOCHEMICAL-CHARACTERIZATION; SINDBIS VIRUS; 5'-TRIPHOSPHATASE; REPLICATION; ATPASE; MOTIF; IDENTIFICATION; EXPRESSION	Chikungunya virus (CHIKV) is an insect borne virus (genus: Alphavirus) which causes acute febrile illness in humans followed by a prolonged arthralgic disease that affects the joints of the extremities. Re-emergence of the virus in the form of outbreaks in last 6-7 years has posed a serious public health problem. CHIKV has a positive sense single stranded RNA genome of about 12,000 nt. Open reading frame 1 of the viral genome encodes a polyprotein precursor, nsP1234, which is processed further into different non structural proteins (nsP1, nsP2, nsP3 and nsP4). Sequence based analyses have shown helicase domain at the N-terminus and protease domain at C-terminus of nsP2. A detailed biochemical analysis of NTPase/RNA helicase and 5'-RNA phosphatase activities of recombinant CHIKV-nsP2T protein (containing conserved NTPase/helicase motifs in the N-terminus and partial papain like protease domain at the C-terminus) was carried out. The protein could hydrolyze all NTPs except dTTP and showed better efficiency for ATP, dATP, GTP and dGTP hydrolysis. ATP was the most preferred substrate by the enzyme. CHIKV-nsP2T also showed 5'-triphosphatase (RTPase) activity that specifically removes the gamma-phosphate from the 5' end of RNA. Both NTPase and RTPase activities of the protein were completely dependent on Mg2+ ions. RTPase activity was inhibited by ATP showing sharing of the binding motif by NTP and RNA. Both enzymatic activities were drastically reduced by mutations in the NTP binding motif (GKT) and co-factor, Mg2+ ion binding motif (DEXX) suggesting that they have a common catalytic site.	[Karpe, Yogesh A.; Aher, Pankaj P.; Lole, Kavita S.] Natl Inst Virol, Hepatitis Div, Pune, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV)	Karpe, YA (corresponding author), Natl Inst Virol, Hepatitis Div, Microbial Containment Complex, Pune, Maharashtra, India.	lolekavita37@yahoo.com			Indian council of Medical research (ICMR)	Indian council of Medical research (ICMR)(Indian Council of Medical Research (ICMR))	This work was funded by the Indian council of Medical research (ICMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHOLA T, 1995, P NATL ACAD SCI USA, V92, P507, DOI 10.1073/pnas.92.2.507; Benarroch D, 2004, VIROLOGY, V328, P208, DOI 10.1016/j.virol.2004.07.004; de Cedron MG, 1999, FEBS LETT, V448, P19, DOI 10.1016/S0014-5793(99)00321-X; Gallivan JP, 2003, FEBS LETT, V554, P485, DOI 10.1016/S0014-5793(03)01229-8; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Gros C, 1996, VIROLOGY, V217, P367, DOI 10.1006/viro.1996.0125; Gu BH, 2000, J VIROL, V74, P1794, DOI 10.1128/JVI.74.4.1794-1800.2000; Hall MC, 1999, MOL MICROBIOL, V34, P867, DOI 10.1046/j.1365-2958.1999.01659.x; HARDY WR, 1989, J VIROL, V63, P4653, DOI 10.1128/JVI.63.11.4653-4664.1989; Ivanov KA, 2004, J VIROL, V78, P7833, DOI 10.1128/JVI.78.14.7833-7838.2004; Kadare G, 1996, J VIROL, V70, P8169; Kadare G, 1997, J VIROL, V71, P2583; Karpe YA, 2010, J VIROL, V84, P9637, DOI 10.1128/JVI.00492-10; Karpe YA, 2010, J VIROL, V84, P3595, DOI 10.1128/JVI.02130-09; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Kim KH, 2004, VIROLOGY, V323, P153, DOI 10.1016/j.virol.2004.03.009; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; LEMM JA, 1994, EMBO J, V13, P2925, DOI 10.1002/j.1460-2075.1994.tb06587.x; LINDER P, 1989, NATURE, V337, P121, DOI 10.1038/337121a0; Merits A, 2001, J GEN VIROL, V82, P765, DOI 10.1099/0022-1317-82-4-765; Pastorino BAM, 2008, VIRUS RES, V131, P293, DOI 10.1016/j.virusres.2007.09.009; RIKKONEN M, 1994, J VIROL, V68, P5804, DOI 10.1128/JVI.68.9.5804-5810.1994; Seybert A, 2000, J VIROL, V74, P9586, DOI 10.1128/JVI.74.20.9586-9593.2000; Seybert A, 2000, RNA, V6, P1056, DOI 10.1017/S1355838200000728; STRAUSS EG, 1992, VIROLOGY, V191, P932, DOI 10.1016/0042-6822(92)90268-T; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Tanner JA, 2003, J BIOL CHEM, V278, P39578, DOI 10.1074/jbc.C300328200; Tuteja N, 2004, EUR J BIOCHEM, V271, P1849, DOI 10.1111/j.1432-1033.2004.04094.x; Vasiljeva L, 2003, J BIOL CHEM, V278, P41636, DOI 10.1074/jbc.M307481200; Vasiljeva L, 2001, J BIOL CHEM, V276, P30786, DOI 10.1074/jbc.M104786200	30	66	67	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22336	10.1371/journal.pone.0022336	http://dx.doi.org/10.1371/journal.pone.0022336			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21811589	Green Published, Green Submitted, gold			2022-12-25	WOS:000292929500055
J	Sala, G; Traini, S; D'Egidio, M; Vianale, G; Rossi, C; Piccolo, E; Lattanzio, R; Piantelli, M; Tinari, N; Natali, PG; Muraro, R; Iacobelli, S				Sala, G.; Traini, S.; D'Egidio, M.; Vianale, G.; Rossi, C.; Piccolo, E.; Lattanzio, R.; Piantelli, M.; Tinari, N.; Natali, P. G.; Muraro, R.; Iacobelli, S.		CINBO	An ErbB-3 antibody, MP-RM-1, inhibits tumor growth by blocking ligand-dependent and independent activation of ErbB-3/Akt signaling	ONCOGENE			English	Article						ErbB-3 receptor; ErbB-3/Akt pathway; monoclonal antibody; targeted therapy	RECEPTOR TYROSINE KINASES; BREAST-CANCER; PHOSPHOLIPASE C-GAMMA-1; MONOCLONAL-ANTIBODIES; LUNG-CANCER; CELL-LINES; EXPRESSION; HER3; RESISTANCE; CARCINOMAS	The ErbB receptors, such as ErbB-1 and ErbB-2, have been intensely pursued as targets for cancer therapeutics. Although initially efficacious in a subset of patients, drugs targeting these receptors led invariably to resistance, which is often associated with reactivation of the ErbB-3-PI3K-Akt signaling. This may be overcome by an ErbB-3 ligand that abrogates receptor-mediated signaling. Toward this end, we have generated a mouse monoclonal antibody, MP-RM-1, against the extracellular domain (ECD) of ErbB-3 receptor. Assessment of human tumor cell lines, as well as early passage tumor cells revealed that MP-RM-1 effectively inhibited both NRG-1 beta-dependent and -independent ErbB-3 activation. The antagonizing effect of MP-RM-1 was of non-competitive type, as binding of [I-125]-labeled NRG-1 beta to ErbB-3 was not influenced by the antibody. MP-RM-1 treatment led, in most instances, to decreased ErbB-3 expression. In addition, MP-RM-1 was able to inhibit the colony formation ability of tumor cells and tumor growth in two human tumor xenograft nude mouse models. Treatment with the antibody was associated with a decreased ErbB-3 and Akt phosphorylation and ErbB-3 expression in the excised tumor tissue. Collectively, these results indicate that MP-RM-1 has the potential to interfere with signaling by ErbB-3 and reinforce the notion that ErbB-3 could be a key target in cancer-drug design. Oncogene (2012) 31, 1275-1286; doi: 10.1038/onc.2011.322; published online 8 August 2011	[Sala, G.; Traini, S.; D'Egidio, M.; Vianale, G.; Rossi, C.; Piccolo, E.; Lattanzio, R.; Piantelli, M.; Tinari, N.; Muraro, R.; Iacobelli, S.] Univ Fdn G DAnnunzio, Dept Oncol & Expt Med, I-66100 Chieti, Italy; [Sala, G.; Traini, S.; D'Egidio, M.; Piccolo, E.; Piantelli, M.; Tinari, N.; Natali, P. G.; Muraro, R.; Iacobelli, S.] MediaPharma Srl, Chieti, Italy	G d'Annunzio University of Chieti-Pescara	Sala, G (corresponding author), Univ Fdn G DAnnunzio, Dept Oncol & Expt Med, Via Colle Ara 1, I-66100 Chieti, Italy.	g.sala@unich.it	Sala, Gianluca/C-2056-2017; Lattanzio, Rossano/K-1927-2018	Sala, Gianluca/0000-0002-4494-915X; Lattanzio, Rossano/0000-0001-9803-4476; Piantelli, Mauro/0000-0003-0154-482X; Traini, Sara/0000-0003-3233-4833; Tinari, Nicola/0000-0001-8449-5407	AIRC	AIRC(Fondazione AIRC per la ricerca sul cancro)	We thank Dr F Petronzelli (Sigma-Tau Pomezia, Italy) for the measurement of MP-RM-1 affinity by surface plasmonic resonance; Dr O Segatto, Dr S Anastasi and Dr M Sallese for advice and reagents, R La Sorda and MR Nicotra for the immunohistochemical analysis, Dr A Sala and Professor V De Laurenzi for discussion. PGN and MP partially supported by AIRC.	ALIMANDI M, 1995, ONCOGENE, V10, P1813; Anastasi S, 2005, ONCOGENE, V24, P4540, DOI 10.1038/sj.onc.1208658; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Baulida J, 1996, J BIOL CHEM, V271, P5251; Bianchi S, 2006, J CELL PHYSIOL, V206, P702, DOI 10.1002/jcp.20535; Chen LQ, 2010, CANCER RES, V70, P5994, DOI 10.1158/0008-5472.CAN-09-4440; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; DIFIORE PP, 1987, CELL, V51, P1063, DOI 10.1016/0092-8674(87)90592-7; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; DIGIESI G, 1992, HYBRIDOMA, V11, P519, DOI 10.1089/hyb.1992.11.519; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fiorini M, 2002, ONCOGENE, V21, P6530, DOI 10.1038/sj.onc.1205823; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Giampaglia M, 2010, CANCER TREAT REV, V36, pS72, DOI 10.1016/S0305-7372(10)70024-4; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Hynes Nancy E., 2007, V172, P45; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Ishikawa N, 2005, CANCER RES, V65, P9176, DOI 10.1158/0008-5472.CAN-05-1556; Karamouzis MV, 2007, INT J BIOCHEM CELL B, V39, P851, DOI 10.1016/j.biocel.2006.11.017; KRAUS MH, 1993, P NATL ACAD SCI USA, V90, P2900, DOI 10.1073/pnas.90.7.2900; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Leonetti C, 1996, JNCI-J NATL CANCER I, V88, P419, DOI 10.1093/jnci/88.7.419; Liu BL, 2007, INT J CANCER, V120, P1874, DOI 10.1002/ijc.22423; Mendelsohn J, 2006, SEMIN ONCOL, V33, P369, DOI 10.1053/j.seminoncol.2006.04.003; MOTTOLESE M, 1988, EUR J CANCER CLIN ON, V24, P1277, DOI 10.1016/0277-5379(88)90215-5; NATALI PG, 1993, BRIT J CANCER, V68, P746, DOI 10.1038/bjc.1993.422; Piccolo E, 2002, ONCOGENE, V21, P6520, DOI 10.1038/sj.onc.1205821; Prewett M, 1998, CLIN CANCER RES, V4, P2957; PRIGENT SA, 1994, EMBO J, V13, P2831, DOI 10.1002/j.1460-2075.1994.tb06577.x; REGECAMBRIN G, 1992, CANCER GENET CYTOGEN, V64, P170, DOI 10.1016/0165-4608(92)90350-H; Reschke M, 2008, CLIN CANCER RES, V14, P5188, DOI 10.1158/1078-0432.CCR-08-0186; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Sala G, 2008, CANCER RES, V68, P10187, DOI 10.1158/0008-5472.CAN-08-1181; Saxena R, 2010, MED RES REV; Schoeberl B, 2010, CANCER RES, V70, P2485, DOI 10.1158/0008-5472.CAN-09-3145; Schoeberl B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000352; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Sithanandam G, 2005, ONCOGENE, V24, P1847, DOI 10.1038/sj.onc.1208381; SUNADA H, 1986, P NATL ACAD SCI USA, V83, P3825, DOI 10.1073/pnas.83.11.3825; Tanner B, 2006, J CLIN ONCOL, V24, P4317, DOI 10.1200/JCO.2005.04.8397; WALLASCH C, 1995, EMBO J, V14, P4267, DOI 10.1002/j.1460-2075.1995.tb00101.x; WEINSTEIN JN, 1992, CANCER RES, V52, pS2747; Witton CJ, 2003, J PATHOL, V200, P290, DOI 10.1002/path.1370; Wu WKK, 2009, ANTICANCER RES, V29, P229; Yi ES, 1997, MODERN PATHOL, V10, P142; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024	48	26	33	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2012	31	10					1275	1286		10.1038/onc.2011.322	http://dx.doi.org/10.1038/onc.2011.322			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	906KS	21822299				2022-12-25	WOS:000301344600007
J	Aggarwal, S; Dewhurst, S; Takimoto, T; Kim, B				Aggarwal, Shilpa; Dewhurst, Stephen; Takimoto, Toru; Kim, Baek			Biochemical Impact of the Host Adaptation-associated PB2 E627K Mutation on the Temperature-dependent RNA Synthesis Kinetics of Influenza A Virus Polymerase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; SINGLE AMINO-ACID; RECEPTOR SPECIFICITY; HIGH VIRULENCE; HUMAN-CELLS; RANGE; NUCLEOPROTEIN; REPLICATION; DETERMINANT; RESIDUES	Most avian influenza A viruses, which preferentially replicate at the high temperatures found in the digestive tract of birds, have a glutamic acid at residue 627 of the viral RNA polymerase PB2 subunit (Glu-627), whereas the human viruses, which optimally replicate at the low temperatures observed in the human respiratory tract, have a lysine (Lys-627). The mechanism of action for this mutation is still not understood, although interaction with host factors has been proposed to play a major role. In this study, we explored an alternative, yet related, hypothesis that this PB2 mutation may alter the temperature-dependent enzymatic polymerase activity of the viral polymerase. First, the avian polymerase protein, which was purified from baculovirus expression system, indeed remained significantly active at higher temperatures (i.e. 37 and 42 degrees C), whereas the human E627K mutant drastically lost activity at these high temperatures. Second, our steady-state kinetics data revealed that the human E627K mutant polymerase is catalytically more active than the avian Glu-627 polymerase at 34 C. Importantly, the E627K mutation elevates apparent K-cat at low temperatures with little effect on K-m, suggesting that the E627K mutation alters the biochemical steps involved in enzyme catalysis rather than the interaction with the incoming NTP. Third, this temperature-dependent kinetic impact of the human E627K mutation was also observed with different RNA templates, with different primers and also in the presence of nucleoprotein. In conclusion, our study suggests that the amino acid sequence variations at residue 627 of PB2 subunit can directly alter the enzyme kinetics of influenza polymerase.	[Aggarwal, Shilpa; Dewhurst, Stephen; Takimoto, Toru; Kim, Baek] Univ Rochester, Dept Microbiol & Immunol, Med Ctr, Rochester, NY 14642 USA	University of Rochester	Kim, B (corresponding author), Univ Rochester, Dept Microbiol & Immunol, Med Ctr, 601 Elmwood Ave,Box 672, Rochester, NY 14642 USA.	baek_kim@urmc.rochester.edu		Dewhurst, Stephen/0000-0001-7729-7920	National Institutes of Health [HHSN266200700008C]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Contract HHSN266200700008C granted to the New York Influenza Center of Excellence.	Aggarwal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010372; ALFORD RH, 1966, P SOC EXP BIOL MED, V122, P800, DOI 10.3181/00379727-122-31255; Boyer PL, 2002, J VIROL, V76, P9143, DOI 10.1128/JVI.76.18.9143-9151.2002; Bradel-Tretheway BG, 2008, J GEN VIROL, V89, P2923, DOI 10.1099/vir.0.2008/006254-0; Bussey KA, 2011, J VIROL, V85, P7020, DOI 10.1128/JVI.00522-11; Bussey KA, 2010, J VIROL, V84, P4395, DOI 10.1128/JVI.02642-09; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; DESSELBERGER U, 1978, P NATL ACAD SCI USA, V75, P3341, DOI 10.1073/pnas.75.7.3341; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Ito T, 2000, J VIROL, V74, P9300, DOI 10.1128/JVI.74.19.9300-9305.2000; Kobasa D, 1999, J VIROL, V73, P6743, DOI 10.1128/JVI.73.8.6743-6751.1999; Kuzuhara T, 2009, J BIOL CHEM, V284, P6855, DOI 10.1074/jbc.C800224200; Labadie K, 2007, VIROLOGY, V362, P271, DOI 10.1016/j.virol.2006.12.027; Liu M, 2003, VIROLOGY, V305, P267, DOI 10.1006/viro.2002.1762; Massin P, 2001, J VIROL, V75, P5398, DOI 10.1128/JVI.75.11.5398-5404.2001; Mayer D, 2007, J PROTEOME RES, V6, P672, DOI 10.1021/pr060432u; Mehle A, 2008, CELL HOST MICROBE, V4, P111, DOI 10.1016/j.chom.2008.06.007; Mena I, 1999, J VIROL, V73, P1186, DOI 10.1128/JVI.73.2.1186-1194.1999; Menendez-Arias L, 2008, VIRUS RES, V134, P124, DOI 10.1016/j.virusres.2007.12.015; MURPHY BR, 1982, INFECT IMMUN, V37, P1119, DOI 10.1128/IAI.37.3.1119-1126.1982; Naffakh N, 2000, J GEN VIROL, V81, P1283, DOI 10.1099/0022-1317-81-5-1283; Ng AKL, 2009, SCI CHINA SER C, V52, P439, DOI 10.1007/s11427-009-0064-x; Parker WB, 2005, VIRUS RES, V107, P165, DOI 10.1016/j.virusres.2004.11.006; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rothwell PJ, 2005, ADV PROTEIN CHEM, V71, P401, DOI 10.1016/S0065-3233(04)71011-6; Salomon R, 2006, J EXP MED, V203, P689, DOI 10.1084/jem.20051938; SCHOLTISSEK C, 1978, VIROLOGY, V87, P13, DOI 10.1016/0042-6822(78)90153-8; Shinya K, 2007, J GEN VIROL, V88, P547, DOI 10.1099/vir.0.82411-0; SNYDER MH, 1987, J VIROL, V61, P2857, DOI 10.1128/JVI.61.9.2857-2863.1987; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Sun YJ, 2007, ANTIMICROB AGENTS CH, V51, P84, DOI 10.1128/AAC.00790-06; Tarendeau F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000136; TREANOR J, 1994, J VIROL, V68, P7684, DOI 10.1128/JVI.68.12.7684-7688.1994; Vines A, 1998, J VIROL, V72, P7626, DOI 10.1128/JVI.72.9.7626-7631.1998; Wainberg MA, 1996, SCIENCE, V271, P1282, DOI 10.1126/science.271.5253.1282; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Yamada S., PLOS PATHOG, V6; Yamada S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001034; Zhang SJ, 2010, BIOCHEM BIOPH RES CO, V391, P570, DOI 10.1016/j.bbrc.2009.11.100	42	30	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34504	34513		10.1074/jbc.M111.262048	http://dx.doi.org/10.1074/jbc.M111.262048			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21816827	Green Published, hybrid			2022-12-25	WOS:000295406300004
J	Hashimoto, H; Takeuchi, T; Komatsu, K; Miyazaki, K; Sato, M; Higashi, S				Hashimoto, Hiroshi; Takeuchi, Tomoka; Komatsu, Kyoko; Miyazaki, Kaoru; Sato, Mamoru; Higashi, Shouichi			Structural Basis for Matrix Metalloproteinase-2 (MMP-2)-selective Inhibitory Action of beta-Amyloid Precursor Protein-derived Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1.8-ANGSTROM CRYSTAL-STRUCTURE; AMINO-ACID-RESIDUES; ALZHEIMERS-DISEASE; CATALYTIC DOMAIN; TISSUE INHIBITOR; EXTRACELLULAR-MATRIX; COMPLEX; BINDING; CANCER; IDENTIFICATION	Unlike other synthetic or physiological inhibitors for matrix metalloproteinases (MMPs), the beta-amyloid precursor protein-derived inhibitory peptide (APP-IP) having an ISYGNDALMP sequence has a high selectivity toward MMP-2. Our previous study identified amino acid residues of MMP-2 essential for its selective inhibition by APP-IP and demonstrated that the N to C direction of the decapeptide inhibitor relative to the substrate-binding cleft of MMP-2 is opposite that of substrate. However, detailed interactions between the two molecules remained to be clarified. Here, we determined the crystal structure of the catalytic domain of MMP-2 in complex with APP-IP. We found that APP-IP in the complex is indeed embedded into the substrate-binding cleft of the catalytic domain in the N to C direction opposite that of substrate. With the crystal structure, it was first clarified that the aromatic side chain of Tyr(3) of the inhibitor is accommodated into the S1' pocket of the protease, and the carboxylate group of Asp(6) of APP-IP coordinates bidentately to the catalytic zinc of the enzyme. The Ala(7) to Pro(10) and Tyr(3) to Ile(1) strands of the inhibitor extend into the nonprime and the prime sides of the cleft, respectively. Therefore, the decapeptide inhibitor has long range contact with the substrate-binding cleft of the protease. This mode of interaction is probably essential for the high MMP-2 selectivity of the inhibitor because MMPs share a common architecture in the vicinity of the catalytic center, but whole structures of their substrate-binding clefts have sufficient variety for the inhibitor to distinguish MMP-2 from other MMPs.	[Takeuchi, Tomoka; Komatsu, Kyoko; Miyazaki, Kaoru; Higashi, Shouichi] Yokohama City Univ, Grad Sch Nanobiosci, Dept Genome Syst Sci, Totsuka Ku, Yokohama, Kanagawa 2440813, Japan; [Hashimoto, Hiroshi; Sato, Mamoru] Yokohama City Univ, Grad Sch Nanobiosci, Dept Supramol Biol, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	Yokohama City University; Yokohama City University	Higashi, S (corresponding author), Yokohama City Univ, Grad Sch Nanobiosci, Dept Genome Syst Sci, Totsuka Ku, 641-12 Maioka Cho, Yokohama, Kanagawa 2440813, Japan.	shigashi@yokohama-cu.ac.jp		Hashimoto, Hiroshi/0000-0003-1503-6789	Yokohama City University, Japan [T2201]; Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [17014077, 21570118]; MEXT	Yokohama City University, Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by 2010 Grant T2201 for Strategic Research Promotion of Yokohama City University, Japan (to S. H.) and Grants-in-aid for Scientific Research on Priority Areas 17014077 (to K. M.) and Research (C) 21570118 (to S. H.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) and the Targeted Proteins Research Program (TPRP) (to H. H. and M. S.) from MEXT.	Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Beher D, 1996, J BIOL CHEM, V271, P1613, DOI 10.1074/jbc.271.3.1613; Betz M, 1997, EUR J BIOCHEM, V247, P356, DOI 10.1111/j.1432-1033.1997.00356.x; BODE W, 1994, EMBO J, V13, P1263, DOI 10.1002/j.1460-2075.1994.tb06378.x; Brandstetter H, 2001, J BIOL CHEM, V276, P17405, DOI 10.1074/jbc.M007475200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caceres J, 1997, J CELL BIOCHEM, V65, P145, DOI 10.1002/(SICI)1097-4644(199705)65:2<145::AID-JCB2>3.0.CO;2-U; D'Alessio S, 2008, J BIOL CHEM, V283, P87, DOI 10.1074/jbc.M705492200; Decock J, 2011, J CELL MOL MED, V15, P1254, DOI 10.1111/j.1582-4934.2011.01302.x; Dhanaraj V, 1999, CROAT CHEM ACTA, V72, P575; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; Finzel BC, 1998, PROTEIN SCI, V7, P2118, DOI 10.1002/pro.5560071008; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Higashi S, 2003, J BIOL CHEM, V278, P14020, DOI 10.1074/jbc.M212264200; Higashi S, 2008, J BIOL CHEM, V283, P10068, DOI 10.1074/jbc.M709509200; Higashi S, 2008, J BIOL CHEM, V283, P35735, DOI 10.1074/jbc.M806285200; Jia MC, 2000, ADV EXP MED BIOL, V476, P181; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; KIBBEY MC, 1993, P NATL ACAD SCI USA, V90, P10150, DOI 10.1073/pnas.90.21.10150; MIYAZAKI K, 1993, NATURE, V362, P839, DOI 10.1038/362839a0; Morgunova E, 2002, P NATL ACAD SCI USA, V99, P7414, DOI 10.1073/pnas.102185399; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Ohsawa I, 2001, J NEUROCHEM, V76, P1411, DOI 10.1046/j.1471-4159.2001.00144.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Park HI, 2002, J BIOL CHEM, V277, P35168, DOI 10.1074/jbc.M205071200; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; SMALL DH, 1992, J NEUROSCI, V12, P4143; Sounnil NE, 2010, INT J CANCER, V126, P1067, DOI 10.1002/ijc.24690; Tochowicz A, 2007, J MOL BIOL, V371, P989, DOI 10.1016/j.jmb.2007.05.068; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Wisniewska M, 2008, J MOL BIOL, V381, P1307, DOI 10.1016/j.jmb.2008.06.088	38	37	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33236	33243		10.1074/jbc.M111.264176	http://dx.doi.org/10.1074/jbc.M111.264176			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21813640	Green Published, hybrid			2022-12-25	WOS:000294968800042
J	Ducimetiere, F; Lurkin, A; Ranchere-Vince, D; Decouvelaere, AV; Peoc'h, M; Istier, L; Chalabreysse, P; Muller, C; Alberti, L; Bringuier, PP; Scoazec, JY; Schott, AM; Bergeron, C; Cellier, D; Blay, JY; Ray-Coquard, I				Ducimetiere, Francoise; Lurkin, Antoine; Ranchere-Vince, Dominique; Decouvelaere, Anne-Valerie; Peoc'h, Michel; Istier, Luc; Chalabreysse, Philippe; Muller, Christine; Alberti, Laurent; Bringuier, Pierre-Paul; Scoazec, Jean-Yves; Schott, Anne-Marie; Bergeron, Christophe; Cellier, Dominic; Blay, Jean-Yves; Ray-Coquard, Isabelle			Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing	PLOS ONE			English	Review							GASTROINTESTINAL STROMAL TUMORS; SOFT-TISSUE SARCOMAS; INFORMATION-SYSTEM PROJECT; EUROPEAN CHILDREN 1978-1997; RHONE-ALPES REGION; CHILDHOOD-CANCER; INTERNATIONAL CLASSIFICATION; ALVEOLAR RHABDOMYOSARCOMA; GENE-EXPRESSION; POPULATION	Background: The exact overall incidence of sarcoma and sarcoma subtypes is not known. The objective of the present population-based study was to determine this incidence in a European region (Rhone-Alpes) of six million inhabitants, based on a central pathological review of the cases. Methodology/Principal Findings: From March 2005 to February 2007, pathology reports and tumor blocks were prospectively collected from the 158 pathologists of the Rhone-Alpes region. All diagnosed or suspected cases of sarcoma were collected, reviewed centrally, examined for molecular alterations and classified according to the 2002 World Health Organization classification. Of the 1287 patients screened during the study period, 748 met the criteria for inclusion in the study. The overall crude and world age-standardized incidence rates were respectively 6.2 and 4.8 per 100,000/year. Incidence rates for soft tissue, visceral and bone sarcomas were respectively 3.6, 2.0 and 0.6 per 100,000. The most frequent histological subtypes were gastrointestinal stromal tumor (18%; 1.1/100,000), unclassified sarcoma (16%; 1/100,000), liposarcoma (15%; 0.9/100,000) and leiomyosarcoma (11%; 0.7/100,000). Conclusions/Significance: The observed incidence of sarcomas was higher than expected. This study is the first detailed investigation of the crude incidence of histological and molecular subtypes of sarcomas.	[Ducimetiere, Francoise; Lurkin, Antoine; Ray-Coquard, Isabelle] Univ Lyon, Canc Ctr Leon Berard, EA 4129, Lyon, France; [Ranchere-Vince, Dominique; Decouvelaere, Anne-Valerie] Univ Lyon, Canc Ctr Leon Berard, Dept Pathol, Lyon, France; [Peoc'h, Michel] Univ St Etienne, Ctr Hosp Univ, Dept Pathol, St Etienne, France; [Istier, Luc] Pathol Lab, Pringy, France; [Chalabreysse, Philippe] Cypath, Pathol Lab, Lyon, France; [Muller, Christine] Pathol Lab, Grenoble, France; [Alberti, Laurent; Blay, Jean-Yves] Univ Lyon, Canc Ctr Leon Berard, INSERM, U590, Lyon, France; [Bringuier, Pierre-Paul; Scoazec, Jean-Yves] Univ Lyon, Hosp Civils Lyon, Hop Edouard Herriot, Dept Pathol, Lyon, France; [Schott, Anne-Marie] Univ Lyon, Hosp Civils Lyon, Pole IMER, Lyon, France; [Bergeron, Christophe] Inst Hematol & Oncol Pediat, Dept Paediat, Lyon, France; [Cellier, Dominic] Merck Serono, Sci Relat, Lyon, France	UNICANCER; Centre Leon Berard; Institut de cancerologie de Lorraine (ICL); UNICANCER; Centre Leon Berard; Institut de cancerologie de Lorraine (ICL); CHU de St Etienne; Universite Jean Monnet; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Institut de cancerologie de Lorraine (ICL); CHU Lyon; CHU Lyon; Merck KGaA; EMD Serono Inc.	Ducimetiere, F (corresponding author), Univ Lyon, Canc Ctr Leon Berard, EA 4129, Lyon, France.	ducimeti@lyon.fnclcc.fr	Schott, Anne-Marie/V-7580-2018; Alberti, Laurent/HHZ-3296-2022; Blay, Jean-Yves/N-3966-2016	Schott, Anne-Marie/0000-0003-3337-4474; Alberti, Laurent/0000-0002-7686-1750; Blay, Jean-Yves/0000-0001-7190-120X; Peoc'h, michel/0000-0001-5453-0021	Merck Serono; Conticanet (European Connective Tissue Cancer Network) [FP6-018806]; INCa (French National Cancer Institute); French national cancer league (Ain and Rhone committees)	Merck Serono(Merck & Company); Conticanet (European Connective Tissue Cancer Network); INCa (French National Cancer Institute)(Institut National du Cancer (INCA) France); French national cancer league (Ain and Rhone committees)	This work is financially supported by Merck Serono (http://www.merckserono.fr/fr/index.html), Conticanet (European Connective Tissue Cancer Network FP6-018806, http://www.conticanet.eu/html/), INCa (French National Cancer Institute, http://www.e-cancer.fr/) and the French national cancer league (Ain and Rhone committees, http://www.ligue-cancer.net/). Merck-Serono provided intellectual and administrative support and helped the authors organize steering committees. It is an Academic/Industrial partnership. The study described here is a descriptive and exhaustive epidemiological study about collection of sarcoma cases and it does not concern an industrial product. The other funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	AHMAD O, 2001, 31 GPE WHO; Andersson J, 2006, GASTROENTEROLOGY, V130, P1573, DOI 10.1053/j.gastro.2006.01.043; [Anonymous], 2003, WHO CLASSIFICATION T; [Anonymous], 1999, CANC INCIDENCE SURVI; [Anonymous], 2021, CANC INCIDENCE 5 CON; Antonescu CR, 2006, HISTOPATHOLOGY, V48, P13, DOI 10.1111/j.1365-2559.2005.02285.x; Arbiser ZK, 2001, AM J CLIN PATHOL, V116, P473; Berger C, 2006, ARCH PEDIATRIE, V13, P121, DOI 10.1016/j.arcped.2005.10.022; Cassier PA, 2010, BRIT J CANCER, V103, P165, DOI 10.1038/sj.bjc.6605743; Clark MA, 2005, NEW ENGL J MED, V353, P701, DOI 10.1056/NEJMra041866; Coindre JM, 2003, HISTOPATHOLOGY, V43, P1, DOI 10.1046/j.1365-2559.2003.01639.x; Colonna M, 2008, REV EPIDEMIOL SANTE, V56, P434, DOI 10.1016/j.respe.2008.10.001; Corless CL, 2005, J CLIN ONCOL, V23, P5357, DOI 10.1200/JCO.2005.14.068; Corless CL, 2004, J CLIN ONCOL, V22, P3813, DOI 10.1200/JCO.2004.05.140; Daugaard S, 2004, EUR J CANCER, V40, P543, DOI 10.1016/j.ejca.2003.11.009; Engholm G, 2010, NORDCAN CANC INCIDEN; Eyre R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-357; Ferrari A, 2005, J CLIN ONCOL, V23, P4021, DOI 10.1200/JCO.2005.02.053; Fletcher CDM, 2002, HUM PATHOL, V33, P459, DOI 10.1053/hupa.2002.123545; Fletcher CDM, 2002, WHO CLASSIFICATION T; Goettsch WG, 2005, EUR J CANCER, V41, P2868, DOI 10.1016/j.ejca.2005.09.009; Guillou L, 1997, J CLIN ONCOL, V15, P350, DOI 10.1200/JCO.1997.15.1.350; Hamilton SR, 2000, WHO CLASSIFICATION T; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Kaatsch P, 2006, EUR J CANCER, V42, P1961, DOI 10.1016/j.ejca.2006.05.014; Kramarova E, 1996, INT J CANCER, V68, P759; Ladanyi M, 2002, CANCER RES, V62, P135; Lazar Alexander J F, 2007, Curr Oncol Rep, V9, P309, DOI 10.1007/s11912-007-0038-8; Levi F, 1999, EUR J CANCER, V35, P1711, DOI 10.1016/S0959-8049(99)00179-3; Linabery AM, 2008, CANCER, V112, P416, DOI 10.1002/cncr.23169; Lurkin A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-150; Meis-Kindblom JM, 1999, ACTA ORTHOP SCAND, V70, P18, DOI 10.1080/17453674.1999.11744818; Menegoz F, 1997, EUR J CANCER PREV, V6, P442, DOI 10.1097/00008469-199710000-00005; Miettinen M, 2006, ADV EXP MED BIOL, V587, P99; Miettinen M, 2006, SEMIN DIAGN PATHOL, V23, P70, DOI 10.1053/j.semdp.2006.09.001; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; Nielsen TO, 2010, J CLIN ONCOL, V28, P1796, DOI 10.1200/JCO.2009.26.1917; Nilsson B, 2005, CANCER-AM CANCER SOC, V103, P821, DOI 10.1002/cncr.20862; PARKIN DM, 1993, INT J CANCER, V53, P371, DOI 10.1002/ijc.2910530305; Pastore G, 2006, EUR J CANCER, V42, P2136, DOI 10.1016/j.ejca.2006.05.016; Perez EA, 2006, J AM COLL SURGEONS, V202, P623, DOI 10.1016/j.jamcollsurg.2006.01.002; Peter M, 2001, LAB INVEST, V81, P905, DOI 10.1038/labinvest.3780299; Pritchard-Jones K, 2006, EUR J CANCER, V42, P2183, DOI 10.1016/j.ejca.2006.06.006; Rosenberg S.A., 2008, DEVITA HELLMAN ROSEN; ROSS JA, 1993, CANCER, V72, P486, DOI 10.1002/1097-0142(19930715)72:2<486::AID-CNCR2820720226>3.0.CO;2-R; Soliman H, 2009, SEMIN ONCOL, V36, P227, DOI 10.1053/j.seminoncol.2009.03.006; Sorensen PHB, 2002, J CLIN ONCOL, V20, P2672, DOI 10.1200/JCO.2002.03.137; Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910; Stiller CA, 2006, EUR J CANCER, V42, P2006, DOI 10.1016/j.ejca.2006.06.002; STILLER CA, 1994, PAEDIATR PERINAT EP, V8, P107, DOI 10.1111/j.1365-3016.1994.tb00439.x; Toro JR, 2006, INT J CANCER, V119, P2922, DOI 10.1002/ijc.22239; Tryggvason G, 2005, INT J CANCER, V117, P289, DOI 10.1002/ijc.21167; Vauhkonen H, 2006, ADV EXP MED BIOL, V587, P53; Wibmer C, 2009, ANN ONCOL; Williamson D, 2010, J CLIN ONCOL, V28, P2151, DOI 10.1200/JCO.2009.26.3814; Wolden SL, 2010, SEMIN RADIAT ONCOL, V20, P45, DOI 10.1016/j.semradonc.2009.09.003; Worch J, 2010, CANCER-AM CANCER SOC, V116, P983, DOI 10.1002/cncr.24865; Zahm SH, 1997, SEMIN ONCOL, V24, P504	58	331	342	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e20294	10.1371/journal.pone.0020294	http://dx.doi.org/10.1371/journal.pone.0020294			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826194	gold, Green Submitted, Green Published			2022-12-25	WOS:000293558900002
J	Li, Y; Luo, JM; Lau, WM; Zheng, GQ; Fu, SP; Wang, TT; Zeng, HP; So, KF; Chung, SK; Tong, Y; Liu, KJ; Shen, JG				Li, Yue; Luo, Jianmin; Lau, Wui-Man; Zheng, Guoqing; Fu, Shuping; Wang, Ting-Ting; Zeng, He-Ping; So, Kwok-Fai; Chung, Sookja Kim; Tong, Yao; Liu, Kejian; Shen, Jiangang			Caveolin-1 Plays a Crucial Role in Inhibiting Neuronal Differentiation of Neural Stem/Progenitor Cells via VEGF Signaling-Dependent Pathway	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FACTOR RECEPTOR; STEM-CELLS; DOPAMINERGIC DIFFERENTIATION; ENHANCES PROLIFERATION; PROGENITOR CELLS; ISCHEMIC-INJURY; KINASE-ACTIVITY; DENTATE GYRUS; ADULT BRAIN	In the present study, we aim to elucidate the roles of caveolin-1(Cav-1), a 22 kDa protein in plasma membrane invaginations, in modulating neuronal differentiation of neural progenitor cells (NPCs). In the hippocampal dentate gyrus, we found that Cav-1 knockout mice revealed remarkably higher levels of vascular endothelial growth factor (VEGF) and the more abundant formation of newborn neurons than wild type mice. We then studied the potential mechanisms of Cav-1 in modulating VEGF signaling and neuronal differentiation in isolated cultured NPCs under normoxic and hypoxic conditions. Hypoxic embryonic rat NPCs were exposed to 1% O-2 for 24 h and then switched to 21% O-2 for 1, 3, 7 and 14 days whereas normoxic NPCs were continuously cultured with 21% O-2. Compared with normoxic NPCs, hypoxic NPCs had down-regulated expression of Cav-1 and up-regulated VEGF expression and p44/42MAPK phosphorylation, and enhanced neuronal differentiation. We further studied the roles of Cav-1 in inhibiting neuronal differentiation by using Cav-1 scaffolding domain peptide and Cav-1-specific small interfering RNA. In both normoxic and hypoxic NPCs, Cav-1 peptide markedly down-regulated the expressions of VEGF and flk1, decreased the phosphorylations of p44/42MAPK, Akt and Stat3, and inhibited neuronal differentiation, whereas the knockdown of Cav-1 promoted the expression of VEGF, phosphorylations of p44/42MAPK, Akt and Stat3, and stimulated neuronal differentiation. Moreover, the enhanced phosphorylations of p44/42MAPK, Akt and Stat3, and neuronal differentiation were abolished by co-treatment of VEGF inhibitor V1. These results provide strong evidence to prove that Cav-1 can inhibit neuronal differentiation via down-regulations of VEGF, p44/42MAPK, Akt and Stat3 signaling pathways, and that VEGF signaling is a crucial target of Cav-1. The hypoxia-induced down-regulation of Cav-1 contributes to enhanced neuronal differentiation in NPCs.	[Li, Yue; Luo, Jianmin; Zheng, Guoqing; Fu, Shuping; Tong, Yao; Shen, Jiangang] Univ Hong Kong, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Li, Yue; Lau, Wui-Man; Fu, Shuping; Wang, Ting-Ting; So, Kwok-Fai; Chung, Sookja Kim; Shen, Jiangang] Univ Hong Kong, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China; [Zheng, Guoqing] Wenzhou Med Coll, Affiliated Hosp 2, Ctr Neurol & Rehabil, Wenzhou, Peoples R China; [Wang, Ting-Ting; Zeng, He-Ping] S China Univ Technol, Inst Funct Mol, Sch Chem, Guangzhou, Guangdong, Peoples R China; [Lau, Wui-Man; So, Kwok-Fai; Chung, Sookja Kim] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Liu, Kejian] Univ New Mexico, Coll Pharm, Ctr Biomed Res Excellence, Albuquerque, NM 87131 USA	University of Hong Kong; University of Hong Kong; Wenzhou Medical University; South China University of Technology; University of Hong Kong; University of New Mexico	Li, Y (corresponding author), Univ Hong Kong, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China.	shenjg@hkucc.hku.hk	Li, Kevin/AAX-1664-2020; Luo, jian/HGE-7331-2022; wang, tingting/AAK-2640-2020; Zheng, Guo-qing/A-4412-2019	Li, Kevin/0000-0001-8198-9911; Zheng, Guo-qing/0000-0001-5286-5696; zeng, heping/0000-0002-9025-9643; LAU, Wui Man/0000-0002-4552-2780; So, Kwok-Fai/0000-0003-4039-4246	Hong Kong RGC [777610M, 774808M]; University of Hong Kong [200807176043]; Dr. Wong BL family donation	Hong Kong RGC(Hong Kong Research Grants Council); University of Hong Kong(University of Hong Kong); Dr. Wong BL family donation	This work was supported by Hong Kong RGC General Research Fund (GRF No. 777610M, No. 774808M, JS), Small Project Funding of the University of Hong Kong (200807176043, JS) and Dr. Wong BL family donation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Benoit BO, 2001, J NEUROBIOL, V46, P265, DOI 10.1002/1097-4695(200103)46:4<265::AID-NEU1007>3.0.CO;2-B; Binetruy-Tournaire R, 2000, EMBO J, V19, P1525, DOI 10.1093/emboj/19.7.1525; BONFANTI L, 1994, NEUROSCIENCE, V62, P291, DOI 10.1016/0306-4522(94)90333-6; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Bu J, 2003, J NEUROSCI RES, V72, P185, DOI 10.1002/jnr.10556; Bucci M, 2000, NAT MED, V6, P1362, DOI 10.1038/82176; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Campos LS, 2006, J BIOL CHEM, V281, P5300, DOI 10.1074/jbc.M511886200; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Caputo R, 2003, CLIN CANCER RES, V9, P2015; Chung JK, 1997, MOL CELL BIOL, V17, P6508, DOI 10.1128/MCB.17.11.6508; Ciccolini F, 1998, J NEUROSCI, V18, P7869; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Dougher M, 1999, ONCOGENE, V18, P1619, DOI 10.1038/sj.onc.1202478; Dulak J, 2000, ARTERIOSCL THROM VAS, V20, P659, DOI 10.1161/01.ATV.20.3.659; Fabel K, 2003, EUR J NEUROSCI, V18, P2803, DOI 10.1111/j.1460-9568.2003.03041.x; Galbiati F, 1998, P NATL ACAD SCI USA, V95, P10257, DOI 10.1073/pnas.95.17.10257; Gaudreault SB, 2005, J NEUROCHEM, V92, P831, DOI 10.1111/j.1471-4159.2004.02917.x; Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235; Hashimoto T, 2006, DEVELOPMENT, V133, P2201, DOI 10.1242/dev.02385; Hennequin LF, 1999, J MED CHEM, V42, P5369, DOI 10.1021/jm990345w; Holmqvist K, 2004, J BIOL CHEM, V279, P22267, DOI 10.1074/jbc.M312729200; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Jasmin JF, 2009, CELL CYCLE, V8, P3978, DOI 10.4161/cc.8.23.10206; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Ju H, 1997, J BIOL CHEM, V272, P18522, DOI 10.1074/jbc.272.30.18522; Kang MJ, 2006, NEUROREPORT, V17, P823, DOI 10.1097/01.wnr.0000220139.83671.60; Kang SK, 2010, TISSUE ENG PT A, V16, P2687, DOI [10.1089/ten.tea.2010.0010, 10.1089/ten.TEA.2010.0010]; Kataru RP, 2009, BLOOD, V113, P5650, DOI 10.1182/blood-2008-09-176776; Kendall RL, 1999, J BIOL CHEM, V274, P6453, DOI 10.1074/jbc.274.10.6453; Khaibullina AA, 2004, DEV BRAIN RES, V148, P59, DOI 10.1016/j.devbrainres.2003.09.022; Kim HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004987; Kim JY, 2009, NEURON, V63, P761, DOI 10.1016/j.neuron.2009.08.008; Kokaia Z, 2003, CURR OPIN NEUROBIOL, V13, P127, DOI 10.1016/S0959-4388(03)00017-5; Labrecque L, 2003, MOL BIOL CELL, V14, P334, DOI 10.1091/mbc.E02-07-0379; Li Y, 2011, BIOCHEM BIOPH RES CO, V407, P517, DOI 10.1016/j.bbrc.2011.03.050; Li ZG, 2006, DEV GROWTH DIFFER, V48, P513, DOI 10.1111/j.1440-169x.2006.00889.x; Liu JL, 1998, J NEUROSCI, V18, P7768; Lu KT, 2011, J NEUROTRAUM, V28, P441, DOI 10.1089/neu.2010.1473; Macas J, 2006, J NEUROSCI, V26, P13114, DOI 10.1523/JNEUROSCI.4667-06.2006; Marlow R, 2010, P NATL ACAD SCI USA, V107, P10520, DOI 10.1073/pnas.1001896107; Mcfee RM, 2009, BIOL REPROD, V81, P966, DOI 10.1095/biolreprod.109.078071; Muller S, 2009, STEM CELLS, V27, P431, DOI 10.1634/stemcells.2008-0234; Picard-Riera N, 2004, J NEUROSCI RES, V76, P223, DOI 10.1002/jnr.20040; Plane JM, 2004, NEUROBIOL DIS, V16, P585, DOI 10.1016/j.nbd.2004.04.003; Raballo R, 2000, J NEUROSCI, V20, P5012; Roitbak T, 2008, J CEREBR BLOOD F MET, V28, P1530, DOI 10.1038/jcbfm.2008.38; Russo SJ, 2010, TRENDS NEUROSCI, V33, P267, DOI 10.1016/j.tins.2010.02.002; Santilli G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008575; Schanzer A, 2004, BRAIN PATHOL, V14, P237; Shen JG, 2006, J NEUROCHEM, V96, P1078, DOI 10.1111/j.1471-4159.2005.03589.x; Shioda N, 2009, INT REV NEUROBIOL, V85, P375, DOI 10.1016/S0074-7742(09)85026-5; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Storch A, 2001, EXP NEUROL, V170, P317, DOI 10.1006/exnr.2001.7706; Studer L, 2000, J NEUROSCI, V20, P7377; Sung SM, 2007, NEUROCHEM RES, V32, P1932, DOI 10.1007/s11064-007-9390-1; Tahir AA, 2009, CANCER BIOL THER, V8, P2286; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Tanaka Y, 2005, NEUROSCI LETT, V383, P28, DOI 10.1016/j.neulet.2005.03.056; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Thored P, 2007, STROKE, V38, P3032, DOI 10.1161/STROKEAHA.107.488445; Vojtek AB, 2003, MOL CELL BIOL, V23, P4417, DOI 10.1128/MCB.23.13.4417-4427.2003; Volonte D, 2004, FASEB J, V18, P237, DOI 10.1096/fj.04-2215fje; Wang CM, 2011, NEUROSCI LETT, V488, P70, DOI 10.1016/j.neulet.2010.10.079; Wang JW, 2008, J NEUROSCI, V28, P1374, DOI 10.1523/JNEUROSCI.3632-07.2008; Wang YM, 2007, J NEUROSCI RES, V85, P740, DOI 10.1002/jnr.21169; Warner-Schmidt JL, 2008, CURR OPIN PHARMACOL, V8, P14, DOI 10.1016/j.coph.2007.10.013; Xia H, 2010, AM J PATHOL, V176, P2626, DOI 10.2353/ajpath.2010.091117; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451	71	26	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22901	10.1371/journal.pone.0022901	http://dx.doi.org/10.1371/journal.pone.0022901			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826216	Green Submitted, gold, Green Published			2022-12-25	WOS:000293558900042
J	Tan, L; Sui, X; Deng, HK; Ding, MX				Tan, Lei; Sui, Xin; Deng, Hongkui; Ding, Mingxiao			Holoclone Forming Cells from Pancreatic Cancer Cells Enrich Tumor Initiating Cells and Represent a Novel Model for Study of Cancer Stem Cells	PLOS ONE			English	Article							HUMAN OVARIAN-CANCER; SELF-RENEWAL; BREAST-CANCER; PROSPECTIVE IDENTIFICATION; CLONAL ANALYSIS; CARCINOMA; BMI-1; LINE; GEMCITABINE; EXPRESSION	Background: Pancreatic cancer is one of the direct causes of cancer-related death. High level of chemoresistance is one of the major obstacles of clinical treatment. In recent years, cancer stem cells have been widely identified and indicated as the origin of chemoresistance in multi-types of solid tumors. Increasing evidences suggest that cancer stem cells reside in the cells capable of forming holoclones continuously. However, in pancreatic cancer, holoclone-forming cells have not been characterized yet. Therefore, the goal of our present study was to indentify the holoclone-forming pancreatic cancer stem cells and develop an in vitro continuous colony formation system, which will greatly facilitate the study of pancreatic cancer stem cells. Methodology/Principal Findings: Pancreatic cancer cell line BxPC3 was submitted to monoclonal cultivation to generate colonies. Based on the morphologies, colonies were classified and analyzed for their capacities of secondary colony formation, long-term survival in vitro, tumor formation in vivo, and drug resistance. Flowcytometry and quantitative RT-PCR were performed to detect the expression level of cancer stem cells associated cell surface markers, regulatory genes and microRNAs in distinct types of colonies. Three types of colonies with distinct morphologies were identified and termed as holo-, mero-, and paraclones, in which only holoclones generated descendant colonies of all three types in further passages. Compared to mero- and paraclones, holoclones possessed higher capacities of long-term survival, tumor initiation, and chemoresistance. The preferential expression of cancer stem cells related marker (CXCR4), regulatory genes (BMI1, GLI1, and GLI2) and microRNAs (miR-214, miR-21, miR-221, miR-222 and miR-155) in holoclones were also highlighted. Conclusions/Significance: Our results indicate that the pancreatic tumor-initiating cells with high level of chemoresistance were enriched in holoclones derived from BxPC3 cell line. Generation of holoclones can serve as a novel model for studying cancer stem cells, and attribute to developing new anti-cancer drugs.	[Tan, Lei; Sui, Xin; Deng, Hongkui; Ding, Mingxiao] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China	Peking University	Tan, L (corresponding author), Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China.	Dingmx01@pku.edu.cn		tan, lei/0000-0002-8473-4911	Ministry of Education [705001]; National Natural Science Foundation of China for Creative Research Groups [30421004]; 111 Project	Ministry of Education; National Natural Science Foundation of China for Creative Research Groups(National Natural Science Foundation of China (NSFC)); 111 Project(Ministry of Education, China - 111 Project)	This study was supported by a Ministry of Education grant (705001) (http://www.moe.edu.cn/), National Natural Science Foundation of China for Creative Research Groups (30421004) (http://www.nsfc.gov.cn), and 111 Project to HD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdouh M, 2009, J NEUROSCI, V29, P8884, DOI 10.1523/JNEUROSCI.0968-09.2009; Ahlgren JD, 1996, CANCER-AM CANCER SOC, V78, P654; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Chen RH, 2010, CANCER CELL, V17, P362, DOI 10.1016/j.ccr.2009.12.049; Chen SS, 2003, STEM CELLS, V21, P281, DOI 10.1634/stemcells.21-3-281; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Crea F, 2011, INT J CANCER, V128, P1946, DOI 10.1002/ijc.25522; de Braud F, 2004, CRIT REV ONCOL HEMAT, V50, P147, DOI 10.1016/S1040-8428(03)00156-2; Dembinski JL, 2009, CLIN EXP METASTAS, V26, P611, DOI 10.1007/s10585-009-9260-0; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Garcia-Manteiga J, 2003, CLIN CANCER RES, V9, P5000; Guo RJ, 2011, ONCOL REP, V25, P141, DOI 10.3892/or_00001053; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hosen N, 2007, STEM CELLS, V25, P1635, DOI 10.1634/stemcells.2006-0229; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Kanno SI, 2007, CLIN CHIM ACTA, V377, P144, DOI 10.1016/j.cca.2006.09.014; Kong W, 2010, J BIOL CHEM, V285, P17869, DOI 10.1074/jbc.M110.101055; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li H, 2008, CANCER RES, V68, P1820, DOI 10.1158/0008-5472.CAN-07-5878; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Locke M, 2005, CANCER RES, V65, P8944, DOI 10.1158/0008-5472.CAN-05-0931; Ma L, 2010, ACTA BIOCH BIOPH SIN, V42, P593, DOI 10.1093/abbs/gmq067; MARECHAL R, 2005, CLIN CANCER RES, V15, P2913; Molina-Arcas M, 2005, LEUKEMIA, V19, P64, DOI 10.1038/sj.leu.2403582; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Park JK, 2009, PANCREAS, V38, pE190, DOI 10.1097/MPA.0b013e3181ba82e1; Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769; QUANCAI C, 1992, BASIC MED SCI CLIN, V12, P50; Rizo A, 2009, BLOOD, V114, P1498, DOI 10.1182/blood-2009-03-209734; ROCHAT A, 1994, CELL, V76, P1063, DOI 10.1016/0092-8674(94)90383-2; Rosenberg L, 1997, INT J PANCREATOL, V22, P81; Rothenberg ML, 1996, CANCER, V78, P627; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; SILVA IA, 2011, CANC RES; Singh S, 2010, BRIT J CANCER, V103, P1671, DOI 10.1038/sj.bjc.6605968; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; TAN MH, 1986, CANCER INVEST, V4, P15, DOI 10.3109/07357908609039823; Tang DG, 2007, MOL CARCINOGEN, V46, P1, DOI 10.1002/mc.20255; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yu F, 2010, ONCOGENE, V29, P4194, DOI 10.1038/onc.2010.167; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhou ZH, 2009, CANCER LETT, V281, P92, DOI 10.1016/j.canlet.2009.02.033	48	31	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e23383	10.1371/journal.pone.0023383	http://dx.doi.org/10.1371/journal.pone.0023383			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826251	Green Submitted, gold, Green Published			2022-12-25	WOS:000293558900077
J	Yebra, M; Diaferia, GR; Montgomery, AMP; Kaido, T; Brunken, WJ; Koch, M; Hardiman, G; Crisa, L; Cirulli, V				Yebra, Mayra; Diaferia, Giuseppe R.; Montgomery, Anthony M. P.; Kaido, Thomas; Brunken, William J.; Koch, Manuel; Hardiman, Gary; Crisa, Laura; Cirulli, Vincenzo			Endothelium-Derived Netrin-4 Supports Pancreatic Epithelial Cell Adhesion and Differentiation through Integrins alpha 2 beta 1 and alpha 3 beta 1	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; BETA-CELLS; EXTRACELLULAR-MATRIX; GROWTH-FACTOR; INSULIN-SECRETION; GENE-TRANSCRIPTION; BASEMENT-MEMBRANE; PROGENITOR CELLS; MAMMARY-GLAND; MESSENGER-RNA	Background: Netrins have been extensively studied in the developing central nervous system as pathfinding guidance cues, and more recently in non-neural tissues where they mediate cell adhesion, migration and differentiation. Netrin-4, a distant relative of Netrins 1-3, has been proposed to affect cell fate determination in developing epithelia, though receptors mediating these functions have yet to be identified. Methodology/Principal Findings: Using human embryonic pancreatic cells as a model of developing epithelium, here we report that Netrin-4 is abundantly expressed in vascular endothelial cells and pancreatic ductal cells, and supports epithelial cell adhesion through integrins alpha 2 beta 1 and alpha 3 beta 1. Interestingly, we find that Netrin-4 recognition by embryonic pancreatic cells through integrins alpha 2 beta 1 and alpha 3 beta 1 promotes insulin and glucagon gene expression. In addition, full genome microarray analysis revealed that fetal pancreatic cell adhesion to Netrin-4 causes a prominent down-regulation of cyclins and up-regulation of negative regulators of the cell cycle. Consistent with these results, a number of other genes whose activities have been linked to developmental decisions and/or cellular differentiation are up-regulated. Conclusions/Significance: Given the recognized function of blood vessels in epithelial tissue morphogenesis, our results provide a mechanism by which endothelial-derived Netrin-4 may function as a pro-differentiation cue for adjacent developing pancreatic cell populations expressing adhesion receptors alpha 2 beta 1 and alpha 3 beta 1 integrins.	[Yebra, Mayra; Diaferia, Giuseppe R.; Montgomery, Anthony M. P.; Kaido, Thomas; Cirulli, Vincenzo] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Brunken, William J.] Suny Downstate Med Ctr, Dept Anat & Cellular Biol, Brooklyn, NY 11203 USA; [Koch, Manuel] Univ Cologne, Ctr Biochem, Inst Oral & Musculoskeletal Biol, Cologne, Germany; [Hardiman, Gary] Univ Calif San Diego, Biomed Genom Microarray Facil BIOGEM, La Jolla, CA 92093 USA; [Hardiman, Gary] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Crisa, Laura] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Crisa, Laura; Cirulli, Vincenzo] Univ Washington, Dept Med, Seattle, WA USA; [Crisa, Laura; Cirulli, Vincenzo] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Crisa, Laura; Cirulli, Vincenzo] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA	University of California System; University of California San Diego; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of Cologne; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Yebra, M (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.	vcirulli@u.washington.edu	Cirulli, Vincenzo/AAG-1102-2022; Koch, Manuel/AAG-9914-2021; Diaferia, Giuseppe/AAN-5910-2020; Cirulli, Vincenzo/AFK-2791-2022	Koch, Manuel/0000-0002-2962-7814; Diaferia, Giuseppe/0000-0003-4022-8483; Hardiman, Gary/0000-0003-4558-0400; Brunken, William J/0000-0001-7330-1814	NIH [DK55183, DK63443, DK55183-S1, CA69112, HL62477, DK063491, DK080506, HL075270, RR04050]; JDRF [197009]; Larry L. Hillblom Foundation; JDRF; NATIONAL CANCER INSTITUTE [R01CA069112] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075270, R01HL062477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055183, R24DK080506, R01DK063443, P30DK063491] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF(Juvenile Diabetes Research Foundation); Larry L. Hillblom Foundation; JDRF(Juvenile Diabetes Research Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	V. Cirulli was supported by NIH grants DK55183 and DK63443, a JDRF Research grant 197009, and a Network grant from The Larry L. Hillblom Foundation; M. Yebra by a NIH Minority Research Supplement (DK55183-S1); A. M. P. M. by NIH grants CA69112 and HL62477; G. Hardiman by NIH grants DK063491 and DK080506; L. Crisa by a JDRF Innovative Grant and NIH grant HL075270. G. Diaferia was the recipient of a JDRF Postdoctoral Fellowship. Confocal microscopy and imaging analysis was performed at The National Center for Microscopy and Imaging Research (UCSD), supported by NIH grant RR04050 to Dr. Mark H. Ellisman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allar MA, 2004, ENDOCRINOLOGY, V145, P2467, DOI 10.1210/en.2003-1641; Artner I, 2007, P NATL ACAD SCI USA, V104, P3853, DOI 10.1073/pnas.0700013104; Beattie GM, 1997, J CLIN ENDOCR METAB, V82, P1852, DOI 10.1210/jc.82.6.1852; Beattie GM, 1999, J MOL MED-JMM, V77, P70, DOI 10.1007/s001090050304; Belkin AM, 2000, MICROSC RES TECHNIQ, V51, P280, DOI 10.1002/1097-0029(20001101)51:3<280::AID-JEMT7>3.0.CO;2-O; Brakebusch C, 1997, J CELL SCI, V110, P2895; Butler PC, 2007, NAT CLIN PRACT ENDOC, V3, P758, DOI 10.1038/ncpendmet0647; Chadalavada Rajendrakumar S. V., 2005, Functional & Integrative Genomics, V5, P59, DOI 10.1007/s10142-005-0132-7; Cirulli V, 2000, J CELL BIOL, V150, P1445, DOI 10.1083/jcb.150.6.1445; Cirulli V, 2007, NAT REV MOL CELL BIO, V8, P296, DOI 10.1038/nrm2142; Cleaver O, 2001, DEV BIOL, V234, P1, DOI 10.1006/dbio.2001.0214; Cozar-Castellano I, 2006, DIABETES, V55, P70, DOI 10.2337/diabetes.55.01.06.db05-0632; EBERWINE J, 1992, P NATL ACAD SCI USA, V89, P3010, DOI 10.1073/pnas.89.7.3010; EBERWINE J, 1992, METHOD ENZYMOL, V216, P80; Edlund H, 1999, CURR OPIN CELL BIOL, V11, P663, DOI 10.1016/S0955-0674(99)00033-2; Fassler R, 1996, CURR OPIN CELL BIOL, V8, P641, DOI 10.1016/S0955-0674(96)80105-0; Georgia S, 2006, DEV BIOL, V298, P22, DOI 10.1016/j.ydbio.2006.05.036; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gmyr V, 2004, BIOCHEM BIOPH RES CO, V320, P27, DOI 10.1016/j.bbrc.2004.05.125; Grzesiak JJ, 2011, INT J CANCER, V129, P2905, DOI 10.1002/ijc.25942; Gutierrez J, 2006, J CELL PHYSIOL, V206, P58, DOI 10.1002/jcp.20428; Hoeflich A, 1996, AM J PHYSIOL-ENDOC M, V271, pE922, DOI 10.1152/ajpendo.1996.271.5.E922; Ivins JK, 2000, J NEUROSCI, V20, P6551, DOI 10.1523/JNEUROSCI.20-17-06551.2000; Jensen J, 2000, DIABETES, V49, P163, DOI 10.2337/diabetes.49.2.163; Kaido T, 2004, J BIOL CHEM, V279, P53762, DOI 10.1074/jbc.M411202200; Kaido T, 2004, J BIOL CHEM, V279, P17731, DOI 10.1074/jbc.M308425200; Kaido T, 2006, DIABETES, V55, P2723, DOI 10.2337/db06-0120; Kassem SA, 2001, DIABETES, V50, P2763, DOI 10.2337/diabetes.50.12.2763; Kim HJ, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-23; Kim SK, 2001, GENE DEV, V15, P111, DOI 10.1101/gad.859401; Kim SK, 1997, DEVELOPMENT, V124, P4243; Kishioka Y, 2008, J CELL PHYSIOL, V215, P856, DOI 10.1002/jcp.21371; Koch M, 2000, J CELL BIOL, V151, P221, DOI 10.1083/jcb.151.2.221; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lammert E, 2003, MECH DEVELOP, V120, P59, DOI 10.1016/S0925-4773(02)00332-5; Lecanda F, 1997, J CELL BIOCHEM, V67, P386, DOI 10.1002/(SICI)1097-4644(19971201)67:3<386::AID-JCB10>3.3.CO;2-5; LEE MH, 1995, GENE DEV, V9, P639, DOI 10.1101/gad.9.6.639; Li Y, 2007, MOL THER, V15, P1616, DOI 10.1038/sj.mt.6300250; Liu Y, 2004, CURR BIOL, V14, P897, DOI 10.1016/j.cub.2004.05.020; MATSUOKA S, 1995, GENE DEV, V9, P650, DOI 10.1101/gad.9.6.650; Matsuoka T, 2003, MOL CELL BIOL, V23, P6049, DOI 10.1128/MCB.23.17.6049-6062.2003; Menko KS, 2001, DEV DYNAM, V220, P337, DOI 10.1002/dvdy.1114; Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.0.CO;2-U; Nakajima I, 2002, BIOL CELL, V94, P197, DOI 10.1016/S0248-4900(02)01189-9; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; Park KW, 2005, DEV DYNAM, V234, P726, DOI 10.1002/dvdy.20474; Parnaud G, 2006, DIABETES, V55, P1413, DOI 10.2337/db05-1388; Qin ST, 2007, MOL CELL NEUROSCI, V34, P243, DOI 10.1016/j.mcn.2006.11.002; QUARTO R, 1993, DEVELOPMENT, V117, P245; RUOSLAHTI E, 1992, COLD SPRING HARB SYM, V57, P309, DOI 10.1101/SQB.1992.057.01.035; Salminen M, 2000, DEVELOPMENT, V127, P13; Santra M, 2000, J BIOL CHEM, V275, P35153, DOI 10.1074/jbc.M006821200; Sasik R, 2004, J MOL ENDOCRINOL, V33, P1, DOI 10.1677/jme.0.0330001; Scharfmann R, 2000, DIABETOLOGIA, V43, P1083, DOI 10.1007/s001250051498; Schneiders FI, 2007, J BIOL CHEM, V282, P23750, DOI 10.1074/jbc.M703137200; Shimizu H, 2000, J ENDOCRINOL, V166, P121, DOI 10.1677/joe.0.1660121; Srinivasan K, 2003, DEV CELL, V4, P371, DOI 10.1016/S1534-5807(03)00054-6; Staquicinia FI, 2009, P NATL ACAD SCI USA, V106, P2903, DOI 10.1073/pnas.0813286106; Streuli C, 1999, CURR OPIN CELL BIOL, V11, P634, DOI 10.1016/S0955-0674(99)00026-5; Tate MC, 2004, MOL CELL NEUROSCI, V27, P22, DOI 10.1016/j.mcn.2004.05.001; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Yanagisawa M, 2001, FEBS LETT, V489, P139, DOI 10.1016/S0014-5793(01)02095-6; Yang YHC, 2011, DIABETOLOGIA, V54, P828, DOI 10.1007/s00125-010-2012-5; Yebra M, 2003, DEV CELL, V5, P695, DOI 10.1016/S1534-5807(03)00330-7; Yew KH, 2005, J BIOL CHEM, V280, P32209, DOI 10.1074/jbc.M505465200; Yin Y, 2000, MECH DEVELOP, V96, P115, DOI 10.1016/S0925-4773(00)00369-5; Yu JM, 2006, MOL CELL BIOCHEM, V288, P17, DOI 10.1007/s11010-005-9113-3; Zhang CG, 2004, MOL BRAIN RES, V130, P68, DOI 10.1016/j.molbrainres.2004.07.009; Zhang XH, 2003, SURGERY, V133, P429, DOI 10.1067/msy.2003.107; Zhang X, 2007, NAT CELL BIOL, V9, P743, DOI 10.1038/ncb1603	70	36	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22750	10.1371/journal.pone.0022750	http://dx.doi.org/10.1371/journal.pone.0022750			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829502	gold, Green Submitted, Green Published			2022-12-25	WOS:000293286500025
J	Zanoni, BC; Phungula, T; Zanoni, HM; France, H; Feeney, ME				Zanoni, Brian C.; Phungula, Thuli; Zanoni, Holly M.; France, Holly; Feeney, Margaret E.			Risk Factors Associated with Increased Mortality among HIV Infected Children Initiating Antiretroviral Therapy (ART) in South Africa	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SEX-DIFFERENCES; RNA LEVELS; GENDER-DIFFERENCES; CARE; PROGRESSION; OUTCOMES; WOMEN; COHORT; ADULTS	Objective: To identify demographic and clinical risk factors associated with mortality after initiation of antiretroviral therapy (ART) in a cohort of human immunodeficiency (HIV) infected children in KwaZulu-Natal, South Africa. Methods: We performed a retrospective cohort study of 537 children initiating antiretroviral therapy at McCord Hospital in KwaZulu-Natal, South Africa. Data were extracted from electronic medical records and risk factors associated with mortality were assessed using Cox regression analysis. Results: Overall there were 47 deaths from the cohort of 537 children initiating ART with over 991 child-years of follow-up (median 22 months on ART), yielding a mortality rate of 4.7 deaths per 100 child years on ART. Univariate analysis indicated that mortality was significantly associated with lower weight-for-age Z-score (p<0.0001), chronic diarrhea (p = 0.0002), lower hemoglobin (p = 0.002), age <3 years (p = 0.003), and CD4% <10% (p = 0.005). The final multivariable Cox proportional hazards mortality model found age less than 3 years (p = 0.004), CD4 <10% (p = 0.01), chronic diarrhea (p = 0.03), weight-for-age Z-score (<0.0001) and female gender as a covariate varying with time (p = 0.03) all significantly associated with mortality. Conclusion: In addition to recognized risk factors such as young age and advanced immunosuppression, we found female gender to be significantly associated with mortality in this pediatric ART cohort. Future studies are needed to determine whether intrinsic biologic differences or socio-cultural factors place female children with HIV at increased risk of death following initiation of ART.	[Zanoni, Brian C.; Feeney, Margaret E.] MIT, Ragon Inst Massachusetts Gen Hosp, Charlestown, MA USA; [Zanoni, Brian C.; Feeney, Margaret E.] Harvard Univ, Charlestown, MA USA; [Zanoni, Brian C.] Harvard Univ, Sch Med, Boston, MA USA; [Zanoni, Brian C.; Phungula, Thuli; Zanoni, Holly M.; France, Holly] McCord Hosp, Sinikithemba Clin & Philani Program, Durban, South Africa; [Feeney, Margaret E.] Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA	Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard University; Harvard Medical School; University of California System; University of California San Francisco	Zanoni, BC (corresponding author), MIT, Ragon Inst Massachusetts Gen Hosp, Charlestown, MA USA.	margaret.feeney@ucsf.edu	Zanoni, Brian/AAI-4916-2021		Sullivan Family Foundation; Elizabeth Glaser Pediatric AIDS Foundation; Jewelers for Children Elizabeth Glaser Scientist Award	Sullivan Family Foundation; Elizabeth Glaser Pediatric AIDS Foundation; Jewelers for Children Elizabeth Glaser Scientist Award	This work was generously supported by the Sullivan Family Foundation and the Elizabeth Glaser Pediatric AIDS Foundation (M. E. F.). M. E. F. is the recipient of the Jewelers for Children Elizabeth Glaser Scientist Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolton-Moore C, 2007, JAMA-J AM MED ASSOC, V298, P1888, DOI 10.1001/jama.298.16.1888; Bong CN, 2007, AIDS, V21, P1805, DOI 10.1097/QAD.0b013e3282c3a9e4; Box TL, 2003, J WOMEN HEALTH GEN-B, V12, P391, DOI 10.1089/154099903765448907; Braitstein P, 2008, J WOMENS HEALTH, V17, P47, DOI 10.1089/jwh.2007.0353; Callens SFJ, 2009, PEDIATR INFECT DIS J, V28, P35, DOI 10.1097/INF.0b013e318184eeb9; Chen SCC, 2008, TROP MED INT HEALTH, V13, P513, DOI 10.1111/j.1365-3156.2008.02029.x; Collazos J, 2007, AIDS, V21, P835, DOI 10.1097/QAD.0b013e3280b0774a; Farzadegan H, 1998, LANCET, V352, P1510, DOI 10.1016/S0140-6736(98)02372-1; Fenner L, 2010, JAIDS-J ACQ IMM DEF, V54, P524, DOI 10.1097/QAI.0b013e3181e0c4cf; Flynn P, 2007, PEDIATRICS, V119, P821, DOI 10.1542/peds.2006-3694; Foca M, 2006, PEDIATRICS, V118, P146, DOI 10.1542/peds.2005-0294; Gandhi M, 2002, CLIN INFECT DIS, V35, P313, DOI 10.1086/341249; Giaquinto C, 2002, AIDS, V16, P97, DOI 10.1097/00002030-200201040-00012; Kiboneka A, 2008, AIDS, V22, P2493, DOI 10.1097/QAD.0b013e328318f148; Kipp W, 2010, AIDS CARE, V22, P271, DOI 10.1080/09540120903193625; Leyenaar JK, 2010, PEDIATR INFECT DIS J, V29, P340, DOI 10.1097/INF.0b013e3181bf8ecb; Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004; Muula AS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-63; Prendergast A, 2007, LANCET, V370, P68, DOI 10.1016/S0140-6736(07)61051-4; Reddi Anand, 2007, BMC Pediatr, V7, P13, DOI 10.1186/1471-2431-7-13; Richardson BA, 2003, J VIROL, V77, P7120, DOI 10.1128/JVI.77.12.7120-7123.2003; Shapiro MF, 1999, JAMA-J AM MED ASSOC, V281, P2305, DOI 10.1001/jama.281.24.2305; Sohler NL, 2009, AIDS PATIENT CARE ST, V23, P775, DOI 10.1089/apc.2009.0041; Sterling TR, 2001, NEW ENGL J MED, V344, P720, DOI 10.1056/NEJM200103083441003; Sterling TR, 1999, J INFECT DIS, V180, P666, DOI 10.1086/314967; Taha T E, 2000, Pediatrics, V106, pE77, DOI 10.1542/peds.106.6.e77; *UNAIDS, 2009, AIDS EP UPD; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Wamalwa DC, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-33; World Health Organization, 2010, ANT THER HIV INF INF; Yotebieng M, 2010, AIDS, V24, P1341, DOI 10.1097/QAD.0b013e328339e576; Zanoni BC, 2011, AIDS, V25, P49, DOI 10.1097/QAD.0b013e32833f9e04	32	43	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22706	10.1371/journal.pone.0022706	http://dx.doi.org/10.1371/journal.pone.0022706			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829487	Green Published, gold, Green Submitted			2022-12-25	WOS:000293286500020
J	Madec, Y; Germanaud, D; Moya-Alvarez, V; Alkassoum, W; Issa, A; Amadou, M; Tchiombiano, S; Pizzocolo, C; Huber, F; Diallo, S; Abdoulaye-Mamadou, R				Madec, Yoann; Germanaud, David; Moya-Alvarez, Violeta; Alkassoum, Wafa; Issa, Aichatou; Amadou, Morou; Tchiombiano, Stephanie; Pizzocolo, Cecilia; Huber, Florence; Diallo, Sanata; Abdoulaye-Mamadou, Roubanatou			HIV Prevalence and Impact on Renutrition in Children Hospitalised for Severe Malnutrition in Niger: An Argument for More Systematic Screening	PLOS ONE			English	Article							MALNOURISHED CHILDREN; MORTALITY	Background: In developing countries, malnutrition is a contributing factor in over 50% of child deaths. Mortality rates are higher in underweight children, and HIV-infection is known to increase underweight. Our goals were to evaluate the prevalence of HIV among children hospitalised for severe malnutrition (SM) at the Niamey national hospital (Niger), and to compare renutrition and mortality by HIV-status. Methods: Retrospective study based on all children <5 years hospitalised for SM between January 1(st) 2008 and July 1(st) 2009. HIV-prevalence was the ratio of HIV+ children on the number of children tested. Duration of renutrition and mortality were described using survival curves. Results: During the study period, 477 children were hospitalised for SM. HIV testing was accepted in 470 (98.5%), of which 40 were HIV+ (HIV prevalence (95% confidence interval) of 8.6% (6.2-11.5)). Duration of renutrition was longer in HIV+ than HIV- children (mean: 22 vs. 15 days; p = 0.003). During renutrition, 8 (20%) and 61 (14%) HIV+ and HIV- children died, respectively (p = 0.81). Conclusion: Around 9% of children hospitalised for severe malnutrition were HIV infected, while in Niger HIV prevalence in adults is estimated at 0.8%. This pleads for wider access to HIV testing in this population.	[Madec, Yoann] Inst Pasteur, Unite Epidemiol Malad Emergentes, Paris, France; [Germanaud, David; Moya-Alvarez, Violeta; Pizzocolo, Cecilia; Huber, Florence] Solthis, Paris, France; [Alkassoum, Wafa; Issa, Aichatou; Amadou, Morou; Abdoulaye-Mamadou, Roubanatou] Hop Natl Niamey, Serv Pediat, Niamey, Niger; [Tchiombiano, Stephanie; Diallo, Sanata; Abdoulaye-Mamadou, Roubanatou] Solthis, Niamey, Niger	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Madec, Y (corresponding author), Inst Pasteur, Unite Epidemiol Malad Emergentes, Paris, France.	yoann.madec@pasteur.fr	Germanaud, David/Q-2774-2017; Moya-Alvarez, Violeta/AAK-2238-2020	Germanaud, David/0000-0001-5055-4624; Moya-Alvarez, Violeta/0000-0001-7901-2263; Madec, Yoann/0000-0002-6201-1261; Huber, Florence/0000-0002-4340-0106				Akenami FOT, 1997, ACTA TROP, V64, P167, DOI 10.1016/S0001-706X(96)00629-8; ANAKY MF, B WHO, V88, P490; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Chinkhumba J, 2008, T ROY SOC TROP MED H, V102, P639, DOI 10.1016/j.trstmh.2008.04.028; Connelly A, 2008, SHOULD REHABILITATIO; Coviello V, 2004, STATA J, V4, P103, DOI 10.1177/1536867X0400400201; Fergusson P, 2009, T ROY SOC TROP MED H, V103, P541, DOI 10.1016/j.trstmh.2008.10.029; Heikens GT, 2008, LANCET, V371, P1305, DOI 10.1016/S0140-6736(08)60565-6; KELLERMAN S, PLOS MED, V7; Maitland K, 2006, PLOS MED, V3, P2431, DOI 10.1371/journal.pmed.0030500; Mishra V., 2009, LEVELS SPREAD HIV SE; PRAZUCK T, 1993, AIDS, V7, P103, DOI 10.1097/00002030-199301000-00016; Rollins NC, 2008, AIDS, V22, P2349, DOI 10.1097/QAD.0b013e328312c740; UNICEF, UNICEF STAT; WAMALWA DC, BMC PEDIAT, V10, P33; World Health Organization, 1999, MAN SEV MALN MAN PHY	16	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22787	10.1371/journal.pone.0022787	http://dx.doi.org/10.1371/journal.pone.0022787			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829514	Green Published, gold			2022-12-25	WOS:000293284600047
J	Boutry, C; Rezac, M; Blackledge, TA				Boutry, Cecilia; Rezac, Milan; Blackledge, Todd Alan			Plasticity in Major Ampullate Silk Production in Relation to Spider Phylogeny and Ecology	PLOS ONE			English	Article							CLAVIPES DRAGLINE SILK; BLACK-WIDOW SPIDER; MECHANICAL-PROPERTIES; TENSILE PROPERTIES; FIBERS SPUN; WEB SPIDER; PROTEIN; ORIENTATION; FIBROIN; BIOMECHANICS	Spider major ampullate silk is a high-performance biomaterial that has received much attention. However, most studies ignore plasticity in silk properties. A better understanding of silk plasticity could clarify the relative importance of chemical composition versus processing of silk dope for silk properties. It could also provide insight into how control of silk properties relates to spider ecology and silk uses. We compared silk plasticity (defined as variation in the properties of silk spun by a spider under different conditions) between three spider clades in relation to their anatomy and silk biochemistry. We found that silk plasticity exists in RTA clade and orbicularian spiders, two clades that differ in their silk biochemistry. Orbiculariae seem less dependent on external spinning conditions. They probably use a valve in their spinning duct to control friction forces and speed during spinning. Our results suggest that plasticity results from different processing of the silk dope in the spinning duct. Orbicularian spiders seem to display better control of silk properties, perhaps in relation to their more complex spinning duct valve.	[Boutry, Cecilia; Rezac, Milan; Blackledge, Todd Alan] Univ Akron, Dept Biol, Akron, OH 44325 USA; [Boutry, Cecilia; Rezac, Milan; Blackledge, Todd Alan] Univ Akron, Integrated Biosci Program, Akron, OH 44325 USA; [Rezac, Milan] Crop Res Inst, Dept Entomol, Prague 6, Ruzyne, Czech Republic	University System of Ohio; University of Akron; University System of Ohio; University of Akron; Czech Crop Research Institute (CRI)	Boutry, C (corresponding author), Univ Akron, Dept Biol, Akron, OH 44325 USA.	cb54@zips.uakron.edu	Řezáč, Milan/ABE-8186-2020	Rezac, Milan/0000-0003-4373-7064	National Science Foundation [DEB-0516038, IOS-0745379, DBI-0521261]; Czech Ministry of Agriculture [MZE0002700604]; University of Akron	National Science Foundation(National Science Foundation (NSF)); Czech Ministry of Agriculture(Ministry of Agriculture, Czech Republic); University of Akron	This research was supported by awards DEB-0516038, IOS-0745379 and DBI-0521261 from the National Science Foundation to TAB, grant #MZE0002700604 from the Czech Ministry of Agriculture to MR, and a University of Akron Integrated Bioscience award to CB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackledge TA, 2006, J EXP BIOL, V209, P2452, DOI 10.1242/jeb.02275; Blackledge TA, 2005, J EXP BIOL, V208, P1937, DOI 10.1242/jeb.01597; Blackledge TA, 2005, INVERTEBR BIOL, V124, P165, DOI 10.1111/j.1744-7410.2005.00016.x; Blackledge TA, 2009, P NATL ACAD SCI USA, V106, P5229, DOI 10.1073/pnas.0901377106; Blamires SJ, 2010, J EXP BIOL, V213, P3906, DOI 10.1242/jeb.046730; Boutry C, 2008, J EXP ZOOL PART A, V309A, P542, DOI 10.1002/jez.487; Boutry C, 2009, ZOOLOGY, V112, P451, DOI 10.1016/j.zool.2009.03.003; CAPELLO J, 1994, ACS SYM SER, P311; Chen X, 2006, SOFT MATTER, V2, P448, DOI 10.1039/b601286h; CRAIG CL, 1987, BIOL J LINN SOC, V30, P135, DOI 10.1111/j.1095-8312.1987.tb00294.x; Craig CL, 2003, SPIDERWEBS SILK TRAC; Dicko C, 2004, BIOMACROMOLECULES, V5, P704, DOI 10.1021/bm034307c; Eadie L, 2011, J R SOC INTERFACE, V8, P761, DOI 10.1098/rsif.2010.0487; Eles PT, 2004, BIOMACROMOLECULES, V5, P661, DOI 10.1021/bm0342685; Gaines WA, 2010, J BIOL CHEM, V285, P40745, DOI 10.1074/jbc.M110.163121; Garrido MA, 2002, POLYMER, V43, P1537, DOI 10.1016/S0032-3861(01)00713-3; GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9; Gosline JM, 1999, J EXP BIOL, V202, P3295; Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112; Guinea GV, 2006, BIOMACROMOLECULES, V7, P2173, DOI 10.1021/bm060138v; Guinea GV, 2005, J EXP ZOOL PART A, V303A, P37, DOI 10.1002/jez.a.111; Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0; HINMAN MB, 1992, J BIOL CHEM, V267, P19320; Hinman MB, 2000, TRENDS BIOTECHNOL, V18, P374, DOI 10.1016/S0167-7799(00)01481-5; Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006; Ko FK, 2004, BIOMACROMOLECULES, V5, P780, DOI 10.1021/bm0345099; KOVOOR J, 1977, Annee Biologique, V16, P97; Kummerlen J, 1996, MACROMOLECULES, V29, P2920, DOI 10.1021/ma951098i; Lawrence BA, 2004, BIOMACROMOLECULES, V5, P689, DOI 10.1021/bm0342640; Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780; Liivak O, 1997, MACROMOLECULES, V30, P7127, DOI 10.1021/ma970834a; Liu Y, 2008, BIOMACROMOLECULES, V9, P116, DOI 10.1021/bm700877g; Madsen B, 1999, INT J BIOL MACROMOL, V24, P301, DOI 10.1016/S0141-8130(98)00094-4; Madsen B, 2000, NATURWISSENSCHAFTEN, V87, P148, DOI 10.1007/s001140050694; OPELL BD, 1994, FUNCT ECOL, V8, P85, DOI 10.2307/2390115; Ortlepp CS, 2004, BIOMACROMOLECULES, V5, P727, DOI 10.1021/bm034269x; Perez-Rigueiro J, 2005, J EXP BIOL, V208, P2633, DOI 10.1242/jeb.01701; Perez-Riguero J, 2001, J APPL POLYM SCI, V82, P2245, DOI 10.1002/app.2072; Pollard S.D., 1987, P133; Pouchkina-Stantcheva NN, 2004, COMP BIOCHEM PHYS B, V138, P371, DOI 10.1016/j.cbpc.2004.04.020; Read J, 2006, AM J BOT, V93, P1546, DOI 10.3732/ajb.93.10.1546; Rising A, 2007, INSECT MOL BIOL, V16, P551, DOI 10.1111/j.1365-2583.2007.00749.x; Rising A, 2005, ZOOL SCI, V22, P273, DOI 10.2108/zsj.22.273; Savage KN, 2008, J EXP BIOL, V211, P1948, DOI 10.1242/jeb.014225; Seidel A, 2000, MACROMOLECULES, V33, P775, DOI 10.1021/ma990893j; Sensenig A, 2010, J EVOLUTION BIOL, V23, P1839, DOI 10.1111/j.1420-9101.2010.02048.x; Shao ZZ, 1999, POLYMER, V40, P1799, DOI 10.1016/S0032-3861(98)00266-3; Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84; Swanson BO, 2006, APPL PHYS A-MATER, V82, P213, DOI 10.1007/s00339-005-3427-6; Tian MZ, 2004, BIOMACROMOLECULES, V5, P657, DOI 10.1021/bm034391w; TIETJEN WJ, 1983, SPIDER COMMUNICATION, P249; Tso IM, 2007, ETHOLOGY, V113, P324, DOI 10.1111/j.1439-0310.2007.01318.x; Tso IM, 2005, J EXP BIOL, V208, P1053, DOI 10.1242/jeb.01437; van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299; Vincent JFV, 2002, COMPOS PART A-APPL S, V33, P1311, DOI 10.1016/S1359-835X(02)00167-7; Vollrath F, 2000, J Biotechnol, V74, P67; Vollrath F, 1999, INT J BIOL MACROMOL, V24, P243, DOI 10.1016/S0141-8130(98)00095-6; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000; Vollrath F, 2001, P ROY SOC B-BIOL SCI, V268, P2339, DOI 10.1098/rspb.2001.1590; WILSON RS, 1962, Q J MICROSC SCI, V103, P549; WILSON RS, 1969, AM ZOOL, V9, P103; Woll S, 2007, J CELL BIOL, V177, P795, DOI 10.1083/jcb.200703174; XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120; Zax DB, 2004, BIOMACROMOLECULES, V5, P732, DOI 10.1021/bm034309x	64	17	17	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22467	10.1371/journal.pone.0022467	http://dx.doi.org/10.1371/journal.pone.0022467			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818328	Green Published, gold, Green Submitted			2022-12-25	WOS:000293282700033
J	Lou, HC; Joensson, M; Biermann-Ruben, K; Schnitzler, A; Ostergaard, L; Kjaer, TW; Gross, J				Lou, Hans C.; Joensson, Morten; Biermann-Ruben, Katja; Schnitzler, Alfons; Ostergaard, Leif; Kjaer, Troels W.; Gross, Joachim			Recurrent Activity in Higher Order, Modality Non-Specific Brain Regions: A Granger Causality Analysis of Autobiographic Memory Retrieval	PLOS ONE			English	Article							SELF; CONSCIOUSNESS; FEEDFORWARD; AWARENESS	It has been proposed that the workings of the brain are mainly intrinsically generated recurrent neuronal activity, with sensory inputs as modifiers of such activity in both sensory and higher order modality non-specific regions. This is supported by the demonstration of recurrent neuronal activity in the visual system as a response to visual stimulation. In contrast recurrent activity has never been demonstrated before in higher order modality non-specific regions. Using magneto-encephalography and Granger causality analysis, we tested in a paralimbic network the hypothesis that stimulation may enhance causal recurrent interaction between higher-order, modality non-specific regions. The network includes anterior cingulate/medial prefrontal and posterior cingulate/medial parietal cortices together with pulvinar thalami, a network known to be effective in autobiographic memory retrieval and self-awareness. Autobiographic memory retrieval of previous personal judgments of visually presented words was used as stimuli. It is demonstrated that the prestimulus condition is characterized by causal, recurrent oscillations which are maximal in the lower gamma range. When retrieving previous judgments of visually presented adjectives, this activity is dramatically increased during the stimulus task as ascertained by Granger causality analysis. Our results confirm the hypothesis that stimulation may enhance causal interaction between higher order, modality non-specific brain regions, exemplified in a network of autobiographical memory retrieval.	[Lou, Hans C.; Joensson, Morten; Ostergaard, Leif] Aarhus Univ, Ctr Functionally Integrat Neurosci, Aarhus, Denmark; [Biermann-Ruben, Katja; Schnitzler, Alfons] Univ Dusseldorf, Dept Neurol, D-4000 Dusseldorf, Germany; [Kjaer, Troels W.] Univ Copenhagen, Rigshosp, Dept Clin Neurophysiol, DK-2100 Copenhagen, Denmark; [Gross, Joachim] Univ Glasgow, Dept Psychol, Glasgow, Lanark, Scotland	Aarhus University; Heinrich Heine University Dusseldorf; Rigshospitalet; University of Copenhagen; University of Glasgow	Lou, HC (corresponding author), Aarhus Univ, Ctr Functionally Integrat Neurosci, Aarhus, Denmark.	hanslou1@gmail.com; jgross@psy.gla.ac.uk	Østergaard, Leif/A-9281-2008; Ostergaard, Lars/AAA-3020-2020; Schnitzler, Alfons/AAT-1054-2021; Schnitzler, Alfons/Q-5520-2019; Schnitzler, Alfons/K-4625-2014; Gross, Joachim/C-5886-2009	Østergaard, Leif/0000-0003-2930-6997; Ostergaard, Lars/0000-0003-2459-0511; Schnitzler, Alfons/0000-0002-6414-7939; Schnitzler, Alfons/0000-0002-6414-7939; Gross, Joachim/0000-0002-3994-1006; Ostergaard, Lars/0000-0002-7619-605X	Lundbeck Foundation [226/06]	Lundbeck Foundation(Lundbeckfonden)	This work was funded by the Lundbeck Foundation, grant no. 226/06 (www.Lundbeckfonden.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHONEN AI, 1993, PHYS SCRIPTA, VT49A, P198, DOI 10.1088/0031-8949/1993/T49A/033; Camprodon JA, 2010, J COGNITIVE NEUROSCI, V22, P1262, DOI 10.1162/jocn.2009.21253; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; Chavez M, 2003, J NEUROSCI METH, V124, P113, DOI 10.1016/S0165-0270(02)00367-9; Daselaar SM, 2008, CEREB CORTEX, V18, P217, DOI 10.1093/cercor/bhm048; Dauwels J, 2009, IEEE ENG MED BIO, P2224, DOI 10.1109/IEMBS.2009.5334862; Edelman G.M., 1989, REMEMBERED PRESENT B; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Gaillard R, 2009, PLOS BIOL, V7, P472, DOI 10.1371/journal.pbio.1000061; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Goldman MS, 2009, NEURON, V61, P621, DOI 10.1016/j.neuron.2008.12.012; Gross J, 2003, NEUROIMAGE, V19, P1329, DOI 10.1016/S1053-8119(03)00101-0; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Hacker RS, 2006, APPL ECON, V38, P1489, DOI 10.1080/00036840500405763; James W., 1890, PRINCIPLES PSYCHOL; Kjaer TW, 2002, NEUROIMAGE, V17, P1080, DOI 10.1006/nimg.2002.1230; Kwan VSY, 2007, EXP BRAIN RES, V182, P379, DOI 10.1007/s00221-007-0992-2; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Laureys S, 2004, NEUROREHABILITATION, V19, P335; LIBET B, 1991, BRAIN, V114, P1731, DOI 10.1093/brain/114.4.1731; Libet B, 1982, Hum Neurobiol, V1, P235; Llinas R, 1998, PHILOS T ROY SOC B, V353, P1841, DOI 10.1098/rstb.1998.0336; LLINAS RR, 1991, NEUROSCIENCE, V44, P521, DOI 10.1016/0306-4522(91)90075-Y; Lou HC, 2010, HUM BRAIN MAPP, V31, P185, DOI 10.1002/hbm.20855; Lou HC, 2004, P NATL ACAD SCI USA, V101, P6827, DOI 10.1073/pnas.0400049101; Maguire EA, 2001, PHILOS T R SOC B, V356, P1441, DOI 10.1098/rstb.2001.0944; MOGILNER A, 1991, P NATL ACAD SCI USA, V88, P11037; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; PASCAL B, 1966, PENGUIN, V1, P75; Pascual-Leone A, 2001, SCIENCE, V292, P510, DOI 10.1126/science.1057099; Rolls ET, 1999, J COGNITIVE NEUROSCI, V11, P300, DOI 10.1162/089892999563409; Scholte HS, 2008, J COGNITIVE NEUROSCI, V20, P2097, DOI 10.1162/jocn.2008.20142; Seth AK, 2005, NETWORK-COMP NEURAL, V16, P35, DOI 10.1080/09548980500238756; Sitnikova E, 2008, J NEUROSCI METH, V170, P245, DOI 10.1016/j.jneumeth.2008.01.017; Tononi G, 2008, ANN NY ACAD SCI, V1124, P239, DOI 10.1196/annals.1440.004; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056	36	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22286	10.1371/journal.pone.0022286	http://dx.doi.org/10.1371/journal.pone.0022286			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818307	gold, Green Published, Green Submitted			2022-12-25	WOS:000293282700021
J	Price, DP; Nagarajan, V; Churbanov, A; Houde, P; Milligan, B; Drake, LL; Gustafson, JE; Hansen, IA				Price, David P.; Nagarajan, Vijayaraj; Churbanov, Alexander; Houde, Peter; Milligan, Brook; Drake, Lisa L.; Gustafson, John E.; Hansen, Immo A.			The Fat Body Transcriptomes of the Yellow Fever Mosquito Aedes aegypti, Pre- and Post- Blood Meal	PLOS ONE			English	Article							PROTEIN GENE-EXPRESSION; AMINO-ACID-SEQUENCES; DROSOPHILA-MELANOGASTER; CATHEPSIN-B; SIGNALING CASCADE; IMMUNITY; CDNA; RNA; CARBOXYPEPTIDASE; ANNOTATION	Background: The fat body is the main organ of intermediary metabolism in insects and the principal source of hemolymph proteins. As part of our ongoing efforts to understand mosquito fat body physiology and to identify novel targets for insect control, we have conducted a transcriptome analysis of the fat body of Aedes aegypti before and in response to blood feeding. Results: We created two fat body non-normalized EST libraries, one from mosquito fat bodies non-blood fed (NBF) and another from mosquitoes 24 hrs post-blood meal (PBM). 454 pyrosequencing of the non-normalized libraries resulted in 204,578 useable reads from the NBF sample and 323,474 useable reads from the PBM sample. Alignment of reads to the existing reference Ae. aegypti transcript libraries for analysis of differential expression between NBF and PBM samples revealed 116,912 and 115,051 matches, respectively. De novo assembly of the reads from the NBF sample resulted in 15,456 contigs, and assembly of the reads from the PBM sample resulted in 15,010 contigs. Collectively, 123 novel transcripts were identified within these contigs. Prominently expressed transcripts in the NBF fat body library were represented by transcripts encoding ribosomal proteins. Thirty-five point four percent of all reads in the PBM library were represented by transcripts that encode yolk proteins. The most highly expressed were transcripts encoding members of the cathepsin b, vitellogenin, vitellogenic carboxypeptidase, and vitelline membrane protein families. Conclusion: The two fat body transcriptomes were considerably different from each other in terms of transcript expression in terms of abundances of transcripts and genes expressed. They reflect the physiological shift of the pre-feeding fat body from a resting state to vitellogenic gene expression after feeding.	[Price, David P.; Gustafson, John E.; Hansen, Immo A.] New Mexico State Univ, Program Mol Biol, Las Cruces, NM 88003 USA; [Churbanov, Alexander; Houde, Peter; Milligan, Brook; Drake, Lisa L.; Gustafson, John E.; Hansen, Immo A.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Hansen, Immo A.] New Mexico State Univ, Inst Appl Biosci, Las Cruces, NM 88003 USA; [Churbanov, Alexander; Houde, Peter; Milligan, Brook] New Mexico State Univ, Roadrunner Sequencing Lab, Las Cruces, NM 88003 USA; [Nagarajan, Vijayaraj] NIAID, BCBB, OCICB, OSMO,OD,NIH, Bethesda, MD 20892 USA	New Mexico State University; New Mexico State University; New Mexico State University; New Mexico State University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Price, DP (corresponding author), New Mexico State Univ, Program Mol Biol, Las Cruces, NM 88003 USA.	immoh@nmsu.edu			NIH/NIGMS [1SC2GM092300-01]; NSF [DBI-0821806]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC2GM092300] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH/NIGMS 1SC2GM092300-01 (IAH). NSF DBI-0821806 (PH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagna F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-399; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Attardo GM, 2005, INSECT BIOCHEM MOLEC, V35, P661, DOI 10.1016/j.ibmb.2005.02.013; BECHET DM, 1991, J BIOL CHEM, V266, P14104; Bian G, 2005, P NATL ACAD SCI USA, V102, P13568, DOI 10.1073/pnas.0502815102; BOMAN HG, 1981, TRENDS BIOCHEM SCI, V6, P306, DOI 10.1146/annurev.mi.41.100187.000535; Bonizzoni M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-82; Browder M. H., 2001, Journal of Insect Science (Tucson), V1, P1; CHAN SJ, 1986, P NATL ACAD SCI USA, V83, P7721, DOI 10.1073/pnas.83.20.7721; Chandrasekar R, 2008, ARCH INSECT BIOCHEM, V69, P70, DOI 10.1002/arch.20266; Chapman R.F., 2012, INSECTS STRUCTURE FU; Chatzopoulou FM, 2010, PLANT CELL REP, V29, P523, DOI 10.1007/s00299-010-0841-9; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; CHO WL, 1991, P NATL ACAD SCI USA, V88, P10821, DOI 10.1073/pnas.88.23.10821; Clements AN., 1992, BIOL MOSQUITOES DEV; COHEN LW, 1986, GENE, V48, P219, DOI 10.1016/0378-1119(86)90080-6; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Coutinho-Abreu IV, 2010, PARASITOL INT, V59, P1, DOI 10.1016/j.parint.2009.10.002; Deitsch K.W., 1993, Insect Molecular Biology, V2, P205, DOI 10.1111/j.1365-2583.1994.tb00140.x; DIMARCQ JL, 1994, EUR J BIOCHEM, V221, P201, DOI 10.1111/j.1432-1033.1994.tb18730.x; Dissanayake Sumudu N, 2010, BMC Res Notes, V3, P248, DOI 10.1186/1756-0500-3-248; Dittmer NT, 2003, MOL CELL ENDOCRINOL, V210, P39, DOI 10.1016/j.mce.2003.08.010; Donohue KV, 2010, INSECT BIOCHEM MOLEC, V40, P79, DOI 10.1016/j.ibmb.2009.12.014; DRAKE LLB, PLOS ONE; Edwards MJ, 1998, INSECT BIOCHEM MOLEC, V28, P915, DOI 10.1016/S0965-1748(98)00083-6; Erickson SM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000529; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Feitosa FM, 2006, J INSECT SCI, V6; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hansen IA, 2005, J BIOL CHEM, V280, P20565, DOI 10.1074/jbc.M500712200; Hansen IA, 2004, P NATL ACAD SCI USA, V101, P10626, DOI 10.1073/pnas.0403460101; Hansen IA, 2002, EUR J BIOCHEM, V269, P954, DOI 10.1046/j.0014-2956.2001.02736.x; Harris J, 2006, INT J EXP PATHOL, V87, P29, DOI 10.1111/j.0959-9673.2006.00450.x; Haunerland NH, 1996, INSECT BIOCHEM MOLEC, V26, P755, DOI 10.1016/S0965-1748(96)00035-5; HAUNERLAND NH, 1990, INSECT BIOCHEM, V20, P829, DOI 10.1016/0020-1790(90)90101-Y; Im E, 2005, MOL BIOL CELL, V16, P3488, DOI 10.1091/mbc.E04-11-1029; Jiang ZH, 2005, OBES RES, V13, P1898, DOI 10.1038/oby.2005.233; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kokoza V, 2010, P NATL ACAD SCI USA, V107, P8111, DOI 10.1073/pnas.1003056107; Korochkina SE, 1997, INSECT BIOCHEM MOLEC, V27, P813, DOI 10.1016/S0965-1748(97)00053-2; Lawson D, 2007, NUCLEIC ACIDS RES, V35, pD503, DOI 10.1093/nar/gkl960; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; LIN YG, 1993, DEV BIOL, V155, P558, DOI 10.1006/dbio.1993.1052; LOFTUS BJ, 2005, AEDES AEGYPTI CDNA S; Luckhart S, 2007, DEV COMP IMMUNOL, V31, P647, DOI 10.1016/j.dci.2006.10.005; Niu LL, 2000, INSECT MOL BIOL, V9, P613, DOI 10.1046/j.1365-2583.2000.00226.x; Nowrousian M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000891; PAL R, 1967, B WORLD HEALTH ORGAN, V36, P583; Park JH, 2006, J BIOL CHEM, V281, P11167, DOI 10.1074/jbc.M601517200; Raikhel AS, 2002, INSECT BIOCHEM MOLEC, V32, P1275, DOI 10.1016/S0965-1748(02)00090-5; RAIKHEL AS, 1990, GEN COMP ENDOCR, V77, P423, DOI 10.1016/0016-6480(90)90233-C; RAIKHEL AS, 1992, ANNU REV ENTOMOL, V37, P217, DOI 10.1146/annurev.en.37.010192.001245; Ren QH, 2004, NUCLEIC ACIDS RES, V32, pD284, DOI 10.1093/nar/gkh016; Renwick SB, 1998, STRUCTURE, V6, P1105, DOI 10.1016/S0969-2126(98)00112-9; Richman AM, 1997, EMBO J, V16, P6114, DOI 10.1093/emboj/16.20.6114; Riehle MA, 1999, INSECT BIOCHEM MOLEC, V29, P855, DOI 10.1016/S0965-1748(99)00084-3; Riehle MA, 2003, INSECT MOL BIOL, V12, P225, DOI 10.1046/j.1365-2583.2003.00405.x; Roy SG, 2007, INSECT BIOCHEM MOLEC, V37, P1317, DOI 10.1016/j.ibmb.2007.08.004; Sanders HR, 2003, INSECT BIOCHEM MOLEC, V33, P1105, DOI 10.1016/S0965-1748(03)00124-3; Scaraffia PY, 2010, J INSECT PHYSIOL, V56, P1040, DOI 10.1016/j.jinsphys.2010.02.016; Shin SW, 2002, P NATL ACAD SCI USA, V99, P9978, DOI 10.1073/pnas.162345999; Snigirevskaya ES, 1997, CELL TISSUE RES, V290, P129, DOI 10.1007/s004410050915; Stekel DJ, 2000, GENOME RES, V10, P2055, DOI 10.1101/gr.GR-1325RR; TAKIO K, 1983, P NATL ACAD SCI-BIOL, V80, P3666, DOI 10.1073/pnas.80.12.3666; Tufail M, 2008, J INSECT PHYSIOL, V54, P1447, DOI 10.1016/j.jinsphys.2008.08.007; WATTAM AR, 1992, AM J TROP MED HYG, V47, P702, DOI 10.4269/ajtmh.1992.47.702; WATTAM AR, 1992, J PARASITOL, V78, P1092, DOI 10.2307/3283238; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; WHO, 2007, GLOB PROGR EL LYMPH; Zagrobelny M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-574; Zhu JS, 2003, P NATL ACAD SCI USA, V100, P544, DOI 10.1073/pnas.0235695100; 2010, UNIGENE ORGANIZED VI; 2010, DENGUE FEVER FACT SH; 2010, PRIMER BLAST; SEQ READ ARCH; 2010, CHEVREUX JBAB	81	60	62	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22573	10.1371/journal.pone.0022573	http://dx.doi.org/10.1371/journal.pone.0022573			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818341	Green Published, gold, Green Submitted			2022-12-25	WOS:000293282700042
J	Shiels, PG; McGlynn, LM; MacIntyre, A; Johnson, PCD; Batty, GD; Burns, H; Cavanagh, J; Deans, KA; Ford, I; McConnachie, A; McGinty, A; McLean, JS; Millar, K; Sattar, N; Tannahill, C; Velupillai, YN; Packard, CJ				Shiels, Paul G.; McGlynn, Liane M.; MacIntyre, Alan; Johnson, Paul C. D.; Batty, G. David; Burns, Harry; Cavanagh, Jonathan; Deans, Kevin A.; Ford, Ian; McConnachie, Alex; McGinty, Agnes; McLean, Jennifer S.; Millar, Keith; Sattar, Naveed; Tannahill, Carol; Velupillai, Yoga N.; Packard, Chris J.			Accelerated Telomere Attrition Is Associated with Relative Household Income, Diet and Inflammation in the pSoBid Cohort	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CELLULAR SENESCENCE; SOCIOECONOMIC-STATUS; OXIDATIVE STRESS; OLDER MEN; LENGTH; RISK; MORTALITY; HEALTH; CELLS	Background: It has previously been hypothesized that lower socio-economic status can accelerate biological ageing, and predispose to early onset of disease. This study investigated the association of socio-economic and lifestyle factors, as well as traditional and novel risk factors, with biological-ageing, as measured by telomere length, in a Glasgow based cohort that included individuals with extreme socio-economic differences. Methods: A total of 382 blood samples from the pSoBid study were available for telomere analysis. For each participant, data was available for socio-economic status factors, biochemical parameters and dietary intake. Statistical analyses were undertaken to investigate the association between telomere lengths and these aforementioned parameters. Results: The rate of age-related telomere attrition was significantly associated with low relative income, housing tenure and poor diet. Notably, telomere length was positively associated with LDL and total cholesterol levels, but inversely correlated to circulating IL-6. Conclusions: These data suggest lower socio-economic status and poor diet are relevant to accelerated biological ageing. They also suggest potential associations between elevated circulating IL-6, a measure known to predict cardiovascular disease and diabetes with biological ageing. These observations require further study to tease out potential mechanistic links.	[Shiels, Paul G.; McGlynn, Liane M.; MacIntyre, Alan] Univ Glasgow, Inst Canc Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Johnson, Paul C. D.; Ford, Ian; McConnachie, Alex] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Batty, G. David] MRC, Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [Batty, G. David] UCL, Clin Epidemiol Grp, Dept Epidemiol & Publ Hlth, London, England; [Burns, Harry] Scottish Govt, Edinburgh, Midlothian, Scotland; [Cavanagh, Jonathan; Millar, Keith] Univ Glasgow, Sect Psychol Med, Glasgow, Lanark, Scotland; [Deans, Kevin A.] Glasgow Royal Infirm, Dept Clin Biochem, NHS Greater Glasgow & Clyde, Glasgow G4 0SF, Lanark, Scotland; [Deans, Kevin A.] Aberdeen Royal Infirm, Dept Clin Biochem, Aberdeen, Scotland; [McGinty, Agnes; Packard, Chris J.] Glasgow Clin Res Facil, Glasgow, Lanark, Scotland; [McLean, Jennifer S.; Tannahill, Carol] Glasgow Ctr Populat Hlth, Glasgow, Lanark, Scotland; [Sattar, Naveed] Univ Glasgow, Inst Cardiovasc & Med Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Velupillai, Yoga N.] Univ Coll Cork, Epidemiol & Publ Hlth Dept, Cork, Ireland	University of Glasgow; University of Glasgow; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of London; University College London; University of Glasgow; University of Glasgow; University of Aberdeen; University of Glasgow; University College Cork	Shiels, PG (corresponding author), Univ Glasgow, Inst Canc Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	Paul.Shiels@glasgow.ac.uk	Ford, Ian/ABE-6145-2020; Johnson, Paul C D/O-9695-2014; Batty, GD/Y-4401-2018	Johnson, Paul C D/0000-0001-6663-7520; Batty, GD/0000-0003-1822-5753; Shiels, Paul/0000-0002-7577-9843	Glasgow Centre for Population Health; Glasgow City Council; University of Glasgow; MRC [MC_U130059821] Funding Source: UKRI; Medical Research Council [MC_U130059821] Funding Source: researchfish	Glasgow Centre for Population Health; Glasgow City Council; University of Glasgow; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Glasgow Centre for Population Health, a partnership between NHS Greater Glasgow and Clyde, Glasgow City Council and the University of Glasgow, supported by the Scottish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2007, AGING CELL, V6, P125, DOI 10.1111/j.1474-9726.2006.00258.x; Aviv A, 2006, INT J EPIDEMIOL, V35, P1424, DOI 10.1093/ije/dyl169; Aviv A, 2009, INT J EPIDEMIOL, V38, P1735, DOI 10.1093/ije/dyp298; Batty GD, 2009, J EPIDEMIOL COMMUN H, V63, P839, DOI 10.1136/jech.2009.088427; Benetos A, 2004, HYPERTENSION, V43, P182, DOI 10.1161/01.HYP.0000113081.42868.f4; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Carrero JJ, 2008, J INTERN MED, V263, P302, DOI 10.1111/j.1365-2796.2007.01890.x; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cherkas LF, 2006, AGING CELL, V5, P361, DOI 10.1111/j.1474-9726.2006.00222.x; Danesh J, 2008, PLOS MED, V5, P600, DOI 10.1371/journal.pmed.0050078; Deans KA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4170; Demissie S, 2006, AGING CELL, V5, P325, DOI 10.1111/j.1474-9726.2006.00224.x; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Fuster JJ, 2007, J HYPERTENS, V25, P2185, DOI 10.1097/HJH.0b013e3282ef6196; Gompertz B, 1825, PHILOS T ROY SOC LON, V31, P513, DOI [10.1098/rstl.1825.0026, DOI 10.1098/RSTL.1825.0026]; Hanlon P, 2006, LET GLASGOW FLOURISH; Harris SE, 2006, NEUROSCI LETT, V406, P260, DOI 10.1016/j.neulet.2006.07.055; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Koppelstaetter C, 2008, AGING CELL, V7, P491, DOI 10.1111/j.1474-9726.2008.00398.x; Koppelstaetter C, 2009, CURR MED CHEM, V16, P3469, DOI 10.2174/092986709789057644; Lamb Kelly J, 2009, SEB Exp Biol Ser, V62, P117; Liu Y, 2009, AGING CELL, V8, P439, DOI 10.1111/j.1474-9726.2009.00489.x; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Marmot M., 2004, STATUS SYNDROME YOUR; Martin-Ruiz CM, 2005, AGING CELL, V4, P287, DOI 10.1111/j.1474-9726.2005.00171.x; McGlynn LM, 2009, AGING CELL, V8, P45, DOI 10.1111/j.1474-9726.2008.00447.x; Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104; Nordfjall K, 2008, OBESITY, V16, P2682, DOI 10.1038/oby.2008.413; OLOVNIKO.AM, 1971, DOKL AKAD NAUK SSSR+, V201, P1496; Ornish D, 2008, LANCET ONCOL, V9, P1048, DOI 10.1016/S1470-2045(08)70234-1; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Saretzki G, 2002, ANN NY ACAD SCI, V959, P24, DOI 10.1111/j.1749-6632.2002.tb02079.x; Sattar N, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000099; SHIELS PG, 2010, J GERONTOLOGY; Sprott RL, 2010, EXP GERONTOL, V45, P2, DOI 10.1016/j.exger.2009.07.008; Taylor AE, 2010, AM J CLIN NUTR, V91, P547, DOI 10.3945/ajcn.2009.28757; Velupillai YN, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-126; Wannamethee SG, 2007, DIABETES CARE, V30, P1200, DOI 10.2337/dc06-2416; Welsh P, 2010, CYTOKINE, V50, P94, DOI 10.1016/j.cyto.2009.12.014; Woo J, 2009, AGE AGEING, V38, P553, DOI 10.1093/ageing/afp098	44	106	107	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22521	10.1371/journal.pone.0022521	http://dx.doi.org/10.1371/journal.pone.0022521			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818333	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000293282700035
J	Yore, MM; Kettenbach, AN; Sporn, MB; Gerber, SA; Liby, KT				Yore, Mark M.; Kettenbach, Arminja N.; Sporn, Michael B.; Gerber, Scott A.; Liby, Karen T.			Proteomic Analysis Shows Synthetic Oleanane Triterpenoid Binds to mTOR	PLOS ONE			English	Article							CDDO-METHYL ESTER; NITRIC-OXIDE PRODUCTION; TUMOR-NECROSIS-FACTOR; PRO-SURVIVAL AKT; 2-CYANO-3,12-DIOXOOLEAN-1,9-DIEN-28-OIC ACID; DIRECT INHIBITION; LUNG-CANCER; ETHYL AMIDE; URSANE TRITERPENOIDS; INDUCE APOPTOSIS	New multifunctional drugs that target multiple disease-relevant networks offer a novel approach to the prevention and treatment of many diseases. New synthetic oleanane triterpenoids (SO), such as CDDO (2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid) and its derivatives, are multifunctional compounds originally developed for the prevention and treatment of inflammation and oxidative stress. However, the protein binding partners and mechanisms of action of these SO are not yet fully understood. Here we characterize the putative target profile of one SO, CDDO-Imidazolide (CDDO-Im), by combining affinity purification with mass spectroscopic proteomic analysis to identify 577 candidate binding proteins in whole cells. This SO pharmaco-interactome consists of a diverse but interconnected set of signaling networks; bioinformatic analysis of the protein interactome identified canonical signaling pathways targeted by the SO, including retinoic acid receptor (RAR), estrogen receptor (ER), insulin receptor (IR), janus kinase/signal transducers and activators of transcription (JAK/STAT), and phosphatase and tensin homolog (PTEN). Pull-down studies then further validated a subset of the putative targets. In addition, we now show for the first time that the mammalian target of rapamycin (mTOR) is a direct target of CDDO-Im. We also show that CDDO-Im blocks insulin-induced activation of this pathway by binding to mTOR and inhibiting its kinase activity. Our basic studies confirm that the SO, CDDO-Im, acts on a protein network to elicit its pharmacological activity.	[Yore, Mark M.; Sporn, Michael B.; Liby, Karen T.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Pharmacol, Hanover, NH 03756 USA; [Kettenbach, Arminja N.; Gerber, Scott A.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Genet, Hanover, NH 03756 USA; [Kettenbach, Arminja N.; Gerber, Scott A.] Norris Cotton Canc Ctr, Lebanon, NH USA	Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Yore, MM (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Pharmacol, Hanover, NH 03756 USA.	Michael.Sporn@dartmouth.edu		Kettenbach, Arminja/0000-0003-3979-4576; Gerber, Scott/0000-0002-2964-5051; Liby, Karen/0000-0003-3317-3437	NIH [RO1 CA78814]; Reata Pharmaceuticals; NATIONAL CANCER INSTITUTE [R01CA078814, P30CA023108] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Reata Pharmaceuticals; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	These studies were supported by grants from the NIH (RO1 CA78814) and Reata Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Jaquez HA, 2009, MOL CELL BIOL, V29, P4308, DOI 10.1128/MCB.01665-08; Ahmad R, 2008, CANCER RES, V68, P2920, DOI 10.1158/0008-5472.CAN-07-3036; Ahmad R, 2006, J BIOL CHEM, V281, P35764, DOI 10.1074/jbc.M607160200; Cano M, 2010, VISION RES, V50, P652, DOI 10.1016/j.visres.2009.08.018; Chauhan D, 2004, BLOOD, V103, P3158, DOI 10.1182/blood-2003-08-2873; Couch RD, 2006, MOL PHARMACOL, V69, P1158, DOI 10.1124/mol.105.018572; Couch RD, 2005, BIOORG MED CHEM LETT, V15, P2215, DOI 10.1016/j.bmcl.2005.03.031; Csermely P, 2005, TRENDS PHARMACOL SCI, V26, P178, DOI 10.1016/j.tips.2005.02.007; Deeb D, 2009, PROSTATE, V69, P851, DOI 10.1002/pros.20937; Dinkova-Kostova AT, 2005, P NATL ACAD SCI USA, V102, P4584, DOI 10.1073/pnas.0500815102; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Gao XH, 2010, ANTICANCER RES, V30, P785; Hantschel O, 2008, LEUKEMIA LYMPHOMA, V49, P615, DOI 10.1080/10428190801896103; Hidalgo CA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000353; Honda T, 2004, J MED CHEM, V47, P4923, DOI 10.1021/jm049727e; Honda T, 1998, BIOORG MED CHEM LETT, V8, P2711, DOI 10.1016/S0960-894X(98)00479-X; Honda T, 2002, BIOORG MED CHEM LETT, V12, P1027, DOI 10.1016/S0960-894X(02)00105-1; Honda T, 2000, J MED CHEM, V43, P4233, DOI 10.1021/jm0002230; Honda T, 2000, J MED CHEM, V43, P1866, DOI 10.1021/jm000008j; Hopkins AL, 2006, CURR OPIN STRUC BIOL, V16, P127, DOI 10.1016/j.sbi.2006.01.013; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hopkins AL, 2007, NAT BIOTECHNOL, V25, P1110, DOI 10.1038/nbt1007-1110; HU ZL, 2008, ONLINE J BIOINFORMAT, V8, P108; Hyer ML, 2005, CANCER RES, V65, P4799, DOI 10.1158/0008-5472.CAN-04-3319; Inoki K, 2008, DIABETES RES CLIN PR, V82, pS59, DOI 10.1016/j.diabres.2008.09.028; Ito Y, 2001, MOL PHARMACOL, V59, P1094, DOI 10.1124/mol.59.5.1094; Ito Y, 2000, CELL GROWTH DIFFER, V11, P261; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Konopleva M, 2004, CANCER RES, V64, P7927, DOI 10.1158/0008-5472.CAN-03-2402; Liby K, 2005, CANCER RES, V65, P4789, DOI 10.1158/0008-5472.CAN-04-4539; Liby K, 2008, CLIN CANCER RES, V14, P4556, DOI 10.1158/1078-0432.CCR-08-0040; Liby K, 2008, MOL CANCER THER, V7, P1251, DOI 10.1158/1535-7163.MCT-08-0023; Liby K, 2007, CANCER RES, V67, P2414, DOI 10.1158/0008-5472.CAN-06-4534; Liby K, 2006, CLIN CANCER RES, V12, P4288, DOI 10.1158/1078-0432.CCR-06-0215; Liby K, 2009, CANCER PREV RES, V2, P1050, DOI 10.1158/1940-6207.CAPR-09-0085; Liby KT, 2007, NAT REV CANCER, V7, P357, DOI 10.1038/nrc2129; Lieberthal W, 2009, J AM SOC NEPHROL, V20, P2493, DOI 10.1681/ASN.2008111186; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; McCarthy FM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-229; MORI H, BIOCH BIOPHYS RES CO, V384, P471; Na HK, 2006, MOL CARCINOGEN, V45, P368, DOI 10.1002/mc.20225; Osburn WO, 2008, TOXICOL SCI, V104, P218, DOI 10.1093/toxsci/kfn079; Park J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.16; Pergola PE, 2011, AM J NEPHROL, V33, P469, DOI 10.1159/000327599; Pitha-Rowe I, 2009, INVEST OPHTH VIS SCI, V50, P5339, DOI 10.1167/iovs.09-3648; Place AE, 2003, CLIN CANCER RES, V9, P2798; Reddy NM, 2009, AM J RESP CRIT CARE, V180, P867, DOI 10.1164/rccm.200905-0670OC; Saha PK, 2010, J BIOL CHEM, V285, P40581, DOI 10.1074/jbc.M110.176545; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen Y, 2010, P NATL ACAD SCI USA, V107, P1082, DOI 10.1073/pnas.0909181107; Shishodia S, 2006, CLIN CANCER RES, V12, P1828, DOI 10.1158/1078-0432.CCR-05-2044; Soliman GA, 2010, J BIOL CHEM, V285, P7866, DOI 10.1074/jbc.M109.096222; Sporn MB, 2007, DRUG DEVELOP RES, V68, P174, DOI 10.1002/ddr.20179; Sporn MB, 2011, J NAT PROD, V74, P537, DOI 10.1021/np100826q; Stack C, 2010, FREE RADICAL BIO MED, V49, P147, DOI 10.1016/j.freeradbiomed.2010.03.017; Stadheim TA, 2002, J BIOL CHEM, V277, P16448, DOI 10.1074/jbc.M108974200; Suh N, 1998, CANCER RES, V58, P717; Suh NJ, 1999, CANCER RES, V59, P336; Sussan TE, 2009, P NATL ACAD SCI USA, V106, P250, DOI 10.1073/pnas.0804333106; To C, 2008, J BIOL CHEM, V283, P11700, DOI 10.1074/jbc.M704064200; Vannini N, 2007, MOL CANCER THER, V6, P3139, DOI 10.1158/1535-7163.MCT-07-0451; Wu QQ, 2011, AM J PHYSIOL-RENAL, V300, pF1180, DOI 10.1152/ajprenal.00353.2010; Yang LC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005757; Yates MS, 2007, MOL CANCER THER, V6, P154, DOI 10.1158/1535-7163.MCT-06-0516; Yates MS, 2009, CARCINOGENESIS, V30, P1024, DOI 10.1093/carcin/bgp100; Yates MS, 2006, CANCER RES, V66, P2488, DOI 10.1158/0008-5472.CAN-05-3823; Yore MM, 2006, MOL CANCER THER, V5, P3232, DOI 10.1158/1535-7163.MCT-06-0444; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	69	77	81	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22862	10.1371/journal.pone.0022862	http://dx.doi.org/10.1371/journal.pone.0022862			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818401	gold, Green Published, Green Submitted			2022-12-25	WOS:000293282700085
J	Fernandez-Miragall, O; Hernandez, C				Fernandez-Miragall, Olga; Hernandez, Carmen			An Internal Ribosome Entry Site Directs Translation of the 3 '-Gene from Pelargonium Flower Break Virus Genomic RNA: Implications for Infectivity	PLOS ONE			English	Article							CAP-INDEPENDENT TRANSLATION; 5' UNTRANSLATED REGION; PICORNAVIRUS IRES ELEMENTS; PLANT VIRAL RNAS; 3'-UNTRANSLATED REGION; MESSENGER-RNA; COAT PROTEIN; IN-VITRO; NONTRANSLATED REGION; ENHANCES TRANSLATION	Pelargonium flower break virus (PFBV, genus Carmovirus) has a single-stranded positive-sense genomic RNA (gRNA) which contains five ORFs. The two 59-proximal ORFs encode the replicases, two internal ORFs encode movement proteins, and the 39-proximal ORF encodes a polypeptide (p37) which plays a dual role as capsid protein and as suppressor of RNA silencing. Like other members of family Tombusviridae, carmoviruses express ORFs that are not 59-proximal from subgenomic RNAs. However, in one case, corresponding to Hisbiscus chlorotic ringspot virus, it has been reported that the 39-proximal gene can be translated from the gRNA through an internal ribosome entry site (IRES). Here we show that PFBV also holds an IRES that mediates production of p37 from the gRNA, raising the question of whether this translation strategy may be conserved in the genus. The PFBV IRES was functional both in vitro and in vivo and either in the viral context or when inserted into synthetic bicistronic constructs. Through deletion and mutagenesis studies we have found that the IRES is contained within a 80 nt segment and have identified some structural traits that influence IRES function. Interestingly, mutations that diminish IRES activity strongly reduced the infectivity of the virus while the progress of the infection was favoured by mutations potentiating such activity. These results support the biological significance of the IRES-driven p37 translation and suggest that production of the silencing suppressor from the gRNA might allow the virus to early counteract the defence response of the host, thus facilitating pathogen multiplication and spread.	[Fernandez-Miragall, Olga; Hernandez, Carmen] Univ Politecn Valencia, Consejo Super Invest Cient, Inst Biol Mol & Celular Plantas, E-46071 Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Fernandez-Miragall, O (corresponding author), Univ Politecn Valencia, Consejo Super Invest Cient, Inst Biol Mol & Celular Plantas, E-46071 Valencia, Spain.	cahernan@ibmcp.upv.es	Hernandez, C./R-2047-2018	Hernandez, C./0000-0003-1192-6223	Spanish Ministerio de Ciencia e Innovacion (MICINN) [BFU2006-11230, BFU2009-11699]; Generalitat Valenciana [ACOM/2006/210, ACOMP/2009/040, GVPRE/2008/121]	Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	This research was supported by grants BFU2006-11230 and BFU2009-11699 from the Spanish Ministerio de Ciencia e Innovacion (MICINN) and by grants ACOM/2006/210 and ACOMP/2009/040 (to CH) and GVPRE/2008/121 (to OF-M) from the Generalitat Valenciana. The latter was the recipient of an I3P postdoctoral contract from the Spanish Consejo Superior de Investigaciones Cientificas and an additional contract from MICINN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balvay L, 2009, BBA-GENE REGUL MECH, V1789, P542, DOI 10.1016/j.bbagrm.2009.07.005; BASSO J, 1994, J GEN VIROL, V75, P3157, DOI 10.1099/0022-1317-75-11-3157; Belsham GJ, 2009, VIRUS RES, V139, P183, DOI 10.1016/j.virusres.2008.07.001; Bergamini G, 2000, RNA, V6, P1781, DOI 10.1017/S1355838200001679; Bernstein J, 1997, J BIOL CHEM, V272, P9356; Bradrick SS, 2006, NUCLEIC ACIDS RES, V34, P1293, DOI 10.1093/nar/gkl019; CARRINGTON JC, 1990, J VIROL, V64, P1590, DOI 10.1128/JVI.64.4.1590-1597.1990; Castano A, 2009, VIROLOGY, V386, P417, DOI 10.1016/j.virol.2009.01.017; de Quinto SL, 2002, NUCLEIC ACIDS RES, V30, P4398, DOI 10.1093/nar/gkf569; Dobrikova E, 2003, P NATL ACAD SCI USA, V100, P15125, DOI 10.1073/pnas.2436464100; Dorokhov YL, 2002, P NATL ACAD SCI USA, V99, P5301, DOI 10.1073/pnas.082107599; Dresios J, 2006, NAT STRUCT MOL BIOL, V13, P30, DOI 10.1038/nsmb1031; ELROYSTEIN O, 2007, TRANSLATIONAL CONTRO, V48, P155; Fernandez-Miragall O, 2003, RNA, V9, P1333, DOI 10.1261/rna.5950603; Fernandez-Miragall O, 2009, VIRUS RES, V139, P172, DOI 10.1016/j.virusres.2008.07.009; Fraser CS, 2007, NAT REV MICROBIOL, V5, P29, DOI 10.1038/nrmicro1558; Futterer J, 1996, PLANT MOL BIOL, V32, P159, DOI 10.1007/BF00039382; Gale M, 2000, MICROBIOL MOL BIOL R, V64, P239, DOI 10.1128/MMBR.64.2.239-280.2000; Gallie DR, 1998, GENE, V216, P1, DOI 10.1016/S0378-1119(98)00318-7; GALLIE DR, 1996, PLANT MOL BIOL, V32, P45; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Ishitani M, 1997, PLANT CELL, V9, P1935, DOI 10.1105/tpc.9.11.1935; Ito T, 1998, J VIROL, V72, P8789, DOI 10.1128/JVI.72.11.8789-8796.1998; Ivanov PA, 1997, VIROLOGY, V232, P32, DOI 10.1006/viro.1997.8525; Jaag HM, 2003, P NATL ACAD SCI USA, V100, P8939, DOI 10.1073/pnas.1332697100; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Karetnikov A, 2007, J GEN VIROL, V88, P286, DOI 10.1099/vir.0.82307-0; Knoester M, 1998, P NATL ACAD SCI USA, V95, P1933, DOI 10.1073/pnas.95.4.1933; Koh DCY, 2003, J BIOL CHEM, V278, P20565, DOI 10.1074/jbc.M210212200; Koh DCY, 2002, J VIROL, V76, P1144, DOI 10.1128/JVI.76.3.1144-1153.2002; Koh DCY, 2006, VIRUS RES, V122, P35, DOI 10.1016/j.virusres.2006.06.008; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; KOZAK M, 1992, ANNU REV CELL BIOL, V8, P197, DOI 10.1146/annurev.cb.08.110192.001213; Kozak M, 2001, NUCLEIC ACIDS RES, V29, P5226, DOI 10.1093/nar/29.24.5226; LEVIS C, 1993, VIRUS GENES, V7, P367, DOI 10.1007/BF01703392; LOMMEL SA, 2005, 8 INT COMM TAX VIR, P907; LOPEZ DQ, 1997, J VIROL, V71, P4171; Lopez-Lastra M, 2005, BIOL RES, V38, P121, DOI 10.4067/S0716-97602005000200003; Lu J, 2006, J GEN VIROL, V87, P3667, DOI 10.1099/vir.0.82090-0; Martinez-Salas E, 1999, CURR OPIN BIOTECH, V10, P458, DOI 10.1016/S0958-1669(99)00010-5; Martinez-Turino S, 2009, J GEN VIROL, V90, P519, DOI 10.1099/vir.0.006098-0; Martinez-Turino S, 2011, VIROLOGY, V413, P310, DOI 10.1016/j.virol.2011.03.001; Martinez-Turino S, 2010, J GEN VIROL, V91, P3075, DOI 10.1099/vir.0.023093-0; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Miller WA, 2007, BIOCHEM SOC T, V35, P1629, DOI 10.1042/BST0351629; Miller WA, 2006, ANNU REV PHYTOPATHOL, V44, P447, DOI 10.1146/annurev.phyto.44.070505.143353; Mokrejs M, 2010, NUCLEIC ACIDS RES, V38, pD131, DOI 10.1093/nar/gkp981; Pacheco A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/458927; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Kneller ELP, 2006, VIRUS RES, V119, P63, DOI 10.1016/j.virusres.2005.10.010; Reigadas S, 2005, FEBS LETT, V579, P6803, DOI 10.1016/j.febslet.2005.11.015; Rico P, 2006, J PLANT PATHOL, V88, P103; Rico P, 2004, ARCH VIROL, V149, P641, DOI 10.1007/s00705-003-0231-5; Rico P, 2009, VIRUS RES, V142, P100, DOI 10.1016/j.virusres.2009.01.018; Robertson MEM, 1999, RNA, V5, P1167, DOI 10.1017/S1355838299990301; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; Sambrook J, 2007, MOL CLONING LAB MANU, V3 rd; SCHEPER GC, 1994, FEBS LETT, V352, P271, DOI 10.1016/0014-5793(94)00975-9; Skulachev MV, 1999, VIROLOGY, V263, P139, DOI 10.1006/viro.1999.9928; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Song YT, 2006, J VIROL, V80, P11579, DOI 10.1128/JVI.00675-06; Stupina VA, 2008, RNA, V14, P2379, DOI 10.1261/rna.1227808; TRONO D, 1988, J VIROL, V62, P2291, DOI 10.1128/JVI.62.7.2291-2299.1988; Truniger V, 2008, PLANT J, V56, P716, DOI 10.1111/j.1365-313X.2008.03630.x; Wu BD, 1999, J VIROL, V73, P8982, DOI 10.1128/JVI.73.11.8982-8988.1999; Xia XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004136; Yang LJ, 1997, BIOSCI BIOTECH BIOCH, V61, P2131, DOI 10.1271/bbb.61.2131; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	69	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e22617	10.1371/journal.pone.0022617	http://dx.doi.org/10.1371/journal.pone.0022617			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21818349	Green Published, gold, Green Submitted			2022-12-25	WOS:000293175100035
J	Pore, D; Mahata, N; Pal, A; Chakrabarti, MK				Pore, Debasis; Mahata, Nibedita; Pal, Amit; Chakrabarti, Manoj K.			Outer Membrane Protein A (OmpA) of Shigella flexneri 2a, Induces Protective Immune Response in a Mouse Model	PLOS ONE			English	Article							ESCHERICHIA-COLI; INVASIN COMPLEX; CELL-ENVELOPE; IDENTIFICATION; IMMUNIZATION; EFFICACY; VACCINE; IMMUNOGENICITY; LIPOPROTEIN; INTRANASAL	Background: In our earlier studies 34 kDa outer membrane protein (OMP) of Shigella flexneri 2a has been identified as an efficient immunostimulant. Key Results: In the present study MALDI-TOF MS analysis of the purified 34 kDa OMP of Shigella flexneri 2a shows considerable sequence homology (Identity 65%) with the OmpA of S. flexneri 2a. By using the specific primers, the gene of interest has been amplified from S. flexneri 2a (N.Y-962/92) genomic DNA, cloned in pET100/D-TOPOH vector and expressed using induction with isopropyl thiogalactoside (IPTG) for the first time. Immunogenicity and protective efficacy of the recombinant OmpA has been evaluated in an intranasally immunized murine pulmonary model. The recombinant protein induces significantly enhanced protein specific IgG and IgA Abs in both mucosal and systemic compartments and IgA secreting cells in the systemic compartment (spleen). The mice immunized with OmpA have been protected completely from systemic challenge with a lethal dose of virulent S. flexneri 2a. Immunization with the protein causes mild polymorphonuclear neutrophil infiltration in the lung, without inducing the release of large amounts of proinflammatory cytokines. Conclusion: These results suggest that the OmpA of S. flexneri 2a can be an efficacious mucosal immunogen inducing protective immune responses. Our findings also demonstrate that antibodies and Th1 immune response may be associated with the marked protective efficacy of immunized mice after intranasal shigellae infection.	[Pore, Debasis; Mahata, Nibedita; Pal, Amit; Chakrabarti, Manoj K.] Natl Inst Cholera & Enter Dis, Div Pathophysiol, Kolkata, W Bengal, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Pore, D (corresponding author), Cleveland Clin, Lerner Coll Med, Dept Immunol, Cleveland, OH 44106 USA.	mkc_niced@yahoo.co.in		/0000-0002-6026-1187	Indian Council of Medical Research	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This work was supported by the Indian Council of Medical Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERS K, 1995, VACCINE, V13, P88; Ashkenazi S, 2003, J ANTIMICROB CHEMOTH, V51, P427, DOI 10.1093/jac/dkg080; Bancroft GJ, 1989, J IMMUNOL, V59, P1709; Barry EM, 2006, VACCINE, V24, P3727, DOI 10.1016/j.vaccine.2005.07.013; Belaaouaj AA, 2000, SCIENCE, V289, P1185, DOI 10.1126/science.289.5482.1185; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREWER NR, 1983, RESP PHYSL; Coster TS, 1999, INFECT IMMUN, V67, P3437, DOI 10.1128/IAI.67.7.3437-3443.1999; Croquet-Valdes PA, 2001, VACCINE, V20, P979; Dumetz F, 2007, J APPL MICROBIOL, V103, P1461, DOI 10.1111/j.1365-2672.2007.03359.x; Grewal HMS, 2000, J IMMUNOL METHODS, V239, P53, DOI 10.1016/S0022-1759(00)00171-X; Jennison AV, 2006, WORLD J GASTROENTERO, V12, P6683, DOI 10.3748/wjg.v12.i41.6683; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Kaminski RW, 2009, CLIN VACCINE IMMUNOL, V16, P574, DOI 10.1128/CVI.00435-08; Kaminski RW, 2006, INFECT IMMUN, V74, P2856, DOI 10.1128/IAI.74.5.2856-2866.2006; Kobayashi SD, 2009, WIRES SYST BIOL MED, V1, P309, DOI 10.1002/wsbm.32; Koizumi N, 2003, FEMS MICROBIOL LETT, V226, P215, DOI 10.1016/S0378-1097(03)00619-0; Kotloff KL, 2000, INFECT IMMUN, V68, P1034, DOI 10.1128/IAI.68.3.1034-1039.2000; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Kurohane K, 2005, MICROBIOL IMMUNOL, V49, P149, DOI 10.1111/j.1348-0421.2005.tb03714.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li H, 2009, J PROTEOME RES, V8, P4342, DOI 10.1021/pr900439j; MALLETT CP, 1993, VACCINE, V11, P190, DOI 10.1016/0264-410X(93)90016-Q; MALLETT CP, 1995, INFECT IMMUN, V63, P2382, DOI 10.1128/IAI.63.6.2382-2386.1995; Maniatis T., 1982, MOL CLONING LAB MANU; Mukhopadhaya A, 2006, VACCINE, V24, P6028, DOI 10.1016/j.vaccine.2006.03.026; Mukhopadhaya A, 2003, VACCINE, V21, P3043, DOI 10.1016/S0264-410X(03)00111-7; Ndungu FM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000690; NIESEL DW, 1986, INFECT IMMUN, V52, P828, DOI 10.1128/IAI.52.3.828-833.1986; NIKAIDO H, 1991, J BIOL CHEM, V266, P770; Passwell JH, 2001, INFECT IMMUN, V69, P1351, DOI 10.1128/IAI.69.3.1351-1357.2001; Peng XX, 2004, VACCINE, V22, P2750, DOI 10.1016/j.vaccine.2004.01.038; Pore D, 2010, MOL IMMUNOL, V47, P1739, DOI 10.1016/j.molimm.2010.03.001; Pore D, 2009, VACCINE, V27, P5855, DOI 10.1016/j.vaccine.2009.07.054; PUOHINIEMI R, 1990, INFECT IMMUN, V58, P1691, DOI 10.1128/IAI.58.6.1691-1696.1990; Ranallo RT, 2005, INFECT IMMUN, V73, P258, DOI 10.1128/IAI.73.1.258-267.2005; RAQIB R, 1995, J INFECT DIS, V171, P376, DOI 10.1093/infdis/171.2.376; RAQIB R, 1995, INFECT IMMUN, V63, P289, DOI 10.1128/IAI.63.1.289-296.1995; SCHWEIZER M, 1977, J BACTERIOL, V129, P1651, DOI 10.1128/JB.129.3.1651-1652.1977; Sharma AD, 2005, ANAL BIOCHEM, V337, P354, DOI 10.1016/j.ab.2004.11.029; Shin S, 2005, BIOCHEM BIOPH RES CO, V330, P1199, DOI 10.1016/j.bbrc.2005.03.097; Singer M, 2004, J IMMUNOL, V173, P4197, DOI 10.4049/jimmunol.173.6.4197; SONNTAG I, 1978, J BACTERIOL, V136, P280, DOI 10.1128/JB.136.1.280-285.1978; Soulas C, 2000, J IMMUNOL, V165, P2335, DOI 10.4049/jimmunol.165.5.2335; Torres AG, 2006, INFECT IMMUN, V74, P2676, DOI 10.1128/IAI.74.5.2676-2685.2006; Turbyfill KR, 2008, VACCINE, V26, P1353, DOI 10.1016/j.vaccine.2007.12.040; WEISER JN, 1991, INFECT IMMUN, V59, P2252, DOI 10.1128/IAI.59.7.2252-2258.1991; Wijburg OLC, 2006, J EXP MED, V203, P21, DOI 10.1084/jem.20052093; Ying TY, 2005, PROTEOMICS, V5, P4777, DOI 10.1002/pmic.200401326	49	59	66	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e22663	10.1371/journal.pone.0022663	http://dx.doi.org/10.1371/journal.pone.0022663			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21818362	gold, Green Submitted, Green Published			2022-12-25	WOS:000293175100039
J	Chen, ACH; Arany, PR; Huang, YY; Tomkinson, EM; Sharma, SK; Kharkwal, GB; Saleem, T; Mooney, D; Yull, FE; Blackwell, TS; Hamblin, MR				Chen, Aaron C-H; Arany, Praveen R.; Huang, Ying-Ying; Tomkinson, Elizabeth M.; Sharma, Sulbha K.; Kharkwal, Gitika B.; Saleem, Taimur; Mooney, David; Yull, Fiona E.; Blackwell, Timothy S.; Hamblin, Michael R.			Low-Level Laser Therapy Activates NF-kB via Generation of Reactive Oxygen Species in Mouse Embryonic Fibroblasts	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; KAPPA-B ACTIVATION; PROTEIN-KINASE-D; SIGNALING PATHWAY; TRANSCRIPTION FACTOR; INFRARED RADIATION; GENE-EXPRESSION; IR RADIATION; RED-LIGHT; CELLS	Background: Despite over forty years of investigation on low-level light therapy (LLLT), the fundamental mechanisms underlying photobiomodulation at a cellular level remain unclear. Methodology/Principal Findings: In this study, we isolated murine embryonic fibroblasts (MEF) from transgenic NF-kB luciferase reporter mice and studied their response to 810 nm laser radiation. Significant activation of NF-kB was observed at fluences higher than 0.003 J/cm(2) and was confirmed by Western blot analysis. NF-kB was activated earlier (1 hour) by LLLT compared to conventional lipopolysaccharide treatment. We also observed that LLLT induced intracellular reactive oxygen species (ROS) production similar to mitochondrial inhibitors, such as antimycin A, rotenone and paraquat. Furthermore, we observed similar NF-kB activation with these mitochondrial inhibitors. These results, together with inhibition of laser induced NF-kB activation by antioxidants, suggests that ROS play an important role in the laser induced NF-kB signaling pathways. However, LLLT, unlike mitochondrial inhibitors, induced increased cellular ATP levels, which indicates that LLLT also upregulates mitochondrial respiration. Conclusion: We conclude that LLLT not only enhances mitochondrial respiration, but also activates the redox-sensitive NFkB signaling via generation of ROS. Expression of anti-apoptosis and pro-survival genes responsive to NFkB could explain many clinical effects of LLLT.	[Chen, Aaron C-H; Arany, Praveen R.; Huang, Ying-Ying; Tomkinson, Elizabeth M.; Sharma, Sulbha K.; Kharkwal, Gitika B.; Saleem, Taimur; Hamblin, Michael R.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Arany, Praveen R.] Harvard Univ, Program Leder Human Biol & Translat Med, Cambridge, MA 02138 USA; [Arany, Praveen R.] Harvard Univ, Program Biol Sci Dent Med, Cambridge, MA 02138 USA; [Arany, Praveen R.] Harvard Univ, Sch Dent Med, Program Oral & Maxillofacial Pathol, Boston, MA 02115 USA; [Arany, Praveen R.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Arany, Praveen R.; Mooney, David; Hamblin, Michael R.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Huang, Ying-Ying; Kharkwal, Gitika B.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Huang, Ying-Ying] Guangxi Med Univ, Aesthet & Plast Ctr, Nanning, Peoples R China; [Tomkinson, Elizabeth M.] Smith Coll, Northampton, MA 01063 USA; [Saleem, Taimur] Aga Khan Med Coll, Karachi, Pakistan; [Yull, Fiona E.; Blackwell, Timothy S.] Vanderbilt Univ, Sch Med, Dept Med & Canc Biol, Nashville, TN 37212 USA; [Hamblin, Michael R.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard School of Dental Medicine; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Harvard Medical School; Guangxi Medical University; Smith College; Vanderbilt University; Harvard University; Massachusetts Institute of Technology (MIT)	Chen, ACH (corresponding author), Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA.	hamblin@helix.mgh.harvard.edu	Hamblin, Michael R/H-2758-2019; Arany, Praveen/S-5329-2019; Hamblin, Mike/AAB-2511-2022; Huang, yingying/J-7329-2012; Huang, Ying-ying/G-3153-2011	Hamblin, Michael R/0000-0001-6431-4605; Arany, Praveen/0000-0002-6116-2340; Huang, yingying/0000-0002-4038-0277; Huang, Ying-ying/0000-0003-3066-6981; Mooney, David/0000-0001-6299-1194; Yull, Fiona/0000-0003-1636-7942; Chen, Aaron/0000-0002-8367-8399	National Institutes of Health (NIH) [R01AI050875]; Center for Integration of Medicine and Innovative Technology [DAMD17-02-2-0006]; CDMRP Program in TBI [W81XWH-09-1-0514]; Air Force Office of Scientific Research [FA9950-04-1-0079]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050875] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Integration of Medicine and Innovative Technology; CDMRP Program in TBI; Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grant R01AI050875, Center for Integration of Medicine and Innovative Technology (DAMD17-02-2-0006), CDMRP Program in TBI (W81XWH-09-1-0514) and Air Force Office of Scientific Research (FA9950-04-1-0079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandratou E, 2002, PHOTOCH PHOTOBIO SCI, V1, P547, DOI 10.1039/b110213n; Ali S, 1996, BIOCHEM MOL BIOL INT, V39, P63; Arany PR, 2007, WOUND REPAIR REGEN, V15, P866, DOI 10.1111/j.1524-475X.2007.00306.x; Baichwal VR, 1997, CURR BIOL, V7, pR94, DOI 10.1016/S0960-9822(06)00046-7; Bilski P, 2002, FREE RADICAL BIO MED, V33, P938, DOI 10.1016/S0891-5849(02)00982-6; Blackwell TS, 2000, AM J RESP CRIT CARE, V162, P1095, DOI 10.1164/ajrccm.162.3.9906129; Callaghan GA, 1996, LASER SURG MED, V19, P201; Campbell KJ, 2006, BIOCHEM SOC SYMP, V73, P165, DOI 10.1042/bss0730165; Carmody RJ, 2007, CELL MOL IMMUNOL, V4, P31; D'Angio CT, 2000, MOL GENET METAB, V71, P371, DOI 10.1006/mgme.2000.3074; de Lima FM, 2009, CELL BIOL INT, V33, P1212, DOI 10.1016/j.cellbi.2009.04.025; DENG YT, 2009, MOL CARCINOG; Eichler M, 2007, PHOTOMED LASER SURG, V25, P170, DOI 10.1089/pho.2007.2046; GLASCOTT PA, 1987, CELL MOTIL CYTOSKEL, V8, P118, DOI 10.1002/cm.970080204; Grossman N, 1998, LASER SURG MED, V22, P212, DOI 10.1002/(SICI)1096-9101(1998)22:4<212::AID-LSM5>3.0.CO;2-S; Hauer J, 2005, P NATL ACAD SCI USA, V102, P2874, DOI 10.1073/pnas.0500187102; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; Hode L., 2002, LASER THERAPY CLIN P; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hu WP, 2007, J INVEST DERMATOL, V127, P2048, DOI 10.1038/sj.jid.5700826; Karu T, 1999, J PHOTOCH PHOTOBIO B, V49, P1, DOI 10.1016/S1011-1344(98)00219-X; KARU T, 1989, HEALTH PHYS, V56, P691, DOI 10.1097/00004032-198905000-00015; Karu T., 1998, SCI LOW POWER LASER; Karu TI, 2005, J PHOTOCH PHOTOBIO B, V81, P98, DOI 10.1016/j.jphotobiol.2005.07.002; Karu TI, 2005, PHOTOMED LASER SURG, V23, P355, DOI 10.1089/pho.2005.23.355; Karu TI, 2004, PHOTOCHEM PHOTOBIOL, V80, P366, DOI 10.1562/2004-03-25-RA-123.1; Lane N, 2006, NATURE, V443, P901, DOI 10.1038/443901a; Lavi R, 2003, J BIOL CHEM, V278, P40917, DOI 10.1074/jbc.M303034200; Li NX, 1999, FASEB J, V13, P1137, DOI 10.1096/fasebj.13.10.1137; Lubart R, 2005, PHOTOMED LASER SURG, V23, P3, DOI 10.1089/pho.2005.23.3; Moriyama Y, 2005, PHOTOCHEM PHOTOBIOL, V81, P1351, DOI 10.1562/2005-02-28-RA-450; Pal G, 2007, J PHOTOCH PHOTOBIO B, V86, P252, DOI 10.1016/j.jphotobiol.2006.12.001; Park WH, 2007, J CELL BIOCHEM, V102, P98, DOI 10.1002/jcb.21280; Pastore D, 2000, INT J RADIAT BIOL, V76, P863, DOI 10.1080/09553000050029020; Sadikot RT, 2001, AM J RESP CRIT CARE, V164, P873, DOI 10.1164/ajrccm.164.5.2008059; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; SCHRECK R, 1992, J VIROL, V66, P6288, DOI 10.1128/JVI.66.11.6288-6293.1992; Schroeder P, 2007, FREE RADICAL BIO MED, V43, P128, DOI 10.1016/j.freeradbiomed.2007.04.002; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shiva S, 2001, P NATL ACAD SCI USA, V98, P7212, DOI 10.1073/pnas.131128898; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Storz P, 2005, MOL CELL BIOL, V25, P8520, DOI 10.1128/MCB.25.19.8520-8530.2005; Storz P, 2007, TRENDS CELL BIOL, V17, P13, DOI 10.1016/j.tcb.2006.11.003; Sun Hong, 2007, V383, P303, DOI 10.1007/978-1-59745-335-6_19; Szundi I, 2001, BIOCHEMISTRY-US, V40, P2332, DOI 10.1021/bi002220v; TAFUR J, 2008, PHOTOMED LASER SURG; Tergaonkar V, 2006, INT J BIOCHEM CELL B, V38, P1647, DOI 10.1016/j.biocel.2006.03.023; Wang TL, 2002, INT IMMUNOPHARMACOL, V2, P1509, DOI 10.1016/S1567-5769(02)00058-9; Wong-Riley MTT, 2005, J BIOL CHEM, V280, P4761, DOI 10.1074/jbc.M409650200; Yu W, 1997, PHOTOCHEM PHOTOBIOL, V66, P866, DOI 10.1111/j.1751-1097.1997.tb03239.x; Zhang JT, 2008, J CELL PHYSIOL, V217, P518, DOI 10.1002/jcp.21529; Zhang YO, 2003, J INVEST DERMATOL, V120, P849, DOI 10.1046/j.1523-1747.2003.12133.x	53	306	314	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22453	10.1371/journal.pone.0022453	http://dx.doi.org/10.1371/journal.pone.0022453			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21814580	Green Published, gold			2022-12-25	WOS:000292956800058
J	Zhang, ZW; Kang, JI; Vaucher, E				Zhang, Zi-Wei; Kang, Jun Il; Vaucher, Elvire			Axonal Varicosity Density as an Index of Local Neuronal Interactions	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; NICOTINIC ACETYLCHOLINE-RECEPTOR; CORTICAL CHOLINERGIC INPUTS; BASAL FOREBRAIN; PYRAMIDAL CELLS; PRESYNAPTIC TERMINALS; ATTENTIONAL FUNCTIONS; DIFFUSE TRANSMISSION; SYNAPTIC PLASTICITY; GENE-EXPRESSION	Diffuse transmission is an important non-synaptic communication mode in the cerebral neocortex, in which neurotransmitters released from en passant varicosities interact with surrounding cells. In a previous study we have shown that the cholinergic axonal segments which were in the microproximity with dopaminergic fibers possessed a greater density of en passant varicosities compared to more distant segments, suggesting an activity-dependent level of en passant varicosities in the axonal zone of interaction. To further evaluate this plastic relationship, the density of cholinergic varicosities was quantified on fiber segments within the microproximity of activated or non-activated pyramidal cells of the prefrontal cortex (mPFC). Repetitive 14 days patterned visual stimulation paired with an electrical stimulation of the cholinergic fibers projecting to the mPFC from the HDB was performed to induce persistent axonal plastic changes. The c-Fos early gene immunoreactivity was used as a neuronal activity marker of layer V pyramidal cells, labelled with anti-glutamate transporter EAAC1. Cholinergic fibers were labeled with anti-ChAT (choline acetyltransferase) immunostaining. The density of ChAT+ varicosities on and the length of fiber segments within the 3 mu m microproximity of c-Fos positive/negative pyramidal cells were evaluated on confocal images. More than 50% of the pyramidal cells in the mPFC were c-Fos immunoreactive. Density of ChAT+ varicosities was significantly increased within 3 mu m vicinity of activated pyramidal cells (0.50 +/- 0.01 per mu m of ChAT+ fiber length) compared to non-activated cells in this group (0.34 +/- 0.001; p <= 0.05) or control rats (0.32 +/- 0.02; p <= 0.05). Different types of stimulation (visual, HDB or visual/HDB) induced similar increase of the density of ChAT+ varicosities within microproximity of activated pyramidal cells. This study demonstrated at the subcellular level an activity-dependent enrichment of ChAT+ varicosities in the axonal zone of interaction with other neuronal elements.	[Zhang, Zi-Wei; Kang, Jun Il; Vaucher, Elvire] Univ Montreal, Sch Optometry, Montreal, PQ, Canada; [Zhang, Zi-Wei; Kang, Jun Il] Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Zhang, ZW (corresponding author), Univ Montreal, Sch Optometry, Montreal, PQ, Canada.	elvire.vaucher@umontreal.ca		Vaucher, Elvire/0000-0001-7075-5263	Natural Sciences and Engineering Research Council of Canada [238835-07]; Canadian Institutes of Health Research [MOP-81147]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Grant sponsor: Natural Sciences and Engineering Research Council of Canada; Grant number: 238835-07 (EV) (http://www.nserc-crsng.gc.ca/). Canadian Institutes of Health Research (EV, grant MOP-81147) (http://www.cihr-irsc.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNATI LF, 1995, NEUROSCIENCE, V69, P711, DOI 10.1016/0306-4522(95)00308-6; Anderson JC, 2001, NAT NEUROSCI, V4, P1166, DOI 10.1038/nn772; Arnsten AFT, 2009, CNS DRUGS, V23, P33, DOI 10.2165/00023210-200923000-00005; Bergstrom HC, 2008, SYNAPSE, V62, P31, DOI 10.1002/syn.20467; Brown RW, 2001, BRAIN RES, V899, P94, DOI 10.1016/S0006-8993(01)02201-6; Burk JA, 2008, BEHAV BRAIN RES, V195, P231, DOI 10.1016/j.bbr.2008.09.006; Carr DB, 2007, J NEUROPHYSIOL, V97, P3432, DOI 10.1152/jn.00828.2006; CHEDOTAL A, 1994, J COMP NEUROL, V343, P57, DOI 10.1002/cne.903430105; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Dalley JW, 2004, CEREB CORTEX, V14, P922, DOI 10.1093/cercor/bhh052; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; DEIANA S, 2010, BEHAV BRAIN RES; Descarries L, 2000, PROG BRAIN RES, V125, P27; Descarries L, 1998, J PHYSIOL-PARIS, V92, P215, DOI 10.1016/S0928-4257(98)80013-2; Descarries L, 1997, PROG NEUROBIOL, V53, P603, DOI 10.1016/S0301-0082(97)00050-6; Dotigny F, 2008, NEUROSCIENCE, V154, P1607, DOI 10.1016/j.neuroscience.2008.04.030; Duffy AM, 2009, NEUROSCIENCE, V161, P1091, DOI 10.1016/j.neuroscience.2009.04.024; Fenske MJ, 2006, PROG BRAIN RES, V155, P3, DOI 10.1016/S0079-6123(06)55001-0; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; Gill TM, 2000, J NEUROSCI, V20, P4745, DOI 10.1523/JNEUROSCI.20-12-04745.2000; Gioanni Y, 1999, EUR J NEUROSCI, V11, P18, DOI 10.1046/j.1460-9568.1999.00403.x; Goldwater DS, 2009, NEUROSCIENCE, V164, P798, DOI 10.1016/j.neuroscience.2009.08.053; Golmayo L, 2003, NEUROSCIENCE, V119, P597, DOI 10.1016/S0306-4522(03)00031-9; Greenberg AS, 2010, J NEUROSCI, V30, P14330, DOI 10.1523/JNEUROSCI.4248-09.2010; Gulledge AT, 2009, J NEUROSCI, V29, P9888, DOI 10.1523/JNEUROSCI.1366-09.2009; Hasselmo M.E., 2010, NEUROPSYCHOPHARMACOL; Heidbreder CA, 2003, NEUROSCI BIOBEHAV R, V27, P555, DOI 10.1016/j.neubiorev.2003.09.003; Henny P, 2008, EUR J NEUROSCI, V27, P654, DOI 10.1111/j.1460-9568.2008.06029.x; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Hsieh CY, 2000, BRAIN RES, V880, P51, DOI 10.1016/S0006-8993(00)02766-9; HUGHES P, 1995, PHARMACOL REV, V47, P133; KANG JI, 2009, SOC NEUR 39 ANN M CH; Kang JI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005995; Kim MJ, 2003, NEUROSCIENCE, V120, P283, DOI 10.1016/S0306-4522(03)00021-6; Kocharyan A, 2008, J CEREBR BLOOD F MET, V28, P221, DOI 10.1038/sj.jcbfm.9600558; Laplante F, 2005, NEUROSCIENCE, V132, P501, DOI 10.1016/j.neuroscience.2004.11.059; Larkum ME, 2004, CEREB CORTEX, V14, P1059, DOI 10.1093/cercor/bhh065; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Lendvai B, 2008, PHYSIOL REV, V88, P333, DOI 10.1152/physrev.00040.2006; Livingstone PD, 2010, J MOL NEUROSCI, V40, P172, DOI 10.1007/s12031-009-9232-5; Lopez-Gil X, 2010, CURR PHARM DESIGN, V16, P502, DOI 10.2174/138161210790361416; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Majeed W, 2011, NEUROIMAGE, V54, P1140, DOI 10.1016/j.neuroimage.2010.08.030; Muller D, 2000, HIPPOCAMPUS, V10, P596, DOI 10.1002/1098-1063(2000)10:5<596::AID-HIPO10>3.3.CO;2-P; Nikonenko I, 2003, J NEUROSCI, V23, P8498; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Parikh V, 2008, J NEUROSCI, V28, P3769, DOI 10.1523/JNEUROSCI.5251-07.2008; Parikh V, 2008, ANN NY ACAD SCI, V1129, P225, DOI 10.1196/annals.1417.021; Parikh V, 2010, J NEUROSCI, V30, P3518, DOI 10.1523/JNEUROSCI.5712-09.2010; Passetti F, 2000, EUR J NEUROSCI, V12, P3051, DOI 10.1046/j.1460-9568.2000.00183.x; Prusky GT, 2000, VISION RES, V40, P2201, DOI 10.1016/S0042-6989(00)00081-X; Ramanathan D, 2009, J NEUROSCI, V29, P5992, DOI 10.1523/JNEUROSCI.0230-09.2009; Ricciardi E, 2009, BRAIN RES BULL, V79, P322, DOI 10.1016/j.brainresbull.2009.01.013; Robbins TW, 1998, ANN NY ACAD SCI, V846, P222, DOI 10.1111/j.1749-6632.1998.tb09740.x; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Sabo SL, 2006, J NEUROSCI, V26, P10813, DOI 10.1523/JNEUROSCI.2052-06.2006; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; Sarter M, 2003, NEUROBIOL LEARN MEM, V80, P245, DOI 10.1016/S1074-7427(03)00070-4; Sarter M, 2006, BRAIN RES REV, V51, P145, DOI 10.1016/j.brainresrev.2005.11.002; Sarter M, 2009, BIOCHEM PHARMACOL, V78, P658, DOI 10.1016/j.bcp.2009.04.019; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Shepherd GMG, 2002, P NATL ACAD SCI USA, V99, P6340, DOI 10.1073/pnas.052151299; Shu YS, 2007, J NEUROPHYSIOL, V97, P746, DOI 10.1152/jn.00922.2006; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Stahl SM, 2009, J CLIN PSYCHIAT, V70, P950, DOI 10.4088/JCP.09bs05416; Tavares RF, 2006, NEUROSCIENCE, V143, P231, DOI 10.1016/j.neuroscience.2006.07.030; Thomsen MS, 2010, CEREB CORTEX, V20, P2092, DOI 10.1093/cercor/bhp283; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; VAUCHER E, 1995, J NEUROSCI, V15, P7427; Vertes RP, 2006, NEUROSCIENCE, V142, P1, DOI 10.1016/j.neuroscience.2006.06.027; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Vizi ES, 2004, NEUROCHEM INT, V45, P443, DOI 10.1016/j.neuint.2003.11.016; Wang Y, 2010, EUR J NEUROSCI, V31, P1582, DOI 10.1111/j.1460-9568.2010.07191.x; Weidner R, 2009, J COGNITIVE NEUROSCI, V21, P2100, DOI 10.1162/jocn.2008.21173; Yamasaki M, 2010, J NEUROSCI, V30, P4408, DOI 10.1523/JNEUROSCI.5719-09.2010; Zaborszky L, 2000, BEHAV BRAIN RES, V115, P143, DOI 10.1016/S0166-4328(00)00255-2; Zaborszky L, 1999, ANN NY ACAD SCI, V877, P339, DOI 10.1111/j.1749-6632.1999.tb09276.x; Zhang ZW, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00021	82	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22543	10.1371/journal.pone.0022543	http://dx.doi.org/10.1371/journal.pone.0022543			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811630	Green Submitted, Green Published, gold			2022-12-25	WOS:000292956800067
J	Burastero, SE; Frigerio, B; Lopalco, L; Sironi, F; Breda, D; Longhi, R; Scarlatti, G; Canevari, S; Figini, M; Lusso, P				Burastero, Samuele E.; Frigerio, Barbara; Lopalco, Lucia; Sironi, Francesca; Breda, Daniela; Longhi, Renato; Scarlatti, Gabriella; Canevari, Silvana; Figini, Mariangela; Lusso, Paolo			Broad-Spectrum Inhibition of HIV-1 by a Monoclonal Antibody Directed against a gp120-Induced Epitope of CD4	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; POTENT NEUTRALIZING ANTIBODIES; ENVELOPE GLYCOPROTEIN; RHEUMATOID-ARTHRITIS; VACCINIA VIRUS; TROPIC HIV-1; CELL-FUSION; RECEPTOR; BINDING; GP120	To penetrate susceptible cells, HIV-1 sequentially interacts with two highly conserved cellular receptors, CD4 and a chemokine receptor like CCR5 or CXCR4. Monoclonal antibodies (MAbs) directed against such receptors are currently under clinical investigation as potential preventive or therapeutic agents. We immunized Balb/c mice with molecular complexes of the native, trimeric HIV-1 envelope (Env) bound to a soluble form of the human CD4 receptor. Sera from immunized mice were found to contain gp120-CD4 complex-enhanced antibodies and showed broad-spectrum HIV-1-inhibitory activity. A proportion of MAbs derived from these mice preferentially recognized complex-enhanced epitopes. In particular, a CD4-specific MAb designated DB81 (IgG1K) was found to preferentially bind to a complex-enhanced epitope on the D2 domain of human CD4. MAb DB81 also recognized chimpanzee CD4, but not baboon or macaque CD4, which exhibit sequence divergence in the D2 domain. Functionally, MAb DB81 displayed broad HIV-1-inhibitory activity, but it did not exert suppressive effects on T-cell activation in vitro. The variable regions of the heavy and light chains of MAb DB81 were sequenced. Due to its broad-spectrum anti-HIV-1 activity and lack of immunosuppressive effects, a humanized derivative of MAb DB81 could provide a useful complement to current preventive or therapeutic strategies against HIV-1.	[Burastero, Samuele E.; Lopalco, Lucia; Sironi, Francesca; Breda, Daniela; Scarlatti, Gabriella; Lusso, Paolo] Ist Sci San Raffaele, Dept Immunol Transplantat & Infect Dis, I-20132 Milan, Italy; [Frigerio, Barbara; Canevari, Silvana; Figini, Mariangela] Natl Inst Tumors, Unit Mol Therapies, Dept Expt Oncol, Milan, Italy; [Frigerio, Barbara; Canevari, Silvana; Figini, Mariangela] Natl Inst Tumors, Labs Fdn IRCCS, Milan, Italy; [Longhi, Renato] CNR, Inst Chem Mol Recognit, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR)	Burastero, SE (corresponding author), Ist Sci San Raffaele, Dept Immunol Transplantat & Infect Dis, I-20132 Milan, Italy.	s.burastero@hsr.it	Figini, Mariangela/K-8753-2016; , Lopalco/AAN-2429-2020; Sironi, Francesca/ABH-7705-2020; scarlatti, gabriella/H-1482-2018; , Burastero/AAN-2425-2020; Frigerio, Barbara/K-8669-2016	Figini, Mariangela/0000-0001-9001-8754; Sironi, Francesca/0000-0003-0908-6683; scarlatti, gabriella/0000-0003-2316-2689; , Burastero/0000-0001-7302-6381; Frigerio, Barbara/0000-0001-6700-5744; Lopalco, Lucia/0000-0003-3812-1759	Italian Ministry of Health, through the National Institutes of Health	Italian Ministry of Health, through the National Institutes of Health	This work was partially funded by the Italian Ministry of Health, through the National Institutes of Health, National AIDS Project, to SEB and LL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ALEXANDER WA, 1992, J VIROL, V66, P2934, DOI 10.1128/JVI.66.5.2934-2942.1992; Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; BALDARI CT, 1995, EUR J IMMUNOL, V25, P1843, DOI 10.1002/eji.1830250708; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Boon L, 2002, TOXICOLOGY, V172, P191, DOI 10.1016/S0300-483X(02)00002-1; BRODER CC, 1995, P NATL ACAD SCI USA, V92, P9004, DOI 10.1073/pnas.92.19.9004; Burastero SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-101; Burastero SE, 1996, AIDS RES HUM RETROV, V12, P273, DOI 10.1089/aid.1996.12.273; BURKLY LC, 1992, J IMMUNOL, V149, P1779; CELADA F, 1990, J EXP MED, V172, P1143, DOI 10.1084/jem.172.4.1143; Choy EHS, 2002, RHEUMATOLOGY, V41, P1142, DOI 10.1093/rheumatology/41.10.1142; Denisova G, 2003, MOL IMMUNOL, V40, P231, DOI 10.1016/s0161-5890(03)00147-0; DeVico A, 2007, P NATL ACAD SCI USA, V104, P17477, DOI 10.1073/pnas.0707399104; Earl P, 1991, CURRENT PROTOCOLS MO; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Figini M, 1998, CANCER RES, V58, P991; Fouts TR, 2000, J VIROL, V74, P11427, DOI 10.1128/JVI.74.24.11427-11436.2000; FULLER AO, 1985, J VIROL, V55, P475, DOI 10.1128/JVI.55.2.475-482.1985; GERSHONI JM, 1993, FASEB J, V7, P1185, DOI 10.1096/fasebj.7.12.7690724; Giudicelli V, 2004, NUCLEIC ACIDS RES, V32, pW435, DOI 10.1093/nar/gkh412; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Hepburn TW, 2003, RHEUMATOLOGY, V42, P54, DOI 10.1093/rheumatology/keg030; Jacobson JM, 2010, ANTIMICROB AGENTS CH, V54, P4137, DOI 10.1128/AAC.00086-10; Jacobson JM, 2009, ANTIMICROB AGENTS CH, V53, P450, DOI 10.1128/AAC.00942-08; KANG CY, 1994, J VIROL, V68, P5854, DOI 10.1128/JVI.68.9.5854-5862.1994; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; LANE RD, 1984, J IMMUNOL METHODS, V72, P71, DOI 10.1016/0022-1759(84)90434-4; Lopalco L, 2005, J GEN VIROL, V86, P339, DOI 10.1099/vir.0.80585-0; Lusso P, 2006, EMBO J, V25, P447, DOI 10.1038/sj.emboj.7600947; Lusso P, 2005, J VIROL, V79, P6957, DOI 10.1128/JVI.79.11.6957-6968.2005; LUSSO P, 1995, J VIROL, V69, P3712, DOI 10.1128/JVI.69.6.3712-3720.1995; MILLER N, 1988, J VIROL, V62, P2366, DOI 10.1128/JVI.62.7.2366-2372.1988; Moulard M, 2002, P NATL ACAD SCI USA, V99, P6913, DOI 10.1073/pnas.102562599; NUSSBAUM O, 1994, J VIROL, V68, P5411, DOI 10.1128/JVI.68.9.5411-5422.1994; Salzwedel K, 2000, J VIROL, V74, P326, DOI 10.1128/JVI.74.1.326-333.2000; Scarlatti G, 1997, NAT MED, V3, P1259, DOI 10.1038/nm1197-1259; SKINNER MA, 1988, J VIROL, V62, P4195, DOI 10.1128/JVI.62.11.4195-4200.1988; Song RJ, 2010, J VIROL, V84, P6935, DOI 10.1128/JVI.00453-10; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Thomas C, 2009, NAT MED, V15, P855, DOI 10.1038/nm0809-855; TRKOLA A, 1995, J VIROL, V69, P6609, DOI 10.1128/JVI.69.11.6609-6617.1995; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Vita C, 1999, P NATL ACAD SCI USA, V96, P13091, DOI 10.1073/pnas.96.23.13091; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; WANG JH, 1990, NATURE, V348, P411, DOI 10.1038/348411a0; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Xiao XD, 2003, VACCINE, V21, P4275, DOI 10.1016/S0264-410X(03)00494-8; Yachou A, 1999, BIOCHEM BIOPH RES CO, V265, P428, DOI 10.1006/bbrc.1999.1686	49	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22081	10.1371/journal.pone.0022081	http://dx.doi.org/10.1371/journal.pone.0022081			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21818294	Green Published, gold, Green Submitted			2022-12-25	WOS:000292929500037
J	Chung, SJ; Verheij, MMM; Hesseling, P; van Vugt, RWM; Buell, M; Belluzzi, JD; Geyer, MA; Martens, GJM; Civelli, O				Chung, Shinjae; Verheij, Michel M. M.; Hesseling, Peter; van Vugt, Ruben W. M.; Buell, Mahalah; Belluzzi, James D.; Geyer, Mark A.; Martens, Gerard J. M.; Civelli, Olivier			The Melanin-Concentrating Hormone (MCH) System Modulates Behaviors Associated with Psychiatric Disorders	PLOS ONE			English	Article							PREPULSE INHIBITION; NUCLEUS-ACCUMBENS; STARTLE REFLEX; DOPAMINE SUPERSENSITIVITY; TYROSINE-HYDROXYLASE; ANIMAL-MODELS; RAT-BRAIN; RECEPTOR; AMPHETAMINE; LIGAND	Deficits in sensorimotor gating measured by prepulse inhibition (PPI) of the startle have been known as characteristics of patients with schizophrenia and related neuropsychiatric disorders. PPI disruption is thought to rely on the activity of the mesocorticolimbic dopaminergic system and is inhibited by most antipsychotic drugs. These drugs however act also at the nigrostriatal dopaminergic pathway and exert adverse locomotor responses. Finding a way to inhibit the mesocorticolimbic-without affecting the nigrostriatal-dopaminergic pathway may thus be beneficial to antipsychotic therapies. The melanin-concentrating hormone (MCH) system has been shown to modulate dopamine-related responses. Its receptor (MCH1R) is expressed at high levels in the mesocorticolimbic and not in the nigrostriatal dopaminergic pathways. Interestingly a genomic linkage study revealed significant associations between schizophrenia and markers located in the MCH1R gene locus. We hypothesize that the MCH system can selectively modulate the behavior associated with the mesocorticolimbic dopamine pathway. Using mice, we found that central administration of MCH potentiates apomorphine-induced PPI deficits. Using congenic rat lines that differ in their responses to PPI, we found that the rats that are susceptible to apomorphine (APO-SUS rats) and exhibit PPI deficits display higher MCH mRNA expression in the lateral hypothalamic region and that blocking the MCH system reverses their PPI deficits. On the other hand, in mice and rats, activation or inactivation of the MCH system does not affect stereotyped behaviors, dopamine-related responses that depend on the activity of the nigrostriatal pathway. Furthermore MCH does not affect dizocilpine-induced PPI deficit, a glutamate related response. Thus, our data present the MCH system as a regulator of sensorimotor gating, and provide a new rationale to understand the etiologies of schizophrenia and related psychiatric disorders.	[Chung, Shinjae; Belluzzi, James D.; Civelli, Olivier] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA; [Civelli, Olivier] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA; [Civelli, Olivier] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92717 USA; [Verheij, Michel M. M.; Hesseling, Peter; van Vugt, Ruben W. M.; Martens, Gerard J. M.] Radboud Univ Nijmegen, Dept Mol Anim Physiol, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Verheij, Michel M. M.; Hesseling, Peter; van Vugt, Ruben W. M.; Martens, Gerard J. M.] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Buell, Mahalah; Geyer, Mark A.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Radboud University Nijmegen; Radboud University Nijmegen; University of California System; University of California San Diego	Chung, SJ (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA.	ocivelli@uci.edu	Civelli, Olivier/A-8392-2012; Martens, Gerard JM/D-1925-2010		National Alliance for Research on Schizophrenia and Depression; Davis Foundation; Hilda and Preston Davis Foundation; Veteran's Administration [VISN 22]; Mental Illness Research, Education, and Clinical Center; Dutch Top Institute Pharma [T5-209];  [MH60231];  [DA024746];  [DK063001];  [MH052885]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052885, R01MH060231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024746] Funding Source: NIH RePORTER	National Alliance for Research on Schizophrenia and Depression(NARSAD); Davis Foundation; Hilda and Preston Davis Foundation; Veteran's Administration(US Department of Veterans Affairs); Mental Illness Research, Education, and Clinical Center; Dutch Top Institute Pharma; ; ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants MH60231, DA024746, DK063001, the Eric L. and Lila D. Nelson Chair in Neuropharmacology and an Established Investigator Award from the National Alliance for Research on Schizophrenia and Depression to OC. SC was supported by Davis Foundation Postdoctoral Fellowship Program in Eating Disorders Research supported by Hilda and Preston Davis Foundation. MG was supported by MH052885 and the Veteran's Administration VISN 22 Mental Illness Research, Education, and Clinical Center. MV, RvV and GM were supported by grant T5-209 from the Dutch Top Institute Pharma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt SS, 2010, HORM BEHAV, V57, P342, DOI 10.1016/j.yhbeh.2010.01.003; Bachner D, 1999, FEBS LETT, V457, P522, DOI 10.1016/S0014-5793(99)01092-3; BAKSHI VP, 1994, J PHARMACOL EXP THER, V271, P787; BITTENCOURT JC, 1992, J COMP NEUROL, V319, P218, DOI 10.1002/cne.903190204; Black KJ, 2006, NEUROLOGY, V67, P1118, DOI 10.1212/01.wnl.0000243252.71365.81; Borowsky B, 2002, NAT MED, V8, P825, DOI 10.1038/nm741; BRAFF D, 1978, PSYCHOPHYSIOLOGY, V15, P339, DOI 10.1111/j.1469-8986.1978.tb01390.x; BRAFF DL, 1990, ARCH GEN PSYCHIAT, V47, P181; BRAFF DL, 1992, ARCH GEN PSYCHIAT, V49, P206; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; BRAKKEE JH, 1979, LAB ANIM SCI, V29, P78; Chambers J, 1999, NATURE, V400, P261, DOI 10.1038/22313; Chung SJ, 2009, P NATL ACAD SCI USA, V106, P6772, DOI 10.1073/pnas.0811331106; COOLS AR, 1990, BRAIN RES BULL, V24, P49, DOI 10.1016/0361-9230(90)90288-B; Croizier S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028574; David DJ, 2007, J PHARMACOL EXP THER, V321, P237, DOI 10.1124/jpet.106.109678; Ellenbroek BA, 2000, NEUROPSYCHOPHARMACOL, V23, P99, DOI 10.1016/S0893-133X(00)00088-9; ELLENBROEK BA, 1995, J NEUROSCI, V15, P7604; Ellenbroek BA, 2002, BEHAV GENET, V32, P349, DOI 10.1023/A:1020214322065; Evans AH, 2004, MOVEMENT DISORD, V19, P397, DOI 10.1002/mds.20045; Fasano A, 2008, DRUG ALCOHOL DEPEN, V96, P178, DOI 10.1016/j.drugalcdep.2008.02.005; FOG R, 1970, PSYCHOPHARMACOLOGIA, V16, P305, DOI 10.1007/BF00404736; FOG R, 1971, EXP NEUROL, V31, P75, DOI 10.1016/0014-4886(71)90178-6; Georgescu D, 2005, J NEUROSCI, V25, P2933, DOI 10.1523/JNEUROSCI.1714-04.2005; Geyer MA, 2002, MOL PSYCHIATR, V7, P1039, DOI 10.1038/sj.mp.4001159; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; KAWAUCHI H, 1983, NATURE, V305, P321, DOI 10.1038/305321a0; KEITH VA, 1991, BIOL PSYCHIAT, V30, P557, DOI 10.1016/0006-3223(91)90025-H; LAHOSTE GJ, 1992, SYNAPSE, V12, P14, DOI 10.1002/syn.890120103; Lembo PMC, 1999, NAT CELL BIOL, V1, P267, DOI 10.1038/12978; LJUNGBERG T, 1978, PHARMACOL BIOCHEM BE, V8, P483, DOI 10.1016/0091-3057(78)90088-6; Mahone EM, 2004, J PEDIATR-US, V145, P391, DOI 10.1016/j.jpeds.2004.06.014; MCGHIE A, 1961, BRIT J MED PSYCHOL, V34, P103, DOI 10.1111/j.2044-8341.1961.tb00936.x; Nagasaki H, 2009, EUR J PHARMACOL, V602, P194, DOI 10.1016/j.ejphar.2008.10.068; OLIANAS MC, 1988, EUR J PHARMACOL, V150, P389, DOI 10.1016/0014-2999(88)90025-8; Qu DQ, 1996, NATURE, V380, P243, DOI 10.1038/380243a0; Ralph-Williams RJ, 2002, J NEUROSCI, V22, P9604; RANDRUP A, 1967, PSYCHOPHARMACOLOGIA, V11, P300, DOI 10.1007/BF00404607; RIDLEY RM, 1994, PROG NEUROBIOL, V44, P221, DOI 10.1016/0301-0082(94)90039-6; RYLANDER G, 1972, PSYCHIAT NEUROL NEUR, V75, P203; Saito Y, 2001, J COMP NEUROL, V435, P26, DOI 10.1002/cne.1191; Saito Y, 1999, NATURE, V400, P265, DOI 10.1038/22321; SCHIORRING E, 1981, PHARMACOL BIOCHEM BE, V14, P109, DOI 10.1016/S0091-3057(81)80018-4; Sears RM, 2010, J NEUROSCI, V30, P8263, DOI 10.1523/JNEUROSCI.5858-09.2010; Severinsen JE, 2006, AM J MED GENET B, V141B, P524, DOI 10.1002/ajmg.b.30335; Shimomura Y, 1999, BIOCHEM BIOPH RES CO, V261, P622, DOI 10.1006/bbrc.1999.1104; Smith DG, 2006, NEUROPSYCHOPHARMACOL, V31, P1135, DOI 10.1038/sj.npp.1300913; Smith DG, 2005, J NEUROSCI, V25, P914, DOI 10.1523/JNEUROSCI.4079-04.2005; SWERDLOW NR, 1994, ARCH GEN PSYCHIAT, V51, P139; SWERDLOW NR, 1990, PSYCHOPHARMACOLOGY, V101, P414, DOI 10.1007/BF02244063; Swerdlow NR, 2001, PSYCHOPHARMACOLOGY, V156, P194, DOI 10.1007/s002130100799; Swerdlow NR, 1998, SCHIZOPHRENIA BULL, V24, P285, DOI 10.1093/oxfordjournals.schbul.a033326; SWERDLOW NR, 1992, PSYCHOPHARMACOLOGY, V108, P189, DOI 10.1007/BF02245306; Tyhon A, 2008, PHARMACOL BIOCHEM BE, V88, P446, DOI 10.1016/j.pbb.2007.10.001; Tyhon A, 2008, EUR J PHARMACOL, V599, P72, DOI 10.1016/j.ejphar.2008.09.027; van der Elst MCJ, 2005, EXP BRAIN RES, V160, P418, DOI 10.1007/s00221-004-2025-8; van der Elst MCJ, 2005, LIFE SCI, V76, P1391, DOI 10.1016/j.lfs.2004.10.023	57	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e19286	10.1371/journal.pone.0019286	http://dx.doi.org/10.1371/journal.pone.0019286			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21818251	gold, Green Published			2022-12-25	WOS:000292929500001
J	Hara, N; Namba, K; Minamino, T				Hara, Noritaka; Namba, Keiichi; Minamino, Tohru			Genetic Characterization of Conserved Charged Residues in the Bacterial Flagellar Type III Export Protein FlhA	PLOS ONE			English	Article							TERMINAL CYTOPLASMIC DOMAIN; SALMONELLA-TYPHIMURIUM; MEMBRANE COMPONENT; SECRETION SYSTEMS; ATP SYNTHASE; APPARATUS; FLII; MECHANISMS; REGULATOR; ROTATION	For assembly of the bacterial flagellum, most of flagellar proteins are transported to the distal end of the flagellum by the flagellar type III protein export apparatus powered by proton motive force (PMF) across the cytoplasmic membrane. FlhA is an integral membrane protein of the export apparatus and is involved in an early stage of the export process along with three soluble proteins, FliH, FliI, and FliJ, but the energy coupling mechanism remains unknown. Here, we carried out site-directed mutagenesis of eight, highly conserved charged residues in putative juxta-and trans-membrane helices of FlhA. Only Asp-208 was an essential acidic residue. Most of the FlhA substitutions were tolerated, but resulted in loss-of-function in the Delta fliH-fliI mutant background, even with the second-site flhB(P28T) mutation that increases the probability of flagellar protein export in the absence of FliH and FliI. The addition of FliH and FliI allowed the D45A, R85A, R94K and R270A mutant proteins to work even in the presence of the flhB(P28T) mutation. Suppressor analysis of a flhA(K203W) mutation showed an interaction between FlhA and FliR. Taken all together, we suggest that Asp-208 is directly involved in PMF-driven protein export and that the cooperative interactions of FlhA with FlhB, FliH, FliI, and FliR drive the translocation of export substrate.	[Hara, Noritaka; Namba, Keiichi; Minamino, Tohru] Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan; [Minamino, Tohru] Japan Sci & Technol Agcy, Kawaguchi, Saitama, Japan	Osaka University; Japan Science & Technology Agency (JST)	Hara, N (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan.	tohru@fbs.osaka-u.ac.jp	Namba, Keiichi/A-9406-2016		Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Science Foundation;  [21227006];  [22570161]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); ; 	NH is a research fellow of the Japan Society for the Promotion of Science. TM is a PRESTO researcher of Japan Science and Technology Agency. This work was supported in part by Grants-in-Aid for Scientific Research (21227006 to KN and 22570161 to TM), and Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by Takeda Science Foundation (to TM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bange G, 2010, P NATL ACAD SCI USA, V107, P11295, DOI 10.1073/pnas.1001383107; Barker CS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001143; Choe S, 1995, P NATL ACAD SCI USA, V92, P12046, DOI 10.1073/pnas.92.26.12046; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Evans LDB, 2006, P NATL ACAD SCI USA, V103, P17474, DOI 10.1073/pnas.0605197103; Fan F, 1996, J BIOL CHEM, V271, P31981, DOI 10.1074/jbc.271.50.31981; Fan F, 1997, MOL MICROBIOL, V26, P1035, DOI 10.1046/j.1365-2958.1997.6412010.x; Gonzalez-Pedrajo B, 2002, MOL MICROBIOL, V45, P967, DOI 10.1046/j.1365-2958.2002.03047.x; Hirano T, 2009, J BACTERIOL, V191, P3938, DOI 10.1128/JB.01811-08; HOPPE J, 1980, FEBS LETT, V109, P107, DOI 10.1016/0014-5793(80)81321-4; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Ibuki T, 2011, NAT STRUCT MOL BIOL, V18, P277, DOI 10.1038/nsmb.1977; Imada K, 2007, P NATL ACAD SCI USA, V104, P485, DOI 10.1073/pnas.0608090104; Imada K, 2010, P NATL ACAD SCI USA, V107, P8812, DOI 10.1073/pnas.1001866107; Karlinsey JE, 2000, MOL MICROBIOL, V37, P1220, DOI 10.1046/j.1365-2958.2000.02081.x; Karlinsey JE, 2006, J BACTERIOL, V188, P103, DOI 10.1128/JB.188.1.103-114.2006; Kihara M, 2001, J BACTERIOL, V183, P1655, DOI 10.1128/JB.183.5.1655-1662.2001; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; MALOY SR, 1981, J BACTERIOL, V145, P1110, DOI 10.1128/JB.145.2.1110-1111.1981; McMurry JL, 2004, J BACTERIOL, V186, P7586, DOI 10.1128/JB.186.22.7586-7592.2004; MILLER MJ, 1990, P NATL ACAD SCI USA, V87, P4900, DOI 10.1073/pnas.87.13.4900; Minamino T, 2000, MOL MICROBIOL, V37, P1494, DOI 10.1046/j.1365-2958.2000.02106.x; Minamino T, 1999, J BACTERIOL, V181, P1388, DOI 10.1128/JB.181.5.1388-1394.1999; MINAMINO T, 1994, J BACTERIOL, V176, P7630, DOI 10.1128/JB.176.24.7630-7637.1994; Minamino T, 2004, J MOL MICROB BIOTECH, V7, P5, DOI 10.1159/000077865; Minamino T, 2000, MOL MICROBIOL, V35, P1052, DOI 10.1046/j.1365-2958.2000.01771.x; Minamino T, 2003, J BACTERIOL, V185, P3983, DOI 10.1128/JB.185.13.3983-3988.2003; Minamino T, 2008, NATURE, V451, P485, DOI 10.1038/nature06449; Minamino T, 2010, J BACTERIOL, V192, P1929, DOI 10.1128/JB.01328-09; Minamino T, 2009, MOL MICROBIOL, V74, P1471, DOI 10.1111/j.1365-2958.2009.06946.x; Minamino T, 2008, CURR OPIN STRUC BIOL, V18, P693, DOI 10.1016/j.sbi.2008.09.006; Minamino T, 2008, MOL BIOSYST, V4, P1105, DOI 10.1039/b808065h; Mitome N, 2010, BIOCHEM J, V430, P171, DOI 10.1042/BJ20100621; Moore SA, 2010, J BIOL CHEM, V285, P21060, DOI 10.1074/jbc.M110.119412; Pallen MJ, 2006, PROTEIN SCI, V15, P935, DOI 10.1110/ps.051958806; Paul K, 2008, NATURE, V451, P489, DOI 10.1038/nature06497; Saijo-Hamano Y, 2004, J MOL BIOL, V343, P457, DOI 10.1016/j.jmb.2004.08.067; Saijo-Hamano Y, 2010, MOL MICROBIOL, V76, P260, DOI 10.1111/j.1365-2958.2010.07097.x; SHARP LL, 1995, BIOCHEMISTRY-US, V34, P9166, DOI 10.1021/bi00028a028; SHARP LL, 1995, P NATL ACAD SCI USA, V92, P7946, DOI 10.1073/pnas.92.17.7946; Thomas J, 2004, P NATL ACAD SCI USA, V101, P3945, DOI 10.1073/pnas.0307223101; Van Arnam JS, 2004, J BACTERIOL, V186, P2495, DOI 10.1128/JB.186.8.2495-2498.2004; von Ballmoos C, 2008, ANNU REV BIOPHYS, V37, P43, DOI 10.1146/annurev.biophys.37.032807.130018; YAMAGUCHI S, 1984, J GEN MICROBIOL, V130, P255; Zhu K, 2002, BIOCHEMISTRY-US, V41, P9516, DOI 10.1021/bi0203280	45	60	60	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22417	10.1371/journal.pone.0022417	http://dx.doi.org/10.1371/journal.pone.0022417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21811603	gold, Green Submitted, Green Published			2022-12-25	WOS:000292929500061
J	Liu, ZD; Wang, B; Xu, BB; Sun, JH				Liu, Zhudong; Wang, Bo; Xu, Bingbing; Sun, Jianghua			Monoterpene Variation Mediated Attack Preference Evolution of the Bark Beetle Dendroctonus valens	PLOS ONE			English	Article							MOUNTAIN PINE-BEETLE; RED TURPENTINE BEETLE; FIR PSEUDOTSUGA-MENZIESII; COLONIZATION PATTERNS; OLFACTORY RECOGNITION; BEHAVIORAL-RESPONSES; HOST SELECTION; COLEOPTERA; SCOLYTIDAE; CURCULIONIDAE	Several studies suggest that some bark beetle like to attack large trees. The invasive red turpentine beetle (RTB), Dendroctonus valens LeConte, one of the most destructive forest pests in China, is known to exhibit this behavior. Our previous study demonstrated that RTBs preferred to attack large-diameter trees (diameter at breast height, DBH >= 30 cm) over small-diameter trees (DBH <= 10 cm) in the field. In the current study, we studied the attacking behavior and the underlying mechanisms in the laboratory. Behavioral assays showed that RTBs preferred the bark of large-DBH trees and had a higher attack rate on the bolts of these trees. Y-tube assays showed that RTBs preferred the volatiles released by large-DBH trees to those released by small-DBH trees. Subsequent analysis revealed that both large-and small-DBH trees had the same composition of monoterpenes, but the concentration of each component differed; thus it appeared that the concentrations acted as cues for RTBs to locate the right-sized host which was confirmed by further behavioral assays. Moreover, large-DBH pine trees provided more spacious habitat and contained more nutrients, such as nitrogen, than did small-DBH pine trees, which benefited RTBs' fecundity and larval development. RTBs seem to have evolved mechanisms to locate those large hosts that will allow them to maximize their fitness. Monoterpene variation mediated attack preference implies the potential for the management of RTB.	[Liu, Zhudong; Wang, Bo; Xu, Bingbing; Sun, Jianghua] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing 100864, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS	Liu, ZD (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing 100864, Peoples R China.	liuzdqyj@yahoo.com; sunjh@ioz.ac.cn		Wang, Bo/0000-0002-3541-4639; sun, jianghua/0000-0002-9465-3672	National Basic Research Program [2009CB119204]; National Natural Science Foundation of China [30921063]	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Basic Research Program (2009CB119204) and National Natural Science Foundation of China (30921063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKTINS MD, 1966, CAN ENTOMOL, V98, P285; AMMAN GD, 1972, J ECON ENTOMOL, V65, P138, DOI 10.1093/jee/65.1.138; AMMAN GD, 1995, 424 USDA FOR SERV; AMMAN GD, 1983, INT145 USDA FOR RANG; Ayres MP, 2000, ECOLOGY, V81, P2198, DOI 10.1890/0012-9658(2000)081[2198:NBOPFB]2.0.CO;2; BERNAYS EA, 2000, ABSTRACT BOOK, V1; Borden J.H., 1985, P257; Brattli JG, 1998, J APPL ENTOMOL, V122, P345, DOI 10.1111/j.1439-0418.1998.tb01511.x; BURNELL DG, 1977, RES POPUL ECOL, V19, P99, DOI 10.1007/BF02510942; Byers John A., 1995, P154; Campbell SA, 2006, ECOL ENTOMOL, V31, P437, DOI 10.1111/j.1365-2311.2006.00809.x; Campbell SA, 2009, OIKOS, V118, P553, DOI 10.1111/j.1600-0706.2009.16761.x; Chow PS, 2004, TREE PHYSIOL, V24, P1129, DOI 10.1093/treephys/24.10.1129; Cibrian-Tovar D., 1995, FOREST INSECTS MEXIC; COBB FW, 1968, HILGARDIA, V39, P127, DOI 10.3733/hilg.v39n06p127; Cole D.M, 1973, USDA FOREST SERVICE; DICKENS JC, 1992, EXPERIENTIA, V48, P523, DOI 10.1007/BF01928180; Dobson Heidi E.M., 1994, P47; Eaton B., 1967, IMPORTANT FOREST INS, P21; ELKINTON JS, 1980, CAN ENTOMOL, V112, P797, DOI 10.4039/Ent112797-8; Erbilgin N, 2007, J CHEM ECOL, V33, P131, DOI 10.1007/s10886-006-9200-2; Fettig CJ, 2007, FOREST ECOL MANAG, V238, P24, DOI 10.1016/j.foreco.2006.10.011; Fettig CJ, 2006, FOREST ECOL MANAG, V230, P55, DOI 10.1016/j.foreco.2006.04.018; GAMBLIEL HA, 1995, BIOCHEM SYST ECOL, V23, P469, DOI 10.1016/0305-1978(95)00033-Q; HAACK RA, 1984, CAN ENTOMOL, V116, P625, DOI 10.4039/Ent116625-4; HOBSON KR, 1993, J CHEM ECOL, V19, P1837, DOI 10.1007/BF00983790; HYNUM BG, 1980, CAN ENTOMOL, V112, P185, DOI 10.4039/Ent112185-2; Kelley ST, 1998, EVOLUTION, V52, P1731, DOI [10.2307/2411346, 10.1111/j.1558-5646.1998.tb02253.x]; KLEIN WH, 1978, ENVIRON ENTOMOL, V7, P732, DOI 10.1093/ee/7.5.732; KNUDSEN JT, 1993, PHYTOCHEMISTRY, V33, P253, DOI 10.1016/0031-9422(93)85502-I; Liu ZD, 2008, INSECT SCI, V15, P349, DOI 10.1111/j.1744-7917.2008.00220.x; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; MCGHEHEY JH, 1968, CAN ENTOMOL, V100, P1153, DOI 10.4039/Ent1001153-11; McHugh CW, 2003, ENVIRON ENTOMOL, V32, P510, DOI 10.1603/0046-225X-32.3.510; Miao Zhen-Wang, 2003, Entomological Knowledge, V40, P346; OWEN DR, 2003, 9 CAL DEP FOR FIR PR; PAYNE TL, 1980, TECHNICAL B USDA, pCH2; PERSON H. L., 1931, Journal of Forestry, V29, P696; PREISLER HK, 1993, FOREST SCI, V39, P528; Pureswaran DS, 2005, AGR FOREST ENTOMOL, V7, P219, DOI 10.1111/j.1461-9555.2005.00264.x; Pureswaran DS, 2003, ENVIRON ENTOMOL, V32, P963, DOI 10.1603/0046-225X-32.5.963; Pureswaran DS, 2004, BIOCHEM SYST ECOL, V32, P1109, DOI 10.1016/j.bse.2004.04.006; RAFFA KF, 1987, AM NAT, V129, P234, DOI 10.1086/284633; Rappaport NG, 2001, ENVIRON ENTOMOL, V30, P837, DOI 10.1603/0046-225X-30.5.837; REDAK RA, 1984, OECOLOGIA, V62, P61, DOI 10.1007/BF00377374; Redmer JS, 2001, J ECON ENTOMOL, V94, P844, DOI 10.1603/0022-0493-94.4.844; Safranyik L, 2004, FOREST ECOL MANAG, V200, P23, DOI 10.1016/j.foreco.2004.06.004; Schlyter F, 1999, PHEROMONES OF NON-LEPIDOPTERAN INSECTS ASSOCIATED WITH AGRICULTURAL PLANTS, P113; SCHROEDER LM, 1992, J CHEM ECOL, V18, P1583, DOI 10.1007/BF00993231; Sequeira AS, 2000, P ROY SOC B-BIOL SCI, V267, P2359, DOI 10.1098/rspb.2000.1292; Slansky F. Jr, 1985, P87; SMITH RH, 1971, USDA FOREST PEST LEA, V55, P9; *SPSS INC, 1999, BAS SPSS WIND 10 0; STADLER E, 1976, P 15 INT C ENT, P228; Sun JH, 2004, ENVIRON ENTOMOL, V33, P206, DOI 10.1603/0046-225X-33.2.206; Tomlin ES, 1997, FOREST SCI, V43, P501; VISSER JH, 1986, ANNU REV ENTOMOL, V31, P328; VITE JP, 1962, CONTRIB BOYCE THOMPS, V21, P251; WARING RH, 1985, ECOLOGY, V66, P889, DOI 10.2307/1940551; WOOD DL, 1982, ANNU REV ENTOMOL, V27, P411, DOI 10.1146/annurev.en.27.010182.002211; WOOD SL, 1982, GREAT BASIN NATURAL, V6; Yan ZL, 2005, BIODIVERS CONSERV, V14, P1735, DOI 10.1007/s10531-004-0697-9; Zhang LW, 2007, ANN FOREST SCI, V64, P267, DOI 10.1051/forest:2007004; Zhang LW, 2009, ENVIRON ENTOMOL, V38, P472, DOI 10.1603/022.038.0221; Zhang QH, 2004, AGR FOREST ENTOMOL, V6, P1, DOI 10.1111/j.1461-9555.2004.00202.x; Zhang QH, 2001, J CHEM ECOL, V27, P995, DOI 10.1023/A:1010395221953; [No title captured]	67	18	19	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22005	10.1371/journal.pone.0022005	http://dx.doi.org/10.1371/journal.pone.0022005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21811555	Green Published, Green Submitted, gold			2022-12-25	WOS:000292929500027
J	Semple, MG; Taylor-Robinson, DC; Lane, S; Smyth, RL				Semple, Malcolm G.; Taylor-Robinson, David C.; Lane, Steven; Smyth, Rosalind L.			Household Tobacco Smoke and Admission Weight Predict Severe Bronchiolitis in Infants Independent of Deprivation: Prospective Cohort Study	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; FAILURE-TO-THRIVE; PARENTAL SMOKING; RISK-FACTORS; PASSIVE SMOKING; EARLY-CHILDHOOD; HEALTH; METAANALYSIS; ILLNESSES; EXPOSURE	Objectives: To examine demographic, environmental and clinical factors associated with severe bronchiolitis in infants admitted to hospital and quantify the independent effects of these factors. Design: Prospective cohort study. Setting: Alder Hey Children's Hospital, Liverpool, United Kingdom. Participants: 378 infants admitted to hospital with a diagnosis of bronchiolitis, of whom 299 (79%) were antigen positive to respiratory syncytial virus (RSV). Outcome: Severity of disease during admission, defined as "no need for supplemental oxygen" (reference group), "any need for supplemental oxygen" and "any need for mechanical ventilation". Results: Univariate analysis found male sex (p = 0.035) and tobacco smoking by a household member (p<0.001) were associated with need for both supplemental oxygen and mechanical ventilation. Premature birth, low gestation, low birth weight, low admission weight and low corrected age on admission were also associated with need for mechanical ventilation (all p <= 0.002). Deprivation scores (IMD 2004) were significantly higher in households where a member smoked compared to non-smoking households (p<0.001). The odds of smoking predicted by deprivation were 7 times higher (95% CI (3.59, 14.03)), when comparing the least and most deprived quintiles of the study population. Family history of atopic disease and deprivation score were not associated with severe disease. Multivariate multinomial logistic regression which initially included all covariates, found household tobacco smoking (adjusted OR = 2.45, 95% CI (1.60, 3.74) predicted need for oxygen supplementation. Household tobacco smoking (adjusted OR = 5.49, (2.78, 10.83)) and weight (kg) on admission (adjusted OR = 0.51, (0.40, 0.65)) were both significant predictors in the final model for mechanical ventilation. The same associations and similar size of effects were found when only children with proven RSV infection were included in analysis. Conclusions: Low admission weight and householder tobacco smoking increased the risk of severe bronchiolitis in infants admitted to hospital. These effects were independent of a standard deprivation measure. NIHR Study Ref. DHCS/G121/10.	[Semple, Malcolm G.; Smyth, Rosalind L.] Univ Liverpool, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England; [Taylor-Robinson, David C.] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England; [Lane, Steven] Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Liverpool; University of Liverpool	Semple, MG (corresponding author), Univ Liverpool, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England.	m.g.semple@liverpool.ac.uk	Semple, Malcolm Gracie/A-8790-2008	Semple, Malcolm Gracie/0000-0001-9700-0418	Department of Health, United Kingdom (NIHR) [DHCS/G121/10]; MRC; Medical Research Council [G0802448] Funding Source: researchfish; MRC [G0802448] Funding Source: UKRI	Department of Health, United Kingdom (NIHR)(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by a National Clinician Scientist Award to MGS by the Department of Health, United Kingdom (NIHR Study Ref. DHCS/G121/10). DTR is funded by an MRC Population Health Scientist Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradley JP, 2005, PEDIATRICS, V115, pE7, DOI 10.1542/peds.2004-0059; Brown AE, 2010, EUR J PUBLIC HEALTH, V20, P231, DOI 10.1093/eurpub/ckp114; Carroll KN, 2008, PEDIATRICS, V122, P58, DOI 10.1542/peds.2007-2087; Emond A, 2007, ARCH DIS CHILD, V92, P115, DOI 10.1136/adc.2005.091496; Feltes TF, 2003, J PEDIATR-US, V143, P532, DOI 10.1067/S0022-3476(03)00454-2; Haberg SE, 2007, AM J EPIDEMIOL, V166, P679, DOI 10.1093/aje/kwm134; HOLBERG CJ, 1991, AM J EPIDEMIOL, V133, P1135, DOI 10.1093/oxfordjournals.aje.a115826; Jackson B, 2004, INT J EPIDEMIOL, V33, P271, DOI 10.1093/ije/dyh003; Jones LL, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-5; Klein SL, 2000, NEUROSCI BIOBEHAV R, V24, P627, DOI 10.1016/S0149-7634(00)00027-0; Koehoorn M, 2008, PEDIATRICS, V122, P1196, DOI 10.1542/peds.2007-2231; Leader S, 2002, PEDIATR INFECT DIS J, V21, P629, DOI 10.1097/00006454-200207000-00005; Margolis PA, 1997, PEDIATR PULM, V23, P417, DOI 10.1002/(SICI)1099-0496(199706)23:6<417::AID-PPUL4>3.0.CO;2-F; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; PATRICK DL, 1994, AM J PUBLIC HEALTH, V84, P1086, DOI 10.2105/AJPH.84.7.1086; Scottish Intercollegiate Guidelines Network, 2006, BRONCH CHILDR NAT CL; Semple MG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001038; Simoes EAF, 2003, J PEDIATR-US, V143, pS118, DOI 10.1067/S0022-3476(03)00511-0; Strachan DP, 1997, THORAX, V52, P905, DOI 10.1136/thx.52.10.905; Tobacco Advisory Group of the Royal College of Physicians, 2010, PASS SMOK CHILDR; Twigg L, 2004, SMOKING EPIDEMIC ENG; *U OXF SOC DIS RES, 2004, COMM LOC GOV; WALKER A, 2000, LIVING BRITAIN RESUL; WRIGHT AL, 1991, J PEDIATR-US, V118, P207, DOI 10.1016/S0022-3476(05)80484-6; Wright CM, 2006, ARCH DIS CHILD, V91, P312, DOI 10.1136/adc.2005.077750; WRIGHT CM, 1994, ACTA PAEDIATR, V83, P357, DOI 10.1111/j.1651-2227.1994.tb18119.x	26	40	43	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22425	10.1371/journal.pone.0022425	http://dx.doi.org/10.1371/journal.pone.0022425			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21811609	Green Published, gold, Green Submitted			2022-12-25	WOS:000292929500066
J	Yrigollen, CM; Tassone, F; Durbin-Johnson, B; Tassone, F				Yrigollen, Carolyn M.; Tassone, Federica; Durbin-Johnson, Blythe; Tassone, Flora			The Role of AGG Interruptions in the Transcription of FMR1 Premutation Alleles	PLOS ONE			English	Article							FRAGILE-X-SYNDROME; MESSENGER-RNA; TREMOR/ATAXIA SYNDROME; EXPANDED ALLELES; CGG REPEAT; CLINICAL PHENOTYPE; GENE; CARRIERS; POPULATION; PREVALENCE	Fragile X associated disorders are caused by a premutation allele in the fragile X mental retardation 1 gene (FMR1) and are hypothesized to result from the toxic effect of elevated levels of expanded FMR1 transcripts. Increased levels of FMR1 mRNA have indeed been reported in premutation carriers; however the mechanism by which expanded alleles lead to elevated levels of FMR1 mRNA in premutation carriers is unknown. Within the CGG repeat tract AGG interruptions are found, generally 1-3 present in normal/intermediate alleles (6-54 CGG repeats) and usually 0-1 in premutation alleles (55-200 CGG repeats). They are present at specific locations, generally occurring after 9 or 10 uninterrupted CGG repeats [(CGG)(9)AGG(CGG)(9)AGG(CGG)(n)]. We evaluated both the number of AGG interruptions and the resulting length of the uninterrupted 3' CGG repeat pure tract in premutation alleles derived from two large cohorts of male and female carriers to determine whether the presence of AGG interruptions or the length of a pure stretch of CGG repeats influence the levels of FMR1 mRNA in blood. Our findings indicate that neither the number of AGG interruptions, nor their position along the CGG tract have a significant affect on mRNA levels in premutation carriers. We also, as expected based on previous findings, observed a highly significant correlation between CGG repeat number (as both total length and length of pure CGG stretch) and FMR1 mRNA expression levels, in both males and females. Importantly, we did not observe any significant difference in FMR1 mRNA levels in premutation carriers based on age.	[Yrigollen, Carolyn M.; Tassone, Federica; Tassone, Flora] Univ Calif Davis, Dept Biochem & Mol Med, Sch Med, Davis, CA 95616 USA; [Durbin-Johnson, Blythe] Univ Calif Davis, Dept Publ Hlth Sci, Sch Med, Davis, CA 95616 USA; [Tassone, Flora] Univ Calif Davis, Med Ctr, MIND Inst, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Yrigollen, CM (corresponding author), Univ Calif Davis, Dept Biochem & Mol Med, Sch Med, Davis, CA 95616 USA.	ftassone@ucdavis.edu		Yrigollen, Carolyn/0000-0002-2399-6176	National Institutes of Health [HD02274, HD04066, HD36071]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002274, R01HD036071] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the National Institutes of Health through individual research awards [HD02274, HD04066, HD36071]. Statistical support for this publication was made possible by the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research [UL1 RR024146]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EG, 2004, HUM GENET, V114, P439, DOI 10.1007/s00439-004-1086-x; Amiri K, 2008, ARCH NEUROL-CHICAGO, V65, P19, DOI 10.1001/archneurol.2007.30; Aziz M, 2003, AM J MED GENET B, V121B, P119, DOI 10.1002/ajmg.b.20030; Bailey DB, 2008, AM J MED GENET A, V146A, P2060, DOI 10.1002/ajmg.a.32439; BOURGEOIS J, 2009, FRAGILE X P IN PRESS; Boyle L, 2010, AM J MED GENET C, V154C, P469, DOI 10.1002/ajmg.c.30277; Chen LJ, 2010, J MOL DIAGN, V12, P589, DOI 10.2353/jmoldx.2010.090227; Chen YC, 2010, HUM MOL GENET, V19, P196, DOI 10.1093/hmg/ddp479; Chonchaiya Weerasak, 2009, Adv Pediatr, V56, P165, DOI 10.1016/j.yapd.2009.08.008; Coffey SM, 2008, AM J MED GENET A, V146A, P1009, DOI 10.1002/ajmg.a.32060; CRONISTER A, 1991, AM J MED GENET, V38, P269, DOI 10.1002/ajmg.1320380221; Dombrowski C, 2002, HUM MOL GENET, V11, P371, DOI 10.1093/hmg/11.4.371; EICHLER EE, 1995, NAT GENET, V11, P301, DOI 10.1038/ng1195-301; Eichler EE, 1996, AM J MED GENET, V64, P220, DOI 10.1002/(SICI)1096-8628(19960712)64:1<220::AID-AJMG40>3.0.CO;2-M; Farzin F, 2006, J DEV BEHAV PEDIATR, V27, pS137, DOI 10.1097/00004703-200604002-00012; Fernandez-Carvajal I, 2009, J MOL DIAGN, V11, P324, DOI 10.2353/jmoldx.2009.080173; Garcia-Arocena D, 2010, HUM MOL GENET, V19, pR83, DOI 10.1093/hmg/ddq166; Greco CM, 2008, ARCH NEUROL-CHICAGO, V65, P1114, DOI 10.1001/archneur.65.8.1114; Hagerman PJ, 2008, J MED GENET, V45, P498, DOI 10.1136/jmg.2008.059055; Hagerman PJ, 2004, AM J HUM GENET, V74, P805, DOI 10.1086/386296; Hagerman RJ, 2001, NEUROLOGY, V57, P127, DOI 10.1212/WNL.57.1.127; Hessl D, 2005, AM J MED GENET B, V139B, P115, DOI 10.1002/ajmg.b.30241; Jacquemont S, 2003, AM J HUM GENET, V72, P869, DOI 10.1086/374321; Jarem DA, 2010, BIOCHEMISTRY-US, V49, P6826, DOI 10.1021/bi1007782; Kenneson A, 2001, HUM MOL GENET, V10, P1449, DOI 10.1093/hmg/10.14.1449; Leehey MA, 2009, J INVEST MED, V57, P830, DOI 10.2310/JIM.0b013e3181af59c4; Ludwig AL, 2009, NUCLEIC ACIDS RES, V37, P6896, DOI 10.1093/nar/gkp713; Maddalena Anne, 2001, Genetics in Medicine, V3, P200, DOI 10.1097/00125817-200105000-00010; Oostra BA, 2009, BBA-GEN SUBJECTS, V1790, P467, DOI 10.1016/j.bbagen.2009.02.007; Peprah E, 2010, J HUM GENET, V55, P66, DOI 10.1038/jhg.2009.121; Primerano B, 2002, RNA, V8, P1482, DOI 10.1017/s1355838202020642; Roberts JE, 2009, AM J MED GENET B, V150B, P130, DOI 10.1002/ajmg.b.30786; Rodriguez-Revenga L, 2008, PSYCHIAT GENET, V18, P153, DOI 10.1097/YPG.0b013e3282f97e0b; ROUSSEAU F, 1995, AM J HUM GENET, V57, P1006; Sherman SL, 2000, AM J MED GENET, V97, P189, DOI 10.1002/1096-8628(200023)97:3<189::AID-AJMG1036>3.0.CO;2-J; Sullivan AK, 2005, HUM REPROD, V20, P402, DOI 10.1093/humrep/deh635; Tassone F, 2000, AM J HUM GENET, V66, P6, DOI 10.1086/302720; Tassone F, 2008, J MOL DIAGN, V10, P43, DOI 10.2353/jmoldx.2008.070073; Tassone F, 2007, RNA, V13, P555, DOI 10.1261/rna.280807; Toledano-Alhadef H, 2001, AM J HUM GENET, V69, P351, DOI 10.1086/321974; Wittenberger MD, 2007, FERTIL STERIL, V87, P456, DOI 10.1016/j.fertnstert.2006.09.004; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179; Zittel S, 2009, J NEUROL NEUROSUR PS, V80, P812, DOI 10.1136/jnnp.2008.160960	43	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e21728	10.1371/journal.pone.0021728	http://dx.doi.org/10.1371/journal.pone.0021728			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21818263	Green Published, gold, Green Submitted			2022-12-25	WOS:000292929500007
J	Sayan, AE; Stanford, R; Vickery, R; Grigorenko, E; Diesch, J; Kulbicki, K; Edwards, R; Pal, R; Greaves, P; Jariel-Encontre, I; Piechaczyk, M; Kriajevska, M; Mellon, JK; Dhillon, AS; Tulchinsky, E				Sayan, A. E.; Stanford, R.; Vickery, R.; Grigorenko, E.; Diesch, J.; Kulbicki, K.; Edwards, R.; Pal, R.; Greaves, P.; Jariel-Encontre, I.; Piechaczyk, M.; Kriajevska, M.; Mellon, J. K.; Dhillon, A. S.; Tulchinsky, E.			Fra-1 controls motility of bladder cancer cells via transcriptional upregulation of the receptor tyrosine kinase AXL	ONCOGENE			English	Article						Fos-related antigen-1; cell motility; bladder cancer	BREAST-CANCER; PROTEASOMAL DEGRADATION; CARCINOMA-CELLS; FAMILY-MEMBERS; C-MET; EXPRESSION; AP-1; RAS; TARGET; GENE	Fos-related antigen 1 (Fra-1) is a Fos family member overexpressed in several types of human cancers. Here, we report that Fra-1 is highly expressed in the muscle-invasive form of the carcinoma of the bladder (80%) and to a lesser extent in superficial bladder cancer (42%). We demonstrate that in this type of cancer Fra-1 is regulated via a C-terminal instability signal and C-terminal phosphorylation. We show that manipulation of Fra-1 expression levels in bladder cancer cell lines affects cell morphology, motility and proliferation. The gene coding for AXL tyrosine kinase is directly upregulated by Fra-1 in bladder cancer and in other cell lines. Importantly, our data demonstrate that AXL mediates the effect of Fra-1 on tumour cell motility but not on cell proliferation. We suggest that AXL may represent an attractive therapeutic target in cancers expressing high Fra-1 levels. Oncogene (2012) 31, 1493-1503; doi:10.1038/onc.2011.336; published online 8 August 2011	[Sayan, A. E.; Stanford, R.; Vickery, R.; Kulbicki, K.; Pal, R.; Kriajevska, M.; Mellon, J. K.; Tulchinsky, E.] Univ Leicester, Dept Canc Studies & Mol Med, Leicester, Leics, England; [Sayan, A. E.] Univ Southampton, Sch Med, Cancer Sci Div, Southampton, Hants, England; [Grigorenko, E.] Life Technol Inc, Woburn, MA USA; [Diesch, J.; Dhillon, A. S.] Univ Melbourne, Dept Biochem & Mol Biol, Inst Bio21, Melbourne, Vic, Australia; [Edwards, R.; Greaves, P.] MRC, Toxicol Unit, Leicester, Leics, England; [Jariel-Encontre, I.; Piechaczyk, M.] Univ Montpellier 1 & 2, CNRS, Inst Genet Mol Montpellier, Montpellier, France	University of Leicester; University of Southampton; Thermo Fisher Scientific; University of Melbourne; University of Leicester; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Dhillon, AS (corresponding author), Peter MacCallum Canc Ctr, Growth & Differentiat Program, Div Res, St Andrews Pl E Melbourne, Melbourne, Vic 3002, Australia.	Amardeep.Dhillon@petermac.org; et32@le.ac.uk	PIECHACZYK, Marc/E-7896-2013; Diesch, Jeannine/J-8558-2017; SAYAN, A. EMRE/H-7330-2012; Tulchinsky, Eugene/ABD-7070-2021	PIECHACZYK, Marc/0000-0003-1367-2597; Diesch, Jeannine/0000-0002-4667-3468; SAYAN, A. EMRE/0000-0002-5291-1485; Stanford, Richard/0000-0002-0189-7468; Dhillon, Amardeep/0000-0002-6065-663X	Association for International Cancer Research [07-0083]; National Health and Medical Research Council of Australia; French Ligue Nationale contre le Cancer	Association for International Cancer Research; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); French Ligue Nationale contre le Cancer(Ligue nationale contre le cancer)	This work was supported by the Association for International Cancer Research grant 07-0083 (to ET) and by a grant from the National Health and Medical Research Council of Australia (to AD). MP is supported by an 'Equipe Labelisee' grant from the French Ligue Nationale contre le Cancer	Andersen H, 2005, MOL CELL BIOL, V25, P9138, DOI 10.1128/MCB.25.20.9138-9150.2005; Andersen H, 2002, ONCOGENE, V21, P4843, DOI 10.1038/sj.onc.1205590; Basbous J, 2007, MOL CELL BIOL, V27, P3936, DOI 10.1128/MCB.01776-06; Belguise K, 2005, ONCOGENE, V24, P1434, DOI 10.1038/sj.onc.1208312; BELLOSTA P, 1995, MOL CELL BIOL, V15, P614; BERGERS G, 1995, MOL CELL BIOL, V15, P3748; Burch PM, 2004, MOL CELL BIOL, V24, P4696, DOI 10.1128/MCB.24.11.4696-4709.2004; Casalino L, 2003, MOL CELL BIOL, V23, P4401, DOI 10.1128/MCB.23.12.4401-4415.2003; Casalino L, 2007, EMBO J, V26, P1878, DOI 10.1038/sj.emboj.7601617; Chiappetta G, 2000, CLIN CANCER RES, V6, P4300; Chiappetta G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-17; Debinski W, 2005, MOL CANCER RES, V3, P237; Dixon James M, 2009, Biotechniques, V46, pii, DOI 10.2144/000112746; Doehn U, 2009, MOL CELL, V35, P511, DOI 10.1016/j.molcel.2009.08.002; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Hafizi S, 2006, CYTOKINE GROWTH F R, V17, P295, DOI 10.1016/j.cytogfr.2006.04.004; Heiring C, 2004, J BIOL CHEM, V279, P6952, DOI 10.1074/jbc.M311750200; Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997; Hu CY, 2001, CLIN CANCER RES, V7, P2213; Hutterer M, 2008, CLIN CANCER RES, V14, P130, DOI 10.1158/1078-0432.CCR-07-0862; Kakumoto K, 2006, P NATL ACAD SCI USA, V103, P5490, DOI 10.1073/pnas.0601222103; Knowles MA, 2008, INT J CLIN ONCOL, V13, P287, DOI 10.1007/s10147-008-0812-0; Kustikova O, 1998, MOL CELL BIOL, V18, P7095, DOI 10.1128/MCB.18.12.7095; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; McHugh LA, 2009, INT J ONCOL, V34, P1155, DOI 10.3892/ijo_00000244; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; Mitra AP, 2009, ANNU REV PATHOL-MECH, V4, P251, DOI 10.1146/annurev.pathol.4.110807.092230; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Ozanne BW, 2006, CURR OPIN GENET DEV, V16, P65, DOI 10.1016/j.gde.2005.12.012; Pollock CB, 2005, CANCER RES, V65, P1244, DOI 10.1158/0008-5472.CAN-04-1911; Ramos-Nino ME, 2003, CANCER RES, V63, P3539; Rankin EB, 2010, CANCER RES, V70, P7570, DOI 10.1158/0008-5472.CAN-10-1267; Sainaghi PP, 2005, J CELL PHYSIOL, V204, P36, DOI 10.1002/jcp.20265; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shieh YS, 2005, NEOPLASIA, V7, P1058, DOI 10.1593/neo.05640; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Verde P, 2007, CELL CYCLE, V6, P2633, DOI 10.4161/cc.6.21.4850; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4; Vial E, 2003, J CELL SCI, V116, P4957, DOI 10.1242/jcs.00812; Vikhanskaya F, 2007, NAT CELL BIOL, V9, P698, DOI 10.1038/ncb1598; Yeh CY, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-139; Young MR, 2006, GENE, V379, P1, DOI 10.1016/j.gene.2006.05.001; Zhang WH, 2005, AM J CLIN PATHOL, V124, P11, DOI 10.1309/T1H2Y2CHWY7PD2BN; Zhang YX, 2008, CANCER RES, V68, P1905, DOI 10.1158/0008-5472.CAN-07-2661	45	68	70	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2012	31	12					1493	1503		10.1038/onc.2011.336	http://dx.doi.org/10.1038/onc.2011.336			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	916VT	21822309				2022-12-25	WOS:000302132000003
J	Dumont, M; Stack, C; Elipenahli, C; Jainuddin, S; Gerges, M; Starkova, NN; Yang, LC; Starkov, AA; Beal, F				Dumont, Magali; Stack, Cliona; Elipenahli, Ceyhan; Jainuddin, Shari; Gerges, Meri; Starkova, Natalia N.; Yang, Lichuan; Starkov, Anatoly A.; Beal, Flint			Behavioral deficit, oxidative stress, and mitochondrial dysfunction precede tau pathology in P301S transgenic mice	FASEB JOURNAL			English	Article						tauopathy; exploration; tangles	LIPID-PEROXIDATION PRODUCT; MOUSE MODEL; NEURODEGENERATIVE TAUOPATHIES; ALZHEIMERS-DISEASE; PROTEIN; CELLS	Abnormal tau accumulation can lead to the development of neurodegenerative diseases. P301S mice overexpress the human tau mutated gene, resulting in tau hyperphosphorylation and tangle formation. Mice also develop synaptic deficits and microglial activation prior to any neurodegeneration and tangles. Oxidative stress can also affect tauopathy. We studied the role of oxidative stress in relationship to behavioral abnormalities and disease progression in P301S mice at 2, 7, and 10 mo of age. At 7 mo of age, P301S mice had behavioral abnormalities, such as hyperactivity and disinhibition. At the same age, we observed increased carbonyls in P301S mitochondria (similar to 215 and 55% increase, males/females), and deregulation in the activity and content of mitochondrial enzymes involved in reactive oxygen species formation and energy metabolism, such as citrate synthase (similar to 19 and similar to 5% decrease, males/females), MnSOD (similar to 16% decrease, males only), cytochrome C (similar to 19% decrease, females only), and cytochrome C oxidase (similar to 20% increase, females only). These changes in mitochondria proteome appeared before tau hyperphosphorylation and tangle formation, which were observed at 10 mo and were associated with GSK3 beta activation. At that age, mitochondria proteome deregulation became more apparent in male P301S mitochondria. The data strongly suggest that oxidative stress and mitochondrial abnormalities appear prior to tau pathology.-Dumont, M., Stack, C., Elipenahli, C., Jainuddin, S., Gerges, M., Starkova, M. N., Yang, L., Starkov, A. A., Beal, F. Behavioral deficit, oxidative stress, and mitochondrial dysfunction precede tau pathology in P301S transgenic mice. FASEB J. 25, 4063-4072 (2011). www.fasebj.org	[Dumont, Magali; Stack, Cliona; Elipenahli, Ceyhan; Jainuddin, Shari; Gerges, Meri; Starkova, Natalia N.; Yang, Lichuan; Starkov, Anatoly A.; Beal, Flint] Weill Cornell Med Coll, Dept Neurol & Neurosci, New York, NY 10065 USA	Cornell University	Dumont, M (corresponding author), Weill Cornell Med Coll, Dept Neurol & Neurosci, 525 E 68th St,Rm A569A, New York, NY 10065 USA.	mad2138@med.cornell.edu	Starkov, Anatoly/B-2688-2012	Starkov, Anatoly/0000-0002-1334-4828; DUMONT, MAGALI/0000-0001-9990-6512	National Institute of Aging [PO AG014930]; NATIONAL INSTITUTE ON AGING [P01AG014930] Funding Source: NIH RePORTER	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Tau Consortium. The authors thank Dr. Peter Davies (Albert Einstein College of Medicine, Manhasset, NY, USA) for providing the tau antibodies (CP13, PHF1, MC1, and DA9). A. A. S was supported by the National Institute of Aging (PO AG014930).	Agarwal R, 2002, J CHROMATOGR B, V775, P121, DOI 10.1016/S1570-0232(02)00273-8; ARRIGONI O, 1962, NATURE, V193, P1256, DOI 10.1038/1931256a0; Cente M, 2006, EUR J NEUROSCI, V24, P1085, DOI 10.1111/j.1460-9568.2006.04986.x; Chen JQ, 2009, BBA-MOL CELL RES, V1793, P1540, DOI 10.1016/j.bbamcr.2009.06.001; Chou JL, 2011, J PROTEOMICS, V74, P466, DOI 10.1016/j.jprot.2010.12.012; Correia Sonia C, 2010, Curr Aging Sci, V3, P113; David DC, 2005, J BIOL CHEM, V280, P23802, DOI 10.1074/jbc.M500356200; Dias-Santagata D, 2007, J CLIN INVEST, V117, P236, DOI 10.1172/JCI28769; Du H, 2010, P NATL ACAD SCI USA, V107, P18670, DOI 10.1073/pnas.1006586107; Dumont M, 2010, NEUROCHEM INT, V56, P345, DOI 10.1016/j.neuint.2009.11.006; Eckert A, 2008, J MOL MED, V86, P1255, DOI 10.1007/s00109-008-0391-6; ESPOSTI MD, 1993, BIOCHEM BIOPH RES CO, V190, P1090, DOI 10.1006/bbrc.1993.1161; Gasparini L, 2007, NEURODEGENER DIS, V4, P236, DOI 10.1159/000101848; Goedert M, 2005, BBA-MOL BASIS DIS, V1739, P240, DOI 10.1016/j.bbadis.2004.08.007; Gomez-Ramos A, 2003, J NEUROSCI RES, V71, P863, DOI 10.1002/jnr.10525; Hernandez F, 2010, EXP NEUROL, V223, P322, DOI 10.1016/j.expneurol.2009.09.011; Hirata-Fukae C, 2008, BRAIN RES, V1216, P92, DOI 10.1016/j.brainres.2008.03.079; Hooper C, 2008, J NEUROCHEM, V104, P1433, DOI 10.1111/j.1471-4159.2007.05194.x; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Ingram EM, 2002, TRENDS MOL MED, V8, P555, DOI 10.1016/S1471-4914(02)02440-1; Lee VMY, 2005, BBA-MOL BASIS DIS, V1739, P251, DOI 10.1016/j.bbadis.2004.06.014; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu Q, 2005, FREE RADICAL BIO MED, V38, P746, DOI 10.1016/j.freeradbiomed.2004.11.005; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Melov S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000536; Misiak M, 2010, BBA-BIOENERGETICS, V1797, P1178, DOI 10.1016/j.bbabio.2010.04.009; Noble W, 2010, CNS NEUROL DISORD-DR, V9, P403, DOI 10.2174/187152710791556131; Perez M, 2000, FEBS LETT, V486, P270, DOI 10.1016/S0014-5793(00)02323-1; Scattoni ML, 2010, BEHAV BRAIN RES, V208, P250, DOI 10.1016/j.bbr.2009.12.002; Simpkins JW, 2010, BBA-GEN SUBJECTS, V1800, P1113, DOI 10.1016/j.bbagen.2009.11.013; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; SPERBER BR, 1995, NEUROSCI LETT, V197, P149, DOI 10.1016/0304-3940(95)11902-9; Starkov AA, 2010, METHODS MOL BIOL, V648, P245, DOI 10.1007/978-1-60761-756-3_16; Starkov AA, 2008, ANN NY ACAD SCI, V1147, P37, DOI 10.1196/annals.1427.015; Thomas B, 2012, ANTIOXID REDOX SIGN, V16, P855, DOI 10.1089/ars.2010.3849; Yoshiyama Y, 2001, Curr Neurol Neurosci Rep, V1, P413, DOI 10.1007/s11910-001-0100-0; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010	38	87	88	2	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	NOV	2011	25	11					4063	4072		10.1096/fj.11-186650	http://dx.doi.org/10.1096/fj.11-186650			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	844BT	21825035	Green Published			2022-12-25	WOS:000296723100029
J	Thorp, E; Vaisar, T; Subramanian, M; Mautner, L; Blobel, C; Tabas, I				Thorp, Edward; Vaisar, Tomas; Subramanian, Manikandan; Mautner, Lauren; Blobel, Carl; Tabas, Ira			Shedding of the Mer Tyrosine Kinase Receptor Is Mediated by ADAM17 Protein through a Pathway Involving Reactive Oxygen Species, Protein Kinase C delta, and p38 Mitogen-activated Protein Kinase (MAPK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; ALPHA-CONVERTING-ENZYME; ARREST-SPECIFIC GENE; NF-KAPPA-B; APOPTOTIC CELLS; TNF-ALPHA; EXPRESSION ANALYSIS; POTENTIAL ROLE; CUTTING EDGE; SOLUBLE FORM	Mer tyrosine kinase (MerTK) is an integral membrane protein that is preferentially expressed by phagocytic cells, where it promotes efferocytosis and inhibits inflammatory signaling. Proteolytic cleavage of MerTK at an unidentified site leads to shedding of its soluble ectodomain (soluble MER; sMER), which can inhibit thrombosis in mice and efferocytosis in vitro. Herein, we show that MerTK is cleaved at proline 485 in murine macrophages. Site-directed deletion of 6 amino acids spanning proline 485 rendered MerTK resistant to proteolysis and suppression of efferocytosis by cleavage-inducing stimuli. LPS is a known inducer of MerTK cleavage, and the intracellular signaling pathways required for this action are unknown. LPS/TLR4-mediated generation of sMER required disintegrin and metalloproteinase ADAM17 and was independent of Myd88, instead requiring TRIF adaptor signaling. LPS-induced cleavage was suppressed by deficiency of NADPH oxidase 2 (Nox2) and PKC delta. The addition of the antioxidant N-acetyl cysteine inhibited PKC delta, and silencing of PKC delta inhibited MAPK p38, which was also required. In a mouse model of endotoxemia, we discovered that LPS induced plasma sMER, and this was suppressed by Adam17 deficiency. Thus, a TRIF-mediated pattern recognition receptor signaling cascade requires NADPH oxidase to activate PKC delta and then p38, culminating in ADAM17-mediated proteolysis of MerTK. These findings link innate pattern recognition receptor signaling to proteolytic inactivation of MerTK and generation of sMER and uncover targets to test how MerTK cleavage affects efferocytosis efficiency and inflammation resolution in vivo.	[Thorp, Edward; Subramanian, Manikandan; Mautner, Lauren; Tabas, Ira] Columbia Univ, Dept Med Pathol & Cell Biol & Physiol, New York, NY 10032 USA; [Thorp, Edward; Subramanian, Manikandan; Mautner, Lauren; Tabas, Ira] Columbia Univ, Dept Cellular Biophys, New York, NY 10032 USA; [Vaisar, Tomas] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Blobel, Carl] Hosp Special Surg, New York, NY 10021 USA	Columbia University; Columbia University; University of Washington; University of Washington Seattle	Thorp, E (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pathol, 303 E Chicago Ave,Tarry Bldg 3-705, Chicago, IL 60611 USA.	ebthorp@northwestern.edu; iat1@columbia.edu		Thorp, Edward/0000-0003-1387-7058; Vaisar, Tomas/0000-0002-7406-6606; Subramanian, Manikandan/0000-0002-2608-3890	National Institutes of Health (NIH); NHLBI; Program of Excellence in Nanotechnology (PEN) [HHSN268201000045C]; NIH [HL54591, HL75662, 1K99HL097021]; National Center for Research Resources (NCRR) [UL1 RR 024156];  [GM64750]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024156] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075662, P01HL054591, K99HL097021, T35HL007616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064750] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Program of Excellence in Nanotechnology (PEN); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NHLBI, Program of Excellence in Nanotechnology (PEN) Award Contract HHSN268201000045C and NIH Grants HL54591 and HL75662 (to I. T.), GM64750 (to C. B.), and UL1 RR 024156 from the National Center for Research Resources (NCRR), a component of the NIH, and 1K99HL097021 (to E. T.).	ADERKA D, 1992, J EXP MED, V175, P323, DOI 10.1084/jem.175.2.323; Althoff K, 2000, EUR J BIOCHEM, V267, P2624, DOI 10.1046/j.1432-1327.2000.01278.x; Anwar A, 2009, J LEUKOCYTE BIOL, V86, P73, DOI [10.1189/jlb.0608334, 10.1189/JLB.0608334]; Becherer JD, 2003, CURR TOP DEV BIOL, V54, P101, DOI 10.1016/S0070-2153(03)54006-6; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Bostanci N, 2009, ORAL MICROBIOL IMMUN, V24, P146, DOI 10.1111/j.1399-302X.2008.00488.x; Brandl K, 2010, P NATL ACAD SCI USA, V107, P19967, DOI 10.1073/pnas.1014669107; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; Chen CL, 2010, J CELL SCI, V123, P2901, DOI 10.1242/jcs.069765; Chen CL, 2004, ARTERIOSCL THROM VAS, V24, P1118, DOI 10.1161/01.ATV.0000130662.30537.08; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; Costa M, 1996, J CELL PHYSIOL, V168, P737, DOI 10.1002/(SICI)1097-4652(199609)168:3<737::AID-JCP27>3.0.CO;2-U; CROWE PD, 1995, J EXP MED, V181, P1205, DOI 10.1084/jem.181.3.1205; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Fan J, 2003, J CLIN INVEST, V112, P1234, DOI 10.1172/JCI200318696; Feng XY, 2011, IMMUNOLOGY, V132, P287, DOI 10.1111/j.1365-2567.2010.03364.x; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Glenn G, 2008, FEBS LETT, V582, P911, DOI 10.1016/j.febslet.2008.02.029; Gomez MI, 2005, J IMMUNOL, V175, P1930, DOI 10.4049/jimmunol.175.3.1930; GRAHAM DK, 1994, CELL GROWTH DIFFER, V5, P647; GRAHAM DK, 1995, ONCOGENE, V10, P2349; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Hurtado B, 2011, THROMB HAEMOSTASIS, V105, P873, DOI 10.1160/TH10-10-0630; Ishimoto Y, 2000, J BIOCHEM-TOKYO, V127, P411, DOI 10.1093/oxfordjournals.jbchem.a022622; Kanthasamy AG, 2003, ANTIOXID REDOX SIGN, V5, P609, DOI 10.1089/152308603770310275; Koff JL, 2008, AM J PHYSIOL-LUNG C, V294, pL1068, DOI 10.1152/ajplung.00025.2008; Konishi H, 1997, P NATL ACAD SCI USA, V94, P11233, DOI 10.1073/pnas.94.21.11233; Kubo-Murai M, 2007, MOL IMMUNOL, V44, P2257, DOI 10.1016/j.molimm.2006.11.005; Le Gall SM, 2010, J CELL SCI, V123, P3913, DOI 10.1242/jcs.069997; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Lee MC, 2008, J LEUKOCYTE BIOL, V84, P835, DOI 10.1189/jlb.1007691; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Li Y., 2006, J LEUKOCYTE BIOL, V81, P483; McGettrick AF, 2006, P NATL ACAD SCI USA, V103, P9196, DOI 10.1073/pnas.0600462103; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Mullberg J, 1997, FEBS LETT, V401, P235, DOI 10.1016/S0014-5793(96)01480-9; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Myers TJ, 2009, MOL BIOL CELL, V20, P5236, DOI 10.1091/mbc.E08-12-1256; Nagata K, 1996, J BIOL CHEM, V271, P30022, DOI 10.1074/jbc.271.47.30022; OBRYAN JP, 1995, J BIOL CHEM, V270, P551, DOI 10.1074/jbc.270.2.551; PABST MJ, 1980, J EXP MED, V151, P101, DOI 10.1084/jem.151.1.101; Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Reyland ME, 2009, FRONT BIOSCI-LANDMRK, V14, P2386, DOI 10.2741/3385; Rousseau S, 2008, J CELL SCI, V121, P149, DOI 10.1242/jcs.018671; Sather S, 2007, BLOOD, V109, P1026, DOI 10.1182/blood-2006-05-021634; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Shao MXG, 2005, P NATL ACAD SCI USA, V102, P767, DOI 10.1073/pnas.0408932102; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Thorp E., 2010, ART THROMB VASC BIOL, V15; Thorp E, 2008, ARTERIOSCL THROM VAS, V28, P1421, DOI 10.1161/ATVBAHA.108.167197; Tibrewal N, 2008, J BIOL CHEM, V283, P3618, DOI 10.1074/jbc.M706906200; Uehara H, 2008, J IMMUNOL, V180, P2522, DOI 10.4049/jimmunol.180.4.2522; Ushio-Fukai M, 2006, SCI STKE, V2006, pre8, DOI DOI 10.1126/STKE.3492006RE8; Vollrath D, 2001, P NATL ACAD SCI USA, V98, P12584, DOI 10.1073/pnas.221364198; Wang Y, 2009, J IMMUNOL, V182, P2449, DOI 10.4049/jimmunol.0802770; Wu Y, 2005, J CELL SCI, V118, P539, DOI 10.1242/jcs.01632; Xu PL, 2010, MOL CELL, V37, P551, DOI 10.1016/j.molcel.2010.01.034; Young LH, 2005, CARDIOVASC DRUG REV, V23, P255; Zhang ZL, 2001, FASEB J, V15, P303; Ziegler K, 2009, CELL HOST MICROBE, V5, P341, DOI 10.1016/j.chom.2009.03.006	65	181	189	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33335	33344		10.1074/jbc.M111.263020	http://dx.doi.org/10.1074/jbc.M111.263020			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21828049	Green Published, hybrid			2022-12-25	WOS:000294968800052
J	Taylor-Robinson, D; Agarwal, U; Diggle, PJ; Platt, MJ; Yoxall, B; Alfirevic, Z				Taylor-Robinson, David; Agarwal, Umber; Diggle, Peter J.; Platt, Mary Jane; Yoxall, Bill; Alfirevic, Zarko			Quantifying the Impact of Deprivation on Preterm Births: A Retrospective Cohort Study	PLOS ONE			English	Article							SOCIOECONOMIC INEQUALITIES; MORTALITY; POVERTY; HEALTH; RISK	Background: Social deprivation is associated with higher rates of preterm birth and subsequent infant mortality. Our objective was to identify risk factors for preterm birth in the UK's largest maternity unit, with a particular focus on social deprivation, and related factors. Methodology/Principal Findings: Retrospective cohort study of 39,873 women in Liverpool, UK, from 2002-2008. Singleton pregnancies were stratified into uncomplicated low risk pregnancies and a high risk group complicated by medical problems. Multiple logistic regression, and generalized additive models were used to explore the effect of covariates including area deprivation, smoking status, BMI, parity and ethnicity on the risk of preterm birth (34(+0) weeks). In the low risk group, preterm birth rates increased with deprivation, reaching 1.6% (CI95 1.4 to 1.8) in the most deprived quintile; the unadjusted odds ratio comparing an individual in the most deprived quintile, to one in the least deprived quintile was 1.5 (CI95 1.2 to 1.9). Being underweight and smoking were both independently associated with preterm birth in the low risk group, and adjusting for these factors explained the association between deprivation and preterm birth. Preterm birth was five times more likely in the high risk group (RR 4.8 CI95 4.3 to 5.4), and there was no significant relationship with deprivation. Conclusions: Deprivation has significant impact on preterm birth rates in low risk women. The relationship between low socio-economic status and preterm births appears to be related to low maternal weight and smoking in more deprived groups.	[Taylor-Robinson, David] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England; [Agarwal, Umber; Yoxall, Bill] Liverpool Womens Natl Hlth Serv Fdn Trust, Liverpool, Merseyside, England; [Diggle, Peter J.] Univ Lancaster, Sch Hlth & Med, Lancaster, England; [Platt, Mary Jane] Univ E Anglia, Norwich NR4 7TJ, Norfolk, England; [Alfirevic, Zarko] Univ Liverpool, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England	University of Liverpool; Lancaster University; University of East Anglia; University of Liverpool	Taylor-Robinson, D (corresponding author), Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England.	dctr@liv.ac.uk	Platt, MJ/K-4588-2012; Agarwal, Umber/AAO-7959-2020	Platt, MJ/0000-0002-9372-9575; Diggle, Peter/0000-0003-3521-5020	UK Medical Research Council [G0802448]; MRC [G0802448] Funding Source: UKRI; Medical Research Council [G0802448] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	DT-R is funded by the UK Medical Research Council on a Population Health Scientist Fellowship (G0802448) http://www.mrc.ac.uk/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, PER MORT 2007; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P1; Behrman RE, 2007, PRETERM BIRTH CAUSES; *COMM LOC GOV, 2007, COMM NEIGHB IND DEP; Darzi A., 2008, HIGH QUALITY CARE AL; DeFranco EA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-316; DH, 2010, EQ EXC LIB NHS; DH, 2010, HLTH LIV HLTH PEOPL; Genereux M, 2008, J EPIDEMIOL COMMUN H, V62, P695, DOI 10.1136/jech.2007.066167; Goldenberg RL, 2003, SEMIN PERINATOL, V27, P185, DOI 10.1016/S0146-0005(03)00017-X; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gray R, 2008, BJOG-INT J OBSTET GY, V115, P82, DOI 10.1111/j.1471-0528.2007.01582.x; HAN Z, 2010, INT J EPIDEMIOL; Hastie TJ., 1990, GEN ADDITIVE MODELS; Iams JD, 2008, LANCET, V371, P164, DOI 10.1016/S0140-6736(08)60108-7; Janghorbani M, 2006, J MATERN-FETAL NEO M, V19, P85, DOI 10.1080/14767050500363428; Kramer MS, 2001, PAEDIATR PERINAT EP, V15, P104, DOI 10.1046/j.1365-3016.2001.00012.x; Mackenbach JP, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3460; Marmot M., 2014, STRATEGIC REV HLTH I; Messer LC, 2008, SOC SCI MED, V67, P1247, DOI 10.1016/j.socscimed.2008.06.009; Morgen CS, 2008, INT J EPIDEMIOL, V37, P1109, DOI 10.1093/ije/dyn112; Mortensen LH, 2010, SCAND J PUBLIC HEALT, V38, P40, DOI 10.1177/1403494809353820; Nagahawatte NT, 2008, ANN NY ACAD SCI, V1136, P80, DOI 10.1196/annals.1425.016; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Smith LK, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6654; Smith LK, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4702; Torloni MR, 2009, J MATERN-FETAL NEO M, V22, P957, DOI 10.3109/14767050903042561; Zeka A, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-60	29	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e23163	10.1371/journal.pone.0023163	http://dx.doi.org/10.1371/journal.pone.0023163			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826237	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000293558900063
J	Stephens, JD; Santos, SR; Folkerts, DR				Stephens, Jessica D.; Santos, Scott R.; Folkerts, Debbie R.			Genetic Differentiation, Structure, and a Transition Zone among Populations of the Pitcher Plant Moth Exyra semicrocea: Implications for Conservation	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; LEPIDOPTERA; SARRACENIACEAE; PHYLOGEOGRAPHY; RESTRICTION; DIVERSITY; AMPLIFICATION; BIOGEOGRAPHY; ASSOCIATIONS; POLYMORPHISM	Pitcher plant bogs, or carnivorous plant wetlands, have experienced extensive habitat loss and fragmentation throughout the southeastern United States Coastal Plain, resulting in an estimated reduction to <3% of their former range. This situation has lead to increased management attention of these habitats and their carnivorous plant species. However, conservation priorities focus primarily on the plants since little information currently exists on other community members, such as their endemic arthropod biota. Here, we investigated the population structure of one of these, the obligate pitcher plant moth Exyra semicrocea (Lepidoptera: Noctuidae), using mitochondrial cytochrome c oxidase subunit I (COI) gene sequences. Examination of 221 individuals from 11 populations across eight southeastern US states identified 51 unique haplotypes. These haplotypes belonged to one of two divergent (similar to 1.9-3.0%) lineages separated by the Mississippi alluvial plain. Populations of the West Gulf Coastal Plain exhibited significant genetic structure, contrasting with similarly distanced populations east of the Mississippi alluvial plain. In the eastern portion of the Coastal Plain, an apparent transition zone exists between two regionally distinct population groups, with a well-established genetic discontinuity for other organisms coinciding with this zone. The structure of E. semicrocea appears to have been influenced by patchy pitcher plant bog habitats in the West Gulf Coastal Plain as well as impacts of Pleistocene interglacials on the Apalachicola-Chattahoochee-Flint River Basin. These findings, along with potential extirpation of E. semicrocea at four visited, but isolated, sites highlight the need to consider other endemic or associated community members when managing and restoring pitcher plant bog habitats.	[Stephens, Jessica D.; Santos, Scott R.; Folkerts, Debbie R.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Stephens, Jessica D.; Santos, Scott R.] Auburn Univ, Molette Biol Lab Environm & Climate Change Studie, Auburn, AL 36849 USA; [Santos, Scott R.] Auburn Univ, Cell & Mol Biosci Peak Program, Auburn, AL 36849 USA	Auburn University System; Auburn University; Auburn University System; Auburn University; Auburn University System; Auburn University	Stephens, JD (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	jdstephe@gmail.com	Santos, Scott R/A-7472-2009		Estuarine Reserves Division, Office of Ocean and Coastal Resource Management, National Ocean Service, National Oceanic and Atmospheric Administration [NA10NOS4200038]; Sigma Xi [G2009150743]	Estuarine Reserves Division, Office of Ocean and Coastal Resource Management, National Ocean Service, National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); Sigma Xi	This research was conducted under an award from the Estuarine Reserves Division, Office of Ocean and Coastal Resource Management, National Ocean Service, National Oceanic and Atmospheric Administration (Award # NA10NOS4200038) and a Grant-In Aid of Research provided by Sigma Xi (Award # G2009150743). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Avise John C., 1996, P431; BARTRAM W, 1791, TRAVELS N S CAROLINA; Brant SV, 2003, MOL ECOL, V12, P1435, DOI 10.1046/j.1365-294X.2003.01789.x; Brewer JS, 2011, AQUAT BOT, V94, P62, DOI 10.1016/j.aquabot.2010.11.005; BRIDGES E L, 1989, Natural Areas Journal, V9, P246; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Burbrink FT, 2000, EVOLUTION, V54, P2107, DOI 10.1554/0014-3820(2000)054[2107:MDPOTP]2.0.CO;2; Chapman HH, 1932, ECOLOGY, V13, P328, DOI 10.2307/1932309; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; COFFROTH MA, 1992, MAR BIOL, V114, P317, DOI 10.1007/BF00349534; CRANDALL KA, 1994, MODELS PHYLOGENY REC, P273; Dahlem GA, 2006, ANN ENTOMOL SOC AM, V99, P218, DOI 10.1603/0013-8746(2006)099[0218:FFDSAW]2.0.CO;2; Darwin C., 1875, INSECTIVOROUS PLANTS; Diamond J., 2010, RUZHYA MIKROBY STALI; Ehrlich P.R., 1981, pi; EHRLICH PR, 1990, POPULATION EXPLOSION; Ellison AM, 2009, J EXP BOT, V60, P19, DOI 10.1093/jxb/ern179; Engle VD, 2000, HYDROBIOLOGIA, V436, P17, DOI 10.1023/A:1026572601578; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2006, NAT REV GENET, V7, P745, DOI 10.1038/nrg1904; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Folkerts D, 1999, INVERTEBRATES IN FRESHWATER WETLANDS OF NORTH AMERICA, P247; Folkerts DR, 1996, ENTOMOL NEWS, V107, P128; FOLKERTS GW, 1982, AM SCI, V70, P260; FOLKERTS GW, 1991, J ALA ACAD SCI, V62, P199; FOLKERTS GW, 1993, TIPULARIA, V8, P10; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fu YX, 1997, GENETICS, V147, P915; GIVNISH TJ, 1984, AM NAT, V124, P479, DOI 10.1086/284289; Godt MJW, 1998, AM J BOT, V85, P802, DOI 10.2307/2446415; Godt MJW, 1996, AM J BOT, V83, P1016, DOI 10.2307/2445990; HARPER RM, 1918, J ELISHA MITCHELL SC, V34, P110; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Holt CR, 2011, SOUTHEAST NAT, V10, P289, DOI 10.1656/058.010.0209; Hudson RR, 2000, GENETICS, V155, P2011; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; JONES FM, 1921, NAT HIST, V21, P297; Jones JC, 2004, WILDLIFE SOC B, V32, P456, DOI 10.2193/0091-7648(2004)32[456:HAOGTB]2.0.CO;2; Keddy PA, 2009, SOUTHEAST NAT, V8, P213, DOI 10.1656/058.008.0202; Koopman MM, 2010, CONSERV GENET, V11, P2027, DOI 10.1007/s10592-010-0095-7; KOOPMAN MM, 2011, ECOLOGY LET IN PRESS; Lafontaine J.D., 1991, P1; LOPEZ JV, 1994, J MOL EVOL, V39, P174; MACROBERTS M H, 1991, Phytologia, V70, P119; MACROBERTS MH, 2001, BOG RES PAPERS BOT E, V1, P1; MANTEL N, 1967, CANCER RES, V27, P209; Meng XF, 2008, MOL ECOL, V17, P2880, DOI 10.1111/j.1365-294X.2008.03792.x; Miller BP, 2007, DIVERS DISTRIB, V13, P406, DOI 10.1111/j.1472-4642.2007.00348.x; Moritz C, 1999, HEREDITAS, V130, P217, DOI 10.1111/j.1601-5223.1999.00217.x; MOYLE PB, 1990, CONSERV BIOL, V4, P275, DOI 10.1111/j.1523-1739.1990.tb00289.x; Nei M, 1987, MOL EVOLUTIONARY GEN; Nielsen R, 2001, GENETICS, V158, P885; NORSE EA, 1990, ANCIENT FORESTS PACI; NOSS R F, 1989, Natural Areas Journal, V9, P211; NOSS RF, 1995, 28 NAT BIOL SERV US; Oksanen J., 2013, VEGAN COMMUNITY ECOL; Pauly GB, 2007, MOL ECOL, V16, P415, DOI 10.1111/j.1365-294X.2006.03149.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; R Core Team, 2021, R LANG ENV STAT COMP; ROEHRDANZ RL, 1994, ANN ENTOMOL SOC AM, V87, P856, DOI 10.1093/aesa/87.6.856; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rymal D.E., 1982, Journal of the Alabama Academy of Science, V53, P131; RYMAL DE, 1980, THESIS AUBURN U AUBU; SHERIDAN PM, 1991, CARNIVOROUS PLANT NE, V20, P102; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; SOLTIS DE, 2006, MOL ECOL, V14, P671; SOULE ME, 1991, SCIENCE, V253, P744, DOI 10.1126/science.253.5021.744; Swift C.C., 1986, P213; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; TEMPLETON AR, 1992, GENETICS, V132, P619; THOMAS RD, 1993, ATLAS VASCULAR FLORA, V1; *USDA, 2009, 708744490 USDA NRCS; WALTERS JR, 1988, ETHOLOGY, V78, P275; Wang ZF, 2004, J HERED, V95, P234, DOI 10.1093/jhered/esh043; Wilson E.O., 1988, P3; WILSON EO, 1985, BIOSCIENCE, V35, P700, DOI 10.2307/1310051; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Zakharov EV, 2004, SYST BIOL, V53, P193, DOI 10.1080/10635150490423403	83	17	17	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22658	10.1371/journal.pone.0022658	http://dx.doi.org/10.1371/journal.pone.0022658			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829473	gold, Green Published, Green Submitted			2022-12-25	WOS:000293284600021
J	Zhang, LS; Lv, RL; Dou, XY; Qi, ZQ; Hua, CL; Zhang, HF; Wang, ZY; Zheng, XB; Zhang, ZG				Zhang, Lisha; Lv, Ruili; Dou, Xianying; Qi, Zhongqiang; Hua, Chenlei; Zhang, Haifeng; Wang, Zhengyi; Zheng, Xiaobo; Zhang, Zhengguang			The Function of MoGlk1 in Integration of Glucose and Ammonium Utilization in Magnaporthe oryzae	PLOS ONE			English	Article							CARBON CATABOLITE REPRESSION; SACCHAROMYCES-CEREVISIAE; BIOCHEMICAL-CHARACTERIZATION; TRANSCRIPTION FACTOR; PLANT INFECTION; HEXOKINASE; METABOLISM; PATHOGENICITY; GLUCOKINASE; EXPRESSION	Hexokinases are conserved proteins functioning in glucose sensing and signaling. The rice blast fungus Magnaporthe oryzae contains several hexokinases, including MoHxk1 (hexokinase) and MoGlk1 (glucokinase) encoded respectively by MoHXK1 and MoGLK1 genes. The heterologous expression of MoGlk1 and MoHxk1 in Saccharomyces cerevisiae confirmed their conserved functions. Disruption of MoHXK1 resulted in growth reduction in medium containing fructose as the sole carbon source, whereas disruption of MoGLK1 did not cause the similar defect. However, the Delta Moglk1 mutant displayed decreased proton extrusion and a lower biomass in the presence of ammonium, suggesting a decline in the utilization of ammonium. Additionally, the MoGLK1 allele lacking catalytic activity restored growth to the Delta Moglk1 mutant. Moreover, the expression of MoPMA1 encoding a plasma membrane H+-ATPase decreased in the Delta Moglk1 mutant that can be suppressed by glucose and G-6-P. Thus, MoGlk1, but not MoHxk1, regulates ammonium utilization through a mechanism that is independent from its catalytic activity.	[Zhang, Lisha; Lv, Ruili; Dou, Xianying; Qi, Zhongqiang; Hua, Chenlei; Zhang, Haifeng; Zheng, Xiaobo; Zhang, Zhengguang] Nanjing Agr Univ, Coll Plant Protect, Dept Plant Pathol, Nanjing, Peoples R China; [Zhang, Lisha; Lv, Ruili; Dou, Xianying; Qi, Zhongqiang; Hua, Chenlei; Zhang, Haifeng; Zheng, Xiaobo; Zhang, Zhengguang] Minist Educ, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Peoples R China; [Wang, Zhengyi] Zhejiang Univ, Inst Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China	Nanjing Agricultural University; Zhejiang University	Zhang, ZG (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Dept Plant Pathol, Nanjing, Peoples R China.	zhgzhang@njau.edu.cn	Zhang, Zhengguang/F-3917-2014; Zhang, Lisha/AAB-8787-2020		Ministry of Education of China [NCET-07-0442]; Natural Science Foundations of China [30771394, 30971890]	Ministry of Education of China(Ministry of Education, China); Natural Science Foundations of China(National Natural Science Foundation of China (NSFC))	This work was supported by the New Century Excellent Scholar Project of the Ministry of Education of China (NCET-07-0442 to ZZ), and the Natural Science Foundations of China (30771394 and 30971890 to XZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuatzi D, 2004, J BIOL CHEM, V279, P14440, DOI 10.1074/jbc.M313431200; Ahuatzi D, 2007, J BIOL CHEM, V282, P4485, DOI 10.1074/jbc.M606854200; Bertram PG, 2002, MOL CELL BIOL, V22, P1246, DOI 10.1128/MCB.22.4.1246-1252.2002; CASTRILLO JI, 1995, YEAST, V11, P1353, DOI 10.1002/yea.320111404; Cho YH, 2006, CELL, V127, P579, DOI 10.1016/j.cell.2006.09.028; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; deJong JC, 1997, NATURE, V389, P244, DOI 10.1038/38418; Diderich JA, 2001, APPL ENVIRON MICROB, V67, P1587, DOI 10.1128/AEM.67.4.1587-1593.2001; ENTIAN KD, 1980, MOL GEN GENET, V177, P345, DOI 10.1007/BF00267449; ENTIAN KD, 1980, MOL GEN GENET, V178, P633, DOI 10.1007/BF00337871; Flipphi M, 2003, J BIOL CHEM, V278, P11849, DOI 10.1074/jbc.M209443200; Foster AJ, 2003, EMBO J, V22, P225, DOI 10.1093/emboj/cdg018; Guo M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001302; Guo M, 2010, MOL PLANT MICROBE IN, V23, P1053, DOI 10.1094/MPMI-23-8-1053; Harrington GN, 2003, PLANT CELL, V15, P2493, DOI 10.1105/tpc.151130; HOWARD RJ, 1991, P NATL ACAD SCI USA, V88, P11281, DOI 10.1073/pnas.88.24.11281; Howard RJ, 1996, ANNU REV MICROBIOL, V50, P491, DOI 10.1146/annurev.micro.50.1.491; HUTH J, 1988, ZBL MIKROBIOL, V143, P179, DOI 10.1016/S0232-4393(88)80038-6; Jang JC, 1997, PLANT CELL, V9, P5, DOI 10.1105/tpc.9.1.5; Jernejc K, 2001, APPL MICROBIOL BIOT, V57, P368; Johnston M, 2005, BIOCHEM SOC T, V33, P247, DOI 10.1042/BST0330247; Kraakman LS, 1999, BIOCHEM J, V343, P159, DOI 10.1042/0264-6021:3430159; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LAGOS R, 1980, EUR J BIOCHEM, V104, P357, DOI 10.1111/j.1432-1033.1980.tb04436.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOBO Z, 1977, ARCH BIOCHEM BIOPHYS, V182, P639, DOI 10.1016/0003-9861(77)90544-6; MICHELS CA, 1980, J BACTERIOL, V143, P674, DOI 10.1128/JB.143.2.674-679.1980; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Moreno F, 2005, BIOCHEM SOC T, V33, P265, DOI 10.1042/BST0330265; Oliveira IC, 1999, PLANT PHYSIOL, V121, P301, DOI 10.1104/pp.121.1.301; Panneman H, 1996, EUR J BIOCHEM, V240, P518, DOI 10.1111/j.1432-1033.1996.0518h.x; Panneman H, 1998, EUR J BIOCHEM, V258, P223, DOI 10.1046/j.1432-1327.1998.2580223.x; Rolland F, 2005, BIOCHEM SOC T, V33, P269, DOI 10.1042/BST0330269; Rolland F, 2002, FEMS YEAST RES, V2, P183, DOI 10.1111/j.1567-1364.2002.tb00084.x; Rolland F, 2001, TRENDS BIOCHEM SCI, V26, P310, DOI 10.1016/S0968-0004(01)01805-9; Rossell S, 2008, FEMS YEAST RES, V8, P155, DOI 10.1111/j.1567-1364.2007.00282.x; Rui O, 2007, MICROBIOL-SGM, V153, P2791, DOI 10.1099/mic.0.2007/006338-0; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; SERRANO R, 1988, BIOCHIM BIOPHYS ACTA, V947, P1, DOI 10.1016/0304-4157(88)90017-2; Song WW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013193; Stulke J, 1999, CURR OPIN MICROBIOL, V2, P195, DOI 10.1016/S1369-5274(99)80034-4; Sweigard JA, 1997, FUNGAL GENET NEWSL, V44, P52, DOI DOI 10.4148/1941-4765.1287; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vaulont S, 2000, J BIOL CHEM, V275, P31555, DOI 10.1074/jbc.R000016200; Wang ZY, 2007, MOL PLANT MICROBE IN, V20, P475, DOI 10.1094/MPMI-20-5-0475; Wang ZY, 2005, BIOCHEM SOC T, V33, P384, DOI 10.1042/BST0330384; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Wilson RA, 2007, EMBO J, V26, P3673, DOI 10.1038/sj.emboj.7601795; Wilson RA, 2010, P NATL ACAD SCI USA, V107, P21902, DOI 10.1073/pnas.1006839107; Yi M, 2008, FUNGAL GENET BIOL, V45, P1172, DOI 10.1016/j.fgb.2008.05.003; Zhang HF, 2009, FEMS MICROBIOL LETT, V293, P160, DOI 10.1111/j.1574-6968.2009.01524.x; ZIMMERMANN FK, 1977, MOL GEN GENET, V154, P75, DOI 10.1007/BF00265579	56	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22809	10.1371/journal.pone.0022809	http://dx.doi.org/10.1371/journal.pone.0022809			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818394	gold, Green Submitted, Green Published			2022-12-25	WOS:000293282700079
J	Impoinvil, DE; Solomon, T; Schluter, WW; Rayamajhi, A; Bichha, RP; Shakya, G; Caminade, C; Baylis, M				Impoinvil, Daniel E.; Solomon, Tom; Schluter, W. William; Rayamajhi, Ajit; Bichha, Ram Padarath; Shakya, Geeta; Caminade, Cyril; Baylis, Matthew			The Spatial Heterogeneity between Japanese Encephalitis Incidence Distribution and Environmental Variables in Nepal	PLOS ONE			English	Article							WEST-NILE-VIRUS; CULEX-TRITAENIORHYNCHUS; DIPTERA; ABUNDANCE; MOSQUITOS; TRANSMISSION; CULICIDAE; INFECTION; KATHMANDU; EPIDEMIC	Background: To identify potential environmental drivers of Japanese Encephalitis virus (JE) transmission in Nepal, we conducted an ecological study to determine the spatial association between 2005 Nepal JE incidence, and climate, agricultural, and land-cover variables at district level. Methods: District-level data on JE cases were examined using Local Indicators of Spatial Association (LISA) analysis to identify spatial clusters from 2004 to 2008 and 2005 data was used to fit a spatial lag regression model with climate, agriculture and land-cover variables. Results: Prior to 2006, there was a single large cluster of JE cases located in the Far-West and Mid-West terai regions of Nepal. After 2005, the distribution of JE cases in Nepal shifted with clusters found in the central hill areas. JE incidence during the 2005 epidemic had a stronger association with May mean monthly temperature and April mean monthly total precipitation compared to mean annual temperature and precipitation. A parsimonious spatial lag regression model revealed, 1) a significant negative relationship between JE incidence and April precipitation, 2) a significant positive relationship between JE incidence and percentage of irrigated land 3) a non-significant negative relationship between JE incidence and percentage of grassland cover, and 4) a unimodal non-significant relationship between JE Incidence and pig-to-human ratio. Conclusion: JE cases clustered in the terai prior to 2006 where it seemed to shift to the Kathmandu region in subsequent years. The spatial pattern of JE cases during the 2005 epidemic in Nepal was significantly associated with low precipitation and the percentage of irrigated land. Despite the availability of an effective vaccine, it is still important to understand environmental drivers of JEV transmission since the enzootic cycle of JEV transmission is not likely to be totally interrupted. Understanding the spatial dynamics of JE risk factors may be useful in providing important information to the Nepal immunization program.	[Impoinvil, Daniel E.; Baylis, Matthew] Univ Liverpool, Inst Infect & Global Hlth, Dept Epidemiol & Populat Hlth, LUCINDA Grp, Neston, Cheshire, England; [Impoinvil, Daniel E.; Solomon, Tom; Rayamajhi, Ajit] Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Brain Infect Grp, Liverpool L69 3BX, Merseyside, England; [Schluter, W. William] WHO, Country Off Nepal, Programme Immunizat Preventable Dis, Kathmandu, Nepal; [Rayamajhi, Ajit] Kanti Childrens Hosp, Natl Acad Med Sci, Dept Pediat, Kathmandu, Nepal; [Bichha, Ram Padarath] Govt Nepal, Minist Hlth & Populat, Dept Hlth Serv, Child Hlth Div, Kathmandu, Nepal; [Shakya, Geeta] Govt Nepal, Minist Hlth & Populat, Dept Hlth Serv, Natl Publ Hlth Lab, Kathmandu, Nepal; [Caminade, Cyril] Univ Liverpool, Sch Environm Sci, Dept Earths Changing Environm, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Liverpool; World Health Organization; University of Liverpool	Impoinvil, DE (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Dept Epidemiol & Populat Hlth, LUCINDA Grp, Leahurst Campus, Neston, Cheshire, England.	d.impoinvil@liverpool.ac.uk	Baylis, Matthew/S-7694-2019	Baylis, Matthew/0000-0003-0335-187X; Solomon, Tom/0000-0001-7266-6547; Caminade, Cyril/0000-0002-3846-7082	Leverhulme Trust; MRC [G116/194] Funding Source: UKRI; Medical Research Council [G116/194] Funding Source: researchfish	Leverhulme Trust(Leverhulme Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the Leverhulme Trust Research Leadership Award: "Predicting the effects of climate change on infectious diseases of animals", granted to Matthew Baylis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselin L., EXPLORING SPATIAL DA; Bhattachan A, 2009, EMERG INFECT DIS, V15, P1691, DOI 10.3201/eid1510.081641; Bi P, 2007, J INFECTION, V55, P551, DOI 10.1016/j.jinf.2007.07.004; *CDCP, QUEST ANSW JAP ENC; Darsie RF, 1997, J AM MOSQUITO CONTR, V13, P286; Darsie RF, 1996, J AM MOSQUITO CONTR, V12, P130; Darsie RF, 2009, J AM MOSQUITO CONTR, V25, P248, DOI 10.2987/09-5754.1; Das PK, 2006, J VECTOR ECOL, V31, P84, DOI 10.3376/1081-1710(2006)31[84:PIBCVM]2.0.CO;2; Ellis AM, 2008, J ANIM ECOL, V77, P247, DOI 10.1111/j.1365-2656.2007.01345.x; Endy TP, 2002, CURR TOP MICROBIOL, V267, P11; GINGRICH JB, 1992, J MED ENTOMOL, V29, P436, DOI 10.1093/jmedent/29.3.436; Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025; Gregory D., 2009, DICT HUMAN GEOGRAPHY; Hanna JN, 1996, MED J AUSTRALIA, V165, P256, DOI 10.5694/j.1326-5377.1996.tb124960.x; Henrich TJ, 2003, MICROBES INFECT, V5, P603, DOI 10.1016/S1286-4579(03)00100-X; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hsu SM, 2008, EPIDEMIOL INFECT, V136, P980, DOI 10.1017/S0950268807009454; Kleinbaum DG, 1998, APPL REGRESSION ANAL; Kulldorff M, 2006, STAT MED, V25, P3929, DOI 10.1002/sim.2490; Landesman WJ, 2007, VECTOR-BORNE ZOONOT, V7, P337, DOI 10.1089/vbz.2006.0590; LINDENBACH BD, 2001, FIELDS VIROLOGY, P991; Liu W, 2010, EPIDEMIOL INFECT, V138, P1292, DOI 10.1017/S0950268810000063; MARSHALL RJ, 1991, J R STAT SOC C-APPL, V40, P283; Masuoka P, 2010, GEOSPATIAL HEALTH, V5, P45, DOI 10.4081/gh.2010.186; MOGI M, 1983, AM J TROP MED HYG, V32, P170, DOI 10.4269/ajtmh.1983.32.170; Murty US, 2010, J VECTOR DIS, V47, P26; OLSON JG, 1983, J MED ENTOMOL, V20, P108, DOI 10.1093/jmedent/20.1.108; Openshaw, 1984, CONCEPTS TECHNIQUES, V38; Pant GR, 2006, ANN NY ACAD SCI, V1081, P124, DOI 10.1196/annals.1373.013; Pant GR, 2006, COMP IMMUNOL MICROB, V29, P166, DOI 10.1016/j.cimid.2006.03.003; Pant S. D., 2009, Journal of Nepal Paediatric Society, V29, P35, DOI 10.3126/jnps.v29i1.1600; Partridge J, 2007, AM J TROP MED HYG, V77, P1146, DOI 10.4269/ajtmh.2007.77.1146; REISEN W K, 1976, Southeast Asian Journal of Tropical Medicine and Public Health, V7, P61; Richards EE, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-32; Shaman J, 2005, J MED ENTOMOL, V42, P134, DOI 10.1603/0022-2585(2005)042[0134:DAAETO]2.0.CO;2; Shaman J, 2010, INT J ENV RES PUB HE, V7, P494, DOI 10.3390/ijerph7020494; Solomon T, 2006, NEW ENGL J MED, V355, P869, DOI 10.1056/NEJMp058263; TAKAHASHI M, 1976, J MED ENTOMOL, V13, P275, DOI 10.1093/jmedent/13.3.275; UMENAI T, 1985, B WORLD HEALTH ORGAN, V63, P625; Vythilingam I, 1997, J MED ENTOMOL, V34, P257, DOI 10.1093/jmedent/34.3.257; Wang GM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-38; Ward M.D., 2008, SPATIAL REGRESSION M; Wierzba TF, 2008, AM J TROP MED HYG, V78, P1002, DOI 10.4269/ajtmh.2008.78.1002; Wimberly MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003744; Wong DWS, 2005, STAT ANAL GEOGRAPHIC; Zimmerman MD, 1997, AM J TROP MED HYG, V57, P283, DOI 10.4269/ajtmh.1997.57.283	46	63	66	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22192	10.1371/journal.pone.0022192	http://dx.doi.org/10.1371/journal.pone.0022192			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811573	gold, Green Published, Green Submitted			2022-12-25	WOS:000292956800029
J	Jin, HJ; Lv, SQ; Yang, JH; Wang, XN; Hu, HZ; Su, CQ; Zhou, CL; Li, J; Huang, Y; Li, LF; Liu, XY; Wu, MC; Qian, QJ				Jin, Huajun; Lv, Saiqun; Yang, Jiahe; Wang, Xiaoning; Hu, Huanzhang; Su, Changqing; Zhou, Chengliang; Li, Jiang; Huang, Yao; Li, Linfang; Liu, Xinyuan; Wu, Mengchao; Qian, Qijun			Use of MicroRNA Let-7 to Control the Replication Specificity of Oncolytic Adenovirus in Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							MESSENGER-RNA; CANCER; EXPRESSION; GROWTH; IDENTIFICATION; REPRESSION; GENERATION; EFFICACY; THERAPY; TARGET	Highly selective therapy for hepatocellular carcinoma (HCC) remains an unmet medical need. In present study, we found that the tumor suppressor microRNA, let-7 was significantly downregulated in a proportion of primary HCC tissues (12 of 33, 36.4%) and HCC cell lines. In line with this finding, we have engineered a chimeric Ad5/11 fiber oncolytic adenovirus, SG7011 let7T, by introducing eight copies of let-7 target sites (let7T) into the 39 untranslated region of E1A, a key gene associated with adenoviral replication. The results showed that the E1A expression (both RNA and protein levels) of the SG7011 let7T was tightly regulated according to the endogenous expression level of the let-7. As contrasted with the wild-type adenovirus and the control virus, the replication of SG7011 let7T was distinctly inhibited in normal liver cells lines (i.e. L-02 and WRL-68) expressing high level of let-7 (. 300 folds), whereas was almost not impaired in HCC cells (i.e. Hep3B and PLC/PRF/5) with low level of let-7. Consequently, the cytotoxicity of SG7011 let7T to normal liver cells was successfully decreased while was almost not attenuated in HCC cells in vitro. The antitumor ability of SG7011 let7T in vivo was maintained in mice with Hep3B xenograft tumor, whereas was greatly decreased against the SMMC-7721 xenograft tumor expressing a high level of let-7 similar with L-02 when compared to the wild-type adenovirus. These results suggested that SG7011 let7T may be a promising anticancer agent or vector to mediate the expression of therapeutic gene, broadly applicable in the treatment for HCC and other cancers where the let-7 gene is downregulated.	[Jin, Huajun; Lv, Saiqun; Yang, Jiahe; Hu, Huanzhang; Su, Changqing; Zhou, Chengliang; Li, Jiang; Huang, Yao; Li, Linfang; Wu, Mengchao; Qian, Qijun] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China; [Jin, Huajun; Wang, Xiaoning] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China; [Liu, Xinyuan; Qian, Qijun] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China	Naval Medical University; South China University of Technology; Zhejiang Sci-Tech University	Jin, HJ (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China.	qianqj@sino-gene.cn	Liu, Xinyuan/HDM-5505-2022		National Natural Science Foundation of China [81001013, 30730104]; National Natural Science Funds for Distinguished Young Scholar [30925037]; Major State Basic Research Development Program (973 Program) [2010CB529900-G]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Funds for Distinguished Young Scholar(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Major State Basic Research Development Program (973 Program)(National Basic Research Program of China)	The work was supported by National Natural Science Foundation of China (No. 81001013), National Natural Science Funds for Distinguished Young Scholar (No. 30925037), Key Program of National Natural Science Foundation of China (No. 30730104), and Major State Basic Research Development Program (973 Program, No. 2010CB529900-G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Barh D, 2010, CURR ONCOL, V17, P70; Bell JC, 2008, NAT BIOTECHNOL, V26, P1346, DOI 10.1038/nbt1208-1346; Bischoff JR, 1996, SCIENCE, V274, P373, DOI 10.1126/science.274.5286.373; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Cawood R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000440; Edge RE, 2008, MOL THER, V16, P1437, DOI 10.1038/mt.2008.130; Fukazawa T, 2010, INT J MOL MED, V25, P3, DOI 10.3892/ijmm_00000306; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Hamid O, 2003, J CLIN ONCOL, V21, P1498, DOI 10.1200/JCO.2003.09.114; Heise C, 2000, NAT MED, V6, P1134, DOI 10.1038/80474; Herranz H, 2010, GENE DEV, V24, P1339, DOI 10.1101/gad.1937010; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Ji JF, 2010, J HEPATOL, V52, P690, DOI 10.1016/j.jhep.2009.12.025; Kelly EJ, 2008, NAT MED, V14, P1278, DOI 10.1038/nm.1776; Kong YW, 2008, P NATL ACAD SCI USA, V105, P8866, DOI 10.1073/pnas.0800650105; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lan FF, 2011, INT J CANCER, V128, P319, DOI 10.1002/ijc.25336; Lo CM, 2002, HEPATOLOGY, V35, P1164, DOI 10.1053/jhep.2002.33156; Lu L, 2007, CANCER RES, V67, P10117, DOI 10.1158/0008-5472.CAN-07-2544; Mi SL, 2007, P NATL ACAD SCI USA, V104, P19971, DOI 10.1073/pnas.0709313104; Michael MZ, 2003, MOL CANCER RES, V1, P882; Motoyama K, 2008, CLIN CANCER RES, V14, P2334, DOI 10.1158/1078-0432.CCR-07-4667; Poon RTP, 2000, ANN SURG, V232, P10, DOI 10.1097/00000658-200007000-00003; Poulin KL, 2010, J VIROL, V84, P10074, DOI 10.1128/JVI.02665-09; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Roberts LR, 2008, NEW ENGL J MED, V359, P420, DOI 10.1056/NEJMe0802241; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Rowan K, 2010, J NATL CANCER I, V102, P590, DOI 10.1093/jnci/djq165; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Schultz J, 2008, CELL RES, V18, P549, DOI 10.1038/cr.2008.45; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Seregin SS, 2010, BLOOD, V116, P1669, DOI 10.1182/blood-2010-03-276949; Shimizu S, 2010, J HEPATOL, V52, P698, DOI 10.1016/j.jhep.2009.12.024; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Wakiyama M, 2007, GENE DEV, V21, P1857, DOI 10.1101/gad.1566707; Wang GH, 2009, J GENE MED, V11, P477, DOI 10.1002/jgm.1326; Wang V, 2009, BIODRUGS, V23, P15, DOI 10.2165/00063030-200923010-00002; Wang XH, 2008, MOL CANCER THER, V7, P1598, DOI 10.1158/1535-7163.MCT-07-2429; Wang YC, 2010, CARCINOGENESIS, V31, P1516, DOI 10.1093/carcin/bgq107; Ylosmaki E, 2008, J VIROL, V82, P11009, DOI 10.1128/JVI.01608-08; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhang Q, 2004, CANCER RES, V64, P5390, DOI 10.1158/0008-5472.CAN-04-1229; Zhang Q, 2006, CLIN CANCER RES, V12, P6523, DOI 10.1158/1078-0432.CCR-06-1491	45	43	48	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e21307	10.1371/journal.pone.0021307	http://dx.doi.org/10.1371/journal.pone.0021307			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21814544	Green Published, Green Submitted, gold			2022-12-25	WOS:000292956800003
J	Kryuchkov, M; Katanaev, VL; Enin, GA; Sergeev, A; Timchenko, AA; Serdyuk, IN				Kryuchkov, Michail; Katanaev, Vladimir L.; Enin, Gennadiy A.; Sergeev, Anton; Timchenko, Alexander A.; Serdyuk, Igor N.			Analysis of Micro- and Nano-Structures of the Corneal Surface of Drosophila and Its Mutants by Atomic Force Microscopy and Optical Diffraction	PLOS ONE			English	Article							INSECT COMPOUND EYES; CELL POLARITY; WINGLESS; MELANOGASTER; ULTRASTRUCTURE; MORPHOGENESIS; OMMATIDIA; PATTERN; PROTEIN; RETINA	Drosophila melanogaster is a model organism instrumental for numerous biological studies. The compound eye of this insect consists of some eight hundred individual ommatidia or facets, ca. 15 mu m in cross-section. Each ommatidium contains eighteen cells including four cone cells secreting the lens material (cornea). High-resolution imaging of the cornea of different insects has demonstrated that each lens is covered by the nipple arrays - small outgrowths of ca. 200 nm in diameter. Here we for the first time utilize atomic force microscopy (AFM) to investigate nipple arrays of the Drosophila lens, achieving an unprecedented visualization of the architecture of these nanostructures. We find by Fourier analysis that the nipple arrays of Drosophila are disordered, and that the seemingly ordered appearance is a consequence of dense packing of the nipples. In contrast, Fourier analysis confirms the visibly ordered nature of the eye microstructures - the individual lenses. This is different in the frizzled mutants of Drosophila, where both Fourier analysis and optical imaging detect disorder in lens packing. AFM reveals intercalations of the lens material between individual lenses in frizzled mutants, providing explanation for this disorder. In contrast, nanostructures of the mutant lens show the same organization as in wild-type flies. Thus, frizzled mutants display abnormal organization of the corneal micro-, but not nano-structures. At the same time, nipples of the mutant flies are shorter than those of the wild-type. We also analyze corneal surface of glossy-appearing eyes overexpressing Wingless - the lipoprotein ligand of Frizzled receptors, and find the catastrophic aberration in nipple arrays, providing experimental evidence in favor of the major anti-reflective function of these insect eye nanostructures. The combination of the easily tractable genetic model organism and robust AFM analysis represents a novel methodology to analyze development and architecture of these surface formations.	[Kryuchkov, Michail; Katanaev, Vladimir L.; Enin, Gennadiy A.; Sergeev, Anton; Timchenko, Alexander A.; Serdyuk, Igor N.] Russian Acad Sci, Inst Prot Res, Pushchino 142292, Russia; [Katanaev, Vladimir L.] Univ Lausanne, Dept Pharmacol & Toxicol, Lausanne, Switzerland	Russian Academy of Sciences; University of Lausanne	Kryuchkov, M (corresponding author), Russian Acad Sci, Inst Prot Res, Pushchino 142292, Russia.	vladimir.katanaev@unil.ch; serdyuk@vega.protres.ru	Timchenko, Alexander/N-6023-2014; Sergeev, Anton/I-3882-2013; Katanaev, Vladimir/F-9480-2014	Sergeev, Anton/0000-0003-4359-573X; Katanaev, Vladimir/0000-0002-7909-5617; Kryuchkov, Mikhail/0000-0002-7141-2964	Russian Ministry of Science [02.740.11.5016]	Russian Ministry of Science	This work was supported by grant No. 02.740.11.5016 from the Russian Ministry of Science to V. L. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; ADLER PN, 1987, DEV GENET, V8, P99, DOI 10.1002/dvg.1020080206; Anderson MS, 2003, J STRUCT BIOL, V142, P364, DOI 10.1016/S1047-8477(03)00026-1; Bernhard C G, 1968, Q Rev Biophys, V1, P89; BERNHARD CG, 1962, ACTA PHYSIOL SCAND, V56, P385, DOI 10.1111/j.1748-1716.1962.tb02515.x; BERNHARD CG, 1970, Z VERGL PHYSIOL, V67, P1, DOI 10.1007/BF00298117; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; Brunner E, 1999, DEV BIOL, V206, P178, DOI 10.1006/dbio.1998.9136; Cordero JB, 2010, DEV DYNAM, V239, P875, DOI 10.1002/dvdy.22235; Dickson Barry, 1993, P1327; Egger-Adam D, 2008, FRONT BIOSCI-LANDMRK, V13, P4740, DOI 10.2741/3036; Fanto M, 2004, J CELL SCI, V117, P527, DOI 10.1242/jcs.00973; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Frohlich A, 2001, CELL TISSUE RES, V303, P117, DOI 10.1007/s004410000306; GEMNE G, 1971, PHILOS T ROY SOC B, V262, P343, DOI 10.1098/rstb.1971.0100; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; GUBB D, 1982, J EMBRYOL EXP MORPH, V68, P37; KATANAEV VL, 2011, BIOCH MOSC IN PRESS; Koval A., 2011, BIOCH PHARM; Legent Kevin, 2008, V469, P141, DOI 10.1007/978-1-60327-469-2_12; LEVISETTI R, 1986, APPL SURF SCI, V26, P249, DOI 10.1016/0169-4332(86)90067-X; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MILLER WH, 1968, SCIENCE, V162, P760, DOI 10.1126/science.162.3855.760; Narayan V, 2007, SCIENCE, V317, P105, DOI 10.1126/science.1140414; PALASANTZAS G, 2005, HDB NANOSTRUCTURED B, P273; Peisker H, 2010, J EXP BIOL, V213, P3457, DOI 10.1242/jeb.043661; Roberts D.B., 1986, P1; RUBIN GM, 1988, SCIENCE, V240, P1453, DOI 10.1126/science.3131880; Stavenga DG, 2006, P ROY SOC B-BIOL SCI, V273, P661, DOI 10.1098/rspb.2005.3369; Sukontason KL, 2008, PARASITOL RES, V103, P123, DOI 10.1007/s00436-008-0939-y; THEISEN H, 1994, DEVELOPMENT, V120, P347; Tomlinson A, 2003, DEV CELL, V5, P799, DOI 10.1016/S1534-5807(03)00326-5; VINSON CR, 1989, NATURE, V338, P263, DOI 10.1038/338263a0; Wang YS, 2006, P NATL ACAD SCI USA, V103, P19800, DOI 10.1073/pnas.0609712104; Watson GS, 2004, APPL SURF SCI, V235, P139, DOI 10.1016/j.apsusc.2004.05.129; Wolff Tanya, 1993, P1277; ZHENG L, 1995, DEVELOPMENT, V121, P3045	39	22	23	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22237	10.1371/journal.pone.0022237	http://dx.doi.org/10.1371/journal.pone.0022237			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811578	gold, Green Published			2022-12-25	WOS:000292956800034
J	Lannoo, MJ; Petersen, C; Lovich, RE; Nanjappa, P; Phillips, C; Mitchell, JC; Macallister, I				Lannoo, Michael J.; Petersen, Christopher; Lovich, Robert E.; Nanjappa, Priya; Phillips, Christopher; Mitchell, Joseph C.; Macallister, Irene			Do Frogs Get Their Kicks on Route 66? Continental US Transect Reveals Spatial and Temporal Patterns of Batrachochytrium dendrobatidis Infection	PLOS ONE			English	Article							AMPHIBIAN CHYTRID FUNGUS; POPULATION DECLINES; SEASONAL-VARIATION; EMERGING PATHOGEN; AMERICAN BULLFROG; RANA-CATESBEIANA; SURVEY PROTOCOL; WILD FROGS; CHYTRIDIOMYCOSIS; DISEASE	The chytrid fungus Batrachochytrium dendrobatidis (Bd) has been devastating amphibians globally. Two general scenarios have been proposed for the nature and spread of this pathogen: Bd is an epidemic, spreading as a wave and wiping out individuals, populations, and species in its path; and Bd is endemic, widespread throughout many geographic regions on every continent except Antarctica. To explore these hypotheses, we conducted a transcontinental transect of United States Department of Defense (DoD) installations along U. S. Highway 66 from California to central Illinois, and continuing eastward to the Atlantic Seaboard along U. S. Interstate 64 (in sum from Marine Corps Base Camp Pendleton in California to Naval Air Station Oceana in Virginia). We addressed the following questions: 1) Does Bd occur in amphibian populations on protected DoD environments? 2) Is there a temporal pattern to the presence of Bd? 3) Is there a spatial pattern to the presence of Bd? and 4) In these limited human-traffic areas, is Bd acting as an epidemic (i.e., with evidence of recent introduction and/or die-offs due to chytridiomycosis), or as an endemic (present without clinical signs of disease)? Bd was detected on 13 of the 15 bases sampled. Samples from 30 amphibian species were collected (10% of known United States' species); half (15) tested Bd positive. There was a strong temporal (seasonal) component; in total, 78.5% of all positive samples came in the first (spring/early-summer) sampling period. There was also a strong spatial component-the eleven temperate DoD installations had higher prevalences of Bd infection (20.8%) than the four arid (<60 mm annual precipitation) bases (8.5%). These data support the conclusion that Bd is now widespread, and promote the idea that Bd can today be considered endemic across much of North America, extending from coast-to-coast, with the exception of remote pockets of naive populations.	[Lannoo, Michael J.] Indiana Univ Sch Med, Terre Haute, IN USA; [Petersen, Christopher] USN, Facil Engn Command Atlantic, Norfolk, VA USA; [Lovich, Robert E.] USN, Facil Engn Command SW, San Diego, CA 92152 USA; [Nanjappa, Priya] Assoc Fish & Wildlife Agcy, Washington, DC USA; [Phillips, Christopher] Univ Illinois, Inst Nat Resource Sustainabil, Illinois Nat Hist Survey, Champaign, IL 61820 USA; [Mitchell, Joseph C.] Mitchell Ecol Res Serv, Gainesville, FL USA; [Macallister, Irene] USA, Corps Engineers, Construct Engn Res Lab, Champaign, IL USA	Indiana University System; United States Department of Defense; United States Navy; United States Department of Defense; United States Navy; Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); Construction Engineering Research Laboratory (CERL)	Lannoo, MJ (corresponding author), Indiana Univ Sch Med, Terre Haute, IN USA.	mlannoo@iupui.edu			U.S. Department of Defense [09-426]	U.S. Department of Defense(United States Department of Defense)	Support for this project came from a U.S. Department of Defense Legacy grant (#09-426; https://www.dodlegacy.org.legacy/index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Michael J., 2008, Herpetological Review, V39, P324; Adams Michael J., 2007, Herpetological Review, V38, P430; Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; Annis SL, 2004, J WILDLIFE DIS, V40, P420, DOI 10.7589/0090-3558-40.3.420; Berger L, 2005, DIS AQUAT ORGAN, V68, P51, DOI 10.3354/dao068051; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; Blaustein AR, 2005, CONSERV BIOL, V19, P1460, DOI 10.1111/j.1523-1739.2005.00195.x; Briggs CJ, 2005, ECOLOGY, V86, P3149, DOI 10.1890/04-1428; BRIGGS CJ, 2010, PNAS; CARNIVAL ACO, 2009, ECOHEALTH, V3, P41; Chatfield Matthew W. H., 2009, Herpetological Review, V40, P176; CHENG TL, 2011, PNAS, DOI DOI 10.1073/PNAS1105538108; Daszak P, 2004, HERPETOL J, V14, P201; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; Deguise Isabelle, 2009, Northwestern Naturalist, V90, P35; Di Rosa I, 2007, NATURE, V447, pE4, DOI 10.1038/nature05941; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Frias-Alvarez P, 2008, ECOHEALTH, V5, P18, DOI 10.1007/s10393-008-0155-3; Gaertner JP, 2009, ECOHEALTH, V6, P20, DOI 10.1007/s10393-009-0229-x; Gaertner James P., 2009, Herpetological Review, V40, P184; Garner TWJ, 2006, BIOL LETTERS, V2, P455, DOI 10.1098/rsbl.2006.0494; Garner TWJ, 2005, EMERG INFECT DIS, V11, P1639; Goka K, 2009, MOL ECOL, V18, P4757, DOI 10.1111/j.1365-294X.2009.04384.x; Goldberg Caren S., 2009, Herpetological Review, V40, P309; Grant EHC, 2008, APPL HERPETOL, V5, P233; Green DE, 2002, ANN NY ACAD SCI, V969, P323, DOI 10.1111/j.1749-6632.2002.tb04400.x; Hanselmann R, 2004, BIOL CONSERV, V120, P115, DOI 10.1016/j.biocon.2004.02.013; HESTER RE, 2007, BIODIVERSITY THREAT; Hossack BR, 2010, J HERPETOL, V44, P253, DOI 10.1670/09-058.1; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; James TY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000458; Johnson ML, 2003, EMERG INFECT DIS, V9, P922; Johnson ML, 2005, DIS AQUAT ORGAN, V65, P181, DOI 10.3354/dao065181; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Kinney VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016708; Kriger KM, 2007, J ZOOL, V271, P352, DOI 10.1111/j.1469-7998.2006.00220.x; Kriger KM, 2007, DIVERS DISTRIB, V13, P781, DOI 10.1111/j.1472-4642.2007.00394.x; Kriger KM, 2007, CONSERV BIOL, V21, P1280, DOI 10.1111/j.1523-1739.2007.00777.x; Kriger KM, 2006, ECOHEALTH, V3, P171, DOI 10.1007/s10393-006-0027-7; Lampo Margarita, 2008, Herpetological Review, V39, P449; Lauer A, 2007, COPEIA, P630, DOI 10.1643/0045-8511(2007)2007[630:CCBFTE]2.0.CO;2; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Lips KR, 1999, CONSERV BIOL, V13, P117, DOI 10.1046/j.1523-1739.1999.97185.x; Lips KR, 1998, CONSERV BIOL, V12, P106, DOI 10.1046/j.1523-1739.1998.96359.x; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Lips KR, 2003, J HERPETOL, V37, P215, DOI 10.1670/0022-1511(2003)037[0215:CIWFFS]2.0.CO;2; Lips KR, 2003, CONSERV BIOL, V17, P1078, DOI 10.1046/j.1523-1739.2003.01623.x; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Longcore JR, 2007, J WILDLIFE MANAGE, V71, P435, DOI 10.2193/2006-345; Longo AV, 2010, DIS AQUAT ORGAN, V92, P253, DOI 10.3354/dao02054; Lovich Robert, 2008, Herpetological Review, V39, P315; MILLS LS, 2008, CONSERVATION WILDLIF; Mitchell KM, 2008, P ROY SOC B-BIOL SCI, V275, P329, DOI 10.1098/rspb.2007.1356; Morgan JAT, 2007, P NATL ACAD SCI USA, V104, P13845, DOI 10.1073/pnas.0701838104; Murray K., 2010, Ecology, V91, P1557, DOI 10.1890/09-1608.1; Murray Kris, 2010, Ecology (Washington D C), V91, pE091; Murray KA, 2011, J APPL ECOL, V48, P163, DOI 10.1111/j.1365-2664.2010.01890.x; Murray KA, 2009, CONSERV BIOL, V23, P1242, DOI 10.1111/j.1523-1739.2009.01211.x; Muths E, 2008, BIOL CONSERV, V141, P1484, DOI 10.1016/j.biocon.2008.03.011; Carnaval ACOD, 2006, ECOHEALTH, V3, P41, DOI 10.1007/s10393-005-0008-2; Ouellet M, 2005, CONSERV BIOL, V19, P1431, DOI 10.1111/j.1523-1739.2005.00108.x; Pearl CA, 2007, J HERPETOL, V41, P145, DOI 10.1670/0022-1511(2007)41[145:OOTAPB]2.0.CO;2; Pessier AP, 1999, J VET DIAGN INVEST, V11, P194, DOI 10.1177/104063879901100219; Pessier AP, 2010, P WORKSH 16 18 FEBR; Peterson JD, 2007, J WILDLIFE DIS, V43, P450, DOI 10.7589/0090-3558-43.3.450; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Puschendorf R, 2009, DIVERS DISTRIB, V15, P401, DOI 10.1111/j.1472-4642.2008.00548.x; Rachowicz LJ, 2006, ECOLOGY, V87, P1671, DOI 10.1890/0012-9658(2006)87[1671:EIDAAP]2.0.CO;2; Rachowicz LJ, 2005, CONSERV BIOL, V19, P1441, DOI 10.1111/j.1523-1739.2005.00255.x; Rachowicz LJ, 2004, DIS AQUAT ORGAN, V61, P75, DOI 10.3354/dao061075; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Ribas L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008408; Richards Corinne L., 2008, Herpetological Review, V39, P200; Rodder D, 2008, ANIM CONSERV, V11, P513, DOI 10.1111/j.1469-1795.2008.00210.x; Rohr JR, 2008, P NATL ACAD SCI USA, V105, P17436, DOI 10.1073/pnas.0806368105; Ron SR, 2005, BIOTROPICA, V37, P209, DOI 10.1111/j.1744-7429.2005.00028.x; Rothermel BB, 2008, DIS AQUAT ORGAN, V82, P3, DOI 10.3354/dao01974; Rowley JJL, 2007, DIS AQUAT ORGAN, V77, P1, DOI 10.3354/dao01830; Sadinski Walt, 2010, Herpetological Review, V41, P170; Savage AE, 2011, BIOL CONSERV, V144, P1910, DOI 10.1016/j.biocon.2011.03.018; Scalera Riccardo, 2008, Herpetological Review, V39, P199; Skerratt LF, 2008, DIS AQUAT ORGAN, V80, P85, DOI 10.3354/dao01923; Skerratt LF, 2010, DIS AQUAT ORGAN, V92, P117, DOI 10.3354/dao02272; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Stein BA, 2008, BIOSCIENCE, V58, P339, DOI 10.1641/B580409; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tennessen JA, 2009, DEV COMP IMMUNOL, V33, P1247, DOI 10.1016/j.dci.2009.07.004; Vredenburg Vance T., 2001, Herpetological Review, V32, P151; VREDENBURG VT, 2010, PNAS; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Waldman B., 2001, Surveillance (Wellington), V28, P9; Woodhams DC, 2007, ANIM CONSERV, V10, P409, DOI 10.1111/j.1469-1795.2007.00130.x; Woodhams DC, 2005, CONSERV BIOL, V19, P1449, DOI 10.1111/j.1523-1739.2005.004403.x; Woodhams DC, 2003, DIS AQUAT ORGAN, V55, P65, DOI 10.3354/dao055065; WOODHAMS DC, 2007, HERP REV, V39, P66; Woodhams DC, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-8; PARTN AMPH REPT CONS; BD MAPS	101	26	35	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22211	10.1371/journal.pone.0022211	http://dx.doi.org/10.1371/journal.pone.0022211			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811576	Green Published, Green Submitted, gold			2022-12-25	WOS:000292956800032
J	Kawagoe, T; Shimizu, KK; Kakutani, T; Kudoh, H				Kawagoe, Tetsuhiro; Shimizu, Kentaro K.; Kakutani, Tetsuji; Kudoh, Hiroshi			Coexistence of Trichome Variation in a Natural Plant Population: A Combined Study Using Ecological and Candidate Gene Approaches	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; DATURA-WRIGHTII; ARABIDOPSIS-THALIANA; COMPARATIVE GENOMICS; GLANDULAR TRICHOMES; POSITIVE SELECTION; ADAPTIVE EVOLUTION; STATISTICAL-METHOD; FITNESS COSTS; RESISTANCE	The coexistence of distinct phenotypes within populations has long been investigated in evolutionary ecology. Recent studies have identified the genetic basis of distinct phenotypes, but it is poorly understood how the variation in candidate loci is maintained in natural environments. In this study, we examined fitness consequences and genetic basis of variation in trichome production in a natural population of Arabidopsis halleri subsp. gemmifera. Half of the individuals in the study population produced trichomes while the other half were glabrous, and the leaf beetle Phaedon brassicae imposed intensive damage to both phenotypes. The fitness of hairy and glabrous plants showed no significant differences in the field during two years. A similar result was obtained when sibling hairy and glabrous plants were transplanted at the same field site, whereas a fitness cost of trichome production was detected under a weak herbivory condition. Thus, equivalent fitness of hairy and glabrous plants under natural herbivory allows their coexistence in the contemporary population. The pattern of polymorphism of the candidate trichome gene GLABROUS1 (GL1) showed no evidence of long-term maintenance of trichome variation within the population. Although balancing selection under fluctuating biotic environments is often proposed to explain the maintenance of defense variation, the lack of clear evidence of balancing selection in the study population suggests that other factors such as gene flow and neutral process may have played relatively large roles in shaping trichome variation at least for the single population level.	[Kawagoe, Tetsuhiro] Kobe Univ, Fac Sci, Dept Biol, Kobe, Hyogo 657, Japan; [Kawagoe, Tetsuhiro; Shimizu, Kentaro K.] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Kakutani, Tetsuji] Natl Inst Genet, Shizuoka, Japan; [Kudoh, Hiroshi] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan	Kobe University; University of Zurich; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Kyoto University	Kawagoe, T (corresponding author), Kobe Univ, Fac Sci, Dept Biol, Kobe, Hyogo 657, Japan.	kawagoe.t@ecology.kyoto-u.ac.jp	Kudoh, Hiroshi/AAF-9497-2019	Kudoh, Hiroshi/0000-0001-9777-4886; Shimizu, Kentaro K./0000-0002-6483-1781	Japan Society for the Promotion of Science (JSPS); MEXT, Japan [20370012]; Kyoto University; NEXT [GS013]; University of Zurich; Swiss National Science Foundation (SNF); Special Research on Priority Areas [19043010]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kyoto University; NEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); University of Zurich; Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Special Research on Priority Areas	This study was supported by the Japan Society for the Promotion of Science (JSPS) Research Fellowship for Young Scientists and JSPS Fellowship for Research Abroad to T. Kawagoe; Grants-in-Aid, MEXT, Japan (Scientific Research (B), 20370012), Global COE Program A06 of Kyoto University and the NEXT Program (GS013) to HK; the University Research Priority Program in Systems Biology / Functional Genomics of the University of Zurich and by the Swiss National Science Foundation (SNF) to KKS; and Special Research on Priority Areas (19043010) to HK and KKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGREN J, 1993, AM NAT, V141, P338, DOI 10.1086/285477; Aikawa S, 2010, P NATL ACAD SCI USA, V107, P11632, DOI 10.1073/pnas.0914293107; Aminetzach YT, 2005, SCIENCE, V309, P764, DOI 10.1126/science.1112699; Anderson JT, 2011, FUNCT ECOL, V25, P312, DOI 10.1111/j.1365-2435.2010.01785.x; Bailey CD, 2006, MOL BIOL EVOL, V23, P2142, DOI 10.1093/molbev/msl087; Barrett RDH, 2008, SCIENCE, V322, P255, DOI 10.1126/science.1159978; Clauss MJ, 2006, J CHEM ECOL, V32, P2351, DOI 10.1007/s10886-006-9150-8; Clauss MJ, 2006, TRENDS PLANT SCI, V11, P449, DOI 10.1016/j.tplants.2006.07.005; Crawley MJ, 2005, STAT INTRO USING R; Dalin Peter, 2008, P89, DOI 10.1007/978-1-4020-8182-8_4; Dalziel AC, 2009, MOL ECOL, V18, P4997, DOI 10.1111/j.1365-294X.2009.04427.x; de Meaux J, 2003, HEREDITY, V91, P345, DOI 10.1038/sj.hdy.6800342; Ehrenreich IM, 2006, AM J BOT, V93, P953, DOI 10.3732/ajb.93.7.953; Elle E, 1999, EVOLUTION, V53, P22, DOI [10.2307/2640917, 10.1111/j.1558-5646.1999.tb05330.x]; Fitzpatrick MJ, 2007, NATURE, V447, P210, DOI 10.1038/nature05764; FU YX, 1993, GENETICS, V133, P693; Gonzalez J, 2008, PLOS BIOL, V6, P2109, DOI 10.1371/journal.pbio.0060251; Gos G, 2008, MOL ECOL, V17, P4953, DOI 10.1111/j.1365-294X.2008.03968.x; Hare JD, 2004, ECOLOGY, V85, P615, DOI 10.1890/03-3069; Hare JD, 2003, EVOLUTION, V57, P793, DOI 10.1111/j.0014-3820.2003.tb00291.x; Hauser MT, 2001, MOL BIOL EVOL, V18, P1754, DOI 10.1093/oxfordjournals.molbev.a003963; Hedrick PW, 2006, ANNU REV ECOL EVOL S, V37, P67, DOI 10.1146/annurev.ecolsys.37.091305.110132; Hoffmann MH, 2005, EVOLUTION, V59, P1425; HUDSON RR, 1994, GENETICS, V136, P1329; Hulskamp M, 2004, NAT REV MOL CELL BIO, V5, P471, DOI 10.1038/nrm1404; Ingvarsson PK, 2005, MOL BIOL EVOL, V22, P1802, DOI 10.1093/molbev/msi171; Innan H, 2005, GENETICS, V169, P1763, DOI 10.1534/genetics.104.032219; Ishida T, 2008, ANNU REV PLANT BIOL, V59, P365, DOI 10.1146/annurev.arplant.59.032607.092949; Jiang N, 2004, NATURE, V431, P569, DOI 10.1038/nature02953; Kapitonov VV, 1999, GENETICA, V107, P27, DOI 10.1023/A:1004030922447; Karban R., 1992, P195; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Kawagoe T, 2010, OECOLOGIA, V164, P713, DOI 10.1007/s00442-010-1709-y; Kennedy G. G., 1992, Plant resistance to herbivores and pathogens: ecology, evolution, and genetics., P13; Kessler A, 2004, SCIENCE, V305, P665, DOI 10.1126/science.1096931; Kidwell MG, 2001, EVOLUTION, V55, P1, DOI 10.1111/j.0014-3820.2001.tb01268.x; Kidwell MG, 1997, P NATL ACAD SCI USA, V94, P7704, DOI 10.1073/pnas.94.15.7704; Kivimaki M, 2007, MOL ECOL, V16, P453, DOI 10.1111/j.1365-294X.2007.03109.x; Kniskern JM, 2007, EVOLUTION, V61, P377, DOI 10.1111/j.1742-4658.2007.00032.x; Koch M, 2001, AM J BOT, V88, P534, DOI 10.2307/2657117; Koricheva J, 2002, ECOLOGY, V83, P176, DOI 10.2307/2680130; Korves TM, 2007, AM NAT, V169, pE141, DOI 10.1086/513111; Kubota H, 2003, INT J PHYTOREMEDIAT, V5, P197, DOI 10.1080/713779219; Lacombe E, 2008, PLANT SCI, V174, P634, DOI 10.1016/j.plantsci.2008.03.020; LARKIN JC, 1993, PLANT CELL, V5, P1739, DOI 10.1105/tpc.5.12.1739; LEVIN DA, 1973, Q REV BIOL, V48, P3, DOI 10.1086/407484; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; Loe G, 2007, OIKOS, V116, P134, DOI 10.1111/j.2006.0030-1299.15022.x; Lonnig WE, 1997, GENE, V205, P245, DOI 10.1016/S0378-1119(97)00397-1; Lopes FR, 2008, MOL GENET GENOMICS, V279, P385, DOI 10.1007/s00438-008-0319-4; Mauricio R, 1998, AM NAT, V151, P20, DOI 10.1086/286099; Mauricio R, 1997, EVOLUTION, V51, P1435, DOI [10.2307/2411196, 10.1111/j.1558-5646.1997.tb01467.x]; MCDONALD JF, 1993, CURR OPIN GENET DEV, V3, P855, DOI 10.1016/0959-437X(93)90005-A; Mitchell-Olds T, 2007, NAT REV GENET, V8, P845, DOI 10.1038/nrg2207; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Neiman M, 2009, NEW PHYTOL, V183, P740, DOI 10.1111/j.1469-8137.2009.02936.x; OPPENHEIMER DG, 1991, CELL, V67, P483, DOI 10.1016/0092-8674(91)90523-2; R Core Team, 2022, R LANG ENV STAT COMP; Reininga JM, 2009, MOL ECOL, V18, P2844, DOI 10.1111/j.1365-294X.2009.04206.x; Ross-Ibarra J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002411; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sakai H, 2007, GENE, V392, P59, DOI 10.1016/j.gene.2006.11.010; Schranz ME, 2007, CURR OPIN PLANT BIOL, V10, P168, DOI 10.1016/j.pbi.2007.01.014; Schranz ME, 2006, TRENDS PLANT SCI, V11, P535, DOI 10.1016/j.tplants.2006.09.002; Shimizu KK, 2005, PLANT PHYSIOL, V138, P578, DOI 10.1104/pp.105.061655; Shimizu KK, 2002, POPUL ECOL, V44, P221, DOI 10.1007/s101440200025; Siepielski AM, 2009, ECOL LETT, V12, P1261, DOI 10.1111/j.1461-0248.2009.01381.x; SIMMS EL, 1987, AM NAT, V130, P570, DOI 10.1086/284731; Sletvold N, 2010, EVOL ECOL, V24, P1307, DOI 10.1007/s10682-010-9381-6; Stahl EA, 1999, NATURE, V400, P667, DOI 10.1038/23260; Steets JA, 2010, AM J BOT, V97, P1098, DOI 10.3732/ajb.0900362; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Steppuhn A, 2004, PLOS BIOL, V2, P1074, DOI 10.1371/journal.pbio.0020217; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7; TAJIMA F, 1989, GENETICS, V123, P585; Tenaillon MI, 2008, CURR OPIN PLANT BIOL, V11, P110, DOI 10.1016/j.pbi.2007.12.003; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Valverde PL, 2001, J EVOLUTION BIOL, V14, P424, DOI 10.1046/j.1420-9101.2001.00295.x; Wilczek AM, 2009, SCIENCE, V323, P930, DOI 10.1126/science.1165826; Wright SI, 2005, MOL BIOL EVOL, V22, P506, DOI 10.1093/molbev/msi035; [No title captured]; [No title captured]	82	24	25	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22184	10.1371/journal.pone.0022184	http://dx.doi.org/10.1371/journal.pone.0022184			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21811571	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000292929500046
J	Pyonteck, SM; Gadea, BB; Wang, HW; Gocheva, V; Hunter, KE; Tang, LH; Joyce, JA				Pyonteck, S. M.; Gadea, B. B.; Wang, H-W; Gocheva, V.; Hunter, K. E.; Tang, L. H.; Joyce, J. A.			Deficiency of the macrophage growth factor CSF-1 disrupts pancreatic neuroendocrine tumor development	ONCOGENE			English	Article						cancer; tumor-associated macrophage; tumor microenvironment; human PNET; myeloid cell	COLONY-STIMULATING FACTOR-1; MOUSE MODEL; ANGIOGENIC SWITCH; SURVIVAL BENEFIT; RECEPTOR; PROGRESSION; MICE; INFLAMMATION; RESPONSES	Tumor-associated macrophages have recently emerged as a key regulatory cell type during cancer progression, and have been found to promote tumor malignancy in the majority of studies performed to date. We show in this study that CD68(+) macrophages positively correlate with tumor grade and liver metastasis in human pancreatic neuroendocrine tumors (PNETs). To investigate the potential mechanisms whereby macrophages can promote PNET progression, we crossed the RIP1-Tag2 (RT2) mouse model of pancreatic islet cancer to colony-stimulating factor-1 (CSF-1)-deficient Csf1(op/op) mice, which have reduced numbers of tissue macrophages. Csf1(op/op) RT2 mice had a substantial reduction in cumulative tumor burden, which interestingly resulted from a significant decrease in angiogenic switching and tumor number, rather than an evident effect on tumor growth. In the tumors that did develop in CSF-1-deficient animals, however, there were no significant differences in tumor cell proliferation, apoptosis, angiogenesis or invasion. CSF-1 deficiency decreased macrophage infiltration by approximately 50% during all stages of RT2 tumor progression. Interestingly, several cytokines were upregulated in CSF-1-deficient RT2 tumors, and neutrophil infiltration was increased. These results show that macrophages are important for promoting PNET development and suggest that additional factors contribute to the recruitment and survival of myeloid cells in RT2 tumors in the absence of CSF-1. Oncogene (2012) 31, 1459-1467; doi:10.1038/onc.2011.337; published online 8 August 2011	[Pyonteck, S. M.; Gadea, B. B.; Wang, H-W; Gocheva, V.; Hunter, K. E.; Joyce, J. A.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Tang, L. H.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Pyonteck, S. M.; Wang, H-W; Gocheva, V.] Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	Joyce, JA (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave,Box 372, New York, NY 10065 USA.	joycej@mskcc.org		Pyonteck, Stephanie/0000-0002-4143-0969	National Cancer Institute TMEN [NIH U54-CA126518]; NCI [CA125162]; Geoffrey Beene Foundation; NIH; American Cancer Society; Frank L. Horsfall Fellowship; Geoffrey Beene Fellowship; NATIONAL CANCER INSTITUTE [R01CA125162, U54CA126518] Funding Source: NIH RePORTER	National Cancer Institute TMEN; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Geoffrey Beene Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Frank L. Horsfall Fellowship; Geoffrey Beene Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Xiaoping Chen and Kenishana Simpson for excellent technical assistance; Dr Jeffrey Pollard, Albert Einstein College of Medicine for the Csf1<SUP>op</SUP> pyrosequencing protocol; Drs Jan Hendrikx and Jennifer Wilshire, MSKCC Flow Cytometry Core Facility for assistance with flow cytometric sorting; Drs Agnes Viale, Juan Li, Magali Cavatore, Liliana Villafania, MSKCC Genomics Core Facility for assistance with RT-PCR and pyrosequencing; Drs Guangli Li and Ouathek Ouerfelli, MSKCC Organic Synthesis Core Facility for synthesis of the Cy3B-Cathepsin-ABP; and Elyn Reidel, MSKCC Epidemiology and Biostatistics Department, for statistical analysis of tumor size distribution. This research was supported by the following: National Cancer Institute TMEN Grant (NIH U54-CA126518), NCI R01 (CA125162), and the Geoffrey Beene Foundation (JAJ); NIH T32 Training Fellowship (SMP); American Cancer Society Postdoctoral Fellowship (BBG); Frank L. Horsfall Fellowship (HWW, VG); and Geoffrey Beene Fellowship (VG).	Abboud SL, 2002, ENDOCRINOLOGY, V143, P1942, DOI 10.1210/en.143.5.1942; Banaei-Bouchareb L, 2004, J LEUKOCYTE BIOL, V76, P359, DOI 10.1189/jlb.1103591; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Chiu CW, 2010, J CLIN ONCOL, V28, P4425, DOI 10.1200/JCO.2010.28.0198; CHRISTOFORI G, 1995, MOL ENDOCRINOL, V9, P1760, DOI 10.1210/me.9.12.1760; Gocheva V, 2010, BIOL CHEM, V391, P937, DOI 10.1515/BC.2010.080; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Greenbaum D, 2002, MOL CELL PROTEOMICS, V1, P60, DOI 10.1074/mcp.T100003-MCP200; Halfdanarson TR, 2008, ENDOCR-RELAT CANCER, V15, P409, DOI 10.1677/ERC-07-0221; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; Hu Wenwei, 2010, Genes Cancer, V1, P360; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kohler C, 2007, CELL TISSUE RES, V330, P291, DOI 10.1007/s00441-007-0474-7; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Lin EY, 2007, MOL ONCOL, V1, P288, DOI 10.1016/j.molonc.2007.10.003; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Lopez T, 2002, CANCER CELL, V1, P339, DOI 10.1016/S1535-6108(02)00055-7; MacDonald KPA, 2010, BLOOD, V116, P3955, DOI 10.1182/blood-2010-02-266296; Mantovani A, 2010, CYTOKINE GROWTH F R, V21, P27, DOI 10.1016/j.cytogfr.2009.11.007; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Oguma K, 2008, EMBO J, V27, P1671, DOI 10.1038/emboj.2008.105; Pahler J, 2008, NEOPLASIA, V10, P329, DOI 10.1593/neo.07871; Pietras K, 2005, J CLIN ONCOL, V23, P939, DOI 10.1200/JCO.2005.07.093; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Raymond E, 2011, NEW ENGL J MED, V364, P501, DOI 10.1056/NEJMoa1003825; Reidy DL, 2009, NAT CLIN PRACT ONCOL, V6, P143, DOI 10.1038/ncponc1326; Robinson BD, 2009, CLIN CANCER RES, V15, P2433, DOI 10.1158/1078-0432.CCR-08-2179; Ryder M, 2008, ENDOCR-RELAT CANCER, V15, P1069, DOI 10.1677/ERC-08-0036; Song S, 2005, NAT CELL BIOL, V7, P870, DOI 10.1038/ncb1288; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Steiner GE, 2000, J IMMUNOL METHODS, V237, P39, DOI 10.1016/S0022-1759(99)00240-9; Tuveson D, 2011, NATURE, V471, P316, DOI 10.1038/471316a; Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0	41	91	97	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2012	31	11					1459	1467		10.1038/onc.2011.337	http://dx.doi.org/10.1038/onc.2011.337			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	912FL	21822305				2022-12-25	WOS:000301780000012
J	Arora, PD; Wang, YQ; Janmey, PA; Bresnick, A; Yin, HL; McCulloch, CA				Arora, Pamma D.; Wang, Yongqiang; Janmey, Paul A.; Bresnick, Anne; Yin, Helen L.; McCulloch, Christopher A.			Gelsolin and Non-muscle Myosin IIA Interact to Mediate Calcium-regulated Collagen Phagocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN PHOSPHORYLATION; GEL-SOL TRANSFORMATION; PLASMA GELSOLIN; TERMINAL HALF; F-ACTIN; MATRIX-METALLOPROTEINASE; GINGIVAL FIBROBLASTS; CELL-ADHESION; FISSION YEAST; NON-MUSCLE	The formation of adhesion complexes is the rate-limiting step for collagen phagocytosis by fibroblasts, but the role of Ca2+ and the potential interactions of actin-binding proteins in regulating collagen phagocytosis are not well defined. We found that the binding of collagen beads to fibroblasts was temporally and spatially associated with actin assembly at nascent phagosomes, which was absent in gelsolin null cells. Analysis of tryptic digests isolated from gelsolin immunoprecipitates indicated that nonmuscle (NM) myosin IIA may bind to gelsolin. Immunostaining and immunoprecipitation showed that gelsolin andNMmyosin IIA associated at collagen adhesion sites. Gelsolin andNMmyosin IIA were both required for collagen binding and internalization. Collagen binding to cells initiated a prolonged increase of [Ca2+](i), which was absent in cells null for gelsolin or NM myosin IIA. Collagen bead-induced increases of [Ca2+](i) were associated with phosphorylation of the myosin light chain, which was dependent on gelsolin. NM myosin IIA filament assembly, which was dependent on myosin light chain phosphorylation and increased [Ca2+](i), also required gelsolin. Ionomycin-induced increases of [Ca2+](i) overcame the block of myosin filament assembly in gelsolin null cells. We conclude that gelsolin andNMmyosin IIA interact at collagen adhesion sites to enable NM myosin IIA filament assembly and localized, Ca2+-dependent remodeling of actin at the nascent phagosome and that these steps are required for collagen phagocytosis.	[Arora, Pamma D.; Wang, Yongqiang; McCulloch, Christopher A.] Univ Toronto, Matrix Dynam Grp, Toronto, ON M5S 3E2, Canada; [Janmey, Paul A.] Univ Penn 19104, Dept Biomed Engn, Philadelphia, PA 19104 USA; [Bresnick, Anne] Albert Einstein Med Sch, Dept Biochem, Bronx, NY 10461 USA; [Yin, Helen L.] Univ SW Texas Med Sch, Dept Physiol, Dallas, TX 75390 USA	University of Toronto; University of Pennsylvania; Yeshiva University	McCulloch, CA (corresponding author), Rm 244,Fitzgerald Bldg,150 Coll St, Toronto, ON M5S 3E2, Canada.	christopher.mcculloch@utoronto.ca			Canadian Institutes of Health Research [MOP 36332]; Ontario Heart and Stroke Operating Grant [T6022]; Canada Research Chair (Tier 1) in Matrix Dynamics	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Heart and Stroke Operating Grant; Canada Research Chair (Tier 1) in Matrix Dynamics(Canada Research Chairs)	This work was supported by Canadian Institutes of Health Research Operating Grant MOP 36332 (to C. A. M.) and by Ontario Heart and Stroke Operating Grant T6022 (to C. A. M.). C. A. M. is also supported by a Canada Research Chair (Tier 1) in Matrix Dynamics.	Arora PD, 2008, MOL BIOL CELL, V19, P5032, DOI 10.1091/mbc.E08-04-0430; Arora PD, 2005, MOL BIOL CELL, V16, P5175, DOI 10.1091/mbc.E05-07-0648; Arora PD, 2004, MOL BIOL CELL, V15, P588, DOI 10.1091/mbc.E03-07-0468; Arora PD, 2003, EXP CELL RES, V286, P366, DOI 10.1016/S0014-4827(03)00096-X; ARORA PD, 1994, J CELL PHYSIOL, V161, P187, DOI 10.1002/jcp.1041610202; Arora PD, 2000, J BIOL CHEM, V275, P35432, DOI 10.1074/jbc.M003221200; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Azuma T, 1998, EMBO J, V17, P1362, DOI 10.1093/emboj/17.5.1362; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bos JL, 2003, BIOCHEM SOC T, V31, P83, DOI 10.1042/bst0310083; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; Burtnick LD, 2004, EMBO J, V23, P2713, DOI 10.1038/sj.emboj.7600280; Burtnick LD, 1997, CELL, V90, P661, DOI 10.1016/S0092-8674(00)80527-9; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; CHAPONNIER C, 1986, J CELL BIOL, V103, P1473, DOI 10.1083/jcb.103.4.1473; Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; CRAIG R, 1983, NATURE, V302, P436, DOI 10.1038/302436a0; Crowley JL, 2009, MOL BIOL CELL, V20, P948, DOI 10.1091/mbc.E08-08-0867; Defacque H, 2000, CYTOMETRY, V41, P46, DOI 10.1002/1097-0320(20000901)41:1<46::AID-CYTO7>3.0.CO;2-F; Defacque H, 2002, MOL BIOL CELL, V13, P1190, DOI 10.1091/mbc.01-06-0314; Defacque H, 2000, EMBO J, V19, P199, DOI 10.1093/emboj/19.2.199; Dulyaninova NG, 2007, MOL BIOL CELL, V18, P3144, DOI 10.1091/mbc.E06-11-1056; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Everts V, 1996, HISTOCHEM J, V28, P229, DOI 10.1007/BF02409011; Ferrari MB, 2006, CELL BIOCHEM BIOPHYS, V45, P317, DOI 10.1385/CBB:45:3:317; Groves E, 2008, CELL MOL LIFE SCI, V65, P1957, DOI 10.1007/s00018-008-7578-4; HARTWIG JH, 1992, J CELL BIOL, V118, P1421, DOI 10.1083/jcb.118.6.1421; HARTWIG JH, 1995, CELL, V82, P643, DOI 10.1016/0092-8674(95)90036-5; Haviv L, 2008, J MOL BIOL, V375, P325, DOI 10.1016/j.jmb.2007.09.066; Huang Y, 2009, J CELL SCI, V122, P1637, DOI 10.1242/jcs.046219; Humphrey D, 2002, NATURE, V416, P413, DOI 10.1038/416413; Humphries MJ, 2003, TRENDS BIOCHEM SCI, V28, P313, DOI 10.1016/S0968-0004(03)00112-9; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ip K, 2007, CELL PHYSIOL BIOCHEM, V20, P649, DOI 10.1159/000107548; Isik N, 2008, DEV CELL, V15, P590, DOI 10.1016/j.devcel.2008.08.006; JACOBSON K, 1984, P NATL ACAD SCI-BIOL, V81, P6747, DOI 10.1073/pnas.81.21.6747; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; JANMEY PA, 1994, ANNU REV PHYSIOL, V56, P169, DOI 10.1146/annurev.ph.56.030194.001125; JANMEY PA, 1985, BIOCHEMISTRY-US, V24, P3714, DOI 10.1021/bi00335a046; Kiselar JG, 2003, P NATL ACAD SCI USA, V100, P3942, DOI 10.1073/pnas.0736004100; KNOWLES GC, 1991, J CELL SCI, V98, P551; Krause KH, 2000, SCHWEIZ MED WSCHR, V130, P97; KWIATKOWSKI DJ, 1986, NATURE, V323, P455, DOI 10.1038/323455a0; KWIATKOWSKI DJ, 1989, J CELL BIOL, V108, P1717, DOI 10.1083/jcb.108.5.1717; Lee HJ, 2006, MOL BIOL CELL, V17, P4812, DOI 10.1091/mbc.E06-06-0486; LIND SE, 1988, AM REV RESPIR DIS, V138, P429, DOI 10.1164/ajrccm/138.2.429; MCGAW WT, 1983, J INVEST DERMATOL, V81, P375, DOI 10.1111/1523-1747.ep12519983; MELCHER AH, 1981, J ULTRA MOL STRUCT R, V77, P1, DOI 10.1016/S0022-5320(81)80064-0; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Narayan K, 2003, FEBS LETT, V552, P82, DOI 10.1016/S0014-5793(03)00933-5; Nayal A, 2004, CURR OPIN CELL BIOL, V16, P94, DOI 10.1016/j.ceb.2003.11.007; Nishizaka T, 2000, P NATL ACAD SCI USA, V97, P692, DOI 10.1073/pnas.97.2.692; Nyakern-Meazza M, 2002, J BIOL CHEM, V277, P28774, DOI 10.1074/jbc.M203360200; Olazabal IM, 2002, CURR BIOL, V12, P1413, DOI 10.1016/S0960-9822(02)01069-2; Pelham RJ, 2002, NATURE, V419, P82, DOI 10.1038/nature00999; PEREZTAMAYO R, 1978, AM J PATHOL, V92, P509; POPE B, 1991, FEBS LETT, V280, P70, DOI 10.1016/0014-5793(91)80206-I; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; SCHOLEY JM, 1980, NATURE, V287, P233, DOI 10.1038/287233a0; Segal G, 2001, J CELL SCI, V114, P119; Selden LA, 1998, BIOPHYS J, V75, P3092, DOI 10.1016/S0006-3495(98)77750-1; Serrander L, 2000, J IMMUNOL, V165, P2451, DOI 10.4049/jimmunol.165.5.2451; SMITH RC, 1983, PHILOS T ROY SOC B, V302, P73, DOI 10.1098/rstb.1983.0039; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; TANSEY MG, 1994, J BIOL CHEM, V269, P9912; TENCATE AR, 1972, J ANAT, V112, P401; Tjelle TE, 2000, BIOESSAYS, V22, P255, DOI 10.1002/(SICI)1521-1878(200003)22:3<255::AID-BIES7>3.0.CO;2-R; Wang J, 2001, J BIOL CHEM, V276, P14474, DOI 10.1074/jbc.M007324200; Watanabe T, 2007, MOL BIOL CELL, V18, P605, DOI 10.1091/mbc.E06-07-0590; WAY M, 1989, J CELL BIOL, V109, P593, DOI 10.1083/jcb.109.2.593; Weeds A, 1993, CURR OPIN CELL BIOL, V5, P63, DOI 10.1016/S0955-0674(05)80009-2; Wilson CA, 2010, NATURE, V465, P373, DOI 10.1038/nature08994; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; YIN HL, 1979, NATURE, V281, P583, DOI 10.1038/281583a0; YIN HL, 1981, J CELL BIOL, V91, P901, DOI 10.1083/jcb.91.3.901; Yumura S, 2005, MOL BIOL CELL, V16, P4256, DOI 10.1091/mbc.E05-03-0219	79	12	12	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34184	34198		10.1074/jbc.M111.247783	http://dx.doi.org/10.1074/jbc.M111.247783			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21828045	Green Published, hybrid			2022-12-25	WOS:000295159200049
J	Nottingham, RM; Ganley, IG; Barr, FA; Lambright, DG; Pfeffer, SR				Nottingham, Ryan M.; Ganley, Ian G.; Barr, Francis A.; Lambright, David G.; Pfeffer, Suzanne R.			RUTBC1 Protein, a Rab9A Effector That Activates GTP Hydrolysis by Rab32 and Rab33B Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; TRANS-GOLGI NETWORK; LATE ENDOSOMES; HUMAN-CELLS; FAMILY; TRAFFICKING; DOMAIN; GTPASES; IDENTIFICATION; RECRUITMENT	Rab GTPases regulate all steps of membrane trafficking. Their interconversion between active, GTP-bound states and inactive, GDP-bound states is regulated by guanine nucleotide exchange factors and GTPase-activating proteins. The substrates for most Rab GTPase-activating proteins (GAPs) are unknown. Rab9A and its effectors regulate transport of mannose 6-phosphate receptors from late endosomes to the trans-Golgi network. We show here that RUTBC1 is a Tre2/Bub2/Cdc16 domain-containing protein that binds to Rab9A-GTP both in vitro and in cultured cells, but is not a GTPase-activating protein for Rab9A. Biochemical screening of RUTBC1 Rab protein substrates revealed highest in vitro GTP hydrolysis-activating activity with Rab32 and Rab33B. Catalysis required Arg-803 of RUTBC1, and RUTBC1 could activate a catalytically inhibited Rab33B mutant (Q92A), in support of a dual finger mechanism for RUTBC1 action. Rab9A binding did not influence GAP activity of bead-bound RUTBC1 protein. In cells and cell extracts, RUTBC1 influenced the ability of Rab32 to bind its effector protein, Varp, consistent with a physiological role for RUTBC1 in regulating Rab32. In contrast, binding of Rab33B to its effector protein, Atg16L1, was not influenced by RUTBC1 in cells or extracts. The identification of a protein that binds Rab9A and inactivates Rab32 supports a model in which Rab9A and Rab32 act in adjacent pathways at the boundary between late endosomes and the biogenesis of lysosome-related organelles.	[Nottingham, Ryan M.; Ganley, Ian G.; Pfeffer, Suzanne R.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Barr, Francis A.] Univ Liverpool, Canc Res Ctr, Liverpool L3 9TA, Merseyside, England; [Lambright, David G.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	Stanford University; University of Liverpool; University of Massachusetts System; University of Massachusetts Worcester	Pfeffer, SR (corresponding author), 279 Campus Dr B400, Stanford, CA 94305 USA.	pfeffer@stanford.edu		Barr, Francis/0000-0001-7518-253X; Ganley, Ian/0000-0003-1481-9407	National Institutes of Health [DK37332, GM007276]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK037332, R56DK037332, R01DK037332] Funding Source: NIH RePORTER; Medical Research Council [MC_UP_A500_1019] Funding Source: researchfish; MRC [MC_UP_A500_1019] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported, in whole or in part, by National Institutes of Health Grant DK37332 (to S. R. P.).; Supported by National Institutes of Health Training Grant GM007276.	Aivazian D, 2006, J CELL BIOL, V173, P917, DOI 10.1083/jcb.200510010; Albert S, 1999, J BIOL CHEM, V274, P33186, DOI 10.1074/jbc.274.47.33186; Bao XK, 2002, EUR J BIOCHEM, V269, P259, DOI 10.1046/j.0014-2956.2001.02645.x; Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Burguete AS, 2008, CELL, V132, P286, DOI 10.1016/j.cell.2007.11.048; Callebaut I, 2001, TRENDS BIOCHEM SCI, V26, P79, DOI 10.1016/S0968-0004(00)01730-8; Carroll KS, 2001, SCIENCE, V292, P1373, DOI 10.1126/science.1056791; Espinosa EJ, 2009, CELL, V137, P938, DOI 10.1016/j.cell.2009.03.043; Fuchs E, 2007, J CELL BIOL, V177, P1133, DOI 10.1083/jcb.200612068; Ganley IG, 2008, J CELL BIOL, V180, P159, DOI 10.1083/jcb.200707136; Ganley IG, 2004, MOL BIOL CELL, V15, P5420, DOI 10.1091/mbc.E04-08-0747; Haas AK, 2005, NAT CELL BIOL, V7, P887, DOI 10.1038/ncb1290; Haas AK, 2007, J CELL SCI, V120, P2997, DOI 10.1242/jcs.014225; Hayes GL, 2009, MOL BIOL CELL, V20, P209, DOI 10.1091/mbc.E08-07-0740; Hermann GJ, 2005, MOL BIOL CELL, V16, P3273, DOI 10.1091/mbc.E05-01-0060; Hirota Y, 2009, CELL MOL LIFE SCI, V66, P2913, DOI 10.1007/s00018-009-0080-9; Itoh T, 2008, MOL BIOL CELL, V19, P2916, DOI 10.1091/mbc.E07-12-1231; Itoh T, 2006, GENES CELLS, V11, P1023, DOI 10.1111/j.1365-2443.2006.00997.x; Itoh T, 2011, J CELL BIOL, V192, P839, DOI 10.1083/jcb.201008107; Janoueix-Lerosey I, 1998, EUR J BIOCHEM, V252, P290, DOI 10.1046/j.1432-1327.1998.2520290.x; Jiang S, 2005, MOL BIOL CELL, V16, P2586, DOI 10.1091/mbc.e04-10-0861; LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x; Ma JP, 2004, P NATL ACAD SCI USA, V101, P11652, DOI 10.1073/pnas.0401926101; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P243, DOI 10.1016/S0968-0004(97)01073-6; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Ortiz D, 2002, J CELL BIOL, V157, P1005, DOI 10.1083/jcb.200201003; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Park M, 2007, CURR BIOL, V17, P2030, DOI 10.1016/j.cub.2007.10.051; Peck GR, 2009, J BIOL CHEM, V284, P30016, DOI 10.1074/jbc.M109.035568; Raposo G, 2007, CURR OPIN CELL BIOL, V19, P394, DOI 10.1016/j.ceb.2007.05.001; Recacha R, 2009, STRUCTURE, V17, P21, DOI 10.1016/j.str.2008.10.014; Reddy JV, 2006, MOL BIOL CELL, V17, P4353, DOI 10.1091/mbc.E06-02-0153; RIEDERER MA, 1994, J CELL BIOL, V125, P573, DOI 10.1083/jcb.125.3.573; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rivera-Molina FE, 2009, P NATL ACAD SCI USA, V106, P14408, DOI 10.1073/pnas.0906536106; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Shutes A, 2005, METHODS, V37, P183, DOI 10.1016/j.ymeth.2005.05.019; Sklan EH, 2007, J BIOL CHEM, V282, P36354, DOI 10.1074/jbc.M705221200; Starr T, 2010, TRAFFIC, V11, P626, DOI 10.1111/j.1600-0854.2010.01051.x; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; STROM M, 1993, NATURE, V361, P736, DOI 10.1038/361736a0; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tamura K, 2009, MOL BIOL CELL, V20, P2900, DOI 10.1091/mbc.E08-12-1161; Valsdottir R, 2001, FEBS LETT, V508, P201, DOI 10.1016/S0014-5793(01)02993-3; Wasmeier C, 2006, J CELL BIOL, V175, P271, DOI 10.1083/jcb.200606050; Will E, 2001, METHOD ENZYMOL, V329, P50; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yang H, 2007, GENOMICS, V90, P249, DOI 10.1016/j.ygeno.2007.03.013; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047; Young ARJ, 2006, J CELL SCI, V119, P3888, DOI 10.1242/jcs.03172; Zheng JY, 1998, J CELL SCI, V111, P1061	55	46	49	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33213	33222		10.1074/jbc.M111.261115	http://dx.doi.org/10.1074/jbc.M111.261115			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21808068	hybrid, Green Published			2022-12-25	WOS:000294968800040
J	Zambon, AC; Wilderman, A; Ho, A; Insel, PA				Zambon, Alexander C.; Wilderman, Andrea; Ho, Angela; Insel, Paul A.			Increased Expression of the Pro-apoptotic Protein BIM, a Mechanism for cAMP/Protein Kinase A (PKA)-induced Apoptosis of Immature T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; GLUCOCORTICOID-INDUCED APOPTOSIS; S49 LYMPHOMA-CELLS; BCL-2 RELATIVE BIM; CYCLIC-AMP; BH3-ONLY PROTEIN; CD4(+)CD8(+) THYMOCYTES; SIGNALING PATHWAY; DNA FRAGMENTATION; DEPENDENT PATHWAY	The second messenger cAMP is proapoptotic for numerous cell types, but the mechanism for this proapoptotic action is not defined. Here, we use murine CD4(+)/CD8(+) S49 lymphoma cells and isolated thymocytes to assess this mechanism. In WT S49 cells, cAMP acts via protein kinase A (PKA) to induce G(1) phase cell cycle arrest and apoptosis. Treatment of WT and cAMP-Deathless (D-) S49 cells, which lack cAMP-promoted apoptosis, with the PKA agonist 8-(4-chlorophenylthio)-cAMP (CPT-cAMP) differentially regulates transcripts for numerous proapoptotic and antiapoptotic proteins. In contrast, kin-S49 cells (which lack PKA) show no cAMP-promoted changes in transcript expression. In this study, we use knockdown and overexpression approaches to define the role in cAMP/PKA-promoted apoptosis of the proapoptotic factor BIM (Bcl-2 interacting mediator of cell death), whose expression prominently increases in response to CPT-cAMP treatment of WT but not D-or kin-S49 cells. Conditional expression of BimL, one of the three major forms of Bim, increases apoptosis of WT, D-, and kin-S49 cells, whereas inhibition of cAMP-mediated induction of Bim isoforms by shRNAi attenuates CPT-cAMP-mediated apoptosis of WT S49 cells. Bim protein levels increase in subpopulations of CPT-cAMP-treated cells that undergo apoptosis. Thymic CD4(+)/CD8(+) cells isolated from Bim(-/-) mice corroborated the requirement of Bim expression for cAMP-promoted apoptosis. Thus, up-regulation of Bim appears to be an important determinant of cAMP/PKA-mediated apoptosis in immature T cells and may be a mechanism for such apoptosis in other cell types as well.	[Zambon, Alexander C.; Wilderman, Andrea; Ho, Angela; Insel, Paul A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Zambon, Alexander C.; Insel, Paul A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Zambon, AC (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	azambon@ucsd.edu		Wilderman, Andrea/0000-0002-4832-9476	IRACDA National Institutes of Health [GM068524]; American Heart Association [10SDG2630130]; Lymphoma and Leukemia Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM068524] Funding Source: NIH RePORTER	IRACDA National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Lymphoma and Leukemia Society(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by IRACDA National Institutes of Health Grant GM068524 and research grants. This work was also supported by American Heart Association Scientist Development Grant 10SDG2630130 and research grants from the Lymphoma and Leukemia Society.	Akiyama T, 2009, MOL CANCER THER, V8, P3173, DOI 10.1158/1535-7163.MCT-09-0685; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2001, MAMM GENOME, V12, P163, DOI 10.1007/s003350010242; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Chang HS, 2000, CELL IMMUNOL, V203, P29, DOI 10.1006/cimm.2000.1668; Cillessen SAGM, 2010, J PATHOL, V220, P509, DOI 10.1002/path.2670; COFFINO P, 1978, CANCER RES, V38, P4285; COFFINO P, 1975, AM J PATHOL, V81, P199; Danilov AV, 2006, CURR MOL MED, V6, P665, DOI 10.2174/156652406778195008; DRAPPA J, 1993, P NATL ACAD SCI USA, V90, P10340, DOI 10.1073/pnas.90.21.10340; Gillings AS, 2009, FEBS J, V276, P6050, DOI 10.1111/j.1742-4658.2009.07329.x; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; GUNJI H, 1992, J CLIN INVEST, V89, P954, DOI 10.1172/JCI115677; Haker G, 2007, ARCH BIOCHEM BIOPHYS, V462, P150, DOI 10.1016/j.abb.2006.12.022; Harada H, 2004, P NATL ACAD SCI USA, V101, P15313, DOI 10.1073/pnas.0406837101; Heinrichs S, 2003, ONCOGENE, V22, P555, DOI 10.1038/sj.onc.1206138; Insel P. A., 2011, ACTA PHYSL, DOI [10.1111/j.1748-1716.2011.2273.x, DOI 10.1111/J.1748-1716.2011.2273.X]; Ivanov VN, 1997, J BIOL CHEM, V272, P8558; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Ji ZY, 2008, J BIOL CHEM, V283, P21920, DOI 10.1074/jbc.M803193200; Kfir-Erenfeld S, 2010, LEUKEMIA LYMPHOMA, V51, P1968, DOI 10.3109/10428194.2010.506570; Kozuma Y, 2010, J THROMB HAEMOST, V8, P1088, DOI 10.1111/j.1538-7836.2010.03785.x; LEMAIRE I, 1977, CELL, V11, P149, DOI 10.1016/0092-8674(77)90325-7; LEPOSAVIC G, 1992, THYMUS, V19, P77; Lerner A, 2006, BIOCHEM J, V393, P21, DOI 10.1042/BJ20051368; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Magnani E, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-46; Manganini M, 2002, HUM GENE THER, V13, P1793, DOI 10.1089/104303402760372909; Mantena SK, 2006, CARCINOGENESIS, V27, P2018, DOI 10.1093/carcin/bgl043; Martin MC, 2001, J BIOL CHEM, V276, P45041, DOI 10.1074/jbc.M105197200; Medh RD, 1998, CANCER RES, V58, P3684; Miao J, 2007, APOPTOSIS, V12, P1691, DOI 10.1007/s10495-007-0093-5; Molitoris JK, 2011, MOL ENDOCRINOL, V25, P409, DOI 10.1210/me.2010-0402; Moon EY, 2003, BLOOD, V101, P4122, DOI 10.1182/blood-2002-10-3208; Naviglio S, 2009, EXPERT OPIN THER TAR, V13, P83, DOI [10.1517/14728220802602349, 10.1517/14728220802602349 ]; Nishihara H, 2003, P NATL ACAD SCI USA, V100, P8921, DOI 10.1073/pnas.1533221100; OGASAWARA J, 1995, J EXP MED, V181, P485, DOI 10.1084/jem.181.2.485; Ryan JA, 2010, P NATL ACAD SCI USA, V107, P12895, DOI 10.1073/pnas.0914878107; Singh K, 2001, J CELL PHYSIOL, V189, P257, DOI 10.1002/jcp.10024; Suter DM, 2006, STEM CELLS, V24, P615, DOI 10.1634/stemcells.2005-0226; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wang Y, 2006, APOPTOSIS, V11, P441, DOI 10.1007/s10495-005-4293-6; Wang ZQ, 2003, J BIOL CHEM, V278, P23861, DOI 10.1074/jbc.M301843200; Xing Y, 2008, MOL IMMUNOL, V45, P2028, DOI 10.1016/j.molimm.2007.10.028; Yan LZ, 2000, AM J PHYSIOL-CELL PH, V279, pC1665, DOI 10.1152/ajpcell.2000.279.5.C1665; Zambon AC, 2005, P NATL ACAD SCI USA, V102, P8561, DOI 10.1073/pnas.0503363102; Zhang LZ, 2008, J BIOL CHEM, V283, P4304, DOI 10.1074/jbc.M708673200; Zhang LZ, 2008, P NATL ACAD SCI USA, V105, P19532, DOI 10.1073/pnas.0806152105; Zhang LZ, 2004, J BIOL CHEM, V279, P20858, DOI 10.1074/jbc.M310643200	50	31	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33260	33267		10.1074/jbc.M111.268979	http://dx.doi.org/10.1074/jbc.M111.268979			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21808067	hybrid, Green Published			2022-12-25	WOS:000294968800045
J	Azevedo, AS; Grotek, B; Jacinto, A; Weidinger, G; Saude, L				Azevedo, Ana Sofia; Grotek, Bartholomaeus; Jacinto, Antonio; Weidinger, Gilbert; Saude, Leonor			The Regenerative Capacity of the Zebrafish Caudal Fin Is Not Affected by Repeated Amputations	PLOS ONE			English	Article							DEDIFFERENTIATION; CELLS; PROLIFERATION; MECHANISMS; EXPRESSION	Background: The zebrafish has the capacity to regenerate many tissues and organs. The caudal fin is one of the most convenient tissues to approach experimentally due to its accessibility, simple structure and fast regeneration. In this work we investigate how the regenerative capacity is affected by recurrent fin amputations and by experimental manipulations that block regeneration. Methodology/Principal Findings: We show that consecutive repeated amputations of zebrafish caudal fin do not reduce its regeneration capacity and do not compromise any of the successive regeneration steps: wound healing, blastema formation and regenerative outgrowth. Interfering with Wnt/ss-catenin signalling using heat-shock-mediated overexpression of Dickkopf1 completely blocks fin regeneration. Notably, if these fins were re-amputated at the non-inhibitory temperature, the regenerated caudal fin reached the original length, even after several rounds of consecutive Wnt/ss-catenin signalling inhibition and re-amputation. Conclusions/Significance: We show that the caudal fin has an almost unlimited capacity to regenerate. Even after inhibition of regeneration caused by the loss of Wnt/ss-catenin signalling, a new amputation resets the regeneration capacity within the caudal fin, suggesting that blastema formation does not depend on a pool of stem/progenitor cells that require Wnt/ss-catenin signalling for their survival.	[Azevedo, Ana Sofia; Jacinto, Antonio; Saude, Leonor] Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal; [Azevedo, Ana Sofia; Jacinto, Antonio; Saude, Leonor] Univ Lisbon, Fac Med, Inst Histol & Biol Desenvolvimento, P-1699 Lisbon, Portugal; [Azevedo, Ana Sofia; Jacinto, Antonio; Saude, Leonor] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Azevedo, Ana Sofia] Univ Coimbra, Ctr Neurociencias & Biol Celular, Coimbra, Portugal; [Grotek, Bartholomaeus; Weidinger, Gilbert] Tech Univ Dresden, Ctr Biotechnol, D-8027 Dresden, Germany; [Grotek, Bartholomaeus; Weidinger, Gilbert] Tech Univ Dresden, Ctr Regenerat Therapies, D-8027 Dresden, Germany	Universidade de Lisboa; Universidade de Lisboa; Instituto Gulbenkian de Ciencia; Universidade de Coimbra; Technische Universitat Dresden; Technische Universitat Dresden	Azevedo, AS (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal.	gilbert.weidinger@biotec.tu-dresden.de; msaude@fm.ul.pt	Weidinger, Gilbert/A-8342-2010; Saúde, Leonor/D-2720-2012; Jacinto, Antonio/F-5729-2013	Weidinger, Gilbert/0000-0003-3599-6760; Saúde, Leonor/0000-0001-5933-8872; Jacinto, Antonio/0000-0002-4193-6089	(FCT) Fundacao para a Ciencia e a Tecnologia (Portuguese Science and Technology Foundation) [SFRH/BD/33179/2007]; FCT [PTDC/SAU-OBD/64628/2006, PTDC/SAU-OBD/100202/2008]; Deutsche Forschungsgemeinschaft (DFG) [SFB655]	(FCT) Fundacao para a Ciencia e a Tecnologia (Portuguese Science and Technology Foundation)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	A. S. A. was supported by a (FCT) Fundacao para a Ciencia e a Tecnologia (Portuguese Science and Technology Foundation) fellowship (SFRH/BD/33179/2007). L. S. was supported by two FCT grants PTDC/SAU-OBD/64628/2006 and PTDC/SAU-OBD/100202/2008. Work of the Weidinger lab was supported by the Deutsche Forschungsgemeinschaft (DFG) grant "Collaborative Research Center 655: Cells into Tissues: Stem Cell and Progenitor Commitment and Interactions during Tissue Formation," SFB655 to G. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Karim Ahmed E., 1993, Qatar University Science Journal, V13, P101; Anchelin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016955; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Brockes JR, 2002, NAT REV MOL CELL BIO, V3, P566, DOI 10.1038/nrm881; DEARLOVE GE, 1976, J EXP ZOOL, V196, P251, DOI 10.1002/jez.1401960212; Echeverri K, 2002, SEMIN CELL DEV BIOL, V13, P353, DOI 10.1016/S1084952102000915; Echeverri K, 2001, DEV BIOL, V236, P151, DOI 10.1006/dbio.2001.0312; Hall B.K., 2015, BONES CARTILAGE DEV; Handberg-Thorsager M, 2008, FRONT BIOSCI-LANDMRK, V13, P6374, DOI 10.2741/3160; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Iovine MK, 2007, NAT CHEM BIOL, V3, P613, DOI 10.1038/nchembio.2007.36; Johnson SL, 1999, METHOD CELL BIOL, V59, P301; Kawakami Y, 2006, GENE DEV, V20, P3232, DOI 10.1101/gad.1475106; Knopf F, 2011, DEV CELL, V20, P713, DOI 10.1016/j.devcel.2011.04.014; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Lee Y, 2005, DEVELOPMENT, V132, P5173, DOI 10.1242/dev.02101; MARGOTTA V, 2004, REND LINCEI-SCI FIS, V9, P231; Margotta Vito, 2002, Italian Journal of Anatomy and Embryology, V107, P127; Morrison JI, 2006, J CELL BIOL, V172, P433, DOI 10.1083/jcb.200509011; Nechiporuk A, 2002, DEVELOPMENT, V129, P2607; Poss FD, 2000, DEV BIOL, V222, P347, DOI 10.1006/dbio.2000.9722; Poss KD, 2003, DEV DYNAM, V226, P202, DOI 10.1002/dvdy.10220; Quint E, 2002, P NATL ACAD SCI USA, V99, P8713, DOI 10.1073/pnas.122571799; Santos-Ruiz L, 2002, DEV DYNAM, V223, P262, DOI 10.1002/dvdy.10055; Shao JP, 2011, DEV DYNAM, V240, P1271, DOI 10.1002/dvdy.22603; Stoick-Cooper CL, 2007, GENE DEV, V21, P1292, DOI 10.1101/gad.1540507; Tu S, 2011, DEV CELL, V20, P725, DOI 10.1016/j.devcel.2011.04.013; Whitehead GG, 2005, SCIENCE, V310, P1957, DOI 10.1126/science.1117637; Yoshinari N, 2009, DEV BIOL, V325, P71, DOI 10.1016/j.ydbio.2008.09.028	30	63	64	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22820	10.1371/journal.pone.0022820	http://dx.doi.org/10.1371/journal.pone.0022820			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829525	Green Published, gold, Green Submitted			2022-12-25	WOS:000293284600052
J	Bianchi, FT; Camera, P; Ala, U; Imperiale, D; Migheli, A; Boda, E; Tempia, F; Berto, G; Bosio, Y; Oddo, S; LaFerla, FM; Taraglio, S; Dotti, CG; Di Cunto, F				Bianchi, Federico T.; Camera, Paola; Ala, Ugo; Imperiale, Daniele; Migheli, Antonio; Boda, Enrica; Tempia, Filippo; Berto, Gaia; Bosio, Ylenia; Oddo, Salvatore; LaFerla, Frank M.; Taraglio, Stefano; Dotti, Carlos G.; Di Cunto, Ferdinando			The Collagen Chaperone HSP47 Is a New Interactor of APP that Affects the Levels of Extracellular Beta-Amyloid Peptides	PLOS ONE			English	Article							PROTEASE INHIBITOR DOMAIN; PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; MOLECULAR CHAPERONE; A-BETA; EXPRESSION; MICE; IDENTIFICATION; INCREASES; DATABASE	Alzheimer disease (AD) is a neurodegenerative disorder characterized by progressive decline of cognitive function that represents one of the most dramatic medical challenges for the aging population. Ab peptides, generated by processing of the Amyloid Precursor Protein (APP), are thought to play a central role in the pathogenesis of AD. However, the network of physical and functional interactions that may affect their production and deposition is still poorly understood. The use of a bioinformatic approach based on human/mouse conserved coexpression allowed us to identify a group of genes that display an expression profile strongly correlated with APP. Among the most prominent candidates, we investigated whether the collagen chaperone HSP47 could be functionally correlated with APP. We found that HSP47 accumulates in amyloid deposits of two different mouse models and of some AD patients, is capable to physically interact with APP and can be relocalized by APP overexpression. Notably, we found that it is possible to reduce the levels of secreted A beta peptides by reducing the expression of HSP47 or by interfering with its activity via chemical inhibitors. Our data unveil HSP47 as a new functional interactor of APP and imply it as a potential target for preventing the formation and/or growth amyloid plaques.	[Bianchi, Federico T.; Camera, Paola; Ala, Ugo; Berto, Gaia; Bosio, Ylenia; Di Cunto, Ferdinando] Univ Turin, Dept Genet Biol & Biochem, Ctr Mol Biotechnol, Turin, Italy; [Imperiale, Daniele; Migheli, Antonio; Taraglio, Stefano] Azienda Osped ASL TO2, Ctr DOMP, Turin, Italy; [Boda, Enrica; Tempia, Filippo] Univ Turin, Dept Neurosci, Turin, Italy; [Oddo, Salvatore] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [LaFerla, Frank M.] Univ Calif Irvine, Dept Neurobiol & Behav, Inst Memory Impairments & Neurol Disorders, Irvine, CA USA; [Dotti, Carlos G.] VIB, Dept Mol & Dev Genet, Louvain, Belgium; [Dotti, Carlos G.] Katholieke Univ Leuven, Dept Human Genet, Louvain, Belgium	University of Turin; University of Turin; University of Texas System; University of Texas Health San Antonio; University of California System; University of California Irvine; Flanders Institute for Biotechnology (VIB); KU Leuven	Bianchi, FT (corresponding author), Univ Turin, Dept Genet Biol & Biochem, Ctr Mol Biotechnol, Turin, Italy.	ferdinando.dicunto@unito.it	Ala, Ugo/K-2029-2016; Boda, Enrica/AFM-7909-2022; Di Cunto, Ferdinando/K-5575-2016; Tempia, Filippo/A-5883-2012; Dotti, Carlos G/I-5533-2015	Ala, Ugo/0000-0001-5408-6397; Tempia, Filippo/0000-0003-2778-0943; Dotti, Carlos G/0000-0003-4052-1719; di cunto, ferdinando/0000-0001-9367-6357; Bianchi, Federico Tommaso/0000-0002-8385-3310; Oddo, Salvatore/0000-0001-7304-7430; BODA, Enrica/0000-0002-1006-2577	Piedmont Region; Bando Regionale sulla Ricerca Scientifica Applicata [A134]; Piattaforme Tecnologiche Innovative	Piedmont Region(Regione Piemonte); Bando Regionale sulla Ricerca Scientifica Applicata; Piattaforme Tecnologiche Innovative	This work was supported by two grants from Piedmont Region to FDC. The first is project n. A134, funded under the call "Bando Regionale sulla Ricerca Scientifica Applicata -2004". The second is the DRUIDI (DRUg development In DIsease) project, funded under the call "Piattaforme Tecnologiche Innovative 2008". The funder (Piedmont Region) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLINQUANT B, 1995, J CELL BIOL, V128, P919, DOI 10.1083/jcb.128.5.919; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BAKER FL, 1986, CANCER RES, V46, P1263; BANKER G, 1988, NATURE, V336, P185, DOI 10.1038/336185a0; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Caceres J, 1997, J CELL BIOCHEM, V65, P145, DOI 10.1002/(SICI)1097-4644(199705)65:2<145::AID-JCB2>3.0.CO;2-U; Chang K, 2006, NAT METHODS, V3, P707, DOI 10.1038/NMETH923; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DOTTI CG, 1987, NATURE, V330, P254, DOI 10.1038/330254a0; Gollub J, 2003, NUCLEIC ACIDS RES, V31, P94, DOI 10.1093/nar/gkg078; Graham DI, 1996, ACT NEUR S, V66, P96; Hashimoto T, 2002, EMBO J, V21, P1524, DOI 10.1093/emboj/21.7.1524; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Hoshino T, 2007, BIOCHEM J, V402, P581, DOI 10.1042/BJ20061318; Kloskowska E, 2008, NEUROSCI LETT, V436, P250, DOI 10.1016/j.neulet.2008.03.034; Liu ML, 2009, J CELL SCI, V122, P1917, DOI 10.1242/jcs.042226; Ma QH, 2008, NAT CELL BIOL, V10, P283, DOI 10.1038/ncb1690; Masumura M, 2000, J NEUROTRAUM, V17, P123, DOI 10.1089/neu.2000.17.123; Matsui T, 2007, BRAIN RES, V1161, P116, DOI 10.1016/j.brainres.2007.05.050; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Menendez-Gonzalez M, 2005, NEURODEGENER DIS, V2, P277, DOI 10.1159/000092315; MOYA KL, 1994, DEV BIOL, V161, P597, DOI 10.1006/dbio.1994.1055; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; Nagata K, 2003, SEMIN CELL DEV BIOL, V14, P275, DOI 10.1016/j.semcdb.2003.09.020; NEVE RL, 1988, NEURON, V1, P669, DOI 10.1016/0896-6273(88)90166-3; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Pellegrino M, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-179; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; POTEMPSKA A, 1993, ARCH BIOCHEM BIOPHYS, V304, P448, DOI 10.1006/abbi.1993.1374; Priller C, 2006, J NEUROSCI, V26, P7212, DOI 10.1523/JNEUROSCI.1450-06.2006; Qiu CX, 2007, CURR OPIN PSYCHIATR, V20, P380, DOI 10.1097/YCO.0b013e32816ebc7b; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Reinhard C, 2005, EMBO J, V24, P3996, DOI 10.1038/sj.emboj.7600860; Sabo SL, 2001, J CELL BIOL, V153, P1403, DOI 10.1083/jcb.153.7.1403; Satoh M, 1996, J CELL BIOL, V133, P469, DOI 10.1083/jcb.133.2.469; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; Tatu U, 1997, J CELL BIOL, V136, P555, DOI 10.1083/jcb.136.3.555; Thomson CA, 2005, J MED CHEM, V48, P1680, DOI 10.1021/jm049148+; van Horssen J, 2002, BRAIN PATHOL, V12, P456; Veznedaroglu E, 2002, J NEUROSURG, V97, P1125, DOI 10.3171/jns.2002.97.5.1125; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang DS, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/58406; WILLOUGHBY DA, 1992, EXP NEUROL, V118, P332, DOI 10.1016/0014-4886(92)90191-R; Zhu XW, 2007, J NEUROL SCI, V257, P240, DOI 10.1016/j.jns.2007.01.039	50	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22370	10.1371/journal.pone.0022370	http://dx.doi.org/10.1371/journal.pone.0022370			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829458	Green Published, gold			2022-12-25	WOS:000293284600011
J	Sibley, CD; Grinwis, ME; Field, TR; Eshaghurshan, CS; Faria, MM; Dowd, SE; Parkins, MD; Rabin, HR; Surette, MG				Sibley, Christopher D.; Grinwis, Margot E.; Field, Tyler R.; Eshaghurshan, Christina S.; Faria, Monica M.; Dowd, Scot E.; Parkins, Michael D.; Rabin, Harvey R.; Surette, Michael G.			Culture Enriched Molecular Profiling of the Cystic Fibrosis Airway Microbiome	PLOS ONE			English	Article							TAG-ENCODED FLX; RESTRICTION-FRAGMENT-LENGTH; RIBOSOMAL-RNA SEQUENCES; GINGIVAL CREVICE AREA; BACTERIAL DIVERSITY; PHYLOGENETIC-RELATIONSHIPS; PULMONARY INFECTIONS; ANAEROBIC-BACTERIA; RARE BIOSPHERE; CD-HIT	The microbiome of the respiratory tract, including the nasopharyngeal and oropharyngeal microbiota, is a dynamic community of microorganisms that is highly diverse. The cystic fibrosis (CF) airway microbiome refers to the polymicrobial communities present in the lower airways of CF patients. It is comprised of chronic opportunistic pathogens (such as Pseudomonas aeruginosa) and a variety of organisms derived mostly from the normal microbiota of the upper respiratory tract. The complexity of these communities has been inferred primarily from culture independent molecular profiling. As with most microbial communities it is generally assumed that most of the organisms present are not readily cultured. Our culture collection generated using more extensive cultivation approaches, reveals a more complex microbial community than that obtained by conventional CF culture methods. To directly evaluate the cultivability of the airway microbiome, we examined six samples in depth using culture-enriched molecular profiling which combines culture-based methods with the molecular profiling methods of terminal restriction fragment length polymorphisms and 16S rRNA gene sequencing. We demonstrate that combining culture-dependent and culture-independent approaches enhances the sensitivity of either approach alone. Our techniques were able to cultivate 43 of the 48 families detected by deep sequencing; the five families recovered solely by culture-independent approaches were all present at very low abundance (<0.002% total reads). 46% of the molecular signatures detected by culture from the six patients were only identified in an anaerobic environment, suggesting that a large proportion of the cultured airway community is composed of obligate anaerobes. Most significantly, using 20 growth conditions per specimen, half of which included anaerobic cultivation and extended incubation times we demonstrate that the majority of bacteria present can be cultured.	[Sibley, Christopher D.; Grinwis, Margot E.; Field, Tyler R.; Eshaghurshan, Christina S.; Faria, Monica M.; Parkins, Michael D.; Rabin, Harvey R.; Surette, Michael G.] Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB, Canada; [Parkins, Michael D.; Rabin, Harvey R.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Parkins, Michael D.; Rabin, Harvey R.] Univ Calgary, Adult Cyst Fibrosis Clin, Calgary, AB, Canada; [Dowd, Scot E.] Med Biofilm Res Inst, Lubbock, TX USA; [Dowd, Scot E.] Res & Testing Lab S Plains, Lubbock, TX USA; [Surette, Michael G.] McMaster Univ, Fac Hlth Sci, Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada	University of Calgary; University of Calgary; University of Calgary; McMaster University	Sibley, CD (corresponding author), Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB, Canada.	surette@mcmaster.ca	Surette, Michael G/AAE-8825-2020; Dowd, Scot E/M-5386-2017	Dowd, Scot E/0000-0002-6296-1427	Canadian Cystic Fibrosis Foundation; Canadian Institutes of Health Research; AHFMR; CIHR	Canadian Cystic Fibrosis Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); AHFMR(Alberta Heritage Foundation for Medical Research); CIHR(Canadian Institutes of Health Research (CIHR))	This study was supported by grants from the Canadian Cystic Fibrosis Foundation and Canadian Institutes of Health Research to MGS. MGS is supported as an Alberta Heritage Foundation for Medical Research (AHFMR) Scientist and Canada Research Chair in Microbial Gene Expression. An AHFMR studentship and a Canada Graduate Scholarship from CIHR supported CDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accurso F J, 1997, Curr Opin Pulm Med, V3, P400, DOI 10.1097/00063198-199711000-00002; Achtman M, 2008, NAT REV MICROBIOL, V6, P431, DOI 10.1038/nrmicro1872; Alain K, 2009, EXTREMOPHILES, V13, P583, DOI 10.1007/s00792-009-0261-3; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; BIK EM, 2010, ISME J; Bittar F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002908; Callaway TR, 2009, POULTRY SCI, V88, P298, DOI 10.3382/ps.2008-00222; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; D'Onofrio A, 2010, CHEM BIOL, V17, P254, DOI 10.1016/j.chembiol.2010.02.010; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dowd SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003326; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Dowd SE, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-93; Ecker DJ, 2008, NAT REV MICROBIOL, V6, P553, DOI 10.1038/nrmicro1918; Facklam R, 2002, CLIN MICROBIOL REV, V15, P613, DOI 10.1128/CMR.15.4.613-630.2002; Finegold S.M., 1983, HUMAN INTESTINAL MIC, P3, DOI DOI 10.1016/B978-0-12-341280-5.50007-0; Flint HJ, 2007, ENVIRON MICROBIOL, V9, P1101, DOI 10.1111/j.1462-2920.2007.01281.x; GILLIGAN PH, 2006, CUMITECH CYSTIC FIBR; GORDON DF, 1971, APPL MICROBIOL, V21, P1046, DOI 10.1128/AEM.21.6.1046-1050.1971; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Hugenholtz P, 2008, NATURE, V455, P481, DOI 10.1038/455481a; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ingham CJ, 2007, P NATL ACAD SCI USA, V104, P18217, DOI 10.1073/pnas.0701693104; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; Kaplan CW, 2003, J MICROBIOL METH, V54, P121, DOI 10.1016/S0167-7012(03)00003-4; KAWAMURA Y, 1995, INT J SYST BACTERIOL, V45, P406, DOI 10.1099/00207713-45-2-406; Keller M, 2004, NAT REV MICROBIOL, V2, P141, DOI 10.1038/nrmicro819; Klepac-Ceraj V, 2010, ENV MICROBIOL; Kolak M, 2003, INT J MED MICROBIOL, V293, P309, DOI 10.1078/1438-4221-00265; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kopke B, 2005, APPL ENVIRON MICROB, V71, P7819, DOI 10.1128/AEM.71.12.7819-7830.2005; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Leadbetter JR, 2003, CURR OPIN MICROBIOL, V6, P274, DOI 10.1016/S1369-5274(03)00041-9; Leake J L, 2009, J Wound Care, V18, P103; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; MANGANIELLO AD, 1977, J PERIODONTAL RES, V12, P107, DOI 10.1111/j.1600-0765.1977.tb00113.x; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Miller MB, 2003, J CLIN MICROBIOL, V41, P4009, DOI 10.1128/JCM.41.9.4009-4015.2003; Moore W E, 1994, Periodontol 2000, V5, P66, DOI 10.1111/j.1600-0757.1994.tb00019.x; MOORE WEC, 1974, APPL MICROBIOL, V27, P961, DOI 10.1128/AEM.27.5.961-979.1974; MUYZER G, 1995, ARCH MICROBIOL, V164, P165, DOI 10.1007/BF02529967; PACE NR, 1986, ADV MICROB ECOL, V9, P1; Parkins MD, 2008, PEDIATR PULM, V43, P490, DOI 10.1002/ppul.20809; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Raoult D, 2004, NAT REV MICROBIOL, V2, P151, DOI 10.1038/nrmicro820; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Reeder J, 2009, NAT METHODS, V6, P636, DOI 10.1038/nmeth0909-636; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Rogers GB, 2003, J CLIN MICROBIOL, V41, P3548, DOI 10.1128/JCM.41.8.3548-3558.2003; Rogers Geraint B, 2009, BMC Pulm Med, V9, P14, DOI 10.1186/1471-2466-9-14; Rogers GB, 2009, J MED MICROBIOL, V58, P1401, DOI 10.1099/jmm.0.013334-0; Sait M, 2002, ENVIRON MICROBIOL, V4, P654, DOI 10.1046/j.1462-2920.2002.00352.x; Schutte UME, 2008, APPL MICROBIOL BIOT, V80, P365, DOI 10.1007/s00253-008-1565-4; Sibley CD, 2006, FUTURE MICROBIOL, V1, P53, DOI 10.2217/17460913.1.1.53; Sibley CD, 2010, J CLIN MICROBIOL, V48, P2592, DOI 10.1128/JCM.00414-10; Sibley CD, 2008, P NATL ACAD SCI USA, V105, P15070, DOI 10.1073/pnas.0804326105; SOCRANSKY SS, 1963, ARCH ORAL BIOL, V8, P275, DOI 10.1016/0003-9969(63)90019-0; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; STALEY JT, 1985, ANNU REV MICROBIOL, V39, P321, DOI 10.1146/annurev.mi.39.100185.001541; Suchodolski JS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-210; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tu O, 1998, NUCLEIC ACIDS RES, V26, P2797, DOI 10.1093/nar/26.11.2797; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; TURNBAUGH PJ, 2010, P NATL ACAD SCI US; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WARD DM, 1990, NATURE, V345, P63, DOI 10.1038/345063a0; Watve M, 2000, CURR SCI INDIA, V78, P1535; Wilson KH, 1996, APPL ENVIRON MICROB, V62, P2273, DOI 10.1128/AEM.62.7.2273-2278.1996; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Wolcott R D, 2009, J Wound Care, V18, P317; Wolcott RD, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-226; Zengler K, 2002, P NATL ACAD SCI USA, V99, P15681, DOI 10.1073/pnas.252630999; Zengler K, 2009, MICROBIOL MOL BIOL R, V73, P712, DOI 10.1128/MMBR.00027-09	85	144	146	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22702	10.1371/journal.pone.0022702	http://dx.doi.org/10.1371/journal.pone.0022702			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829484	Green Published, Green Submitted, gold			2022-12-25	WOS:000293284600029
J	Jeong, YS; Kim, D; Lee, YS; Kim, HJ; Han, JY; Im, SS; Chong, HK; Kwon, JK; Cho, YH; Kim, WK; Osborne, TF; Horton, JD; Jun, HS; Ahn, YH; Ahn, SM; Cha, JY				Jeong, Yun-Seung; Kim, Deokhoon; Lee, Yong Seok; Kim, Ha-Jung; Han, Jung-Youn; Im, Seung-Soon; Chong, Hansook Kim; Kwon, Je-Keun; Cho, Yun-Ho; Kim, Woo Kyung; Osborne, Timothy F.; Horton, Jay D.; Jun, Hee-Sook; Ahn, Yong-Ho; Ahn, Sung-Min; Cha, Ji-Young			Integrated Expression Profiling and Genome-Wide Analysis of ChREBP Targets Reveals the Dual Role for ChREBP in Glucose-Regulated Gene Expression	PLOS ONE			English	Article							CARBOHYDRATE-RESPONSE ELEMENT; CENTER-DOT-MLX; CHIP-SEQ DATA; BINDING PROTEIN; TRANSCRIPTION FACTOR; INTERACTING PROTEIN; DNA-BINDING; OB/OB MICE; LIVER; SITES	The carbohydrate response element binding protein (ChREBP), a basic helix-loop-helix/leucine zipper transcription factor, plays a critical role in the control of lipogenesis in the liver. To identify the direct targets of ChREBP on a genome-wide scale and provide more insight into the mechanism by which ChREBP regulates glucose-responsive gene expression, we performed chromatin immunoprecipitation-sequencing and gene expression analysis. We identified 1153 ChREBP binding sites and 783 target genes using the chromatin from HepG2, a human hepatocellular carcinoma cell line. A motif search revealed a refined consensus sequence (CABGTG-nnCnG-nGnSTG) to better represent critical elements of a functional ChREBP binding sequence. Gene ontology analysis shows that ChREBP target genes are particularly associated with lipid, fatty acid and steroid metabolism. In addition, other functional gene clusters related to transport, development and cell motility are significantly enriched. Gene set enrichment analysis reveals that ChREBP target genes are highly correlated with genes regulated by high glucose, providing a functional relevance to the genome-wide binding study. Furthermore, we have demonstrated that ChREBP may function as a transcriptional repressor as well as an activator.	[Jeong, Yun-Seung; Kim, Deokhoon; Kim, Ha-Jung; Han, Jung-Youn; Cho, Yun-Ho; Kim, Woo Kyung; Jun, Hee-Sook; Ahn, Sung-Min; Cha, Ji-Young] Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Dept Mol Med, Inchon, South Korea; [Lee, Yong Seok; Kwon, Je-Keun] KRIBB, KOBIC, Taejon, South Korea; [Lee, Yong Seok] Samsung SDS, Healthcare Serv Grp, Seoul, South Korea; [Im, Seung-Soon; Osborne, Timothy F.] Sanford Burnham Med Res Inst, Orlando, FL USA; [Im, Seung-Soon; Chong, Hansook Kim; Osborne, Timothy F.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA; [Horton, Jay D.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Ahn, Yong-Ho] Yonsei Univ, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea; [Ahn, Sung-Min] Gachon Univ, Gil Hosp, Dept Translat Med, Inchon, South Korea	Gachon University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Samsung; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California Irvine; University of Texas System; University of Texas Southwestern Medical Center Dallas; Yonsei University; Yonsei University Health System; Gachon University	Jeong, YS (corresponding author), Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Dept Mol Med, Inchon, South Korea.	smahn@gachon.ac.kr; jycha@gachon.ac.kr	AHN, Yong Ho/H-6712-2017	AHN, Yong Ho/0000-0002-4133-0757; Jun, Hee-Sook/0000-0002-1166-4932; Im, Seung-Soon/0000-0002-2743-2108; Cha, JI-Young/0000-0002-8557-6214; Ahn, Sung-Min/0000-0002-5031-1929	Ministry of Education, Science and Technology [2010-0015289, 2010-0016469, 2009-0081789]	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology [2010-0015289, 2010-0016469 to J-Y C, 2009-0081789 to J-Y C and S-M A]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY TL, 2002, CURR PROTOC BIOINFOR, pCH2; Cairo S, 2001, HUM MOL GENET, V10, P617, DOI 10.1093/hmg/10.6.617; Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; Chen YQ, 1998, J BIOL CHEM, V273, P8225, DOI 10.1074/jbc.273.14.8225; Daniel S, 1996, J BIOL CHEM, V271, P14692, DOI 10.1074/jbc.271.25.14692; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; Dentin R, 2006, DIABETES, V55, P2159, DOI 10.2337/db06-0200; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Iizuka K, 2006, AM J PHYSIOL-ENDOC M, V291, pE358, DOI 10.1152/ajpendo.00027.2006; Iizuka K, 2008, BIOCHEM BIOPH RES CO, V374, P95, DOI 10.1016/j.bbrc.2008.06.101; Im SS, 2005, DIABETES, V54, P1684, DOI 10.2337/diabetes.54.6.1684; Ishii S, 2004, P NATL ACAD SCI USA, V101, P15597, DOI 10.1073/pnas.0405238101; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Jin VX, 2009, BIOINFORMATICS, V25, P3191, DOI 10.1093/bioinformatics/btp570; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Jover R, 2001, HEPATOLOGY, V33, P668, DOI 10.1053/jhep.2001.22176; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; Kurrasch DM, 2004, METHOD ENZYMOL, V389, P3; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li T, 2008, GASTROENTEROLOGY, V134, P1994, DOI 10.1053/j.gastro.2008.02.076; Long AD, 2001, J BIOL CHEM, V276, P19937, DOI 10.1074/jbc.M010192200; Ma L, 2005, J BIOL CHEM, V280, P12019, DOI 10.1074/jbc.M413063200; Ma L, 2007, NUCLEIC ACIDS RES, V35, P35, DOI 10.1093/nar/gkl987; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Mardis ER, 2007, NAT METHODS, V4, P613, DOI 10.1038/nmeth0807-613; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Noordeen NA, 2010, DIABETES, V59, P153, DOI 10.2337/db08-0868; Osborne TF, 2000, J BIOL CHEM, V275, P32379, DOI 10.1074/jbc.R000017200; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Sans CL, 2006, MOL CELL BIOL, V26, P4863, DOI 10.1128/MCB.00657-05; SHIH HM, 1995, J BIOL CHEM, V270, P21991, DOI 10.1074/jbc.270.37.21991; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stoeckman AK, 2004, J BIOL CHEM, V279, P15662, DOI 10.1074/jbc.M311301200; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tong XM, 2009, P NATL ACAD SCI USA, V106, P21660, DOI 10.1073/pnas.0911316106; Towle HC, 1997, ANNU REV NUTR, V17, P405, DOI 10.1146/annurev.nutr.17.1.405; Tsatsos NG, 2008, ENDOCRINOLOGY, V149, P5155, DOI 10.1210/en.2008-0215; Wederell ED, 2008, NUCLEIC ACIDS RES, V36, P4549, DOI 10.1093/nar/gkn382; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Yu FX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008397; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103	47	110	115	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22544	10.1371/journal.pone.0022544	http://dx.doi.org/10.1371/journal.pone.0022544			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811631	gold, Green Published			2022-12-25	WOS:000292956800068
J	Oliaro-Bosso, S; Caron, G; Taramino, S; Ermondi, G; Viola, F; Balliano, G				Oliaro-Bosso, Simonetta; Caron, Giulia; Taramino, Silvia; Ermondi, Giuseppe; Viola, Franca; Balliano, Gianni			Characterization of the Channel Constriction Allowing the Access of the Substrate to the Active Site of Yeast Oxidosqualene Cyclase	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI; SACCHAROMYCES-CEREVISIAE; DIRECTED MUTAGENESIS; ENZYME MECHANISMS; SQUALENE; INHIBITORS; DERIVATIVES; PROTEINS; DYNAMICS	In oxidosqualene cyclases (OSCs), an enzyme which has been extensively studied as a target for hypocholesterolemic or antifungal drugs, a lipophilic channel connects the surface of the protein with the active site cavity. Active site and channel are separated by a narrow constriction operating as a mobile gate for the substrate passage. In Saccharomyces cerevisiae OSC, two aminoacidic residues of the channel/constriction apparatus, Ala525 and Glu526, were previously showed as critical for maintaining the enzyme functionality. In this work sixteen novel mutants, each bearing a substitution at or around the channel constrictions, were tested for their enzymatic activity. Modelling studies showed that the most functionality-lowering substitutions deeply alter the H-bond network involving the channel/constriction apparatus. A rotation of Tyr239 is proposed as part of the mechanism permitting the access of the substrate to the active site. The inhibition of OSC by squalene was used as a tool for understanding whether the residues under study are involved in a pre-catalytic selection and docking of the substrate oxidosqualene.	[Oliaro-Bosso, Simonetta; Caron, Giulia; Taramino, Silvia; Ermondi, Giuseppe; Viola, Franca; Balliano, Gianni] Univ Turin, Fac Farm, Dipartimento Sci & Tecnol Farmaco, Turin, Italy	University of Turin	Oliaro-Bosso, S (corresponding author), Univ Turin, Fac Farm, Dipartimento Sci & Tecnol Farmaco, Turin, Italy.	gianni.balliano@unito.it		Ermondi, Giuseppe/0000-0003-3710-3102; Caron, Giulia/0000-0002-2417-5900	University of Turin (MIUR); regional government (Regione Piemonte)	University of Turin (MIUR)(Ministry of Education, Universities and Research (MIUR)); regional government (Regione Piemonte)(Regione Piemonte)	This study was supported by the University of Turin (MIUR ex 60%) and the regional government (Regione Piemonte). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Ausubel F. M., 2002, SHORT PROTOCOLS MOL; Balliano G, 2009, BIOORG MED CHEM LETT, V19, P718, DOI 10.1016/j.bmcl.2008.12.040; Ceruti M, 2001, LIPIDS, V36, P629, DOI 10.1007/s11745-001-0767-8; CERUTI M, 1987, EUR J MED CHEM, V22, P199, DOI 10.1016/0223-5234(87)90050-X; Corey EJ, 1996, BIOCHEM BIOPH RES CO, V219, P327, DOI 10.1006/bbrc.1996.0232; Doruker P, 2000, PROTEINS, V40, P512, DOI 10.1002/1097-0134(20000815)40:3<512::AID-PROT180>3.3.CO;2-D; FIELD RB, 1979, LIPIDS, V14, P741, DOI 10.1007/BF02533900; Milla P, 2002, EUR J BIOCHEM, V269, P2108, DOI 10.1046/j.1432-1033.2002.02861.x; Milla P, 2002, J BIOL CHEM, V277, P2406, DOI 10.1074/jbc.M104195200; Oliaro-Bosso S, 2005, BIOCHEM SOC T, V33, P1202, DOI 10.1042/BST0331202; Oliaro-Bosso S, 2005, LIPIDS, V40, P1257, DOI 10.1007/s11745-005-1493-y; Oliaro-Bosso S, 2005, CHEMBIOCHEM, V6, P2221, DOI 10.1002/cbic.200500107; Oliaro-Bosso S, 2004, LIPIDS, V39, P1007, DOI 10.1007/s11745-004-1323-2; Oliaro-Bosso S, 2009, J ENZYM INHIB MED CH, V24, P589, DOI [10.1080/14756360802318688, 10.1080/14756360802318688 ]; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Poralla K, 2004, CHEM BIOL, V11, P12, DOI 10.1016/j.chembiol.2003.01.008; Reinert DJ, 2004, CHEM BIOL, V11, P121, DOI 10.1016/j.chembiol.2003.12.013; Thoma R, 2004, NATURE, V432, P118, DOI 10.1038/nature02993; Vetting MW, 2000, STRUCTURE, V8, P429, DOI 10.1016/S0969-2126(00)00122-2; Wendt KU, 2005, ANGEW CHEM INT EDIT, V44, P3966, DOI 10.1002/anie.200500804; Wendt KU, 2000, ANGEW CHEM INT EDIT, V39, P2812, DOI 10.1002/1521-3773(20000818)39:16<2812::AID-ANIE2812>3.0.CO;2-#; Wendt KU, 1997, SCIENCE, V277, P1811, DOI 10.1126/science.277.5333.1811	23	6	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22134	10.1371/journal.pone.0022134	http://dx.doi.org/10.1371/journal.pone.0022134			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811565	Green Published, gold			2022-12-25	WOS:000292956800024
J	Andresen, E; Gunther, G; Bullwinkel, J; Lange, C; Heine, H				Andresen, Ellen; Guenther, Gunar; Bullwinkel, Joern; Lange, Christoph; Heine, Holger			Increased Expression of Beta-Defensin 1 (DEFB1) in Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							WIDE LINKAGE ANALYSIS; AIR-FLOW OBSTRUCTION; HUMAN BETA-DEFENSIN-1; HISTONE H3; ANTIMICROBIAL PEPTIDES; SPIROMETRIC PHENOTYPES; DNA METHYLATION; INNATE IMMUNITY; ACTIVE GENES; TRANSCRIPTION	On-going airway inflammation is characteristic for the pathophysiology of chronic obstructive pulmonary disease (COPD). However, the key factors determining the decrease in lung function, an important clinical parameter of COPD, are not clear. Genome-wide linkage analyses provide evidence for significant linkage to airway obstruction susceptibility loci on chromosome 8p23, the location of the human defensin gene cluster. Moreover, a genetic variation in the defensin beta 1 (DEFB1) gene was found to be associated with COPD. Therefore, we hypothesized that DEFB1 is differently regulated and expressed in human lungs during COPD progression. Gene expression of DEFB1 was assessed in bronchial epithelium and BAL fluid cells of healthy controls and patients with COPD and using bisulfite sequencing and ChIP analysis, the epigenetic control of DEFB1 mRNA expression was investigated. We can demonstrate that DEFB1 mRNA expression was significantly increased in bronchopulmonary specimen of patients with COPD (n = 34) vs. healthy controls (n = 10) (p<0.0001). Furthermore, a significant correlation could be detected between DEFB1 and functional parameters such as FEV(1) (p = 0.0024) and the FEV(1)/VC ratio (p = 0.0005). Upregulation of DEFB1 mRNA was paralleled by changes in HDAC1-3, HDAC5 and HDAC8 mRNA expression. Whereas bisulfite sequencing revealed no differences in the methylation state of DEFB1 promoter between patients with COPD and controls, ChIP analysis showed that enhanced DEFB1 mRNA expression was associated with the establishment of an active histone code. Thus, expression of human DEFB1 is upregulated and related to the decrease in pulmonary function in patients with COPD.	[Andresen, Ellen; Heine, Holger] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Innate Immun, Sect Immunoregulat, Borstel, Germany; [Guenther, Gunar; Lange, Christoph] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Clin Infect Dis, Dept Pneumol, Borstel, Germany; [Bullwinkel, Joern] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Immunoepigenet, Dept Immunol & Cell Biol, Borstel, Germany	Forschungszentrum Borstel; Forschungszentrum Borstel; Forschungszentrum Borstel	Andresen, E (corresponding author), Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Innate Immun, Sect Immunoregulat, Borstel, Germany.	hheine@fz-borstel.de	Lange, Christoph/J-6289-2012; Bullwinkel, Jörn/AAW-4318-2021; Heine, Holger/H-4552-2012; Günther, Gunar/ABC-6829-2021	Lange, Christoph/0000-0002-9691-4741; Bullwinkel, Jörn/0000-0002-7525-6057; Heine, Holger/0000-0001-8128-5068; Gunther, Gunar/0000-0002-2217-4322	German Research Council	German Research Council(German Research Foundation (DFG))	This work was supported by the German Research Council (H. Heine, C. Lange) and carried out as part of the SFB617 (project A23). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts AM, 2008, CELL MOL LIFE SCI, V65, P2069, DOI 10.1007/s00018-008-8035-0; ANTHONISEN NR, 1987, ANN INTERN MED, V106, P196, DOI 10.7326/0003-4819-106-2-196; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bose SK, 2009, MOL IMMUNOL, V46, P1140, DOI 10.1016/j.molimm.2008.11.004; Brinkman AB, 2007, NUCLEIC ACIDS RES, V35, P801, DOI 10.1093/nar/gkl1014; Brinkman AB, 2006, EMBO REP, V7, P628, DOI 10.1038/sj.embor.7400686; Bullard RS, 2008, MOL IMMUNOL, V45, P839, DOI 10.1016/j.molimm.2006.11.026; Bullwinkel J, 2006, J CELL PHYSIOL, V206, P624, DOI 10.1002/jcp.20494; Casanova C, 2005, AM J RESP CRIT CARE, V171, P591, DOI 10.1164/rccm.200407-867OC; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Chang SJ, 2007, NAT IMMUNOL, V8, P723, DOI 10.1038/ni1473; Delcuve GP, 2009, J CELL PHYSIOL, V219, P243, DOI 10.1002/jcp.21678; Demedts IK, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-53; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Harder J, 2007, J ENDOTOXIN RES, V13, P317, DOI 10.1177/0968051907088275; Haussinger K, 2004, Pneumologie, V58, P344; Hersh Craig P, 2006, COPD, V3, P189, DOI 10.1080/15412550601009321; Hu RC, 2004, CHINESE MED J-PEKING, V117, P1637; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Laubel DM, 2006, CURR TOP MICROBIOL, V306, P153; Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X; Liu LD, 1997, GENOMICS, V43, P316, DOI 10.1006/geno.1997.4801; Matsushita I, 2002, BIOCHEM BIOPH RES CO, V291, P17, DOI 10.1006/bbrc.2002.6395; Miranda TB, 2007, J CELL PHYSIOL, V213, P384, DOI 10.1002/jcp.21224; Mroz RM, 2007, J PHYSIOL PHARMACOL, V58, P453; Palmer LJ, 2003, HUM MOL GENET, V12, P1199, DOI 10.1093/hmg/ddg125; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rajendrasozhan S, 2008, ANTIOXID REDOX SIGN, V10, P799, DOI 10.1089/ars.2007.1938; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Silverman EK, 2002, AM J HUM GENET, V70, P1229, DOI 10.1086/340316; Silverman EK, 2002, HUM MOL GENET, V11, P623, DOI 10.1093/hmg/11.6.623; SPARKES RS, 1989, GENOMICS, V5, P240, DOI 10.1016/0888-7543(89)90052-9; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Valore EV, 1998, J CLIN INVEST, V101, P1633, DOI 10.1172/JCI1861; Vogelmeier C, 2007, Pneumologie, V61, pe1, DOI 10.1055/s-2007-959200; Wang A, 2002, SCIENCE, V298, P1412, DOI 10.1126/science.1077790; Waterborg JH, 2002, BIOCHEM CELL BIOL, V80, P363, DOI 10.1139/O02-080; Wiencke JK, 2008, ONCOGENE, V27, P2412, DOI 10.1038/sj.onc.1210895; Wood AM, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-130; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Zhang YJ, 2008, CURR MED CHEM, V15, P2840, DOI 10.2174/092986708786242796; Zhao CQ, 1996, FEBS LETT, V396, P319, DOI 10.1016/0014-5793(96)01123-4	50	56	58	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e21898	10.1371/journal.pone.0021898	http://dx.doi.org/10.1371/journal.pone.0021898			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21818276	gold, Green Published, Green Submitted			2022-12-25	WOS:000292929500017
J	Rudrabhatla, P; Jaffe, H; Pant, HC				Rudrabhatla, Parvathi; Jaffe, Howard; Pant, Harish C.			Direct evidence of phosphorylated neuronal intermediate filament proteins in neurofibrillary tangles (NFTs): phosphoproteomics of Alzheimer's NFTs	FASEB JOURNAL			English	Article						Tau; sarkosyl; AD brain	PAIRED HELICAL FILAMENTS; NEUROFILAMENT PROTEIN; PYRAMIDAL NEURONS; HYPERPHOSPHORYLATED-TAU; QUANTITATIVE-ANALYSIS; COGNITIVE IMPAIRMENT; STEREOLOGIC ANALYSIS; VULNERABLE SUBSET; DISEASE; ANTIBODIES	Alzheimer's disease (AD) is a neurodegenerative disorder characterized by brain pathology of intracellular neurofibrillary tangles (NFTs) and extracellular amyloid plaques. NFTs contain aberrantly hyperphosphorylated Tau as paired helical filaments (PHFs). Although NFs have been shown immunohistologically to be part of NFTs, there has been debate that the identity of NF proteins in NFTs is due to the cross-reactivity of phosphorylated NF antibodies with phospho-Tau. Here, we provide direct evidence on the identity of NFs in NFTs by immunochemical and mass spectrometric analysis. We have purified sarkosyl-insoluble NFTs and performed liquid chromatography/tandem mass spectrometry of NFT tryptic digests. The phosphoproteomics of NFTs clearly identified NF-M phosphopeptides SPVPKS*PVEEAK, corresponding to Ser685, and KAES*PVKEEAVAEVVTITK, corresponding to Ser736, and an NF-H phosphopeptide, EPDDAKAKEPS*KP, corresponding to Ser942. Western blotting of purified tangles with SMI31 showed a 150-kDa band corresponding to phospho-NF-M, while RT97 antibodies detected phospho-NF-H. The proteomics analysis also identified an NF-L peptide (ALYEQEIR, EAEEEKKVEGAGEEQAAAK) and another intermediate filament protein, vimentin (FADLSEAANR). Mass spectrometry revealed Tau phosphopeptides corresponding to Thr231, Ser235, Thr181, Ser184, Ser185, Thr212, Thr217, Ser396, and Ser403. And finally, phosphopeptides corresponding to MAP1B (corresponding to Ser1270, Ser1274, and Ser1779) and MAP2 (corresponding to Thr350, Ser1702, and Ser1706) were identified. In corresponding matched control preparations of PHF/NFTs, none of these phosphorylated neuronal cytoskeletal proteins were found. These studies independently demonstrate that NF proteins are an integral part of NFTs in AD brains.-Rudrabhatla, P., Jaffe, H., Pant, H. C. Direct evidence of phosphorylated neuronal intermediate filament proteins in neurofibrillary tangles (NFTs): phosphoproteomics of Alzheimer's NFTs. FASEB J. 25, 3896-3905 (2011). www.fasebj.org	[Pant, Harish C.] NINDS, Cytoskeletal Regulatory Prot Sect, Neurochem Lab, NIH, Bethesda, MD 20892 USA; [Jaffe, Howard] NINDS, Prot Peptide Sequencing Facil, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Pant, HC (corresponding author), NINDS, Cytoskeletal Regulatory Prot Sect, Neurochem Lab, NIH, Bldg 49,Rm 2A28, Bethesda, MD 20892 USA.	panth@ninds.nih.gov		Rudrabhatla, Parvathi/0000-0002-7537-3130	U.S. National Institute of Neurological Disorders and Stroke, National Institutes of Health; Dr. Philip Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002725] Funding Source: NIH RePORTER	U.S. National Institute of Neurological Disorders and Stroke, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Dr. Philip Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by the grants from the U.S. National Institute of Neurological Disorders and Stroke, National Institutes of Health. The authors acknowledge the Harvard Brain Resource Center (Boston, MA, USA) and the National Institute of Child Health and Human Development Brain and Tissue Bank (Bethesda, MD, USA) for providing human brain tissue. The authors thank Dr. Philip Grant for extensive editing and reviewing the manuscript.	Alonso AD, 2006, P NATL ACAD SCI USA, V103, P8864, DOI 10.1073/pnas.0603214103; Alzheimer A., 1907, ALLGEMEINE Z PSYCHIA, V64, P146, DOI DOI 10.1002/CA.980080612; ANDERTON BH, 1982, NATURE, V298, P84, DOI 10.1038/298084a0; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Ayala-Grosso C, 2006, NEUROSCIENCE, V141, P863, DOI 10.1016/j.neuroscience.2006.04.041; BIERER LM, 1995, ARCH NEUROL-CHICAGO, V52, P81, DOI 10.1001/archneur.1995.00540250089017; Bussiere T, 2003, J COMP NEUROL, V463, P281, DOI 10.1002/cne.10760; Bussiere T, 2003, NEUROSCIENCE, V117, P577, DOI 10.1016/S0306-4522(02)00942-9; DELACOURTE A, 1986, J NEUROL SCI, V76, P173, DOI 10.1016/0022-510X(86)90167-X; Dosemeci A, 2010, BIOCHEM BIOPH RES CO, V391, P78, DOI 10.1016/j.bbrc.2009.10.167; GAMBETTI P, 1983, LAB INVEST, V49, P430; Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; Goedert M., 1997, MOL GENETIC BASIS NE, P613; GomezIsla T, 1996, J NEUROSCI, V16, P4491; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1984, ACTA NEUROPATHOL, V62, P259, DOI 10.1007/BF00687607; GRUNDKEIQBAL I, 1979, ANN NEUROL, V6, P532, DOI 10.1002/ana.410060612; Guillozet AL, 2003, ARCH NEUROL-CHICAGO, V60, P729, DOI 10.1001/archneur.60.5.729; Hanger DP, 2007, J BIOL CHEM, V282, P23645, DOI 10.1074/jbc.M703269200; HOF PR, 1990, J COMP NEUROL, V301, P44, DOI 10.1002/cne.903010105; HOF PR, 1990, J COMP NEUROL, V301, P55, DOI 10.1002/cne.903010106; IHARA Y, 1981, P JPN ACAD B-PHYS, V57, P152, DOI 10.2183/pjab.57.152; IQBAL K, 1984, ACTA NEUROPATHOL, V62, P167, DOI 10.1007/BF00691849; IQBAL K, 1974, BRAIN RES, V77, P337, DOI 10.1016/0006-8993(74)90798-7; ISHII T, 1979, ACTA NEUROPATHOL, V48, P105, DOI 10.1007/BF00691151; Johnson GVW, 2004, J CELL SCI, V117, P5721, DOI 10.1242/jcs.01558; Kelleher I, 2007, J NEUROCHEM, V103, P2256, DOI 10.1111/j.1471-4159.2007.04930.x; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; Kimura T, 2007, EMBO J, V26, P5143, DOI 10.1038/sj.emboj.7601917; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; KOSIK KS, 1984, BIOCHEM INT, V9, P483; KSIEZAKREDING H, 1987, P NATL ACAD SCI USA, V84, P3410, DOI 10.1073/pnas.84.10.3410; Lee VMY, 1999, METHOD ENZYMOL, V309, P81; Mazanetz MP, 2007, NAT REV DRUG DISCOV, V6, P464, DOI 10.1038/nrd2111; MILLER CCJ, 1986, EMBO J, V5, P269, DOI 10.1002/j.1460-2075.1986.tb04209.x; Mitchell TW, 2002, ANN NEUROL, V51, P182, DOI 10.1002/ana.10086; Morrison JH, 2002, PROG BRAIN RES, V136, P467; MORRISON JH, 1987, BRAIN RES, V416, P331, DOI 10.1016/0006-8993(87)90914-0; NUKINA N, 1987, P NATL ACAD SCI USA, V84, P3415, DOI 10.1073/pnas.84.10.3415; NUKINA N, 1986, J BIOCHEM-TOKYO, V99, P1541, DOI 10.1093/oxfordjournals.jbchem.a135625; PERRY G, 1985, P NATL ACAD SCI USA, V82, P3916, DOI 10.1073/pnas.82.11.3916; Rudrabhatla P, 2011, ADV NEUROBIOL, V3, P627, DOI 10.1007/978-1-4419-6787-9_26; Rudrabhatla P, 2010, FASEB J, V24, P4396, DOI 10.1096/fj.10-157859; SACHER MG, 1992, BIOCHEM BIOPH RES CO, V186, P524, DOI 10.1016/S0006-291X(05)80839-3; SELKOE DJ, 1982, SCIENCE, V215, P1243, DOI 10.1126/science.6120571; Sengupta A, 1998, ARCH BIOCHEM BIOPHYS, V357, P299, DOI 10.1006/abbi.1998.0813; Shea TB, 1997, J NEUROSCI RES, V48, P515, DOI 10.1002/(SICI)1097-4547(19970615)48:6<515::AID-JNR4>3.0.CO;2-D; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STERNBERGER LA, 1983, P NATL ACAD SCI-BIOL, V80, P6126, DOI 10.1073/pnas.80.19.6126; STERNBERGER NH, 1985, P NATL ACAD SCI USA, V82, P4274, DOI 10.1073/pnas.82.12.4274; Stone K. L., 1993, PRACTICAL GUIDE PROT, P43; Wu J, 2007, J PROTEOME RES, V6, P4684, DOI 10.1021/pr070481m	54	79	84	0	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2011	25	11					3896	3905		10.1096/fj.11-181297	http://dx.doi.org/10.1096/fj.11-181297			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	844BT	21828286	Green Published			2022-12-25	WOS:000296723100014
J	Alvarez-Fernandez, M; Halim, VA; Aprelia, M; Mohammed, S; Medema, RH				Alvarez-Fernandez, Monica; Halim, Vincentius A.; Aprelia, Melinda; Mohammed, Shabaz; Medema, Rene H.			Protein Phosphatase 2A (B55 alpha) Prevents Premature Activation of Forkhead Transcription Factor FoxM1 by Antagonizing Cyclin A/Cyclin-dependent Kinase-mediated Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; MITOTIC EXIT; IDENTIFICATION; COMPLEXES; PROGRAM; BINDING; DOMAIN	The forkhead transcription factor FoxM1 controls expression of a large number of genes that are specifically expressed during the G(2) phase of the cell cycle. Throughout most of the cell cycle, FoxM1 activity is restrained by an autoinhibitory mechanism, involving a repressor domain present in the N-terminal part of the protein. Activation of FoxM1 in G(2) is achieved by Cyclin A/Cyclin-dependent kinase (Cdk)-mediated phosphorylation, which alleviates autoinhibition by the N-terminal repressor domain. Here, we show that FoxM1 interacts with B55 alpha, a regulatory subunit of protein phosphatase 2A (PP2A). B55 alpha binds the catalytic subunit of PP2A, and this promotes dephosphorylation and inactivation of FoxM1. Indeed, we find that overexpression of B55 alpha results in decreased FoxM1 activity. Inversely, depletion of B55 alpha results in premature activation of FoxM1. The activation of FoxM1 that is observed upon depletion of B55 alpha is fully dependent on Cyclin A/Cdk-mediated phosphorylation of FoxM1. Taken together, these data demonstrate that B55 alpha acts to antagonize Cyclin A/Cdk-dependent activation of FoxM1, to ensure that FoxM1 activity is restricted to the G(2) phase of the cell cycle.	[Alvarez-Fernandez, Monica; Halim, Vincentius A.; Aprelia, Melinda; Medema, Rene H.] UMC Utrecht, Dept Med Oncol, NL-3584 CG Utrecht, Netherlands; [Alvarez-Fernandez, Monica; Halim, Vincentius A.; Aprelia, Melinda; Medema, Rene H.] UMC Utrecht, Canc Genom Ctr, NL-3584 CG Utrecht, Netherlands; [Halim, Vincentius A.; Mohammed, Shabaz] Univ Utrecht, Biomol Mass Spectrometry & Prote Grp, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Halim, Vincentius A.; Mohammed, Shabaz] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Netherlands Prote Ctr, NL-3584 CH Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University	Medema, RH (corresponding author), UMC Utrecht, Dept Med Oncol, Univ Weg 100,Stratenum 2-118, NL-3584 CG Utrecht, Netherlands.	r.h.medema@umcutrecht.nl	Fernández, Mónica Alvarez/C-5972-2009; Medema, Rene H/E-2981-2013; Mohammed, Shabaz/D-1042-2010; Mohammed, Shabaz/AAY-6313-2020	Fernández, Mónica Alvarez/0000-0002-6454-5128; Mohammed, Shabaz/0000-0003-2640-9560; Mohammed, Shabaz/0000-0003-2640-9560; Medema, Rene/0000-0002-6754-0381	Dutch Cancer Society [UU-2007-3826]; Netherlands Genomic Initiative of Netherlands Organization for Scientific Research	Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Genomic Initiative of Netherlands Organization for Scientific Research	This work was supported by Dutch Cancer Society Grant UU-2007-3826) and The Netherlands Genomic Initiative of Netherlands Organization for Scientific Research.	Alvarez-Fernandez M, 2010, EMBO REP, V11, P452, DOI 10.1038/embor.2010.46; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Chae HD, 2004, ONCOGENE, V23, P4084, DOI 10.1038/sj.onc.1207482; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Futcher B, 2002, CURR OPIN CELL BIOL, V14, P676, DOI 10.1016/S0955-0674(02)00391-5; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Laoukili J, 2008, CELL CYCLE, V7, P2720, DOI 10.4161/cc.7.17.6580; Laoukili J, 2008, MOL CELL BIOL, V28, P3076, DOI 10.1128/MCB.01710-07; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; Mortensen P, 2010, J PROTEOME RES, V9, P393, DOI 10.1021/pr900721e; Park HJ, 2008, ONCOGENE, V27, P1696, DOI 10.1038/sj.onc.1210814; Pinkse MWH, 2008, J PROTEOME RES, V7, P687, DOI 10.1021/pr700605z; Saville MK, 1998, ONCOGENE, V17, P2679, DOI 10.1038/sj.onc.1202503; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2	22	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33029	33036		10.1074/jbc.M111.253724	http://dx.doi.org/10.1074/jbc.M111.253724			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21813648	Green Published, hybrid			2022-12-25	WOS:000294968800021
J	Prejean, J; Song, RG; Hernandez, A; Ziebell, R; Green, T; Walker, F; Lin, LS; An, Q; Mermin, J; Lansky, A; Hall, HI				Prejean, Joseph; Song, Ruiguang; Hernandez, Angela; Ziebell, Rebecca; Green, Timothy; Walker, Frances; Lin, Lillian S.; An, Qian; Mermin, Jonathan; Lansky, Amy; Hall, H. Irene		HIV Incidence Surveillance Grp	Estimated HIV Incidence in the United States, 2006-2009	PLOS ONE			English	Article							HIV/AIDS SURVEILLANCE DATA; INFECTION; TRANSMISSION	Background: The estimated number of new HIV infections in the United States reflects the leading edge of the epidemic. Previously, CDC estimated HIV incidence in the United States in 2006 as 56,300 (95% CI: 48,200-64,500). We updated the 2006 estimate and calculated incidence for 2007-2009 using improved methodology. Methodology: We estimated incidence using incidence surveillance data from 16 states and 2 cities and a modification of our previously described stratified extrapolation method based on a sample survey approach with multiple imputation, stratification, and extrapolation to account for missing data and heterogeneity of HIV testing behavior among population groups. Principal Findings: Estimated HIV incidence among persons aged 13 years and older was 48,600 (95% CI: 42,400-54,700) in 2006, 56,000 (95% CI: 49,100-62,900) in 2007, 47,800 (95% CI: 41,800-53,800) in 2008 and 48,100 (95% CI: 42,200-54,000) in 2009. From 2006 to 2009 incidence did not change significantly overall or among specific race/ethnicity or risk groups. However, there was a 21% (95% CI: 1.9%-39.8%; p = 0.017) increase in incidence for people aged 13-29 years, driven by a 34% (95% CI: 8.4%-60.4%) increase in young men who have sex with men (MSM). There was a 48% increase among young black/African American MSM (12.3%-83.0%; p < 0.001). Among people aged 13-29, only MSM experienced significant increases in incidence, and among 13-29 year-old MSM, incidence increased significantly among young, black/African American MSM. In 2009, MSM accounted for 61% of new infections, heterosexual contact 27%, injection drug use (IDU) 9%, and MSM/IDU 3%. Conclusions/Significance: Overall, HIV incidence in the United States was relatively stable 2006-2009; however, among young MSM, particularly black/African American MSM, incidence increased. HIV continues to be a major public health burden, disproportionately affecting several populations in the United States, especially MSM and racial and ethnic minorities. Expanded, improved, and targeted prevention is necessary to reduce HIV incidence.	[Prejean, Joseph; Song, Ruiguang; Hernandez, Angela; Green, Timothy; Walker, Frances; Lin, Lillian S.; An, Qian; Mermin, Jonathan; Lansky, Amy; Hall, H. Irene] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, Atlanta, GA 30333 USA; [Ziebell, Rebecca] Ginn Grp, Peachtree City, GA USA	Centers for Disease Control & Prevention - USA	Prejean, J (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, Atlanta, GA 30333 USA.	nzp1@cdc.gov	Mermin, Jonathan/J-9847-2012		Centers for Disease Control and Prevention (CDC)	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The Centers for Disease Control and Prevention (CDC) provides funding to state and local health departments to conduct surveillance of HIV disease in accordance with their own disease reporting regulations. CDC provides technical guidance for the collection of data by the state and local health departments and data are sent to CDC for national-level analyses. The analysis methods for this manuscript were developed by CDC. CDC makes all decisions regarding the publication of national surveillance data as a means to describe the HIV epidemic. The Ginn Group, Peachtree City, Georgia, United States of America, a subcontractor of the Northrop Grumman Corporation, employs Rebecca Ziebell and provided scientific analysis services as directed by CDC through a contract with CDC.	Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P681; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Campsmith ML, 2010, JAIDS-J ACQ IMM DEF, V53, P619, DOI 10.1097/QAI.0b013e3181bf1c45; *CDCP, 2007, US BED HIV 1 CAPT EI; Centers for Disease Control and Prevention, 2010, HIV SURV REP 2008, V20; Durant T., 2007, Morbidity and Mortality Weekly Report, V56, P189; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Harrison KM, 2008, PUBLIC HEALTH REP, V123, P618, DOI 10.1177/003335490812300512; Holtgrave DR, 2009, JAIDS-J ACQ IMM DEF, V50, P236, DOI 10.1097/QAI.0b013e31819001be; Jansen I, 2010, 2010 C RETR OPP INF; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Karon JM, 2008, STAT MED, V27, P4617, DOI 10.1002/sim.3144; KLEINBAUM DG, 1988, APPL REGRESSION ANAL, P266; Le Vu S, 2010, 2010 C RETR OPP INF; Lee LM, 2007, PUBLIC HEALTH REP, V122, P72, DOI 10.1177/00333549071220S111; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Parekh BS, 2010, AIDS RES HUM RETROV, DOI [10.1089/aid.2010.0159, DOI 10.1089/AID.2010.0159]; Prejean J., 2008, Morbidity and Mortality Weekly Report, V57, P985; PURCELL DW, 2010, 2010 NAT STD PREV C; Song RG, 2005, STAT MED, V24, P453, DOI 10.1002/sim.1935; Sullivan PS, 2009, ANN EPIDEMIOL, V19, P423, DOI 10.1016/j.annepidem.2009.03.004; *UNAIDS, 2005, M UNAIDS REF GROUP E; US Census Bureau, 2009, POP EST ENT DAT SET; Zetola NM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002591	25	738	750	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e17502	10.1371/journal.pone.0017502	http://dx.doi.org/10.1371/journal.pone.0017502			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826193	Green Submitted, Green Published, gold			2022-12-25	WOS:000293558900001
J	Schrimpf, JE; Tu, EM; Wang, H; Wong, YM; Morrison, LA				Schrimpf, Jane E.; Tu, Eleain M.; Wang, Hong; Wong, Yee M.; Morrison, Lynda A.			B7 Costimulation Molecules Encoded by Replication-Defective, vhs-Deficient HSV-1 Improve Vaccine-Induced Protection against Corneal Disease	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; CD8(+) T-CELLS; HOST SHUTOFF VHS; MHC CLASS-II; TYPE-1 HSV-1; TRIGEMINAL GANGLION; IMMUNE-RESPONSES; GLYCOPROTEIN-B; C57BL/6 MICE; INFECTION	Herpes simplex virus 1 (HSV-1) causes herpes stromal keratitis (HSK), a sight-threatening disease of the cornea for which no vaccine exists. A replication-defective, HSV-1 prototype vaccine bearing deletions in the genes encoding ICP8 and the virion host shutoff (vhs) protein reduces HSV-1 replication and disease in a mouse model of HSK. Here we demonstrate that combining deletion of ICP8 and vhs with virus-based expression of B7 costimulation molecules created a vaccine strain that enhanced T cell responses to HSV-1 compared with the ICP8(-)vhs(-) parental strain, and reduced the incidence of keratitis and acute infection of the nervous system after corneal challenge. Post-challenge T cell infiltration of the trigeminal ganglia and antigen-specific recall responses in local lymph nodes correlated with protection. Thus, B7 costimulation molecules expressed from the genome of a replication-defective, ICP8(-)vhs(-) virus enhance vaccine efficacy by further reducing HSK.	[Schrimpf, Jane E.; Tu, Eleain M.; Wang, Hong; Wong, Yee M.; Morrison, Lynda A.] St Louis Univ Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA	Saint Louis University	Schrimpf, JE (corresponding author), St Louis Univ Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA.	morrisla@slu.edu			National Institutes of Health [R21EY016447]; research division of Fight for Sight [GA02020]; NATIONAL EYE INSTITUTE [R21EY016447] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); research division of Fight for Sight; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by award R21EY016447 from the National Institutes of Health http://www.nih.gov/, a Grant in Aid GA02020 from the research division of Fight for Sight http://www.fightforsight.org/, and institutional funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awasthi S, 2008, VACCINE, V26, P1195, DOI 10.1016/j.vaccine.2007.12.032; Banerjee K, 2005, J LEUKOCYTE BIOL, V77, P24, DOI 10.1189/jlb.0904486; Banerjee K, 2004, J IMMUNOL, V173, P7575, DOI 10.4049/jimmunol.173.12.7575; Bettahi I, 2007, INVEST OPHTH VIS SCI, V48, P4643, DOI 10.1167/iovs.07-0356; BONNEAU RH, 1993, VIROLOGY, V195, P62, DOI 10.1006/viro.1993.1346; Borriello F, 1997, IMMUNITY, V6, P303, DOI 10.1016/S1074-7613(00)80333-7; Brehm MA, 1997, J VIROL, V71, P3534, DOI 10.1128/JVI.71.5.3534-3544.1997; Cotter CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008684; Dambach MJ, 2006, MOL THER, V13, P891, DOI 10.1016/j.ymthe.2006.02.006; Dana MR, 2000, CORNEA, V19, P625, DOI 10.1097/00003226-200009000-00008; Dasgupta G, 2009, EXPERT REV VACCINES, V8, P1023, DOI 10.1586/ERV.09.60; Dudek T, 2006, VIROLOGY, V344, P230, DOI 10.1016/j.virol.2005.09.020; Emtage PCR, 1998, J IMMUNOL, V160, P2531; Frank GM, 2010, J IMMUNOL, V184, P277, DOI 10.4049/jimmunol.0902373; Frye TD, 2002, ARCH VIROL, V147, P1747, DOI 10.1007/s00705-002-0830-6; Gangappa S, 2000, INVEST OPHTH VIS SCI, V41, P453; Gangappa S, 1998, J IMMUNOL, V161, P4289; GAO M, 1989, J VIROL, V63, P5258, DOI 10.1128/JVI.63.12.5258-5267.1989; Geiss BJ, 2000, J VIROL, V74, P11137, DOI 10.1128/JVI.74.23.11137-11144.2000; HANKE T, 1991, J VIROL, V65, P1177, DOI 10.1128/JVI.65.3.1177-1186.1991; He JC, 1999, J INTERF CYTOK RES, V19, P609, DOI 10.1089/107999099313749; Hodge JW, 2005, J IMMUNOL, V174, P5994, DOI 10.4049/jimmunol.174.10.5994; HOGGAN MD, 1959, AM J HYG, V70, P208, DOI 10.1093/oxfordjournals.aje.a120071; Inoue T, 2000, INVEST OPHTH VIS SCI, V41, P4209; JANEWAY CA, 1994, CELL, V76, P275, DOI 10.1016/0092-8674(94)90335-2; KNIPE DM, 1982, J VIROL, V43, P314, DOI 10.1128/JVI.43.1.314-324.1982; Lang A, 2005, J IMMUNOL, V174, P2919, DOI 10.4049/jimmunol.174.5.2919; LAVAIL JH, 1993, J COMP NEUROL, V327, P133, DOI 10.1002/cne.903270111; Lee YS, 2006, CLIN CANCER RES, V12, P5859, DOI 10.1158/1078-0432.CCR-06-0935; LIESEGANG TJ, 1989, ARCH OPHTHALMOL-CHIC, V107, P1155, DOI 10.1001/archopht.1989.01070020221029; Liu T, 2000, J EXP MED, V191, P1459, DOI 10.1084/jem.191.9.1459; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marti WR, 1997, J IMMUNOL METHODS, V200, P191, DOI 10.1016/S0022-1759(96)00210-4; McAdam AJ, 2000, J VIROL, V74, P203, DOI 10.1128/JVI.74.1.203-208.2000; Morrison LA, 1996, VIROLOGY, V220, P402, DOI 10.1006/viro.1996.0328; Morrison LA, 1998, VIROLOGY, V243, P178, DOI 10.1006/viro.1998.9047; Morrison LA, 1997, VIROLOGY, V239, P315, DOI 10.1006/viro.1997.8884; MORRISON LA, 1994, J VIROL, V68, P689, DOI 10.1128/JVI.68.2.689-696.1994; Mosca JD, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-32; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mott KR, 2009, J VIROL, V83, P2246, DOI 10.1128/JVI.02234-08; Oertli D, 1997, CLIN EXP IMMUNOL, V110, P144, DOI 10.1046/j.1365-2249.1997.5061405.x; Osorio Y, 2005, J VIROL, V79, P3297, DOI 10.1128/JVI.79.6.3297-3308.2005; Osorio Y, 2004, INVEST OPHTH VIS SCI, V45, P506, DOI 10.1167/iovs.03-0828; Panoutsakopoulou V, 2001, IMMUNITY, V15, P137, DOI 10.1016/S1074-7613(01)00172-8; Petrulio CA, 2006, EXPERT REV VACCINES, V5, P9, DOI 10.1586/14760584.5.1.9; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prechtel AT, 2005, J GEN VIROL, V86, P1645, DOI 10.1099/vir.0.80852-0; Ramachandran S, 2010, J VIROL, V84, P8811, DOI 10.1128/JVI.00496-10; Samady L, 2003, J VIROL, V77, P3768, DOI 10.1128/JVI.77.6.3768-3776.2003; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sheridan BS, 2007, EXPERT OPIN BIOL TH, V7, P1323, DOI 10.1517/14712598.7.9.1323; STRELOW LI, 1995, J VIROL, V69, P6779, DOI 10.1128/JVI.69.11.6779-6786.1995; Stuart PM, 2004, J GEN VIROL, V85, P2055, DOI 10.1099/vir.0.80049-0; Thebeau LG, 2002, J VIROL, V76, P2563, DOI 10.1128/JVI.76.5.2563-2566.2002; Thebeau LG, 2007, J VIROL, V81, P12200, DOI 10.1128/JVI.01224-07; Tigges MA, 1996, J IMMUNOL, V156, P3901; Todo T, 2001, CANCER RES, V61, P153; Vagvala SP, 2009, J VIROL, V83, P953, DOI 10.1128/JVI.02022-08; VALYINAGY T, 1991, J VIROL, V65, P4142, DOI 10.1128/JVI.65.8.4142-4152.1991; Walker J, 1998, VACCINE, V16, P1, DOI 10.1016/S0264-410X(97)00164-3; Wallace ME, 1999, J VIROL, V73, P7619, DOI 10.1128/JVI.73.9.7619-7626.1999; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964; Zajac P, 1998, CANCER RES, V58, P4567	64	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22772	10.1371/journal.pone.0022772	http://dx.doi.org/10.1371/journal.pone.0022772			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826207	Green Submitted, Green Published, gold			2022-12-25	WOS:000293558900033
J	Godri, KJ; Harrison, RM; Evans, T; Baker, T; Dunster, C; Mudway, IS; Kelly, FJ				Godri, Krystal J.; Harrison, Roy M.; Evans, Tim; Baker, Timothy; Dunster, Christina; Mudway, Ian S.; Kelly, Frank J.			Increased Oxidative Burden Associated with Traffic Component of Ambient Particulate Matter at Roadside and Urban Background Schools Sites in London	PLOS ONE			English	Article							AIR-POLLUTION; RESPIRATORY SYMPTOMS; TRANSITION-METALS; CELL-CULTURE; IN-VIVO; PARTICLES; EMISSIONS; EXHAUST; EXPOSURE; PM2.5	As the incidence of respiratory and allergic symptoms has been reported to be increased in children attending schools in close proximity to busy roads, it was hypothesised that PM from roadside schools would display enhanced oxidative potential (OP). Two consecutive one-week air quality monitoring campaigns were conducted at seven school sampling sites, reflecting roadside and urban background in London. Chemical characteristics of size fractionated particulate matter (PM) samples were related to the capacity to drive biological oxidation reactions in a synthetic respiratory tract lining fluid. Contrary to hypothesised contrasts in particulate OP between school site types, no robust size-fractionated differences in OP were identified due high temporal variability in concentrations of PM components over the one-week sampling campaigns. For OP assessed both by ascorbate (OPAA m(-3)) and glutathione (OPGSH m 23) depletion, the highest OP per cubic metre of air was in the largest size fraction, PM1.9-10.2. However, when expressed per unit mass of particles OPAA mu g(-1) showed no significant dependence upon particle size, while OPGSH mu g(-1) had a tendency to increase with increasing particle size, paralleling increased concentrations of Fe, Ba and Cu. The two OP metrics were not significantly correlated with one another, suggesting that the glutathione and ascorbate depletion assays respond to different components of the particles. Ascorbate depletion per unit mass did not show the same dependence as for GSH and it is possible that other trace metals (Zn, Ni, V) or organic components which are enriched in the finer particle fractions, or the greater surface area of smaller particles, counter-balance the redox activity of Fe, Ba and Cu in the coarse particles. Further work with longer-term sampling and a larger suite of analytes is advised in order to better elucidate the determinants of oxidative potential, and to fuller explore the contrasts between site types.	[Godri, Krystal J.; Harrison, Roy M.; Evans, Tim] Univ Birmingham, Sch Geog Earth & Environm Sci, Div Environm Hlth & Risk Management, Birmingham, W Midlands, England; [Godri, Krystal J.; Baker, Timothy; Dunster, Christina; Mudway, Ian S.; Kelly, Frank J.] Kings Coll London, Sch Biomed & Hlth Sci, MRC HPA Ctr Environm Hlth, London WC2R 2LS, England	University of Birmingham; Imperial College London; University of London; King's College London	Godri, KJ (corresponding author), Univ Birmingham, Sch Geog Earth & Environm Sci, Div Environm Hlth & Risk Management, Birmingham, W Midlands, England.	r.m.harrison@bham.ac.uk	Kelly, Frank/ABG-3411-2021; Kelly, Frank J/C-6125-2009; Harrison, Roy M/A-2256-2008	Kelly, Frank/0000-0003-2558-8392; Kelly, Frank J/0000-0003-2558-8392; Harrison, Roy M/0000-0002-2684-5226; Mudway, Ian/0000-0003-1239-5014; Godri Pollitt, Krystal/0000-0001-7332-2228	NERC; MRC; Medical Research Council [G1000758, G0801056B, G1000758B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish; Natural Environment Research Council [ncas10006, NE/E008739/1, NE/E008798/1] Funding Source: researchfish; NERC [ncas10006, NE/E008739/1, NE/E008798/1] Funding Source: UKRI	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding for this study was received from NERC and MRC under the Environment and Human Health Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER MA, 1990, ANAL BIOCHEM, V190, P360, DOI 10.1016/0003-2697(90)90208-Q; Birmili W, 2006, ENVIRON SCI TECHNOL, V40, P1144, DOI 10.1021/es0486925; Capaldo K, 1999, NATURE, V400, P743, DOI 10.1038/23438; CHURCH TM, 1988, LONG RANGE ATMOSPHER, P37; Corbett JJ, 1997, SCIENCE, V278, P823, DOI 10.1126/science.278.5339.823; Costa DL, 1997, ENVIRON HEALTH PERSP, V105, P1053, DOI 10.2307/3433509; Dalsoren SB, 2009, ATMOS CHEM PHYS, V9, P2171, DOI 10.5194/acp-9-2171-2009; Deacon AR, 1997, SCI TOTAL ENVIRON, V203, P17, DOI 10.1016/S0048-9697(97)00130-7; *DETR, 1999, ATMOS ENVIRON, V35, P4581; DOYLE IR, 1994, AM J RESP CELL MOL, V11, P405, DOI 10.1165/ajrcmb.11.4.7917309; Dreher KL, 1997, J TOXICOL ENV HEALTH, V50, P285, DOI 10.1080/009841097160492; Fuller GW, 2006, ATMOS ENVIRON, V40, P6134, DOI 10.1016/j.atmosenv.2006.05.031; Gauderman WJ, 2007, LANCET, V369, P571, DOI 10.1016/S0140-6736(07)60037-3; Gietl JK, 2010, ATMOS ENVIRON, V44, P141, DOI 10.1016/j.atmosenv.2009.10.016; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Halliwell B, 2003, FEBS LETT, V540, P3, DOI 10.1016/S0014-5793(03)00235-7; Harrison RM, 1997, ATMOS ENVIRON, V31, P3309, DOI 10.1016/S1352-2310(97)00152-0; Harrison RM, 1997, ATMOS ENVIRON, V31, P4103, DOI 10.1016/S1352-2310(97)00296-3; HATCH GE, 1985, ENVIRON RES, V36, P67, DOI 10.1016/0013-9351(85)90008-8; HUANG XD, 1994, ATMOS ENVIRON, V28, P1385, DOI 10.1016/1352-2310(94)90201-1; Imhof D, 2005, ATMOS ENVIRON, V39, P5710, DOI 10.1016/j.atmosenv.2004.07.036; IRIYAMA K, 1984, ANAL BIOCHEM, V141, P238, DOI 10.1016/0003-2697(84)90451-2; ISAKSEN I, 2001, ATMOS ENVIRON, V35, P3659; Islam T, 2007, THORAX, V62, P957, DOI 10.1136/thx.2007.078964; Janssen NAH, 2003, ENVIRON HEALTH PERSP, V111, P1512, DOI 10.1289/ehp.6243; Katsouyanni K, 2001, EPIDEMIOLOGY, V12, P521, DOI 10.1097/00001648-200109000-00011; KELLY F, 2009, CONGESTION CHARGING; Kunzli N, 2006, ENVIRON HEALTH PERSP, V114, P684, DOI 10.1289/ehp.8584; Li N, 2002, INHAL TOXICOL, V14, P459, DOI 10.1080/089583701753678571; Miller CA, 1998, COMBUST SCI TECHNOL, V134, P477, DOI 10.1080/00102209808924146; Nawrot TS, 2009, ATMOS ENVIRON, V43, P4595, DOI 10.1016/j.atmosenv.2009.06.010; Nel A E, 2001, Curr Opin Pulm Med, V7, P20, DOI 10.1097/00063198-200101000-00004; Nicolai T, 2003, EUR RESPIR J, V21, P956, DOI 10.1183/09031936.03.00041103a; Pakkanen TA, 2003, ATMOS ENVIRON, V37, P1673, DOI 10.1016/S1352-2310(03)00011-6; Pourazar J, 2005, AM J PHYSIOL-LUNG C, V289, pL724, DOI 10.1152/ajplung.00055.2005; Pritchard RJ, 1996, INHAL TOXICOL, V8, P457, DOI 10.3109/08958379609005440; SAMET JM, 2000, NATL MORBIDITY MOR 2; Sekine K, 2004, OCCUP ENVIRON MED, V61, P350, DOI 10.1136/oem.2002.005934; SORME L, 2001, WATER AIR SOIL POLL, V1, P213, DOI DOI 10.1023/A:1017516523915; vanVliet P, 1997, ENVIRON RES, V74, P122, DOI 10.1006/enrs.1997.3757; Wessels A, 2010, ENVIRON SCI TECHNOL, V44, P3539, DOI 10.1021/es9036226; WESTERLUND KG, 2001, SL INFRATEKNIK AB, V3; WJST M, 1993, BRIT MED J, V307, P596, DOI 10.1136/bmj.307.6904.596; Zanobetti A, 2002, EPIDEMIOLOGY, V13, P87, DOI 10.1097/00001648-200201000-00014; Zielinski H, 1999, AM J PHYSIOL-LUNG C, V277, pL719, DOI 10.1152/ajplung.1999.277.4.L719	45	92	94	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e21961	10.1371/journal.pone.0021961	http://dx.doi.org/10.1371/journal.pone.0021961			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818283	Green Published, gold, Green Submitted			2022-12-25	WOS:000293282700013
J	Heijmans, J; Muncan, V; Jacobs, RJ; de Jonge-Muller, ESM; Graven, L; Biemond, I; Ederveen, AG; Groothuis, PG; Mosselman, S; Hardwick, JC; Hommes, DW; van den Brink, GR				Heijmans, Jarom; Muncan, Vanesa; Jacobs, Rutger J.; de Jonge-Muller, Eveline S. M.; Graven, Laura; Biemond, Izak; Ederveen, Antwan G.; Groothuis, Patrick G.; Mosselman, Sietse; Hardwick, James C.; Hommes, Daniel W.; van den Brink, Gijs R.			Intestinal Tumorigenesis Is Not Affected by Progesterone Signaling in Rodent Models	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; ESTROGEN PLUS PROGESTIN; COLON-CANCER; MEDROXYPROGESTERONE ACETATE; POSTMENOPAUSAL WOMEN; COLORECTAL-CANCER; TUMOR PROGRESSION; RECEPTOR KNOCKOUT; MAMMARY-GLAND; MOUSE MODELS	Clinical data suggest that progestins have chemopreventive properties in the development of colorectal cancer. We set out to examine a potential protective effect of progestins and progesterone signaling on colon cancer development. In normal and neoplastic intestinal tissue, we found that the progesterone receptor (PR) is not expressed. Expression was confined to sporadic mesenchymal cells. To analyze the influence of systemic progesterone receptor signaling, we crossed mice that lacked the progesterone receptor (PRKO) to the Apc(Min/+) mouse, a model for spontaneous intestinal polyposis. PRKO-Apc(Min/+) mice exhibited no change in polyp number, size or localization compared to Apc(Min/+). To examine effects of progestins on the intestinal epithelium that are independent of the PR, we treated mice with MPA. We found no effects of either progesterone or MPA on gross intestinal morphology or epithelial proliferation. Also, in rats treated with MPA, injection with the carcinogen azoxymethane did not result in a difference in the number or size of aberrant crypt foci, a surrogate end-point for adenoma development. We conclude that expression of the progesterone receptor is limited to cells in the intestinal mesenchyme. We did not observe any effect of progesterone receptor signaling or of progestin treatment in rodent models of intestinal tumorigenesis.	[Heijmans, Jarom; Muncan, Vanesa; Jacobs, Rutger J.; de Jonge-Muller, Eveline S. M.; Graven, Laura; Biemond, Izak; Hardwick, James C.; Hommes, Daniel W.; van den Brink, Gijs R.] Leiden Univ, Med Ctr, Dept Gastroenterol & Hepatol, Leiden, Netherlands; [Heijmans, Jarom; Muncan, Vanesa; van den Brink, Gijs R.] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 AZ Amsterdam, Netherlands; [Ederveen, Antwan G.; Groothuis, Patrick G.; Mosselman, Sietse] Womens Hlth Dept, Oss, Netherlands; [van den Brink, Gijs R.] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Heijmans, J (corresponding author), Leiden Univ, Med Ctr, Dept Gastroenterol & Hepatol, Leiden, Netherlands.	j.heijmans@amc.nl; g.r.vandenbrink@amc.nl	Biemond, Izak/A-3540-2016; Ederveen, Antwan G.H./I-3557-2016; Hardwick, James/J-4862-2013	Biemond, Izak/0000-0002-3137-7527; Ederveen, Antwan G.H./0000-0003-1128-227X; Heijmans, Jarom/0000-0001-9615-7851; Hardwick, James/0000-0002-9575-5099	Merck, Sharpe Dohme (MSD)	Merck, Sharpe Dohme (MSD)(Merck & Company)	This study was funded with an unrestricted grant from Merck, Sharpe & Dohme (MSD). P.G.G., A.G.E. and S.M. are researchers employed by MSD. They have contributed to this study by critical appraisal of the data and the manuscript and by sharing expert opinion. Furthermore, MSD had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; BeazerBarclay Y, 1996, CARCINOGENESIS, V17, P1757, DOI 10.1093/carcin/17.8.1757; Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Bentel JM, 1999, MOL CELL ENDOCRINOL, V154, P11, DOI 10.1016/S0303-7207(99)00109-4; BERTHOIS Y, 1986, P NATL ACAD SCI USA, V83, P2496, DOI 10.1073/pnas.83.8.2496; BIRD RP, 1987, CANCER LETT, V37, P147, DOI 10.1016/0304-3835(87)90157-1; Blois SM, 2007, NAT MED, V13, P1450, DOI 10.1038/nm1680; Cao L, 2010, CELL, V142, P52, DOI 10.1016/j.cell.2010.05.029; Chlebowski RT, 2004, NEW ENGL J MED, V350, P991, DOI 10.1056/NEJMoa032071; Giardiello FM, 2005, GASTROENTEROLOGY, V128, P1077, DOI 10.1053/j.gastro.2004.10.010; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Half E, 2009, EXPERT OPIN PHARMACO, V10, P211, DOI [10.1517/14656560802560153 , 10.1517/14656560802560153]; Hardwick JCH, 2001, ONCOGENE, V20, P819, DOI 10.1038/sj.onc.1204162; Hughes GC, 2008, J IMMUNOL, V180, P2029, DOI 10.4049/jimmunol.180.4.2029; Ismail PM, 2003, STEROIDS, V68, P779, DOI 10.1016/S0039-128X(03)00133-8; Jones LA, 2010, J IMMUNOL, V185, P4525, DOI 10.4049/jimmunol.0901155; KIRTON KT, 1974, CONTRACEPTION, V10, P39, DOI 10.1016/0010-7824(74)90130-9; Mani SK, 2006, MOL ENDOCRINOL, V20, P1322, DOI 10.1210/me.2005-0466; MARTIN L, 1973, J ENDOCRINOL, V56, P303, DOI 10.1677/joe.0.0560303; McCart AE, 2008, PATHOL RES PRACT, V204, P479, DOI 10.1016/j.prp.2008.03.004; MEGGOUH F, 1991, CANCER-AM CANCER SOC, V67, P1964, DOI 10.1002/1097-0142(19910401)67:7<1964::AID-CNCR2820670724>3.0.CO;2-S; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Mote PA, 2006, ENDOCRINOLOGY, V147, P5503, DOI 10.1210/en.2006-0040; Mulac-Jericevic B, 2003, P NATL ACAD SCI USA, V100, P9744, DOI 10.1073/pnas.1732707100; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rickard DJ, 2008, ENDOCRINOLOGY, V149, P2383, DOI 10.1210/en.2007-1247; Ritenbaugh C, 2008, CANCER EPIDEM BIOMAR, V17, P2609, DOI 10.1158/1055-9965.EPI-08-0385; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; SICA V, 1984, CANCER RES, V44, P4670; SINGH S, 1993, GUT, V34, P611, DOI 10.1136/gut.34.5.611; Slattery ML, 2000, AM J CLIN PATHOL, V113, P364, DOI 10.1309/5MHB-K6XX-QV50-PCJQ; Takayama T, 1998, NEW ENGL J MED, V339, P1277, DOI 10.1056/NEJM199810293391803; Taketo MM, 2009, GASTROENTEROLOGY, V136, P780, DOI 10.1053/j.gastro.2008.12.049; Tanaka Y, 2008, MENOPAUSE, V15, P442, DOI 10.1097/gme.0b013e318156fb77; Wood GA, 2007, REPRODUCTION, V133, P1035, DOI 10.1530/REP-06-0302; Yamanouchi Keitaro, 2000, Journal of Reproduction and Development, V46, P257, DOI 10.1262/jrd.46.257; Zhang ZM, 2005, J BIOL CHEM, V280, P28468, DOI 10.1074/jbc.M504144200	39	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22620	10.1371/journal.pone.0022620	http://dx.doi.org/10.1371/journal.pone.0022620			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818351	Green Published, gold, Green Submitted			2022-12-25	WOS:000293282700049
J	Kuo, YC; Ho, JH; Yen, TJ; Chen, HF; Lee, OKS				Kuo, Yi-Chun; Ho, Jennifer H.; Yen, Ta-Jen; Chen, How-Foo; Lee, Oscar Kuang-Sheng			Development of a Surface Plasmon Resonance Biosensor for Real-Time Detection of Osteogenic Differentiation in Live Mesenchymal Stem Cells	PLOS ONE			English	Article							OSTEOBLAST DIFFERENTIATION; OB-CADHERIN; BONE; MARROW; EXPRESSION; GROWTH	Surface plasmon resonance (SPR) biosensors have been recognized as a useful tool and widely used for real-time dynamic analysis of molecular binding affinity because of its high sensitivity to the change of the refractive index of tested objects. The conventional methods inmolecular biology to evaluate cell differentiation require cell lysis or fixation, which make investigation in live cells difficult. In addition, a certain amount of cells are needed in order to obtain adequate protein or messenger ribonucleic acid for various assays. To overcome this limitation, we developed a unique SPR-based biosensing apparatus for real-time detection of cell differentiation in live cells according to the differences of optical properties of the cell surface caused by specific antigen-antibody binding. In this study, we reported the application of this SPR-based system to evaluate the osteogenic differentiation of mesenchymal stem cells (MSCs). OB-cadherin expression, which is up-regulated during osteogenic differentiation, was targeted under our SPR system by conjugating antibodies against OB-cadherin on the surface of the object. A linear relationship between the duration of osteogenic induction and the difference in refractive angle shift with very high correlation coefficient was observed. To sum up, the SPR system and the protocol reported in this study can rapidly and accurately define osteogenic maturation of MSCs in a live cell and label-free manner with no need of cell breakage. This SPR biosensor will facilitate future advances in a vast array of fields in biomedical research and medical diagnosis.	[Kuo, Yi-Chun; Lee, Oscar Kuang-Sheng] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Kuo, Yi-Chun; Lee, Oscar Kuang-Sheng] Natl Yang Ming Univ, Stem Cell Res Ctr, Taipei 112, Taiwan; [Ho, Jennifer H.] Taipei Med Univ, Grad Inst Clin Med, Taipei, Taiwan; [Ho, Jennifer H.] Taipei Med Univ, Wan Fang Med Ctr, Ctr Stem Cell Res, Taipei, Taiwan; [Ho, Jennifer H.] Taipei Med Univ, Wan Fang Med Ctr, Dept Ophthalmol, Taipei, Taiwan; [Yen, Ta-Jen] Natl Tsing Hua Univ, Dept Mat Sci & Engn, Hsinchu, Taiwan; [Chen, How-Foo; Lee, Oscar Kuang-Sheng] Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan; [Lee, Oscar Kuang-Sheng] Taipei Vet Gen Hosp, Dept Orthopaed & Traumatol, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; National Tsing Hua University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Kuo, YC (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan.	hfchen3@ym.edu.tw; kslee@vghtpe.gov.tw		Yen, Ta-Jen/0000-0003-3613-699X	Taiwan National Science Council [NSC-99-2911-I-009-101]; Taipei Veterans General Hospital [VGH100E1-010, VGH100C-056, VN100-05, VGH100D-003-2]; National Science Council, Taiwan [NSC99-2120-M-010-001, NSC99-2627-B-010-003, NSC99-3111-B-010-002, NSC98-2314-B-010-001-MY3, NSC 99-2911-I-010-501, NSC 99-3114-B-002-005, NSC 99-2112-M-010-001-MY3]; Wan Fang Hospital [100swf03]; Ministry of Education	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Wan Fang Hospital; Ministry of Education	This work was supported in part by the UST-UCSD International Center of Excellence in Advanced Bioengineering, sponsored by the Taiwan National Science Council I-RiCE Program under Grant Number: NSC-99-2911-I-009-101. The authors also acknowledge financial support from the Taipei Veterans General Hospital (VGH100E1-010, VGH100C-056, VN100-05 and VGH100D-003-2) and the National Science Council, Taiwan (NSC99-2120-M-010-001, NSC99-2627-B-010-003, NSC99-3111-B-010-002, NSC98-2314-B-010-001-MY3, NSC 99-2911-I-010-501, NSC 99-3114-B-002-005, and NSC 99-2112-M-010-001-MY3), as well as Wan Fang Hospital (100swf03). This study was also supported by a grant from the Ministry of Education, Aim for the Top University Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007; Chan LY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001164; Cheng MT, 2009, TISSUE ENG PT A, V15, P3979, DOI [10.1089/ten.tea.2009.0172, 10.1089/ten.TEA.2009.0172]; Di Gregorio-Taguchi GB, 2000, J BONE MINER RES, V15, pS376; Foltankova V, 2010, HAEMATOL-HEMATOL J, V95, P691; Glaser BT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006490; HARRIS SA, 1995, J BONE MINER RES, V10, pS412; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Huang CF, 2010, CANCER RES, V70, P4580, DOI 10.1158/0008-5472.CAN-09-3016; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kato K, 2007, ANAL CHEM, V79, P8616, DOI 10.1021/ac071548s; Kon E, 2000, J BIOMED MATER RES, V49, P328; Kuo TK, 2008, GASTROENTEROLOGY, V134, P2111, DOI 10.1053/j.gastro.2008.03.015; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; LIN SH, 2010, CANCER RES, V70, P4580; Lira CBB, 2008, PROTEIN EXPRES PURIF, V61, P220, DOI 10.1016/j.pep.2008.06.007; Nogues C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012152; Panetta NJ, 2009, PANMINERVA MED, V51, P25; Pang L, 2009, OPT EXPRESS, V17, P14700, DOI 10.1364/OE.17.014700; PEREIRA RF, 1995, P NATL ACAD SCI USA, V92, P4857, DOI 10.1073/pnas.92.11.4857; Peterson AW, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-16; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Shi X, 2007, BONE, V40, pS271; Shih YRV, 2009, CELL PROLIFERAT, V42, P461, DOI 10.1111/j.1365-2184.2009.00614.x; Shih YRV, 2006, STEM CELLS, V24, P2391, DOI 10.1634/stemcells.2006-0253; Smith JR, 2004, STEM CELLS, V22, P823, DOI 10.1634/stemcells.22-5-823; Thariani R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009833; Thiele RR, 2006, J BONE MINER RES, V21, pS344	29	28	28	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22382	10.1371/journal.pone.0022382	http://dx.doi.org/10.1371/journal.pone.0022382			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818317	Green Submitted, Green Published, gold			2022-12-25	WOS:000293282700028
J	Wang, Q; Birod, K; Angioni, C; Grosch, S; Geppert, T; Schneider, P; Rupp, M; Schneider, G				Wang, Quan; Birod, Kerstin; Angioni, Carlo; Groesch, Sabine; Geppert, Tim; Schneider, Petra; Rupp, Matthias; Schneider, Gisbert			Spherical Harmonics Coefficients for Ligand-Based Virtual Screening of Cyclooxygenase Inhibitors	PLOS ONE			English	Article							STRUCTURAL BASIS; 3D STRUCTURE; SHAPE; BINDING; SEARCH; PSEUDORECEPTOR; DESCRIPTORS; RECOGNITION; RESOLUTION; MOLECULES	Background: Molecular descriptors are essential for many applications in computational chemistry, such as ligand-based similarity searching. Spherical harmonics have previously been suggested as comprehensive descriptors of molecular structure and properties. We investigate a spherical harmonics descriptor for shape-based virtual screening. Methodology/Principal Findings: We introduce and validate a partially rotation-invariant three-dimensional molecular shape descriptor based on the norm of spherical harmonics expansion coefficients. Using this molecular representation, we parameterize molecular surfaces, i.e., isosurfaces of spatial molecular property distributions. We validate the shape descriptor in a comprehensive retrospective virtual screening experiment. In a prospective study, we virtually screen a large compound library for cyclooxygenase inhibitors, using a self-organizing map as a pre-filter and the shape descriptor for candidate prioritization. Conclusions/Significance: 12 compounds were tested in vitro for direct enzyme inhibition and in a whole blood assay. Active compounds containing a triazole scaffold were identified as direct cyclooxygenase-1 inhibitors. This outcome corroborates the usefulness of spherical harmonics for representation of molecular shape in virtual screening of large compound collections. The combination of pharmacophore and shape-based filtering of screening candidates proved to be a straightforward approach to finding novel bioactive chemotypes with minimal experimental effort.	[Wang, Quan] Goethe Univ Frankfurt, Frankfurt Inst Adv Studies, Frankfurt, Germany; [Birod, Kerstin; Angioni, Carlo; Groesch, Sabine] Goethe Univ Frankfurt, Inst Clin Pharmacol, Frankfurt, Germany; [Geppert, Tim; Schneider, Petra; Schneider, Gisbert] Swiss Fed Inst Technol, Inst Pharmaceut Sci, Zurich, Switzerland; [Rupp, Matthias] Tech Univ Berlin, Machine Learning Grp, Berlin, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Swiss Federal Institutes of Technology Domain; ETH Zurich; Technical University of Berlin	Wang, Q (corresponding author), Goethe Univ Frankfurt, Frankfurt Inst Adv Studies, Frankfurt, Germany.	gisbert.schneider@pharma.ethz.ch	Rupp, Matthias S/P-8680-2016; Groesch, Sabine/H-4251-2018	Rupp, Matthias S/0000-0002-2934-2958; Groesch, Sabine/0000-0002-7262-6307; Wang, Quan/0000-0003-4826-2408; Schneider, Petra/0000-0001-8296-6105; Schneider, Gisbert/0000-0001-6706-1084	DFG [MU 987/4-2]; European Community under PASCAL2 network of excellence [ICT-216886]	DFG(German Research Foundation (DFG)); European Community under PASCAL2 network of excellence(European Commission)	The authors received an academic MOE software license from Chemical Computing Group Inc., Montreal, Canada. M.R. acknowledges partial support from DFG grant MU 987/4-2 and the FP7-ICT programme of the European Community under the PASCAL2 network of excellence, ICT-216886. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankerst M, 1999, LECT NOTES COMPUT SC, V1651, P207; Ballester PJ, 2007, J COMPUT CHEM, V28, P1711, DOI [10.1002/jcc.20681, 10.1002/JCC.20681]; Ben-Israel A., 2003, GEN INVERSES; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BOHM HJ, 2000, VIRTUAL SCREENING BI; BRECHBUHLER C, 1995, COMPUT VIS IMAGE UND, V61, P154, DOI 10.1006/cviu.1995.1013; Cai W, 2008, J MOL MODEL, V14, P393, DOI 10.1007/s00894-008-0286-z; Chen DY, 2003, COMPUT GRAPH FORUM, V22, P223, DOI 10.1111/1467-8659.00669; CLARK T, 2010, PARASURF 10 USER MAN; Consonni V, 2002, J CHEM INF COMP SCI, V42, P693, DOI 10.1021/ci0155053; CRAMER RD, 1988, J AM CHEM SOC, V110, P5959, DOI 10.1021/ja00226a005; Cruciani C, 2000, J MOL STRUC-THEOCHEM, V503, P17, DOI 10.1016/S0166-1280(99)00360-7; Davis P.J., 1972, HDB MATH FUNCTIONS F, V10; Douguet D, 2008, CURR COMPUT-AID DRUG, V4, P180, DOI 10.2174/157340908785747456; DUNCAN BS, 1993, BIOPOLYMERS, V33, P219, DOI 10.1002/bip.360330204; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fechner U, 2004, QSAR COMB SCI, V23, P19, DOI 10.1002/qsar.200330855; Funkhouser T, 2003, ACM T GRAPHIC, V22, P83, DOI 10.1145/588272.588279; Gramatica P, 2000, CHEMOSPHERE, V41, P763, DOI 10.1016/S0045-6535(99)00463-4; Grant JA, 1996, J COMPUT CHEM, V17, P1653, DOI 10.1002/(SICI)1096-987X(19961115)17:14<1653::AID-JCC7>3.0.CO;2-K; Grant JA, 2001, J COMPUT CHEM, V22, P608, DOI 10.1002/jcc.1032; Hawkins PCD, 2008, J COMPUT AID MOL DES, V22, P179, DOI 10.1007/s10822-007-9166-3; Hemmer MC, 1999, VIB SPECTROSC, V19, P151, DOI 10.1016/S0924-2031(99)00014-4; HORN BKP, 1984, P IEEE, V72, P1671, DOI 10.1109/PROC.1984.13073; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Iyer N, 2005, COMPUT AIDED DESIGN, V37, P509, DOI 10.1016/j.cad.2004.07.002; Jain AN, 2008, J COMPUT AID MOL DES, V22, P133, DOI 10.1007/s10822-008-9196-5; Jakobi AJ, 2008, J MOL MODEL, V14, P547, DOI 10.1007/s00894-008-0302-3; Jamitzky F, 2001, ULTRAMICROSCOPY, V86, P241, DOI 10.1016/S0304-3991(00)00111-X; JOHNSON M, CONCEPTS APPL MOL SI; JOLLIFFE I, 2004, PRINCIPLE COMPONENT; JURS P, 2003, HDB CHEMOINFORMATICS, V3, P1314; KAZHDAN M, 2003, S GEOM PROC, P167; Kohonen T., 2001, SELF ORG MAPS, DOI [DOI 10.1007/978-3-642-56927-2, 10.1007/978-3-642-56927-2, DOI 10.1007/978-3-642-56927-2_1]; KUBINYI H, 2003, HDB CHEMOINFORMATICS, V4, P1532; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; Lin JH, 2005, J CHEM INF MODEL, V45, P1010, DOI 10.1021/ci050059v; Mackey MD, 2009, J CHEM INF MODEL, V49, P1154, DOI 10.1021/ci8003978; Mavridis L, 2007, J CHEM INF MODEL, V47, P1787, DOI 10.1021/ci7001507; Mavridis L, 2010, BIOCOMPUT-PAC SYM, P281; MAX NL, 1988, IEEE COMPUT GRAPH, V8, P42, DOI 10.1109/38.7748; Morris RJ, 2005, BIOINFORMATICS, V21, P2347, DOI 10.1093/bioinformatics/bti337; Novotni M., 2003, P 8 ACM S SOL MOD AP, P216; Osada R, 2001, INTERNATIONAL CONFERENCE ON SHAPE MODELING AND APPLICATIONS, PROCEEDING, P154, DOI 10.1109/SMA.2001.923386; Perez-Nueno VI, 2011, MOL INFORM, V30, P151, DOI 10.1002/minf.201000149; Proschak E, 2008, J COMPUT CHEM, V29, P108, DOI 10.1002/jcc.20770; RANDIC M, 1994, J CHEM INF COMP SCI, V34, P277, DOI 10.1021/ci00018a008; Riendeau D, 1997, BRIT J PHARMACOL, V121, P105, DOI 10.1038/sj.bjp.0701076; Ripphausen P, 2011, DRUG DISCOV TODAY, V16, P372, DOI 10.1016/j.drudis.2011.02.011; Ritchie DW, 1999, J COMPUT CHEM, V20, P383, DOI 10.1002/(SICI)1096-987X(199903)20:4<383::AID-JCC1>3.0.CO;2-M; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; Robinson DD, 1997, J CHEM INF COMP SCI, V37, P943, DOI 10.1021/ci970423t; Rupp M, 2009, J COMPUT CHEM, V30, P2285, DOI 10.1002/jcc.21218; Rush TS, 2005, J MED CHEM, V48, P1489, DOI 10.1021/jm040163o; Schmidt R, 2005, J CHROMATOGR B, V826, P188, DOI 10.1016/j.jchromb.2005.09.001; Schneider G, 1999, ANGEW CHEM INT EDIT, V38, P2894, DOI 10.1002/(SICI)1521-3773(19991004)38:19<2894::AID-ANIE2894>3.0.CO;2-F; Schneider G, 1998, PROG BIOPHYS MOL BIO, V70, P175, DOI 10.1016/S0079-6107(98)00026-1; Schneider P, 2003, QSAR COMB SCI, V22, P713, DOI 10.1002/qsar.200330825; Schuur J, 1997, ANAL CHEM, V69, P2398, DOI 10.1021/ac9611071; Shilane P, 2004, PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON SHAPE MODELING AND APPLICATIONS, P167, DOI 10.1109/SMI.2004.1314504; Tanrikulu Y, 2008, NAT REV DRUG DISCOV, V7, P667, DOI 10.1038/nrd2615; Tanrikulu Y, 2007, CHEMBIOCHEM, V8, P1932, DOI 10.1002/cbic.200700195; Tanrikulu Y, 2009, CHEMMEDCHEM, V4, P820, DOI 10.1002/cmdc.200800443; Todeschini R., 2008, HDB MOL DESCRIPTORS; Truchon JF, 2007, J CHEM INF MODEL, V47, P488, DOI 10.1021/ci600426e; Vainio MJ, 2009, J CHEM INF MODEL, V49, P492, DOI 10.1021/ci800315d; VanDrie JH, 1997, J CHEM INF COMP SCI, V37, P38, DOI 10.1021/ci960464+; Vecchio AJ, 2010, J BIOL CHEM, V285, P22152, DOI 10.1074/jbc.M110.119867; Venkatraman V, 2010, J CHEM INF MODEL, V50, P2079, DOI 10.1021/ci100263p; Venkatraman V, 2009, CELL BIOCHEM BIOPHYS, V54, P23, DOI 10.1007/s12013-009-9051-x; Vilenkin N Ja, 1968, TRANSLATIONS MATH MO, V22; Vranic DV, 2003, 2003 INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, VOL 3, PROCEEDINGS, P757; Yuan C, 2006, P NATL ACAD SCI USA, V103, P6142, DOI 10.1073/pnas.0601805103	74	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e21554	10.1371/journal.pone.0021554	http://dx.doi.org/10.1371/journal.pone.0021554			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818259	Green Published, Green Submitted, gold			2022-12-25	WOS:000293282700007
J	Yang, B; Tian, C; Zhang, ZG; Han, FC; Azem, R; Yu, HP; Zheng, Y; Jin, G; Arnold, JE; Zheng, QY				Yang, Bin; Tian, Cong; Zhang, Zhi-guang; Han, Feng-chan; Azem, Rami; Yu, Heping; Zheng, Ye; Jin, Ge; Arnold, James E.; Zheng, Qing Y.			Sh3pxd2b Mice Are a Model for Craniofacial Dysmorphology and Otitis Media	PLOS ONE			English	Article							HUMAN MIDDLE-EAR; EUSTACHIAN-TUBE; DOWN-SYNDROME; MOUSE MODELS; EFFUSION; CHILDREN; MORPHOLOGY; HEARING; INFANCY	Craniofacial defects that occur through gene mutation during development increase vulnerability to eustachian tube dysfunction. These defects can lead to an increased incidence of otitis media. We examined the effects of a mutation in the Sh3pxd2b gene (Sh3pxd2b(nee)) on the progression of otitis media and hearing impairment at various developmental stages. We found that all mice that had the Sh3pxd2b(nee) mutation went on to develop craniofacial dysmorphologies and subsequently otitis media, by as early as 11 days of age. We found noteworthy changes in cilia and goblet cells of the middle ear mucosa in Sh3pxd2b(nee) mutant mice using scanning electronic microscopy. By measuring craniofacial dimensions, we determined for the first time in an animal model that this mouse has altered eustachian tube morphology consistent with a more horizontal position of the eustachian tube. All mutants were found to have hearing impairment. Expression of TNF-alpha and TLR2, which correlates with inflammation in otitis media, was up-regulated in the ears of mutant mice when examined by immunohistochemistry and semi-quantitative RT-PCR. The mouse model with a mutation in the Sh3pxd2b gene (Sh3pxd2b(nee)) mirrors craniofacial dysmorphology and otitis media in humans.	[Yang, Bin; Zhang, Zhi-guang] Sun Yat Sen Univ, Dept Oral & Maxillofacial Surg, Guanghua Sch Stomatol, Guangzhou 510275, Guangdong, Peoples R China; [Tian, Cong; Han, Feng-chan; Azem, Rami; Yu, Heping; Zheng, Ye; Arnold, James E.; Zheng, Qing Y.] Case Western Reserve Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Cleveland, OH USA; [Jin, Ge] Case Western Reserve Univ, Sch Dent Med, Cleveland, OH 44106 USA	Sun Yat Sen University; Case Western Reserve University; Case Western Reserve University	Yang, B (corresponding author), Sun Yat Sen Univ, Dept Oral & Maxillofacial Surg, Guanghua Sch Stomatol, Guangzhou 510275, Guangdong, Peoples R China.	drzhangzg@163.com; qyz@case.edu	Tian, Cong/E-6300-2012; Tian, Cong/D-4921-2011; Zheng, Qing/C-1731-2012	Tian, Cong/0000-0002-5645-6600	NIH [R01DC007392, R01DC009246]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009246, R01DC007392] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This publication was supported by NIH grants R01DC007392 and R01DC009246. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHO OP, 1995, ARCH OTOLARYNGOL, V121, P432; Buschman MD, 2009, MOL BIOL CELL, V20, P1302, DOI 10.1091/mbc.E08-09-0949; Cunsolo E, 2010, Int J Immunopathol Pharmacol, V23, P4; Depreux FFS, 2008, J CLIN INVEST, V118, P651, DOI 10.1172/JCI32899; Di Francesco R, 2008, INT J PEDIATR OTORHI, V72, P1151, DOI 10.1016/j.ijporl.2008.03.027; Di Francesco RC, 2007, ENT-EAR NOSE THROAT, V86, P738, DOI 10.1177/014556130708601210; Diaz B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000368; Doyle WJ, 2010, INT J PEDIATR OTORHI, V74, P986, DOI 10.1016/j.ijporl.2010.05.021; Engel JAM, 2005, INT J PEDIATR OTORHI, V69, P533, DOI 10.1016/j.ijporl.2004.11.026; FLYNN T, 2009, INT J PEDIAT OTORHIN; Gianni D, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000370; Granstrom G, 2009, PERIODONTOL 2000, V49, P179, DOI 10.1111/j.1600-0757.2008.00281.x; GREEN MARGARET C., 1952, OHIO JOUR SCI, V52, P31; Han FC, 2009, INT J EXP PATHOL, V90, P480, DOI 10.1111/j.1365-2613.2009.00677.x; Han FC, 2009, INFECT IMMUN, V77, P3100, DOI 10.1128/IAI.00204-09; Harimaya A, 2009, INT J PEDIATR OTORHI, V73, P677, DOI 10.1016/j.ijporl.2008.12.033; Iqbal Z, 2010, AM J HUM GENET, V86, P254, DOI 10.1016/j.ajhg.2010.01.009; Jang CH, 2010, INT J PEDIATR OTORHI, V74, P71, DOI 10.1016/j.ijporl.2009.10.020; JUHN SK, 1985, AURIS NASUS LARYNX S, V1, pS63; Kemaloglu YK, 2000, INT J PEDIATR OTORHI, V55, P21, DOI 10.1016/S0165-5876(00)00367-0; Kemaloglu YK, 2000, INT J PEDIATR OTORHI, V53, P195, DOI 10.1016/S0165-5876(00)82007-8; Klein JO, 2000, VACCINE, V19, pS2, DOI 10.1016/S0264-410X(00)00271-1; Lee YC, 2008, CLIN EXP OTORHINOLAR, V1, P189, DOI 10.3342/ceo.2008.1.4.189; Leichtle A, 2009, INNATE IMMUN-LONDON, V15, P205, DOI 10.1177/1753425909103170; Lin JZ, 2003, JARO-J ASSOC RES OTO, V4, P384, DOI 10.1007/s10162-002-3023-9; Makibara RR, 2010, BRAZ J OTORHINOLAR, V76, P340, DOI 10.1590/S1808-86942010000300012; Mao M, 2009, MAMM GENOME, V20, P462, DOI 10.1007/s00335-009-9210-9; MARCHANT CD, 1984, J PEDIATR-US, V104, P826, DOI 10.1016/S0022-3476(84)80475-8; Paradise JL, 1997, PEDIATRICS, V99, P318, DOI 10.1542/peds.99.3.318; Pau HW, 2009, ACTA OTO-LARYNGOL, V129, P1182, DOI 10.3109/00016480802570537; Purzycki A, 2009, J CRANIOFAC SURG, V20, P1407, DOI 10.1097/SCS.0b013e3181aee369; RICHARDSON MA, 1981, AM FAM PHYSICIAN, V23, P159; Richtsmeier JT, 2000, DEV DYNAM, V217, P137, DOI 10.1002/(SICI)1097-0177(200002)217:2<137::AID-DVDY1>3.0.CO;2-N; Rosenfeld RM, 2004, OTOLARYNG HEAD NECK, V130, pS95, DOI 10.1016/j.otohns.2004.02.002; Samuel EA, 2008, CYTOKINE, V41, P38, DOI 10.1016/j.cyto.2007.10.009; Saunders J, 2011, AM J OTOLARYNG, V32, P32, DOI 10.1016/j.amjoto.2009.09.010; Sehhati-Chafai-Leuwer S, 2006, J CRANIO MAXILL SURG, V34, P351, DOI 10.1016/j.jcms.2006.03.006; Sheahan P, 2003, INT J PEDIATR OTORHI, V67, P785, DOI 10.1016/S0165-5876(03)00098-3; Netto LFS, 2009, INT J PEDIATR OTORHI, V73, P1751, DOI 10.1016/j.ijporl.2009.09.033; STOOL SE, 1994, OTITIS MEDIA EFFUSIO, P94; Todd NW, 1998, AM J OTOL, V19, P558; Trune DR, 2009, BRAIN RES, V1277, P90, DOI 10.1016/j.brainres.2009.02.047; Ungkanont K, 2010, INT J PEDIATR OTORHI, V74, P1063, DOI 10.1016/j.ijporl.2010.06.006; Visosky AMB, 2003, LARYNGOSCOPE, V113, P1508, DOI 10.1097/00005537-200309000-00017; Weaver AM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.288pe56; Zheng QY, 2006, BRAIN RES, V1091, P9, DOI 10.1016/j.brainres.2006.01.046; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	47	21	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22622	10.1371/journal.pone.0022622	http://dx.doi.org/10.1371/journal.pone.0022622			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818352	gold, Green Published, Green Submitted			2022-12-25	WOS:000293282700050
J	An, MW; Reich, NG; Crawford, SO; Brookmeyer, R; Louis, TA; Nelson, KE				An, Ming-Wen; Reich, Nicholas G.; Crawford, Stephen O.; Brookmeyer, Ron; Louis, Thomas A.; Nelson, Kenrad E.			A Stochastic Simulator of a Blood Product Donation Environment with Demand Spikes and Supply Shocks	PLOS ONE			English	Article							UNITED-STATES; TRANSFUSION; COLLECTION; DONORS	The availability of an adequate blood supply is a critical public health need. An influenza epidemic or another crisis affecting population mobility could create a critical donor shortage, which could profoundly impact blood availability. We developed a simulation model for the blood supply environment in the United States to assess the likely impact on blood availability of factors such as an epidemic. We developed a simulator of a multi-state model with transitions among states. Weekly numbers of blood units donated and needed were generated by negative binomial stochastic processes. The simulator allows exploration of the blood system under certain conditions of supply and demand rates, and can be used for planning purposes to prepare for sudden changes in the public's health. The simulator incorporates three donor groups (first-time, sporadic, and regular), immigration and emigration, deferral period, and adjustment factors for recruitment. We illustrate possible uses of the simulator by specifying input values for an 8-week flu epidemic, resulting in a moderate supply shock and demand spike (for example, from postponed elective surgeries), and different recruitment strategies. The input values are based in part on data from a regional blood center of the American Red Cross during 1996-2005. Our results from these scenarios suggest that the key to alleviating deficit effects of a system shock may be appropriate timing and duration of recruitment efforts, in turn depending critically on anticipating shocks and rapidly implementing recruitment efforts.	[An, Ming-Wen] Vassar Coll, Dept Math, Poughkeepsie, NY 12601 USA; [An, Ming-Wen; Reich, Nicholas G.; Louis, Thomas A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Reich, Nicholas G.; Crawford, Stephen O.; Nelson, Kenrad E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Brookmeyer, Ron] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA USA	Vassar College; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California Los Angeles	An, MW (corresponding author), Vassar Coll, Dept Math, Poughkeepsie, NY 12601 USA.	mian@vassar.edu	Reich, Nicholas/L-1168-2019	Reich, Nicholas/0000-0003-3503-9899	American Red Cross; U.S. NIH, National Institute of Diabetes, Digestive and Kidney Diseases [R01 DK061662]; American National Red Cross; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061662] Funding Source: NIH RePORTER	American Red Cross; U.S. NIH, National Institute of Diabetes, Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American National Red Cross; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors acknowledge Dr. Shimian Zou, Jonathan Trouern-Trend, Edward P. Notari, Dr. Roger Dodd, Kerri Dorsey, Dr. Chyang Fang, and Fatemeh Musavi from the American Red Cross Holland Laboratory for their support. The American Red Cross generously provided both financial support and data.; American National Red Cross and for TA Louis by grant R01 DK061662 from the U.S. NIH, National Institute of Diabetes, Digestive and Kidney Diseases. Staff from the American Red Cross (one of the funders) are credited in the Acknowledgments section and were involved in the study design, data collection, decision to publish, and preparation of the manuscript although such involvement was not related to any potential financial benefits to the funder. The NIH, National Institute of Diabetes, Digestive and Kidney Diseases played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. WellPoint provided no financial support to this study and played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Crawford SO, 2008, TRANSFUSION, V48, P1576, DOI 10.1111/j.1537-2995.2008.01755.x; Custer B, 2005, MED DECIS MAKING, V25, P571, DOI 10.1177/0272989X05280557; Heinrich J, 1999, AVAILABILITY BLOOD; *NCHS, 2006, NAT CTR HLTH STAT BI; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Riley W, 2007, TRANSFUSION, V47, P1180, DOI 10.1111/j.1537-2995.2007.01252.x; Schreiber GB, 2005, VOX SANG, V88, P114, DOI 10.1111/j.1423-0410.2005.00593.x; Sullivan MT, 2007, TRANSFUSION, V47, P385, DOI 10.1111/j.1537-2995.2007.01128.x; Sullivan MT, 2005, TRANSFUSION, V45, P141, DOI 10.1111/j.1537-2995.2004.03288.x; Wallace EL, 1998, TRANSFUSION, V38, P625, DOI 10.1046/j.1537-2995.1998.38798346630.x	10	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e21752	10.1371/journal.pone.0021752	http://dx.doi.org/10.1371/journal.pone.0021752			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21814550	Green Published, Green Submitted, gold			2022-12-25	WOS:000293175100007
J	Bancroft, TD; Servos, P; Hockley, WE				Bancroft, Tyler D.; Servos, Philip; Hockley, William E.			Mechanisms of Interference in Vibrotactile Working Memory	PLOS ONE			English	Article							DECISION-MAKING; FUNCTIONAL MRI; BRAIN-REGIONS; NEURAL CODES; DISCRIMINATION; FREQUENCY; STIMULI; CORTEX; ROLES; TASK	In previous studies of interference in vibrotactile working memory, subjects were presented with an interfering distractor stimulus during the delay period between the target and probe stimuli in a delayed match-to-sample task. The accuracy of same/different decisions indicated feature overwriting was the mechanism of interference. However, the distractor was presented late in the delay period, and the distractor may have interfered with the decision-making process, rather than the maintenance of stored information. The present study varies the timing of distractor onset, (either early, in the middle, or late in the delay period), and demonstrates both overwriting and non-overwriting forms of interference.	[Bancroft, Tyler D.; Servos, Philip; Hockley, William E.] Wilfrid Laurier Univ, Dept Psychol, Waterloo, ON N2L 3C5, Canada	Wilfrid Laurier University	Bancroft, TD (corresponding author), Wilfrid Laurier Univ, Dept Psychol, Waterloo, ON N2L 3C5, Canada.	pservos@wlu.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [194188]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was funded by Natural Sciences and Engineering Research Council of Canada (NSERC) grant number 194188 (www.NSERC.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bancroft T, 2011, EXP BRAIN RES, V208, P529, DOI 10.1007/s00221-010-2501-2; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Graham SJ, 2001, MAGNET RESON MED, V46, P436, DOI 10.1002/mrm.1211; Haegens S, 2010, HUM BRAIN MAPP, V31, P26, DOI 10.1002/hbm.20842; Hannula H, 2010, NEUROIMAGE, V49, P1091, DOI 10.1016/j.neuroimage.2009.07.049; NAIRNE JS, 1990, MEM COGNITION, V18, P251, DOI 10.3758/BF03213879; Oberauer K, 2009, MEM COGNITION, V37, P346, DOI 10.3758/MC.37.3.346; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Romo R, 2001, ANNU REV NEUROSCI, V24, P107, DOI 10.1146/annurev.neuro.24.1.107; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Romo R, 2002, NAT NEUROSCI, V5, P1217, DOI 10.1038/nn950; Rypma B, 1999, NEUROIMAGE, V9, P216, DOI 10.1006/nimg.1998.0404; Rypma B, 1999, P NATL ACAD SCI USA, V96, P6558, DOI 10.1073/pnas.96.11.6558; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; Sinclair RJ, 1996, PERCEPT PSYCHOPHYS, V58, P680, DOI 10.3758/BF03213100; Soros P, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-48; Spitzer B, 2010, J NEUROSCI, V30, P4496, DOI 10.1523/JNEUROSCI.6041-09.2010	17	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e22518	10.1371/journal.pone.0022518	http://dx.doi.org/10.1371/journal.pone.0022518			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21818331	Green Published, gold, Green Submitted			2022-12-25	WOS:000293175100030
J	Paoletti, F; Malerba, F; Kelly, G; Noinville, S; Lamba, D; Cattaneo, A; Pastore, A				Paoletti, Francesca; Malerba, Francesca; Kelly, Geoff; Noinville, Sylvie; Lamba, Doriano; Cattaneo, Antonino; Pastore, Annalisa			Conformational Plasticity of proNGF	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; INTRINSICALLY UNSTRUCTURED PROTEINS; STRUCTURAL DISORDER; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PRION PROTEIN; MOUSE PRONGF; RECEPTOR; SPECTROSCOPY; FLEXIBILITY	Nerve Growth Factor is an essential protein that supports neuronal survival during development and influences neuronal function throughout adulthood, both in the central and peripheral nervous system. The unprocessed precursor of NGF, proNGF, seems to be endowed with biological functions distinct from those of the mature protein, such as chaperone-like activities and apoptotic and/or neurotrophic properties. We have previously suggested, based on Small Angle X-ray Scattering data, that recombinant murine proNGF has features typical of an intrinsically unfolded protein. Using complementary biophysical techniques, we show here new evidence that clarifies and widens this hypothesis through a detailed comparison of the structural properties of NGF and proNGF. Our data provide direct information about the dynamic properties of the pro-peptide and indicate that proNGF assumes in solution a compact globular conformation. The N-terminal pro-peptide extension influences the chemical environment of the mature protein and protects the protein from proteolytic digestion. Accordingly, we observe that unfolding of proNGF involves a two-steps mechanism. The distinct structural properties of proNGF as compared to NGF agree with and rationalise a different functional role of the precursor.	[Paoletti, Francesca; Malerba, Francesca; Cattaneo, Antonino] European Brain Res Inst, Rome, Italy; [Malerba, Francesca] Scuola Normale Super Pisa, Pisa, Italy; [Kelly, Geoff] NMR Ctr MRC, London, England; [Noinville, Sylvie] CR1 CNRS INRA, Unite Virol & Immunol Mol, Jouy En Josas, France; [Lamba, Doriano] CNR, Ist Cristallog, Trieste, Italy; [Pastore, Annalisa] MRC Natl Inst Med Res, London, England	Scuola Normale Superiore di Pisa; MRC National Institute for Medical Research; INRAE; Consiglio Nazionale delle Ricerche (CNR); Istituto Di Cristallografia (IC-CNR); MRC National Institute for Medical Research	Paoletti, F (corresponding author), European Brain Res Inst, Rome, Italy.	apastor@nimr.mrc.ac.uk	Cattaneo, Antonino/AAA-7252-2019; Lamba, Doriano/B-2961-2011; Noinville, Sylvie/S-8318-2019; Lamba, Doriano/L-9808-2018; Cattaneo, Antonino/K-4471-2016	Lamba, Doriano/0000-0001-6859-7868; Noinville, Sylvie/0000-0002-8320-9488; Lamba, Doriano/0000-0001-6859-7868; Cattaneo, Antonino/0000-0002-6975-8923	"Programma Nazionale della Ricerca" (PNR) [RBP063ANC001]; Ministero Italiano dell'Universita e Ricerca Scientifica [PRIN 2007LP44TW]; EMBO [ASTF 70-2009]; Medical Research Council [MC_U117584256, MC_U117533887] Funding Source: researchfish; MRC [MC_U117584256, MC_U117533887] Funding Source: UKRI	"Programma Nazionale della Ricerca" (PNR); Ministero Italiano dell'Universita e Ricerca Scientifica; EMBO(European Molecular Biology Organization (EMBO)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research was sponsored by "Programma Nazionale della Ricerca'' (PNR, Project RBP063ANC001) and from "Progetti di Ricerca di Interesse Nazionale'' (PRIN 2007LP44TW) of the Ministero Italiano dell'Universita e Ricerca Scientifica. FP was recipient of a Short-term EMBO fellowship (ASTF 70-2009). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Baujard-Lamotte L, 2008, COLLOID SURFACE B, V63, P129, DOI 10.1016/j.colsurfb.2007.11.015; Bruno MA, 2006, P NATL ACAD SCI USA, V103, P6735, DOI 10.1073/pnas.0510645103; CHAO MV, 1986, SCIENCE, V232, P518, DOI 10.1126/science.3008331; Curtis-Fisk J, 2008, PROTEIN EXPRES PURIF, V61, P212, DOI 10.1016/j.pep.2008.06.009; DeYoung LR, 1996, PROTEIN SCI, V5, P1554, DOI 10.1002/pro.5560050811; Fahnestock M, 2004, J NEUROCHEM, V89, P581, DOI 10.1111/j.1471-4159.2004.02360.x; Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016; Feng D, 2010, J MOL BIOL, V396, P967, DOI 10.1016/j.jmb.2009.12.030; GIBBS SJ, 1991, J MAGN RESON, V93, P395, DOI 10.1016/0022-2364(91)90014-K; He XL, 2004, SCIENCE, V304, P870, DOI 10.1126/science.1095190; HOLLAND DR, 1994, J MOL BIOL, V239, P385, DOI 10.1006/jmbi.1994.1380; Kliemannel M, 2004, FEBS LETT, V566, P207, DOI 10.1016/j.febslet.2004.04.034; Kliemannel M, 2007, PROTEIN SCI, V16, P411, DOI 10.1110/ps.062376207; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Masino L, 2003, FEBS LETT, V549, P21, DOI 10.1016/S0014-5793(03)00748-8; MCDONALD NQ, 1991, NATURE, V354, P411, DOI 10.1038/354411a0; MILNER J, 1995, TRENDS BIOCHEM SCI, V20, P49, DOI 10.1016/S0968-0004(00)88954-9; Mossakowska D E, 1997, Methods Mol Biol, V60, P325; Mouri A, 2007, BIOCHEM BIOPH RES CO, V353, P1056, DOI 10.1016/j.bbrc.2006.12.136; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Pagadala PC, 2006, P NATL ACAD SCI USA, V103, P17939, DOI 10.1073/pnas.0604139103; Paoletti F, 2006, BIOCHEM SOC T, V34, P605, DOI 10.1042/BST0340605; Paoletti F, 2009, PROTEINS, V75, P990, DOI 10.1002/prot.22311; Prischi F, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1097; Rattenholl A, 2001, EUR J BIOCHEM, V268, P3296, DOI 10.1046/j.1432-1327.2001.02232.x; Rattenholl A, 2001, J MOL BIOL, V305, P523, DOI 10.1006/jmbi.2000.4295; Revault M, 2005, BBA-GEN SUBJECTS, V1724, P367, DOI 10.1016/j.bbagen.2005.05.005; Schmid F. Z., 1997, PROTEIN STRUCTURE PR, P261; Shooter EM, 2001, ANNU REV NEUROSCI, V24, P601, DOI 10.1146/annurev.neuro.24.1.601; Teng KK, 2004, CELL MOL LIFE SCI, V61, P35, DOI 10.1007/s00018-003-3099-3; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wiesmann C, 1999, NATURE, V401, P184, DOI 10.1038/43705; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Zhang H, 1997, BIOCHEMISTRY-US, V36, P3543, DOI 10.1021/bi961965r	39	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e22615	10.1371/journal.pone.0022615	http://dx.doi.org/10.1371/journal.pone.0022615			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21818348	Green Published, gold, Green Submitted			2022-12-25	WOS:000293175100034
J	Gilbert-Sirieix, M; Makoukji, J; Kimura, S; Talbot, M; Caillou, B; Massaad, C; Massaad-Massade, L				Gilbert-Sirieix, Marie; Makoukji, Joelle; Kimura, Shioko; Talbot, Monique; Caillou, Bernard; Massaad, Charbel; Massaad-Massade, Liliane			Wnt/beta-Catenin Signaling Pathway Is a Direct Enhancer of Thyroid Transcription Factor-1 in Human Papillary Thyroid Carcinoma Cells	PLOS ONE			English	Article							BETA-CATENIN; NUCLEAR-LOCALIZATION; MOLECULAR-MECHANISM; EXPRESSION; CANCER; GENE; TARGET; TTF-1; OVEREXPRESSION; THYROGLOBULIN	The Wnt/beta-catenin signaling pathway is involved in the normal development of thyroid gland, but its disregulation provokes the appearance of several types of cancers, including papillary thyroid carcinomas (PTC) which are the most common thyroid tumours. The follow-up of PTC patients is based on the monitoring of serum thyroglobulin levels which is regulated by the thyroid transcription factor 1 (TTF-1): a tissue-specific transcription factor essential for the differentiation of the thyroid. We investigated whether the Wnt/beta-catenin pathway might regulate TTF-1 expression in a human PTC model and examined the molecular mechanisms underlying this regulation. Immunofluorescence analysis, real time RT-PCR and Western blot studies revealed that TTF-1 as well as the major Wnt pathway components are co-expressed in TPC-1 cells and human PTC tumours. Knocking-down the Wnt/beta-catenin components by siRNAs inhibited both TTF-1 transcript and protein expression, while mimicking the activation of Wnt signaling by lithium chloride induced TTF-1 gene and protein expression. Functional promoter studies and ChIP analysis showed that the Wnt/beta-catenin pathway exerts its effect by means of the binding of beta-catenin to TCF/LEF transcription factors on the level of an active TCF/LEF response element at [2798, 2792 bp] in TTF-1 promoter. In conclusion, we demonstrated that the Wnt/beta-catenin pathway is a direct and forward driver of the TTF-1 expression. The localization of TCF-4 and TTF-1 in the same area of PTC tissues might be of clinical relevance, and justifies further examination of these factors in the papillary thyroid cancers follow-up.	[Gilbert-Sirieix, Marie; Massaad-Massade, Liliane] Inst Gustave Roussy, CNRS, UMR 8203, Villejuif, France; [Makoukji, Joelle; Massaad, Charbel] Univ Paris 05, CNRS, UMR 8194, Paris, France; [Kimura, Shioko] NCI, Lab Metab, Bethesda, MD 20892 USA; [Talbot, Monique; Caillou, Bernard] Inst Gustave Roussy, CNRS, UMR 8200, Villejuif, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Gilbert-Sirieix, M (corresponding author), Inst Gustave Roussy, CNRS, UMR 8203, Villejuif, France.	liliane.massade@igr.fr	Massaad, Massaad-Massade or Massade or/O-7226-2017	Massaad, Massaad-Massade or Massade or/0000-0002-9636-4559	Centre National de la Recherche Scientifique; University Paris 11; Institut Gustave Roussy; NATIONAL CANCER INSTITUTE [ZIABC005522] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); University Paris 11; Institut Gustave Roussy; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Centre National de la Recherche Scientifique, by the University Paris 11, and by Institut Gustave Roussy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbosh PH, 2005, THYROID, V15, P551, DOI 10.1089/thy.2005.15.551; Adler JT, 2010, J SURG RES, V159, P640, DOI 10.1016/j.jss.2008.08.004; Cai YC, 2001, HUM PATHOL, V32, P1087, DOI 10.1053/hupa.2001.28245; Chen G, 2010, MOL BIOL REP, V37, P2773, DOI 10.1007/s11033-009-9819-5; CIVITAREALE D, 1989, EMBO J, V8, P2537, DOI 10.1002/j.1460-2075.1989.tb08391.x; FABBRO D, 1994, CANCER RES, V54, P4744; Fenton CL, 2001, ANN CLIN LAB SCI, V31, P245; Garcia-Jimenez C, 2007, ARQ BRAS ENDOCRINOL, V51, P654, DOI 10.1590/S0004-27302007000500003; GUAZZI S, 1990, EMBO J, V9, P3631, DOI 10.1002/j.1460-2075.1990.tb07574.x; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552; Hussein SM, 2003, J BIOL CHEM, V278, P48805, DOI 10.1074/jbc.M305472200; Ishigaki K, 2002, J CLIN ENDOCR METAB, V87, P3433, DOI 10.1210/jc.87.7.3433; Ito Y, 2009, ENDOCR J, V56, P177, DOI 10.1507/endocrj.K08E-166; Kim WB, 2007, J ENDOCRINOL, V193, P93, DOI 10.1677/JOE-06-0025; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kondo T, 2009, LAB INVEST, V89, P791, DOI 10.1038/labinvest.2009.50; Kunnimalaiyaan M, 2007, MOL CANCER THER, V6, P1151, DOI 10.1158/1535-7163.MCT-06-0665; Lantsov D, 2005, HISTOPATHOLOGY, V47, P248, DOI 10.1111/j.1365-2559.2005.02218.x; Lin JD, 2008, CLIN CHIM ACTA, V388, P15, DOI 10.1016/j.cca.2007.11.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Ricarte JCM, 2009, TRANSL ONCOL, V2, P236, DOI 10.1593/tlo.09151; Meireles AM, 2007, THYROID, V17, P707, DOI 10.1089/thy.2007.0097; Nakatani Y, 2002, MODERN PATHOL, V15, P617, DOI 10.1038/modpathol.3880575; Oguchi H, 1998, ENDOCRINOLOGY, V139, P1999, DOI 10.1210/en.139.4.1999; Oliveira AT, 2001, AM J SURG PATHOL, V25, P815, DOI 10.1097/00000478-200106000-00015; Ordonez NG, 2000, ADV ANAT PATHOL, V7, P123, DOI 10.1097/00125480-200007020-00007; Pilli T, 2009, THYROID, V19, P1333, DOI 10.1089/thy.2009.0195; Rao AS, 2005, EUR J ENDOCRINOL, V153, P929, DOI 10.1530/eje.1.02038; Rao AS, 2006, J CLIN ENDOCR METAB, V91, P159, DOI 10.1210/jc.2005-1381; Roh MS, 2002, J KOREAN MED SCI, V17, P512, DOI 10.3346/jkms.2002.17.4.512; Rosai J, 2003, TUMORI J, V89, P517, DOI 10.1177/030089160308900511; SCHLUMBERGER M, 2007, ANN ENDOCRINOLOGIE; Schwartz DR, 2003, CANCER RES, V63, P2913; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Seifeddine R, 2008, CANCER RES, V68, P2158, DOI 10.1158/0008-5472.CAN-07-1190; Smith JC, 2000, PHILOS T ROY SOC B, V355, P923, DOI 10.1098/rstb.2000.0627; Srodon M, 2002, HUM PATHOL, V33, P642, DOI 10.1053/hupa.2002.124910; Takahashi M, 2002, ONCOGENE, V21, P5861, DOI 10.1038/sj.onc.1205755; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; van Staveren WCG, 2007, CANCER RES, V67, P8113, DOI 10.1158/0008-5472.CAN-06-4026; Veliz J, 2008, REV MED CHILE, V136, P1107, DOI /S0034-98872008000900003; Ziad EA, 2008, FOLIA HISTOCHEM CYTO, V46, P461, DOI 10.2478/v10042-008-0071-y	44	27	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22280	10.1371/journal.pone.0022280	http://dx.doi.org/10.1371/journal.pone.0022280			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21814573	Green Published, gold, Green Submitted			2022-12-25	WOS:000292956800037
J	Kuroda, A; Tsukamoto, Y; Nguyen, LT; Noguchi, T; Takeuchi, I; Uchida, M; Uchida, T; Hijiya, N; Nakada, C; Okimoto, T; Kodama, M; Murakami, K; Matsuura, K; Seto, M; Ito, H; Fujioka, T; Moriyama, M				Kuroda, Akiko; Tsukamoto, Yoshiyuki; Lam Tung Nguyen; Noguchi, Tsuyoshi; Takeuchi, Ichiro; Uchida, Masahiro; Uchida, Tomohisa; Hijiya, Naoki; Nakada, Chisato; Okimoto, Tadayoshi; Kodama, Masaaki; Murakami, Kazunari; Matsuura, Keiko; Seto, Masao; Ito, Hisao; Fujioka, Toshio; Moriyama, Masatsugu			Genomic Profiling of Submucosal-Invasive Gastric Cancer by Array-Based Comparative Genomic Hybridization	PLOS ONE			English	Article							DNA COPY-NUMBER; INTRATUMORAL CYTOGENETIC HETEROGENEITY; IN-SITU HYBRIDIZATION; GENE-EXPRESSION; PANCREATIC-CANCER; MICROARRAY ANALYSES; CELL CARCINOMA; BREAST-CANCER; OCCURS LATE; ADENOCARCINOMA	Genomic copy number aberrations (CNAs) in gastric cancer have already been extensively characterized by array comparative genomic hybridization (array CGH) analysis. However, involvement of genomic CNAs in the process of submucosal invasion and lymph node metastasis in early gastric cancer is still poorly understood. In this study, to address this issue, we collected a total of 59 tumor samples from 27 patients with submucosal-invasive gastric cancers (SMGC), analyzed their genomic profiles by array CGH, and compared them between paired samples of mucosal (MU) and submucosal (SM) invasion (23 pairs), and SM invasion and lymph node (LN) metastasis (9 pairs). Initially, we hypothesized that acquisition of specific CNA(s) is important for these processes. However, we observed no significant difference in the number of genomic CNAs between paired MU and SM, and between paired SM and LN. Furthermore, we were unable to find any CNAs specifically associated with SM invasion or LN metastasis. Among the 23 cases analyzed, 15 had some similar pattern of genomic profiling between SM and MU. Interestingly, 13 of the 15 cases also showed some differences in genomic profiles. These results suggest that the majority of SMGCs are composed of heterogeneous subpopulations derived from the same clonal origin. Comparison of genomic CNAs between SMGCs with and without LN metastasis revealed that gain of 11q13, 11q14, 11q22, 14q32 and amplification of 17q21 were more frequent in metastatic SMGCs, suggesting that these CNAs are related to LN metastasis of early gastric cancer. In conclusion, our data suggest that generation of genetically distinct subclones, rather than acquisition of specific CNA at MU, is integral to the process of submucosal invasion, and that subclones that acquire gain of 11q13, 11q14, 11q22, 14q32 or amplification of 17q21 are likely to become metastatic.	[Kuroda, Akiko; Tsukamoto, Yoshiyuki; Lam Tung Nguyen; Uchida, Tomohisa; Hijiya, Naoki; Nakada, Chisato; Matsuura, Keiko; Moriyama, Masatsugu] Oita Univ, Fac Med, Dept Mol Pathol, Oita 87011, Japan; [Kuroda, Akiko; Lam Tung Nguyen; Okimoto, Tadayoshi; Kodama, Masaaki; Murakami, Kazunari; Fujioka, Toshio] Oita Univ, Fac Med, Dept Gen Med, Oita 87011, Japan; [Noguchi, Tsuyoshi] Oita Univ, Fac Med, Dept Gastrointestinal Surg, Oita 87011, Japan; [Takeuchi, Ichiro] Nagoya Inst Technol, Dept Comp Sci Sci & Engn Simulat, Nagoya, Aichi, Japan; [Uchida, Masahiro; Okimoto, Tadayoshi; Kodama, Masaaki; Murakami, Kazunari; Fujioka, Toshio] Oita Univ, Fac Med, Dept Gastroenterol, Oita 87011, Japan; [Seto, Masao] Aichi Canc Ctr, Res Inst, Div Mol Med, Nagoya, Aichi 464, Japan; [Ito, Hisao] Tottori Univ, Fac Med, Dept Pathol & Microbiol, Div Organ Pathol, Yonago, Tottori 683, Japan	Oita University; Oita University; Oita University; Nagoya Institute of Technology; Oita University; Aichi Cancer Center; Tottori University	Kuroda, A (corresponding author), Oita Univ, Fac Med, Dept Mol Pathol, Oita 87011, Japan.	tuka@oita-u.ac.jp			Ministry of Education, Science, Sports and Culture of Japan; Discretion of the President, Oita University;  [20790286]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Discretion of the President, Oita University; 	This research was supported in part by the Ministry of Education, Science, Sports and Culture of Japan, and Grants-in-Aid for Young Scientists (B), No. 20790286 (http://www.mext.go.jp), and the Research Fund at the Discretion of the President, Oita University (http://www.oita-u.ac.jp/english/index.html). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubele M, 1999, CANCER GENET CYTOGEN, V110, P94, DOI 10.1016/S0165-4608(98)00205-2; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; Barros-Silva JD, 2009, BRIT J CANCER, V100, P487, DOI 10.1038/sj.bjc.6604885; Cooke SL, 2010, ONCOGENE, V29, P4905, DOI 10.1038/onc.2010.245; COOKE SL, ONCOGENE, V29, P4905; COOKE SL, BR J CANC, V104, P361; Davies JJ, 2005, CHROMOSOME RES, V13, P237, DOI 10.1007/s10577-005-2168-x; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; FALCK VG, 1989, J PATHOL, V159, P107, DOI 10.1002/path.1711590204; Gorringe KL, 2005, GENE CHROMOSOME CANC, V42, P247, DOI 10.1002/gcc.20136; Harada K, 1998, CANCER RES, V58, P4694; Harada T, 2002, CANCER RES, V62, P835; Haruta H, 2008, J DIGEST DIS, V9, P213, DOI 10.1111/j.1751-2980.2008.00349.x; Heidenblad M, 2005, ONCOGENE, V24, P1794, DOI 10.1038/sj.onc.1208383; Heng HHQ, 2010, J CELL BIOCHEM, V109, P1072, DOI 10.1002/jcb.22497; Heng HHQ, 2009, J CELL PHYSIOL, V220, P538, DOI 10.1002/jcp.21799; Hyman E, 2002, CANCER RES, V62, P6240; Jarvinen AK, 2006, ONCOGENE, V25, P6997, DOI 10.1038/sj.onc.1209690; Khalique L, 2007, J PATHOL, V211, P286, DOI 10.1002/path.2112; Kim MA, 2007, HUM PATHOL, V38, P1386, DOI 10.1016/j.humpath.2007.02.005; Kwee RM, 2008, GASTRIC CANCER, V11, P134, DOI 10.1007/s10120-008-0476-5; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; Sayagues JM, 2010, J PATHOL, V221, P308, DOI 10.1002/path.2712; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Mora J, 2001, BRIT J CANCER, V85, P182, DOI 10.1054/bjoc.2001.1849; Nakayama T, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-311; Park DI, 2006, DIGEST DIS SCI, V51, P1371, DOI 10.1007/s10620-005-9057-1; PARK JB, 1989, CANCER RES, V49, P6605; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peng DF, 2004, J PATHOL, V203, P884, DOI 10.1002/path.1586; Polyak K, 2008, CLIN CANCER RES, V14, P339, DOI 10.1158/1078-0432.CCR-07-2188; Ried T, 1999, GENE CHROMOSOME CANC, V25, P195, DOI 10.1002/(SICI)1098-2264(199907)25:3<195::AID-GCC1>3.0.CO;2-8; SEMBA K, 1985, P NATL ACAD SCI USA, V82, P6497, DOI 10.1073/pnas.82.19.6497; Takada H, 2005, CANCER SCI, V96, P100, DOI 10.1111/j.1349-7006.2005.00016.x; Takehana T, 2002, INT J CANCER, V98, P833, DOI 10.1002/ijc.10257; Tomioka N, 2010, CANCER GENET CYTOGEN, V201, P6, DOI 10.1016/j.cancergencyto.2010.04.017; Torres L, 2007, BREAST CANCER RES TR, V102, P143, DOI 10.1007/s10549-006-9317-6; Tsukamoto Y, 2008, J PATHOL, V216, P471, DOI 10.1002/path.2424; Uchida M, 2010, J PATHOL, V221, P96, DOI 10.1002/path.2686; Vauhkonen H, 2007, CYTOGENET GENOME RES, V119, P39, DOI 10.1159/000109617; Vauhkonen H, 2006, CANCER GENET CYTOGEN, V167, P150, DOI 10.1016/j.cancergencyto.2005.11.014; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Weiss MM, 2004, CELL ONCOL, V26, P307; Wilentz RE, 2000, CANCER RES, V60, P2002; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yang S, 2007, GENOMICS, V89, P451, DOI 10.1016/j.ygeno.2006.12.001; Yoshimoto T, 2007, J PATHOL, V213, P392, DOI 10.1002/path.2239	49	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22313	10.1371/journal.pone.0022313	http://dx.doi.org/10.1371/journal.pone.0022313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811585	Green Published, Green Submitted, gold			2022-12-25	WOS:000292956800039
J	Miro-Murillo, M; Elorza, A; Soro-Arnaiz, I; Albacete-Albacete, L; Ordonez, A; Balsa, E; Vara-Vega, A; Vazquez, S; Fuertes, E; Fernandez-Criado, C; Landazuri, MO; Aragones, J				Miro-Murillo, Marta; Elorza, Ainara; Soro-Arnaiz, Ines; Albacete-Albacete, Lucas; Ordonez, Angel; Balsa, Eduardo; Vara-Vega, Alicia; Vazquez, Silvia; Fuertes, Esther; Fernandez-Criado, Carmen; Landazuri, Manuel O.; Aragones, Julian			Acute Vhl Gene Inactivation Induces Cardiac HIF-Dependent Erythropoietin Gene Expression	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; EXCESSIVE ERYTHROCYTOSIS; VASCULAR TUMORS; MESSENGER-RNA; HYPOXIA; MICE; HIF-1-ALPHA; SYSTEM; CELLS; CARDIOPROTECTION	Von Hippel Lindau (Vhl) gene inactivation results in embryonic lethality. The consequences of its inactivation in adult mice, and of the ensuing activation of the hypoxia-inducible factors (HIFs), have been explored mainly in a tissue-specific manner. This mid-gestation lethality can be also circumvented by using a floxed Vhl allele in combination with an ubiquous tamoxifen-inducible recombinase Cre-ERT2. Here, we characterize a widespread reduction in Vhl gene expression in Vhl(floxed)-UBC-Cre-ERT2 adult mice after dietary tamoxifen administration, a convenient route of administration that has yet to be fully characterized for global gene inactivation. Vhl gene inactivation rapidly resulted in a marked splenomegaly and skin erythema, accompanied by renal and hepatic induction of the erythropoietin (Epo) gene, indicative of the in vivo activation of the oxygen sensing HIF pathway. We show that acute Vhl gene inactivation also induced Epo gene expression in the heart, revealing cardiac tissue to be an extra-renal source of EPO. Indeed, primary cardiomyocytes and HL-1 cardiac cells both induce Epo gene expression when exposed to low O-2 tension in a HIF-dependent manner. Thus, as well as demonstrating the potential of dietary tamoxifen administration for gene inactivation studies in UBC-Cre-ERT2 mouse lines, this data provides evidence of a cardiac oxygen-sensing VHL/HIF/EPO pathway in adult mice.	[Miro-Murillo, Marta; Fernandez-Criado, Carmen] Autonomous Univ Madrid, Anim Facil, E-28049 Madrid, Spain; [Elorza, Ainara; Soro-Arnaiz, Ines; Albacete-Albacete, Lucas; Ordonez, Angel; Balsa, Eduardo; Vara-Vega, Alicia; Vazquez, Silvia; Fuertes, Esther; Landazuri, Manuel O.; Aragones, Julian] Autonomous Univ Madrid, Sanit Res Inst Princesa IP, Hosp La Princesa, Dept Immunol, E-28049 Madrid, Spain	Autonomous University of Madrid; Autonomous University of Madrid; Hospital de La Princesa	Miro-Murillo, M (corresponding author), Autonomous Univ Madrid, Anim Facil, E-28049 Madrid, Spain.	jaragones.hlpr@salud.madrid.org	Elorza, Ainara/I-1642-2015; Balsa Martinez, Eduardo/A-8111-2019	Aragones Lopez, Julian/0000-0002-0193-4679; Balsa Martinez, Eduardo/0000-0002-6836-7023; Vazquez Cuesta, Silvia Noemi/0000-0002-9065-9487	Ministerio de Educacion y Ciencia [BFU2008-03407/BMC]; RECAVA [RD06/0014/0031]; CICYT [SAF2007-60592]; CAM [SAL0311/2006]	Ministerio de Educacion y Ciencia(Spanish Government); RECAVA; CICYT(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); CAM	This work was supported by grants from Ministerio de Educacion y Ciencia (BFU2008-03407/BMC), RECAVA (RD06/0014/0031), CICYT (SAF2007-60592) and CAM (SAL0311/2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boutin AT, 2008, CELL, V133, P223, DOI 10.1016/j.cell.2008.02.038; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Burger D, 2009, Curr Mol Pharmacol, V2, P56; Cai Z, 2008, CARDIOVASC RES, V77, P463, DOI 10.1093/cvr/cvm035; Camici GG, 2007, METHOD ENZYMOL, V435, P147, DOI 10.1016/S0076-6879(07)35008-8; Casanova E, 2002, GENESIS, V34, P208, DOI 10.1002/gene.10153; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; Chen SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002360; Eckardt KU, 2005, EUR J CLIN INVEST, V35, P13, DOI 10.1111/j.1365-2362.2005.01525.x; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; FANDREY J, 1993, BLOOD, V81, P617; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Forde A, 2002, GENESIS, V33, P191, DOI 10.1002/gene.10117; Giaccia A, 2003, NAT REV DRUG DISCOV, V2, P803, DOI 10.1038/nrd1199; Gnarra JR, 1997, P NATL ACAD SCI USA, V94, P9102, DOI 10.1073/pnas.94.17.9102; GOLDBERG MA, 1991, SEMIN HEMATOL, V28, P35; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Heinicke K, 2006, AM J PHYSIOL-REG I, V291, pR947, DOI 10.1152/ajpregu.00152.2006; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hsiao EC, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt52; Huang Y, 2004, FASEB J, V18, P1138, DOI 10.1096/fj.04-1510fje; IMAGAWA S, 1989, ADV EXP MED BIOL, V271, P75; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jurgensen JS, 2004, FASEB J, V18, P1415, DOI 10.1096/fj.04-1605fje; Kapitsinou PP, 2010, BLOOD, V116, P3039, DOI 10.1182/blood-2010-02-270322; Katsantoni EZ, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-108; Kiermayer C, 2007, GENESIS, V45, P11, DOI 10.1002/dvg.20244; Kim CH, 2002, CIRC RES, V90, pE25, DOI 10.1161/hh0202.104923; Lei L, 2008, MOL CELL BIOL, V28, P3790, DOI 10.1128/MCB.01580-07; Lu HS, 2005, J BIOL CHEM, V280, P41928, DOI 10.1074/jbc.M508718200; Ma WB, 2003, CANCER RES, V63, P5320; Mengozzi M, 2006, HEART, V92, P838, DOI 10.1136/hrt.2005.064105; Mole DR, 2008, PEDIATR NEPHROL, V23, P681, DOI 10.1007/s00467-007-0632-x; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Ryou MG, 2009, AM J PHYSIOL-HEART C, V297, pH1914, DOI 10.1152/ajpheart.01213.2008; Semenza GL, 2002, INTERNAL MED, V41, P79, DOI 10.2169/internalmedicine.41.79; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; Stroka DM, 2001, FASEB J, V15, P2445, DOI 10.1096/fj.01-0125com; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; Traykova-Brauch M, 2008, NAT MED, V14, P979, DOI 10.1038/nm.1865; Ueda K, 2010, J CLIN INVEST, V120, P2016, DOI 10.1172/JCI39896; Vogel J, 2003, BLOOD, V102, P2278, DOI 10.1182/blood-2003-01-0283; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Weidemann A, 2009, J CLIN INVEST, V119, P3373, DOI 10.1172/JCI39378; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; Wiesener MS, 2002, FASEB J, V16, P271, DOI 10.1096/fj.02-0445fje; Young AP, 2008, NAT CELL BIOL, V10, P361, DOI 10.1038/ncb1699; ZANJANI ED, 1981, J CLIN INVEST, V67, P1183, DOI 10.1172/JCI110133	52	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22589	10.1371/journal.pone.0022589	http://dx.doi.org/10.1371/journal.pone.0022589			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811636	Green Submitted, gold, Green Published			2022-12-25	WOS:000292956800073
J	Narayanan, SP; Suwanpradid, J; Saul, A; Xu, ZM; Still, A; Caldwell, RW; Caldwell, RB				Narayanan, Subhadra P.; Suwanpradid, Jutamas; Saul, Alan; Xu, Zhimin; Still, Amber; Caldwell, Robert W.; Caldwell, Ruth B.			Arginase 2 Deletion Reduces Neuro-Glial Injury and Improves Retinal Function in a Model of Retinopathy of Prematurity	PLOS ONE			English	Article							OXYGEN-INDUCED RETINOPATHY; NITRIC-OXIDE SYNTHASE; MILD RETINOPATHY; CELL CHANGES; RAT RETINA; MOUSE; APOPTOSIS; CHILDREN; HISTORY; BRAIN	Background: Retinopathy of prematurity (ROP) is a major cause of vision impairment in low birth weight infants. While previous work has focused on defining the mechanisms of vascular injury leading to retinal neovascularization, recent studies show that neurons are also affected. This study was undertaken to determine the role of the mitochondrial arginine/ornithine regulating enzyme arginase 2 (A2) in retinal neuro-glial cell injury in the mouse model of ROP. Methods and Findings: Studies were performed using wild type (WT) and A2 knockout (A2-/-) mice exposed to Oxygen Induced Retinopathy (OIR). Neuronal injury and apoptosis were assessed using immunohistochemistry, TUNEL (terminal deoxynucleotidyl transferase dUTP nick end) labeling and Western blotting. Electroretinography (ERG) was used to assess retinal function. Neuro-glial injury in WT ROP mice was evident by TUNEL labeling, retinal thinning, decreases in number of rod bipolar cells and glial cell activation as compared with room air controls. Significant reduction in numbers of TUNEL positive cells, inhibition of retinal thinning, preservation of the rod bipolar cells and prevention of glial activation were observed in the A2-/- retinas. Retinal function was markedly impaired in the WT OIR mice as shown by decreases in amplitude of the b-wave of the ERG. This defect was significantly reduced in A2-/- mice. Levels of the pro-apoptotic proteins p53, cleaved caspase 9, cytochrome C and the mitochondrial protein Bim were markedly increased in WT OIR retinas compared to controls, whereas the pro-survival mitrochondrial protein BCL-xl was reduced. These alterations were largely blocked in the A2-/- OIR retina. Conclusions: Our data implicate A2 in neurodegeneration during ROP. Deletion of A2 significantly improves neuronal survival and function, possibly through the regulation of mitochondrial membrane permeability mediated apoptosis during retinal ischemia. These molecular events are associated with decreased activation of glial cells, suggesting a rescue effect on macroglia as well.	[Narayanan, Subhadra P.; Suwanpradid, Jutamas; Xu, Zhimin; Caldwell, Ruth B.] Georgia Hlth Sci Univ, Vasc Biol Ctr, Augusta, GA USA; [Narayanan, Subhadra P.; Caldwell, Ruth B.] Georgia Hlth Sci Univ, Dept Cellular Biol & Anat, Augusta, GA USA; [Saul, Alan; Still, Amber; Caldwell, Ruth B.] Georgia Hlth Sci Univ, Dept Ophthalmol, Augusta, GA USA; [Caldwell, Robert W.] Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, Augusta, GA USA; [Caldwell, Ruth B.] Charlie Norwood VA Med Ctr, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Narayanan, SP (corresponding author), Georgia Hlth Sci Univ, Vasc Biol Ctr, Augusta, GA USA.	rcaldwel@georgiahealth.edu	Suwanpradid, Jutamas/K-5799-2019; Xu, Zhimin/L-9853-2013	Narayanan, Priya/0000-0001-5903-879X; Caldwell, Ruth/0000-0003-0168-0354	VA Merit Review Award;  [NIH-EY04618];  [NIH-EY011766];  [NIH-HL70215]; NATIONAL EYE INSTITUTE [R01EY004618, R01EY011766] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070215] Funding Source: NIH RePORTER	VA Merit Review Award(US Department of Veterans Affairs); ; ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH-EY04618, NIH-EY011766, NIH-HL70215, and VA Merit Review Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akula JD, 2008, MOL VIS, V14, P2499; AKULA JD, EXP EYE RES; Barnaby AM, 2007, INVEST OPHTH VIS SCI, V48, P4854, DOI 10.1167/iovs.07-0406; Bartoli M, 2009, INVEST OPHTH VIS SCI, V50, P4934, DOI 10.1167/iovs.08-2158; Braissant O, 1999, MOL BRAIN RES, V70, P231, DOI 10.1016/S0169-328X(99)00151-5; Cederbaum SD, 2004, MOL GENET METAB, V81, pS38, DOI 10.1016/j.ymgme.2003.10.012; Culmsee C, 2005, BIOCHEM BIOPH RES CO, V331, P761, DOI 10.1016/j.bbrc.2005.03.149; Dembinska O, 2001, INVEST OPHTH VIS SCI, V42, P1111; Downie LE, 2007, J COMP NEUROL, V504, P404, DOI 10.1002/cne.21449; Downie LE, 2010, J COMP NEUROL, V518, P41, DOI 10.1002/cne.22205; Durante W, 2007, CLIN EXP PHARMACOL P, V34, P906, DOI 10.1111/j.1440-1681.2007.04638.x; Eldred WD, 2005, VISION RES, V45, P3469, DOI 10.1016/j.visres.2005.07.033; Fletcher EL, 2010, DOC OPHTHALMOL, V120, P67, DOI 10.1007/s10633-009-9193-6; Fulton AB, 2005, DOC OPHTHALMOL, V111, P7, DOI 10.1007/s10633-005-2621-3; Fulton AB, 2001, ARCH OPHTHALMOL-CHIC, V119, P499; Fulton AB, 1996, J OPT SOC AM A, V13, P566, DOI 10.1364/JOSAA.13.000566; Fulton AB, 2009, PROG RETIN EYE RES, V28, P452, DOI 10.1016/j.preteyeres.2009.06.003; Gu XL, 2002, INVEST OPHTH VIS SCI, V43, P496; Hansen RM, 2000, INVEST OPHTH VIS SCI, V41, P320; Hetman M, 2010, J NEUROCHEM, V114, P1537, DOI 10.1111/j.1471-4159.2010.06859.x; HONG LZ, 2005, NEUROSCI B, V26, P232; Ivanova S, 2002, P NATL ACAD SCI USA, V99, P5579, DOI 10.1073/pnas.082609299; Kolb H., 1995, WEBVISION ORG RETINA; Lachapelle P, 1999, CAN J PHYSIOL PHARM, V77, P48, DOI 10.1139/cjpp-77-1-48; LAU A, PFLUGERS ARCH, V460, P525; Liu K, 2006, INVEST OPHTH VIS SCI, V47, P5447, DOI 10.1167/iovs.06-0702; Neufeld AH, 2002, EXP EYE RES, V75, P521, DOI 10.1006/exer.2002.2042; Ning T, 2004, VISION RES, V44, P3307, DOI 10.1016/j.visres.2004.07.041; O'Connor AR, 2002, PEDIATRICS, V109, P12, DOI 10.1542/peds.109.1.12; Pernet V, 2007, J NEUROCHEM, V103, P1481, DOI 10.1111/j.1471-4159.2007.04843.x; Romero MJ, 2008, CIRC RES, V102, P95, DOI 10.1161/CIRCRESAHA.107.155028; Sakamoto K, 2006, EXP EYE RES, V82, P512, DOI 10.1016/j.exer.2005.08.011; Sass G, 2007, J IMMUNOL, V179, P7042, DOI 10.4049/jimmunol.179.10.7042; Sennlaub F, 2002, J NEUROSCI, V22, P3987, DOI 10.1523/JNEUROSCI.22-10-03987.2002; Sennlaub F, 2001, J CLIN INVEST, V107, P717, DOI 10.1172/JCI10874; Shi O, 2001, MOL CELL BIOL, V21, P811, DOI 10.1128/MCB.21.3.811-813.2001; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; STEVENSON L, 2002, INVEST OPHTH VIS SCI, V51, P3291; Takano K, 2005, CURR NEUROVASC RES, V2, P213, DOI 10.2174/1567202054368335; Wood PL, 2006, BRAIN RES, V1095, P190, DOI 10.1016/j.brainres.2006.04.038; Yang XL, 2004, PROG NEUROBIOL, V73, P127, DOI 10.1016/j.pneurobio.2004.04.002; Yu H, 2001, J NEUROSCI RES, V66, P406, DOI 10.1002/jnr.1233; Zhang WB, 2009, AM J PATHOL, V175, P891, DOI 10.2353/ajpath.2009.081115	43	47	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22460	10.1371/journal.pone.0022460	http://dx.doi.org/10.1371/journal.pone.0022460			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811615	Green Published, Green Submitted, gold			2022-12-25	WOS:000292956800060
J	Conway, MJ; Cruz, L; Alam, S; Christensen, ND; Meyers, C				Conway, Michael J.; Cruz, Linda; Alam, Samina; Christensen, Neil D.; Meyers, Craig			Differentiation-Dependent Interpentameric Disulfide Bond Stabilizes Native Human Papillomavirus Type 16	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; SARCOMA-ASSOCIATED HERPESVIRUS; MAJOR CAPSID PROTEIN; KAPOSIS-SARCOMA; POLYOMAVIRUS CAPSIDS; L1; INFECTION; PROPAGATION; CELLS; DNA	Genetic and biochemical analyses of human papillomavirus type 16 (HPV16) capsids have shown that certain conserved L1 cysteine residues are critical for capsid assembly, integrity, and maturation. Since previous studies utilized HPV capsids produced in monolayer culture-based protein expression systems, the ascribed roles for these cysteine residues were not placed in the temporal context of the natural host environment for HPV, stratifying and differentiating human tissue. Here we extend upon previous observation, that HPV16 capsids mature and become stabilized over time (10-day to 20-day) in a naturally occurring tissue-spanning redox gradient, by identifying temporal roles for individual L1 cysteine residues. Specifically, the C175S substitution severely undermined wild-type titers of the virus within both 10 and 20-day tissue, while C428S, C185S, and C175,185S substitutions severely undermined wild-type titers only within 20-day tissue. All mutations led to 20-day virions that were less stable than wild-type and failed to form L1 multimers via nonreducing SDS-PAGE. Furthermore, Optiprep-fractionated 20-day C428S, C175S, and C175,185S capsids appeared permeable to endonucleases in comparison to wild-type and C185S capsids. Exposure to an oxidizing environment failed to enhance infectious titers of any of the cysteine mutants over time as with wild-type. Introduction of these cys mutants results in failure of the virus to mature.	[Conway, Michael J.; Cruz, Linda; Alam, Samina; Meyers, Craig] Penn State Univ, Dept Microbiol & Immunol, Coll Med, Hershey, PA USA; [Christensen, Neil D.] Penn State Univ, Dept Pathol, Coll Med, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Conway, MJ (corresponding author), Penn State Univ, Dept Microbiol & Immunol, Coll Med, Hershey, PA USA.	cmm10@psu.edu	alam, samina/V-1599-2018		National Institute of Allergy and Infectious Diseases (NIAID) [R01AI57988]; Pennsylvania Department of Health [4100050904]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057988] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Pennsylvania Department of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a PHS grant from the National Institute of Allergy and Infectious Diseases (NIAID) (R01AI57988) and by TSF GRSA grant # 4100050904 from the Pennsylvania Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER TS, 1989, BIOPHYS J, V55, P243, DOI 10.1016/S0006-3495(89)82799-7; BAKER TS, 1991, BIOPHYS J, V60, P1445, DOI 10.1016/S0006-3495(91)82181-6; Belnap DM, 1996, J MOL BIOL, V259, P249, DOI 10.1006/jmbi.1996.0317; BIRD G, 2008, J VIROL; Buck CB, 2005, J VIROL, V79, P2839, DOI 10.1128/JVI.79.5.2839-2846.2005; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; BUCK CB, 2008, J VIROL; Chen XJS, 2000, MOL CELL, V5, P557, DOI 10.1016/S1097-2765(00)80449-9; Christensen ND, 2001, VIROLOGY, V291, P324, DOI 10.1006/viro.2001.1220; Chromy LR, 2006, J VIROL, V80, P5086, DOI 10.1128/JVI.80.10.5086-5091.2006; Chromy LR, 2003, P NATL ACAD SCI USA, V100, P10477, DOI 10.1073/pnas.1832245100; Conway MJ, 2009, J DENT RES, V88, P307, DOI 10.1177/0022034509333446; Conway MJ, 2009, VIROLOGY, V393, P295, DOI 10.1016/j.virol.2009.08.010; Conway MJ, 2009, J VIROL, V83, P10515, DOI 10.1128/JVI.00731-09; CONWAY MJ, 2011, PLOS ONE IN PRESS; Culp TD, 2003, J VIROL METHODS, V111, P135, DOI 10.1016/S0166-0934(03)00170-8; Culp TD, 2006, J VIROL, V80, P11381, DOI 10.1128/JVI.01328-06; Day PM, 2004, P NATL ACAD SCI USA, V101, P14252, DOI 10.1073/pnas.0404229101; Finnen RL, 2003, J VIROL, V77, P4818, DOI 10.1128/JVI.77.8.4818-4826.2003; Fligge C, 2001, J VIROL, V75, P7727, DOI 10.1128/JVI.75.16.7727-7731.2001; Flore O, 1998, NATURE, V394, P588, DOI 10.1038/29093; Foreman KE, 1997, NEW ENGL J MED, V336, P163, DOI 10.1056/NEJM199701163360302; Friborg J, 1998, J VIROL, V72, P10073, DOI 10.1128/JVI.72.12.10073-10082.1998; Gambhira R, 2007, J VIROL, V81, P13927, DOI 10.1128/JVI.00936-07; Ishii Y, 2005, VIRUS GENES, V31, P321, DOI 10.1007/s11262-005-3250-3; Ishii Y, 2003, VIROLOGY, V308, P128, DOI 10.1016/S0042-6822(02)00099-5; Ishii Y, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-110; Kedes DH, 1997, J CLIN INVEST, V99, P2082, DOI 10.1172/JCI119380; KIRNBAUER R, 1993, J VIROL, V67, P6929, DOI 10.1128/JVI.67.12.6929-6936.1993; KIRNBAUER R, 1992, P NATL ACAD SCI USA, V89, P12180, DOI 10.1073/pnas.89.24.12180; Li ML, 1998, J VIROL, V72, P2160, DOI 10.1128/JVI.72.3.2160-2167.1998; McLaughlin-Drubin ME, 2005, METH MOLEC MED, V119, P171; McLaughlin-Drubin ME, 2004, VIROLOGY, V322, P213, DOI 10.1016/j.virol.2004.02.011; McLaughlin-Drubin ME, 2003, VIROLOGY, V312, P1, DOI 10.1016/S0042-6822(03)00312-X; MEYERS C, 1992, SCIENCE, V257, P971, DOI 10.1126/science.1323879; Meyers C, 1997, J VIROL, V71, P7381, DOI 10.1128/JVI.71.10.7381-7386.1997; Modis Y, 2002, EMBO J, V21, P4754, DOI 10.1093/emboj/cdf494; Mukherjee S, 2008, J MOL BIOL, V381, P229, DOI 10.1016/j.jmb.2008.05.079; Nicklas JA, 2003, J FORENSIC SCI, V48, P936; Renne R, 1996, NAT MED, V2, P342, DOI 10.1038/nm0396-342; Sapp M, 1998, J VIROL, V72, P6186, DOI 10.1128/JVI.72.7.6186-6189.1998; Smith JL, 2007, J VIROL, V81, P9922, DOI 10.1128/JVI.00988-07; Song HB, 2010, VIRUS RES, V147, P113, DOI 10.1016/j.virusres.2009.10.019; Trus BL, 1997, NAT STRUCT BIOL, V4, P413, DOI 10.1038/nsb0597-413; WOLF M, P NATL ACAD SCI US, V107, P6298	45	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22427	10.1371/journal.pone.0022427	http://dx.doi.org/10.1371/journal.pone.0022427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21811610	gold, Green Published, Green Submitted			2022-12-25	WOS:000292929500067
J	Cutler, JE; Corti, M; Lambert, P; Ferris, M; Xin, H				Cutler, Jim E.; Corti, Miriam; Lambert, Patrick; Ferris, Michael; Xin, Hong			Horizontal Transmission of Candida albicans and Evidence of a Vaccine Response in Mice Colonized with the Fungus	PLOS ONE			English	Article							GASTRO-INTESTINAL TRACT; INTENSIVE-CARE-UNIT; CELL-WALL; TORULOPSIS-PINTOLOPESII; MICROBIAL COLONIZATION; GASTROINTESTINAL-TRACT; MANNAN; DISSEMINATION; PROTECTION; ANTIBODIES	Disseminated candidiasis is the third leading nosocomial blood stream infection in the United States and is often fatal. We previously showed that disseminated candidiasis was preventable in normal mice by immunization with either a glycopeptide or a peptide synthetic vaccine, both of which were Candida albicans cell wall derived. A weakness of these studies is that, unlike humans, mice do not have a C. albicans GI flora and they lack Candida serum antibodies. We examined the influence of C. albicans GI tract colonization and serum antibodies on mouse vaccination responses to the peptide, Fba, derived from fructose bisphosphate aldolase which has cytosolic and cell wall distributions in the fungus. We evaluated the effect of live C. albicans in drinking water and antimicrobial agents on establishment of Candida colonization of the mouse GI tract. Body mass, C. albicans in feces, and fungal-specific serum antibodies were monitored longitudinally. Unexpectedly, C. albicans colonization occurred in mice that received only antibiotics in their drinking water, provided that the mice were housed in the same room as intentionally colonized mice. The fungal strain in unintentionally colonized mice appeared identical to the strain used for intentional GI-tract colonization. This is the first report of horizontal transmission and spontaneous C. albicans colonization in mice. Importantly, many Candida-colonized mice developed serum fungal-specific antibodies. Despite the GI-tract colonization and presence of serum antibodies, the animals made antibodies in response to the Fba immunogen. This mouse model has potential for elucidating C. albicans horizontal transmission and for exploring factors that induce host defense against disseminated candidiasis. Furthermore, a combined protracted GI-tract colonization with Candida and the possibility of serum antibody responses to the presence of the fungus makes this an attractive mouse model for testing the efficacy of vaccines designed to prevent human disseminated candidiasis.	[Cutler, Jim E.; Ferris, Michael; Xin, Hong] Louisiana State Univ Hlth Sci Ctr, Dept Pediat, New Orleans, LA USA; [Cutler, Jim E.; Corti, Miriam; Lambert, Patrick] Childrens Hosp, Res Inst Children, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Children's Hospital of New Orleans	Cutler, JE (corresponding author), Louisiana State Univ Hlth Sci Ctr, Dept Pediat, New Orleans, LA USA.	jcutler@chnola-research.org			RIC; NIH-NIAID [PO1 AI061537]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI061537] Funding Source: NIH RePORTER	RIC(Defence Research & Development Organisation (DRDO)); NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the RIC and by an NIH-NIAID program grant PO1 AI061537. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTWOHL JE, 1979, APPL ENVIRON MICROB, V37, P697, DOI 10.1128/AEM.37.4.697-703.1979; Bliss JM, 2008, PEDIATR INFECT DIS J, V27, P231, DOI 10.1097/INF.0b013e31815bb69d; Bougnoux ME, 2006, J CLIN MICROBIOL, V44, P1810, DOI 10.1128/JCM.44.5.1810-1820.2006; Bougnoux ME, 2002, J CLIN MICROBIOL, V40, P1290, DOI 10.1128/JCM.40.4.1290-1297.2002; Cliff PR, 2008, J HOSP INFECT, V69, P24, DOI 10.1016/j.jhin.2008.02.006; Conti HR, 2010, MICROBES INFECT, V12, P518, DOI 10.1016/j.micinf.2010.03.013; Cutler JE, 2007, NAT REV MICROBIOL, V5, P13, DOI 10.1038/nrmicro1537; DOMER JE, 1987, ANTIMICROB AGENTS CH, V31, P691, DOI 10.1128/AAC.31.5.691; EKENNA O, 1987, INFECT IMMUN, V55, P1558, DOI 10.1128/IAI.55.7.1558-1563.1987; FIELD LH, 1981, INFECT IMMUN, V31, P783, DOI 10.1128/IAI.31.2.783-791.1981; Goins TL, 2000, J CLIN MICROBIOL, V38, P2862, DOI 10.1128/JCM.38.8.2862-2869.2000; Han Y, 1997, INFECT IMMUN, V65, P4100, DOI 10.1128/IAI.65.10.4100-4107.1997; Han Y, 1999, J INFECT DIS, V179, P1477, DOI 10.1086/314779; HAN YM, 1995, INFECT IMMUN, V63, P2714, DOI 10.1128/IAI.63.7.2714-2719.1995; HAZEN KC, 1987, J MICROBIOL METH, V6, P289, DOI 10.1016/0167-7012(87)90066-2; HERAEZ ML, 2010, J PROTEOMICS, V73, P1404; Horn DL, 2009, CLIN INFECT DIS, V48, P1695, DOI 10.1086/599039; Hsu FC, 2009, J MICROBIOL IMMUNOL, V42, P378; KANBE T, 1994, INFECT IMMUN, V62, P1662, DOI 10.1128/IAI.62.5.1662-1668.1994; KANBE T, 1993, INFECT IMMUN, V61, P2578, DOI 10.1128/IAI.61.6.2578-2584.1993; Karwa R, 2009, ANN PHARMACOTHER, V43, P1818, DOI 10.1345/aph.1M218; Klis FM, 2001, MED MYCOL, V39, P1, DOI 10.1080/744118876; Kobayashi H, 1998, ARCH MICROBIOL, V169, P188, DOI 10.1007/s002030050559; Kobayashi H, 2003, ARCH MICROBIOL, V180, P76, DOI 10.1007/s00203-003-0550-7; Koh AY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040035; Lupetti A, 2002, J CLIN MICROBIOL, V40, P2363, DOI 10.1128/JCM.40.7.2363-2369.2002; Mellado E, 2000, DIAGN MICR INFEC DIS, V38, P21, DOI 10.1016/S0732-8893(00)00165-6; Mochon AB, 2005, MED MYCOL, V43, P97, DOI 10.1080/13693780500035979; Nitz M, 2002, J BIOL CHEM, V277, P3440, DOI 10.1074/jbc.M109274200; Odds FC, 2006, J CLIN MICROBIOL, V44, P3647, DOI 10.1128/JCM.00934-06; Odds FC., 1988, CANDIDA CANDIDOSIS; Pitarch A, 2006, MOL CELL PROTEOMICS, V5, P79, DOI 10.1074/mcp.M500243-MCP200; Pitarch A, 2002, MOL CELL PROTEOMICS, V1, P967, DOI 10.1074/mcp.M200062-MCP200; Ponton J, 2001, MED MYCOL, V39, P101, DOI 10.1080/744118882; SAMONIS G, 1994, ANTIMICROB AGENTS CH, V38, P602, DOI 10.1128/AAC.38.3.602; SAVAGE D, 1967, J BACTERIOL, V94, P1811, DOI 10.1128/JB.94.6.1811-1816.1967; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Shibata N, 2003, EUR J BIOCHEM, V270, P2565, DOI 10.1046/j.1432-1033.2003.03622.x; Spellberg B, 2008, J INFECT DIS, V197, P967, DOI 10.1086/529204; SUEGARA N, 1979, INFECT IMMUN, V25, P139, DOI 10.1128/IAI.25.1.139-145.1979; Tansho S, 2004, MEDIAT INFLAMM, V13, P189, DOI 10.1080/09511920410001713510; Tavanti A, 2003, J CLIN MICROBIOL, V41, P3765, DOI 10.1128/JCM.41.8.3765-3776.2003; TEWARI RP, 1978, J INFECT DIS, V138, P605, DOI 10.1093/infdis/138.5.605; Torosantucci A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005392; van de Veerdonk FL, 2010, CURR OPIN CRIT CARE, V16, P453, DOI 10.1097/MCC.0b013e32833e046e; VARGAS SL, 1993, INFECT IMMUN, V61, P619, DOI 10.1128/IAI.61.2.619-626.1993; White SJ, 2007, PLOS PATHOG, V3, P1866, DOI 10.1371/journal.ppat.0030184; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Wrobel L, 2008, EUKARYOT CELL, V7, P1475, DOI 10.1128/EC.00162-08; XIN H, 2007, ASM P; Xin H, 2008, P NATL ACAD SCI USA, V105, P13526, DOI 10.1073/pnas.0803195105; Xin H, 2006, INFECT IMMUN, V74, P4310, DOI 10.1128/IAI.00234-06	52	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22030	10.1371/journal.pone.0022030	http://dx.doi.org/10.1371/journal.pone.0022030			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21818288	Green Submitted, gold, Green Published			2022-12-25	WOS:000292929500030
J	Vandenberg, LN; Pennarola, BW; Levin, M				Vandenberg, Laura N.; Pennarola, Brian W.; Levin, Michael			Low Frequency Vibrations Disrupt Left-Right Patterning in the Xenopus Embryo	PLOS ONE			English	Article							LEFT-RIGHT ASYMMETRY; LEFT-RIGHT AXIS; SEA-URCHIN DEVELOPMENT; MAGNETIC-FIELDS; GENE-EXPRESSION; EARLY STEP; UNCONVENTIONAL MYOSIN; T-LYMPHOCYTES; CELL POLARITY; GAP-JUNCTIONS	The development of consistent left-right (LR) asymmetry across phyla is a fascinating question in biology. While many pharmacological and molecular approaches have been used to explore molecular mechanisms, it has proven difficult to exert precise temporal control over functional perturbations. Here, we took advantage of acoustical vibration to disrupt LR patterning in Xenopus embryos during tightly-circumscribed periods of development. Exposure to several low frequencies induced specific randomization of three internal organs (heterotaxia). Investigating one frequency (7 Hz), we found two discrete periods of sensitivity to vibration; during the first period, vibration affected the same LR pathway as nocodazole, while during the second period, vibration affected the integrity of the epithelial barrier; both are required for normal LR patterning. Our results indicate that low frequency vibrations disrupt two steps in the early LR pathway: the orientation of the LR axis with the other two axes, and the amplification/restriction of downstream LR signals to asymmetric organs.	[Vandenberg, Laura N.; Levin, Michael] Tufts Univ, Ctr Regenerat & Dev Biol, Medford, MA 02155 USA; [Vandenberg, Laura N.; Pennarola, Brian W.; Levin, Michael] Tufts Univ, Dept Biol, Medford, MA 02155 USA	Tufts University; Tufts University	Vandenberg, LN (corresponding author), Tufts Univ, Ctr Regenerat & Dev Biol, Medford, MA 02155 USA.	michael.levin@tufts.edu	Levin, Michael/A-5918-2011	Levin, Michael/0000-0001-7292-8084	American Heart Association [0740088N]; NIH [R01-GM077425]; NRSA [1F32GM087107]; Tufts University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM087107, R01GM077425] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tufts University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Heart Association Established Investigator Grant 0740088N and NIH grant R01-GM077425 to ML, NRSA grant 1F32GM087107 to LNV, and a Neubauer Fellowship from Tufts University to BWP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2004, PLANT CELL PHYSIOL, V45, P211, DOI 10.1093/pcp/pch026; Adams DS, 2006, DEVELOPMENT, V133, P1657, DOI 10.1242/dev.02341; Armakolas A, 2007, SCIENCE, V315, P100, DOI 10.1126/science.1129429; Aw S, 2008, MECH DEVELOP, V125, P353, DOI 10.1016/j.mod.2007.10.011; Aw S, 2010, DEV BIOL, V346, P39, DOI 10.1016/j.ydbio.2010.07.011; Aw S, 2009, DEVELOPMENT, V136, P355, DOI 10.1242/dev.015974; Bajoghli B, 2007, DEV BIOL, V303, P347, DOI 10.1016/j.ydbio.2006.11.020; Basu B, 2008, CURR TOP DEV BIOL, V85, P151, DOI 10.1016/S0070-2153(08)00806-5; Blackiston Douglas, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5532; BLUM M, 2006, DEV BIOL, V295; Blum M, 2009, DEV DYNAM, V238, P1215, DOI 10.1002/dvdy.21855; Brizuela BJ, 2001, DEV BIOL, V230, P217, DOI 10.1006/dbio.2000.0116; Brueckner M, 2001, AM J MED GENET, V101, P339, DOI 10.1002/1096-8628(20010715)101:4<339::AID-AJMG1442>3.0.CO;2-P; Bunney TD, 2003, DEVELOPMENT, V130, P4847, DOI 10.1242/dev.00698; Casey B, 2000, CURR OPIN GENET DEV, V10, P257, DOI 10.1016/S0959-437X(00)00085-X; Casey B, 1998, HUM MOL GENET, V7, P1565, DOI 10.1093/hmg/7.10.1565; Chuang CF, 2007, CELL, V129, P787, DOI 10.1016/j.cell.2007.02.052; Coutelis JB, 2008, SEMIN CELL DEV BIOL, V19, P252, DOI 10.1016/j.semcdb.2008.01.006; Danilchik MV, 2006, DEVELOPMENT, V133, P4517, DOI 10.1242/dev.02642; DANOS MC, 1995, DEVELOPMENT, V121, P1467; FRANKEL J, 1991, CIBA F SYMP, V162, P73; Fukumoto T, 2005, DEV NEUROSCI-BASEL, V27, P349, DOI 10.1159/000088451; Fukumoto T, 2005, CURR BIOL, V15, P794, DOI 10.1016/j.cub.2005.03.044; Gros J, 2009, SCIENCE, V324, P941, DOI 10.1126/science.1172478; HARLAND RM, 1991, XENOPUS LAEVIS PRACT, P685; Hashimoto T, 2002, PHILOS T ROY SOC B, V357, P799, DOI 10.1098/rstb.2002.1088; Hibino T, 2006, DEV GENES EVOL, V216, P265, DOI 10.1007/s00427-005-0051-6; Hozumi S, 2006, NATURE, V440, P798, DOI 10.1038/nature04625; HUTTER H, 1995, DEVELOPMENT, V121, P3417; Huuskonen H, 2001, REPROD TOXICOL, V15, P49; Ikeda K, 2010, METHOD CELL BIOL, V97, P401, DOI 10.1016/S0091-679X(10)97021-0; Kitazawa C, 2007, J EXP ZOOL PART A, V307A, P249, DOI 10.1002/jez.378; Klar Amar J S, 2008, Breast Dis, V29, P47; Kosaki K, 1998, SEMIN CELL DEV BIOL, V9, P89, DOI 10.1006/scdb.1997.0187; Kramer KL, 2002, CELL, V111, P981, DOI 10.1016/S0092-8674(02)01200-X; Kuroda R, 2009, NATURE, V462, P790, DOI 10.1038/nature08597; Levin M, 2005, MECH DEVELOP, V122, P3, DOI 10.1016/j.mod.2004.08.006; Levin M, 2004, CRIT REV ORAL BIOL M, V15, P197, DOI 10.1177/154411130401500403; Levin M, 2003, DEV BIOL, V259, P482; Levin M, 1998, GENE DEV, V12, P763, DOI 10.1101/gad.12.6.763; Levin M, 1999, DEVELOPMENT, V126, P4703; Levin M, 2002, CELL, V111, P77, DOI 10.1016/S0092-8674(02)00939-X; Levin M, 1998, DEV BIOL, V203, P90, DOI 10.1006/dbio.1998.9024; LEVIN M, 1995, BIOELECTROMAGNETICS, V16, P231, DOI 10.1002/bem.2250160405; Levin M, 2007, BIOESSAYS, V29, P271, DOI 10.1002/bies.20545; Levin Michael, 2006, Birth Defects Research, V78, P191, DOI 10.1002/bdrc.20078; Levin M, 2006, DEV NEUROSCI-BASEL, V28, P171, DOI 10.1159/000091915; Lewis Marian L, 2002, Adv Space Biol Med, V8, P77; Lewis ML, 2001, FASEB J, V15, P1783, DOI 10.1096/fj.00-0820fje; McGrath J, 2003, CURR OPIN GENET DEV, V13, P385, DOI 10.1016/S0959-437X(03)00091-1; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Merzdorf CS, 1998, DEV BIOL, V195, P187, DOI 10.1006/dbio.1997.8846; MESHCHERYAKOV VN, 1975, ROUX ARCH DEV BIOL, V177, P193, DOI 10.1007/BF00848080; Morokuma J, 2008, CELL PHYSIOL BIOCHEM, V21, P357, DOI 10.1159/000129628; Muders K, 2006, DEV BIOL, V295, P450, DOI 10.1016/j.ydbio.2006.04.389; MULLER HAJ, 1995, DEV DYNAM, V202, P405; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Palmer AR, 2004, SCIENCE, V306, P828, DOI 10.1126/science.1103707; Pekker I, 2005, PLANT CELL, V17, P2899, DOI 10.1105/tpc.105.034876; PRIESS JR, 1994, CURR OPIN GENET DEV, V4, P563, DOI 10.1016/0959-437X(94)90073-C; Qiu DY, 2005, DEV DYNAM, V234, P176, DOI 10.1002/dvdy.20509; Ramsdell AF, 1999, DEVELOPMENT, V126, P5195; Sampath K, 1997, DEVELOPMENT, V124, P3293; Schweickert A, 2007, CURR BIOL, V17, P60, DOI 10.1016/j.cub.2006.10.067; Serluca FC, 2009, DEVELOPMENT, V136, P1621, DOI 10.1242/dev.020735; Shibazaki Y, 2004, CURR BIOL, V14, P1462, DOI 10.1016/j.cub.2004.08.018; Shimeld SM, 2006, DEV DYNAM, V235, P1543, DOI 10.1002/dvdy.20792; Simard A, 2006, MECH DEVELOP, V123, P210, DOI 10.1016/j.mod.2005.12.004; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Speder P, 2006, NATURE, V440, P803, DOI 10.1038/nature04623; Speder P, 2007, CURR OPIN GENET DEV, V17, P351, DOI 10.1016/j.gde.2007.05.008; Supp DM, 1999, DEVELOPMENT, V126, P5495; Supp DM, 1997, NATURE, V389, P963, DOI 10.1038/40140; Tabin CJ, 2003, GENE DEV, V17, P1, DOI 10.1101/gad.1053803; Tanaka Y, 2005, NATURE, V435, P172, DOI 10.1038/nature03494; Thitamadee S, 2002, NATURE, V417, P193, DOI 10.1038/417193a; Tofani S, 2001, BIOELECTROMAGNETICS, V22, P419, DOI 10.1002/bem.69; UBEDA A, 1994, BIOELECTROMAGNETICS, V15, P385, DOI 10.1002/bem.2250150503; Vandenberg LN, 2010, DEV DYNAM, V239, P3131, DOI 10.1002/dvdy.22450; Vandenberg LN, 2010, DEVELOPMENT, V137, P1095, DOI 10.1242/dev.041798; Vandenberg LN, 2009, SEMIN CELL DEV BIOL, V20, P456, DOI 10.1016/j.semcdb.2008.11.010; VanHoven MK, 2006, NEURON, V51, P291, DOI 10.1016/j.neuron.2006.06.029; Vick P, 2009, DEV BIOL, V331, P281, DOI 10.1016/j.ydbio.2009.05.547; Weaver C, 2004, DEVELOPMENT, V131, P3491, DOI 10.1242/dev.01284; Wheeler GN, 2009, DEV DYNAM, V238, P1287, DOI 10.1002/dvdy.21967; WOOD WB, 1991, CIBA F SYMP, V162, P143; Xu B, 2010, DEV BIOL, V348, P3, DOI 10.1016/j.ydbio.2010.08.018; Xu JS, 2007, P NATL ACAD SCI USA, V104, P9296, DOI 10.1073/pnas.0703153104; Yost HJ, 2001, INT REV CYTOL, V203, P357; YOST HJ, 1991, CIBA F SYMP, V162, P165	91	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e23306	10.1371/journal.pone.0023306	http://dx.doi.org/10.1371/journal.pone.0023306			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826245	Green Published, gold			2022-12-25	WOS:000293558900071
J	Ahn, JY; Yang, LY; Paster, BJ; Ganly, I; Morris, L; Pei, ZH; Hayes, RB				Ahn, Jiyoung; Yang, Liying; Paster, Bruce J.; Ganly, Ian; Morris, Luc; Pei, Zhiheng; Hayes, Richard B.			Oral Microbiome Profiles: 16S rRNA Pyrosequencing and Microarray Assay Comparison	PLOS ONE			English	Article							PERIODONTITIS; MICROFLORA; SEQUENCES	Objectives: The human oral microbiome is potentially related to diverse health conditions and high-throughput technology provides the possibility of surveying microbial community structure at high resolution. We compared two oral microbiome survey methods: broad-based microbiome identification by 16S rRNA gene sequencing and targeted characterization of microbes by custom DNA microarray. Methods: Oral wash samples were collected from 20 individuals at Memorial Sloan-Kettering Cancer Center. 16S rRNA gene survey was performed by 454 pyrosequencing of the V3-V5 region (450 bp). Targeted identification by DNA microarray was carried out with the Human Oral Microbe Identification Microarray (HOMIM). Correlations and relative abundance were compared at phylum and genus level, between 16S rRNA sequence read ratio and HOMIM hybridization intensity. Results: The major phyla, Firmicutes, Proteobacteria, Bacteroidetes, Actinobacteria, and Fusobacteria were identified with high correlation by the two methods (r = 0.70 similar to 0.86). 16S rRNA gene pyrosequencing identified 77 genera and HOMIM identified 49, with 37 genera detected by both methods; more than 98% of classified bacteria were assigned in these 37 genera. Concordance by the two assays (presence/absence) and correlations were high for common genera (Streptococcus, Veillonella, Leptotrichia, Prevotella, and Haemophilus; Correlation = 0.70-0.84). Conclusion: Microbiome community profiles assessed by 16S rRNA pyrosequencing and HOMIM were highly correlated at the phylum level and, when comparing the more commonly detected taxa, also at the genus level. Both methods are currently suitable for high-throughput epidemiologic investigations relating identified and more common oral microbial taxa to disease risk; yet, pyrosequencing may provide a broader spectrum of taxa identification, a distinct sequence-read record, and greater detection sensitivity.	[Ahn, Jiyoung; Hayes, Richard B.] NYU, Dept Environm Med, Sch Med, Div Epidemiol, New York, NY 10016 USA; [Yang, Liying; Pei, Zhiheng] NYU, Dept Pathol, Sch Med, New York, NY 10016 USA; [Paster, Bruce J.] Forsyth Inst, Dept Mol Genet, Cambridge, MA USA; [Paster, Bruce J.] Harvard Univ, Sch Dent Med, Boston, MA 02115 USA; [Ganly, Ian; Morris, Luc] Mem Sloan Kettering Canc Ctr, Dept Head & Neck Surg, New York, NY 10021 USA	New York University; New York University; Harvard University; Forsyth Institute; Harvard University; Harvard School of Dental Medicine; Memorial Sloan Kettering Cancer Center	Ahn, JY (corresponding author), NYU, Dept Environm Med, Sch Med, Div Epidemiol, 550 1St Ave, New York, NY 10016 USA.	jiyoung.ahn@nyumc.org	Paster, Bruce J/AAP-8559-2021	Ahn, Jiyoung/0000-0002-2900-2304; Ganly, Ian/0000-0001-7636-5426; Pei, Zhiheng/0000-0001-8570-6747; Yang, Liying/0000-0003-1442-4915; Hayes, Richard/0000-0002-0918-661X	National Institutes of Health Roadmap Initiative and National Cancer Institute [UH3CA140233]; National Cancer Institute [R01 CA159036]; National Institute of Allergy and Infectious Diseases [R01AI063477]; NATIONAL CANCER INSTITUTE [UH3CA140233, R01CA159036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063477] Funding Source: NIH RePORTER	National Institutes of Health Roadmap Initiative and National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants UH3CA140233 from Human Microbiome Project of the National Institutes of Health Roadmap Initiative and National Cancer Institute, R01 CA159036 from National Cancer Institute, and R01AI063477 from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiko Y, 2010, J PERIODONTAL RES, V45, P389, DOI 10.1111/j.1600-0765.2009.01250.x; Buchen L, 2010, NATURE, V468, P492, DOI 10.1038/468492a; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Colombo APV, 2009, J PERIODONTOL, V80, P1421, DOI 10.1902/jop.2009.090185; Meurman Jukka H, 2010, J Oral Microbiol, V2, DOI 10.3402/jom.v2i0.5195; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Paster BJ, 2009, PERIODONTOL 2000, V51, P38, DOI 10.1111/j.1600-0757.2009.00316.x; Pei ZH, 2004, P NATL ACAD SCI USA, V101, P4250, DOI 10.1073/pnas.0306398101; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Preza D, 2009, EUR J CLIN MICROBIOL, V28, P509, DOI 10.1007/s10096-008-0662-8; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07	14	116	127	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22788	10.1371/journal.pone.0022788	http://dx.doi.org/10.1371/journal.pone.0022788			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829515	Green Published, gold, Green Submitted			2022-12-25	WOS:000293286500029
J	Cripps, IL; Munday, PL; McCormick, MI				Cripps, Ingrid L.; Munday, Philip L.; McCormick, Mark I.			Ocean Acidification Affects Prey Detection by a Predatory Reef Fish	PLOS ONE			English	Article							CHEMICAL ALARM SIGNALS; MARINE ECOSYSTEMS; ACIDIC CONDITIONS; DIVERSITY; ECOLOGY; IMPACT; CUES; POPULATIONS; COMPLEXITY; MORTALITY	Changes in olfactory-mediated behaviour caused by elevated CO2 levels in the ocean could affect recruitment to reef fish populations because larval fish become more vulnerable to predation. However, it is currently unclear how elevated CO2 will impact the other key part of the predator-prey interaction - the predators. We investigated the effects of elevated CO2 and reduced pH on olfactory preferences, activity levels and feeding behaviour of a common coral reef meso-predator, the brown dottyback (Pseudochromis fuscus). Predators were exposed to either current-day CO2 levels or one of two elevated CO2 levels (similar to 600 mu atm or similar to 950 mu atm) that may occur by 2100 according to climate change predictions. Exposure to elevated CO2 and reduced pH caused a shift from preference to avoidance of the smell of injured prey, with CO2 treated predators spending approximately 20% less time in a water stream containing prey odour compared with controls. Furthermore, activity levels of fish was higher in the high CO2 treatment and feeding activity was lower for fish in the mid CO2 treatment; indicating that future conditions may potentially reduce the ability of the fish to respond rapidly to fluctuations in food availability. Elevated activity levels of predators in the high CO2 treatment, however, may compensate for reduced olfactory ability, as greater movement facilitated visual detection of food. Our findings show that, at least for the species tested to date, both parties in the predator-prey relationship may be affected by ocean acidification. Although impairment of olfactory-mediated behaviour of predators might reduce the risk of predation for larval fishes, the magnitude of the observed effects of elevated CO2 acidification appear to be more dramatic for prey compared to predators. Thus, it is unlikely that the altered behaviour of predators is sufficient to fully compensate for the effects of ocean acidification on prey mortality.	[Cripps, Ingrid L.; Munday, Philip L.; McCormick, Mark I.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Munday, Philip L.; McCormick, Mark I.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Cripps, IL (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	ingrid.cripps@gmail.com	McCormick, Mark I/J-8301-2014; Munday, Philip L/F-5443-2011	McCormick, Mark I/0000-0001-9289-1645; Munday, Philip L/0000-0001-9725-2498	ARC Centre of Excellence for Coral Reef Studies [95917]; James Cook University; AIMS@JCU; Australian Research Council	ARC Centre of Excellence for Coral Reef Studies(Australian Research Council); James Cook University; AIMS@JCU; Australian Research Council(Australian Research Council)	This work was financed by the ARC Centre of Excellence for Coral Reef Studies (Grant 95917), James Cook University, and AIMS@JCU. PLM was supported by an Australian Research Council Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almany GR, 2006, CORAL REEFS, V25, P19, DOI 10.1007/s00338-005-0044-y; Almany GR, 2004, ECOLOGY, V85, P2933, DOI 10.1890/03-3150; Atema J., 1980, FISH BEHAV ITS USE C, V5, P57; Bailey KM, 2010, BIOL LETTERS, V6, P579, DOI 10.1098/rsbl.2010.0326; Beets J, 1997, MAR ECOL PROG SER, V148, P11, DOI 10.3354/meps148011; Bernstein L, 2008, CLIMATE CHANGE 2007; Beukers JS, 1998, OECOLOGIA, V114, P50, DOI 10.1007/s004420050419; Beukers-Stewart BD, 2004, J EXP MAR BIOL ECOL, V299, P155, DOI 10.1016/j.jembe.2003.08.015; Bibby R, 2007, BIOLOGY LETT, V3, P699, DOI 10.1098/rsbl.2007.0457; Brown GE, 2000, BEHAVIOUR, V137, P181, DOI 10.1163/156853900502015; Brown GE, 2002, CAN J FISH AQUAT SCI, V59, P1331, DOI 10.1139/F02-104; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; CARR MH, 1995, MAR ECOL PROG SER, V124, P31, DOI 10.3354/meps124031; Chivers DP, 1996, AM NAT, V148, P649, DOI 10.1086/285945; Dixson DL, 2010, ECOL LETT, V13, P68, DOI 10.1111/j.1461-0248.2009.01400.x; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; Ferrari MCO, 2011, GLOBAL CHANGE BIOL, V17, P2980, DOI 10.1111/j.1365-2486.2011.02439.x; Ferrari MCO, 2010, CAN J ZOOL, V88, P698, DOI 10.1139/Z10-029; Gazeau F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028554; Gerking SD, 1994, FEEDING ECOLOGY FISH, P15; Hara TJ, 2006, J FISH BIOL, V68, P810, DOI 10.1111/j.1095.8649.2006.00967.x; HARA TJ, 1994, REV FISH BIOL FISHER, V4, P1, DOI 10.1007/BF00043259; Havenhand JN, 2008, CURR BIOL, V18, pR651, DOI 10.1016/j.cub.2008.06.015; Hay ME, 2009, ANNU REV MAR SCI, V1, P193, DOI 10.1146/annurev.marine.010908.163708; Heinlein JM, 2010, CORAL REEFS, V29, P527, DOI 10.1007/s00338-010-0592-7; Hixon M.A., 1991, P475; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Holbrook SJ, 2002, ECOLOGY, V83, P2855, DOI 10.2307/3072021; Holmes TH, 2010, MAR ECOL PROG SER, V399, P273, DOI 10.3354/meps08337; Ishii Y, 2010, POPUL ECOL, V52, P27, DOI 10.1007/s10144-009-0185-x; Kerr RA, 2010, SCIENCE, V328, P1500, DOI 10.1126/science.328.5985.1500; Kleypas JA, 2009, OCEANOGRAPHY, V22, P108, DOI 10.5670/oceanog.2009.101; Leduc AOHC, 2004, OECOLOGIA, V139, P318, DOI 10.1007/s00442-004-1492-8; Leduc AOHC, 2003, J FISH BIOL, V63, P1331, DOI 10.1046/j.1095-8649.2003.00230.x; MATHIS A, 1995, AM NAT, V145, P994, DOI 10.1086/285780; MEEHL G. A., CLIMATE CHANGE 2007; Munday PL, 2010, P NATL ACAD SCI USA, V107, P12930, DOI 10.1073/pnas.1004519107; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; Munday PL, 1997, J FISH BIOL, V51, P931, DOI 10.1006/jfbi.1997.0498; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Pelejero C, 2010, TRENDS ECOL EVOL, V25, P332, DOI 10.1016/j.tree.2010.02.002; Raven J., 2005, OCEAN ACIDIFICATION, P1; Simpson SD, 2011, BIOL LETTERS, V7, P917, DOI 10.1098/rsbl.2011.0293; Wisenden BD, 2000, PHILOS T ROY SOC B, V355, P1205, DOI 10.1098/rstb.2000.0668	47	136	138	1	175	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22736	10.1371/journal.pone.0022736	http://dx.doi.org/10.1371/journal.pone.0022736			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829497	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000293284600037
J	Handorf, AM; Li, WJ				Handorf, Andrew M.; Li, Wan-Ju			Fibroblast Growth Factor-2 Primes Human Mesenchymal Stem Cells for Enhanced Chondrogenesis	PLOS ONE			English	Article							MARROW STROMAL CELLS; HUMAN ARTICULAR CHONDROCYTES; IN-VITRO CHONDROGENESIS; BONE-MARROW; ACTIN CYTOSKELETON; CULTURE-CONDITIONS; PROGENITOR CELLS; COLLAGEN GENE; SOX9; DIFFERENTIATION	Human mesenchymal stem cells (hMSCs) are multipotent cells capable of differentiating into a variety of mature cell types, including osteoblasts, adipocytes and chondrocytes. It has previously been shown that, when expanded in medium supplemented with fibroblast growth factor-2 (FGF-2), hMSCs show enhanced chondrogenesis (CG). Previous work concluded that the enhancement of CG could be attributed to the selection of a cell subpopulation with inherent chondrogenic potential. In this study, we show that FGF-2 pretreatment actually primed hMSCs to undergo enhanced CG by increasing basal Sox9 protein levels. Our results show that Sox9 protein levels were elevated within 30 minutes of exposure to FGF-2 and progressively increased with longer exposures. Further, we show using flow cytometry that FGF-2 increased Sox9 protein levels per cell in proliferating and non-proliferating hMSCs, strongly suggesting that FGF-2 primes hMSCs for subsequent CG by regulating Sox9. Indeed, when hMSCs were exposed to FGF-2 for 2 hours and subsequently differentiated into the chondrogenic lineage using pellet culture, phosphorylated-Sox9 (pSox9) protein levels became elevated and ultimately resulted in an enhancement of CG. However, small interfering RNA (siRNA)-mediated knockdown of Sox9 during hMSC expansion was unable to negate the prochondrogenic effects of FGF-2, suggesting that the FGF-2-mediated enhancement of hMSC CG is only partly regulated through Sox9. Our findings provide new insights into the mechanism by which FGF-2 regulates predifferentiation hMSCs to undergo enhanced CG.	[Handorf, Andrew M.] Univ Wisconsin, Dept Orthoped & Rehabil, Madison, WI 53706 USA; Univ Wisconsin, Dept Biomed Engn, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Handorf, AM (corresponding author), Univ Wisconsin, Dept Orthoped & Rehabil, Madison, WI 53706 USA.	li@ortho.wisc.edu	Li, Wan-Ju/B-4911-2011	Li, Wan-Ju/0000-0002-6579-8063	departmental internal grant	departmental internal grant	This study was funded by a departmental internal grant as part of the new investigator's start-up fund. There are no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesida AB, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1929; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Banfi A, 2000, EXP HEMATOL, V28, P707, DOI 10.1016/S0301-472X(00)00160-0; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bianchi G, 2003, EXP CELL RES, V287, P98, DOI 10.1016/S0014-4827(03)00138-1; Chiou M, 2006, BIOCHEM BIOPH RES CO, V343, P644, DOI 10.1016/j.bbrc.2006.02.171; Delorme B, 2009, STEM CELLS, V27, P1142, DOI 10.1002/stem.34; Dupree MA, 2006, BIOPHYS J, V91, P3097, DOI 10.1529/biophysj.106.087098; Dy P, 2010, DEV BIOL, V341, P346, DOI 10.1016/j.ydbio.2010.02.024; Erickson IE, 2009, TISSUE ENG PT A, V15, P1041, DOI 10.1089/ten.tea.2008.0099; Esposito MT, 2009, TISSUE ENG PT A, V15, P2525, DOI 10.1089/ten.tea.2008.0509; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Ikeda T, 2004, ARTHRITIS RHEUM-US, V50, P3561, DOI 10.1002/art.20611; Im GI, 2006, TISSUE ENG, V12, P527, DOI 10.1089/ten.2006.12.527; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Kumar D, 2009, MOL CELL BIOL, V29, P4262, DOI 10.1128/MCB.01779-08; KUPCSIK L, 2010, TISSUE ENG A; LAZARUS HM, 1995, BONE MARROW TRANSPL, V16, P557; Lee HT, 2003, MOL VIS, V9, P624; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Li J, 2010, CELL PROLIFERAT, V43, P333, DOI 10.1111/j.1365-2184.2010.00682.x; Lorda-Diez CI, 2009, J BIOL CHEM, V284, P29988, DOI 10.1074/jbc.M109.014811; LOTY S, 1995, BIOL CELL, V83, P149, DOI 10.1016/0248-4900(96)81303-7; Mastrogiacomo M, 2001, OSTEOARTHR CARTILAGE, V9, pS36, DOI 10.1053/joca.2001.0442; Muraglia A, 2000, J CELL SCI, V113, P1161; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Peat G, 2003, J CLIN EPIDEMIOL, V56, P1030, DOI 10.1016/S0895-4356(03)00204-X; Prockop DJ, 2003, P NATL ACAD SCI USA, V100, P11917, DOI 10.1073/pnas.1834138100; SAVAGE MP, 1995, DEV DYNAM, V202, P343, DOI 10.1002/aja.1002020404; Schmidt A, 2006, STEM CELLS, V24, P1750, DOI 10.1634/stemcells.2005-0191; Seifarth C, 2009, HISTOL HISTOPATHOL, V24, P1245, DOI 10.14670/HH-24.1245; Solchaga LA, 2005, J CELL PHYSIOL, V203, P398, DOI 10.1002/jcp.20238; Sotiropoulou PA, 2006, STEM CELLS, V24, P462, DOI 10.1634/stemcells.2004-0331; Stokes DG, 2001, BIOCHEM J, V360, P461, DOI 10.1042/0264-6021:3600461; Tew SR, 2005, OSTEOARTHR CARTILAGE, V13, P80, DOI 10.1016/j.joca.2004.10.011; Tsutsumi S, 2001, BIOCHEM BIOPH RES CO, V288, P413, DOI 10.1006/bbrc.2001.5777; Watanabe H, 2001, J BIOL CHEM, V276, P14466, DOI 10.1074/jbc.M005724200; Woods A, 2006, J BIOL CHEM, V281, P13134, DOI 10.1074/jbc.M509433200; Xu Y, 2008, PLAST RECONSTR SURG, V122, P1649, DOI 10.1097/PRS.0b013e31818cbf44; ZANETTI NC, 1984, J CELL BIOL, V99, P115, DOI 10.1083/jcb.99.1.115	40	86	88	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22887	10.1371/journal.pone.0022887	http://dx.doi.org/10.1371/journal.pone.0022887			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818404	Green Published, Green Submitted, gold			2022-12-25	WOS:000293282700088
J	Annibale, P; Vanni, S; Scarselli, M; Rothlisberger, U; Radenovic, A				Annibale, Paolo; Vanni, Stefano; Scarselli, Marco; Rothlisberger, Ursula; Radenovic, Aleksandra			Quantitative Photo Activated Localization Microscopy: Unraveling the Effects of Photoblinking	PLOS ONE			English	Article							SINGLE MOLECULES; DYE MOLECULES; SUPERRESOLUTION; PROTEINS; DYNAMICS; COLOCALIZATION; KINETICS; BLINKING; LIMIT; GFP	In this work we discuss how to use photophysical information for improved quantitative measurements using Photo Activated Localization Microscopy (PALM) imaging. We introduce a method that reliably estimates the number of photoblinking molecules present in a biological sample and gives a robust way to quantify proteins at the single-cell level from PALM images. We apply this method to determine the amount of beta 2 adrenergic receptor, a prototypical G Protein Coupled Receptor, expressed on the plasma membrane of HeLa cells.	[Annibale, Paolo; Scarselli, Marco; Radenovic, Aleksandra] Ecole Polytech Fed Lausanne, Inst Bioengn, Lab Nanoscale Biol, Lausanne, Switzerland; [Vanni, Stefano; Rothlisberger, Ursula] Ecole Polytech Fed Lausanne, Lab Computat Chem & Biochem, Inst Chem Sci & Engn, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Annibale, P (corresponding author), Ecole Polytech Fed Lausanne, Inst Bioengn, Lab Nanoscale Biol, Lausanne, Switzerland.	aleksandra.radenovic@epfl.ch	Radenovic, Aleksandra/C-5350-2011; Vanni, Stefano/AAO-3144-2020; Vanni, Stefano/D-6414-2011; Radenovic, Aleksandra/AAZ-5582-2021; Annibale, Paolo/E-1406-2015	Vanni, Stefano/0000-0003-2146-1140; Vanni, Stefano/0000-0003-2146-1140; Radenovic, Aleksandra/0000-0001-8194-2785; Annibale, Paolo/0000-0003-3208-5347; Scarselli, Marco/0000-0001-5087-3182	FNS [200021-125319, 20021-132206, CRSII3_132396]	FNS(Swiss National Science Foundation (SNSF))	This work was financially supported by FNS grants no. 200021-125319, no 20021-132206, and CRSII3_132396 (http://www.snf.ch/E/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Annibale P, 2010, J PHYS CHEM LETT, V1, P1506, DOI 10.1021/jz1003523; Annibale P, 2011, NAT METHODS, V8, P527, DOI 10.1038/nmeth.1627; Baddeley D, 2009, P NATL ACAD SCI USA, V106, P22275, DOI 10.1073/pnas.0908971106; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; BJORN F, 2010, NATURE IMMUNOLOGY, V11, P6; Bornfleth H, 1998, J MICROSC-OXFORD, V189, P118, DOI 10.1046/j.1365-2818.1998.00276.x; BURNS DH, 1985, APPL OPTICS, V24, P154, DOI 10.1364/AO.24.000154; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; Gordon MP, 2004, P NATL ACAD SCI USA, V101, P6462, DOI 10.1073/pnas.0401638101; Greenfield D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000137; Ha T, 1996, PHYS REV LETT, V77, P3979, DOI 10.1103/PhysRevLett.77.3979; Haase M, 2004, J PHYS CHEM B, V108, P10445, DOI 10.1021/jp0313674; Habuchi S, 2005, P NATL ACAD SCI USA, V102, P9511, DOI 10.1073/pnas.0500489102; Heilemann M, 2002, ANAL CHEM, V74, P3511, DOI 10.1021/ac025576g; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hoogenboom JP, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.097401; Huang B, 2007, SCIENCE, V315, P81, DOI 10.1126/science.1133992; Lacoste TD, 2000, P NATL ACAD SCI USA, V97, P9461, DOI 10.1073/pnas.170286097; Lagerholm BC, 2005, ANNU REV PHYS CHEM, V56, P309, DOI 10.1146/annurev.physchem.56.092503.141211; Lidke KA, 2005, OPT EXPRESS, V13, P7052, DOI 10.1364/OPEX.13.007052; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Moerner WE, 1999, SCIENCE, V283, P1670, DOI 10.1126/science.283.5408.1670; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schwille P, 2000, P NATL ACAD SCI USA, V97, P151, DOI 10.1073/pnas.97.1.151; SHANNON CE, 1949, P IRE, V37, P10, DOI 10.1109/JRPROC.1949.232969; SHIMIZU KT, 2001, PHYS REV B, V63; Shroff H, 2008, NAT METHODS, V5, P417, DOI [10.1038/nmeth.1202, 10.1038/NMETH.1202]; Shroff H, 2007, P NATL ACAD SCI USA, V104, P20308, DOI 10.1073/pnas.0710517105; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; Yeow EKL, 2006, J PHYS CHEM A, V110, P1726, DOI 10.1021/jp055496r; Yip WT, 1998, J PHYS CHEM A, V102, P7564, DOI 10.1021/jp981808x; Zondervan R, 2003, J PHYS CHEM A, V107, P6770, DOI 10.1021/jp034723r	37	192	193	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e22678	10.1371/journal.pone.0022678	http://dx.doi.org/10.1371/journal.pone.0022678			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21818365	Green Published, gold, Green Submitted			2022-12-25	WOS:000293175100041
J	Chew, A; Salama, P; Robbshaw, A; Klopcic, B; Zeps, N; Platell, C; Lawrance, IC				Chew, Angela; Salama, Paul; Robbshaw, Anneli; Klopcic, Borut; Zeps, Nikolajs; Platell, Cameron; Lawrance, Ian C.			SPARC, FOXP3, CD8 and CD45 Correlation with Disease Recurrence and Long-Term Disease-Free Survival in Colorectal Cancer	PLOS ONE			English	Article							REGULATORY T-CELLS; OVARIAN-CANCER; EXPRESSION ANALYSIS; PROGNOSTIC-FACTOR; GENE-EXPRESSION; COLON-CANCER; CARCINOMA; PROGRESSION; INFLAMMATION; RICH	Background: SPARC is a matricellular protein involved in tissue remodelling, cell migration and angiogenesis, while forkhead box P3 (FOXP3) protein functions as a transcription factor involved in immune cell regulation. Both SPARC and FOXP3 can play an anti-tumorigenic role in cancer progression. The aim was to determine if SPARC, FOXP3, CD8 and CD45RO expression levels are associated with colorectal cancer (CRC) stage, disease outcome and long-term cancer-specific survival (CSS) in stage II and III CRC. Methods and Findings: SPARC expression was initially assessed in 120 paired normal and stage I-IV CRCs. Subsequently, approximately 1000 paired patient samples of stage II or III CRCs in tissue microarrays were stained for SPARC, FOXP3, CD8 or CD45RO. Proportional hazards modelling assessed correlations between these markers and clinicopathological data, including disease outcome and cancer specific survival (CSS). Both SPARC and FOXP3 expression were significantly greater in CRC than normal colon (p<0.0001). High SPARC expression correlated with good disease outcome (>= 60 mths without disease recurrence, p = 0.0039) and better long-term CSS in stage II CRC (<0.0001). In stage III CRC, high SPARC expression correlated with better long-term CSS (p<0.0001) and less adjuvant chemotherapy use (p = 0.01). High FOXP3 correlated with a good disease outcome, better long-term CSS and less adjuvant chemotherapy use in stage II (p<0.0037, <0.0001 and p = 0.04 respectively), but not in stage III CRC. High CD8 and CD45RO expression correlated with better disease outcome in stage II CRC, and better CSS, but the differences were not as marked as for SPARC and FOXP3. Conclusions: These data suggest that high SPARC and FOXP3 are associated with better disease outcome in stage II CRC and may be prognostic indicators of CSS. Further assessment of whether these markers predict patients at high risk of recurrence with stage II CRC and functional studies of these effects are underway	[Chew, Angela; Robbshaw, Anneli; Klopcic, Borut; Lawrance, Ian C.] Fremantle Hosp, Ctr Inflammatory Bowel Dis, Fremantle, WA, Australia; [Chew, Angela; Klopcic, Borut; Lawrance, Ian C.] Univ Western Australia, Sch Med & Pharmacol, Fremantle, WA, Australia; [Salama, Paul; Zeps, Nikolajs; Platell, Cameron] Univ Western Australia, Sch Surg, Nedlands, WA 6009, Australia; [Zeps, Nikolajs] Sir Charles Gairdner Hosp, Nedlands, WA 6009, Australia; [Zeps, Nikolajs] St John God Pathol, Subiaco, WA, Australia; [Platell, Cameron] St John God Colorectal Serv, Subiaco, WA, Australia	University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; St John of God Health Care; St John of God Health Care	Chew, A (corresponding author), Fremantle Hosp, Ctr Inflammatory Bowel Dis, Fremantle, WA, Australia.	Ian.Lawrance@uwa.edu.au	Zeps, Nikolajs/AAF-3186-2021; Lawrance, Ian C/H-5252-2014; Zeps, Nikolajs/C-4180-2013	Zeps, Nikolajs/0000-0002-6404-6839; Zeps, Nikolajs/0000-0002-6404-6839; Robbshaw, Anneli/0000-0002-9594-8587; Salama, Paul/0000-0003-4375-899X	University, State and Commonwealth Governments; Fremantle Hospital Medical Research Foundation; National Health and Medical Research Council [NHMRC 458755]	University, State and Commonwealth Governments; Fremantle Hospital Medical Research Foundation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The authors wish to thank A/Prof Stan Krajewski, Dr Maryla Krajewska and Lisa Spalding for their technical support and assistance in the construction of the TMAs, Dr Amber Appelbee for her assistance with the TMA analysis, Dr Cindy Forrest for her histopathological expertise, A/Prof Kevin Murray and Laura Firth for their statistical expertises and A/Prof Barry Iacopetta, for providing the clinical database used in this study. The authors acknowledge the facilities and technical assistance of the Australian Microscopy & Microanalysis Research Facility at the Centre for Microscopy, Characterisation & Analysis, The University of Western Australia, a facility funded by the University, State and Commonwealth Governments, with special thanks to A/Prof Paul Rigby and A/Prof Kathy Heel for their technical support with the TMA scanning.; The research was undertaken with the support from the Fremantle Hospital Medical Research Foundation and the National Health and Medical Research Council (NHMRC# 458755). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS, 2005, AUSTR SOC TRENDS; Arnold SA, 2009, J CELL COMMUN SIGNAL, V3, P255, DOI 10.1007/s12079-009-0072-4; Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Brabender J, 2003, BRIT J CANCER, V89, P1508, DOI 10.1038/sj.bjc.6601324; *CCA, 2010, COL CANC; Chai SM, 2004, CLIN GASTROENTEROL H, V2, P1017, DOI 10.1016/S1542-3565(04)00451-3; Cheetham S, 2008, BRIT J CANCER, V98, P1810, DOI 10.1038/sj.bjc.6604377; Chiba T, 2004, BRIT J CANCER, V91, P1711, DOI 10.1038/sj.bjc.6602201; Chlenski A, 2007, ONCOGENE, V26, P4513, DOI 10.1038/sj.onc.1210247; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Erdman SE, 2010, TOXICOL PATHOL, V38, P76, DOI 10.1177/0192623309354110; Hiraoka N, 2006, CLIN CANCER RES, V12, P5423, DOI 10.1158/1078-0432.CCR-06-0369; Iacobuzio-Donahue CA, 2002, CANCER RES, V62, P5351; Kobayashi N, 2007, CLIN CANCER RES, V13, P902, DOI 10.1158/1078-0432.CCR-06-2363; Koch M, 2006, ANN SURG, V244, P986, DOI 10.1097/01.sla.0000247058.43243.7b; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; Ledda F, 1997, J INVEST DERMATOL, V108, P210, DOI 10.1111/1523-1747.ep12334263; Miracco C, 2007, ONCOL REP, V18, P1115; Murphy J, 2000, AM J GASTROENTEROL, V95, P3607; Naito Y, 1998, CANCER RES, V58, P3491; National Cancer Institute, 2010, COMM CANC TYP; Needham DJ, 2006, BIOCHEM BIOPH RES CO, V343, P684, DOI 10.1016/j.bbrc.2006.03.018; Oberg A, 2002, INT J COLORECTAL DIS, V17, P25; Ohtani Haruo, 2007, Cancer Immun, V7, P4; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Perrone G, 2008, EUR J CANCER, V44, P1875, DOI 10.1016/j.ejca.2008.05.017; Reding T, 2009, PHYSIOL GENOMICS, V38, P196, DOI 10.1152/physiolgenomics.00028.2009; SAGE EH, 1995, J CELL BIOCHEM, V57, P127, DOI 10.1002/jcb.240570113; Said NA, 2008, NEOPLASIA, V10, P1092, DOI 10.1593/neo.08672; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Sheehan KM, 2005, HISTOPATHOLOGY, V46, P287, DOI 10.1111/j.1365-2559.2005.02083.x; Srivastava S, 2001, CLIN CANCER RES, V7, P1118; STRANDJORD TP, 1995, AM J RESP CELL MOL, V13, P279, DOI 10.1165/ajrcmb.13.3.7654384; Tai IT, 2005, J CLIN INVEST, V115, P1492, DOI 10.1172/JCI23002; Takemasa I, 2001, BIOCHEM BIOPH RES CO, V285, P1244, DOI 10.1006/bbrc.2001.5277; Wang CS, 2004, BRIT J CANCER, V91, P1924, DOI 10.1038/sj.bjc.6602213; *WHO, 2009, CANC; Wolf D, 2005, CLIN CANCER RES, V11, P8326, DOI 10.1158/1078-0432.CCR-05-1244; Yamashita K, 2003, CANCER, V97, P2412, DOI 10.1002/cncr.11368; Yiu GK, 2001, AM J PATHOL, V159, P609, DOI 10.1016/S0002-9440(10)61732-4; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	41	54	57	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e22047	10.1371/journal.pone.0022047	http://dx.doi.org/10.1371/journal.pone.0022047			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21818290	Green Submitted, Green Published, gold			2022-12-25	WOS:000293175100013
J	Batista, DDJ; Batista, MM; de Oliveira, GM; Britto, CC; Rodrigues, ACM; Stephens, CE; Boykin, DW; Soeiro, MDC				Jaen Batista, Denise da Gama; Batista, Marcos Meuser; de Oliveira, Gabriel Melo; Britto, Constanca Carvalho; Mondaine Rodrigues, Ana Carolina; Stephens, Chad E.; Boykin, David W.; Correia Soeiro, Maria de Nazare			Combined Treatment of Heterocyclic Analogues and Benznidazole upon Trypanosoma cruzi In Vivo	PLOS ONE			English	Article							CHAGAS-DISEASE; TNF-ALPHA; INFLAMMATORY RESPONSE; SCHIZOTRYPANUM CRUZI; BLOOD-SAMPLES; SCH 56592; DIAMIDINES; STRAINS; SUSCEPTIBILITY; PAFURAMIDINE	Chagas disease caused by Trypanosoma cruzi is an important cause of mortality and morbidity in Latin America but no vaccines or safe chemotherapeutic agents are available. Combined therapy is envisioned as an ideal approach since it may enhance efficacy by acting upon different cellular targets, may reduce toxicity and minimize the risk of drug resistance. Therefore, we investigated the activity of benznidazole (Bz) in combination with the diamidine prodrug DB289 and in combination with the arylimidamide DB766 upon T. cruzi infection in vivo. The oral treatment of T. cruzi-infected mice with DB289 and Benznidazole (Bz) alone reduced the number of circulating parasites compared with untreated mice by about 70% and 90%, respectively. However, the combination of these two compounds decreased the parasitemia by 99% and protected against animal mortality by 100%, but without providing a parasitological cure. When Bz (p.o) was combined with DB766 (via ip route), at least a 99.5% decrease in parasitemia levels was observed. DB766+Bz also provided 100% protection against mice mortality while Bz alone provided about 87% protection. This combined therapy also reduced the tissular lesions induced by T. cruzi infection: Bz alone reduced GPT and CK plasma levels by about 12% and 78% compared to untreated mice group, the combination of Bz with DB766 resulted in a reduction of GPT and CK plasma levels of 56% and 91%. Cure assessment through hemocultive and PCR approaches showed that Bz did not provide a parasitological cure, however, DB766 alone or associated with Bz cured >= 13% of surviving animals.	[Jaen Batista, Denise da Gama; Batista, Marcos Meuser; de Oliveira, Gabriel Melo; Correia Soeiro, Maria de Nazare] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Celular, Rio De Janeiro, Brazil; [Britto, Constanca Carvalho; Mondaine Rodrigues, Ana Carolina] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Mol & Doencas Endem, Rio De Janeiro, Brazil; [Stephens, Chad E.] Augusta State Univ, Dept Chem & Phys, Augusta, GA USA; [Boykin, David W.] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; University System of Georgia; Augusta University; University System of Georgia; Georgia State University	Batista, DDJ (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Celular, Rio De Janeiro, Brazil.	soeiro@ioc.fiocruz.br	de Nazaré Correia Soeiro, Maria/S-1894-2019; Britto, Constanca/L-7658-2016	de Nazaré Correia Soeiro, Maria/0000-0003-0078-6106; Britto, Constanca/0000-0003-0788-7030	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ-APQ1 and Pensa Rio); Conselho Nacional Desenvolvimento Cientifico e Tecnologico (CNPq); PAPES V/Fundacao Oswaldo Cruz (FIOCRUZ) [403451/2008-6]; Consortium for Parasitic Drug Development (CPDD); Bill and Melinda Gates Foundation	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ-APQ1 and Pensa Rio); Conselho Nacional Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PAPES V/Fundacao Oswaldo Cruz (FIOCRUZ); Consortium for Parasitic Drug Development (CPDD); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The present study was supported by grants from Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ-APQ1 and Pensa Rio), Conselho Nacional Desenvolvimento Cientifico e Tecnologico (CNPq), PAPES V/Fundacao Oswaldo Cruz (FIOCRUZ) (403451/2008-6) and the Consortium for Parasitic Drug Development (CPDD). Funding to DWB by the Bill and Melinda Gates Foundation is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilate AMB, 2008, REV INST MED TROP SP, V50, P67, DOI 10.1590/S0036-46652008000200001; Boykin DW, 1998, J MED CHEM, V41, P124, DOI 10.1021/jm970570i; Brener Z., 1962, REV INST MED TROP SP, V4, P386; BRITTO C, 1993, MEM I OSWALDO CRUZ, V88, P171, DOI 10.1590/S0074-02761993000100030; Bustamante JM, 2008, NAT MED, V14, P542, DOI 10.1038/nm1744; Chagas C, 1909, MEM I OSWALDO CRUZ, V1, P159, DOI DOI 10.1590/S0074-02761909000200008; Chen D, 2007, EXPERT REV ANTI-INFE, V5, P921, DOI 10.1586/14787210.5.6.921; Coura JR, 2009, MEM I OSWALDO CRUZ, V104, P31, DOI 10.1590/S0074-02762009000900006; Coura JR, 2002, MEM I OSWALDO CRUZ, V97, P3, DOI 10.1590/S0074-02762002000100001; da Silva CF, 2008, ANTIMICROB AGENTS CH, V52, P3307, DOI 10.1128/AAC.00038-08; Pacheco MGDO, 2009, EXP PARASITOL, V123, P73, DOI 10.1016/j.exppara.2009.06.004; de Souza EM, 2006, J ANTIMICROB CHEMOTH, V58, P610, DOI 10.1093/jac/dkl259; de Souza EM, 2004, BIOCHEM PHARMACOL, V68, P593, DOI 10.1016/j.bcp.2004.04.019; FILARDI LS, 1987, T ROY SOC TROP MED H, V81, P755, DOI 10.1016/0035-9203(87)90020-4; Francisco AF, 2008, EXP PARASITOL, V120, P314, DOI 10.1016/j.exppara.2008.08.002; Hall JE, 1998, ANTIMICROB AGENTS CH, V42, P666, DOI 10.1128/AAC.42.3.666; Herwaldt BL, 2001, CLIN MICROBIOL REV, V14, P659, DOI 10.1128/CMR.14.3.659-688.2001; Batista DDJ, 2010, ANTIMICROB AGENTS CH, V54, P2940, DOI 10.1128/AAC.01617-09; Leiby DA, 2002, TRANSFUSION, V42, P549, DOI 10.1046/j.1537-2995.2002.00077.x; Lima ES, 2001, INT J EXP PATHOL, V82, P327, DOI 10.1046/j.1365-2613.2001.00203.x; Manarin R, 2008, AM J TROP MED HYG, V79, P793, DOI 10.4269/ajtmh.2008.79.793; McKerrow JH, 2009, MEM I OSWALDO CRUZ, V104, P263, DOI 10.1590/S0074-02762009000900034; MEIRELLES MNL, 1982, Z PARASINTENK, V68, P7, DOI DOI 10.1007/BF00926652; Milei J, 2009, AM HEART J, V157, P22, DOI 10.1016/j.ahj.2008.08.024; Molina J, 2000, ANTIMICROB AGENTS CH, V44, P150, DOI 10.1128/AAC.44.1.150-155.2000; Munoz J, 2009, ACTA TROP, V111, P51, DOI 10.1016/j.actatropica.2009.02.005; Nobrega AA, 2009, EMERG INFECT DIS, V15, P653, DOI 10.3201/eid1504.081450; Nowicki MJ, 2006, TRANSPLANTATION, V81, P477, DOI 10.1097/01.tp.0000195778.08411.b8; Nwaka S, 2006, NAT REV DRUG DISCOV, V5, P941, DOI 10.1038/nrd2144; Nyunt MM, 2009, AM J TROP MED HYG, V80, P528, DOI 10.4269/ajtmh.2009.80.528; Pascutti MF, 2004, LIFE SCI, V76, P685, DOI 10.1016/j.lfs.2004.09.013; Pereira KS, 2009, J FOOD PROTECT, V72, P441, DOI 10.4315/0362-028X-72.2.441; Dias JCP, 2006, REV SOC BRAS MED TRO, V39, P370, DOI 10.1590/S0037-86822006000400010; QUAY J, 1993, EXP LUNG RES, V19, P429, DOI 10.3109/01902149309064356; Rassi A, 2009, MEM I OSWALDO CRUZ, V104, P152, DOI 10.1590/S0074-02762009000900021; Revelli S, 1999, PARASITOL RES, V85, P147, DOI 10.1007/s004360050524; SALOMAO K, 2009, EVID BASED COMPLEMEN; Silva CF, 2007, BIOCHEM PHARMACOL, V73, P1939, DOI 10.1016/j.bcp.2007.03.020; Soeiro M N C, 2008, Curr Mol Pharmacol, V1, P151; Soeiro MDC, 2009, MEM I OSWALDO CRUZ, V104, P301, DOI 10.1590/S0074-02762009000900040; Soeiro MNC, 2009, EXPERT OPIN THER TAR, V13, P105, DOI [10.1517/14728220802623881, 10.1517/14728220802623881 ]; Soeiro MNC, 2005, EXPERT OPIN INV DRUG, V14, P957, DOI 10.1517/13543784.14.8.957; STAROBINAS N, 1991, RES IMMUNOL, V142, P117, DOI 10.1016/0923-2494(91)90019-F; Stephens CE, 2001, J MED CHEM, V44, P1741, DOI 10.1021/jm000413a; Tanowitz HB, 2009, PROG CARDIOVASC DIS, V51, P524, DOI 10.1016/j.pcad.2009.02.001; TARLETON RL, 1988, CLIN EXP IMMUNOL, V73, P186; Thuita JK, 2008, ACTA TROP, V108, P6, DOI 10.1016/j.actatropica.2008.07.006; Urbina JA, 1998, ANTIMICROB AGENTS CH, V42, P1771, DOI 10.1128/AAC.42.7.1771; Urbina JA, 2003, TRENDS PARASITOL, V19, P495, DOI 10.1016/j.pt.2003.09.001; Urbina JA, 2009, MEM I OSWALDO CRUZ, V104, P311, DOI 10.1590/S0074-02762009000900041; Wang MZ, 2010, ANTIMICROB AGENTS CH, V54, P2507, DOI 10.1128/AAC.00250-10; Wenzler T, 2009, ANTIMICROB AGENTS CH, V53, P4185, DOI 10.1128/AAC.00225-09; Werbovetz K, 2006, CURR OPIN INVESTIG D, V7, P147; WHO, 2002, WHO TECHN REP SER, V905, P40; *WHO, 2009, CONTR NEGL TROP DIS; WINCKER P, 1994, AM J TROP MED HYG, V51, P771, DOI 10.4269/ajtmh.1994.51.771; Yeramian P, 2005, J INFECT DIS, V192, P319, DOI 10.1086/430928	57	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e22155	10.1371/journal.pone.0022155	http://dx.doi.org/10.1371/journal.pone.0022155			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21814568	Green Submitted, gold, Green Published			2022-12-25	WOS:000293175100014
J	Duris, Z; Horka, I; Juracka, PJ; Petrusek, A; Sandford, F				Duris, Zdenek; Horka, Ivona; Juracka, Petr Jan; Petrusek, Adam; Sandford, Floyd			These Squatters Are Not Innocent: The Evidence of Parasitism in Sponge-Inhabiting Shrimps	PLOS ONE			English	Article							COMMUNITY STRUCTURE; PONTONIINE SHRIMPS; CRUSTACEA DECAPODA; MUTUALISM; PALAEMONIDAE; INVERTEBRATES; COMMENSALISM; DEMOSPONGIAE; EVOLUTION; SYMBIOSIS	Marine sponges are frequently inhabited by a wide range of associated invertebrates, including caridean shrimps. Symbiotic shrimps are often considered to be commensals; however, in most cases, the relationship with sponge hosts remains unclear. Here we demonstrate that sponge-inhabiting shrimps are often parasites adapted to consumption of sponge tissues. First, we provide detailed examination of morphology and stomach contents of Typton carneus (Decapoda: Palaemonidae: Pontoniinae), a West Atlantic tropical shrimp living in fire sponges of the genus Tedania. Remarkable shear-like claws of T. carneus show evidence of intensive shearing, likely the result of crushing siliceous sponge spicules. Examination of stomach contents revealed that the host sponge tissue is a major source of food for T. carneus. A parasitic mode of life is also reflected in adaptations of mouth appendages, in the reproduction strategy, and in apparent sequestration of host pigments by shrimp. Consistent results were obtained also for congeneric species T. distinctus (Western Atlantic) and T. spongicola (Mediterranean). The distribution of shrimps among sponge hosts (mostly solitary individuals or heterosexual pairs) suggests that Typton shrimps actively prevent colonisation of their sponge by additional conspecifics, thus protecting their resource and reducing the damage to the hosts. We also demonstrate feeding on host tissues by sponge-associated shrimps of the genera Onycocaris, Periclimenaeus, and Thaumastocaris (Pontoniinae) and Synalpheus (Alpheidae). The parasitic mode of life appears to be widely distributed among sponge-inhabiting shrimps. However, it is possible that under some circumstances, the shrimps provide a service to the host sponge by preventing a penetration by potentially more damaging associated animals. The overall nature of interspecific shrimp-sponge relationships thus warrants further investigation.	[Duris, Zdenek; Horka, Ivona] Univ Ostrava, Fac Sci, Dept Biol & Ecol, Ostrava, Czech Republic; [Horka, Ivona; Juracka, Petr Jan; Petrusek, Adam] Charles Univ Prague, Fac Sci, Dept Ecol, Prague, Czech Republic	University of Ostrava; Charles University Prague	Duris, Z (corresponding author), Univ Ostrava, Fac Sci, Dept Biol & Ecol, Ostrava, Czech Republic.	zdenek.duris@osu.cz	Juračka, Petr Jan/O-5909-2017; Horka, Ivona/D-7465-2014; Petrusek, Adam/A-3510-2008	Juračka, Petr Jan/0000-0002-9152-4576; Horka, Ivona/0000-0002-8942-9481; Petrusek, Adam/0000-0001-5150-4370	Global Partner Program	Global Partner Program	The study was facilitated by support from the Global Partner Program, administered by the Associated Colleges of the Midwest, U.S.A. (FS), by the Czech National Committee for cooperation with IOC UNESCO (ZD., AP), the Institute of Environmental Technologies, Ostrava (reg. no. CZ.1.05/2.1.00/03.0100; ZD.), the Czech Ministry of Education (project no. MSM0021620828; AP), and by permit no. 00030-06 of the Fisheries Department, Belizean Ministry of Agriculture and Fisheries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsler MO, 2009, ANTARCT SCI, V21, P579, DOI 10.1017/S0954102009990356; Anker A, 2006, EVOLUTION, V60, P2507, DOI 10.1111/j.0014-3820.2006.tb01886.x; Arndt W., 1933, Mitteilungen aus dem Zoologischen Museum in Berlin, V19, P221; BRUCE A J, 1981, Journal of Crustacean Biology, V1, P241, DOI 10.2307/1548162; BRUCE A J, 1987, Beagle, V4, P49; BRUCE A J, 1973, Records of the Australian Museum, V28, P253; Bruce AJ, 2010, ZOOTAXA, P338; BRUCE A J, 1983, Records of the Australian Museum, V35, P19; Bruce A. J., 2010, Beagle, V26, P69; BRUCE A J, 1976, Micronesica, V12, P83; BRUCE A J, 1979, Records of the Australian Museum, V32, P69; Bruce A. J., 1976, BIOL GEOLOGY CORAL R, P37; BRUCE AJ, 1976, CRUSTACEANA, V31, P301, DOI 10.1163/156854076X00080; Bruce AJ, 2000, J CRUSTACEAN BIOL, V20, P87, DOI 10.1163/1937240X-90000011; BRUCE AJ, 1977, CRUSTACEANA, V32, P304, DOI 10.1163/156854077X00782; Bruce AJ, 2004, ZOOSYSTEMA, V26, P279; BRUCE AJ, 1995, THESES ZOOL, V25; BRUCE AJ, 1990, P 2 INT MAR BIOL WOR, P611; Bruce Alexander J., 1996, Memoires du Museum National d'Histoire Naturelle, V168, P197; CASTRO P, 1971, PAC SCI, V25, P395; CHACE FA, 1972, SMITHSON CONTRIB ZOO, V98; CHADWICK NE, 2008, P AQ EIL IMPR GULF E, P209; Cheney KL, 2005, BIOL LETTERS, V1, P162, DOI 10.1098/rsbl.2004.0288; Duarte LFL, 1996, ESTUAR COAST SHELF S, V42, P139, DOI 10.1006/ecss.1996.0011; Duffy J. Emmett, 2003, P217; Duffy JE, 1996, NATURE, V381, P512, DOI 10.1038/381512a0; Duffy JE, 2002, BEHAV ECOL SOCIOBIOL, V51, P488, DOI 10.1007/s00265-002-0455-5; Fautin DG, 1995, MAR ECOL PROG SER, V129, P77, DOI 10.3354/meps129077; Fransen C.H.J.M., 2003, Zoologische Verhandelingen (Leiden), V345, P129; Fransen CHJM, 2006, ZOOSYSTEMA, V28, P713; Fujino T., 1968, Ohmu, V1, P85; Genkai-Kato M, 1999, THEOR POPUL BIOL, V55, P309, DOI 10.1006/tpbi.1998.1407; GLYNN PW, 1980, OECOLOGIA, V47, P287, DOI 10.1007/BF00398518; Hay ME, 2004, ANNU REV ECOL EVOL S, V35, P175, DOI 10.1146/annurev.ecolsys.34.011802.132357; Holte AE, 2001, EXP APPL ACAROL, V25, P97, DOI 10.1023/A:1010655610575; HOLTHUIS LB, 1951, A HANCOCK FDN PUBL, V11; HOPPE WF, 1988, MAR ECOL PROG SER, V50, P117, DOI 10.3354/meps050117; Hultgren KM, 2010, MAR ECOL PROG SER, V407, P1, DOI 10.3354/meps08609; Isbister GK, 2005, TOXICON, V46, P782, DOI 10.1016/j.toxicon.2005.08.009; KNOWLTON N, 1982, BEHAV ECOL SOCIOBIOL, V10, P289, DOI 10.1007/BF00302819; Leung TLF, 2008, VIE MILIEU, V58, P107; Marin I., 2007, Zoologische Mededelingen (Leiden), V81, P217; MARIN IN, 2006, THESIS MOSCOW; OSHEL PE, 1985, MAR ECOL PROG SER, V23, P307, DOI 10.3354/meps023307; PATTON WK, 1985, J CRUSTACEAN BIOL, V5, P616, DOI 10.2307/1548239; Pawlik, 1997, P 8 INT COR REEF S, V2, P1255; Pawlik JR, 1998, LIMNOL OCEANOGR, V43, P1396, DOI 10.4319/lo.1998.43.6.1396; Pearse A. S., 1934, Papers from the Tortugas Laboratory of the Carnegie Institution of Washington, V28, P117; Ruetzler K., 2004, BOLL MUS IST BIOL UN, V68, P85; RUTZLER K, 1990, NEW PERSPECTIVES SPO; SCHUBAUER JP, 1990, P NEW PERSP SPONG BI, P443; Thiel M, 2001, SYMBIOSIS, V30, P163; URIZ MJ, 1992, MAR ECOL PROG SER, V81, P247, DOI 10.3354/meps081247; WESTINGA E, 1981, MAR BIOL, V62, P139, DOI 10.1007/BF00388176; Wulff JL, 2006, BIOL BULL-US, V211, P83, DOI 10.2307/4134581; Wulff JL, 2006, CAN J ZOOL, V84, P146, DOI 10.1139/Z06-019	56	46	48	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e21987	10.1371/journal.pone.0021987	http://dx.doi.org/10.1371/journal.pone.0021987			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21814564	gold, Green Published, Green Submitted			2022-12-25	WOS:000292956800016
J	Savino, M; Annibali, D; Carucci, N; Favuzzi, E; Cole, MD; Evan, GI; Soucek, L; Nasi, S				Savino, Mauro; Annibali, Daniela; Carucci, Nicoletta; Favuzzi, Emilia; Cole, Michael D.; Evan, Gerard I.; Soucek, Laura; Nasi, Sergio			The Action Mechanism of the Myc Inhibitor Termed Omomyc May Give Clues on How to Target Myc for Cancer Therapy	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; LOOP-HELIX PROTEINS; C-MYC; TRANSCRIPTION FACTOR; GENE-REGULATION; LEUCINE ZIPPER; DNA-BINDING; IN-VIVO; N-MYC; EXPRESSION	Recent evidence points to Myc - a multifaceted bHLHZip transcription factor deregulated in the majority of human cancers - as a priority target for therapy. How to target Myc is less clear, given its involvement in a variety of key functions in healthy cells. Here we report on the action mechanism of the Myc interfering molecule termed Omomyc, which demonstrated astounding therapeutic efficacy in transgenic mouse cancer models in vivo. Omomyc action is different from the one that can be obtained by gene knockout or RNA interference, approaches designed to block all functions of a gene product. This molecule - instead - appears to cause an edge-specific perturbation that destroys some protein interactions of the Myc node and keeps others intact, with the result of reshaping the Myc transcriptome. Omomyc selectively targets Myc protein interactions: it binds c-and N-Myc, Max and Miz-1, but does not bind Mad or select HLH proteins. Specifically, it prevents Myc binding to promoter E-boxes and transactivation of target genes while retaining Miz-1 dependent binding to promoters and transrepression. This is accompanied by broad epigenetic changes such as decreased acetylation and increased methylation at H3 lysine 9. In the presence of Omomyc, the Myc interactome is channeled to repression and its activity appears to switch from a pro-oncogenic to a tumor suppressive one. Given the extraordinary therapeutic impact of Omomyc in animal models, these data suggest that successfully targeting Myc for cancer therapy might require a similar twofold action, in order to prevent Myc/Max binding to E-boxes and, at the same time, keep repressing genes that would be repressed by Myc.	[Savino, Mauro; Annibali, Daniela; Carucci, Nicoletta; Favuzzi, Emilia; Nasi, Sergio] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol, CNR, IBPM, Rome, Italy; [Cole, Michael D.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Evan, Gerard I.; Soucek, Laura] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Soucek, Laura] VHIO, Barcelona, Spain	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; Princeton University; University of California System; University of California San Francisco; Vall d'Hebron Institut d'Oncologia (VHIO)	Savino, M (corresponding author), Univ Roma La Sapienza, Dipartimento Biol & Biotecnol, CNR, IBPM, Rome, Italy.	sergio.nasi@uniroma1.it	Soucek, Laura/AAG-7393-2019; Annibali, Daniela/AAC-5270-2019; Soucek, Laura/AAG-8377-2019; Annibali, Daniela/AAE-3004-2019	Soucek, Laura/0000-0002-4750-7971; Annibali, Daniela/0000-0001-8413-7669; Favuzzi, Emilia/0000-0003-4256-1490	AIRC; ASI; MIUR; Fondazione Guido Berlucchi; Bear Necessities Pediatric Cancer Foundation; CNR; CNR - Sapienza University; Cancer Research UK [12077] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA055248] Funding Source: NIH RePORTER	AIRC(Fondazione AIRC per la ricerca sul cancro); ASI(Agenzia Spaziale Italiana (ASI)); MIUR(Ministry of Education, Universities and Research (MIUR)); Fondazione Guido Berlucchi; Bear Necessities Pediatric Cancer Foundation; CNR(Consiglio Nazionale delle Ricerche (CNR)); CNR - Sapienza University; Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by research grants from AIRC, ASI, MIUR and Fondazione Guido Berlucchi (SN), a Bear Necessities Pediatric Cancer Foundation grant (LS), a CNR short term mobility fellowship (SN) and by CNR - Sapienza University PhD fellowships (MS, DA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKMANN H, 1991, GENE DEV, V5, P1057, DOI 10.1101/gad.5.6.1057; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Bush A, 1998, GENE DEV, V12, P3797, DOI 10.1101/gad.12.24.3797; Chandriani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006693; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chen YL, 2007, PLOS COMPUT BIOL, V3, P602, DOI 10.1371/journal.pcbi.0030063; Ciarapica R, 2009, ONCOGENE, V28, P1881, DOI 10.1038/onc.2009.56; Clausen DM, 2010, J PHARMACOL EXP THER, V335, P715, DOI 10.1124/jpet.110.170555; Cole MD, 2006, CURR TOP MICROBIOL, V302, P33; Cotterman R, 2008, CANCER RES, V68, P9654, DOI 10.1158/0008-5472.CAN-08-1961; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; DANG CV, 1989, NATURE, V337, P664, DOI 10.1038/337664a0; Dang CV, 1999, MOL CELL BIOL, V19, P1; Dugan KA, 2002, ONCOGENE, V21, P5835, DOI 10.1038/sj.onc.1205763; EILERS M, 1991, EMBO J, V10, P133, DOI 10.1002/j.1460-2075.1991.tb07929.x; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Greasley PJ, 2000, NUCLEIC ACIDS RES, V28, P446, DOI 10.1093/nar/28.2.446; Gustafson WC, 2010, ONCOGENE, V29, P1249, DOI 10.1038/onc.2009.512; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Herold S, 2002, MOL CELL, V10, P509, DOI 10.1016/S1097-2765(02)00633-0; Iritani BM, 1999, P NATL ACAD SCI USA, V96, P13180, DOI 10.1073/pnas.96.23.13180; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; Kidder BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003932; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Knoepfler PS, 2007, CANCER RES, V67, P5061, DOI 10.1158/0008-5472.CAN-07-0426; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Lin CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007839; Lofstedt T, 2009, EXP CELL RES, V315, P1924, DOI 10.1016/j.yexcr.2009.02.015; Martinato F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003650; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; MUKHERJEE B, 1992, GENE DEV, V6, P1480, DOI 10.1101/gad.6.8.1480; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; O'Connell BC, 2003, J BIOL CHEM, V278, P12563, DOI 10.1074/jbc.M210462200; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Patel JH, 2006, J BIOL CHEM, V281, P3283, DOI 10.1074/jbc.M513038200; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PERSSON H, 1984, SCIENCE, V225, P687, DOI 10.1126/science.6431612; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; Ponzielli R, 2005, EUR J CANCER, V41, P2485, DOI 10.1016/j.ejca.2005.08.017; Prochownik EV, 1998, GENE CHROMOSOME CANC, V22, P295, DOI 10.1002/(SICI)1098-2264(199808)22:4<295::AID-GCC5>3.0.CO;2-Q; Qing GL, 2010, CANCER RES, V70, P10351, DOI 10.1158/0008-5472.CAN-10-0740; Ricci-Vitiani L, 2004, J EXP MED, V200, P1257, DOI 10.1084/jem.20040921; Rothermund K, 2005, CANCER RES, V65, P2097, DOI 10.1158/0008-5472.CAN-04-2928; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Oskarsson T, 2006, GENE DEV, V20, P2024, DOI 10.1101/gad.381206; Sodir NM, 2011, GENE DEV, V25, P907, DOI 10.1101/gad.2038411; Soucek L, 2004, CELL DEATH DIFFER, V11, P1038, DOI 10.1038/sj.cdd.4401443; Soucek L, 2002, CANCER RES, V62, P3507; Soucek L, 1998, ONCOGENE, V17, P2463, DOI 10.1038/sj.onc.1202199; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; SUN XH, 1991, MOL CELL BIOL, V11, P5603, DOI 10.1128/MCB.11.11.5603; von Eyss B, 2011, GENE DEV, V25, P895, DOI 10.1101/gad.2053311; Wanzel M, 2003, TRENDS CELL BIOL, V13, P146, DOI 10.1016/S0962-8924(03)00003-5; Wechsler DS, 1997, CANCER RES, V57, P4905; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80	66	72	78	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22284	10.1371/journal.pone.0022284	http://dx.doi.org/10.1371/journal.pone.0022284			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811581	Green Published, gold, Green Submitted			2022-12-25	WOS:000292956800038
J	Sachar, S; Saxena, RK				Sachar, Sumedha; Saxena, Rajiv K.			Cytotoxic Effect of Poly-Dispersed Single Walled Carbon Nanotubes on Erythrocytes In Vitro and In Vivo	PLOS ONE			English	Article							MICE; TOXICITY; CIRCULATION; FUNCTIONALIZATION; SENESCENCE; EXPRESSION; CLEARANCE; STRESS	Single wall Carbon Nanotubes (SWCNTs) are hydrophobic and do not disperse in aqueous solvents. Acid functionalization of SWCNTs results in attachment of carboxy and sulfonate groups to carbon atoms and the resulting acid functionalized product (AF-SWCNTs) is negatively charged and disperses easily in water and buffers. In the present study, effect of AF-SWCNTs on blood erythrocytes was examined. Incubation of mouse erythrocytes with AF-SWCNTs and not with control SWCNTs, resulted in a dose and time dependent lysis of erythrocyte. Using fluorescence tagged AF-SWCNTs, binding of AF-SWCNTs with erythrocytes could be demonstrated. Confocal microscopy results indicated that AF-SWCNTs could enter the erythrocytes. Treatment with AF-SWCNTs resulted in exposure of hydrophobic patches on erythrocyte membrane that is indicative of membrane damage. A time and dose dependent increase in externalization of phosphatidylserine on erythrocyte membrane bilayer was also found. Administration of AF-SWCNTs through intravenous route resulted in a transient anemia as seen by a sharp decline in blood erythrocyte count accompanied with a significant drop in blood haemoglobin level. Administration of AF-SWCNTs through intratracheal administration also showed significant decline in RBC count while administration through other routes (gavage and intra-peritoneal) was not effective. By using a recently developed technique of a two step in vivo biotinylation of erythrocytes that enables simultaneous enumeration of young (age<10 days) and old (age>40 days) erythrocytes in mouse blood, it was found that the in vivo toxic effect of AF-SWCNTs was more pronounced on older subpopulation of erythrocytes. Subpopulation of old erythrocytes fell after treatment with AF-SWCNTs but recovered by third day after the intravenous administration of AF-SWCNTs. Taken together our results indicate that treatment with AF-SWCNTs results in acute membrane damage and eventual lysis of erythrocytes. Intravenous administration of AF-SWCNTs resulted in a transient anemia in which older erythrocytes are preferably lysed.	[Sachar, Sumedha; Saxena, Rajiv K.] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Sachar, S (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	rajivksaxena@hotmail.com			Department of Science and Technology (DST) [SR/SO/HS-133/2007]; DBT	Department of Science and Technology (DST)(Department of Science & Technology (India)); DBT(Department of Biotechnology (DBT) India)	This study was supported by a Department of Science and Technology (DST) grant (SR/SO/HS-133/2007) to RKS, and a fellowship from DBT to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CARDAMONE M, 1992, BIOCHEM J, V282, P589, DOI 10.1042/bj2820589; Erdely A, 2009, NANO LETT, V9, P36, DOI 10.1021/nl801828z; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Khandelwal S, 2008, EXP GERONTOL, V43, P764, DOI 10.1016/j.exger.2008.05.002; Khandelwal S, 2007, TRANSFUSION, V47, P1725, DOI 10.1111/j.1537-2995.2007.01348.x; Khandelwal S, 2006, EXP GERONTOL, V41, P855, DOI 10.1016/j.exger.2006.06.045; Kiefer CR, 2000, CURR OPIN HEMATOL, V7, P113, DOI 10.1097/00062752-200003000-00007; Lam CW, 2006, CRIT REV TOXICOL, V36, P189, DOI 10.1080/10408440600570233; Lam CW, 2004, TOXICOL SCI, V77, P126, DOI 10.1093/toxsci/kfg243; McDevitt MR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000907; Mukherjee K, 2007, BIOCHEM BIOPH RES CO, V362, P651, DOI 10.1016/j.bbrc.2007.08.048; Saxena RK, 2007, NANOTOXICOLOGY, V1, P291, DOI 10.1080/17435390701803110; Saxena RK, 2009, CURR SCI INDIA, V97, P500; Schipper ML, 2008, NAT NANOTECHNOL, V3, P216, DOI 10.1038/nnano.2008.68; Socolovsky M, 2007, CURR OPIN HEMATOL, V14, P215, DOI 10.1097/MOH.0b013e3280de2bf1; Stoker Emily, 2008, Int J Toxicol, V27, P441, DOI 10.1080/10915810802552138; Tong HY, 2009, TOXICOL APPL PHARM, V239, P224, DOI 10.1016/j.taap.2009.05.019; Wang YB, 2006, J AM CHEM SOC, V128, P95, DOI 10.1021/ja053003q; Wu DC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011303; Xu ZX, 2008, APPL SURF SCI, V254, P1915, DOI 10.1016/j.apsusc.2007.07.189	20	43	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22032	10.1371/journal.pone.0022032	http://dx.doi.org/10.1371/journal.pone.0022032			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21818289	Green Submitted, Green Published, gold			2022-12-25	WOS:000292929500031
J	Banci, L; Bertini, I; Cefaro, C; Ciofi-Baffoni, S; Gallo, A				Banci, Lucia; Bertini, Ivano; Cefaro, Chiara; Ciofi-Baffoni, Simone; Gallo, Angelo			Functional Role of Two Interhelical Disulfide Bonds in Human Cox17 Protein from a Structural Perspective	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR CHEMICAL-SHIFTS; COPPER METALLOCHAPERONE COX17; CYTOCHROME-C-OXIDASE; INTERMEMBRANE SPACE; ELECTRON-TRANSFER; RELAY SYSTEM; MITOCHONDRIA; CHAPERONE; MIA40; SCO1	Human Cox17 is the mitochondrial copper chaperone responsible for supplying copper ions, through the assistance of Sco1, Sco2, and Cox11, to cytochrome c oxidase, the terminal enzyme of the mitochondrial energy-transducing respiratory chain. It consists of a coiled coil-helix-coiled coil-helix domain stabilized by two disulfide bonds and binds one copper(I) ion through a Cys-Cys motif. Here, the structures and the backbone mobilities of two Cox17 mutated forms with only one interhelical disulfide bond have been analyzed. It appears that the inner disulfide bond (formed by Cys-36 and Cys-45) stabilizes interhelical hydrophobic interactions, providing a structure with essentially the same structural dynamic properties of the mature Cox17 state. On the contrary, the external disulfide bond (formed by Cys-26 and Cys-55) generates a conformationally flexible alpha-helical protein, indicating that it is not able to stabilize interhelical packing contacts, but is important for structurally organizing the copper-binding site region.	[Bertini, Ivano] Univ Florence, Magnet Resonance Ctr, I-50019 Florence, Italy; Univ Florence, Dept Chem, I-50019 Florence, Italy	University of Florence; University of Florence	Bertini, I (corresponding author), Univ Florence, Magnet Resonance Ctr, Via Luigi Sacconi 6, I-50019 Florence, Italy.	ivanobertini@cerm.unifi.it	Gallo, Angelo/N-3781-2017; Ciofi-Baffoni, Simone/AAH-9778-2021	Gallo, Angelo/0000-0001-9778-4822; Ciofi Baffoni, Simone/0000-0002-2376-3321; BANCI, LUCIA/0000-0003-0562-5774	WeNMR Project [261572]; national GRID initiative of Belgium; national GRID initiative of Italy; national GRID initiative of Germany; national GRID initiative of The Netherlands; national GRID initiative of Portugal; national GRID initiative of United Kingdom; national GRID initiative of South Africa; Latin America GRID infrastructure via the Gisela; MIUR [RBRN07BMCT]; United States National Institutes of Health [P41 RR-01081]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER	WeNMR Project; national GRID initiative of Belgium; national GRID initiative of Italy; national GRID initiative of Germany; national GRID initiative of The Netherlands; national GRID initiative of Portugal; national GRID initiative of United Kingdom; national GRID initiative of South Africa; Latin America GRID infrastructure via the Gisela; MIUR(Ministry of Education, Universities and Research (MIUR)); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by WeNMR Project (European FP7 e-Infrastructure grant, Contract 261572), supported by the national GRID initiatives of Belgium, Italy, Germany, The Netherlands (via the Dutch BiG Grid project), Portugal, the United Kingdom, South Africa, and the Latin America GRID infrastructure via the Gisela and by the Italian FIRB PROTEOMICA MIUR Contract RBRN07BMCT. Molecular graphics images were produced using the UCSF Chimera (39) package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, supported by United States National Institutes of Health Grant P41 RR-01081.	Arnesano F, 2005, STRUCTURE, V13, P713, DOI 10.1016/j.str.2005.02.015; Banci L, 2008, P NATL ACAD SCI USA, V105, P6803, DOI 10.1073/pnas.0800019105; Banci L, 2008, J BIOL CHEM, V283, P7912, DOI 10.1074/jbc.M708016200; Banci L, 2007, P NATL ACAD SCI USA, V104, P15, DOI 10.1073/pnas.0606189103; Banci L, 2010, P NATL ACAD SCI USA, V107, P20190, DOI 10.1073/pnas.1010095107; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; Banci L, 2009, NAT STRUCT MOL BIOL, V16, P198, DOI 10.1038/nsmb.1553; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Bien M, 2010, MOL CELL, V37, P516, DOI 10.1016/j.molcel.2010.01.017; CASE DA, 2008, AMBER 10 8 0; Depuydt M, 2011, ANTIOXID REDOX SIGN, V15, P49, DOI 10.1089/ars.2010.3575; Eghbalnia HR, 2005, J BIOMOL NMR, V32, P71, DOI 10.1007/s10858-005-5705-1; Heaton D, 2000, J BIOL CHEM, V275, P37582, DOI 10.1074/jbc.M006639200; Heaton DN, 2001, BIOCHEMISTRY-US, V40, P743, DOI 10.1021/bi002315x; Hell K, 2008, BBA-MOL CELL RES, V1783, P601, DOI 10.1016/j.bbamcr.2007.12.005; Herrmann JM, 2007, J CELL BIOL, V176, P559, DOI 10.1083/jcb.200611060; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Horng YC, 2004, J BIOL CHEM, V279, P35334, DOI 10.1074/jbc.M404747200; Keller R., 2004, COMPUTER AIDED RESON, V1; Maxfield AB, 2004, J BIOL CHEM, V279, P5072, DOI 10.1074/jbc.M311772200; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; OTTING G, 1993, BIOCHEMISTRY-US, V32, P3571, DOI 10.1021/bi00065a008; Palumaa P, 2004, BIOCHEM J, V382, P307, DOI 10.1042/BJ20040360; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Punter FA, 2000, HUM GENET, V107, P69, DOI 10.1007/s004390050013; Punter FA, 2003, J BIOL CHEM, V278, P30875, DOI 10.1074/jbc.M302358200; Riemer J, 2009, SCIENCE, V324, P1284, DOI 10.1126/science.1170653; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sideris DP, 2010, ANTIOXID REDOX SIGN, V13, P1189, DOI 10.1089/ars.2010.3157; Sideris DP, 2009, J CELL BIOL, V187, P1007, DOI 10.1083/jcb.200905134; Siluvai GS, 2011, J BIOL INORG CHEM, V16, P285, DOI 10.1007/s00775-010-0725-z; Terziyska N, 2009, J BIOL CHEM, V284, P1353, DOI 10.1074/jbc.M805035200; Voronova A, 2007, BIOCHEM J, V408, P139, DOI 10.1042/BJ20070804; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Xiao ZG, 2011, J BIOL CHEM, V286, P11047, DOI 10.1074/jbc.M110.213074; Zhou L, 2008, BIOCHEM J, V413, P459, DOI 10.1042/BJ20080467	39	18	21	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34382	34390		10.1074/jbc.M111.246223	http://dx.doi.org/10.1074/jbc.M111.246223			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21816817	hybrid, Green Published			2022-12-25	WOS:000295159200066
J	Inoue, T; Kobayashi, K; Inoguchi, T; Sonoda, N; Fujii, M; Maeda, Y; Fujimura, Y; Miura, D; Hirano, K; Takayanagi, R				Inoue, Tomoaki; Kobayashi, Kunihisa; Inoguchi, Toyoshi; Sonoda, Noriyuki; Fujii, Masakazu; Maeda, Yasutaka; Fujimura, Yoshinori; Miura, Daisuke; Hirano, Ken-ichi; Takayanagi, Ryoichi			Reduced Expression of Adipose Triglyceride Lipase Enhances Tumor Necrosis Factor alpha-induced Intercellular Adhesion Molecule-1 Expression in Human Aortic Endothelial Cells via Protein Kinase C-dependent Activation of Nuclear Factor-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIABETES-MELLITUS; OXIDATIVE STRESS; DIACYLGLYCEROL SYNTHESIS; TRANSCRIPTION FACTOR; GLUCOSE; DISEASE; ACID; ACCUMULATION; MECHANISMS; STEATOSIS	We examined the effects of adipose triglyceride lipase (ATGL) on the initiation of atherosclerosis. ATGL was recently identified as a rate-limiting triglyceride (TG) lipase. Mutations in the human ATGL gene are associated with neutral lipid storage disease with myopathy, a rare genetic disease characterized by excessive accumulation of TG in multiple tissues. The cardiac phenotype, known as triglyceride deposit cardiomyovasculopathy, shows massive TG accumulation in both coronary atherosclerotic lesions and the myocardium. Recent reports show that myocardial triglyceride content is significantly higher in patients with prediabetes or diabetes and that ATGL expression is decreased in the obese insulin-resistant state. Therefore, we investigated the effect of decreased ATGL activity on the development of atherosclerosis using human aortic endothelial cells. We found that ATGL knockdown enhanced monocyte adhesion via increased expression of TNF alpha-induced intercellular adhesion molecule-1 (ICAM-1). Next, we determined the pathways (MAPK, PKC, or NF kappa B) involved in ICAM-1 up-regulation induced by ATGL knockdown. Both phosphorylation of PKC and degradation of I kappa B alpha were increased in ATGL knockdown human aortic endothelial cells. In addition, intracellular diacylglycerol levels and free fatty acid uptake via CD36 were significantly increased in these cells. Inhibition of the PKC pathway using calphostin C and GF109203X suppressed TNF alpha-induced ICAM-1 expression. In conclusion, we showed that ATGL knockdown increased monocyte adhesion to the endothelium through enhanced TNF alpha-induced ICAM-1 expression via activation of NF kappa B and PKC. These results suggest that reduced ATGL expression may influence the atherogenic process in neutral lipid storage diseases and in the insulin-resistant state.	[Inoue, Tomoaki; Kobayashi, Kunihisa; Inoguchi, Toyoshi; Sonoda, Noriyuki; Fujii, Masakazu; Maeda, Yasutaka; Takayanagi, Ryoichi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Higashi Ku, Fukuoka 8128582, Japan; [Kobayashi, Kunihisa] Fukuoka Univ, Chikushi Hosp, Dept Endocrinol & Diabet Mellitus, Fukuoka 8188502, Japan; [Inoguchi, Toyoshi; Sonoda, Noriyuki; Fujimura, Yoshinori; Miura, Daisuke] Kyushu Univ, Innovat Ctr Med Redox Nav, Higashi Ku, Fukuoka 8128582, Japan; [Hirano, Ken-ichi] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan	Kyushu University; Fukuoka University; Kyushu University; Osaka University	Kobayashi, K (corresponding author), 1-1-1 Zokumyoin, Fukuoka 8188502, Japan.	nihisak@fukuoka-u.ac.jp	Kobayashi, Kunihisa/V-9554-2019; Fujimura, Yoshinori/AAG-4403-2019; fujimura, yoshinori/E-4684-2012; Miura, Daisuke/H-1517-2019	Kobayashi, Kunihisa/0000-0002-7741-846X; Fujimura, Yoshinori/0000-0003-0798-0649; Inoguchi, Toyoshi/0000-0002-7344-6199	Ministry of Health, Labor, and Welfare of the Japanese Government	Ministry of Health, Labor, and Welfare of the Japanese Government(Ministry of Health, Labour and Welfare, Japan)	This work was supported by research grants-in-aid for rare and intractable diseases from the Ministry of Health, Labor, and Welfare of the Japanese Government (to K. H. and K. K.).	BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405; Belfrage P, 1978, Adv Exp Med Biol, V101, P113; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Casasnovas JM, 1998, J VIROL, V72, P6244, DOI 10.1128/JVI.72.7.6244-6246.1998; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Febbraio M, 2007, INT J BIOCHEM CELL B, V39, P2012, DOI 10.1016/j.biocel.2007.03.012; FINCO TS, 1994, P NATL ACAD SCI USA, V91, P11884, DOI 10.1073/pnas.91.25.11884; FOLCH J, 1957, J BIOL CHEM, V226, P497; GERRITY RG, 1981, AM J PATHOL, V103, P181; HA HJ, 1994, FREE RADICAL BIO MED, V16, P271, DOI 10.1016/0891-5849(94)90152-X; Hirano K, 2008, NEW ENGL J MED, V359, P2396, DOI 10.1056/NEJMc0805305; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; INOGUCHI T, 1994, AM J PHYSIOL, V267, pE369, DOI 10.1152/ajpendo.1994.267.3.E369; Jocken JWE, 2007, J CLIN ENDOCR METAB, V92, P2292, DOI 10.1210/jc.2006-1318; Kakimoto M, 2002, DIABETES, V51, P1588, DOI 10.2337/diabetes.51.5.1588; Kevil CG, 2001, AM J PHYSIOL-CELL PH, V281, pC1442, DOI 10.1152/ajpcell.2001.281.5.C1442; Kienesberger PC, 2009, J BIOL CHEM, V284, P30218, DOI 10.1074/jbc.M109.047787; Kobayashi K, 2008, J CLIN ENDOCR METAB, V93, P2877, DOI 10.1210/jc.2007-2247; Kuroki T, 1998, BIOCHEM BIOPH RES CO, V247, P473, DOI 10.1006/bbrc.1998.8814; Lingvay I, 2009, NAT REV CARDIOL, V6, P268, DOI 10.1038/nrcardio.2009.30; McGavock JM, 2007, CIRCULATION, V116, P1170, DOI 10.1161/CIRCULATIONAHA.106.645614; Muller M, 2002, MOL CELL BIOL, V22, P1060, DOI 10.1128/MCB.22.4.1060-1072.2002; OBERLEY LW, 1988, FREE RADICAL BIO MED, V5, P113, DOI 10.1016/0891-5849(88)90036-6; Ozes ON, 1999, NATURE, V401, P82; Ragheb R, 2008, BIOCHEM BIOPH RES CO, V370, P134, DOI 10.1016/j.bbrc.2008.03.044; Read MA, 1997, J BIOL CHEM, V272, P2753, DOI 10.1074/jbc.272.5.2753; Rijzewijk LJ, 2008, J AM COLL CARDIOL, V52, P1793, DOI 10.1016/j.jacc.2008.07.062; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Schmitz ML, 2003, FASEB J, V17, P2187, DOI 10.1096/fj.02-1100rev; Seckin D, 2006, DIABETES RES CLIN PR, V73, P191, DOI 10.1016/j.diabres.2006.01.001; SLUSS HK, 1994, MOL CELL BIOL, V14, P8376, DOI 10.1128/MCB.14.12.8376; Steinberg GR, 2007, AM J PHYSIOL-ENDOC M, V293, pE958, DOI 10.1152/ajpendo.00235.2007; Tsubouchi H, 2005, FREE RADICAL BIO MED, V39, P444, DOI 10.1016/j.freeradbiomed.2005.03.031; WOLF BA, 1989, BIOCHEMISTRY-US, V28, P4291, DOI 10.1021/bi00436a026; WOLFF SP, 1991, FREE RADICAL BIO MED, V10, P339, DOI 10.1016/0891-5849(91)90040-A; Yu HY, 2001, DIABETOLOGIA, V44, P614, DOI 10.1007/s001250051668; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	39	24	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32045	32053		10.1074/jbc.M111.285650	http://dx.doi.org/10.1074/jbc.M111.285650			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21828047	hybrid, Green Published			2022-12-25	WOS:000294726800014
J	Sjolund, J; Bostrom, AK; Lindgren, D; Manna, S; Moustakas, A; Ljungberg, B; Johansson, M; Fredlund, E; Axelson, H				Sjolund, Jonas; Bostrom, Anna-Karin; Lindgren, David; Manna, Sugata; Moustakas, Aristidis; Ljungberg, Borje; Johansson, Martin; Fredlund, Erik; Axelson, Hakan			The Notch and TGF-beta Signaling Pathways Contribute to the Aggressiveness of Clear Cell Renal Cell Carcinoma	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TO-MESENCHYMAL TRANSITION; GENE-EXPRESSION; INTRACELLULAR DOMAIN; TUBULE CELLS; HUMAN CANCER; INHIBITION; RECEPTOR; SMAD3; METASTASIS	Background: Despite recent progress, therapy for metastatic clear cell renal cell carcinoma (CCRCC) is still inadequate. Dysregulated Notch signaling in CCRCC contributes to tumor growth, but the full spectrum of downstream processes regulated by Notch in this tumor form is unknown. Methodology/Principal Findings: We show that inhibition of endogenous Notch signaling modulates TGF-beta dependent gene regulation in CCRCC cells. Analysis of gene expression data representing 176 CCRCCs showed that elevated TGF-beta pathway activity correlated significantly with shortened disease specific survival (log-rank test, p = 0.006) and patients with metastatic disease showed a significantly elevated TGF-beta signaling activity (two-sided Student's t-test, p = 0.044). Inhibition of Notch signaling led to attenuation of both basal and TGF-beta 1 induced TGF-beta signaling in CCRCC cells, including an extensive set of genes known to be involved in migration and invasion. Functional analyses revealed that Notch inhibition decreased the migratory and invasive capacity of CCRCC cells. Conclusion: An extensive cross-talk between the Notch and TGF-beta signaling cascades is present in CCRCC and the functional properties of these two pathways are associated with the aggressiveness of this disease.	[Sjolund, Jonas; Bostrom, Anna-Karin; Lindgren, David; Manna, Sugata; Johansson, Martin; Fredlund, Erik; Axelson, Hakan] Lund Univ, Univ Hosp MAS, Ctr Mol Pathol, Dept Lab Med, Malmo, Sweden; [Moustakas, Aristidis] Uppsala Univ, Biomed Ctr, Ludwig Inst Canc Res, Uppsala, Sweden; [Ljungberg, Borje] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden	Lund University; Skane University Hospital; Ludwig Institute for Cancer Research; Uppsala University; Umea University	Sjolund, J (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.	hakan.axelson@med.lu.se		Ljungberg, Borje/0000-0002-4121-3753; Sjolund, Jonas/0000-0002-6992-3415	Swedish Cancer Society [09 0643]; Swedish Research Council [90348001]; Ake Wiberg's Foundation; Ollie and Elof Ericsson's Foundation; Crafoord Foundation; Gunnar Nilsson's Cancer Foundation; Royal Physiographic Society in Lund; Malmo University Hospital	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Ake Wiberg's Foundation; Ollie and Elof Ericsson's Foundation(Ericsson); Crafoord Foundation; Gunnar Nilsson's Cancer Foundation; Royal Physiographic Society in Lund; Malmo University Hospital	This work was supported by grants from the Swedish Cancer Society (grant no 09 0643), the Swedish Research Council (grant no 90348001), Ake Wiberg's Foundation, Ollie and Elof Ericsson's Foundation, the Crafoord Foundation, Gunnar Nilsson's Cancer Foundation, The Royal Physiographic Society in Lund, and Malmo University Hospital Research Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananth S, 1999, CANCER RES, V59, P2210; Asano N, 2008, J IMMUNOL, V180, P2796, DOI 10.4049/jimmunol.180.5.2796; Aster JC, 1997, J BIOL CHEM, V272, P11336; Blokzijl A, 2003, J CELL BIOL, V163, P723, DOI 10.1083/jcb.200305112; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Chen CR, 2001, P NATL ACAD SCI USA, V98, P992, DOI 10.1073/pnas.98.3.992; Chen S, 2004, KIDNEY INT, V65, P1191, DOI 10.1111/j.1523-1755.2004.00492.x; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Copland JA, 2003, ONCOGENE, V22, P8053, DOI 10.1038/sj.onc.1206835; Coulouarn C, 2008, HEPATOLOGY, V47, P2059, DOI 10.1002/hep.22283; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dudas PL, 2009, NEPHROL DIAL TRANSPL, V24, P1406, DOI 10.1093/ndt/gfn662; Fredlund E, 2008, P NATL ACAD SCI USA, V105, P14094, DOI 10.1073/pnas.0804455105; Fu YX, 2009, J BIOL CHEM, V284, P19452, DOI 10.1074/jbc.M109.011833; Garber K, 2007, J NATL CANCER I, V99, P1284, DOI 10.1093/jnci/djm148; Gonzalez-Garcia S, 2009, J EXP MED, V206, P779, DOI 10.1084/jem.20081922; Guh JY, 2003, KIDNEY INT, V64, P2041, DOI 10.1046/j.1523-1755.2003.00330.x; Hegele A, 2002, UROL RES, V30, P126, DOI 10.1007/s00240-002-0245-6; Hubble J, 2009, NUCLEIC ACIDS RES, V37, pD898, DOI 10.1093/nar/gkn786; HUMES HD, 1991, LAB INVEST, V64, P538; Jones J, 2005, CLIN CANCER RES, V11, P5730, DOI 10.1158/1078-0432.CCR-04-2225; Kennard S, 2008, J BIOL CHEM, V283, P1324, DOI 10.1074/jbc.M706651200; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Kominsky SL, 2007, J BONE MINER RES, V22, P37, DOI 10.1359/JBMR.061005; Kovacs G, 1997, J PATHOL, V183, P131, DOI 10.1002/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO;2-G; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Lindgren D, 2006, ONCOGENE, V25, P2685, DOI 10.1038/sj.onc.1209249; Linehan WM, 2009, INT J BIOCHEM CELL B, V41, P753, DOI 10.1016/j.biocel.2008.09.024; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Masuda S, 2005, CANCER SCI, V96, P274, DOI 10.1111/j.1349-7006.2005.00048.x; Mitropoulos D, 2004, UROL RES, V32, P317, DOI 10.1007/s00240-003-0360-z; Miyajima A, 2003, UROLOGY, V61, P1072, DOI 10.1016/S0090-4295(02)02553-0; Nichols JT, 2007, TRAFFIC, V8, P959, DOI 10.1111/j.1600-0854.2007.00592.x; Niimi H, 2007, J CELL BIOL, V176, P695, DOI 10.1083/jcb.200612129; Ono Y, 2007, J CELL PHYSIOL, V210, P358, DOI 10.1002/jcp.20838; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Parker AS, 2007, HUM PATHOL, V38, P453, DOI 10.1016/j.humpath.2006.08.029; Real PJ, 2009, NAT MED, V15, P50, DOI 10.1038/nm.1900; Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2; Samon JB, 2008, BLOOD, V112, P1813, DOI 10.1182/blood-2008-03-144980; Sievers E, 2007, UROL INT, V79, P235, DOI 10.1159/000107956; Sjolund J, 2008, J CLIN INVEST, V118, P217, DOI 10.1172/JCI32086; Stockhausen MT, 2005, EXP CELL RES, V310, P218, DOI 10.1016/j.yexcr.2005.07.011; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun YP, 2005, ONCOGENE, V24, P5365, DOI 10.1038/sj.onc.1208528; Takahashi M, 2001, P NATL ACAD SCI USA, V98, P9754, DOI 10.1073/pnas.171209998; Thurston G, 2007, NAT REV CANCER, V7, P327, DOI 10.1038/nrc2130; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verrecchia F, 2001, J BIOL CHEM, V276, P17058, DOI 10.1074/jbc.M100754200; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zhao HJ, 2006, PLOS MED, V3, P115, DOI 10.1371/journal.pmed.0030013	54	51	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e23057	10.1371/journal.pone.0023057	http://dx.doi.org/10.1371/journal.pone.0023057			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826227	Green Published, Green Submitted, gold			2022-12-25	WOS:000293558900053
J	Prosser, LA; Lavelle, TA; Fiore, AE; Bridges, CB; Reed, C; Jain, S; Dunham, KM; Meltzer, MI				Prosser, Lisa A.; Lavelle, Tara A.; Fiore, Anthony E.; Bridges, Carolyn B.; Reed, Carrie; Jain, Seema; Dunham, Kelly M.; Meltzer, Martin I.			Cost-Effectiveness of 2009 Pandemic Influenza A(H1N1) Vaccination in the United States	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; IMMUNIZATION-PROGRAM; ECONOMIC-IMPACT; BENEFITS; EFFICACY; HEALTH; ADULTS; H1N1; ASSOCIATION; BURDEN	Background: Pandemic influenza A(H1N1) (pH1N1) was first identified in North America in April 2009. Vaccination against pH1N1 commenced in the U. S. in October 2009 and continued through January 2010. The objective of this study was to evaluate the cost-effectiveness of pH1N1 vaccination. Methodology: A computer simulation model was developed to predict costs and health outcomes for a pH1N1 vaccination program using inactivated vaccine compared to no vaccination. Probabilities, costs and quality-of-life weights were derived from emerging primary data on pH1N1 infections in the US, published and unpublished data for seasonal and pH1N1 illnesses, supplemented by expert opinion. The modeled target population included hypothetical cohorts of persons aged 6 months and older stratified by age and risk. The analysis used a one-year time horizon for most endpoints but also includes longer-term costs and consequences of long-term sequelae deaths. A societal perspective was used. Indirect effects (i.e., herd effects) were not included in the primary analysis. The main endpoint was the incremental cost-effectiveness ratio in dollars per quality-adjusted life year (QALY) gained. Sensitivity analyses were conducted. Results: For vaccination initiated prior to the outbreak, pH1N1 vaccination was cost-saving for persons 6 months to 64 years under many assumptions. For those without high risk conditions, incremental cost-effectiveness ratios ranged from $8,000-$52,000/QALY depending on age and risk status. Results were sensitive to the number of vaccine doses needed, costs of vaccination, illness rates, and timing of vaccine delivery. Conclusions: Vaccination for pH1N1 for children and working-age adults is cost-effective compared to other preventive health interventions under a wide range of scenarios. The economic evidence was consistent with target recommendations that were in place for pH1N1 vaccination. We also found that the delays in vaccine availability had a substantial impact on the cost-effectiveness of vaccination.	[Prosser, Lisa A.; Dunham, Kelly M.] Univ Michigan Hlth Syst, Div Gen Pediat, Child Hlth Evaluat & Res Unit, Ann Arbor, MI USA; [Lavelle, Tara A.] Harvard Univ, PhD Program Hlth Policy, Cambridge, MA 02138 USA; [Fiore, Anthony E.; Bridges, Carolyn B.; Reed, Carrie; Jain, Seema; Meltzer, Martin I.] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	University of Michigan System; University of Michigan; Harvard University; Centers for Disease Control & Prevention - USA	Prosser, LA (corresponding author), Univ Michigan Hlth Syst, Div Gen Pediat, Child Hlth Evaluat & Res Unit, Ann Arbor, MI USA.	lisapros@med.umich.edu	Fiore, Anthony/AAO-8956-2020; Meltzer, Martin/AAT-3235-2021	Meltzer, Martin/0000-0002-7250-0472; Dunham, Kelly/0000-0002-7393-9049	Harvard-CDC Joint Initiative in Vaccine Economics	Harvard-CDC Joint Initiative in Vaccine Economics	Funding for this project was provided from the Harvard-CDC Joint Initiative in Vaccine Economics. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong BG, 2004, BMJ-BRIT MED J, V329, P660, DOI 10.1136/bmj.38198.594109.AE; Baguelin M, 2010, VACCINE, V28, P2370, DOI 10.1016/j.vaccine.2010.01.002; Beigi RH, 2009, CLIN INFECT DIS, V49, P1784, DOI 10.1086/649013; Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; BREMAN JG, 1984, AM J EPIDEMIOL, V119, P880, DOI 10.1093/oxfordjournals.aje.a113810; *BUR LAB STAT, 2009, NAT COMP SURV MEAN H; Bureau of Labor Statistics, 2009, CONS PRIC IND; Centers for Disease Control and Prevention, 2009, MMWR-MORBID MORTAL W, V58, P435, DOI DOI 10.1007/S00134-010-2021-3; Centers for Disease Control and Prevention, 2009, MMWR-MORBID MORTAL W, V58, P431; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P433; Centers for Medicare and Medicaid Services (CMS), 2009, PHYS FEE SCHED; Coleman MS, 2005, VACCINE, V23, P915, DOI 10.1016/j.vaccine.2004.07.028; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Glazner JE, 2004, PEDIATRICS, V113, P1582, DOI 10.1542/peds.113.6.1582; Goldie SJ, 2004, JNCI-J NATL CANCER I, V96, P604, DOI 10.1093/jnci/djh104; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; GROSS PA, 1995, ANN INTERN MED, V123, P518, DOI 10.7326/0003-4819-123-7-199510010-00008; Hebert PL, 2005, HEALTH SERV RES, V40, P517, DOI 10.1111/j.1475-6773.2005.0e371.x; HURWITZ ES, 1981, NEW ENGL J MED, V304, P1557, DOI 10.1056/NEJM198106253042601; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Jordan H. T., 2009, Morbidity and Mortality Weekly Report, V58, P470; Keren R, 2006, PEDIATRICS, V118, pE1321, DOI 10.1542/peds.2006-0598; Khazeni N, 2009, ANN INTERN MED, V151, P829, DOI [10.7326/0000605-200912150-00157, 10.7326/0003-4819-151-12-200912150-00157]; King JC, 2006, NEW ENGL J MED, V355, P2523, DOI 10.1056/NEJMoa055414; Kulasingam SL, 2003, JAMA-J AM MED ASSOC, V290, P781, DOI 10.1001/jama.290.6.781; LANGMUIR AD, 1984, AM J EPIDEMIOL, V119, P841, DOI 10.1093/oxfordjournals.aje.a113809; Lasky T, 1998, NEW ENGL J MED, V339, P1797, DOI 10.1056/NEJM199812173392501; Lee BY, 2010, VACCINE, V28, P4875, DOI 10.1016/j.vaccine.2010.05.002; Lee BY, 2010, AM J PREV MED, V38, P247, DOI 10.1016/j.amepre.2009.11.009; MARKS JS, 1980, JAMA-J AM MED ASSOC, V243, P2490, DOI 10.1001/jama.243.24.2490; MEDLOCK J, 2009, SCIENCE; MELTZER M, 2009, INFLUENZA VACC UNPUB; Meltzer MI, 1999, EMERG INFECT DIS, V5, P659, DOI 10.3201/eid0505.990507; Miller MA, 2008, J INFECT DIS, V198, P305, DOI 10.1086/589716; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Monto AS, 2009, NEW ENGL J MED, V361, P1260, DOI 10.1056/NEJMoa0808652; Nichol KL, 2003, VACCINE, V21, P1769, DOI 10.1016/S0264-410X(03)00070-7; PARKIN WE, 1978, PENN MED, V81, P47; Pisu M, 2005, PHARMACOECONOMICS, V23, P55, DOI 10.2165/00019053-200523010-00005; PROSSER L, 2008, VALUING HLTH LIFESPA; Prosser LA, 2004, PEDIATRICS, V113, P283, DOI 10.1542/peds.113.2.283; Prosser LA, 2005, HEALTH QUAL LIFE OUT, V3, P1; Prosser LA, 2008, PHARMACOECONOMICS, V26, P163, DOI 10.2165/00019053-200826020-00006; Prosser LA, 2006, EMERG INFECT DIS, V12, P1548, DOI 10.3201/eid1210.051015; REED C, 2009, EMERGING INFECT DIS; ROHRER JW, 1978, CAN MED ASSOC J, V118, P1528; ROSCELLI JD, 1991, AM J EPIDEMIOL, V133, P952, DOI 10.1093/oxfordjournals.aje.a115974; SAFRANEK TJ, 1991, AM J EPIDEMIOL, V133, P940, DOI 10.1093/oxfordjournals.aje.a115973; Sander B, 2010, VACCINE, V28, P6210, DOI 10.1016/j.vaccine.2010.07.010; Sanders GD, 2003, EMERG INFECT DIS, V9, P37; SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795; Shrestha SS, 2011, CLIN INFECT DIS, V52, pS75, DOI 10.1093/cid/ciq012; Singleton JA, 2005, AM J INFECT CONTROL, V33, P563, DOI 10.1016/j.ajic.2005.03.016; Taira AV, 2004, EMERG INFECT DIS, V10, P1915, DOI 10.3201/eid1011.040222; Talbot HK, 2009, VACCINE, V27, P1923, DOI 10.1016/j.vaccine.2009.01.108; Yang Y, 2009, SCIENCE; 1979, WEEKLY EPIDEMIOL MAR, P82	59	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22308	10.1371/journal.pone.0022308	http://dx.doi.org/10.1371/journal.pone.0022308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829456	Green Published, gold, Green Submitted			2022-12-25	WOS:000293286500012
J	Manera, V; Del Giudice, M; Bara, BG; Verfaillie, K; Becchio, C				Manera, Valeria; Del Giudice, Marco; Bara, Bruno G.; Verfaillie, Karl; Becchio, Cristina			The Second-Agent Effect: Communicative Gestures Increase the Likelihood of Perceiving a Second Agent	PLOS ONE			English	Article							BIOLOGICAL MOTION PERCEPTION; EXPECTATIONS	Background: Beyond providing cues about an agent's intention, communicative actions convey information about the presence of a second agent towards whom the action is directed (second-agent information). In two psychophysical studies we investigated whether the perceptual system makes use of this information to infer the presence of a second agent when dealing with impoverished and/or noisy sensory input. Methodology/Principal Findings: Participants observed point-light displays of two agents (A and B) performing separate actions. In the Communicative condition, agent B's action was performed in response to a communicative gesture by agent A. In the Individual condition, agent A's communicative action was replaced with a non-communicative action. Participants performed a simultaneous masking yes-no task, in which they were asked to detect the presence of agent B. In Experiment 1, we investigated whether criterion c was lowered in the Communicative condition compared to the Individual condition, thus reflecting a variation in perceptual expectations. In Experiment 2, we manipulated the congruence between A's communicative gesture and B's response, to ascertain whether the lowering of c in the Communicative condition reflected a truly perceptual effect. Results demonstrate that information extracted from communicative gestures influences the concurrent processing of biological motion by prompting perception of a second agent (second-agent effect). Conclusions/Significance: We propose that this finding is best explained within a Bayesian framework, which gives a powerful rationale for the pervasive role of prior expectations in visual perception.	[Manera, Valeria; Del Giudice, Marco; Bara, Bruno G.; Becchio, Cristina] Univ Turin, Ctr Cognit Sci, Dept Psychol, Turin, Italy; [Manera, Valeria; Verfaillie, Karl] Katholieke Univ Leuven, Expt Psychol Lab, Dept Psychol, Louvain, Belgium	University of Turin; KU Leuven	Manera, V (corresponding author), Univ Turin, Ctr Cognit Sci, Dept Psychol, Turin, Italy.	cristina.becchio@unito.it	Del Giudice, Marco/F-7007-2010; Manera, Valeria/H-7551-2012; Manera, Valeria/O-3498-2016	Del Giudice, Marco/0000-0001-8526-1573; Manera, Valeria/0000-0003-4490-4485; Becchio, Cristina/0000-0002-6845-0521	Regione Piemonte, bando Scienze Umane e Sociali; Research Foundation Flanders (FWO) [FWO G.0621.07]	Regione Piemonte, bando Scienze Umane e Sociali(Regione Piemonte); Research Foundation Flanders (FWO)(FWO)	This research was supported by a grant from the Regione Piemonte, bando Scienze Umane e Sociali 2008, L. R. n. 4/2006, and by a grant from the Research Foundation Flanders (FWO), FWO G.0621.07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bara B.G., 2010, COGNITIVE PRAGMATICS; Chalk M, 2010, J VISION, V10, DOI 10.1167/10.8.2; Chambon V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017133; Clark H.H., 1992, ARENAS LANGUAGE USE; Dekeyser M, 2002, BEHAV RES METH INS C, V34, P375, DOI 10.3758/BF03195465; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Geisler WS, 2003, COGNITIVE SCI, V27, P379, DOI 10.1016/S0364-0213(03)00009-0; GRICE PAUL, 1989, STUDIES WAY WORDS, P24; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Macmillan N. A., 2005, DETECTION THEORY USE; MACMILLAN NA, 1985, PSYCHOL BULL, V98, P185, DOI 10.1037/0033-2909.98.1.185; Manera V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014594; Manera V, 2010, BEHAV RES METHODS, V42, P168, DOI 10.3758/BRM.42.1.168; Neri P, 1998, NATURE, V395, P894, DOI 10.1038/27661; Neri P, 2006, NAT NEUROSCI, V9, P1186, DOI 10.1038/nn1759; Peuskens H, 2005, EUR J NEUROSCI, V21, P2864, DOI 10.1111/j.1460-9568.2005.04106.x; Rauss K, 2011, NEUROSCI BIOBEHAV R, V35, P1237, DOI 10.1016/j.neubiorev.2010.12.011; Saygin AP, 2004, J NEUROSCI, V24, P6181, DOI 10.1523/JNEUROSCI.0504-04.2004; Schilbach Leonhard, 2010, Nat Rev Neurosci, V11, P449, DOI 10.1038/nrn2805-c1; Sebanz N, 2009, TOP COGN SCI, V1, P353, DOI 10.1111/j.1756-8765.2009.01024.x; Sterzer P, 2008, CURR BIOL, V18, pR697, DOI 10.1016/j.cub.2008.06.021; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; Tomasello M, 2008, JEAN NICOD LECT, P1; Vaina LM, 2001, P NATL ACAD SCI USA, V98, P11656, DOI 10.1073/pnas.191374198; Yuille A, 2006, TRENDS COGN SCI, V10, P301, DOI 10.1016/j.tics.2006.05.002	25	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22650	10.1371/journal.pone.0022650	http://dx.doi.org/10.1371/journal.pone.0022650			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	799KC	21829472	Green Submitted, Green Published, gold			2022-12-25	WOS:000293284600020
J	Weltmeier, F; Borlak, J				Weltmeier, Fridtjof; Borlak, Juergen			A High Resolution Genome-Wide Scan of HNF4 alpha Recognition Sites Infers a Regulatory Gene Network in Colon Cancer	PLOS ONE			English	Article							HEPATOCYTE NUCLEAR FACTOR-4-ALPHA; DISEASE CANDIDATE GENES; FACTOR-BINDING SITES; TRANSCRIPTION FACTORS; PEROXISOME PROLIFERATORS; KIDNEY-CELLS; ALPHA-GENE; CHIP-CHIP; EXPRESSION; RECEPTOR	The hepatic nuclear factor HNF4 alpha is a versatile transcription factor and controls expression of many genes in development, metabolism and disease. To delineate its regulatory gene network in colon cancer and to define novel gene targets a comprehensive genome-wide scan was carried out at a resolution of 35 bp with chromatin IP DNA obtained from the human colon carcinoma cell line Caco-2 that is a particularly rich source of HNF4 alpha. More than 90% of HNF4 alpha binding sites were mapped as promoter distal sequences while enhancer elements could be defined to foster chromatin loops for interaction with other promoter-bound transcription factors. Sequence motif analysis by various genetic algorithms evidenced a unique enhanceosome that consisted of the nuclear proteins ER alpha, AP1, GATA and HNF1 alpha as cooperating transcription factors. Overall >17,500 DNA binding sites were identified with a gene/binding site ratio that differedw >6-fold between chromosomes and clustered in distinct chromosomal regions amongst >6600 genes targeted by HNF4 alpha. Evidence is presented for nuclear receptor cross-talk of HNF4 alpha and estrogen receptor a that is recapitulated at the sequence level. Remarkably, the Y-chromosome is devoid of HNF4 alpha binding sites. The functional importance of enrichment sites was confirmed in genome-wide gene expression studies at varying HNF4 alpha protein levels. Taken collectively, a genome-wide scan of HNF4 alpha binding sites is reported to better understand basic mechanisms of transcriptional control of HNF4 alpha targeted genes. Novel promoter distal binding sites are identified which form an enhanceosome thereby facilitating RNA processing events.	[Weltmeier, Fridtjof; Borlak, Juergen] Fraunhofer Inst Toxicol & Expt Med, Dept Mol Med & Med Biotechnol, Hannover, Germany; [Borlak, Juergen] Hannover Med Sch, Ctr Pharmacol & Toxicol, D-3000 Hannover, Germany	Fraunhofer Gesellschaft; Hannover Medical School	Weltmeier, F (corresponding author), Fraunhofer Inst Toxicol & Expt Med, Dept Mol Med & Med Biotechnol, Hannover, Germany.	juergen.borlak@item.fraunhofer.de			Lower Saxony Ministry of Culture and Sciences; Volkswagen foundation, Germany [25A.5-7251-99-3/00]	Lower Saxony Ministry of Culture and Sciences; Volkswagen foundation, Germany(Volkswagen)	This work was funded by the Lower Saxony Ministry of Culture and Sciences and the Volkswagen foundation, Germany. Grant number: 25A.5-7251-99-3/00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battle MA, 2006, P NATL ACAD SCI USA, V103, P8419, DOI 10.1073/pnas.0600246103; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Borlak J, 2001, BIOCHEM PHARMACOL, V61, P145, DOI 10.1016/S0006-2952(00)00537-2; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Cheng ASL, 2006, MOL CELL, V21, P393, DOI 10.1016/j.molcel.2005.12.016; Chiba H, 2003, EXP CELL RES, V286, P288, DOI 10.1016/S0014-4827(03)00116-2; Dekker J, 2008, SCIENCE, V319, P1793, DOI 10.1126/science.1152850; Delie F, 1997, CRIT REV THER DRUG, V14, P221; Dongol B, 2007, J LIPID RES, V48, P1781, DOI 10.1194/jlr.M700119-JLR200; Fourel G, 1996, J VIROL, V70, P8571, DOI 10.1128/JVI.70.12.8571-8583.1996; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Grigo K, 2008, BIOL CHEM, V389, P179, DOI 10.1515/BC.2008.011; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Harnish DC, 1996, J BIOL CHEM, V271, P13621, DOI 10.1074/jbc.271.23.13621; Hertz R, 1996, J BIOL CHEM, V271, P218, DOI 10.1074/jbc.271.1.218; HERTZ R, 1995, J BIOL CHEM, V270, P13470, DOI 10.1074/jbc.270.22.13470; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Jiang GQ, 1997, MOL CELL BIOL, V17, P6546, DOI 10.1128/MCB.17.11.6546; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Kankainen M, 2004, NUCLEIC ACIDS RES, V32, pW222, DOI 10.1093/nar/gkh463; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Lazarevich N, 2004, HEPATOLOGY, V39, P1038, DOI 10.1002/hep.20155; Lucas B, 2005, ONCOGENE, V24, P6418, DOI 10.1038/sj.onc.1208794; Michelson AM, 2002, P NATL ACAD SCI USA, V99, P546, DOI 10.1073/pnas.032685999; Miura A, 2006, J BIOL CHEM, V281, P5246, DOI 10.1074/jbc.M507496200; Naiki T, 2002, J BIOL CHEM, V277, P14011, DOI 10.1074/jbc.M105403200; Niehof M, 2005, MOL PHARMACOL, V67, P604, DOI 10.1124/mol.104.008672; Niehof M, 2008, DIABETES, V57, P1069, DOI 10.2337/db07-1065; Niehof M, 2008, GASTROENTEROLOGY, V134, P1191, DOI 10.1053/j.gastro.2008.01.027; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Rada-Iglesias A, 2005, HUM MOL GENET, V14, P3435, DOI 10.1093/hmg/ddi378; Rohrbeck A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007315; Schrem H, 2002, PHARMACOL REV, V54, P129, DOI 10.1124/pr.54.1.129; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; SLADEK FM, 1993, RECEPTOR, V3, P223; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Sumi K, 2007, MOL CELL BIOL, V27, P4248, DOI 10.1128/MCB.01894-06; Tong WD, 2003, ENVIRON HEALTH PERSP, V111, P1819, DOI 10.1289/ehp.6497; Watt AJ, 2003, HEPATOLOGY, V37, P1249, DOI 10.1053/jhep.2003.50273; West AG, 2005, HUM MOL GENET, V14, pR101, DOI 10.1093/hmg/ddi104; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0	48	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e21667	10.1371/journal.pone.0021667	http://dx.doi.org/10.1371/journal.pone.0021667			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829439	Green Published, Green Submitted, gold			2022-12-25	WOS:000293284600007
J	Kang, JH; Asai, D; Tsuchiya, A; Mori, T; Niidome, T; Katayama, Y				Kang, Jeong-Hun; Asai, Daisuke; Tsuchiya, Akira; Mori, Takeshi; Niidome, Takuro; Katayama, Yoshiki			Peptide Substrates for Rho-Associated Kinase 2 (Rho-Kinase 2/ROCK2)	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; SMOOTH-MUSCLE; MYOSIN PHOSPHATASE; MEDIATED PHOSPHORYLATION; SIGNAL-TRANSDUCTION; NEURONAL CELLS; ROCK-I; SPECIFICITY; ACTIVATION; IDENTIFICATION	Peptide substrates sensitive for a certain protein kinase could be important for new-drug development and to understand the mechanism of diseases. Rho-associated kinase (Rho-kinase/ROCK) is a serine/threonine kinase, and plays an important part in cardiovascular disease, migration and invasion of tumor cells, and in neurological disorders. The purpose of this study was to find substrates with high affinity and sensitivity for ROCK2. We synthesized 136 peptide substrates from protein substrates for ROCK2 with different lengths and charged peptides. Incorporation of (32)P [counts per minute (CPM)] for each peptide substrate was determined by the radiolabel assay using [gamma-(32)P] ATP. When the top five peptide substrates showing high CPMs (R4, R22, R133, R134, and R135) were phosphorylated by other enzymes (PKA, PKC alpha, and ERK1), R22, R133, and R135 displayed the highest CPM level for ROCK2 compared with other enzymes, whereas R4 and R134 showed similar CPM levels for ROCK2 and PKC alpha. We hypothesize that R22, R133, and R135 can be useful peptide substrates for ROCK2.	[Kang, Jeong-Hun] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Biomed Engn, Suita, Osaka, Japan; [Asai, Daisuke] St Marianna Univ, Sch Med, Dept Microbiol, Kawasaki, Kanagawa, Japan; [Tsuchiya, Akira; Mori, Takeshi; Niidome, Takuro; Katayama, Yoshiki] Kyushu Univ, Fac Engn, Dept Appl Chem, Fukuoka 812, Japan; [Mori, Takeshi; Niidome, Takuro; Katayama, Yoshiki] Kyushu Univ, Ctr Future Chem, Fukuoka 812, Japan	National Cerebral & Cardiovascular Center - Japan; Saint Marianna University; Kyushu University; Kyushu University	Kang, JH (corresponding author), Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Biomed Engn, Suita, Osaka, Japan.	jrjhkang@ri.ncvc.go.jp; ykatatcm@mail.cstm.kyushu-u.ac.jp	Mori, Takeshi/AAO-1094-2020; Niidome, Takuro/F-1508-2010; Asai, Daisuke/D-8371-2015	Niidome, Takuro/0000-0002-8070-8708; Kang, Jeong-Hun/0000-0001-9229-3063; Asai, Daisuke/0000-0003-4015-6694	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was financially supported by a grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 2003, J NEUROCHEM, V87, P780, DOI 10.1046/j.1471-4159.2003.02054.x; Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; CHENG HC, 1993, MOL CELL BIOCHEM, V128, P103, DOI 10.1007/BF01076761; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; Fukata Y, 1999, J CELL BIOL, V145, P347, DOI 10.1083/jcb.145.2.347; Ghoreschi K, 2009, NAT IMMUNOL, V10, P356, DOI 10.1038/ni.1701; Goto H, 1998, J BIOL CHEM, V273, P11728, DOI 10.1074/jbc.273.19.11728; Hagerty L, 2007, J BIOL CHEM, V282, P4884, DOI 10.1074/jbc.M609990200; Hashimoto R, 2000, J NEUROCHEM, V75, P373, DOI 10.1046/j.1471-4159.2000.0750373.x; Hofmann J, 1997, FASEB J, V11, P649, DOI 10.1096/fasebj.11.8.9240967; Hong SY, 2010, MOL CELL BIOCHEM, V335, P263, DOI 10.1007/s11010-009-0276-1; HOUSE C, 1990, CELL SIGNAL, V2, P187, DOI 10.1016/0898-6568(90)90022-3; HUG H, 1993, BIOCHEM J, V291, P329, DOI 10.1042/bj2910329; JAIN MK, 1989, BIOCHIM BIOPHYS ACTA, V1003, P91, DOI 10.1016/0005-2760(89)90104-5; Joshi B, 2008, CANCER RES, V68, P8210, DOI 10.1158/0008-5472.CAN-08-0343; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kaneko T, 2000, BIOCHEM BIOPH RES CO, V273, P110, DOI 10.1006/bbrc.2000.2901; Kaneko T, 2005, GENES CELLS, V10, P973, DOI 10.1111/j.1365-2443.2005.00895.x; Kang JH, 2008, PROTEOMICS, V8, P2006, DOI 10.1002/pmic.200701045; Kang JH, 2007, BIOCHIMIE, V89, P39, DOI 10.1016/j.biochi.2006.08.003; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; KEMP BE, 1975, P NATL ACAD SCI USA, V72, P3448, DOI 10.1073/pnas.72.9.3448; KEMP BE, 1977, J BIOL CHEM, V252, P4888; Koivunen P, 2006, J BIOL CHEM, V281, P28712, DOI 10.1074/jbc.M604628200; Kosako H, 1997, J BIOL CHEM, V272, P10333; Kubo Takekazu, 2007, Recent Pat CNS Drug Discov, V2, P173, DOI 10.2174/157488907782411738; Leemhuis J, 2002, J PHARMACOL EXP THER, V300, P1000, DOI 10.1124/jpet.300.3.1000; Liu YL, 2004, CIRC RES, V95, P579, DOI 10.1161/01.RES.0000141428.53262.a4; Loirand G, 2006, CIRC RES, V98, P322, DOI 10.1161/01.RES.0000201960.04223.3c; Madigan JP, 2009, BIOCHEM J, V424, P153, DOI 10.1042/BJ20082377; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Mueller BK, 2005, NAT REV DRUG DISCOV, V4, P387, DOI 10.1038/nrd1719; Murthy KS, 2006, ANNU REV PHYSIOL, V68, P345, DOI 10.1146/annurev.physiol.68.040504.094707; Nagumo H, 2001, BIOCHEM BIOPH RES CO, V280, P605, DOI 10.1006/bbrc.2000.4179; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Nishikawa K, 2000, MOL CELL, V6, P969, DOI 10.1016/S1097-2765(05)00085-7; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Oka M, 2008, BRIT J PHARMACOL, V155, P444, DOI 10.1038/bjp.2008.239; Patil SB, 2006, AM J PHYSIOL-GASTR L, V290, pG83, DOI 10.1152/ajpgi.00178.2005; REARSON RB, 1988, PROTEIN PHOSPHORYLAT, P65; Riento K, 2005, EMBO J, V24, P1170, DOI 10.1038/sj.emboj.7600612; Sasaki Y, 2003, J PHARMACOL SCI, V93, P35, DOI 10.1254/jphs.93.35; Shin HK, 2008, EXPERT OPIN THER TAR, V12, P1547, DOI 10.1517/14728220802539244 ; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Sumi T, 2001, J BIOL CHEM, V276, P670, DOI 10.1074/jbc.M007074200; Zhou Q, 2009, CURR PHARM DESIGN, V15, P3108, DOI 10.2174/138161209789057986; Zohrabian VM, 2009, ANTICANCER RES, V29, P119	50	14	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22699	10.1371/journal.pone.0022699	http://dx.doi.org/10.1371/journal.pone.0022699			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818369	Green Published, Green Submitted, gold			2022-12-25	WOS:000293282700062
J	Pathak, AP; Kim, E; Zhang, JY; Jones, MV				Pathak, Arvind P.; Kim, Eugene; Zhang, Jiangyang; Jones, Melina V.			Three-Dimensional Imaging of the Mouse Neurovasculature with Magnetic Resonance Microscopy	PLOS ONE			English	Article							CEREBRAL BLOOD-VOLUME; COMPUTED-TOMOGRAPHY; TUMOR ANGIOGENESIS; BRAIN-TUMORS; AXONAL PROJECTIONS; SYSTEMS BIOLOGY; BREAST-CANCER; VASCULATURE; MICE; MICROENVIRONMENT	Knowledge of the three-dimensional (3D) architecture of blood vessels in the brain is crucial because the progression of various neuropathologies ranging from Alzheimer's disease to brain tumors involves anomalous blood vessels. The challenges in obtaining such data from patients, in conjunction with development of mouse models of neuropathology, have made the murine brain indispensable for investigating disease induced neurovascular changes. Here we describe a novel method for "whole brain'' 3D mapping of murine neurovasculature using magnetic resonance microscopy (mMRI). This approach preserves the vascular and white matter tract architecture, and can be combined with complementary MRI contrast mechanisms such as diffusion tensor imaging (DTI) to examine the interplay between the vasculature and white matter reorganization that often characterizes neuropathologies. Following validation with micro computed tomography (mCT) and optical microscopy, we demonstrate the utility of this method by: (i) combined 3D imaging of angiogenesis and white matter reorganization in both, invasive and non-invasive brain tumor models; (ii) characterizing the morphological heterogeneity of the vascular phenotype in the murine brain; and (iii) conducting "multi-scale'' imaging of brain tumor angiogenesis, wherein we directly compared in vivo MRI blood volume measurements with ex vivo vasculature data.	[Pathak, Arvind P.; Zhang, Jiangyang] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA; [Pathak, Arvind P.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Kim, Eugene] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Jones, Melina V.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University	Pathak, AP (corresponding author), Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA.	pathak@mri.jhu.edu		Zhang, Jiangyang/0000-0003-0740-2662; Kim, Eugene/0000-0003-0066-7051; Zhang, Jiangyang/0000-0003-4146-8163	Radiological Society of North America (RSNA) Research and Education Foundation [RSD0718]; NIH [P50CA103175]; NATIONAL CANCER INSTITUTE [P50CA103175] Funding Source: NIH RePORTER	Radiological Society of North America (RSNA) Research and Education Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research supported by a Research Seed Grant RSD0718 from the Radiological Society of North America (RSNA) Research and Education Foundation, and NIH P50CA103175 - Career Development Award (APP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres AC, 2010, J MAMMARY GLAND BIOL, V15, P319, DOI 10.1007/s10911-010-9186-9; Beckers J, 2009, NAT REV GENET, V10, P371, DOI 10.1038/nrg2578; Berrios-Otero CA, 2009, MAGN RESON MED, V62, P1431, DOI 10.1002/mrm.22113; Boero JA, 1999, J APPL PHYSIOL, V86, P1211, DOI 10.1152/jappl.1999.86.4.1211; BONEKAMP D, 2010, P ISMRM 18 ANN M; BOOKSTEIN FL, 1989, IEEE T PATTERN ANAL, V11, P567, DOI 10.1109/34.24792; Brubaker LM, 2005, CANCER RES, V65, P8218, DOI 10.1158/0008-5472.CAN-04-4355; Chi A, 2007, EXPERT REV ANTICANC, V7, P1537, DOI 10.1586/14737140.7.11.1537; Chugh BP, 2009, NEUROIMAGE, V47, P1312, DOI 10.1016/j.neuroimage.2009.03.083; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; de Groot JF, 2010, NEURO-ONCOLOGY, V12, P233, DOI 10.1093/neuonc/nop027; DEANE BR, 1981, J NEUROL SCI, V49, P55, DOI 10.1016/0022-510X(81)90188-X; Dorr A, 2007, NEUROIMAGE, V35, P1409, DOI 10.1016/j.neuroimage.2006.12.040; Heinzer S, 2008, NEUROIMAGE, V39, P1549, DOI 10.1016/j.neuroimage.2007.10.054; Henkelman RM, 2010, ANNU REV BIOMED ENG, V12, P143, DOI 10.1146/annurev-bioeng-070909-105343; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Johnson GA, 2007, NEUROIMAGE, V37, P82, DOI 10.1016/j.neuroimage.2007.05.013; Johnson GA, 1997, ANN NY ACAD SCI, V820, P139, DOI 10.1111/j.1749-6632.1997.tb46193.x; JOHNSON GA, 1993, MAGN RESON QUART, V9, P1; Kherlopian AR, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-74; Kienast Y, 2010, NAT MED, V16, P116, DOI 10.1038/nm.2072; Kiessling F, 2004, NAT MED, V10, P1133, DOI 10.1038/nm1101; KIM E, 2011, J CEREB BLOOD FLOW M; KONERDING MA, 1989, ACTA ANAT, V136, P21; Le Bourhis X, 2010, BREAST CANCER RES TR, V120, P17, DOI 10.1007/s10549-009-0686-5; LEE TC, 1994, CVGIP-GRAPH MODEL IM, V56, P462, DOI 10.1006/cgip.1994.1042; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Pathak AP, 2003, J MAGN RESON IMAGING, V18, P397, DOI 10.1002/jmri.10371; Pathak AP, 2001, MAGNET RESON MED, V46, P735, DOI 10.1002/mrm.1252; PATHAK AP, 2008, P ISMRM 16 ANN M; Pathak AP, 2008, ANGIOGENESIS, V11, P321, DOI 10.1007/s10456-008-9119-z; RIDLER TW, 1978, IEEE T SYST MAN CYB, V8, P630, DOI 10.1109/tsmc.1978.4310039; Risser L, 2007, J CEREBR BLOOD F MET, V27, P293, DOI 10.1038/sj.jcbfm.9600332; Sato Y, 1998, Med Image Anal, V2, P143, DOI 10.1016/S1361-8415(98)80009-1; Tsai PS, 2009, J NEUROSCI, V29, P14553, DOI 10.1523/JNEUROSCI.3287-09.2009; Vajkoczy P, 2000, J NEURO-ONCOL, V50, P99, DOI 10.1023/A:1006474832189; Vakoc BJ, 2009, NAT MED, V15, P1219, DOI 10.1038/nm.1971; Verant P, 2007, J CEREBR BLOOD F MET, V27, P1072, DOI 10.1038/sj.jcbfm.9600415; Vermeulen PB, 2010, CANCER-AM CANCER SOC, V116, P2748, DOI 10.1002/cncr.25169; Xue R, 1999, MAGNET RESON MED, V42, P1123, DOI 10.1002/(SICI)1522-2594(199912)42:6<1123::AID-MRM17>3.0.CO;2-H; Zacchigna S, 2008, NAT REV NEUROSCI, V9, P169, DOI 10.1038/nrn2336; Zagorchev Lyubomir, 2010, J Angiogenes Res, V2, P7, DOI 10.1186/2040-2384-2-7; Zhang JY, 2007, MAGN RESON MED, V58, P454, DOI 10.1002/mrm.21371	44	38	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22643	10.1371/journal.pone.0022643	http://dx.doi.org/10.1371/journal.pone.0022643			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818357	gold, Green Published, Green Submitted			2022-12-25	WOS:000293282700055
J	Uhlemann, AC; Knox, J; Miller, M; Hafer, C; Vasquez, G; Ryan, M; Vavagiakis, P; Shi, QH; Lowy, FD				Uhlemann, Anne-Catrin; Knox, Justin; Miller, Maureen; Hafer, Cory; Vasquez, Glenny; Ryan, Megan; Vavagiakis, Peter; Shi, Qiuhu; Lowy, Franklin D.			The Environment as an Unrecognized Reservoir for Community-Associated Methicillin Resistant Staphylococcus aureus USA300: A Case-Control Study	PLOS ONE			English	Article							CATABOLIC MOBILE ELEMENT; CHANGING EPIDEMIOLOGY; NASAL CARRIAGE; PCR STRATEGY; INFECTION; CONTAMINATION; COLONIZATION; POPULATION; SURFACES; SURVIVAL	Background: Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections are spreading, but the source of infections in non-epidemic settings remains poorly defined. Methods: We carried out a community-based, case-control study investigating socio-demographic risk factors and infectious reservoirs associated with MRSA infections. Case patients presented with CA-MRSA infections to a New York hospital. Age-matched controls without infections were randomly selected from the hospital's Dental Clinic patient population. During a home visit, case and control subjects completed a questionnaire, nasal swabs were collected from index respondents and household members and standardized environmental surfaces were swabbed. Genotyping was performed on S. aureus isolates. Results: We enrolled 95 case and 95 control subjects. Cases more frequently reported diabetes mellitus and a higher number of skin infections among household members. Among case households, 53 (56%) were environmentally contaminated with S. aureus, compared to 36 (38%) control households (p = .02). MRSA was detected on fomites in 30 (32%) case households and 5 (5%; p<.001) control households. More case patients, 20 (21%) were nasally colonized with MRSA than were control indexes, 2 (2%; p<.001). In a subgroup analysis, the clinical isolate (predominantly USA300), was more commonly detected on environmental surfaces in case households with recurrent MRSA infections (16/36, 44%) than those without (14/58, 24%, p = .04). Conclusions: The higher frequency of environmental contamination of case households with S. aureus in general and MRSA in particular implicates this as a potential reservoir for recolonization and increased risk of infection. Environmental colonization may contribute to the community spread of epidemic strains such as USA300.	[Uhlemann, Anne-Catrin; Knox, Justin; Hafer, Cory; Vasquez, Glenny; Ryan, Megan; Lowy, Franklin D.] Columbia Univ, Coll Phys & Surg, Dept Med, Div Infect Dis, New York, NY 10027 USA; [Miller, Maureen] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Vavagiakis, Peter] Panna Technol Inc, New York, NY USA; [Shi, Qiuhu] New York Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Valhalla, NY 10595 USA; [Lowy, Franklin D.] Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY USA	Columbia University; Columbia University; New York Medical College; Columbia University	Uhlemann, AC (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Med, Div Infect Dis, New York, NY 10027 USA.	au2110@columbia.edu	Knox, Justin/AAA-1729-2021	Knox, Justin/0000-0001-6771-8138	National Institute of Allergy and Infectious Diseases at the National Institutes of Health [R01-AI077690, K08-AI090013]; Paul A. Marks scholarship; Columbia University Medical Center; Pfizer; Lucille P. Markey fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI090013, R01AI077690] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Paul A. Marks scholarship; Columbia University Medical Center; Pfizer(Pfizer); Lucille P. Markey fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (grant number R01-AI077690 to FDL and K08-AI090013 to ACU), and the Lucille P. Markey fund and the Paul A. Marks scholarship (to ACU) by Columbia University Medical Center Institutional grants. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: ACU and FDL report receiving research grant support from Pfizer, which was not related to this study here. PV is an employee of Panna Technologies. This software company had no financial interest in the outcome of the study. This also does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. All other authors have no competing conflicts of interest to declare.	Boyce JM, 1997, INFECT CONT HOSP EP, V18, P622; Cespedes C, 2005, J INFECT DIS, V191, P444, DOI 10.1086/427240; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; Charlebois ED, 2002, CLIN INFECT DIS, V34, P425, DOI 10.1086/338069; Cook HA, 2007, CLIN INFECT DIS, V44, P410, DOI 10.1086/510681; Crum NF, 2006, AM J MED, V119, P943, DOI 10.1016/j.amjmed.2006.01.004; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Ellington MJ, 2008, J ANTIMICROB CHEMOTH, V61, P73, DOI 10.1093/jac/dkm422; Frazee BW, 2005, ANN EMERG MED, V46, P401, DOI 10.1016/j.annemergmed.2005.05.023; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; Goering RV, 2007, J CLIN MICROBIOL, V45, P1981, DOI 10.1128/JCM.00273-07; Gonzalez BE, 2005, PEDIATRICS, V115, P642, DOI 10.1542/peds.2004-2300; Hamdan-Partida A, 2010, J CLIN MICROBIOL, V48, P1701, DOI 10.1128/JCM.01929-09; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Huijsdens XW, 2006, J CLIN MICROBIOL, V44, P2994, DOI 10.1128/JCM.00846-06; Jones TF, 2006, CLIN INFECT DIS, V42, pE76, DOI 10.1086/503265; Kniehl E, 2005, J HOSP INFECT, V59, P180, DOI 10.1016/j.jhin.2004.06.016; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Larsen AR, 2009, J CLIN MICROBIOL, V47, P3765, DOI 10.1128/JCM.00934-09; Lee CJ, 2011, CLIN INFECT DIS, V52, P775, DOI 10.1093/cid/cir026; MASTERTON RG, 1995, J HOSP INFECT, V29, P318, DOI 10.1016/0195-6701(95)90284-8; Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Miller LG, 2008, CLIN INFECT DIS, V46, P752, DOI 10.1086/526773; Miller M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006708; Otter JA, 2010, LANCET INFECT DIS, V10, P227, DOI 10.1016/S1473-3099(10)70053-0; Pan ES, 2005, J INFECT DIS, V192, P811, DOI 10.1086/432072; Peters PJ, 2010, EPIDEMIOL INFECT, P1; SCOTT E, 1990, J APPL BACTERIOL, V68, P271, DOI 10.1111/j.1365-2672.1990.tb02574.x; Scott E, 2008, AM J INFECT CONTROL, V36, P458, DOI 10.1016/j.ajic.2007.10.012; Scott E, 2009, AM J INFECT CONTROL, V37, P447, DOI 10.1016/j.ajic.2008.12.001; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Tolba O, 2007, AM J INFECT CONTROL, V35, P342, DOI 10.1016/j.ajic.2006.10.015; Turabelidze G, 2006, EMERG INFECT DIS, V12, P422, DOI 10.3201/eid1203.050625; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Wagenvoort JHT, 2000, J HOSP INFECT, V45, P231, DOI 10.1053/jhin.2000.0757; Yang ES, 2010, CLIN MICROBIOL INFEC, V16, P425, DOI 10.1111/j.1469-0691.2009.02836.x	39	71	73	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e22407	10.1371/journal.pone.0022407	http://dx.doi.org/10.1371/journal.pone.0022407			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21818321	Green Published, gold			2022-12-25	WOS:000293175100025
J	Kreiss, A; Cheng, YY; Kimble, F; Wells, B; Donovan, S; Belov, K; Woods, GM				Kreiss, Alexandre; Cheng, Yuanyuan; Kimble, Frank; Wells, Barrie; Donovan, Shaun; Belov, Katherine; Woods, Gregory M.			Allorecognition in the Tasmanian Devil (Sarcophilus harrisii), an Endangered Marsupial Species with Limited Genetic Diversity	PLOS ONE			English	Article							FACIAL-TUMOR DISEASE; TRANSMISSIBLE VENEREAL TUMOR; IMMUNE-RESPONSE; CLASS-I; MELANOMA-CELLS; ANTIGEN; MECHANISMS; EXPRESSION; SURFACE; TRANSPLANTATION	Tasmanian devils (Sarcophilus harrisii) are on the verge of extinction due to a transmissible cancer, devil facial tumour disease (DFTD). This tumour is an allograft that is transmitted between individuals without immune recognition of the tumour cells. The mechanism to explain this lack of immune recognition and acceptance is not well understood. It has been hypothesized that lack of genetic diversity at the Major Histocompatibility Complex (MHC) allowed the tumour cells to grow in genetically similar hosts without evoking an immune response to alloantigens. We conducted mixed lymphocyte reactions and skin grafts to measure functional MHC diversity in the Tasmanian devil population. The limited MHC diversity was sufficient to produce measurable mixed lymphocyte reactions. There was a wide range of responses, from low or no reaction to relatively strong responses. The highest responses occurred when lymphocytes from devils from the east of Tasmania were mixed with lymphocytes from devils from the west of Tasmania. All of the five successful skin allografts were rejected within 14 days after surgery, even though little or no MHC I and II mismatches were found. Extensive T-cell infiltration characterised the immune rejection. We conclude that Tasmanian devils are capable of allogeneic rejection. Consequently, a lack of functional allorecognition mechanisms in the devil population does not explain the transmission of a contagious cancer.	[Kreiss, Alexandre; Woods, Gregory M.] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas 7001, Australia; [Cheng, Yuanyuan; Belov, Katherine] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Kimble, Frank; Wells, Barrie] Univ Tasmania, Sch Med, Hobart, Tas 7001, Australia; [Donovan, Shaun] Royal Hobart Hosp, Dept Pathol, Hobart, Tas, Australia	University of Tasmania; University of Sydney; University of Tasmania; Royal Hobart Hospital	Kreiss, A (corresponding author), Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas 7001, Australia.	akreiss@utas.edu.au	Cheng, Yuanyuan/M-6476-2017; Woods, Greg/J-7533-2014	Cheng, Yuanyuan/0000-0002-1747-9308; Woods, Greg/0000-0001-8421-7917; Belov, Katherine/0000-0002-9762-5554	Australian Research Council [LP0989727 ARC]; Dr Eric Guiler Tasmanian Devil Research Grant; Department of Primary Industries, Water and Environment of Tasmania	Australian Research Council(Australian Research Council); Dr Eric Guiler Tasmanian Devil Research Grant; Department of Primary Industries, Water and Environment of Tasmania	The Australian Research Council (LP0989727 ARC) and Dr Eric Guiler Tasmanian Devil Research Grant provided financial support for this project. AK and KB were funded by an ARC linkage grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are thankful to Mrs. Ginny Ralph and the devil keepers for help with the animals, and to the Department of Primary Industries, Water and Environment of Tasmania, for support for this project. The authors are very grateful to Dr. Sarah Peck, Dr. Colette Harmsen and Dr. Kim Scogvold, who performed the anaesthesia and post-operative care of all devils. Dr. David Challis and Dr. David Obendorf provided advice on the histological interpretation of skin grafts, and Mrs. Narelle Phillips provided technical support with skin graft sections.	Ackerman AL, 2004, NAT IMMUNOL, V5, P678, DOI 10.1038/ni1082; ADLER JH, 1989, ISRAEL J MED SCI, V25, P206; ASHBEL R, 1945, NATURE, V155, P607, DOI 10.1038/155607b0; Belov K, 2011, MAMM GENOME, V22, P83, DOI 10.1007/s00335-010-9294-2; Berlanda M, 2008, TRANSPL P, V40, P1847, DOI 10.1016/j.transproceed.2008.05.013; Castro-Prieto A, 2011, MOL BIOL EVOL, V28, P1455, DOI 10.1093/molbev/msq330; CHEN HD, 1983, J INVEST DERMATOL, V81, P20, DOI 10.1111/1523-1747.ep12537487; Cho PS, 2007, BLOOD, V110, P3996, DOI 10.1182/blood-2007-02-074450; COHEN D, 1985, ADV CANCER RES, V43, P75, DOI 10.1016/S0065-230X(08)60943-4; COHEN D, 1984, JNCI-J NATL CANCER I, V72, P395; Derks RA, 2005, CURR OPIN IMMUNOL, V17, P560, DOI 10.1016/j.coi.2005.07.011; Fassati A, 2010, CANCER IMMUNOL IMMUN, V59, P643, DOI 10.1007/s00262-009-0809-1; FERRONE S, 1995, IMMUNOL TODAY, V16, P487, DOI 10.1016/0167-5699(95)80033-6; Game DS, 2002, TRANSPL IMMUNOL, V10, P101, DOI 10.1016/S0966-3274(02)00055-2; Game DS, 2001, WIEN KLIN WOCHENSCHR, V113, P832; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hawkins CE, 2006, BIOL CONSERV, V131, P307, DOI 10.1016/j.biocon.2006.04.010; Hernandez-Fuentes M P, 1999, Rev Immunogenet, V1, P282; Hsiao YW, 2008, CANCER IMMUNOL IMMUN, V57, P1091, DOI 10.1007/s00262-007-0446-5; Hsiao YW, 2004, J IMMUNOL, V172, P1508, DOI 10.4049/jimmunol.172.3.1508; Ikeda H, 1997, IMMUNITY, V6, P199, DOI 10.1016/S1074-7613(00)80426-4; Jensen PE, 2007, NAT IMMUNOL, V8, P1041, DOI 10.1038/ni1516; Jeras M, 2002, TRANSPL IMMUNOL, V10, P205, DOI 10.1016/S0966-3274(02)00067-9; Jones ME, 2004, MOL ECOL, V13, P2197, DOI 10.1111/j.1365-294X.2004.02239.x; Kanitakis J, 2005, EUR J DERMATOL, V15, P235; KLEIN J, 1986, NATURAL HIST MAJOR H; Kreiss A, 2008, DEV COMP IMMUNOL, V32, P544, DOI 10.1016/j.dci.2007.09.002; Kreiss A, 2009, ANAT REC, V292, P611, DOI 10.1002/ar.20896; Kreiss A, 2009, VET IMMUNOL IMMUNOP, V130, P135, DOI 10.1016/j.vetimm.2009.02.003; Krichen H, 2011, TRANSPL P, V43, P433, DOI 10.1016/j.transproceed.2011.01.029; Kumanovics A, 2003, ANNU REV IMMUNOL, V21, P629, DOI 10.1146/annurev.immunol.21.090501.080116; Lee KH, 1998, J IMMUNOL, V161, P4183; Lehmann C, 2000, BLOOD, V96, P594; Loh R, 2006, VET PATHOL, V43, P896, DOI 10.1354/vp.43-6-896; Loh R, 2006, VET PATHOL, V43, P890, DOI 10.1354/vp.43-6-890; Maeurer MJ, 1996, CLIN CANCER RES, V2, P641; McCallum H, 2007, ECOHEALTH, V4, P318, DOI 10.1007/s10393-007-0118-0; Medawar PB, 1944, J ANAT, V78, P176; Munson L, 2005, J WILDLIFE DIS, V41, P542, DOI 10.7589/0090-3558-41.3.542; Murchison EP, 2010, SCIENCE, V327, P84, DOI 10.1126/science.1180616; Nishigaki F, 1990, Rinsho Byori, V38, P151; OBRIEN SJ, 1985, SCIENCE, V227, P1428, DOI 10.1126/science.2983425; Santos JP, 2010, NEFROLOGIA, V30, P80, DOI 10.3265/Nefrologia.pre2010.Nov.10694; Pearse AM, 2006, NATURE, V439, P549, DOI 10.1038/439549a; Richters CD, 2005, CLIN DERMATOL, V23, P338, DOI 10.1016/j.clindermatol.2004.07.022; Rinkevich B, 2004, IMMUNOL REV, V198, P25, DOI 10.1111/j.0105-2896.2004.0114.x; RIVOLTINI L, 1995, CANCER RES, V55, P3149; Sarris AH, 1999, ANN ONCOL, V10, P433, DOI 10.1023/A:1008301602785; Sasaki Nori, 2008, Clin Transpl, P241; Shaw BE, 2010, BRIT J HAEMATOL, V150, P251, DOI 10.1111/j.1365-2141.2010.08224.x; SHERMAN LA, 1993, ANNU REV IMMUNOL, V11, P385, DOI 10.1146/annurev.immunol.11.1.385; Siddle HV, 2007, P NATL ACAD SCI USA, V104, P16221, DOI 10.1073/pnas.0704580104; Siddle HV, 2007, IMMUNOGENETICS, V59, P753, DOI 10.1007/s00251-007-0238-2; Siddle HV, 2010, P ROY SOC B-BIOL SCI, V277, P2001, DOI 10.1098/rspb.2009.2362; Stoner DS, 1996, P NATL ACAD SCI USA, V93, P15254, DOI 10.1073/pnas.93.26.15254; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOVAR C, 2011, VET PATHOL; Vokaer B, 2010, J IMMUNOL, V185, P3417, DOI 10.4049/jimmunol.0903961; WACHTEL SS, 1971, TRANSPLANTATION, V12, P61, DOI 10.1097/00007890-197107000-00011; Woods GM, 2007, ECOHEALTH, V4, P338, DOI 10.1007/s10393-007-0117-1	60	47	49	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22402	10.1371/journal.pone.0022402	http://dx.doi.org/10.1371/journal.pone.0022402			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811598	Green Submitted, gold, Green Published			2022-12-25	WOS:000292956800052
J	Muxel, SM; do Rosario, APF; Zago, CA; Castillo-Mendez, SI; Sardinha, LR; Rodriguez-Malaga, SM; Camara, NOS; Alvarez, JM; Lima, MRD				Muxel, Sandra Marcia; Freitas do Rosario, Ana Paula; Zago, Claudia Augusta; Castillo-Mendez, Sheyla Ines; Sardinha, Luiz Roberto; Rodriguez-Malaga, Sergio Marcelo; Saraiva Camara, Niels Olsen; Alvarez, Jose Maria; D'Imperio Lima, Maria Regina			The Spleen CD4(+) T Cell Response to Blood-Stage Plasmodium chabaudi Malaria Develops in Two Phases Characterized by Different Properties	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ENDOGENOUS GAMMA-INTERFERON; PROTECTIVE IMMUNITY; FACTOR-ALPHA; B-CELLS; FALCIPARUM-MALARIA; ACQUIRED-IMMUNITY; DENDRITIC CELLS; INNATE IMMUNITY; RODENT MALARIA	The pivotal role of spleen CD4(+) T cells in the development of both malaria pathogenesis and protective immunity makes necessary a profound comprehension of the mechanisms involved in their activation and regulation during Plasmodium infection. Herein, we examined in detail the behaviour of non-conventional and conventional splenic CD4(+) T cells during P. chabaudi malaria. We took advantage of the fact that a great proportion of CD4(+) T cells generated in CD1d(-/-) mice are I-A(b)-restricted (conventional cells), while their counterparts in I-Ab(-/-) mice are restricted by CD1d and other class IB major histocompatibility complex (MHC) molecules (non-conventional cells). We found that conventional CD4(+) T cells are the main protagonists of the immune response to infection, which develops in two consecutive phases concomitant with acute and chronic parasitaemias. The early phase of the conventional CD4(+) T cell response is intense and short lasting, rapidly providing large amounts of proinflammatory cytokines and helping follicular and marginal zone B cells to secrete polyclonal immunoglobulin. Both TNF-alpha and IFN-gamma production depend mostly on conventional CD4(+) T cells. IFN-gamma is produced simultaneously by non-conventional and conventional CD4(+) T cells. The early phase of the response finishes after a week of infection, with the elimination of a large proportion of CD4(+) T cells, which then gives opportunity to the development of acquired immunity. Unexpectedly, the major contribution of CD1d-restricted CD4(+) T cells occurs at the beginning of the second phase of the response, but not earlier, helping both IFN-gamma and parasite-specific antibody production. We concluded that conventional CD4(+) T cells have a central role from the onset of P. chabaudi malaria, acting in parallel with non-conventional CD4(+) T cells as a link between innate and acquired immunity. This study contributes to the understanding of malaria immunology and opens a perspective for future studies designed to decipher the molecular mechanisms behind immune responses to Plasmodium infection.	[Muxel, Sandra Marcia; Freitas do Rosario, Ana Paula; Zago, Claudia Augusta; Castillo-Mendez, Sheyla Ines; Sardinha, Luiz Roberto; Rodriguez-Malaga, Sergio Marcelo; Saraiva Camara, Niels Olsen; Alvarez, Jose Maria; D'Imperio Lima, Maria Regina] Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, BR-05508 Sao Paulo, Brazil; [Sardinha, Luiz Roberto] Inst Israelita Ensino & Pesquisa Albert Einstein, Sao Paulo, Brazil	Universidade de Sao Paulo; Hospital Israelita Albert Einstein	Muxel, SM (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, BR-05508 Sao Paulo, Brazil.	sandrammuxel@gmail.com	Freitas do Rosário, Ana Paula/G-2451-2012; Alvarez, Jose M/I-6181-2012; Muxel, Sandra/F-7464-2012; camara, niels olsen saraiva/AAX-3269-2020; D'Império Lima, Maria Regina/I-4747-2012; Camara, Niels OS/G-8336-2011; Rodriguez-Málaga, Sérgio/AGJ-8068-2022; Sardinha, Luiz Roberto/C-2367-2012; Complexos, INCT Fluidos/H-9172-2013	Alvarez, Jose M/0000-0002-9711-4914; Muxel, Sandra/0000-0003-0118-5361; camara, niels olsen saraiva/0000-0001-5436-1248; D'Império Lima, Maria Regina/0000-0002-4683-7709; Camara, Niels OS/0000-0001-5436-1248; Rodriguez-Málaga, Sérgio/0000-0003-3899-4031; Castillo, Sheyla/0000-0002-0655-1781	FAPESP; CAPES; CNPq	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from FAPESP (www.fapesp.br), CAPES (www.capes.gov.br), and CNPq (www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman AH, 2003, J IMMUNOL, V171, P317, DOI 10.4049/jimmunol.171.1.317; Bastos KRB, 2002, J INTERF CYTOK RES, V22, P1191, DOI 10.1089/10799900260475713; Castillo-Mendez SI, 2007, SCAND J IMMUNOL, V66, P309, DOI 10.1111/j.1365-3083.2007.01972.x; CAVACINI LA, 1986, INFECT IMMUN, V52, P637, DOI 10.1128/IAI.52.3.637-643.1986; Cavinato RA, 2001, PARASITE IMMUNOL, V23, P587, DOI 10.1046/j.1365-3024.2001.00419.x; Chen YH, 1999, J IMMUNOL, V162, P4560; Cigel F, 2003, IMMUNOL LETT, V89, P243, DOI 10.1016/S0165-2478(03)00152-4; CLARK IA, 1978, LANCET, V2, P75; COX J, 1987, PARASITE IMMUNOL, V9, P543, DOI 10.1111/j.1365-3024.1987.tb00529.x; Donovan MJ, 2007, PARASITE IMMUNOL, V29, P515, DOI 10.1111/j.1365-3024.2007.00970.x; Duarte J, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-1; Elias RM, 2005, J IMMUNOL, V174, P790, DOI 10.4049/jimmunol.174.2.790; Engwerda C, 2005, CURR TOP MICROBIOL, V297, P103; Engwerda CR, 2002, AM J PATHOL, V161, P429, DOI 10.1016/S0002-9440(10)64199-5; Franklin BS, 2007, MICROBES INFECT, V9, P881, DOI 10.1016/j.micinf.2007.03.007; Franklin BS, 2009, P NATL ACAD SCI USA, V106, P5789, DOI 10.1073/pnas.0809742106; do Rosario APF, 2008, J IMMUNOL, V181, P8344, DOI 10.4049/jimmunol.181.12.8344; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; Helmby H, 2000, INFECT IMMUN, V68, P1485, DOI 10.1128/IAI.68.3.1485-1490.2000; Ing R, 2009, INFECT IMMUN, V77, P770, DOI 10.1128/IAI.00994-08; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; KWIATKOWSKI D, 1990, IMMUNOL LETT, V25, P213, DOI 10.1016/0165-2478(90)90117-9; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Li C, 2003, INFECT IMMUN, V71, P4850, DOI 10.1128/IAI.71.9.4850-4856.2003; Li C, 1999, INFECT IMMUN, V67, P4435, DOI 10.1128/IAI.67.9.4435-4442.1999; LIMA MRD, 1991, INT IMMUNOL, V3, P1207, DOI 10.1093/intimm/3.12.1207; Lopes-Carvalho T, 2005, CURR OPIN IMMUNOL, V17, P244, DOI 10.1016/j.coi.2005.04.009; Lyke KE, 2004, INFECT IMMUN, V72, P5630, DOI 10.1128/IAI.72.10.5630-5637.2004; Mannoor MK, 2001, CELL IMMUNOL, V211, P96, DOI 10.1006/cimm.2001.1833; MEDING SJ, 1991, EUR J IMMUNOL, V21, P1433, DOI 10.1002/eji.1830210616; Moir S, 2000, J EXP MED, V192, P637, DOI 10.1084/jem.192.5.637; Mota MM, 1998, INFECT IMMUN, V66, P4080; MUXEL SM, 2010, J INTERFERON CYTOKIN; Pleass RJ, 2009, PARASITE IMMUNOL, V31, P529, DOI 10.1111/j.1365-3024.2009.01101.x; PODOBA JE, 1991, INFECT IMMUN, V59, P51, DOI 10.1128/IAI.59.1.51-58.1991; Ropert C, 2008, SEMIN IMMUNOPATHOL, V30, P41, DOI 10.1007/s00281-007-0103-2; Sanchez-Torres L, 2001, PARASITE IMMUNOL, V23, P617, DOI 10.1046/j.1365-3024.2001.00422.x; Schmieg J, 2003, MICROBES INFECT, V5, P499, DOI 10.1016/S1286-4579(03)00072-8; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Seixas E, 2009, EUR J IMMUNOL, V39, P1850, DOI 10.1002/eji.200838403; Soulard V, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-128; Sponaas AM, 2009, BLOOD, V114, P5522, DOI 10.1182/blood-2009-04-217489; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; STEVENSON MM, 1990, INFECT IMMUN, V58, P3225, DOI 10.1128/IAI.58.10.3225-3232.1990; Su Z, 2000, INFECT IMMUN, V68, P4399, DOI 10.1128/IAI.68.8.4399-4406.2000; SUSS G, 1988, INFECT IMMUN, V56, P3081; Taniguchi T, 2007, IMMUNOLOGY, V122, P514, DOI 10.1111/j.1365-2567.2007.02661.x; TAVERNE J, 1987, CLIN EXP IMMUNOL, V67, P1; *WHO, 2007, WHO MAL OTH VECT PAR; ZIEGLER SF, 1994, STEM CELLS, V12, P456, DOI 10.1002/stem.5530120502	53	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22434	10.1371/journal.pone.0022434	http://dx.doi.org/10.1371/journal.pone.0022434			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21814579	gold, Green Published, Green Submitted			2022-12-25	WOS:000292956800055
J	White, J; Richard, M; Massot, M; Meylan, S				White, Joel; Richard, Murielle; Massot, Manuel; Meylan, Sandrine			Cloacal Bacterial Diversity Increases with Multiple Mates: Evidence of Sexual Transmission in Female Common Lizards	PLOS ONE			English	Article							TRANSMITTED-DISEASE; MATING SYSTEMS; SELECTION; FITNESS; EVOLUTION; PATERNITY; BIRDS	Sexually transmitted diseases have often been suggested as a potential cost of multiple mating and as playing a major role in the evolution of mating systems. Yet there is little empirical data relating mating strategies to sexually transmitted microorganisms in wild populations. We investigated whether mating behaviour influences the diversity and composition of cloacal assemblages by comparing bacterial communities in the cloaca of monandrous and polyandrous female common lizards Zootoca vivipara sampled after the mating period. We found that polyandrous females harboured more diverse communities and differed more in community composition than did monandrous females. Furthermore, cloacal diversity and variability were found to decrease with age in polyandrous females. Our results suggest that the higher bacterial diversity found in polyandrous females is due to the sexual transmission of bacteria by multiple mates. The impact of mating behaviour on the cloacal microbiota may have fitness consequences for females and may comprise a selective pressure shaping the evolution of mating systems.	[White, Joel; Richard, Murielle; Massot, Manuel; Meylan, Sandrine] Univ Paris 06, Ecol & Evolut UMPC ENS CNRS, Paris, France; [White, Joel] Univ Antwerp, Evolutionary Ecol Grp, B-2020 Antwerp, Belgium; [Meylan, Sandrine] Univ Paris 04, Inst Univ Format Maitres Paris, Ecole Interne, F-75230 Paris 05, France	UDICE-French Research Universities; Sorbonne Universite; University of Antwerp; UDICE-French Research Universities; Sorbonne Universite	White, J (corresponding author), Univ Paris 06, Ecol & Evolut UMPC ENS CNRS, Paris, France.	joel.white@ua.ac.be	sandrine, MEYLAN/AAD-3073-2020; Richard, Murielle/E-9718-2013; Massot, Manuel/AGH-2703-2022; White, Joel/M-6795-2019; White, Joel/D-8482-2011	White, Joel/0000-0002-1427-4411; Massot, Manuel/0000-0002-2762-4417; Sandrine, MEYLAN/0000-0002-0865-3335	Agence Nationale de la Recherche [ANR-07-BLAN-0217]; Fondation Fyssen	Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation Fyssen	This study was funded by an Agence Nationale de la Recherche grant (ANR-07-BLAN-0217) to MM. JW was supported by a Fondation Fyssen post-doctoral grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooks R, 1999, TRENDS ECOL EVOL, V14, P336, DOI 10.1016/S0169-5347(99)01689-4; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cote J, 2010, J EXP BIOL, V213, P2116, DOI 10.1242/jeb.040220; Fitze PS, 2005, EVOLUTION, V59, P2451, DOI 10.1554/05-208.1; HAMILTON WD, 1990, AM ZOOL, V30, P341; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Hofmann S, 2006, J HERPETOL, V40, P1, DOI 10.1670/58-05A.1; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Kokko H, 2002, EVOLUTION, V56, P1091; Kuehl CJ, 2005, INFECT IMMUN, V73, P6952, DOI 10.1128/IAI.73.10.6852-6961.2005; Kulkarni S, 2007, BEHAV PROCESS, V74, P88, DOI 10.1016/j.beproc.2006.10.005; Laloi D, 2004, MOL ECOL, V13, P719, DOI 10.1046/j.1365-294X.2004.02102.x; Le Galliard JF, 2008, EVOL ECOL RES, V10, P157; Le Galliard JF, 2004, NATURE, V432, P502, DOI 10.1038/nature03057; Lombardo MP, 1999, BEHAV ECOL, V10, P333, DOI 10.1093/beheco/10.3.333; Lorenzon P, 2001, EVOLUTION, V55, P392; Martin MO, 2010, SYMBIOSIS, V51, P97, DOI 10.1007/s13199-010-0078-y; Massot M, 2000, J EVOLUTION BIOL, V13, P707; MASSOT M, 1992, ECOLOGY, V73, P1742, DOI 10.2307/1940026; Meylan S, 2010, GEN COMP ENDOCR, V169, P158, DOI 10.1016/j.ygcen.2010.08.002; Olsson M., 1998, P503, DOI 10.1016/B978-012100543-6/50038-6; Poiani A, 2002, EMU, V102, P291, DOI 10.1071/MU01055; Ranjard L, 2000, APPL ENVIRON MICROB, V66, P5334, DOI 10.1128/AEM.66.12.5334-5339.2000; Richard M, 2009, P ROY SOC B-BIOL SCI, V276, P2779, DOI 10.1098/rspb.2009.0319; SHELDON BC, 1993, PHILOS T R SOC B, V339, P491, DOI 10.1098/rstb.1993.0044; Sorci G, 1999, EVOL ECOL RES, V1, P303; Stevens CE, 1998, PHYSIOL REV, V78, P393, DOI 10.1152/physrev.1998.78.2.393; Thrall PH, 2000, P ROY SOC B-BIOL SCI, V267, P1555, DOI 10.1098/rspb.2000.1178; Uller T, 2008, MOL ECOL, V17, P2566, DOI 10.1111/j.1365-294X.2008.03772.x; WAGNER RH, 1992, BEHAV ECOL SOCIOBIOL, V29, P455; White J, 2010, ECOL LETT, V13, P1515, DOI 10.1111/j.1461-0248.2010.01542.x; Whittingham LA, 2010, MOL ECOL, V19, P2328, DOI 10.1111/j.1365-294X.2010.04640.x	33	59	60	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22339	10.1371/journal.pone.0022339	http://dx.doi.org/10.1371/journal.pone.0022339			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811590	Green Published, gold			2022-12-25	WOS:000292956800044
J	Flechsig, H; Popp, D; Mikhailov, AS				Flechsig, Holger; Popp, Denny; Mikhailov, Alexander S.			In Silico Investigation of Conformational Motions in Superfamily 2 Helicase Proteins	PLOS ONE			English	Article							VIRUS NS3 HELICASE; ELASTIC-NETWORK MODEL; RNA TRANSLOCATION; CRYSTAL-STRUCTURE; ATP HYDROLYSIS; DNA HELICASES; MECHANISM; DYNAMICS; DOMAIN; MACHINES	Helicases are motor proteins that play a central role in the metabolism of DNA and RNA in biological cells. Using the energy of ATP molecules, they are able to translocate along the nucleic acids and unwind their duplex structure. They have been extensively characterized in the past and grouped into superfamilies based on structural similarities and sequential motifs. However, their functional aspects and the mechanism of their operation are not yet well understood. Here, we consider three helicases from the major superfamily 2 - Hef, Hel308 and XPD - and study their conformational dynamics by using coarse-grained relaxational elastic network models. Specifically, their responses to mechanical perturbations are analyzed. This enables us to identify robust and ordered conformational motions which may underlie the functional activity of these proteins. As we show, such motions are well-organized and have large amplitudes. Their possible roles in the processing of nucleic substrate are discussed.	[Flechsig, Holger; Popp, Denny; Mikhailov, Alexander S.] Max Planck Gesell, Fritz Haber Inst, Dept Phys Chem, Berlin, Germany; [Popp, Denny] Tech Univ Bergakad Freiberg, Dept Phys Chem, D-09596 Freiberg, Germany	Max Planck Society; Fritz Haber Institute of the Max Planck Society; Technical University Freiberg	Flechsig, H (corresponding author), Max Planck Gesell, Fritz Haber Inst, Dept Phys Chem, Berlin, Germany.	flechsig@fhi-berlin.mpg.de	Flechsig, Holger/C-3452-2011; Popp, Denny/A-3894-2012	Flechsig, Holger/0000-0003-4984-9294; Popp, Denny/0000-0001-5656-2027				Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Appleby TC, 2011, J MOL BIOL, V405, P1139, DOI 10.1016/j.jmb.2010.11.034; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Cui Q., 2006, NORMAL MODE ANAL THE; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; Enernark EJ, 2008, CURR OPIN STRUC BIOL, V18, P243, DOI 10.1016/j.sbi.2008.01.007; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Flechsig H, 2010, P NATL ACAD SCI USA, V107, P20875, DOI 10.1073/pnas.1014631107; Frick DN, 2006, CURR PHARM DESIGN, V12, P1315, DOI 10.2174/138161206776361147; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Gu MG, 2010, P NATL ACAD SCI USA, V107, P521, DOI 10.1073/pnas.0913380107; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jankowsky E, 2007, CURR OPIN STRUC BIOL, V17, P316, DOI 10.1016/j.sbi.2007.05.007; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Kwong AD, 2005, NAT REV DRUG DISCOV, V4, P845, DOI 10.1038/nrd1853; Liu H, 2008, CELL, V133, P801, DOI 10.1016/j.cell.2008.04.029; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Myong S, 2010, CURR OPIN STRUC BIOL, V20, P121, DOI 10.1016/j.sbi.2009.12.008; Nishino T, 2005, STRUCTURE, V13, P143, DOI 10.1016/j.str.2004.11.008; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Richards JD, 2008, J BIOL CHEM, V283, P5118, DOI 10.1074/jbc.M707548200; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Soultanas P, 2001, TRENDS BIOCHEM SCI, V26, P47, DOI 10.1016/S0968-0004(00)01734-5; Stember JN, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3167410; Tirion MM, 1996, PHYS REV LETT, V77, P1905, DOI 10.1103/PhysRevLett.77.1905; Togashi Y, 2007, P NATL ACAD SCI USA, V104, P8697, DOI 10.1073/pnas.0702950104; Togashi Y, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000814; Tozzini V, 2005, CURR OPIN STRUC BIOL, V15, P144, DOI 10.1016/j.sbi.2005.02.005; UEDA Y, 1978, BIOPOLYMERS, V17, P1531, DOI 10.1002/bip.1978.360170612; Woodman IL, 2007, J MOL BIOL, V374, P1139, DOI 10.1016/j.jmb.2007.10.004; Yang L, 2009, P NATL ACAD SCI USA, V106, P12347, DOI 10.1073/pnas.0902159106; Zheng WJ, 2007, PROTEINS, V67, P886, DOI 10.1002/prot.21326; Zheng WJ, 2003, P NATL ACAD SCI USA, V100, P13253, DOI 10.1073/pnas.2235686100	38	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e21809	10.1371/journal.pone.0021809	http://dx.doi.org/10.1371/journal.pone.0021809			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21829442	Green Published, Green Submitted, gold			2022-12-25	WOS:000292929500009
J	Miyake, T; Parsons, SJ				Miyake, T.; Parsons, S. J.			Functional interactions between Choline kinase alpha, epidermal growth factor receptor and c-Src in breast cancer cell proliferation	ONCOGENE			English	Article						choline kinase; proliferation; c-Src; EGFR; breast cancer; tyrosine phosphorylation	TYROSINE KINASES; PHOSPHORYLATION; ACTIVATION; SITES; EGFR; OVEREXPRESSION; ONCOGENESIS; EXPRESSION; LUNG; Y845	Epidermal growth factor receptor (EGFR) family members and c-Src are co-overexpressed in many cancers. The synergistic effect of EGFR and c-Src has been shown in the tumorigenesis of breast and other cancers. Reported mechanisms of synergy include transcriptional regulation by STAT5b and the regulation of cellular ATP production by mitochondrial protein COX II. Here, we report a new mechanism of EGFR-c-Src synergy through choline kinase alpha (CHKA). The first enzyme of the phosphatidyl choline production pathway, CHKA, is overexpressed in many cancers, and the product of the enzyme, phosphocholine, is also increased in tumor cells. In this report, we find that CHKA forms a complex with EGFR in a c-Src-dependent manner. Endogenous CHKA and EGFR co-immunoprecipitated from a variety of breast cancer cell lines and immortalized mammary epithelial cells. CHKA interacted with the EGFR kinase domain upon c-Src co-overexpression and was phosphorylated in a c-Src-dependent manner on Y197 and Y333. Overexpression of EGFR and c-Src increased total cellular activity and protein levels of CHKA. Mutation of CHKA Y197 and Y333 reduced complex formation, EGFR-dependent activation of CHKA enzyme activity and epidermal growth factor (EGF)-dependent DNA synthesis. Furthermore, small interfering RNA-mediated knockdown of CHKA in MCF-7 and MCF-10A cells reduced EGF-dependent cell proliferation. Together, these results strongly implicate a new c-Src-dependent link between CHKA and EGFR, which contributes to the regulation of cell proliferation and tumorigenesis. Oncogene (2012) 31, 1431-1441; doi:10.1038/onc.2011.332; published online 8 August 2011	[Parsons, S. J.] Univ Virginia Hlth Syst, Dept Microbiol, Charlottesville, VA 22908 USA; [Parsons, S. J.] Univ Virginia Hlth Syst, Ctr Canc, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Parsons, SJ (corresponding author), Univ Virginia Hlth Syst, Dept Microbiol, POB 800734,1300 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	sap@virginia.edu			NIH-NCI [R01CA123037]; NATIONAL CANCER INSTITUTE [R01CA123037] Funding Source: NIH RePORTER	NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Nicholas E Sherman in the WM Keck Biomedical Mass Spectrometry Laboratory for analysis of CHKA2 phosphorylation sites, and Drs Jill Slack-Davis and John DaSilva for their critical comments. We also thank members of Sarah J Parsons' laboratory and the Women's Oncology Group in the University of Virginia Cancer Center for helpful discussions. This work was supported by NIH-NCI grant R01CA123037(SJP).	Aoyama C, 2004, PROG LIPID RES, V43, P266, DOI 10.1016/j.plipres.2003.12.001; Belsches-Jablonski AP, 2001, ONCOGENE, V20, P1465, DOI 10.1038/sj.onc.1204205; Biscardi JS, 1998, MOL CARCINOGEN, V21, P261, DOI 10.1002/(SICI)1098-2744(199804)21:4<261::AID-MC5>3.0.CO;2-N; Biscardi JS, 1999, ADV CANCER RES, V76, P61; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Biscardi JS, 2000, BREAST CANCER RES, V2, P203, DOI 10.1186/bcr55; Boerner JL, 2004, MOL CELL BIOL, V24, P7059, DOI 10.1128/MCB.24.16.7059-7071.2004; Chua BT, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-131; CUADRADO A, 1993, ONCOGENE, V8, P2959; de Molina AR, 2002, ONCOGENE, V21, P4317, DOI 10.1038/sj.onc.1205556; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Demory ML, 2009, J BIOL CHEM, V284, P36592, DOI 10.1074/jbc.M109.000760; Dimri M, 2007, CANCER RES, V67, P4164, DOI 10.1158/0008-5472.CAN-06-2580; Glunde K, 2006, MOL PHARMACEUT, V3, P496, DOI 10.1021/mp060067e; Grigera PR, 2005, J CELL SCI, V118, P4931, DOI 10.1242/jcs.02696; Hackel PO, 2001, BIOL CHEM, V382, P1649, DOI 10.1515/BC.2001.200; Hernando E, 2009, ONCOGENE, V28, P2425, DOI 10.1038/onc.2009.91; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; ISHIDATE K, 1992, METHOD ENZYMOL, V209, P121; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Ishizawar RC, 2007, ONCOGENE, V26, P3503, DOI 10.1038/sj.onc.1210138; Kloth MT, 2003, J BIOL CHEM, V278, P1671, DOI 10.1074/jbc.M207289200; Krishnamachary B, 2009, CANCER RES, V69, P3464, DOI 10.1158/0008-5472.CAN-08-4120; Liao HN, 2006, BBA-MOL CELL BIOL L, V1761, P111, DOI 10.1016/j.bbalip.2006.01.005; MAA MC, 1995, P NATL ACAD SCI USA, V92, P6981, DOI 10.1073/pnas.92.15.6981; Malito E, 2006, J MOL BIOL, V364, P136, DOI 10.1016/j.jmb.2006.08.084; Mao WG, 1997, ONCOGENE, V15, P3083, DOI 10.1038/sj.onc.1201496; Morse DL, 2009, NMR BIOMED, V22, P114, DOI 10.1002/nbm.1318; Peisach D, 2003, STRUCTURE, V11, P703, DOI 10.1016/S0969-2126(03)00094-7; Qiu C, 2009, BIOCHEMISTRY-US, V48, P6624, DOI 10.1021/bi900755n; Ramirez de Molina A, 2002, BIOCHEM BIOPH RES CO, V296, P580, DOI 10.1016/S0006-291X(02)00920-8; Ramirez de Molina A, 2004, CANCER RES, V64, P6732, DOI 10.1158/0008-5472.CAN-04-0489; Ramirez de Molina A, 2002, ONCOGENE, V21, P937, DOI 10.1038/sj.onc.1205144; Ramirez de Molina A, 2007, LANCET ONCOL, V8, P889, DOI 10.1016/S1470-2045(07)70279-6; STOVER DR, 1995, J BIOL CHEM, V270, P15591, DOI 10.1074/jbc.270.26.15591; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; Uchida T, 1996, BBA-LIPID LIPID MET, V1304, P89, DOI 10.1016/S0005-2760(96)00109-9; Wright JD, 1996, BBA-MOL CELL RES, V1312, P85, DOI 10.1016/0167-4889(96)00027-4; Wu GS, 2010, BIOCHEM CELL BIOL, V88, P559, DOI 10.1139/O09-160; Yalcin A, 2010, ONCOGENE, V29, P139, DOI 10.1038/onc.2009.317; Yanga S, 2008, EXP CELL RES, V314, P413, DOI 10.1016/j.yexcr.2007.09.002	42	54	56	0	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2012	31	11					1431	1441		10.1038/onc.2011.332	http://dx.doi.org/10.1038/onc.2011.332			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	912FL	21822308	Green Accepted			2022-12-25	WOS:000301780000010
J	Benbow, JH; DeGray, B; Ehrlich, BE				Benbow, Jennifer H.; DeGray, Brenda; Ehrlich, Barbara E.			Protection of Neuronal Calcium Sensor 1 Protein in Cells Treated with Paclitaxel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; CALPAIN; FREQUENIN; BINDING; OSCILLATIONS; DEGRADATION; NEUROPATHY; REGULATOR; SYSTEM; FAMILY	Paclitaxel (Taxol) is one of the most effective treatment options for patients suffering from a variety of cancers. A major side effect seen in a high percentage of patients treated with paclitaxel is irreversible peripheral neuropathy. We previously reported that prolonged treatment with paclitaxel activates a calcium-dependent enzyme, calpain, which degrades neuronal calcium sensor 1 (NCS-1) and subsequent loss of intracellular calcium signaling. Because it appears that activation of calpain is an early step in this destructive cascade, we proposed that inhibition of calpain will protect against the unwanted side effects of paclitaxel treatment. First, NCS-1 levels and intracellular calcium signaling were found to be protected by the presence of lactacystin, a protesome inhibitor. To reinforce the role of calpain in this process, we showed that increased concentrations of calpastatin, a naturally occurring calpain inhibitor, were protective. Next, we tested two mutated versions of NCS-1 developed with point mutations at the P2 position of the calpain cleavage site of NCS-1 to decrease the likelihood of NCS-1 degradation. One mutant was cleaved more favorably by calpain compared with NCS-1 WT, whereas the other mutant was less favorably cleaved. Expression of either mutated version of NCS-1 in neuroblastoma cells protected intracellular calcium signals from paclitaxel-induced changes. These results support our hypothesis that it is possible to protect cells from paclitaxel-induced degradation of NCS-1 by inhibiting calpain activity.	[Ehrlich, Barbara E.] Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA; Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University; Yale University	Ehrlich, BE (corresponding author), Yale Univ, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	barbara.ehrlich@yale.edu	/AAX-8408-2021	/0000-0001-9657-9704	National Institutes of Health [DK57751, DK61747, 5T32DK007356-32]; Department of Defense for Breast Cancer Research [DOD J00181]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007356, R01DK061747, P01DK057751] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense for Breast Cancer Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK57751 and DK61747. This work was also supported by National Institutes of Health Training Grant 5T32DK007356-32 administered by the Department of Digestive Diseases at Yale University and by Department of Defense for Breast Cancer Research Grant DOD J00181.	Aravind P, 2008, J MOL BIOL, V376, P1100, DOI 10.1016/j.jmb.2007.12.033; Bingol B, 2005, CURR OPIN NEUROBIOL, V15, P536, DOI 10.1016/j.conb.2005.08.016; Blachford C, 2009, CELL CALCIUM, V46, P257, DOI 10.1016/j.ceca.2009.08.002; Boehmerle W, 2007, P NATL ACAD SCI USA, V104, P11103, DOI 10.1073/pnas.0701546104; Boehmerle W, 2006, P NATL ACAD SCI USA, V103, P18356, DOI 10.1073/pnas.0607240103; Bourne Y, 2001, J BIOL CHEM, V276, P11949, DOI 10.1074/jbc.M009373200; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Cuerrier D, 2005, J BIOL CHEM, V280, P40632, DOI 10.1074/jbc.M506870200; Estrada M, 2006, J CELL SCI, V119, P733, DOI 10.1242/jcs.02775; Fenteany G, 1998, J BIOL CHEM, V273, P8545, DOI 10.1074/jbc.273.15.8545; Fisher JR, 2000, PROTEIN EXPRES PURIF, V20, P66, DOI 10.1006/prep.2000.1298; Florea AM, 2009, NEUROTOXICOLOGY, V30, P803, DOI 10.1016/j.neuro.2009.04.014; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hilfiker S, 2003, BIOCHEM SOC T, V31, P828, DOI 10.1042/BST0310828; Hilkens P H, 1997, J Peripher Nerv Syst, V2, P350; Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4; McFerran BW, 1998, J BIOL CHEM, V273, P22768, DOI 10.1074/jbc.273.35.22768; Mielke S, 2006, EUR J CANCER, V42, P24, DOI 10.1016/j.ejca.2005.06.030; Nakamura TY, 2001, P NATL ACAD SCI USA, V98, P12808, DOI 10.1073/pnas.221168498; Petko JA, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-27; Preston N J, 1996, Eur J Cancer Care (Engl), V5, P147, DOI 10.1111/j.1365-2354.1996.tb00226.x; Ramos-Franco J, 1998, BIOPHYS J, V75, P2783, DOI 10.1016/S0006-3495(98)77721-5; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Schlecker C, 2006, J CLIN INVEST, V116, P1668, DOI 10.1172/JCI22466; SPENCER CM, 1994, DRUGS, V48, P794, DOI 10.2165/00003495-199448050-00009; Sussman JL, 1998, ACTA CRYSTALLOGR D, V54, P1078, DOI 10.1107/S0907444998009378; Wang MS, 2004, BRAIN, V127, P671, DOI 10.1093/brain/awh078	27	15	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34575	34582		10.1074/jbc.M111.265751	http://dx.doi.org/10.1074/jbc.M111.265751			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21808066	Green Published, hybrid			2022-12-25	WOS:000295406300012
J	Ferraris, DM; Sbardella, D; Petrera, A; Marini, S; Amstutz, B; Coletta, M; Sander, P; Rizzi, M				Ferraris, Davide M.; Sbardella, Diego; Petrera, Agnese; Marini, Stefano; Amstutz, Beat; Coletta, Massimo; Sander, Peter; Rizzi, Menico			Crystal Structure of Mycobacterium tuberculosis Zinc-dependent Metalloprotease-1 (Zmp1), a Metalloprotease Involved in Pathogenicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIN-CONVERTING ENZYME-1; BENZOFUSED MACROCYCLIC LACTAMS; MEMBRANE-BOUND METALLOPROTEASE; NEUTRAL ENDOPEPTIDASE; ACTIVE-SITE; INFLAMMASOME; POTENT; NEPRILYSIN; INHIBITOR	Mycobacterium tuberculosis, the causative agent of tuberculosis, parasitizes host macrophages. The resistance of the tubercle bacilli to the macrophage hostile environment relates to their ability to impair phagosome maturation and its fusion with the lysosome, thus preventing the formation of the phago-lysosome and eventually arresting the process of phagocytosis. The M. tuberculosis zinc-dependent metalloproteaseZmp1has been proposed to play a key role in the process of phagosome maturation inhibition and emerged as an important player in pathogenesis. Here, we report the crystal structure of wild-type Zmp1 at 2.6A resolution in complex with the generic zinc metalloprotease inhibitor phosphoramidon, which we demonstrated to inhibit the enzyme potently. Our data represent the first structural characterization of a bacterial member of the zinc-dependent M13 endopeptidase family and revealed a significant degree of conservation with eukaryotic enzymes. However, structural comparison of the Zmp1-phosphoramidon complex with homologous human proteins neprilysin and endothelinconverting enzyme-1 revealed unique features of the Zmp1 active site to be exploited for the rational design of specific inhibitors that may prove useful as a pharmacological tool for better understanding Zmp1 biological function.	[Rizzi, Menico] Univ Piemonte Orientale Amedeo Avogadro, DiSCAFF, DISCAFF Dept Chem Food Pharmaceut & Pharmacol Sci, I-28100 Novara, Italy; [Sbardella, Diego; Marini, Stefano; Coletta, Massimo] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00133 Rome, Italy; [Sbardella, Diego] Interuniv Consortium Res Chem Met Biol Syst, I-70126 Bari, Italy; [Petrera, Agnese; Amstutz, Beat; Sander, Peter] Univ Zurich, Inst Med Microbiol, CH-8006 Zurich, Switzerland	University of Eastern Piedmont Amedeo Avogadro; University of Rome Tor Vergata; University of Zurich	Rizzi, M (corresponding author), Univ Piemonte Orientale Amedeo Avogadro, DiSCAFF, DISCAFF Dept Chem Food Pharmaceut & Pharmacol Sci, Via Bovio 6, I-28100 Novara, Italy.	menico.rizzi@pharm.unipmn.it	Marini, Stefano/B-1161-2012; Coletta, Massimiliano/GSN-5927-2022; Sbardella, Diego/K-7519-2016; Sander, Peter/D-2548-2009; Ferraris, Davide Maria/AAP-7110-2020; Coletta, Massimo/N-9049-2015; Ferraris, Davide Maria/AAO-9743-2020; Sbardella, Diego/N-9187-2015	Marini, Stefano/0000-0003-1299-6696; Sbardella, Diego/0000-0002-9924-7761; Sander, Peter/0000-0003-1581-0682; Ferraris, Davide Maria/0000-0001-5112-9910; COLETTA, Massimiliano/0000-0002-5489-9467	European Union [SysteMTb HEALTH-F4-2010-241587, New TBvac 241745]; Swiss National Science Foundation [31003A_135705]	European Union(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the European Union FP7 program SysteMTb HEALTH-F4-2010-241587 and New TBvac 241745 projects and by Swiss National Science Foundation Grant 31003A_135705.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bianchetti L, 2002, PROTEINS, V47, P481, DOI 10.1002/prot.10075; Chan J, 2004, CLIN IMMUNOL, V110, P2, DOI 10.1016/S1521-6616(03)00210-9; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; De Lombaert S, 2000, J MED CHEM, V43, P488, DOI 10.1021/jm990507o; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DELOMBAERT S, 1994, BIOCHEM BIOPH RES CO, V204, P407, DOI 10.1006/bbrc.1994.2473; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FRANCIS F, 1995, NAT GENET, V11, P130, DOI 10.1038/ng1095-130; Gaucher JF, 1999, BIOCHEMISTRY-US, V38, P12569, DOI 10.1021/bi991043z; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guarda G, 2010, IMMUNOLOGY, V130, P329, DOI 10.1111/j.1365-2567.2010.03283.x; Ikeda K, 1999, J BIOL CHEM, V274, P32469, DOI 10.1074/jbc.274.45.32469; Johnson GD, 2002, ARCH BIOCHEM BIOPHYS, V398, P240, DOI 10.1006/abbi.2001.2708; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Ksander GM, 1997, J MED CHEM, V40, P506, DOI 10.1021/jm960583g; Ksander GM, 1997, J MED CHEM, V40, P495, DOI 10.1021/jm960582o; KUKKOLA PJ, 1995, J CARDIOVASC PHARM, V26, pS65; LEE S, 1991, P NATL ACAD SCI USA, V88, P6353, DOI 10.1073/pnas.88.14.6353; Lorand L, 1976, Methods Enzymol, V45, P31; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muttucumaru DGN, 2011, TUBERCULOSIS, V91, P111, DOI 10.1016/j.tube.2010.11.010; O'Sullivan O, 2004, J MOL BIOL, V340, P385, DOI 10.1016/j.jmb.2004.04.058; Oefner C, 2000, J MOL BIOL, V296, P341, DOI 10.1006/jmbi.1999.3492; Oefner C, 2004, ACTA CRYSTALLOGR D, V60, P392, DOI 10.1107/S0907444903027410; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006; Ramachandra L, 2005, INFECT IMMUN, V73, P1097, DOI 10.1128/IAI.73.2.1097-1105.2005; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schulz H, 2009, J MOL BIOL, V385, P178, DOI 10.1016/j.jmb.2008.10.052; Shetty SS, 1998, J CARDIOVASC PHARM, V31, pS68, DOI 10.1097/00005344-199800001-00022; Shimada K, 1996, BIOCHEM J, V315, P863, DOI 10.1042/bj3150863; SUDA H, 1973, J ANTIBIOT, V26, P621, DOI 10.7164/antibiotics.26.621; Sutterwala FS, 2007, J LEUKOCYTE BIOL, V82, P259, DOI 10.1189/jlb.1206755; Tallant C, 2010, BBA-MOL CELL RES, V1803, P20, DOI 10.1016/j.bbamcr.2009.04.003; Torres M, 2006, INFECT IMMUN, V74, P1621, DOI 10.1128/IAI.74.3.1621-1630.2006; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; XU D, 1994, CELL, V78, P473, DOI 10.1016/0092-8674(94)90425-1	48	27	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32475	32482		10.1074/jbc.M111.271809	http://dx.doi.org/10.1074/jbc.M111.271809			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21813647	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000294726800057
J	Meier, D; Schindler, D				Meier, Daniel; Schindler, Detlev			Fanconi Anemia Core Complex Gene Promoters Harbor Conserved Transcription Regulatory Elements	PLOS ONE			English	Article							FA-C CELLS; DNA-DAMAGE; K-BOX; PROTEIN; PATHWAY; IDENTIFICATION; INTERFERON; ENHANCER; GROWTH; SMAD4	The Fanconi anemia (FA) gene family is a recent addition to the complex network of proteins that respond to and repair certain types of DNA damage in the human genome. Since little is known about the regulation of this novel group of genes at the DNA level, we characterized the promoters of the eight genes (FANCA, B, C, E, F, G, L and M) that compose the FA core complex. The promoters of these genes show the characteristic attributes of housekeeping genes, such as a high GC content and CpG islands, a lack of TATA boxes and a low conservation. The promoters functioned in a monodirectional way and were, in their most active regions, comparable in strength to the SV40 promoter in our reporter plasmids. They were also marked by a distinctive transcriptional start site (TSS). In the 5' region of each promoter, we identified a region that was able to negatively regulate the promoter activity in HeLa and HEK 293 cells in isolation. The central and 3' regions of the promoter sequences harbor binding sites for several common and rare transcription factors, including STAT, SMAD, E2F, AP1 and YY1, which indicates that there may be cross-connections to several established regulatory pathways. Electrophoretic mobility shift assays and siRNA experiments confirmed the shared regulatory responses between the prominent members of the TGF-beta and JAK/STAT pathways and members of the FA core complex. Although the promoters are not well conserved, they share region and sequence specific regulatory motifs and transcription factor binding sites (TBFs), and we identified a bi-partite nature to these promoters. These results support a hypothesis based on the co-evolution of the FA core complex genes that was expanded to include their promoters.	[Meier, Daniel; Schindler, Detlev] Univ Wurzburg, Dept Human Genet, D-8700 Wurzburg, Germany	University of Wurzburg	Meier, D (corresponding author), Univ Wurzburg, Dept Human Genet, D-8700 Wurzburg, Germany.	daniel.meier@biozentrum.uni-wuerzburg.de			University of Wurzburg; DFG; Department of Human Genetics in the University of Wurzburg School of Medicine	University of Wurzburg; DFG(German Research Foundation (DFG)); Department of Human Genetics in the University of Wurzburg School of Medicine	This study was supported, in part, by the Schroeder-Kurth Fund at the University of Wurzburg and the Department of Human Genetics in the University of Wurzburg School of Medicine (general support). The publication was supported by the DFG open-access fund (www.dfg.de)(publication fees). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi AA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000366; Ali AM, 2009, MUTAT RES-FUND MOL M, V668, P20, DOI 10.1016/j.mrfmmm.2009.04.002; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Bornstein S, 2009, J CLIN INVEST, V119, P3408, DOI 10.1172/JCI38854; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Cheng YH, 2004, BIOL REPROD, V70, P694, DOI 10.1095/biolreprod.103.023473; Cheng YH, 2003, J CLIN ENDOCR METAB, V88, P3305, DOI 10.1210/jc.2002-021831; Ciccia A, 2007, MOL CELL, V25, P331, DOI 10.1016/j.molcel.2007.01.003; Crossan GP, 2011, NAT GENET, V43, P147, DOI 10.1038/ng.752; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; de Winter JP, 2000, HUM MOL GENET, V9, P2665, DOI 10.1093/hmg/9.18.2665; Fagerlie SR, 2004, J IMMUNOL, V173, P3863, DOI 10.4049/jimmunol.173.6.3863; Fagerlie SR, 2001, BLOOD, V97, P3017, DOI 10.1182/blood.V97.10.3017; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Farre D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r140; Fu HY, 2006, BIOCHEM BIOPH RES CO, V343, P1009, DOI 10.1016/j.bbrc.2006.02.176; Hoskins EE, 2008, ONCOGENE, V27, P4798, DOI 10.1038/onc.2008.121; Joenje H, 2001, NAT REV GENET, V2, P446, DOI 10.1038/35076590; Kee Y, 2010, GENE DEV, V24, P1680, DOI 10.1101/gad.1955310; Lai EC, 2000, DEVELOPMENT, V127, P291; Lai EC, 1998, DEVELOPMENT, V125, P4077; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Ling C, 2007, EMBO J, V26, P2104, DOI 10.1038/sj.emboj.7601666; LUSTIG JP, 1995, ORAL ONCOL, V31B, P68; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Medhurst AL, 2001, HUM MOL GENET, V10, P423, DOI 10.1093/hmg/10.4.423; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Moustakas A, 2002, GENE DEV, V16, P1867, DOI 10.1101/gad.1016802; Moustakas A, 2002, IMMUNOL LETT, V82, P85, DOI 10.1016/S0165-2478(02)00023-8; Moustakas Aristidis, 2002, Journal of Cell Science, V115, P3355; Nabokina SM, 2004, AM J PHYSIOL-GASTR L, V287, pG822, DOI 10.1152/ajpgi.00234.2004; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Pang QS, 2000, MOL CELL BIOL, V20, P4724, DOI 10.1128/MCB.20.13.4724-4735.2000; RAUSCHENDORF MA, 2010, INT J ANDROL; SAVOIA A, 1995, HUM MOL GENET, V4, P1321, DOI 10.1093/hmg/4.8.1321; Shuai K, 2000, ONCOGENE, V19, P2638, DOI 10.1038/sj.onc.1203522; Singh TR, 2010, MOL CELL, V37, P879, DOI 10.1016/j.molcel.2010.01.036; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Smale ST, 1997, BBA-GENE STRUCT EXPR, V1351, P73, DOI 10.1016/S0167-4781(96)00206-0; Stoepker C, 2011, NAT GENET, V43, P138, DOI 10.1038/ng.751; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; Wakaguri H, 2008, NUCLEIC ACIDS RES, V36, pD97, DOI 10.1093/nar/gkm901; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Williams JG, 2000, CURR OPIN GENET DEV, V10, P503, DOI 10.1016/S0959-437X(00)00119-2; Yan ZJ, 2010, MOL CELL, V37, P865, DOI 10.1016/j.molcel.2010.01.039; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814	49	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22911	10.1371/journal.pone.0022911	http://dx.doi.org/10.1371/journal.pone.0022911			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826217	Green Published, Green Submitted, gold			2022-12-25	WOS:000293558900043
J	Magdesian, MH; Gralle, M; Guerreiro, LH; Beltrao, PJI; Carvalho, MMVF; Santos, LED; de Mello, FG; Reis, RAM; Ferreira, ST				Magdesian, Margaret H.; Gralle, Matthias; Guerreiro, Luiz H.; Beltrao, Paulo Jose I.; Carvalho, Milena M. V. F.; Santos, Luis Eduardo da S.; de Mello, Fernando G.; Reis, Ricardo A. M.; Ferreira, Sergio T.			Secreted Human Amyloid Precursor Protein Binds Semaphorin 3a and Prevents Semaphorin-Induced Growth Cone Collapse	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; BETA; DOMAIN; APP; MECHANISMS; RECEPTORS; MIGRATION; OLIGOMERS; SURVIVAL; REGION	The amyloid precursor protein (APP) is well known for giving rise to the amyloid-beta peptide and for its role in Alzheimer's disease. Much less is known, however, on the physiological roles of APP in the development and plasticity of the central nervous system. We have used phage display of a peptide library to identify high-affinity ligands of purified recombinant human sAPP alpha(695) (the soluble, secreted ectodomain from the main neuronal APP isoform). Two peptides thus selected exhibited significant homologies with the conserved extracellular domain of several members of the semaphorin (Sema) family of axon guidance proteins. We show that sAPP alpha(695) binds both purified recombinant Sema3A and Sema3A secreted by transfected HEK293 cells. Interestingly, sAPP alpha(695) inhibited the collapse of embryonic chicken (Gallus gallus domesticus) dorsal root ganglia growth cones promoted by Sema3A (K-d <= 8.10(-9) M). Two Sema3A-derived peptides homologous to the peptides isolated by phage display blocked sAPP alpha binding and its inhibitory action on Sema3A function. These two peptides are comprised within a domain previously shown to be involved in binding of Sema3A to its cellular receptor, suggesting a competitive mechanism by which sAPP alpha modulates the biological action of semaphorins.	[Magdesian, Margaret H.; Gralle, Matthias; Guerreiro, Luiz H.; Beltrao, Paulo Jose I.; Carvalho, Milena M. V. F.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Program Biochem & Cellular Biophys, Inst Med Biochem, Rio De Janeiro, Brazil; [Santos, Luis Eduardo da S.; de Mello, Fernando G.; Reis, Ricardo A. M.] Univ Fed Rio de Janeiro, Program Neurobiol, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Magdesian, MH (corresponding author), Univ Fed Rio de Janeiro, Program Biochem & Cellular Biophys, Inst Med Biochem, Rio De Janeiro, Brazil.	magdesian@bioqmed.ufrj.br; gralle@bioqmed.ufrj.br	Ferreira, Sergio/AAZ-1576-2020; Gralle, Matthias/B-9005-2014; Santos, Luís/B-4961-2015; Neurociencia, Inct/I-1011-2013; de Melo Reis, Ricardo A/E-9962-2011; Rosado, Luiz L H/N-1472-2015	Ferreira, Sergio/0000-0001-7160-9866; Santos, Luís/0000-0002-0694-733X; de Melo Reis, Ricardo A/0000-0001-9689-4085; Rosado, Luiz L H/0000-0002-9390-8397; Miranda da Silva Iwakami Beltrao, Paulo Jose/0000-0002-2449-248X	Howard Hughes Medical Institute; Instituto Nacional de Neurociencia Translacional; Pronex-FAPERJ; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Instituto Nacional de Neurociencia Translacional; Pronex-FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants from the Howard Hughes Medical Institute (www.hhmi.org) to STF; Instituto Nacional de Neurociencia Translacional (www.cnpq.br) and Pronex-FAPERJ (www.faperj.br) to STF and FGdM; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br) to STF, RAMR, and MG; and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (www.faperj.br) to MHM, MG, and STF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams RH, 1997, EMBO J, V16, P6077, DOI 10.1093/emboj/16.20.6077; ALLINQUANT B, 1995, J CELL BIOL, V128, P919, DOI 10.1083/jcb.128.5.919; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antipenko A, 2003, NEURON, V39, P589, DOI 10.1016/S0896-6273(03)00502-6; Bagri A, 2002, ADV EXP MED BIOL, V515, P13; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; Ben-Zvi A, 2008, J NEUROSCI, V28, P12427, DOI 10.1523/JNEUROSCI.3573-08.2008; Bouzioukh F, 2006, EUR J NEUROSCI, V23, P2247, DOI 10.1111/j.1460-9568.2006.04783.x; Calissano P, 2010, DEV NEUROBIOL, V70, P372, DOI 10.1002/dneu.20759; de Wit J, 2006, TRAFFIC, V7, P1060, DOI 10.1111/j.1600-0854.2006.00442.x; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Fenstermaker V, 2004, J NEUROBIOL, V58, P403, DOI 10.1002/neu.10304; Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882; Gallo G, 2004, J NEUROBIOL, V58, P92, DOI 10.1002/neu.10282; Goshima Y, 1999, J NEUROBIOL, V39, P579, DOI 10.1002/(SICI)1097-4695(19990615)39:4<579::AID-NEU11>3.0.CO;2-9; Gralle M, 2002, BIOPHYS J, V83, P3513, DOI 10.1016/S0006-3495(02)75351-4; Gralle M, 2007, PROG NEUROBIOL, V82, P11, DOI 10.1016/j.pneurobio.2007.02.001; Gralle M, 2009, J BIOL CHEM, V284, P15016, DOI 10.1074/jbc.M808755200; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HE Z, 2002, SCI STKE, V119, pRE1, DOI DOI 10.1126/STKE.2002.119.RE1; Hoe HS, 2009, J BIOL CHEM, V284, P8495, DOI 10.1074/jbc.M900141200; Hoe HS, 2009, J NEUROSCI, V29, P7459, DOI 10.1523/JNEUROSCI.4872-08.2009; HUNG AY, 1992, P NATL ACAD SCI USA, V89, P9439, DOI 10.1073/pnas.89.20.9439; Ikin AF, 2007, MOL CELL NEUROSCI, V35, P57, DOI 10.1016/j.mcn.2007.02.003; JIN LW, 1994, J NEUROSCI, V14, P5461; Kalil K, 2005, CURR OPIN NEUROBIOL, V15, P521, DOI 10.1016/j.conb.2005.08.005; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Koppel AM, 1997, NEURON, V19, P531, DOI 10.1016/S0896-6273(00)80369-4; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEBLANC AC, 1992, J NEUROSCI RES, V31, P635, DOI 10.1002/jnr.490310407; Magdesian MH, 2008, J BIOL CHEM, V283, P9359, DOI 10.1074/jbc.M707108200; Magdesian MH, 2005, J BIOL CHEM, V280, P31085, DOI 10.1074/jbc.M502406200; Marin O, 2001, SCIENCE, V293, P872, DOI 10.1126/science.1061891; MILWARD EA, 1992, NEURON, V9, P129, DOI 10.1016/0896-6273(92)90228-6; MOYA KL, 1994, DEV BIOL, V161, P597, DOI 10.1006/dbio.1994.1055; Osterfield M, 2008, DEVELOPMENT, V135, P1189, DOI 10.1242/dev.007401; Pasterkamp RJ, 2009, CURR OPIN NEUROBIOL, V19, P263, DOI 10.1016/j.conb.2009.06.001; Paula-Lima AC, 2009, INT J BIOCHEM CELL B, V41, P1361, DOI 10.1016/j.biocel.2008.12.003; Pawlik M, 2007, BIOCHEM BIOPH RES CO, V355, P907, DOI 10.1016/j.bbrc.2007.02.047; Perez RG, 1997, J NEUROSCI, V17, P9407; R Development Core Team, 2009, R FDN STAT COMP; Reis RADM, 2008, BRAIN RES, V1205, P1, DOI 10.1016/j.brainres.2008.02.035; Rusu P, 2007, EUR J NEUROSCI, V25, P1079, DOI 10.1111/j.1460-9568.2007.05341.x; Sahay A, 2005, J NEUROSCI, V25, P3613, DOI 10.1523/JNEUROSCI.5255-04.2005; Sanchez-Camacho C, 2009, BIOESSAYS, V31, P1013, DOI 10.1002/bies.200900063; SMALL DH, 1994, J NEUROSCI, V14, P2117; Toyofuku T, 2005, NAT NEUROSCI, V8, P1712, DOI 10.1038/nn1596; Wang ZL, 2009, J NEUROSCI, V29, P10788, DOI 10.1523/JNEUROSCI.2132-09.2009; YAMAMOTO K, 1994, J NEUROBIOL, V25, P585, DOI 10.1002/neu.480250510; Yang L, 2009, J NEUROSCI, V29, P15660, DOI 10.1523/JNEUROSCI.4104-09.2009; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; YOUNGPEARSE TL, 2008, NEURAL DEV, V23, P3; Zhou YP, 2008, TRENDS BIOCHEM SCI, V33, P161, DOI 10.1016/j.tibs.2008.01.006	56	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22857	10.1371/journal.pone.0022857	http://dx.doi.org/10.1371/journal.pone.0022857			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829538	Green Published, gold, Green Submitted			2022-12-25	WOS:000293286500040
J	Wang, CY; Hua, CY; Hsu, HE; Hsu, CL; Tseng, HY; Wright, DE; Hsu, PH; Jen, CH; Lin, CY; Wu, MY; Tsai, MD; Kao, CF				Wang, Chen-Yi; Hua, Chia-Yin; Hsu, Hsiang-En; Hsu, Chia-Ling; Tseng, Hsin-Yi; Wright, Duncan E.; Hsu, Pang-Hung; Jen, Chih-Hung; Lin, Chia-Yeh; Wu, Meng-Ying; Tsai, Min-Daw; Kao, Cheng-Fu			The C-Terminus of Histone H2B Is Involved in Chromatin Compaction Specifically at Telomeres, Independently of Its Monoubiquitylation at Lysine 123	PLOS ONE			English	Article							SILENT CHROMATIN; TRANSCRIPTIONAL ACTIVATION; YEAST; HETEROCHROMATIN; METHYLATION; COMPLEX; BINDING; H3; UBIQUITYLATION; ACETYLATION	Telomeric heterochromatin assembly in budding yeast propagates through the association of Silent Information Regulator (SIR) proteins with nucleosomes, and the nucleosome array has been assumed to fold into a compacted structure. It is believed that the level of compaction and gene repression within heterochromatic regions can be modulated by histone modifications, such as acetylation of H3 lysine 56 and H4 lysine 16, and monoubiquitylation of H2B lysine 123. However, it remains unclear as to whether or not gene silencing is a direct consequence of the compaction of chromatin. Here, by investigating the role of the carboxy-terminus of histone H2B in heterochromatin formation, we identify that the disorderly compaction of chromatin induced by a mutation at H2B T122 specifically hinders telomeric heterochromatin formation. H2B T122 is positioned within the highly conserved AVTKY motif of the alpha C helix of H2B. Heterochromatin containing the T122E substitution in H2B remains inaccessible to ectopic dam methylase with dramatically increased mobility in sucrose gradients, indicating a compacted chromatin structure. Genetic studies indicate that this unique phenotype is independent of H2B K123 ubiquitylation and Sir4. In addition, using ChIP analysis, we demonstrate that telomere structure in the mutant is further disrupted by a defect in Sir2/Sir3 binding and the resulting invasion of euchromatic histone marks. Thus, we have revealed that the compaction of chromatin per se is not sufficient for heterochromatin formation. Instead, these results suggest that an appropriately arrayed chromatin mediated by H2B C-terminus is required for SIR binding and the subsequent formation of telomeric chromatin in yeast, thereby identifying an intrinsic property of the nucleosome that is required for the establishment of telomeric heterochromatin. This requirement is also likely to exist in higher eukaryotes, as the AVTKY motif of H2B is evolutionarily conserved.	[Wang, Chen-Yi; Hua, Chia-Yin; Hsu, Hsiang-En; Hsu, Chia-Ling; Tseng, Hsin-Yi; Wright, Duncan E.; Lin, Chia-Yeh; Wu, Meng-Ying; Kao, Cheng-Fu] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Hsu, Pang-Hung; Tsai, Min-Daw] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Hsu, Pang-Hung] Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Dept Life Sci, Keelung, Taiwan; [Jen, Chih-Hung] VGH Yang Ming Genome Res Ctr, Taipei, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan Ocean University	Wang, CY (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan.	ckao@gate.sinica.edu.tw	Hsu, Pang-Hung/C-5587-2018; Kao, Cheng-Fu/AAE-8400-2022; Tsai, Ming-Daw/G-4689-2019	Hsu, Pang-Hung/0000-0001-6873-6434; Kao, Cheng-Fu/0000-0002-8875-8152; Tsai, Ming-Daw/0000-0003-1374-0414	Academia Sinica, Taiwan; National Science Council, Taiwan [NSC98-2320B-001-015-MY3]; National Health Research Institutes, Taiwan [NHRI-EX98-9817NC]	Academia Sinica, Taiwan(Academia Sinica - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	CYW is supported by a postdoctoral fellowship of Academia Sinica, Taiwan. This work was funded by National Science Council, Taiwan: NSC98-2320B-001-015-MY3 (http://web1.nsc.gov.tw/) and National Health Research Institutes, Taiwan: NHRI-EX98-9817NC (http://www.nhri.org.tw/NHRI_WEB/nhriw001Action.do). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Ahmed K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010531; Ahmed Kashif, 2008, V464, P415; APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; Atkin AL, 1999, METH MOL B, V122, P131; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Buhler M, 2009, EMBO J, V28, P2149, DOI 10.1038/emboj.2009.185; Chandrasekharan MB, 2010, MOL CELL BIOL, V30, P3216, DOI 10.1128/MCB.01008-09; Chen LY, 2005, CELL, V120, P37, DOI 10.1016/j.cell.2004.11.030; de Bruin D, 2001, NATURE, V409, P109, DOI 10.1038/35051119; Dekker J, 2008, J BIOL CHEM, V283, P34532, DOI 10.1074/jbc.M806479200; Eissenberg JC, 2005, NATURE, V438, P1090, DOI 10.1038/4381090a; Eltsov M, 2008, P NATL ACAD SCI USA, V105, P19732, DOI 10.1073/pnas.0810057105; Emre NCT, 2005, MOL CELL, V17, P585, DOI 10.1016/j.molcel.2005.01.007; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Fussner E, 2011, TRENDS BIOCHEM SCI, V36, P1, DOI 10.1016/j.tibs.2010.09.002; Gardner RG, 2005, MOL CELL BIOL, V25, P6123, DOI 10.1128/MCB.25.14.6123-6139.2005; Gasser SM, 2004, COLD SPRING HARB SYM, P327; Gotta M, 1996, J CELL BIOL, V134, P1349, DOI 10.1083/jcb.134.6.1349; GOTTSCHLING DE, 1992, P NATL ACAD SCI USA, V89, P4062, DOI 10.1073/pnas.89.9.4062; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Henry KW, 2002, NAT STRUCT BIOL, V9, P565, DOI 10.1038/nsb0802-565; Hoffman GA, 2002, METHOD ENZYMOL, V344, P617; Hoppe GJ, 2002, MOL CELL BIOL, V22, P4167, DOI 10.1128/MCB.22.12.4167-4180.2002; Johnson A, 2009, MOL CELL, V35, P769, DOI 10.1016/j.molcel.2009.07.030; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; Kao CF, 2004, GENE DEV, V18, P184, DOI 10.1101/gad.1149604; Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Koch MR, 2009, P NATL ACAD SCI USA, V106, P11224, DOI 10.1073/pnas.0900809106; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Laribee RN, 2005, CURR BIOL, V15, P1487, DOI 10.1016/j.cub.2005.07.028; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liou GG, 2005, CELL, V121, P515, DOI 10.1016/j.cell.2005.03.035; Luo KH, 2002, GENE DEV, V16, P1528, DOI 10.1101/gad.988802; Maeshima K, 2010, CURR OPIN CELL BIOL, V22, P291, DOI 10.1016/j.ceb.2010.03.001; Millar CB, 2006, NAT REV MOL CELL BIO, V7, P657, DOI 10.1038/nrm1986; Moazed D, 2001, MOL CELL, V8, P489, DOI 10.1016/S1097-2765(01)00340-9; Norris A, 2010, GENE DEV, V24, P115, DOI 10.1101/gad.1865510; Norris A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000301; Onishi M, 2007, MOL CELL, V28, P1015, DOI 10.1016/j.molcel.2007.12.004; Pirrotta V, 2005, MOL CELL, V18, P395, DOI 10.1016/j.molcel.2005.04.013; Poveda A, 2004, J BIOL CHEM, V279, P16033, DOI 10.1074/jbc.M314228200; Ren C, 2005, J AM SOC MASS SPECTR, V16, P1641, DOI 10.1016/j.jasms.2005.06.001; RINE J, 1987, GENETICS, V116, P9; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Rusche LN, 2002, MOL BIOL CELL, V13, P2207, DOI 10.1091/mbc.E02-03-0175; Sekinger EA, 2001, CELL, V105, P403, DOI 10.1016/S0092-8674(01)00329-4; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Sperling AS, 2009, P NATL ACAD SCI USA, V106, P13153, DOI 10.1073/pnas.0906866106; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Talbert PB, 2006, NAT REV GENET, V7, P793, DOI 10.1038/nrg1920; Tremethick DJ, 2007, CELL, V128, P651, DOI 10.1016/j.cell.2007.02.008; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; van Leeuwen F, 2002, CURR OPIN CELL BIOL, V14, P756, DOI 10.1016/S0955-0674(02)00393-9; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Wood A, 2005, MOL CELL, V20, P589, DOI 10.1016/j.molcel.2005.09.010; Xu F, 2007, MOL CELL, V27, P890, DOI 10.1016/j.molcel.2007.07.021; Zhou BO, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001272	65	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22209	10.1371/journal.pone.0022209	http://dx.doi.org/10.1371/journal.pone.0022209			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829450	Green Published, gold			2022-12-25	WOS:000293286500008
J	Glaser, C; Rzehak, P; Demmelmair, H; Klopp, N; Heinrich, J; Koletzko, B				Glaser, Claudia; Rzehak, Peter; Demmelmair, Hans; Klopp, Norman; Heinrich, Joachim; Koletzko, Berthold		LISA Study Grp	Influence of FADS Polymorphisms on Tracking of Serum Glycerophospholipid Fatty Acid Concentrations and Percentage Composition in Children	PLOS ONE			English	Article							PLASMA PHOSPHOLIPIDS; GENE-CLUSTER; CARDIOVASCULAR-DISEASE; 3-YEAR TRACKING; DIETARY-INTAKE; BLOOD; ADOLESCENTS; VARIANTS; REFLECT; ESTERS	Background: Tracking of fatty acid (FA) contribution to plasma or serum lipids over time was shown in children and adults. However, the potential role of FADS gene variants has not been investigated. Methods and Principal Findings: Serum GP FA composition of 331 children aged 2 and 6 years, participating in an ongoing birth cohort study, was analyzed. Correlation coefficients were estimated to describe FA tracking over 4 years and to assess the influence of FADS variants on tracking. We found low to moderate tracking (r = 0.12-0.49) of FA compositions and concentration between 2 and 6 years. Concentration changes of total monounsaturated FA and total saturated FA over time correlated closely (r = 0.79) but percentage values were unrelated (r = -0.02). Tracking for n-6 long chain polyunsaturated fatty acid (LC-PUFA) concentrations was lower in subjects homozygous for the major allele of FADS variants and higher in carriers of at least one minor allele, whereas for total n-3 LC-PUFA concentrations and compositions this was vice versa. For individual n-3 PUFA inconsistent results were found. Conclusions and Significance: Serum GP FA composition shows low to moderate tracking over 4 years with a higher tracking for LC-PUFA metabolites than for their precursor FA. Serum PUFA levels and their tracking seem to be more influenced by lipid and lipoprotein metabolism than by FA specific pathways.	[Glaser, Claudia; Demmelmair, Hans; Koletzko, Berthold] Univ Munich, Med Ctr, Dr von Hauner Childrens Hosp, Div Metab & Nutr Med, Munich, Germany; [Rzehak, Peter; Klopp, Norman; Heinrich, Joachim] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [Rzehak, Peter] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Glaser, C (corresponding author), Univ Munich, Med Ctr, Dr von Hauner Childrens Hosp, Div Metab & Nutr Med, Munich, Germany.	office.koletzko@med.uni-muenchen.de	Heinrich, Joachim/N-1720-2013; Sack, Ulrich/J-6301-2015	Heinrich, Joachim/0000-0002-9620-1629; Sack, Ulrich/0000-0002-7813-0492; Bolte, Gabriele/0000-0002-0269-5059	Kompetenznetz Adipositas ("Competence Network Obesity"); German Federal Ministry of Education and Research [FKZ: 01GI0826]; Munich Center of Health Sciences (MCHEALTH); Federal Ministry for Education, Science, Research and Technology [01 EG 9705/2, 01EG9732]; Federal Ministry of Environment (IUF) [FKS 20462296]; Bristol-Myers Squibb Foundation, New York, NY, USA	Kompetenznetz Adipositas ("Competence Network Obesity"); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Munich Center of Health Sciences (MCHEALTH); Federal Ministry for Education, Science, Research and Technology; Federal Ministry of Environment (IUF); Bristol-Myers Squibb Foundation, New York, NY, USA(Bristol-Myers Squibb)	This work was supported financially in part by the "Kompetenznetz Adipositas" ("Competence Network Obesity") funded by the German Federal Ministry of Education and Research (FKZ: 01GI0826) and by the Munich Center of Health Sciences (MCHEALTH). The LISA-plus study was funded by grants of the Federal Ministry for Education, Science, Research and Technology (Grant No. 01 EG 9705/2 and 01EG9732) and the 6 years follow-up of the LISA-plus study was partly funded by the Federal Ministry of Environment (IUF, FKS 20462296). Berthold Koletzko is the recipient of a Freedom to Discover Award of the Bristol-Myers Squibb Foundation, New York, NY, USA. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baylin A, 2006, CURR OPIN LIPIDOL, V17, P22, DOI 10.1097/01.mol.0000199814.46720.83; Calder PC, 2008, MOL NUTR FOOD RES, V52, P885, DOI 10.1002/mnfr.200700289; Calder PC, 2009, BIOFACTORS, V35, P266, DOI 10.1002/biof.42; Carter KW, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-60; Chong MFF, 2008, AM J CLIN NUTR, V87, P817, DOI 10.1093/ajcn/87.4.817; Crowe FL, 2008, AM J CLIN NUTR, V88, P1353, DOI 10.3945/ajcn.2008.26369; Glaser C, 2010, METABOLISM, V59, P993, DOI 10.1016/j.metabol.2009.10.022; Glaser C, 2010, J LIPID RES, V51, P216, DOI 10.1194/jlr.D000547; Guerra A, 2007, ANN NUTR METAB, V51, P433, DOI 10.1159/000111163; Harris WS, 2004, PREV MED, V39, P212, DOI 10.1016/j.ypmed.2004.02.030; Heinrich J, 2002, EUR RESPIR J, V20, P617, DOI 10.1183/09031936.02.02322001; Hodge AM, 2007, AM J CLIN NUTR, V86, P189, DOI 10.1093/ajcn/86.1.189; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Hodson L, 2009, AM J PHYSIOL-ENDOC M, V296, pE64, DOI 10.1152/ajpendo.90730.2008; Koletzko B, 2011, AM J CLIN NUTR, V93, P211, DOI 10.3945/ajcn.110.006189; MA J, 1995, AM J CLIN NUTR, V62, P572, DOI 10.1093/ajcn/62.3.572; Malerba G, 2008, LIPIDS, V43, P289, DOI 10.1007/s11745-008-3158-5; MOILANEN T, 1986, ATHEROSCLEROSIS, V59, P113, DOI 10.1016/0021-9150(86)90039-0; MOILANEN T, 1992, AM J EPIDEMIOL, V136, P1487, DOI 10.1093/oxfordjournals.aje.a116469; MOILANEN T, 1987, ATHEROSCLEROSIS, V67, P191, DOI 10.1016/0021-9150(87)90279-6; Ohrvall M, 1996, EUR J CLIN NUTR, V50, P381; Patterson E, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-91; Rzehak P, 2009, BRIT J NUTR, V101, P20, DOI 10.1017/S0007114508992564; Rzehak P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013261; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Sioen I, 2007, BRIT J NUTR, V98, P819, DOI 10.1017/S0007114507756544; Twisk JW, 2003, APPL LONGITUDINAL DA, P225; von Schacky C, 2007, CURR OPIN CLIN NUTR, V10, P129, DOI 10.1097/MCO.0b013e3280127af0; Zutavern A, 2008, PEDIATRICS, V121, pE44, DOI 10.1542/peds.2006-3553	29	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e21933	10.1371/journal.pone.0021933	http://dx.doi.org/10.1371/journal.pone.0021933			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818279	Green Published, gold, Green Submitted			2022-12-25	WOS:000293282700012
J	Taki, Y; Thyreau, B; Kinomura, S; Sato, K; Goto, R; Kawashima, R; Fukuda, H				Taki, Yasuyuki; Thyreau, Benjamin; Kinomura, Shigeo; Sato, Kazunori; Goto, Ryoi; Kawashima, Ryuta; Fukuda, Hiroshi			Correlations among Brain Gray Matter Volumes, Age, Gender, and Hemisphere in Healthy Individuals	PLOS ONE			English	Article							MAGNETIZATION-TRANSFER RATIO; HORMONE REPLACEMENT THERAPY; VOXEL-BASED MORPHOMETRY; LIFETIME ALCOHOL INTAKE; ADULT HUMAN BRAINS; BODY-MASS INDEX; SEX-DIFFERENCES; CEREBRAL-CORTEX; WHITE-MATTER; EXECUTIVE FUNCTIONS	To determine the relationship between age and gray matter structure and how interactions between gender and hemisphere impact this relationship, we examined correlations between global or regional gray matter volume and age, including interactions of gender and hemisphere, using a general linear model with voxel-based and region-of-interest analyses. Brain magnetic resonance images were collected from 1460 healthy individuals aged 20-69 years; the images were linearly normalized and segmented and restored to native space for analysis of global gray matter volume. Linearly normalized images were then non-linearly normalized and smoothed for analysis of regional gray matter volume. Analysis of global gray matter volume revealed a significant negative correlation between gray matter ratio (gray matter volume divided by intracranial volume) and age in both genders, and a significant interaction effect of age x gender on the gray matter ratio. In analyzing regional gray matter volume, the gray matter volume of all regions showed significant main effects of age, and most regions, with the exception of several including the inferior parietal lobule, showed a significant age x gender interaction. Additionally, the inferior temporal gyrus showed a significant age x gender x hemisphere interaction. No regional volumes showed significant age x hemisphere interactions. Our study may contribute to clarifying the mechanism(s) of normal brain aging in each brain region.	[Taki, Yasuyuki; Thyreau, Benjamin; Kawashima, Ryuta] Tohoku Univ, Div Dev Cognit Neurosci, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Kinomura, Shigeo; Sato, Kazunori; Goto, Ryoi; Fukuda, Hiroshi] Tohoku Univ, Dept Nucl Med & Radiol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Kawashima, Ryuta] Tohoku Univ, Dept Funct Brain Imaging, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Kawashima, Ryuta] Tohoku Univ, Smart Ageing Int Res Ctr, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University	Taki, Y (corresponding author), Tohoku Univ, Div Dev Cognit Neurosci, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan.	ytaki@idac.tohoku.ac.jp			National Institute of Mental Health; National Institute of Neurological Disorders and Stroke; National Institute on Drug Abuse; National Cancer Institute of the United States of America; Telecommunications Advancement Organization of Japan; Japan Society for the Promotion of Science [97L00202]; Ministry of Education, Culture, Sports, Science and Technology; Tohoku University; JSPS-CIHR; Ministry of Education, Science, Sports and Culture [18790864, 22103501]	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Cancer Institute of the United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Telecommunications Advancement Organization of Japan; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tohoku University; JSPS-CIHR(Canadian Institutes of Health Research (CIHR)); Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was funded by the National Institute of Mental Health, the National Institute of Neurological Disorders and Stroke, the National Institute on Drug Abuse, and the National Cancer Institute of the United States of America. Part of this research was supported by a grant from the Telecommunications Advancement Organization of Japan, as well as the Japan Society for the Promotion of Science Research for the Future Program (97L00202). This research was also supported, in part, by the 21st Century Center of Excellence Program (Ministry of Education, Culture, Sports, Science and Technology) entitled, "Future Medical Engineering-based Bio-nanotechnology,'' of Tohoku University, and a grant from the JSPS-CIHR Joint Health Research Program. This work was also partially supported by the Ministry of Education, Science, Sports and Culture, Grant of 18790864 and 22103501. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allen JS, 2005, NEUROBIOL AGING, V26, P1245, DOI 10.1016/j.neurobiolaging.2005.05.023; Amagai Y, 2006, J EPIDEMIOL, V16, P161, DOI 10.2188/jea.16.161; Ashburner J, 1997, NEUROIMAGE, V6, P344, DOI 10.1006/nimg.1997.0299; Bartzokis G, 2001, ARCH GEN PSYCHIAT, V58, P461, DOI 10.1001/archpsyc.58.5.461; BENES FM, 1989, SCHIZOPHRENIA BULL, V15, P585, DOI 10.1093/schbul/15.4.585; Busatto Geraldo F, 2008, Expert Rev Neurother, V8, P1691, DOI 10.1586/14737175.8.11.1691; Chen XH, 2007, NEUROIMAGE, V36, P691, DOI 10.1016/j.neuroimage.2007.03.063; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; COWELL PE, 1994, J NEUROSCI, V14, P4748; De Bellis MD, 2001, CEREB CORTEX, V11, P552, DOI 10.1093/cercor/11.6.552; de Bruin EA, 2005, NEUROIMAGE, V26, P536, DOI 10.1016/j.neuroimage.2005.01.036; Draganski B, 2011, NEUROIMAGE, V55, P1423, DOI 10.1016/j.neuroimage.2011.01.052; Driscoll I, 2009, NEUROLOGY, V72, P1906, DOI 10.1212/WNL.0b013e3181a82634; Du AT, 2006, NEUROBIOL AGING, V27, P733, DOI 10.1016/j.neurobiolaging.2005.03.021; Erickson KI, 2005, NEUROBIOL AGING, V26, P1205, DOI 10.1016/j.neurobiolaging.2004.11.009; Fjell AM, 2009, CEREB CORTEX, V19, P2001, DOI 10.1093/cercor/bhn232; Fotenos AF, 2005, NEUROLOGY, V64, P1032, DOI 10.1212/01.WNL.0000154530.72969.11; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gauthier CT, 2009, CORTEX, V45, P164, DOI 10.1016/j.cortex.2007.09.006; Giedd JN, 2004, ANN NY ACAD SCI, V1021, P77, DOI 10.1196/annals.1308.009; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Grieve SM, 2005, HUM BRAIN MAPP, V25, P391, DOI 10.1002/hbm.20115; Gunning-Dixon FM, 2003, NEUROPSYCHOLOGIA, V41, P1929, DOI 10.1016/S0028-3932(03)00129-5; GUR RC, 1991, P NATL ACAD SCI USA, V88, P2845, DOI 10.1073/pnas.88.7.2845; Hackert VH, 2002, NEUROIMAGE, V17, P1365, DOI 10.1006/nimg.2002.1248; Helms G, 2008, MAGN RESON MED, V60, P1396, DOI 10.1002/mrm.21732; Jacobs B, 1997, J COMP NEUROL, V386, P661; Jernigan TL, 2001, NEUROBIOL AGING, V22, P581, DOI 10.1016/S0197-4580(01)00217-2; Kramer JH, 2007, NEUROPSYCHOLOGY, V21, P412, DOI 10.1037/0894-4105.21.4.412; Kubota M, 2001, J NEUROL NEUROSUR PS, V71, P104, DOI 10.1136/jnnp.71.1.104; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lemaitre H, 2005, NEUROIMAGE, V26, P900, DOI 10.1016/j.neuroimage.2005.02.042; Luders E, 2004, NEUROIMAGE, V22, P656, DOI 10.1016/j.neuroimage.2004.01.032; MacLullich AMJ, 2002, NEUROLOGY, V59, P169, DOI 10.1212/WNL.59.2.169; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; MARTINI L, 1991, J STEROID BIOCHEM, V39, P819, DOI 10.1016/0960-0760(91)90031-Y; MEYER JS, 1992, J NEUROL SCI, V110, P1; NAFTOLIN F, 1990, BIOL REPROD, V42, P21, DOI 10.1095/biolreprod42.1.21; Pannacciulli N, 2006, NEUROIMAGE, V31, P1419, DOI 10.1016/j.neuroimage.2006.01.047; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Raji CA, 2009, NEUROLOGY, V73, P1899, DOI 10.1212/WNL.0b013e3181c3f293; Raji CA, 2010, HUM BRAIN MAPP, V31, P353, DOI 10.1002/hbm.20870; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Raz N, 2004, NEUROREPORT, V15, P2531, DOI 10.1097/00001756-200411150-00020; Raz N, 2003, BEHAV NEUROSCI, V117, P1169, DOI 10.1037/0735-7044.117.6.1169; Raz N, 2004, NEUROBIOL AGING, V25, P377, DOI 10.1016/S0197-4580(03)00118-0; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Resnick SM, 2003, J NEUROSCI, V23, P3295; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; SALERNO JA, 1992, HYPERTENSION, V20, P340, DOI 10.1161/01.HYP.20.3.340; Sato K, 2003, NEURAL NETWORKS, V16, P1301, DOI 10.1016/j.neunet.2003.06.004; Scahill RI, 2003, ARCH NEUROL-CHICAGO, V60, P989, DOI 10.1001/archneur.60.7.989; Silver NC, 1996, J NEUROL NEUROSUR PS, V61, P208, DOI 10.1136/jnnp.61.2.208; Silver NC, 1997, J NEUROL NEUROSUR PS, V62, P223, DOI 10.1136/jnnp.62.3.223; Smith CD, 2007, NEUROBIOL AGING, V28, P1075, DOI 10.1016/j.neurobiolaging.2006.05.018; Sowell ER, 2007, CEREB CORTEX, V17, P1550, DOI 10.1093/cercor/bhl066; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Sowell ER, 2001, J NEUROSCI, V21, P8819, DOI 10.1523/JNEUROSCI.21-22-08819.2001; Strassburger TL, 1997, STROKE, V28, P1410, DOI 10.1161/01.STR.28.7.1410; Sullivan EV, 2004, NEUROBIOL AGING, V25, P185, DOI 10.1016/S0197-4580(03)00044-7; Taki Y, 2006, ALCOHOL CLIN EXP RES, V30, P1045, DOI 10.1111/j.1530-0277.2006.00118.x; Taki Y, 2004, NEUROBIOL AGING, V25, P455, DOI 10.1016/j.neurobiolaging.2003.09.002; Taki Y, 2008, OBESITY, V16, P119, DOI 10.1038/oby.2007.4; Taki Y, 2011, NEUROBIOL AGING, V32, P907, DOI 10.1016/j.neurobiolaging.2009.05.003; Talairach J., 1988, COPLANAR STEREOTAXIC; TERRY RD, 1987, ANN NEUROL, V21, P530, DOI 10.1002/ana.410210603; Thambisetty M, 2010, NEUROIMAGE, V52, P1215, DOI 10.1016/j.neuroimage.2010.04.258; Thompson PM, 2003, J NEUROSCI, V23, P994; Walhovd KB, 2005, NEUROBIOL AGING, V26, P1261, DOI 10.1016/j.neurobiolaging.2005.05.020; Ward MA, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-23; Xu J, 2000, AM J NEURORADIOL, V21, P112; Zimmerman ME, 2006, AM J GERIAT PSYCHIAT, V14, P823, DOI 10.1097/01.JGP.0000238502.40963.ac	75	79	79	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22734	10.1371/journal.pone.0022734	http://dx.doi.org/10.1371/journal.pone.0022734			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818377	Green Published, Green Submitted, gold			2022-12-25	WOS:000293282700067
J	Xu, M; Yu, L; Wan, B; Yu, L; Huang, Q				Xu, Min; Yu, Lu; Wan, Bo; Yu, Long; Huang, Qiang			Predicting Inactive Conformations of Protein Kinases Using Active Structures: Conformational Selection of Type-II Inhibitors	PLOS ONE			English	Article							ABL TYROSINE KINASE; CRYSTAL-STRUCTURE; DRUG TARGETS; C-ABL; BINDING; IMATINIB; ALGORITHM; STI-571; DYNAMICS; LEUKEMIA	Protein kinases have been found to possess two characteristic conformations in their activation-loops: the active DFG-in conformation and the inactive DFG-out conformation. Recently, it has been very interesting to develop type-II inhibitors which target the DFG-out conformation and are more specific than the type-I inhibitors binding to the active DFG-in conformation. However, solving crystal structures of kinases with the DFG-out conformation remains a challenge, and this seriously hampers the application of the structure-based approaches in development of novel type-II inhibitors. To overcome this limitation, here we present a computational approach for predicting the DFG-out inactive conformation using the DFG-in active structures, and develop related conformational selection protocols for the uses of the predicted DFG-out models in the binding pose prediction and virtual screening of type-II ligands. With the DFG-out models, we predicted the binding poses for known type-II inhibitors, and the results were found in good agreement with the X-ray crystal structures. We also tested the abilities of the DFG-out models to recognize their specific type-II inhibitors by screening a database of small molecules. The AUC (area under curve) results indicated that the predicted DFG-out models were selective toward their specific type-II inhibitors. Therefore, the computational approach and protocols presented in this study are very promising for the structure-based design and screening of novel type-II kinase inhibitors.	[Xu, Min; Yu, Lu; Wan, Bo; Yu, Long; Huang, Qiang] Fudan Univ, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200433, Peoples R China	Fudan University	Xu, M (corresponding author), Fudan Univ, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200433, Peoples R China.	huangqiang@fudan.edu.cn			HI-tech Research and Development Program of China [2008AA02Z311]; National Natural Sciences Foundation of China [30570406]; Shanghai Leading Academic Discipline Project [B111]; Shanghai Supercomputer Center of China	HI-tech Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Shanghai Supercomputer Center of China	This study was supported by the HI-tech Research and Development Program of China (No. 2008AA02Z311), the National Natural Sciences Foundation of China (No. 30570406), the Shanghai Leading Academic Discipline Project (B111), and Shanghai Supercomputer Center of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandrov A, 2010, J BIOL CHEM, V285, P13807, DOI 10.1074/jbc.M110.109660; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Brady GP, 2000, J COMPUT AID MOL DES, V14, P383, DOI 10.1023/A:1008124202956; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; Capra M, 2006, CANCER RES, V66, P8147, DOI 10.1158/0008-5472.CAN-05-3489; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Eswar N., 2006, CURR PROT BIOINF, V15, P1, DOI [10.1002/0471250953.bi0506s15, DOI 10.1002/0471250953.BI0506S15]; Huang BD, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-19; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Hunter T, 1998, Harvey Lect, V94, P81; Imming P, 2006, NAT REV DRUG DISCOV, V5, P821, DOI 10.1038/nrd2132; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jenwitheesuk E, 2005, ANTIVIR THER, V10, P893; Jenwitheesuk Ekachai, 2003, BMC Struct Biol, V3, P2, DOI 10.1186/1472-6807-3-2; Jura N, 2011, MOL CELL, V42, P9, DOI 10.1016/j.molcel.2011.03.004; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Kufareva I, 2008, J MED CHEM, V51, P7921, DOI 10.1021/jm8010299; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marsden BD, 2008, CURR OPIN CHEM BIOL, V12, P40, DOI 10.1016/j.cbpa.2008.01.042; Mol CD, 2004, CURR OPIN DRUG DISC, V7, P639; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nagar B, 2002, CANCER RES, V62, P4236; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Okram B, 2006, CHEM BIOL, V13, P779, DOI 10.1016/j.chembiol.2006.05.015; Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249; Ranjitkar P, 2010, CHEM BIOL, V17, P195, DOI 10.1016/j.chembiol.2010.01.008; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Seeliger MA, 2007, STRUCTURE, V15, P299, DOI 10.1016/j.str.2007.01.015; Shan YB, 2009, P NATL ACAD SCI USA, V106, P139, DOI 10.1073/pnas.0811223106; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Vajpai N, 2008, J BIOL CHEM, V283, P18292, DOI 10.1074/jbc.M801337200; Vieth M, 2005, DRUG DISCOV TODAY, V10, P839, DOI 10.1016/S1359-6446(05)03477-X; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yang S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000047; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	44	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22644	10.1371/journal.pone.0022644	http://dx.doi.org/10.1371/journal.pone.0022644			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818358	gold, Green Published, Green Submitted			2022-12-25	WOS:000293282700056
J	Clare, EL; Lim, BK; Fenton, MB; Hebert, PDN				Clare, Elizabeth L.; Lim, Burton K.; Fenton, M. Brock; Hebert, Paul D. N.			Neotropical Bats: Estimating Species Diversity with DNA Barcodes	PLOS ONE			English	Article							CYTOCHROME-B; POPULATION-SIZE; CHIROPTERA; PHYLOGEOGRAPHY; ARTIBEUS; DIFFERENTIATION; SYSTEMATICS; VAMPYRESSA; EVOLUTION; SOFTWARE	DNA barcoding using the cytochrome c oxidase subunit 1 gene (COI) is frequently employed as an efficient method of species identification in animal life and may also be used to estimate species richness, particularly in understudied faunas. Despite numerous past demonstrations of the efficiency of this technique, few studies have attempted to employ DNA barcoding methodologies on a large geographic scale, particularly within tropical regions. In this study we survey current and potential species diversity using DNA barcodes with a collection of more than 9000 individuals from 163 species of Neotropical bats (order Chiroptera). This represents one of the largest surveys to employ this strategy on any animal group and is certainly the largest to date for land vertebrates. Our analysis documents the utility of this tool over great geographic distances and across extraordinarily diverse habitats. Among the 163 included species 98.8% possessed distinct sets of COI haplotypes making them easily recognizable at this locus. We detected only a single case of shared haplotypes. Intraspecific diversity in the region was high among currently recognized species (mean of 1.38%, range 0-11.79%) with respect to birds, though comparable to other bat assemblages. In 44 of 163 cases, well-supported, distinct intraspecific lineages were identified which may suggest the presence of cryptic species though mean and maximum intraspecific divergence were not good predictors of their presence. In all cases, intraspecific lineages require additional investigation using complementary molecular techniques and additional characters such as morphology and acoustic data. Our analysis provides strong support for the continued assembly of DNA barcoding libraries and ongoing taxonomic investigation of bats.	[Clare, Elizabeth L.; Hebert, Paul D. N.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Lim, Burton K.] Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada; [Fenton, M. Brock] Univ Western Ontario, Dept Biol, London, ON, Canada	University of Guelph; Royal Ontario Museum; Western University (University of Western Ontario)	Clare, EL (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	elclare.evol.biology@gmail.com	Hebert, Paul DN/C-4161-2013; Lim, Burton/A-1148-2011	Hebert, Paul DN/0000-0002-3081-6700; Clare, Elizabeth/0000-0002-6563-3365; Lim, Burton/0000-0002-0884-0421	Natural Sciences and Engineering Research Council of Canada (NSERC); Genome Canada through the Ontario Genomics Institute; Biodiversity Institute of Ontario	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Genome Canada through the Ontario Genomics Institute(Genome Canada); Biodiversity Institute of Ontario	This research was supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) to PDNH and MBF and by a Canadian Graduate Scholarship and Postdoctoral Fellowship from NSERC to ELC. Additional funding for this research was provided by Genome Canada through the Ontario Genomics Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research would not have been possible without support provided by the Biodiversity Institute of Ontario and access to the collections held by the Royal Ontario Museum (Toronto Ontario, Canada). We particularly thank Dr. Judith Eger and Dr. Mark Engstrom at the Royal Ontario Museum for facilitating collection access and Dr. Alex Borisenko, Dr. Natalia Ivanova, Agata Pawlowski and Miranda Elliott at the Biodiversity Institute of Ontario for assistance with informatics and molecular analysis. Dr. Robin Floyd and two anonymous reviewers provided excellent feedback on this manuscript.	BAKER RJ, 2002, OCCASIONAL PAPERS MU, V217, P1, DOI [DOI 10.5962/BHL.TITLE.156831, 10.5962/bhl.title.156831]; Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; Barquez Ruben M., 2001, Acta Zoologica Mexicana Nueva Serie, V82, P29; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Borisenko AV, 2008, MOL ECOL RESOUR, V8, P471, DOI 10.1111/j.1471-8286.2007.01998.x; BORISENKO AV, 2009, RUSSIAN J THERIOLOGY, V7, P57; Bradley RD, 2001, J MAMMAL, V82, P960, DOI 10.1644/1545-1542(2001)082<0960:ATOTGS>2.0.CO;2; Brinklov S, 2011, J ACOUST SOC AM, V129, P427, DOI 10.1121/1.3519396; CLARE, 2011, PLOS ONE IN PRESS; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; Ditchfield AD, 2000, MOL ECOL, V9, P1307, DOI 10.1046/j.1365-294x.2000.01013.x; FLOYD RM, 2003, THESIS U EDINBURGH; Francis CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012575; Garnier JN, 2001, MOL ECOL, V10, P2031, DOI 10.1046/j.0962-1083.2001.01338.x; Gillespie JH, 2001, EVOLUTION, V55, P2161; Hajibabaei M, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-24; Hajibabaei M, 2006, GENOME, V49, P851, DOI 10.1139/G06-025; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hoffmann FG, 2003, MOL ECOL, V12, P3403, DOI 10.1046/j.1365-294X.2003.02009.x; Hoffmann FG, 2003, MOL ECOL, V12, P2981, DOI 10.1046/j.1365-294X.2003.01959.x; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Kelly RP, 2007, MOL ECOL NOTES, V7, P177, DOI 10.1111/j.1471-8286.2006.01641.x; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Kerr KCR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004379; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kingston T, 2004, NATURE, V429, P654, DOI 10.1038/nature02487; Kohn MH, 1999, P ROY SOC B-BIOL SCI, V266, P657, DOI 10.1098/rspb.1999.0686; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Larsen PA, 2007, J MAMMAL, V88, P712, DOI 10.1644/06-MAMM-A-125R.1; Lewis-Oritt N, 2001, J MAMMAL, V82, P748, DOI 10.1644/1545-1542(2001)082<0748:MEFEOP>2.0.CO;2; Lewis-Oritt N, 2001, MOL PHYLOGENET EVOL, V20, P426, DOI 10.1006/mpev.2001.0978; Lim BK, 2004, ACTA CHIROPTEROL, V6, P1; Lim BK, 2003, ACTA CHIROPTEROL, V5, P15, DOI 10.3161/001.005.0102; Lim BK, 2001, BIODIVERS CONSERV, V10, P613, DOI 10.1023/A:1016660123189; Lim BK, 2008, ACTA CHIROPTEROL, V10, P243, DOI 10.3161/150811008X414827; Lorenz JG, 2005, PHILOS T R SOC B, V360, P1869, DOI 10.1098/rstb.2005.1718; Martins FM, 2007, J ZOOL SYST EVOL RES, V45, P372, DOI 10.1111/j.1439-0469.2007.00419.x; Martins FM, 2009, BMC EVOL BIOL, V9, DOI [10.1186/1471-2148-9-36, 10.1186/1471-2148-9-294]; Mayer F, 2001, P ROY SOC B-BIOL SCI, V268, P1825, DOI 10.1098/rspb.2001.1744; Meiklejohn CD, 2007, TRENDS GENET, V23, P259, DOI 10.1016/j.tig.2007.03.008; Mora EC, 2007, NATURWISSENSCHAFTEN, V94, P380, DOI 10.1007/s00114-006-0198-7; Porter CA, 2004, J MAMMAL, V85, P126, DOI 10.1644/BWG-110; Rach J, 2008, P ROY SOC B-BIOL SCI, V275, P237, DOI 10.1098/rspb.2007.1290; Reeder DeeAnn M., 2007, Occasional Papers Museum of Texas Tech University, V269, P1; Sarkar IN, 2008, MOL ECOL RESOUR, V8, P1256, DOI 10.1111/j.1755-0998.2008.02235.x; Shen YY, 2010, P NATL ACAD SCI USA, V107, P8666, DOI 10.1073/pnas.0912613107; Simmons Nancy B., 1998, Bulletin of the American Museum of Natural History, V237, P1; Simmons NB, 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Solari Sergio, 2006, Occasional Papers Museum of Texas Tech University, V254, P1; Voigt CC, 1999, BEHAV ECOL SOCIOBIOL, V47, P29, DOI 10.1007/s002650050646; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; WILLIG MR, 1989, J BIOGEOGR, V16, P189, DOI 10.2307/2845093	54	111	126	5	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e22648	10.1371/journal.pone.0022648	http://dx.doi.org/10.1371/journal.pone.0022648			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21818359	gold, Green Published, Green Submitted			2022-12-25	WOS:000293175100037
J	Vijay, S; Kumar, P; Chauhan, LS; Rao, SVN; Vaidyanathan, P				Vijay, Sophia; Kumar, Prahlad; Chauhan, Lakbir Singh; Rao, Saroja Vadigepalli Narayan; Vaidyanathan, Preetish			Treatment Outcome and Mortality at One and Half Year Follow-Up of HIV Infected TB Patients Under TB Control Programme in a District of South India	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; TUBERCULOSIS PATIENTS; PULMONARY TUBERCULOSIS; DEVELOPING-COUNTRIES; CLINICAL-FEATURES; SURVIVAL; DISEASE; IMPACT; MANIFESTATIONS	Background: There is paucity of data from India on the impact of HIV related immunosuppression in response to TB treatment and mortality among HIV infected TB patients. We assessed the TB treatment outcome and mortality in a cohort of HIV infected TB patients treated with intermittent short course chemotherapy under TB control programme in a high HIV prevalent district of south India. Methodology/Findings: Among 3798 TB patients registered for treatment in Mysore district from July 2007 to June 2008, 281 HIV infected patients formed the study group. The socio-demographic and treatment related data of these patients was obtained from TB and HIV programme records and patient interviews 19 months after TB treatment initiation by field investigators. Treatment success rate of 281 patients was 75% while in smear positive pulmonary tuberculosis cases it was 62%, attributable to defaults (16%) and deaths (19%). Only 2 patients had treatment failure. Overall, 83 (30%) patients were reported dead; 26 while on treatment and 57 after TB treatment. Association of treatment related factors with treatment outcome and survival status was studied through logistic regression analysis. Factors significantly associated with ` unfavourable outcome' were disease classification as Pulmonary [aOR-1.96, CI (1.02-3.77)], type of patient as retreatment [aOR-4.78, CI (2.12-10.76)], and non initiation of ART [aOR-4.90, CI (1.85-12.96)]. Factors associated with ` Death' were non initiation of ART [aOR-2.80, CI (1.15-6.81)] and CPT [aOR-3.46, CI (1.47-8.14)]. Conclusion: Despite the treatment success of 75% the high mortality (30%) in the study group is a matter of concern and needs immediate intervention. Non initiation of ART has emerged as a high risk factor for unfavourable treatment outcome and mortality. These findings underscore the importance of expanding and improving delivery of ART services as a priority and reconsideration of the programme guidelines for ART initiation in HIV infected TB patients.	[Vijay, Sophia; Kumar, Prahlad; Rao, Saroja Vadigepalli Narayan; Vaidyanathan, Preetish] Natl TB Inst, Bangalore, Karnataka, India; [Chauhan, Lakbir Singh] Minist Hlth & Family Welf, Directorate Gen Hlth Serv, Cent TB Div, New Delhi, India		Vijay, S (corresponding author), Natl TB Inst, Bangalore, Karnataka, India.	nti@ntiindia.org.in			Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India [T.18020/2/2005-TB/HIV (Pt. 7)]	Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India	Financial support for the research was granted by the Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India, Grant No. T.18020/2/2005-TB/HIV (Pt. 7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKAH AN, 1995, LANCET, V345, P607, DOI 10.1016/S0140-6736(95)90519-7; Alpert PL, 1997, CLIN INFECT DIS, V24, P661, DOI 10.1093/clind/24.4.661; Badri M, 2001, INT J TUBERC LUNG D, V5, P225; *CENTR TB DIV, 2010, RNTCP PERF REP IND 2; CHAISSON RE, 1990, AM REV RESPIR DIS, V142, P259, DOI 10.1164/ajrccm/142.1.259; CHAISSON RE, 1987, AM REV RESPIR DIS, V136, P570, DOI 10.1164/ajrccm/136.3.570; COLEBUNDERS RL, 1989, AM REV RESPIR DIS, V139, P1082, DOI 10.1164/ajrccm/139.5.1082; COLLINS JA, 2010, REV PANAM INFECT, V12, P37; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Corbett EL, 2002, CLIN INFECT DIS, V34, P1251, DOI 10.1086/339540; Dean GL, 2002, AIDS, V16, P75, DOI 10.1097/00002030-200201040-00010; Dheda K, 2004, J INFECT DIS, V190, P1670, DOI 10.1086/424676; Girardi E, 2000, AIDS, V14, pS47; *GOV IND, TECHN OP GUID TUB CO; HARRIES AD, 1990, LANCET, V335, P387, DOI 10.1016/0140-6736(90)90216-R; JONES BE, 1993, AM REV RESPIR DIS, V148, P1292, DOI 10.1164/ajrccm/148.5.1292; KASSIM S, 1995, AIDS, V9, P1185, DOI 10.1097/00002030-199510000-00011; Leroy V, 1997, AM J EPIDEMIOL, V145, P293; LLIBRE JM, 1992, Q J MED, V82, P149; LUCAS SB, 1993, AIDS, V7, P1569, DOI 10.1097/00002030-199312000-00005; Manosuthi W, 2006, JAIDS-J ACQ IMM DEF, V43, P42, DOI 10.1097/01.qai.0000230521.86964.86; Murray J F, 1991, Bull Int Union Tuberc Lung Dis, V66, P21; Nahid P, 2007, AM J RESP CRIT CARE, V175, P1199, DOI 10.1164/rccm.200509-1529OC; NARAIN JP, 1992, TUBERCLE LUNG DIS, V73, P311, DOI 10.1016/0962-8479(92)90033-G; *NAT AIDS CONTR OR, 2008, TRAIN MAN INT TB HIV; National AIDS Control Organisation, ANN REP 2009 10; National AIDS Control Organization, 2008, OP GUID INT COUNS TE; National AIDS Control Organization ICMR-National Institute of Medical Statistics, 2018, HIV EST 2017 TECHN R; NUNN P, 1992, AM REV RESPIR DIS, V146, P849, DOI 10.1164/ajrccm/146.4.849; Paranjape RS, 1997, INDIAN J MED RES, V106, P207; PITCHENIK AE, 1984, ANN INTERN MED, P641; PUROHIT SD, 1996, LUNG INDIA, V14, P113; Quy HT, 2006, INT J TUBERC LUNG D, V10, P45; Rana FS, 2000, J ACQ IMMUN DEF SYND, V24, P23; RAVIGLIONE MC, 1992, B WORLD HEALTH ORGAN, V70, P515; Singh A, 2003, Indian J Med Sci, V57, P16; SMALL PM, 1991, NEW ENGL J MED, V324, P289, DOI 10.1056/NEJM199101313240503; Swaminathan S, 2008, NATL MED J INDIA, V21, P3; THEUER CP, 1990, J INFECT DIS, V162, P8, DOI 10.1093/infdis/162.1.8; Vijay S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007899; Whalen CC, 2000, AIDS, V14, P1219, DOI 10.1097/00002030-200006160-00020; World Health Organization, 2010, GLOB TUB CONTR WHO R	42	36	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e21008	10.1371/journal.pone.0021008	http://dx.doi.org/10.1371/journal.pone.0021008			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21814542	Green Submitted, gold, Green Published			2022-12-25	WOS:000293175100002
J	Goldberg, JB; Ganesan, S; Comstock, AT; Zhao, Y; Sajjan, US				Goldberg, Joanna B.; Ganesan, Shyamala; Comstock, Adam T.; Zhao, Ying; Sajjan, Uma S.			Cable Pili and the Associated 22 Kda Adhesin Contribute to Burkholderia Cenocepacia Persistence In Vivo	PLOS ONE			English	Article							AERUGINOSA LUNG INFECTION; CYSTIC-FIBROSIS PATIENTS; AIRWAY EPITHELIAL-CELLS; PSEUDOMONAS-AERUGINOSA; CEPACIA COMPLEX; INTRACELLULAR SURVIVAL; SQUAMOUS EPITHELIUM; IMMUNE-RESPONSE; KNOCKOUT MICE; MOUSE MODEL	Background: Infection by Burkholderia cenocepacia in cystic fibrosis (CF) patients is associated with poor clinical prognosis. Previously, we demonstrated that one of the highly transmissible strains, BC7, expresses cable pili and the associated 22 kDa adhesin, both of which contribute to BC7 binding to airway epithelial cells. However, the contribution of these factors to induce inflammation and bacterial persistence in vivo is not known. Methodology/Principal Findings: Wild-type BC7 stimulated higher IL-8 responses than the BC7 cbl and BC7 adhA mutants in both CF and normal bronchial epithelial cells. To determine the role of cable pili and the associated adhesin, we characterized a mouse model of B. cenocepacia, where BC7 are suspended in Pseudomonas aeruginosa alginate. C57BL/6 mice were infected intratracheally with wild-type BC7 suspended in either alginate or PBS and were monitored for lung bacterial load and inflammation. Mice infected with BC7 suspended in PBS completely cleared the bacteria by 3 days and resolved the inflammation. In contrast, mice infected with BC7 suspended in alginate showed persistence of bacteria and moderate lung inflammation up to 5 days post-infection. Using this model, mice infected with the BC7 cbl and BC7 adhA mutants showed lower bacterial loads and mild inflammation compared to mice infected with wild-type BC7. Complementation of the BC7 cblS mutation in trans restored the capacity of this strain to persist in vivo. Immunolocalization of bacteria revealed wild-type BC7 in both airway lumen and alveoli, while the BC7 cbl and BC7 adhA mutants were found mainly in airway lumen and peribronchiolar region. Conclusions and Significance: B. cenocepacia suspended in alginate can be used to determine the capacity of bacteria to persist and cause lung inflammation in normal mice. Both cable pili and adhesin contribute to BC7-stimulated IL-8 response in vitro, and BC7 persistence and resultant inflammation in vivo.	[Goldberg, Joanna B.] Univ Virginia Hlth Syst, Dept Microbiol, Charlottesville, VA USA; [Ganesan, Shyamala; Comstock, Adam T.; Zhao, Ying; Sajjan, Uma S.] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA	University of Virginia; University of Michigan System; University of Michigan	Goldberg, JB (corresponding author), Univ Virginia Hlth Syst, Dept Microbiol, Charlottesville, VA USA.	usajjan@umich.edu	Ganesan, Shyamala/L-2114-2013	Ganesan, Shyamala/0000-0002-1021-3670	Cystic Fibrosis Foundation; National Institute of Health: Cystic Fibrosis Foundation [USAJJAN08G0, GOLDBE07G0]; National Institutes of Health [AI072679]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI072679] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institute of Health: Cystic Fibrosis Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by both the Cystic Fibrosis Foundation and the National Institute of Health: Cystic Fibrosis Foundation (USAJJAN08G0 to USS and GOLDBE07G0 to JBG; National Institutes of Health (AI072679 to JBG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernier SP, 2003, INFECT IMMUN, V71, P5306, DOI 10.1128/IAI.71.9.5306-5313.2003; Burns JL, 1998, CLIN INFECT DIS, V27, P158, DOI 10.1086/514631; CASH HA, 1979, AM REV RESPIR DIS, V119, P453; Chattoraj SS, 2010, INFECT IMMUN, V78, P984, DOI 10.1128/IAI.01192-09; Cieri MV, 2002, INFECT IMMUN, V70, P1081, DOI 10.1128/IAI.70.3.1081-1086.2002; Henry DA, 1997, J CLIN MICROBIOL, V35, P614, DOI 10.1128/JCM.35.3.614-619.1997; Hoffmann N, 2005, INFECT IMMUN, V73, P2504, DOI 10.1128/IAI.73.4.2504-2514.2005; Hoffmann N, 2007, ANTIMICROB AGENTS CH, V51, P3677, DOI 10.1128/AAC.01011-06; ISLES A, 1984, J PEDIATR-US, V104, P206, DOI 10.1016/S0022-3476(84)80993-2; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Mahenthiralingam E, 2008, J APPL MICROBIOL, V104, P1539, DOI 10.1111/j.1365-2672.2007.03706.x; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; Martin DW, 2000, INFECT IMMUN, V68, P24, DOI 10.1128/IAI.68.1.24-29.2000; McAllister F, 2005, J IMMUNOL, V175, P404, DOI 10.4049/jimmunol.175.1.404; Morissette C, 1996, INFECT IMMUN, V64, P4984, DOI 10.1128/IAI.64.12.4984-4992.1996; Moser C, 2000, APMIS, V108, P329, DOI 10.1034/j.1600-0463.2000.d01-64.x; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Roger P, 1999, EUR RESPIR J, V13, P1301, DOI 10.1183/09031936.99.13613109; Sajjan SU, 2008, INFECT IMMUN, V76, P5447, DOI 10.1128/IAI.00451-08; Sajjan U, 2002, CELL MICROBIOL, V4, P73, DOI 10.1046/j.1462-5822.2002.00171.x; Sajjan U, 2001, J MED MICROBIOL, V50, P535, DOI 10.1099/0022-1317-50-6-535; Sajjan U, 2000, J MED MICROBIOL, V49, P875, DOI 10.1099/0022-1317-49-10-875; Sajjan US, 2008, CELL MICROBIOL, V10, P188, DOI 10.1111/j.1462-5822.2007.01029.x; Sajjan US, 2006, CELL MICROBIOL, V8, P1456, DOI 10.1111/j.1462-5822.2006.00724.x; SAJJAN US, 1992, J CLIN INVEST, V89, P648, DOI 10.1172/JCI115631; SAJJAN US, 1993, INFECT IMMUN, V61, P3157, DOI 10.1128/IAI.61.8.3157-3163.1993; Sajjan US, 2000, INFECT IMMUN, V68, P1787, DOI 10.1128/IAI.68.4.1787-1795.2000; Song ZJ, 2003, J MED MICROBIOL, V52, P731, DOI 10.1099/jmm.0.05122-0; Tomich M, 2003, FEMS MICROBIOL LETT, V228, P287, DOI 10.1016/S0378-1097(03)00785-7; Tomich M, 2004, J BACTERIOL, V186, P3826, DOI 10.1128/JB.186.12.3826-3836.2004; Tsai WC, 2009, INFLAMM RES, V58, P491, DOI 10.1007/s00011-009-0015-9; Tsai WC, 1998, J IMMUNOL, V161, P2435; Urban TA, 2005, INFECT IMMUN, V73, P5426, DOI 10.1128/IAI.73.9.5426-5437.2005; Vanlaere E, 2008, INT J SYST EVOL MICR, V58, P1580, DOI 10.1099/ijs.0.65634-0; Wu H, 2000, MICROBIOL-SGM, V146, P2481, DOI 10.1099/00221287-146-10-2481	35	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22435	10.1371/journal.pone.0022435	http://dx.doi.org/10.1371/journal.pone.0022435			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811611	Green Submitted, Green Published, gold			2022-12-25	WOS:000292956800056
J	Herzner, AM; Dischinger, J; Szekat, C; Josten, M; Schmitz, S; Yakeleba, A; Reinartz, R; Jansen, A; Sahl, HG; Piel, J; Bierbaum, G				Herzner, Anna Maria; Dischinger, Jasmin; Szekat, Christiane; Josten, Michaele; Schmitz, Stephanie; Yakeleba, Anja; Reinartz, Ricarda; Jansen, Andrea; Sahl, Hans-Georg; Piel, Joern; Bierbaum, Gabriele			Expression of the Lantibiotic Mersacidin in Bacillus amyloliquefaciens FZB42	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; HETEROLOGOUS EXPRESSION; SUBTILIS 168; GENES; BACILLUS-SUBTILIS-168; BIOSYNTHESIS; MUTAGENESIS; CONVERSION; SYSTEM	Lantibiotics are small peptide antibiotics that contain the characteristic thioether amino acids lanthionine and methyllanthionine. As ribosomally synthesized peptides, lantibiotics possess biosynthetic gene clusters which contain the structural gene (lanA) as well as the other genes which are involved in lantibiotic modification (lanM, lanB, lanC, lanP), regulation (lanR, lanK), export (lanT(P)) and immunity (lanEFG). The lantibiotic mersacidin is produced by Bacillus sp. HIL Y-85,54728, which is not naturally competent. Methodology/Principal Findings: The aim of these studies was to test if the production of mersacidin could be transferred to a naturally competent Bacillus strain employing genomic DNA of the producer strain. Bacillus amyloliquefaciens FZB42 was chosen for these experiments because it already harbors the mersacidin immunity genes. After transfer of the biosynthetic part of the gene cluster by competence transformation, production of active mersacidin was obtained from a plasmid in trans. Furthermore, comparison of several DNA sequences and biochemical testing of B. amyloliquefaciens FZB42 and B. sp. HIL Y-85,54728 showed that the producer strain of mersacidin is a member of the species B. amyloliquefaciens. Conclusions/Significance: The lantibiotic mersacidin can be produced in B. amyloliquefaciens FZB42, which is closely related to the wild type producer strain of mersacidin. The new mersacidin producer strain enables us to use the full potential of the biosynthetic gene cluster for genetic manipulation and downstream modification approaches.	[Herzner, Anna Maria; Dischinger, Jasmin; Szekat, Christiane; Josten, Michaele; Schmitz, Stephanie; Yakeleba, Anja; Reinartz, Ricarda; Jansen, Andrea; Sahl, Hans-Georg; Bierbaum, Gabriele] Univ Bonn, Inst Med Microbiol Immunol & Parasitol, D-5300 Bonn, Germany; [Piel, Joern] Univ Bonn, Kekule Inst Organ Chem & Biochem, D-5300 Bonn, Germany	University of Bonn; University of Bonn	Herzner, AM (corresponding author), Univ Bonn, Inst Med Microbiol Immunol & Parasitol, D-5300 Bonn, Germany.	bierbaum@mibi03.meb.uni-bonn.de			DFG (Deutsche Forschungsgemeinschaft) [Bi504-9/1, FOR 854]; Medical Faculty of the University of Bonn	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Medical Faculty of the University of Bonn	This study was supported by a grant of the DFG to G. Bierbaum (Deutsche Forschungsgemeinschaft Bi504-9/1, FOR 854) and the Bonfor program of the Medical Faculty of the University of Bonn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altena K, 2000, APPL ENVIRON MICROB, V66, P2565, DOI 10.1128/AEM.66.6.2565-2571.2000; ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; Appleyard AN, 2009, CHEM BIOL, V16, P490, DOI 10.1016/j.chembiol.2009.03.011; AUGUSTIN J, 1992, EUR J BIOCHEM, V204, P1149, DOI 10.1111/j.1432-1033.1992.tb16740.x; BABASAKI K, 1985, J BIOCHEM, V98, P585, DOI 10.1093/oxfordjournals.jbchem.a135315; BORRISS R, 2010, INT J SYST IN PRESS; Brotz H, 1998, ANTIMICROB AGENTS CH, V42, P154, DOI 10.1128/AAC.42.1.154; Caetano T, 2011, CHEM BIOL, V18, P90, DOI 10.1016/j.chembiol.2010.11.010; CHATTERJEE S, 1992, J ANTIBIOT, V45, P832, DOI 10.7164/antibiotics.45.832; Chen XH, 2009, J BIOTECHNOL, V140, P27, DOI 10.1016/j.jbiotec.2008.10.011; Chen XH, 2007, NAT BIOTECHNOL, V25, P1007, DOI 10.1038/nbt1325; Guder A, 2002, APPL ENVIRON MICROB, V68, P106, DOI 10.1128/AEM.68.1.106-113.2002; Heidrich C, 1998, APPL ENVIRON MICROB, V64, P3140; HILTON MD, 1988, J BACTERIOL, V170, P482, DOI 10.1128/jb.170.1.482-484.1988; Idriss EE, 2002, MICROBIOL-SGM, V148, P2097, DOI 10.1099/00221287-148-7-2097; Julkowska D, 2005, J BACTERIOL, V187, P65, DOI 10.1128/JB.187.1.65-76.2005; Koumoutsi A, 2004, J BACTERIOL, V186, P1084, DOI 10.1128/JB.186.4.1084-1096.2004; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; LIU W, 1991, J BACTERIOL, V173, P7387, DOI 10.1128/jb.173.22.7387-7390.1991; Paik SH, 1998, J BIOL CHEM, V273, P23134, DOI 10.1074/jbc.273.36.23134; Reva ON, 2004, FEMS MICROBIOL ECOL, V48, P249, DOI 10.1016/j.femsec.2004.02.003; Ruckert C., 2011, J BIOTECHNO IN PRESS; Ryan MP, 2001, LETT APPL MICROBIOL, V32, P71, DOI 10.1046/j.1472-765X.2001.00864.x; Sass P, 2009, INT J MED MICROBIOL, V299, P313, DOI 10.1016/j.ijmm.2008.10.005; Schmitz S, 2006, APPL ENVIRON MICROB, V72, P7270, DOI 10.1128/AEM.00723-06; Scholz R, 2011, J BACTERIOL, V193, P215, DOI 10.1128/JB.00784-10; Szekat C, 2003, APPL ENVIRON MICROB, V69, P3777, DOI 10.1128/AEM.69.7.3777-3783.2003; Tamehiro N, 2002, ANTIMICROB AGENTS CH, V46, P315, DOI 10.1128/AAC.46.2.315-320.2002; Tsuge K, 1999, ANTIMICROB AGENTS CH, V43, P2183, DOI 10.1128/AAC.43.9.2183; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Yuksel S, 2007, APPL MICROBIOL BIOT, V74, P640, DOI 10.1007/s00253-006-0713-y; Zeigler DR, 2008, J BACTERIOL, V190, P6983, DOI 10.1128/JB.00722-08	32	38	41	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22389	10.1371/journal.pone.0022389	http://dx.doi.org/10.1371/journal.pone.0022389			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811596	gold, Green Submitted, Green Published			2022-12-25	WOS:000292956800051
J	Shahab, SW; Matyunina, LV; Mezencev, R; Walker, LD; Bowen, NJ; Benigno, BB; McDonald, JF				Shahab, Shubin W.; Matyunina, Lilya V.; Mezencev, Roman; Walker, L. DeEtte; Bowen, Nathan J.; Benigno, Benedict B.; McDonald, John F.			Evidence for the Complexity of MicroRNA-Mediated Regulation in Ovarian Cancer: A Systems Approach	PLOS ONE			English	Article							REAL-TIME PCR; EXPRESSION PROFILES; MESSENGER-RNAS; TARGETS; IDENTIFICATION; SIGNATURES; MIRNAS; GENES; REPRESSION; MIRBASE	MicroRNAs (miRNAs) are short (similar to 22 nucleotides) regulatory RNAs that can modulate gene expression and are aberrantly expressed in many diseases including cancer. Previous studies have shown that miRNAs inhibit the translation and facilitate the degradation of their targeted messenger RNAs (mRNAs) making them attractive candidates for use in cancer therapy. However, the potential clinical utility of miRNAs in cancer therapy rests heavily upon our ability to understand and accurately predict the consequences of fluctuations in levels of miRNAs within the context of complex tumor cells. To evaluate the predictive power of current models, levels of miRNAs and their targeted mRNAs were measured in laser captured micro-dissected (LCM) ovarian cancer epithelial cells (CEPI) and compared with levels present in ovarian surface epithelial cells (OSE). We found that the predicted inverse correlation between changes in levels of miRNAs and levels of their mRNA targets held for only similar to 11% of predicted target mRNAs. We demonstrate that this low inverse correlation between changes in levels of miRNAs and their target mRNAs in vivo is not merely an artifact of inaccurate miRNA target predictions but the likely consequence of indirect cellular processes that modulate the regulatory effects of miRNAs in vivo. Our findings underscore the complexities of miRNA-mediated regulation in vivo and the necessity of understanding the basis of these complexities in cancer cells before the therapeutic potential of miRNAs can be fully realized.	[Shahab, Shubin W.; Matyunina, Lilya V.; Mezencev, Roman; Walker, L. DeEtte; McDonald, John F.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Shahab, Shubin W.; Matyunina, Lilya V.; Mezencev, Roman; Walker, L. DeEtte; McDonald, John F.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Matyunina, Lilya V.; Mezencev, Roman; Walker, L. DeEtte; Bowen, Nathan J.; Benigno, Benedict B.; McDonald, John F.] Ovarian Canc Inst, Atlanta, GA USA; [Bowen, Nathan J.] Clark Atlanta Univ, Dept Biol Sci, Atlanta, GA 30314 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Clark Atlanta University	Shahab, SW (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	john.mcdonald@biology.gatech.edu	Mezencev, Roman/O-8489-2019; Benigno, Benedict/GPW-8134-2022; Mezencev, Roman/A-8573-2009; Bowen, Nathan J./M-3202-2019	Mezencev, Roman/0000-0003-4361-7628; Bowen, Nathan J./0000-0002-1609-6698; McDonald, John F/0000-0002-4263-8155	Ovarian Cancer Institute; Ovarian Cycle Foundation; Robinson Family Foundation; Deborah Nash Willingham Endowment Fund; Waterfall Foundation; OBNET Women's Healthcare	Ovarian Cancer Institute; Ovarian Cycle Foundation; Robinson Family Foundation; Deborah Nash Willingham Endowment Fund; Waterfall Foundation; OBNET Women's Healthcare	This work was supported by The Ovarian Cancer Institute, The Ovarian Cycle Foundation, The Robinson Family Foundation, The Deborah Nash Willingham Endowment Fund, The Waterfall Foundation and OBNET Women's Healthcare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Auersperg N, 2011, INT J GYNECOL PATHOL, V30, P12, DOI 10.1097/PGP.0b013e3181f45f3e; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; BUICK RN, 1985, CANCER RES, V45, P3668; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; da Costa LFT, 2001, CURR OPIN ONCOL, V13, P58, DOI 10.1097/00001622-200101000-00012; Dahiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002436; Diaz-Cano SJ, 2008, HISTOPATHOLOGY, V53, P1, DOI 10.1111/j.1365-2559.2007.02937.x; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Enright AJ, 2004, GENOME BIOL, V5; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grun D, 2005, PLOS COMPUT BIOL, V1, P51, DOI 10.1371/journal.pcbi.0010013; Guimbellot JS, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-15; Hammond SM, 2006, TRENDS MOL MED, V12, P99, DOI 10.1016/j.molmed.2006.01.004; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Koppelstaetter C, 2005, MECH AGEING DEV, V126, P1331, DOI 10.1016/j.mad.2005.08.003; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kuhn DE, 2008, METHODS, V44, P47, DOI 10.1016/j.ymeth.2007.09.005; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Micallef J, 2009, CANCER RES, V69, P7548, DOI 10.1158/0008-5472.CAN-08-4783; Mieczkowski J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-104; Min H, 2010, EXP MOL MED, V42, P233, DOI 10.3858/emm.2010.42.4.032; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Nam S, 2009, NUCLEIC ACIDS RES, V37, pW356, DOI 10.1093/nar/gkp294; Naora Honami, 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S1462399407000324; Pardee AB, 2006, CELL CYCLE, V5, P846, DOI 10.4161/cc.5.8.2634; Pattyn F, 2003, NUCLEIC ACIDS RES, V31, P122, DOI 10.1093/nar/gkg011; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Ritchie W, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000513; Ruike Y, 2008, J HUM GENET, V53, P515, DOI 10.1007/s10038-008-0279-x; Saito T, 2010, NEW BIOTECHNOL, V27, P243, DOI 10.1016/j.nbt.2010.02.016; Schaar DG, 2009, EXP HEMATOL, V37, P245, DOI 10.1016/j.exphem.2008.10.002; SCULLY RE, 2004, OVARIAN SURFACE EPIT, P2543; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Tang GL, 2008, BBA-GENE REGUL MECH, V1779, P655, DOI 10.1016/j.bbagrm.2008.06.006; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Tong AW, 2008, CANCER GENE THER, V15, P341, DOI 10.1038/cgt.2008.8; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Visone R, 2009, AM J PATHOL, V174, P1131, DOI 10.2353/ajpath.2009.080794; Volinia S, 2010, GENOME RES, V20, P589, DOI 10.1101/gr.098046.109; Wang YP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-218; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; Wiemer EAC, 2007, EUR J CANCER, V43, P1529, DOI 10.1016/j.ejca.2007.04.002; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wyman SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005311; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xin FX, 2009, BIOINFORMATICS, V25, P430, DOI 10.1093/bioinformatics/btn646; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103	75	39	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22508	10.1371/journal.pone.0022508	http://dx.doi.org/10.1371/journal.pone.0022508			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811625	Green Submitted, Green Published, gold			2022-12-25	WOS:000292956800064
J	Westman, E; Cavallin, L; Muehlboeck, JS; Zhang, Y; Mecocci, P; Vellas, B; Tsolaki, M; Kloszewska, I; Soininen, H; Spenger, C; Lovestone, S; Simmons, A; Wahlund, LO				Westman, Eric; Cavallin, Lena; Muehlboeck, J-Sebastian; Zhang, Yi; Mecocci, Patrizia; Vellas, Bruno; Tsolaki, Magda; Kloszewska, Iwona; Soininen, Hilkka; Spenger, Christian; Lovestone, Simon; Simmons, Andrew; Wahlund, Lars-Olof		AddNeuroMed Consortium	Sensitivity and Specificity of Medial Temporal Lobe Visual Ratings and Multivariate Regional MRI Classification in Alzheimer's Disease	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; GEOMETRICALLY ACCURATE; CORTICAL THICKNESSES; SEGMENTATION; DIAGNOSIS; ASSOCIATION; BIOMARKERS; SEVERITY; DEMENTIA; ATROPHY	Background: Visual assessment rating scales for medial temporal lobe (MTL) atrophy have been used by neuroradiologists in clinical practice to aid the diagnosis of Alzheimer's disease (AD). Recently multivariate classification methods for magnetic resonance imaging (MRI) data have been suggested as alternative tools. If computerized methods are to be implemented in clinical practice they need to be as good as, or better than experienced neuroradiologists and carefully validated. The aims of this study were: (1) To compare the ability of MTL atrophy visual assessment rating scales, a multivariate MRI classification method and manually measured hippocampal volumes to distinguish between subjects with AD and healthy elderly controls (CTL). (2) To assess how well the three techniques perform when predicting future conversion from mild cognitive impairment (MCI) to AD. Methods: High resolution sagittal 3D T1w MP-RAGE datasets were acquired from 75 AD patients, 101 subjects with MCI and 81 CTL from the multi-centre AddNeuroMed study. An automated analysis method was used to generate regional volume and regional cortical thickness measures, providing 57 variables for multivariate analysis (orthogonal partial least squares to latent structures using seven-fold cross-validation). Manual hippocampal measurements were also determined for each subject. Visual rating assessment of MTL atrophy was performed by an experienced neuroradiologist according to the approach of Scheltens et al. Results: We found prediction accuracies for distinguishing between AD and CTL of 83% for multivariate classification, 81% for the visual rating assessments and 89% for manual measurements of total hippocampal volume. The three different techniques showed similar accuracy in predicting conversion from MCI to AD at one year follow-up. Conclusion: Visual rating assessment of the MTL gave similar prediction accuracy to multivariate classification and manual hippocampal volumes. This suggests a potential future role for computerized methods as a complement to clinical assessment of AD.	[Westman, Eric; Wahlund, Lars-Olof] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Cavallin, Lena; Muehlboeck, J-Sebastian; Zhang, Yi; Spenger, Christian] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Cavallin, Lena] Karolinska Univ Hosp, Dept Radiol, Stockholm, Sweden; [Mecocci, Patrizia] Univ Perugia, Inst Gerontol & Geriatr, I-06100 Perugia, Italy; [Vellas, Bruno] Univ Toulouse, INSERM, U558, Toulouse, France; [Tsolaki, Magda] Aristotle Univ Thessaloniki, GR-54006 Thessaloniki, Greece; [Kloszewska, Iwona] Med Univ Lodz, Lodz, Poland; [Soininen, Hilkka] Univ Eastern Finland, Kuopio, Finland; [Soininen, Hilkka] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Lovestone, Simon; Simmons, Andrew] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Lovestone, Simon; Simmons, Andrew] NIHR Biomed Res Ctr Mental Hlth, London, England	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Perugia; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Aristotle University of Thessaloniki; Medical University Lodz; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of London; King's College London; University of London; King's College London	Westman, E (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden.	eric.westman@ki.se	Simmons, Andrew/B-8848-2008; Mecocci, Patrizia/W-2116-2019; Westman, Eric/H-5771-2011	Simmons, Andrew/0000-0003-2306-5811; Mecocci, Patrizia/0000-0003-0729-5246; Westman, Eric/0000-0002-3115-2977; Lovestone, Simon/0000-0003-0473-4565; wahlund, lars-olof/0000-0002-9905-8426; Tsolaki, Magda/0000-0002-2072-8010	European Union [FP6-2004-LIFESCIHEALTH-5]; NIHR Biomedical Research Centre for Mental Health at the South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College, London	European Union(European Commission); NIHR Biomedical Research Centre for Mental Health at the South London(National Institute for Health Research (NIHR)); Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College, London	This study was supported by InnoMed (Innovative Medicines in Europe) an Integrated Project funded by the European Union of the Sixth Framework program priority FP6-2004-LIFESCIHEALTH-5, Life Sciences, Genomics and Biotechnology for Health. AS and SL were supported by funds from the NIHR Biomedical Research Centre for Mental Health at the South London (www.nihr.ac.uk), Maudsley NHS Foundation Trust and Institute of Psychiatry, King's College, London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Bylesjo M, 2007, PLANT J, V52, P1181, DOI 10.1111/j.1365-313X.2007.03293.x; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; Davatzikos C, 2008, NEUROIMAGE, V41, P1220, DOI 10.1016/j.neuroimage.2008.03.050; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Eriksson L., 2006, MULTI MEGAVARIATE 1; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Kantarci Kejal, 2005, Expert Rev Neurother, V5, P663, DOI 10.1586/14737175.5.5.663; Kloppel S, 2008, BRAIN, V131, P2969, DOI 10.1093/brain/awn239; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Liu YW, 2010, DEMENT GERIATR COGN, V30, P229, DOI 10.1159/000320136; Liu YW, 2010, J ALZHEIMERS DIS, V21, P947, DOI 10.3233/JAD-2010-100201; Liu YW, 2011, NEUROBIOL AGING, V32, P1198, DOI 10.1016/j.neurobiolaging.2009.07.008; Liu YW, 2010, NEUROBIOL AGING, V31, P1375, DOI 10.1016/j.neurobiolaging.2010.01.022; Lovestone S, 2007, J NUTR HEALTH AGING, V11, P359; Lovestone S, 2009, ANN NY ACAD SCI, V1180, P36, DOI 10.1111/j.1749-6632.2009.05064.x; McIntosh AR, 2004, NEUROIMAGE, V23, pS250, DOI 10.1016/j.neuroimage.2004.07.020; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Oberg J, 2008, NEUROBIOL AGING, V29, P1423, DOI 10.1016/j.neurobiolaging.2007.03.002; Pantel J, 2000, HIPPOCAMPUS, V10, P752, DOI 10.1002/1098-1063(2000)10:6<752::AID-HIPO1012>3.0.CO;2-Y; QIZILBASH N, 2002, EVINDENCED BASED DEM, P20; Rantalainen M, 2006, J PROTEOME RES, V5, P2642, DOI 10.1021/pr060124w; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Simmons A, 2011, INT J GERIATR PSYCH, V26, P75, DOI 10.1002/gps.2491; Simmons A, 2009, ANN NY ACAD SCI, V1180, P47, DOI 10.1111/j.1749-6632.2009.05063.x; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Thambisetty M, 2010, ARCH GEN PSYCHIAT, V67, P739, DOI 10.1001/archgenpsychiatry.2010.78; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Tunnard C, 2011, INT J GERIATR PSYCH, V26, P741, DOI 10.1002/gps.2603; WESTMAN E, 2011, NEUROIMAGE IN PRESS; Westman E, 2007, NEUROBIOL DIS, V26, P221, DOI 10.1016/j.nbd.2006.12.012; Westman E, 2011, NEUROIMAGE, V54, P1178, DOI 10.1016/j.neuroimage.2010.08.044; Westman E, 2010, J ALZHEIMERS DIS, V22, P171, DOI 10.3233/JAD-2010-100168; Westman E, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-33; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510	47	94	96	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22506	10.1371/journal.pone.0022506	http://dx.doi.org/10.1371/journal.pone.0022506			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811624	Green Published, gold, Green Submitted			2022-12-25	WOS:000292956800063
J	Peng, DF; Hu, TL; Jiang, AX; Washington, MK; Moskaluk, CA; Schneider-Stock, R; El-Rifai, W				Peng, Dunfa; Hu, Tian-Ling; Jiang, Aixiang; Washington, Mary Kay; Moskaluk, Christopher A.; Schneider-Stock, Regine; El-Rifai, Wael			Location-Specific Epigenetic Regulation of the Metallothionein 3 Gene in Esophageal Adenocarcinomas	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED GENES; DNA METHYLATION; BARRETTS-ESOPHAGUS; CANCER EPIGENETICS; CELL-LINES; HISTONE H3; CROSS-TALK; HYPERMETHYLATION; DISEASE; DAMAGE	Background: Metallothionein 3 (MT3) maintains intracellular metal homeostasis and protects against reactive oxygen species (ROS)-induced DNA damage. In this study, we investigated the epigenetic alterations and gene expression of the MT3 gene in esophageal adenocarcinomas (EACs). Methods and Results: Using quantitative bisulfite pyrosequencing, we detected unique DNA methylation profiles in the MT3 promoter region. The CpG nucleotides from -372 to -306 from the transcription start site (TSS) were highly methylated in tumor (n = 64) and normal samples (n = 51), whereas CpG nucleotides closest to the TSS (-4 and +3) remained unmethylated in all normal and most tumor samples. Conversely, CpG nucleotides in two regions (from 2139 to -49 and +296 to +344) were significantly hypermethylated in EACs as compared to normal samples [FDR<0.001, -log10(FDR)>3.0]. The DNA methylation levels from -127 to -8 CpG sites showed the strongest correlation with MT3 gene expression (r = -0.4, P<0.0001). Moreover, the DNA hypermethylation from 2127 to 28 CpG sites significantly correlated with advanced tumor stages and lymph node metastasis (P = 0.005 and P = 0.0313, respectively). The ChIP analysis demonstrated a more repressive histone modification (H3K9me2) and less active histone modifications (H3K4me2, H3K9ace) in OE33 cells than in FLO-1 cells; concordant with the presence of higher DNA methylation levels and silencing of MT3 expression in OE33 as compared to FLO-1 cells. Treatment of OE33 cells with 5-Aza-deoxycitidine restored MT3 expression with demethylation of its promoter region and reversal of the histone modifications towards active histone marks. Conclusion: In summary, EACs are characterized by frequent epigenetic silencing of MT3. The choice of specific regions in the CpG island is a critical step in determining the functional role and prognostic value of DNA methylation in cancer cells.	[Peng, Dunfa; Hu, Tian-Ling; El-Rifai, Wael] Vanderbilt Univ Sch Med, Dept Surg, Nashville, TN USA; [Jiang, Aixiang] Vanderbilt Univ Sch Med, Dept Biostat, Nashville, TN USA; [Washington, Mary Kay] Vanderbilt Univ Sch Med, Dept Pathol, Nashville, TN USA; [Moskaluk, Christopher A.] Univ Virginia Hlth Ctr, Dept Pathol, Charlottesville, VA USA; [Schneider-Stock, Regine] Erlangen Univ, Dept Pathol, Erlangen, Germany; [El-Rifai, Wael] Vanderbilt Univ Sch Med, Dept Canc Biol, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Virginia; University of Erlangen Nuremberg; Vanderbilt University	Peng, DF (corresponding author), Vanderbilt Univ Sch Med, Dept Surg, Nashville, TN USA.	wael.el-rifai@vanderbilt.edu	Schneider-Stock, Regine/H-8863-2012	Jiang, Aixiang/0000-0002-6153-7595	National Institutes of Health [R01CA106176, R01CA133738]; NATIONAL CANCER INSTITUTE [R01CA133738, R01CA106176] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Institutes of Health grants R01CA106176 and R01CA133738. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTORKI NK, 1990, SEMIN SURG ONCOL, V6, P274, DOI 10.1002/ssu.2980060509; Baylin SB, 1998, ADV CANCER RES, V72, P141; BLOT WJ, 1993, JAMA-J AM MED ASSOC, V270, P1320, DOI 10.1001/jama.270.11.1320; Bonino JA, 2004, CURR OPIN GASTROEN, V20, P375, DOI 10.1097/00001574-200407000-00013; Boonstra JJ, 2010, JNCI-J NATL CANCER I, V102, P271, DOI 10.1093/jnci/djp499; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Carpene E, 2007, J TRACE ELEM MED BIO, V21, P35, DOI 10.1016/j.jtemb.2007.09.011; Coyle P, 2002, CELL MOL LIFE SCI, V59, P627, DOI 10.1007/s00018-002-8454-2; Dasgupta Piyali, 2007, V383, P135, DOI 10.1007/978-1-59745-335-6_9; DeMeester SR, 2006, ANN SURG ONCOL, V13, P12, DOI 10.1245/ASO.2005.12.025; Deng DJ, 2003, CARCINOGENESIS, V24, P25, DOI 10.1093/carcin/24.1.25; Dvorak K, 2007, GUT, V56, P763, DOI 10.1136/gut.2006.103697; El-Rifai W, 2002, CANCER RES, V62, P6823; Esteller M, 2001, CANCER RES, V61, P3225; FALK GW, 1994, GASTROINTEST ENDOSC, V40, P207, DOI 10.1016/S0016-5107(94)70168-7; Falk GW, 2001, ENDOSCOPY, V33, P109; Fitzgerald RC, 2004, CURR OPIN ONCOL, V16, P372, DOI 10.1097/01.cco.0000128277.07747.5e; Garrett SH, 1999, PROSTATE, V41, P196, DOI 10.1002/(SICI)1097-0045(19991101)41:3<196::AID-PROS7>3.0.CO;2-U; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; HESKETH PJ, 1989, CANCER, V64, P526, DOI 10.1002/1097-0142(19890715)64:2<526::AID-CNCR2820640228>3.0.CO;2-B; Jeong HG, 2004, J BIOL CHEM, V279, P34138, DOI 10.1074/jbc.M402530200; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; KAGI JHR, 1989, BIOL TRACE ELEM RES, V21, P111, DOI 10.1007/BF02917243; Kanai Y, 2007, CARCINOGENESIS, V28, P2434, DOI 10.1093/carcin/bgm206; Khalil AM, 2006, CYTOGENET GENOME RES, V112, P11, DOI 10.1159/000087508; Kondo Y, 2009, YONSEI MED J, V50, P455, DOI 10.3349/ymj.2009.50.4.455; Laird PW, 2005, HUM MOL GENET, V14, pR65, DOI 10.1093/hmg/ddi113; Lennartsson A, 2009, BBA-GEN SUBJECTS, V1790, P863, DOI 10.1016/j.bbagen.2008.12.006; Momparler RL, 2003, ONCOGENE, V22, P6479, DOI 10.1038/sj.onc.1206774; OLYAEE M, 1995, GUT, V37, P168, DOI 10.1136/gut.37.2.168; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Peng DF, 2009, GUT, V58, P5, DOI 10.1136/gut.2007.146290; Peng DF, 2006, CARCINOGENESIS, V27, P1160, DOI 10.1093/carcin/bgi361; Pinskaya M, 2009, EPIGENETICS-US, V4, P302, DOI 10.4161/epi.4.5.9369; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Schlemper RJ, 2000, GUT, V47, P251, DOI 10.1136/gut.47.2.251; Sens MA, 2001, AM J PATHOL, V159, P21, DOI 10.1016/S0002-9440(10)61668-9; Sens MA, 2000, ENVIRON HEALTH PERSP, V108, P413; Shukla A, 2009, CELL MOL LIFE SCI, V66, P1419, DOI 10.1007/s00018-008-8605-1; Siewert JR, 2005, J SURG ONCOL, V90, P139, DOI 10.1002/jso.20218; Smith E, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-42; Sogawa CA, 2001, ACTA MED OKAYAMA, V55, P1; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wiencke JK, 2008, ONCOGENE, V27, P2412, DOI 10.1038/sj.onc.1210895; You HJ, 2002, BBA-GEN SUBJECTS, V1573, P33, DOI 10.1016/S0304-4165(02)00325-2; Yu WH, 2001, BRAIN RES, V894, P37, DOI 10.1016/S0006-8993(00)03196-6; Zhou WL, 2009, INT J BIOCHEM CELL B, V41, P12, DOI 10.1016/j.biocel.2008.09.016	47	29	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22009	10.1371/journal.pone.0022009	http://dx.doi.org/10.1371/journal.pone.0022009			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21818286	Green Published, gold, Green Submitted			2022-12-25	WOS:000292929500028
J	Schreur, PJW; Rebel, JMJ; Smits, MA; van Putten, JPM; Smith, HE				Schreur, Paul J. Wichgers; Rebel, Johanna M. J.; Smits, Mari A.; van Putten, Jos P. M.; Smith, Hilde E.			Lgt Processing Is an Essential Step in Streptococcus suis Lipoprotein Mediated Innate Immune Activation	PLOS ONE			English	Article							BACTERIAL LIPOPROTEINS; LIPID MODIFICATION; VIRULENCE; SEROTYPE-2; IDENTIFICATION; PNEUMONIAE; PROTEINS; TYPE-2; PRELIPOPROTEINS; POLYSACCHARIDE	Background: Streptococcus suis causes invasive infections in pigs and occasionally in humans. The host innate immune system plays a major role in counteracting S. suis infections. The main components of S. suis able to activate the innate immune system likely include cell wall constituents that may be released during growth or after cell wall integrity loss, however characterization of these components is still limited. Methology/Principal Findings: A concentrated very potent innate immunity activating supernatant of penicillin-treated S. suis was SDS-PAGE fractionated and tested for porcine peripheral blood mononucleated cell (PBMC) stimulating activity using cytokine gene transcript analysis. More than half of the 24 tested fractions increased IL-1 beta and IL-8 cytokine gene transcript levels in porcine PBMCs. Mass spectrometry of the active fractions indicated 24 proteins including 9 lipoproteins. Genetic inactivation of a putative prolipoprotein diacylglyceryl transferase (Lgt) gene resulted in deficient lipoprotein synthesis as evidenced by palmitate labeling. The Lgt mutant showed strongly reduced activation of porcine PBMCs, indicating that lipoproteins are dominant porcine PBMC activating molecules of S. suis. Conclusion/Significance: This study for the first time identifies and characterizes lipoproteins of S. suis as major activators of the innate immune system of the pig. In addition, we provide evidence that Lgt processing of lipoproteins is required for lipoprotein mediated innate immune activation.	[Schreur, Paul J. Wichgers; Rebel, Johanna M. J.; Smith, Hilde E.] Wageningen UR, Cent Vet Inst, Lelystad, Netherlands; [Schreur, Paul J. Wichgers; van Putten, Jos P. M.] Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands	Wageningen University & Research; Utrecht University	Schreur, PJW (corresponding author), Wageningen UR, Cent Vet Inst, Lelystad, Netherlands.	paul.wichgersschreur@wur.nl	smits, mari/J-4892-2013	smits, mari/0000-0002-3493-291X; van Putten, Jos/0000-0002-4126-8172; Rebel, Annemarie/0000-0003-4765-4215	Dutch Ministry of Agriculture, Nature and Food Quality [KB-08]	Dutch Ministry of Agriculture, Nature and Food Quality	This project was financially supported by the Dutch Ministry of Agriculture, Nature and Food Quality (KB-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda J, 2008, INFECT IMMUN, V76, P1590, DOI 10.1128/IAI.00987-07; ARENDS JP, 1988, REV INFECT DIS, V10, P131; Beineke A, 2008, VET MICROBIOL, V128, P423, DOI 10.1016/j.vetmic.2007.10.028; BUNGENER W, 1989, EUR J CLIN MICROBIOL, V8, P306, DOI 10.1007/BF01963457; Das S, 2009, J BACTERIOL, V191, P4166, DOI 10.1128/JB.01739-08; Denham EL, 2009, MICROBIOL-SGM, V155, P134, DOI 10.1099/mic.0.022061-0; Graveline R, 2007, INT IMMUNOL, V19, P375, DOI 10.1093/intimm/dxm003; Hamilton A, 2006, INFECT IMMUN, V74, P6907, DOI 10.1128/IAI.01116-06; Henneke P, 2008, J IMMUNOL, V180, P6149, DOI 10.4049/jimmunol.180.9.6149; Holden MTG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006072; HUSSAIN M, 1982, J BIOL CHEM, V257, P5177; Keestra AM, 2007, J IMMUNOL, V178, P7110, DOI 10.4049/jimmunol.178.11.7110; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Machata S, 2008, J IMMUNOL, V181, P2028, DOI 10.4049/jimmunol.181.3.2028; Moore LJ, 2003, J INFECT DIS, V188, P1040, DOI 10.1086/378238; PEETERMANS WEC, 1989, J INFECT DIS, V159, P595, DOI 10.1093/infdis/159.3.595; PEREZMARTINEZ G, 1992, MOL GEN GENET, V234, P401, DOI 10.1007/BF00538699; Petit CM, 2001, FEMS MICROBIOL LETT, V200, P229, DOI 10.1111/j.1574-6968.2001.tb10720.x; Rodriguez MS, 1999, J BIOL CHEM, V274, P9108, DOI 10.1074/jbc.274.13.9108; Sambrook J., 2002, MOL CLONING LAB MANU; SANKARAN K, 1994, J BIOL CHEM, V269, P19701; Segura M, 1999, INFECT IMMUN, V67, P4646, DOI 10.1128/IAI.67.9.4646-4654.1999; Segura M, 2006, FEMS IMMUNOL MED MIC, V47, P92, DOI 10.1111/j.1574-695X.2006.00067.x; Silva LMG, 2006, VET MICROBIOL, V115, P117, DOI 10.1016/j.vetmic.2005.12.013; SMITH HE, 1995, MICROBIOL-UK, V141, P181, DOI 10.1099/00221287-141-1-181; Stoll H, 2005, INFECT IMMUN, V73, P2411, DOI 10.1128/IAI.73.4.2411-2423.2005; Sutcliffe IC, 2002, MICROBIOL-SGM, V148, P2065, DOI 10.1099/00221287-148-7-2065; Takamatsu D, 2001, PLASMID, V46, P140, DOI 10.1006/plas.2001.1532; Tanabe SI, 2010, CAN J VET RES, V74, P65; Vadeboncoeur N, 2003, FEMS IMMUNOL MED MIC, V35, P49, DOI 10.1016/S0928-8244(02)00440-6; VONHEIJNE G, 1989, PROTEIN ENG, V2, P531, DOI 10.1093/protein/2.7.531; Wardenburg JB, 2006, P NATL ACAD SCI USA, V103, P13831, DOI 10.1073/pnas.0603072103; Wichgers Schreur PJ, 2009, VET MICROBIOL; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Wisselink HJ, 2000, VET MICROBIOL, V74, P237, DOI 10.1016/S0378-1135(00)00188-7; Zhang AD, 2008, PROTEOMICS, V8, P3506, DOI 10.1002/pmic.200800007; Zhang A, 2009, FEMS MICROBIOL LETT, V295, P17, DOI 10.1111/j.1574-6968.2009.01574.x	37	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22299	10.1371/journal.pone.0022299	http://dx.doi.org/10.1371/journal.pone.0022299			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21811583	Green Published, gold			2022-12-25	WOS:000292929500051
J	Lambe, EK; Fillman, SG; Webster, MJ; Weickert, CS				Lambe, Evelyn K.; Fillman, Stu G.; Webster, Maree J.; Weickert, Cynthia S.			Serotonin Receptor Expression in Human Prefrontal Cortex: Balancing Excitation and Inhibition across Postnatal Development	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; PYRAMIDAL NEURONS; IN-VIVO; GABAERGIC NEURONS; 5-HT1A RECEPTORS; HUMAN BRAIN; RAT; ANXIETY; STRESS; LOCALIZATION	Serotonin and its receptors (HTRs) play critical roles in brain development and in the regulation of cognition, mood, and anxiety. HTRs are highly expressed in human prefrontal cortex and exert control over prefrontal excitability. The serotonin system is a key treatment target for several psychiatric disorders; however, the effectiveness of these drugs varies according to age. Despite strong evidence for developmental changes in prefrontal Htrs of rodents, the developmental regulation of HTR expression in human prefrontal cortex has not been examined. Using postmortem human prefrontal brain tissue from across postnatal life, we investigated the expression of key serotonin receptors with distinct inhibitory (HTR1A, HTR5A) and excitatory (HTR2A, HTR2C, HTR4, HTR6) effects on cortical neurons, including two receptors which appear to be expressed to a greater degree in inhibitory interneurons of cerebral cortex (HTR2C, HTR6). We found distinct developmental patterns of expression for each of these six HTRs, with profound changes in expression occurring early in postnatal development and also into adulthood. However, a collective look at these HTRs in terms of their likely neurophysiological effects and major cellular localization leads to a model that suggests developmental changes in expression of these individual HTRs may not perturb an overall balance between inhibitory and excitatory effects. Examining and understanding the healthy balance is critical to appreciate how abnormal expression of an individual HTR may create a window of vulnerability for the emergence of psychiatric illness.	[Lambe, Evelyn K.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Lambe, Evelyn K.] Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON, Canada; [Fillman, Stu G.; Weickert, Cynthia S.] Schizophrenia Res Inst, Sydney, NSW, Australia; [Fillman, Stu G.; Weickert, Cynthia S.] Neurosci Res Australia, Schizophrenia Res Lab, Randwick, NSW, Australia; [Fillman, Stu G.; Weickert, Cynthia S.] Univ New S Wales, Sch Psychiat, Fac Med, Sydney, NSW, Australia; [Webster, Maree J.] Stanley Med Res Inst, Rockville, MD USA	University of Toronto; University of Toronto; Neuroscience Research Australia; University of New South Wales Sydney	Lambe, EK (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON, Canada.	evelyn.lambe@utoronto.ca	Weickert, Cynthia Shannon/G-3171-2011; Lambe, Evelyn K/K-3699-2015	Lambe, Evelyn K/0000-0002-5994-6090; Shannon Weickert, Cynthia/0000-0002-4560-0259	NSERC; Canada Research Chairs Program; NSW Health; Macquarie Group Foundation, Neuroscience Research Australia; University of New South Wales	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs Program(Canada Research Chairs); NSW Health; Macquarie Group Foundation, Neuroscience Research Australia; University of New South Wales	This work was supported by grants to Evelyn K. Lambe from NSERC and the Canada Research Chairs Program and support to Cynthia S. Weickert from the Schizophrenia Research Institute utilizing funding from NSW Health and the Macquarie Group Foundation, Neuroscience Research Australia and the University of New South Wales. The Macquarie Group Foundation donation does not entail any corporate involvement by the individuals in this study including, but not limited to, employment, consulting, patents or products. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The donation by the Macquarie Group Foundation to our research program does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Amargos-Bosch M, 2004, CEREB CORTEX, V14, P281, DOI 10.1093/cercor/bhg128; Anisman H, 2008, J PSYCHIATR NEUROSCI, V33, P131; Aznar S, 2003, BRAIN RES, V959, P58, DOI 10.1016/S0006-8993(02)03727-7; Beique JC, 2004, J PHYSIOL-LONDON, V556, P739, DOI 10.1113/jphysiol.2003.051284; Beique JC, 2004, J NEUROSCI, V24, P4807, DOI 10.1523/JNEUROSCI.5113-03.2004; Benekareddy M, 2010, J NEUROSCI, V30, P12138, DOI 10.1523/JNEUROSCI.3245-10.2010; Bernotas RC, 2009, BIOORG MED CHEM LETT, V19, P6935, DOI 10.1016/j.bmcl.2009.10.067; Bismark AW, 2010, BIOL PSYCHOL, V83, P153, DOI 10.1016/j.biopsycho.2009.12.002; Bland ST, 2003, NEUROPSYCHOPHARMACOL, V28, P1589, DOI 10.1038/sj.npp.1300206; Brawman-Mintzer O, 2005, J CLIN PSYCHIAT, V66, P1321, DOI 10.4088/JCP.v66n1016; BURNET PWJ, 1995, BRAIN RES, V676, P157, DOI 10.1016/0006-8993(95)00104-X; Cozzi NV, 1996, EUR J PHARMACOL, V309, P25, DOI 10.1016/0014-2999(96)00325-1; de Almeida J, 2007, J NEUROCHEM, V103, P475, DOI 10.1111/j.1471-4159.2007.04768.x; de Almeida J, 2008, J NEUROCHEM, V107, P488, DOI 10.1111/j.1471-4159.2008.05649.x; del Olmo E, 1998, MOL BRAIN RES, V60, P123, DOI 10.1016/S0169-328X(98)00149-1; DUNCAN C, 2009, J PSYCHIATR RES, P1; Dupuis DS, 1999, EUR J NEUROSCI, V11, P1809, DOI 10.1046/j.1460-9568.1999.00600.x; Feng J, 2001, J NEUROSCI, V21, P6502, DOI 10.1523/JNEUROSCI.21-17-06502.2001; Fillman SG, 2010, INT J DEV NEUROSCI, V28, P513, DOI 10.1016/j.ijdevneu.2010.05.004; Fletcher PJ, 2007, PSYCHOPHARMACOLOGY, V195, P223, DOI 10.1007/s00213-007-0891-z; Fontana DJ, 1997, NEUROPHARMACOLOGY, V36, P689, DOI 10.1016/S0028-3908(97)00055-5; Francken BJB, 1998, EUR J PHARMACOL, V361, P299, DOI 10.1016/S0014-2999(98)00744-4; Frederick JA, 1999, SCHIZOPHR RES, V38, P7, DOI 10.1016/S0920-9964(99)00002-X; Frokjaer VG, 2008, BIOL PSYCHIAT, V63, P569, DOI 10.1016/j.biopsych.2007.07.009; Frokjaer VG, 2010, NEUROPSYCHOPHARMACOL, V35, P1129, DOI 10.1038/npp.2009.218; Fung SJ, 2010, AM J PSYCHIAT, V167, P1479, DOI 10.1176/appi.ajp.2010.09060784; Fuster JM, 2002, J NEUROCYTOL, V31, P373, DOI 10.1023/A:1024190429920; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Gartside SE, 2003, EUR J NEUROSCI, V17, P2401, DOI 10.1046/j.1460-9568.2003.02668.x; Gartside SE, 2000, NEUROSCIENCE, V98, P295, DOI 10.1016/S0306-4522(00)00060-9; Goncalves L, 2009, BRAIN RES BULL, V78, P240, DOI 10.1016/j.brainresbull.2008.11.012; Goodfellow NM, 2009, J NEUROSCI, V29, P10094, DOI 10.1523/JNEUROSCI.1960-09.2009; Grailhe R, 1999, NEURON, V22, P581, DOI 10.1016/S0896-6273(00)80712-6; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Hajos M, 2003, NEUROPHARMACOLOGY, V45, P72, DOI 10.1016/S0028-3908(03)00139-4; HASHIMOTO T, 1991, LIFE SCI, V48, P355, DOI 10.1016/0024-3205(91)90556-Q; Hetrick S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004851.pub2; Holmes A, 2008, NEUROSCI BIOBEHAV R, V32, P1293, DOI 10.1016/j.neubiorev.2008.03.006; King MV, 2008, TRENDS PHARMACOL SCI, V29, P482, DOI 10.1016/j.tips.2008.07.001; Kinsey AM, 2001, MOL BRAIN RES, V88, P194, DOI 10.1016/S0169-328X(01)00034-1; Krystal JH, 2009, BRAIN RES, V1293, P13, DOI 10.1016/j.brainres.2009.03.044; Lambe EK, 2007, NEUROSCIENCE, V145, P900, DOI 10.1016/j.neuroscience.2006.12.048; Lambe EK, 2000, J NEUROSCI, V20, P8780; Lanzenberger RR, 2007, BIOL PSYCHIAT, V61, P1081, DOI 10.1016/j.biopsych.2006.05.022; LARUELLE M, 1993, ARCH GEN PSYCHIAT, V50, P810; Levitt P, 1997, TRENDS NEUROSCI, V20, P269, DOI 10.1016/S0166-2236(96)01028-4; Lewis R, 1999, AM J PSYCHIAT, V156, P72, DOI 10.1176/ajp.156.1.72; Liu S, 2007, NEUROSCIENCE, V146, P1677, DOI 10.1016/j.neuroscience.2007.02.064; Lo Iacono L, 2008, J NEUROSCI, V28, P6250, DOI 10.1523/JNEUROSCI.5219-07.2008; Lopez-Figueroa AL, 2004, BIOL PSYCHIAT, V55, P225, DOI 10.1016/j.biopsych.2003.09.017; Lucas G, 2005, BIOL PSYCHIAT, V57, P918, DOI 10.1016/j.biopsych.2004.12.023; Maekawa T, 2010, EMBO J, V29, P184, DOI 10.1038/emboj.2009.318; Mansour-Robaey S, 1998, DEV BRAIN RES, V107, P159, DOI 10.1016/S0165-3806(98)00016-9; Marcus SM, 2008, COMPR PSYCHIAT, V49, P238, DOI 10.1016/j.comppsych.2007.06.012; Marek GJ, 2003, NEUROPSYCHOPHARMACOL, V28, P402, DOI 10.1038/sj.npp.1300057; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Matsukawa M, 2003, NEUROSCIENCE, V122, P627, DOI 10.1016/j.neuroscience.2003.08.047; Middeldorp CM, 2010, GENES BRAIN BEHAV, V9, P808, DOI 10.1111/j.1601-183X.2010.00619.x; Mitchell ES, 2005, PHARMACOL THERAPEUT, V108, P320, DOI 10.1016/j.pharmthera.2005.05.001; Nakamura Y, 2010, J HUM GENET, V55, P838, DOI 10.1038/jhg.2010.110; Naughton M, 2000, HUM PSYCHOPHARM CLIN, V15, P397, DOI 10.1002/1099-1077(200008)15:6<397::AID-HUP212>3.3.CO;2-C; Oberlander TF, 2009, CLIN PHARMACOL THER, V86, P672, DOI 10.1038/clpt.2009.201; Oberlander TF, 2010, ARCH PEDIAT ADOL MED, V164, P444, DOI 10.1001/archpediatrics.2010.51; ODAGAKI Y, 1995, J PHARMACOL EXP THER, V274, P337; Oliver KR, 2000, BRAIN RES, V867, P131, DOI 10.1016/S0006-8993(00)02273-3; OLIVIER JDA, 2010, PROG NEUROPSYCHOPHAR; Pandey GN, 2002, AM J PSYCHIAT, V159, P419, DOI 10.1176/appi.ajp.159.3.419; Pasqualetti M, 1996, MOL BRAIN RES, V39, P223, DOI 10.1016/0169-328X(96)00026-5; Pasqualetti M, 1999, NEUROSCIENCE, V92, P601, DOI 10.1016/S0306-4522(99)00011-1; Pasqualetti M, 1998, ANN NY ACAD SCI, V861, P245, DOI 10.1111/j.1749-6632.1998.tb10202.x; Puig MV, 2010, J NEUROSCI, V30, P2211, DOI 10.1523/JNEUROSCI.3335-09.2010; Puig MV, 2005, CEREB CORTEX, V15, P1, DOI 10.1093/cercor/bhh104; Raymond JR, 2001, PHARMACOL THERAPEUT, V92, P179, DOI 10.1016/S0163-7258(01)00169-3; Riccio O, 2009, MOL PSYCHIATR, V14, P280, DOI 10.1038/mp.2008.89; Santana N, 2004, CEREB CORTEX, V14, P1100, DOI 10.1093/cercor/bhh070; Sato Y, 2009, PROG NEURO-PSYCHOPH, V33, P416, DOI 10.1016/j.pnpbp.2008.12.018; Schechter LE, 2008, NEUROPSYCHOPHARMACOL, V33, P1323, DOI 10.1038/sj.npp.1301503; Shelton RC, 2009, NEUROSCIENCE, V158, P1406, DOI 10.1016/j.neuroscience.2008.11.036; Spindelegger C, 2009, MOL PSYCHIATR, V14, P1040, DOI 10.1038/mp.2008.35; Spinelli S, 2010, BIOL PSYCHIAT, V67, P1146, DOI 10.1016/j.biopsych.2009.12.030; Sumiyoshi T, 1996, BRAIN RES, V708, P209, DOI 10.1016/0006-8993(95)01361-X; Suzuki T, 2003, AM J MED GENET B, V121B, P7, DOI 10.1002/ajmg.b.20060; Svenningsson P, 2007, J NEUROSCI, V27, P4201, DOI 10.1523/JNEUROSCI.3110-06.2007; Tauscher J, 2001, AM J PSYCHIAT, V158, P1326, DOI 10.1176/appi.ajp.158.8.1326; Terry AV, 1998, PSYCHOPHARMACOLOGY, V135, P407, DOI 10.1007/s002130050529; Uhlhaas PJ, 2009, P NATL ACAD SCI USA, V106, P9866, DOI 10.1073/pnas.0900390106; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vazquez DM, 2000, BRAIN RES, V855, P76, DOI 10.1016/S0006-8993(99)02307-0; Verhoeff NPLG, 2000, PSYCHIAT RES-NEUROIM, V99, P123, DOI 10.1016/S0165-1781(00)00198-0; Vysokanov A, 1998, NEUROSCI LETT, V258, P179, DOI 10.1016/S0304-3940(98)00882-9; WAEBER C, 1994, NEUROPHARMACOLOGY, V33, P527, DOI 10.1016/0028-3908(94)90084-1; Warner-Schmidt JL, 2009, J NEUROSCI, V29, P1937, DOI 10.1523/JNEUROSCI.5343-08.2009; Weber ET, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00036; Weickert CS, 2009, MOL PSYCHIATR, V14, P558, DOI 10.1038/mp.2009.5; Weisstaub NV, 2006, SCIENCE, V313, P536, DOI 10.1126/science.1123432; Whitaker-Azmitia P M, 1987, Brain Res, V430, P285; Winstanley CA, 2004, PSYCHOPHARMACOLOGY, V176, P376, DOI 10.1007/s00213-004-1884-9; Wong EHF, 2010, PHARMACOL THERAPEUT, V126, P173, DOI 10.1016/j.pharmthera.2010.02.001; Wong J, 2009, EUR J NEUROSCI, V29, P1311, DOI 10.1111/j.1460-9568.2009.06669.x; Zhang ZW, 2003, J NEUROSCI, V23, P3373	100	51	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22799	10.1371/journal.pone.0022799	http://dx.doi.org/10.1371/journal.pone.0022799			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829518	Green Published, gold, Green Submitted			2022-12-25	WOS:000293286500031
J	Sun, SS; Wang, QZ; Zhao, F; Chen, WT; Li, Z				Sun, Shisheng; Wang, Qinzhe; Zhao, Fei; Chen, Wentian; Li, Zheng			Glycosylation Site Alteration in the Evolution of Influenza A (H1N1) Viruses	PLOS ONE			English	Article							N-LINKED GLYCOSYLATION; RECEPTOR-BINDING PROPERTIES; SWINE INFLUENZA; HEMAGGLUTININ; NEURAMINIDASE; VIRULENCE; RESOURCE; CLEAVAGE; HUMANS; PATHOGENICITY	Influenza virus typically alters protein glycosylation in order to escape immune pressure from hosts and hence to facilitate survival in different host environments. In this study, the patterns and conservation of glycosylation sites on HA and NA of influenza A/H1N1 viruses isolated from various hosts at different time periods were systematically analyzed, by employing a new strategy combining genome-based glycosylation site prediction and 3D modeling of glycoprotein structures, for elucidation of the modes and laws of glycosylation site alteration in the evolution of influenza A/H1N1 viruses. The results showed that influenza H1N1 viruses underwent different alterations of protein glycosylation in different hosts. Two alternative modes of glycosylation site alteration were involved in the evolution of human influenza virus: One was an increase in glycosylation site numbers, which mainly occurred with high frequency in the early stages of evolution. The other was a change in the positional conversion of the glycosylation sites, which was the dominating mode with relatively low frequency in the later evolutionary stages. The mechanisms and possibly biological functions of glycosylation site alteration for the evolution of influenza A/H1N1 viruses were also discussed. Importantly, the significant role of positional alteration of glycosylation sites in the host adaptation of influenza virus was elucidated. Although the results still need to be supported by experimental data, the information here may provide some constructive suggestions for research into the glycosylation of influenza viruses as well as even the design of surveillance and the production of viral vaccines.	[Sun, Shisheng; Wang, Qinzhe; Zhao, Fei; Chen, Wentian; Li, Zheng] NW Univ Xian, Lab Funct Glyc, Coll Life Sci, Natl Engn Res Ctr Miniaturized Detect Syst, Xian 710069, Peoples R China	Northwest University Xi'an	Sun, SS (corresponding author), NW Univ Xian, Lab Funct Glyc, Coll Life Sci, Natl Engn Res Ctr Miniaturized Detect Syst, Xian 710069, Peoples R China.	zhengli@nwu.edu.cn	wang, qinghong/M-7969-2017; Sun, Shisheng/P-5027-2019; Wang, Qinzhe/AAA-2964-2020	Sun, Shisheng/0000-0002-7242-7164	International S&T Cooperation Program [2009DFA32730]; Key Science and Technology Program of the Shaanxi Province of China [2010K12-02(5)]	International S&T Cooperation Program; Key Science and Technology Program of the Shaanxi Province of China	This work was supported by the International S&T Cooperation Program (2009DFA32730) and the Key Science and Technology Program (2010K12-02(5)) of the Shaanxi Province of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2004, J VIROL, V78, P9605, DOI 10.1128/JVI.78.18.9605-9611.2004; AIR GM, 1989, COLD SH Q B, V54, P247; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; Blake TA, 2009, ANAL CHEM, V81, P3109, DOI 10.1021/ac900095h; Bohne-Lang A, 2005, NUCLEIC ACIDS RES, V33, pW214, DOI 10.1093/nar/gki385; BOSCH FX, 1981, VIROLOGY, V113, P725, DOI 10.1016/0042-6822(81)90201-4; Chang SH, 2007, NUCLEIC ACIDS RES, V35, pD376, DOI 10.1093/nar/gkl779; COLMAN PM, 1983, NATURE, V303, P41, DOI 10.1038/303041a0; Das SR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001211; DeLano W.L., 2002, PYMOL OPEN SOURCE MO; DESHPANDE KL, 1987, P NATL ACAD SCI USA, V84, P36, DOI 10.1073/pnas.84.1.36; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Francis T, 1940, J EXP MED, V72, P717, DOI 10.1084/jem.72.6.717; Gambaryan AS, 1998, VIROLOGY, V247, P170, DOI 10.1006/viro.1998.9224; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Gao YW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000709; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Igarashi M, 2008, VIROLOGY, V376, P323, DOI 10.1016/j.virol.2008.03.036; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Lin TW, 2009, VIROLOGY, V392, P73, DOI 10.1016/j.virol.2009.06.028; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Matsuoka Y, 2009, J VIROL, V83, P4704, DOI 10.1128/JVI.01987-08; Mishin VP, 2005, J VIROL, V79, P12416, DOI 10.1128/JVI.79.19.12416-12424.2005; MUNK K, 1992, GLYCOBIOLOGY, V2, P233, DOI 10.1093/glycob/2.3.233; Myers KP, 2007, CLIN INFECT DIS, V44, P1084, DOI 10.1086/512813; Nelson MI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000012; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; OHUCHI M, 1989, VIROLOGY, V168, P274, DOI 10.1016/0042-6822(89)90267-5; Ohuchi M, 1997, J VIROL, V71, P8377, DOI 10.1128/JVI.71.11.8377-8384.1997; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Schulze IT, 1997, J INFECT DIS S1, V176, P24; Schwarzer J, 2009, VACCINE, V27, P4325, DOI 10.1016/j.vaccine.2009.04.076; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Stuart-Harris CH, 1939, LANCET, V1, P497; Varghese JN, 1983, NATURE, P303; Vigerust DJ, 2007, J VIROL, V81, P8593, DOI 10.1128/JVI.00769-07; Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003; Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106; Wei CJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000799; Wu ZLL, 2009, BIOCHEM BIOPH RES CO, V379, P749, DOI 10.1016/j.bbrc.2008.12.139; Zhang H, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r73; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106; Zhirnov OP, 2009, J CLIN VIROL, V45, P322, DOI 10.1016/j.jcv.2009.05.030; Zimmer SM, 2009, NEW ENGL J MED, V361, P279, DOI 10.1056/NEJMra0904322	50	73	88	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22844	10.1371/journal.pone.0022844	http://dx.doi.org/10.1371/journal.pone.0022844			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829533	Green Published, Green Submitted, gold			2022-12-25	WOS:000293284600057
J	Simon, JC; Boutin, S; Tsuchida, T; Koga, R; Le Gallic, JF; Frantz, A; Outreman, Y; Fukatsu, T				Simon, Jean-Christophe; Boutin, Sebastien; Tsuchida, Tsutomu; Koga, Ryuichi; Le Gallic, Jean-Francois; Frantz, Adrien; Outreman, Yannick; Fukatsu, Takema			Facultative Symbiont Infections Affect Aphid Reproduction	PLOS ONE			English	Article							ACYRTHOSIPHON-PISUM HARRIS; MALE-KILLING BACTERIA; LIFE-HISTORY TRAITS; PEA APHID; HORIZONTAL TRANSFER; HOST-POPULATIONS; ECOLOGICAL SPECIALIZATION; ENDOSYMBIOTIC BACTERIA; GENETIC-VARIATION; MYZUS-PERSICAE	Some bacterial symbionts alter their hosts reproduction through various mechanisms that enhance their transmission in the host population. In addition to its obligatory symbiont Buchnera aphidicola, the pea aphid Acyrthosiphon pisum harbors several facultative symbionts influencing several aspects of host ecology. Aphids reproduce by cyclical parthenogenesis whereby clonal and sexual reproduction alternate within the annual life cycle. Many species, including the pea aphid, also show variation in their reproductive mode at the population level, with some lineages reproducing by cyclical parthenogenesis and others by permanent parthenogenesis. While the role of facultative symbionts has been well studied during the parthenogenetic phase of their aphid hosts, very little is known on their possible influence during the sexual phase. Here we investigated whether facultative symbionts modulate the capacity to produce sexual forms in various genetic backgrounds of the pea aphid with controlled symbiont composition and also in different aphid genotypes from natural populations with previously characterized infection status and reproductive mode. We found that most facultative symbionts exhibited detrimental effects on their hosts fitness under sex-inducing conditions in comparison with the reference lines. We also showed that the loss of sexual phase in permanently parthenogenetic lineages of A. pisum was not explained by facultative symbionts. Finally, we demonstrated that Spiroplasma infection annihilated the production of males in the host progeny by inducing a male-killing phenotype, an unexpected result for organisms such as aphids that reproduce primarily through clonal reproduction.	[Simon, Jean-Christophe; Boutin, Sebastien; Le Gallic, Jean-Francois; Outreman, Yannick] Univ Rennes 1, INRA Agrocampus Ouest, UMR 1099, INRA, Le Rheu, France; [Tsuchida, Tsutomu; Koga, Ryuichi; Fukatsu, Takema] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan; [Tsuchida, Tsutomu] Toyama Univ, Toyama Support Ctr Young Principal Investigators, Toyama 930, Japan; [Frantz, Adrien] Univ Paris 06, UMR 7625, Paris, France	INRAE; Institut Agro; Agrocampus Ouest; Universite de Rennes; National Institute of Advanced Industrial Science & Technology (AIST); University of Toyama; UDICE-French Research Universities; Sorbonne Universite	Simon, JC (corresponding author), Univ Rennes 1, INRA Agrocampus Ouest, UMR 1099, INRA, Agrocampus Ouest, Le Rheu, France.	jean-christophe.simon@rennes.inra.fr	Simon, Jean-Christophe/I-2700-2014; Yannick, OUTREMAN/B-9309-2012; Boutin, Sébastien/AAX-5334-2021; FRANTZ, Adrien/P-7008-2015; , AGROCAMPUS OUEST/O-6651-2016	Yannick, OUTREMAN/0000-0002-7337-3049; Boutin, Sébastien/0000-0002-0499-2460; FRANTZ, Adrien/0000-0002-3508-9047; , AGROCAMPUS OUEST/0000-0002-1800-4558	Egide (France); JAPS (Japan) [09887QE]	Egide (France); JAPS (Japan)	This work received support from Egide (France) and JAPS (Japan) through a "Sakura" project (09887QE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLACKMAN RL, 1972, B ENTOMOL RES, V62, P281, DOI 10.1017/S0007485300047726; Caillaud MC, 2002, HEREDITY, V89, P346, DOI 10.1038/sj.hdy.6800146; Carletto J, 2008, ENTOMOL EXP APPL, V129, P228, DOI 10.1111/j.1570-7458.2008.00760.x; Chen DQ, 2000, ENTOMOL EXP APPL, V95, P315, DOI 10.1023/A:1004083324807; Chen DQ, 1997, CURR MICROBIOL, V34, P220, DOI 10.1007/s002849900172; Chiel E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004767; Dedryver CA, 1998, ECOL ENTOMOL, V23, P123, DOI 10.1046/j.1365-2311.1998.00113.x; Degnan PH, 2010, ENVIRON MICROBIOL, V12, P2060, DOI 10.1111/j.1462-2920.2009.02085.x; Dion E, 2011, BIOL LETTERS, V7, P743, DOI 10.1098/rsbl.2011.0249; Douglas AE, 2006, PHYSIOL ENTOMOL, V31, P262, DOI 10.1111/j.1365-3032.2006.00516.x; Dunbar HE, 2007, PLOS BIOL, V5, P1006, DOI 10.1371/journal.pbio.0050096; Dyer KA, 2004, GENETICS, V168, P1443, DOI 10.1534/genetics.104.027854; Engelstadter J, 2007, GENETICS, V175, P245, DOI 10.1534/genetics.106.060921; Engelstadter J, 2009, ANNU REV ECOL EVOL S, V40, P127, DOI 10.1146/annurev.ecolsys.110308.120206; Ferrari J, 2007, OECOLOGIA, V153, P323, DOI 10.1007/s00442-007-0730-2; Frantz A, 2006, J EVOLUTION BIOL, V19, P392, DOI 10.1111/j.1420-9101.2005.01025.x; Frantz A, 2010, B ENTOMOL RES, V100, P59, DOI 10.1017/S0007485309006750; Frantz A, 2006, P R SOC B, V273, P2887, DOI 10.1098/rspb.2006.3665; Frantz A, 2009, BIOL J LINN SOC, V97, P718, DOI 10.1111/j.1095-8312.2009.01221.x; Fukatsu T, 2001, APPL ENVIRON MICROB, V67, P1284, DOI 10.1128/AEM.67.3.1284-1291.2001; Gomez-Valero L, 2004, J BACTERIOL, V186, P6626, DOI 10.1128/JB.186.19.6626-6633.2004; Guay JF, 2009, J INSECT PHYSIOL, V55, P919, DOI 10.1016/j.jinsphys.2009.06.006; Haynes S, 2003, APPL ENVIRON MICROB, V69, P7216, DOI 10.1128/AEM.69.12.7216-7223.2003; Huigens ME, 2004, P ROY SOC B-BIOL SCI, V271, P509, DOI 10.1098/rspb.2003.2640; HURST GDD, 1993, HEREDITY, V71, P81, DOI 10.1038/hdy.1993.110; Hurst GDD, 2000, EMERG INFECT DIS, V6, P329, DOI 10.3201/eid0604.000402; Koga R, 2003, P ROY SOC B-BIOL SCI, V270, P2543, DOI 10.1098/rspb.2003.2537; Koga R, 2007, FEMS MICROBIOL ECOL, V60, P229, DOI 10.1111/j.1574-6941.2007.00284.x; Le Trionnaire G, 2007, INSECT BIOCHEM MOLEC, V37, P1094, DOI 10.1016/j.ibmb.2007.06.008; Leonardo TE, 2006, P ROY SOC B-BIOL SCI, V273, P1079, DOI 10.1098/rspb.2005.3408; Leonardo TE, 2004, ECOL LETT, V7, P461, DOI 10.1111/j.1461-0248.2004.00602.x; LETRIONNAIRE G, 2009, BMC GENOMICS, V10, P14; McLean AHC, 2011, P ROY SOC B-BIOL SCI, V278, P760, DOI 10.1098/rspb.2010.1654; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Moran NA, 2006, P NATL ACAD SCI USA, V103, P12803, DOI 10.1073/pnas.0605772103; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Oliver KM, 2009, SCIENCE, V325, P992, DOI 10.1126/science.1174463; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P7495, DOI 10.1073/pnas.0811117106; *R DEV COR TEAM, 2008, R FUND STAT COMP; Rispe C, 1999, OIKOS, V86, P254, DOI 10.2307/3546443; Russell JA, 2005, APPL ENVIRON MICROB, V71, P7987, DOI 10.1128/AEM.71.12.7987-7994.2005; Russell JA, 2003, MOL ECOL, V12, P1061, DOI 10.1046/j.1365-294X.2003.01780.x; Sakurai M, 2005, APPL ENVIRON MICROB, V71, P4069, DOI 10.1128/AEM.71.7.4069-4075.2005; Sandstrom JP, 2001, MOL ECOL, V10, P217, DOI 10.1046/j.1365-294X.2001.01189.x; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Simon JC, 2007, ECOL ENTOMOL, V32, P296, DOI 10.1111/j.1365-2311.2007.00868.x; Simon JC, 2003, P ROY SOC B-BIOL SCI, V270, P1703, DOI 10.1098/rspb.2003.2430; Simon JC, 2002, TRENDS ECOL EVOL, V17, P34, DOI 10.1016/S0169-5347(01)02331-X; Simon JC, 1999, MOL ECOL, V8, P531, DOI 10.1046/j.1365-294x.1999.00583.x; Tsuchida T, 2004, SCIENCE, V303, P1989, DOI 10.1126/science.1094611; Tsuchida T, 2002, MOL ECOL, V11, P2123, DOI 10.1046/j.1365-294X.2002.01606.x; Tsuchida T, 2010, SCIENCE, V330, P1102, DOI 10.1126/science.1195463; von Burg S, 2008, P ROY SOC B-BIOL SCI, V275, P1089, DOI 10.1098/rspb.2008.0018; Vorburger C, 2009, EVOLUTION, V63, P1439, DOI 10.1111/j.1558-5646.2009.00660.x	57	126	131	0	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e21831	10.1371/journal.pone.0021831	http://dx.doi.org/10.1371/journal.pone.0021831			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818272	Green Published, Green Submitted, gold			2022-12-25	WOS:000293282700011
J	Cleghorn, WM; Tsakem, EL; Song, XF; Vishnivetskiy, SA; Seo, J; Chen, J; Gurevich, EV; Gurevich, VV				Cleghorn, Whitney M.; Tsakem, Elviche L.; Song, Xiufeng; Vishnivetskiy, Sergey A.; Seo, Jungwon; Chen, Jeannie; Gurevich, Eugenia V.; Gurevich, Vsevolod V.			Progressive Reduction of its Expression in Rods Reveals Two Pools of Arrestin-1 in the Outer Segment with Different Roles in Photoresponse Recovery	PLOS ONE			English	Article							VISUAL ARRESTIN; IN-VIVO; MULTIPLE PHOSPHORYLATION; MONOMERIC RHODOPSIN; DIRECT BINDING; S-ANTIGEN; PHOTORECEPTOR; INACTIVATION; MICROTUBULES; TRANSDUCTION	Light-induced rhodopsin signaling is turned off with sub-second kinetics by rhodopsin phosphorylation followed by arrestin-1 binding. To test the availability of the arrestin-1 pool in dark-adapted outer segment (OS) for rhodopsin shutoff, we measured photoresponse recovery rates of mice with arrestin-1 content in the OS of 2.5%, 5%, 60%, and 100% of wild type (WT) level by two-flash ERG with the first (desensitizing) flash at 160, 400, 1000, and 2500 photons/rod. The time of half recovery (t(half)) in WT retinas increases with the intensity of the initial flash, becoming, similar to 2.5-fold longer upon activation of 2500 than after 160 rhodopsins/rod. Mice with 60% and even 5% of WT arrestin-1 level recovered at WT rates. In contrast, the mice with 2.5% of WT arrestin-1 had a dramatically slower recovery than the other three lines, with the t(half) increasing, similar to 28 fold between 160 and 2500 rhodopsins/rod. Even after the dimmest flash, the rate of recovery of rods with 2.5% of normal arrestin-1 was two times slower than in other lines, indicating that arrestin-1 level in the OS between 100% and 5% of WT is sufficient for rapid recovery, whereas with lower arrestin-1 the rate of recovery dramatically decreases with increased light intensity. Thus, the OS has two distinct pools of arrestin-1: cytoplasmic and a separate pool comprising, similar to 2.5% that is not immediately available for rhodopsin quenching. The observed delay suggests that this pool is localized at the periphery, so that its diffusion across the OS rate-limits the recovery. The line with very low arrestin-1 expression is the first where rhodopsin inactivation was made rate-limiting by arrestin manipulation.	[Cleghorn, Whitney M.; Tsakem, Elviche L.; Song, Xiufeng; Vishnivetskiy, Sergey A.; Seo, Jungwon; Gurevich, Eugenia V.; Gurevich, Vsevolod V.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37235 USA; [Chen, Jeannie] Univ So Calif, Dept Cell & Neurobiol, Los Angeles, CA USA	Vanderbilt University; University of Southern California	Cleghorn, WM (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37235 USA.	Vsevolod.Gurevich@vanderbilt.edu	Gurevich, Vsevolod/A-3236-2008; Vishnivetskiy, Sergey/AAJ-8661-2020	Gurevich, Vsevolod/0000-0002-3950-5351; 	National Institutes of Health [T32 EY07135, EY011500, GM077561, GM081756, NS045117, NS065868, EY012155, EY008126]; NATIONAL EYE INSTITUTE [T32EY007135, P30EY008126, R01EY012155, R01EY011500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081756, R01GM077561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065868, R01NS045117] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by National Institutes of Health grants T32 EY07135 (WMC), EY011500, GM077561, and GM081756 (VVG), NS045117 and NS065868 (EVG), EY012155 (JC), and P30 core grant in vision research EY008126 (to Vanderbilt University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MR, 2011, BIOCHEMISTRY-US, V50, P3749, DOI 10.1021/bi200175q; Bayburt TH, 2011, J BIOL CHEM, V286, P1420, DOI 10.1074/jbc.M110.151043; BIRCH DG, 1995, INVEST OPHTH VIS SCI, V36, P1603; BROEKHUYSE RM, 1985, CURR EYE RES, V4, P613, DOI 10.3109/02713688508999993; Burns ME, 2010, PHYSIOLOGY, V25, P72, DOI 10.1152/physiol.00001.2010; Burns ME, 2009, BIOPHYS J, V97, P1538, DOI 10.1016/j.bpj.2009.06.037; Calvert PD, 2001, NATURE, V411, P90, DOI 10.1038/35075083; Caruso G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001031; Chen CK, 2010, J NEUROSCI, V30, P1213, DOI 10.1523/JNEUROSCI.4353-09.2010; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; CHEN J, 1995, SCIENCE, V267, P374, DOI 10.1126/science.7824934; Doan T, 2009, J NEUROSCI, V29, P11867, DOI 10.1523/JNEUROSCI.0819-09.2009; Eckmiller MS, 2000, VISUAL NEUROSCI, V17, P711, DOI 10.1017/S0952523800175054; ELIAS RV, 2004, MOL VIS, V10; Gross OP, 2010, J NEUROSCI, V30, P3450, DOI 10.1523/JNEUROSCI.5391-09.2010; Gurevich Vsevolod V., 2008, P55; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; GUREVICH VV, 1995, J BIOL CHEM, V270, P6010, DOI 10.1074/jbc.270.11.6010; Hanson SM, 2006, J BIOL CHEM, V281, P9765, DOI 10.1074/jbc.M510738200; Hanson SM, 2006, J BIOL CHEM, V281, P3458, DOI 10.1074/jbc.M512148200; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hanson SM, 2008, STRUCTURE, V16, P924, DOI 10.1016/j.str.2008.03.006; Hanson SM, 2007, J MOL BIOL, V368, P375, DOI 10.1016/j.jmb.2007.02.053; Hanson SM, 2007, EMBO J, V26, P1726, DOI 10.1038/sj.emboj.7601614; Hanson SM, 2007, P NATL ACAD SCI USA, V104, P3125, DOI 10.1073/pnas.0610886104; Hetling JR, 1999, J PHYSIOL-LONDON, V516, P593, DOI 10.1111/j.1469-7793.1999.0593v.x; Huang SP, 2010, J NEUROSCI, V30, P9381, DOI 10.1523/JNEUROSCI.1207-10.2010; Imamoto Y, 2003, BIOPHYS J, V85, P1186, DOI 10.1016/S0006-3495(03)74554-8; KIM M, 2011, BIOCHEMISTR IN PRESS, V50; Kim M, 2011, BIOCHEMISTRY-US, V50, P2235, DOI 10.1021/bi1018607; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; Krupnick JG, 1997, J BIOL CHEM, V272, P18125, DOI 10.1074/jbc.272.29.18125; Luo DG, 2008, P NATL ACAD SCI USA, V105, P9855, DOI 10.1073/pnas.0708405105; Lyubarsky AL, 2002, VISION RES, V42, P401, DOI 10.1016/S0042-6989(01)00214-0; Lyubarsky AL, 2004, VISION RES, V44, P3235, DOI 10.1016/j.visres.2004.09.019; Lyubarsky AL, 1996, J NEUROSCI, V16, P563, DOI 10.1523/jneurosci.16-02-00563.1996; Makino CL, 2003, CURR OPIN NEUROBIOL, V13, P404, DOI 10.1016/S0959-4388(03)00091-6; McGinnis JF, 2002, J NEUROSCI RES, V67, P290, DOI 10.1002/jnr.10120; Mendez A, 2000, NEURON, V28, P153, DOI 10.1016/S0896-6273(00)00093-3; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; Nair KS, 2004, J BIOL CHEM, V279, P41240, DOI 10.1074/jbc.M406768200; Nikonov SS, 2008, NEURON, V59, P462, DOI 10.1016/j.neuron.2008.06.011; NIR I, 1993, EXP EYE RES, V57, P307, DOI 10.1006/exer.1993.1129; NIR I, 1992, J HISTOCHEM CYTOCHEM, V40, P343, DOI 10.1177/40.3.1372630; Orisme W, 2010, CELL SIGNAL, V22, P447, DOI 10.1016/j.cellsig.2009.10.016; Peet JA, 2004, J CELL SCI, V117, P3049, DOI 10.1242/jcs.01167; PEPPERBERG DR, 1992, VISUAL NEUROSCI, V8, P9, DOI 10.1017/S0952523800006441; Pepperberg DR, 1997, VISUAL NEUROSCI, V14, P73, DOI 10.1017/S0952523800008774; PHILP NJ, 1987, FEBS LETT, V225, P127, DOI 10.1016/0014-5793(87)81144-4; Pugh E.N., 2000, HDB BIOL PHYS, V3, P183, DOI DOI 10.1016/S1383-8121(00)80008-1; Robson JG, 1996, J OPT SOC AM A, V13, P613, DOI 10.1364/JOSAA.13.000613; ROBSON JG, 1995, VISUAL NEUROSCI, V12, P837, DOI 10.1017/S0952523800009408; Schubert C, 1999, J BIOL CHEM, V274, P21186, DOI 10.1074/jbc.274.30.21186; Shen L, 2010, IET SYST BIOL, V4, P12, DOI 10.1049/iet-syb.2008.0154; Slepak VZ, 2008, IUBMB LIFE, V60, P2, DOI 10.1002/iub.7; Smith WC, 2011, INVEST OPHTH VIS SCI, V52, P1832, DOI 10.1167/iovs.10-5724; Song X, 2011, NEUROSCIENCE, V174, P37, DOI 10.1016/j.neuroscience.2010.11.009; Song XF, 2006, J BIOL CHEM, V281, P21491, DOI 10.1074/jbc.M603659200; Song X, 2009, CURR BIOL, V19, P700, DOI 10.1016/j.cub.2009.02.065; Strissel KJ, 2006, J NEUROSCI, V26, P1146, DOI 10.1523/JNEUROSCI.4289-05.2006; Tsukamoto H, 2010, J MOL BIOL, V399, P501, DOI 10.1016/j.jmb.2010.04.029; Vishnivetskiy SA, 2004, J BIOL CHEM, V279, P1262, DOI 10.1074/jbc.M308834200; VISHNIVETSKIY SA, 2011, J BIOL CHEM IN PRESS, V286; Vishnivetskiy SA, 2007, J BIOL CHEM, V282, P32075, DOI 10.1074/jbc.M706057200; Vishnivetskiy SA, 2010, J MOL BIOL, V395, P42, DOI 10.1016/j.jmb.2009.10.058; Wen XH, 2009, BIOPHYS J, V96, P939, DOI 10.1016/j.bpj.2008.10.016; WILDEN U, 1995, BIOCHEMISTRY-US, V34, P1446, DOI 10.1021/bi00004a040; Wu N, 2006, J MOL BIOL, V364, P955, DOI 10.1016/j.jmb.2006.09.075; Xu J, 1997, NATURE, V389, P505, DOI 10.1038/39068	70	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e22797	10.1371/journal.pone.0022797	http://dx.doi.org/10.1371/journal.pone.0022797			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21818392	Green Published, gold, Green Submitted			2022-12-25	WOS:000293175100050
J	Glendinning, SK; Buckingham, SD; Sattelle, DB; Wonnacott, S; Wolstenholme, AJ				Glendinning, Susan K.; Buckingham, Steven D.; Sattelle, David B.; Wonnacott, Susan; Wolstenholme, Adrian J.			Glutamate-Gated Chloride Channels of Haemonchus contortus Restore Drug Sensitivity to Ivermectin Resistant Caenorhabditis elegans	PLOS ONE			English	Article							STRONGYLOIDES-STERCORALIS; PARASITIC NEMATODES; BRUGIA-MALAYI; TRANSGENE EXPRESSION; TRANSCRIPTION FACTOR; FUNCTIONAL-ANALYSIS; RNA INTERFERENCE; GENE; SUBUNITS; RECEPTOR	Anthelmintic resistance is a major problem in livestock farming, especially of small ruminants, but our understanding of it has been limited by the difficulty in carrying out functional genetic studies on parasitic nematodes. An important nematode infecting sheep and goats is Haemonchus contortus; in many parts of the world this species is resistant to almost all the currently available drugs, including ivermectin. It is extremely polymorphic and to date it has proved impossible to relate any sequence polymorphisms to its ivermectin resistance status. Expression of candidate drug-resistance genes in Caenorhabditis elegans could provide a convenient means to study the effects of polymorphisms found in resistant parasites, but may be complicated by differences between the gene families of target and model organisms. We tested this using the glutamate-gated chloride channel (GluCl) gene family, which forms the ivermectin drug target and are candidate resistance genes. We expressed GluCl subunits from C. elegans and H. contortus in a highly resistant triple mutant C. elegans strain (DA1316) under the control of the avr-14 promoter; expression of GFP behind this promoter recapitulated the pattern previously reported for avr-14. Expression of ivermectin-sensitive subunits from both species restored drug sensitivity to transgenic worms, though some quantitative differences were noted between lines. Expression of an ivermectin-insensitive subunit, Hco-GLC-2, had no effect on drug sensitivity. Expression of a previously uncharacterised parasite-specific subunit, Hco-GLC-6, caused the transgenic worms to become ivermectin sensitive, suggesting that this subunit also encodes a GluCl that responds to the drug. These results demonstrate that both orthologous and paralogous subunits from C. elegans and H. contortus are able to rescue the ivermectin sensitivity of mutant C. elegans, though some quantitative differences were observed between transgenic lines in some assays. C. elegans is a suitable system for studying parasitic nematode genes that may be involved in drug resistance.	[Glendinning, Susan K.; Wonnacott, Susan; Wolstenholme, Adrian J.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Buckingham, Steven D.] Univ Oxford Wadham Coll, Oxford OX1 3PN, England; [Sattelle, David B.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Wolstenholme, Adrian J.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA; [Wolstenholme, Adrian J.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA	University of Bath; University of Oxford; University of Manchester; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Glendinning, SK (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	adrianw@uga.edu	Wolstenholme, Adrian/AAY-1611-2020	Wolstenholme, Adrian/0000-0001-7989-3929	Wellcome Trust [083921]; NIH National Center for Research Resources	Wellcome Trust(Wellcome TrustEuropean Commission); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by an award from the Wellcome Trust, Reference 083921 (www.wellcome.ac.uk). Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beech RN, 2010, TRENDS PARASITOL, V26, P334, DOI 10.1016/j.pt.2010.04.003; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Britton C, 2002, MOL BIOCHEM PARASIT, V122, P21, DOI 10.1016/S0166-6851(02)00066-X; Britton C, 2006, INT J PARASITOL, V36, P651, DOI 10.1016/j.ijpara.2006.02.010; Brooker S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000779; Buckingham SD, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-84; Castelletto ML, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000370; Cheeseman CL, 2001, MOL BIOCHEM PARASIT, V114, P161, DOI 10.1016/S0166-6851(01)00258-4; Churcher TS, 2009, P NATL ACAD SCI USA, V106, P16716, DOI 10.1073/pnas.0906176106; Cook A, 2006, MOL BIOCHEM PARASIT, V147, P118, DOI 10.1016/j.molbiopara.2006.02.003; Couthier A, 2004, MOL BIOCHEM PARASIT, V133, P241, DOI 10.1016/j.molbiopara.2003.10.012; Crook M, 2010, INT J PARASITOL, V40, P1675, DOI 10.1016/j.ijpara.2010.07.003; CULLY DF, 1994, NATURE, V371, P707, DOI 10.1038/371707a0; Cully DF, 1996, PARASITOLOGY, V113, pS191, DOI 10.1017/S0031182000077970; Dent JA, 2000, P NATL ACAD SCI USA, V97, P2674, DOI 10.1073/pnas.97.6.2674; Dent JA, 1997, EMBO J, V16, P5867, DOI 10.1093/emboj/16.19.5867; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; Forrester SG, 2004, BIOCHEM PHARMACOL, V67, P1019, DOI 10.1016/j.bcp.2003.08.047; Fox LM, 2006, CURR OPIN INFECT DIS, V19, P588, DOI 10.1097/QCO.0b013e328010774c; Geary TG, 2010, INT J PARASITOL, V40, P1, DOI 10.1016/j.ijpara.2009.11.001; Geldhof P, 2007, PARASITOLOGY, V134, P609, DOI 10.1017/S0031182006002071; Gillan V, 2009, INT J PARASITOL, V39, P1071, DOI 10.1016/j.ijpara.2009.02.024; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Horoszok L, 2001, BRIT J PHARMACOL, V132, P1247, DOI 10.1038/sj.bjp.0703937; Jagannathan S, 1999, MOL BIOCHEM PARASIT, V103, P129, DOI 10.1016/S0166-6851(99)00120-6; Junio AB, 2008, EXP PARASITOL, V118, P253, DOI 10.1016/j.exppara.2007.08.018; Kampkotter A, 2003, J MOL BIOL, V325, P25, DOI 10.1016/S0022-2836(02)01174-9; Kaplan RM, 2004, TRENDS PARASITOL, V20, P477, DOI 10.1016/j.pt.2004.08.001; KWA MSG, 1995, J MOL BIOL, V246, P500, DOI 10.1006/jmbi.1994.0102; Laughton DL, 1997, GENE, V201, P119, DOI 10.1016/S0378-1119(97)00436-8; Laughton DL, 1997, J EXP BIOL, V200, P1509; Liu CH, 2007, MOL BIOCHEM PARASIT, V156, P62, DOI 10.1016/j.molbiopara.2007.07.012; Lok JB, 2008, PARASITE IMMUNOL, V30, P203, DOI 10.1111/j.1365-3024.2008.01006.x; Lok JB, 2002, MOL BIOCHEM PARASIT, V119, P279, DOI 10.1016/S0166-6851(01)00414-5; Lynagh T, 2010, INT J PARASITOL, V40, P1477, DOI 10.1016/j.ijpara.2010.07.010; Massey HC, 2006, INT J PARASITOL, V36, P347, DOI 10.1016/j.ijpara.2005.11.007; McCavera S, 2007, PARASITOLOGY, V134, P1111, DOI 10.1017/S0031182007000042; McCavera S, 2009, MOL PHARMACOL, V75, P1347, DOI 10.1124/mol.108.053363; Moreno Y, 2010, P NATL ACAD SCI USA, V107, P20120, DOI 10.1073/pnas.1011983107; Njue AI, 2004, J NEUROCHEM, V89, P1137, DOI 10.1111/j.1471-4159.2004.02379.x; Omura S, 2008, INT J ANTIMICROB AG, V31, P91, DOI 10.1016/j.ijantimicag.2007.08.023; Osei-Atweneboano MY, 2007, LANCET, V369, P2021, DOI 10.1016/S0140-6736(07)60942-8; Pemberton DJ, 2001, MOL PHARMACOL, V59, P1037, DOI 10.1124/mol.59.5.1037; Portillo V, 2003, J COMP NEUROL, V462, P213, DOI 10.1002/cne.10735; Samarasinghe B, 2011, INT J PARASITOL, V41, P51, DOI 10.1016/j.ijpara.2010.07.005; Vassilatis DK, 1997, J BIOL CHEM, V272, P33167, DOI 10.1074/jbc.272.52.33167; Vercruysse J, 2002, MACROCYCLIC LACTONES; Welz C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001330; Williamson Sally M., 2007, Invertebrate Neuroscience, V7, P219, DOI 10.1007/s10158-007-0056-0; Wolstenholme AJ, 2005, PARASITOLOGY, V131, pS85, DOI 10.1017/S0031182005008218; Wolstenholme AJ, 2004, TRENDS PARASITOL, V20, P469, DOI 10.1016/j.pt.2004.07.010; Yates DM, 2003, INT J PARASITOL, V33, P1183, DOI 10.1016/S0020-7519(03)00172-3	52	53	54	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e22390	10.1371/journal.pone.0022390	http://dx.doi.org/10.1371/journal.pone.0022390			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21818319	Green Published, gold, Green Submitted			2022-12-25	WOS:000293175100024
J	Karali, M; Manfredi, A; Puppo, A; Marrocco, E; Gargiulo, A; Allocca, M; Della Corte, M; Rossi, S; Giunti, M; Bacci, ML; Simonelli, F; Surace, EM; Banfi, S; Auricchio, A				Karali, Marianthi; Manfredi, Anna; Puppo, Agostina; Marrocco, Elena; Gargiulo, Annagiusi; Allocca, Mariacarmela; Della Corte, Michele; Rossi, Settimio; Giunti, Massimo; Bacci, Maria Laura; Simonelli, Francesca; Surace, Enrico Maria; Banfi, Sandro; Auricchio, Alberto			MicroRNA-Restricted Transgene Expression in the Retina	PLOS ONE			English	Article							LEBER CONGENITAL AMAUROSIS; GENE-THERAPY; IN-VIVO; ROD; IDENTIFICATION; VISION; RHODOPSIN; VECTORS; REGION; SAFETY	Background: Gene transfer using adeno-associated viral (AAV) vectors has been successfully applied in the retina for the treatment of inherited retinal dystrophies. Recently, microRNAs have been exploited to fine-tune transgene expression improving therapeutic outcomes. Here we evaluated the ability of retinal-expressed microRNAs to restrict AAV-mediated transgene expression to specific retinal cell types that represent the main targets of common inherited blinding conditions. Methodology/Principal Findings: To this end, we generated AAV2/5 vectors expressing EGFP and containing four tandem copies of miR-124 or miR-204 complementary sequences in the 39UTR of the transgene expression cassette. These vectors were administered subretinally to adult C57BL/6 mice and Large White pigs. Our results demonstrate that miR-124 and miR-204 target sequences can efficiently restrict AAV2/5-mediated transgene expression to retinal pigment epithelium and photoreceptors, respectively, in mice and pigs. Interestingly, transgene restriction was observed at low vector doses relevant to therapy. Conclusions: We conclude that microRNA-mediated regulation of transgene expression can be applied in the retina to either restrict to a specific cell type the robust expression obtained using ubiquitous promoters or to provide an additional layer of gene expression regulation when using cell-specific promoters.	[Karali, Marianthi; Manfredi, Anna; Puppo, Agostina; Marrocco, Elena; Gargiulo, Annagiusi; Allocca, Mariacarmela; Simonelli, Francesca; Surace, Enrico Maria; Banfi, Sandro; Auricchio, Alberto] TIGEM, Naples, Italy; [Auricchio, Alberto] Univ Naples Federico II, Dept Pediat, Naples, Italy; [Banfi, Sandro] Univ Naples 2, Dept Gen Pathol, Naples, Italy; [Giunti, Massimo; Bacci, Maria Laura] Univ Bologna, Dept Vet Med Sci DSMVET, Bologna, Italy; [Della Corte, Michele; Rossi, Settimio; Simonelli, Francesca] Univ Naples 2, Dept Ophthalmol, Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II; Universita della Campania Vanvitelli; University of Bologna; Universita della Campania Vanvitelli	Karali, M (corresponding author), TIGEM, Naples, Italy.	banfi@tigem.it; auricchio@tigem.it	Banfi, Sandro/K-3963-2018; Rossi, Settimio/AHI-1119-2022; Rossi, Settimio/J-4922-2012; Simonelli, Francesca/AHE-7571-2022; AURICCHIO, Alberto/AHE-7979-2022; Bacci, Maria Laura/B-8494-2013	Banfi, Sandro/0000-0002-6541-8833; Simonelli, Francesca/0000-0001-8520-6769; AURICCHIO, Alberto/0000-0002-0832-2472; Bacci, Maria Laura/0000-0001-6702-5868; Surace, Enrico Maria/0000-0002-2975-942X; Karali, Marianthi/0000-0003-0757-3330	Fondazione Telethon; Italian Ministry of Health; European Commission ["AAVEYE" (HEALTH-2007-B-223445), "TREATRUSH" (HEALTH-F2-2010-242013)]; Marie Curie European Reintegration Grant [PERG03-GA-2008-231068]	Fondazione Telethon(Fondazione TelethonEuropean Commission); Italian Ministry of Health(Ministry of Health, Italy); European Commission(European CommissionEuropean Commission Joint Research Centre); Marie Curie European Reintegration Grant(European Commission)	This work was supported by the Fondazione Telethon, the Italian Ministry of Health and the European Commission grants "AAVEYE" (HEALTH-2007-B-223445) and "TREATRUSH" (HEALTH-F2-2010-242013) under the 7th Framework Programme. MK acknowledges financial support by a Marie Curie European Reintegration Grant (grant n. PERG03-GA-2008-231068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland GM, 2005, MOL THER, V12, P1072, DOI 10.1016/j.ymthe.2005.08.008; ALLOCCA M, 2011, INVEST OPHTHALM 0127; Allocca M, 2007, J VIROL, V81, P11372, DOI 10.1128/JVI.01327-07; Arora A, 2007, INVEST OPHTH VIS SCI, V48, P3962, DOI 10.1167/iovs.06-1221; Auricchio A, 2001, HUM MOL GENET, V10, P3075, DOI 10.1093/hmg/10.26.3075; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Bennicelli J, 2008, MOL THER, V16, P458, DOI 10.1038/sj.mt.6300389; Bernstein AM, 1999, BLOOD, V93, P571, DOI 10.1182/blood.V93.2.571.402k05_571_579; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Boulanger A, 2000, J BIOL CHEM, V275, P31274, DOI 10.1074/jbc.M003441200; Brown BD, 2007, BLOOD, V110, P4144, DOI 10.1182/blood-2007-03-078493; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Brown BD, 2009, NAT REV GENET, V10, P578, DOI 10.1038/nrg2628; BRUNETTIPIERRI N, 2010, ONLINE METABOLIC MOL; Cideciyan AV, 2009, HUM GENE THER, V20, P999, DOI 10.1089/hum.2009.086; Cideciyan AV, 2009, NEW ENGL J MED, V361, P725, DOI 10.1056/NEJMc0903652; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Colella P, 2009, TRENDS MOL MED, V15, P23, DOI 10.1016/j.molmed.2008.11.003; Colin A, 2009, GLIA, V57, P667, DOI 10.1002/glia.20795; Conte I, 2010, P NATL ACAD SCI USA, V107, P15491, DOI 10.1073/pnas.0914785107; Deo M, 2006, DEV DYNAM, V235, P2538, DOI 10.1002/dvdy.20847; Flannery JG, 1997, P NATL ACAD SCI USA, V94, P6916, DOI 10.1073/pnas.94.13.6916; Gentner B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001522; Gentner B, 2009, NAT METHODS, V6, P63, DOI [10.1038/NMETH.1277, 10.1038/nmeth.1277]; Glushakova LG, 2006, MOL VIS, V12, P298; Guduric-Fuchs J, 2009, MOL VIS, V15, P1915; HARGRAVE PA, 1992, FASEB J, V6, P2323, DOI 10.1096/fasebj.6.6.1544542; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Hendrickson A, 2002, EXP EYE RES, V74, P435, DOI 10.1006/exer.2002.1181; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; KAPLAN J, ONLINE METABOLIC MOL; Karali M, 2007, INVEST OPHTH VIS SCI, V48, P509, DOI 10.1167/iovs.06-0866; Karali M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-715; Karginov FV, 2007, P NATL ACAD SCI USA, V104, P19291, DOI 10.1073/pnas.0709971104; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Li AM, 2002, INVEST OPHTH VIS SCI, V43, P1375; Liang FQ, 2001, METH MOLEC MED, V47, P125, DOI 10.1385/1-59259-085-3:125; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Maguire AM, 2009, LANCET, V374, P1597, DOI 10.1016/S0140-6736(09)61836-5; Mohand-Said S, 2001, PROG RETIN EYE RES, V20, P451, DOI 10.1016/S1350-9462(01)00006-4; MUSSOLINO C, 2011, GENE THER       0317, DOI DOI 10.1038/GT.2011.1033; Papapetrou EP, 2009, J CLIN INVEST, V119, P157, DOI 10.1172/JCI37216; Reddy AM, 2008, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-65; Romand R, 2008, J COMP NEUROL, V508, P879, DOI 10.1002/cne.21707; Sachdeva R, 2010, P NATL ACAD SCI USA, V107, P11602, DOI 10.1073/pnas.1006568107; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; Surace EM, 2003, PROG RETIN EYE RES, V22, P705, DOI 10.1016/S1350-9462(03)00052-1; Surace EM, 2008, VISION RES, V48, P353, DOI 10.1016/j.visres.2007.07.027; Vetrini F, 2004, MOL CELL BIOL, V24, P6550, DOI 10.1128/mcb.24.15.6550-6559.2004; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Xie J, 2011, MOL THER, V19, P526, DOI 10.1038/mt.2010.279	52	54	57	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e22166	10.1371/journal.pone.0022166	http://dx.doi.org/10.1371/journal.pone.0022166			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21818300	Green Published, gold, Green Submitted			2022-12-25	WOS:000293175100015
J	Tarrio, R; Ayala, FJ; Rodriguez-Trelles, F				Tarrio, Rosa; Ayala, Francisco J.; Rodriguez-Trelles, Francisco			The Vein Patterning 1 (VEP1) Gene Family Laterally Spread through an Ecological Network	PLOS ONE			English	Article							SHORT-CHAIN DEHYDROGENASE/REDUCTASE; PROGESTERONE 5-BETA-REDUCTASE; PHYLOGENETIC CLASSIFICATION; PHYSCOMITRELLA-PATENS; COENZYME SPECIFICITY; MOLECULAR EVIDENCE; MYCORRHIZAL FUNGI; TRANSFERRED GENES; PROTEIN EVOLUTION; CRYSTAL-STRUCTURE	Lateral gene transfer (LGT) is a major evolutionary mechanism in prokaryotes. Knowledge about LGT- particularly, multicellular- eukaryotes has only recently started to accumulate. A widespread assumption sees the gene as the unit of LGT, largely because little is yet known about how LGT chances are affected by structural/functional features at the subgenic level. Here we trace the evolutionary trajectory of VEin Patterning 1, a novel gene family known to be essential for plant development and defense. At the subgenic level VEP1 encodes a dinucleotide-binding Rossmann-fold domain, in common with members of the short-chain dehydrogenase/reductase (SDR) protein family. We found: i) VEP1 likely originated in an aerobic, mesophilic and chemoorganotrophic alpha-proteobacterium, and was laterally propagated through nets of ecological interactions, including multiple LGTs between phylogenetically distant green plant/fungi-associated bacteria, and five independent LGTs to eukaryotes. Of these latest five transfers, three are ancient LGTs, implicating an ancestral fungus, the last common ancestor of land plants and an ancestral trebouxiophyte green alga, and two are recent LGTs to modern embryophytes. ii) VEP1's rampant LGT behavior was enabled by the robustness and broad utility of the dinucleotide-binding Rossmann-fold, which provided a platform for the evolution of two unprecedented departures from the canonical SDR catalytic triad. iii) The fate of VEP1 in eukaryotes has been different in different lineages, being ubiquitous and highly conserved in land plants, whereas fungi underwent multiple losses. And iv) VEP1-harboring bacteria include non-phytopathogenic and phytopathogenic symbionts which are non-randomly distributed with respect to the type of harbored VEP1 gene. Our findings suggest that VEP1 may have been instrumental for the evolutionary transition of green plants to land, and point to a LGT-mediated 'Trojan Horse' mechanism for the evolution of bacterial pathogenesis against plants. VEP1 may serve as tool for revealing microbial interactions in plant/fungi-associated environments.	[Tarrio, Rosa] Univ Santiago de Compostela, CIBERER, Genome Med Grp, Santiago De Compostela, Spain; [Rodriguez-Trelles, Francisco] Univ Autonoma Barcelona, Dept Genet & Microbiol, Grp Biol Evolut, E-08193 Barcelona, Spain; [Tarrio, Rosa; Ayala, Francisco J.; Rodriguez-Trelles, Francisco] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidade de Santiago de Compostela; Autonomous University of Barcelona; University of California System; University of California Irvine	Tarrio, R (corresponding author), Univ Santiago de Compostela, CIBERER, Genome Med Grp, Santiago De Compostela, Spain.	franciscojose.rodrigueztrelles@uab.cat	Rodriguez-Trelles, Francisco/E-7666-2016; Tarrío, Rosa/E-8305-2016	Rodriguez-Trelles, Francisco/0000-0001-6279-3630; Tarrío, Rosa/0000-0003-2814-261X	Spanish Ministerio de Ciencia e Innovacion [BFU2008-01420/BMC]; Generalitat de Catalunya [2009SGR 636]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported by the Spanish Ministerio de Ciencia e Innovacion (BFU2008-01420/BMC) and Grant 2009SGR 636 from Generalitat de Catalunya to the Grup de Biologia Evolutiva. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Allen EE, 2005, NAT REV MICROBIOL, V3, P489, DOI 10.1038/nrmicro1157; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson JO, 2005, CELL MOL LIFE SCI, V62, P1182, DOI 10.1007/s00018-005-4539-z; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Babst BA, 2009, TREE GENET GENOMES, V5, P459, DOI 10.1007/s11295-009-0200-6; Bapteste E, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-34; Bashton M, 2002, J MOL BIOL, V315, P927, DOI 10.1006/jmbi.2001.5288; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Becker B, 2009, ANN BOT-LONDON, V103, P999, DOI 10.1093/aob/mcp044; Bednarek P, 2009, SCIENCE, V324, P746, DOI 10.1126/science.1171661; Beiko RG, 2005, P NATL ACAD SCI USA, V102, P14332, DOI 10.1073/pnas.0504068102; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; Bloom JD, 2006, MOL BIOL EVOL, V23, P1751, DOI 10.1093/molbev/msl040; Boc A, 2010, SYST BIOL, V59, P195, DOI 10.1093/sysbio/syp103; Bonfante P, 2009, ANNU REV MICROBIOL, V63, P363, DOI 10.1146/annurev.micro.091208.073504; Boto L, 2010, P ROY SOC B-BIOL SCI, V277, P819, DOI 10.1098/rspb.2009.1679; Boucher Y, 2003, ANNU REV GENET, V37, P283, DOI 10.1146/annurev.genet.37.050503.084247; Bray JE, 2009, CHEM-BIOL INTERACT, V178, P99, DOI 10.1016/j.cbi.2008.10.058; Burda E, 2009, ADV SYNTH CATAL, V351, P2787, DOI 10.1002/adsc.200900024; Caetano-Anolles G, 2009, BIOCHEM J, V417, P621, DOI 10.1042/BJ20082063; Cardinale M, 2008, FEMS MICROBIOL ECOL, V66, P63, DOI 10.1111/j.1574-6941.2008.00546.x; Cardinale M, 2006, FEMS MICROBIOL ECOL, V57, P484, DOI 10.1111/j.1574-6941.2006.00133.x; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chaffron S, 2010, GENOME RES, V20, P947, DOI 10.1101/gr.104521.109; Chan CX, 2009, GENOME BIOL EVOL, V1, P429, DOI 10.1093/gbe/evp044; Chan CX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004524; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Choudhary DK, 2009, MICROBIOL RES, V164, P493, DOI 10.1016/j.micres.2008.08.007; Cordero OX, 2009, P NATL ACAD SCI USA, V106, P21748, DOI 10.1073/pnas.0907584106; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dagan T, 2007, P NATL ACAD SCI USA, V104, P870, DOI 10.1073/pnas.0606318104; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Dessailly BH, 2009, BIOCHEM SOC T, V37, P745, DOI 10.1042/BST0370745; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Draghi JA, 2010, NATURE, V463, P353, DOI 10.1038/nature08694; EDDY SR, 2010, HMMER USERS GUIDE PR; Emiliani G, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-7; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Ferrada E, 2008, P ROY SOC B-BIOL SCI, V275, P1595, DOI 10.1098/rspb.2007.1617; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Frigaard NU, 2006, NATURE, V439, P847, DOI 10.1038/nature04435; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; Galtier N, 1998, MOL BIOL EVOL, V15, P871, DOI 10.1093/oxfordjournals.molbev.a025991; Gardener BBM, 2004, PHYTOPATHOLOGY, V94, P1252, DOI 10.1094/PHYTO.2004.94.11.1252; Gardiner DM, 2004, MOL MICROBIOL, V53, P1307, DOI 10.1111/j.1365-2958.2004.04215.x; GARTNER DE, 1994, EUR J BIOCHEM, V225, P1125, DOI 10.1111/j.1432-1033.1994.1125b.x; GARTNER DE, 1990, FEBS LETT, V271, P239, DOI 10.1016/0014-5793(90)80415-F; Gavidia I, 2007, PHYTOCHEMISTRY, V68, P853, DOI 10.1016/j.phytochem.2006.11.019; Gerstein M, 1997, J MOL BIOL, V274, P562, DOI 10.1006/jmbi.1997.1412; Gherardini PF, 2010, NUCLEIC ACIDS RES, V38, P3809, DOI 10.1093/nar/gkq090; Girke T, 2004, PLANT PHYSIOL, V136, P3003, DOI 10.1104/pp.104.049965; Gogarten JP, 2003, CURR BIOL, V13, pR53, DOI 10.1016/S0960-9822(02)01426-4; Goldenfeld N, 2007, NATURE, V445, P369, DOI 10.1038/445369a; Gonzalez I, 2005, FEMS MICROBIOL ECOL, V54, P401, DOI 10.1016/j.femsec.2005.05.004; Gottig N, 2008, P NATL ACAD SCI USA, V105, P18631, DOI 10.1073/pnas.0810107105; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; GRIMONT PAD, 1978, ANNU REV MICROBIOL, V32, P221, DOI 10.1146/annurev.mi.32.100178.001253; Grube Martin, 2009, Fungal Biology Reviews, V23, P72, DOI 10.1016/j.fbr.2009.10.001; Grube M, 2009, ISME J, V3, P1105, DOI 10.1038/ismej.2009.63; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gustavsson S, 2005, PLANT PHYSIOL, V139, P287, DOI 10.1104/pp.105.063198; Hao WL, 2006, GENOME RES, V16, P636, DOI 10.1101/gr.4746406; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; HENDY MD, 1989, SYST ZOOL, V38, P297, DOI 10.2307/2992396; Herl V, 2006, PHYTOCHEMISTRY, V67, P225, DOI 10.1016/j.phytochem.2005.11.013; Hertzberg M, 2001, P NATL ACAD SCI USA, V98, P14732, DOI 10.1073/pnas.261293398; Holliday GL, 2007, J MOL BIOL, V372, P1261, DOI 10.1016/j.jmb.2007.07.034; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hooper SD, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r45; Huang JL, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r109; HUELSENBECK JP, 1993, SYST BIOL, V42, P247, DOI 10.2307/2992463; Jacobi CA, 1997, APPL ENVIRON MICROB, V63, P719, DOI 10.1128/AEM.63.2.719-723.1997; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Jornvall H, 2010, BIOCHEM BIOPH RES CO, V396, P125, DOI 10.1016/j.bbrc.2010.03.094; Jun JH, 2002, PLANT CELL PHYSIOL, V43, P323, DOI 10.1093/pcp/pcf042; Kallberg Y, 2006, FEBS J, V273, P1177, DOI 10.1111/j.1742-4658.2006.05153.x; Kallberg Y, 2002, PROTEIN SCI, V11, P636, DOI 10.1110/ps.26902; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Keeling PJ, 2009, CURR OPIN GENET DEV, V19, P613, DOI 10.1016/j.gde.2009.10.001; Kloesges T, 2011, MOL BIOL EVOL, V28, P1057, DOI 10.1093/molbev/msq297; Konagurthu AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010048; Kumar S, 2001, GENETICS, V158, P1321; Kunin V, 2005, GENOME RES, V15, P954, DOI 10.1101/gr.3666505; Kurland CG, 2003, P NATL ACAD SCI USA, V100, P9658, DOI 10.1073/pnas.1632870100; Lamb HK, 2003, J BIOL CHEM, V278, P32107, DOI 10.1074/jbc.M304104200; Lang AS, 2007, TRENDS MICROBIOL, V15, P54, DOI 10.1016/j.tim.2006.12.001; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lee MM, 2009, NUCLEIC ACIDS RES, V37, pW53, DOI 10.1093/nar/gkp301; Lewis LA, 2004, AM J BOT, V91, P1535, DOI 10.3732/ajb.91.10.1535; Liba CM, 2006, J APPL MICROBIOL, V101, P1076, DOI 10.1111/j.1365-2672.2006.03010.x; Lima WC, 2008, FEMS MICROBIOL LETT, V281, P87, DOI 10.1111/j.1574-6968.2008.01083.x; LOCKHART PJ, 1994, MOL BIOL EVOL, V11, P605; MADDISON DR, 2007, ZOOTAXA, V1668; Madera M, 2008, BIOINFORMATICS, V24, P2630, DOI 10.1093/bioinformatics/btn504; Marcet-Houben M, 2010, TRENDS GENET, V26, P5, DOI 10.1016/j.tig.2009.11.007; Martiny JBH, 2005, ECOL LETT, V8, P1334, DOI 10.1111/j.1461-0248.2005.00837.x; Moran NA, 2000, TRENDS ECOL EVOL, V15, P321, DOI 10.1016/S0169-5347(00)01902-9; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nakamura Y, 2004, NAT GENET, V36, P760, DOI 10.1038/ng1381; Nishiyama T, 2003, P NATL ACAD SCI USA, V100, P8007, DOI 10.1073/pnas.0932694100; Nobeli I, 2009, NAT BIOTECHNOL, V27, P157, DOI 10.1038/nbt1519; Nosenko T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-173; Notredame C, 2003, BIOINFORMATICS AND GENOMES: CURRENT PERSPECTIVES, P27; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Orengo CA, 1999, CURR OPIN STRUC BIOL, V9, P374, DOI 10.1016/S0959-440X(99)80051-7; Pearl F, 2005, NUCLEIC ACIDS RES, V33, pD247, DOI 10.1093/nar/gki024; Perez-Bermudez P, 2010, NEW PHYTOL, V185, P687, DOI 10.1111/j.1469-8137.2009.03080.x; Perotto S, 1997, TRENDS MICROBIOL, V5, P496, DOI 10.1016/S0966-842X(97)01154-2; Persson B, 2009, CHEM-BIOL INTERACT, V178, P94, DOI 10.1016/j.cbi.2008.10.040; Podar M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r158; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Rachid S, 2009, CHEM BIOL, V16, P70, DOI 10.1016/j.chembiol.2008.11.005; Raes J, 2007, CURR OPIN STRUC BIOL, V17, P362, DOI 10.1016/j.sbi.2007.05.010; Ragan MA, 2009, PHILOS T R SOC B, V364, P2241, DOI 10.1098/rstb.2009.0031; Ralph SG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-57; Ranea JAG, 2006, J MOL EVOL, V63, P513, DOI 10.1007/s00239-005-0289-7; Reeves GA, 2006, J MOL BIOL, V360, P725, DOI 10.1016/j.jmb.2006.05.035; Reichenbach H, 1999, ENVIRON MICROBIOL, V1, P15, DOI 10.1046/j.1462-2920.1999.00016.x; Reiter WD, 2008, CURR OPIN PLANT BIOL, V11, P236, DOI 10.1016/j.pbi.2008.03.009; Richards TA, 2009, PLANT CELL, V21, P1897, DOI 10.1105/tpc.109.065805; Riechmann L, 2006, J MOL BIOL, V363, P460, DOI 10.1016/j.jmb.2006.08.031; Rivera MC, 2004, NATURE, V431, P152, DOI 10.1038/nature02848; Roca-Perez L, 2004, PHYTOCHEMISTRY, V65, P1869, DOI 10.1016/j.phytochem.2004.05.004; Rodriguez-Trelles F, 2005, BIOESSAYS, V27, P592, DOI 10.1002/bies.20241; Rodriguez-Trelles F, 2006, ANNU REV GENET, V40, P47, DOI 10.1146/annurev.genet.40.110405.090625; Ros VID, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-20; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; Sadreyev RI, 2009, NUCLEIC ACIDS RES, V37, pW90, DOI 10.1093/nar/gkp360; Schmitt I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004437; Seifert GJ, 2004, CURR OPIN PLANT BIOL, V7, P277, DOI 10.1016/j.pbi.2004.03.004; Selbmann L, 2010, POLAR BIOL, V33, P71, DOI 10.1007/s00300-009-0686-2; Sorek R, 2007, SCIENCE, V318, P1449, DOI 10.1126/science.1147112; Stajich JE, 2009, CURR BIOL, V19, pR840, DOI 10.1016/j.cub.2009.07.004; Swindells MB, 1998, BIOESSAYS, V20, P884; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tanaka N, 1996, STRUCTURE, V4, P33, DOI 10.1016/S0969-2126(96)00007-X; Tarrio R, 2001, MOL BIOL EVOL, V18, P1464, DOI 10.1093/oxfordjournals.molbev.a003932; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Thorn A, 2008, J BIOL CHEM, V283, P17260, DOI 10.1074/jbc.M706185200; Torrents E, 2002, J MOL EVOL, V55, P138, DOI 10.1007/s00239-002-2311-7; Wagner A, 2005, FEBS LETT, V579, P1772, DOI 10.1016/j.febslet.2005.01.063; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Woese CR, 2009, MICROBIOL MOL BIOL R, V73, P14, DOI 10.1128/MMBR.00002-09; Yang KY, 1997, MOL CELLS, V7, P131; Yang S, 2005, P NATL ACAD SCI USA, V102, P373, DOI 10.1073/pnas.0408810102; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001; Zheng XF, 2007, P NATL ACAD SCI USA, V104, P8809, DOI 10.1073/pnas.0700480104	158	15	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e22279	10.1371/journal.pone.0022279	http://dx.doi.org/10.1371/journal.pone.0022279			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21818306	gold, Green Published			2022-12-25	WOS:000293175100018
J	Chen, CS; Anaya, JM; Zhang, SJ; Spurgin, J; Chuang, CY; Xu, C; Miao, AJ; Chen, EYT; Schwehr, KA; Jiang, YL; Quigg, A; Santschi, PH; Chin, WC				Chen, Chi-Shuo; Anaya, Jesse M.; Zhang, Saijin; Spurgin, Jessica; Chuang, Chia-Ying; Xu, Chen; Miao, Ai-Jun; Chen, Eric Y-T; Schwehr, Kathleen A.; Jiang, Yuelu; Quigg, Antonietta; Santschi, Peter H.; Chin, Wei-Chun			Effects of Engineered Nanoparticles on the Assembly of Exopolymeric Substances from Phytoplankton	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; EXTRACELLULAR POLYMERIC SUBSTANCES; PHAEODACTYLUM-TRICORNUTUM; DIATOM AMPHORA; PARTICLES TEP; MARINE; WATER; EPS; BACTERIA; SYSTEMS	The unique properties of engineered nanoparticles (ENs) that make their industrial applications so attractive simultaneously raise questions regarding their environmental safety. ENs exhibit behaviors different from bulk materials with identical chemical compositions. Though the nanotoxicity of ENs has been studied intensively, their unintended environmental impacts remain largely unknown. Herein we report experimental results of EN interactions with exopolymeric substances (EPS) from three marine phytoplankton species: Amphora sp., Ankistrodesmus angustus and Phaeodactylum tricornutum. EPS are polysaccharide-rich anionic colloid polymers released by various microorganisms that can assemble into microgels, possibly by means of hydrophobic and ionic mechanisms. Polystyrene nanoparticles (23 nm) were used in our study as model ENs. The effects of ENs on EPS assembly were monitored with dynamic laser scattering (DLS). We found that ENs can induce significant acceleration in Amphora sp. EPS assembly; after 72 hours EN-EPS aggregation reached equilibrium, forming microscopic gels of similar to 4-6 mu m in size. In contrast, ENs only cause moderate assembly kinetic acceleration for A. angustus and P. tricornutum EPS samples. Our results indicate that the effects of ENs on EPS assembly kinetics mainly depend on the hydrophobic interactions of ENs with EPS polymers. The cycling mechanism of EPS is complex. Nonetheless, the change of EPS assembly kinetics induced by ENs can be considered as one potential disturbance to the marine carbon cycle.	[Chen, Chi-Shuo; Anaya, Jesse M.; Chen, Eric Y-T; Chin, Wei-Chun] Univ Calif, Merced, CA 95343 USA; [Zhang, Saijin; Spurgin, Jessica; Chuang, Chia-Ying; Xu, Chen; Schwehr, Kathleen A.; Jiang, Yuelu; Quigg, Antonietta; Santschi, Peter H.] Texas A&M Univ, Dept Marine Sci, Galveston, TX 77553 USA; [Quigg, Antonietta] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA; [Zhang, Saijin; Spurgin, Jessica; Chuang, Chia-Ying; Xu, Chen; Schwehr, Kathleen A.; Jiang, Yuelu; Quigg, Antonietta; Santschi, Peter H.] Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA; [Miao, Ai-Jun] Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing 210008, Jiangsu Prov, Peoples R China	University of California System; University of California Merced; Texas A&M University System; Texas A&M University System; Texas A&M University System; Texas A&M University College Station; Nanjing University	Chen, CS (corresponding author), Univ Calif, Merced, CA 95343 USA.	wchin2@ucmerced.edu	Chin, Wei-Chun/A-6068-2008; Schwehr, Kathy/AAF-2713-2021; Jiang, Yuelu/G-4062-2012; Chuang, Chia Ying/AAP-4605-2021; Anaya, Juan-Manuel/J-1960-2016; Quigg, Antonietta S/A-9345-2010; zhang, saijin/A-4986-2013; Santschi, Peter H/D-5712-2012; Jiang, Yuelu/AHI-0383-2022	Chin, Wei-Chun/0000-0003-4881-9085; Jiang, Yuelu/0000-0002-7448-4410; Chuang, Chia Ying/0000-0002-2619-438X; Anaya, Juan-Manuel/0000-0002-6444-1249; Santschi, Peter H/0000-0001-8188-7691; Jiang, Yuelu/0000-0002-7448-4410; Schwehr, Kathleen A./0000-0001-9721-2314	National Science Foundation [CBET-0933137, CBET-0932404, NA10OAR4170060]; National Center on Minority Health and Health Disparities [1P20MD005049]; UC Merced; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD005049] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Center on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); UC Merced; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in part, by the National Science Foundation to Peter H. Santschi and Antonietta Quigg (CBET-0933137), and to Wei-Chun Chin (CBET-0932404) and California Sea Grant (NA10OAR4170060) to Wei-Chun Chin. CSC, JMA and EYTC were supported by UC Merced Center of Excellence on Health Disparities (1P20MD005049-01 from the National Center on Minority Health and Health Disparities), UC LEADS program, California Sea Grant trainee program and GRC summer fellowship from UC Merced. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAN R, 1987, ARCH HYDROBIOL, V110, P321; Artham T, 2009, INT BIODETER BIODEGR, V63, P884, DOI 10.1016/j.ibiod.2009.03.003; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Azam F, 2001, NATURE, V414, P495, DOI 10.1038/35107174; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; BAINES SB, 1991, LIMNOL OCEANOGR, V36, P1078, DOI 10.4319/lo.1991.36.6.1078; Bhaskar PV, 2005, CURR SCI INDIA, V88, P45; Bhattacharya P, 2010, J PHYS CHEM C, V114, P16556, DOI 10.1021/jp1054759; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; CHEN EYT, PLOS ONE, V5; Chin WC, 1998, NATURE, V391, P568, DOI 10.1038/35345; Chisholm SW, 2000, NATURE, V407, P685, DOI 10.1038/35037696; CONNER AJ, 1981, ENVIRON EXP BOT, V21, P241, DOI 10.1016/0098-8472(81)90031-9; COOKSEY KE, 1995, AQUAT MICROB ECOL, V9, P87, DOI 10.3354/ame009087; DANIEL GF, 1980, HELGOLANDER MEERESUN, V34, P123, DOI 10.1007/BF01984035; De Gennes P.-G., 1979, SCALING CONCEPTS POL; De Martino A, 2007, J PHYCOL, V43, P992, DOI 10.1111/j.1529-8817.2007.00384.x; DEGENNES PG, 1982, ANNU REV PHYS CHEM, V33, P49, DOI 10.1146/annurev.pc.33.100182.000405; Derraik JGB, 2002, MAR POLLUT BULL, V44, P842, DOI 10.1016/S0025-326X(02)00220-5; Dickinson E, 2003, FOOD HYDROCOLLOID, V17, P25, DOI 10.1016/S0268-005X(01)00120-5; Ding YX, 2007, MAR CHEM, V106, P456, DOI 10.1016/j.marchem.2007.04.005; Ding YX, 2009, TERR ATMOS OCEAN SCI, V20, P741, DOI 10.3319/TAO.2008.08.26.01(Oc); Ding YX, 2008, MAR CHEM, V112, P11, DOI 10.1016/j.marchem.2008.05.003; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; Ferry JL, 2009, NAT NANOTECHNOL, V4, P441, DOI [10.1038/NNANO.2009.157, 10.1038/nnano.2009.157]; Flemming HC, 2007, J BACTERIOL, V189, P7945, DOI 10.1128/JB.00858-07; FLEMMING HC, NATURE REV MICROBIOL, V8, P623; FOGG GE, 1983, BOT MAR, V26, P3, DOI 10.1515/botm.1983.26.1.3; Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3; HEDGES JI, 1992, MAR CHEM, V39, P67, DOI 10.1016/0304-4203(92)90096-S; Kerner M, 2003, NATURE, V422, P150, DOI 10.1038/nature01469; Kiorboe T, 2001, LIMNOL OCEANOGR, V46, P1309, DOI 10.4319/lo.2001.46.6.1309; Leppard GG, 2008, CURR NANOSCI, V4, P278, DOI 10.2174/157341308785161109; Maynard AD, 2006, NATURE, V444, P267, DOI 10.1038/444267a; Miao AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015196; Miao AJ, 2010, ENVIRON TOXICOL CHEM, V29, P2814, DOI 10.1002/etc.340; Miao AJ, 2009, ENVIRON POLLUT, V157, P3034, DOI 10.1016/j.envpol.2009.05.047; MORETFERGUSON S, MARINE POLLUTION B, V60, P1873; Navarro E, 2008, ECOTOXICOLOGY, V17, P372, DOI 10.1007/s10646-008-0214-0; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Passow U, 2002, PROG OCEANOGR, V55, P287, DOI 10.1016/S0079-6611(02)00138-6; PASSOW U, 1994, MAR ECOL PROG SER, V113, P185, DOI 10.3354/meps113185; Provencher SW, 1996, PART PART SYST CHAR, V13, P291, DOI 10.1002/ppsc.19960130507; Quiroz NGA, 2006, MAR CHEM, V100, P337, DOI 10.1016/j.marchem.2006.10.023; Scala S, 2002, PLANT PHYSIOL, V129, P993, DOI 10.1104/pp.010713; STENSTROM TA, 1989, APPL ENVIRON MICROB, V55, P142; Thompson RC, 2004, SCIENCE, V304, P838, DOI 10.1126/science.1094559; Verdugo P, 2004, MAR CHEM, V92, P67, DOI 10.1016/j.marchem.2004.06.017; Verdugo P, 2008, FARADAY DISCUSS, V139, P393, DOI 10.1039/b800149a; Ward JE, 2004, J EXP MAR BIOL ECOL, V300, P83, DOI 10.1016/j.jembe.2004.03.002; WATTERS DL, MARINE POLLUTION B, V60, P131; Wells ML, 1998, NATURE, V391, P530, DOI 10.1038/35248; Werlin R, 2011, NAT NANOTECHNOL, V6, P65, DOI 10.1038/NNANO.2010.251; WERLIN R, NAT NANOTECHNOL, V6, P65; Wigglesworth-Cooksey B, 2005, APPL ENVIRON MICROB, V71, P428, DOI 10.1128/AEM.71.1.428-435.2005; Wotton RS, 2005, BIOSCIENCE, V55, P137, DOI 10.1641/0006-3568(2005)055[0137:SFAOWB]2.0.CO;2; Wotton RS, 2004, SCI MAR, V68, P13, DOI 10.3989/scimar.2004.68s113; Yablon DG, 2004, APPL SPECTROSC, V58, P843, DOI 10.1366/0003702041389328; YONGMANITCHAI W, 1991, APPL ENVIRON MICROB, V57, P419, DOI 10.1128/AEM.57.2.419-425.1991; ZARFL C, MARINE POLLUTION B, V60, P1810; Zhang SJ, 2009, LIMNOL OCEANOGR-METH, V7, P419, DOI 10.4319/lom.2009.7.419; Zhang SJ, 2008, MAR CHEM, V112, P81, DOI 10.1016/j.marchem.2008.05.009	62	56	56	3	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e21865	10.1371/journal.pone.0021865	http://dx.doi.org/10.1371/journal.pone.0021865			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811550	gold, Green Published, Green Submitted			2022-12-25	WOS:000292956800012
J	Kovanda, A; Kocjan, BJ; Potocnik, M; Poljak, M				Kovanda, Anja; Kocjan, Bostjan J.; Potocnik, Marko; Poljak, Mario			Characterization of a Novel Cutaneous Human Papillomavirus Genotype HPV-125	PLOS ONE			English	Article							HPV TYPES; SKIN; PCR; CARCINOMAS; SPECTRUM; SAMPLES; CANCER	The DNA genome of a novel HPV genotype, HPV-125, isolated from a hand wart of an immuno-competent 19-year old male was fully cloned, sequenced and characterized. The full genome of HPV-125 is 7,809-bp in length with a GC content of 46.4%. By comparing the nucleotide sequence of the complete L1 gene, HPV-125 is phylogenetically placed within cutaneotrophic species 2 of Alphapapillomaviruses, and is most closely related to HPV-3 and HPV-28. HPV-125 has a typical genomic organization of Alphapapillomaviruses and contains genes coding for five early proteins, E6, E7, E1, E2 and E4 and two late capsid proteins, L1 and L2. The genome contains two non-coding regions: the first located between the L1 and E6 genes (nucleotide positions 7,137-7,809, length 673-bp) and the second between genes E2 and L2 (nucleotide positions 3,757-4,216, length 460-bp). The E6 protein of HPV-125 contains two regular zinc-binding domains at amino acid positions 29 and 102, whereas the E7 protein exhibits one such domain at position 50. HPV-125 lacks the regular pRb-binding core sequence within its E7 protein. In order to assess the tissue predilection and clinical significance of HPV-125, a quantitative type-specific real-time PCR was developed. The 95% limit-of-detection of the assay was 2.5 copies per reaction (range 1.7-5.7) and the intra-and inter-assay coefficients of variation were 0.47 and 2.00 for 100 copies per reaction, and 1.15 and 2.15 for 10 copies per reaction, respectively. Testing of a representative collection of HPV-associated mucosal and cutaneous benign and malignant neoplasms and hair follicles (a total of 601 samples) showed that HPV-125 is a relatively rare HPV genotype, with cutaneous tropism etiologically linked with sporadic cases of common warts.	[Kovanda, Anja; Kocjan, Bostjan J.; Poljak, Mario] Univ Ljubljana, Inst Microbiol & Immunol, Fac Med, Ljubljana, Slovenia; [Potocnik, Marko] Univ Med Ctr Ljubljana, Dept Dermatovenereol, Ljubljana, Slovenia	University of Ljubljana; University Medical Centre Ljubljana	Kovanda, A (corresponding author), Univ Ljubljana, Inst Microbiol & Immunol, Fac Med, Ljubljana, Slovenia.	mario.poljak@mf.uni-lj.si	Kovanda, Anja/F-5828-2013; Kovanda, Anja/AAX-1117-2020	Kovanda, Anja/0000-0002-7468-878X; Kovanda, Anja/0000-0002-7468-878X	Slovenian Research Agency; Ministry of Health [Z3-0220-0381-08]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Ministry of Health	This work was sponsored by the Slovenian Research Agency and the Ministry of Health, which funded A. K. through the Young Researcher Training Program and B.J.K. through grant Z3-0220-0381-08. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonsson A, 2003, J GEN VIROL, V84, P1881, DOI 10.1099/vir.0.18836-0; Antonsson A, 2000, J VIROL, V74, P11636, DOI 10.1128/JVI.74.24.11636-11641.2000; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Boulet G, 2007, INT J BIOCHEM CELL B, V39, P2006, DOI 10.1016/j.biocel.2007.07.004; BOUVARD V, 2009, LANCET ONCOL, V10, P321, DOI [DOI 10.1016/S1470-2045(09)70096-8, 10.1016/s1470-2045(09)70096-8]; Boxman ILA, 1997, J INVEST DERMATOL, V108, P712, DOI 10.1111/1523-1747.ep12292090; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Delius H, 1998, VIROLOGY, V240, P359, DOI 10.1006/viro.1997.8943; deVilliers EM, 1997, INT J CANCER, V73, P356, DOI 10.1002/(SICI)1097-0215(19971104)73:3<356::AID-IJC9>3.3.CO;2-S; FAVRE M, 1989, J VIROL, V63, P4906, DOI 10.1128/JVI.63.11.4906-.1989; FAVRE M, 1989, J VIROL, V63, P4905, DOI 10.1128/JVI.63.11.4905-.1989; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Harwood CA, 1999, J CLIN MICROBIOL, V37, P3545, DOI 10.1128/JCM.37.11.3545-3555.1999; Hazard K, 2007, J INVEST DERMATOL, V127, P116, DOI 10.1038/sj.jid.5700570; Hazard K, 2006, INT J CANCER, V119, P1073, DOI 10.1002/ijc.21920; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007, IARC Monogr Eval Carcinog Risks Hum, V90, P1; Jablonska S, 1985, Clin Dermatol, V3, P71, DOI 10.1016/0738-081X(85)90051-3; Jancar N, 2009, EUR J OBSTET GYN R B, V145, P184, DOI 10.1016/j.ejogrb.2009.04.030; KOCJAN BJ, 2004, INT S CUT HPV INF DE; Kocjan Bogtjan J., 2005, Infection Genetics and Evolution, V5, P255, DOI 10.1016/j.meegid.2004.05.009; Kohler A, 2010, VIROLOGY, V399, P129, DOI 10.1016/j.virol.2009.12.023; KREMSDORF D, 1983, J VIROL, V48, P340, DOI 10.1128/JVI.48.2.340-351.1983; Nei M, 2000, MOL EVOLUTION PHYLOG; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SHAMANIN V, 1994, J GEN VIROL, V75, P1149, DOI 10.1099/0022-1317-75-5-1149; SHAMANIN V, 1994, CANCER RES, V54, P4610; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TIEBEN LM, 1993, J VIROL METHODS, V42, P265, DOI 10.1016/0166-0934(93)90038-S; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0	32	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22414	10.1371/journal.pone.0022414	http://dx.doi.org/10.1371/journal.pone.0022414			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811601	gold, Green Published, Green Submitted			2022-12-25	WOS:000292956800053
J	Morgan, DJ; Day, HR; Harris, AD; Furuno, JP; Perencevich, EN				Morgan, Daniel J.; Day, Hannah R.; Harris, Anthony D.; Furuno, Jon P.; Perencevich, Eli N.			The Impact of Contact Isolation on the Quality of Inpatient Hospital Care	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; ACTIVE SURVEILLANCE CULTURES; OF-CARE; MORTALITY-RATES; PERFORMANCE; INFECTIONS; ASSOCIATION; PRECAUTIONS; IMPROVEMENT; PREVENTION	Background: Contact Isolation is a common hospital infection prevention method that may improve infectious outcomes but may also hinder healthcare delivery. Methods: To evaluate the impact of Contact Isolation on compliance with individual and composite process of care quality measures, we formed four retrospective diagnosis-based cohorts from a 662-bed tertiary-care medical center. Each cohort contained patients evaluated for one of four Centers for Medicare and Medicaid Services (CMS) Hospital Compare process measures including Acute Myocardial Infarction (AMI), Congestive Heart Failure (CHF), Pneumonia (PNA) and Surgical Care Improvement Project (SCIP) from January 1, 2007 through May 30, 2009. Results: The 6716-admission cohort included 1259 with AMI, 834 with CHF, 1377 with PNA and 3246 in SCIP. Contact Isolation was associated with not meeting 4 of 23 individual hospital measures (4 of 10 measures were not met for care provided while patients are typically isolated). Contact Isolation was independently associated with lower compliance with the composite pneumonia process-of-care measure (OR 0.3, 95% CI 0.1-0.7). AMI, CHF and SCIP composite measures were not impacted by Contact Isolation. Conclusions: Contact Isolation was associated with lower adherence to some pneumonia quality of care process measures of care on inpatient wards but did not impact CHF, AMI or SCIP measures.	[Morgan, Daniel J.; Day, Hannah R.; Harris, Anthony D.; Furuno, Jon P.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Morgan, Daniel J.; Harris, Anthony D.] VA Maryland Hlth Care Syst, Baltimore, MD USA; [Perencevich, Eli N.] Univ Iowa, Carver Coll Med & Iowa City VA, Iowa City, IA USA	University System of Maryland; University of Maryland Baltimore; University of Iowa	Morgan, DJ (corresponding author), Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA.	dmorgan@epi.umaryland.edu		Perencevich, Eli/0000-0002-3721-3355	AHRQ [K08 HS18111-01]; NIH [5K24AI079040-02]; VA HSRD Merit IIR [05-123]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS018111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI079040] Funding Source: NIH RePORTER; AHRQ [5K08HS018111-03] Funding Source: Federal RePORTER	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA HSRD Merit IIR; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This work was funded by K08 HS18111-01 AHRQ to DJM, 5K24AI079040-02 NIH to ADH and a VA HSR&D Merit IIR, 05-123 to ENP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braun BI, 1999, EVAL HEALTH PROF, V22, P283, DOI 10.1177/016327879902200301; Chassin MR, 2010, NEW ENGL J MED, V363, P683, DOI 10.1056/NEJMsb1002320; *CTR MED MED SERV, MED MOD UPD; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Edmond MB, 2008, AM J INFECT CONTROL, V36, P461, DOI 10.1016/j.ajic.2007.09.011; Evans HL, 2003, SURGERY, V134, P180, DOI 10.1067/msy.2003.222; Fetter RB, 1980, MED CARE S, V18, P1; Fiore Anthony E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Haley CC, 2007, J CLIN MICROBIOL, V45, P3031, DOI 10.1128/JCM.00315-07; Harris AD, 2002, ANTIMICROB AGENTS CH, V46, P854, DOI 10.1128/AAC.46.3.854-858.2002; Harris AD, 2010, ANTIMICROB AGENTS CH, V54, P3143, DOI 10.1128/AAC.01590-09; Higashi T, 2007, NEW ENGL J MED, V356, P2496, DOI 10.1056/NEJMsa066253; Jha AK, 2007, HEALTH AFFAIR, V26, P1104, DOI 10.1377/hlthaff.26.4.1104; KIRKLAND K, 2008, ISOLATION PRECAUTION; Kirkland KB, 1999, LANCET, V354, P1177, DOI 10.1016/S0140-6736(99)04196-3; Min LC, 2007, MED CARE, V45, P480, DOI 10.1097/MLR.0b013e318030fff9; Morgan DJ, 2009, AM J INFECT CONTROL, V37, P85, DOI 10.1016/j.ajic.2008.04.257; National Quality Forum, NQF END STAND; Nolan T, 2006, JAMA-J AM MED ASSOC, V295, P1168, DOI 10.1001/jama.295.10.1168; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Robinson KA, 2001, JAMA-J AM MED ASSOC, V285, P1729, DOI 10.1001/jama.285.13.1729; Saint S, 2003, AM J INFECT CONTROL, V31, P354, DOI 10.1016/S0196-6553(02)48250-8; SALEMI C, 1995, AM J INFECT CONTROL, V23, P188, DOI 10.1016/0196-6553(95)90040-3; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007; Stelfox HT, 2003, JAMA-J AM MED ASSOC, V290, P1899, DOI 10.1001/jama.290.14.1899; Stulberg JJ, 2010, JAMA-J AM MED ASSOC, V303, P2479, DOI 10.1001/jama.2010.841; Weber SG, 2007, INFECT CONT HOSP EP, V28, P249, DOI 10.1086/512261; Werner RM, 2006, JAMA-J AM MED ASSOC, V296, P2694, DOI 10.1001/jama.296.22.2694; Williams SC, 2005, NEW ENGL J MED, V353, P255, DOI 10.1056/NEJMsa043778	29	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22190	10.1371/journal.pone.0022190	http://dx.doi.org/10.1371/journal.pone.0022190			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811572	Green Submitted, Green Published, gold			2022-12-25	WOS:000292956800028
J	Tiefenbrunn, T; Liu, W; Chen, Y; Katritch, V; Stout, CD; Fee, JA; Cherezov, V				Tiefenbrunn, Theresa; Liu, Wei; Chen, Ying; Katritch, Vsevolod; Stout, C. David; Fee, James A.; Cherezov, Vadim			High Resolution Structure of the ba3 Cytochrome c Oxidase from Thermus thermophilus in a Lipidic Environment	PLOS ONE			English	Article							CRYSTALLIZING MEMBRANE-PROTEINS; SENSORY RHODOPSIN-II; X-RAY-STRUCTURE; ANGSTROM RESOLUTION; PARACOCCUS-DENITRIFICANS; CHEMICAL CHARACTERIZATION; BINDING SITES; BA(3) OXIDASE; CUBIC PHASES; ACTIVE-SITE	The fundamental chemistry underpinning aerobic life on Earth involves reduction of dioxygen to water with concomitant proton translocation. This process is catalyzed by members of the heme-copper oxidase (HCO) superfamily. Despite the availability of crystal structures for all types of HCO, the mode of action for this enzyme is not understood at the atomic level, namely how vectorial H+ and e(-) transport are coupled. Toward addressing this problem, we report wild type and A120F mutant structures of the ba(3)-type cytochrome c oxidase from Thermus thermophilus at 1.8 angstrom resolution. The enzyme has been crystallized from the lipidic cubic phase, which mimics the biological membrane environment. The structures reveal 20 ordered lipid molecules that occupy binding sites on the protein surface or mediate crystal packing interfaces. The interior of the protein encloses 53 water molecules, including 3 trapped in the designated K-path of proton transfer and 8 in a cluster seen also in A-type enzymes that likely functions in egress of product water and proton translocation. The hydrophobic O-2-uptake channel, connecting the active site to the lipid bilayer, contains a single water molecule nearest the Cu-B atom but otherwise exhibits no residual electron density. The active site contains strong electron density for a pair of bonded atoms bridging the heme Fe-a3 and Cu-B atoms that is best modeled as peroxide. The structure of ba(3)-oxidase reveals new information about the positioning of the enzyme within the membrane and the nature of its interactions with lipid molecules. The atomic resolution details provide insight into the mechanisms of electron transfer, oxygen diffusion into the active site, reduction of oxygen to water, and pumping of protons across the membrane. The development of a robust system for production of ba(3)-oxidase crystals diffracting to high resolution, together with an established expression system for generating mutants, opens the door for systematic structure-function studies.	[Tiefenbrunn, Theresa; Liu, Wei; Chen, Ying; Stout, C. David; Fee, James A.; Cherezov, Vadim] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Katritch, Vsevolod] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Katritch, Vsevolod] Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA	Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Tiefenbrunn, T (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jafee@scripps.edu; vcherezo@scripps.edu	Katritch, Vsevolod/Q-8357-2016; Cherezov, Vadim/L-9812-2013; Liu, Wei/F-1820-2011; Katritch, Vsevolod/Y-2721-2019	Katritch, Vsevolod/0000-0003-3883-4505; Cherezov, Vadim/0000-0002-5265-3914; Tiefenbrunn, Theresa/0000-0002-3043-4788	NIH [GM073197, GM035342]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073197, R01GM035342] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in parts by the NIH grants GM073197 (VC) and GM035342 (JAF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGMON N, 1995, CHEM PHYS LETT, V244, P456, DOI 10.1016/0009-2614(95)00905-J; Aoyama H, 2009, P NATL ACAD SCI USA, V106, P2165, DOI 10.1073/pnas.0806391106; Belrhali H, 1999, STRUCTURE, V7, P909, DOI 10.1016/S0969-2126(99)80118-X; Buschmann S, 2010, SCIENCE, V329, P327, DOI 10.1126/science.1187303; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Caffrey M, 2009, ANNU REV BIOPHYS, V38, P29, DOI 10.1146/annurev.biophys.050708.133655; CHANCE B, 1978, BIOCHIM BIOPHYS ACTA, V503, P37, DOI 10.1016/0005-2728(78)90160-3; Chang HY, 2009, P NATL ACAD SCI USA, V106, P16169, DOI 10.1073/pnas.0905264106; Chen AH, 1998, CHEM PHYS LIPIDS, V95, P11, DOI 10.1016/S0009-3084(98)00060-7; Chen Y, 2005, PROTEIN EXPRES PURIF, V40, P299, DOI 10.1016/j.pep.2004.11.014; Cherezov V, 2006, J MOL BIOL, V357, P1605, DOI 10.1016/j.jmb.2006.01.049; Cherezov V, 2004, ACTA CRYSTALLOGR D, V60, P1795, DOI 10.1107/S0907444904019109; Cherezov V, 2008, PROTEINS, V71, P24, DOI 10.1002/prot.21841; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Chishiro T, 2003, ANGEW CHEM INT EDIT, V42, P2788, DOI 10.1002/anie.200351415; EINARSDOTTIR O, 1988, J BIOL CHEM, V263, P13641; EISENBERGER P, 1976, P NATL ACAD SCI USA, V73, P491, DOI 10.1073/pnas.73.2.491; Farver O, 2010, BIOCHEMISTRY-US, DOI 10.1021/bi100548n; Fee JA, 2008, J AM CHEM SOC, V130, P15002, DOI 10.1021/ja803112w; Gonen T, 2005, NATURE, V438, P633, DOI 10.1038/nature04321; Gordeliy VI, 2002, NATURE, V419, P484, DOI 10.1038/nature01109; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Hoyrup P, 2004, PHYS CHEM CHEM PHYS, V6, P1608, DOI 10.1039/b314146b; Hunsicker-Wang LM, 2005, ACTA CRYSTALLOGR D, V61, P340, DOI 10.1107/S0907444904033906; Hunte C, 2008, CURR OPIN STRUC BIOL, V18, P406, DOI 10.1016/j.sbi.2008.03.008; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kaila VRI, 2011, BBA-BIOENERGETICS, V1807, P769, DOI 10.1016/j.bbabio.2010.12.016; KEIGHTLEY JA, 1995, J BIOL CHEM, V270, P20345, DOI 10.1074/jbc.270.35.20345; Koepke J, 2009, BBA-BIOENERGETICS, V1787, P635, DOI 10.1016/j.bbabio.2009.04.003; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Kuhnel K, 2007, P NATL ACAD SCI USA, V104, P99, DOI 10.1073/pnas.0606285103; Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Lee HJ, 2010, J AM CHEM SOC, V132, P16225, DOI 10.1021/ja107244g; Liu B, 2009, BIOCHEMISTRY-US, V48, P820, DOI 10.1021/bi801759a; LOH HH, 1980, ANNU REV PHARMACOL, V20, P201, DOI 10.1146/annurev.pa.20.040180.001221; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Luna VM, 2008, BIOCHEMISTRY-US, V47, P4657, DOI 10.1021/bi800045y; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McRee DE, 2004, ACTA CRYSTALLOGR D, V60, P2276, DOI 10.1107/S0907444904025491; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Ostermeier C, 1997, P NATL ACAD SCI USA, V94, P10547, DOI 10.1073/pnas.94.20.10547; PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676; Qin L, 2007, CURR OPIN STRUC BIOL, V17, P444, DOI 10.1016/j.sbi.2007.07.001; Qin L, 2006, P NATL ACAD SCI USA, V103, P16117, DOI 10.1073/pnas.0606149103; Reichow SL, 2009, CURR OPIN STRUC BIOL, V19, P560, DOI 10.1016/j.sbi.2009.07.012; ROBINSON NC, 1993, J BIOENERG BIOMEMBR, V25, P153, DOI 10.1007/BF00762857; Royant A, 2001, P NATL ACAD SCI USA, V98, P10131, DOI 10.1073/pnas.181203898; Sakaguchi M, 2010, J BIOENERG BIOMEMBR, V42, P241, DOI 10.1007/s10863-010-9282-y; Salomonsson L, 2004, P NATL ACAD SCI USA, V101, P11617, DOI 10.1073/pnas.0402242101; Schmidt B, 2003, P NATL ACAD SCI USA, V100, P15539, DOI 10.1073/pnas.2633243100; Sedlak E, 2006, BIOCHEMISTRY-US, V45, P746, DOI 10.1021/bi050870z; SEELIG A, 1977, BIOCHEMISTRY-US, V16, P45, DOI 10.1021/bi00620a008; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Smirnova I, 2010, BIOCHEMISTRY-US, V49, P7033, DOI 10.1021/bi100749p; Soulimane T, 2000, EMBO J, V19, P1766, DOI 10.1093/emboj/19.8.1766; Svensson-Ek M, 2002, J MOL BIOL, V321, P329, DOI 10.1016/S0022-2836(02)00619-8; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Unno M, 2007, J AM CHEM SOC, V129, P13394, DOI 10.1021/ja076108x; Vogeley L, 2004, SCIENCE, V306, P1390, DOI 10.1126/science.1103943; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Yang YL, 2006, J LIPID RES, V47, P1823, DOI 10.1194/jlr.M600034-JLR200; Yin H, 2010, J PHYS CHEM B, V114, P16290, DOI 10.1021/jp108731r; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723; ZIMMERMANN BH, 1988, P NATL ACAD SCI USA, V85, P5779, DOI 10.1073/pnas.85.16.5779	69	93	93	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22348	10.1371/journal.pone.0022348	http://dx.doi.org/10.1371/journal.pone.0022348			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21814577	Green Published, gold, Green Submitted			2022-12-25	WOS:000292956800045
J	Tucker, NR; Middleton, RC; Le, QP; Shelden, EA				Tucker, Nathan R.; Middleton, Ryan C.; Le, Quynh P.; Shelden, Eric A.			HSF1 Is Essential for the Resistance of Zebrafish Eye and Brain Tissues to Hypoxia/Reperfusion Injury	PLOS ONE			English	Article							SHOCK TRANSCRIPTION FACTOR-1; HYPOXIA-INDUCIBLE FACTOR; ISCHEMIA-REPERFUSION INJURY; RETINAL GANGLION-CELLS; HEAT-SHOCK; GENE-EXPRESSION; ISCHEMIA/REPERFUSION INJURY; REGULATORY DIFFERENCES; HIPPOCAMPAL-NEURONS; CEREBRAL-ISCHEMIA	Ischemia and subsequent reperfusion (IR) produces injury to brain, eye and other tissues, contributing to the progression of important clinical pathologies. The response of cells to IR involves activation of several signaling pathways including those activating hypoxia and heat shock responsive transcription factors. However, specific roles of these responses in limiting cell damage and preventing cell death after IR have not been fully elucidated. Here, we have examined the role of heat shock factor 1 (HSF1) in the response of zebrafish embryos to hypoxia and subsequent return to normoxic conditions (HR) as a model for IR. Heat shock preconditioning elevated heat shock protein expression and protected zebrafish embryo eye and brain tissues against HR-induced apoptosis. These effects were inhibited by translational suppression of HSF1 expression. Reduced expression of HSF1 also increased cell death in brain and eye tissues of embryos subjected to hypoxia and reperfusion without prior heat shock. Surprisingly, reduced expression of HSF1 had only a modest effect on hypoxia-induced expression of Hsp70 and no effect on hypoxia-induced expression of Hsp27. These results establish the zebrafish embryo as a model for the study of ischemic injury in the brain and eye and reveal a critical role for HSF1 in the response of these tissues to HR. Our results also uncouple the role of HSF1 expression from that of Hsp27, a well characterized heat shock protein considered essential for cell survival after hypoxia. Alternative roles for HSF1 are considered.	[Tucker, Nathan R.; Middleton, Ryan C.; Le, Quynh P.; Shelden, Eric A.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Shelden, Eric A.] Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA	Washington State University; Washington State University	Tucker, NR (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	eshelden@wsu.edu	, Eric/GWC-7636-2022	Tucker, Nathan/0000-0002-5071-4218	United States National Science Foundation [IOS 0818993]; Division Of Integrative Organismal Systems [0818993] Funding Source: National Science Foundation	United States National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a grant from the United States National Science Foundation (IOS 0818993) to EAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird NA, 2006, J BIOL CHEM, V281, P38675, DOI 10.1074/jbc.M608013200; Bickler PE, 2010, J NEUROSCI RES, V88, P3520, DOI 10.1002/jnr.22508; Biermann J, 2010, INVEST OPHTH VIS SCI, V51, P526, DOI 10.1167/iovs.09-3903; Birch-Machin I, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r63; Brown IR, 1996, J NEUROSCI RES, V44, P52, DOI 10.1002/(SICI)1097-4547(19960401)44:1<52::AID-JNR7>3.0.CO;2-H; Burns TC, 2009, J COMP NEUROL, V515, P125, DOI 10.1002/cne.22038; Chi NC, 2004, CARDIOVASC RES, V61, P437, DOI 10.1016/j.cardiores.2003.11.033; Collard CD, 2001, ANESTHESIOLOGY, V94, P1133, DOI 10.1097/00000542-200106000-00030; Cunliffe VT, 2004, DEVELOPMENT, V131, P2983, DOI 10.1242/dev.01166; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dillmann W H, 1999, Infect Dis Obstet Gynecol, V7, P55, DOI 10.1002/(SICI)1098-0997(1999)7:1/2<55::AID-IDOG11>3.0.CO;2-M; Dirks RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010158; Eickelberg O, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000022008.30175.5B; Evans TG, 2005, CELL STRESS CHAPERON, V10, P66, DOI 10.1379/CSC-79R.1; Evans TG, 2007, COMP BIOCHEM PHYS A, V146, P131, DOI 10.1016/j.cbpa.2006.09.023; Franklin TB, 2005, INT J HYPERTHER, V21, P379, DOI 10.1080/02656730500069955; Hatayama T, 1997, J BIOCHEM-TOKYO, V122, P904; Higashi T, 1995, MOL BRAIN RES, V34, P262, DOI 10.1016/0169-328X(95)00163-M; Huang WJ, 2009, INT J CANCER, V124, P298, DOI 10.1002/ijc.23906; Kaarniranta K, 2002, MOL BRAIN RES, V101, P136, DOI 10.1016/S0169-328X(02)00179-1; KELLY S, 2002, CURR MED RES OPIN, V18, P55; Kwon HM, 2008, NEUROL RES, V30, P740, DOI 10.1179/174313208X289615; Kwong JMK, 2006, NEUROSCI LETT, V405, P191, DOI 10.1016/j.neulet.2006.06.070; Latchman DS, 2005, INT J HYPERTHER, V21, P393, DOI 10.1080/02656730400023664; Lee Ji-Won, 2004, Experimental & Molecular Medicine, V36, P1; Liu Q, 2007, EXP EYE RES, V84, P163, DOI 10.1016/j.exer.2006.09.011; Lu AG, 2002, J NEUROCHEM, V81, P355, DOI 10.1046/j.1471-4159.2002.00835.x; Marcuccilli CJ, 1996, J NEUROSCI, V16, P478; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Mendelsohn BA, 2008, DEV DYNAM, V237, P1780, DOI 10.1002/dvdy.21581; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; Nishizawa J, 1996, CIRCULATION, V94, P2185, DOI 10.1161/01.CIR.94.9.2185; Oza J, 2008, CELL STRESS CHAPERON, V13, P73, DOI 10.1007/s12192-008-0013-9; PARDHASARADHI K, 1994, CURR EYE RES, V13, P739, DOI 10.3109/02713689409047008; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Rabergh CMI, 2000, J EXP BIOL, V203, P1817; Schmitt EA, 1999, J COMP NEUROL, V404, P515; Shamovsky I, 2004, MECH AGEING DEV, V125, P767, DOI 10.1016/j.mad.2004.07.006; Sreedharan R, 2005, AM J PHYSIOL-RENAL, V288, pF322, DOI 10.1152/ajprenal.00307.2004; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Tsonis PA, 2004, EXP EYE RES, V78, P161, DOI 10.1016/j.exer.2003.10.022; Tucker NR, 2009, EXP CELL RES, V315, P3176, DOI 10.1016/j.yexcr.2009.06.030; Tucker NR, 2009, CELL STRESS CHAPERON, V14, P521, DOI 10.1007/s12192-009-0105-1; VANWHY SK, 1994, J CLIN INVEST, V94, P1518, DOI 10.1172/JCI117492; Wang GH, 2001, GENESIS, V30, P195, DOI 10.1002/gene.1064; WELCH WJ, 1992, PHYSIOL REV, V72, P1063, DOI 10.1152/physrev.1992.72.4.1063; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Whitlock NA, 2005, INVEST OPHTH VIS SCI, V46, P1092, DOI 10.1167/iovs.04-0043; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Yamagami K, 1998, J SURG RES, V79, P47, DOI 10.1006/jsre.1998.5403; Yan LJ, 2005, ANTIOXID REDOX SIGN, V7, P465, DOI 10.1089/ars.2005.7.465; Yan LJ, 2002, EMBO J, V21, P5164, DOI 10.1093/emboj/cdf528; Yin C, 2005, J MOL CELL CARDIOL, V39, P681, DOI 10.1016/j.yjmcc.2005.06.005; Zannino DA, 2009, J NEUROSCI, V29, P2322, DOI 10.1523/JNEUROSCI.3755-08.2009; Zou YZ, 2003, CIRCULATION, V108, P3024, DOI 10.1161/01.CIR.0000101923.54751.77	55	21	26	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22268	10.1371/journal.pone.0022268	http://dx.doi.org/10.1371/journal.pone.0022268			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21814572	Green Published, Green Submitted, gold			2022-12-25	WOS:000292956800036
J	Ma, Y; Sugiura, R; Koike, A; Ebina, H; Sio, SO; Kuno, T				Ma, Yan; Sugiura, Reiko; Koike, Atsushi; Ebina, Hidemine; Sio, Susie O.; Kuno, Takayoshi			Transient Receptor Potential (TRP) and Cch1-Yam8 Channels Play Key Roles in the Regulation of Cytoplasmic Ca2+ in Fission Yeast	PLOS ONE			English	Article							SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; CALCINEURIN; GENE; CALMODULIN; HOMOLOG; HOMEOSTASIS; FLUORESCENCE; SPORULATION; DISRUPTION	The regulation of cytoplasmic Ca2+ is crucial for various cellular processes. Here, we examined the cytoplasmic Ca2+ levels in living fission yeast cells by a highly sensitive bioluminescence resonance energy transfer-based assay using GFP-aequorin fusion protein linked by 19 amino acid. We monitored the cytoplasmic Ca2+ level and its change caused by extracellular stimulants such as CaCl2 or NaCl plus FK506 (calcineurin inhibitor). We found that the extracellularly added Ca2+ caused a dose-dependent increase in the cytoplasmic Ca2+ level and resulted in a burst-like peak. The overexpression of two transient receptor potential (TRP) channel homologues, Trp1322 or Pkd2, markedly enhanced this response. Interestingly, the burst-like peak upon TRP overexpression was completely abolished by gene deletion of calcineurin and was dramatically decreased by gene deletion of Prz1, a downstream transcription factor activated by calcineurin. Furthermore, 1 hour treatment with FK506 failed to suppress the burst-like peak. These results suggest that the burst-like Ca2+ peak is dependent on the transcriptional activity of Prz1, but not on the direct TRP dephosphorylation. We also found that extracellularly added NaCl plus FK506 caused a synergistic cytosolic Ca2+ increase that is dependent on the inhibition of calcineurin activity, but not on the inhibition of Prz1. The synergistic Ca2+ increase is abolished by the addition of the Ca2+ chelator BAPTA into the media, and is also abolished by deletion of the gene encoding a subunit of the Cch1-Yam8 Ca2+ channel complex, indicating that the synergistic increase is caused by the Ca2+ influx from the extracellular medium via the Cch1-Yam8 complex. Furthermore, deletion of Pmk1 MAPK abolished the Ca2+ influx, and overexpression of the constitutively active Pek1 MAPKK enhanced the influx. These results suggest that Pmk1 MAPK and calcineurin positively and negatively regulate the Cch1-Yam8 complex, respectively, via modulating the balance between phosphorylation and dyphosphorylation state.	[Ma, Yan; Koike, Atsushi; Ebina, Hidemine; Kuno, Takayoshi] Kobe Univ, Div Mol Pharmacol & Pharmacogen, Dept Biochem & Mol Biol, Grad Sch Med, Kobe, Hyogo 657, Japan; [Sugiura, Reiko] Kinki Univ, Sch Pharmaceut Sci, Lab Mol Pharmacogen, Higashiosaka, Osaka 577, Japan; [Sio, Susie O.] Univ Philippines Manila, Dept Pharmacol & Toxicol, Coll Med, Manila, Philippines	Kobe University; Kindai University (Kinki University); University of the Philippines System; University of the Philippines Manila	Ma, Y (corresponding author), Kobe Univ, Div Mol Pharmacol & Pharmacogen, Dept Biochem & Mol Biol, Grad Sch Med, Kobe, Hyogo 657, Japan.	mayan@med.kobe-u.ac.jp			Japan Society for the Promotion of Science [22390048, 21790241]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Financial support for this study was provided by Grant-in-Aid for Scientific Research, on Scientific Research (B) to Takayoshi Kuno (No. 22390048) and on Grant-in-Aid for Young Scientists (B) to Yan Ma (No. 21790241), from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/e-grants/grants.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydar E, 2009, J MEMBRANE BIOL, V229, P141, DOI 10.1007/s00232-009-9180-6; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Batiza AF, 1996, J BIOL CHEM, V271, P23357, DOI 10.1074/jbc.271.38.23357; Bonilla M, 2003, MOL BIOL CELL, V14, P4296, DOI 10.1091/mbc.E03-02-0113; Carnero E, 2000, MOL GEN GENET, V264, P173, DOI 10.1007/s004380000318; Deng L, 2006, MOL BIOL CELL, V17, P4790, DOI 10.1091/mbc.E06-06-0526; Denis V, 2002, J CELL BIOL, V156, P29, DOI 10.1083/jcb.200111004; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; Gorokhovatsky AY, 2004, BIOCHEM BIOPH RES CO, V320, P703, DOI 10.1016/j.bbrc.2004.06.014; HALACHMI D, 1989, FEBS LETT, V256, P55, DOI 10.1016/0014-5793(89)81717-X; Hamasaki-Katagiri N, 2010, J BIOL CHEM, V285, P4405, DOI 10.1074/jbc.M109.058594; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Hirayama S, 2003, J BIOL CHEM, V278, P18078, DOI 10.1074/jbc.M212900200; Kita A, 2004, MOL BIOL CELL, V15, P2920, DOI 10.1091/mbc.E03-09-0659; Locke EG, 2000, MOL CELL BIOL, V20, P6686, DOI 10.1128/MCB.20.18.6686-6694.2000; Ma Y, 2007, CURR GENET, V52, P97, DOI 10.1007/s00294-007-0142-1; Ma Y, 2006, MOL BIOL CELL, V17, P5028, DOI 10.1091/mbc.E06-08-0688; Matsumoto TK, 2002, J BIOL CHEM, V277, P33075, DOI 10.1074/jbc.M205037200; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MCLEOD M, 1987, EMBO J, V6, P729, DOI 10.1002/j.1460-2075.1987.tb04814.x; MCPHERSON PS, 1993, J BIOL CHEM, V268, P13765; Miseta A, 1999, J BIOL CHEM, V274, P5939, DOI 10.1074/jbc.274.9.5939; Montell C, 2001, Sci STKE, V2001, pre1, DOI 10.1126/stke.2001.90.re1; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Palmer CP, 2005, BIOCHEM J, V387, P211, DOI 10.1042/BJ20041710; Palmer CP, 2001, P NATL ACAD SCI USA, V98, P7801, DOI 10.1073/pnas.141036198; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Sio SO, 2005, J BIOL CHEM, V280, P12231, DOI 10.1074/jbc.M414234200; Sugiura R, 1999, NATURE, V399, P479, DOI 10.1038/20951; Sugiura R, 1998, EMBO J, V17, P140, DOI 10.1093/emboj/17.1.140; Tadross MR, 2008, CELL, V133, P1228, DOI 10.1016/j.cell.2008.05.025; TAKEDA T, 1989, P NATL ACAD SCI USA, V86, P9737, DOI 10.1073/pnas.86.24.9737; Toda T, 1996, MOL CELL BIOL, V16, P6752; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; YOSHIDA T, 1994, J CELL SCI, V107, P1725; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	37	33	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22421	10.1371/journal.pone.0022421	http://dx.doi.org/10.1371/journal.pone.0022421			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21811607	Green Published, Green Submitted, gold			2022-12-25	WOS:000292929500064
J	Mackintosh, C; Ordonez, JL; Garcia-Dominguez, DJ; Sevillano, V; Llombart-Bosch, A; Szuhai, K; Scotlandi, K; Alberghini, M; Sciot, R; Sinnaeve, F; Hogendoorn, PCW; Picci, P; Knuutila, S; Dirksen, U; Debiec-Rychter, M; Schaefer, KL; de Alava, E				Mackintosh, C.; Ordonez, J. L.; Garcia-Dominguez, D. J.; Sevillano, V.; Llombart-Bosch, A.; Szuhai, K.; Scotlandi, K.; Alberghini, M.; Sciot, R.; Sinnaeve, F.; Hogendoorn, P. C. W.; Picci, P.; Knuutila, S.; Dirksen, U.; Debiec-Rychter, M.; Schaefer, K-L; de Alava, E.			1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma	ONCOGENE			English	Article						Ewing sarcoma; 1q Gain; CDT2; clinical outcome; microarrays	COMPARATIVE GENOMIC HYBRIDIZATION; CHROMOSOME-TRANSLOCATION; GENETIC CHANGES; DNA-DAMAGE; CELL-LINES; ARRAY CGH; S-PHASE; TUMORS; DEGRADATION; ABERRATIONS	Despite extensive characterization of the role of the EWS-ETS fusions, little is known about secondary genetic alterations and their clinical contribution to Ewing sarcoma (ES). It has been demonstrated that the molecular structure of EWS-ETS lacks prognostic value. Moreover, CDKN2A deletion and TP53 mutation, despite carrying a poor prognosis, are infrequent. In this scenario identifying secondary genetic alterations with a significant prevalence could contribute to understand the molecular mechanisms underlying the most aggressive forms of ES. We screened a 67 ES tumor set for copy number alterations by array comparative genomic hybridization. 1q gain (1qG), detected in 31% of tumor samples, was found markedly associated with relapse and poor overall and disease-free survival and demonstrated a prognostic value independent of classical clinical parameters. Reanalysis of an expression dataset belonging to an independent tumor set (n = 37) not only validated this finding but also led us to identify a transcriptomic profile of severe cell cycle deregulation in 1qG ES tumors. Consistently, a higher proliferation rate was detected in this tumor subset by Ki-67 immunohistochemistry. CDT2, a 1q-located candidate gene encoding a protein involved in ubiquitin ligase activity and significantly overexpressed in 1qG ES tumors, was validated in vitro and in vivo proving its major contribution to this molecular and clinical phenotype. This integrative genomic study of 105 ES tumors in overall renders the potential value of 1qG and CDT2 overexpression as prognostic biomarkers and also affords a rationale for the application of already available new therapeutic compounds selectively targeting the protein-ubiquitin machinery. Oncogene (2012) 31, 1287-1298; doi: 10.1038/onc.2011.317; published online 8 August 2011	[Mackintosh, C.; Ordonez, J. L.; Garcia-Dominguez, D. J.; Sevillano, V.; de Alava, E.] Ctr Invest Canc IBMCC USAL CSIC, Mol Pathol Program, Salamanca 37007, Spain; [Llombart-Bosch, A.] Univ Valencia, Dept Pathol, Valencia, Spain; [Szuhai, K.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands; [Scotlandi, K.; Picci, P.] Ist Ortoped Rizzoli, Lab Oncol Res, Bologna, Italy; [Alberghini, M.] Ist Ortoped Rizzoli, Dept Pathol, Bologna, Italy; [Sciot, R.] Catholic Univ Louvain, Dept Pathol, B-3000 Louvain, Belgium; [Sinnaeve, F.] Catholic Univ Louvain, Dept Orthoped Surg, B-3000 Louvain, Belgium; [Hogendoorn, P. C. W.] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands; [Knuutila, S.] Univ Helsinki, Dept Pathol, Helsinki, Finland; [Knuutila, S.] Helsinki Univ Cent Hosp, Helsinki, Finland; [Dirksen, U.] Univ Childrens Hosp Muenster, Dept Pediat Hematol & Oncol, Munster, Germany; [Debiec-Rychter, M.] Catholic Univ Louvain, Ctr Human Genet, B-3000 Louvain, Belgium; [Schaefer, K-L] Univ Dusseldorf, Inst Pathol, Dusseldorf, Germany; [de Alava, E.] Univ Hosp Salamanca, Dept Pathol, Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Valencia; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; IRCCS Istituto Ortopedico Rizzoli; IRCCS Istituto Ortopedico Rizzoli; Universite Catholique Louvain; Universite Catholique Louvain; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Munster; Universite Catholique Louvain; Heinrich Heine University Dusseldorf; University of Salamanca	Mackintosh, C (corresponding author), Ctr Invest Canc IBMCC USAL CSIC, Mol Pathol Program, Campus Miguel de Unamuno S-N, Salamanca 37007, Spain.	cmackintosh@usal.es; edealava@usal.es	Ordóñez, José Luis/B-6069-2017; Dirksen, Uta/AGX-8472-2022; Garcia, Daniel Jose/X-6857-2019; Hogendoorn, Pancras/O-6494-2019; de Alava, Enrique/GOH-0368-2022; Garcia, Daniel Jose/B-5366-2016; Hogendoorn, Pancras C.W./H-5859-2015; IBIS, SARCOMAS/O-1893-2015; Szuhai, Karoly/A-1100-2008; Scotlandi, Katia/J-9009-2016; Picci, Piero/J-5979-2016	Ordóñez, José Luis/0000-0002-3791-4215; Hogendoorn, Pancras/0000-0002-1513-8104; de Alava, Enrique/0000-0001-8400-046X; Garcia, Daniel Jose/0000-0001-8150-2747; Hogendoorn, Pancras C.W./0000-0002-1513-8104; Szuhai, Karoly/0000-0002-1228-4245; Scotlandi, Katia/0000-0001-6114-9499; sciot, raf/0000-0003-2244-5839; Mackintosh, Carlos/0000-0002-6786-9558; Sinnaeve, Friedl/0000-0003-4321-7771; Picci, Piero/0000-0002-8519-4101	European Commission; Maria Garcia-Estrada Foundation; Ministry of Science and Innovation of Spain [PI081828, RD06/0020/0059]; Deutsche Krebshilfe [50-2551 Ju3, 50-2551-Ju4]; Federal Ministry of Education and Research Germany, BMBF (TranSaRNet) [01GM0869]; Deutsches Zentrum fur Luft- und Raumfahrt e.V.	European Commission(European CommissionEuropean Commission Joint Research Centre); Maria Garcia-Estrada Foundation; Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Deutsche Krebshilfe(Deutsche Krebshilfe); Federal Ministry of Education and Research Germany, BMBF (TranSaRNet)(Federal Ministry of Education & Research (BMBF)); Deutsches Zentrum fur Luft- und Raumfahrt e.V.(Helmholtz AssociationGerman Aerospace Centre (DLR))	Centro de Investigacion del Cancer-IBMCC, Heinrich-Heine-University Duesseldorf, Catholic University of Leuven, University of Valencia, Istituti Ortopedici Rizzoli, University of Helsinki, Leiden University Medical Center and University Children's Hospital Muenster are partners of the EuroBoNeT consortium, a network of excellence granted by the European Commission for studying the pathology and genetics of bone tumors. Daniel J Garcia-Dominguez is supported by a grant from the Maria Garcia-Estrada Foundation. Research in Enrique de Alava's lab is also supported by the Ministry of Science and Innovation of Spain-FEDER (PI081828, RD06/0020/0059). Trial center Muenster is supported by grants from Deutsche Krebshilfe, 50-2551 Ju3 und 50-2551-Ju4 and Federal Ministry of Education and Research Germany, BMBF (TranSaRNet) 01GM0869, Deutsches Zentrum fur Luft- und Raumfahrt e.V. We thank Dr Hung-Wei Pan and Dr Hey-Chi Hsu (Department of Pathology, College of Medicine, National Taiwan University, Taipei, Taiwan) for the anti-CDT2 antibody and pBABE-CDT2 construction. Thanks are due to Cristina Teodosio and Martin Perez de Andres for their kind help with the flow cytometer, to Andreas Ranft for helping with the clinical data, to Agustin Mayo Iscar for his help with statistics, and to Antonella Chiechi, Alicia Ginel and Alberto de Luis for their advice.	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; AURIAS A, 1984, CANCER GENET CYTOGEN, V12, P21, DOI 10.1016/0165-4608(84)90003-7; Balcarkova J, 2009, CANCER GENET CYTOGEN, V192, P68, DOI 10.1016/j.cancergencyto.2009.02.020; Banks D, 2006, CELL CYCLE, V5, P1719, DOI 10.4161/cc.5.15.3150; Brisset S, 2001, CANCER GENET CYTOGEN, V130, P57, DOI 10.1016/S0165-4608(01)00454-X; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Ferreira BI, 2008, ONCOGENE, V27, P2084, DOI 10.1038/sj.onc.1210845; Friedrichs N, 2006, DIAGN MOL PATHOL, V15, P83, DOI 10.1097/00019606-200606000-00004; HAAS AL, 1982, J BIOL CHEM, V257, P329; Haeusler J, 2010, CANCER-AM CANCER SOC, V116, P443, DOI 10.1002/cncr.24740; Hattinger CM, 1996, GENE CHROMOSOME CANC, V17, P141, DOI 10.1002/(SICI)1098-2264(199611)17:3<141::AID-GCC1>3.0.CO;2-4; Hattinger CM, 2002, BRIT J CANCER, V86, P1763, DOI 10.1038/sj.bjc.6600332; Higa LA, 2006, CELL CYCLE, V5, P71, DOI 10.4161/cc.5.1.2266; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Higa LA, 2006, CELL CYCLE, V5, P1675, DOI 10.4161/cc.5.15.3149; Hing S, 2001, AM J PATHOL, V158, P393, DOI 10.1016/S0002-9440(10)63982-X; Huang HY, 2005, J CLIN ONCOL, V23, P548, DOI 10.1200/JCO.2005.02.081; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kauer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005415; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; Kjellman P, 2001, GENE CHROMOSOME CANC, V32, P43, DOI 10.1002/gcc.1165; Knuutila S, 1998, CANCER GENET CYTOGEN, V100, P25, DOI 10.1016/S0165-4608(97)00001-0; Kullendorff CM, 1999, MED PEDIATR ONCOL, V32, P79, DOI 10.1002/(SICI)1096-911X(199902)32:2<79::AID-MPO1>3.0.CO;2-R; Le Deley MC, 2010, J CLIN ONCOL, V28, P1982, DOI 10.1200/JCO.2009.23.3585; Liu CL, 2007, J BIOL CHEM, V282, P1109, DOI 10.1074/jbc.M606535200; Lo KC, 2007, CLIN CANCER RES, V13, P7022, DOI 10.1158/1078-0432.CCR-07-1420; Ordonez JL, 2009, CANCER RES, V69, P7140, DOI 10.1158/0008-5472.CAN-08-4041; Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200; Ottaviano L, 2010, GENE CHROMOSOME CANC, V49, P40, DOI 10.1002/gcc.20717; Ozaki T, 2001, GENE CHROMOSOME CANC, V32, P164, DOI 10.1002/gcc.1178; Pezzolo A, 2009, NEURO-ONCOLOGY, V11, P192, DOI 10.1215/15228517-2008-086; Ralph E, 2006, EMBO REP, V7, P1134, DOI 10.1038/sj.embor.7400827; Roberts P, 2008, GENE CHROMOSOME CANC, V47, P207, DOI 10.1002/gcc.20523; Sansam CL, 2006, GENE DEV, V20, P3117, DOI 10.1101/gad.1482106; Savola S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-17; Scotlandi K, 2009, J CLIN ONCOL, V27, P2209, DOI 10.1200/JCO.2008.19.2542; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tarkkanen M, 1999, CANCER GENET CYTOGEN, V114, P35, DOI 10.1016/S0165-4608(99)00031-X; TURCCAREL C, 1984, CANCER GENET CYTOGEN, V12, P1, DOI 10.1016/0165-4608(84)90002-5; van de Wiel MA, 2005, BIOINFORMATICS, V21, P3193, DOI 10.1093/bioinformatics/bti489; van de Wiel MA, 2007, CANCER INFORM, V3, P55; van de Wiel MA, 2007, BIOINFORMATICS, V23, P892, DOI 10.1093/bioinformatics/btm030; van Doorninck JA, 2010, J CLIN ONCOL, V28, P1989, DOI 10.1200/JCO.2009.24.5845; WHANGPENG J, 1984, NEW ENGL J MED, V311, P584, DOI 10.1056/NEJM198408303110907	45	65	65	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2012	31	10					1287	1298		10.1038/onc.2011.317	http://dx.doi.org/10.1038/onc.2011.317			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	906KS	21822310	Green Published			2022-12-25	WOS:000301344600008
J	Boutemy, LS; King, SRF; Win, J; Hughes, RK; Clarke, TA; Blumenschein, TMA; Kamoun, S; Banfield, MJ				Boutemy, Laurence S.; King, Stuart R. F.; Win, Joe; Hughes, Richard K.; Clarke, Thomas A.; Blumenschein, Tharin M. A.; Kamoun, Sophien; Banfield, Mark J.			Structures of Phytophthora RXLR Effector Proteins A CONSERVED BUT ADAPTABLE FOLD UNDERPINS FUNCTIONAL DIVERSITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE RESISTANCE; PLANT IMMUNITY; CELL-DEATH; AVIRULENCE; AVR3A; HYPERSENSITIVITY; SUPPRESSION; ACTIVATION; VIRULENCE; EVOLUTION	Phytopathogens deliver effector proteins inside host plant cells to promote infection. These proteins can also be sensed by the plant immune system, leading to restriction of pathogen growth. Effector genes can display signatures of positive selection and rapid evolution, presumably a consequence of their co-evolutionary arms race with plants. The molecular mechanisms underlying how effectors evolve to gain new virulence functions and/or evade the plant immune system are poorly understood. Here, we report the crystal structures of the effector domains from two oomycete RXLR proteins, Phytophthora capsici AVR3a11 and Phytophthora infestans PexRD2. Despite sharing <20% sequence identity in their effector domains, they display a conserved core alpha-helical fold. Bioinformatic analyses suggest that the core fold occurs in similar to 44% of annotated Phytophthora RXLR effectors, both as a single domain and in tandem repeats of up to 11 units. Functionally important and polymorphic residues map to the surface of the structures, and PexRD2, but not AVR3a11, oligomerizes in planta. We conclude that the core alpha-helical fold enables functional adaptation of these fast evolving effectors through (i) insertion/deletions in loop regions between alpha-helices, (ii) extensions to the N and C termini, (iii) amino acid replacements in surface residues, (iv) tandem domain duplications, and (v) oligomerization. We hypothesize that the molecular stability provided by this core fold, combined with considerable potential for plasticity, underlies the evolution of effectors that maintain their virulence activities while evading recognition by the plant immune system.	[Win, Joe; Kamoun, Sophien] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Boutemy, Laurence S.; King, Stuart R. F.; Hughes, Richard K.; Banfield, Mark J.] John Innes Ctr, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England; [Clarke, Thomas A.; Blumenschein, Tharin M. A.] Univ E Anglia, Ctr Mol & Struct Biochem, Norwich NR4 7TJ, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of East Anglia	Kamoun, S (corresponding author), Sainsbury Lab, Norwich NR4 7UH, Norfolk, England.	sophien.kamoun@tsl.ac.uk; mark.banfield@jic.ac.uk	Kamoun, Sophien/B-3529-2009; Blumenschein, Tharin/C-5984-2009; Hughes, Richard K./E-9642-2015; Banfield, Mark/C-7453-2013; Win, Joe/H-2557-2014; clarke, tom/D-1837-2009	Kamoun, Sophien/0000-0002-0290-0315; Blumenschein, Tharin/0000-0002-4932-5178; Hughes, Richard K./0000-0001-9910-6566; Banfield, Mark/0000-0001-8921-3835; Win, Joe/0000-0002-9851-2404; clarke, tom/0000-0002-6234-1914; King, Stuart/0000-0003-4374-3587	Gatsby Charitable Foundation; Biotechnology and Biological Sciences Research Council; Royal Society; BBSRC [BBS/E/J/000C0624] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0624] Funding Source: researchfish	Gatsby Charitable Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Gatsby Charitable Foundation, the Biotechnology and Biological Sciences Research Council (studentship to S. R. F. K. and core funding to M. J. B.), and the Royal Society (through a University Research Fellowship to M. J. B.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; Aminetzach YT, 2009, CURR BIOL, V19, P1925, DOI 10.1016/j.cub.2009.09.022; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; BOS JIB, 2007, THESIS OHIO STATE U; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Bos JIB, 2010, P NATL ACAD SCI USA, V107, P9909, DOI 10.1073/pnas.0914408107; Bos JIB, 2009, MOL PLANT MICROBE IN, V22, P269, DOI 10.1094/MPMI-22-3-0269; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jiang RHY, 2008, P NATL ACAD SCI USA, V105, P4874, DOI 10.1073/pnas.0709303105; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; KEARNEY B, 1990, NATURE, V346, P385, DOI 10.1038/346385a0; Kim MG, 2005, CELL, V121, P749, DOI 10.1016/j.cell.2005.03.025; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lindbo JA, 2007, PLANT PHYSIOL, V145, P1232, DOI 10.1104/pp.107.106377; Liu ZY, 2005, MOL BIOL EVOL, V22, P659, DOI 10.1093/molbev/msi049; Markson JS, 2009, FEBS LETT, V583, P3938, DOI 10.1016/j.febslet.2009.11.021; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nomura K, 2006, SCIENCE, V313, P220, DOI 10.1126/science.1129523; Oh SK, 2009, PLANT CELL, V21, P2928, DOI 10.1105/tpc.109.068247; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Raffaele S, 2010, SCIENCE, V330, P1540, DOI 10.1126/science.1193070; Samanta U, 1999, ACTA CRYSTALLOGR D, V55, P1421, DOI 10.1107/S090744499900726X; Schmidt SM, 2011, CURR OPIN PLANT BIOL, V14, P392, DOI 10.1016/j.pbi.2011.03.006; Schornack S, 2010, P NATL ACAD SCI USA, V107, P17421, DOI 10.1073/pnas.1008491107; Schornack S, 2009, MOL PLANT PATHOL, V10, P795, DOI 10.1111/j.1364-3703.2009.00593.x; Shan WX, 2004, MOL PLANT MICROBE IN, V17, P394, DOI 10.1094/MPMI.2004.17.4.394; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Vleeshouwers VGAA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002875; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Wierenga RK, 2001, FEBS LETT, V492, P193, DOI 10.1016/S0014-5793(01)02236-0; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534	51	128	132	0	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35834	35842		10.1074/jbc.M111.262303	http://dx.doi.org/10.1074/jbc.M111.262303			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21813644	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000295927100056
J	Nohara, A; Okada, S; Ohshima, K; Pessin, JE; Mori, M				Nohara, Atsushi; Okada, Shuichi; Ohshima, Kihachi; Pessin, Jeffrey E.; Mori, Masatomo			Cyclin-dependent Kinase-5 Is a Key Molecule in Tumor Necrosis Factor-alpha-induced Insulin Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED GLUT4 TRANSLOCATION; 3T3-L1 ADIPOCYTES; TNF-ALPHA; TRANSCRIPTIONAL REPRESSION; OBESITY; PHOSPHORYLATION; GENES; COMPARTMENTALIZATION; ACTIVATION; EXPRESSION	The mechanism of TNF-alpha-induced insulin resistance has remained unresolved with evidence for down-regulation of insulin effector targets effects or blockade of proximal as well as distal insulin signaling events depending upon the dose, time, and cell type examined. To address this issue we examined the acute actions of TNF-alpha in differentiated 3T3L1 adipocytes. Acute (5-15 min) treatment with 20 ng/ml (similar to 0.8 nM) TNF-alpha had no significant effect on IRS1-associated phosphatidylinositol 3-kinase. In contrast, TNF-alpha increased insulin-stimulated cyclin-dependent kinase-5 (CDK5) phosphorylation on tyrosine residue 15 through an Erk-dependent pathway and up-regulated the expression of the CDK5 regulator protein p35. In parallel, TNF-alpha stimulation also resulted in the phosphorylation and GTP loading of the Rho family GTP-binding protein, TC10 alpha. TNF-alpha enhanced the depolymerization of cortical F-actin and inhibited insulin-stimulated glucose transporter-4 (GLUT4) translocation. Treatment with the MEK inhibitor, PD98059, blocked the TNF-alpha-induced increase in CDK5 phosphorylation and the depolymerization of cortical F-actin. Conversely, siRNA-mediated knockdown of CDK5 or treatment with the MEK inhibitor restored the impaired insulin-stimulated GLUT4 translocation induced by TNF-alpha. Furthermore, siRNA-mediated knockdown of p44/42 Erk also rescued the TNF-alpha inhibition of insulin-stimulated GLUT4 translocation. Together, these data demonstrate that TNF-alpha-mediated insulin resistance of glucose uptake can occur through a MEK/Erk-dependent activation of CDK5.	[Nohara, Atsushi; Okada, Shuichi; Mori, Masatomo] Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Maebashi, Gunma 371, Japan; [Ohshima, Kihachi] Gunma Univ, Hlth & Med Ctr, Maebashi, Gunma 3718511, Japan; [Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Med & Mol Pharmacol, Bronx, NY 10461 USA	Gunma University; Gunma University; Yeshiva University; Albert Einstein College of Medicine	Mori, M (corresponding author), Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, 3-39-15 Showa Machi, Maebashi, Gunma 371, Japan.	okadash@showa.gunma-u.ac.jp			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020541] Funding Source: NIH RePORTER; NIDDK NIH HHS [P60 DK020541] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Eyster CA, 2009, VITAM HORM, V80, P193, DOI 10.1016/S0083-6729(08)00608-0; Guo DQ, 1996, J BIOL CHEM, V271, P615, DOI 10.1074/jbc.271.2.615; Hisanaga S., 2008, KINASE ACTIVITY CDK5, P1; Hoehn KL, 2008, CELL METAB, V7, P421, DOI 10.1016/j.cmet.2008.04.005; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Kanzaki M, 2002, J BIOL CHEM, V277, P25867, DOI 10.1074/jbc.C200292200; Kanzaki M, 2003, CURR BIOL, V13, pR574, DOI 10.1016/S0960-9822(03)00478-0; Kanzaki M, 2001, J BIOL CHEM, V276, P42436, DOI 10.1074/jbc.M108297200; Mao DQ, 2010, J BIOL CHEM, V285, P14671, DOI 10.1074/jbc.M109.066118; Min J, 1999, MOL CELL, V3, P751, DOI 10.1016/S1097-2765(01)80007-1; Moller DE, 2000, TRENDS ENDOCRIN MET, V11, P212, DOI 10.1016/S1043-2760(00)00272-1; Nolte LA, 1998, DIABETES, V47, P721, DOI 10.2337/diabetes.47.5.721; Okada S, 2008, J BIOL CHEM, V283, P35455, DOI 10.1074/jbc.M806531200; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; Sato K, 2007, J NEUROSCI RES, V85, P3071, DOI 10.1002/jnr.21438; STEPHENS JM, 1991, J BIOL CHEM, V266, P21839; STEPHENS JM, 1992, J BIOL CHEM, V267, P13580; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Tagami S, 2002, J BIOL CHEM, V277, P3085, DOI 10.1074/jbc.M103705200; Tilg H, 2006, GASTROENTEROLOGY, V131, P934, DOI 10.1053/j.gastro.2006.05.054; Utreras E, 2009, J BIOL CHEM, V284, P2275, DOI 10.1074/jbc.M805052200; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Valverde AM, 1998, ENDOCRINOLOGY, V139, P1229, DOI 10.1210/en.139.3.1229; Watson RT, 2001, J CELL BIOL, V154, P829, DOI 10.1083/jcb.200102078; WEINER FR, 1991, J BIOL CHEM, V266, P23525; Yamada E, 2005, J CELL BIOL, V168, P921, DOI 10.1083/jcb.200408182; Yamaguchi K, 2003, HYPERTENS RES, V26, P389, DOI 10.1291/hypres.26.389; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Zaid H, 2008, BIOCHEM J, V413, P201, DOI 10.1042/BJ20080723	33	23	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33457	33465		10.1074/jbc.M111.231431	http://dx.doi.org/10.1074/jbc.M111.231431			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21813649	hybrid, Green Published			2022-12-25	WOS:000294968800063
J	Sears, N; Sen, GC; Stark, GR; Chattopadhyay, S				Sears, Nathaniel; Sen, Ganes C.; Stark, George R.; Chattopadhyay, Saurabh			Caspase-8-mediated Cleavage Inhibits IRF-3 Protein by Facilitating Its Proteasome-mediated Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INTERFERON REGULATORY FACTOR-3; INNATE ANTIVIRAL RESPONSE; SENDAI-VIRUS INFECTION; SVM-BASED PREDICTION; DOUBLE-STRANDED-RNA; CELL LINE; TRANSCRIPTION FACTOR; NEGATIVE REGULATION; IMMUNE-RESPONSES	Interferon regulatory factor 3 (IRF-3) plays a central role in inducing the expression of cellular antiviral genes, including the interferon-beta gene, in response to Pattern Recognition Receptors. IRF-3 is targeted for proteasome-mediated degradation, which modulates the strength and duration of the innate immune responses that depend on it. We have found that caspase-8, which is activated by cytosolic RIG-I-dependent signaling, catalyzes an essential intermediate step in the ubiquitination and proteasome-mediated degradation of IRF-3. Mutation of a consensus cleavage site within IRF-3 generates a form that is not cleaved by caspase-8 and that is protected from ubiquitination and degradation. An in vitro assay confirms the direct action of caspase-8 cleavage on IRF-3. We also show that caspase-8-mediated cleavage of IRF-3 helps to modulate dsRNA-dependent gene induction.	[Sears, Nathaniel; Sen, Ganes C.; Stark, George R.; Chattopadhyay, Saurabh] Cleveland Clin, Dept Mol Genet, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Chattopadhyay, S (corresponding author), Cleveland Clin, Dept Mol Genet, Lerner Res Inst, 9500 Euclid Ave,NE20, Cleveland, OH 44195 USA.	chattos@ccf.org	Chattopadhyay, Saurabh/I-4091-2019	Chattopadhyay, Saurabh/0000-0002-2930-1523; Sears, Nathaniel/0000-0002-6879-9782	National Institutes of Health [R01 AI 073303, P01 CA062220]; NATIONAL CANCER INSTITUTE [P01CA062220, R01CA095851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI 073303 (to G. C. S.) and P01CA062220 (to G. C. S. and G. R. S.).	Areste C, 2009, J BIOL CHEM, V284, P23272, DOI 10.1074/jbc.M109.033290; Barro M, 2005, P NATL ACAD SCI USA, V102, P4114, DOI 10.1073/pnas.0408376102; Bibeau-Poirier A, 2006, J IMMUNOL, V177, P5059, DOI 10.4049/jimmunol.177.8.5059; Chattopadhyay S, 2011, J VIROL, V85, P3708, DOI 10.1128/JVI.02133-10; Chattopadhyay S, 2010, EMBO J, V29, P1762, DOI 10.1038/emboj.2010.50; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Chen ZH, 2007, VIROLOGY, V366, P277, DOI 10.1016/j.virol.2007.04.023; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Elco CP, 2005, J VIROL, V79, P3920, DOI 10.1128/JVI.79.7.3920-3929.2005; Genin P, 2009, CYTOKINE GROWTH F R, V20, P283, DOI 10.1016/j.cytogfr.2009.07.005; Han KJ, 2004, J BIOL CHEM, V279, P15652, DOI 10.1074/jbc.M311629200; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kovalenko A, 2009, J EXP MED, V206, P2161, DOI 10.1084/jem.20090616; Kubota T, 2008, J BIOL CHEM, V283, P25660, DOI 10.1074/jbc.M804479200; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Leaman DW, 1998, P NATL ACAD SCI USA, V95, P9442, DOI 10.1073/pnas.95.16.9442; Lee HR, 2009, J INTERF CYTOK RES, V29, P621, DOI 10.1089/jir.2009.0067; Li HM, 2009, CELL DEATH DIFFER, V16, P1615, DOI 10.1038/cdd.2009.97; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Lu G, 2006, CELL MOL BIOL, V52, P29, DOI 10.1170/T695; Meylan E, 2002, EMBO REP, V3, P1201, DOI 10.1093/embo-reports/kvf236; Peters K, 2008, J VIROL, V82, P3500, DOI 10.1128/JVI.02536-07; Prinarakis E, 2008, EMBO J, V27, P865, DOI 10.1038/emboj.2008.28; Rajput A, 2011, IMMUNITY, V34, P340, DOI 10.1016/j.immuni.2010.12.018; RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z; Rebsamen M, 2008, CELL DEATH DIFFER, V15, P1804, DOI 10.1038/cdd.2008.119; Saira K, 2007, J VIROL, V81, P3077, DOI 10.1128/JVI.02064-06; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Takahashi K, 2006, J IMMUNOL, V176, P4520, DOI 10.4049/jimmunol.176.8.4520; Wee LJK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S14; Wee LJK, 2007, BIOINFORMATICS, V23, P3241, DOI 10.1093/bioinformatics/btm334; White CL, 2011, J VIROL, V85, P5224, DOI 10.1128/JVI.00053-11; Yang K, 2009, J IMMUNOL, V182, P3782, DOI 10.4049/jimmunol.0803126; Yang P, 2007, INVEST OPHTH VIS SCI, V48, P3341, DOI 10.1167/iovs.06-1340; Yu YX, 2010, IMMUNITY, V33, P863, DOI 10.1016/j.immuni.2010.11.027; Zeng WW, 2009, MOL CELL, V36, P315, DOI 10.1016/j.molcel.2009.09.037; Zhang M, 2008, CELL RES, V18, P1096, DOI 10.1038/cr.2008.277	40	32	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33037	33044		10.1074/jbc.M111.257022	http://dx.doi.org/10.1074/jbc.M111.257022			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21816816	Green Published, hybrid			2022-12-25	WOS:000294968800022
J	Scheiber, IBR; Hohnstein, A; Kotrschal, K; Weiss, BM				Scheiber, Isabella B. R.; Hohnstein, Aileen; Kotrschal, Kurt; Weiss, Brigitte M.			Juvenile Greylag Geese (Anser anser) Discriminate between Individual Siblings	PLOS ONE			English	Article							PASSIVE SOCIAL SUPPORT; GENETICAL EVOLUTION; KIN RECOGNITION; SEX-DIFFERENCES; GOOSE FAMILIES; SONGBIRD; BIRDS	Social species that maintain individualised relationships with certain others despite continuous changes in age, reproductive status and dominance rank between group members ought to be capable of individual recognition. Tests of "true" individual recognition, where an individual recognises unique features of another, are rare, however. Often kinship and/or familiarity suffice to explain dyadic interactions. The complex relationships within a greylag goose flock suggest that they should be able to recognise individuals irrespective of familiarity or kinship. We tested whether six-week-old hand-raised greylags can discriminate between two of their siblings. We developed a new experimental protocol, in which geese were trained to associate social siblings with geometrical symbols. Subsequently, focals were presented with two geometrical symbols in the presence of a sibling associated with one of the symbols. Significant choice of the geometrical symbol associated with the target present indicated that focals were able to distinguish between individual targets. Greylag goslings successfully learned this association-discrimination task, regardless of genetic relatedness or sex of the sibling targets. Social relationships within a goose flock thus may indeed be based on recognition of unique features of individual conspecifics.	[Scheiber, Isabella B. R.; Hohnstein, Aileen; Kotrschal, Kurt; Weiss, Brigitte M.] Konrad Lorenz Forsch Stelle Ethol, Grunau, Austria; [Scheiber, Isabella B. R.; Kotrschal, Kurt] Univ Vienna, Dept Behav Biol, Vienna, Austria; [Hohnstein, Aileen] Humboldt Univ, Inst Biol, Berlin, Germany; [Weiss, Brigitte M.] Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland	University of Vienna; Humboldt University of Berlin; University of Neuchatel	Scheiber, IBR (corresponding author), Konrad Lorenz Forsch Stelle Ethol, Grunau, Austria.	isabella.scheiber@klf.ac.at	Scheiber, Isabella B. R./E-4109-2015	Scheiber, Isabella B. R./0000-0003-3438-1836; Weiss, Brigitte/0000-0001-6316-5636	"Fonds zur Forderung der wissenschaftlichen Forschung" (Austrian Science Fund) [18601-B17, 21489-B17]; Austrian Science Fund (FWF) [P 21489] Funding Source: researchfish	"Fonds zur Forderung der wissenschaftlichen Forschung" (Austrian Science Fund)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was funded by "Fonds zur Forderung der wissenschaftlichen Forschung" (Austrian Science Fund) projects 18601-B17 to IBRS and 21489-B17 to KK (www.fwf.ac.at). We acknowledge the "Verein der Forderer der Konrad Lorenz Forschungsstelle" for permanent support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron-Cohen S, 2007, ESSENTIAL DIFFERENCE; Bates LA, 2008, BIOL LETTERS, V4, P34, DOI 10.1098/rsbl.2007.0529; BEECHER MD, 1988, BEHAV GENET, V18, P465, DOI 10.1007/BF01065515; BURTT EH, 1977, ANIM BEHAV, V25, P231, DOI 10.1016/0003-3472(77)90086-0; Daisley JN, 2005, HORM BEHAV, V47, P185, DOI 10.1016/j.yhbeh.2004.09.006; Draganoiu TI, 2006, ANIM BEHAV, V71, P1039, DOI 10.1016/j.anbehav.2005.06.022; Drummond H, 2006, Q REV BIOL, V81, P3, DOI 10.1086/503922; Frigerio D., 2001, Acta Ethologica, V3, P121, DOI 10.1007/s102110000028; Galwey N.W., 2006, INTRO MIXED MODELLIN; GAULIN SJC, 1990, J COMP PSYCHOL, V104, P88, DOI 10.1037/0735-7036.104.1.88; Gheusi G, 1997, ANIM BEHAV, V53, P935, DOI 10.1006/anbe.1996.0314; GODARD R, 1991, NATURE, V350, P228, DOI 10.1038/350228a0; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Halpern D., 2013, SEX DIFFERENCES COGN, V4th; Halpern DF, 2004, CURR DIR PSYCHOL SCI, V13, P135, DOI 10.1111/j.0963-7214.2004.00292.x; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; HAMILTON WD, 1964, J THEOR BIOL, V7, P17, DOI 10.1016/0022-5193(64)90039-6; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hemetsberger J, 2010, INTERACT STUD, V11, P380, DOI 10.1075/is.11.3.03hem; Hinde, 1983, PRIMATE SOCIAL RELAT; HOHNSTEIN A, 2010, THESIS HUMBOLD U BER; Hudson R, 2008, BEHAV ECOL SOCIOBIOL, V62, P299, DOI 10.1007/s00265-007-0417-z; KALAS S, 1977, Z TIERPSYCHOL, V45, P174; Kalmbach E, 2006, IBIS, V148, P66, DOI 10.1111/j.1474-919X.2006.00496.x; Kimura Doreen, 2002, Neuro Endocrinol Lett, V23 Suppl 4, P67; Kimura Doreen., 2000, SEX COGNITION, V1; Komdeur J, 1999, TRENDS ECOL EVOL, V14, P237, DOI 10.1016/S0169-5347(98)01573-0; Kotrschal K, 2010, ANIMAL BEHAV EVOLUTI, P121; Kotrschal Kurt, 2006, P45; Lorenz K., 1988, HIER BIN ICH WO BIST; Maestripieri D, 1999, NEUROSCI BIOBEHAV R, V23, P411, DOI 10.1016/S0149-7634(98)00042-6; Morley KI, 2001, BEHAV GENET, V31, P511, DOI 10.1023/A:1013337209957; Nakagawa S, 2004, BIOL REV, V79, P101, DOI 10.1017/S1464793103006249; Rendall D, 1996, ANIM BEHAV, V51, P1007, DOI 10.1006/anbe.1996.0103; Sayigh LS, 1999, ANIM BEHAV, V57, P41, DOI 10.1006/anbe.1998.0961; Scheiber IBR, 2005, BEHAVIOUR, V142, P1535, DOI 10.1163/156853905774831873; Scheiber IBR, 2009, ANIM BEHAV, V77, P1211, DOI 10.1016/j.anbehav.2009.01.026; Scheiber IBR, 2009, HORM BEHAV, V55, P133, DOI 10.1016/j.yhbeh.2008.09.006; Seyfarth RM, 2003, ANIMAL SOCIAL COMPLEXITY, P207; SHUGART GW, 1977, P COLON WATERBIRD, V1, P10; Steiger S, 2008, TRENDS ECOL EVOL, V23, P355, DOI 10.1016/j.tree.2008.01.014; Sturkie P.D., 1986, AVIAN PHYSIOL, DOI DOI 10.1007/978-1-4612-4862-0_5; Swoboda R, 2006, THESIS U VIENNA VIEN; Tang-Martinez Z, 2009, J CHEM ECOL, V35, P400, DOI 10.1007/s10886-009-9622-8; Tibbetts EA, 2002, P ROY SOC B-BIOL SCI, V269, P1423, DOI 10.1098/rspb.2002.2031; Tibbetts EA, 2007, TRENDS ECOL EVOL, V22, P529, DOI 10.1016/j.tree.2007.09.001; Tricarico E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018710; WASSERMANN EA, 2006, COMP COGNITION ANIMA; Weiss BM, 2008, MOL ECOL RESOUR, V8, P1411, DOI 10.1111/j.1755-0998.2008.02339.x; Weiss BM, 2004, ETHOLOGY, V110, P429, DOI 10.1111/j.1439-0310.2004.00979.x; WEISS BM, 2000, THESIS U VIENNA VIEN; Garamszegi LZ, 2009, BEHAV ECOL, V20, P1363, DOI 10.1093/beheco/arp137; [No title captured]	53	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22853	10.1371/journal.pone.0022853	http://dx.doi.org/10.1371/journal.pone.0022853			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826212	Green Published, gold, Green Submitted			2022-12-25	WOS:000293558900038
J	Ginestet, CE; Nichols, TE; Bullmore, ET; Simmons, A				Ginestet, Cedric E.; Nichols, Thomas E.; Bullmore, Ed T.; Simmons, Andrew			Brain Network Analysis: Separating Cost from Topology Using Cost-Integration	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; CORTICAL NETWORKS; EFFICIENCY; ORGANIZATION; FREQUENCY; DYNAMICS	A statistically principled way of conducting brain network analysis is still lacking. Comparison of different populations of brain networks is hard because topology is inherently dependent on wiring cost, where cost is defined as the number of edges in an unweighted graph. In this paper, we evaluate the benefits and limitations associated with using cost-integrated topological metrics. Our focus is on comparing populations of weighted undirected graphs that differ in mean association weight, using global efficiency. Our key result shows that integrating over cost is equivalent to controlling for any monotonic transformation of the weight set of a weighted graph. That is, when integrating over cost, we eliminate the differences in topology that may be due to a monotonic transformation of the weight set. Our result holds for any unweighted topological measure, and for any choice of distribution over cost levels. Cost-integration is therefore helpful in disentangling differences in cost from differences in topology. By contrast, we show that the use of the weighted version of a topological metric is generally not a valid approach to this problem. Indeed, we prove that, under weak conditions, the use of the weighted version of global efficiency is equivalent to simply comparing weighted costs. Thus, we recommend the reporting of (i) differences in weighted costs and (ii) differences in cost-integrated topological measures with respect to different distributions over the cost domain. We demonstrate the application of these techniques in a re-analysis of an fMRI working memory task. We also provide a Monte Carlo method for approximating cost-integrated topological measures. Finally, we discuss the limitations of integrating topology over cost, which may pose problems when some weights are zero, when multiplicities exist in the ranks of the weights, and when one expects subtle cost-dependent topological differences, which could be masked by cost-integration.	[Ginestet, Cedric E.; Simmons, Andrew] Kings Coll London, Dept Neuroimaging, Inst Psychiat, London WC2R 2LS, England; [Ginestet, Cedric E.; Simmons, Andrew] Kings Coll London, NIHR, Biomed Res Ctr Mental Hlth, Inst Psychiat, London WC2R 2LS, England; [Nichols, Thomas E.] Univ Warwick, Dept Stat, Coventry CV4 7AL, W Midlands, England; [Bullmore, Ed T.] Univ Cambridge, Dept Psychiat, Brain Mapping Unit, Sch Clin Med, Cambridge, England	University of London; King's College London; University of London; King's College London; University of Warwick; University of Cambridge	Ginestet, CE (corresponding author), Kings Coll London, Dept Neuroimaging, Inst Psychiat, London WC2R 2LS, England.	cedric.ginestet@kcl.ac.uk	Simmons, Andrew/B-8848-2008; Bullmore, Ed/C-1706-2012; Nichols, Thomas E./N-9902-2017; Ginestet, Cedric/B-8722-2012	Simmons, Andrew/0000-0003-2306-5811; Bullmore, Ed/0000-0002-8955-8283; Nichols, Thomas E./0000-0002-4516-5103; Ginestet, Cedric/0000-0003-2412-7690	United Kingdom National Institute for Health Research (NIHR) Biomedical Research Centre for Mental Health (BRC-MH) at the South London; Maudsley NHS Foundation Trust; King's College London; Guy's and St Thomas' Charitable Foundation; South London; Maudsley Trustees; MRC [G0900908] Funding Source: UKRI; Medical Research Council [G0900908] Funding Source: researchfish	United Kingdom National Institute for Health Research (NIHR) Biomedical Research Centre for Mental Health (BRC-MH) at the South London(National Institute for Health Research (NIHR)); Maudsley NHS Foundation Trust; King's College London(General Electric); Guy's and St Thomas' Charitable Foundation; South London; Maudsley Trustees; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	CEG and AS were supported by a fellowship from the United Kingdom National Institute for Health Research (NIHR) Biomedical Research Centre for Mental Health (BRC-MH) at the South London and Maudsley NHS Foundation Trust and King's College London. This work has also been funded by the Guy's and St Thomas' Charitable Foundation as well as the South London and Maudsley Trustees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; ASTOLFI L, 2009, C P IEEE ENG MED BIO, P2208; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernardo JM, 1994, BAYESIAN THEORY; Billingsley P, 1995, WILEY SERIES PROBABI; Bollobas B, 2003, HANDBOOK OF GRAPHS AND NETWORKS: FROM THE GENOME TO THE INTERNET, P1; Cecchi GA, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-S1-S5; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Fallani FDV, 2008, NEUROINFORMATICS, V6, P23, DOI 10.1007/s12021-007-9006-6; Gilks W.R., 1996, INTRO MARKOV CHAIN M; Ginestet CE, 2011, NEUROIMAGE, V55, P688, DOI 10.1016/j.neuroimage.2010.11.030; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2009, BRAIN, V132, P3366, DOI 10.1093/brain/awp089; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Kaiser M, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/8/083042; Kolaczyk ED, 2009, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-88146-1_1; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Lin RH, 2006, BAYESIAN ANAL, V1, P915, DOI 10.1214/06-BA130; Minka TP., 2001, THESIS MIT CAMBRIDGE; Newman M.E.J., 2010, NETWORKS INTRO; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Pachou E, 2008, BRAIN TOPOGR, V21, P128, DOI 10.1007/s10548-008-0062-5; PINHEIRO J, 2000, MIXED EFFECTS MODE S; Robert C.P., 2004, TECHNOMETRICS, V2nd ed., DOI [10.1007/978-1-4757-4145-2, DOI 10.2307/1270959]; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salvador R, 2008, NEUROIMAGE, V39, P279, DOI 10.1016/j.neuroimage.2007.08.018; Simmons A, 1999, MAGNET RESON MED, V41, P1274, DOI 10.1002/(SICI)1522-2594(199906)41:6<1274::AID-MRM27>3.0.CO;2-1; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	42	125	126	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e21570	10.1371/journal.pone.0021570	http://dx.doi.org/10.1371/journal.pone.0021570			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829437	Green Submitted, gold, Green Published			2022-12-25	WOS:000293284600005
J	Wasser, K; Schnaudigel, S; Wohlfahrt, J; Psychogios, MN; Knauth, M; Groschel, K				Wasser, Katrin; Schnaudigel, Sonja; Wohlfahrt, Janin; Psychogios, Marios-Nikos; Knauth, Michael; Groeschel, Klaus			Inflammation and In-Stent Restenosis: The Role of Serum Markers and Stent Characteristics in Carotid Artery Stenting	PLOS ONE			English	Article							C-REACTIVE PROTEIN; DUPLEX ULTRASOUND; FOLLOW-UP; ENDARTERECTOMY; MECHANISMS; CRITERIA	Background: Carotid angioplasty and stenting (CAS) may currently be recommended especially in younger patients with a high-grade carotid artery stenosis. However, evidence is accumulating that in-stent restenosis (ISR) could be an important factor endangering the long-term efficacy of CAS. The aim of this study was to investigate the influence of inflammatory serum markers and procedure-related factors on ISR as diagnosed with duplex sonography. Methods: We analyzed 210 CAS procedures in 194 patients which were done at a single university hospital between May 2003 and June 2010. Periprocedural C-reactive protein (CRP) and leukocyte count as well as stent design and geometry, and other periprocedural factors were analyzed with respect to the occurrence of an ISR as diagnosed with serial carotid duplex ultrasound investigations during clinical long-term follow-up Results: Over a median of 33.4 months follow-up (IQR: 14.9-53.7) of 210 procedures (mean age of 67.9 +/- 9.7 years, 71.9% male, 71.0% symptomatic) an ISR of >= 70% was detected in 5.7% after a median of 8.6 months (IQR: 3.4-17.3). After multiple regression analysis, leukocyte count after CAS-intervention (odds ratio (OR): 1.31, 95% confidence interval (CI): 1.02-1.69; p = 0.036), as well as stent length and width were associated with the development of an ISR during follow-up (OR: 1.25, 95% CI: 1.05-1.65, p = 0.022 and OR: 0.28, 95% CI: 0.09-0.84, p = 0.010). Conclusions: The majority of ISR during long-term follow-up after CAS occur within the first year. ISR is associated with periinterventional inflammation markers and influenced by certain stent characteristics such as stent length and width. Our findings support the assumption that stent geometry leading to vessel injury as well as periprocedural inflammation during CAS plays a pivotal role in the development of carotid artery ISR.	[Wasser, Katrin; Schnaudigel, Sonja; Wohlfahrt, Janin; Groeschel, Klaus] Univ Gottingen, Dept Neurol, D-3400 Gottingen, Germany; [Psychogios, Marios-Nikos; Knauth, Michael] Univ Gottingen, Dept Neuroradiol, Gottingen, Germany; [Psychogios, Marios-Nikos] Univ Gottingen, Dept Diagnost Radiol, Gottingen, Germany	University of Gottingen; University of Gottingen; University of Gottingen	Wasser, K (corresponding author), Univ Gottingen, Dept Neurol, D-3400 Gottingen, Germany.	klaus.groeschel@medizin.uni-goettingen.de	Gröschel, Klaus/ABC-4777-2021	Gröschel, Klaus/0000-0002-0244-6116				Bonati LH, 2011, EUR J VASC ENDOVASC, V41, P153, DOI 10.1016/j.ejvs.2011.01.001; Bonati LH, 2010, LANCET, V376, P1062, DOI 10.1016/S0140-6736(10)61009-4; Brott TG, 2010, NEW ENGL J MED, V363, P11, DOI 10.1056/NEJMoa0912321; Buffon A, 1999, J AM COLL CARDIOL, V34, P1512, DOI 10.1016/S0735-1097(99)00348-4; Clark DJ, 2006, J AM COLL CARDIOL, V47, P2390, DOI 10.1016/j.jacc.2006.01.076; Eckstein HH, 2008, LANCET NEUROL, V7, P893, DOI 10.1016/S1474-4422(08)70196-0; Ederle J, 2010, J NEUROL NEUROSUR PS, V81, P477, DOI 10.1136/jnnp.2008.144956; Farb A, 1999, CIRCULATION, V99, P44, DOI 10.1161/01.CIR.99.1.44; Farrell B, 1998, LANCET, V351, P1379, DOI 10.1016/s0140-6736(97)09292-1; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Groschel K, 2007, AM J NEURORADIOL, V28, P1743, DOI 10.3174/ajnr.A0650; Groschel K, 2008, J NEUROL SCI, V273, P112, DOI 10.1016/j.jns.2008.07.004; Gupta R, 2010, J NEUROIMAGING, V20, P74, DOI 10.1111/j.1552-6569.2008.00313.x; JAGELS MA, 1994, IMMUNOPHARMACOLOGY, V28, P1, DOI 10.1016/0162-3109(94)90034-5; Kastrup A, 2007, ACTA CHIR BELG, V107, P119, DOI 10.1080/00015458.2007.11680028; Kornowski R, 1998, J AM COLL CARDIOL, V31, P224, DOI 10.1016/S0735-1097(97)00450-6; Lal BK, 2008, J VASC SURG, V47, P63, DOI 10.1016/j.jvs.2007.09.038; Meier P, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c467; Naggara O, 2011, STROKE, V42, P380, DOI 10.1161/STROKEAHA.110.588772; Nederkoorn PJ, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-36; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Roger Veronique L, 2011, Circulation, V123, pe18, DOI 10.1161/CIR.0b013e3182009701; Schillinger M, 2003, RADIOLOGY, V227, P516, DOI 10.1148/radiol.2272020183; Setacci C, 2008, STROKE, V39, P1189, DOI 10.1161/STROKEAHA.107.497487; Steinbauer MGM, 2008, J VASC SURG, V48, P93, DOI 10.1016/j.jvs.2008.02.049; Walter DH, 2001, J AM COLL CARDIOL, V37, P839, DOI 10.1016/S0735-1097(00)01193-1; Weintraub WS, 2007, AM J CARDIOL, V100, p3K, DOI 10.1016/j.amjcard.2007.06.002; Welt FGP, 2002, ARTERIOSCL THROM VAS, V22, P1769, DOI 10.1161/01.ATV.0000037100.44766.5B	28	33	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22683	10.1371/journal.pone.0022683	http://dx.doi.org/10.1371/journal.pone.0022683			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829478	Green Published, gold, Green Submitted			2022-12-25	WOS:000293284600024
J	Gudi, V; Skuljec, J; Yildiz, O; Frichert, K; Skripuletz, T; Moharregh-Khiabani, D; Voss, E; Wissel, K; Wolter, S; Stangel, M				Gudi, Viktoria; Skuljec, Jelena; Yildiz, Oezlem; Frichert, Konstantin; Skripuletz, Thomas; Moharregh-Khiabani, Darius; Voss, Elke; Wissel, Kirsten; Wolter, Sabine; Stangel, Martin			Spatial and Temporal Profiles of Growth Factor Expression during CNS Demyelination Reveal the Dynamics of Repair Priming	PLOS ONE			English	Article							CILIARY NEUROTROPHIC FACTOR; LEUKEMIA INHIBITORY FACTOR; CENTRAL-NERVOUS-SYSTEM; OLIGODENDROCYTE PRECURSOR CELLS; MULTIPLE-SCLEROSIS LESIONS; SPINAL-CORD DEMYELINATION; BRAIN AGGREGATE CULTURES; IN-VIVO; FACTOR GDNF; IGF-I	Demyelination is the cause of disability in various neurological disorders. It is therefore crucial to understand the molecular regulation of oligodendrocytes, the myelin forming cells in the CNS. Growth factors are known to be essential for the development and maintenance of oligodendrocytes and are involved in the regulation of glial responses in various pathological conditions. We employed the well established murine cuprizone model of toxic demyelination to analyze the expression of 13 growth factors in the CNS during de- and remyelination. The temporal mRNA expression profile during demyelination and the subsequent remyelination were analyzed separately in the corpus callosum and cerebral cortex using laser microdissection and real-time PCR techniques. During demyelination a similar pattern of growth factor mRNA expression was observed in both areas with a strong up-regulation of NRG1 and GDNF and a slight increase of CNTF in the first week of cuprizone treatment. HGF, FGF-2, LIF, IGF-1, and TGF-beta 1 were up-regulated mainly during peak demyelination. In contrast, during remyelination there were regional differences in growth factor mRNA expression levels. GDNF, CNTF, HGF, FGF-2, and BDNF were elevated in the corpus callosum but not in the cortex, suggesting tissue differences in the molecular regulation of remyelination in the white and grey matter. To clarify the cellular source we isolated microglia from the cuprizone lesions. GDNF, IGF-1, and FGF mRNA were detected in the microglial fraction with a temporal pattern corresponding to that from whole tissue PCR. In addition, immunohistochemical analysis revealed IGF-1 protein expression also in the reactive astrocytes. CNTF was located in astrocytes. This study identified seven different temporal expression patterns for growth factors in white and grey matter and demonstrated the importance of early tissue priming and exact orchestration of different steps during callosal and cortical de- and remyelination.	[Gudi, Viktoria; Skuljec, Jelena; Yildiz, Oezlem; Frichert, Konstantin; Skripuletz, Thomas; Moharregh-Khiabani, Darius; Voss, Elke; Stangel, Martin] Hannover Med Sch, Dept Neurol, D-3000 Hannover, Germany; [Gudi, Viktoria; Skuljec, Jelena; Stangel, Martin] Ctr Syst Neurosci, Hannover, Germany; [Wissel, Kirsten] Hannover Med Sch, Dept Otolaryngol, D-3000 Hannover, Germany; [Wolter, Sabine] Hannover Med Sch, Dept Pharmacol, D-3000 Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Gudi, V (corresponding author), Hannover Med Sch, Dept Neurol, D-3000 Hannover, Germany.	Stangel.Martin@MH-Hannover.de	Stangel, Martin/AAH-5345-2020; Skuljec, Jelena/ABF-6712-2020	Skuljec, Jelena/0000-0001-8509-6563	Georg-Christoph-Lichtenberg Fellowship; State of Lower Saxony; Hannover Medical School, Department for gender equality	Georg-Christoph-Lichtenberg Fellowship; State of Lower Saxony(European Commission); Hannover Medical School, Department for gender equality	This work has been supported by the Georg-Christoph-Lichtenberg Fellowship by the State of Lower Saxony and by the grant from Hannover Medical School, Department for gender equality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert M, 2007, BRAIN PATHOL, V17, P129, DOI 10.1111/j.1750-3639.2006.00043.x; Albrecht PJ, 2003, NEUROBIOL DIS, V13, P89, DOI 10.1016/S0969-9961(03)00019-6; Althaus HH, 2008, J MOL NEUROSCI, V35, P65, DOI 10.1007/s12031-008-9053-y; Armstrong RC, 2002, J NEUROSCI, V22, P8574; Bansal R, 1997, ADV EXP MED BIOL, V429, P69; Barres BA, 1996, MOL CELL NEUROSCI, V8, P146, DOI 10.1006/mcne.1996.0053; Batchelor PE, 1999, J NEUROSCI, V19, P1708; Bo L, 2003, MULT SCLER, V9, P323, DOI 10.1191/1352458503ms917oa; Butt AM, 2000, J NEUROSCI RES, V59, P477, DOI 10.1002/(SICI)1097-4547(20000215)59:4<477::AID-JNR2>3.0.CO;2-J; Cardona AE, 2006, NAT PROTOC, V1, P1947, DOI 10.1038/nprot.2006.327; Frota ERC, 2009, NEUROSCI LETT, V460, P130, DOI 10.1016/j.neulet.2009.05.057; Copelman CA, 2000, GLIA, V30, P342, DOI 10.1002/(SICI)1098-1136(200006)30:4<342::AID-GLIA30>3.0.CO;2-8; Dallner C, 2002, GLIA, V37, P374; De Haas AH, 2007, GLIA, V55, P1374, DOI 10.1002/glia.20554; Diemel LT, 2003, J NEUROSCI RES, V74, P858, DOI 10.1002/jnr.10837; Du YZ, 2003, DEV NEUROSCI-BASEL, V25, P116, DOI 10.1159/000072261; Franklin RJM, 1999, J NEUROSCI RES, V58, P207, DOI 10.1002/(SICI)1097-4547(19991015)58:2<207::AID-JNR1>3.0.CO;2-1; Fushimi S, 2004, NEUROPATHOLOGY, V24, P208, DOI 10.1111/j.1440-1789.2004.00561.x; Goddard DR, 2001, MOL CELL NEUROSCI, V18, P557, DOI 10.1006/mcne.2001.1025; Gudi V, 2009, BRAIN RES, V1283, P127, DOI 10.1016/j.brainres.2009.06.005; Hashimoto M, 2005, J NEUROSCI RES, V79, P476, DOI 10.1002/jnr.20368; Havenith CEG, 1998, GLIA, V22, P348, DOI 10.1002/(SICI)1098-1136(199804)22:4<348::AID-GLIA4>3.3.CO;2-X; Hendriks JJA, 2008, J NEUROIMMUNOL, V204, P52, DOI 10.1016/j.jneuroim.2008.07.015; HESSE A, 2009, NEUROBIOL DIS; Hinks GL, 1999, MOL CELL NEUROSCI, V14, P153, DOI 10.1006/mcne.1999.0771; Ikeda T, 2002, INT J DEV NEUROSCI, V20, P555, DOI 10.1016/S0736-5748(02)00082-5; Kahn MA, 1997, J NEUROCHEM, V68, P1413; Kerr BJ, 2004, EXP NEUROL, V188, P391, DOI 10.1016/j.expneurol.2004.04.012; Lalive PH, 2005, EUR J IMMUNOL, V35, P727, DOI 10.1002/eji.200425430; Lee YJ, 2006, NEUROSCI LETT, V410, P178, DOI 10.1016/j.neulet.2006.09.090; Lindner M, 2008, NEUROPATH APPL NEURO, V34, P105, DOI 10.1111/j.1365-2990.2007.00879.x; Mason JL, 2000, J NEUROSCI RES, V61, P251, DOI 10.1002/1097-4547(20000801)61:3<251::AID-JNR3>3.0.CO;2-W; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; MAYER M, 1994, DEVELOPMENT, V120, P143; MCKINNON RD, 1993, J CELL BIOL, V121, P1397, DOI 10.1083/jcb.121.6.1397; MCKINNON RD, 1990, NEURON, V5, P603, DOI 10.1016/0896-6273(90)90215-2; Miller RH, 2007, NAT NEUROSCI, V10, P1351, DOI 10.1038/nn1995; Mirowska-Guzel D, 2009, IMMUNOPHARM IMMUNOT, V31, P32, DOI 10.1080/08923970802379819; Miyazaki H, 2001, BRAIN RES, V922, P165, DOI 10.1016/S0006-8993(01)03013-X; MOZELL RL, 1991, J NEUROSCI RES, V30, P382, DOI 10.1002/jnr.490300214; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Power J, 2002, DEV BIOL, V245, P362, DOI 10.1006/dbio.2002.0610; Rehbinder C, 1996, LAB ANIM, V30, P193, DOI 10.1258/002367796780684881; Rosenberg SS, 2006, BRAIN PATHOL, V16, P288, DOI 10.1111/j.1750-3639.2006.00035.x; Satake K, 2000, NEUROREPORT, V11, P3877, DOI 10.1097/00001756-200011270-00054; Skripuletz T, 2008, AM J PATHOL, V172, P1053, DOI 10.2353/ajpath.2008.070850; Stankoff B, 2002, J NEUROSCI, V22, P9221; Sugiura S, 2000, EUR J NEUROSCI, V12, P457, DOI 10.1046/j.1460-9568.2000.00922.x; SuterCrazzolara C, 1996, MOL BRAIN RES, V41, P175, DOI 10.1016/0169-328X(96)00089-7; van Horssen J, 2007, J NEUROPATH EXP NEUR, V66, P321, DOI 10.1097/nen.0b013e318040b2de; WOLSWIJK G, 1992, J CELL BIOL, V118, P889, DOI 10.1083/jcb.118.4.889; Woodruff RH, 2004, MOL CELL NEUROSCI, V25, P252, DOI 10.1016/j.mcn.2003.10.014; Yan HL, 2002, J NEUROSCI RES, V69, P597, DOI 10.1002/jnr.10323; YE P, 1995, J NEUROSCI, V15, P7344; Ye P, 2002, J NEUROSCI, V22, P6041	55	74	75	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22623	10.1371/journal.pone.0022623	http://dx.doi.org/10.1371/journal.pone.0022623			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818353	gold, Green Published, Green Submitted			2022-12-25	WOS:000293282700051
J	Ino, K; Udagawa, I; Iwabata, K; Takakusagi, Y; Kubota, M; Kurosaka, K; Arai, K; Seki, Y; Nogawa, M; Tsunoda, T; Mizukami, F; Taguchi, H; Sakaguchi, K				Ino, Keita; Udagawa, Itsumi; Iwabata, Kazuki; Takakusagi, Yoichi; Kubota, Munehiro; Kurosaka, Keiichi; Arai, Kazuhito; Seki, Yasutaka; Nogawa, Masaya; Tsunoda, Tatsuo; Mizukami, Fujio; Taguchi, Hayao; Sakaguchi, Kengo			Heterogeneous Nucleation of Protein Crystals on Fluorinated Layered Silicate	PLOS ONE			English	Article							LIPID LAYERS; EPITAXIAL NUCLEATION; SAPONITE CLAYS; CRYSTALLIZATION; SURFACES; GROWTH; LYSOZYME; ADSORPTION; SUBSTRATE; MICA	Here, we describe an improved system for protein crystallization based on heterogeneous nucleation using fluorinated layered silicate. In addition, we also investigated the mechanism of nucleation on the silicate surface. Crystallization of lysozyme using silicates with different chemical compositions indicated that fluorosilicates promoted nucleation whereas the silicates without fluorine did not. The use of synthesized saponites for lysozyme crystallization confirmed that the substitution of hydroxyl groups contained in the lamellae structure for fluorine atoms is responsible for the nucleation-inducing property of the nucleant. Crystallization of twelve proteins with a wide range of pI values revealed that the nucleation promoting effect of the saponites tended to increase with increased substitution rate. Furthermore, the saponite with the highest fluorine content promoted nucleation in all the test proteins regardless of their overall net charge. Adsorption experiments of proteins on the saponites confirmed that the density of adsorbed molecules increased according to the substitution rate, thereby explaining the heterogeneous nucleation on the silicate surface.	[Ino, Keita; Udagawa, Itsumi; Iwabata, Kazuki; Takakusagi, Yoichi; Arai, Kazuhito; Seki, Yasutaka; Nogawa, Masaya; Taguchi, Hayao; Sakaguchi, Kengo] Tokyo Univ Sci, Dept Appl Biol Sci, Chiba, Japan; [Kubota, Munehiro; Kurosaka, Keiichi] Kunimine Ind Co Ltd, Iwaki Lab, Fukushima, Japan; [Tsunoda, Tatsuo; Mizukami, Fujio] Natl Inst Adv Ind Sci & Technol, Res Ctr Compact Chem Syst, Tsukuba, Ibaraki, Japan	Tokyo University of Science; National Institute of Advanced Industrial Science & Technology (AIST)	Ino, K (corresponding author), Tokyo Univ Sci, Dept Appl Biol Sci, Chiba, Japan.	kengo@rs.noda.tus.ac.jp	Takakusagi, Yoichi/AAA-1998-2021	Takakusagi, Yoichi/0000-0002-6786-0748; Taguchi, Hayao/0000-0001-5270-581X	Tokyo University of Science	Tokyo University of Science	This work was supported by Tokyo University of Science. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JM, 1979, CLAY CLAY MINER, V27, P137, DOI 10.1346/CCMN.1979.0270210; Asanithi P, 2009, ACS APPL MATER INTER, V1, P1203, DOI 10.1021/am9000858; Asherie N, 2004, METHODS, V34, P266, DOI 10.1016/j.ymeth.2004.03.028; Bisio C, 2008, LANGMUIR, V24, P2808, DOI 10.1021/la703308b; BLOW DM, 1994, PROTEIN SCI, V3, P1638, DOI 10.1002/pro.5560031003; Chayen NE, 2006, P NATL ACAD SCI USA, V103, P597, DOI 10.1073/pnas.0504860102; Chayen NE, 2004, CURR OPIN STRUC BIOL, V14, P577, DOI 10.1016/j.sbi.2004.08.002; Chayen NE, 2001, J MOL BIOL, V312, P591, DOI 10.1006/jmbi.2001.4995; Curcio E, 2006, J PHYS CHEM B, V110, P12438, DOI 10.1021/jp061531y; D'Arcy A, 2003, ACTA CRYSTALLOGR D, V59, P1343, DOI 10.1107/S0907444903009430; Daly SM, 2003, LANGMUIR, V19, P3848, DOI 10.1021/la026690x; DARST SA, 1995, CURR OPIN STRUC BIOL, V5, P640, DOI 10.1016/0959-440X(95)80056-5; EDWARDS AM, 1994, NAT STRUCT BIOL, V1, P195, DOI 10.1038/nsb0394-195; Falini G, 2002, ACTA CRYSTALLOGR D, V58, P1649, DOI 10.1107/S0907444902012763; Fermani S, 2001, J CRYST GROWTH, V224, P327, DOI 10.1016/S0022-0248(01)00797-7; Georgieva DG, 2007, ACTA CRYSTALLOGR D, V63, P564, DOI 10.1107/S0907444907007810; HEMMING SA, 1995, J MOL BIOL, V246, P308, DOI 10.1006/jmbi.1994.0086; Jaber M, 2005, CR CHIM, V8, P229, DOI 10.1016/j.crci.2004.10.025; Kallio JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004198; Kimble WL, 1998, J CRYST GROWTH, V187, P268, DOI 10.1016/S0022-0248(97)00838-5; KLOPROGGE JT, 1993, CLAY CLAY MINER, V41, P103, DOI 10.1346/CCMN.1993.0410111; KOIDE S, 1991, J BIOCHEM-TOKYO, V109, P6; Kubota M, 2008, COLLOID SURFACE B, V64, P88, DOI 10.1016/j.colsurfb.2008.01.012; Liu YX, 2007, J PHYS CHEM B, V111, P13971, DOI 10.1021/jp0741612; MCPHERSON A, 1988, SCIENCE, V239, P385, DOI 10.1126/science.239.4838.385; McPherson A., 1999, CRYSTALLIZATION BIOL, P165; OYA A, 1986, J MATER SCI, V21, P1227, DOI 10.1007/BF00553255; Paxton TE, 1999, J CRYST GROWTH, V198, P656, DOI 10.1016/S0022-0248(98)01231-7; Perez FD, 1995, CHEM MATER, V7, P2277, DOI 10.1021/cm00060a015; PUNZI JS, 1991, J APPL CRYSTALLOGR, V24, P406, DOI 10.1107/S0021889891001644; Reinholdt M, 2005, CLAY MINER, V40, P177, DOI 10.1180/0009855054020164; Rong L, 2004, J SYNCHROTRON RADIAT, V11, P27, DOI 10.1107/S0909049503023525; Rong L, 2002, J CRYST GROWTH, V235, P489, DOI 10.1016/S0022-0248(01)01792-4; Rong L, 2001, JPN J APPL PHYS 1, V40, P6677, DOI 10.1143/JJAP.40.6677; Sanjoh A, 2001, J CRYST GROWTH, V232, P618, DOI 10.1016/S0022-0248(01)01057-0; Sanjoh A, 1999, J CRYST GROWTH, V196, P691, DOI 10.1016/S0022-0248(98)00821-5; SCHOLLENBERGER CJ, 1945, SOIL SCI, V59, P13, DOI 10.1097/00010694-194501000-00004; Stolyarova S, 2006, BIOPHYS J, V91, P3857, DOI 10.1529/biophysj.106.082545; Sugahara M, 2008, ACTA CRYSTALLOGR D, V64, P686, DOI 10.1107/S0907444908009980; SUGIYAMA H, 1988, J MATER SCI, V23, P1764, DOI 10.1007/BF01115720; Sun LH, 2010, CRYST GROWTH DES, V10, P2766, DOI 10.1021/cg100274m; Takehara M, 2008, ANAL BIOCHEM, V373, P322, DOI 10.1016/j.ab.2007.10.046; Tang L, 2005, ACTA CRYSTALLOGR D, V61, P53, DOI 10.1107/S0907444904026009; Thakur AS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001091; Tosi G, 2008, ACTA CRYSTALLOGR D, V64, P1054, DOI 10.1107/S0907444908025079; Utracki LA, 2007, POLYM ADVAN TECHNOL, V18, P1, DOI 10.1002/pat.852; Vasina EN, 2004, LANGMUIR, V20, P8699, DOI 10.1021/la0490588; Vogels RJMJ, 2005, AM MINERAL, V90, P931, DOI 10.2138/am.2005.1616; Vogels RJMJ, 1995, STUD SURF SCI CATAL, V91, P1153; Wertz CF, 2002, LANGMUIR, V18, P1190, DOI 10.1021/la0108813	50	17	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22582	10.1371/journal.pone.0022582	http://dx.doi.org/10.1371/journal.pone.0022582			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818343	Green Submitted, Green Published, gold			2022-12-25	WOS:000293282700044
J	Rider, TH; Zook, CE; Boettcher, TL; Wick, ST; Pancoast, JS; Zusman, BD				Rider, Todd H.; Zook, Christina E.; Boettcher, Tara L.; Wick, Scott T.; Pancoast, Jennifer S.; Zusman, Benjamin D.			Broad-Spectrum Antiviral Therapeutics	PLOS ONE			English	Article							INNATE IMMUNITY; ACTIVATION; TRANSDUCTION; RECOGNITION; SUPPRESSION; CASPASES; PROTEINS; DOMAINS; BINDING	Currently there are relatively few antiviral therapeutics, and most which do exist are highly pathogen-specific or have other disadvantages. We have developed a new broad-spectrum antiviral approach, dubbed Double-stranded RNA (dsRNA) Activated Caspase Oligomerizer (DRACO) that selectively induces apoptosis in cells containing viral dsRNA, rapidly killing infected cells without harming uninfected cells. We have created DRACOs and shown that they are nontoxic in 11 mammalian cell types and effective against 15 different viruses, including dengue flavivirus, Amapari and Tacaribe arenaviruses, Guama bunyavirus, and H1N1 influenza. We have also demonstrated that DRACOs can rescue mice challenged with H1N1 influenza. DRACOs have the potential to be effective therapeutics or prophylactics for numerous clinical and priority viruses, due to the broad-spectrum sensitivity of the dsRNA detection domain, the potent activity of the apoptosis induction domain, and the novel direct linkage between the two which viruses have never encountered.	[Rider, Todd H.; Zook, Christina E.; Boettcher, Tara L.; Wick, Scott T.; Pancoast, Jennifer S.; Zusman, Benjamin D.] MIT, Lincoln Lab, Lexington, MA 02173 USA	Lincoln Laboratory; Massachusetts Institute of Technology (MIT)	Rider, TH (corresponding author), MIT, Lincoln Lab, 244 Wood St, Lexington, MA 02173 USA.	thor@LL.MIT.EDU		Wick, Scott/0000-0002-6906-4980; Zusman, Benjamin D/0000-0001-5397-6486	National Institute of Allergy and Infectious Diseases [AI057159]; New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases; Defense Advanced Research Projects Agency; Defense Threat Reduction Agency; Defense Research Engineering; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Defense Research Engineering; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is funded by grant AI057159 (http://www.niaid.nih.gov/Pages/default.aspx) from the National Institute of Allergy and Infectious Diseases and the New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases, with previous funding from the Defense Advanced Research Projects Agency, Defense Threat Reduction Agency, and Director of Defense Research & Engineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the United States government.	Bao Q, 2007, CELL DEATH DIFFER, V14, P56, DOI 10.1038/sj.cdd.4402028; Bisbal C, 2007, BIOCHIMIE, V89, P789, DOI 10.1016/j.biochi.2007.02.006; Boomker JM, 2005, CYTOKINE GROWTH F R, V16, P91, DOI 10.1016/j.cytogfr.2004.12.002; Callus BA, 2007, CELL DEATH DIFFER, V14, P73, DOI 10.1038/sj.cdd.4402034; Demberg T, 2009, INT REV IMMUNOL, V28, P20, DOI 10.1080/08830180802684331; Eberstadt M, 1998, NATURE, V392, P941, DOI 10.1038/31972; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; Goun EA, 2006, CHEMBIOCHEM, V7, P1497, DOI 10.1002/cbic.200600171; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; Ho A, 2001, CANCER RES, V61, P474; Hovanessian AG, 2007, BIOCHIMIE, V89, P779, DOI 10.1016/j.biochi.2007.02.003; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Knipe DM., 2006, FIELDS VIROLOGY, V5th ed; Krausslich H.-G, 2009, HDB EXPT PHARM, V189; Langland JO, 2006, J VIROL, V80, P10083, DOI 10.1128/JVI.00607-06; Muppidi JR, 2006, CELL DEATH DIFFER, V13, P1641, DOI 10.1038/sj.cdd.4401855; Nogal ML, 2001, J VIROL, V75, P2535, DOI 10.1128/JVI.75.6.2535-2543.2001; Placido D, 2007, STRUCTURE, V15, P395, DOI 10.1016/j.str.2007.03.001; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Postigo A, 2009, MICROBES INFECT, V11, P1071, DOI 10.1016/j.micinf.2009.08.012; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; RIDER TH, 2009, Patent No. 7566694; RIDER TH, 2006, Patent No. 7125839; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Samuel CE, 2004, NAT BIOTECHNOL, V22, P280, DOI 10.1038/nbt0304-280; Weber F, 2007, BIOCHIMIE, V89, P836, DOI 10.1016/j.biochi.2007.01.005; Wu SY, 1996, J BIOL CHEM, V271, P1756, DOI 10.1074/jbc.271.3.1756; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633	30	47	55	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22572	10.1371/journal.pone.0022572	http://dx.doi.org/10.1371/journal.pone.0022572			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818340	gold, Green Published			2022-12-25	WOS:000293282700041
J	Sarkar, IN; Trizna, M				Sarkar, Indra Neil; Trizna, Michael			The Barcode of Life Data Portal: Bridging the Biodiversity Informatics Divide for DNA Barcoding	PLOS ONE			English	Article							TOOL	With the volume of molecular sequence data that is systematically being generated globally, there is a need for centralized resources for data exploration and analytics. DNA Barcode initiatives are on track to generate a compendium of molecular sequence-based signatures for identifying animals and plants. To date, the range of available data exploration and analytic tools to explore these data have only been available in a boutique form-often representing a frustrating hurdle for many researchers that may not necessarily have resources to install or implement algorithms described by the analytic community. The Barcode of Life Data Portal (BDP) is a first step towards integrating the latest biodiversity informatics innovations with molecular sequence data from DNA barcoding. Through establishment of community driven standards, based on discussion with the Data Analysis Working Group (DAWG) of the Consortium for the Barcode of Life (CBOL), the BDP provides an infrastructure for incorporation of existing and next-generation DNA barcode analytic applications in an open forum.	[Sarkar, Indra Neil] Univ Vermont, Ctr Clin & Translat Sci, Burlington, VT 05405 USA; [Sarkar, Indra Neil] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA; [Sarkar, Indra Neil] Univ Vermont, Dept Comp Sci, Burlington, VT USA; [Trizna, Michael] Smithsonian Inst, Consortium Barcode Life, Washington, DC 20560 USA	University of Vermont; University of Vermont; University of Vermont; Smithsonian Institution	Sarkar, IN (corresponding author), Univ Vermont, Ctr Clin & Translat Sci, Burlington, VT 05405 USA.	neil.sarkar@uvm.edu	Hug, Balthasar L./G-1568-2010	Sarkar, Indra Neil/0000-0003-2054-7356; Trizna, Michael/0000-0002-0537-8382	National Institutes of Health [R01LM009725]; Alfred P. Sloan Foundation; NATIONAL LIBRARY OF MEDICINE [R01LM009725] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	INS is supported in part by a grant from the National Institutes of Health (R01LM009725). Financial support for much of the Data Analysis Working Group (DAWG) activities, including the development of the Barcode of Life Data Portal (BDP), is primarily from the Alfred P. Sloan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austerlitz F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S10; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Bertolazzi P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S7; Chu KH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S8; Ebach MC, 2005, NATURE, V434, P697, DOI 10.1038/434697b; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Gregory TR, 2005, NATURE, V434, P1067, DOI 10.1038/4341067b; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hull D, 2006, NUCLEIC ACIDS RES, V34, pW729, DOI 10.1093/nar/gkl320; Kuksa P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S9; Perez-Iratxeta C, 2007, BRIEF BIOINFORM, V8, P88, DOI 10.1093/bib/bbl035; Sarkar IN, 2008, MOL ECOL RESOUR, V8, P1256, DOI 10.1111/j.1755-0998.2008.02235.x; Schindel DE, 2005, NATURE, V435, P17, DOI 10.1038/435017b; Stein LD, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-114; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011	18	17	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e14689	10.1371/journal.pone.0014689	http://dx.doi.org/10.1371/journal.pone.0014689			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818249	Green Published, Green Submitted, gold			2022-12-25	WOS:000293282700001
J	Takashima, N; Odaka, YS; Sakoori, K; Akagi, T; Hashikawa, T; Morimura, N; Yamada, K; Aruga, J				Takashima, Noriko; Odaka, Yuri S.; Sakoori, Kazuto; Akagi, Takumi; Hashikawa, Tsutomu; Morimura, Naoko; Yamada, Kazuyuki; Aruga, Jun			Impaired Cognitive Function and Altered Hippocampal Synapse Morphology in Mice Lacking Lrrtm1, a Gene Associated with Schizophrenia	PLOS ONE			English	Article							1ST-EPISODE SCHIZOPHRENIA; METAANALYSIS; RECEPTOR; SENSITIVITY; DYSFUNCTION; MODELS; FAMILY	Recent genetic linkage analysis has shown that LRRTM1 (Leucine rich repeat transmembrane neuronal 1) is associated with schizophrenia. Here, we characterized Lrrtm1 knockout mice behaviorally and morphologically. Systematic behavioral analysis revealed reduced locomotor activity in the early dark phase, altered behavioral responses to novel environments (open-field box, light-dark box, elevated plus maze, and hole board), avoidance of approach to large inanimate objects, social discrimination deficit, and spatial memory deficit. Upon administration of the NMDA receptor antagonist MK-801, Lrrtm1 knockout mice showed both locomotive activities in the open-field box and responses to the inanimate object that were distinct from those of wild-type mice, suggesting that altered glutamatergic transmission underlay the behavioral abnormalities. Furthermore, administration of a selective serotonin reuptake inhibitor (fluoxetine) rescued the abnormality in the elevated plus maze. Morphologically, the brains of Lrrtm1 knockout mice showed reduction in total hippocampus size and reduced synaptic density. The hippocampal synapses were characterized by elongated spines and diffusely distributed synaptic vesicles, indicating the role of Lrrtm1 in maintaining synaptic integrity. Although the pharmacobehavioral phenotype was not entirely characteristic of those of schizophrenia model animals, the impaired cognitive function may warrant the further study of LRRTM1 in relevance to schizophrenia.	[Takashima, Noriko; Odaka, Yuri S.; Sakoori, Kazuto; Morimura, Naoko; Aruga, Jun] RIKEN, Lab Behav & Dev Disorders, BSI, Wako, Saitama, Japan; [Akagi, Takumi; Hashikawa, Tsutomu] RIKEN, Support Unit Neuromorphol Anal, BSI, Wako, Saitama, Japan; [Yamada, Kazuyuki] RIKEN, Support Unit Anim Experiments, BSI, Wako, Saitama, Japan	RIKEN; RIKEN; RIKEN	Takashima, N (corresponding author), RIKEN, Lab Behav & Dev Disorders, BSI, Wako, Saitama, Japan.	jaruga@brain.riken.jp	Aruga, Jun/H-5837-2011	Aruga, Jun/0000-0001-7936-1375	RIKEN Brain Science Institute (BSI); MEXT (Ministry of Education, Culture, Sports, Science, and Technology, Japan) [21240031]	RIKEN Brain Science Institute (BSI); MEXT (Ministry of Education, Culture, Sports, Science, and Technology, Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was funded by RIKEN Brain Science Institute (BSI) and supported by a MEXT (Ministry of Education, Culture, Sports, Science, and Technology, Japan) Grant-in-Aid for Scientific Research (A) (21240031) to JA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Aruga J, 2002, J NEUROSCI, V22, P218, DOI 10.1523/JNEUROSCI.22-01-00218.2002; Association AP DSM-IV APA on, 2000, DIAGN STAT MAN MENT; Calabrese EJ, 2008, CRIT REV TOXICOL, V38, P489, DOI 10.1080/10408440802014238; Cao BJ, 1997, EUR J PHARMACOL, V335, P117, DOI 10.1016/S0014-2999(97)01234-X; Cloos JM, 2005, CURR OPIN PSYCHIATR, V18, P45; Desbonnet L, 2009, BEHAV BRAIN RES, V204, P258, DOI 10.1016/j.bbr.2009.04.001; Ellison-Wright I, 2008, AM J PSYCHIAT, V165, P1015, DOI 10.1176/appi.ajp.2008.07101562; Francks C, 2007, MOL PSYCHIATR, V12, P1129, DOI 10.1038/sj.mp.4002053; Freedman R, 2003, NEW ENGL J MED, V349, P1738, DOI 10.1056/NEJMra035458; Gaspar PA, 2009, J NEUROCHEM, V111, P891, DOI 10.1111/j.1471-4159.2009.06325.x; Gunduz-Bruce H, 2009, BRAIN RES REV, V60, P279, DOI 10.1016/j.brainresrev.2008.07.006; Jaaro-Peled H, 2010, SCHIZOPHRENIA BULL, V36, P301, DOI 10.1093/schbul/sbp133; Jaaro-Peled H, 2009, TRENDS NEUROSCI, V32, P485, DOI 10.1016/j.tins.2009.05.007; Karayiorgou M, 2010, NAT REV NEUROSCI, V11, P402, DOI 10.1038/nrn2841; Kellendonk C, 2009, TRENDS NEUROSCI, V32, P347, DOI 10.1016/j.tins.2009.02.003; Lauren J, 2003, GENOMICS, V81, P411, DOI 10.1016/S0888-7543(03)00030-2; LILJEQUIST S, 1991, PSYCHOPHARMACOLOGY, V104, P17, DOI 10.1007/BF02244548; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Ludwig KU, 2009, MOL PSYCHIATR, V14, P743, DOI 10.1038/mp.2009.28; Powell SB, 2009, BEHAV BRAIN RES, V204, P282, DOI 10.1016/j.bbr.2009.04.021; Qi CT, 2008, EUR J PHARMACOL, V580, P161, DOI 10.1016/j.ejphar.2007.07.071; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Sakatani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008309; SIDDIQUI TJ, J NEUROSCI, V30, P7495; Steen RG, 2006, BRIT J PSYCHIAT, V188, P510, DOI 10.1192/bjp.188.6.510; Uz T, 2004, NEUROREPORT, V15, P691, DOI 10.1097/00001756-200403220-00023; Vita A, 2006, SCHIZOPHR RES, V82, P75, DOI 10.1016/j.schres.2005.11.004; Yoshiike Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003029; Young JW, 2010, CURR TOP BEHAV NEURO, V4, P391, DOI 10.1007/7854_2010_62	31	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22716	10.1371/journal.pone.0022716	http://dx.doi.org/10.1371/journal.pone.0022716			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818371	Green Submitted, gold, Green Published			2022-12-25	WOS:000293282700064
J	Agua-Doce, A; Graca, L				Agua-Doce, Ana; Graca, Luis			Prevention of House Dust Mite Induced Allergic Airways Disease in Mice through Immune Tolerance	PLOS ONE			English	Article							REGULATORY T-CELLS; MONOCLONAL ANTI-CD4 ANTIBODY; TRANSPLANTATION TOLERANCE; RHEUMATOID-ARTHRITIS; MURINE MODEL; DOUBLE-BLIND; IN-VIVO; ASTHMA; INFLAMMATION; BLOCKADE	Allergic airways disease is a consequence of a Th2 response to an allergen leading to a series of manifestations such as production of allergen-specific IgE, inflammatory infiltrates in the airways, and airway hyper-reactivity (AHR). Several strategies have been reported for tolerance induction to allergens leading to protection from allergic airways disease. We now show that CD4 blockade at the time of house dust mite sensitization induces antigen-specific tolerance in mice. Tolerance induction is robust enough to be effective in pre-sensitized animals, even in those where AHR was preestablished. Tolerant mice are protected from airways eosinophilia, Th2 lung infiltration, and AHR. Furthermore, anti-CD4 treated mice remain immune competent to mount immune responses, including Th2, to unrelated antigens. Our findings, therefore, describe a strategy for tolerance induction potentially applicable to other immunogenic proteins besides allergens.	[Agua-Doce, Ana; Graca, Luis] Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal; [Agua-Doce, Ana; Graca, Luis] Inst Gulbenkian Ciencias, Oeiras, Portugal	Universidade de Lisboa; Instituto Gulbenkian de Ciencia	Agua-Doce, A (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal.	lgraca@fm.ul.pt	Graca, Luis/B-8887-2008; Agua-Doce, Ana/L-2997-2014	Graca, Luis/0000-0001-6935-8500; Agua-Doce, Ana/0000-0002-0466-7297	Fundacao para a Ciencia e Tecnologia Portugal [PTDC/SAU-MII/64279/2006, PIC/IC/82895/2007]; Sudoe [Immunonet-SOE1/1P1/E014]	Fundacao para a Ciencia e Tecnologia Portugal(Portuguese Foundation for Science and Technology); Sudoe	Funded by Fundacao para a Ciencia e Tecnologia Portugal - PTDC/SAU-MII/64279/2006, and PIC/IC/82895/2007, and Immunonet-SOE1/1P1/E014 from Sudoe, http://alfa.fct.mctes.pt/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AB, 2003, J CLIN INVEST, V111, P1887, DOI 10.1172/JCI200317477; Akdis M, 2007, J ALLERGY CLIN IMMUN, V119, P780, DOI 10.1016/j.jaci.2007.01.022; Ballow M, 2006, J ALLERGY CLIN IMMUN, V118, P1209, DOI 10.1016/j.jaci.2006.09.024; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; de Lafaille MAC, 2010, CURR OPIN IMMUNOL, V22, P616, DOI 10.1016/j.coi.2010.08.014; GAVETT SH, 1994, AM J RESP CELL MOL, V10, P587, DOI 10.1165/ajrcmb.10.6.8003337; Graca L, 2004, P NATL ACAD SCI USA, V101, P10122, DOI 10.1073/pnas.0400084101; Graca L, 2003, CURR OPIN IMMUNOL, V15, P499, DOI 10.1016/S0952-7915(03)00098-0; Hammad H, 2008, NAT REV IMMUNOL, V8, P193, DOI 10.1038/nri2275; Holgate ST, 2008, NAT REV IMMUNOL, V8, P218, DOI 10.1038/nri2262; Holt PG, 2008, NAT REV IMMUNOL, V8, P142, DOI 10.1038/nri2236; Honey K, 1999, J IMMUNOL, V163, P4805; HORNEFF G, 1991, CLIN IMMUNOL IMMUNOP, V59, P89, DOI 10.1016/0090-1229(91)90084-N; Kearley J, 2007, J EXP MED, V204, P1289, DOI 10.1084/jem.20062093; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Kon OM, 1998, LANCET, V352, P1109, DOI 10.1016/S0140-6736(97)12261-9; Krinzman SJ, 1996, J CLIN INVEST, V98, P2693, DOI 10.1172/JCI119093; Li L, 1999, J IMMUNOL, V163, P6557; Linhart B, 2007, J IMMUNOL, V178, P3924, DOI 10.4049/jimmunol.178.6.3924; Marshall SE, 1996, TRANSPLANTATION, V62, P1614, DOI 10.1097/00007890-199612150-00015; MORELAND LW, 1995, ARTHRITIS RHEUM, V38, P1581, DOI 10.1002/art.1780381109; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Ng CM, 2006, PHARM RES-DORDR, V23, P95, DOI 10.1007/s11095-005-8814-3; QIN SX, 1990, EUR J IMMUNOL, V20, P2737, DOI 10.1002/eji.1830201231; Seshasayee D, 2007, J CLIN INVEST, V117, P3868, DOI 10.1172/JCI33559; Strickland DH, 2006, J EXP MED, V203, P2649, DOI 10.1084/jem.20060155; Trambley J, 1999, J CLIN INVEST, V104, P1715, DOI 10.1172/JCI8082; vanOosten BW, 1997, NEUROLOGY, V49, P351, DOI 10.1212/WNL.49.2.351; Verhasselt V, 2008, NAT MED, V14, P170, DOI 10.1038/nm1718; Xystrakis E, 2006, J CLIN INVEST, V116, P146, DOI 10.1172/JCI21759; Zosky GR, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-15; Zuany-Amorim C, 2002, NAT MED, V8, P625, DOI 10.1038/nm0602-625	32	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e22320	10.1371/journal.pone.0022320	http://dx.doi.org/10.1371/journal.pone.0022320			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21818308	Green Published, Green Submitted, gold			2022-12-25	WOS:000293175100019
J	Hwang, S; Kim, M; Ryu, S; Jeon, B				Hwang, Sunyoung; Kim, Minkyeong; Ryu, Sangryeol; Jeon, Byeonghwa			Regulation of Oxidative Stress Response by CosR, an Essential Response Regulator in Campylobacter jejuni	PLOS ONE			English	Article							ALKYL HYDROPEROXIDE REDUCTASE; SALMONELLA PATHOGENICITY ISLAND-2; IRON SUPEROXIDE-DISMUTASE; ESCHERICHIA-COLI K-12; GENE-EXPRESSION; HELICOBACTER-PYLORI; HYDROGEN-PEROXIDE; 2-COMPONENT SYSTEM; MOLECULAR CHARACTERIZATION; TRANSCRIPTION FACTOR	CosR (Campylobacter oxidative stress regulator; Cj0355c) is an OmpR-type response regulator essential for the viability of Campylobacter jejuni, a leading foodborne pathogen causing human gastroenteritis worldwide. Despite importance, the function of CosR remains completely unknown mainly because of cell death caused by its knockout mutation. To overcome this technical limitation, in this study, antisense technology was used to investigate the regulatory function of CosR by modulating the level of CosR expression. Two-dimensional gel electrophoresis (2DGE) was performed to identify the CosR regulon either by suppressing CosR expression with antisense peptide nucleic acid (PNA) or by overexpressing CosR in C. jejuni. According to the results of 2DGE, CosR regulated 32 proteins involved in various cellular processes. Notably, CosR negatively regulated a few key proteins of the oxidative stress response of C. jejuni, such as SodB, Dps, Rrc and LuxS, whereas CosR positively controlled AhpC. Electrophoretic mobility shift assay showed that CosR directly bound to the promoter region of the oxidative stress genes. DNase I footprinting assays identified 21-bp CosR binding sequences in the sodB and ahpC promoters, suggesting CosR specifically recognizes and binds to the regulated genes. Interestingly, the level of CosR protein was significantly reduced by paraquat (a superoxide generator) but not by hydrogen peroxide. Consistent with the overall negative regulation of oxidative stress defense proteins by CosR, the CosR knockdown by antisense rendered C. jejuni more resistant to oxidative stress compared to the wild type. Overall, this study reveals the important role played by the essential response regulator CosR in the oxidative stress defense of C. jejuni.	[Hwang, Sunyoung; Kim, Minkyeong; Ryu, Sangryeol] Seoul Natl Univ, Dept Food Biotechnol, Dept Agr Biotechnol, Seoul, South Korea; [Hwang, Sunyoung; Kim, Minkyeong; Ryu, Sangryeol] Seoul Natl Univ, Ctr Agr Biomat, Seoul, South Korea; [Jeon, Byeonghwa] Univ Prince Edward Isl, Atlantic Vet Coll, Dept Pathol & Microbiol, Charlottetown, PE C1A 4P3, Canada	Seoul National University (SNU); Seoul National University (SNU); University of Prince Edward Island	Hwang, S (corresponding author), Seoul Natl Univ, Dept Food Biotechnol, Dept Agr Biotechnol, Seoul, South Korea.	sangryu@snu.ac.kr; bjeon@upei.ca	Jeon, Byeonghwa/AAB-6806-2020	Jeon, Byeonghwa/0000-0002-6665-5558	University of Prince Edward Island; Ministry for Health, Welfare and Family Affairs, Republic of Korea [A09058009010000100]; Ministry of Education	University of Prince Edward Island; Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Ministry of Education	This work was supported by startup funding from the University of Prince Edward Island to BJ, and a grant (A09058009010000100) to SR from the Korean Health Technology R&D Project, the Ministry for Health, Welfare and Family Affairs, Republic of Korea. SH and MK are recipients of the graduate fellowship provided by the Ministry of Education through the Brain Korea 21 Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atack JM, 2009, FUTURE MICROBIOL, V4, P677, DOI 10.2217/FMB.09.44; Baillon MLA, 1999, J BACTERIOL, V181, P4798, DOI 10.1128/JB.181.16.4798-4804.1999; Beier D, 2000, J BACTERIOL, V182, P2068, DOI 10.1128/JB.182.8.2068-2076.2000; Boneca IG, 2008, APPL ENVIRON MICROB, V74, P2095, DOI 10.1128/AEM.01348-07; Braasch DA, 2002, BIOCHEMISTRY-US, V41, P4503, DOI 10.1021/bi0122112; Bras AM, 1999, J BACTERIOL, V181, P3298; COMPAN I, 1993, J BACTERIOL, V175, P1687, DOI 10.1128/JB.175.6.1687-1696.1993; Delany I, 2002, J BACTERIOL, V184, P4800, DOI 10.1128/JB.184.17.4800-4810.2002; Dryselius R, 2003, OLIGONUCLEOTIDES, V13, P427, DOI 10.1089/154545703322860753; Dubrac S, 2000, J BACTERIOL, V182, P3802, DOI 10.1128/JB.182.13.3802-3808.2000; Eppinger M, 2004, NAT REV MICROBIOL, V2, P872, DOI 10.1038/nrmicro1024; Ernst FD, 2005, J BACTERIOL, V187, P3687, DOI 10.1128/JB.187.11.3687-3692.2005; Feng XH, 2003, MOL MICROBIOL, V48, P1131, DOI 10.1046/j.1365-2958.2003.03502.x; Garenaux A, 2008, RES MICROBIOL, V159, P718, DOI 10.1016/j.resmic.2008.08.001; Geller BL, 2003, ANTIMICROB AGENTS CH, V47, P3233, DOI 10.1128/AAC.47.10.3233-3239.2003; Good L, 2001, NAT BIOTECHNOL, V19, P360, DOI 10.1038/86753; Good L, 2003, CELL MOL LIFE SCI, V60, P854, DOI 10.1007/s00018-003-3045-4; GRANT KA, 1995, MICROBIOL-SGM, V141, P1369, DOI 10.1099/13500872-141-6-1369; Hall SJ, 2008, J BACTERIOL, V190, P8075, DOI 10.1128/JB.00821-08; He YP, 2008, FOODBORNE PATHOG DIS, V5, P399, DOI 10.1089/fpd.2008.0106; Hendrixson DR, 2003, MOL MICROBIOL, V50, P687, DOI 10.1046/j.1365-2958.2003.03731.x; Herring CD, 2004, J BACTERIOL, V186, P2673, DOI 10.1128/JB.186.9.2673-2681.2004; Holmes K, 2005, MICROBIOL-SGM, V151, P243, DOI 10.1099/mic.0.27412-0; Huang KJ, 1997, P NATL ACAD SCI USA, V94, P2828, DOI 10.1073/pnas.94.7.2828; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Ishikawa T, 2003, J BACTERIOL, V185, P1010, DOI 10.1128/JB.185.3.1010-1017.2003; Itou H, 2001, J BIOCHEM-TOKYO, V129, P343, DOI 10.1093/oxfordjournals.jbchem.a002863; Jensen ON, 1999, METH MOL B, V112, P513; Jeon B, 2007, J BACTERIOL, V189, P7399, DOI 10.1128/JB.01012-07; Jeon B, 2009, J ANTIMICROB CHEMOTH, V63, P946, DOI 10.1093/jac/dkp067; Joslin SN, 2009, J BACTERIOL, V191, P2656, DOI 10.1128/JB.01689-08; Karlyshev AV, 2005, APPL ENVIRON MICROB, V71, P4004, DOI 10.1128/AEM.71.7.4004-4013.2005; Kenney LJ, 2002, CURR OPIN MICROBIOL, V5, P135, DOI 10.1016/S1369-5274(02)00310-7; Kim CC, 2004, J BACTERIOL, V186, P4694, DOI 10.1128/JB.186.14.4694-4704.2004; Kim JN, 2008, CURR MICROBIOL, V57, P391, DOI 10.1007/s00284-008-9225-6; Lee AK, 2000, J BACTERIOL, V182, P771, DOI 10.1128/JB.182.3.771-781.2000; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOVLEY DR, 1986, APPL ENVIRON MICROB, V52, P751, DOI 10.1128/AEM.52.4.751-757.1986; MacKichan JK, 2004, MOL MICROBIOL, V54, P1269, DOI 10.1111/j.1365-2958.2004.04371.x; MAEDA S, 1990, J BACTERIOL, V172, P501, DOI 10.1128/JB.172.1.501-503.1990; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Mattison K, 2002, J MOL BIOL, V315, P497, DOI 10.1006/jmbi.2001.5222; MCCORD JM, 1999, ANAL SUPEROXIDE DISM; McDaniel TK, 2001, HELICOBACTER, V6, P15, DOI 10.1046/j.1523-5378.2001.00001.x; Mitrophanov AY, 2008, GENE DEV, V22, P2601, DOI 10.1101/gad.1700308; Muller S, 2007, MICROBIOL RES, V162, P1, DOI 10.1016/j.micres.2006.01.003; Nekhotiaeva N, 2004, MOL THER, V10, P652, DOI 10.1016/j.ymthe.2004.07.006; Nielsen PE, 2004, MOL BIOTECHNOL, V26, P233, DOI 10.1385/MB:26:3:233; Oshima T, 2002, MOL MICROBIOL, V46, P281, DOI 10.1046/j.1365-2958.2002.03170.x; Palyada K, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-481; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; PESCI EC, 1994, INFECT IMMUN, V62, P2687, DOI 10.1128/IAI.62.7.2687-2694.1994; Pooga M, 2001, BIOMOL ENG, V17, P183, DOI 10.1016/S1389-0344(01)00075-2; Purdy D, 1999, APPL ENVIRON MICROB, V65, P2540; Raphael BH, 2005, J BACTERIOL, V187, P3662, DOI 10.1128/JB.187.11.3662-3670.2005; Rocha ER, 1999, J BACTERIOL, V181, P5701, DOI 10.1128/JB.181.18.5701-5710.1999; RYU S, 1994, J BIOL CHEM, V269, P4767; Schar J, 2005, J BACTERIOL, V187, P3100, DOI 10.1128/JB.187.9.3100-3109.2005; Scherer LJ, 2003, NAT BIOTECHNOL, V21, P1457, DOI 10.1038/nbt915; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; SMITH FE, 1984, CLIN BIOCHEM, V17, P306, DOI 10.1016/S0009-9120(84)90613-1; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Svensson SL, 2009, MOL MICROBIOL, V71, P253, DOI 10.1111/j.1365-2958.2008.06534.x; van Vliet AHM, 1999, J BACTERIOL, V181, P6371, DOI 10.1128/JB.181.20.6371-6376.1999; Velayudhan J, 2002, MICROBIOL-SGM, V148, P685, DOI 10.1099/00221287-148-3-685; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Werner A, 2009, RNA BIOL, V6, P43, DOI 10.4161/rna.6.1.7568; Wolfe AJ, 2010, CURR OPIN MICROBIOL, V13, P204, DOI 10.1016/j.mib.2010.01.002; Wosten MMSM, 2004, J BIOL CHEM, V279, P16214, DOI 10.1074/jbc.M400357200; Yamasaki M, 2004, FEMS MICROBIOL LETT, V235, P57, DOI 10.1016/j.femsle.2004.04.012; Yoshida T, 2006, J BIOL CHEM, V281, P17114, DOI 10.1074/jbc.M602112200; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718; Yun H, 2008, J BACTERIOL, V190, P4512, DOI 10.1128/JB.00105-08; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	74	63	64	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22300	10.1371/journal.pone.0022300	http://dx.doi.org/10.1371/journal.pone.0022300			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21811584	Green Published, Green Submitted, gold			2022-12-25	WOS:000292929500052
J	Balut, CM; Loch, CM; Devor, DC				Balut, Corina M.; Loch, Christian M.; Devor, Daniel C.			Role of ubiquitylation and USP8-dependent deubiquitylation in the endocytosis and lysosomal targeting of plasma membrane KCa3.1	FASEB JOURNAL			English	Article						TUBEs; DUB Chip; PR-619	CA2+-ACTIVATED K+ CHANNEL; PROTEIN-COUPLED RECEPTORS; DEUBIQUITINATING ENZYMES; UBIQUITIN ISOPEPTIDASE; SMALL-CONDUCTANCE; DOWN-REGULATION; CELL-SURFACE; TRAFFICKING; DEGRADATION; GROWTH	We recently demonstrated that plasma membrane KCa3.1 is rapidly endocytosed and targeted for lysosomal degradation via a Rab7- and ESCRT-dependent pathway. Herein, we assess the role of ubiquitylation in this process. Using a biotin ligase acceptor peptide (BLAP)-tagged KCa3.1, in combination with tandem ubiquitin binding entities (TUBEs), we demonstrate that KCa3.1 is polyubiquitylated following endocytosis. Hypertonic sucrose inhibited KCa3.1 endocytosis and resulted in a significant decrease in channel ubiquitylation. Inhibition of the ubiquitin-activating enzyme (E1) with UBEI-41 resulted in reduced KCa3.1 ubiquitylation and internalization. The general deubiquitylase (DUB) inhibitor, PR-619 attenuated KCa3.1 degradation, indicative of deubiquitylation being required for lysosomal delivery. Using the DUB Chip, a protein microarray containing 35 DUBs, we demonstrate a time-dependent association between KCa3.1 and USP8 following endocytosis, which was confirmed by coimmunoprecipitation. Further, overexpression of wild-type USP8 accelerates channel deubiquitylation, while either a catalytically inactive mutant USP8 or siRNA-mediated knockdown of USP8 enhanced accumulation of ubiquitylated KCa3.1, thereby inhibiting channel degradation. In summary, by combining BLAP-tagged KCa3.1 with TUBEs and DUB Chip methodologies, we demonstrate that polyubiquitylation mediates the targeting of membrane KCa3.1 to the lysosomes and also that USP8 regulates the rate of KCa3.1 degradation by deubiquitylating KCa3.1 prior to lysosomal delivery.-Balut, C. M., Loch, C. M., Devor, D. C. Role of ubiquitylation and USP8-dependent deubiquitylation in the endocytosis and lysosomal targeting of plasma membrane KCa3.1. FASEB J. 25, 3938-3948 (2011). www.fasebj.org	[Balut, Corina M.; Devor, Daniel C.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA; [Loch, Christian M.] LifeSensors Inc, Malvern, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Devor, DC (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, S331 BST,3500 Terrace St, Pittsburgh, PA 15261 USA.	dd2@pitt.edu			U.S. National Institutes of Health [HL083060, HL092157]; American Heart Fellowship [0825542D]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083060, R01HL092157] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors gratefully acknowledge Dr. Patrick H. Thibodeau for scientific discussions and for kindly helping with BirA purification. The authors also acknowledge Dr. Kirk Hamilton for critically reading the manuscript and for many helpful discussions. This work was supported by U.S. National Institutes of Health grants (HL083060, HL092157) to D.C.D. and an American Heart Fellowship (0825542D) to C.M.B.	Alwan HAJ, 2007, J BIOL CHEM, V282, P1658, DOI 10.1074/jbc.M604711200; Balut CM, 2010, AM J PHYSIOL-CELL PH, V299, pC1015, DOI 10.1152/ajpcell.00120.2010; Balut CM, 2010, FUTURE MED CHEM, V2, P707, DOI [10.4155/fmc.10.182, 10.4155/FMC.10.182]; Chen I, 2005, NAT METHODS, V2, P99, DOI 10.1038/NMETH735; Chen JX, 2009, TRAFFIC, V10, P1488, DOI 10.1111/j.1600-0854.2009.00961.x; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Cottrell GS, 2007, J BIOL CHEM, V282, P12260, DOI 10.1074/jbc.M606338200; Davies BA, 2009, CHEM REV, V109, P1575, DOI 10.1021/cr800473s; Farr GA, 2009, J CELL BIOL, V186, P269, DOI 10.1083/jcb.200901021; Gao YJ, 2008, J BIOL CHEM, V283, P9049, DOI 10.1074/jbc.M708022200; Gao YJ, 2010, J BIOL CHEM, V285, P17938, DOI 10.1074/jbc.M109.086553; Hasdemir B, 2007, J BIOL CHEM, V282, P29646, DOI 10.1074/jbc.M702974200; Hasdemir B, 2009, J BIOL CHEM, V284, P28453, DOI 10.1074/jbc.M109.025692; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hislop JN, 2011, TRAFFIC, V12, P137, DOI 10.1111/j.1600-0854.2010.01121.x; Hislop JN, 2009, J BIOL CHEM, V284, P19361, DOI 10.1074/jbc.M109.001644; Hjerpe R, 2009, EMBO REP, V10, P1250, DOI 10.1038/embor.2009.192; Jones HM, 2005, J BIOL CHEM, V280, P37257, DOI 10.1074/jbc.M508601200; Jones HM, 2004, J BIOL CHEM, V279, P15531, DOI 10.1074/jbc.M400069200; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kolodziejski PJ, 2002, P NATL ACAD SCI USA, V99, P12315, DOI 10.1073/pnas.192345199; Lamb CA, 2010, TRAFFIC, V11, P1445, DOI 10.1111/j.1600-0854.2010.01113.x; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Loch CM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002402; Millard SM, 2006, J CELL BIOL, V173, P463, DOI 10.1083/jcb.200602082; Mizuno E, 2006, TRAFFIC, V7, P1017, DOI 10.1111/j.1600-0854.2006.00452.x; Naviglio S, 1998, EMBO J, V17, P3241, DOI 10.1093/emboj/17.12.3241; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Row PE, 2006, J BIOL CHEM, V281, P12618, DOI 10.1074/jbc.M512615200; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Syme CA, 2003, J BIOL CHEM, V278, P8476, DOI 10.1074/jbc.M210072200; Tanowitz M, 2002, J BIOL CHEM, V277, P50219, DOI 10.1074/jbc.C200536200; Tian XF, 2011, ASSAY DRUG DEV TECHN, V9, P165, DOI 10.1089/adt.2010.0317; Tu LW, 1999, BIOPHYS J, V76, P2004, DOI 10.1016/S0006-3495(99)77358-3; Tuteja D, 2010, CIRC RES, V107, P851, DOI 10.1161/CIRCRESAHA.109.215269; Wulff H, 2007, CURR MED CHEM, V14, P1437, DOI 10.2174/092986707780831186	41	45	45	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	NOV	2011	25	11					3938	3948		10.1096/fj.11-187005	http://dx.doi.org/10.1096/fj.11-187005			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	844BT	21828287	Green Published			2022-12-25	WOS:000296723100018
J	Hattori, N; Carrino, DA; Lauer, ME; Vasanji, A; Wylie, JD; Nelson, CM; Apte, SS				Hattori, Noriko; Carrino, David A.; Lauer, Mark E.; Vasanji, Amit; Wylie, James D.; Nelson, Courtney M.; Apte, Suneel S.			Pericellular Versican Regulates the Fibroblast-Myofibroblast Transition A ROLE FOR ADAMTS5 PROTEASE-MEDIATED PROTEOLYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE; ADAMTS METALLOPROTEASES; MOLECULAR-MECHANISMS; HYALURONAN; MATRIX; CLEAVAGE; PROTEOGLYCANS; AGGRECAN; MICROENVIRONMENT; DIFFERENTIATION	The cell and its glycosaminoglycan-rich pericellular matrix (PCM) comprise a functional unit. Because modification of PCM influences cell behavior, we investigated molecular mechanisms that regulate PCM volume and composition. In fibroblasts and other cells, aggregates of hyaluronan and versican are found in the PCM. Dermal fibroblasts from Adamts5(-/-) mice, which lack a versican-degrading protease, ADAMTS5, had reduced versican proteolysis, increased PCM, altered cell shape, enhanced alpha-smooth muscle actin (SMA) expression and increased contractility within three-dimensional collagen gels. The myofibroblast-like phenotype was associated with activation of TGF beta signaling. We tested the hypothesis that fibroblast-myofibroblast transition in Adamts5(-/-) cells resulted from versican accumulation in PCM. First, we noted that versican overexpression inhumandermal fibroblasts led to increased SMA expression, enhanced contractility, and increased Smad2 phosphorylation. In contrast, dermal fibroblasts from Vcan haploinsufficient (Vcan(hdf/+)) mice had reduced contractility relative to wild type fibroblasts. Using a genetic approach to directly test if myofibroblast transition in Adamts5(-/-) cells resulted from increased PCM versican content, we generated Adamts5(-/-); Vcan(hdf/+) mice and isolated their dermal fibroblasts for comparison with dermal fibroblasts from Adamts5(-/-) mice. In Adamts5(-/-) fibroblasts, Vcan haploinsufficiency or exogenous ADAMTS5 restored normal fibroblast contractility. These findings demonstrate that altering PCM versican content through proteolytic activity of ADAMTS5 profoundly influenced the dermal fibroblast phenotype and may regulate a phenotypic continuum between the fibroblast and its alter ego, the myofibroblast. We propose that a physiological function of ADAMTS5 in dermal fibroblasts is to maintain optimal versican content and PCM volume by continually trimming versican in hyaluronan-versican aggregates.	[Apte, Suneel S.] Case Western Reserve Univ, Dept Biomed Engn, Lerner Res Inst, Cleveland Clin, Cleveland, OH 44195 USA; [Carrino, David A.] Case Western Reserve Univ, Skeletal Res Ctr, Dept Biol, Cleveland, OH 44195 USA	Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University	Apte, SS (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Lerner Res Inst, Cleveland Clin, ND20,9500 Euclid Ave, Cleveland, OH 44195 USA.	aptes@ccf.org		Wylie, James/0000-0003-2657-0311; Apte, Suneel/0000-0001-8441-1226	National Institutes of Health [AR53890, HL 107147]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053890] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR53890 and HL 107147.	Abraham DJ, 2005, TRENDS IMMUNOL, V26, P587, DOI 10.1016/j.it.2005.09.004; Aspberg A, 1999, J BIOL CHEM, V274, P20444, DOI 10.1074/jbc.274.29.20444; ASPBERG A, 1995, P NATL ACAD SCI USA, V92, P10590, DOI 10.1073/pnas.92.23.10590; BENNETT HS, 1963, J HISTOCHEM CYTOCHEM, V11, P14, DOI 10.1177/11.1.14; Brown HM, 2010, BIOL REPROD, V83, P549, DOI 10.1095/biolreprod.110.084434; Camaioni A, 1996, ARCH BIOCHEM BIOPHYS, V325, P190, DOI 10.1006/abbi.1996.0024; CARRINO DA, 1991, BIOCHEM INT, V24, P485; Carrino DA, 2000, ARCH BIOCHEM BIOPHYS, V373, P91, DOI 10.1006/abbi.1999.1545; Carrino DA, 2011, GLYCOBIOLOGY, V21, P257, DOI 10.1093/glycob/cwq162; Cheng G, 2011, MATRIX BIOL, V30, P126, DOI 10.1016/j.matbio.2010.12.003; Choocheep K, 2010, J BIOL CHEM, V285, P21114, DOI 10.1074/jbc.M109.096479; CLARRIS BJ, 1967, NATURE, V214, P1159, DOI 10.1038/2141159a0; CLARRIS BJ, 1968, EXP CELL RES, V49, P181, DOI 10.1016/0014-4827(68)90530-2; Dupuis LE, 2011, DEV BIOL, V357, P152, DOI 10.1016/j.ydbio.2011.06.041; Enomoto H, 2010, DEVELOPMENT, V137, P4029, DOI 10.1242/dev.050591; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; Evanko SP, 2001, ARCH BIOCHEM BIOPHYS, V394, P29, DOI 10.1006/abbi.2001.2507; Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008; Gao G, 2004, J BIOL CHEM, V279, P10042, DOI 10.1074/jbc.M312100200; Isogai Z, 2002, J BIOL CHEM, V277, P4565, DOI 10.1074/jbc.M110583200; Kern CB, 2010, MATRIX BIOL, V29, P304, DOI 10.1016/j.matbio.2010.01.005; KNUDSON CB, 1993, J CELL BIOL, V120, P825, DOI 10.1083/jcb.120.3.825; KNUDSON W, 1991, J CELL SCI, V99, P227; Koo BH, 2010, AM J PATHOL, V176, P1494, DOI 10.2353/ajpath.2010.090655; Kultti A, 2006, J BIOL CHEM, V281, P15821, DOI 10.1074/jbc.M512840200; Kuno K, 1999, J BIOL CHEM, V274, P18821, DOI 10.1074/jbc.274.26.18821; Kuznetsova SA, 2006, J CELL SCI, V119, P4499, DOI 10.1242/jcs.03171; Lauer ME, 2009, J BIOL CHEM, V284, P5299, DOI 10.1074/jbc.M807965200; Longpre JM, 2009, INT J BIOCHEM CELL B, V41, P1116, DOI 10.1016/j.biocel.2008.10.008; Maleski M, 1997, GLIA, V20, P193, DOI 10.1002/(SICI)1098-1136(199707)20:3<193::AID-GLIA3>3.0.CO;2-9; McCulloch DR, 2009, DEV CELL, V17, P687, DOI 10.1016/j.devcel.2009.09.008; McCulloch DR, 2009, GENE EXPR PATTERNS, V9, P314, DOI 10.1016/j.gep.2009.02.006; Meran S, 2008, J BIOL CHEM, V283, P6530, DOI 10.1074/jbc.M704819200; Meran S, 2007, J BIOL CHEM, V282, P25687, DOI 10.1074/jbc.M700773200; Mjaatvedt CH, 1998, DEV BIOL, V202, P56, DOI 10.1006/dbio.1998.9001; OIKE Y, 1980, BIOCHEM J, V191, P193, DOI 10.1042/bj1910193; Olin AI, 2001, J BIOL CHEM, V276, P1253, DOI 10.1074/jbc.M006783200; POOLE CA, 1987, J ORTHOP RES, V5, P509, DOI 10.1002/jor.1100050406; Ricciardelli C, 2007, J BIOL CHEM, V282, P10814, DOI 10.1074/jbc.M606991200; Sandy JD, 2001, J BIOL CHEM, V276, P13372, DOI 10.1074/jbc.M009737200; Silver DL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000003; Somerville RPT, 2003, J BIOL CHEM, V278, P9503, DOI 10.1074/jbc.M211009200; Stankunas K, 2008, DEV CELL, V14, P298, DOI 10.1016/j.devcel.2007.11.018; Thompson WR, 2011, J BONE MINER RES, V26, P618, DOI 10.1002/jbmr.236; VanTeeffelen JW, 2007, TRENDS CARDIOVAS MED, V17, P101, DOI 10.1016/j.tcm.2007.02.002; Velasco J, 2011, J BIOL CHEM, V286, P26016, DOI 10.1074/jbc.M110.208694; Webber J, 2009, AM J PATHOL, V175, P148, DOI 10.2353/ajpath.2009.080837; Webber J, 2009, J BIOL CHEM, V284, P9083, DOI 10.1074/jbc.M806989200; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277	49	71	71	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34298	34310		10.1074/jbc.M111.254938	http://dx.doi.org/10.1074/jbc.M111.254938			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21828051	Green Published, hybrid			2022-12-25	WOS:000295159200059
J	Robinson, JW; Potter, LR				Robinson, Jerid W.; Potter, Lincoln R.			ATP Potentiates Competitive Inhibition of Guanylyl Cyclase A and B by the Staurosporine Analog, Go6976 RECIPROCAL REGULATION OF ATP AND GTP BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATRIURETIC-PEPTIDE RECEPTOR; PROTEIN-KINASE-C; NPR-B/GC-B; ADENINE-NUCLEOTIDES; DOMAIN; DESENSITIZATION; ACTIVATION; CALCIUM	Natriuretic peptides and ATP activate and Go6976 inhibits guanylyl cyclase (GC)-A and GC-B. Here, the mechanism of inhibition was determined. Go6976 progressively increased the Michaelis-Menten constant and decreased the Hill coefficient without reducing the maximal velocity of GC-A and GC-B. In the presence of 1 mM ATP, the K-i was 1 mu M for both enzymes. Inhibition of GC-B was minimal in the absence of ATP, and 1 mM ATP increased the inhibition 4-fold. In a reciprocal manner, 10 mu M Go6976 increased the potency of ATP for GC-B 4-fold. In contrast to a recent study (Duda, T., Yadav, P., and Sharma, R. K. (2010) FEBS J. 277, 2550-2553), neither staurosporine nor Go6976 activated GC-A or GC-B. This is the first study to show that Go6976 reduces GTP binding and the first demonstration of a competitive inhibitor of a receptor guanylyl cyclase. We conclude that Go6976 reduces GTP binding to the catalytic site of GC-A and GC-B and that ATP increases the magnitude of the inhibition.	[Potter, Lincoln R.] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Potter, Lincoln R.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Potter, LR (corresponding author), Univ Minnesota, Dept Pharmacol, 6-155 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	potter@umn.edu			University of Minnesota Graduate School [21,922]; National Institutes of Health from the NIAMS [T32AR050938]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL093402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR050938] Funding Source: NIH RePORTER	University of Minnesota Graduate School(University of Minnesota System); National Institutes of Health from the NIAMS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by Grant-in Aid 21,922 from the University of Minnesota Graduate School (to L. R. P.) and National Institutes of Health Training Grant T32AR050938 (to J. W. R.) from the NIAMS.	Abbey SE, 2002, J BIOL CHEM, V277, P42423, DOI 10.1074/jbc.M206686200; Abbey-Hosch SE, 2005, BIOCHEM PHARMACOL, V70, P686, DOI 10.1016/j.bcp.2005.04.034; Antos LK, 2007, AM J PHYSIOL-ENDOC M, V293, pE1756, DOI 10.1152/ajpendo.00321.2007; CHINKERS M, 1989, SCIENCE, V245, P1392, DOI 10.1126/science.2571188; Dickey DM, 2010, MOL PHARMACOL, V78, P431, DOI 10.1124/mol.110.066084; Duda T, 2011, BIOCHEMISTRY-US, V50, P1213, DOI 10.1021/bi1018978; Duda T, 2010, FEBS J, V277, P2550, DOI 10.1111/j.1742-4658.2010.07670.x; Fan DH, 2005, MOL PHARMACOL, V67, P174, DOI 10.1124/mol.104.002436; Flora DR, 2010, ENDOCRINOLOGY, V151, P2769, DOI 10.1210/en.2009-1239; Foster DC, 1998, J BIOL CHEM, V273, P16311, DOI 10.1074/jbc.273.26.16311; He XL, 2006, J MOL BIOL, V361, P698, DOI 10.1016/j.jmb.2006.06.060; Joubert S, 2001, BIOCHEMISTRY-US, V40, P11096, DOI 10.1021/bi010580s; KOLLER KJ, 1992, MOL CELL BIOL, V12, P2581, DOI 10.1128/MCB.12.6.2581; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Ogawa H, 2004, J BIOL CHEM, V279, P28625, DOI 10.1074/jbc.M313222200; Potter LR, 2011, PHARMACOL THERAPEUT, V130, P71, DOI 10.1016/j.pharmthera.2010.12.005; ROBINSON JW, 2011, BR J PHARM      0303, DOI DOI 10.1111/J.1476-5381.2011.01291.X; RONDEAU JJ, 1995, BIOCHEMISTRY-US, V34, P2130, DOI 10.1021/bi00007a005; SCHULZ S, 1989, CELL, V58, P1155, DOI 10.1016/0092-8674(89)90513-8; Yoder AR, 2008, PEPTIDES, V29, P1575, DOI 10.1016/j.peptides.2008.04.020; Yoder AR, 2010, BIOCHEMISTRY-US, V49, P10137, DOI 10.1021/bi101700e	21	9	9	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33841	33844		10.1074/jbc.M111.273565	http://dx.doi.org/10.1074/jbc.M111.273565			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21828054	Green Published, hybrid			2022-12-25	WOS:000295159200015
J	Banks, SC; Knight, EJ; McBurney, L; Blair, D; Lindenmayer, DB				Banks, Sam C.; Knight, Emma J.; McBurney, Lachlan; Blair, David; Lindenmayer, David B.			The Effects of Wildfire on Mortality and Resources for an Arboreal Marsupial: Resilience to Fire Events but Susceptibility to Fire Regime Change	PLOS ONE			English	Article							MOUNTAIN BRUSHTAIL POSSUM; TRICHOSURUS-CANINUS PHALANGERIDAE; CLIMATE-CHANGE; NEST TREES; NATURAL DISTURBANCE; FORESTS; SUCCESSION; RECOLONIZATION; BIODIVERSITY; VEGETATION	Background: Big environmental disturbances have big ecological effects, yet these are not always what we might expect. Understanding the proximate effects of major disturbances, such as severe wildfires, on individuals, populations and habitats will be essential for understanding how predicted future increases in the frequency of such disturbances will affect ecosystems. However, researchers rarely have access to data from immediately before and after such events. Here we report on the effects of a severe and extensive forest wildfire on mortality, reproductive output and availability of key shelter resources for an arboreal marsupial. We also investigated the behavioural response of individuals to changed shelter resource availability in the post-fire environment. Methodology/Principal Findings: We fitted proximity-logging radiotransmitters to mountain brushtail possums (Trichosurus cunninghami) before, during and after the 2009 wildfires in Victoria, Australia. Surprisingly, we detected no mortality associated with the fire, and despite a significant post-fire decrease in the proportion of females carrying pouch young in the burnt area, there was no short-term post-fire population decline. The major consequence of this fire for mountain brushtail possums was the loss of over 80% of hollow-bearing trees. The types of trees preferred as shelter sites (highly decayed dead standing trees) were those most likely to collapse after fire. Individuals adapted to resource decline by being more flexible in resource selection after the fire, but not by increased resource sharing. Conclusions/Significance: Despite short-term demographic resilience and behavioural adaptation following this fire, the major loss of decayed hollow trees suggests the increased frequency of stand-replacing wildfires predicted under climate change will pose major challenges for shelter resource availability for hollow-dependent fauna. Hollow-bearing trees are typically biological legacies of previous forest generations in post-fire regrowth forests but will cease to be recruited to future regrowth forests if the interval between severe fires becomes too rapid for hollow formation.	[Banks, Sam C.; Knight, Emma J.; McBurney, Lachlan; Blair, David; Lindenmayer, David B.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia	Australian National University	Banks, SC (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia.	sam.banks@anu.edu.au	Banks, Sam/K-4907-2012; Lindenmayer, David B/P-7183-2017	Banks, Sam/0000-0003-2415-0057; Lindenmayer, David B/0000-0002-4766-4088; Knight, Emma/0000-0002-4549-1531	Hermon Slade Foundation [HSF 08-4]; Australian Research Council [DP 0984876]	Hermon Slade Foundation; Australian Research Council(Australian Research Council)	This work was funded by the Hermon Slade Foundation (www.hermonslade.org.au; Grant HSF 08-4) and the Australian Research Council (www.arc.gov.au; Discovery Project DP 0984876). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelstam PK, 1998, J VEG SCI, V9, P593, DOI 10.2307/3237275; [Anonymous], 2010, R LANG ENV STAT COMP; ASHTON DH, 1981, FIRE AUSTR BIOTA; Banks SC, 2011, P ROY SOC B-BIOL SCI, V278, P2768, DOI 10.1098/rspb.2010.2657; Banks SC, 2011, OIKOS, V120, P26, DOI 10.1111/j.1600-0706.2010.18765.x; Banks SC, 2010, OECOLOGIA, V162, P359, DOI 10.1007/s00442-009-1464-0; Bradshaw CJA, 2009, TRENDS ECOL EVOL, V24, P541, DOI 10.1016/j.tree.2009.03.019; Burton PJ, 2008, INT J WILDLAND FIRE, V17, P754, DOI 10.1071/WF07149; Cary GJ, 2000, ADV GLOB CHANGE RES, V3, P233; Driscoll DA, 2010, BIOL CONSERV, V143, P1928, DOI 10.1016/j.biocon.2010.05.026; FOX BJ, 1982, ECOLOGY, V63, P1332, DOI 10.2307/1938861; Franklin J.F., 2000, CONSERVATION BIOL PR, V1, P9, DOI DOI 10.1111/J.1526-4629.2000.TB00155.X; Gardner A, 2004, J EVOLUTION BIOL, V17, P1195, DOI 10.1111/j.1420-9101.2004.00775.x; Gibbons P., 2002, TREE HOLLOWS WILDLIF, DOI [10.1071/9780643090033, DOI 10.1071/9780643090033]; HAMILTON WD, 1970, NATURE, V228, P1218, DOI 10.1038/2281218a0; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hodson J, 2010, OECOLOGIA, V164, P73, DOI 10.1007/s00442-010-1691-4; Isaac JL, 2008, POPUL ECOL, V50, P101, DOI 10.1007/s10144-007-0057-1; Jones J, 2001, ECOLOGY, V82, P2628, DOI 10.1890/0012-9658(2001)082[2628:ATEOND]2.0.CO;2; Knight TM, 2005, ECOLOGY, V86, P587, DOI 10.1890/04-1069; Lindenmayer DB, 2011, BIOL CONSERV, V144, P1663, DOI 10.1016/j.biocon.2011.02.022; Lindenmayer DB, 2009, CONSERV LETT, V2, P271, DOI 10.1111/j.1755-263X.2009.00080.x; Lindenmayer DB, 1997, WILDLIFE RES, V24, P661, DOI 10.1071/WR96112; Lindenmayer DB, 1996, WILDLIFE RES, V23, P531, DOI 10.1071/WR9960531; LINDENMAYER DB, 1990, AUST WILDLIFE RES, V17, P467, DOI 10.1071/WR9900467; Lindenmayer DB, 1997, ECOL APPL, V7, P625, DOI 10.1890/1051-0761(1997)007[0625:DACOTW]2.0.CO;2; LINDENMAYER DB, 1991, AUST J ECOL, V16, P91, DOI 10.1111/j.1442-9993.1991.tb01484.x; Lindenmayer DB, 1998, WILDLIFE RES, V25, P627, DOI 10.1071/WR97081; Parker KR, 2005, ECOL APPL, V15, P2037, DOI 10.1890/04-1723; Payne RW, 2008, GENSTAT WINDOWS; Pitman AJ, 2007, CLIMATIC CHANGE, V84, P383, DOI 10.1007/s10584-007-9243-6; Seebeck J.H., 1984, P145; Thompson JR, 2007, P NATL ACAD SCI USA, V104, P10743, DOI 10.1073/pnas.0700229104; Turner MG, 1998, ECOSYSTEMS, V1, P511, DOI 10.1007/s100219900047; Turner MG, 2010, ECOLOGY, V91, P2833, DOI 10.1890/10-0097.1; TYNDALEBISCOE CH, 1969, J ANIM ECOL, V38, P651, DOI 10.2307/3041; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Whelan R.J.., 1995, ECOLOGY FIRE; Whelan RJ, 2002, FLAMMABLE AUSTR FIRE; WHITTAKER RJ, 1989, ECOL MONOGR, V59, P59, DOI 10.2307/2937282; Williams NM, 2010, BIOL CONSERV, V143, P2280, DOI 10.1016/j.biocon.2010.03.024; Williams RJ, 2008, INT J WILDLAND FIRE, V17, P685, DOI 10.1071/WF07155; Winter LE, 2002, CAN J FOREST RES, V32, P1039, DOI 10.1139/X02-031; Wotton BM, 2010, INT J WILDLAND FIRE, V19, P253, DOI 10.1071/WF09002; [No title captured]	46	50	53	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22952	10.1371/journal.pone.0022952	http://dx.doi.org/10.1371/journal.pone.0022952			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826221	Green Published, gold			2022-12-25	WOS:000293558900047
J	Chen, TA; Wang, JL; Hung, SW; Chu, CL; Cheng, YC; Liang, SM				Chen, Tai-An; Wang, Jui-Ling; Hung, Shao-Wen; Chu, Chiao-Li; Cheng, Yung-Chih; Liang, Shu-Mei			Recombinant VP1, an Akt Inhibitor, Suppresses Progression of Hepatocellular Carcinoma by Inducing Apoptosis and Modulation of CCL2 Production	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; MOUTH-DISEASE VIRUS; ADENOVIRUS E4ORF4 PROTEIN; NF-KAPPA-B; TARGETED THERAPIES; DOWN-REGULATION; SERUM-LEVELS; BCL-XL; CANCER; EXPRESSION	Background: The application of viral elements in tumor therapy is one facet of cancer research. Recombinant capsid protein VP1 (rVP1) of foot-and-mouth disease virus has previously been demonstrated to induce apoptosis in cancer cell lines. Here, we aim to further investigate its apoptotic mechanism and possible anti-metastatic effect in murine models of hepatocellular carcinoma (HCC), one of the most common human cancers worldwide. Methodology/Principal Findings: Treatment with rVP1 inhibited cell proliferation in two murine HCC cell lines, BNL and Hepa1-6, with IC50 values in the range of 0.1-0.2 mu M. rVP1 also induced apoptosis in these cells, which was mediated by Akt deactivation and dissociation of Ku70-Bax, and resulted in conformational changes and mitochondrial translocation of Bax, leading to the activation of caspases-9, -3 and -7. Treatment with 0.025 mu M rVP1, which did not affect the viability of normal hepatocytes, suppressed cell migration and invasion via attenuating CCL2 production. The production of CCL2 was modulated by Akt-dependent NF-kappa B activation that was decreased after rVP1 treatment. The in vivo antitumor effects of rVP1 were assessed in both subcutaneous and orthotopic mouse models of HCC in immune-competent BALB/c mice. Intratumoral delivery of rVP1 inhibited subcutaneous tumor growth as a result of increased apoptosis. Intravenous administration of rVP1 in an orthotopic HCC model suppressed tumor growth, inhibited intra-hepatic metastasis, and prolonged survival. Furthermore, a decrease in the serum level of CCL2 was observed in rVP1-treated mice. Conclusions/Significance: The data presented herein suggest that, via inhibiting Akt phosphorylation, rVP1 suppresses the growth, migration, and invasion of murine HCC cells by inducing apoptosis and attenuating CCL2 production both in vitro and in vivo. Recombinant protein VP1 thus has the potential to be developed as a new therapeutic agent for HCC.	[Chen, Tai-An; Wang, Jui-Ling; Hung, Shao-Wen; Chu, Chiao-Li; Cheng, Yung-Chih; Liang, Shu-Mei] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan	Academia Sinica - Taiwan	Chen, TA (corresponding author), Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan.	smyang@gate.sinica.edu.tw	Cheng, Yung-Chih/G-2816-2010	Liang, Shu-Mei/0000-0001-8926-4747	National Science Council, Taiwan [NSC 96-2313-B-001-005-MY3]; Academia Sinica; National Research Program for Genomic Medicine [NSC 98-3112-B-001-020]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan); National Research Program for Genomic Medicine(Ministry of Science and Technology, Taiwan)	This study was supported by a grant (NSC 96-2313-B-001-005-MY3) to S-ML from the National Science Council, Taiwan. T-AC received an Academia Sinica postdoctoral fellowship. The Taiwan Mouse Clinic, the staff of which provided technical support for tumor tissue processing, was funded by the National Research Program for Genomic Medicine (NSC 98-3112-B-001-020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaravadi R, 2005, J CLIN INVEST, V115, P2618, DOI 10.1172/JCI26273; Ara T, 2010, EUR J CANCER, V46, P1223, DOI 10.1016/j.ejca.2010.02.026; Ayene IS, 2005, MOL CANCER THER, V4, P529, DOI 10.1158/1535-7163.MCT-04-0130; Beerheide W, 2000, BIOCHEM BIOPH RES CO, V273, P54, DOI 10.1006/bbrc.2000.2891; BELSHAM GJ, 1993, PROG BIOPHYS MOL BIO, V60, P241, DOI 10.1016/0079-6107(93)90016-D; Branton PE, 2001, ONCOGENE, V20, P7855, DOI 10.1038/sj.onc.1204862; Broek IV, 2003, BRIT J CANCER, V88, P855, DOI 10.1038/sj.bjc.6600833; Craig MJ, 2006, CANCER METAST REV, V25, P611, DOI 10.1007/s10555-006-9027-x; Dagouassat M, 2010, INT J CANCER, V126, P1095, DOI 10.1002/ijc.24800; Desai N, 2006, CLIN CANCER RES, V12, P1317, DOI 10.1158/1078-0432.CCR-05-1634; Fabregat I, 2007, LIVER INT, V27, P155, DOI 10.1111/j.1478-3231.2006.01409.x; Fridlender ZG, 2011, AM J RESP CELL MOL, V44, P230, DOI 10.1165/rcmb.2010-0080OC; Gama V, 2009, CELL DEATH DIFFER, V16, P758, DOI 10.1038/cdd.2009.6; Greten TF, 2009, BRIT J CANCER, V100, P19, DOI 10.1038/sj.bjc.6604784; Hayashi T, 2005, INT J ONCOL, V26, P1313; Haybaeck J, 2009, CANCER CELL, V16, P295, DOI 10.1016/j.ccr.2009.08.021; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hefler L, 1999, BRIT J CANCER, V81, P855, DOI 10.1038/sj.bjc.6690776; Kooistra K, 2007, MINI-REV MED CHEM, V7, P1155, DOI 10.2174/138955707782331713; Lalier L, 2007, APOPTOSIS, V12, P887, DOI 10.1007/s10495-007-0749-1; Lebrecht A, 2004, TUMOR BIOL, V25, P14, DOI 10.1159/000077718; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2008, J HEPATOL, V48, pS20, DOI 10.1016/j.jhep.2008.01.022; Lu YS, 2007, HEPATOLOGY, V46, P1119, DOI 10.1002/hep.21804; Lu Y, 2007, J CELL BIOCHEM, V101, P676, DOI 10.1002/jcb.21220; Lu Y, 2006, PROSTATE, V66, P1311, DOI 10.1002/pros.20464; LUCITO R, 1992, J VIROL, V66, P983, DOI 10.1128/JVI.66.2.983-991.1992; Mahfouz M, 2007, PLASMID, V57, P4, DOI 10.1016/j.plasmid.2006.11.001; Mestdagt M, 2006, INT J CANCER, V118, P35, DOI 10.1002/ijc.21291; Monti P, 2003, CANCER RES, V63, P7451; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Pang RWC, 2007, ONCOLOGY-BASEL, V72, P30, DOI 10.1159/000111705; Peng JM, 2004, J BIOL CHEM, V279, P52168, DOI 10.1074/jbc.M403686200; Poon RTP, 2000, ANN SURG, V232, P10, DOI 10.1097/00000658-200007000-00003; Rashmi R, 2004, CARCINOGENESIS, V25, P1867, DOI 10.1093/carcin/bgh213; Roca H, 2009, J BIOL CHEM, V284, P34342, DOI 10.1074/jbc.M109.042671; Sawada M, 2003, NAT CELL BIOL, V5, P320, DOI 10.1038/ncb950; Shieh JJ, 2001, VACCINE, V19, P4002, DOI 10.1016/S0264-410X(01)00114-1; Shirabe K, 1996, CANCER, V77, P1050, DOI 10.1002/(SICI)1097-0142(19960315)77:6<1050::AID-CNCR7>3.0.CO;2-L; Shtrichman R, 1999, P NATL ACAD SCI USA, V96, P10080, DOI 10.1073/pnas.96.18.10080; Tai DI, 2000, CANCER, V89, P2274, DOI 10.1002/1097-0142(20001201)89:11<2274::AID-CNCR16>3.0.CO;2-2; TAKAYASU K, 1992, HEPATOLOGY, V16, P906, DOI 10.1002/hep.1840160409; Takehara T, 2001, HEPATOLOGY, V34, P55, DOI 10.1053/jhep.2001.25387; Tarzami ST, 2005, BIOCHEM BIOPH RES CO, V335, P1008, DOI 10.1016/j.bbrc.2005.07.168; Thompson WL, 2009, BRAIN RES, V1287, P47, DOI 10.1016/j.brainres.2009.06.081; Tietze MK, 2000, CANCER GENE THER, V7, P1315, DOI 10.1038/sj.cgt.0241; Villanueva A, 2010, ANNU REV MED, V61, P317, DOI 10.1146/annurev.med.080608.100623; Voiculescu M, 2008, J GASTROINTEST LIVER, V17, P315; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Wang JH, 2003, VACCINE, V21, P3721, DOI 10.1016/S0264-410X(03)00363-3; Yang NS, 2005, J GENE MED, V7, P708, DOI 10.1002/jgm.723; YUKI K, 1990, CANCER-AM CANCER SOC, V66, P2174, DOI 10.1002/1097-0142(19901115)66:10<2174::AID-CNCR2820661022>3.0.CO;2-A; Zhang J, 2010, CYTOKINE GROWTH F R, V21, P41, DOI 10.1016/j.cytogfr.2009.11.009; Zhang K, 2005, CLIN CANCER RES, V11, P7532, DOI 10.1158/1078-0432.CCR-05-0400	54	25	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e23317	10.1371/journal.pone.0023317	http://dx.doi.org/10.1371/journal.pone.0023317			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826248	Green Submitted, gold, Green Published			2022-12-25	WOS:000293558900074
J	Li, L; Zhang, K; Cai, XJ; Feng, M; Zhang, Y; Zhang, M				Li, Li; Zhang, Ke; Cai, Xiao-Jun; Feng, Min; Zhang, Yun; Zhang, Mei			Adiponectin Upregulates Prolyl-4-Hydroxylase alpha 1 Expression in Interleukin 6-Stimulated Human Aortic Smooth Muscle Cells by Regulating ERK 1/2 and Sp1	PLOS ONE			English	Article							NF-KAPPA-B; ARTICULAR CHONDROCYTES; TRANSCRIPTION FACTORS; TISSUE INHIBITOR; GENE-EXPRESSION; IN-VIVO; COLLAGEN; PATHWAY; ATHEROSCLEROSIS; KINASE	Adiponectin is an anti-atherogenic adipokine that inhibits the development of plaque by mechanisms that are not completely understood. Extracellular matrix (ECM) may have a role in the pathogenesis of atherosclerosis. We explored the effect and mechanisms of adiponectin on the synthesis of prolyl-4-hydroxylase (P4H) in interleukin 6 (IL-6)-stimulated human aortic smooth muscle cells (HASMCs). P4H alpha 1 mRNA level was quantified by RT-PCR, the protein levels of phosphorylated extracellular signal-regulated kinase 1/2 (ERK1/2) and P4H alpha 1 were quantified by western blot analysis, and activation of specific protein 1 (Sp1) was determined by electrophoretic mobility shift assay and subcellular localization of Sp1 by immunofluorescence analysis. Adiponectin significantly increased P4H alpha 1 mRNA and protein levels in IL-6-stimulated HASMCs in a dose-and time-dependent manner. As well, ERK1/2 and Sp1 played a crucial role in the effect of adiponectin upregulating P4H alpha 1 expression in IL-6-stimulated HASMCs. Adiponectin abrogated the effects of IL-6 on collagen III level, which may indicate that P4H alpha 1 is essential for folding the procollagen polypeptide chains into stabilized collagen. Adiponectin attenuates IL-6-inhibited P4H alpha 1 synthesis and stabilizes collagen formation in HASMCs through a Sp1-ERK1/2P4H alpha 1-dependent pathway.	[Li, Li; Zhang, Ke; Cai, Xiao-Jun; Feng, Min; Zhang, Yun; Zhang, Mei] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan 250100, Shandong, Peoples R China; [Li, Li; Zhang, Ke; Cai, Xiao-Jun; Feng, Min; Zhang, Yun; Zhang, Mei] Shandong Univ, Qilu Hosp, Chinese Minist Publ Hlth, Jinan 250100, Shandong, Peoples R China; [Li, Li; Cai, Xiao-Jun] Shandong Univ, Jinan Cent Hosp, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Li, L (corresponding author), Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan 250100, Shandong, Peoples R China.	spear11@sina.com	王, 强/F-4212-2011		National Basic Research Program of China (973 Program) [2011CB503906]; HI-TECH Technique and Development Program of China (863 Program) [2007AA02Z448]; National Natural Science Foundation of China [30728025, 30970709]; Medical Science and Technology Development Program of Shandong Province [2006GG2202039, 2009HW035]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); HI-TECH Technique and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Science and Technology Development Program of Shandong Province	This work was supported by the National Basic Research Program of China (973 Program, 2011CB503906), the HI-TECH Technique and Development Program of China (863 Program, 2007AA02Z448), the National Natural Science Foundation of China (No. 30728025, 30970709), the Medical Science and Technology Development Program of Shandong Province (No. 2006GG2202039,2009HW035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunen P, 1998, J BIOL CHEM, V273, P5989, DOI 10.1074/jbc.273.11.5989; Barnes PJ, 1998, EUR RESPIR J, V12, P221, DOI 10.1183/09031936.98.12010221; Bode MK, 1999, ARTERIOSCL THROM VAS, V19, P1506, DOI 10.1161/01.ATV.19.6.1506; Cai XJ, 2010, MOL ENDOCRINOL, V24, P218, DOI 10.1210/me.2009-0128; Chen L, 2006, J BIOL CHEM, V281, P10849, DOI 10.1074/jbc.M511237200; Curry JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003405; Ezure T, 2007, BIOFACTORS, V31, P229, DOI 10.1002/biof.5520310310; Feng M, 2010, CLIN EXP PHARMACOL P, V37, P162, DOI 10.1111/j.1440-1681.2009.05246.x; Hot A, 2011, ANN RHEUM DIS, V70, P341, DOI 10.1136/ard.2010.132233; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; Kang EH, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3218; Kim JY, 2011, J ETHNOPHARMACOL, V133, P687, DOI 10.1016/j.jep.2010.10.051; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; KYRIAZI E, 2011, HORM METAB RES; Lee M, 2004, J CELL BIOCHEM, V91, P1260, DOI 10.1002/jcb.20021; Legendre F, 2005, J RHEUMATOL, V32, P1307; Li L, 2010, CIRC J, V74, P552, DOI 10.1253/circj.CJ-09-0304; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; Menghini R, 2005, CIRCULATION, V111, P1946, DOI 10.1161/01.CIR.0000161814.02942.B2; Milanini-Mongiat J, 2002, J BIOL CHEM, V277, P20631, DOI 10.1074/jbc.M201753200; Mukhopadhyay A, 2007, EXP DERMATOL, V16, P1023, DOI 10.1111/j.1600-0625.2007.00627.x; Poree B, 2008, J BIOL CHEM, V283, P4850, DOI 10.1074/jbc.M706387200; Purushothaman KR, 2011, VASC MED, V16, P103, DOI 10.1177/1358863X11402249; Qureshi HY, 2005, J CELL PHYSIOL, V203, P345, DOI 10.1002/jcp.20228; Raveendran M, 2004, BIOCHEM BIOPH RES CO, V323, P592, DOI 10.1016/j.bbrc.2004.08.129; Rockel JS, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2595; Rocnik EF, 1998, J CLIN INVEST, V101, P1889, DOI 10.1172/JCI1025; Schulz C, 2008, BASIC RES CARDIOL, V103, P356, DOI 10.1007/s00395-008-0722-3; Sigala I, 2011, AM J PHYSIOL-REG I, V300, pR1152, DOI 10.1152/ajpregu.00376.2010; Sopasakis VR, 2004, OBES RES, V12, P454, DOI 10.1038/oby.2004.51; SUNDARARAJ KP, 2009, J BIOL CHEM, V23, P567; Takahra T, 2004, INT J BIOCHEM CELL B, V36, P353, DOI 10.1016/S1357-2725(03)00260-7; Valgimigli M, 2004, J AM COLL CARDIOL, V43, P2000, DOI 10.1016/j.jacc.2004.01.036; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Zhang C, 2007, ARTERIOSCL THROM VAS, V27, P1760, DOI 10.1161/ATVBAHA.107.144881; Zhang H, 2010, J ENDOCRINOL INVEST, V33, P707, DOI [10.1007/BF03346674, 10.3275/6886]; Zoico E, 2009, INT J MOL MED, V24, P847, DOI 10.3892/ijmm_00000302	37	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22819	10.1371/journal.pone.0022819	http://dx.doi.org/10.1371/journal.pone.0022819			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829524	gold, Green Submitted, Green Published			2022-12-25	WOS:000293286500034
J	Fathi, A; Hatami, M; Hajihosseini, V; Fattahi, F; Kiani, S; Baharvand, H; Salekdeh, GH				Fathi, Ali; Hatami, Maryam; Hajihosseini, Vahid; Fattahi, Faranak; Kiani, Sahar; Baharvand, Hossein; Salekdeh, Ghasem Hosseini			Comprehensive Gene Expression Analysis of Human Embryonic Stem Cells during Differentiation into Neural Cells	PLOS ONE			English	Article							NERVOUS-SYSTEM; RETINOIC ACID; PROTEIN; LONG; ACTIVATION; GENERATION; CYTOSCAPE; SURVIVAL; NEURONS; GROWTH	Global gene expression analysis of human embryonic stem cells (hESCs) that differentiate into neural cells would help to further define the molecular mechanisms involved in neurogenesis in humans. We performed a comprehensive transcripteome analysis of hESC differentiation at three different stages: early neural differentiation, neural ectoderm, and differentiated neurons. We identified and validated time-dependent gene expression patterns and showed that the gene expression patterns reflect early ESC differentiation. Sets of genes are induced in primary ectodermal lineages and then in differentiated neurons, constituting consecutive waves of known and novel genes. Pathway analysis revealed dynamic expression patterns of members of several signaling pathways, including NOTCH, mTOR and Toll like receptors (TLR), during neural differentiation. An interaction network analysis revealed that the TGF beta family of genes, including LEFTY1, ID1 and ID2, are possible key players in the proliferation and maintenance of neural ectoderm. Collectively, these results enhance our understanding of the molecular dynamics underlying neural commitment and differentiation.	[Fathi, Ali; Hajihosseini, Vahid; Fattahi, Faranak; Baharvand, Hossein; Salekdeh, Ghasem Hosseini] Avicenna Res Inst ACECR, Royan Inst Stem Cell Biol & Technol, Cell Sci Res Ctr, Dept Mol Syst Biol, Tehran, Iran; [Hatami, Maryam; Kiani, Sahar] Avicenna Res Inst ACECR, Royan Inst Stem Cell Biol & Technol, Cell Sci Res Ctr, Dept Stem Cells & Dev Biol, Tehran, Iran; [Hajihosseini, Vahid; Fattahi, Faranak] Univ Tehran, Coll Sci, Dept Biotechnol, Tehran, Iran; [Baharvand, Hossein] Univ Sci & Culture, Avicenna Res Inst ACECR, Dept Dev Biol, Tehran, Iran; [Salekdeh, Ghasem Hosseini] Agr Biotechnol Res Inst Iran, Dept Syst Biol, Karaj, Iran	University of Tehran	Fathi, A (corresponding author), Avicenna Res Inst ACECR, Royan Inst Stem Cell Biol & Technol, Cell Sci Res Ctr, Dept Mol Syst Biol, Tehran, Iran.	Baharvand@RoyanInstitute.org; Salekdeh@Royaninstitute.org	Kiani, Sahar/AAO-3557-2020; Salekdeh, Ghasem Hosseini/E-4198-2012	Kiani, Sahar/0000-0001-7779-9998; Salekdeh, Ghasem Hosseini/0000-0002-5124-4721	Royan Institute	Royan Institute	This study was funded by a grant provided from the Royan Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JI, 2004, J CELL BIOCHEM, V93, P563, DOI 10.1002/jcb.20168; Aiba K, 2006, STEM CELLS, V24, P889, DOI 10.1634/stemcells.2005-0332; Baharvand H, 2006, DEV GROWTH DIFFER, V48, P117, DOI 10.1111/j.1440-169x.2006.00851.x; Baharvand H, 2007, INT J DEV BIOL, V51, P371, DOI 10.1387/ijdb.072280hb; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BergeLefranc JL, 1996, HUM MOL GENET, V5, P1637, DOI 10.1093/hmg/5.10.1637; Borghese L, 2010, STEM CELLS, V28, P955, DOI 10.1002/stem.408; Brondani V, 2002, J MOL BIOL, V319, P715, DOI 10.1016/S0022-2836(02)00376-5; BURGESS GM, 1989, J NEUROSCI, V9, P3314; Cau E, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-36; Chiba S, 2006, STEM CELLS, V24, P2437, DOI 10.1634/stemcells.2005-0661; Chung S, 2009, CELL STEM CELL, V5, P646, DOI 10.1016/j.stem.2009.09.015; Covacu R, 2009, J IMMUNOL, V182, P6889, DOI 10.4049/jimmunol.0802907; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Empson RM, 2006, J NEUROCHEM, V99, P850, DOI 10.1111/j.1471-4159.2006.04123.x; Erhardt JA, 1998, J BIOL CHEM, V273, P35222, DOI 10.1074/jbc.273.52.35222; Faedo A, 2010, J NEUROSCI, V30, P4015, DOI 10.1523/JNEUROSCI.0307-10.2010; Ferri ALM, 2007, DEVELOPMENT, V134, P2761, DOI 10.1242/dev.000141; Grandbarbe L, 2003, DEVELOPMENT, V130, P1391, DOI 10.1242/dev.00374; Gurok U, 2004, J NEUROSCI, V24, P5982, DOI 10.1523/JNEUROSCI.0809-04.2004; Hatami M, 2009, CYTOTHERAPY, V11, P618, DOI 10.1080/14653240903005802; HELIN K, 1993, GENE DEV, V7, P1850, DOI 10.1101/gad.7.10.1850; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; JONESVILLENEUVE EMV, 1983, MOL CELL BIOL, V3, P2271, DOI 10.1128/MCB.3.12.2271; Jurga M, 2006, J NEUROSCI RES, V84, P993, DOI 10.1002/jnr.20994; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Kee Y, 2005, GENE DEV, V19, P744, DOI 10.1101/gad.1257405; Lathia JD, 2008, J NEUROSCI, V28, P13978, DOI 10.1523/JNEUROSCI.2140-08.2008; Lee MS, 2006, STEM CELLS, V24, P1946, DOI 10.1634/stemcells.2005-0325; Lee SMK, 1997, DEVELOPMENT, V124, P959; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Martinsen BJ, 1998, SCIENCE, V281, P988, DOI 10.1126/science.281.5379.988; Moeller C, 2003, DEVELOPMENT, V130, P5103, DOI 10.1242/dev.00686; NEMEROFF CB, 1986, PSYCHONEUROENDOCRINO, V11, P15, DOI 10.1016/0306-4530(86)90029-6; Ohsawa S, 2005, J NEUROSCI RES, V79, P451, DOI 10.1002/jnr.20365; Owczarek S, 2010, FASEB J, V24, P1139, DOI 10.1096/fj.09-140509; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Ray WJ, 1997, J BIOL CHEM, V272, P18702, DOI 10.1074/jbc.272.30.18702; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; ROTH J, 1985, J CELL BIOL, V100, P118, DOI 10.1083/jcb.100.1.118; Sakurai Y, 2010, DEV BIOL, V347, P392, DOI 10.1016/j.ydbio.2010.08.028; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shin S, 2007, STEM CELLS, V25, P1298, DOI 10.1634/stemcells.2006-0660; Shirato H, 2009, J BIOL CHEM, V284, P733, DOI 10.1074/jbc.M804994200; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Stenina OI, 2003, CIRCULATION, V108, P1514, DOI 10.1161/01.CIR.0000089085.76320.4E; Suh YJ, 2008, MOL CELLS, V26, P338; Sun MK, 2011, J NEUROSCI, V31, P687, DOI 10.1523/JNEUROSCI.3854-10.2011; SUZUKI N, 1990, EMBO J, V9, P3723, DOI 10.1002/j.1460-2075.1990.tb07585.x; Thangnipon W, 1983, Brain Res, V313, P177; THOMAS JB, 1988, CELL, V52, P133, DOI 10.1016/0092-8674(88)90537-5; Toy J, 1998, P NATL ACAD SCI USA, V95, P10643, DOI 10.1073/pnas.95.18.10643; Wang JF, 2008, J RADIAT RES, V49, P391, DOI 10.1269/jrr.08012; Woo SM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-97; Wu JQ, 2010, P NATL ACAD SCI USA, V107, P5254, DOI 10.1073/pnas.0914114107; XU YH, 2010, J LIPID RES; Yu XB, 2008, CELL STEM CELL, V2, P461, DOI 10.1016/j.stem.2008.03.001; Zhang X, 2002, GENE DEV, V16, P2097, DOI 10.1101/gad.1007602; Zhou JX, 2009, P NATL ACAD SCI USA, V106, P7840, DOI 10.1073/pnas.0901854106; Zhu XY, 2005, J BIOL CHEM, V280, P12503, DOI 10.1074/jbc.M413631200	62	49	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22856	10.1371/journal.pone.0022856	http://dx.doi.org/10.1371/journal.pone.0022856			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829537	Green Published, gold, Green Submitted			2022-12-25	WOS:000293284600059
J	LoBue, V; Coan, JA; Thrasher, C; DeLoache, JS				LoBue, Vanessa; Coan, James A.; Thrasher, Cat; DeLoache, Judy S.			Prefrontal Asymmetry and Parent-Rated Temperament in Infants	PLOS ONE			English	Article							FRONTAL EEG ASYMMETRY; BRAIN ELECTRICAL-ACTIVITY; INDIVIDUAL-DIFFERENCES; SOCIAL-BEHAVIOR; AFFECTIVE STYLE; HEART-RATE; EMOTION; PATTERNS; ELECTROENCEPHALOGRAM; SEPARATION	Indicators of temperament appear early in infancy and remain relatively stable over time. Despite a great deal of interest in biological indices of temperament, most studies of infant temperament rely on parental reports or behavioral tasks. Thus, the extent to which commonly used temperament measures relate to potential biological indicators of infant temperament is still relatively unknown. The current experiment examines the relationship between a common parental report measure of temperament - the Infant Behavior Questionnaire - Revised (IBQ-R) - and measures of frontal EEG asymmetry in infants. We examined associations between the subscales of the IBQ-R and frontal EEG asymmetry scores recorded during a combined series of neutral attentional and putatively emotional recording conditions in infants between 7 and 9 months of age. We predicted that approach-related subscales of the IBQ-R (e. g., Approach, Soothability) would be related to greater left prefrontal asymmetry, while withdrawal-related subscales (e. g., Distress to Limitations, Fear, Falling Reactivity, Perceptual Sensitivity) would be related to greater right prefrontal asymmetry. In the mid- and lateral-frontal regions, Approach, Distress to Limitations, Fear, Soothability, and Perceptual Sensitivity were generally associated with greater left frontal activation (rs >=.23, ps<0.05), while only Falling Reactivity was associated with greater right frontal activation (rs <=-.44, ps<0.05). Results suggest that variability in frontal EEG asymmetry is robustly associated with parental report measures of temperament in infancy.	[LoBue, Vanessa] Rutgers State Univ, Dept Psychol, Newark, NJ 07102 USA; [Coan, James A.; Thrasher, Cat; DeLoache, Judy S.] Univ Virginia, Dept Psychol, Charlottesville, VA 22903 USA	Rutgers State University Newark; Rutgers State University New Brunswick; University of Virginia	LoBue, V (corresponding author), Rutgers State Univ, Dept Psychol, Newark, NJ 07102 USA.	vlobue@psychology.rutgers.edu						Aiken L.S., 1991, MULTIPLE REGRESSION; Allen JJB, 2004, BIOL PSYCHOL, V67, P183, DOI 10.1016/j.biopsycho.2004.03.007; Anderson NB, 1999, PSYCHOPHYSIOLOGY, V36, P1, DOI 10.1017/S0048577299972001; Banse R, 1996, J PERS SOC PSYCHOL, V70, P614, DOI 10.1037/0022-3514.70.3.614; Bates J.E., 1989, TEMPERAMENT CHILDHOO, P3; Berger H, 1932, ARCH PSYCHIAT NERVEN, V97, P6, DOI 10.1007/BF01815532; Cacioppo JT, 1999, CURR DIR PSYCHOL SCI, V8, P133, DOI 10.1111/1467-8721.00031; Carver CS, 2009, PSYCHOL BULL, V135, P183, DOI 10.1037/a0013965; Coan J. A., 2008, HDB ATTACHMENT THEOR, P241; Coan JA, 2004, BIOL PSYCHOL, V67, P7, DOI 10.1016/j.biopsycho.2004.03.002; Coan JA, 2006, BIOL PSYCHOL, V72, P198, DOI 10.1016/j.biopsycho.2005.10.003; COAN JA, 2008, CHILD PSYCHOPATHOLOG; Davidson Richard J., 1995, P361; DAVIDSON RJ, 1982, SCIENCE, V218, P1235, DOI 10.1126/science.7146906; DAVIDSON RJ, 1985, PSYCHOPHYSIOLOGY, V22, P353, DOI 10.1111/j.1469-8986.1985.tb01615.x; DAVIDSON RJ, 1989, J ABNORM PSYCHOL, V98, P127, DOI 10.1037/0021-843X.98.2.127; Davidson RJ, 2004, PHILOS T R SOC B, V359, P1395, DOI 10.1098/rstb.2004.1510; DAVIDSON RJ, 1992, PSYCHOL SCI, V3, P39, DOI 10.1111/j.1467-9280.1992.tb00254.x; Davidson RJ, 1998, COGNITION EMOTION, V12, P307, DOI 10.1080/026999398379628; de Haan M, 2004, J CHILD PSYCHOL PSYC, V45, P1209, DOI 10.1111/j.1469-7610.2004.00320.x; DeLoache J.S., 2011, ANIMALS AFFECT US EX, P85, DOI [10.1037/12301-004, DOI 10.1037/12301-004, https://doi.org/10.1037/12301-004]; DeLoache JS, 2009, DEVELOPMENTAL SCI, V12, P201, DOI 10.1111/j.1467-7687.2008.00753.x; Engels AS, 2007, PSYCHOPHYSIOLOGY, V44, P352, DOI 10.1111/j.1469-8986.2007.00518.x; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; Fox N A, 1994, Monogr Soc Res Child Dev, V59, P152, DOI 10.2307/1166143; Fox N. A., 1984, PSYCHOBIOLOGY AFFECT, P353; Fox NA, 1995, CHILD DEV, V66, P1770, DOI 10.2307/1131909; FOX NA, 1987, DEV PSYCHOL, V23, P233, DOI 10.1037/0012-1649.23.2.233; Fox NA, 2005, ANNU REV PSYCHOL, V56, P235, DOI 10.1146/annurev.psych.55.090902.141532; FOX NA, 1991, AM PSYCHOL, V46, P863, DOI 10.1037/0003-066X.46.8.863; FOX NA, 1986, NEUROPSYCHOLOGIA, V24, P417, DOI 10.1016/0028-3932(86)90028-X; Fox NA, 2001, DEV COGN NEUROSCI, P631; Fox NA, 1999, INFANT BEHAV DEV, V22, P445, DOI 10.1016/S0163-6383(00)00018-7; Gartstein MA, 2003, INFANT BEHAV DEV, V26, P64, DOI 10.1016/S0163-6383(02)00169-8; Gazzaniga M. S., 1998, MINDS; Hagemann D, 2004, BIOL PSYCHOL, V67, P157, DOI 10.1016/j.biopsycho.2004.03.006; Hane AA, 2008, DEV PSYCHOL, V44, P1491, DOI 10.1037/a0012855; Harmon-Jones E, 2004, BIOL PSYCHOL, V67, P51, DOI 10.1016/j.biopsycho.2004.03.003; Heller W, 1997, COGNITION EMOTION, V11, P637, DOI 10.1080/026999397379845a; Henderson HA, 2001, J AM ACAD CHILD PSY, V40, P68, DOI 10.1097/00004583-200101000-00018; Henderson HA, 2007, DEV REV, V27, P396, DOI 10.1016/j.dr.2007.06.004; Jackson DC, 2003, PSYCHOL SCI, V14, P612, DOI 10.1046/j.0956-7976.2003.psci_1473.x; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; LEWIS M, 2007, INTRO INFANT DEV; Light SN, 2009, DEV PSYCHOL, V45, P525, DOI 10.1037/a0014576; MARSHALL PJ, 2009, INFANT EEG EVENT REL; NELSON CA, 1986, CHILD DEV, V57, P1483, DOI 10.1111/j.1467-8624.1986.tb00473.x; Nitschke JB, 1999, PSYCHOPHYSIOLOGY, V36, P628, DOI 10.1017/S0048577299972013; PICKARD MB, BEASTS BABIES INFANT; PIVIK RT, 1993, PSYCHOPHYSIOLOGY, V30, P547, DOI 10.1111/j.1469-8986.1993.tb02081.x; Posner MI, 2007, ANNU REV PSYCHOL, V58, P1, DOI 10.1146/annurev.psych.58.110405.085516; Reid SA, 1998, PSYCHOPHYSIOLOGY, V35, P389, DOI 10.1111/1469-8986.3540389; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Rothbart M. K., 1991, EXPLORATIONS TEMPERA, P61, DOI DOI 10.1007/978-1-4899-0643-4_5; Rothbart M.K., 1981, ADV DEV PSYCHOL, V1, P37; Rothbart MK, 2007, CURR DIR PSYCHOL SCI, V16, P207, DOI 10.1111/j.1467-8721.2007.00505.x; ROTHBART MK, 1981, CHILD DEV, V52, P569, DOI 10.1111/j.1467-8624.1981.tb03082.x; ROTHBART MK, 2007, BLACKWELL HDB EARLY, P338; RUTTER M, 1987, AM J ORTHOPSYCHIAT, V57, P316, DOI 10.1111/j.1939-0025.1987.tb03541.x; Santesso DL, 2007, BRAIN COGNITION, V65, P14, DOI 10.1016/j.bandc.2007.02.008; Sbarra DA, 2008, PERS SOC PSYCHOL REV, V12, P141, DOI 10.1177/1088868308315702; SCHMIDT LA, 1994, BIOL PSYCHOL, V38, P183, DOI 10.1016/0301-0511(94)90038-8; Schmidt LA, 2008, PERS INDIV DIFFER, V44, P216, DOI 10.1016/j.paid.2007.08.001; Schmidt LA, 2009, PSYCHOL SCI, V20, P831, DOI 10.1111/j.1467-9280.2009.02374.x; STEFANSKY W, 1972, TECHNOMETRICS, V14, P469, DOI 10.2307/1267436; Stewart JL, 2011, J AFFECT DISORDERS, V129, P167, DOI 10.1016/j.jad.2010.08.029; Stroganova TA, 1999, CLIN NEUROPHYSIOL, V110, P997, DOI 10.1016/S1388-2457(98)00009-1; Thomas A., 1977, TEMPERAMENT DEV; TOMARKEN AJ, 1992, PSYCHOPHYSIOLOGY, V29, P576, DOI 10.1111/j.1469-8986.1992.tb02034.x; Towers DN, 2009, PSYCHOPHYSIOLOGY, V46, P132, DOI 10.1111/j.1469-8986.2008.00759.x; Wolford G, 2000, J NEUROSCI, V20, part. no.	71	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22694	10.1371/journal.pone.0022694	http://dx.doi.org/10.1371/journal.pone.0022694			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	799KC	21829482	Green Published, gold, Green Submitted			2022-12-25	WOS:000293284600027
J	Zenkert, C; Takahashi, T; Diesner, MO; Ozbek, S				Zenkert, Claudia; Takahashi, Toshio; Diesner, Mark-Oliver; Oezbek, Suat			Morphological and Molecular Analysis of the Nematostella vectensis Cnidom	PLOS ONE			English	Article							HYDRA NEMATOCYSTS; SEA-ANEMONE; MINICOLLAGEN; DISCHARGE; EVOLUTION; GENOME	The starlet sea anemone Nematostella vectensis is an emerging model organism for developmental and evolutionary biology. Due to the availability of genome data and its amenability to genetic manipulation Nematostella serves as a source for comparative molecular and phylogenetic studies. Despite this fact, the characterization of the nematocyst inventory and of nematocyst-specific genes is still fragmentary and sometimes misleading in this cnidarian species. Here, we present a thorough qualitative and quantitative analysis of nematocysts in Nematostella vectensis. In addition, we have cloned major nematocyst components, Nematostella minicollagens 1, 3 and 4, and show their expression patterns by in situ hybridization and immunocytochemistry using specific antibodies. Our data provides tools and insights for further studies on nematocyst morphogenesis in Nematostella and comparative evolution in cnidarians.	[Zenkert, Claudia; Diesner, Mark-Oliver; Oezbek, Suat] Univ Heidelberg, Dept Mol Evolut & Genom, Ctr Organismal Studies, Heidelberg, Germany; [Takahashi, Toshio] Suntory Fdn Life Sci, Bioorgan Res Inst, Osaka, Japan	Ruprecht Karls University Heidelberg; Suntory Holdings Ltd	Zenkert, C (corresponding author), Univ Heidelberg, Dept Mol Evolut & Genom, Ctr Organismal Studies, Heidelberg, Germany.	suat.oezbek@cos.uni-heidelberg.de	Özbek, Suat/D-3701-2014	Ozbek, Suat/0000-0003-2569-3942	German Science Foundation [OE416/4-1]	German Science Foundation(German Research Foundation (DFG))	This work was supported by the German Science Foundation (OE416/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk P, 2008, J MOL BIOL, V376, P1008, DOI 10.1016/j.jmb.2007.10.090; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; David CN, 2008, TRENDS GENET, V24, P431, DOI 10.1016/j.tig.2008.07.001; Fritzenwanker JH, 2002, DEV GENES EVOL, V212, P99, DOI 10.1007/s00427-002-0214-7; HOLSTEIN TW, 1994, SCIENCE, V265, P402, DOI 10.1126/science.265.5170.402; Kass-Simon G, 2002, CAN J ZOOL, V80, P1772, DOI 10.1139/Z02-135; Meier S, 2007, CURR BIOL, V17, P173, DOI 10.1016/j.cub.2006.10.063; Nuchter T, 2006, CURR BIOL, V16, pR316, DOI 10.1016/j.cub.2006.03.089; Ozbek S, 2009, TOXICON, V54, P1038, DOI 10.1016/j.toxicon.2009.03.006; Ozbek S, 2002, J BIOL CHEM, V277, P49200, DOI 10.1074/jbc.M209401200; OZBEK S, 2010, PROTOPLASMA, P1; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Renfer E, 2010, P NATL ACAD SCI USA, V107, P104, DOI 10.1073/pnas.0909148107; Steele RE, 2011, TRENDS GENET, V27, P7, DOI 10.1016/j.tig.2010.10.002; WEILL R, 1934, CONTRIBUTION ETUDE C, V1, P1; WEILL R., 1934, CONTRIBUTION ETUDE C, VII, P351; Wittlieb J, 2006, P NATL ACAD SCI USA, V103, P6208, DOI 10.1073/pnas.0510163103	17	54	55	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22725	10.1371/journal.pone.0022725	http://dx.doi.org/10.1371/journal.pone.0022725			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829492	Green Published, Green Submitted, gold			2022-12-25	WOS:000293284600032
J	Verberk, WCEP; Bilton, DT				Verberk, Wilco C. E. P.; Bilton, David T.			Can Oxygen Set Thermal Limits in an Insect and Drive Gigantism?	PLOS ONE			English	Article							TEMPERATURE-DEPENDENT BIOGEOGRAPHY; TERRESTRIAL ARTHROPODS; BODY-SIZE; TOLERANCE; LIMITATION; EVOLUTION; ANIMALS; PHYSIOLOGY; HYPOXIA; ECOLOGY	Background: Thermal limits may arise through a mismatch between oxygen supply and demand in a range of animal taxa. Whilst this oxygen limitation hypothesis is supported by data from a range of marine fish and invertebrates, its generality remains contentious. In particular, it is unclear whether oxygen limitation determines thermal extremes in tracheated arthropods, where oxygen limitation may be unlikely due to the efficiency and plasticity of tracheal systems in supplying oxygen directly to metabolically active tissues. Although terrestrial taxa with open tracheal systems may not be prone to oxygen limitation, species may be affected during other life-history stages, particularly if these rely on diffusion into closed tracheal systems. Furthermore, a central role for oxygen limitation in insects is envisaged within a parallel line of research focussing on insect gigantism in the late Palaeozoic. Methodology/Principal Findings: Here we examine thermal maxima in the aquatic life stages of an insect at normoxia, hypoxia (14 kPa) and hyperoxia (36 kPa). We demonstrate that upper thermal limits do indeed respond to external oxygen supply in the aquatic life stages of the stonefly Dinocras cephalotes, suggesting that the critical thermal limits of such aquatic larvae are set by oxygen limitation. This could result from impeded oxygen delivery, or limited oxygen regulatory capacity, both of which have implications for our understanding of the limits to insect body size and how these are influenced by atmospheric oxygen levels. Conclusions/Significance: These findings extend the generality of the hypothesis of oxygen limitation of thermal tolerance, suggest that oxygen constraints on body size may be stronger in aquatic environments, and that oxygen toxicity may have actively selected for gigantism in the aquatic stages of Carboniferous arthropods.	[Verberk, Wilco C. E. P.; Bilton, David T.] Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England	University of Plymouth	Verberk, WCEP (corresponding author), Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England.	wilco@aquaticecology.nl	Verberk, Wilco/E-6337-2011	Verberk, Wilco/0000-0002-0691-583X; Bilton, David/0000-0003-1136-0848	Netherlands Organisation for Scientific Research (NWO-RUBICON) [825.09.009]	Netherlands Organisation for Scientific Research (NWO-RUBICON)(Netherlands Organization for Scientific Research (NWO))	This study was funded by the Netherlands Organisation for Scientific Research (NWO-RUBICON fellowship no. 825.09.009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASTM, 1980, AM STAND TEST MAT, P279; Atkinson D, 2006, EVOL DEV, V8, P202, DOI 10.1111/j.1525-142X.2006.00090.x; Berner RA, 2007, SCIENCE, V316, P557, DOI 10.1126/science.1140273; Braddy SJ, 2008, BIOL LETTERS, V4, P106, DOI 10.1098/rsbl.2007.0491; Butterfield NJ, 2009, GEOBIOLOGY, V7, P1, DOI 10.1111/j.1472-4669.2009.00188.x; Calosi P, 2008, J BIOGEOGR, V35, P295, DOI 10.1111/j.1365-2699.2007.01787.x; Chapelle G, 1999, NATURE, V399, P114, DOI 10.1038/20099; Chapelle G, 2004, OIKOS, V106, P167, DOI 10.1111/j.0030-1299.2004.12934.x; Chown SL, 2001, J INSECT PHYSIOL, V47, P649, DOI 10.1016/S0022-1910(00)00163-3; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; FOX HM, 1955, PROC R SOC SER B-BIO, V143, P214, DOI 10.1098/rspb.1955.0006; Frederich M, 2000, AM J PHYSIOL-REG I, V279, pR1531, DOI 10.1152/ajpregu.2000.279.5.R1531; GRAHAM JB, 1995, NATURE, V375, P117, DOI 10.1038/375117a0; Grimaldi David, 2005, pi; Harrison J, 2006, RESP PHYSIOL NEUROBI, V154, P4, DOI 10.1016/j.resp.2006.02.008; Harrison JF, 2010, P ROY SOC B-BIOL SCI, V277, P1937, DOI 10.1098/rspb.2010.0001; Hetz SK, 2005, NATURE, V433, P516, DOI 10.1038/nature03106; Hoback WW, 2001, J INSECT PHYSIOL, V47, P533, DOI 10.1016/S0022-1910(00)00153-0; JONES JD, 1972, SPECIAL TOPICS BIOL; Kaiser A, 2007, P NATL ACAD SCI USA, V104, P13198, DOI 10.1073/pnas.0611544104; Klok CJ, 2009, J EVOLUTION BIOL, V22, P2496, DOI 10.1111/j.1420-9101.2009.01866.x; Klok CJ, 2010, J INSECT PHYSIOL, V56, P461, DOI 10.1016/j.jinsphys.2009.08.004; Klok CJ, 2004, J EXP BIOL, V207, P2361, DOI 10.1242/jeb.01023; KUKALOVAPECK J, 1983, CAN J ZOOL, V61, P1618, DOI 10.1139/z83-217; Lane N., 2002, OXYGEN MOL MADE WORL; Lighton JRB, 2007, J THERM BIOL, V32, P134, DOI 10.1016/j.jtherbio.2007.01.009; LOUDON C, 1989, J EXP BIOL, V147, P217; Marais E, 2009, J INSECT PHYSIOL, V55, P336, DOI 10.1016/j.jinsphys.2008.11.016; Nel AN, 2008, J IBER GEOL, V34, P115; Okajima R, 2008, LETHAIA, V41, P423, DOI 10.1111/j.1502-3931.2008.00094.x; Owerkowicz T, 2009, J EXP BIOL, V212, P1237, DOI 10.1242/jeb.023945; Peck LS, 2009, FUNCT ECOL, V23, P248, DOI 10.1111/j.1365-2435.2008.01537.x; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Portner HO, 2006, DEEP-SEA RES PT II, V53, P1071, DOI 10.1016/j.dsr2.2006.02.015; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Portner HO, 2001, NATURWISSENSCHAFTEN, V88, P137; Rudkin DM, 2003, J PALEONTOL, V77, P99, DOI 10.1017/S0022336000043456; SHEAR WA, 1990, CAN J ZOOL, V68, P1807, DOI 10.1139/z90-262; Socha JJ, 2008, J EXP BIOL, V211, P3409, DOI 10.1242/jeb.019877; Somero GN, 2004, COMP BIOCHEM PHYS B, V139, P321, DOI 10.1016/j.cbpc.2004.05.003; Stevens MM, 2010, J EXP BIOL, V213, P2209, DOI 10.1242/jeb.040170; Terblanche JS, 2007, P ROY SOC B-BIOL SCI, V274, P2935, DOI 10.1098/rspb.2007.0985; Van Voorhies WA, 2009, J EXP BIOL, V212, P3132, DOI 10.1242/jeb.031179; Verberk WCEP, 2011, ECOLOGY, V92, P1565, DOI 10.1890/10-2369.1; Westneat MW, 2003, SCIENCE, V299, P558, DOI 10.1126/science.1078008; Whitney RJ, 1939, J EXP BIOL, V16, P374; Wijnhoven S, 2003, AQUAT ECOL, V37, P151, DOI 10.1023/A:1023982200529; WINTERSTEIN H, 2005, NARKOSE Z ALLG PHYSL, V5, P323; Woods HA, 2009, P R SOC B, V276, P1069, DOI 10.1098/rspb.2008.1489; Woods HA, 2004, J EXP BIOL, V207, P2267, DOI 10.1242/jeb.00991; WOOTTON R J, 1972, Palaeontology (Oxford), V15, P662; WOOTTON RJ, 1988, PALAEOGEOGR PALAEOCL, V62, P477, DOI 10.1016/0031-0182(88)90068-5	52	81	82	2	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22610	10.1371/journal.pone.0022610	http://dx.doi.org/10.1371/journal.pone.0022610			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818347	gold, Green Published			2022-12-25	WOS:000293282700048
J	Szatanik, M; Hong, E; Ruckly, C; Ledroit, M; Giorgini, D; Jopek, K; Nicola, MA; Deghmane, AE; Taha, MK				Szatanik, Marek; Hong, Eva; Ruckly, Corinne; Ledroit, Morgan; Giorgini, Dario; Jopek, Katarzyna; Nicola, Marie-Anne; Deghmane, Ala-Eddine; Taha, Muhamed-Kheir			Experimental Meningococcal Sepsis in Congenic Transgenic Mice Expressing Human Transferrin	PLOS ONE			English	Article							NEISSERIA-MENINGITIDIS; EPITHELIAL-CELLS; UP-REGULATION; IRAK-M; EPIDEMIOLOGY; GONORRHOEAE; MONOCYTES; ADHESION; DISEASE; MODEL	Severe meningococcal sepsis is still of high morbidity and mortality. Its management may be improved by an experimental model allowing better understanding of its pathophysiology. We developed an animal model of meningococcal sepsis in transgenic BALB/c mice expressing human transferrin. We studied experimental meningococcal sepsis in congenic transgenic BALB/c mice expressing human transferrin by transcriptional profiling using microarray analysis of blood and brain samples. Genes encoding acute phase proteins, chemokines and cytokines constituted the largest strongly regulated groups. Dynamic bioluminescence imaging further showed high blood bacterial loads that were further enhanced after a primary viral infection by influenza A virus. Moreover, IL-1 receptor-associated kinase-3 (IRAK-3) was induced in infected mice. IRAK-3 is a negative regulator of Toll-dependant signaling and its induction may impair innate immunity and hence result in an immunocompromised state allowing bacterial survival and systemic spread during sepsis. This new approach should enable detailed analysis of the pathophysiology of meningococcal sepsis and its relationships with flu infection.	[Szatanik, Marek; Hong, Eva; Ruckly, Corinne; Ledroit, Morgan; Giorgini, Dario; Jopek, Katarzyna; Deghmane, Ala-Eddine; Taha, Muhamed-Kheir] Inst Pasteur, Unite Infect Bacterienne Invas, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Szatanik, M (corresponding author), Inst Pasteur, Unite Infect Bacterienne Invas, Paris, France.	mktaha@pasteur.fr	Deghmane, Ala-Eddine/CAF-2140-2022		Institut Pasteur	Institut Pasteur(European Commission)	The work was supported exclusively by the Institut Pasteur with no external funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alonso JM, 2003, FEMS MICROBIOL LETT, V222, P99, DOI 10.1016/S0378-1097(03)00252-0; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Brun-Buisson C, 2004, INTENS CARE MED, V30, P580, DOI 10.1007/s00134-003-2121-4; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Deghmane AE, 2010, J INFECT DIS, V202, P247, DOI 10.1086/653583; Deghmane AE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000405; Deng JC, 2006, J CLIN INVEST, V116, P2532, DOI 10.1172/JCI28054; Escoll P, 2003, BIOCHEM BIOPH RES CO, V311, P465, DOI 10.1016/j.bbrc.2003.10.019; Granoff DM, 2009, INFECT IMMUN, V77, P764, DOI 10.1128/IAI.01191-08; Grassme H, 2001, APOPTOSIS, V6, P441, DOI 10.1023/A:1012485506972; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; HUBERT B, 1992, J INFECT DIS, V166, P542, DOI 10.1093/infdis/166.3.542; Johansson L, 2003, SCIENCE, V301, P373, DOI 10.1126/science.1086476; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Lee SMY, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-147; Li PF, 2010, J BIOL CHEM, V285, P22713, DOI 10.1074/jbc.M110.105692; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Marques F, 2008, J CEREBR BLOOD F MET, V28, P450, DOI 10.1038/sj.jcbfm.9600557; MUNOZ C, 1991, J CLIN INVEST, V88, P1747, DOI 10.1172/JCI115493; Rameix-Welti MA, 2009, INFECT IMMUN, V77, P3588, DOI 10.1128/IAI.00155-09; Reigstad CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005842; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Schneider MC, 2007, TRENDS MICROBIOL, V15, P233, DOI 10.1016/j.tim.2007.03.005; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; Schuerholz T, 2008, Minerva Anestesiol, V74, P181; Seki M, 2004, CLIN EXP IMMUNOL, V137, P35, DOI 10.1111/j.1365-2249.2004.02481.x; TAHA MK, 1988, EMBO J, V7, P4367, DOI 10.1002/j.1460-2075.1988.tb03335.x; Taha MK, 1998, MOL MICROBIOL, V28, P1153, DOI 10.1046/j.1365-2958.1998.00876.x; Takeda K, 2004, J DERMATOL SCI, V34, P73, DOI 10.1016/j.jdermsci.2003.10.002; van Deuren M, 2000, CLIN MICROBIOL REV, V13, P144, DOI 10.1128/CMR.13.1.144-166.2000; Zarantonelli ML, 2007, INFECT IMMUN, V75, P5609, DOI 10.1128/IAI.00781-07	34	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22210	10.1371/journal.pone.0022210	http://dx.doi.org/10.1371/journal.pone.0022210			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811575	Green Published, Green Submitted, gold			2022-12-25	WOS:000292956800031
J	van Manen, D; Delaneau, O; Kootstra, NA; Boeser-Nunnink, BD; Limou, S; Bol, SM; Burger, JA; Zwinderman, AH; Moerland, PD; van't Slot, R; Zagury, JF; van't Wout, AB; Schuitemaker, H				van Manen, Danielle; Delaneau, Olivier; Kootstra, Neeltje A.; Boeser-Nunnink, Brigitte D.; Limou, Sophie; Bol, Sebastiaan M.; Burger, Judith A.; Zwinderman, Aeilko H.; Moerland, Perry D.; van't Slot, Ruben; Zagury, Jean-Francois; van't Wout, Angelique B.; Schuitemaker, Hanneke			Genome-Wide Association Scan in HIV-1-Infected Individuals Identifying Variants Influencing Disease Course	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PLASMA HIV-RNA; CLINICAL-COURSE; PREDICTIVE-VALUE; CELL COUNT; HLA-C; AIDS; PROGRESSION; DETERMINANTS; RESTRICTION	Background: AIDS develops typically after 7-11 years of untreated HIV-1 infection, with extremes of very rapid disease progression (<2 years) and long-term non-progression (>15 years). To reveal additional host genetic factors that may impact on the clinical course of HIV-1 infection, we designed a genome-wide association study (GWAS) in 404 participants of the Amsterdam Cohort Studies on HIV-1 infection and AIDS. Methods: The association of SNP genotypes with the clinical course of HIV-1 infection was tested in Cox regression survival analyses using AIDS-diagnosis and AIDS-related death as endpoints. Results: Multiple, not previously identified SNPs, were identified to be strongly associated with disease progression after HIV-1 infection, albeit not genome-wide significant. However, three independent SNPs in the top ten associations between SNP genotypes and time between seroconversion and AIDS-diagnosis, and one from the top ten associations between SNP genotypes and time between seroconversion and AIDS-related death, had P-values smaller than 0.05 in the French Genomics of Resistance to Immunodeficiency Virus cohort on disease progression. Conclusions: Our study emphasizes that the use of different phenotypes in GWAS may be useful to unravel the full spectrum of host genetic factors that may be associated with the clinical course of HIV-1 infection.	[van Manen, Danielle; Kootstra, Neeltje A.; Boeser-Nunnink, Brigitte D.; Bol, Sebastiaan M.; Burger, Judith A.; van't Wout, Angelique B.; Schuitemaker, Hanneke] Univ Amsterdam, Landsteiner Lab, Dept Expt Immunol, Amsterdam, Netherlands; [van Manen, Danielle; Kootstra, Neeltje A.; Boeser-Nunnink, Brigitte D.; Bol, Sebastiaan M.; Burger, Judith A.; van't Wout, Angelique B.; Schuitemaker, Hanneke] Univ Amsterdam, Acad Med Ctr, Ctr Infect Dis & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Delaneau, Olivier; Limou, Sophie; Zagury, Jean-Francois] Conservatoire Natl Arts & Metiers, Chaire Bioinformat, Paris, France; [Delaneau, Olivier; Limou, Sophie; Zagury, Jean-Francois] ANRS Genom Grp, Paris, France; [Zwinderman, Aeilko H.; Moerland, Perry D.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Moerland, Perry D.] NBIC, Nijmegen, Netherlands; [van't Slot, Ruben] Univ Med Ctr, Dept Biomed Genet, Complex Genet Sect, Utrecht, Netherlands	University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; heSam Universite; Conservatoire National Arts & Metiers (CNAM); University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center	van Manen, D (corresponding author), Univ Amsterdam, Landsteiner Lab, Dept Expt Immunol, Amsterdam, Netherlands.	h.schuitemaker@amc.uva.nl	Moerland, Perry/AAG-1425-2020; /AAR-2792-2021; Limou, Sophie/AHD-3272-2022	Moerland, Perry/0000-0002-2357-3659; Limou, Sophie/0000-0002-7702-8234; Kootstra, Neeltje A./0000-0001-9429-7754; Delaneau, Olivier/0000-0002-3906-8446; Bol, Sebastiaan/0000-0002-3843-6657	Netherlands Organization for Scientific Research [9120.6046]; Center for Infectious Disease Control of the Netherlands National Institute for Public Health and the Environment	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Center for Infectious Disease Control of the Netherlands National Institute for Public Health and the Environment	The authors acknowledge funding from the Netherlands Organization for Scientific Research (TOP, registration number 9120.6046). The Amsterdam Cohort Studies on HIV infection and AIDS are financially supported by the Center for Infectious Disease Control of the Netherlands National Institute for Public Health and the Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Catano G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003636; CDC, 1993, MMWR-MORBID MORTAL W, V41, P1; Dalmasso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003907; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; DEWOLF F, 1988, J INFECT DIS, V158, P615, DOI 10.1093/infdis/158.3.615; deWolf F, 1997, AIDS, V11, P1799, DOI 10.1097/00002030-199715000-00003; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Gao XJ, 2005, NAT MED, V11, P1290, DOI 10.1038/nm1333; Ge DL, 2008, GENOME RES, V18, P640, DOI 10.1101/gr.071571.107; Geskus RB, 2000, STAT MED, V19, P1753, DOI 10.1002/1097-0258(20000715)19:13&lt;1753::AID-SIM487&gt;3.0.CO;2-F; He JCJ, 2004, J CLIN INVEST, V114, P643, DOI 10.1172/JCI200421004; Herbeck JT, 2010, J INFECT DIS, V201, P618, DOI 10.1086/649842; Husman AMD, 1997, ANN INTERN MED, V127, P882, DOI 10.7326/0003-4819-127-10-199711150-00004; Ioannidis JPA, 2001, ANN INTERN MED, V135, P782, DOI 10.7326/0003-4819-135-9-200111060-00008; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; KLEIN MR, 1995, TRENDS MICROBIOL, V3, P386, DOI 10.1016/S0966-842X(00)88984-2; Kwa D, 2003, AIDS, V17, P981, DOI 10.1097/00002030-200305020-00006; Le Clerc S, 2009, J INFECT DIS, V200, P1194, DOI 10.1086/605892; Limou S, 2009, J INFECT DIS, V199, P419, DOI 10.1086/596067; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Loeuillet C, 2008, PLOS BIOL, V6, P319, DOI 10.1371/journal.pbio.0060032; Mellors JW, 2007, JAMA-J AM MED ASSOC, V297, P2349, DOI 10.1001/jama.297.21.2349; MELLORS JW, 1995, ANN INTERN MED, V122, P573, DOI 10.7326/0003-4819-122-8-199504150-00003; Meyer L, 1999, AIDS, V13, P624, DOI 10.1097/00002030-199904010-00015; Michael NL, 1997, LANCET, V350, P741, DOI 10.1016/S0140-6736(05)63552-0; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Navis M, 2007, J IMMUNOL, V179, P3133, DOI 10.4049/jimmunol.179.5.3133; O'Brien SJ, 2004, NAT GENET, V36, P565, DOI 10.1038/ng1369; Pelak K, 2010, J INFECT DIS, V201, P1141, DOI 10.1086/651382; Rodriguez B, 2006, JAMA-J AM MED ASSOC, V296, P1498, DOI 10.1001/jama.296.12.1498; Schellens IM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-S3-O41; Spijkerman IJB, 1997, AIDS, V11, P1383, DOI 10.1097/00002030-199711000-00013; Steemers Frank J., 2007, Biotechnology Journal, V2, P41, DOI 10.1002/biot.200600213; Troyer JL, 2011, J INFECT DIS, V203, P1491, DOI 10.1093/infdis/jir046; van Manen D, 2009, AIDS, V23, P19, DOI 10.1097/QAD.0b013e32831db247; van Rij RP, 1998, J INFECT DIS, V178, P1806, DOI 10.1086/314522; van Rij RP, 1998, AIDS, V12, pF85, DOI 10.1097/00002030-199809000-00001; VANGRIENSVEN GJP, 1989, BMJ-BRIT MED J, V298, P218, DOI 10.1136/bmj.298.6668.218; vanHaastrecht HJA, 1996, AM J EPIDEMIOL, V143, P380; VEUGELERS PJ, 1994, AM J EPIDEMIOL, V140, P747, DOI 10.1093/oxfordjournals.aje.a117322	44	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22208	10.1371/journal.pone.0022208	http://dx.doi.org/10.1371/journal.pone.0022208			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811574	Green Published, gold, Green Submitted			2022-12-25	WOS:000292956800030
J	Xu, Y; Zhao, F; Wang, Z; Song, Y; Luo, Y; Zhang, X; Jiang, L; Sun, Z; Miao, Z; Xu, H				Xu, Y.; Zhao, F.; Wang, Z.; Song, Y.; Luo, Y.; Zhang, X.; Jiang, L.; Sun, Z.; Miao, Z.; Xu, H.			MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1	ONCOGENE			English	Article						MicroRNA; gastric cancer; miR-335; SP1; Bcl-w	TRANSCRIPTION FACTOR SP1; SINGLE NUCLEOTIDE POLYMORPHISM; DOWN-REGULATION; TUMOR-SUPPRESSOR; EXPRESSION; GENE; FAMILY; RISK; PROLIFERATION; APOPTOSIS	Aberrant expression of miR-335 has been frequently reported in cancer studies, suggesting that there is a close correlation between miR-335 and cancer during its development, progression, metastasis and prognosis. The expression of miR-335 in gastric cancer and its effects are not known. Relative expression of miR-335 in 4 gastric cancer cell lines and in 70 gastric cancer tissues was confirmed by real-time quantitative reverse transcriptase-PCR compared with controls. Transwell cell migration and Matrigel invasion assay in vitro and metastasis formation assay in vivo were used to examine the effects of miR-335 expression on gastric cancer cell invasion and metastasis. The effect of miR-335 expression on gastric cancer cell proliferation was estimated by the 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide assay. Luciferase reporter assay and western blot were used to examine the potential target genes and related pathways. Gene silencing with small-interfering RNA was used to examine the effects of target genes on gastric cancer cell invasion. miR-335 was dramatically down-regulated in gastric cancer cell lines than in the normal gastric cell line GES-1. Low expression of miR-335 was significantly associated with lymph-node metastasis, poor pT stage, poor pN stage and invasion of lymphatic vessels. Overexpression of miR-335 suppressed gastric cancer cell invasion and metastasis in vitro and in vivo, but has no significant effects on cell proliferation. Furthermore, miR-335 might suppress gastric cancer invasion and metastasis by targeting Bcl-w and specificity protein 1 (SP1). Taken together, our results provide evidence that miR-335 might function as a metastasis suppressor in gastric cancer by targeting SP1 directly and indirectly through the Bcl-w-induced phosphoinositide 3-kinase-Akt-Sp1 pathway. miR-335 showing altered expression at different stages of gastric cancer could be a target for gastric cancer therapies and could be further developed as a potential prognostic factor. Oncogene (2012) 31, 1398-1407; doi:10.1038/onc.2011.340; published online 8 August 2011	[Xu, Y.; Zhao, F.; Wang, Z.; Song, Y.; Sun, Z.; Miao, Z.; Xu, H.] China Med Univ, Dept Surg Oncol & Gen Surg, Hosp 1, Shenyang 110001, Peoples R China; [Xu, Y.] China Med Univ, Dept Breast Surg, Hosp 1, Shenyang 110001, Peoples R China; [Luo, Y.; Zhang, X.; Jiang, L.] China Med Univ, Res Ctr Med Genom, Shenyang 110001, Peoples R China; [Luo, Y.; Zhang, X.; Jiang, L.] China Med Univ, MOH Key Lab Cell Biol, Shenyang 110001, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University	Xu, H (corresponding author), China Med Univ, Dept Surg Oncol & Gen Surg, Hosp 1, 155 N Nanjing St, Shenyang 110001, Peoples R China.	huimianxu@yahoo.cn	wang, zhen ning/E-1878-2011; Gao, Peng/B-8031-2013; Xu, Yingying/E-3884-2018	wang, zhen ning/0000-0003-0557-3097; Xu, Yingying/0000-0003-4924-9379	National Science Foundation of China [81000943, 30873043]; Scientific Research Foundation for Doctors of Liaoning Province [20101146]; Key Laboratory Programme of Education Department of Liaoning Province [LS2010165]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for Doctors of Liaoning Province; Key Laboratory Programme of Education Department of Liaoning Province	We thank the Department of Surgical Oncology of the First Hospital of China Medical University for providing human gastric tissue samples. We also thank the College of China Medical University for technical assistance in experiments. This work was supported by the National Science Foundation of China (no. 81000943 and no. 30873043), the Scientific Research Foundation for Doctors of Liaoning Province (no. 20101146) and the Key Laboratory Programme of Education Department of Liaoning Province (LS2010165).	Antonsson B, 2001, CELL TISSUE RES, V306, P347, DOI 10.1007/s00441-001-0472-0; Bae IH, 2006, CANCER RES, V66, P4991, DOI 10.1158/0008-5472.CAN-05-4254; Bae IH, 2009, CANCER LETT, V277, P22, DOI 10.1016/j.canlet.2008.11.022; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chen Y, 2010, J GASTROINTEST SURG, V14, P1170, DOI 10.1007/s11605-010-1202-2; Chiang YP, 2011, J GASTROINTEST SURG, V15, P63, DOI 10.1007/s11605-010-1367-8; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Du Y, 2009, J GASTROENTEROL, V44, P556, DOI 10.1007/s00535-009-0037-7; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Jiang CG, 2010, J SURG ONCOL, V102, P737, DOI 10.1002/jso.21678; Kanai M, 2006, CLIN CANCER RES, V12, P6395, DOI 10.1158/1078-0432.CCR-06-1034; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Kuo LY, 2006, J CELL PHYSIOL, V207, P729, DOI 10.1002/jcp.20616; Lee HW, 2003, CANCER RES, V63, P1093; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lou Z, 2005, CANCER RES, V65, P1007; Marcucci G, 2008, J CLIN ONCOL, V26, P5078, DOI 10.1200/JCO.2008.17.5554; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Qin HW, 1999, J BIOL CHEM, V274, P29130, DOI 10.1074/jbc.274.41.29130; Ronchetti D, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-37; Song YX, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-1; Soon PSH, 2009, CLIN CANCER RES, V15, P7684, DOI 10.1158/1078-0432.CCR-09-1587; Sorrentino A, 2008, GYNECOL ONCOL, V111, P478, DOI 10.1016/j.ygyno.2008.08.017; Sun Z, 2010, ANN SURG ONCOL, V17, P1278, DOI 10.1245/s10434-009-0890-x; Sun Z, 2009, ANN SURG ONCOL, V16, P3028, DOI 10.1245/s10434-009-0624-0; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Uren RT, 2007, J CELL BIOL, V177, P277, DOI 10.1083/jcb.200606065; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wada R, 2010, INT J CANCER, V127, P1106, DOI 10.1002/ijc.25126; Wang FJ, 2010, GYNECOL ONCOL, V119, P586, DOI 10.1016/j.ygyno.2010.07.021; Wang LW, 2003, CLIN CANCER RES, V9, P6371; Wang LW, 2005, CLIN EXP METASTAS, V22, P205, DOI 10.1007/s10585-005-5684-3; Wang YX, 2010, J DIGEST DIS, V11, P50, DOI 10.1111/j.1751-2980.2009.00413.x; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Wu Q, 2010, BIOCHEM BIOPH RES CO, V392, P340, DOI 10.1016/j.bbrc.2009.12.182; Xu YY, 2007, WORLD J GASTROENTERO, V13, P5133, DOI 10.3748/wjg.v13.i38.5133; Yao JC, 2004, CLIN CANCER RES, V10, P4109, DOI 10.1158/1078-0432.CCR-03-0628; Yao MZ, 2005, J NEUROSCI, V25, P1149, DOI 10.1523/JNEUROSCI.4736-04.2005; Yu CY, 2002, CANCER RES, V62, P6430; Zhang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007826	49	163	175	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2012	31	11					1398	1407		10.1038/onc.2011.340	http://dx.doi.org/10.1038/onc.2011.340			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	912FL	21822301	Green Published, hybrid			2022-12-25	WOS:000301780000007
J	Tong, M; Arora, K; White, MM; Nichols, RA				Tong, Mei; Arora, Komal; White, Michael M.; Nichols, Robert A.			Role of Key Aromatic Residues in the Ligand-binding Domain of alpha 7 Nicotinic Receptors in the Agonist Action of beta-Amyloid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLIOMA HYBRID-CELLS; ALZHEIMERS-DISEASE; ACETYLCHOLINE-RECEPTOR; NEUROBLASTOMA-CELLS; SYNAPTIC PLASTICITY; IN-VIVO; EXTRACELLULAR DOMAIN; HIPPOCAMPAL SLICE; CRYSTAL-STRUCTURE; ENDOGENOUS TAU	Soluble beta-amyloid (A beta) resides in certain regions of the brain at or near picomolar concentration, rising in level during the prodromic stage of Alzheimer disease. Recently, we identified the homomeric alpha 7 nicotinic acetylcholine receptor (alpha 7-nAChR) as one possible functional target for picomolar A beta. This study was aimed at addressing which residues in alpha 7-nAChRs potentially interact with A beta to regulate the presynaptic function of this receptor. Site-directed mutagenesis was carried out to study the key aromatic residues in the mouse alpha 7-nAChR agonist-binding pocket. Mutations of tyrosine188 resulted in a decrease in activation of presynaptic alpha 7-nAChRs by ACh and A beta but with no change in response to nicotine, indicating the critical role of Tyr-188 in presynaptic regulation by A beta. Coimmunoprecipitation additionally revealed direct binding of A beta to alpha 7-nAChRs and to the Tyr-188 mutant receptor. In contrast, mutations of Tyr-195 in alpha 7-nAChR led to decreased activation by nicotine without apparent effects on ACh- or A beta-induced responses. Agonist-induced responses of Tyr-93 mutant alpha 7-nAChRs indicated possible interactions of nicotine and A beta with its hydroxyl group, but there was no change in presynaptic responses after mutation of Trp-149. All of the mutants were shown to be expressed on the plasma membrane using cell surface labeling. Together, these results directly demonstrate an essential role for the aromatic residue Tyr-188 as a key component in the agonist binding domain for the activation of alpha 7-nAChRs by A beta	[Tong, Mei; Arora, Komal; Nichols, Robert A.] Univ Hawaii Manoa, Dept Cell & Mol Biol, Honolulu, HI 96813 USA; [Tong, Mei] Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19102 USA; [White, Michael M.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA	University of Hawaii System; University of Hawaii Manoa; Drexel University; Drexel University	Nichols, RA (corresponding author), Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, 651 Ilalo St, Honolulu, HI 96813 USA.	robert.nichols@hawaii.edu			American Health Assistance Foundation; The Hawaii Community Foundation; National Institute on Aging [AG21586]; National Center for Research Resources of the National Institutes of Health via Research Centers in Minority Institutions [G12 RR003061]; Centers of Biomedical Research Excellence [P20 RR016453]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003061, P20RR016453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021586] Funding Source: NIH RePORTER	American Health Assistance Foundation(BrightFocus Foundation); The Hawaii Community Foundation; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Research Resources of the National Institutes of Health via Research Centers in Minority Institutions; Centers of Biomedical Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by grants from the American Health Assistance Foundation, The Hawaii Community Foundation, and the National Institute on Aging Grant AG21586. Support for the confocal microscopy core at the University of Hawaii was provided by the National Center for Research Resources of the National Institutes of Health via Research Centers in Minority Institutions Grant G12 RR003061 and Centers of Biomedical Research Excellence Grant P20 RR016453.	Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; AYLWIN ML, 1994, FEBS LETT, V349, P99, DOI 10.1016/0014-5793(94)00649-0; Barrantes FJ, 2004, BRAIN RES REV, V47, P71, DOI 10.1016/j.brainresrev.2004.06.008; Randall JB, 2006, NAT MED, V12, P856, DOI 10.1038/nm1438; Bell KA, 2004, J NEUROCHEM, V91, P349, DOI 10.1111/j.1471-4159.2004.02722.x; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Dineley KT, 2001, J NEUROSCI, V21, P4125, DOI 10.1523/JNEUROSCI.21-12-04125.2001; Dougherty DA, 2001, NATURE, V411, P252, DOI 10.1038/35077192; Dougherty JJ, 2003, J NEUROSCI, V23, P6740; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; GALZI JL, 1991, FEBS LETT, V294, P198, DOI 10.1016/0014-5793(91)80668-S; Gay EA, 2007, J PHYSIOL-LONDON, V584, P727, DOI 10.1113/jphysiol.2007.142554; Gee VJ, 2007, BRIT J PHARMACOL, V152, P501, DOI 10.1038/sj.bjp.0707429; Grandori R, 1997, PROTEIN ENG, V10, P1099, DOI 10.1093/protein/10.9.1099; HAN HQ, 1991, NATURE, V349, P697, DOI 10.1038/349697a0; Kenney JW, 2008, MOL NEUROBIOL, V38, P101, DOI 10.1007/s12035-008-8037-9; Khan GM, 2010, EUR J NEUROSCI, V31, P788, DOI 10.1111/j.1460-9568.2010.07116.x; Lazarov O, 2002, J NEUROSCI, V22, P9785; Liu QS, 2001, P NATL ACAD SCI USA, V98, P4734, DOI 10.1073/pnas.081553598; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; MCGEE R, 1978, P NATL ACAD SCI USA, V75, P1314, DOI 10.1073/pnas.75.3.1314; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Mehta TK, 2009, J NEUROCHEM, V109, P1452, DOI 10.1111/j.1471-4159.2009.06070.x; NELSON P, 1976, P NATL ACAD SCI USA, V73, P123, DOI 10.1073/pnas.73.1.123; OLEARY ME, 1992, J BIOL CHEM, V267, P8360; Pettit DL, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-01-j0003.2001; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Ronde P, 2001, NEUROSCIENCE, V102, P979, DOI 10.1016/S0306-4522(00)00512-1; Ronde P, 2000, J PHYSIOL-LONDON, V529, P307, DOI 10.1111/j.1469-7793.2000.00307.x; Sandberg A, 2010, P NATL ACAD SCI USA, V107, P15595, DOI 10.1073/pnas.1001740107; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Sharma G, 2003, NEURON, V38, P929, DOI 10.1016/S0896-6273(03)00322-2; Sheng JG, 2002, J NEUROSCI, V22, P9794; Small DH, 2007, J NEUROCHEM, V101, P1527, DOI 10.1111/j.1471-4159.2006.04444.x; Spier AD, 1999, MOL BRAIN RES, V67, P221; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang HY, 2009, J NEUROSCI, V29, P10961, DOI 10.1523/JNEUROSCI.6088-08.2009; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; Wang HY, 2000, J NEUROCHEM, V75, P1155, DOI 10.1046/j.1471-4159.2000.0751155.x; Wu G, 1998, J NEUROCYTOL, V27, P1, DOI 10.1023/A:1006910001869; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010	45	35	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34373	34381		10.1074/jbc.M111.241299	http://dx.doi.org/10.1074/jbc.M111.241299			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21828053	Green Published, hybrid			2022-12-25	WOS:000295159200065
J	Hwang, HI; Ji, JH; Jang, YJ				Hwang, Hyo-In; Ji, Jae-Hoon; Jang, Young-Joo			Phosphorylation of Ran-binding Protein-1 by Polo-like Kinase-1 Is Required for Interaction with Ran and Early Mitotic Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; MAMMALIAN-CELLS; SPINDLE; MITOSIS; GTPASE; PLK1; AMPLIFICATION; CHROMOSOMES; CENTROSOME; DOMAIN	Polo-like kinase-1 (Plk1) is essential for progression of mitosis and localizes to centrosomes, central spindles, midbody, and kinetochore. Ran, a small GTPase of the Ras superfamily, plays a role in microtubule dynamics and chromosome segregation during mitosis. Although Ran-binding protein-1 (RanBP1) has been reported as a regulator of RanGTPase for its mitotic functions, the action mechanism between Ran and RanBP1 during mitosis is still unknown. Here, we demonstrated in vitro and in vivo phosphorylation of RanBP1 by Plk1 as well as the importance of phosphorylation of RanBP1 in the interaction between Plk1 and Ran during early mitosis. Both phosphorylation-defective and N-terminal deletion mutant constructs of RanBP1 disrupted the interaction with Ran, and depletion of Plk1 also disrupted the formation of a complex between Ran and RanBP1. In addition, the results from both ectopic expression of phosphorylation-defective mutant construct and a functional complementation on RanBP1 deficiency with this mutant indicated that phosphorylation of RanBP1 by Plk1 might be crucial to microtubule nucleation and spindle assembly during mitosis.	[Jang, Young-Joo] Dankook Univ, Lab Cell Cycle & Signal Transduct, World Class Univ Res Dept Nanobiomed Sci, Cheonan 330714, South Korea; Dankook Univ, Inst Tissue Regenerat Engn, Cheonan 330714, South Korea	Dankook University; Dankook University	Jang, YJ (corresponding author), Dankook Univ, Lab Cell Cycle & Signal Transduct, World Class Univ Res Dept Nanobiomed Sci, 29 Anseo Dong, Cheonan 330714, South Korea.	jameschi@paran.com; yjjang@dankook.ac.kr			National Research Foundation of Korea [R31-10069]; Ministry of Education, Science, and Technology [2009-0093829]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by National Research Foundation of Korea Grant R31-10069 (World Class University program) and Grant 2009-0093829 (Priority Research Centers Program) funded by the Ministry of Education, Science, and Technology.	Abrieu A, 1998, J CELL SCI, V111, P1751; Arnaoutov A, 2005, CELL CYCLE, V4, P1161, DOI 10.4161/cc.4.9.1979; Arnaoutov A, 2003, DEV CELL, V5, P99, DOI 10.1016/S1534-5807(03)00194-1; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bin OY, 1997, J BIOL CHEM, V272, P28646, DOI 10.1074/jbc.272.45.28646; BISCHOFF FR, 1995, P NATL ACAD SCI USA, V92, P1749, DOI 10.1073/pnas.92.5.1749; BISCHOFF FR, 1995, EMBO J, V14, P705, DOI 10.1002/j.1460-2075.1995.tb07049.x; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; Dasso M, 2002, CURR BIOL, V12, pR502, DOI 10.1016/S0960-9822(02)00970-3; Di Fiore B, 2003, J CELL SCI, V116, P3399, DOI 10.1242/jcs.00624; DIMATTEO G, 1995, CELL GROWTH DIFFER, V6, P1213; Donaldson MM, 2001, J CELL SCI, V114, P2357; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; Guarguaglini G, 2000, CELL GROWTH DIFFER, V11, P455; Hutchins JRA, 2004, CURR BIOL, V14, P1099, DOI 10.1016/j.cub.2004.05.021; Jang YJ, 2002, J BIOL CHEM, V277, P44115, DOI 10.1074/jbc.M202172200; Jang YJ, 2002, P NATL ACAD SCI USA, V99, P1984, DOI 10.1073/pnas.042689299; Ji JH, 2006, J BIOCHEM MOL BIOL, V39, P709; Joseph J, 2002, J CELL BIOL, V156, P595, DOI 10.1083/jcb.200110109; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Karaiskou A, 1999, J CELL SCI, V112, P3747; Keryer G, 2003, MOL BIOL CELL, V14, P4260, DOI 10.1091/mbc.E02-11-0773; Kumagai A, 1996, SCIENCE, V273, P1377, DOI 10.1126/science.273.5280.1377; Lane HA, 1997, TRENDS CELL BIOL, V7, P63, DOI 10.1016/S0962-8924(96)10051-9; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Lee KS, 1997, MOL CELL BIOL, V17, P3408, DOI 10.1128/MCB.17.6.3408; Li HY, 2007, CELL CYCLE, V6, P1886, DOI 10.4161/cc.6.15.4487; Li HY, 2004, GENE DEV, V18, P512, DOI 10.1101/gad.1177304; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; Moore WJ, 2002, CURR BIOL, V12, P1442, DOI 10.1016/S0960-9822(02)01076-X; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; OHKURA H, 1995, GENE DEV, V9, P1059, DOI 10.1101/gad.9.9.1059; Peloponese JM, 2005, P NATL ACAD SCI USA, V102, P18974, DOI 10.1073/pnas.0506659103; Qian YW, 1998, MOL CELL BIOL, V18, P4262, DOI 10.1128/MCB.18.7.4262; Quimby BB, 2003, CURR OPIN CELL BIOL, V15, P338, DOI 10.1016/S0955-0674(03)00046-2; Seong YS, 2002, J BIOL CHEM, V277, P32282, DOI 10.1074/jbc.M202602200; SUNKEL CE, 1988, J CELL SCI, V89, P25; Swaminathan S, 2004, J CELL BIOL, V164, P965, DOI 10.1083/jcb.200309126; Tedeschi A, 2007, J CELL SCI, V120, P3748, DOI 10.1242/jcs.009308; Toyoshima-Morimoto F, 2001, NATURE, V410, P215, DOI 10.1038/35065617; Uchiumi T, 1997, J BIOL CHEM, V272, P9166; Yoon SO, 2008, MOL CELL, V29, P362, DOI 10.1016/j.molcel.2007.12.024	44	6	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33012	33020		10.1074/jbc.M111.255620	http://dx.doi.org/10.1074/jbc.M111.255620			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21813642	Green Published, hybrid			2022-12-25	WOS:000294968800019
J	Shibayama, N; Sugiyama, K; Park, SY				Shibayama, Naoya; Sugiyama, Kanako; Park, Sam-Yong			Structures and Oxygen Affinities of Crystalline Human Hemoglobin C (beta 6 Glu -> Lys) in the R and R2 Quaternary Structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CARBONMONOXY-HEMOGLOBIN; ALLOSTERIC REGULATION; X-RAY; BINDING; STATE; DEOXYHEMOGLOBIN; METHEMOGLOBIN; CONSTANTS; SUBUNITS; MUTATION	Recent crystallographic studies suggested that fully liganded human hemoglobin can adopt multiple quaternary conformations that include the two previously solved relaxed conformations, R and R2, whereas fully unliganded deoxyhemoglobin may adopt only one T (tense) quaternary conformation. An important unanswered question is whether R, R2, and other relaxed quaternary conformations represent different physiological states with different oxygen affinities. Here, we answer this question by showing the oxygen equilibrium curves of single crystals of human hemoglobin in the R and R2 state. In this study, we have used a naturally occurring mutant hemoglobin C (beta 6 Glu -> Lys) to stabilize the R and R2 crystals. Additionally, we have refined the x-ray crystal structure of carbonmonoxyhemoglobin C, in the R and R2 state, to 1.4 and 1.8 angstrom resolution, respectively, to compare precisely the structures of both types of relaxed states. Despite the large quaternary structural difference between the R and R2 state, both crystals exhibit similar noncooperative oxygen equilibrium curves with a very high affinity for oxygen, comparable with the fourth oxygen equilibrium constant (K-4) of human hemoglobin in solution. One small difference is that the R2 crystals have an oxygen affinity that is 2-3 times higher than that of the R crystals. These results demonstrate that the functional difference between the two typical relaxed quaternary conformations is small and physiologically less important, indicating that these relaxed conformations simply reflect a structural polymorphism of a high affinity relaxed state.	[Shibayama, Naoya] Jichi Med Univ, Dept Physiol, Div Biophys, Shimotsuke, Tochigi 3290498, Japan; [Sugiyama, Kanako; Park, Sam-Yong] Yokohama City Univ, Prot Design Lab, Yokohama, Kanagawa 2300045, Japan	Jichi Medical University; Yokohama City University	Shibayama, N (corresponding author), Jichi Med Univ, Dept Physiol, Div Biophys, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	shibayam@jichi.ac.jp		Shibayama, Naoya/0000-0002-2208-1126	Japan Society for the Promotion of Science [23570197]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was in part supported by Grant-in-aid for Scientific Research 23570197 from the Japan Society for the Promotion of Science (to N. S.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BALDWIN JM, 1980, J MOL BIOL, V136, P103, DOI 10.1016/0022-2836(80)90308-3; Birukou I, 2011, J BIOL CHEM, V286, P10515, DOI 10.1074/jbc.M110.176271; Birukou I, 2010, J BIOL CHEM, V285, P8840, DOI 10.1074/jbc.M109.053934; Biswal BK, 2001, CURR SCI INDIA, V81, P1100; COLOMBO MF, 1992, SCIENCE, V256, P655, DOI 10.1126/science.1585178; Dewan JC, 2002, ACTA CRYSTALLOGR D, V58, P2038, DOI 10.1107/S0907444902016426; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERMI G, 1984, J MOL BIOL, V175, P159, DOI 10.1016/0022-2836(84)90472-8; FITZGERALD PMD, 1979, J MOL BIOL, V132, P603; Harrington DJ, 1997, J MOL BIOL, V272, P398, DOI 10.1006/jmbi.1997.1253; IMAI K, 1975, J BIOL CHEM, V250, P2227; Imai K., 1982, ALLOSTRIC EFFECTS HA; Jenkins JD, 2009, ACTA CRYSTALLOGR D, V65, P41, DOI 10.1107/S0907444908037256; KAVANAUGH JS, 1992, BIOCHEMISTRY-US, V31, P4111, DOI 10.1021/bi00131a030; LADNER RC, 1977, J MOL BIOL, V114, P385, DOI 10.1016/0022-2836(77)90256-X; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lukin JA, 2003, P NATL ACAD SCI USA, V100, P517, DOI 10.1073/pnas.232715799; MIMS MP, 1983, J BIOL CHEM, V258, P4219; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MOZZARELLI A, 1991, NATURE, V351, P416, DOI 10.1038/351416a0; Mueser TC, 2000, BIOCHEMISTRY-US, V39, P15353, DOI 10.1021/bi0012944; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park SY, 2006, J MOL BIOL, V360, P690, DOI 10.1016/j.jmb.2006.05.036; Park SY, 2004, BIOCHEMISTRY-US, V43, P8711, DOI 10.1021/bi049932w; Patskovska LN, 2005, ACTA CRYSTALLOGR D, V61, P566, DOI 10.1107/S0907444905004622; PERUTZ MF, 1989, Q REV BIOPHYS, V22, P139, DOI 10.1017/S0033583500003826; RIVETTI C, 1993, BIOCHEMISTRY-US, V32, P2888, DOI 10.1021/bi00062a021; Safo MK, 2011, BBA-PROTEINS PROTEOM, V1814, P797, DOI 10.1016/j.bbapap.2011.02.013; Safo MK, 2005, BIOCHEMISTRY-US, V44, P8347, DOI 10.1021/bi050412q; SHAANAN B, 1983, J MOL BIOL, V171, P31, DOI 10.1016/S0022-2836(83)80313-1; Shibayama N., 2011, HEMOGLOBIN RECENT DE, P138; SILVA MM, 1992, J BIOL CHEM, V267, P17248; SMITH FR, 1991, PROTEINS, V10, P81, DOI 10.1002/prot.340100202; SRINIVASAN R, 1994, P NATL ACAD SCI USA, V91, P11113, DOI 10.1073/pnas.91.23.11113; Unzai S, 1996, J BIOL CHEM, V271, P12451, DOI 10.1074/jbc.271.21.12451; Unzai S, 1998, J BIOL CHEM, V273, P23150, DOI 10.1074/jbc.273.36.23150; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409	39	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33661	33668		10.1074/jbc.M111.266056	http://dx.doi.org/10.1074/jbc.M111.266056			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21816820	Green Published, hybrid			2022-12-25	WOS:000294968800082
J	Tang, WJ; Li, Y; Osimiri, L; Zhang, C				Tang, Wanjin; Li, Yang; Osimiri, Lindsey; Zhang, Chi			Osteoblast-specific Transcription Factor Osterix (Osx) Is an Upstream Regulator of Satb2 during Bone Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED TRANSCRIPTION; DIFFERENTIATION; EXPRESSION; PROTEIN; GENE; GROWTH; CANCER; OSTEOPOROSIS; TARGET	Osterix (Osx) is an osteoblast-specific transcription factor essential for osteoblast differentiation and bone formation. Osx knock-out mice lack bone completely. Satb2 is critical for osteoblast differentiation as a special AT-rich binding transcription factor. It is not known how Satb2 is transcriptionally regulated during bone formation. In this study, quantitative real-time RTPCR results demonstrated that Satb2 was down-regulated in Osx-null calvaria. In stable C2C12 mesenchymal cells using the tetracycline (Tet)-Off system, overexpression of Osx stimulated Satb2 expression. Moreover, inhibition of Osx by siRNA led to repression of Satb2 expression in osteoblasts. These results suggest that Osx controls Satb2 expression. Transient transfection assay showed that Osx activated 1kb Satb2 promoter reporter activity in a dose-dependent manner. To define the region of Satb2 promoter responsive to Osx activation, a series of deletion mutants of Satb2 constructs were made, and the minimal region was narrowed down to the proximal 130 bp of the Satb2 promoter. Further point mutation studies found that two GC-rich region mutations disrupted the Satb2 130bp promoter activation by Osx, suggesting that these GC-rich binding sites were responsible for Satb2 activation by Osx. Gel shift assay showed that Osx bound to the Satb2 promoter sequence directly. ChIP assays indicated that endogenous Osx associated with the native Satb2 promoter in osteoblasts. Importantly, Satb2 siRNA significantly inhibited Osx-induced osteoblast marker gene expressions. Taken together, our findings indicate that Osx is an upstream regulator of Satb2 during bone formation. This reveals a new additional link of the transcriptional regulation mechanism that Osx controls bone formation.	[Tang, Wanjin; Li, Yang; Osimiri, Lindsey; Zhang, Chi] Univ Texas SW Med Ctr Dallas, Bone Res Lab, Texas Scottish Rite Hosp Children, Dallas, TX 75390 USA; [Zhang, Chi] Univ Texas SW Med Ctr Dallas, Dept Orthoped Surg, Dallas, TX 75390 USA; [Zhang, Chi] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	Texas Scottish Rite Hospital for Children; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhang, C (corresponding author), Univ Texas SW Med Ctr Dallas, Bone Res Lab, Texas Scottish Rite Hosp Children, 2222 Welborn St, Dallas, TX 75219 USA.	Chi5.Zhang@utsouthwestern.edu	Zhang, Chi/K-4467-2012		Arthritis Foundation; Texas Scottish Rite Hospital for Children [RAP01]	Arthritis Foundation; Texas Scottish Rite Hospital for Children	This work was supported by a research grant from the Arthritis Foundation (to C. Z.) and a RAP01 grant from the Texas Scottish Rite Hospital for Children (to C. Z.).	Aprelikova O, 2010, CELL CYCLE, V9, P4387, DOI 10.4161/cc.9.21.13674; Britanova O, 2006, AM J HUM GENET, V79, P668, DOI 10.1086/508214; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Gyorgy AB, 2008, EUR J NEUROSCI, V27, P865, DOI 10.1111/j.1460-9568.2008.06061.x; Hassan MQ, 2010, P NATL ACAD SCI USA, V107, P19879, DOI 10.1073/pnas.1007698107; KIM RH, 1994, MATRIX BIOL, V14, P31, DOI 10.1016/0945-053X(94)90027-2; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Leoyklang P, 2007, HUM MUTAT, V28, P732, DOI 10.1002/humu.20515; Mallo M, 2010, DEV BIOL, V344, P7, DOI 10.1016/j.ydbio.2010.04.024; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Patani N, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-18; Rosen CJ, 2000, BEST PRACT RES CL EN, V14, P181, DOI 10.1053/beem.2000.0068; Savarese F, 2009, GENE DEV, V23, P2625, DOI 10.1101/gad.1815709; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Timpson NJ, 2009, HUM MOL GENET, V18, P1510, DOI 10.1093/hmg/ddp052; Wang S, 2009, J PATHOL, V219, P114, DOI 10.1002/path.2575; Yang F, 2010, BIOCHEM BIOPH RES CO, V400, P684, DOI 10.1016/j.bbrc.2010.08.128; Zhang C, 2001, J BIOL CHEM, V276, P40614, DOI 10.1074/jbc.M106263200; Zhang C, 2003, J BIOL CHEM, V278, P35325, DOI 10.1074/jbc.M305191200; Zhang C, 2008, P NATL ACAD SCI USA, V105, P6936, DOI 10.1073/pnas.0710831105; Zhang C, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-37; Zhou X, 2010, P NATL ACAD SCI USA, V107, P12919, DOI 10.1073/pnas.0912855107	26	63	67	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					32995	33002		10.1074/jbc.M111.244236	http://dx.doi.org/10.1074/jbc.M111.244236			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21828043	Green Published, hybrid			2022-12-25	WOS:000294968800017
J	Redjimi, N; Duperrier-Amouriaux, K; Raimbaud, I; Luescher, I; Dojcinovic, D; Classe, JM; Berton-Rigaud, D; Frenel, JS; Bourbouloux, E; Valmori, D; Ayyoub, M				Redjimi, Nassima; Duperrier-Amouriaux, Karine; Raimbaud, Isabelle; Luescher, Immanuel; Dojcinovic, Danijel; Classe, Jean-Marc; Berton-Rigaud, Dominique; Frenel, Jean-Sebastien; Bourbouloux, Emmanuelle; Valmori, Danila; Ayyoub, Maha			NY-ESO-1-Specific Circulating CD4(+) T Cells in Ovarian Cancer Patients Are Prevalently T(H)1 Type Cells Undetectable in the CD25(+)FOXP3(+)Treg Compartment	PLOS ONE			English	Article							TESTIS ANTIGEN NY-ESO-1; METASTATIC MELANOMA; IMMUNE-RESPONSES; TUMOR-REGRESSION; LUNG-CANCER; AUTOIMMUNITY; IDENTIFICATION; SPECIFICITY; PROGRESSION; REPERTOIRE	Spontaneous CD4(+) T-cell responses to the tumor-specific antigen NY-ESO-1 (ESO) are frequently found in patients with epithelial ovarian cancer (EOC). If these responses are of effector or/and Treg type, however, has remained unclear. Here, we have used functional approaches together with recently developed MHC class II/ESO tetramers to assess the frequency, phenotype and function of ESO-specific cells in circulating lymphocytes from EOC patients. We found that circulating ESO-specific CD4(+) T cells in EOC patients with spontaneous immune responses to the antigen are prevalently T(H)1 type cells secreting IFN-gamma but no IL-17 or IL-10 and are not suppressive. We detected tetramer(+) cells ex vivo, at an average frequency of 1: 25000 memory cells, that is, significantly lower than in patients immunized with an ESO vaccine. ESO tetramer(+) cells were mostly effector memory cells at advanced stages of differentiation and were not detected in circulating CD25(+)FOXP3(+)Treg. Thus, spontaneous CD4(+) T-cell responses to ESO in cancer patients are prevalently of T(H)1 type and not Treg. Their relatively low frequency and advanced differentiation stage, however, may limit their efficacy, that may be boosted by immunogenic ESO vaccines.	[Redjimi, Nassima; Duperrier-Amouriaux, Karine; Raimbaud, Isabelle; Valmori, Danila; Ayyoub, Maha] CLCC Rene Gauducheau, INSERM, U892, St Herblain, France; [Luescher, Immanuel; Dojcinovic, Danijel] Univ Lausanne, Ludwig Inst Canc Res, Lausanne Branch, CH-1066 Epalinges, Switzerland; [Classe, Jean-Marc] CLCC Rene Gauducheau, Dept Surg, St Herblain, France; [Berton-Rigaud, Dominique; Frenel, Jean-Sebastien; Bourbouloux, Emmanuelle] CLCC Rene Gauducheau, Dept Med Oncol, St Herblain, France; [Valmori, Danila] Univ Nantes, Fac Med, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut de Cancerologie de l'Ouest (ICO); Ludwig Institute for Cancer Research; University of Lausanne; UNICANCER; Institut de Cancerologie de l'Ouest (ICO); UNICANCER; Institut de Cancerologie de l'Ouest (ICO); Nantes Universite	Redjimi, N (corresponding author), CLCC Rene Gauducheau, INSERM, U892, St Herblain, France.	Danila.Valmori@univ-nantes.fr; Maha.Ayyoub@univ-nantes.fr	Ansquer, Catherine/M-1519-2015; Ayyoub, Maha/G-2778-2013; Ayyoub, Maha/A-2074-2017; Valmori, Danila/K-2439-2015; Valmori, Danila/AAL-9766-2021; FRENEL, Jean-Sebastien/L-1620-2015	Ayyoub, Maha/0000-0003-2022-0898; FRENEL, Jean-Sebastien/0000-0002-5273-0561	Fondation de France; Cancer Research Institute; Ludwig Institute for Cancer Research	Fondation de France(Fondation de France); Cancer Research Institute; Ludwig Institute for Cancer Research	This study was supported by the Fondation de France, the Cancer Research Institute and the Ludwig Institute for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes I, 2008, IMMUNITY, V29, P782, DOI 10.1016/j.immuni.2008.09.016; Attia P, 2005, J CLIN ONCOL, V23, P6043, DOI 10.1200/JCO.2005.06.205; Ayyoub M, 2006, CLIN IMMUNOL, V118, P188, DOI 10.1016/j.clim.2005.10.002; Ayyoub M, 2010, CLIN CANCER RES, V16, P4607, DOI 10.1158/1078-0432.CCR-10-1485; Ayyoub M, 2010, P NATL ACAD SCI USA, V107, P7437, DOI 10.1073/pnas.1001322107; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Fourcade J, 2010, J IMMUNOL, V184, P6709, DOI 10.4049/jimmunol.0903612; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Haringer B, 2009, J EXP MED, V206, P1009, DOI 10.1084/jem.20082238; Hiraoka N, 2006, CLIN CANCER RES, V12, P5423, DOI 10.1158/1078-0432.CCR-06-0369; Jager E, 1998, J EXP MED, V187, P265, DOI 10.1084/jem.187.2.265; Kennedy R, 2008, IMMUNOL REV, V222, P129, DOI 10.1111/j.1600-065X.2008.00616.x; Kobayashi N, 2007, CLIN CANCER RES, V13, P902, DOI 10.1158/1078-0432.CCR-06-2363; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Lute KD, 2005, BLOOD, V106, P3127, DOI 10.1182/blood-2005-06-2298; Maker AV, 2005, ANN SURG ONCOL, V12, P1005, DOI 10.1245/ASO.2005.03.536; Mougiakakos D, 2010, ADV CANCER RES, V107, P57, DOI 10.1016/S0065-230X(10)07003-X; Muranski P, 2009, CURR OPIN IMMUNOL, V21, P200, DOI 10.1016/j.coi.2009.02.004; Nicholaou T, 2009, CLIN CANCER RES, V15, P2166, DOI 10.1158/1078-0432.CCR-08-2484; Odunsi K, 2003, CANCER RES, V63, P6076; Okoye A, 2007, J EXP MED, V204, P2171, DOI 10.1084/jem.20070567; Riou C, 2007, J EXP MED, V204, P79, DOI 10.1084/jem.20061681; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Valmori D, 2005, CLIN IMMUNOL, V117, P24, DOI 10.1016/j.clim.2005.05.003; Valmori D, 2005, J CLIN INVEST, V115, P1953, DOI 10.1172/JCI23963; Valmori D, 2000, CANCER RES, V60, P4499; Valmori D, 2007, P NATL ACAD SCI USA, V104, P8947, DOI 10.1073/pnas.0703395104; Valmori D, 2010, P NATL ACAD SCI USA, V107, P19402, DOI 10.1073/pnas.1008247107; Vence L, 2007, P NATL ACAD SCI USA, V104, P20884, DOI 10.1073/pnas.0710557105; Woo EY, 2002, J IMMUNOL, V168, P4272, DOI 10.4049/jimmunol.168.9.4272; Woo EY, 2001, CANCER RES, V61, P4766; Wu X, 2010, CANCER IMMUNOL IMMUN, V59, P279, DOI 10.1007/s00262-009-0749-9	37	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22845	10.1371/journal.pone.0022845	http://dx.doi.org/10.1371/journal.pone.0022845			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829534	Green Published, gold, Green Submitted			2022-12-25	WOS:000293286500038
J	Marko, NF; Quackenbush, J; Weil, RJ				Marko, Nicholas F.; Quackenbush, John; Weil, Robert J.			Why Is There a Lack of Consensus on Molecular Subgroups of Glioblastoma? Understanding the Nature of Biological and Statistical Variability in Glioblastoma Expression Data	PLOS ONE			English	Article							MICROARRAY EXPERIMENTAL-DESIGN; FALSE DISCOVERY RATE; GENE-EXPRESSION; SAMPLE-SIZE; QUALITY-CONTROL; NCBI GEO; NOISE; POWER; QA/QC; CLASSIFICATION	Introduction: Gene expression patterns characterizing clinically-relevant molecular subgroups of glioblastoma are difficult to reproduce. We suspect a combination of biological and analytic factors confounds interpretation of glioblastoma expression data. We seek to clarify the nature and relative contributions of these factors, to focus additional investigations, and to improve the accuracy and consistency of translational glioblastoma analyses. Methods: We analyzed gene expression and clinical data for 340 glioblastomas in The Cancer Genome Atlas (TCGA). We developed a logic model to analyze potential sources of biological, technical, and analytic variability and used standard linear classifiers and linear dimensional reduction algorithms to investigate the nature and relative contributions of each factor. Results: Commonly-described sources of classification error, including individual sample characteristics, batch effects, and analytic and technical noise make measurable but proportionally minor contributions to inconsistent molecular classification. Our analysis suggests that three, previously underappreciated factors may account for a larger fraction of classification errors: inherent non-linear/non-orthogonal relationships among the genes used in conjunction with classification algorithms that assume linearity; skewed data distributions assumed to be Gaussian; and biologic variability (noise) among tumors, of which we propose three types. Conclusions: Our analysis of the TCGA data demonstrates a contributory role for technical factors in molecular classification inconsistencies in glioblastoma but also suggests that biological variability, abnormal data distribution, and non-linear relationships among genes may be responsible for a proportionally larger component of classification error. These findings may have important implications for both glioblastoma research and for translational application of other large-volume biological databases.	[Marko, Nicholas F.; Weil, Robert J.] Cleveland Clin, Dept Neurosurg, Cleveland, OH 44106 USA; [Marko, Nicholas F.; Weil, Robert J.] Cleveland Clin, Brain Tumor & Neurooncol Ctr, Cleveland, OH 44106 USA; [Quackenbush, John] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Quackenbush, John] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute	Marko, NF (corresponding author), Cleveland Clin, Dept Neurosurg, Cleveland, OH 44106 USA.	markon@ccf.org; weilr@ccf.org		Quackenbush, John/0000-0002-2702-5879	Neuro-oncology Center at the Cleveland Clinic Foundation	Neuro-oncology Center at the Cleveland Clinic Foundation	The authors wish to thank the Melvin Burkhardt chair in neurosurgical oncology and the Karen Colina Wilson research endowment within the Brain Tumor and Neuro-oncology Center at the Cleveland Clinic Foundation for partial support and funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no current external funding sources for this study.	Adolph SC, 2007, FUNCT ECOL, V21, P178, DOI 10.1111/j.1365-2435.2006.01209.x; *AFF, 2002, STAIST ALG DESCR DOC; Aris VM, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-185; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BARNETT GH, 2007, HIGH GRADE GLIOMAS D, V13; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; BLOCH K, 2002, WORKSH GEN SIGN PROC; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BOWMAN C, P FIELDS MITACS IND; Bredel M, 2009, JAMA-J AM MED ASSOC, V302, P261, DOI 10.1001/jama.2009.997; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Chen JJ, 2007, BMC BIOINFORMATICS, V8, P1, DOI 10.1186/1471-2105-8-412; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; CHU G, SIGNIFICANCE ANAL MI; Colman H, 2010, NEURO-ONCOLOGY, V12, P49, DOI 10.1093/neuonc/nop007; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; Diaconis P, 2008, ANN APPL STAT, V2, P777, DOI 10.1214/08-AOAS165; DROR R, 2001, NOISE MODELS GENE AR; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fan Xiaohui, 2009, BMC Proc, V3 Suppl 2, pS4; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Fuscoe JC, 2007, ENVIRON MOL MUTAGEN, V48, P349, DOI 10.1002/em.20293; Hardin J, 2009, BIOSTATISTICS, V10, P446, DOI 10.1093/biostatistics/kxp003; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Holland EC, 2000, P NATL ACAD SCI USA, V97, P6242, DOI 10.1073/pnas.97.12.6242; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Ioannidis JPA, 2005, LANCET, V365, P454, DOI 10.1016/S0140-6736(05)17878-7; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Johnson K, 2003, BIOTECHNIQUES, P62; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kleihues P, 2000, PATHOLOGY GENETICS T; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li SYS, 2005, STAT MED, V24, P2267, DOI 10.1002/sim.2119; Lin WJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-48; Marko NF, 2008, GENOMICS, V91, P395, DOI 10.1016/j.ygeno.2008.01.002; Marko NF, 2010, GENOMICS, V95, P16, DOI 10.1016/j.ygeno.2009.09.007; Marshall E, 2004, SCIENCE, V306, P630, DOI 10.1126/science.306.5696.630; MATHISON S, 2005, ENCY EVALUATION, V35; Nutt CL, 2003, CANCER RES, V63, P1602; Page GP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-84; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Pawitan Y, 2005, BIOINFORMATICS, V21, P3017, DOI 10.1093/bioinformatics/bti448; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Podani J, 2002, ECOLOGY, V83, P3331; Quackenbush J, 2006, NEW ENGL J MED, V354, P2463, DOI 10.1056/NEJMra042342; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Rich JN, 2005, CANCER RES, V65, P4051, DOI 10.1158/0008-5472.CAN-04-3936; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Salomonis N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-217; SCHERER A, BATCH EFFECTS NOISE; Seo J, 2004, BIOINFORMATICS, V20, P2534, DOI 10.1093/bioinformatics/bth280; Shi LM, 2008, CURR OPIN BIOTECH, V19, P10, DOI 10.1016/j.copbio.2007.11.003; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shi LM, 2004, EXPERT REV MOL DIAGN, V4, P761, DOI 10.1586/14737159.4.6.761; Shlens J., 2009, TUTORIAL PRINCIPAL C; Soukas A, 2000, GENE DEV, V14, P963; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P785, DOI 10.1016/S1470-2045(09)70172-X; Tabachnick BG, 2007, USING MULTIVARIATE S, Vxxvii, P980; The Cancer Genome Atlas, CANC GENOME ATLAS; Theilhaber J, 2002, GENOME RES, V12, P165, DOI 10.1101/gr.182601; Tong TJ, 2008, STAT MED, V27, P1960, DOI 10.1002/sim.3237; Tu Y, 2002, P NATL ACAD SCI USA, V99, P14031, DOI 10.1073/pnas.222164199; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wei CM, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-87; Yang MCK, 2003, PHYSIOL GENOMICS, V16, P24, DOI 10.1152/physiolgenomics.00037.2003; Zhang J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006274; WK KELLOGG FDN EVALU	76	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e20826	10.1371/journal.pone.0020826	http://dx.doi.org/10.1371/journal.pone.0020826			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829433	Green Submitted, Green Published, gold			2022-12-25	WOS:000293284600001
J	Sachdeva, KS; Satyanarayana, S; Dewan, PK; Nair, SA; Reddy, R; Kundu, D; Chadha, SS; Venkatachalaiah, AKM; Parmar, M; Chauhan, LS				Sachdeva, Kuldeep Singh; Satyanarayana, Srinath; Dewan, Puneet Kumar; Nair, Sreenivas Achuthan; Reddy, Raveendra; Kundu, Debasish; Chadha, Sarabjit Singh; Venkatachalaiah, Ajay Kumar Madhugiri; Parmar, Malik; Chauhan, Lakhbir Singh			Source of Previous Treatment for Re-Treatment TB Cases Registered under the National TB Control Programme, India, 2010	PLOS ONE			English	Article							TUBERCULOSIS PATIENTS; SOUTH-INDIA; DOTS PROGRAM; RISK-FACTORS; DEFAULT; STATE; CARE	Background: In 2009, nearly half (289,756) of global re-treatment TB notifications are from India; no nationally-representative data on the source of previous treatment was available to inform strategies for improvement of initial TB treatment outcome. Objectives: To assess the source of previous treatment for re-treatment TB patients registered under India's Revised National TB control Programme (RNTCP). Methodology: A nationally-representative cross sectional study was conducted in a sample of 36 randomly-selected districts. All consecutively registered retreatment TB patients during a defined 15-day period in these 36 districts were contacted and the information on the source of previous treatment sought. Results: Data was collected from all 1712 retreatment TB patients registered in the identified districts during the study period. The data includes information on 595 'relapse' cases, 105 'failure' cases, 437 'treatment after default (TAD)' cases and 575 're-treatment others' cases. The source of most recent previous anti-tuberculosis therapy for 754 [44% (95% CI, 38.2%-49.9%)] of the re-treatment TB patients was from providers outside the TB control programme. A higher proportion of patients registered as TAD (64%) and 'retreatment others' (59%) were likely to be treated outside the National Programme, when compared to the proportion among 'relapse' (22%) or 'failure' (6%). Extrapolated to national registration, of the 292,972 re-treatment registrations in 2010, 128,907 patients would have been most recently treated outside the national programme. Conclusion: Nearly half of the re-treatment cases registered with the national programme were most recently treated outside the programme setting. Enhanced efforts towards extending treatment support and supervision to patients treated by private sector treatment providers are urgently required to improve the quality of treatment and reduce the numbers of patients with recurrent disease. In addition, reasons for the large number of recurrent TB cases from those already treated by the national programme require urgent detailed investigation.	[Sachdeva, Kuldeep Singh; Satyanarayana, Srinath; Venkatachalaiah, Ajay Kumar Madhugiri; Parmar, Malik; Chauhan, Lakhbir Singh] Govt India, Minist Hlth & Family Welf, Directorate Gen Hlth Serv, Cent TB Div, New Delhi, India; [Satyanarayana, Srinath; Nair, Sreenivas Achuthan; Chadha, Sarabjit Singh] SE Asia Reg Off, New Delhi, India; [Dewan, Puneet Kumar; Reddy, Raveendra; Kundu, Debasish; Venkatachalaiah, Ajay Kumar Madhugiri; Parmar, Malik] WHO Country Off, Off World Hlth Org WHO Representat India, New Delhi, India	World Health Organization	Sachdeva, KS (corresponding author), Govt India, Minist Hlth & Family Welf, Directorate Gen Hlth Serv, Cent TB Div, New Delhi, India.	ssrinath@theunion.org		Satyanarayana, Srinath/0000-0002-5420-2551; Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531; Nair, Sreenivas/0000-0002-2586-6797	Union's USAID	Union's USAID(United States Agency for International Development (USAID))	The authors are thankful to the State TB Officers, District TB Officers, their staff and the WHO-RNTCP Medical Consultants of the 36 districts for enthusiastically participating in the data collection process. The protocol for the study was developed during a protocol development workshop conducted at National TB Institute, Bangalore, under The Union's USAID-funded TREAT TB Initiative in September 2009. In this regard, authors are thankful to The Director and Staff of the National Tuberculosis Institute, Bangalore, and Staff of The Union for guiding the authors on protocol development. Finally, the authors are grateful to all the patients, who provided the required data.	British Tuberculosis Association, 1950, TUBERCLE, V31, P121; *CENTR TB DIV, 2008, REV REC REP FORM ADD; Central Tuberculosis Division, 2005, TECHN OP GUID TUB CO; Central Tuberculosis Division, 2010, TUB IND 2010; Dewan PK, 2006, BMJ-BRIT MED J, V332, P574, DOI 10.1136/bmj.38738.473252.7C; Fair E, 2007, EXPERT REV ANTI-INFE, V5, P61, DOI 10.1586/14787210.5.1.61; Jha UM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008873; Lal SS, 2011, INT J TUBERC LUNG D, V15, P97; Narayanan S, 2010, J INFECT DIS, V201, P691, DOI 10.1086/650528; Ramachandran R, 2009, INT J TUBERC LUNG D, V13, P1154; Rusen ID, 2009, INT J TUBERC LUNG D, V13, P1192; Santha T, 2002, INT J TUBERC LUNG D, V6, P780; Sisodia RS, 2006, INT J TUBERC LUNG D, V10, P1373; Srinath S, 2011, INT J TUBERC LUNG D, V15, P105; Thomas A, 2005, INT J TUBERC LUNG D, V9, P556; Vijay S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010043; Wells WA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018964; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; World Health Organization, 2006, GLOB PLAN STOP TB 20	19	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22061	10.1371/journal.pone.0022061	http://dx.doi.org/10.1371/journal.pone.0022061			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21814566	Green Published, Green Submitted, gold			2022-12-25	WOS:000292956800020
J	He, SP; Huang, KW; Zhang, X; Yu, XC; Huang, P; An, CC				He, Shanping; Huang, Kuowei; Zhang, Xu; Yu, Xiangchun; Huang, Ping; An, Chengcai			The LSD1-Type Zinc Finger Motifs of Pisum sativa LSD1 Are a Novel Nuclear Localization Signal and Interact with Importin Alpha	PLOS ONE			English	Article							RUNAWAY CELL-DEATH; DNA-BINDING DOMAIN; ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTOR; DISEASE RESISTANCE; PROTEIN; GENE; SEQUENCE; LESION-SIMULATING-DISEASE1; IDENTIFICATION	Background: Genetic studies of the Arabidopsis mutant lsd1 highlight the important role of LSD1 in the negative regulation of plant programmed cell death (PCD). Arabidopsis thaliana LSD1 (AtLSD1) contains three LSD1-type zinc finger motifs, which are involved in the protein-protein interaction. Methodology/Principal Findings: To further understand the function of LSD1, we have analyzed cellular localization and functional localization domains of Pisum sativa LSD1 (PsLSD1), which is a homolog of AtLSD1. Subcellular localization analysis of green fluorescent protein (GFP)-tagged PsLSD1 indicates that PsLSD1 is localized in the nucleus. Using a series of GFP-tagged PsLSD1 deletion mutants, we found that the three LSD1-type zinc finger motifs of PsLSD1 alone can target GFP to the nucleus, whereas deletion of the three zinc finger motifs or any individual zinc finger motif causes PsLSD1 to lose its nuclear localization, indicating that the three zinc finger motifs are necessary and sufficient for its nuclear localization. Moreover, site-directed mutagenesis analysis of GFP-tagged PsLSD1 indicates that tertiary structure and basic amino acids of each zinc finger motif are necessary for PsLSD1 nuclear localization. In addition, yeast two-hybrid, pull-down, and BiFC assays demonstrate that the three zinc finger motifs of PsLSD1 directly bind to importin alpha in vitro and in vivo. Conclusions/Significance: Our data demonstrate that the LSD1-type zinc finger motifs of PsLSD1 are a novel nuclear localization signal and directly bind to importin alpha, and suggest that the nuclear import of LSD1 may rely on the interaction between its zinc finger motifs and importin alpha. Moreover, the nuclear localization of PsLSD1 suggests that LSD1 may function as a transcription regulator involved in negatively regulating PCD.	[He, Shanping; Huang, Kuowei; Zhang, Xu; Yu, Xiangchun; Huang, Ping; An, Chengcai] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China	Peking University	He, SP (corresponding author), Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.	chcaian@pku.edu.cn			National Key Basic Science '973' Program [2011CB016141]; National Natural Science Foundation [90817001, 30671402]; National Special Projects for R&D of Transgenic Plants [2008ZX08009-004, 2008ZX08010-001]; Chinese Government [2006AA06Z341]	National Key Basic Science '973' Program; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Special Projects for R&D of Transgenic Plants; Chinese Government	This work was supported by grants from the National Key Basic Science '973' Program (2011CB016141), the National Natural Science Foundation (90817001 and 30671402), the National Special Projects for R&D of Transgenic Plants (2008ZX08009-004 and 2008ZX08010-001), and the State '863' High Technology R&D Program (2006AA06Z341) of the Chinese Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Aviv DH, 2002, PLANT J, V29, P381, DOI 10.1046/j.0960-7412.2001.01225.x; BAKER CJ, 1995, ANNU REV PHYTOPATHOL, V33, P299, DOI 10.1146/annurev.py.33.090195.001503; Bhattacharjee S, 2008, PLANT CELL, V20, P2661, DOI 10.1105/tpc.108.060467; Bracha-Drori K, 2004, PLANT J, V40, P419, DOI 10.1111/j.1365-313X.2004.02206.x; Bruening W, 1996, FEBS LETT, V393, P41, DOI 10.1016/0014-5793(96)00853-8; Coll NS, 2010, SCIENCE, V330, P1393, DOI 10.1126/science.1194980; DIETRICH RA, 1994, CELL, V77, P565, DOI 10.1016/0092-8674(94)90218-6; Dietrich RA, 1997, CELL, V88, P685, DOI 10.1016/S0092-8674(00)81911-X; Epple P, 2003, P NATL ACAD SCI USA, V100, P6831, DOI 10.1073/pnas.1130421100; Fries T, 2007, J BIOL CHEM, V282, P19292, DOI 10.1074/jbc.M700217200; Hatayama M, 2008, HUM MOL GENET, V17, P3459, DOI 10.1093/hmg/ddn239; He SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018750; Higashi Y, 2002, J BIOL CHEM, V277, P42224, DOI 10.1074/jbc.M203594200; Ito T, 2009, BIOCHEM BIOPH RES CO, V380, P28, DOI 10.1016/j.bbrc.2008.12.165; Jabs T, 1996, SCIENCE, V273, P1853, DOI 10.1126/science.273.5283.1853; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kaminaka H, 2006, EMBO J, V25, P4400, DOI 10.1038/sj.emboj.7601312; Kliebenstein DJ, 1999, MOL PLANT MICROBE IN, V12, P1022, DOI 10.1094/MPMI.1999.12.11.1022; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Kuwahara J, 2000, Nucleic Acids Symp Ser, P265; Lange A, 2008, J BIOL CHEM, V283, P12926, DOI 10.1074/jbc.M800898200; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Mateo A, 2004, PLANT PHYSIOL, V136, P2818, DOI 10.1104/pp.104.043646; MATHENY C, 1994, J BIOL CHEM, V269, P8176; Muhlenbock P, 2008, PLANT CELL, V20, P2339, DOI 10.1105/tpc.108.059618; Muhlenbock P, 2007, PLANT CELL, V19, P3819, DOI 10.1105/tpc.106.048843; Pandya K, 2002, J BIOL CHEM, V277, P16304, DOI 10.1074/jbc.M200866200; Quadrini KJ, 2002, J BIOL CHEM, V277, P32243, DOI 10.1074/jbc.M205677200; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Shimojo M, 2001, J BIOL CHEM, V276, P13121, DOI 10.1074/jbc.M011193200; Spittau B, 2007, J CELL BIOCHEM, V101, P712, DOI 10.1002/jcb.21228; von Arnim AG, 1998, GENE, V221, P35, DOI 10.1016/S0378-1119(98)00433-8; Walther RF, 2005, J BIOL CHEM, V280, P17549, DOI 10.1074/jbc.M501548200; Yamasaki H, 2005, GENES CELLS, V10, P455, DOI 10.1111/j.1365-2443.2005.00850.x; Yang ML, 1999, J BIOL CHEM, V274, P27399, DOI 10.1074/jbc.274.39.27399; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97	39	16	17	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22131	10.1371/journal.pone.0022131	http://dx.doi.org/10.1371/journal.pone.0022131			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21811563	Green Published, Green Submitted, gold			2022-12-25	WOS:000292929500042
J	Carr, CM; Hardy, SM; Brown, TM; Macdonald, TA; Hebert, PDN				Carr, Christina M.; Hardy, Sarah M.; Brown, Tanya M.; Macdonald, Tara A.; Hebert, Paul D. N.			A Tri-Oceanic Perspective: DNA Barcoding Reveals Geographic Structure and Cryptic Diversity in Canadian Polychaetes	PLOS ONE			English	Article							GENETIC DIFFERENTIATION; POPULATION-STRUCTURE; SPECIES COMPLEX; SEQUENCE DATA; PATTERNS; BIODIVERSITY; ATLANTIC; ANNELIDA; PACIFIC; GENUS	Background: Although polychaetes are one of the dominant taxa in marine communities, their distributions and taxonomic diversity are poorly understood. Recent studies have shown that many species thought to have broad distributions are actually a complex of allied species. In Canada, 12% of polychaete species are thought to occur in Atlantic, Arctic, and Pacific Oceans, but the extent of gene flow among their populations has not been tested. Methodology/Principal Findings: Sequence variation in a segment of the mitochondrial cytochrome c oxidase I (COI) gene was employed to compare morphological versus molecular diversity estimates, to examine gene flow among populations of widespread species, and to explore connectivity patterns among Canada's three oceans. Analysis of 1876 specimens, representing 333 provisional species, revealed 40 times more sequence divergence between than within species (16.5% versus 0.38%). Genetic data suggest that one quarter of previously recognized species actually include two or more divergent lineages, indicating that richness in this region is currently underestimated. Few species with a tri-oceanic distribution showed genetic cohesion. Instead, large genetic breaks occur between Pacific and Atlantic-Arctic lineages, suggesting their long-term separation. High connectivity among Arctic and Atlantic regions and low connectivity with the Pacific further supports the conclusion that Canadian polychaetes are partitioned into two distinct faunas. Conclusions/Significance: Results of this study confirm that COI sequences are an effective tool for species identification in polychaetes, and suggest that DNA barcoding will aid the recognition of species overlooked by the current taxonomic system. The consistent geographic structuring within presumed widespread species suggests that historical range fragmentation during the Pleistocene ultimately increased Canadian polychaete diversity and that the coastal British Columbia fauna played a minor role in Arctic recolonization following deglaciation. This study highlights the value of DNA barcoding for providing rapid insights into species distributions and biogeographic patterns in understudied groups.	[Carr, Christina M.; Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Hardy, Sarah M.] Univ Alaska, Sch Fisheries & Ocean Sci, Fairbanks, AK 99701 USA; [Brown, Tanya M.; Macdonald, Tara A.] Fisheries & Oceans Canada, Inst Ocean Sci, Sidney, BC, Canada	University of Guelph; University of Alaska System; University of Alaska Fairbanks; Fisheries & Oceans Canada	Carr, CM (corresponding author), Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada.	carrc@uoguelph.ca	Hebert, Paul DN/C-4161-2013	Hebert, Paul DN/0000-0002-3081-6700; Mincks, Sarah/0000-0002-3328-712X	Natural Sciences and Engineering Research Council (NSERC); Genome Canada through the Ontario Genomics Institute; Ontario Ministry of Research and Innovation; Census of Marine Life Arctic Ocean Diversity (ArcOD); Churchill Northern Studies Centre; Indian and Northern Affairs Canada; ArcticNet, a Network of Centres of Excellence	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Genome Canada through the Ontario Genomics Institute(Genome Canada); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Census of Marine Life Arctic Ocean Diversity (ArcOD); Churchill Northern Studies Centre; Indian and Northern Affairs Canada; ArcticNet, a Network of Centres of Excellence	This work was supported by a Natural Sciences and Engineering Research Council (NSERC) International Polar Year grant, an award from Genome Canada through the Ontario Genomics Institute, a grant from the Ontario Ministry of Research and Innovation, by Census of Marine Life Arctic Ocean Diversity (ArcOD) grants to SMH and CMC, a Northern Research Fund grant through the Churchill Northern Studies Centre, a Northern Scientific Training Program grant through Indian and Northern Affairs Canada, and a grant from ArcticNet, a Network of Centres of Excellence (Project ArcticNet Nunatsiavut Nuluak). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt A, 1998, MOL ECOL, V7, P1053, DOI 10.1046/j.1365-294x.1998.00429.x; Arvanitidis C, 2002, MAR ECOL PROG SER, V244, P139, DOI 10.3354/meps244139; Barroso R, 2010, MAR BIOL, V157, P69, DOI 10.1007/s00227-009-1296-9; Bastrop R, 1998, MOL BIOL EVOL, V15, P97, DOI 10.1093/oxfordjournals.molbev.a025919; Bastrop R, 2006, BIOL INVASIONS, V8, P1195, DOI 10.1007/s10530-005-6186-6; Bhaud M, 2006, SCI MAR, V70, P35, DOI 10.3989/scimar.2006.70s335; Bhaud MR, 2001, J MAR BIOL ASSOC UK, V81, P225, DOI 10.1017/S002531540100368X; Bleidorn C, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-47; BRIGGS JC, 1970, SYST ZOOL, V19, P19, DOI 10.2307/2412025; Briggs JC, 2007, DIVERS DISTRIB, V13, P544, DOI 10.1111/j.1472-4642.2007.00362.x; CARR CM, 2011, MAR BIODIV IN PRESS; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chevaldonne P, 2002, CAH BIOL MAR, V43, P367; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Colwell RK, 2009, ESTIMATES STAT ESTIM; DAVENPORT D, 1950, BIOL BULL, V98, P81, DOI 10.2307/1538570; Dodson JJ, 2007, MOL ECOL, V16, P5030, DOI 10.1111/j.1365-294X.2007.03559.x; DUNTON K, 1992, TRENDS ECOL EVOL, V7, P183, DOI 10.1016/0169-5347(92)90070-R; Fauchald K., 1984, P1; FAUCHALD K, 2009, WORLD POLYCHAETA DAT; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Glasby CJ, 1999, J BIOGEOGR, V26, P507, DOI 10.1046/j.1365-2699.1999.00297.x; Glover AG, 2005, MAR ECOL-EVOL PERSP, V26, P223, DOI 10.1111/j.1439-0485.2005.00060.x; Hardy Sarah Mincks, 2011, Marine Biodiversity, V41, P195, DOI 10.1007/s12526-010-0056-x; Hart MW, 2007, BIOL LETTERS, V3, P509, DOI 10.1098/rsbl.2007.0307; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hernandez CE, 2005, ECOGRAPHY, V28, P363, DOI 10.1111/j.0906-7590.2005.04013.x; Hobaek A, 1999, AMBIO, V28, P245; HUTCHINGS PA, 2000, POLYCHAETES ALLIES S, P1; Ivanova NV, 2008, PLANT MOL BIOL REP, V26, P186, DOI 10.1007/s11105-008-0029-4; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jirkov I.A., 2001, POLYCHAETA ARCTIC OC; Jolly MT, 2005, HEREDITY, V94, P23, DOI 10.1038/sj.hdy.6800543; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knowlton N, 2000, HYDROBIOLOGIA, V420, P73, DOI 10.1023/A:1003933603879; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Maltagliati F, 2000, MAR BIOL, V136, P871, DOI 10.1007/s002270000288; MANCHENKO GP, 1993, BIOCHEM SYST ECOL, V21, P543, DOI 10.1016/0305-1978(93)90053-T; Marko PB, 2004, MOL ECOL, V13, P597, DOI 10.1046/j.1365-294X.2004.02096.x; MARTIN D, 2006, ORG DIVERS EVOL, V6, P325, DOI DOI 10.1016/J.0DE.2006.01.001; Moreno RA, 2006, J BIOGEOGR, V33, P750, DOI 10.1111/j.1365-2699.2005.01394.x; NEI M, 2000, MOL EVOLUTION PHYLOG; Nikula R, 2007, EVOLUTION, V61, P928, DOI 10.1111/j.1558-5646.2007.00066.x; Nygren A, 2011, MAR BIOL RES, V7, P54, DOI 10.1080/17451001003713555; Nygren A, 2011, MOL PHYLOGENET EVOL, V58, P132, DOI 10.1016/j.ympev.2010.10.010; Olson MA, 2009, BIOL BULL-US, V217, P86, DOI 10.1086/BBLv217n1p86; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.ecolsys.25.1.547; PALUMBI SR, 1991, EVOLUTION, V45, P1790, DOI 10.1111/j.1558-5646.1991.tb02688.x; Pernet B, 1999, EVOLUTION, V53, P435, DOI 10.1111/j.1558-5646.1999.tb03779.x; Pleijel F, 2009, ZOOL SCR, V38, P89, DOI 10.1111/j.1463-6409.2008.00356.x; POCKLINGTON P, 1987, CAN J ZOOL, V65, P391, DOI 10.1139/z87-060; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Quijon PA, 2005, POLAR BIOL, V28, P495, DOI 10.1007/s00300-005-0719-4; RADULOVICI AE, 2010, MOVING FAST FORWARD, V3, P450; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rice SA, 2008, INVERTEBR BIOL, V127, P45, DOI 10.1111/j.1744-7410.2007.00104.x; Rohfritsch A, 2005, HEREDITY, V95, P315, DOI 10.1038/sj.hdy.6800727; ROUSE G.W., 2001, POLYCHAETES; Sato M, 1997, MAR BIOL, V130, P163, DOI 10.1007/s002270050235; Shorthouse D.P., 2010, SIMPLEMAPPR WEB ENAB; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Sorensen T, 1948, K DAN VIDENSK SELSK, V5, P1, DOI DOI 10.1234/12345678; Stabeno PJ, 1999, UASGCP REP, V99, P1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TEMPLETON AR, 1992, GENETICS, V132, P619; USHAKOV PV, 1965, POLYCHAETA FAR E SEA; VANOPPEN MJH, 1995, MAR BIOL, V123, P179, DOI 10.1007/BF00350338; VERMEIJ GJ, 1991, PALEOBIOLOGY, V17, P281, DOI 10.1017/S0094837300010617; WAYNE RK, 1992, CONSERV BIOL, V6, P590, DOI 10.1046/j.1523-1739.1992.06040590.x; WEBB T, 1992, ANNU REV ECOL SYST, V23, P141, DOI 10.1146/annurev.es.23.110192.001041; Westheide W, 2003, HELGOLAND MAR RES, V57, P1, DOI 10.1007/s10152-002-0114-2; Witt JDS, 2006, MOL ECOL, V15, P3073, DOI 10.1111/j.1365-294X.2006.02999.x; Worheide G, 2005, INTEGR COMP BIOL, V45, P377, DOI 10.1093/icb/45.2.377; Zhou X, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-30	79	218	235	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e22232	10.1371/journal.pone.0022232	http://dx.doi.org/10.1371/journal.pone.0022232			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21829451	Green Published, Green Submitted, gold			2022-12-25	WOS:000292811300052
J	Uemura, M; Zheng, Q; Koh, CM; Nelson, WG; Yegnasubramanian, S; De Marzo, AM				Uemura, M.; Zheng, Q.; Koh, C. M.; Nelson, W. G.; Yegnasubramanian, S.; De Marzo, A. M.			Overexpression of ribosomal RNA in prostate cancer is common but not linked to rDNA promoter hypomethylation	ONCOGENE			English	Article						epigenetics; rDNA; rRNA; DNA methylation; prostate cancer	POLYMERASE-I; C-MYC; TRANSCRIPTION; GENES; CELLS; NUCLEOLAR; DNA; HYPERMETHYLATION; METHYLATION; BIOLOGY	Alterations in nucleoli, including increased numbers, increased size, altered architecture and increased function are hallmarks of prostate cancer cells. The mechanisms that result in increased nucleolar size, number and function in prostate cancer have not been fully elucidated. The nucleolus is formed around repeats of a transcriptional unit encoding a 45S ribosomal RNA (rRNA) precursor that is then processed to yield the mature 18S, 5.8S and 28S RNA species. Although it has been generally accepted that tumor cells overexpress rRNA species, this has not been examined in clinical prostate cancer. We find that indeed levels of the 45S rRNA, 28S, 18S and 5.8S are overexpressed in the majority of human primary prostate cancer specimens as compared with matched benign tissues. One mechanism that can alter nucleolar function and structure in cancer cells is hypomethylation of CpG dinucleotides of the upstream rDNA promoter region. However, this mechanism has not been examined in prostate cancer. To determine whether rRNA overexpression could be explained by hypomethylation of these CpG sites, we also evaluated the DNA methylation status of the rDNA promoter in prostate cancer cell lines and the clinical specimens. Bisulfite sequencing of genomic DNA revealed two roughly equal populations of loci in cell lines consisting of those that contained densely methylated deoxycytidine residues within CpGs and those that were largely unmethylated. All clinical specimens also contained two populations with no marked changes in methylation of this region in cancer as compared with normal. We recently reported that MYC can regulate rRNA levels in human prostate cancer; here we show that MYC mRNA levels are correlated with 45S, 18S and 5.8S rRNA levels. Further, as a surrogate for nucleolar size and number, we examined the expression of fibrillarin, which did not correlate with rRNA levels. We conclude that rRNA levels are increased in human prostate cancer, but that hypomethylation of the rDNA promoter does not explain this increase, nor does hypomethylation explain alterations in nucleolar number and structure in prostate cancer cells. Rather, rRNA levels and nucleolar size and number relate more closely to MYC overexpression. Oncogene (2012) 31, 1254-1263; doi:10.1038/onc.2011.319; published online 8 August 2011	[Uemura, M.; Zheng, Q.; Koh, C. M.; Nelson, W. G.; De Marzo, A. M.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21287 USA; [Nelson, W. G.; Yegnasubramanian, S.; De Marzo, A. M.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21287 USA; [Nelson, W. G.; De Marzo, A. M.] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21287 USA; [Nelson, W. G.; Yegnasubramanian, S.; De Marzo, A. M.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21287 USA; [Nelson, W. G.; De Marzo, A. M.] Johns Hopkins Univ, Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	De Marzo, AM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, CRB 2-144,1550 Orleans St, Baltimore, MD 21287 USA.	ademarz@jhmi.edu	uemura, motohide/G-6101-2011		Patrick C Walsh Prostate Cancer Fund; Prostate SPORE [P50CA58236]; NATIONAL CANCER INSTITUTE [P30CA006973, P50CA058236] Funding Source: NIH RePORTER	Patrick C Walsh Prostate Cancer Fund; Prostate SPORE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Patrick C Walsh Prostate Cancer Fund of which AMD is the Peter J Sharp Scholar, and Prostate SPORE P50CA58236. We wish to thank Helen Fedor and the Brady Urological Institute Prostate Specimen Repository for fresh prostate tissues.	Bostwick DG, 1996, PROSTATE, V29, P117; Derenzini M, 1998, AM J PATHOL, V152, P1291; Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844; EPSTEIN JI, 2002, PROSTATE BIOPSY INTE; Espada J, 2007, NUCLEIC ACIDS RES, V35, P2191, DOI 10.1093/nar/gkm118; Fischer AH, 2004, J CELL BIOCHEM, V91, P170, DOI 10.1002/jcb.10735; Gagnon-Kugler T, 2009, MOL CELL, V35, P414, DOI 10.1016/j.molcel.2009.07.008; Ghoshal K, 2004, J BIOL CHEM, V279, P6783, DOI 10.1074/jbc.M309393200; GONZALEZ IL, 1995, GENOMICS, V27, P320, DOI 10.1006/geno.1995.1049; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Grummt I, 2010, FEBS J, V277, P4626, DOI 10.1111/j.1742-4658.2010.07892.x; Grummt I, 2010, CELL CYCLE, V9, P225, DOI 10.4161/cc.9.2.10614; HALTINER MM, 1986, MOL CELL BIOL, V6, P227, DOI 10.1128/MCB.6.1.227; Koh C, 2010, AM J PATHOL, V4, P1824; McGowan PO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002085; McMahon M, 2010, J BIOL CHEM, V285, P18309, DOI 10.1074/jbc.M110.108555; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Schlosser I, 2003, NUCLEIC ACIDS RES, V31, P6148, DOI 10.1093/nar/gkg794; Shiue CN, 2009, ONCOGENE, V28, P1833, DOI 10.1038/onc.2009.21; Shiue CN, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.3.11376; White RJ, 2005, NAT REV MOL CELL BIO, V6, P69, DOI 10.1038/nrm1551; Williamson D, 2006, GENE CHROMOSOME CANC, V45, P839, DOI 10.1002/gcc.20347; Yegnasubramanian S, 2004, CANCER RES, V64, P1975, DOI 10.1158/0008-5472.CAN-03-3972	26	60	61	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2012	31	10					1254	1263		10.1038/onc.2011.319	http://dx.doi.org/10.1038/onc.2011.319			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	906KS	21822302	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000301344600005
J	Takahata, Y; Takarada, T; Hinoi, E; Nakamura, Y; Fujita, H; Yoneda, Y				Takahata, Yoshifumi; Takarada, Takeshi; Hinoi, Eiichi; Nakamura, Yukari; Fujita, Hiroyuki; Yoneda, Yukio			Osteoblastic gamma-Aminobutyric Acid, Type B Receptors Negatively Regulate Osteoblastogenesis toward Disturbance of Osteoclastogenesis Mediated by Receptor Activator of Nuclear Factor kappa B Ligand in Mouse Bone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION IN-VITRO; GABA(B) RECEPTOR; GENE-EXPRESSION; CHONDROGENIC DIFFERENTIATION; MORPHOGENETIC PROTEIN-2; TRANSCRIPTION FACTOR-4; GLUTAMATE RECEPTORS; OSTERIX; RUNX2; BRAIN	The prevailing view is that signaling machineries for the neurotransmitter GABA are also expressed by cells outside the CNS. In cultured murine calvarial osteoblasts, mRNA was constitutively expressed for both subunits 1 and 2 of metabotropic GABA(B) receptor (GABA(B)R), along with inhibition by the GABA(B)R agonist baclofen of cAMP formation, alkaline phosphatase (ALP) activity, and Ca2+ accumulation. Moreover, baclofen significantly inhibited the transactivation of receptor activator of nuclear factor-kappa B ligand (RANKL) gene in a manner sensitive to a GABA(B)R antagonist, in addition to decreasing mRNA expression of bone morphogenetic protein-2 (BMP2), osteocalcin, and osterix. In osteoblastic MC3T3-E1 cells stably transfected with GABA(B)R1 subunit, significant reductions were seen in ALP activity and Ca2+ accumulation, as well as mRNA expression of osteocalcin, osteopontin, and osterix. In cultured calvarial osteoblasts from GABA(B)R1-null mice exhibiting low bone mineral density in tibia and femur, by contrast, both ALP activity and Ca2+ accumulation were significantly increased together with promoted expression of both mRNA and proteins for BMP2 and osterix. No significant change was seen in the number of multinucleated cells stained for tartrate-resistant acid phosphatase during the culture of osteoclasts prepared from GABA(B)R1-null mice, whereas a significant increase was seen in the number of tartrate-resistant acid phosphatase-positive multinucleated cells in co-culture of osteoclasts with osteoblasts isolated from GABA(B)R1-null mice. These results suggest that GABA(B)R is predominantly expressed by osteoblasts to negatively regulate osteoblastogenesis through down-regulation of BMP2 expression toward disturbance of osteoclastogenesis after down-regulation of RANKL expression in mouse bone.	[Takahata, Yoshifumi; Takarada, Takeshi; Hinoi, Eiichi; Nakamura, Yukari; Fujita, Hiroyuki; Yoneda, Yukio] Kanazawa Univ, Grad Sch Nat Sci & Technol, Mol Pharmacol Lab, Div Pharmaceut Sci, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University	Yoneda, Y (corresponding author), Kanazawa Univ, Grad Sch Nat Sci & Technol, Mol Pharmacol Lab, Div Pharmaceut Sci, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	yyoneda@p.kanazawa-u.ac.jp	Yoneda, Yukio/ABI-1864-2020; Takahata, Yoshifumi/AAZ-6869-2021	Yoneda, Yukio/0000-0002-4624-177X; Takarada, Takeshi/0000-0002-2363-7704	Ministry of Education, Culture, Sports, Science and Technology, Japan [22500330, 21659018]; Grants-in-Aid for Scientific Research [09J03309] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aids for Scientific Research 22500330 (to T. T.) and 21659018 (to Y. Y.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Castelli MP, 1999, LIFE SCI, V64, P1321, DOI 10.1016/S0024-3205(99)00067-3; Chien KR, 2005, CELL, V120, P533, DOI 10.1016/j.cell.2005.02.006; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; ERDO SL, 1982, J NEUROCHEM, V38, P1174, DOI 10.1111/j.1471-4159.1982.tb05368.x; Fu HH, 2007, J BIOMED MATER RES A, V83A, P770, DOI 10.1002/jbm.a.31356; Fujimori S, 2002, BIOCHEM BIOPH RES CO, V293, P1445, DOI 10.1016/S0006-291X(02)00405-9; Hanai J, 1999, J BIOL CHEM, V274, P31577, DOI 10.1074/jbc.274.44.31577; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Hinoi E, 2002, BIOCHEM BIOPH RES CO, V297, P452, DOI 10.1016/S0006-291X(02)02223-4; Hinoi E, 2006, J BIOL CHEM, V281, P18015, DOI 10.1074/jbc.M600603200; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kobayashi H, 2000, BIOCHEM BIOPH RES CO, V273, P630, DOI 10.1006/bbrc.2000.2981; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Mehta AK, 1999, BRAIN RES REV, V29, P196, DOI 10.1016/S0165-0173(98)00052-6; MODY I, 1994, TRENDS NEUROSCI, V17, P517, DOI 10.1016/0166-2236(94)90155-4; Mori K, 2006, J CELL BIOCHEM, V98, P1629, DOI 10.1002/jcb.20891; Nakamura Y, 2009, J PHARMACOL SCI, V109, P413, DOI 10.1254/jphs.08315FP; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nehring RB, 2000, J BIOL CHEM, V275, P35185, DOI 10.1074/jbc.M002727200; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; OKADA Y, 1976, SCIENCE, V194, P620, DOI 10.1126/science.185693; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Takahata Y, 2009, J CELL PHYSIOL, V218, P268, DOI 10.1002/jcp.21594; Takarada T, 2008, J CELL PHYSIOL, V215, P320, DOI 10.1002/jcp.21310; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; White JH, 2000, P NATL ACAD SCI USA, V97, P13967, DOI 10.1073/pnas.240452197; Xiao GZ, 2005, J BIOL CHEM, V280, P30689, DOI 10.1074/jbc.M500750200; YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681; Zambotti A, 2002, J BIOL CHEM, V277, P41497, DOI 10.1074/jbc.M204271200	36	25	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					32906	32917		10.1074/jbc.M111.253526	http://dx.doi.org/10.1074/jbc.M111.253526			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21828041	hybrid, Green Published			2022-12-25	WOS:000294968800009
J	Bai, JP; Swartz, DJ; Protasevich, II; Brouillette, CG; Harrell, PM; Hildebrandt, E; Gasser, B; Mattanovich, D; Ward, A; Chang, G; Urbatsch, IL				Bai, Jiangping; Swartz, Douglas J.; Protasevich, Irina I.; Brouillette, Christie G.; Harrell, Patina M.; Hildebrandt, Ellen; Gasser, Brigitte; Mattanovich, Diethard; Ward, Andrew; Chang, Geoffrey; Urbatsch, Ina L.			A Gene Optimization Strategy that Enhances Production of Fully Functional P-Glycoprotein in Pichia pastoris	PLOS ONE			English	Article							NUCLEOTIDE-BINDING DOMAINS; HIGH-LEVEL EXPRESSION; BLOOD-BRAIN-BARRIER; MULTIDRUG-RESISTANCE; PROTEIN-PRODUCTION; HETEROLOGOUS PROTEINS; METHYLOTROPHIC YEAST; ELECTRON-MICROSCOPY; CODON OPTIMIZATION; ABC TRANSPORTERS	Background: Structural and biochemical studies of mammalian membrane proteins remain hampered by inefficient production of pure protein. We explored codon optimization based on highly expressed Pichia pastoris genes to enhance co-translational folding and production of P-glycoprotein (Pgp), an ATP-dependent drug efflux pump involved in multidrug resistance of cancers. Methodology/Principal Findings: Codon-optimized "Opti-Pgp" and wild-type Pgp, identical in primary protein sequence, were rigorously analyzed for differences in function or solution structure. Yeast expression levels and yield of purified protein from P. pastoris (similar to 130 mg per kg cells) were about three-fold higher for Opti-Pgp than for wild-type protein. Opti-Pgp conveyed full in vivo drug resistance against multiple anticancer and fungicidal drugs. ATP hydrolysis by purified Opti-Pgp was strongly stimulated similar to 15-fold by verapamil and inhibited by cyclosporine A with binding constants of 4.2 +/- 2.2 mu M and 1.1 +/- 0.26 mu M, indistinguishable from wild-type Pgp. Maximum turnover number was 2.1 +/- 0.28 mu mol/min/mg and was enhanced by 1.2-fold over wild-type Pgp, likely due to higher purity of Opti-Pgp preparations. Analysis of purified wild-type and Opti-Pgp by CD, DSC and limited proteolysis suggested similar secondary and ternary structure. Addition of lipid increased the thermal stability from T-m similar to 40 degrees C to 49 degrees C, and the total unfolding enthalpy. The increase in folded state may account for the increase in drug-stimulated ATPase activity seen in presence of lipids. Conclusion: The significantly higher yields of protein in the native folded state, higher purity and improved function establish the value of our gene optimization approach, and provide a basis to improve production of other membrane proteins.	[Bai, Jiangping; Swartz, Douglas J.; Harrell, Patina M.; Hildebrandt, Ellen; Urbatsch, Ina L.] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA; [Bai, Jiangping; Swartz, Douglas J.; Harrell, Patina M.; Hildebrandt, Ellen; Urbatsch, Ina L.] Texas Tech Univ, Hlth Sci Ctr, Ctr Membrane Prot Res, Lubbock, TX 79430 USA; [Protasevich, Irina I.; Brouillette, Christie G.] Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA; [Brouillette, Christie G.] Univ Alabama Birmingham, Ctr Biophys Sci & Engn, Birmingham, AL USA; [Gasser, Brigitte; Mattanovich, Diethard] Univ Nat Resources & Life Sci, Dept Biotechnol, Vienna, Austria; [Ward, Andrew; Chang, Geoffrey] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Natural Resources & Life Sciences, Vienna; Scripps Research Institute	Bai, JP (corresponding author), Gansu Agr Univ, Gansu Key Lab Crop Genet & Germplasm Enhancement, Lanzhou, Peoples R China.		Ward, Andrew B/F-9203-2014; Gasser, Brigitte/AAD-8172-2020; Ward, Andrew/ABD-7728-2021	Ward, Andrew B/0000-0001-7153-3769; Ward, Andrew/0000-0001-7153-3769; Mattanovich, Diethard/0000-0002-0907-4167; Gasser, Brigitte/0000-0003-2881-6370	Cancer Prevention and Research Institute of Texas [RP101073]; National Institutes of Health [U54-GM94610]; Department of Defense [W81XWH-05-1-0316]; Cystic Fibrosis Foundation Therapeutics Inc. [URBATS06XX0, BROUIL07XX0]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094610] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Cystic Fibrosis Foundation Therapeutics Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Cancer Prevention and Research Institute of Texas RP101073, National Institutes of Health U54-GM94610, the Department of Defense W81XWH-05-1-0316, and the Cystic Fibrosis Foundation Therapeutics Inc. URBATS06XX0 and BROUIL07XX0. The CFFT encourages publication and distribution of reagents to foster research: "It is the policy of CFFT to make available to the public the results and accomplishments of the activities that it funds. Restricted availability of unique resources upon which further studies are dependent can impede the advancement of research and the delivery of medical care. Therefore, when these resources are developed with CFFT funds and the associated research findings have been published, they should be made readily available for research purposes to the scientific community" (from CFFT Terms and Conditions of Award, June 10, 2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Baumann K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-141; BROUILLETTE CG, 1987, BIOCHEMISTRY-US, V26, P7431, DOI 10.1021/bi00397a035; Callaghan R, 1997, BBA-BIOMEMBRANES, V1328, P109, DOI 10.1016/S0005-2736(97)00079-5; Cereghino GPL, 1999, CURR OPIN BIOTECH, V10, P422, DOI 10.1016/S0958-1669(99)00004-X; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; Chloupkova M, 2007, BIOCHEMISTRY-US, V46, P7992, DOI 10.1021/bi700020m; Daly R, 2005, J MOL RECOGNIT, V18, P119, DOI 10.1002/jmr.687; De Schutter K, 2009, NAT BIOTECHNOL, V27, P561, DOI 10.1038/nbt.1544; Dragosits M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-207; Dragosits M, 2009, J PROTEOME RES, V8, P1380, DOI 10.1021/pr8007623; Eckford PDW, 2009, CHEM REV, V109, P2989, DOI 10.1021/cr9000226; Farinha Carlos M, 2004, J Cyst Fibros, V3 Suppl 2, P73, DOI 10.1016/j.jcf.2004.05.017; Gimenez F, 2004, JAIDS-J ACQ IMM DEF, V36, P649, DOI 10.1097/00126334-200406010-00001; Gottesman MM, 2006, FEBS LETT, V580, P998, DOI 10.1016/j.febslet.2005.12.060; Gutmann DAP, 2010, TRENDS BIOCHEM SCI, V35, P36, DOI 10.1016/j.tibs.2009.07.009; Hani J, 1998, NUCLEIC ACIDS RES, V26, P689, DOI 10.1093/nar/26.3.689; Huang H, 2008, APPL MICROBIOL BIOT, V78, P95, DOI 10.1007/s00253-007-1290-4; Hughes JR, 2008, NEUROL RES, V30, P920, DOI 10.1179/174313208X319116; IKEMURA T, 1982, J MOL BIOL, V158, P573, DOI 10.1016/0022-2836(82)90250-9; Jaenicke R, 2000, ADV PROTEIN CHEM, V53, P329; Johnson BJH, 2010, BIOCHEMISTRY-US, V49, P3403, DOI 10.1021/bi902064g; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kimchi-Sarfaty C, 2007, PHARMACOGENOMICS, V8, P29, DOI 10.2217/14622416.8.1.29; Komar AA, 2009, TRENDS BIOCHEM SCI, V34, P16, DOI 10.1016/j.tibs.2008.10.002; Lavner Y, 2005, GENE, V345, P127, DOI 10.1016/j.gene.2004.11.035; Lee JY, 2002, J BIOL CHEM, V277, P40125, DOI 10.1074/jbc.M206871200; Lee JY, 2008, J BIOL CHEM, V283, P5769, DOI 10.1074/jbc.M707028200; Lee SG, 2010, PROTEIN EXPRES PURIF, V71, P108, DOI 10.1016/j.pep.2010.01.017; Lerner-Marmarosh N, 1999, J BIOL CHEM, V274, P34711, DOI 10.1074/jbc.274.49.34711; Lin-Cereghino GP, 2006, MOL CELL BIOL, V26, P883, DOI 10.1128/MCB.26.3.883-897.2006; Lombardi A, 2010, FASEB J, V24, P253, DOI 10.1096/fj.08-118042; Mattanovich D, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-53; Mattanovich D, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-29; Novy R., 2001, INNOVATIONS, V12, P1; Nuti SL, 2002, J BIOL CHEM, V277, P29417, DOI 10.1074/jbc.M204054200; Ortega A, 1996, BBA-BIOMEMBRANES, V1283, P45, DOI 10.1016/0005-2736(96)00072-7; Pariante CM, 2008, EUR J PHARMACOL, V583, P263, DOI 10.1016/j.ejphar.2007.11.067; PRIVALOV PL, 1982, ADV PROTEIN CHEM, V35, P1, DOI 10.1016/S0065-3233(08)60468-4; Quartley Erin, 2009, Journal of Structural and Functional Genomics, V10, P233, DOI 10.1007/s10969-009-9068-9; RAYMOND M, 1992, SCIENCE, V256, P232, DOI 10.1126/science.1348873; RAYMOND M, 1994, MOL CELL BIOL, V14, P277, DOI 10.1128/MCB.14.1.277; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Reinau ME, 2009, ARCH BIOCHEM BIOPHYS, V492, P48, DOI 10.1016/j.abb.2009.09.018; Sauer M, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-17; Sauna ZE, 2007, CANCER RES, V67, P9609, DOI 10.1158/0008-5472.CAN-07-2377; Schinkel AH, 1999, ADV DRUG DELIVER REV, V36, P179, DOI 10.1016/S0169-409X(98)00085-4; Scholz C, 2011, J BIOL CHEM, V286, P13346, DOI 10.1074/jbc.M110.216416; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Sinclair G, 2002, PROTEIN EXPRES PURIF, V26, P96, DOI 10.1016/S1046-5928(02)00526-0; Soubias O, 2008, J AM CHEM SOC, V130, P12465, DOI 10.1021/ja803599x; Sreekrishna K, 1997, GENE, V190, P55, DOI 10.1016/S0378-1119(96)00672-5; SREEKRISHNA K, 1993, INDUSTRIAL MICROORGANISMS: BASIC AND APPLIED MOLECULAR GENETICS, P119; STOWELL MHB, 1995, ADV PROTEIN CHEM, V46, P279, DOI 10.1016/S0065-3233(08)60338-1; Su ZJ, 2007, APPL MICROBIOL BIOT, V73, P1355, DOI 10.1007/s00253-006-0604-2; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Teng D, 2007, APPL MICROBIOL BIOT, V74, P1074, DOI 10.1007/s00253-006-0765-z; Tombline G, 2005, J BIOENERG BIOMEMBR, V37, P497, DOI [10.1007/s10863-005-9498-4, 10.1007/s10863-005-9498/4]; Tombline G, 2004, J BIOL CHEM, V279, P31212, DOI 10.1074/jbc.M404689200; Tsai CJ, 2008, J MOL BIOL, V383, P281, DOI 10.1016/j.jmb.2008.08.012; Urbatsch IL, 2000, J BIOL CHEM, V275, P25031, DOI 10.1074/jbc.M003962200; Urbatsch IL, 2003, J BIOL CHEM, V278, P23171, DOI 10.1074/jbc.M301957200; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Urbatsch IL, 1998, BIOCHEMISTRY-US, V37, P4592, DOI 10.1021/bi9728001; Urbatsch IL, 2001, J BIOL CHEM, V276, P26980, DOI 10.1074/jbc.M010829200; Urbatsch IL, 2001, ARCH BIOCHEM BIOPHYS, V388, P171, DOI 10.1006/abbi.2001.2299; Urbatsch IL, 2000, BIOCHEMISTRY-US, V39, P14138, DOI 10.1021/bi001128w; VERNET T, 1987, GENE, V52, P225, DOI 10.1016/0378-1119(87)90049-7; Zhao X, 2000, Sheng Wu Gong Cheng Xue Bao, V16, P308	70	71	76	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22577	10.1371/journal.pone.0022577	http://dx.doi.org/10.1371/journal.pone.0022577			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826197	Green Published, Green Submitted, gold			2022-12-25	WOS:000293558900018
J	Guerout, N; Paviot, A; Bon-Mardion, N; Duclos, C; Genty, D; Jean, L; Boyer, O; Marie, JP				Guerout, Nicolas; Paviot, Alexandre; Bon-Mardion, Nicolas; Duclos, Celia; Genty, Damien; Jean, Laetitia; Boyer, Olivier; Marie, Jean-Paul			Co-Transplantation of Olfactory Ensheathing Cells from Mucosa and Bulb Origin Enhances Functional Recovery after Peripheral Nerve Lesion	PLOS ONE			English	Article							SPINAL-CORD; NEURAL CREST; RAT MODEL; REINNERVATION; FIBROBLASTS; REGROWTH; PROMOTES; CULTURES; SYSTEM; INJURY	Olfactory ensheathing cells (OECs) represent an interesting candidate for cell therapy and could be obtained from olfactory mucosa (OM-OECs) or olfactory bulbs (OB-OECs). Recent reports suggest that, depending on their origin, OECs display different functional properties. We show here the complementary and additive effects of co-transplanting OM-OECs and OB-OECs after lesion of a peripheral nerve. For this, a selective motor denervation of the laryngeal muscles was performed by a section/anastomosis of the recurrent laryngeal nerve (RLN). Two months after surgery, recovery of the laryngeal movements and synkinesis phenonema were analyzed by videolaryngoscopy. To complete these assessments, measure of latency and potential duration were determined by electrophysiological recordings and myelinated nerve fiber profiles were defined based on toluidine blue staining. To explain some of the mechanisms involved, tracking of GFP positive OECs was performed. It appears that transplantation of OM-OECs or OB-OECs displayed opposite abilities to improve functional recovery. Indeed, OM-OECs increased recuperation of laryngeal muscles activities without appropriate functional recovery. In contrast, OB-OECs induced some functional recovery by enhancing axonal regrowth. Importantly, co-transplantation of OM-OECs and OB-OECs supported a major functional recovery, with reduction of synkinesis phenomena. This study is the first which clearly demonstrates the complementary and additive properties of OECs obtained from olfactory mucosa and olfactory bulb to improve functional recovery after transplantation in a nerve lesion model.	[Guerout, Nicolas; Paviot, Alexandre; Bon-Mardion, Nicolas; Duclos, Celia; Marie, Jean-Paul] Univ Rouen, Inst Rech & Innovat Biomed Haute Normandie IRIB, Fac Med & Pharm, Expt Surg Lab,GRHV,UPRES EA 3830, Rouen, France; [Paviot, Alexandre; Bon-Mardion, Nicolas; Marie, Jean-Paul] Hop Charles Nicolle, Rouen Univ Hosp, Otorhinolaryngol Head & Neck Surg Dept, Rouen, France; [Genty, Damien] Hop Charles Nicolle, Rouen Univ Hosp, Pathol Lab Pavillon Jacques Delarue, Rouen, France; [Jean, Laetitia; Boyer, Olivier] Univ Rouen, Inst Med Res, Fac Med & Pharm, INSERM U905, Rouen, France	Universite de Rouen Normandie; CHU de Rouen; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie	Guerout, N (corresponding author), Univ Rouen, Inst Rech & Innovat Biomed Haute Normandie IRIB, Fac Med & Pharm, Expt Surg Lab,GRHV,UPRES EA 3830, Rouen, France.	nicolas_guerout_76@hotmail.com	Boyer, Olivier/N-6552-2013	Boyer, Olivier/0000-0002-7591-307X	ADIR (Aide a Domicile aux Insuffisants Respiratoires); Fondation de l'Avenir	ADIR (Aide a Domicile aux Insuffisants Respiratoires); Fondation de l'Avenir	The study was financially supported by ADIR (Aide a Domicile aux Insuffisants Respiratoires) and by Fondation de l'Avenir. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barraud P, 2010, P NATL ACAD SCI USA, V107, P21040, DOI 10.1073/pnas.1012248107; de Corgnol AC, 2011, ANN OTO RHINOL LARYN, V120, P273, DOI 10.1177/000348941112000410; Deumens R, 2006, EXP NEUROL, V200, P89, DOI 10.1016/j.expneurol.2006.01.030; DOUCETTE R, 1991, J COMP NEUROL, V312, P451, DOI 10.1002/cne.903120311; DOUCETTE R, 1990, GLIA, V3, P433, DOI 10.1002/glia.440030602; Forni PE, 2011, J NEUROSCI, V31, P6915, DOI 10.1523/JNEUROSCI.6087-10.2011; Franssen EHP, 2007, BRAIN RES REV, V56, P236, DOI 10.1016/j.brainresrev.2007.07.013; Gorrie CA, 2010, BRAIN RES, V1337, P8, DOI 10.1016/j.brainres.2010.04.019; Guerout N, 2011, MUSCLE NERVE, V43, P543, DOI 10.1002/mus.21907; Guerout N, 2010, GLIA, V58, P1570, DOI 10.1002/glia.21030; Guntinas-Lichius O, 2002, J NEUROSCI, V22, P7121; Inagi K, 1997, ANN OTO RHINOL LARYN, V106, P1012, DOI 10.1177/000348949710601204; Jani HR, 2004, GLIA, V47, P130, DOI 10.1002/glia.20038; Johansson S, 2005, BRAIN, V128, P2961, DOI 10.1093/brain/awh644; Lakatos A, 2003, BRAIN, V126, P598, DOI 10.1093/brain/awg055; Li Y, 2005, GLIA, V52, P245, DOI 10.1002/glia.20241; MARIE JP, 1989, ANN OTO RHINOL LARYN, V98, P530, DOI 10.1177/000348948909800707; Paviot A, 2011, NEUROBIOL DIS, V41, P688, DOI 10.1016/j.nbd.2010.12.004; Radtke Christine, 2009, Eplasty, V9, pe47; Radtke C, 2009, BRAIN RES, V1254, P10, DOI 10.1016/j.brainres.2008.11.036; Raisman G, 2011, EXP NEUROL, V229, P168, DOI 10.1016/j.expneurol.2010.05.007; RAMONCUETO A, 1992, NEUROSCIENCE, V47, P213, DOI 10.1016/0306-4522(92)90134-N; Richter MW, 2005, J NEUROSCI, V25, P10700, DOI 10.1523/JNEUROSCI.3632-05.2005; Roglio I, 2008, BRAIN RES REV, V57, P460, DOI 10.1016/j.brainresrev.2007.04.010; Shyu WC, 2008, J CLIN INVEST, V118, P2482, DOI 10.1172/JCI34363; Srivastava N, 2009, INT J DEV NEUROSCI, V27, P103, DOI 10.1016/j.ijdevneu.2008.08.002; Windus LCE, 2010, CELL MOL LIFE SCI, V67, P1735, DOI 10.1007/s00018-010-0280-3; Wu A, 2011, EXP NEUROL, V229, P143, DOI 10.1016/j.expneurol.2010.07.006; Yamamoto M, 2009, BRAIN RES, V1303, P26, DOI 10.1016/j.brainres.2009.09.073	29	28	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22816	10.1371/journal.pone.0022816	http://dx.doi.org/10.1371/journal.pone.0022816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826209	Green Published, gold, Green Submitted			2022-12-25	WOS:000293558900035
J	Hayashi, T; Hiromoto, Y; Chaichoune, K; Patchimasiri, T; Chakritbudsabong, W; Prayoonwong, N; Chaisilp, N; Wiriyarat, W; Parchariyanon, S; Ratanakorn, P; Uchida, Y; Saito, T				Hayashi, Tsuyoshi; Hiromoto, Yasuaki; Chaichoune, Kridsada; Patchimasiri, Tuangthong; Chakritbudsabong, Warunya; Prayoonwong, Natanan; Chaisilp, Natnapat; Wiriyarat, Witthawat; Parchariyanon, Sujira; Ratanakorn, Parntep; Uchida, Yuko; Saito, Takehiko			Host Cytokine Responses of Pigeons Infected with Highly Pathogenic Thai Avian Influenza Viruses of Subtype H5N1 Isolated from Wild Birds	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; HONG-KONG; INFLUENZA-VIRUS-A/CHICKEN/INDONESIA/2003 H5N1; GENETIC-CHARACTERIZATION; FUNCTIONAL HOMOLOGY; IMMUNE-RESPONSE; COLUMBIA-LIVIA; A H5N1; OUTBREAKS; REPLICATION	Highly pathogenic avian influenza virus (HPAIV) of the H5N1 subtype has been reported to infect pigeons asymptomatically or induce mild symptoms. However, host immune responses of pigeons inoculated with HPAIVs have not been well documented. To assess host responses of pigeons against HPAIV infection, we compared lethality, viral distribution and mRNA expression of immune related genes of pigeons infected with two HPAIVs (A/Pigeon/Thailand/VSMU-7-NPT/2004; Pigeon04 and A/Tree sparrow/Ratchaburi/VSMU-16-RBR/2005; T.sparrow05) isolated from wild birds in Thailand. The survival experiment showed that 25% of pigeons died within 2 weeks after the inoculation of two HPAIVs or medium only, suggesting that these viruses did not cause lethal infection in pigeons. Pigeon04 replicated in the lungs more efficiently than T.sparrow05 and spread to multiple extrapulmonary organs such as the brain, spleen, liver, kidney and rectum on days 2, 5 and 9 post infection. No severe lesion was observed in the lungs infected with Pigeon04 as well as T.sparrow05 throughout the collection periods. Encephalitis was occasionally observed in Pigeon04- or T.sparrow05-infected brain, the severity, however was mostly mild. To analyze the expression of immune-related genes in the infected pigeons, we established a quantitative real-time PCR analysis for 14 genes of pigeons. On day 2 post infection, Pigeon04 induced mRNA expression of Mx1, PKR and OAS to a greater extent than T.sparrow05 in the lungs, however their expressions were not up-regulated concomitantly on day 5 post infection when the peak viral replication was observed. Expressions of TLR3, IFN alpha, IL6, IL8 and CCL5 in the lungs following infection with the two HPAIVs were low. In sum, Pigeon04 exhibited efficient replication in the lungs compared to T.sparrow05, but did not induce excessive host cytokine expressions. Our study has provided the first insight into host immune responses of pigeons against HPAIV infection.	[Hayashi, Tsuyoshi; Hiromoto, Yasuaki; Uchida, Yuko; Saito, Takehiko] Thailand Japan Zoonot Dis Collaborating Ctr ZDCC, Bangkok, Thailand; [Hayashi, Tsuyoshi; Hiromoto, Yasuaki; Uchida, Yuko; Saito, Takehiko] Natl Agr & Food Res Org NARO, Natl Inst Anim Hlth, Res Team Zoonot Dis, Tsukuba, Ibaraki, Japan; [Chaichoune, Kridsada; Chakritbudsabong, Warunya; Prayoonwong, Natanan; Chaisilp, Natnapat; Wiriyarat, Witthawat; Ratanakorn, Parntep] Mahidol Univ, Fac Vet Sci, Monitoring & Surveillance Ctr Zoonot Dis Wildlife, Phuttamonthon, Nakhon Pathom, Thailand; [Patchimasiri, Tuangthong; Parchariyanon, Sujira] Natl Inst Anim Hlth, Bangkok, Thailand	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Mahidol University	Hayashi, T (corresponding author), Thailand Japan Zoonot Dis Collaborating Ctr ZDCC, Bangkok, Thailand.	taksaito@affrc.go.jp	Saito, Takehiko/AFM-3038-2022; Hayashi, Tsuyoshi/GNW-6250-2022		Founding Research Center for Emerging and Reemerging Infectious Diseases	Founding Research Center for Emerging and Reemerging Infectious Diseases	This work was supported by the program of the Founding Research Center for Emerging and Reemerging Infectious Diseases launched by a project commissioned by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The poultry isolators used in this study were supported by the National Center for Genetic Engineering and Biotechnology, Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alammar L, 2011, J IMMUNOL, V186, P4008, DOI 10.4049/jimmunol.1003757; ALONGKORN A, 2008, EMERG INFECT DIS, V14, P1739; Amonsin A, 2006, VIROLOGY, V344, P480, DOI 10.1016/j.virol.2005.08.032; Barber MRW, 2010, P NATL ACAD SCI USA, V107, P5913, DOI 10.1073/pnas.1001755107; Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Biswas PK, 2009, EMERG INFECT DIS, V15, P1931, DOI 10.3201/eid1512.090643; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Cilloniz C, 2010, J VIROL, V84, P7613, DOI 10.1128/JVI.00553-10; Ellis TM, 2004, AVIAN PATHOL, V33, P492, DOI 10.1080/03079450400003601; Hayashi T, 2011, VIROLOGY, V412, P9, DOI 10.1016/j.virol.2010.12.040; Ito T, 2002, VIRUS RES, V84, P27, DOI 10.1016/S0168-1702(01)00414-2; Jia BB, 2008, ARCH VIROL, V153, P1821, DOI 10.1007/s00705-008-0193-8; Keawcharoen J, 2004, EMERG INFECT DIS, V10, P2189, DOI 10.3201/eid1012.040759; Kenny EF, 2008, CYTOKINE, V43, P342, DOI 10.1016/j.cyto.2008.07.010; Klopfleisch R, 2006, VET PATHOL, V43, P463, DOI 10.1354/vp.43-4-463; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Koedel U, 2004, BRAIN, V127, P1437, DOI 10.1093/brain/awh171; Lafferty EI, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-57; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Li ZJ, 2006, J VIROL, V80, P11115, DOI 10.1128/JVI.00993-06; Lin WC, 2010, EXP BIOL MED, V235, P57, DOI 10.1258/ebm.2009.009256; Liu YH, 2009, AVIAN PATHOL, V38, P263, DOI 10.1080/03079450903055363; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Morgan KN, 2007, APPL ANIM BEHAV SCI, V102, P262, DOI 10.1016/j.applanim.2006.05.032; Peiris JSM, 2009, TRENDS IMMUNOL, V30, P574, DOI 10.1016/j.it.2009.09.004; Perkins LEL, 2003, AVIAN DIS, V47, P956, DOI 10.1637/0005-2086-47.s3.956; Perkins LEL, 2002, AVIAN DIS, V46, P53, DOI 10.1637/0005-2086(2002)046[0053:POAHKO]2.0.CO;2; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; REED L. J., 1938, AMER JOUR HYG, V27, P493; Siengsanan J, 2009, J WILDLIFE DIS, V45, P740, DOI 10.7589/0090-3558-45.3.740; Songserm T, 2006, EMERG INFECT DIS, V12, P681, DOI 10.3201/eid1204.051396; Songserm T, 2006, EMERG INFECT DIS, V12, P1744, DOI 10.3201/eid1211.060542; Sturm-Ramirez KM, 2004, J VIROL, V78, P4892, DOI 10.1128/JVI.78.9.4892-4901.2004; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Suzuki K, 2009, J VIROL, V83, P7475, DOI 10.1128/JVI.01434-08; Uchida Y, 2008, VIRUS RES, V138, P70, DOI 10.1016/j.virusres.2008.08.007; Ueda M, 2010, J VIROL, V84, P3068, DOI 10.1128/JVI.01923-09; Wasilenko JL, 2009, ARCH VIROL, V154, P969, DOI 10.1007/s00705-009-0399-4; Werner O, 2007, J GEN VIROL, V88, P3089, DOI 10.1099/vir.0.83105-0; Wu YF, 2008, VET IMMUNOL IMMUNOP, V125, P205, DOI 10.1016/j.vetimm.2008.03.001; Wu YF, 2007, VET IMMUNOL IMMUNOP, V116, P37, DOI 10.1016/j.vetimm.2006.12.010; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; Yoneyama S, 2010, J VET MED SCI, V72, P481, DOI 10.1292/jvms.09-0342; Zhu QY, 2008, J VIROL, V82, P220, DOI 10.1128/JVI.00978-07	45	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e23103	10.1371/journal.pone.0023103	http://dx.doi.org/10.1371/journal.pone.0023103			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826229	Green Submitted, Green Published, gold			2022-12-25	WOS:000293558900055
J	Sylva, M; Li, VSW; Buffing, AAA; van Es, JH; van den Born, M; van der Velden, S; Gunst, Q; Koolstra, JH; Moorman, AFM; Clevers, H; van den Hoff, MJB				Sylva, Marc; Li, Vivian S. W.; Buffing, Anita A. A.; van Es, Johan H.; van den Born, Maaike; van der Velden, Saskia; Gunst, Quinn; Koolstra, Jan Harm; Moorman, Antoon F. M.; Clevers, Hans; van den Hoff, Maurice J. B.			The BMP Antagonist Follistatin-Like 1 Is Required for Skeletal and Lung Organogenesis	PLOS ONE			English	Article							AXIAL SKELETON; BONE-FORMATION; CHICKEN HEART; IN-VIVO; MOUSE; EXPRESSION; GENE; DIFFERENTIATION; SOX9; IDENTIFICATION	Follistatin-like 1 (Fstl1) is a secreted protein of the BMP inhibitor class. During development, expression of Fstl1 is already found in cleavage stage embryos and becomes gradually restricted to mesenchymal elements of most organs during subsequent development. Knock down experiments in chicken and zebrafish demonstrated a role as a BMP antagonist in early development. To investigate the role of Fstl1 during mouse development, a conditional Fstl1 KO allele as well as a Fstl1-GFP reporter mouse were created. KO mice die at birth from respiratory distress and show multiple defects in lung development. Also, skeletal development is affected. Endochondral bone development, limb patterning as well as patterning of the axial skeleton are perturbed in the absence of Fstl1. Taken together, these observations show that Fstl1 is a crucial regulator in BMP signalling during mouse development.	[Sylva, Marc; Buffing, Anita A. A.; van der Velden, Saskia; Gunst, Quinn; Moorman, Antoon F. M.; van den Hoff, Maurice J. B.] Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, NL-1105 AZ Amsterdam, Netherlands; [Li, Vivian S. W.; van Es, Johan H.; van den Born, Maaike; Clevers, Hans] KNAW, Hubrecht Inst, Utrecht, Netherlands; [Li, Vivian S. W.; van Es, Johan H.; van den Born, Maaike; Clevers, Hans] Univ Med Ctr, Utrecht, Netherlands; [Koolstra, Jan Harm] Acad Ctr Dent Amsterdam ACTA, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam	Sylva, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.j.vandenhoff@amc.uva.nl	van+Es, Johan/ABD-5411-2021; Koolstra, Jan Harm/B-5344-2013	Koolstra, Jan Harm/0000-0002-1202-2296; Li, Vivian/0000-0003-2041-0085; van der velden, saskia/0000-0002-0809-1993; van den Hoff, Maurice/0000-0002-3837-8055	Netherlands Heart Foundation [1996M002]; European Community [LSHM-CT-2005-018630]	Netherlands Heart Foundation(Netherlands Heart Foundation); European Community(European Commission)	This work was supported by the Netherlands Heart Foundation grant 1996M002 and the European Community's Sixth Framework Program contract ("HeartRepair") grant LSHM-CT-2005-018630. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams D, 2007, GENE EXPR PATTERNS, V7, P491, DOI 10.1016/j.modgep.2006.10.009; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Bachiller D, 2003, DEVELOPMENT, V130, P3567, DOI 10.1242/dev.00581; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Benazet JD, 2009, SCIENCE, V323, P1050, DOI 10.1126/science.1168755; Bi WM, 2001, P NATL ACAD SCI USA, V98, P6698, DOI 10.1073/pnas.111092198; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Bussen M, 2004, GENE DEV, V18, P1209, DOI 10.1101/gad.300104; Compagni A, 2003, DEV CELL, V5, P217, DOI 10.1016/S1534-5807(03)00198-9; Dal-Pra S, 2006, DEV BIOL, V298, P514, DOI 10.1016/j.ydbio.2006.07.002; de Boer BA, 2011, DEVELOPMENT, V138, P159, DOI 10.1242/dev.051086; Dionne MS, 2001, MOL CELL BIOL, V21, P636, DOI 10.1128/MCB.21.2.636-643.2001; Esterberg R, 2008, DEVELOPMENT, V135, P3891, DOI 10.1242/dev.029264; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Geng Y, 2011, P NATL ACAD SCI USA, V108, P7058, DOI 10.1073/pnas.1007293108; GREEN EL, 1946, AM NAT, V80, P619, DOI 10.1086/281482; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; JEANNOTTE L, 1993, GENE DEV, V7, P2085, DOI 10.1101/gad.7.11.2085; Khokha MK, 2003, NAT GENET, V34, P303, DOI 10.1038/ng1178; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; MARTIN JF, 1995, GENE DEV, V9, P1237, DOI 10.1101/gad.9.10.1237; MATZUK MM, 1995, NATURE, V374, P360, DOI 10.1038/374360a0; McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320; Pizette S, 1999, DEVELOPMENT, V126, P883; Retting KN, 2009, DEVELOPMENT, V136, P1093, DOI 10.1242/dev.029926; Schmahl J, 2007, NAT GENET, V39, P52, DOI 10.1038/ng1922; Seemann P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000747; SHIBANUMA M, 1993, EUR J BIOCHEM, V217, P13, DOI 10.1111/j.1432-1033.1993.tb18212.x; Snarr BS, 2007, CIRC RES, V101, P971, DOI 10.1161/CIRCRESAHA.107.162206; Somi S, 2006, J HISTOCHEM CYTOCHEM, V54, P649, DOI 10.1369/jhc.5A6846.2006; Su H, 2002, GENESIS, V32, P187, DOI 10.1002/gene.10043; Tanaka M, 2010, FEBS J, V277, P4278, DOI 10.1111/j.1742-4658.2010.07816.x; Towers P, 1999, DEV BIOL, V214, P298, DOI 10.1006/dbio.1999.9421; Umulis D, 2009, DEVELOPMENT, V136, P3715, DOI 10.1242/dev.031534; Van den Berg G, 2007, ANAT REC, V290, P783, DOI 10.1002/ar.20559; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Walsh DW, 2010, TRENDS CELL BIOL, V20, P244, DOI 10.1016/j.tcb.2010.01.008; Weaver M, 1999, DEVELOPMENT, V126, P4005; Wijgerde M, 2005, DEV BIOL, V286, P149, DOI 10.1016/j.ydbio.2005.07.016; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Yoon BS, 2005, P NATL ACAD SCI USA, V102, P5062, DOI 10.1073/pnas.0500031102; Zakin L, 2010, DEV BIOL, V347, P204, DOI 10.1016/j.ydbio.2010.08.025; Zhou JL, 2006, GENE, V372, P191, DOI 10.1016/j.gene.2005.12.020; Zou HY, 1996, SCIENCE, V272, P738, DOI 10.1126/science.272.5262.738	47	75	77	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22616	10.1371/journal.pone.0022616	http://dx.doi.org/10.1371/journal.pone.0022616			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826198	Green Submitted, Green Published, gold			2022-12-25	WOS:000293558900021
J	Mofarrahi, M; Hussain, SNA				Mofarrahi, Mahroo; Hussain, Sabah N. A.			Expression and Functional Roles of Angiopoietin-2 in Skeletal Muscles	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR-NECROSIS-FACTOR; FATTY-ACID OXIDATION; IN-VIVO; CELL-PROLIFERATION; H2O2; MIGRATION; PROTECTS; SURVIVAL; RECEPTOR	Background: Angiopoietin-1 (ANGPT1) and angiopoietin-2 (ANGPT2) are angiogenesis factors that modulate endothelial cell differentiation, survival and stability. Recent studies have suggested that skeletal muscle precursor cells constitutively express ANGPT1 and adhere to recombinant ANGPT1 and ANGPT2 proteins. It remains unclear whether or not they also express ANGPT2, or if ANGPT2 regulates the myogenesis program of muscle precursors. In this study, ANGPT2 regulatory factors and the effects of ANGPT2 on proliferation, migration, differentiation and survival were identified in cultured primary skeletal myoblasts. The cellular networks involved in the actions of ANGPT2 on skeletal muscle cells were also analyzed. Methodology/Principal Findings: Primary skeletal myoblasts were isolated from human and mouse muscles. Skeletal myoblast survival, proliferation, migration and differentiation were measured in-vitro in response to recombinant ANGPT2 protein and to enhanced ANGPT2 expression delivered with adenoviruses. Real-time PCR and ELISA measurements revealed the presence of constitutive ANGPT2 expression in these cells. This expression increased significantly during myoblast differentiation into myotubes. In human myoblasts, ANGPT2 expression was induced by H2O2, but not by TNF alpha, IL1 beta or IL6. ANGPT2 significantly enhanced myoblast differentiation and survival, but had no influence on proliferation or migration. ANGPT2-induced survival was mediated through activation of the ERK1/2 and PI-3 kinase/AKT pathways. Microarray analysis revealed that ANGPT2 upregulates genes involved in the regulation of cell survival, protein synthesis, glucose uptake and free fatty oxidation. Conclusion/Significance: Skeletal muscle precursors constitutively express ANGPT2 and this expression is upregulated during differentiation into myotubes. Reactive oxygen species exert a strong stimulatory influence on muscle ANGPT2 expression while pro-inflammatory cytokines do not. ANGPT2 promotes skeletal myoblast survival and differentiation. These results suggest that muscle-derived ANGPT2 production may play a positive role in skeletal muscle fiber repair.	[Mofarrahi, Mahroo] McGill Univ Hlth Ctr, Royal Victoria Hosp, Crit Care Div, Montreal, PQ, Canada; McGill Univ Hlth Ctr, Royal Victoria Hosp, Div Resp, Montreal, PQ, Canada; McGill Univ, Dept Med, Meakins Christie Labs, Montreal, PQ, Canada	McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital; McGill University	Mofarrahi, M (corresponding author), McGill Univ Hlth Ctr, Royal Victoria Hosp, Crit Care Div, Montreal, PQ, Canada.	sabah.hussain@muhc.mcgill.ca	Hussain, Sabah/ABC-5315-2021		Canadian Institute of Health Research; The Frederick Banting and Charles Best Canada Graduate Doctoral Award; McGill University	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); The Frederick Banting and Charles Best Canada Graduate Doctoral Award(Canadian Institutes of Health Research (CIHR)); McGill University	This study funded by grants from the Canadian Institute of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; M. Mofarrahi is the recipient of The Frederick Banting and Charles Best Canada Graduate Doctoral Award. S.N.A. Hussain is the recipient of James McGill Professorship, McGill University.	Abdel-Malak NA, 2008, BLOOD, V111, P4145, DOI 10.1182/blood-2007-08-110338; Abdulmalek K, 2001, AM J PHYSIOL-LUNG C, V281, pL582, DOI 10.1152/ajplung.2001.281.3.L582; Amano S, 2005, MICROVASC RES, V69, P45, DOI 10.1016/j.mvr.2004.11.001; Brauchle M, 1996, J BIOL CHEM, V271, P21793, DOI 10.1074/jbc.271.36.21793; Brindle NPJ, 2006, CIRC RES, V98, P1014, DOI 10.1161/01.RES.0000218275.54089.12; Chua CC, 1998, FREE RADICAL BIO MED, V25, P891, DOI 10.1016/S0891-5849(98)00115-4; Dallabrida SM, 2005, CIRC RES, V96, DOI 10.1161/01.RES.0000158285.57191.60; Eguchi M, 2008, FEBS J, V275, P3136, DOI 10.1111/j.1742-4658.2008.06465.x; Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685; Florian M, 2008, ENDOTHELIUM-J ENDOTH, V15, P265, DOI 10.1080/10623320802487775; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Giuliano JS, 2007, SHOCK, V28, P650, DOI 10.1097/shk.0b013e318123867b; Harfouche R, 2003, FASEB J, V17, P1523, DOI 10.1096/fj.02-0698fje; Harfouche R, 2002, MICROVASC RES, V64, P135, DOI 10.1006/mvre.2002.2421; Harfouche R, 2006, AM J PHYSIOL-HEART C, V291, pH1635, DOI 10.1152/ajpheart.01318.2005; Hegen A, 2004, ARTERIOSCL THROM VAS, V24, P1803, DOI 10.1161/01.ATV.0000140819.81839.0e; Kim I, 2000, ONCOGENE, V19, P4549, DOI 10.1038/sj.onc.1203800; Kim I, 2000, BIOCHEM BIOPH RES CO, V269, P361, DOI 10.1006/bbrc.2000.2296; Koga K, 2001, CANCER RES, V61, P6248; Kosmidou I, 2001, AM J PHYSIOL-LUNG C, V280, pL585, DOI 10.1152/ajplung.2001.280.4.L585; Kumpers P, 2009, CRIT CARE, V13, DOI 10.1186/cc7866; Kuroki M, 1996, J CLIN INVEST, V98, P1667, DOI 10.1172/JCI118962; Lloyd PG, 2003, AM J PHYSIOL-HEART C, V284, pH1668, DOI 10.1152/ajpheart.00743.2002; Lochmuller H, 1999, EXP CELL RES, V248, P186, DOI 10.1006/excr.1999.4407; Machida S, 2004, P NUTR SOC, V63, P337, DOI 10.1079/PNS2004354; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Mandriota SJ, 1998, CIRC RES, V83, P852, DOI 10.1161/01.RES.83.8.852; Mofarrahi M, 2008, AM J PHYSIOL-LUNG C, V294, pL955, DOI 10.1152/ajplung.00449.2007; Orfanos SE, 2007, CRIT CARE MED, V35, P199, DOI 10.1097/01.CCM.0000251640.77679.D7; Ramsay TG, 2003, J ANIM SCI, V81, P3046; Roviezzo F, 2005, J PHARMACOL EXP THER, V314, P738, DOI 10.1124/jpet.105.086553; Sheehan SM, 2000, MUSCLE NERVE, V23, P239, DOI 10.1002/(SICI)1097-4598(200002)23:2<239::AID-MUS15>3.0.CO;2-U; Sheehan SM, 1999, J CELL PHYSIOL, V181, P499, DOI 10.1002/(SICI)1097-4652(199912)181:3<499::AID-JCP14>3.0.CO;2-1; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Solberg R, 2005, J CELL BIOCHEM, V96, P89, DOI 10.1002/jcb.20521; Suzuki A, 2007, MOL CELL BIOL, V27, P4317, DOI 10.1128/MCB.02222-06; Takai H, 2007, CELL, V131, P1248, DOI 10.1016/j.cell.2007.10.052; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Wilson LA, 2005, FASEB J, V19, P2085, DOI 10.1096/fj.05-4401fje; Xu Y, 2001, J BIOL CHEM, V276, P34990, DOI 10.1074/jbc.M103661200	40	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22882	10.1371/journal.pone.0022882	http://dx.doi.org/10.1371/journal.pone.0022882			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829546	gold, Green Submitted, Green Published			2022-12-25	WOS:000293286500045
J	Panigada, S; Lauriano, G; Burt, L; Pierantonio, N; Donovan, G				Panigada, Simone; Lauriano, Giancarlo; Burt, Louise; Pierantonio, Nino; Donovan, Greg			Monitoring Winter and Summer Abundance of Cetaceans in the Pelagos Sanctuary (Northwestern Mediterranean Sea) Through Aerial Surveys	PLOS ONE			English	Article							WHALES BALAENOPTERA-PHYSALUS; FIN WHALES; STRIPED DOLPHINS; TOXICOLOGICAL HAZARD; COMMON DOLPHINS; NORTH-ATLANTIC; CLIMATE-CHANGE; MITOCHONDRIAL; DESIGN; WATERS	Systematic long-term monitoring of abundance is essential to inform conservation measures and evaluate their effectiveness. To instigate such work in the Pelagos Sanctuary in the Mediterranean, two aerial surveys were conducted in winter and summer 2009. A total of 467 (131 in winter, 336 in summer) sightings of 7 species was made. Sample sizes were sufficient to estimate abundance of fin whales in summer (148; 95% CI = 87-254) and striped dolphins in winter (19,462; 95% CI = 12 939-29 273) and in summer (38 488; 95% CI = 27 447-53 968). Numbers of animals within the Sanctuary are significantly higher in summer, when human activities and thus potential population level impacts are highest. Comparisons with data from past shipboard surveys suggest an appreciable decrease in fin whales within the Sanctuary area and an appreciable increase in striped dolphins. Aerial surveys proved to be more efficient than ship surveys, allowing more robust estimates, with smaller CIs and CVs. These results provide essential baseline data for this marine protected area and continued regular surveys will allow the effectiveness of the MPA in terms of cetacean conservation to be evaluated and inform future management measures. The collected data may also be crucial in assessing whether ship strikes, one of the main causes of death for fin whales in the Mediterranean, are affecting the Mediterranean population.	[Panigada, Simone; Pierantonio, Nino] Tethys Res Inst, Milan, Italy; [Panigada, Simone; Lauriano, Giancarlo] Inst Environm Protect & Res ISPRA, Rome, Italy; [Burt, Louise] Univ St Andrews, RUWPA, St Andrews KY16 9AJ, Fife, Scotland; [Donovan, Greg] Int Whaling Commiss, Cambridge, England	Italian Institute for Environmental Protection & Research (ISPRA); University of St Andrews	Panigada, S (corresponding author), Tethys Res Inst, Milan, Italy.	panigada@inwind.it	Pierantonio, Nino/AAO-7663-2020; Lauriano, Giancarlo/ABG-8461-2021	Pierantonio, Nino/0000-0002-1210-8831; 	Italian Ministry of the Environment	Italian Ministry of the Environment	This research was funded by the Italian Ministry of the Environment within the projects aiming to "Assess the presence of critical habitats for cetaceans within the Pelagos Sanctuary" (Tethys) and "Summer cetacean abundance estimates in the Pelagos sanctuary" (ISPRA ex ICRAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparaion of the manuscript.	*ACCOBAMS, 2008, 2008 WORKSH SURV ACC; Aguilar Alex, 2000, Journal of Cetacean Research and Management, V2, P17; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Andriolo A., 2006, Journal of Cetacean Research and Management, V8, P307; [Anonymous], 2008, SMALL CETACEANS EURO; Arcangeli A., 2009, P 23 C EUR CET SOC I; Bearzi G, 2003, MAMMAL REV, V33, P224, DOI 10.1046/j.1365-2907.2003.00032.x; Berube M, 1998, MOL ECOL, V7, P585, DOI 10.1046/j.1365-294x.1998.00359.x; Buckland S.T., 2001, pi; Canadas A., 2004, Journal of Cetacean Research and Management, V6, P191; Canese S, 2006, J MAR BIOL ASSOC UK, V86, P903, DOI 10.1017/S0025315406013853; CASTELLOTE M, 2010, THESIS U COMPLUTENSE; Clark CW, 2002, MAR MAMMAL SCI, V18, P286, DOI 10.1111/j.1748-7692.2002.tb01035.x; Cornax M., 2006, ITALIAN DRIFTNETTERS; Cornax MJ., 2009, ADRIFT SWORDFISH DRI, P112; Cornax MJ, 2007, THONAILLE USE DRIFTN; Di Natale Antonio, 1994, Reports of the International Whaling Commission Special Issue, V15, P189; Donovan G.P., 1989, International Whaling Commission Report of the Commission, V39, P437; DONOVAN GP, 2008, DEV EFFECTIVE UNPUB; Donovan Greg, 2005, P161; Evans PGH, 2010, J MAR BIOL ASSOC UK, V90, P1483, DOI 10.1017/S0025315410001815; Fewster RM, 2009, BIOMETRICS, V65, P225, DOI 10.1111/j.1541-0420.2008.01018.x; Forcada J, 1998, J SEA RES, V39, P313, DOI 10.1016/S1385-1101(97)00063-4; FORCADA J, 1995, MAMMALIA, V59, P127, DOI 10.1515/mamm.1995.59.1.127; FORCADA J, 1994, MAR MAMMAL SCI, V10, P137, DOI 10.1111/j.1748-7692.1994.tb00256.x; Fossi MC, 2007, ENVIRON RES, V104, P174, DOI 10.1016/j.envres.2006.06.014; Fossi MC, 2003, MAR POLLUT BULL, V46, P972, DOI 10.1016/S0025-326X(03)00113-9; Gambaiani DD, 2009, J MAR BIOL ASSOC UK, V89, P179, DOI 10.1017/S0025315408002476; Gannier A, 2006, MAMMALIA, V70, P17, DOI 10.1515/MAMM.2006.003; Garcia-Martinez J, 1999, MOL ECOL, V8, P1069, DOI 10.1046/j.1365-294x.1999.00672.x; GERRODETTE T, 1993, WILDLIFE SOC B, V21, P515; GERRODETTE T, 1987, ECOLOGY, V68, P1364, DOI 10.2307/1939220; GOFFART A, 1995, OCEANOL ACTA, V18, P329; de Segura AG, 2006, MAR BIOL, V150, P149, DOI 10.1007/s00227-006-0334-0; Heide-Jorgensen M. P., 2010, Journal of Cetacean Research and Management, V11, P83; Hiby L, 1999, MARINE MAMMAL SURVEY AND ASSESSMENT METHODS, P179; Hooker SK, 1999, CONSERV BIOL, V13, P592, DOI 10.1046/j.1523-1739.1999.98099.x; Jahoda M, 2003, MAR MAMMAL SCI, V19, P96, DOI 10.1111/j.1748-7692.2003.tb01095.x; LARAN S, 2002, J MAR BIOL ASSOC UK, V87, P345; Laran S, 2008, ICES J MAR SCI, V65, P1260, DOI 10.1093/icesjms/fsn086; Laran Sophie, 2010, Journal of Cetacean Research and Management, V11, P31; Lauriano Giancarlo, 2010, Journal of Cetacean Research and Management, V11, P279; Littaye A, 2004, REMOTE SENS ENVIRON, V90, P44, DOI 10.1016/j.rse.2003.11.017; Marques FFC, 2004, ADVANCED DISTANCE SAMPLING: ESTIMATING ABUNDANCE OF BIOLOGICAL POPULATIONS, P31; Notarbartolo di Sciara G, 1999, EUROPEAN RES CETACEA, V12, P124; Notarbartolo-di-Sciara G, 2003, MAMMAL REV, V33, P105, DOI 10.1046/j.1365-2907.2003.00005.x; Notarbartolo-Di-Sciara G, 2008, AQUAT CONSERV, V18, P367, DOI 10.1002/aqc.855; Palka D. L., 2006, 0603 NE FISH SCI CTR; Palka DL, 2001, CAN J FISH AQUAT SCI, V58, P777, DOI 10.1139/cjfas-58-4-777; Palsboll PJ, 2004, EVOLUTION, V58, P670, DOI 10.1111/j.0014-3820.2004.tb01691.x; Panigada S, 2008, REMOTE SENS ENVIRON, V112, P3400, DOI 10.1016/j.rse.2007.11.017; Panigada Simone, 2005, Journal of Cetacean Research and Management, V7, P137; Panigada S, 2006, MAR POLLUT BULL, V52, P1287, DOI 10.1016/j.marpolbul.2006.03.014; Raga JA, 2008, EMERG INFECT DIS, V14, P471, DOI 10.3201/eid1403.071230; Reeves R.R., 2006, STATUS DISTRIBUTION; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Taylor BL, 2007, MAR MAMMAL SCI, V23, P157, DOI 10.1111/j.1748-7692.2006.00092.x; Thomas L., 2009, DISTANCE 6 0 RELEASE; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Valsecchi E, 2004, ANIM CONSERV, V7, P139, DOI 10.1017/S1367943004001325	60	76	80	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22878	10.1371/journal.pone.0022878	http://dx.doi.org/10.1371/journal.pone.0022878			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829544	Green Published, gold			2022-12-25	WOS:000293286500044
J	Carrer, M				Carrer, Marco			Individualistic and Time-Varying Tree-Ring Growth to Climate Sensitivity	PLOS ONE			English	Article							RESPONSES; FOREST; VARIABILITY; TRENDS	The development of dendrochronological time series in order to analyze climate-growth relationships usually involves first a rigorous selection of trees and then the computation of the mean tree-growth measurement series. This study suggests a change in the perspective, passing from an analysis of climate-growth relationships that typically focuses on the mean response of a species to investigating the whole range of individual responses among sample trees. Results highlight that this new approach, tested on a larch and stone pine tree-ring dataset, outperforms, in terms of information obtained, the classical one, with significant improvements regarding the strength, distribution and time-variability of the individual tree-ring growth response to climate. Moreover, a significant change over time of the tree sensitivity to climatic variability has been detected. Accordingly, the best-responder trees at any one time may not always have been the best-responders and may not continue to be so. With minor adjustments to current dendroecological protocol and adopting an individualistic approach, we can improve the quality and reliability of the ecological inferences derived from the climate-growth relationships.	Univ Padua, Dipartimento TeSAF, Forest Ecol Res Unit, Legnaro, PD, Italy	University of Padua	Carrer, M (corresponding author), Univ Padua, Dipartimento TeSAF, Forest Ecol Res Unit, Legnaro, PD, Italy.	marco.carrer@unipd.it	Carrer, Marco/D-8727-2011	Carrer, Marco/0000-0003-1581-6259	University of Padova [CPDA071953]	University of Padova	MC has been supported by the University of Padova Project EXTRA, CPDA071953. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer I, 2007, INT J CLIMATOL, V27, P17, DOI 10.1002/joc.1377; Biondi F, 2008, TREE-RING RES, V64, P81, DOI 10.3959/2008-6.1; Black BA, 2005, J TORREY BOT SOC, V132, P103, DOI 10.3159/1095-5674(2005)132[103:DHACRI]2.0.CO;2; Bohm R, 2001, INT J CLIMATOL, V21, P1779, DOI 10.1002/joc.689; Box G.E.P., 1976, TIME SERIES ANAL FOR; Bradley R. S., 1999, PALEOCLIMATOLOGY REC; Briffa KR, 2004, GLOBAL PLANET CHANGE, V40, P11, DOI 10.1016/S0921-8181(03)00095-X; Bunn AG, 2004, TREE-RING RES, V60, P77, DOI 10.3959/1536-1098-60.2.77; Linares JC, 2009, TREE PHYSIOL, V29, P1525, DOI 10.1093/treephys/tpp084; Carrer M, 2006, NEW PHYTOL, V170, P861, DOI 10.1111/j.1469-8137.2006.01703.x; Carrer M, 2004, ECOLOGY, V85, P730, DOI 10.1890/02-0478; Carrer M, 2001, J VEG SCI, V12, P643, DOI 10.2307/3236904; Carrer M, 2007, J ECOL, V95, P1072, DOI 10.1111/j.1365-2745.2007.01281.x; Carrer M, 2010, OIKOS, V119, P1515, DOI 10.1111/j.1600-0706.2010.18293.x; Chen PY, 2010, GLOBAL CHANGE BIOL, V16, P3374, DOI 10.1111/j.1365-2486.2010.02166.x; Cherubini P, 1998, FOREST ECOL MANAG, V109, P103, DOI 10.1016/S0378-1127(98)00242-4; Cook E., 1990, METHODS DENDROCHRONO, P104, DOI 10.1007/978-94-015-7879-0; Cook E. R., 1981, Tree-Ring Bulletin, V41, P45; Cook ER, 1997, HOLOCENE, V7, P361, DOI 10.1177/095968369700700314; COOK ER, 1995, HOLOCENE, V5, P229, DOI 10.1177/095968369500500211; De Luis M, 2009, TREES-STRUCT FUNCT, V23, P1065, DOI 10.1007/s00468-009-0349-5; DOUGLAS AE, 1919, CARNEGIE I WASHINGTO, V289, P1; Dyer T.G.J., 2006, TREE RINGS CLIMATE, DOI 10.2307/2402947; Ellenberg H., 1988, Vegetation ecology of Central Europe.; Esper J, 2002, SCIENCE, V295, P2250, DOI 10.1126/science.1066208; Frank David, 2005, Dendrochronologia, V22, P107, DOI 10.1016/j.dendro.2005.02.004; Fraver S, 2005, CAN J FOREST RES, V35, P1648, DOI 10.1139/X05-092; FRITTS HC, 1989, ADV ECOL RES, V19, P111; Grimm V., 2005, INDIVIDUAL BASED MOD; Guiot J., 1991, Tree-Ring Bulletin, V51, P39; Helama S, 2004, THEOR APPL CLIMATOL, V79, P239, DOI 10.1007/s00704-004-0077-0; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Jacoby GC, 2000, QUATERNARY RES, V53, P312, DOI 10.1006/qres.2000.2130; JACOBY GC, 1995, GLOBAL BIOGEOCHEM CY, V9, P227, DOI 10.1029/95GB00321; MAYR E, NEW PHILOS BIOL OBSE; Meko D, 1997, J CLIMATE, V10, P687, DOI 10.1175/1520-0442(1997)010<0687:DRWTVP>2.0.CO;2; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Peters K., 1981, Tree-Ring Bulletin, V41, P1; Peterson D. L., 1998, IMPACTS CLIMATE VARI, P191; PHIPPS RL, 1985, 854148 US GEOL SURV, P1; Piovesan G, 2001, CAN J BOT, V79, P1039, DOI 10.1139/cjb-79-9-1039; Pisaric MFJ, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029139; Piutti E, 1997, CAN J FOREST RES, V27, P277, DOI 10.1139/x96-176; Schweingruber F. H., 1996, Tree rings and environment: dendroecology.; Schweingruber F. H., 1990, METHODS DENDROCHRONO, P23, DOI [10.1007/978- 94-015-7879-0, DOI 10.1007/978-94-015-7879-0]; Swetnam TW, 1999, ECOL APPL, V9, P1189, DOI 10.1890/1051-0761(1999)009[1189:AHEUTP]2.0.CO;2; SWETNAM TW, 1985, USDA FOREST SERVICE, V639, P1; Wilmking M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023331; Wilmking M, 2004, GLOBAL CHANGE BIOL, V10, P1724, DOI 10.1111/j.1365-2486.2004.00826.x; Zar JH, 1999, BIOSTATISTICAL ANAL	50	90	94	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22813	10.1371/journal.pone.0022813	http://dx.doi.org/10.1371/journal.pone.0022813			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829523	Green Submitted, Green Published, gold			2022-12-25	WOS:000293284600051
J	Horbul, JE; Schmechel, SC; Miller, BRL; Rice, SA; Southern, PJ				Horbul, Julie E.; Schmechel, Stephen C.; Miller, Barrie R. L.; Rice, Stephen A.; Southern, Peter J.			Herpes Simplex Virus-Induced Epithelial Damage and Susceptibility to Human Immunodeficiency Virus Type 1 Infection in Human Cervical Organ Culture	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; CD4(+) T-CELLS; CANDIDATE TOPICAL MICROBICIDES; HUMAN PALATINE TONSIL; FEMALE GENITAL-TRACT; HIV-1 TRANSMISSION; HSV-2 REACTIVATION; COITAL ACT; WOMEN; LYMPHOCYTES	Normal human premenopausal cervical tissue has been used to derive primary cell populations and to establish ex vivo organ culture systems to study infections with herpes simplex virus (HSV-1 or HSV-2) and human immunodeficiency virus type 1 (HIV-1). Infection with either HSV-1 or HSV-2 rapidly induced multinuclear giant cell formation and widespread damage in mucosal epithelial cells. Subsequent exposure of the damaged mucosal surfaces to HIV-1 revealed frequent co-localization of HSV and HIV-1 antigens. The short-term organ culture system provides direct experimental support for the epidemiological findings that pre-existing sexually transmitted infections, including primary and recurrent herpes virus infections at mucosal surfaces, represent major risk factors for acquisition of primary HIV-1 infection. Epithelial damage in combination with pre-existing inflammation, as described here for overtly normal human premenopausal cervix, creates a highly susceptible environment for the initiation and establishment of primary HIV-1 infection in the sub-mucosa of the cervical transformation zone.	[Horbul, Julie E.; Miller, Barrie R. L.; Rice, Stephen A.; Southern, Peter J.] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; [Schmechel, Stephen C.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Horbul, JE (corresponding author), Univ Wisconsin Hosp & Clin, Madison, WI 53792 USA.	south003@umn.edu			Minnesota Medical Foundation; NIH [AI 042737, DE 15090, P30 CA77598, P50 CA101955, KL2 RR033182]; University of Minnesota Academic Health Center; NATIONAL CANCER INSTITUTE [P50CA101955, P30CA077598] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114, KL2TR000113] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR033182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042737, R21AI042737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE015090] Funding Source: NIH RePORTER	Minnesota Medical Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota Academic Health Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	These studies were supported in part by predoctoral awards (JEH) and a basic research grant (SCS) from the Minnesota Medical Foundation and by funds provided by the NIH: AI 042737 (SAR) and DE 15090 (PS). BioNet facilities are supported by NIH grants P30 CA77598 (D. Yee), P50 CA101955 (D Buchsbaum) and KL2 RR033182 (B. Blazar) and the University of Minnesota Academic Health Center. No additional external funding was received for this study. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002230; ALBRECHT MA, 1989, J VIROL, V63, P1861, DOI 10.1128/JVI.63.5.1861-1868.1989; Andrei G, 2006, ANTIVIR RES, V71, P96, DOI 10.1016/j.antiviral.2006.05.023; Bafica A, 2004, J IMMUNOL, V172, P7229, DOI 10.4049/jimmunol.172.12.7229; Bomsel M, 1997, NAT MED, V3, P42, DOI 10.1038/nm0197-42; Bosnjak L, 2005, J IMMUNOL, V174, P2220, DOI 10.4049/jimmunol.174.4.2220; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Cachay ER, 2007, J INFECT DIS, V195, P1270, DOI 10.1086/513568; Calistri A, 1999, J ACQ IMMUN DEF SYND, V21, P90; Cheshenko N, 2004, ANTIMICROB AGENTS CH, V48, P2025, DOI 10.1128/AAC.48.6.2025-2036.2004; Cohen CR, 2010, AIDS, V24, P2069, DOI 10.1097/QAD.0b013e32833c323b; Collins KB, 2000, NAT MED, V6, P475, DOI 10.1038/74743; Coombs RW, 2003, AIDS, V17, P455, DOI 10.1097/00002030-200303070-00001; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; Corey L, 2007, J INFECT DIS, V195, P1242, DOI 10.1086/513570; CRITTENDEN JA, 1992, FERTIL STERIL, V57, P1294; de Jong MAWP, 2010, TRENDS IMMUNOL, V31, P452, DOI 10.1016/j.it.2010.08.002; de Jong MAWP, 2010, J IMMUNOL, V185, P1633, DOI 10.4049/jimmunol.0904137; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Divito S, 2006, IMMUNOL RES, V36, P119, DOI 10.1385/IR:36:1:119; Efstathiou S, 2005, VIRUS RES, V111, P108, DOI 10.1016/j.virusres.2005.04.017; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Fuchs J, 2010, J INFECT DIS, V201, P1164, DOI 10.1086/651381; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; GIBBS JS, 1994, AIDS RES HUM RETROV, V10, P607, DOI 10.1089/aid.1994.10.607; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Greenhead P, 2000, J VIROL, V74, P5577, DOI 10.1128/JVI.74.12.5577-5586.2000; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Han JY, 2007, VIROLOGY, V359, P253, DOI 10.1016/j.virol.2006.09.038; Hladik F, 2007, IMMUNITY, V26, P257, DOI 10.1016/j.immuni.2007.01.007; Ito M, 1997, J INFECT DIS, V175, P1220, DOI 10.1086/593672; Jacobson DL, 2000, SEX TRANSM DIS, V27, P252, DOI 10.1097/00007435-200005000-00003; Johansson EL, 1999, IMMUNOLOGY, V96, P272; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Kapiga SH, 2007, J INFECT DIS, V195, P1260, DOI 10.1086/513566; Koelle DM, 2003, CLIN MICROBIOL REV, V16, P96, DOI 10.1128/CMR.16.1.96-113.2003; LAGA M, 1993, AIDS, V7, P95, DOI 10.1097/00002030-199301000-00015; Levine WC, 1998, J INFECT DIS, V177, P167, DOI 10.1086/513820; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Lisco A, 2008, CELL HOST MICROBE, V4, P260, DOI 10.1016/j.chom.2008.07.008; Lusk MJ, 2008, CURR OPIN INFECT DIS, V21, P49, DOI 10.1097/QCO.0b013e3282f3d988; Madan RP, 2007, J VIROL, V81, P7636, DOI 10.1128/JVI.02851-06; Maher D, 2005, P NATL ACAD SCI USA, V102, P11504, DOI 10.1073/pnas.0500848102; Maher D, 2004, J INFECT DIS, V190, P1989, DOI 10.1086/425423; Maher DM, 2005, J HISTOCHEM CYTOCHEM, V53, P631, DOI 10.1369/jhc.4A6534.2005; MasCasullo V, 2005, VIRAL IMMUNOL, V18, P595, DOI 10.1089/vim.2005.18.595; Mendez-Samperio P, 2000, J INTERF CYTOK RES, V20, P273, DOI 10.1089/107999000312405; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Moscicki AB, 2001, J INFECT DIS, V183, P865, DOI 10.1086/319261; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; Nickel JC, 2001, BJU INT, V87, P797, DOI 10.1046/j.1464-410x.2001.02193.x; NORVELL MK, 1984, J REPROD MED, V29, P269; Nystrom K, 2004, J VIROL METHODS, V118, P83, DOI 10.1016/j.jviromet.2004.01.019; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Pope M, 2003, NAT MED, V9, P847, DOI 10.1038/nm0703-847; POSAVAD CM, 1992, J VIROL, V66, P6264, DOI 10.1128/JVI.66.11.6264-6272.1992; Prakash M, 2003, AM J OBSTET GYNECOL, V188, P376, DOI 10.1067/mob.2003.16; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Quinn TC, 2005, SCIENCE, V308, P1582, DOI 10.1126/science.1112489; Rebbapragada A, 2007, AIDS, V21, P589, DOI 10.1097/QAD.0b013e328012b896; Reynolds SJ, 2003, J INFECT DIS, V187, P1513, DOI 10.1086/368357; RINALDO CR, 1978, J IMMUNOL, V120, P130; Roberts Craig, 2005, Herpes, V12, P10; Robertson SA, 2005, CELL TISSUE RES, V322, P43, DOI 10.1007/s00441-005-1127-3; Rottingen JA, 2001, SEX TRANSM DIS, V28, P579; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Schacker T, 1998, JAMA-J AM MED ASSOC, V280, P61, DOI 10.1001/jama.280.1.61; Sharova N, 2005, EMBO J, V24, P2481, DOI 10.1038/sj.emboj.7600707; Sommers MS, 2007, TRAUMA VIOLENCE ABUS, V8, P270, DOI 10.1177/1524838007303194; Southern PJ, 2011, MUCOSAL IMMUNOL, V4, P383, DOI 10.1038/mi.2011.12; Stern JE, 1998, OBSTET GYNECOL, V91, P987, DOI 10.1016/S0029-7844(98)00086-6; Syrjanen S, 1996, J VIROL, V70, P6524; Tanton C, 2010, J INFECT DIS, V201, P1285, DOI 10.1086/651696; Tsai WP, 1996, VIROLOGY, V226, P205, DOI 10.1006/viro.1996.0648; Vanpouille C, 2010, J INFECT DIS, V201, P635, DOI 10.1086/650343; Vernazza PL, 1996, J VIROL METHODS, V56, P33, DOI 10.1016/0166-0934(95)01899-9; Visalli RJ, 1997, VIROLOGY, V230, P236, DOI 10.1006/viro.1997.8484; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; Wald A, 1997, J CLIN INVEST, V99, P1092, DOI 10.1172/JCI119237; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353; Zhang ZQ, 2004, P NATL ACAD SCI USA, V101, P5640, DOI 10.1073/pnas.0308425101; Zhu J, 2007, J EXP MED, V204, P595, DOI 10.1084/jem.20061792; Zhu J, 2009, NAT MED, V15, P886, DOI 10.1038/nm.2006	85	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22638	10.1371/journal.pone.0022638	http://dx.doi.org/10.1371/journal.pone.0022638			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818356	gold, Green Published, Green Submitted			2022-12-25	WOS:000293282700054
J	Latiano, A; Palmieri, O; Latiano, T; Corritore, G; Bossa, F; Martino, G; Biscaglia, G; Scimeca, D; Valvano, MR; Pastore, M; Marseglia, A; D'Inca, R; Andriulli, A; Annese, V				Latiano, Anna; Palmieri, Orazio; Latiano, Tiziana; Corritore, Giuseppe; Bossa, Fabrizio; Martino, Giuseppina; Biscaglia, Giuseppe; Scimeca, Daniela; Valvano, Maria Rosa; Pastore, Maria; Marseglia, Antonio; D'Inca, Renata; Andriulli, Angelo; Annese, Vito			Investigation of Multiple Susceptibility Loci for Inflammatory Bowel Disease in an Italian Cohort of Patients	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COLITIS-RISK LOCI; CROHNS-DISEASE; ULCERATIVE-COLITIS; SEQUENCE VARIANTS; TNFSF15; POLYMORPHISMS; CONTRIBUTE; AUTOPHAGY; NUMBER	Background: Recent GWAs and meta-analyses have outlined about 100 susceptibility genes/loci for inflammatory bowel diseases (IBD). In this study we aimed to investigate the influence of SNPs tagging the genes/loci PTGER4, TNFSF15, NKX2-3, ZNF365, IFNG, PTPN2, PSMG1, and HLA in a large pediatric- and adult-onset IBD Italian cohort. Methods: Eight SNPs were assessed in 1,070 Crohn's disease (CD), 1,213 ulcerative colitis (UC), 557 of whom being diagnosed at the age of <= 16 years, and 789 healthy controls. Correlations with sub-phenotypes and major variants of NOD2 gene were investigated. Results: The SNPs tagging the TNFSF15, NKX2-3, ZNF365, and PTPN2 genes were associated with CD (P values ranging from 0.037 to 7x10(-6)). The SNPs tagging the PTGER4, NKX2-3, ZNF365, IFNG, PSMG1, and HLA area were associated with UC (P values 0.047 to 4 x 10(-5)). In the pediatric cohort the associations of TNFSF15, NKX2-3 with CD, and PTGER4, NKX2-3, ZNF365, IFNG, PSMG1 with UC, were confirmed. Association with TNFSF15 and pediatric UC was also reported. A correlation with NKX2-3 and need for surgery (P = 0.038), and with HLA and steroid-responsiveness (P = 0.024) in UC patients was observed. Moreover, significant association in our CD cohort with TNFSF15 SNP and colonic involvement (P = 0.021), and with ZNF365 and ileal location (P = 0.024) was demonstrated. Conclusions: We confirmed in a large Italian cohort the associations with CD and UC of newly identified genes, both in adult and pediatric cohort of patients, with some influence on sub-phenotypes.	[Latiano, Anna; Palmieri, Orazio; Latiano, Tiziana; Corritore, Giuseppe; Bossa, Fabrizio; Martino, Giuseppina; Biscaglia, Giuseppe; Scimeca, Daniela; Valvano, Maria Rosa; Andriulli, Angelo] IRCCS Casa Sollievo Sofferenza, Gastroenterol Unit, San Giovanni Rotondo, Italy; [Pastore, Maria; Marseglia, Antonio] IRCCS Casa Sollievo Sofferenza, Div Paediat, San Giovanni Rotondo, Italy; [D'Inca, Renata] Univ Padua, Dept Surg & Gastroenterol Sci, Padua, Italy; [Annese, Vito] Univ Hosp Careggi, Div Gastroenterol, Florence, Italy	IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; University of Padua; University of Florence; Azienda Ospedaliero Universitaria Careggi	Latiano, A (corresponding author), IRCCS Casa Sollievo Sofferenza, Gastroenterol Unit, San Giovanni Rotondo, Italy.	a.latiano@operapadrepio.it	Scimeca, Daniela/AAC-7625-2022; Latiano, Anna/R-1965-2016; Andriulli, Angelo/B-5027-2017; Biscaglia, Giuseppe/K-2153-2016; Annese, Vito/AGW-4200-2022; Valvano, Maria/B-5118-2017; Palmieri, Orazio/J-7697-2012; Bossa, Fabrizio/B-3078-2017	Latiano, Anna/0000-0003-3719-2061; Andriulli, Angelo/0000-0001-8862-7083; Biscaglia, Giuseppe/0000-0002-3799-2547; Annese, Vito/0000-0002-0082-892X; Valvano, Maria/0000-0003-4704-8354; Palmieri, Orazio/0000-0002-0019-7929; Bossa, Fabrizio/0000-0002-4518-9949; Scimeca, Daniela/0000-0003-4633-7912	 [RC0902GA33]		The study was supported by a grant from the Italian Minister of the Health (RC0902GA33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amre DK, 2010, ALIMENT PHARM THER, V31, P1186, DOI 10.1111/j.1365-2036.2010.04294.x; Amre DK, 2009, AM J GASTROENTEROL, V104, P2824, DOI 10.1038/ajg.2009.430; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Asano K, 2009, NAT GENET, V41, P1325, DOI 10.1038/ng.482; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Escher JC, 2005, J PEDIATR GASTR NUTR, V41, P1; Essers JB, 2009, INFLAMM BOWEL DIS, V15, P1508, DOI 10.1002/ibd.20922; Faubion WA, 2001, GASTROENTEROLOGY, V121, P255, DOI 10.1053/gast.2001.26279; Fisher SA, 2008, NAT GENET, V40, P710, DOI 10.1038/ng.145; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Franke A, 2008, NAT GENET, V40, P713, DOI 10.1038/ng.148; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Imielinski M, 2009, NAT GENET, V41, P1335, DOI 10.1038/ng.489; Kugathasan S, 2008, NAT GENET, V40, P1211, DOI 10.1038/ng.203; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Migone TS, 2002, IMMUNITY, V16, P479, DOI 10.1016/S1074-7613(02)00283-2; MUNKHOLM P, 1994, GUT, V35, P360, DOI 10.1136/gut.35.3.360; Pabst O, 2000, EMBO J, V19, P2015, DOI 10.1093/emboj/19.9.2015; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Picornell Y, 2007, INFLAMM BOWEL DIS, V13, P1333, DOI 10.1002/ibd.20223; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Prehn JL, 2004, CLIN IMMUNOL, V112, P66, DOI 10.1016/j.clim.2004.02.007; Rioux JD, 2000, AM J HUM GENET, V66, P1863, DOI 10.1086/302913; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Rioux JD, 2009, P NATL ACAD SCI USA, V106, P18680, DOI 10.1073/pnas.0909307106; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Satsangi J, 1996, LANCET, V347, P1212, DOI 10.1016/S0140-6736(96)90734-5; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; Thiebaut R, 2009, AM J GASTROENTEROL, V104, P384, DOI 10.1038/ajg.2008.36; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Tremelling M, 2008, INFLAMM BOWEL DIS, V14, P733, DOI 10.1002/ibd.20399; *UK IBD GEN CONS, 2009, NAT GENET, V12, P1330; Weersma RK, 2009, AM J GASTROENTEROL, V104, P630, DOI 10.1038/ajg.2008.112; *WELLC TRUST CAS C, 2007, NATURE, V47, P61; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yamazaki K, 2005, HUM MOL GENET, V14, P3499, DOI 10.1093/hmg/ddi379; Yang SK, 2008, AM J GASTROENTEROL, V103, P1437, DOI 10.1111/j.1572-0241.2007.01752.x	39	43	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22688	10.1371/journal.pone.0022688	http://dx.doi.org/10.1371/journal.pone.0022688			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818367	Green Submitted, Green Published, gold			2022-12-25	WOS:000293282700060
J	Palazy, L; Bonenfant, C; Gaillard, JM; Courchamp, F				Palazy, Lucille; Bonenfant, Christophe; Gaillard, Jean-Michel; Courchamp, Franck			Cat Dilemma: Too Protected To Escape Trophy Hunting?	PLOS ONE			English	Article							CONSERVATION; RARITY; POPULATION; IMPACT	Trophy hunting is one of the most controversial issues in the field of biodiversity conservation. In particular, proponents and opponents debate fiercely over whether it poses a threat to hunted populations. Here, we show that trophy hunting constitutes a greater menace to threatened species than previously realized. Because humans value rarity, targeted species that are threatened are likely to be disproportionately hunted, thereby becoming even more vulnerable, which could eventually push them to extinction. With the ten felid species currently hunted for their trophies, we present evidence that (1) the number of killed individuals increases with time, in several cases exponentially, despite population declines, (2) the price of trophies is strongly dependent on species protection status, (3) changes of protection status coincide with counter-intuitive changes of hunting pressures: protection intensification with augmented hunting effort, and protection relaxation with lower effort. This suggests an over-exploitation of trophy-hunted felids and the necessity of a better quota system coupled with reconsidered protection methods.	[Palazy, Lucille; Courchamp, Franck] Univ Paris 11, CNRS, UMR 8079, F-91405 Orsay, France; [Palazy, Lucille; Bonenfant, Christophe; Gaillard, Jean-Michel] Univ Lyon 1, CNRS, UMR 5558, F-69622 Villeurbanne, France	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	Palazy, L (corresponding author), Univ Paris 11, CNRS, UMR 8079, F-91405 Orsay, France.	lucille.palazy@u-psud.fr	Courchamp, Franck/ABE-7204-2020; Bonenfant, Christophe/I-8645-2019	Courchamp, Franck/0000-0001-7605-4548; Bonenfant, Christophe/0000-0002-9924-419X	Agence Nationale de la Recherche	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the Agence Nationale de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGULO E, 2009, P R SOC B, V276, P131; Angulo E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005215; Berec L, 2007, TRENDS ECOL EVOL, V22, P185, DOI 10.1016/j.tree.2006.12.002; Booth V.R., 2009, CIC TECH SER PUB, V7, P40; BRESLOW N, 1970, BIOMETRIKA, V57, P579, DOI 10.2307/2334776; C?lix M., 2018, EUROPEAN RED LIST SA; Caro TM, 1998, AFR J ECOL, V36, P321, DOI 10.1046/j.1365-2028.1998.00146.x; Chapron G, 2008, J APPL ECOL, V45, P1667, DOI 10.1111/j.1365-2664.2008.01538.x; Courchamp F, 2006, PLOS BIOL, V4, P2405, DOI 10.1371/journal.pbio.0040415; Frisina M.R., 2009, RECREATIONAL HUNTING, P141, DOI DOI 10.1002/9781444303179; Gandy S. E., 2004, Koedoe, V47, P119; Gault A, 2008, CONSERV LETT, V1, P199, DOI 10.1111/j.1755-263X.2008.00038.x; Grieser-Johns A., 2005, GOING GOING GONE ILL; Hall RJ, 2008, CONSERV LETT, V1, P75, DOI 10.1111/j.1755-263X.2008.00013.x; Kotler P., 2008, PRINCIPLES MARKETING; Leader-Williams N, 2001, SCIENCE, V293, P2203; Lewis DM, 1997, CONSERV BIOL, V11, P59, DOI 10.1046/j.1523-1739.1997.94389.x; Lindsey PA, 2007, BIOL CONSERV, V134, P455, DOI 10.1016/j.biocon.2006.09.005; Loveridge A.J., 2006, KEY TOPICS CONSERVAT, P224; LOVERIDGE AJ, 2009, SCI RECREATIONAL HUN, P108; Macdonald David W., 2010, P599; Milner-Gulland EJ, 2003, NATURE, V422, P135, DOI 10.1038/422135a; Packer C, 2011, CONSERV BIOL, V25, P142, DOI 10.1111/j.1523-1739.2010.01576.x; Packer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005941; PALAZY L, 2011, RARITY TROPHY HUNTIN; Rivalan P, 2007, NATURE, V447, P529, DOI 10.1038/447529a; Rosen GE, 2010, ECOHEALTH, V7, P24, DOI 10.1007/s10393-010-0317-y; Satish L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010063; SILVA M, 1995, CRC HDB MAMMALIAN BO; Slotow R, 2000, NATURE, V408, P425, DOI 10.1038/35044191; Swenson JE, 1997, NATURE, V386, P450, DOI 10.1038/386450a0; TOURNANT P, RARITY OVEREXP UNPUB; Whitman K, 2004, NATURE, V428, P175, DOI 10.1038/nature02395; Whitman KL, 2007, CONSERV BIOL, V21, P591, DOI 10.1111/j.1523-1739.2007.00700.x	34	17	17	2	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22424	10.1371/journal.pone.0022424	http://dx.doi.org/10.1371/journal.pone.0022424			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818322	Green Published, gold, Green Submitted			2022-12-25	WOS:000293282700030
J	Caillou, B; Talbot, M; Weyemi, U; Pioche-Durieu, C; Al Ghuzlan, A; Bidart, JM; Chouaib, S; Schlumberger, M; Dupuy, C				Caillou, Bernard; Talbot, Monique; Weyemi, Urbain; Pioche-Durieu, Catherine; Al Ghuzlan, Abir; Bidart, Jean Michel; Chouaib, Salem; Schlumberger, Martin; Dupuy, Corinne			Tumor-Associated Macrophages (TAMs) Form an Interconnected Cellular Supportive Network in Anaplastic Thyroid Carcinoma	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; INTRATUMORAL DISTRIBUTION; INVASIVE CAPACITY; DENDRITIC CELLS; IN-VITRO; MONOCYTES; EXPRESSION; BIOLOGY; CANCER; INVADOPODIA	Background: A relationship between the increased density of tumor-associated macrophages (TAMs) and decreased survival was recently reported in thyroid cancer patients. Among these tumors, anaplastic thyroid cancer (ATC) is one of the most aggressive solid tumors in humans. TAMs (type M2) have been recognized as promoting tumor growth. The purpose of our study was to analyze with immunohistochemistry the presence of TAMs in a series of 27 ATC. Methodology/Principal Findings: Several macrophages markers such as NADPH oxidase complex NOX2-p22phox, CD163 and CD 68 were used. Immunostainings showed that TAMs represent more than 50% of nucleated cells in all ATCs. Moreover, these markers allowed the identification of elongated thin ramified cytoplasmic extensions, bestowing a "microglia-like" appearance on these cells which we termed "Ramified TAMs" (RTAMs). In contrast, cancer cells were totally negative. Cellular stroma was highly simplified since apart from cancer cells and blood vessels, RTAMs were the only other cellular component. RTAMs were evenly distributed and intermingled with cancer cells, and were in direct contact with other RTAMs via their ramifications. Moreover, RTAMs displayed strong immunostaining for connexin Cx43. Long chains of interconnected RTAMs arose from perivascular clusters and were dispersed within the tumor parenchyma. When expressed, the glucose transporter Glut1 was found in RTAMs and blood vessels, but rarely in cancer cells. Conclusion: ATCs display a very dense network of interconnected RTAMs in direct contact with intermingled cancer cells. To our knowledge this is the first time that such a network is described in a malignant tumor. This network was found in all our studied cases and appeared specific to ATC, since it was not found in differentiated thyroid cancers specimens. Taken together, these results suggest that RTAMs network is directly related to the aggressiveness of the disease via metabolic and trophic functions which remain to be determined.	[Caillou, Bernard; Al Ghuzlan, Abir; Bidart, Jean Michel] Inst Gustave Roussy, Dept Biopathol, Villejuif, France; [Talbot, Monique; Weyemi, Urbain; Dupuy, Corinne] CNRS, FRE 2939, Villejuif, France; [Pioche-Durieu, Catherine] CNRS, UMR 8126, Villejuif, France; [Chouaib, Salem] INSERM, U753, Villejuif, France; [Schlumberger, Martin] Inst Gustave Roussy, Dept Nucl Med & Endocrine Oncol, Villejuif, France	UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy	Caillou, B (corresponding author), Inst Gustave Roussy, Dept Biopathol, Villejuif, France.	bercaillou@gmail.com	Chouaib, Salem/F-7939-2016; Weyemi, Urbain/E-2083-2016	Al Ghuzlan, Abir/0000-0001-5198-6111; Durieu, Catherine/0000-0003-0988-1169	Canceropole ile de France; Institut National du Cancer	Canceropole ile de France(Region Ile-de-France); Institut National du Cancer(Institut National du Cancer (INCA) France)	This work was supported by a grant from Canceropole ile de France and Institut National du Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ain KB, 1998, THYROID, V8, P715, DOI 10.1089/thy.1998.8.715; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Anghelina M, 2002, COLD SPRING HARB SYM, V67, P209, DOI 10.1101/sqb.2002.67.209; Anghelina M, 2006, J CELL MOL MED, V10, P708, DOI 10.2755/jcmm010.003.21; Are C, 2006, ANN SURG ONCOL, V13, P453, DOI 10.1245/ASO.2006.05.042; AWWAD HK, 1986, INT J RADIAT ONCOL, V12, P1329, DOI 10.1016/0360-3016(86)90165-3; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Beranek JT, 2005, ANN RHEUM DIS, V64, P342; Bogsrud TV, 2008, THYROID, V18, P713, DOI 10.1089/thy.2007.0350; Brindle K, 2008, NAT REV CANCER, V8, P94, DOI 10.1038/nrc2289; Brown JM, 1998, CANCER RES, V58, P1408; Brown RS, 1996, J NUCL MED, V37, P1042; Buhtoiarov IN, 2005, J IMMUNOL, V174, P6013, DOI 10.4049/jimmunol.174.10.6013; BUSTOS R, 1989, FEBS LETT, V251, P143, DOI 10.1016/0014-5793(89)81444-9; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Cornett Wendy R, 2007, Curr Oncol Rep, V9, P152, DOI 10.1007/s11912-007-0014-3; Corzo CA, 2009, J IMMUNOL, V182, P5693, DOI 10.4049/jimmunol.0900092; Dbouk HA, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-4; Diaz B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000368; Dome B, 2007, AM J PATHOL, V170, P1, DOI 10.2353/ajpath.2007.060302; Evans WH, 2006, BIOCHEM J, V397, P1, DOI 10.1042/BJ20060175; Fabriek BO, 2005, IMMUNOBIOLOGY, V210, P153, DOI 10.1016/j.imbio.2005.05.010; FINA L, 1990, BLOOD, V75, P2417; Frank S J, 1990, Semin Immunol, V2, P89; Fu YC, 2004, BLOOD CELL MOL DIS, V32, P182, DOI 10.1016/j.bcmd.2003.09.002; Giardina SF, 2007, BIOCHEM BIOPH RES CO, V362, P747, DOI 10.1016/j.bbrc.2007.08.066; Glod J, 2006, BLOOD, V107, P940, DOI 10.1182/blood-2004-11-4403; Goldberg GS, 2004, BBA-BIOMEMBRANES, V1662, P96, DOI 10.1016/j.bbamem.2003.11.022; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; GROEGER G, 2009, ANTIOXID REDOX SIGNA; Guiducci C, 2005, CANCER RES, V65, P3437, DOI 10.1158/0008-5472.CAN-04-4262; Havemann K, 2003, ADV EXP MED BIOL, V522, P47; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hlatky L, 2002, JNCI-J NATL CANCER I, V94, P883; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kono K, 1996, EUR J IMMUNOL, V26, P1308, DOI 10.1002/eji.1830260620; KUBOTA R, 1992, J NUCL MED, V33, P1972; Kumar B, 2008, CANCER RES, V68, P1777, DOI 10.1158/0008-5472.CAN-07-5259; Kunisch E, 2004, ANN RHEUM DIS, V63, P774, DOI 10.1136/ard.2003.013029; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Li B, 2009, CANCER RES, V69, P338, DOI 10.1158/0008-5472.CAN-08-1565; Mander PK, 2006, J IMMUNOL, V176, P1046, DOI 10.4049/jimmunol.176.2.1046; MANTOVANI A, 1992, IMMUNOL TODAY, V13, P265, DOI 10.1016/0167-5699(92)90008-U; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; MUKAI M, 1987, CANCER RES, V47, P2167; ORDONEZ NG, 1991, AM J CLIN PATHOL, V96, P15, DOI 10.1093/ajcp/96.1.15; Oviedo-Orta E, 2004, BBA-BIOMEMBRANES, V1662, P102, DOI 10.1016/j.bbamem.2003.10.021; Poisson T, 2010, EUR J NUCL MED MOL I, V37, P2277, DOI 10.1007/s00259-010-1570-6; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Pries AR, 2010, NAT REV CANCER, V10, P587, DOI 10.1038/nrc2895; Pries AR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000394; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Scavelli C, 2008, ONCOGENE, V27, P663, DOI 10.1038/sj.onc.1210691; Schaer DJ, 2002, BRIT J HAEMATOL, V119, P239, DOI 10.1046/j.1365-2141.2002.03790.x; Schmeisser A, 2003, ADV EXP MED BIOL, V522, P59; Schmeisser A, 2001, CARDIOVASC RES, V49, P671, DOI 10.1016/S0008-6363(00)00270-4; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; SHINKAI K, 1986, CANCER LETT, V32, P7, DOI 10.1016/0304-3835(86)90033-9; Simek J, 2009, J CELL SCI, V122, P554, DOI 10.1242/jcs.036970; Stout RD, 2009, J LEUKOCYTE BIOL, V86, P1105, DOI 10.1189/jlb.0209073; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Weaver AM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.288pe56; Yamaguchi H, 2006, EUR J CELL BIOL, V85, P213, DOI 10.1016/j.ejcb.2005.10.004	68	122	126	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22567	10.1371/journal.pone.0022567	http://dx.doi.org/10.1371/journal.pone.0022567			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811634	gold, Green Submitted, Green Published			2022-12-25	WOS:000292956800071
J	Yan, BY; Li, P				Yan, Boyuan; Li, Peng			An Integrative View of Mechanisms Underlying Generalized Spike-and-Wave Epileptic Seizures and Its Implication on Optimal Therapeutic Treatments	PLOS ONE			English	Article							CORTICALLY GENERATED SEIZURES; CELLULAR MECHANISMS; ABSENCE SEIZURES; FAST COMPONENTS; NA+ CURRENT; NEURONS; MODEL; RAT; OSCILLATIONS; LAMOTRIGINE	Many types of epileptic seizures are characterized by generalized spike-and-wave discharges. In the past, notable effort has been devoted to understanding seizure dynamics and various hypotheses have been proposed to explain the underlying mechanisms. In this paper, by taking an integrative view of the underlying mechanisms, we demonstrate that epileptic seizures can be generated by many different combinations of synaptic strengths and intrinsic membrane properties. This integrative view has important medical implications: the specific state of a patient characterized by a set of biophysical characteristics ultimately determines the optimal therapeutic treatment. Through the same view, we further demonstrate the potentiation effect of rational polypharmacy in the treatment of epilepsy and provide a new angle to resolve the debate on polypharmacy. Our results underscore the need for personalized medicine and demonstrate that computer modeling and simulation may play an important role in assisting the clinicians in selecting the optimal treatment on an individual basis.	[Yan, Boyuan; Li, Peng] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Yan, BY (corresponding author), Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA.	byan@tamu.edu						Achard P, 2006, PLOS COMPUT BIOL, V2, P794, DOI 10.1371/journal.pcbi.0020094; Ambrosio AF, 1999, NEUROPHARMACOLOGY, V38, P1349, DOI 10.1016/S0028-3908(99)00058-1; Bialer M, 2010, NAT REV DRUG DISCOV, V9, P68, DOI 10.1038/nrd2997; Bower JM, 1998, BOOK GENESIS EXPLORI; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; de Curtis M, 1999, NEUROSCIENCE, V88, P107, DOI 10.1016/S0306-4522(98)00201-2; Destexhe A, 1996, J NEUROSCI, V16, P169; Destexhe A, 2001, NEUROCOMPUTING, V38, P555, DOI 10.1016/S0925-2312(01)00348-4; DESTEXHE A, 1994, NEURAL COMPUT, V6, P14, DOI 10.1162/neco.1994.6.1.14; DESTEXHE A, 1995, P NATL ACAD SCI USA, V92, P9515, DOI 10.1073/pnas.92.21.9515; Destexhe A, 1998, J NEUROSCI, V18, P9099; Destexhe A, 1996, J NEUROPHYSIOL, V76, P2049, DOI 10.1152/jn.1996.76.3.2049; Destexhe A, 1998, J NEUROPHYSIOL, V79, P999; DICHTER MA, 1987, SCIENCE, V237, P157, DOI 10.1126/science.3037700; DRONGELEN W, 2005, IEEE T NEUR SYS REH, V13, P236; DRONGELEN WV, 2007, J CLIN NEUROPHYSIOL, V24, P182; DRONGELEN WV, 2003, J NEUROPHYSIOL, V90, P1571; FERRENDELLI JA, 1977, EPILEPSIA, V18, P331, DOI 10.1111/j.1528-1157.1977.tb04975.x; GIARETTA D, 1987, BRAIN RES, V405, P68, DOI 10.1016/0006-8993(87)90990-5; HALLIWELL JV, 1986, NEUROSCI LETT, V67, P1, DOI 10.1016/0304-3940(86)90198-9; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOSFORD DA, 1992, SCIENCE, V257, P398, DOI 10.1126/science.1321503; Hosford DA, 1997, EPILEPSY RES, V27, P55, DOI 10.1016/S0920-1211(97)01023-1; HUGUENARD JR, 1992, J NEUROSCI, V12, P3804, DOI 10.1523/jneurosci.12-10-03804.1992; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; JANNICELLI J, 2009, CLIN TRENDS NEWS NEU, V17; KIRKER S, 1990, ACTA NEUROLOGIC S133, V82, P38; Leresche N, 1998, J NEUROSCI, V18, P4842; LIU Z, 1992, NEUROSCIENCE, V48, P87, DOI 10.1016/0306-4522(92)90340-8; Lytton WW, 2008, NAT REV NEUROSCI, V9, P626, DOI 10.1038/nrn2416; MCCORMICK DA, 1993, CEREB CORTEX, V3, P387, DOI 10.1093/cercor/3.5.387; MCCORMICK DA, 1992, J NEUROPHYSIOL, V68, P1384, DOI 10.1152/jn.1992.68.4.1384; PANAYIOTOPOULOS CP, 1993, LANCET, V341, P445, DOI 10.1016/0140-6736(93)93048-6; PISANI F, 1993, LANCET, V341, P1224, DOI 10.1016/0140-6736(93)91062-Q; POLLEN DA, 1964, ELECTROEN CLIN NEURO, V17, P398, DOI 10.1016/0013-4694(64)90163-4; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; REYNOLDS EH, 1981, EPILEPSIA, V22, P1, DOI 10.1111/j.1528-1157.1981.tb04327.x; RICHENS A, 1995, SEIZURE, V4, P211, DOI 10.1016/S1059-1311(05)80063-9; ROBINSON MK, 1993, EPILEPSIA S2, V34, P109; ROGAWSKI MA, 1999, ADV NEUROL, V9, P947; SCHMIDT D, 1983, EPILEPSIA, V24, P368, DOI 10.1111/j.1528-1157.1983.tb04900.x; SCHMIDT D, 1982, J NEUROL NEUROSUR PS, V45, P1119, DOI 10.1136/jnnp.45.12.1119; SCHWINDT PC, 1988, J NEUROPHYSIOL, V59, P424, DOI 10.1152/jn.1988.59.2.424; Segal MM, 1997, J NEUROPHYSIOL, V77, P3021, DOI 10.1152/jn.1997.77.6.3021; SHORVON SD, 1977, BRIT MED J, V1, P1635, DOI 10.1136/bmj.1.6077.1635; SHORVON SD, 1979, BRIT MED J, V2, P1023, DOI 10.1136/bmj.2.6197.1023; Smith KA, 1996, BRAIN RES, V729, P147, DOI 10.1016/0006-8993(96)00174-6; SNEAD OC, 1992, EUR J PHARMACOL, V213, P343, DOI 10.1016/0014-2999(92)90623-C; Spadoni F, 2002, NEUROREPORT, V13, P1167, DOI 10.1097/00001756-200207020-00019; Steriade M, 1998, J NEUROPHYSIOL, V80, P1456, DOI 10.1152/jn.1998.80.3.1456; Steriade M, 1998, J NEUROPHYSIOL, V80, P1439, DOI 10.1152/jn.1998.80.3.1439; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; STEWART J, 1992, SEIZURE SA, V1, pP13; Tatulian L, 2001, J NEUROSCI, V21, P5535, DOI 10.1523/JNEUROSCI.21-15-05535.2001; Taverna S, 1999, J PHARMACOL EXP THER, V288, P960; Taverna S, 1998, EPILEPSY RES, V32, P304, DOI 10.1016/S0920-1211(98)00060-6; Timofeev I, 2004, J NEUROPHYSIOL, V92, P1133, DOI 10.1152/jn.00523.2003; Timofeev I, 2004, NEUROSCIENCE, V123, P299, DOI 10.1016/j.neuroscience.2003.08.051; Traub R.D., 1991, NEURONAL NETWORKS HI; Ullah G., 2009, SCHOLARPEDIA, V4, P1409; Vanier MC, 1999, J COMPUT NEUROSCI, V7, P149, DOI 10.1023/A:1008972005316; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750; WONG RKS, 1978, BRAIN RES, V159, P385, DOI 10.1016/0006-8993(78)90544-9; Zhang XL, 2000, EPILEPSIA, V41, pS52	64	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22440	10.1371/journal.pone.0022440	http://dx.doi.org/10.1371/journal.pone.0022440			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811612	Green Published, gold, Green Submitted			2022-12-25	WOS:000292956800057
J	Han, ZY; Nogusa, S; Nicolas, E; Balachandran, S; Taylor, J				Han, Ziying; Nogusa, Shoko; Nicolas, Emmanuelle; Balachandran, Siddharth; Taylor, John			Interferon Impedes an Early Step of Hepatitis Delta Virus Infection	PLOS ONE			English	Article							B-VIRUS; INHIBITORS; INSIGHTS; ANTIGEN; SYSTEM	Hepatitis delta virus (HDV) infects hepatocytes, the major cell type of the liver. Infection of the liver may be either transient or chronic. The prognosis for patients with chronic HDV infection is poor, with a high risk of cirrhosis and hepatocellular carcinoma. The best antiviral therapy is weekly administration for at least one year of high doses of interferon alpha. This efficacy of interferon therapy has been puzzling in that HDV replication in transfected cell lines is reported as insensitive to administration of interferon alpha or gamma. Similarly, this study shows that even when an interferon response was induced by transfection of poly(IC) into a cell line, HDV RNA accumulation was only modestly inhibited. However, when the HDV replication was initiated by infection of primary human hepatocytes, simultaneous addition of interferons alpha or gamma at 600 units/ml, a concentration comparable to that achieved in treated patients, the subsequent HDV RNA accumulation was inhibited by at least 80%. These interferon treatments were shown to produce significant time-dependent increases of host response proteins such as for Stat-1, phosphoStat-1, Mx1/2/3 and PKR, and yet interferon pretreatment of hepatocytes did not confer an increased inhibition of HDV replication over interferon treatment at the time of (or after) infection. These and other data support the interpretation that interferon action against HDV replication can occur and is largely mediated at the level of entry into primary human hepatocytes. Thus in vivo, the success of long-term interferon therapy for chronic HDV, may likewise involve blocking HDV spread by interfering with the initiation of productive infection of naive hepatocytes.	[Han, Ziying; Nogusa, Shoko; Nicolas, Emmanuelle; Balachandran, Siddharth; Taylor, John] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Han, ZY (corresponding author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	John.Taylor@fccc.edu			Fox Chase Cancer Center; Public Health Service [CA-06927]; American Cancer Society [RSG-09-195-01-MPC]; Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER	Fox Chase Cancer Center; Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); American Cancer Society(American Cancer Society); Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	JMT was supported by the President's Fund of the Fox Chase Cancer Center, a Public Health Service grant CA-06927 to FCCC and an appropriation from the Commonwealth of Pennsylvania. SB was supported by an American Cancer Society Research Scholar Grant (RSG-09-195-01-MPC) and FCCC support via the Kidney Cancer Keystone Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2007, BIOCHEM SOC T, V35, P1461, DOI 10.1042/BST0351461; Balachandran S, 1998, EMBO J, V17, P6888, DOI 10.1093/emboj/17.23.6888; Barrera A, 2005, J VIROL, V79, P9786, DOI 10.1128/JVI.79.15.9786-9798.2005; Bordier BB, 2002, J VIROL, V76, P10465, DOI 10.1128/JVI.76.20.10465-10472.2002; Chang J, 2003, J VIROL, V77, P9728, DOI 10.1128/JVI.77.17.9728-9731.2003; Chang JH, 2006, J VIROL, V80, P3205, DOI 10.1128/JVI.80.7.3205-3214.2006; Chang JH, 2005, J VIROL, V79, P8182, DOI 10.1128/JVI.79.13.8182-8188.2005; Farci P, 2011, SHERLOCK'S DISEASES OF THE LIVER AND BILIARY SYSTEM, 12TH EDITION, P393; Fernandez M, 2002, J VIROL, V76, P895, DOI 10.1128/JVI.76.2.895-904.2002; Glebe D, 2007, WORLD J GASTROENTERO, V13, P22, DOI 10.3748/wjg.v13.i1.22; Gripon P, 2005, J VIROL, V79, P1613, DOI 10.1128/JVI.79.3.1613-1622.2005; Gudima S, 2007, J VIROL, V81, P3608, DOI 10.1128/JVI.02277-06; Guo H, 2009, J VIROL, V83, P847, DOI 10.1128/JVI.02008-08; ILAN Y, 1992, J INFECT DIS, V166, P1164, DOI 10.1093/infdis/166.5.1164; McNair A N, 1993, Prog Clin Biol Res, V382, P161; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Petersen J, 2008, NAT BIOTECHNOL, V26, P335, DOI 10.1038/nbt1389; Pugnale P, 2009, HEPATOLOGY, V49, P398, DOI 10.1002/hep.22654; RIZZETTO M, 1983, ANN INTERN MED, V98, P437, DOI 10.7326/0003-4819-98-4-437; RIZZETTO M, 1977, GUT, V18, P997, DOI 10.1136/gut.18.12.997; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Taylor J. M., 2007, FIELDS VIROLOGY, P3031; Taylor JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015784; Taylor JM, 2011, MOL PATHOL LIB, V5, P589, DOI 10.1007/978-1-4419-7107-4_39; Urban S, 2008, FUTURE VIROL, V3, P253, DOI 10.2217/17460794.3.3.253; van Boxel-Dezaire AHH, 2007, CURR TOP MICROBIOL, V316, P119; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; van Boxel-Dezaire AHH, 2010, J IMMUNOL, V185, P5888, DOI 10.4049/jimmunol.0902314; Wedemeyer H, 2011, NEW ENGL J MED, V364, P322, DOI 10.1056/NEJMoa0912696; Wedemeyer H, 2010, J HEPATOL, V52, P627, DOI 10.1016/j.jhep.2010.02.001; Wedemeyer H, 2010, NAT REV GASTRO HEPAT, V7, P31, DOI 10.1038/nrgastro.2009.205	31	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22415	10.1371/journal.pone.0022415	http://dx.doi.org/10.1371/journal.pone.0022415			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21811602	Green Published, gold, Green Submitted			2022-12-25	WOS:000292929500060
J	Jones, TA; Ogunkolade, BW; Szary, J; Aarum, J; Mumin, MA; Patel, S; Pieri, CA; Sheer, D				Jones, Tania A.; Ogunkolade, Babatunji W.; Szary, Jaroslaw; Aarum, Johan; Mumin, Muhammad A.; Patel, Shyam; Pieri, Christopher A.; Sheer, Denise			Widespread Expression of BORIS/CTCFL in Normal and Cancer Cells	PLOS ONE			English	Article							MESSENGER-RNA; BORIS; CTCF; NUCLEOLUS; PROTEIN; TRANSCRIPTION; GENE; EPIGENETICS; DEREPRESSION; MAGE-A1	BORIS (CTCFL) is the paralog of CTCF (CCCTC-binding factor; NM_006565), a ubiquitously expressed DNA-binding protein with diverse roles in gene expression and chromatin organisation. BORIS and CTCF have virtually identical zinc finger domains, yet display major differences in their respective C-and N-terminal regions. Unlike CTCF, BORIS expression has been reported only in the testis and certain malignancies, leading to its classification as a "cancer-testis" antigen. However, the expression pattern of BORIS is both a significant and unresolved question in the field of DNA binding proteins. Here, we identify BORIS in the cytoplasm and nucleus of a wide range of normal and cancer cells. We compare the localization of CTCF and BORIS in the nucleus and demonstrate enrichment of BORIS within the nucleolus, inside the nucleolin core structure and adjacent to fibrillarin in the dense fibrillar component. In contrast, CTCF is not enriched in the nucleolus. Live imaging of cells transiently transfected with GFP tagged BORIS confirmed the nucleolar accumulation of BORIS. While BORIS transcript levels are low compared to CTCF, its protein levels are readily detectable. These findings show that BORIS expression is more widespread than previously believed, and suggest a role for BORIS in nucleolar function.	[Jones, Tania A.; Ogunkolade, Babatunji W.; Szary, Jaroslaw; Aarum, Johan; Mumin, Muhammad A.; Patel, Shyam; Pieri, Christopher A.; Sheer, Denise] Queen Mary Univ London, Ctr Neurosci & Trauma, Blizard Inst, Barts & London Sch Med & Dent, London, England	University of London; Queen Mary University London	Jones, TA (corresponding author), Queen Mary Univ London, Ctr Neurosci & Trauma, Blizard Inst, Barts & London Sch Med & Dent, London, England.	d.sheer@qmul.ac.uk	Sheer, Denise/C-6705-2011; Jones, Tania/C-8912-2011; Corbett-Jones, Tania A/E-4891-2013	Sheer, Denise/0000-0001-9067-1796; Jones, Tania/0000-0002-0067-3382; Corbett-Jones, Tania A/0000-0002-0067-3382; Aarum, Johan/0000-0001-9783-0964; Pieri, Christopher/0000-0002-1274-2349; Mumin, Muhammad Ashraful/0000-0001-6865-456X	Cancer Research UK [C5321/A8318]	Cancer Research UK(Cancer Research UK)	This work was funded by Cancer Research UK programme grant C5321/A8318. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Bartova E, 2010, J HISTOCHEM CYTOCHEM, V58, P391, DOI 10.1369/jhc.2009.955435; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Campbell AE, 2010, BIOCHEM BIOPH RES CO, V396, P648, DOI 10.1016/j.bbrc.2010.04.146; Chen DY, 2001, J CELL BIOL, V153, P169, DOI 10.1083/jcb.153.1.169; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; D'Arcy V, 2008, BRIT J CANCER, V98, P571, DOI 10.1038/sj.bjc.6604181; Darcy V, 2006, CLIN CANCER RES, V12, P5978, DOI 10.1158/1078-0432.CCR-05-2731; Dougherty CJ, 2008, BIOCHEM BIOPH RES CO, V370, P109, DOI 10.1016/j.bbrc.2008.03.040; Hines WC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009738; Hoffmann MJ, 2006, BIOCHEM PHARMACOL, V72, P1577, DOI 10.1016/j.bcp.2006.06.020; Hong JA, 2005, CANCER RES, V65, P7763, DOI 10.1158/0008-5472.CAN-05-0823; Hore TA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000169; Kang Y, 2007, ONCOGENE, V26, P4394, DOI 10.1038/sj.onc.1210218; Kholmanskikh O, 2008, INT J CANCER, V122, P777, DOI 10.1002/ijc.23140; Kim SK, 2003, DNA CELL BIOL, V22, P171, DOI 10.1089/104454903321655792; Klenova E, 2005, CELL CYCLE, V4, P96, DOI 10.4161/cc.4.1.1398; Klenova EA, 2002, SEMIN CANCER BIOL, V12, P399, DOI 10.1016/S1044-579X(02)00060-3; KLENOVA EM, 1993, MOL CELL BIOL, V13, P7612, DOI 10.1128/MCB.13.12.7612; Looijenga LHJ, 2006, CANCER RES, V66, P290, DOI 10.1158/0008-5472.CAN-05-2936; Loukinov DI, 2002, P NATL ACAD SCI USA, V99, P6806, DOI 10.1073/pnas.092123699; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; Pugacheva EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013872; Raska I, 2004, BIOL CELL, V96, P579, DOI 10.1016/j.biolcel.2004.04.015; Risinger JI, 2007, CLIN CANCER RES, V13, P1713, DOI 10.1158/1078-0432.CCR-05-2569; Scott MS, 2010, NUCLEIC ACIDS RES, V38, P7388, DOI 10.1093/nar/gkq653; Sirri V, 2008, HISTOCHEM CELL BIOL, V129, P13, DOI 10.1007/s00418-007-0359-6; Torrano V, 2006, J CELL SCI, V119, P1746, DOI 10.1242/jcs.02890; Ulaner GA, 2003, HUM MOL GENET, V12, P535, DOI 10.1093/hmg/ddg034; van de Nobelen S, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-19; Vatolin S, 2005, CANCER RES, V65, P7751, DOI 10.1158/0008-5472.CAN-05-0858; Woloszynska-Read Anna, 2007, Cancer Immun, V7, P21; WOLOSZYNSKAREAD A, 2011, CLIN CANC RES	36	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22399	10.1371/journal.pone.0022399	http://dx.doi.org/10.1371/journal.pone.0022399			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21811597	Green Published, gold, Green Submitted			2022-12-25	WOS:000292929500057
J	Airoldi, L; Bulleri, F				Airoldi, Laura; Bulleri, Fabio			Anthropogenic Disturbance Can Determine the Magnitude of Opportunistic Species Responses on Marine Urban Infrastructures	PLOS ONE			English	Article							COASTAL-DEFENSE STRUCTURES; FRAGILE SSP TOMENTOSOIDES; INTRODUCED GREEN-ALGA; INTERTIDAL ASSEMBLAGES; SOUTHERN CALIFORNIA; INVASION SUCCESS; ARTIFICIAL REEFS; COMMUNITIES; HABITATS; SEAWALLS	Background: Coastal landscapes are being transformed as a consequence of the increasing demand for infrastructures to sustain residential, commercial and tourist activities. Thus, intertidal and shallow marine habitats are largely being replaced by a variety of artificial substrata (e. g. breakwaters, seawalls, jetties). Understanding the ecological functioning of these artificial habitats is key to planning their design and management, in order to minimise their impacts and to improve their potential to contribute to marine biodiversity and ecosystem functioning. Nonetheless, little effort has been made to assess the role of human disturbances in shaping the structure of assemblages on marine artificial infrastructures. We tested the hypothesis that some negative impacts associated with the expansion of opportunistic and invasive species on urban infrastructures can be related to the severe human disturbances that are typical of these environments, such as those from maintenance and renovation works. Methodology/Principal Findings: Maintenance caused a marked decrease in the cover of dominant space occupiers, such as mussels and oysters, and a significant enhancement of opportunistic and invasive forms, such as biofilm and macroalgae. These effects were particularly pronounced on sheltered substrata compared to exposed substrata. Experimental application of the disturbance in winter reduced the magnitude of the impacts compared to application in spring or summer. We use these results to identify possible management strategies to inform the improvement of the ecological value of artificial marine infrastructures. Conclusions/Significance: We demonstrate that some of the impacts of globally expanding marine urban infrastructures, such as those related to the spread of opportunistic, and invasive species could be mitigated through ecologically-driven planning and management of long-term maintenance of these structures. Impact mitigation is a possible outcome of policies that consider the ecological features of built infrastructures and the fundamental value of controlling biodiversity in marine urban systems.	[Airoldi, Laura] Univ Bologna, Dipartimento Biol Evoluzionist Sperimentale, Ravenna, Italy; [Airoldi, Laura] Univ Bologna, Ctr Interdipartimentale Ric Sci Ambientali Ravenn, Ravenna, Italy; [Airoldi, Laura] Wesleyan Univ, Dept Earth & Environm Sci, Middletown, CT USA; [Bulleri, Fabio] Univ Pisa, Dipartimento Biol, CoNISMa, Pisa, Italy; [Bulleri, Fabio] Univ Sassari, Dipartimento Sci Bot Ecol & Geol, I-07100 Sassari, Italy	University of Bologna; University of Bologna; Wesleyan University; CoNISMa; University of Pisa; University of Sassari	Airoldi, L (corresponding author), Univ Bologna, Dipartimento Biol Evoluzionist Sperimentale, Ravenna, Italy.	laura.airoldi@unibo.it	Airoldi, Laura/I-3553-2019	Airoldi, Laura/0000-0001-5046-0871; Bulleri, Fabio/0000-0002-7335-6791	EU [EU - FP7 - ENV2009-1, 244104, EVK3-CT-2000-00041]; MIAT project MED RED; MIUR; Assegni di Ricerca of the University of Pisa; University of Sassari; Eastern College Consortium (E.C.Co) at Wesleyan University	EU(European Commission); MIAT project MED RED; MIUR(Ministry of Education, Universities and Research (MIUR)); Assegni di Ricerca of the University of Pisa; University of Sassari; Eastern College Consortium (E.C.Co) at Wesleyan University	Support comes from the EU projects THESEUS (EU - FP7 - ENV2009-1, grant 244104) and DELOS (EVK3-CT-2000-00041), The MIAT project MED RED and from the MIUR projects COFIN (ex 40%) and PRIN (BIORES). F. B. was further supported by Assegni di Ricerca of the University of Pisa and University of Sassari, respectively, and L. A. was supported by an Eastern College Consortium (E.C.Co) Scholarship at Wesleyan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2005, COAST ENG, V52, P1073, DOI 10.1016/j.coastaleng.2005.09.007; Airoldi L, 1998, ECOLOGY, V79, P2759, DOI 10.1890/0012-9658(1998)079[2759:RODSSA]2.0.CO;2; Airoldi L, 2005, MAR ECOL PROG SER, V299, P55, DOI 10.3354/meps299055; Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Anderson MJ, 2008, PERMANOVA PRIMER GUI; Bacchiocchi F, 2003, ESTUAR COAST SHELF S, V56, P1157, DOI 10.1016/S0272-7714(02)00322-0; BACCHIOCCHI F, 2004, THESIS U PARMA PARMA; BenedettiCecchi L, 1996, MAR ECOL PROG SER, V138, P93, DOI 10.3354/meps138093; Brown CJ, 2005, BIOFOULING, V21, P73, DOI 10.1080/08927010512331344197; Bulleri F, 2006, MAR BIOL, V148, P1213, DOI 10.1007/s00227-005-0181-4; Bulleri F, 2005, J APPL ECOL, V42, P1063, DOI 10.1111/j.1365-2664.2005.01096.x; Bulleri F, 2005, MAR ECOL PROG SER, V287, P53, DOI 10.3354/meps287053; Bulleri F, 2005, AUSTRAL ECOL, V30, P655, DOI 10.1111/j.1442-9993.2005.01507.x; Bulleri F, 2007, EUR J PHYCOL, V42, P137, DOI 10.1080/09670260701231243; Bulleri F, 2010, J APPL ECOL, V47, P26, DOI 10.1111/j.1365-2664.2009.01751.x; Burcharth H.F., 2007, ENV DESIGN GUIDELINE; BURCHARTH HF, 1993, COASTAL ESTUARIAL HA, P381; Burt J, 2009, CORAL REEFS, V28, P663, DOI 10.1007/s00338-009-0500-1; Burt J, 2011, ECOL ENG, V37, P191, DOI 10.1016/j.ecoleng.2010.09.004; Burt J, 2009, J EXP MAR BIOL ECOL, V373, P72, DOI 10.1016/j.jembe.2009.03.009; CECCHERELLI VU, 1984, MAR ECOL PROG SER, V16, P173, DOI 10.3354/meps016173; Cencini C, 1998, J COASTAL RES, V14, P774; Chapman MG, 2009, OECOLOGIA, V161, P625, DOI 10.1007/s00442-009-1393-y; Chapman MG, 2003, MAR ECOL PROG SER, V264, P21, DOI 10.3354/meps264021; Chapman MG, 2003, LANDSCAPE URBAN PLAN, V62, P159, DOI 10.1016/S0169-2046(02)00148-2; Clark GF, 2011, ECOL LETT, V14, P52, DOI 10.1111/j.1461-0248.2010.01550.x; Clark GF, 2009, OIKOS, V118, P1679, DOI 10.1111/j.1600-0706.2009.17564.x; Connell SD, 2000, J EXP MAR BIOL ECOL, V247, P183, DOI 10.1016/S0022-0981(00)00147-7; Dafforn KA, 2009, BIOFOULING, V25, P277, DOI 10.1080/08927010802710618; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Davis JLD, 2002, MAR BIOL, V140, P1249, DOI 10.1007/s00227-002-0779-8; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; DENLEY EJ, 1979, J EXP MAR BIOL ECOL, V36, P269, DOI 10.1016/0022-0981(79)90122-9; DUGAN JE, 2011, TREATISE ES IN PRESS; Fauvelot C, 2009, MAR BIOL, V156, P2313, DOI 10.1007/s00227-009-1259-1; Gacia E, 2007, SCI MAR, V71, P259, DOI 10.3989/scimar.2007.71n2259; Glasby TM, 2007, MAR BIOL, V151, P887, DOI 10.1007/s00227-006-0552-5; Glasby TM, 1999, AMBIO, V28, P595; Glasby TM, 1999, ESTUAR COAST SHELF S, V48, P281, DOI 10.1006/ecss.1998.0417; Godefroid S, 2003, LANDSCAPE URBAN PLAN, V65, P169, DOI 10.1016/S0169-2046(03)00013-6; GREGORY PT, 2004, PORT ENG PLANNING CO; Guidetti P, 2005, MAR ENVIRON RES, V59, P333, DOI 10.1016/j.marenvres.2004.05.008; HARGER J R E, 1971, Veliger, V14, P195; Iannuzzi TJ, 1996, ESTUARIES, V19, P257, DOI 10.2307/1352231; Inger R, 2009, J APPL ECOL, V46, P1145, DOI 10.1111/j.1365-2664.2009.01697.x; Iskander MM, 2007, J ENVIRON MANAGE, V85, P1109, DOI 10.1016/j.jenvman.2006.11.018; IVERSEN E S, 1984, North American Journal of Fisheries Management, V4, P294, DOI 10.1577/1548-8659(1984)4<294:ARUMDI>2.0.CO;2; Ivesa L, 2010, MAR ECOL PROG SER, V407, P55, DOI 10.3354/meps08539; JOHANNESSON K, 1990, HYDROBIOLOGIA, V193, P99, DOI 10.1007/BF00028069; Koike K., 1996, GEOJOURNAL, V38, P301, DOI [10.1007/BF00204722, DOI 10.1007/BF00204722]; Lohrer AM, 2008, ECOLOGY, V89, P1299, DOI 10.1890/07-0421.1; Lozon Joseph D., 1997, Environmental Reviews, V5, P131, DOI 10.1139/er-5-2-131; Martins GM, 2009, MAR ENVIRON RES, V67, P237, DOI 10.1016/j.marenvres.2009.03.002; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Miller MW, 2009, MAR ECOL PROG SER, V387, P147, DOI 10.3354/meps08097; Morand P, 1996, BOT MAR, V39, P491, DOI 10.1515/botm.1996.39.1-6.491; Moreira J, 2006, MAR ECOL PROG SER, V322, P179, DOI 10.3354/meps322179; Moschella PS, 2005, COAST ENG, V52, P1053, DOI 10.1016/j.coastaleng.2005.09.014; Norkko A, 2006, J EXP MAR BIOL ECOL, V330, P195, DOI 10.1016/j.jembe.2005.12.027; PAINE RT, 1981, ECOL MONOGR, V51, P145, DOI 10.2307/2937261; Perkol-Finkel S, 2006, MAR ENVIRON RES, V61, P121, DOI 10.1016/j.marenvres.2005.08.001; Perkol-Finkel S, 2005, BIOFOULING, V21, P127, DOI 10.1080/08927010500133451; Perkol-Finkel S, 2009, J EXP MAR BIOL ECOL, V369, P1, DOI 10.1016/j.jembe.2008.09.016; Phillips JA, 2006, MAR POLLUT BULL, V52, P962, DOI 10.1016/j.marpolbul.2006.04.015; Pinn EH, 2005, ESTUAR COAST SHELF S, V62, P271, DOI 10.1016/j.ecss.2004.09.002; Pister B, 2009, MAR BIOL, V156, P861, DOI 10.1007/s00227-009-1130-4; REBELE F, 1994, GLOBAL ECOL BIOGEOGR, V4, P173, DOI 10.2307/2997649; Seed R., 1976, MARINE MUSSELS THEIR, P13; SOUSA WP, 1979, ECOL MONOGR, V49, P227, DOI 10.2307/1942484; Stachowicz JJ, 2006, MAR ECOL PROG SER, V311, P251, DOI 10.3354/meps311251; Suchanek T.H., 1992, MUSSEL MYTILUS ECOLO, P87; Thompson RC, 2002, ENVIRON CONSERV, V29, P168, DOI 10.1017/S0376892902000115; Underwood A.J, 1997, EXPT ECOLOGY THEIR L; Van der Meer J.W., 1988, ROCK SLOPES GRAVEL B; Vaselli S, 2008, MAR ENVIRON RES, V66, P395, DOI 10.1016/j.marenvres.2008.06.002	75	131	134	1	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22985	10.1371/journal.pone.0022985	http://dx.doi.org/10.1371/journal.pone.0022985			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826224	Green Published, gold			2022-12-25	WOS:000293558900050
J	McCaffrey, K; Hawkins, MB; Godwin, J				McCaffrey, Katherine; Hawkins, Mary Beth; Godwin, John			Sexual Phenotype Differences in zic2 mRNA Abundance in the Preoptic Area of a Protogynous Teleost, Thalassoma bifasciatum	PLOS ONE			English	Article							CEREBELLAR GRANULE CELLS; CORAL-REEF FISH; BLUEHEAD WRASSE; ARGININE VASOTOCIN; SADDLEBACK WRASSE; GENE FAMILY; BRAIN; EXPRESSION; BEHAVIOR; NEUROGENESIS	The highly conserved members of the zic family of zinc-finger transcription factors are primarily known for their roles in embryonic signaling pathways and regulation of cellular proliferation and differentiation. This study describes sexual phenotype differences in abundances of zic2 mRNA in the preoptic area of the hypothalamus, a region strongly implicated in sexual behavior and function, in an adult teleost, Thalassoma bifasciatum. The bluehead wrasse (Thalassoma bifasciatum) is a valuable model for studying neuroendocrine processes because it displays two discrete male phenotypes, initial phase (IP) males and territorial, terminal phase (TP) males, and undergoes socially-controlled protogynous sex change. Previously generated microarray-based comparisons suggested that zic2 was upregulated in the brains of terminal phase males relative to initial phase males. To further explore this difference, we cloned a 727 bp sequence for neural zic2 from field-collected animals. Riboprobe-based in situ hybridization was employed to localize zic2 signal in adult bluehead brains and assess the relative abundance of brain zic2 mRNA across sexual phenotypes. We found zic2 mRNA expression was extremely abundant in the granular cells of the cerebellum and widespread in other brain regions including in the thalamus, hypothalamus, habenula, torus semicircularis, torus longitudinalis, medial longitudinal fascicle and telencephalic areas. Quantitative autoradiography and phosphorimaging showed zic2 mRNA hybridization signal in the preoptic area of the hypothalamus was significantly higher in terminal phase males relative to both initial phase males and females, and silver grain analysis confirmed this relationship between phenotypes. No significant difference in abundance was found in zic2 signal across phenotypes in the habenula, a brain region not implicated in the control of sexual behavior, or cerebellum.	[McCaffrey, Katherine] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA; N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	McCaffrey, K (corresponding author), N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA.	john_godwin@ncsu.edu		Godwin, John/0000-0002-0928-501X	National Science Foundation (NSF) [0416926]; North Carolina State University (NCSU)	National Science Foundation (NSF)(National Science Foundation (NSF)); North Carolina State University (NCSU)	This work was supported by National Science Foundation (NSF) grant 0416926 to John Godwin and Mary Beth Hawkins and the North Carolina State University (NCSU) Reinard Harkema Graduate Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aruga J, 2002, J NEUROSCI, V22, P218, DOI 10.1523/JNEUROSCI.22-01-00218.2002; ARUGA J, 1994, J NEUROCHEM, V63, P1880; Aruga J, 1996, J BIOL CHEM, V271, P1043, DOI 10.1074/jbc.271.2.1043; BENEDYK MJ, 1994, GENE DEV, V8, P105, DOI 10.1101/gad.8.1.105; Bidus MA, 2006, CLIN CANCER RES, V12, P83, DOI 10.1158/1078-0432.CCR-05-0835; Brown L, 2009, GENE EXPR PATTERNS, V9, P43, DOI 10.1016/j.gep.2008.08.002; Chapouton P, 2007, BIOESSAYS, V29, P745, DOI 10.1002/bies.20615; Cooke B, 1998, FRONT NEUROENDOCRIN, V19, P323, DOI 10.1006/frne.1998.0171; Demski L.S., 1983, P317; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; ELLISON G, 1994, BRAIN RES REV, V19, P223, DOI 10.1016/0165-0173(94)90012-4; Elofsson U, 1997, J COMP PHYSIOL A, V181, P484, DOI 10.1007/s003590050132; Foran CM, 1999, GEN COMP ENDOCR, V116, P141, DOI 10.1006/gcen.1999.7357; Godwin J, 1996, P ROY SOC B-BIOL SCI, V263, P1683, DOI 10.1098/rspb.1996.0246; Godwin J, 2000, BRAIN BEHAV EVOLUT, V55, P77, DOI 10.1159/000006643; Grinberg I, 2005, CLIN GENET, V67, P290, DOI 10.1111/j.1399-0004.2005.00418.x; GROBER MS, 1991, J NEUROBIOL, V22, P734, DOI 10.1002/neu.480220708; Gure AO, 2000, P NATL ACAD SCI USA, V97, P4198, DOI 10.1073/pnas.97.8.4198; Heimovics SA, 2009, NEUROSCIENCE, V159, P962, DOI 10.1016/j.neuroscience.2009.01.042; Herrera E, 2003, CELL, V114, P545, DOI 10.1016/S0092-8674(03)00684-6; Inoue T, 2008, J NEUROSCI, V28, P4712, DOI 10.1523/JNEUROSCI.5735-07.2008; KOYAMA Y, 1984, BEHAV NEURAL BIOL, V40, P70, DOI 10.1016/S0163-1047(84)90182-1; Larson ET, 2003, NEUROSCIENCE, V119, P251, DOI 10.1016/S0306-4522(03)00119-2; Larson ET, 2003, GEN COMP ENDOCR, V130, P289, DOI 10.1016/S0016-6480(02)00622-6; Marsh KE, 2006, BRAIN RES, V1126, P91, DOI 10.1016/j.brainres.2006.09.017; MEEK J, 1989, J COMP NEUROL, V281, P362, DOI 10.1002/cne.902810304; Merzdorf CS, 2007, DEV DYNAM, V236, P922, DOI 10.1002/dvdy.21098; Nagai T, 2000, P NATL ACAD SCI USA, V97, P1618, DOI 10.1073/pnas.97.4.1618; Patisaul HB, 1999, MOL BRAIN RES, V67, P165, DOI 10.1016/S0169-328X(99)00058-3; Rink E, 2001, BRAIN RES, V889, P316, DOI 10.1016/S0006-8993(00)03174-7; Sakuma K, 2010, J CANCER RES CLIN, V136, P553, DOI 10.1007/s00432-009-0689-y; Salero E, 2007, P NATL ACAD SCI USA, V104, P2997, DOI 10.1073/pnas.0610879104; Semsar K, 2004, HORM BEHAV, V45, P345, DOI 10.1016/j.yhbeh.2004.01.003; Semsar K, 2001, HORM BEHAV, V40, P21, DOI 10.1006/hbeh.2001.1663; Toyama R, 2004, GENE EXPR PATTERNS, V4, P345, DOI 10.1016/j.modgep.2003.09.011; WANG RY, 1977, SCIENCE, V197, P89, DOI 10.1126/science.194312; WARNER RR, 1984, AM SCI, V72, P128; WARNER RR, 1991, BIOL BULL-US, V181, P199, DOI 10.2307/1542090; Williams IM, 2008, NEUROBIOL DIS, V30, P139, DOI 10.1016/j.nbd.2008.01.002; WULLIMANN MF, 1991, CELL TISSUE RES, V266, P285, DOI 10.1007/BF00318184; Yang Y, 2000, J BIOL CHEM, V275, P38863, DOI 10.1074/jbc.M007906200; Yokota N, 1996, CANCER RES, V56, P377; [No title captured]	43	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e23213	10.1371/journal.pone.0023213	http://dx.doi.org/10.1371/journal.pone.0023213			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826240	Green Published, Green Submitted, gold			2022-12-25	WOS:000293558900066
J	Natsume-Kitatani, Y; Shiga, M; Mamitsuka, H				Natsume-Kitatani, Yayoi; Shiga, Motoki; Mamitsuka, Hiroshi			Genome-Wide Integration on Transcription Factors, Histone Acetylation and Gene Expression Reveals Genes Co-Regulated by Histone Modification Patterns	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST; ACETYLTRANSFERASE; CHROMATIN; ESA1; CODE; STRENGTH; NETWORK; GLUCOSE; CANCER	N-terminal tails of H2A, H2B, H3 and H4 histone families are subjected to posttranslational modifications that take part in transcriptional regulation mechanisms, such as transcription factor binding and gene expression. Regulation mechanisms under control of histone modification are important but remain largely unclear, despite of emerging datasets for comprehensive analysis of histone modification. In this paper, we focus on what we call genetic harmonious units (GHUs), which are co-occurring patterns among transcription factor binding, gene expression and histone modification. We present the first genome-wide approach that captures GHUs by combining ChIP-chip with microarray datasets from Saccharomyces cerevisiae. Our approach employs noise-robust soft clustering to select patterns which share the same preferences in transcription factor-binding, histone modification and gene expression, which are all currently implied to be closely correlated. The detected patterns are a well-studied acetylation of lysine 16 of H4 in glucose depletion as well as co-acetylation of five lysine residues of H3 with H4 Lys12 and H2A Lys7 responsible for ribosome biogenesis. Furthermore, our method further suggested the recognition of acetylated H4 Lys16 being crucial to histone acetyltransferase ESA1, whose essential role is still under controversy, from a microarray dataset on ESA1 and its bypass suppressor mutants. These results demonstrate that our approach allows us to provide clearer principles behind gene regulation mechanisms under histone modifications and detect GHUs further by applying to other microarray and ChIP-chip datasets. The source code of our method, which was implemented in MATLAB (http://www.mathworks.com/), is available from the supporting page for this paper: http://www.bic.kyoto-u.ac.jp/pathway/natsume/hm_detector.htm.	[Natsume-Kitatani, Yayoi; Shiga, Motoki; Mamitsuka, Hiroshi] Kyoto Univ, Inst Chem Res, Bioinformat Ctr, Uji, Kyoto, Japan; [Natsume-Kitatani, Yayoi; Shiga, Motoki; Mamitsuka, Hiroshi] Japan Sci & Technol Agcy JST BIRD, Inst Bioinformat Res & Dev, Saitama, Japan	Kyoto University	Natsume-Kitatani, Y (corresponding author), Japan Sci & Technol Agcy JST, PRESTO, Saitama, Japan.	mami@kuicr.kyoto-u.ac.jp	Shiga, Motoki/AAH-9738-2019; Mamitsuka, Hiroshi/R-1110-2016	Shiga, Motoki/0000-0003-2434-4716; Mamitsuka, Hiroshi/0000-0002-6607-5617	BIRD (Institute for Bioinformatics Research and Development) of JST (Japan Science and Technology Agency); BIRD, JST	BIRD (Institute for Bioinformatics Research and Development) of JST (Japan Science and Technology Agency)(Japan Science & Technology Agency (JST)); BIRD, JST(Japan Science & Technology Agency (JST))	This work is supported by BIRD (Institute for Bioinformatics Research and Development) of JST (Japan Science and Technology Agency), http://www-bird.jst.go.jp/index_e.html. All authors have been supported partially by BIRD, JST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee A., 2005, J MACH LEARN RES, V6, P1; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; Buck MJ, 2004, GENOMICS, V83, P349, DOI 10.1016/j.ygeno.2003.11.004; Capaldi AP, 2008, NAT GENET, V40, P1300, DOI 10.1038/ng.235; Clarke AS, 1999, MOL CELL BIOL, V19, P2515; Decker PV, 2008, GENETICS, V178, P1209, DOI 10.1534/genetics.107.080135; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; EICKBUSH TH, 1978, BIOCHEMISTRY-US, V17, P4955, DOI 10.1021/bi00616a016; Futschik Matthias E., 2005, Journal of Bioinformatics and Computational Biology, V3, P965, DOI 10.1142/S0219720005001375; Garcia-Manero Guillermo, 2007, Hematology Am Soc Hematol Educ Program, P405; Gelade R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-233; Gray ST, 2005, DIABETES-METAB RES, V21, P416, DOI 10.1002/dmrr.559; Guo X, 2006, BIOINFORMATICS, V22, P392, DOI 10.1093/bioinformatics/bti823; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Lafon-Hughes L, 2008, MUTAT RES-REV MUTAT, V658, P191, DOI 10.1016/j.mrrev.2008.01.008; Lee YL, 2008, MOL CELLS, V26, P299; LESS MW, 2009, ENDOCR METAB IMMUNE, V9, P84; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; Miyoshi K, 2003, NUCLEIC ACIDS RES, V31, P1969, DOI 10.1093/nar/gkg278; Pham H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100194; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Smith ER, 1998, P NATL ACAD SCI USA, V95, P3561, DOI 10.1073/pnas.95.7.3561; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Vaquero A, 2007, ONCOGENE, V26, P5505, DOI 10.1038/sj.onc.1210617; VONLUXBURG U, 2007, STAT COMPUT, V17, P1; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Yin ZK, 2003, MOL MICROBIOL, V48, P713, DOI 10.1046/j.1365-2958.2003.03478.x; Yuan GC, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r70; Zheng YG, 2008, MED RES REV, V28, P645, DOI 10.1002/med.20120; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031	35	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22281	10.1371/journal.pone.0022281	http://dx.doi.org/10.1371/journal.pone.0022281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829453	Green Submitted, Green Published, gold			2022-12-25	WOS:000293286500010
J	Gao, HB; Cui, HY; Cui, XL; Shi, XM; Zhao, Y; Zhao, XY; Quan, YM; Yan, SA; Zeng, WW; Wang, YF				Gao, Hongbo; Cui, Hongyu; Cui, Xianlan; Shi, Xingming; Zhao, Yan; Zhao, Xiaoyan; Quan, Yanming; Yan, Shuai; Zeng, Weiwei; Wang, Yunfeng			Expression of HA of HPAI H5N1 Virus at US2 Gene Insertion Site of Turkey Herpesvirus Induced Better Protection than That at US10 Gene Insertion Site	PLOS ONE			English	Article							MAREKS-DISEASE VIRUS; BACTERIAL ARTIFICIAL CHROMOSOME; AVIAN INFLUENZA-VIRUSES; NEWCASTLE-DISEASE; RECOMBINANT HERPESVIRUS; MATERNAL ANTIBODIES; GLYCOPROTEIN-B; SIMPLEX-VIRUS; IBDV VP2; CHICKENS	Herpesvirus of turkey (HVT) is being widely used as a vector for development of recombinant vaccines and US2 and US10 genes are often chosen as insertion sites for targeted gene expression. However, the different effects of the two genes for generation of recombinant HVT vaccines were unknown. In order to compare the effects of inserted genes in the two sites on the efficacy of the recombinant vaccines, host-protective haemagglutinin (HA) gene of the highly pathogenic avian influenza virus (HPAIV) H5N1 was inserted into either US2 or US10 gene locus of the HVT. The resulting US2 (rHVT-US2-HA) or US10 (rHVT-US10-HA) recombinant HVT viruses were used to infect chicken embryo fibroblasts. Plaques and the growth kinetics of rHVT-US2-HA-infected chicken embryo fibroblasts were similar to those of parental HVT whereas rHVT-US10-HA infected chicken embryo fibroblasts had different growth kinetics and plaque formation. The viremia levels in rHVT-US10-HA virus-infected chickens were significantly lower than those of rHVT-US2-HA group on 28 days post infection. The vaccine efficacy of the two recombinant viruses against H5N1 HPAIV and virulent Marek's disease virus was also evaluated in 1-day-old vaccinated chickens. rHVT-US2-HA-vaccinated chickens were better protected with reduced mortality than rHVT-US10-HA-vaccinated animals following HPAIV challenge. Furthermore, the overall hemaglutination inhibition antibody titers of rHVT-US2-HA-vaccinated chickens were higher than those of rHVT-US10-HA-vaccinated chickens. Protection levels against Marek's disease virus challenge following vaccination with either rHVT-US2-HA or rHVT-US10-HA, however, were similar to those of the parental HVT virus. These results, for the first time, indicate that US2 gene provides a favorable foreign gene insertion site for generation of recombinant HVT vaccines.	[Gao, Hongbo; Cui, Hongyu; Shi, Xingming; Zhao, Yan; Zhao, Xiaoyan; Quan, Yanming; Yan, Shuai; Zeng, Weiwei; Wang, Yunfeng] Chinese Acad Agr Sci, Div Avian Infect Dis, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin, Peoples R China; [Cui, Hongyu] Hebei North Univ, Dept Anim Med, Coll Anim Sci & Vet Med, Zhang Jia Kou, Peoples R China; [Cui, Xianlan] Hlth Anim Lab, Dept Primary Ind Pk Water & Environm, Prospect, Australia	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Hebei North University	Gao, HB (corresponding author), Chinese Acad Agr Sci, Div Avian Infect Dis, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin, Peoples R China.	yfwang@hvri.ac.cn	Cui, Xianlan/N-1734-2017; Gao, Hongbo/AHE-9262-2022	Cui, Xianlan/0000-0002-5029-1286; 	National Key Laboratory of Veterinary Biotechnology of China [NKLVBP200803]	National Key Laboratory of Veterinary Biotechnology of China	The study was supported by a grant from the National Key Laboratory of Veterinary Biotechnology as Basic Research Programs of China (NKLVBP200803). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; BACON LD, 1992, AVIAN DIS, V36, P378, DOI 10.2307/1591516; Baigent SJ, 2006, J GEN VIROL, V87, P769, DOI 10.1099/vir.0.81498-0; Calnek BW, 1991, MAREKS DIS; CANTELLO JL, 1991, J VIROL, V65, P1584, DOI 10.1128/JVI.65.3.1584-1588.1991; Chen Su-juan, 2006, Weishengwu Xuebao, V46, P111; Cheng Jian, 2002, Weishengwu Xuebao, V42, P442; Cui HY, 2009, J VIROL METHODS, V156, P66, DOI 10.1016/j.jviromet.2008.10.021; Cui SJ, 2008, J VET DIAGN INVEST, V20, P567, DOI 10.1177/104063870802000505; DARTEIL R, 1995, VIROLOGY, V211, P481, DOI 10.1006/viro.1995.1430; FAUQET CM, 2005, 8 ICTV; GAGE PJ, 1993, J VIROL, V67, P2191, DOI 10.1128/JVI.67.4.2191-2201.1993; Ge JY, 2007, J VIROL, V81, P150, DOI 10.1128/JVI.01514-06; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; Lan Desong, 2008, Weishengwu Xuebao, V48, P811; Lee LF, 2008, VACCINE, V26, P1887, DOI 10.1016/j.vaccine.2008.01.046; Liu Ai-ling, 2009, Chinese Journal of Virology, V25, P368; Liu ChaoNan, 2006, Scientia Agricultura Sinica, V39, P412; Ma MX, 2006, VACCINE, V24, P4304, DOI 10.1016/j.vaccine.2006.03.006; MORGAN RW, 1993, AVIAN DIS, V37, P1032, DOI 10.2307/1591910; MORGAN RW, 1992, AVIAN DIS, V36, P858, DOI 10.2307/1591544; Nayak B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006509; OKAZAKI W, 1970, AVIAN DIS, V14, P413, DOI 10.2307/1588488; PARCELLS MS, 1994, J VIROL, V68, P8239, DOI 10.1128/JVI.68.12.8239-8253.1994; PURCHASE HG, 1971, INFECT IMMUN, V3, P295, DOI 10.1128/IAI.3.2.295-303.1971; PURCHASE HG, 1972, AVIAN DIS, V16, P57, DOI 10.2307/1588900; Rauw F, 2010, VACCINE, V28, P823, DOI 10.1016/j.vaccine.2009.10.049; Reddy SK, 1996, VACCINE, V14, P469, DOI 10.1016/0264-410X(95)00242-S; ROSS LJN, 1993, J GEN VIROL, V74, P371, DOI 10.1099/0022-1317-74-3-371; Sakaguchi M, 1998, VACCINE, V16, P472, DOI 10.1016/S0264-410X(97)80001-1; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schroer D, 2009, AVIAN DIS, V53, P190, DOI 10.1637/8416-072308-Reg.1; Shi Wei-song, 2008, Chinese Journal of Virology, V24, P117; Tsukamoto K, 1999, VIROLOGY, V257, P352, DOI 10.1006/viro.1999.9641; Veits J, 2008, VACCINE, V26, P1688, DOI 10.1016/j.vaccine.2008.01.016; Veits J, 2006, P NATL ACAD SCI USA, V103, P8197, DOI 10.1073/pnas.0602461103; WEBSTER RG, 1991, VACCINE, V9, P303, DOI 10.1016/0264-410X(91)90055-B; WITTER RL, 1970, AM J VET RES, V31, P525; Xia CY, 2000, CHINESE J VET SCI TE, V30, P24; ZELNIK V, 1995, J GEN VIROL, V76, P2903, DOI 10.1099/0022-1317-76-11-2903	40	25	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22549	10.1371/journal.pone.0022549	http://dx.doi.org/10.1371/journal.pone.0022549			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818336	gold, Green Submitted, Green Published			2022-12-25	WOS:000293282700037
J	Lijtmaer, DA; Kerr, KCR; Barreira, AS; Hebert, PDN; Tubaro, PL				Lijtmaer, Dario A.; Kerr, Kevin C. R.; Barreira, Ana S.; Hebert, Paul D. N.; Tubaro, Pablo L.			DNA Barcode Libraries Provide Insight into Continental Patterns of Avian Diversification	PLOS ONE			English	Article							PARASITOID FLIES DIPTERA; HISTORICAL DIVERSIFICATION; BIOLOGICAL IDENTIFICATIONS; MOLECULAR-IDENTIFICATION; LATITUDINAL GRADIENT; NEOTROPICAL TANAGERS; GENETIC FOOTPRINTS; HOST-SPECIFICITY; RAIN-FOREST; SPECIATION	Background: The causes for the higher biodiversity in the Neotropics as compared to the Nearctic and the factors promoting species diversification in each region have been much debated. The refuge hypothesis posits that high tropical diversity reflects high speciation rates during the Pleistocene, but this conclusion has been challenged. The present study investigates this matter by examining continental patterns of avian diversification through the analysis of large-scale DNA barcode libraries. Methodology and Principal Findings: Standardized COI datasets from the avifaunas of Argentina, the Nearctic, and the Palearctic were analyzed. Average genetic distances between closest congeners and sister species were higher in Argentina than in North America reflecting a much higher percentage of recently diverged species in the latter region. In the Palearctic genetic distances between closely related species appeared to be more similar to those of the southern Neotropics. Average intraspecific variation was similar in Argentina and North America, while the Palearctic fauna had a higher value due to a higher percentage of variable species. Geographic patterning of intraspecific structure was more complex in the southern Neotropics than in the Nearctic, while the Palearctic showed an intermediate level of complexity. Conclusions and Significance: DNA barcodes can reveal continental patterns of diversification. Our analysis suggests that avian species are older in Argentina than in the Nearctic, supporting the idea that the greater diversity of the Neotropical avifauna is not caused by higher recent speciation rates. Species in the Palearctic also appear to be older than those in the Nearctic. These results, combined with the patterns of geographic structuring found in each region, suggest a major impact of Pleistocene glaciations in the Nearctic, a lesser effect in the Palearctic and a mild effect in the southern Neotropics.	[Lijtmaer, Dario A.; Barreira, Ana S.; Tubaro, Pablo L.] Museo Argentino Ciencias Nat Bernardino Rivadavia, Div Omitol, Buenos Aires, DF, Argentina; [Kerr, Kevin C. R.; Hebert, Paul D. N.] Univ Guelph, Dept Integrat Biol, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada	Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); University of Guelph	Lijtmaer, DA (corresponding author), Museo Argentino Ciencias Nat Bernardino Rivadavia, Div Omitol, Buenos Aires, DF, Argentina.	dlijtmaer@macn.gov.ar	Kerr, Kevin/B-8510-2013; Hebert, Paul DN/C-4161-2013	Kerr, Kevin/0000-0002-6784-3884; Hebert, Paul DN/0000-0002-3081-6700; Barreira, Ana S./0000-0001-7568-488X	Consejo Nacional de Investigaciones Cientificas y Tecnicas of Argentina (CONICET); Agencia Nacional de Promocion Cientifica y Tecnologica of Argentina (ANPCyT); Lounsbery Foundation; Fundacion Williams; Natural Sciences and Engineering Research Council of Canada (NSERC); Genome Canada through the Ontario Genomics Institute; Ontario Ministry of Research and Innovation; International Development Research Centre of Canada (IDRC)	Consejo Nacional de Investigaciones Cientificas y Tecnicas of Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica of Argentina (ANPCyT)(ANPCyT); Lounsbery Foundation; Fundacion Williams; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Genome Canada through the Ontario Genomics Institute(Genome Canada); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); International Development Research Centre of Canada (IDRC)	This research program was funded by grants from the Consejo Nacional de Investigaciones Cientificas y Tecnicas of Argentina (CONICET), from the Agencia Nacional de Promocion Cientifica y Tecnologica of Argentina (ANPCyT), from the Lounsbery Foundation and Fundacion Williams to PLT, from the Natural Sciences and Engineering Research Council of Canada (NSERC), from Genome Canada through the Ontario Genomics Institute, from the Ontario Ministry of Research and Innovation to PDNH, and from the International Development Research Centre of Canada (IDRC) to PLT and PDNH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007092; Aliabadian M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004119; Ardura A, 2010, BIOL CONSERV, V143, P1438, DOI 10.1016/j.biocon.2010.03.019; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P457, DOI 10.1098/rspb.1998.0317; Beheregaray LB, 2008, MOL ECOL, V17, P3754, DOI 10.1111/j.1365-294X.2008.03857.x; Borisenko AV, 2008, MOL ECOL RESOUR, V8, P471, DOI 10.1111/j.1471-8286.2007.01998.x; Brumfield RT, 2007, EVOLUTION, V61, P346, DOI 10.1111/j.1558-5646.2007.00039.x; Brumfield RT, 1996, EVOLUTION, V50, P1607, DOI 10.1111/j.1558-5646.1996.tb03933.x; Burns KJ, 2004, MOL PHYLOGENET EVOL, V32, P838, DOI 10.1016/j.ympev.2004.02.013; Bush Mark B., 2006, Biota Neotrop., V6, P0, DOI 10.1590/S1676-06032006000100002; CAPPARELLA AP, 1988, ACTA C INT ORNITHOLO, V19, P1658; CAPPARELLA AP, 1991, ACTA C INT ORNITHOL, V20, P307; Chesser RT, 2000, MOL PHYLOGENET EVOL, V15, P369, DOI 10.1006/mpev.1999.0774; Clare EL, 2009, MOL ECOL, V18, P2532, DOI 10.1111/j.1365-294X.2009.04184.x; Cohen NJ, 2009, J FOOD PROTECT, V72, P810, DOI 10.4315/0362-028X-72.4.810; Colinvaux PA, 2000, QUATERNARY SCI REV, V19, P141, DOI 10.1016/S0277-3791(99)00059-1; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; CRACRAFT J, 1988, EVOLUTION, V42, P603, DOI 10.1111/j.1558-5646.1988.tb04164.x; Cracraft J, 1985, ORNITHOLOGICAL MONOG, V36, P49, DOI DOI 10.2307/40168278; Craft KJ, 2010, P NATL ACAD SCI USA, V107, P5041, DOI 10.1073/pnas.0913084107; Dove CJ, 2008, J WILDLIFE MANAGE, V72, P1231, DOI 10.2193/2007-272; Eaton MJ, 2010, CONSERV GENET, V11, P1389, DOI 10.1007/s10592-009-9967-0; FISCHER AG, 1960, EVOLUTION, V14, P64, DOI 10.2307/2405923; Foottit RG, 2008, MOL ECOL RESOUR, V8, P1189, DOI 10.1111/j.1755-0998.2008.02297.x; Garros C, 2008, MOL ECOL RESOUR, V8, P512, DOI 10.1111/j.1471-8286.2007.02013.x; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; HAFFER JURGEN, 1967, AMER MUS NOVITATES, V2294, P1; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heusser CJ, 1999, GEOGR ANN A, V81A, P231, DOI 10.1111/1468-0459.00058; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt Godfrey M, 2004, Front Zool, V1, P4; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Himes CMT, 2008, J BIOGEOGR, V35, P1415, DOI 10.1111/j.1365-2699.2008.01895.x; Johnsen A, 2010, J ORNITHOL, V151, P565, DOI 10.1007/s10336-009-0490-3; Johnson NK, 2004, EVOLUTION, V58, P1122; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Kerr KCR, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-29; Kerr KCR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004379; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klicka J, 1997, SCIENCE, V277, P1666, DOI 10.1126/science.277.5332.1666; Klicka J, 1999, P ROY SOC B-BIOL SCI, V266, P695, DOI 10.1098/rspb.1999.0691; Kotlik P, 2006, P NATL ACAD SCI USA, V103, P14860, DOI 10.1073/pnas.0603237103; Lessa EP, 2010, MOL ECOL, V19, P3031, DOI 10.1111/j.1365-294X.2010.04734.x; Lessa EP, 2003, P NATL ACAD SCI USA, V100, P10331, DOI 10.1073/pnas.1730921100; Lovette IJ, 2005, TRENDS ECOL EVOL, V20, P57, DOI 10.1016/j.tree.2004.11.011; Lovette IJ, 2004, AUK, V121, P1, DOI 10.1642/0004-8038(2004)121[0001:MDAMSF]2.0.CO;2; Marra PP, 2009, FRONT ECOL ENVIRON, V7, P297, DOI 10.1890/090066; Martin PR, 2010, EVOLUTION, V64, P336, DOI 10.1111/j.1558-5646.2009.00831.x; Marussich WA, 2007, MOL ECOL, V16, P1925, DOI 10.1111/j.1365-294X.2007.03278.x; Mila B, 2000, P ROY SOC B-BIOL SCI, V267, P1033, DOI 10.1098/rspb.2000.1107; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; NEI M, 2000, MOL EVOLUTION PHYLOG; Newton I., 2003, SPECIATION BIOGEOGRA; Nores M, 2004, GLOBAL ECOL BIOGEOGR, V13, P149, DOI 10.1111/j.1466-882X.2004.00076.x; Nores M, 1999, J BIOGEOGR, V26, P475, DOI 10.1046/j.1365-2699.1999.t01-1-00311.x; Pereira SL, 2006, MOL BIOL EVOL, V23, P1731, DOI 10.1093/molbev/msl038; Poljak S, 2010, MOL PHYLOGENET EVOL, V55, P38, DOI 10.1016/j.ympev.2009.12.021; RABASA J, 2008, LATE CENOZOIC PATAGO; Rowe KC, 2004, P NATL ACAD SCI USA, V101, P10355, DOI 10.1073/pnas.0401338101; Roy Michael S., 1997, P325, DOI 10.1016/B978-012498315-1/50018-2; Rull V, 2008, MOL ECOL, V17, P2722, DOI 10.1111/j.1365-294X.2008.03789.x; Runck AM, 2005, MOL ECOL, V14, P1445, DOI 10.1111/j.1365-294X.2005.02501.x; Sanin C, 2009, MOL PHYLOGENET EVOL, V53, P547, DOI 10.1016/j.ympev.2009.06.022; Sedano RE, 2010, J BIOGEOGR, V37, P325, DOI 10.1111/j.1365-2699.2009.02200.x; Smith MA, 2008, MOL ECOL RESOUR, V8, P235, DOI 10.1111/j.1471-8286.2007.01964.x; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Tavares ES, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-81; Tobias JA, 2008, SCIENCE, V319, DOI 10.1126/science.1150568; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; WALLACE AR, 1978, TROPICAL NATURE OTHE; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2008, MAR FRESHWATER RES, V59, P57, DOI 10.1071/MF07148; Waugh J, 2011, MOL ECOL RESOUR, V11, P38, DOI 10.1111/j.1755-0998.2010.02884.x; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; Weir JT, 2007, SCIENCE, V315, P1574, DOI 10.1126/science.1135590; Weir JT, 2006, EVOLUTION, V60, P842; Weir JT, 2011, P ROY SOC B-BIOL SCI, V278, P1713, DOI 10.1098/rspb.2010.2037; Weir JT, 2004, P ROY SOC B-BIOL SCI, V271, P1881, DOI 10.1098/rspb.2004.2803; Wong EHK, 2008, FOOD RES INT, V41, P828, DOI 10.1016/j.foodres.2008.07.005; Wooding S, 1997, MOL BIOL EVOL, V14, P1096, DOI 10.1093/oxfordjournals.molbev.a025719; ZINK RM, 1995, P NATL ACAD SCI USA, V92, P5832, DOI 10.1073/pnas.92.13.5832; Zink RM, 2004, PHILOS T ROY SOC B, V359, P215, DOI 10.1098/rstb.2003.1392; Zink RM, 2002, J AVIAN BIOL, V33, P175, DOI 10.1034/j.1600-048X.2002.330208.x; Zink RM, 2008, J ORNITHOL, V149, P399, DOI 10.1007/s10336-008-0276-z	91	22	24	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e20744	10.1371/journal.pone.0020744	http://dx.doi.org/10.1371/journal.pone.0020744			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818252	Green Published, gold			2022-12-25	WOS:000293282700004
J	Moleon, M; Sanchez-Zapata, JA; Gil-Sanchez, JM; Barea-Azcon, JM; Ballesteros-Duperon, E; Virgos, E				Moleon, Marcos; Sanchez-Zapata, Jose A.; Gil-Sanchez, Jose M.; Barea-Azcon, Jose M.; Ballesteros-Duperon, Elena; Virgos, Emilio			Laying the Foundations for a Human-Predator Conflict Solution: Assessing the Impact of Bonelli's Eagle on Rabbits and Partridges	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASE; ORYCTOLAGUS-CUNICULUS; HIERAAETUS-FASCIATUS; RED GROUSE; FUNCTIONAL-RESPONSES; RAPTOR PREDATION; EUROPEAN RABBITS; HEN HARRIERS; SEX-RATIOS; PREY	Background: Predation may potentially lead to negative effects on both prey (directly via predators) and predators (indirectly via human persecution). Predation pressure studies are, therefore, of major interest in the fields of theoretical knowledge and conservation of prey or predator species, with wide ramifications and profound implications in human-wildlife conflicts. However, detailed works on this issue in highly valuable -in conservation terms- Mediterranean ecosystems are virtually absent. This paper explores the predator-hunting conflict by examining a paradigmatic, Mediterranean-wide (endangered) predator-two prey (small game) system. Methodology/Principal Findings: We estimated the predation impact ('kill rate' and 'predation rate', i.e., number of prey and proportion of the prey population eaten, respectively) of Bonelli's eagle Aquila fasciata on rabbit Oryctolagus cuniculus and red-legged partridge Alectoris rufa populations in two seasons (the eagle's breeding and non-breeding periods, 100 days each) in SE Spain. The mean estimated kill rate by the seven eagle reproductive units in the study area was c. 304 rabbits and c. 262 partridges in the breeding season, and c. 237 rabbits and c. 121 partridges in the non-breeding period. This resulted in very low predation rates (range: 0.3-2.5%) for both prey and seasons. Conclusions/Significance: The potential role of Bonelli's eagles as a limiting factor for rabbits and partridges at the population scale was very poor. The conflict between game profitability and conservation interest of either prey or predators is apparently very localised, and eagles, quarry species and game interests seem compatible in most of the study area. Currently, both the persecution and negative perception of Bonelli's eagle (the 'partridge-eating eagle' in Spanish) have a null theoretical basis in most of this area.	[Moleon, Marcos; Gil-Sanchez, Jose M.; Barea-Azcon, Jose M.; Ballesteros-Duperon, Elena] Empresa Gest Medioambiental Consejeri Medio Ambie, Granada, Spain; [Sanchez-Zapata, Jose A.] Univ Miguel Hernandez, Dept Biol Aplicada, Alicante, Spain; [Virgos, Emilio] Univ Rey Juan Carlos, Escuela Super Ciencias Expt & Tecnol, Dept Biol & Geol, Madrid, Spain	Universidad Miguel Hernandez de Elche; Universidad Rey Juan Carlos	Moleon, M (corresponding author), Univ Witwatersrand, Ctr African Ecol, Sch Anim Plant & Environm Sci, Johannesburg, South Africa.	mmoleonpaiz@hotmail.com	Sánchez, Jose María Gil/J-4282-2017; Sanchez-Zapata, Jose Antonio/H-1413-2015; Moleón, Marcos/K-2875-2014; Gil-Sánchez, Jose María/AAW-1016-2021	Sanchez-Zapata, Jose Antonio/0000-0001-8230-4953; Moleón, Marcos/0000-0002-3126-619X; Gil-Sánchez, Jose María/0000-0002-7052-8332	regional government of Spain (Egmasa-Consejeria de Medio Ambiente, Junta de Andalucia); Spanish Ministry of Education [I+D+i 2008-2011]	regional government of Spain (Egmasa-Consejeria de Medio Ambiente, Junta de Andalucia)(Junta de Andalucia); Spanish Ministry of Education(Spanish Government)	This study was partially supported by two conservation projects of the regional government of Spain (Egmasa-Consejeria de Medio Ambiente, Junta de Andalucia). MM benefited from a postdoctoral fellowship from the Spanish Ministry of Education (Programa Nacional de Movilidad de Recursos Humanos del Plan Nacional de I+D+i 2008-2011) during the final stage of the paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARROYO B, 2001, RAPT RES FDN ANN M W; BirdLife International, 2004, BIRDS EUR POP EST TR; Blanco-Aguiar JA., 2003, ATLAS AVES REPROD ES, P212; Bosch R, 2010, IBIS, V152, P105, DOI 10.1111/j.1474-919X.2009.00985.x; Braza F., 1985, Ardeola, V32, P39; Carrete M, 2007, BIOL CONSERV, V136, P143, DOI 10.1016/j.biocon.2006.11.025; *CONS MED AMB, 2008, PROGR ACT CONS AG PE; Crawley MJ, 1992, POPULATION BIOL PRED; Delibes-Mateos M, 2008, CONSERV BIOL, V22, P1106, DOI 10.1111/j.1523-1739.2008.00993.x; Donald PF, 2007, IBIS, V149, P671, DOI 10.1111/j.1474-919X.2007.00724.x; Donazar J.A., 1989, Donana Acta Vertebrata, V16, P219; ERLINGE S, 1984, AM NAT, V123, P125, DOI 10.1086/284191; Gil Sanchez Jose Maria, 1998, Ardeola, V45, P151; Gil-Sanchez JM, 2004, BIOL CONSERV, V118, P685, DOI 10.1016/j.biocon.2003.10.017; Gil-Sanchez JM, 1999, ACTA THERIOL, V44, P421, DOI 10.4098/AT.arch.99-40; Gil-Sanchez Jose Maria, 2000, Ardeola, V47, P1; GONZALEZ LM, 1991, HIST NATURAL AGUILA; Holt AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002400; Jovani R, 2006, TRENDS PARASITOL, V22, P214, DOI 10.1016/j.pt.2006.02.011; Kenward RE, 1999, J RAPTOR RES, V33, P73; Kenward RE, 2001, J APPL ECOL, V38, P813, DOI 10.1046/j.1365-2664.2001.00636.x; LINDEN H, 1983, J ANIM ECOL, V52, P953, DOI 10.2307/4466; MADRONO A, LIBRO ROJO AVES ESPA; MARCSTROM V, 1988, J ANIM ECOL, V57, P859, DOI 10.2307/5097; Minguez E, 2001, J RAPTOR RES, V35, P228; Moleon M, 2006, AGUILA PERDICERA ESP, P24; MOLEON M, 2007, THESIS U GRANADA; MOLEON M, 2004, ACTA GRANATENSE, V3, P11; Moleon M, 2007, ARDEOLA, V54, P135; Moleon M, 2009, J BIOGEOGR, V36, P1502, DOI 10.1111/j.1365-2699.2009.02078.x; Moleon M, 2009, BIRD STUDY, V56, P142, DOI 10.1080/00063650802648069; Moleon M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002307; Nadal J, 1996, REV ECOL-TERRE VIE, V51, P243; Newton I., 1998, POPULATION LIMITATIO; Nielsen OK, 1999, J ANIM ECOL, V68, P1034, DOI 10.1046/j.1365-2656.1999.00351.x; Owen-Smith N, 2008, J ANIM ECOL, V77, P173, DOI 10.1111/j.1365-2656.2007.01314.x; Palma L, 2006, J APPL ECOL, V43, P1075, DOI 10.1111/j.1365-2664.2006.01213.x; Palomares F, 2001, WILDLIFE MONOGR, P1; Palomo LJ., 2007, ATLAS LIBRO ROJO MAM; Park KJ, 2008, IBIS, V150, P9, DOI 10.1111/j.1474-919X.2008.00847.x; Real J, 1996, J WILDLIFE MANAGE, V60, P632, DOI 10.2307/3802082; Real J., 2004, LIBRO ROJO AVES ESPA, P154; Redpath SM, 1999, J ANIM ECOL, V68, P879, DOI 10.1046/j.1365-2656.1999.00340.x; *REGHAB, 2002, 5 FOR PROGR EUR UN; Sergio F, 2008, IBIS, V150, P132, DOI 10.1111/j.1474-919X.2008.00786.x; Soriguer R. C., 1981, DONANA ACTA VERTEBRA, V8, P1; Telleria JL, 1986, MANUAL CENSO VERTEBR; Thirgood S, 2000, CONSERV BIOL, V14, P95, DOI 10.1046/j.1523-1739.2000.99013.x; Thirgood S, 2008, J APPL ECOL, V45, P1550, DOI 10.1111/j.1365-2664.2008.01519.x; Thirgood SJ, 2000, J ANIM ECOL, V69, P504, DOI 10.1046/j.1365-2656.2000.00413.x; THOMAS L., 2006, DISTANCE 5 0 RELEASE; TROUT RC, 1989, MAMMAL REV, V19, P153, DOI 10.1111/j.1365-2907.1989.tb00409.x; Valkama J, 2005, BIOL REV, V80, P171, DOI 10.1017/S146479310400658X; Villafuerte R, 1998, BIOL CONSERV, V84, P181, DOI 10.1016/S0006-3207(97)00094-3; Virgos E, 2005, BIODIVERS CONSERV, V14, P3475, DOI 10.1007/s10531-004-0823-8; Virgos E, 2007, BIODIVERS CONSERV, V16, P3489, DOI 10.1007/s10531-006-9054-5; WATSON J, 1997, GOLDEN EAGLE; Whitfield DP, 2003, BIOL CONSERV, V114, P157, DOI 10.1016/S0006-3207(03)00019-3	58	22	22	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22851	10.1371/journal.pone.0022851	http://dx.doi.org/10.1371/journal.pone.0022851			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818399	gold, Green Published, Green Submitted			2022-12-25	WOS:000293282700083
J	Seddon, AWR; Froyd, CA; Leng, MJ; Milne, GA; Willis, KJ				Seddon, Alistair W. R.; Froyd, Cynthia A.; Leng, Melanie J.; Milne, Glenn A.; Willis, Katherine J.			Ecosystem Resilience and Threshold Response in the Galapagos Coastal Zone	PLOS ONE			English	Article							SEA-LEVEL RISE; MANGROVE FORESTS; SURFACE ELEVATION; STABLE-ISOTOPES; CLIMATE-CHANGE; PALEOSALINITY; INDICATORS; RATIOS; RECORD	Background: The Intergovernmental Panel on Climate Change (IPCC) provides a conservative estimate on rates of sea-level rise of 3.8 mm yr(-1) at the end of the 21(st) century, which may have a detrimental effect on ecologically important mangrove ecosystems. Understanding factors influencing the long-term resilience of these communities is critical but poorly understood. We investigate ecological resilience in a coastal mangrove community from the Galapagos Islands over the last 2700 years using three research questions: What are the 'fast and slow' processes operating in the coastal zone? Is there evidence for a threshold response? How can the past inform us about the resilience of the modern system? Methodology/Principal Findings: Palaeoecological methods (AMS radiocarbon dating, stable carbon isotopes (delta C-13)) were used to reconstruct sedimentation rates and ecological change over the past 2,700 years at Diablas lagoon, Isabela, Galapagos. Bulk geochemical analysis was also used to determine local environmental changes, and salinity was reconstructed using a diatom transfer function. Changes in relative sea level (RSL) were estimated using a glacio-isostatic adjustment model. Non-linear behaviour was observed in the Diablas mangrove ecosystem as it responded to increased salinities following exposure to tidal inundations. A negative feedback was observed which enabled the mangrove canopy to accrete vertically, but disturbances may have opened up the canopy and contributed to an erosion of resilience over time. A combination of drier climatic conditions and a slight fall in RSL then resulted in a threshold response, from a mangrove community to a microbial mat. Conclusions/Significance: Palaeoecological records can provide important information on the nature of non-linear behaviour by identifying thresholds within ecological systems, and in outlining responses to 'fast' and 'slow' environmental change between alternative stable states. This study highlights the need to incorporate a long-term ecological perspective when designing strategies for maximizing coastal resilience.	[Seddon, Alistair W. R.; Froyd, Cynthia A.; Willis, Katherine J.] Univ Oxford, Dept Zool, Oxford Martin Sch, Biodivers Inst,Long Term Ecol Lab, Oxford OX1 3PS, England; [Froyd, Cynthia A.] Swansea Univ, Dept Geog, Swansea, W Glam, Wales; [Leng, Melanie J.] British Geol Survey, NERC, Isotope Geosci Lab, Nottingham NG12 5GG, England; [Milne, Glenn A.] Univ Ottawa, Dept Earth Sci, Ottawa, ON, Canada; [Willis, Katherine J.] Univ Bergen, Dept Biol, Bergen, Norway	University of Oxford; Swansea University; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey; University of Ottawa; University of Bergen	Seddon, AWR (corresponding author), Univ Oxford, Dept Zool, Oxford Martin Sch, Biodivers Inst,Long Term Ecol Lab, S Parks Rd, Oxford OX1 3PS, England.	alistair.seddon@zoo.ox.ac.uk	Froyd, Cynthia/A-8488-2012	Froyd, Cynthia/0000-0001-5291-9156; Leng, Melanie/0000-0003-1115-5166; Willis, Katherine/0000-0002-6763-2489; Seddon, Alistair/0000-0002-8266-0947	UK Natural Environment Research Council [NE/C510667/1]; Natural Environment Research Council [NE/C510667/1, nigl010001] Funding Source: researchfish; NERC [nigl010001] Funding Source: UKRI	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was supported by the UK Natural Environment Research Council, postgraduate studentship (AS) and grant NE/C510667/1 (CF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adame MF, 2010, ESTUAR COAST SHELF S, V86, P21, DOI 10.1016/j.ecss.2009.10.013; AGARDY T, 2005, MILLENNIUM ECOSYSTEM, P513; Alongi DM, 2008, ESTUAR COAST SHELF S, V76, P1, DOI 10.1016/j.ecss.2007.08.024; Battarbee RW, 2001, TRACKING ENV CHANGE, V3, P155, DOI DOI 10.1007/0-306-47668-1_8; BAULD J, 1981, HYDROBIOLOGIA, V81-2, P87, DOI 10.1007/BF00048708; Bengtsson L, 1986, HDB HOLOCENE PALAEOE, P423; BIRKS HJB, 1990, PHILOS T R SOC B, V327, P263, DOI 10.1098/rstb.1990.0062; Blaauw M, 2010, QUAT GEOCHRONOL, V5, P512, DOI 10.1016/j.quageo.2010.01.002; Boyle JF, 2002, DEV PALEOENVIRON RES, V2, P83; BRADLEY SL, QUATERNARY SCI UNPUB; CLARK JA, 1978, QUATERNARY RES, V9, P265, DOI 10.1016/0033-5894(78)90033-9; Conroy JL, 2008, QUATERNARY SCI REV, V27, P1166, DOI 10.1016/j.quascirev.2008.02.015; Conroy JL, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039558; Conroy JL, 2009, NAT GEOSCI, V2, P46, DOI 10.1038/NGEO390; Dearing JA, 2008, HOLOCENE, V18, P117, DOI 10.1177/0959683607085601; ELLISON JC, 1991, J COASTAL RES, V7, P151; ENGSTROM DR, 1984, CHEM STRATIGRAPHY LA; Ewel KC, 1998, GLOBAL ECOL BIOGEOGR, V7, P83, DOI 10.2307/2997700; Feagin RA, 2010, CONSERV LETT, V3, P1, DOI 10.1111/j.1755-263X.2009.00087.x; Feller IC, 2010, ANNU REV MAR SCI, V2, P395, DOI 10.1146/annurev.marine.010908.163809; Freitas MC, 2002, QUATERN INT, V93-4, P161, DOI 10.1016/S1040-6182(02)00014-9; Geist D., 1996, NOTICIAS GALAPAGOS, V56, P5; Gelin A., 2002, KNOWLEDGE CONSERVATI; Gilman EL, 2008, AQUAT BOT, V89, P237, DOI 10.1016/j.aquabot.2007.12.009; Holling C.S., 1986, SUSTAINABLE DEV BIOS, P292, DOI DOI 10.1371/JOURNAL.PONE.0134639; Holling CS, 2001, PANARCHY, P63; Huxham M, 2010, PHILOS T R SOC B, V365, P2127, DOI 10.1098/rstb.2010.0094; Juggins S, 2009, RIOJA ANAL QUATERNAR; LEWIS JT, 1997, RECORD DEPOSITION MI; Lopez-Buendia AM, 1999, CHEM GEOL, V157, P235, DOI 10.1016/S0009-2541(98)00207-1; Mackie EAV, 2005, J QUATERNARY SCI, V20, P303, DOI 10.1002/jqs.919; McCarroll D, 2004, QUATERNARY SCI REV, V23, P771, DOI 10.1016/j.quascirev.2003.06.017; McCormac FG, 2004, RADIOCARBON, V46, P1087, DOI 10.1017/S0033822200033014; Mckee K., 2000, ATOLL RES B, V468, P47, DOI [10.5479/si.00775630.468.47, DOI 10.5479/SI.00775630.468.47]; Mckee KL, 2007, GLOBAL ECOL BIOGEOGR, V16, P545, DOI 10.1111/j.1466-8238.2007.00317.x; McKee KL, 2011, ESTUAR COAST SHELF S, V91, P475, DOI 10.1016/j.ecss.2010.05.001; Milne GA, 2009, NAT GEOSCI, V2, P471, DOI 10.1038/ngeo544; NAKADA M, 1988, NATURE, V333, P36, DOI 10.1038/333036a0; PARKINSON RW, 1994, J COASTAL RES, V10, P1077; Phillips DL, 2005, OECOLOGIA, V144, P520, DOI [10.1007/s00442-004-1816-8, 10.1007/s000442-004-1816-8]; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; R Core Team, 2021, R LANG ENV STAT COMP; Ramirez-Herrera MT, 2007, HOLOCENE, V17, P1211, DOI 10.1177/0959683607085127; Rockstrom J, 2009, ECOL SOC, V14; Rogers K, 2006, ESTUAR COAST SHELF S, V66, P559, DOI 10.1016/j.ecss.2005.11.004; Rogers K, 2008, J COASTAL RES, V24, P63, DOI 10.2112/05-0519.1; Sachs JP, 2009, NAT GEOSCI, V2, P519, DOI 10.1038/ngeo554; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Shanahan TM, 2009, SCIENCE, V324, P377, DOI 10.1126/science.1166352; Shen CC, 2005, ESTUAR COAST SHELF S, V65, P135, DOI 10.1016/j.ecss.2005.05.010; Siddall M, 2003, NATURE, V423, P853, DOI 10.1038/nature01690; Snell H., 1999, NOTICIAS GALAPAGOS, V60, P11; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Virah-Sawmy M, 2009, GLOBAL ECOL BIOGEOGR, V18, P98, DOI 10.1111/j.1466-8238.2008.00429.x; Weckstrom K, 2006, J PHYCOL, V42, P21, DOI 10.1111/j.1529-8817.2006.00166.x; Willis KJ, 2010, TRENDS ECOL EVOL, V25, P583, DOI 10.1016/j.tree.2010.07.006; WRIGHT HE, 1984, ECOLOGY, V65, P657, DOI 10.2307/1941430	58	25	26	6	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22376	10.1371/journal.pone.0022376	http://dx.doi.org/10.1371/journal.pone.0022376			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811594	Green Published, gold, Green Accepted			2022-12-25	WOS:000292956800050
J	Bevc, S; Konc, J; Stojan, J; Hodoscek, M; Penca, M; Praprotnik, M; Janezic, D				Bevc, Stas; Konc, Janez; Stojan, Jure; Hodoscek, Milan; Penca, Matej; Praprotnik, Matej; Janezic, Dusanka			ENZO: A Web Tool for Derivation and Evaluation of Kinetic Models of Enzyme Catalyzed Reactions	PLOS ONE			English	Article							PROGRESS CURVES; PROCATHEPSIN B; ACETYLCHOLINESTERASE; SUBSTRATE; INHIBITION	We describe a web tool ENZO (Enzyme Kinetics), a graphical interface for building kinetic models of enzyme catalyzed reactions. ENZO automatically generates the corresponding differential equations from a stipulated enzyme reaction scheme. These differential equations are processed by a numerical solver and a regression algorithm which fits the coefficients of differential equations to experimentally observed time course curves. ENZO allows rapid evaluation of rival reaction schemes and can be used for routine tests in enzyme kinetics. It is freely available as a web tool, at http://enzo.cmm.ki.si.	[Bevc, Stas; Konc, Janez; Hodoscek, Milan; Penca, Matej; Praprotnik, Matej; Janezic, Dusanka] Natl Inst Chem, Ljubljana, Slovenia; [Bevc, Stas; Janezic, Dusanka] Univ Primorska, Fac Math Nat Sci & Informat Technol, Koper, Slovenia; [Stojan, Jure] Univ Ljubljana, Fac Med, Ljubljana, Slovenia	National Institute of Chemistry - Slovenia; University of Primorska; University of Ljubljana	Bevc, S (corresponding author), Natl Inst Chem, Ljubljana, Slovenia.	dusa@cmm.ki.si	Konc, Janez/O-3249-2019; Praprotnik, Matej/G-8571-2019	Konc, Janez/0000-0003-0160-3375; Praprotnik, Matej/0000-0003-0825-1659	Ministry of Higher Education, Science, and Technology of Slovenia [P1-0002, P1-0170, J1-2281, J1-2282]; Slovenian Research Agency	Ministry of Higher Education, Science, and Technology of Slovenia; Slovenian Research Agency(Slovenian Research Agency - Slovenia)	Financial support was provided by grants P1-0002, P1-0170, J1-2281, J1-2282 of the Ministry of Higher Education, Science, and Technology of Slovenia and the Slovenian Research Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Colletier JP, 2006, EMBO J, V25, P2746, DOI 10.1038/sj.emboj.7601175; DUGGLEBY RG, 1995, METHOD ENZYMOL, V249, P61; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Harel M, 1996, J AM CHEM SOC, V118, P2340, DOI 10.1021/ja952232h; Johnson KA, 2009, METHOD ENZYMOL, V467, P601, DOI 10.1016/S0076-6879(09)67023-3; Kuzmic P, 2009, METHOD ENZYMOL, V467, P247, DOI 10.1016/S0076-6879(09)67010-5; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; Masson P, 2003, EUR J BIOCHEM, V270, P315, DOI 10.1046/j.1432-1033.2003.03388.x; Michaelis L, 1913, BIOCHEM Z, V49, P333; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PAVLIC MR, 1973, BIOCHIM BIOPHYS ACTA, V327, P393, DOI 10.1016/0005-2744(73)90422-1; Pungercar JR, 2009, FEBS J, V276, P660, DOI 10.1111/j.1742-4658.2008.06815.x; ROSENBERRY TL, 1975, ADV ENZYMOL RAMB, V43, P103; Rozman J, 1999, FEBS LETT, V459, P358, DOI 10.1016/S0014-5793(99)01302-2; Stojan J, 2004, EUR J BIOCHEM, V271, P1364, DOI 10.1111/j.1432-1033.2004.04048.x; Stojan J, 1997, J CHEM INF COMP SCI, V37, P1025, DOI 10.1021/ci960154r; YAMAOKA K, 1983, J PHARMACOBIO-DYNAM, V6, P595	17	50	50	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22265	10.1371/journal.pone.0022265	http://dx.doi.org/10.1371/journal.pone.0022265			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21818304	Green Published, Green Submitted, gold			2022-12-25	WOS:000292929500048
J	Lee, J; Hirsh, AS; Wittner, BS; Maeder, ML; Singavarapu, R; Lang, M; Janarthanan, S; McDermott, U; Yajnik, V; Ramaswamy, S; Joung, JK; Sgroi, DC				Lee, Jeongeun; Hirsh, Andrew S.; Wittner, Ben S.; Maeder, Morgan L.; Singavarapu, Rajasekhar; Lang, Magdalena; Janarthanan, Sailajah; McDermott, Ultan; Yajnik, Vijay; Ramaswamy, Sridhar; Joung, J. Keith; Sgroi, Dennis C.			Induction of Stable Drug Resistance in Human Breast Cancer Cells Using a Combinatorial Zinc Finger Transcription Factor Library	PLOS ONE			English	Article							ESTROGEN-RECEPTOR EXPRESSION; GENE-EXPRESSION; PHENOTYPIC ALTERATION; INCREASE PRODUCTION; DNA RECOGNITION; HUMAN GENOME; IDENTIFICATION; TAMOXIFEN; MYB; SUBCLONES	Combinatorial libraries of artificial zinc-finger transcription factors (ZF-TFs) provide a robust tool for inducing and understanding various functional components of the cancer phenotype. Herein, we utilized combinatorial ZF-TF library technology to better understand how breast cancer cells acquire resistance to fulvestrant, a clinically important anti-endocrine therapeutic agent. From a diverse collection of nearly 400,000 different ZF-TFs, we isolated six ZF-TF library members capable of inducing stable, long-term anti-endocrine drug-resistance in two independent estrogen receptor-positive breast cancer cell lines. Comparative gene expression profile analysis of the six different ZF-TF-transduced breast cancer cell lines revealed five distinct clusters of differentially expressed genes. One cluster was shared among all 6 ZF-TF-transduced cell lines and therefore constituted a common fulvestrant-resistant gene expression signature. Pathway enrichment-analysis of this common fulvestrant resistant signature also revealed significant overlap with gene sets associated with an estrogen receptor-negative-like state and with gene sets associated with drug resistance to different classes of breast cancer anti-endocrine therapeutic agents. Enrichment-analysis of the four remaining unique gene clusters revealed overlap with myb-regulated genes. Finally, we also demonstrated that the common fulvestrant-resistant signature is associated with poor prognosis by interrogating five independent, publicly available human breast cancer gene expression datasets. Our results demonstrate that artificial ZF-TF libraries can be used successfully to induce stable drug-resistance in human cancer cell lines and to identify a gene expression signature that is associated with a clinically relevant drug-resistance phenotype.	[Lee, Jeongeun; Hirsh, Andrew S.; Maeder, Morgan L.; Singavarapu, Rajasekhar; Lang, Magdalena; Joung, J. Keith; Sgroi, Dennis C.] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA USA; [Lee, Jeongeun; Hirsh, Andrew S.; Wittner, Ben S.; Maeder, Morgan L.; Singavarapu, Rajasekhar; Lang, Magdalena; Ramaswamy, Sridhar; Joung, J. Keith; Sgroi, Dennis C.] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA USA; [Hirsh, Andrew S.; Maeder, Morgan L.; Lang, Magdalena; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Lee, Jeongeun; Hirsh, Andrew S.; Singavarapu, Rajasekhar; Lang, Magdalena; Joung, J. Keith; Sgroi, Dennis C.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Wittner, Ben S.; Ramaswamy, Sridhar] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Janarthanan, Sailajah; Yajnik, Vijay] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [McDermott, Ultan] Genome Res Ltd, Wellcome Trust Sanger Inst, Hinxton, England	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Wellcome Trust Sanger Institute	Lee, J (corresponding author), Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA USA.	jjoung@partners.org; dsgroi@partners.org	Sgroi, Dennis/AAV-2487-2021	McDermott, Ultan/0000-0001-9032-4700	National Institutes of Health (NIH) [R01-CA112021, R01 GM069906, T32 CA009216]; Department of Defense [W81XWH-062-033]; AstraZeneca Inc.; Avon Foundation; NATIONAL CANCER INSTITUTE [R01CA112021, T32CA009216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM105378, R01GM069906] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); AstraZeneca Inc.(AstraZeneca); Avon Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Institutes of Health (NIH) R01-CA112021 (D. C. S.), the Department of Defense Breast Cancer Research Program grant W81XWH-062-033 (D. C. S.), NIH R01 GM069906 (J.K.J.), AstraZeneca Inc. (D. C. S. and J.K.J.), and the Avon Foundation (D. C. S.). A. S. H. was supported by NIH T32 CA009216. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae KH, 2003, NAT BIOTECHNOL, V21, P275, DOI 10.1038/nbt796; Blancafort P, 2005, P NATL ACAD SCI USA, V102, P11716, DOI 10.1073/pnas.0501162102; Blancafort P, 2003, NAT BIOTECHNOL, V21, P269, DOI 10.1038/nbt794; Blancafort P, 2008, MOL CANCER THER, V7, P688, DOI 10.1158/1535-7163.MCT-07-0381; Calcagno AM, 2008, BRIT J CANCER, V98, P1515, DOI 10.1038/sj.bjc.6604334; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Clarke M, 1998, LANCET, V351, P1451; Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; Coser KR, 2009, P NATL ACAD SCI USA, V106, P14536, DOI 10.1073/pnas.0907560106; Creighton CJ, 2008, CANCER RES, V68, P7493, DOI 10.1158/0008-5472.CAN-08-1404; Devarajan E, 2002, INT J ONCOL, V20, P913; Drabsch Y, 2007, P NATL ACAD SCI USA, V104, P13762, DOI 10.1073/pnas.0700104104; Fan MY, 2006, CANCER RES, V66, P11954, DOI 10.1158/0008-5472.CAN-06-1666; Frasor J, 2004, CANCER RES, V64, P1522, DOI 10.1158/0008-5472.CAN-03-3326; GUERIN M, 1990, ONCOGENE, V5, P131; Jeng MH, 1998, ENDOCRINOLOGY, V139, P4164, DOI 10.1210/en.139.10.4164; Joung JK, 2000, P NATL ACAD SCI USA, V97, P7382, DOI 10.1073/pnas.110149297; Kwon RJ, 2006, BIOTECHNOL LETT, V28, P9, DOI 10.1007/s10529-005-4680-7; Lee DK, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh114; Lee DK, 2003, GENOME RES, V13, P2708, DOI 10.1101/gr.1397903; Lei WL, 2004, J BIOL CHEM, V279, P29519, DOI 10.1074/jbc.M403133200; Liu Q, 2002, J BIOL CHEM, V277, P3850, DOI 10.1074/jbc.M110669200; Magnenat L, 2004, J MOL BIOL, V341, P635, DOI 10.1016/j.jmb.2004.06.030; Masri S, 2008, CANCER RES, V68, P4910, DOI 10.1158/0008-5472.CAN-08-0303; Massarweh S, 2008, CANCER RES, V68, P826, DOI 10.1158/0008-5472.CAN-07-2707; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Miao J, 2007, P NATL ACAD SCI USA, V104, P17093, DOI 10.1073/pnas.0707938104; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Miller TW, 2011, CLIN CANCER RES, V17, P2024, DOI 10.1158/1078-0432.CCR-10-2567; Park KS, 2005, J BACTERIOL, V187, P5496, DOI 10.1128/JB.187.15.5496-5499.2005; Park KS, 2005, BIOTECHNOL PROGR, V21, P664, DOI 10.1021/bp049658x; Park KS, 2003, NAT BIOTECHNOL, V21, P1208, DOI 10.1038/nbt868; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Stein RA, 2008, CANCER RES, V68, P8805, DOI 10.1158/0008-5472.CAN-08-1594; Stossi F, 2004, ENDOCRINOLOGY, V145, P3473, DOI 10.1210/en.2003-1682; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Witmer BS, 2008, CLIN CANCER RES, V14, P2988, DOI 10.1158/1078-0432.CCR-07-4723; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183	43	8	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e21112	10.1371/journal.pone.0021112	http://dx.doi.org/10.1371/journal.pone.0021112			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21818254	Green Published, Green Submitted, gold			2022-12-25	WOS:000292929500003
J	Steinert, G; Oancea, C; Roos, J; Hagemeyer, H; Maier, T; Ruthardt, M; Puccetti, E				Steinert, Gunnar; Oancea, Claudia; Roos, Jessica; Hagemeyer, Heike; Maier, Thorsten; Ruthardt, Martin; Puccetti, Elena			Sulindac Sulfide Reverses Aberrant Self-Renewal of Progenitor Cells Induced by the AML-Associated Fusion Proteins PML/RAR alpha and PLZF/RAR alpha	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; FAMILIAL ADENOMATOUS POLYPOSIS; WNT/BETA-CATENIN-PATHWAY; ACUTE MYELOID-LEUKEMIA; WNT SIGNALING PATHWAY; BETA-CATENIN; STEM-CELLS; TRANSLOCATION PRODUCTS; PROMYELOCYTIC LEUKEMIA; PROSTATE-CANCER	Chromosomal translocations can lead to the formation of chimeric genes encoding fusion proteins such as PML/RAR alpha, PLZF/RAR alpha, and AML-1/ETO, which are able to induce and maintain acute myeloid leukemia (AML). One key mechanism in leukemogenesis is increased self renewal of leukemic stem cells via aberrant activation of the Wnt signaling pathway. Either X-RAR, PML/RAR alpha and PLZF/RAR alpha or AML-1/ETO activate Wnt signaling by upregulating gamma-catenin and beta-catenin. In a prospective study, a lower risk of leukemia was observed with aspirin use, which is consistent with numerous studies reporting an inverse association of aspirin with other cancers. Furthermore, a reduction in leukemia risk was associated with use of non-steroidal anti-inflammatory drug (NSAID), where the effects on AML risk was FAB subtype-specific. To better investigate whether NSAID treatment is effective, we used Sulindac Sulfide in X-RAR alpha-positive progenitor cell models. Sulindac Sulfide (SSi) is a derivative of Sulindac, a NSAID known to inactivate Wnt signaling. We found that SSi downregulated both beta-catenin and gamma-catenin in X-RAR alpha-expressing cells and reversed the leukemic phenotype by reducing stem cell capacity and increasing differentiation potential in X-RAR alpha-positive HSCs. The data presented herein show that SSi inhibits the leukemic cell growth as well as hematopoietic progenitors cells (HPCs) expressing PML/RAR alpha, and it indicates that Sulindac is a valid molecular therapeutic approach that should be further validated using in vivo leukemia models and in clinical settings.	[Steinert, Gunnar; Oancea, Claudia; Roos, Jessica; Ruthardt, Martin] Goethe Univ Frankfurt, Dept Hematol, Frankfurt, Germany; [Steinert, Gunnar; Hagemeyer, Heike; Puccetti, Elena] Univ Marburg, Inst Mol Biol & Tumor Res, Marburg, Germany; [Roos, Jessica; Maier, Thorsten] Goethe Univ Frankfurt, Inst Pharmaceut Chem, Frankfurt, Germany	Goethe University Frankfurt; Philipps University Marburg; Goethe University Frankfurt	Steinert, G (corresponding author), Goethe Univ Frankfurt, Dept Hematol, Frankfurt, Germany.	ruthardt@em.uni-frankfurt.de; puccetti@staff.uni-marburg.de		Ruthardt, Martin/0000-0003-1021-3811; Chiriches, Claudia/0000-0003-3758-1892	Alfred und Angelika Gutermuth Foundation; Lipid Signaling Forschungszentrum Frankfurt (LiFF); Deutsche Krebshilfe e.V. [DKH-108693, DKH-108694, DKH-107741]; Deutsche Forschungsgemeinschaft [DFG-TRR 17-N01, DFG-RU 728/3-2]; Deutsche Jose Carreras Leukamie-Stiftung e.V. [DJCLS - R 07/27f]	Alfred und Angelika Gutermuth Foundation; Lipid Signaling Forschungszentrum Frankfurt (LiFF); Deutsche Krebshilfe e.V.(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Jose Carreras Leukamie-Stiftung e.V.	This project was initially supported by a grant from the Alfred und Angelika Gutermuth Foundation to E.P. The project is funded by a grant from Lipid Signaling Forschungszentrum Frankfurt (LiFF). E.P. is further funded by grants from Deutsche Krebshilfe e.V. (DKH-108693) and Deutsche Forschungsgemeinschaft (DFG-TRR 17-N01). M.R. is funded by grants from Deutsche Forschungsgemeinschaft (DFG-RU 728/3-2), Deutsche Krebshilfe e.V. (DKH-108694 and DKH-107741) and Deutsche Jose Carreras Leukamie-Stiftung e.V. (DJCLS - R 07/27f). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boon EMJ, 2004, BRIT J CANCER, V90, P224, DOI 10.1038/sj.bjc.6601505; Brown WA, 2001, DIGEST DIS SCI, V46, P2314, DOI 10.1023/A:1012326525692; Chang WCL, 2005, ANN NY ACAD SCI, V1059, P41, DOI 10.1196/annals.1339.020; Chesire DR, 2003, ENDOCR-RELAT CANCER, V10, P537, DOI 10.1677/erc.0.0100537; Chesire DR, 2002, ONCOGENE, V21, P2679, DOI 10.1038/sj.onc.1205352; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Coulombel L, 2004, ONCOGENE, V23, P7210, DOI 10.1038/sj.onc.1207941; Dihlmann S, 2005, INT J CANCER, V113, P515, DOI 10.1002/ijc.20609; Dihlmann S, 2003, MOL CANCER THER, V2, P509; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; Fanelli M, 2004, J BIOL CHEM, V279, P5374, DOI 10.1074/jbc.M306407200; Gardner SH, 2004, BRIT J CANCER, V91, P153, DOI 10.1038/sj.bjc.6601901; Giardiello FM, 1996, GUT, V38, P578, DOI 10.1136/gut.38.4.578; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Hawcroft G, 2002, CARCINOGENESIS, V23, P107, DOI 10.1093/carcin/23.1.107; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Herrmann C, 1998, ONCOGENE, V17, P1769, DOI 10.1038/sj.onc.1202085; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Huang Y, 2001, CANCER RES, V61, P6918; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; Kasum CM, 2003, CANCER EPIDEM BIOMAR, V12, P534; Kishida S, 1999, MOL CELL BIOL, V19, P4414; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Lee HK, 2006, NUCLEIC ACIDS RES, V34, P5705, DOI 10.1093/nar/gkl698; Li H, 2002, CANCER BIOL THER, V1, P621, DOI 10.4161/cbt.309; Li Y, 2000, ONCOGENE, V19, P1002, DOI 10.1038/sj.onc.1203273; Lu DS, 2004, P NATL ACAD SCI USA, V101, P3118, DOI 10.1073/pnas.0308648100; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Moon Y, 2008, LIFE SCI, V82, P591, DOI 10.1016/j.lfs.2007.11.030; Muller-Tidow C, 2004, MOL CELL BIOL, V24, P2890, DOI 10.1128/MCB.24.7.2890-2904.2004; Pogoda JM, 2005, INT J CANCER, V114, P634, DOI 10.1002/ijc.20788; Puccetti E, 2004, LEUKEMIA, V18, P1169, DOI 10.1038/sj.leu.2403367; Ray GF, 1995, J PHARMACEUT BIOMED, V14, P213, DOI 10.1016/0731-7085(95)01631-7; Reddy BS, 1999, CANCER RES, V59, P3387; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Rice PL, 2003, MOL CANCER THER, V2, P885; Steinbrink SD, 2010, CELL MOL LIFE SCI, V67, P797, DOI 10.1007/s00018-009-0206-0; Tegeder I, 2001, FASEB J, V15, P2057, DOI 10.1096/fj.01-0390rev; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thompson WJ, 2000, CANCER RES, V60, P3338; van Stolk R, 2000, CLIN CANCER RES, V6, P78; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yamamoto H, 1999, J BIOL CHEM, V274, P10681, DOI 10.1074/jbc.274.16.10681; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003; Zheng XM, 2007, HAEMATOLOGICA, V92, P323, DOI 10.3324/haematol.10541; Zheng XM, 2004, BLOOD, V103, P3535, DOI 10.1182/blood-2003-09-3335	53	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22540	10.1371/journal.pone.0022540	http://dx.doi.org/10.1371/journal.pone.0022540			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21811629	gold, Green Submitted, Green Published			2022-12-25	WOS:000292929500076
J	Virtue, ER; Marsh, GA; Baker, ML; Wang, LF				Virtue, Elena R.; Marsh, Glenn A.; Baker, Michelle L.; Wang, Lin-Fa			Interferon Production and Signaling Pathways Are Antagonized during Henipavirus Infection of Fruit Bat Cell Lines	PLOS ONE			English	Article							HENDRA VIRUS-INFECTION; NIPAH-VIRUS; V-PROTEIN; EQUINE MORBILLIVIRUS; ANTIVIRAL RESPONSES; PTEROPID BATS; TIOMAN VIRUS; FATAL ENCEPHALITIS; NATURAL RESERVOIR; PREVENTING STAT1	Bats are natural reservoirs for a spectrum of infectious zoonotic diseases including the recently emerged henipaviruses (Hendra and Nipah viruses). Henipaviruses have been observed both naturally and experimentally to cause serious and often fatal disease in many different mammal species, including humans. Interestingly, infection of the flying fox with henipaviruses occurs in the absence of clinical disease. The extreme variation in the disease pattern between humans and bats has led to an investigation into the effects of henipavirus infection on the innate immune response in bat cell lines. We report that henipavirus infection does not result in the induction of interferon expression, and the viruses also inhibit interferon signaling. We also confirm that the interferon production and signaling block in bat cells is not due to differing viral protein expression levels between human and bat hosts. This information, in addition to the known lack of clinical signs in bats following henipavirus infection, suggests that bats control henipavirus infection by an as yet unidentified mechanism, not via the interferon response. This is the first report of henipavirus infection in bat cells specifically investigating aspects of the innate immune system.	[Virtue, Elena R.; Marsh, Glenn A.; Baker, Michelle L.; Wang, Lin-Fa] CSIRO Livestock Ind, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Virtue, Elena R.; Wang, Lin-Fa] Australian Biosecur Cooperat Res Ctr Emerging Inf, Brisbane, Qld, Australia; [Virtue, Elena R.; Wang, Lin-Fa] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Melbourne	Virtue, ER (corresponding author), CSIRO Livestock Ind, Australian Anim Hlth Lab, Geelong, Vic, Australia.	glenn.marsh@csiro.au	wang, lin/GSE-3040-2022; Baker, Michelle L/C-9694-2013; Marsh, Glenn A/A-5418-2013; Baker, Michelle/AAX-9171-2020	Baker, Michelle L/0000-0002-7993-9971; Marsh, Glenn A/0000-0002-3469-1837; Baker, Michelle/0000-0002-7993-9971; Wang, Lin-Fa/0000-0003-2752-0535; Tripp, Ralph/0000-0002-2924-9956	Australian Biosecurity Cooperative Research Centre for Emerging Infectious Diseases; OCE; CSIRO Office of the Chief Executive	Australian Biosecurity Cooperative Research Centre for Emerging Infectious Diseases(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); OCE; CSIRO Office of the Chief Executive(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	This work was supported by a PhD Scholarship (ERV) from the Australian Biosecurity Cooperative Research Centre for Emerging Infectious Diseases, an OCE Postdoctoral Fellowship (GAM) and a CEO Science Leader Award (LFW) from the CSIRO Office of the Chief Executive. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Baker ML, 2010, IMMUNOGENETICS, V62, P173, DOI 10.1007/s00251-010-0425-4; Breed AC, 2010, EMERG INFECT DIS, V16, P1997, DOI 10.3201/eid1612.100879; Chadha MS, 2006, EMERG INFECT DIS, V12, P235, DOI 10.3201/eid1202.051247; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2; Chua KB, 2001, VIROLOGY, V283, P215, DOI 10.1006/viro.2000.0882; Chua KB, 1999, LANCET, V354, P1257, DOI 10.1016/S0140-6736(99)04299-3; Conzelmann KK, 2005, J VIROL, V79, P5241, DOI 10.1128/JVI.79.9.5241-5248.2005; COWLED C, 2010, DEV COMP IM IN PRESS; Crameri G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008266; Drexler JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006367; Field H, 2001, MICROBES INFECT, V3, P307, DOI 10.1016/S1286-4579(01)01384-3; Field HE, 2007, AUST VET J, V85, P268, DOI 10.1111/j.1751-0813.2007.00170.x; Field HE, 2000, AUST VET J, V78, P279, DOI 10.1111/j.1751-0813.2000.tb11758.x; Fujii H, 2010, DEV COMP IMMUNOL, V34, P598, DOI 10.1016/j.dci.2010.01.004; Garcia-Sastre A, 2002, MICROBES INFECT, V4, P647, DOI 10.1016/S1286-4579(02)01583-6; Goh KJ, 2000, NEW ENGL J MED, V342, P1229, DOI 10.1056/NEJM200004273421701; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Hayman DTS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002739; He GM, 2010, BIOCHEM GENET, V48, P840, DOI 10.1007/s10528-010-9365-9; Hooper PT, 1996, AUST VET J, V74, P244, DOI 10.1111/j.1751-0813.1996.tb15414.x; Horvath CM, 2004, CYTOKINE GROWTH F R, V15, P117, DOI 10.1016/j.cytogfr.2004.02.003; Hsu VP, 2004, EMERG INFECT DIS, V10, P2082, DOI 10.3201/eid1012.040701; Iehle C, 2007, EMERG INFECT DIS, V13, P159, DOI 10.3201/eid1301.060791; Johara MY, 2001, EMERG INFECT DIS, V7, P439; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kepler TB, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-444; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Leroy EM, 2009, VECTOR-BORNE ZOONOT, V9, P723, DOI 10.1089/vbz.2008.0167; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li Y, 2008, EMERG INFECT DIS, V14, P1974, DOI 10.3201/eid1412.080359; Luby SP, 2009, CLIN INFECT DIS, V49, P1743, DOI 10.1086/647951; MURRAY K, 1995, SCIENCE, V268, P94, DOI 10.1126/science.7701348; MURRAY K, 1995, EMERG INFECT DIS, V1, P31, DOI 10.3201/eid0101.950107; Nor MNM, 2000, REV SCI TECH OIE, V19, P160; Omatsu T, 2008, VET IMMUNOL IMMUNOP, V124, P169, DOI 10.1016/j.vetimm.2008.03.004; Omatsu T, 2007, COMP IMMUNOL MICROB, V30, P357, DOI 10.1016/j.cimid.2007.05.006; OSullivan JD, 1997, LANCET, V349, P93, DOI 10.1016/S0140-6736(96)06162-4; Park MS, 2003, J VIROL, V77, P1501, DOI 10.1128/JVI.77.2.1501-1511.2003; *PBL INTERFERONSOU, 2011, UN TYP 1 INT; Peter A, 2011, J IMMUNOL, V186; Philbey AW, 1998, EMERG INFECT DIS, V4, P269, DOI 10.3201/eid0402.980214; Plowright RK, 2008, P ROY SOC B-BIOL SCI, V275, P861, DOI 10.1098/rspb.2007.1260; Reynes JM, 2005, EMERG INFECT DIS, V11, P1042, DOI 10.3201/eid1107.041350; Rodriguez JJ, 2004, J VIROL, V78, P5358, DOI 10.1128/JVI.78.10.5358-5367.2004; Rodriguez JJ, 2003, J VIROL, V77, P11842, DOI 10.1128/JVI.77.21.11842-11845.2003; Rodriguez JJ, 2002, J VIROL, V76, P11476, DOI 10.1128/JVI.76.22.11476-11483.2002; Rogers RJ, 1996, AUST VET J, V74, P243, DOI 10.1111/j.1751-0813.1996.tb15413.x; Selvey, 1995, J Travel Med, V2, P275, DOI 10.1111/j.1708-8305.1995.tb00679.x; Sendow I, 2006, EMERG INFECT DIS, V12, P711, DOI 10.3201/eid1204.051181; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Stoltz M, 2010, J VIROL, V84, P9140, DOI 10.1128/JVI.00717-10; SULKIN SE, 1966, AM J TROP MED HYG, V15, P406, DOI 10.4269/ajtmh.1966.15.406; Swanepoel R, 1996, EMERG INFECT DIS, V2, P321, DOI 10.3201/eid0204.960407; Taniguchi T, 2002, CURR OPIN IMMUNOL, V14, P111, DOI 10.1016/S0952-7915(01)00305-3; VIRTUE ER, 2011, J VIROL; Wacharapluesadee S, 2005, EMERG INFECT DIS, V11, P1949, DOI 10.3201/eid1112.050613; Wacharapluesadee S, 2010, VECTOR-BORNE ZOONOT, V10, P183, DOI 10.1089/vbz.2008.0105; Weber F, 2004, VIRAL IMMUNOL, V17, P498, DOI 10.1089/vim.2004.17.498; Williamson MM, 1998, AUST VET J, V76, P813, DOI 10.1111/j.1751-0813.1998.tb12335.x; Williamson MM, 2000, J COMP PATHOL, V122, P201, DOI 10.1053/jcpa.1999.0364; Yaiw KC, 2008, J VIROL, V82, P565, DOI 10.1128/JVI.01660-07; YOB JM, 2001, SURVEILLANCE WILDLIF, P79; Young PL, 1996, EMERG INFECT DIS, V2, P239, DOI 10.3201/eid0203.960315; 2004, HLTH SCI B, V2, P5; 2004, HLTH SCI B ICDDR B, V2, P7	70	49	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22488	10.1371/journal.pone.0022488	http://dx.doi.org/10.1371/journal.pone.0022488			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21811620	Green Published, gold			2022-12-25	WOS:000292929500072
J	Zhong, Y; Wang, Z; Fu, BJ; Pan, F; Yachida, S; Dhara, M; Albesiano, E; Li, L; Naito, Y; Vilardell, F; Cummings, C; Martinelli, P; Li, A; Yonescu, R; Ma, QY; Griffin, CA; Real, FX; Iacobuzio-Donahue, CA				Zhong, Yi; Wang, Zheng; Fu, Baojin; Pan, Fan; Yachida, Shinichi; Dhara, Mousumi; Albesiano, Emilia; Li, Li; Naito, Yoshiki; Vilardell, Felip; Cummings, Christopher; Martinelli, Paola; Li, Ang; Yonescu, Raluca; Ma, Qingyong; Griffin, Constance A.; Real, Francisco X.; Iacobuzio-Donahue, Christine A.			GATA6 Activates Wnt Signaling in Pancreatic Cancer by Negatively Regulating the Wnt Antagonist Dickkopf-1	PLOS ONE			English	Article							TRANSCRIPTION FACTORS GATA-4; TUMOR-SUPPRESSOR GENE; BETA-CATENIN; EPIGENETIC INACTIVATION; DUCTAL ADENOCARCINOMA; ZINC-FINGER; E-CADHERIN; IN-VIVO; EXPRESSION; DIFFERENTIATION	Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal disease characterized by late diagnosis and treatment resistance. Recurrent genetic alterations in defined genes in association with perturbations of developmental cell signaling pathways have been associated with PDAC development and progression. Here, we show that GATA6 contributes to pancreatic carcinogenesis during the temporal progression of pancreatic intraepithelial neoplasia by virtue of Wnt pathway activation. GATA6 is recurrently amplified by both quantitative-PCR and fluorescent in-situ hybridization in human pancreatic intraepithelial neoplasia and in PDAC tissues, and GATA6 copy number is significantly correlated with overall patient survival. Forced overexpression of GATA6 in cancer cell lines enhanced cell proliferation and colony formation in soft agar in vitro and growth in vivo, as well as increased Wnt signaling. By contrast siRNA mediated knockdown of GATA6 led to corresponding decreases in these same parameters. The effects of GATA6 were found to be due to its ability to bind DNA, as forced overexpression of a DNA-binding mutant of GATA6 had no effects on cell growth in vitro or in vivo, nor did they affect Wnt signaling levels in these same cells. A microarray analysis revealed the Wnt antagonist Dickopf-1 (DKK1) as a dysregulated gene in association with GATA6 knockdown, and direct binding of GATA6 to the DKK1 promoter was confirmed by chromatin immunoprecipitation and electrophoretic mobility shift assays. Transient transfection of GATA6, but not mutant GATA6, into cancer cell lines led to decreased DKK1 mRNA expression and secretion of DKK1 protein into culture media. Forced overexpression of DKK1 antagonized the effects of GATA6 on Wnt signaling in pancreatic cancer cells. These findings illustrate that one mechanism by which GATA6 promotes pancreatic carcinogenesis is by virtue of its activation of canonical Wnt signaling via regulation of DKK1.	[Zhong, Yi; Wang, Zheng; Fu, Baojin; Yachida, Shinichi; Dhara, Mousumi; Li, Li; Naito, Yoshiki; Vilardell, Felip; Cummings, Christopher; Li, Ang; Yonescu, Raluca; Griffin, Constance A.; Iacobuzio-Donahue, Christine A.] Johns Hopkins Med Inst, Dept Pathol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21205 USA; [Pan, Fan; Albesiano, Emilia; Griffin, Constance A.; Iacobuzio-Donahue, Christine A.] Johns Hopkins Med Inst, Dept Oncol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21205 USA; [Iacobuzio-Donahue, Christine A.] Johns Hopkins Med Inst, Dept Surg, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21205 USA; [Cummings, Christopher] Univ Colorado Sch Med, Denver, CO USA; [Vilardell, Felip] Hosp Arnau Vilanova, Lleida, Spain; [Martinelli, Paola; Real, Francisco X.] Ctr Nacl Invest Oncol, Programa Patol Mol, Madrid, Spain; [Wang, Zheng; Ma, Qingyong] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian, Shanxi, Peoples R China; [Li, Li] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Opthamol, Xian, Shanxi, Peoples R China; [Real, Francisco X.] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Spain	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University of Colorado System; University of Colorado Anschutz Medical Campus; University Hospital Arnau de Vilanova; Xi'an Jiaotong University; Xi'an Jiaotong University; Pompeu Fabra University	Zhong, Y (corresponding author), Johns Hopkins Med Inst, Dept Pathol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21205 USA.	ciacobu@jhmi.edu	Iacobuzio-Donahue, Christine/ABF-1295-2020; Villellas, Felip Vilardell/B-8141-2015; Arribas, Francisco X Real/H-5275-2015; Zhong, Yi/K-7419-2012; Vilardell Villellas, Felip/C-6631-2011	Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Villellas, Felip Vilardell/0000-0002-0876-5425; Arribas, Francisco X Real/0000-0001-9501-498X; Cummings, Christopher/0000-0002-2978-2494; Martinelli, Paola/0000-0002-1643-8731	NIH [CA106610, CA62924, CA140599]; George Rubis Endowment for Pancreatic Cancer Research; Michael Rolfe Pancreatic Cancer Foundation; Sigma Beta Sorority; Joseph C. Monastra Foundation; Alfredo Scatena Memorial; Patty Boshell Pancreas Cancer Foundation; Ministerio de Ciencia e Innovacion, Madrid, Spain [SAF2007-60860]; NATIONAL CANCER INSTITUTE [P30CA008748, P50CA062924, R01CA140599, K08CA106610] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); George Rubis Endowment for Pancreatic Cancer Research; Michael Rolfe Pancreatic Cancer Foundation; Sigma Beta Sorority; Joseph C. Monastra Foundation; Alfredo Scatena Memorial; Patty Boshell Pancreas Cancer Foundation; Ministerio de Ciencia e Innovacion, Madrid, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by NIH grants CA106610, CA62924 and CA140599, The George Rubis Endowment for Pancreatic Cancer Research, The Michael Rolfe Pancreatic Cancer Foundation, Sigma Beta Sorority, The Joseph C. Monastra Foundation, The Alfredo Scatena Memorial, The Patty Boshell Pancreas Cancer Foundation, and Grants SAF2007-60860 and ONCOBIO Consolider from Ministerio de Ciencia e Innovacion, Madrid, Spain (F. R.). The authors have no financial conflicts of interest related to this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afouda BA, 2008, DEVELOPMENT, V135, P3185, DOI 10.1242/dev.026443; Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Al-Aynati MM, 2004, CLIN CANCER RES, V10, P1235, DOI 10.1158/1078-0432.CCR-03-0087; Al-azzeh ED, 2000, BBA-GENE STRUCT EXPR, V1490, P324, DOI 10.1016/S0167-4781(00)00013-0; Bassett MH, 2005, J CLIN ENDOCR METAB, V90, P5446, DOI 10.1210/jc.2005-0836; Capo-Chichi CD, 2003, CANCER RES, V63, P4967; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Decker K, 2006, DEV BIOL, V298, P415, DOI 10.1016/j.ydbio.2006.06.046; di Magliano MP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001155; Fu BJ, 2008, CANCER BIOL THER, V7, P1593, DOI 10.4161/cbt.7.10.6565; Ghering AB, 2004, BIOCHEMISTRY-US, V43, P8346, DOI 10.1021/bi035673j; Guo MZ, 2004, CLIN CANCER RES, V10, P7917, DOI 10.1158/1078-0432.CCR-04-1140; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Haveri H, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-9; HONG SML, 2011, MODERN PATH IN PRESS; Iacobuzio-Donahue CA, 2009, J CLIN ONCOL, V27, P1806, DOI 10.1200/JCO.2008.17.7188; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kamnasaran D, 2007, P NATL ACAD SCI USA, V104, P8053, DOI 10.1073/pnas.0611669104; Kiiveri S, 1999, MOL MED, V5, P490, DOI 10.1007/bf03403542; Kiiveri S, 2004, ENDOCR RES, V30, P919, DOI 10.1081/ERC-200044149; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; Kwei KA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000081; Laitinen MPE, 2000, J CLIN ENDOCR METAB, V85, P3476, DOI 10.1210/jc.85.9.3476; Maeda M, 2005, DEV GROWTH DIFFER, V47, P591; Maeda M, 1996, J EXP BIOL, V199, P513; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Maitra M, 2009, DEV BIOL, V326, P368, DOI 10.1016/j.ydbio.2008.11.004; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Pan F, 2005, EMBO J, V24, P2104, DOI 10.1038/sj.emboj.7600685; Pan F, 2004, J BIOL CHEM, V279, P14477, DOI 10.1074/jbc.C300487200; Pujal J, 2006, BBA-MOL BASIS DIS, V1762, P73, DOI 10.1016/j.bbadis.2005.08.002; Sato N, 2003, CANCER RES, V63, P4158; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Shureiqi I, 2007, FASEB J, V21, P743, DOI 10.1096/fj.06-6830com; Stathis A, 2010, NAT REV CLIN ONCOL, V7, P163, DOI 10.1038/nrclinonc.2009.236; Suzuki H, 2008, BRIT J CANCER, V98, P1147, DOI 10.1038/sj.bjc.6604259; Takahashi N, 2010, INT J CANCER, V126, P1611, DOI 10.1002/ijc.24865; Vonderfecht TR, 2008, BIOCHEM BIOPH RES CO, V369, P1052, DOI 10.1016/j.bbrc.2008.02.136; Wang LD, 2009, CANCER CELL, V15, P207, DOI 10.1016/j.ccr.2009.01.018; Winter JM, 2008, CLIN CANCER RES, V14, P412, DOI 10.1158/1078-0432.CCR-07-0487; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157; Zhao R, 2008, DEV BIOL, V317, P614, DOI 10.1016/j.ydbio.2008.03.013	45	71	74	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22129	10.1371/journal.pone.0022129	http://dx.doi.org/10.1371/journal.pone.0022129			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21811562	Green Published, Green Submitted, gold			2022-12-25	WOS:000292929500041
J	Veschini, L; Crippa, L; Dondossola, E; Doglioni, C; Corti, A; Ferrero, E				Veschini, Lorenzo; Crippa, Luca; Dondossola, Eleonora; Doglioni, Claudio; Corti, Angelo; Ferrero, Elisabetta			The vasostatin-1 fragment of chromogranin A preserves a quiescent phenotype in hypoxia-driven endothelial cells and regulates tumor neovascularization	FASEB JOURNAL			English	Article						cell junctions; tip cells; stalk cells	DEPENDENT MECHANISM; ANGIOGENESIS; MICROENVIRONMENT; NORMALIZATION; EXPRESSION; GROWTH; MORPHOGENESIS; METASTASIS; BORTEZOMIB; THERAPY	The angiogenic switch is a fundamental process for many diseases and for tumor growth. The main proangiogenic stimulus is hypoxia, through activation of the hypoxia-inducible factor (HIF)-1 alpha pathway in endothelial cells (ECs). We have previously shown that the vasostatin-1 (VS-1) fragment of chromogranin A inhibits TNF-alpha-induced vessel permeability and VEGF-induced EC proliferation, together with migration and matrix invasion, which are all critical steps in angiogenesis. The present study was undertaken to investigate the effect of VS-1 on tumor angiogenesis. We found mouse mammary adenocarcinomas (TS/A), genetically engineered to secrete VS-1 (TS/A 1B8), to be characterized by reduced vascular density and more regular vessels, compared with nontransfected tumors [TS/A wild type (WT)]. Supernatants from TS/A WT cells, but not those from TS/A 1B8, generated tip cells and promoted the permeability of primary human umbilical vein ECs, via VE-cadherin redistribution and cytoskeletal disorganization. These effects were abrogated by mAb 5A8, a VS-1-blocking antibody. Furthermore, VS-1 inhibited hypoxia-driven EC morphological changes, VE-cadherin redistribution, intercellular gap formation, tube morphogenesis, and HIF-1 alpha nuclear translocation in vitro. Our findings highlight a previously undescribed function of VS-1 as a regulator of tumor vascularization.-Veschini, L., Crippa, L., Dondossola, E., Doglioni, C., Corti, A., Ferrero, E. The vasostatin-1 fragment of chromogranin a preserves a quiescent phenotype in hypoxia-driven endothelial cells and regulates tumor neovascularization. FASEB J. 25, 3906-3914 (2011). www.fasebj.org	[Veschini, Lorenzo; Ferrero, Elisabetta] Ist Sci San Raffaele, Myeloma Unit, I-20132 Milan, Italy; [Crippa, Luca; Dondossola, Eleonora; Corti, Angelo] Ist Sci San Raffaele, Tumor Biol & Vasc Targeting Unit, I-20132 Milan, Italy; [Crippa, Luca; Dondossola, Eleonora; Corti, Angelo] Ist Sci San Raffaele, Network Mol Neurosci, Italian Inst Technol, I-20132 Milan, Italy; [Doglioni, Claudio] Ist Sci San Raffaele, Pathol Unit, Div Mol Oncol, I-20132 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Istituto Italiano di Tecnologia - IIT; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Ferrero, E (corresponding author), Lymphoid Malignancies Lab, I-20132 Milan, Italy.	ferrero.elisabetta@hsr.it	Corti, Angelo/F-7046-2012; Ferrero, Elisabetta/G-5690-2013	Corti, Angelo/0000-0002-0893-6191; Subba, Rajkrishna/0000-0003-0051-0062; Veschini, Lorenzo/0000-0003-3820-7472; Ferrero, Elisabetta/0000-0003-2571-933X; DOGLIONI, Claudio/0000-0002-4969-5216	Associazione Italiana per la Ricerca sul Cancro; Alleanza Contro il Cancro of Italy	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Alleanza Contro il Cancro of Italy	The authors thank Michael John of the Vita-Salute San Raffaele University for the English revision of the manuscript. We also thank Ilenia Papa for her technical and competent contribution to immunohistochemical preparations. This work was supported by Associazione Italiana per la Ricerca sul Cancro and Alleanza Contro il Cancro of Italy.	Aird WC, 2008, PHARMACOL REP, V60, P139; Bautch VL, 2009, CELL, V136, P810, DOI 10.1016/j.cell.2009.02.021; Belloni D, 2007, FASEB J, V21, P3052, DOI 10.1096/fj.06-6829com; Belloni D, 2010, EXP CELL RES, V316, P1010, DOI 10.1016/j.yexcr.2009.11.005; BHAVANI SS, 2010, CELL MOL LIFE SCI, V67, P861; Calvani M, 2006, BLOOD, V107, P2705, DOI 10.1182/blood-2005-09-3541; Carmeliet P, 2009, NAT REV CLIN ONCOL, V6, P315, DOI 10.1038/nrclinonc.2009.64; Colombo B, 2002, CANCER RES, V62, P941; Corti A, 1997, EUR J BIOCHEM, V248, P692, DOI 10.1111/j.1432-1033.1997.00692.x; Corti A, 2010, CELL MOL NEUROBIOL, V30, P1163, DOI 10.1007/s10571-010-9587-8; Cowan CE, 2010, CIRC RES, V107, P959, DOI 10.1161/CIRCRESAHA.110.219592; De Bock K, 2009, J MOL MED, V87, P561, DOI 10.1007/s00109-009-0482-z; De Smet F, 2009, ARTERIOSCL THROM VAS, V29, P639, DOI 10.1161/ATVBAHA.109.185165; Di Comite G, 2011, J HYPERTENS, V29, P409, DOI 10.1097/HJH.0b013e328341a429; Ferrero E, 2004, FASEB J, V18, P554, DOI 10.1096/fj.03-0922fje; Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524; Fukumura D, 2007, MICROVASC RES, V74, P72, DOI 10.1016/j.mvr.2007.05.003; Fukumura D, 2007, J CELL BIOCHEM, V101, P937, DOI 10.1002/jcb.21187; Gao JM, 2010, BLOOD, V115, P4130, DOI 10.1182/blood-2009-10-248526; Helle KB, 2010, CELL MOL NEUROBIOL, V30, P1145, DOI 10.1007/s10571-010-9552-6; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Langheim S, 2010, AM J PHYSIOL-HEART C, V298, pH746, DOI 10.1152/ajpheart.00617.2009; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; Millan J, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-11; Moserle L, 2009, CURR MOL MED, V9, P935, DOI 10.2174/156652409789712800; Pages G, 2005, CARDIOVASC RES, V65, P564, DOI 10.1016/j.cardiores.2004.09.032; Ramella R, 2010, J CELL BIOCHEM, V110, P70, DOI 10.1002/jcb.22510; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2003, ANNU REV MED, V54, P17, DOI 10.1146/annurev.med.54.101601.152418; Subarsky P, 2003, CLIN EXP METASTAS, V20, P237, DOI 10.1023/A:1022939318102; Theurl M, 2010, CIRC RES, V107, P1326, DOI 10.1161/CIRCRESAHA.110.219493; Veschini L, 2007, BLOOD, V109, P2565, DOI 10.1182/blood-2006-06-032664	33	30	32	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	NOV	2011	25	11					3906	3914		10.1096/fj.11-182410	http://dx.doi.org/10.1096/fj.11-182410			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	844BT	21825034				2022-12-25	WOS:000296723100015
J	Dodson, HC; Morris, MT; Morris, JC				Dodson, Heidi C.; Morris, Meredith T.; Morris, James C.			Glycerol 3-Phosphate Alters Trypanosoma brucei Hexokinase Activity in Response to Environmental Change	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA INTERFERENCE; GLYCOLYSIS; GLYCOSOMES; PHOSPHOFRUCTOKINASE; PURIFICATION; COMPARTMENTATION; INHIBITION; EXPRESSION; TURNOVER; PH	The African trypanosome, Trypanosoma brucei, compartmentalizes some metabolic enzymes within peroxisome-like organelles called glycosomes. The amounts, activities, and types of glycosomal enzymes are modulated coincident with developmental and environmental changes. Pexophagy (fusion of glycosomes with acidic lysosomes) has been proposed to facilitate this glycosome remodeling. Here, we report that, although glycosome-resident enzyme T. brucei hexokinase 1 (TbHK1) protein levels are maintained during pexophagy, acidification inactivates the activity. Glycerol 3-phosphate, which is produced in vivo by a glycosome-resident glycerol kinase, mitigated acid inactivation of lysate-derived TbHK activity. Using recombinant TbHK1, we found that glycerol 3-P influenced enzyme activity at pH 6.5 by preventing substrate and product inhibition by ATP and ADP, respectively. Additionally, TbHK1 inhibition by the flavonol quercetin (QCN) was partially reversed by glycerol 3-P at pH 7.4, whereas at pH 6.5, enzyme activity in the presence of QCN was completely maintained by glycerol 3-P. However, glycerol 3-P did not alter the interaction of QCN with TbHK1, as the lone Trp residue (Trp-177) was quenched under all conditions tested. These findings suggest potential novel mechanisms for the regulation of TbHK1, particularly given the acidification of glycosomes that can be induced under a variety of parasite growth conditions.	[Dodson, Heidi C.; Morris, Meredith T.; Morris, James C.] Clemson Univ, Dept Biochem & Genet, Clemson, SC 29634 USA	Clemson University	Morris, JC (corresponding author), Clemson Univ, Dept Biochem & Genet, 214 BRC,51 New Cherry St, Clemson, SC 29634 USA.	jmorri2@clemson.edu	Morris, James/L-7253-2019	Morris, James/0000-0003-2515-5714	National Institutes of Health [1R15AI075326]; Wade Stackhouse fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI075326] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wade Stackhouse fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grant 1R15AI075326 (to J. C. M.).; Supported by a Wade Stackhouse fellowship.	Albert MA, 2005, J BIOL CHEM, V280, P28306, DOI 10.1074/jbc.M502403200; Chambers JW, 2008, J BIOL CHEM, V283, P14963, DOI 10.1074/jbc.M802124200; Chambers JW, 2008, MOL BIOCHEM PARASIT, V158, P202, DOI 10.1016/j.molbiopara.2007.12.013; Chudzik DM, 2000, J MOL BIOL, V300, P697, DOI 10.1006/jmbi.2000.3910; CRONIN CN, 1985, BIOCHEM J, V227, P113, DOI 10.1042/bj2270113; CRONIN CN, 1987, BIOCHEM J, V245, P13, DOI 10.1042/bj2450013; Dodson HC, 2011, EXP PARASITOL, V127, P423, DOI 10.1016/j.exppara.2010.10.011; Drew ME, 2003, J BIOL CHEM, V278, P46596, DOI 10.1074/jbc.M309320200; Farre JC, 2004, TRENDS CELL BIOL, V14, P515, DOI 10.1016/j.tcb.2004.07.014; Furuya T, 2002, P NATL ACAD SCI USA, V99, P14177, DOI 10.1073/pnas.222454899; Haanstra JR, 2008, P NATL ACAD SCI USA, V105, P17718, DOI 10.1073/pnas.0806664105; Herman M, 2008, AUTOPHAGY, V4, P294, DOI 10.4161/auto.5443; Kessler PS, 2005, J BIOL CHEM, V280, P9030, DOI 10.1074/jbc.M412033200; Kuser PR, 2000, J BIOL CHEM, V275, P20814, DOI 10.1074/jbc.M910412199; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Lorenz P, 1998, EMBO J, V17, P3542, DOI 10.1093/emboj/17.13.3542; MASSON S, 1992, EUR J BIOCHEM, V205, P187, DOI 10.1111/j.1432-1033.1992.tb16767.x; McCann AK, 2008, MOL BIOCHEM PARASIT, V159, P146, DOI 10.1016/j.molbiopara.2008.02.003; Michal G., 1974, METHOD ENZYMAT AN, P1415; MICHELS PAM, 1991, PARASITOL TODAY, V7, P105, DOI 10.1016/0169-4758(91)90167-M; Michels PAM, 2006, BBA-MOL CELL RES, V1763, P1463, DOI 10.1016/j.bbamcr.2006.08.019; MISSET O, 1984, EUR J BIOCHEM, V144, P475, DOI 10.1111/j.1432-1033.1984.tb08490.x; Morris MT, 2006, EUKARYOT CELL, V5, P2014, DOI 10.1128/EC.00146-06; Moyersoen J, 2004, FEMS MICROBIOL REV, V28, P603, DOI 10.1016/j.femsre.2004.06.004; NWAGWU M, 1982, ACTA TROP, V39, P61; OPPERDOES FR, 1984, J CELL BIOL, V98, P1178, DOI 10.1083/jcb.98.4.1178; OPPERDOES FR, 1977, FEBS LETT, V80, P360, DOI 10.1016/0014-5793(77)80476-6; terKuile BH, 1997, J BACTERIOL, V179, P4699, DOI 10.1128/jb.179.15.4699-4705.1997; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wigelsworth DJ, 2004, J BIOL CHEM, V279, P23349, DOI 10.1074/jbc.M401292200; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	31	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33150	33157		10.1074/jbc.M111.235705	http://dx.doi.org/10.1074/jbc.M111.235705			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21813651	Green Published, hybrid			2022-12-25	WOS:000294968800034
J	Chen, JH; Zolkiewska, A				Chen, Jianhan; Zolkiewska, Anna			Force-Induced Unfolding Simulations of the Human Notch1 Negative Regulatory Region: Possible Roles of the Heterodimerization Domain in Mechanosensing	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; MOLECULAR-DYNAMICS SIMULATIONS; HISTOGRAM ANALYSIS METHOD; LIGAND ENDOCYTOSIS; MECHANICAL RESISTANCE; BIPHASIC KINETICS; ATOMISTIC DETAILS; REPLICA-EXCHANGE; STRUCTURAL BASIS; WW DOMAIN	Notch receptors are core components of the Notch signaling pathway and play a central role in cell fate decisions during development as well as tissue homeostasis. Upon ligand binding, Notch is sequentially cleaved at the S2 site by an ADAM protease and at the S3 site by the gamma-secretase complex. Recent X-ray structures of the negative regulatory region (NRR) of the Notch receptor reveal an auto-inhibited fold where three protective Lin12/Notch repeats (LNR) of the NRR shield the S2 cleavage site housed in the heterodimerization (HD) domain. One of the models explaining how ligand binding drives the NRR conformation from a protease-resistant state to a protease-sensitive one invokes a mechanical force exerted on the NRR upon ligand endocytosis. Here, we combined physics-based atomistic simulations and topology-based coarse-grained modeling to investigate the intrinsic and force-induced folding and unfolding mechanisms of the human Notch1 NRR. The simulations support that external force applied to the termini of the NRR disengages the LNR modules from the heterodimerization (HD) domain in a well-defined, largely sequential manner. Importantly, the mechanical force can further drive local unfolding of the HD domain in a functionally relevant fashion that would provide full proteolytic access to the S2 site prior to heterodimer disassociation. We further analyzed local structural features, intrinsic folding free energy surfaces, and correlated motions of the HD domain. The results are consistent with a model in which the HD domain possesses inherent mechanosensing characteristics that could be utilized during Notch activation. This potential role of the HD domain in ligand-dependent Notch activation may have implications for understanding normal and aberrant Notch signaling.	[Chen, Jianhan; Zolkiewska, Anna] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA	Kansas State University	Chen, JH (corresponding author), Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA.	jianhanc@ksu.edu; zolkiea@ksu.edu	Chen, Jianhan/C-7680-2009		NSF [MCB 0952514]; National Institutes of Health [CA151065]; NATIONAL CANCER INSTITUTE [R15CA151065] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NSF through a CAREER Award (MCB 0952514) to JC and by the National Institutes of Health through an R15 Award (CA151065) to AZ. This work is contribution 11-225-J from the Kansas Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnett KL, 2010, NAT STRUCT MOL BIOL, V17, P1312, DOI 10.1038/nsmb.1938; Artayanis-Tsakonas S, 2010, CURR TOP DEV BIOL, V92, P1, DOI 10.1016/S0070-2153(10)92001-2; Aster JC, 2008, ANNU REV PATHOL-MECH, V3, P587, DOI 10.1146/annurev.pathmechdis.3.121806.154300; Bozkulak EC, 2009, MOL CELL BIOL, V29, P5679, DOI 10.1128/MCB.00406-09; Brockwell DJ, 2003, NAT STRUCT BIOL, V10, P731, DOI 10.1038/nsb968; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Bush G, 2001, DEV BIOL, V229, P494, DOI 10.1006/dbio.2000.9992; Chen JH, 2006, J AM CHEM SOC, V128, P3728, DOI 10.1021/ja057216r; Chen JH, 2008, CURR OPIN STRUC BIOL, V18, P140, DOI 10.1016/j.sbi.2008.01.003; Chen JH, 2009, J AM CHEM SOC, V131, P2088, DOI 10.1021/ja809547p; Chitnis A, 2006, DEV DYNAM, V235, P886, DOI 10.1002/dvdy.20683; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Feig M, 2003, J PHYS CHEM B, V107, P2831, DOI 10.1021/jp027293y; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Gallicchio E, 2005, J PHYS CHEM B, V109, P6722, DOI 10.1021/jp045294f; Ganguly D, 2009, J AM CHEM SOC, V131, P5214, DOI 10.1021/ja808999m; Gordon WR, 2008, J CELL SCI, V121, P3109, DOI 10.1242/jcs.035683; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; Gordon WR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006613; Gordon WR, 2009, BLOOD, V113, P4381, DOI 10.1182/blood-2008-08-174748; Grubmuller H, 1996, SCIENCE, V271, P997, DOI 10.1126/science.271.5251.997; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hills RD, 2008, J MOL BIOL, V382, P485, DOI 10.1016/j.jmb.2008.07.007; Hills RD, 2009, INT J MOL SCI, V10, P889, DOI 10.3390/ijms10030889; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Im WP, 2003, J COMPUT CHEM, V24, P1691, DOI 10.1002/jcc.10321; Karanicolas J, 2004, P NATL ACAD SCI USA, V101, P3432, DOI 10.1073/pnas.0304825101; Karanicolas J, 2003, P NATL ACAD SCI USA, V100, P3954, DOI 10.1073/pnas.0731771100; Karanicolas J, 2002, PROTEIN SCI, V11, P2351, DOI 10.1110/ps.0205402; Kelly DF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010532; Khandogin J, 2007, P NATL ACAD SCI USA, V104, P16880, DOI 10.1073/pnas.0703832104; Khandogin J, 2007, J AM CHEM SOC, V129, P3056, DOI 10.1021/ja0688880; Khandogin J, 2006, P NATL ACAD SCI USA, V103, P18546, DOI 10.1073/pnas.0605216103; Koch U, 2010, CURR TOP DEV BIOL, V92, P411, DOI 10.1016/S0070-2153(10)92013-9; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kovall RA, 2008, ONCOGENE, V27, P5099, DOI 10.1038/onc.2008.223; Kovall RA, 2007, CURR OPIN STRUC BIOL, V17, P117, DOI 10.1016/j.sbi.2006.11.004; Kovall RA, 2010, CURR TOP DEV BIOL, V92, P31, DOI 10.1016/S0070-2153(10)92002-4; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Malecki MJ, 2006, MOL CELL BIOL, V26, P4642, DOI 10.1128/MCB.01655-05; Mansour MR, 2006, LEUKEMIA, V20, P537, DOI 10.1038/sj.leu.2404101; Maskos K, 1998, P NATL ACAD SCI USA, V95, P3408, DOI 10.1073/pnas.95.7.3408; Mirny L, 2001, ANNU REV BIOPH BIOM, V30, P361, DOI 10.1146/annurev.biophys.30.1.361; Miyazawa S, 1996, J MOL BIOL, V256, P623, DOI 10.1006/jmbi.1996.0114; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Nichols JT, 2007, J CELL BIOL, V176, P445, DOI 10.1083/jcb.200609014; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Paci E, 2000, P NATL ACAD SCI USA, V97, P6521, DOI 10.1073/pnas.100124597; Parks AL, 2000, DEVELOPMENT, V127, P1373; Puchner EM, 2008, P NATL ACAD SCI USA, V105, P13385, DOI 10.1073/pnas.0805034105; ROUX B, 1995, COMPUT PHYS COMMUN, V91, P275, DOI 10.1016/0010-4655(95)00053-I; Roux B, 1999, BIOPHYS CHEM, V78, P1, DOI 10.1016/S0301-4622(98)00226-9; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Seugnet L, 1997, DEV BIOL, V192, P585, DOI 10.1006/dbio.1997.8723; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Sun X, 1997, DEVELOPMENT, V124, P3439; Tiyanont K, 2011, STRUCTURE, V19, P546, DOI 10.1016/j.str.2011.01.016; van Tetering G, 2009, J BIOL CHEM, V284, P31018, DOI 10.1074/jbc.M109.006775; Varnum-Finney B, 2000, J CELL SCI, V113, P4313; Wang WD, 2005, DEVELOPMENT, V132, P2883, DOI 10.1242/dev.01860; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; West DK, 2006, BIOPHYS J, V90, P287, DOI 10.1529/biophysj.105.071035; Wolynes PG, 2005, Q REV BIOPHYS, V38, P405, DOI 10.1017/S0033583505004075; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Zhu YM, 2006, CLIN CANCER RES, V12, P3043, DOI 10.1158/1078-0432.CCR-05-2832	76	12	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22837	10.1371/journal.pone.0022837	http://dx.doi.org/10.1371/journal.pone.0022837			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829530	Green Published, Green Submitted, gold			2022-12-25	WOS:000293284600055
J	Bai, ZY; Yuan, YM; Yue, GH; Li, JL				Bai, Zhiyi; Yuan, Yiming; Yue, Genhua; Li, Jiale			Molecular Cloning and Copy Number Variation of a Ferritin Subunit (Fth1) and Its Association with Growth in Freshwater Pearl Mussel Hyriopsis cumingii	PLOS ONE			English	Article							GENE-EXPRESSION; MESSENGER-RNA; IRON STORAGE; X-RAY; QUANTIFICATION; IDENTIFICATION; PCR; REARRANGEMENTS; POLYMORPHISM; CONCRETIONS	Iron is one of the most important minor elements in the shells of bivalves. This study was designed to investigate the involvement of ferritin, the principal protein for iron storage, in shell growth. A novel ferritin subunit (Fth1) cDNA from the freshwater pearl mussel (Hyriopsis cumingii) was isolated and characterized. The complete cDNA contained 822 bp, with an open reading frame (ORF) of 525 bp, a 153 bp 5' untranslated region (UTR) and a 144 bp 3' UTR. The complete genomic DNA was 4125 bp, containing four exons and three introns. The ORF encoded a protein of 174 amino acids without a signal sequence. The deduced ferritin contained a highly conserved motif for the ferroxidase center comprising seven residues of a typical vertebrate heavy-chain ferritin. It contained one conserved iron associated residue (Try27) and iron-binding region signature 1 residues. The mRNA contained a 27 bp iron-responsive element with a typical stem-loop structure in the 5'-UTR position. Copy number variants (CNVs) of Fth1 in two populations (PY and JH) were detected using quantitative real-time PCR. Associations between CNVs and growth were also analyzed. The results showed that the copy number of the ferritin gene of in the diploid genome ranged from two to 12 in PY, and from two to six in JH. The copy number variation in PY was higher than that in JH. In terms of shell length, mussels with four copies of the ferritin gene grew faster than those with three copies (P < 0.05), suggesting that CNVs in the ferritin gene are associated with growth in shell length and might be a useful molecular marker in selective breeding of H. cumingii.	[Bai, Zhiyi; Yuan, Yiming; Li, Jiale] Shanghai Ocean Univ, Minist Educ, Key Lab Explorat & Utilizat Aquat Genet Resources, Shanghai, Peoples R China; [Li, Jiale] Shanghai Ocean Univ, E Inst Shanghai Univ, Shanghai, Peoples R China; [Yue, Genhua] Natl Univ Singapore, Mol Populat Genet Grp, Temasek Life Sci Lab, Singapore 117548, Singapore	Shanghai Ocean University; Shanghai Ocean University; National University of Singapore	Bai, ZY (corresponding author), Shanghai Ocean Univ, Minist Educ, Key Lab Explorat & Utilizat Aquat Genet Resources, Shanghai, Peoples R China.	jlli@shou.edu.cn	li, jia/GVT-7587-2022; Yue, GH/F-4801-2015	Yue, GH/0000-0002-3537-2248	Chinese National Programs for Fundamental Research and Development (973 program) [2009CB126000]; National Natural Science Foundation of China [31001110]; Shanghai Leading Academic Discipline Project [Y1101]	Chinese National Programs for Fundamental Research and Development (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This study was supported by the Prophase Program of the Key Project of Chinese National Programs for Fundamental Research and Development (973 program) (2009CB126000), http://www.most.gov.cn/cxfw/, the National Natural Science Foundation of China (31001110), http://www.nsfc.gov.cn/Portal0/default124.htm, and the Shanghai Leading Academic Discipline Project (Y1101), http://www.stcsm.gov.cn/structure/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarskog NK, 2000, HUM GENET, V107, P494, DOI 10.1007/s004390000399; Adams SM, 1997, MICRON, V28, P1, DOI 10.1016/S0968-4328(97)00003-6; Almeida MJ, 1998, J SEA RES, V40, P233, DOI 10.1016/S1385-1101(98)00033-1; Andrews NC, 2008, BLOOD, V112, P219, DOI 10.1182/blood-2007-12-077388; Bai ZY, 2010, J SHELLFISH RES, V29, P527, DOI 10.2983/035.029.0232; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BOMFORD AB, 1992, PATHOBIOLOGY, V60, P10, DOI 10.1159/000163691; Chen T, 2003, EUR J BIOCHEM, V270, P137, DOI 10.1046/j.1432-1033.2003.03373.x; Chevion M, 2008, J MOL CELL CARDIOL, V45, P839, DOI 10.1016/j.yjmcc.2008.08.011; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Dopman EB, 2007, P NATL ACAD SCI USA, V104, P19920, DOI 10.1073/pnas.0709888104; Durand JP, 2004, GENE, V338, P187, DOI 10.1016/j.gene.2004.04.027; Fadista J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003916; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; FOWLER BA, 1975, J FISH RES BOARD CAN, V32, P1767, DOI 10.1139/f75-210; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; HE X, 2010, MOL BIOL REP, DOI DOI 10.1007/S11033-11010-10339-11030; Hollox EJ, 2003, AM J HUM GENET, V73, P591, DOI 10.1086/378157; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Kim SR, 2004, COMP BIOCHEM PHYS B, V138, P423, DOI 10.1016/j.cbpc.2004.05.008; Kindich R, 2005, CLIN CHEM, V51, P649, DOI 10.1373/clinchem.2004.045013; Laccone F, 2004, HUM MUTAT, V23, P234, DOI 10.1002/humu.20004; Larade K, 2004, J EXP BIOL, V207, P1353, DOI 10.1242/jeb.00872; Levenson CW, 2000, DEV BRAIN RES, V119, P105, DOI 10.1016/S0165-3806(99)00163-7; Li JL, 2009, AQUACULT INT, V17, P323, DOI 10.1007/s10499-008-9204-8; Li JL, 2009, AQUACULTURE, V287, P286, DOI 10.1016/j.aquaculture.2008.10.032; Li JZ, 2004, NAT GENET, V36, P952, DOI 10.1038/ng1417; Li M, 2008, COMP BIOCHEM PHYS B, V150, P263, DOI 10.1016/j.cbpb.2008.03.014; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Marigomez I, 2002, MICROSC RES TECHNIQ, V56, P358, DOI 10.1002/jemt.10040; Marino JH, 2003, J IMMUNOL METHODS, V283, P291, DOI 10.1016/S0022-1759(03)00103-0; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Maydan JS, 2007, GENOME RES, V17, P337, DOI 10.1101/gr.5690307; Missirlis F, 2007, GENETICS, V177, P89, DOI 10.1534/genetics.107.075150; Narasimhulu KV, 2000, SPECTROCHIM ACTA A, V56, P1345, DOI 10.1016/S1386-1425(99)00259-0; Pekkarinen M, 1997, J SHELLFISH RES, V16, P169; Perry GH, 2008, GENOME RES, V18, P1698, DOI 10.1101/gr.082016.108; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Rooms L, 2005, HUM MUTAT, V25, P513, DOI 10.1002/humu.20185; ROTHENBERGER S, 1990, NUCLEIC ACIDS RES, V18, P1175, DOI 10.1093/nar/18.5.1175; Sargent PJ, 2005, CURR MED CHEM, V12, P2683, DOI 10.2174/092986705774462969; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Suo ZH, 2004, INT J SURG PATHOL, V12, P311, DOI 10.1177/106689690401200404; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Theil EC, 2003, J NUTR, V133, p1549S, DOI 10.1093/jn/133.5.1549S; THOMSON JD, 1985, J EXP MAR BIOL ECOL, V85, P37, DOI 10.1016/0022-0981(85)90012-7; WALDO GS, 1993, BIOCHEMISTRY-US, V32, P13262, DOI 10.1021/bi00211a039; Wang XM, 2009, COMP BIOCHEM PHYS B, V154, P12, DOI 10.1016/j.cbpb.2009.04.011; Whittall JB, 2006, MOL PHYLOGENET EVOL, V39, P124, DOI 10.1016/j.ympev.2005.10.010; Yamashita M, 1996, J BIOL CHEM, V271, P26908, DOI 10.1074/jbc.271.43.26908; Zhang JQ, 2006, J BIOTECHNOL, V125, P173, DOI 10.1016/j.jbiotec.2006.03.010; Zhang Y, 2003, COMP BIOCHEM PHYS B, V135, P43, DOI 10.1016/S1096-4959(03)00050-2	57	8	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22886	10.1371/journal.pone.0022886	http://dx.doi.org/10.1371/journal.pone.0022886			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818403	Green Submitted, Green Published, gold			2022-12-25	WOS:000293282700087
J	Barr, MS; Farzan, F; Arenovich, T; Chen, R; Fitzgerald, PB; Daskalakis, ZJ				Barr, Mera S.; Farzan, Faranak; Arenovich, Tamara; Chen, Robert; Fitzgerald, Paul B.; Daskalakis, Zafiris J.			The Effect of Repetitive Transcranial Magnetic Stimulation on Gamma Oscillatory Activity in Schizophrenia	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; INTERVAL CORTICAL INHIBITION; POTENTIALLY DELETERIOUS IMPACT; HEALTHY-HUMAN SUBJECTS; WORKING-MEMORY; HOMEOSTATIC PLASTICITY; TMS-EEG; NETWORK OSCILLATIONS; INTERNEURON NETWORKS; PARKINSONS-DISEASE	Background: Gamma (c) oscillations (30-50 Hz) have been shown to be excessive in patients with schizophrenia (SCZ) during working memory (WM). WM is a cognitive process that involves the online maintenance and manipulation of information that is mediated largely by the dorsolateral prefrontal cortex (DLPFC). Repetitive transcranial magnetic stimulation (rTMS) represents a non-invasive method to stimulate the cortex that has been shown to enhance cognition and c oscillatory activity during WM. Methodology and Principal Findings: We examined the effect of 20 Hz rTMS over the DLPFC on gamma oscillatory activity elicited during the N-back task in 24 patients with SCZ compared to 22 healthy subjects. Prior to rTMS, patients with SCZ elicited excessive gamma oscillatory activity compared to healthy subjects across WM load. Active rTMS resulted in the reduction of frontal gamma oscillatory activity in patients with SCZ, while potentiating activity in healthy subjects in the 3-back, the most difficult condition. Further, these effects on gamma oscillatory activity were found to be specific to the frontal brain region and were absent in the parieto-occipital brain region. Conclusions and Significance: We suggest that this opposing effect of rTMS on gamma oscillatory activity in patients with SCZ versus healthy subjects may be related to homeostatic plasticity leading to differential effects of rTMS on gamma oscillatory activity depending on baseline differences. These findings provide important insights into the neurophysiological mechanisms underlying WM deficits in SCZ and demonstrated that rTMS can modulate gamma oscillatory activity that may be a possible avenue for cognitive potentiation in this disorder.	[Barr, Mera S.; Farzan, Faranak; Daskalakis, Zafiris J.] Univ Toronto, Dept Psychiat, Schizophrenia Program, Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Chen, Robert] Univ Toronto, Div Neurol, Toronto Res Inst, Toronto, ON, Canada; [Fitzgerald, Paul B.] Alfred & Monash Univ, Monash Alfred Psychiat Res Ctr, Sch Psychol & Psychiat, Melbourne, Vic, Australia	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; Monash University	Barr, MS (corresponding author), Univ Toronto, Dept Psychiat, Schizophrenia Program, Ctr Addict & Mental Hlth, Toronto, ON, Canada.	Jeff_Daskalakis@camh.net	Daskalakis, Zafiris J/J-5503-2013; Chen, Robert/B-3899-2009; Fitzgerald, Paul B/A-1225-2008	Daskalakis, Zafiris J/0000-0001-9502-0538; Chen, Robert/0000-0002-8371-8629; Fitzgerald, Paul B/0000-0003-4217-8096; Barr, Mera/0000-0002-1103-1887; Farzan, Faranak/0000-0001-9249-2994	Canadian Institutes of Health Research (CIHR) [MOP 62917]; Ontario Mental Health Foundation; National Health and Medical Research Council (NHMRC); Constance and Stephen Lieber through a National Alliance for Research on Schizophrenia and Depression (NARSAD); Neuronetics Inc; Medical Inc	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Mental Health Foundation; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Constance and Stephen Lieber through a National Alliance for Research on Schizophrenia and Depression (NARSAD)(NARSAD); Neuronetics Inc; Medical Inc	This work was funded, in part, by the Canadian Institutes of Health Research (CIHR) (grant no. MOP 62917 to RC), CIHR Industry Partnered (Medtronic Inc) Investigator Award (RC), CIHR Clinician Scientist Award (ZJD), CIHR doctoral award (FF), by an operating and studentship award from the Ontario Mental Health Foundation (ZJD and MB, respectively), by a National Health and Medical Research Council (NHMRC) Practitioner Fellowship (PBF), and by Constance and Stephen Lieber through a National Alliance for Research on Schizophrenia and Depression (NARSAD) Lieber Young Investigator award (ZJD, PBF). ZJD and PBF have both received external funding through Neuronetics Inc and ZJD has also received external funding through Aspect Medical Inc and travel support through Pfizer Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDINGTON D, 1993, BRIT J PSYCHIAT, V163, P39, DOI 10.1192/S0007125000292581; AKBARIAN S, 1995, ARCH GEN PSYCHIAT, V52, P258, DOI 10.1001/archpsyc.1995.03950160008002; ANDREASEN NC, 1989, BRITISH JOURNAL OF PSYCHIATRY, VOL 155, SUPP NO. 7, P49; Baddeley A., 2007, WORKING MEMORY THOUG; Barr MS, 2010, SCHIZOPHR RES, V121, P146, DOI 10.1016/j.schres.2010.05.023; Barr MS, 2010, NEUROPSYCHOPHARMACOL, V35, P848, DOI 10.1038/npp.2009.174; Barr MS, 2009, NEUROPSYCHOPHARMACOL, V34, P2359, DOI 10.1038/npp.2009.79; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Basar-Eroglu C, 2007, INT J PSYCHOPHYSIOL, V64, P39, DOI 10.1016/j.ijpsycho.2006.07.007; BENDER R, 1992, METHOD INFORM MED, V31, P56; BENES FM, 1991, ARCH GEN PSYCHIAT, V48, P996; Bilder RM, 2002, AM J PSYCHIAT, V159, P1018, DOI 10.1176/appi.ajp.159.6.1018; Boggio PS, 2005, MOVEMENT DISORD, V20, P1178, DOI 10.1002/mds.20508; Brahmbhatt SB, 2006, SCHIZOPHR RES, V87, P191, DOI 10.1016/j.schres.2006.05.019; Brown JT, 2007, EUR J NEUROSCI, V25, P2982, DOI 10.1111/j.1460-9568.2007.05544.x; Callicott JH, 2003, AM J PSYCHIAT, V160, P2209, DOI 10.1176/appi.ajp.160.12.2209; Cannon TD, 2005, ARCH GEN PSYCHIAT, V62, P1071, DOI 10.1001/archpsyc.62.10.1071; Chen R, 1997, ELECTROMYOGR MOTOR C, V105, P415, DOI 10.1016/S0924-980X(97)00036-2; Chen XD, 2010, J NEUROSCI, V30, P2611, DOI 10.1523/JNEUROSCI.3771-09.2010; Cho RY, 2006, P NATL ACAD SCI USA, V103, P19878, DOI 10.1073/pnas.0609440103; Daskalakis ZJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2860, DOI 10.1038/npp.2008.22; Daskalakis ZJ, 2006, EXP BRAIN RES, V174, P403, DOI 10.1007/s00221-006-0472-0; Deiber MP, 2007, J COGNITIVE NEUROSCI, V19, P158, DOI 10.1162/jocn.2007.19.1.158; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Farzan F, 2010, J NEUROPHYSIOL, V104, P1339, DOI 10.1152/jn.00279.2010; Farzan F, 2010, BRAIN, V133, P1505, DOI 10.1093/brain/awq046; Farzan F, 2009, NEUROPSYCHOPHARMACOL, V34, P1543, DOI 10.1038/npp.2008.211; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Goncharova II, 2003, CLIN NEUROPHYSIOL, V114, P1580, DOI 10.1016/S1388-2457(03)00093-2; Gonzalez-Burgos G, 2008, SCHIZOPHRENIA BULL, V34, P944, DOI 10.1093/schbul/sbn070; Haenschel C, 2009, J NEUROSCI, V29, P9481, DOI 10.1523/JNEUROSCI.1428-09.2009; Hartmann K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002979; Hashimoto T, 2003, J NEUROSCI, V23, P6315; Hong LE, 2004, SCHIZOPHR RES, V70, P293, DOI 10.1016/j.schres.2003.12.011; Howard MW, 2003, CEREB CORTEX, V13, P1369, DOI 10.1093/cercor/bhg084; Jandl M, 2005, J NEURAL TRANSM, V112, P955, DOI 10.1007/s00702-004-0229-5; Jung SH, 2008, CLIN NEUROPHYSIOL, V119, P71, DOI 10.1016/j.clinph.2007.09.124; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Khedr EM, 2006, MOVEMENT DISORD, V21, P2201, DOI 10.1002/mds.21089; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Koos T, 1999, NAT NEUROSCI, V2, P467, DOI 10.1038/8138; Le Roux N, 2008, EUR J NEUROSCI, V27, P3244, DOI 10.1111/j.1460-9568.2008.06288.x; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lewis DA, 2008, AM J PSYCHIAT, V165, P1585, DOI 10.1176/appi.ajp.2008.08030395; Mann EO, 2007, TRENDS NEUROSCI, V30, P343, DOI 10.1016/j.tins.2007.05.003; Meltzer HY, 1999, SCHIZOPHRENIA BULL, V25, P233, DOI 10.1093/oxfordjournals.schbul.a033376; Mendrek A, 2005, PSYCHOL MED, V35, P187, DOI 10.1017/S0033291704003228; Norman GR., 2000, BIOSTATISTICS BARE E, V2nd; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Penttonen Markku, 2003, Thalamus & Related Systems, V2, P145, DOI 10.1016/S1472-9288(03)00007-4; Rao SG, 2000, J NEUROSCI, V20, P485, DOI 10.1523/JNEUROSCI.20-01-00485.2000; RIECANSKY I, 2010, SCHIZOPHR RES; Roopun AK, 2008, FRONT NEUROSCI-SWITZ, V2, P145, DOI 10.3389/neuro.01.034.2008; Saliba RS, 2007, J NEUROSCI, V27, P13341, DOI 10.1523/JNEUROSCI.3277-07.2007; Saliba RS, 2009, J BIOL CHEM, V284, P32544, DOI 10.1074/jbc.M109.040071; SAWAGUCHI T, 1989, EXP BRAIN RES, V75, P457; Schulze-Rauschenbach SC, 2005, BRIT J PSYCHIAT, V186, P410, DOI 10.1192/bjp.186.5.410; SEJNOWSKI IJ, 1977, J THEOR BIOL, V69, P385, DOI 10.1016/0022-5193(77)90146-1; Shackman AJ, 2010, NEUROPSYCHOPHARMACOL, V35, P847, DOI 10.1038/npp.2009.173; Sharma T, 2003, PSYCHOPHARMACOLOGY, V169, P398, DOI 10.1007/s00213-003-1506-y; Siebner HR, 2004, J NEUROSCI, V24, P3379, DOI 10.1523/JNEUROSCI.5316-03.2004; Spencer KM, 2008, BIOL PSYCHIAT, V63, P744, DOI 10.1016/j.biopsych.2007.10.017; Spitzer RL, 1994, DIAGNOSTIC STAT MANU; Strafella AP, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-15-j0003.2001; Swanwick CC, 2006, MOL CELL NEUROSCI, V31, P481, DOI 10.1016/j.mcn.2005.11.002; Tallon-Baudry C, 1999, VISUAL NEUROSCI, V16, P449, DOI 10.1017/S0952523899163065; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Tan HY, 2005, AM J PSYCHIAT, V162, P1849, DOI 10.1176/appi.ajp.162.10.1849; Traub RD, 2004, ADV EXP MED BIOL, V548, P110; Traub RD, 1996, J PHYSIOL-LONDON, V493, P471, DOI 10.1113/jphysiol.1996.sp021397; Wang XJ, 1996, J NEUROSCI, V16, P6402; WEINBERGER DR, 1986, ARCH GEN PSYCHIAT, V43, P114; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Wilhelm JC, 2008, P NATL ACAD SCI USA, V105, P11412, DOI 10.1073/pnas.0806037105; WILSON FAW, 1994, P NATL ACAD SCI USA, V91, P4009, DOI 10.1073/pnas.91.9.4009; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027; Ziemann U, 1996, EXP BRAIN RES, V109, P127	79	56	56	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22627	10.1371/journal.pone.0022627	http://dx.doi.org/10.1371/journal.pone.0022627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818354	Green Submitted, gold, Green Published			2022-12-25	WOS:000293282700052
J	Narayanan, V; Heiming, RS; Jansen, F; Lesting, J; Sachser, N; Pape, HC; Seidenbecher, T				Narayanan, Venu; Heiming, Rebecca S.; Jansen, Friederike; Lesting, Joerg; Sachser, Norbert; Pape, Hans-Christian; Seidenbecher, Thomas			Social Defeat: Impact on Fear Extinction and Amygdala-Prefrontal Cortical Theta Synchrony in 5-HTT Deficient Mice	PLOS ONE			English	Article							SEROTONIN TRANSPORTER GENE; NUCLEUS RAPHE DORSALIS; ANXIETY-LIKE BEHAVIOR; IN-VIVO; BASOLATERAL AMYGDALA; BRAIN-SEROTONIN; MONOAMINE TRANSPORTERS; VENTRAL HIPPOCAMPUS; GABAERGIC NEURONS; LIFE STRESS	Emotions, such as fear and anxiety, can be modulated by both environmental and genetic factors. One genetic factor is for example the genetically encoded variation of the serotonin transporter (5-HTT) expression. In this context, the 5-HTT plays a key role in the regulation of central 5-HT neurotransmission, which is critically involved in the physiological regulation of emotions including fear and anxiety. However, a systematic study which examines the combined influence of environmental and genetic factors on fear-related behavior and the underlying neurophysiological basis is missing. Therefore, in this study we used the 5-HTT-deficient mouse model for studying emotional dysregulation to evaluate consequences of genotype specific disruption of 5-HTT function and repeated social defeat for fear-related behaviors and corresponding neurophysiological activities in the lateral amygdala (LA) and infralimbic region of the medial prefrontal cortex (mPFC) in male 5-HTT wild-type (+/+), homo-(-/-) and heterozygous (+/-) mice. Naive males and experienced losers (generated in a resident-intruder paradigm) of all three genotypes, unilaterally equipped with recording electrodes in LA and mPFC, underwent a Pavlovian fear conditioning. Fear memory and extinction of conditioned fear was examined while recording neuronal activity simultaneously with fear-related behavior. Compared to naive 5-HTT+/+ and +/- mice, 5-HTT-/- mice showed impaired recall of extinction. In addition, 5-HTT-/- and +/- experienced losers showed delayed extinction learning and impaired recall of extinction. Impaired behavioral responses were accompanied by increased theta synchronization between the LA and mPFC during extinction learning in 5-HTT-/- and +/- losers. Furthermore, impaired extinction recall was accompanied with increased theta synchronization in 5-HTT-/- naive and in 5-HTT-/- and +/- loser mice. In conclusion, extinction learning and memory of conditioned fear can be modulated by both the 5-HTT gene activity and social experiences in adulthood, accompanied by corresponding alterations of the theta activity in the amygdala-prefrontal cortex network.	[Narayanan, Venu; Lesting, Joerg; Pape, Hans-Christian; Seidenbecher, Thomas] Univ Munster, Inst Physiol 1, Munster, Germany; [Heiming, Rebecca S.; Jansen, Friederike; Sachser, Norbert] Univ Munster, Dept Behav Biol, Munster, Germany; [Heiming, Rebecca S.; Sachser, Norbert] Univ Munster, Otto Creutzfeldt Ctr Cognit & Behav Neurosci, Munster, Germany	University of Munster; University of Munster; University of Munster	Narayanan, V (corresponding author), Univ Munster, Inst Physiol 1, Munster, Germany.	seidenbe@uni-muenster.de			German Science Foundation (DFG) [SFB-TRR58, TP A01, A02]	German Science Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Science Foundation (DFG, SFB-TRR58, TP A01; to N. Sachser, K-P. Lesch and T. Seidenbecher and A02 to TS and HCP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari A, 2010, J NEUROSCI METH, V191, P191, DOI 10.1016/j.jneumeth.2010.06.019; Adhikari A, 2010, NEURON, V65, P257, DOI 10.1016/j.neuron.2009.12.002; Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Arango V, 2001, NEUROPSYCHOPHARMACOL, V25, P892, DOI 10.1016/S0893-133X(01)00310-4; Ballenger JC, 1999, BIOL PSYCHIAT, V46, P1579, DOI 10.1016/S0006-3223(99)00220-6; Barr CS, 2004, P NATL ACAD SCI USA, V101, P12358, DOI 10.1073/pnas.0403763101; Bartolomucci A, 2010, DIS MODEL MECH, V3, P459, DOI 10.1242/dmm.004614; Bengel D, 1998, MOL PHARMACOL, V53, P649, DOI 10.1124/mol.53.4.649; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; BRILEY MS, 1980, NEUROPHARMACOLOGY, V19, P1209, DOI 10.1016/0028-3908(80)90204-X; Buwalda B, 2005, NEUROSCI BIOBEHAV R, V29, P83, DOI 10.1016/j.neubiorev.2004.05.005; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; Carroll JC, 2007, BEHAV GENET, V37, P214, DOI 10.1007/s10519-006-9129-9; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Celada P, 2001, J NEUROSCI, V21, P9917, DOI 10.1523/JNEUROSCI.21-24-09917.2001; Champagne FA, 2005, CURR OPIN NEUROBIOL, V15, P704, DOI 10.1016/j.conb.2005.10.001; Clement Y, 2002, BRAIN RES BULL, V57, P57, DOI 10.1016/S0361-9230(01)00637-2; Daws LC, 2006, J NEUROSCI, V26, P6431, DOI 10.1523/JNEUROSCI.4050-05.2006; Fabre V, 2000, EUR J NEUROSCI, V12, P2299, DOI 10.1046/j.1460-9568.2000.00126.x; FLUGGE G, 1995, J NEUROSCI, V15, P7132; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Gingrich JA, 2001, PSYCHOPHARMACOLOGY, V155, P1, DOI 10.1007/s002130000573; Gobbi G, 2001, J PHARMACOL EXP THER, V296, P987; Grace AA, 2002, PHYSIOL BEHAV, V77, P489, DOI 10.1016/S0031-9384(02)00909-5; Gross C, 2004, NEUROTOX RES, V6, P493, DOI 10.1007/BF03033286; Hajos M, 2003, NEUROPHARMACOLOGY, V45, P72, DOI 10.1016/S0028-3908(03)00139-4; Hammack SE, 2009, PROG NEURO-PSYCHOPH, V33, P1309, DOI 10.1016/j.pnpbp.2009.05.013; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hariri AR, 2005, ARCH GEN PSYCHIAT, V62, P146, DOI 10.1001/archpsyc.62.2.146; Heiming RS, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.026.2009; Heinz A, 2005, NAT NEUROSCI, V8, P20, DOI 10.1038/nn1366; Holmes A, 2003, BIOL PSYCHIAT, V54, P953, DOI 10.1016/j.biopsych.2003.09.003; Holmes A, 2002, NEUROPSYCHOPHARMACOL, V27, P914, DOI 10.1016/S0893-133X(02)00374-3; Holmes A, 2001, NEUROSCI BIOBEHAV R, V25, P261, DOI 10.1016/S0149-7634(01)00012-4; Holmes A, 2009, NEUROSCI BIOBEHAV R, V33, P773, DOI 10.1016/j.neubiorev.2008.11.005; Holmes Philip V., 2003, Critical Reviews in Neurobiology, V15, P143, DOI 10.1615/CritRevNeurobiol.v15.i2.30; Jansen F, 2010, BEHAV BRAIN RES, V207, P21, DOI 10.1016/j.bbr.2009.09.033; Jennings KA, 2006, J NEUROSCI, V26, P8955, DOI 10.1523/JNEUROSCI.5356-05.2006; Jungling K, 2008, NEURON, V59, P298, DOI 10.1016/j.neuron.2008.07.002; Julius D, 1998, P NATL ACAD SCI USA, V95, P15153, DOI 10.1073/pnas.95.26.15153; Kaiser S, 2005, NEUROSCI BIOBEHAV R, V29, P283, DOI 10.1016/j.neubiorev.2004.09.015; Kim DK, 2005, NEUROPHARMACOLOGY, V49, P798, DOI 10.1016/j.neuropharm.2005.08.010; Klimesch W, 1996, INT J PSYCHOPHYSIOL, V24, P61, DOI 10.1016/S0167-8760(96)00057-8; Koyama S, 1999, J PHYSIOL-LONDON, V518, P525, DOI 10.1111/j.1469-7793.1999.0525p.x; Koyama S, 2002, LIFE SCI, V72, P375, DOI 10.1016/S0024-3205(02)02280-4; Kugaya A, 2003, NEUROPSYCHOPHARMACOL, V28, P413, DOI 10.1038/sj.npp.1300036; Lee JLC, 2005, NEURON, V47, P795, DOI 10.1016/j.neuron.2005.08.007; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lesch KP, 2004, J PSYCHIATR NEUROSCI, V29, P174; Lesch KP, 1998, BIOL PSYCHIAT, V44, P179, DOI 10.1016/S0006-3223(98)00121-8; Lesting J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021714; Lesting J, 2011, EPILEPSIA, V52, P337, DOI 10.1111/j.1528-1167.2010.02758.x; Li XB, 2001, EUR J PHARMACOL, V425, P43, DOI 10.1016/S0014-2999(01)01159-1; Line SJ, 2011, EUR NEUROPSYCHOPHARM, V21, P108, DOI 10.1016/j.euroneuro.2010.08.005; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lucki I, 2004, J CLIN PSYCHIAT, V65, P11; MA QP, 1991, NEUROSCI LETT, V134, P21, DOI 10.1016/0304-3940(91)90499-J; Malison RT, 1998, BIOL PSYCHIAT, V44, P1090, DOI 10.1016/S0006-3223(98)00272-8; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Marowsky A, 2005, NEURON, V48, P1025, DOI 10.1016/j.neuron.2005.10.029; Marrosu F, 1996, BRAIN RES, V739, P192, DOI 10.1016/S0006-8993(96)00826-8; MARU E, 1979, BRAIN RES, V163, P223, DOI 10.1016/0006-8993(79)90351-2; Mathews TA, 2004, J NEUROSCI METH, V140, P169, DOI 10.1016/j.jneumeth.2004.05.017; Mossner R, 1998, INT J NEUROPSYCHOP, V1, P87, DOI 10.1017/S1461145798001114; Munafo MR, 2005, MOL PSYCHIATR, V10, P415, DOI 10.1038/sj.mp.4001627; Murphy DL, 2001, BRAIN RES BULL, V56, P487, DOI 10.1016/S0361-9230(01)00622-0; Murphy DL, 2004, MOL INTERV, V4, P109, DOI 10.1124/mi.4.2.8; Murphy DL, 1999, TRENDS PHARMACOL SCI, V20, P246, DOI 10.1016/S0165-6147(99)01325-5; Narayanan RT, 2007, EUR J NEUROSCI, V25, P1823, DOI 10.1111/j.1460-9568.2007.05437.x; Narayanan RT, 2007, NEUROREPORT, V18, P1107, DOI 10.1097/WNR.0b013e3282004992; NEMEROFF CB, 1994, AM J PSYCHIAT, V151, P1623; Neumeister A, 2002, ARCH GEN PSYCHIAT, V59, P613, DOI 10.1001/archpsyc.59.7.613; Nietzer SL, 2011, BEHAV BRAIN RES, V220, P42, DOI 10.1016/j.bbr.2011.01.011; Nitz DA, 1999, LEARN MEMORY, V6, P153; Pape HC, 1998, J NEUROPHYSIOL, V79, P217, DOI 10.1152/jn.1998.79.1.217; Pape HC, 2005, NEURON, V48, P877, DOI 10.1016/j.neuron.2005.12.002; PAPE HC, 2010, PHYSL REV IN PRESS; PARE D, 1995, J NEUROPHYSIOL, V74, P1179, DOI 10.1152/jn.1995.74.3.1179; Pare D, 2002, TRENDS COGN SCI, V6, P306, DOI 10.1016/S1364-6613(02)01924-1; Pelletier JG, 2004, BIOL PSYCHIAT, V55, P559, DOI 10.1016/j.biopsych.2003.08.019; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Pinto A, 2003, J COMP NEUROL, V459, P142, DOI 10.1002/cne.10596; Priebe Stefan, 2018, BRIT J PSYCHIAT, V204, P256, DOI [10.1192/bjp.bp.113.135038, DOI 10.1192/BJP.BP.113.135038, DOI 10.1192/BJP.BP.113.131227]; Puig MV, 2005, CEREB CORTEX, V15, P1, DOI 10.1093/cercor/bhh104; Rainnie DG, 1999, J NEUROPHYSIOL, V82, P69, DOI 10.1152/jn.1999.82.1.69; Sangha S, 2009, J NEUROSCI, V29, P15713, DOI 10.1523/JNEUROSCI.2620-09.2009; Savitz J, 2009, PROG NEUROBIOL, V88, P17, DOI 10.1016/j.pneurobio.2009.01.009; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Sierra-Mercado D, 2011, NEUROPSYCHOPHARMACOL, V36, P529, DOI 10.1038/npp.2010.184; STEIN DJ, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002795; STEINBUSCH HWM, 1981, J PHYSIOLOGY PARIS, V77, P157; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Torres GE, 2007, CURR OPIN NEUROBIOL, V17, P304, DOI 10.1016/j.conb.2007.05.002; Veenema AH, 2007, PSYCHONEUROENDOCRINO, V32, P437, DOI 10.1016/j.psyneuen.2007.02.008; VERTES RP, 1994, NEUROSCIENCE, V60, P441, DOI 10.1016/0306-4522(94)90255-0; Wellman CL, 2007, J NEUROSCI, V27, P684, DOI 10.1523/JNEUROSCI.4595-06.2007; Willeit M, 2000, BIOL PSYCHIAT, V47, P482, DOI 10.1016/S0006-3223(99)00293-0; Zahniser NR, 2001, PHARMACOL THERAPEUT, V92, P21, DOI 10.1016/S0163-7258(01)00158-9	99	85	87	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22600	10.1371/journal.pone.0022600	http://dx.doi.org/10.1371/journal.pone.0022600			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818344	Green Submitted, gold, Green Published			2022-12-25	WOS:000293282700045
J	Shokralla, S; Zhou, X; Janzen, DH; Hallwachs, W; Landry, JF; Jacobus, LM; Hajibabaei, M				Shokralla, Shadi; Zhou, Xin; Janzen, Daniel H.; Hallwachs, Winnie; Landry, Jean-Francois; Jacobus, Luke M.; Hajibabaei, Mehrdad			Pyrosequencing for Mini-Barcoding of Fresh and Old Museum Specimens	PLOS ONE			English	Article							DNA; PRESERVATION	DNA barcoding is an effective approach for species identification and for discovery of new and/or cryptic species. Sanger sequencing technology is the method of choice for obtaining standard 650 bp cytochrome c oxidase subunit I (COI) barcodes. However, DNA degradation/fragmentation makes it difficult to obtain a full-length barcode from old specimens. Mini-barcodes of 130 bp from the standard barcode region have been shown to be effective for accurate identification in many animal groups and may be readily obtained from museum samples. Here we demonstrate the application of an alternative sequencing technology, the four-enzymes single-specimen pyrosequencing, in rapid, cost-effective mini-barcode analysis. We were able to generate sequences of up to 100 bp from mini-barcode fragments of COI in 135 fresh and 50 old Lepidoptera specimens (ranging from 53-97 year-old). The sequences obtained using pyrosequencing were of high quality and we were able to robustly match all the tested pyro-sequenced samples to their respective Sanger-sequenced standard barcode sequences, where available. Simplicity of the protocol and instrumentation coupled with higher speed and lower cost per sequence than Sanger sequencing makes this approach potentially useful in efforts to link standard barcode sequences from unidentified specimens to known museum specimens with only short DNA fragments.	[Shokralla, Shadi; Zhou, Xin; Hajibabaei, Mehrdad] Univ Guelph, Dept Integrat Biol, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Janzen, Daniel H.; Hallwachs, Winnie] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Landry, Jean-Francois] Agr & Agri Food Canada, Res Ctr, Ottawa, ON, Canada; [Jacobus, Luke M.] Indiana Univ, Dept Biol, Bloomington, IN USA	University of Guelph; University of Pennsylvania; Agriculture & Agri Food Canada; Indiana University System; Indiana University Bloomington	Shokralla, S (corresponding author), Univ Guelph, Dept Integrat Biol, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada.	sshokral@uoguelph.ca	Zhou, Xin/AAI-9326-2021; Zhou, Xin/D-4025-2009	Zhou, Xin/0000-0002-1407-7952; Zhou, Xin/0000-0002-1407-7952	government of Canada through Genome Canada; Ontario Genomics Institute	government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute	This work was supported by funds from the government of Canada through Genome Canada and the Ontario Genomics Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson ME, 2005, J CLIN VIROL, V33, P25, DOI 10.1016/j.jcv.2004.09.022; Baird DJ, 2011, J N AM BENTHOL SOC, V30, P125, DOI 10.1899/10-013.1; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gharizadeh B, 2004, MYCOSES, V47, P29, DOI 10.1046/j.1439-0507.2003.00949.x; Gharizadeh B, 2006, ELECTROPHORESIS, V27, P3042, DOI 10.1002/elps.200500834; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; IVANOVA N, 2006, MOL ECOLOGY NOTES, V6; Janzen DH, 2005, PHILOS T R SOC B, V360, P1835, DOI 10.1098/rstb.2005.1715; Jordan JA, 2005, J MOL DIAGN, V7, P105, DOI 10.1016/S1525-1578(10)60015-3; Mandrioli M, 2006, ENTOMOL EXP APPL, V120, P239, DOI 10.1111/j.1570-7458.2006.00451.x; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Ronaghi M, 2007, PHARMACOGENOMICS, V8, P1437, DOI 10.2217/14622416.8.10.1437; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092	20	58	63	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e21252	10.1371/journal.pone.0021252	http://dx.doi.org/10.1371/journal.pone.0021252			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818256	Green Published, Green Submitted, gold			2022-12-25	WOS:000293282700005
J	Alharazneh, A; Luk, L; Huth, M; Monfared, A; Steyger, PS; Cheng, AG; Ricci, AJ				Alharazneh, Abdelrahman; Luk, Lauren; Huth, Markus; Monfared, Ashkan; Steyger, Peter S.; Cheng, Alan G.; Ricci, Anthony J.			Functional Hair Cell Mechanotransducer Channels Are Required for Aminoglycoside Ototoxicity	PLOS ONE			English	Article							MECHANOELECTRICAL TRANSDUCTION; GENTAMICIN UPTAKE; COCHLEA; DEATH; CURRENTS; KINETICS; RAT; ADAPTATION; EXPRESSION; DRUGS	Aminoglycosides (AG) are commonly prescribed antibiotics with potent bactericidal activities. One main side effect is permanent sensorineural hearing loss, induced by selective inner ear sensory hair cell death. Much work has focused on AG's initiating cell death processes, however, fewer studies exist defining mechanisms of AG uptake by hair cells. The current study investigated two proposed mechanisms of AG transport in mammalian hair cells: mechanotransducer (MET) channels and endocytosis. To study these two mechanisms, rat cochlear explants were cultured as whole organs in gentamicin-containing media. Two-photon imaging of Texas Red conjugated gentamicin (GTTR) uptake into live hair cells was rapid and selective. Hypocalcemia, which increases the open probability of MET channels, increased AG entry into hair cells. Three blockers of MET channels (curare, quinine, and amiloride) significantly reduced GTTR uptake, whereas the endocytosis inhibitor concanavalin A did not. Dynosore quenched the fluorescence of GTTR and could not be tested. Pharmacologic blockade of MET channels with curare or quinine, but not concanavalin A or dynosore, prevented hair cell loss when challenged with gentamicin for up to 96 hours. Taken together, data indicate that the patency of MET channels mediated AG entry into hair cells and its toxicity. Results suggest that limiting permeation of AGs through MET channel or preventing their entry into endolymph are potential therapeutic targets for preventing hair cell death and hearing loss.	[Alharazneh, Abdelrahman; Luk, Lauren; Huth, Markus; Monfared, Ashkan; Cheng, Alan G.; Ricci, Anthony J.] Stanford Univ, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA; [Alharazneh, Abdelrahman] Mutah Univ, Dept Special Surg, Alkarak, Jordan; [Steyger, Peter S.] Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Portland, OR 97201 USA; [Ricci, Anthony J.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Stanford University; Mutah University; Oregon Health & Science University; Stanford University	Alharazneh, A (corresponding author), Stanford Univ, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA.	aglcheng@stanford.edu; aricci@stanford.edu	Steyger, Peter S./B-9147-2011	Steyger, Peter S./0000-0002-6103-5237; Alharazneh, Abdelrahman/0000-0003-2347-2812; ricci, anthony/0000-0002-1706-8904; Cheng, Alan/0000-0002-4702-8401	National Institute on Deafness and other Communication Disorders [P30 DC010363]; University of California; San Francisco Pathway; Swiss National Science Foundation [PBSKP3_130635/1, R01 DC004555]; Herbert Silverstein Award [K08 DC011043]; SPARK;  [R01 DC003896]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC012183, R01DC004555, P30DC010363, K08DC011043, R01DC003896] Funding Source: NIH RePORTER	National Institute on Deafness and other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); University of California(University of California System); San Francisco Pathway; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Herbert Silverstein Award; SPARK; ; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by National Institute on Deafness and other Communication Disorders P30 DC010363, University of California, San Francisco Pathway to Discovery Fellowship (to LL), Swiss National Science Foundation PBSKP3_130635/1 (to MH), R01 DC004555 (to PSS), Herbert Silverstein Award and K08 DC011043 (all to AGC), and SPARK (to AJR and AGC), and R01 DC003896 (to AJR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banke TG, 2010, AM J PHYSIOL-CELL PH, V298, pC1457, DOI 10.1152/ajpcell.00489.2009; Bermingham-McDonogh O, 2006, J COMP NEUROL, V496, P172, DOI 10.1002/cne.20944; BETZ WJ, 1992, NEURON, V9, P805, DOI 10.1016/0896-6273(92)90235-6; Blanchet C, 2000, J PHYSIOL-LONDON, V525, P641, DOI 10.1111/j.1469-7793.2000.t01-1-00641.x; Cheng AG, 2003, JARO, V4, P91, DOI 10.1007/s10162-002-3016-8; Cheng Alan G, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P343, DOI 10.1097/01.moo.0000186799.45377.63; Cheng AG, 2009, OTOLARYNG HEAD NECK, V141, P86, DOI 10.1016/j.otohns.2009.03.020; Coffin AB, 2009, HEARING RES, V253, P42, DOI 10.1016/j.heares.2009.03.004; COREY DP, 1979, NATURE, V281, P675, DOI 10.1038/281675a0; CRAWFORD AC, 1991, J PHYSIOL-LONDON, V434, P369, DOI 10.1113/jphysiol.1991.sp018475; Cunningham LL, 2002, J NEUROSCI, V22, P8532; DEGROOT JCMJ, 1991, ACTA OTO-LARYNGOL, V111, P273, DOI 10.3109/00016489109137387; DULON D, 1995, PFLUG ARCH EUR J PHY, V430, P365, DOI 10.1007/BF00373911; Farris HE, 2006, J NEUROSCI, V26, P12526, DOI 10.1523/JNEUROSCI.3569-06.2006; Farris HE, 2004, J PHYSIOL-LONDON, V558, P769, DOI 10.1113/jphysiol.2004.061267; Forge A, 2000, AUDIOL NEURO-OTOL, V5, P3, DOI 10.1159/000013861; Forge A, 2000, HEARING RES, V139, P97, DOI 10.1016/S0378-5955(99)00177-X; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; Gale JE, 2002, J NEUROBIOL, V50, P81, DOI 10.1002/neu.10002; Hashino E, 1995, BRAIN RES, V704, P135, DOI 10.1016/0006-8993(95)01198-6; Heller S, 2002, JARO, V3, P488, DOI 10.1007/s10162-002-2050-x; HIEL H, 1992, HEARING RES, V57, P157, DOI 10.1016/0378-5955(92)90148-G; Hirose K, 1999, ANN NY ACAD SCI, V884, P389, DOI 10.1111/j.1749-6632.1999.tb08657.x; Hirose K, 2011, HEARING RES, V272, P108, DOI 10.1016/j.heares.2010.10.011; HUY PTB, 1986, J CLIN INVEST, V77, P1492, DOI 10.1172/JCI112463; Jiang H, 2006, CELL DEATH DIFFER, V13, P20, DOI 10.1038/sj.cdd.4401706; Karasawa T, 2008, J CELL SCI, V121, P2871, DOI 10.1242/jcs.023705; KROESE ABA, 1989, HEARING RES, V37, P203, DOI 10.1016/0378-5955(89)90023-3; KROS CJ, 1992, P ROY SOC B-BIOL SCI, V249, P185, DOI 10.1098/rspb.1992.0102; LIM DJ, 1986, AM J OTOLARYNG, V7, P73, DOI 10.1016/S0196-0709(86)80037-0; Lyford-Pike S, 2007, JARO-J ASSOC RES OTO, V8, P497, DOI 10.1007/s10162-007-0093-8; Mangiardi DA, 2004, J COMP NEUROL, V475, P1, DOI 10.1002/cne.20129; Marcotti W, 2005, J PHYSIOL-LONDON, V567, P505, DOI 10.1113/jphysiol.2005.085951; Meyers JR, 2003, J NEUROSCI, V23, P4054; Myrdal SE, 2005, HEARING RES, V204, P156, DOI 10.1016/j.heares.2005.02.002; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Oesterle EC, 2008, JARO-J ASSOC RES OTO, V9, P65, DOI 10.1007/s10162-007-0106-7; OHMORI H, 1985, J PHYSIOL-LONDON, V359, P189, DOI 10.1113/jphysiol.1985.sp015581; Ou HC, 2009, JARO-J ASSOC RES OTO, V10, P191, DOI 10.1007/s10162-009-0158-y; PRINS JM, 1993, LANCET, V341, P335, DOI 10.1016/0140-6736(93)90137-6; Ricci A, 2002, J NEUROPHYSIOL, V87, P1738, DOI 10.1152/jn.00574.2001; Ricci AJ, 2006, J MEMBRANE BIOL, V209, P71, DOI 10.1007/s00232-005-0834-8; Ricci AJ, 2003, NEURON, V40, P983, DOI 10.1016/S0896-6273(03)00721-9; Richardson GP, 1997, J NEUROSCI, V17, P9506; Rizzi Mark Douglas, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P352, DOI 10.1097/MOO.0b013e3282ef772d; Roehm P, 2007, HEARING RES, V230, P43, DOI 10.1016/j.heares.2007.04.005; RUSCH A, 1994, J PHYSIOL-LONDON, V474, P75; Rybak LP, 2007, KIDNEY INT, V72, P931, DOI 10.1038/sj.ki.5002434; Schmitz C, 2002, J BIOL CHEM, V277, P618, DOI 10.1074/jbc.M109959200; Sha SH, 2001, HEARING RES, V155, P1, DOI 10.1016/S0378-5955(01)00224-6; Steyger PS, 2003, JARO-J ASSOC RES OTO, V4, P565, DOI 10.1007/s10162-003-4002-5; Tauris J, 2009, AUDIOL NEURO-OTOL, V14, P267, DOI 10.1159/000199446; Tiede LM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2714777; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; Waguespack J, 2007, J NEUROSCI, V27, P13890, DOI 10.1523/JNEUROSCI.2159-07.2007; Wang Q, 2009, JARO-J ASSOC RES OTO, V10, P205, DOI 10.1007/s10162-009-0160-4; XI L, 1993, J NEUROPHYSIOL, V70, P1593, DOI 10.1152/jn.1993.70.4.1593	57	164	172	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e22347	10.1371/journal.pone.0022347	http://dx.doi.org/10.1371/journal.pone.0022347			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21818312	Green Published, gold, Green Submitted			2022-12-25	WOS:000293175100021
J	Dahm, CC; Gorst-Rasmussen, A; Jakobsen, MU; Schmidt, EB; Tjonneland, A; Sorensen, TIA; Overvad, K				Dahm, Christina Catherine; Gorst-Rasmussen, Anders; Jakobsen, Marianne Uhre; Schmidt, Erik Berg; Tjonneland, Anne; Sorensen, Thorkild I. A.; Overvad, Kim			Adipose Tissue Fatty Acid Patterns and Changes in Anthropometry: A Cohort Study	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; BODY-MASS INDEX; DIETARY-FAT; EATING PATTERNS; SERUM-LIPIDS; RISK; OBESITY; ASSOCIATION; QUALITY; HEALTH	Introduction: Diets rich in n-3 long chain polyunsaturated fatty acids (LC-PUFA), but low in n-6 LC-PUFA and 18: 1 trans-fatty acids (TFA), may lower the risk of overweight and obesity. These fatty acids have often been investigated individually. We explored associations between global patterns in adipose tissue fatty acids and changes in anthropometry. Methods: 34 fatty acid species from adipose tissue biopsies were determined in a random sample of 1100 men and women from a Danish cohort study. We used sex-specific principal component analysis and multiple linear regression to investigate the associations of adipose tissue fatty acid patterns with changes in weight, waist circumference (WC), and WC controlled for changes in body mass index (WCBMI), adjusting for confounders. Results: 7 principal components were extracted for each sex, explaining 77.6% and 78.3% of fatty acid variation in men and women, respectively. Fatty acid patterns with high levels of TFA tended to be positively associated with changes in weight and WC for both sexes. Patterns with high levels of n-6 LC-PUFA tended to be negatively associated with changes in weight and WC in men, and positively associated in women. Associations with patterns with high levels of n-3 LC-PUFA were dependent on the context of the rest of the fatty acid pattern. Conclusions: Adipose tissue fatty acid patterns with high levels of TFA may be linked to weight gain, but patterns with high n-3 LC-PUFA did not appear to be linked to weight loss. Associations depended on characteristics of the rest of the pattern.	[Dahm, Christina Catherine; Gorst-Rasmussen, Anders; Schmidt, Erik Berg; Overvad, Kim] Aarhus Univ Hosp, Aalborg Hosp, Cardiovasc Res Ctr, Dept Cardiol, Aalborg, Denmark; [Dahm, Christina Catherine; Jakobsen, Marianne Uhre; Overvad, Kim] Aarhus Univ, Sch Publ Hlth, Dept Epidemiol, Aarhus, Denmark; [Gorst-Rasmussen, Anders] Aalborg Univ, Dept Math Sci, Aalborg, Denmark; [Tjonneland, Anne] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; [Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark	Aalborg University; Aalborg University Hospital; Aarhus University; Aarhus University; Aalborg University; Danish Cancer Society; University of Copenhagen	Dahm, CC (corresponding author), Aarhus Univ Hosp, Aalborg Hosp, Cardiovasc Res Ctr, Dept Cardiol, Aalborg, Denmark.	ccd@soci.au.dk	Jakobsen, Marianne Uhre/I-8550-2018; Dahm, Christina C/G-9787-2014	Jakobsen, Marianne Uhre/0000-0001-6518-4136; Dahm, Christina C/0000-0003-0481-2893; Schmidt, Erik Berg/0000-0002-0623-5666; Overvad, Kim/0000-0001-6429-7921; Tjonneland, Anne/0000-0003-4385-2097	Nordic Centre of Excellence on Systems Biology in controlled dietary interventions and cohort studies, SYSDIET [070014]; Danish Cancer Society; Danish Heart Foundation; Danish Obesity Research Centre (DanORC); Danish Council for Strategic Research [2101-06-0005]	Nordic Centre of Excellence on Systems Biology in controlled dietary interventions and cohort studies, SYSDIET; Danish Cancer Society(Danish Cancer Society); Danish Heart Foundation; Danish Obesity Research Centre (DanORC); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This work was financially supported by the Nordic Centre of Excellence on Systems Biology in controlled dietary interventions and cohort studies, SYSDIET (nr 070014), the Danish Cancer Society, the Danish Heart Foundation, and was part of the research program of the Danish Obesity Research Centre (DanORC; www.danorc.dk), which is supported by the Danish Council for Strategic Research (contract 2101-06-0005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allhaud G, 2008, BRIT J NUTR, V100, P461, DOI 10.1017/S0007114508911569; Armitage P, 2001, STAT METHODS MED RES, V4th; Berentzen TL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013097; BEYNEN AC, 1985, AM J CLIN NUTR, V42, P317, DOI 10.1093/ajcn/42.2.317; Bigaard J, 2005, J NUTR, V135, P2263; Biggs ML, 2010, JAMA-J AM MED ASSOC, V303, P2504, DOI 10.1001/jama.2010.843; Bray GA, 2002, J NUTR, V132, P2488, DOI 10.1093/jn/132.9.2488; Buckley JD, 2009, OBES REV, V10, P648, DOI 10.1111/j.1467-789X.2009.00584.x; Gorst-Rasmussen A, 2011, AM J EPIDEMIOL, V173, P1109, DOI 10.1093/aje/kwr059; Gorst-Rasmussen A, 2011, AM J EPIDEMIOL, V173, P1097, DOI 10.1093/aje/kwr060; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hastie T., 1999, IMPUTING MISSING DAT, P1; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Janssen I, 2002, AM J CLIN NUTR, V75, P683, DOI 10.1093/ajcn/75.4.683; Joffe YT, 2010, J NUTR, V140, P901, DOI 10.3945/jn.109.109355; Junyent M, 2010, NUTR METAB CARDIOVAS, V20, P698, DOI 10.1016/j.numecd.2009.06.011; Lau C, 2008, BRIT J NUTR, V99, P1089, DOI 10.1017/S0007114507837494; MALLOWS CL, 1986, TECHNOMETRICS, V28, P313, DOI 10.2307/1268980; Moussavi N, 2008, PUBLIC HEALTH NUTR, V11, P1149, DOI 10.1017/S1368980007001541; Moussavi N, 2008, OBESITY, V16, P7, DOI 10.1038/oby.2007.14; Mozaffarian D, 2009, EUR J CLIN NUTR, V63, pS5, DOI 10.1038/sj.ejcn.1602973; Newby PK, 2006, J NUTR, V136, P626, DOI 10.1093/jn/136.3.626; Newby PK, 2004, NUTR REV, V62, P177, DOI [10.1111/j.1753-4887.2004.tb00040.x, 10.1301/rn.2004.may.177-203]; OVERVAD K, 1991, INT J EPIDEMIOL, V20, P900, DOI 10.1093/ije/20.4.900; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Plourde M, 2008, NUTR REV, V66, P415, DOI 10.1111/j.1753-4887.2008.00051.x; Romaguera D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011588; Silveira MB, 2007, PUBLIC HEALTH NUTR, V10, P1181, DOI 10.1017/S1368980007000687; Skidmore PML, 2010, EUR J CLIN NUTR, V64, P239, DOI 10.1038/ejcn.2009.144; Slattery ML, 1998, AM J EPIDEMIOL, V148, P4, DOI 10.1093/aje/148.1.4-a; Smit LA, 2010, LIPIDS, V45, P693, DOI 10.1007/s11745-010-3442-z; Summerbell CD, 2009, INT J OBESITY, V33, pS1, DOI 10.1038/ijo.2009.80; TJONNELAND A, 1991, INT J EPIDEMIOL, V20, P906, DOI 10.1093/ije/20.4.906; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Warensjo E, 2006, AM J CLIN NUTR, V84, P442; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Witt PM, 2009, CANCER CAUSE CONTROL, V20, P1715, DOI 10.1007/s10552-009-9423-y; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Zou H, 2006, J COMPUT GRAPH STAT, V15, P265, DOI 10.1198/106186006X113430	41	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22587	10.1371/journal.pone.0022587	http://dx.doi.org/10.1371/journal.pone.0022587			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811635	Green Published, gold, Green Submitted			2022-12-25	WOS:000292956800072
J	Gutierrez, ML; Munoz-Bellvis, L; Abad, MD; Bengoechea, O; Gonzalez-Gonzalez, M; Orfao, A; Sayagues, JM				Laura Gutierrez, Maria; Munoz-Bellvis, Luis; del Mar Abad, Maria; Bengoechea, Oscar; Gonzalez-Gonzalez, Maria; Orfao, Alberto; Maria Sayagues, Jose			Association between Genetic Subgroups of Pancreatic Ductal Adenocarcinoma Defined by High Density 500 K SNP-Arrays and Tumor Histopathology	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; DECOY RECEPTOR-3; CYTOGENETIC HETEROGENEITY; CANCER; CARCINOMA; GROWTH; EXPRESSION; DIFFERENTIATION; OVEREXPRESSION; IDENTIFICATION	The specific genes and genetic pathways associated with pancreatic ductal adenocarcinoma are still largely unknown partially due to the low resolution of the techniques applied so far to their study. Here we used high-density 500 K single nucleotide polymorphism (SNP)-arrays to define those chromosomal regions which most commonly harbour copy number (CN) alterations and loss of heterozygozity (LOH) in a series of 20 PDAC tumors and we correlated the corresponding genetic profiles with the most relevant clinical and histopathological features of the disease. Overall our results showed that primary PDAC frequently display (>70%) extensive gains of chromosomes 1q, 7q, 8q and 20q, together with losses of chromosomes 1p, 9p, 12q, 17p and 18q, such chromosomal regions harboring multiple cancer-and PDAC-associated genes. Interestingly, these alterations clustered into two distinct genetic profiles characterized by gains of the 2q14.2, 3q22.1, 5q32, 10q26.13, 10q26.3, 11q13.1, 11q13.3, 11q13.4, 16q24.1, 16q24.3, 22q13.1, 22q13.31 and 22q13.32 chromosomal regions (group 1; n = 9) versus gains at 1q21.1 and losses of the 1p36.11, 6q25.2, 9p22.1, 9p24.3, 17p13.3 and Xp22.33 chromosomal regions (group 2; n = 11). From the clinical and histopathological point of view, group 1 cases were associated with smaller and well/moderately-differentiated grade I/II PDAC tumors, whereas and group 2 PDAC displayed a larger size and they mainly consisted of poorly-differentiated grade III carcinomas. These findings confirm the cytogenetic complexity and heterogenity of PDAC and provide evidence for the association between tumor cytogenetics and its histopathological features. In addition, we also show that the altered regions identified harbor multiple cancer associate genes that deserve further investigation to determine their relevance in the pathogenesis of PDAC.	[Laura Gutierrez, Maria; Gonzalez-Gonzalez, Maria; Orfao, Alberto; Maria Sayagues, Jose] Univ Salamanca, Dept Med, Serv Gen Citometria, E-37008 Salamanca, Spain; [Laura Gutierrez, Maria; Gonzalez-Gonzalez, Maria; Orfao, Alberto; Maria Sayagues, Jose] Univ Salamanca, Ctr Invest Canc IBMCC CSIC USAL, E-37008 Salamanca, Spain; [Munoz-Bellvis, Luis] Hosp Univ Salamanca, Dept Cirugia, Unidad Cirugia Hepatobiliopancreat & Trasplante P, Salamanca, Spain; [del Mar Abad, Maria; Bengoechea, Oscar] Hosp Univ Salamanca, Dept Patol, Salamanca, Spain	University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca; University of Salamanca	Gutierrez, ML (corresponding author), Univ Salamanca, Dept Med, Serv Gen Citometria, E-37008 Salamanca, Spain.	orfao@usal.es	Gutiérrez, María Laura/AAY-9195-2020; Muñoz-Bellvis, Luis/AAU-7364-2021; Orfao, Alberto/B-5801-2017; Muñoz-Bellvis, Luis/A-2245-2016; Gutiérrez, María Laura ML/J-4313-2016	Gutiérrez, María Laura/0000-0003-2997-6317; Muñoz-Bellvis, Luis/0000-0002-7809-5201; Muñoz-Bellvis, Luis/0000-0002-7809-5201; Gutiérrez, María Laura ML/0000-0003-2997-6317; , Maria Gonzalez-Gonzalez/0000-0001-8115-1086	Gerencia Regional de Salud de Castilla y Leon, Valladolid, Spain [86/A/06, GRS432/A/09]; Fundacion Memoria de Don Samuel Solorzano Barruso, Salamanca, Spain [FS/15-2007-2008]; Caja de Burgos (Obra Social) Burgos, Spain; RTICC from the Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion, Madrid, Spain [RD06/0020/0035-FEDER]; Ministerio de Ciencia e Innovacion, Madrid, Spain [CP05/00321, FI08/00721]	Gerencia Regional de Salud de Castilla y Leon, Valladolid, Spain; Fundacion Memoria de Don Samuel Solorzano Barruso, Salamanca, Spain; Caja de Burgos (Obra Social) Burgos, Spain; RTICC from the Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion, Madrid, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Ciencia e Innovacion, Madrid, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was partially supported by grants from the Gerencia Regional de Salud de Castilla y Leon, Valladolid, Spain (86/A/06 and GRS432/A/09), Fundacion Memoria de Don Samuel Solorzano Barruso, Salamanca, Spain (FS/15-2007-2008), Caja de Burgos (Obra Social) Burgos, Spain and the RTICC from the Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion, Madrid, Spain (RD06/0020/0035-FEDER). JM Sayagues and M Gonzalez are supported by grants (CP05/00321 and FI08/00721, respectively) from the Ministerio de Ciencia e Innovacion, Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiatari I, 2009, INT J ONCOL, V35, P1111, DOI 10.3892/ijo_00000426; Adsay NV, 2005, SEMIN RADIAT ONCOL, V15, P254, DOI 10.1016/j.semradonc.2005.04.001; Adsay NV, 2005, AM J SURG PATHOL, V29, P724, DOI 10.1097/01.pas.0000163360.40357.f1; Aguirre AJ, 2004, P NATL ACAD SCI USA, V101, P9067, DOI 10.1073/pnas.0402932101; Blebea J, 2000, J VASC SURG, V32, P364, DOI 10.1067/mva.2000.107763b; Casagrande G, 2006, HAEMATOLOGICA, V91, P765; Chen CX, 2008, CANCER INVEST, V26, P965, DOI 10.1080/07357900801975256; Chen G, 2008, UPSALA J MED SCI, V113, P297, DOI 10.3109/2000-1967-240; de Oliveira SI, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-200; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dupouy S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004223; GORUNOVA L, 1995, GENE CHROMOSOME CANC, V14, P259, DOI 10.1002/gcc.2870140404; Gorunova L, 1998, GENE CHROMOSOME CANC, V23, P81, DOI 10.1002/(SICI)1098-2264(199810)23:2<81::AID-GCC1>3.0.CO;2-0; Grubbs EG, 2006, ANN SURG ONCOL, V13, P1645, DOI 10.1245/s10434-006-9029-5; Gui XY, 2008, PEPTIDES, V29, P1609, DOI 10.1016/j.peptides.2008.04.014; Harada T, 2008, ONCOGENE, V27, P1951, DOI 10.1038/sj.onc.1210832; Harada T, 2007, BRIT J CANCER, V96, P373, DOI 10.1038/sj.bjc.6603563; Harada T, 2002, CANCER RES, V62, P835; Harada T, 2009, PANCREATOLOGY, V9, P13, DOI 10.1159/000178871; Heidenblad M, 2004, CANCER RES, V64, P3052, DOI 10.1158/0008-5472.CAN-03-3159; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Ho CH, 2009, CARCINOGENESIS, V30, P1443, DOI 10.1093/carcin/bgp135; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Karhu R, 2006, GENE CHROMOSOME CANC, V45, P721, DOI 10.1002/gcc.20337; Kimura Y, 2010, CANCER RES, V70, P501, DOI 10.1158/0008-5472.CAN-09-1469; Koorstra JBM, 2008, PANCREATOLOGY, V8, P110, DOI 10.1159/000123838; LaFramboise T, 2009, NUCLEIC ACIDS RES, V37, P4181, DOI 10.1093/nar/gkp552; Gutierrez ML, 2011, HISTOPATHOLOGY, V58, P487, DOI 10.1111/j.1365-2559.2011.03771.x; Milyavsky M, 2007, CANCER CELL, V11, P133, DOI 10.1016/j.ccr.2006.11.022; Mu XM, 2003, PROSTATE, V57, P129, DOI 10.1002/pros.10282; Nowak NJ, 2005, CANCER GENET CYTOGEN, V161, P36, DOI 10.1016/j.cancergencyto.2005.01.009; Rodriguez JA, 2005, WORLD J SURG, V29, P297, DOI 10.1007/s00268-004-7843-0; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schleger C, 2000, J PATHOL, V191, P27, DOI 10.1002/(SICI)1096-9896(200005)191:1<27::AID-PATH582>3.0.CO;2-J; Smith JS, 1999, GENOMICS, V59, P97, DOI 10.1006/geno.1999.5864; Sung HY, 2010, INT J RADIAT BIOL, V86, P780, DOI 10.3109/09553002.2010.484481; Swift SL, 2010, CANCER RES, V70, P347, DOI 10.1158/0008-5472.CAN-09-1252; Tsuji S, 2003, INT J CANCER, V106, P17, DOI 10.1002/ijc.11170; Wagsater D, 2010, CANCER INVEST, V28, P872, DOI 10.3109/07357901003735675; Walker BA, 2006, CLIN LYMPHOMA MYELOM, V7, P186, DOI 10.3816/CLM.2006.n.057; Wang YH, 2005, ONCOGENE, V24, P6637, DOI 10.1038/sj.onc.1208819; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yagn Wen-Bin, 2008, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V30, P728; Zagon IS, 2009, AM J PHYSIOL-REG I, V297, pR1154, DOI 10.1152/ajpregu.00414.2009; Zhou D, 2010, J CANCER RES CLIN, V136, P1719, DOI 10.1007/s00432-010-0830-y	46	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22315	10.1371/journal.pone.0022315	http://dx.doi.org/10.1371/journal.pone.0022315			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811587	gold, Green Published, Green Submitted			2022-12-25	WOS:000292956800040
J	Sulkowski, MJ; Iyer, SC; Kurosawa, MS; Iyer, EPR; Cox, DN				Sulkowski, Mikolaj J.; Iyer, Srividya Chandramouli; Kurosawa, Mathieu S.; Iyer, Eswar Prasad R.; Cox, Daniel N.			Turtle Functions Downstream of Cut in Differentially Regulating Class Specific Dendrite Morphogenesis in Drosophila	PLOS ONE			English	Article							SYNAPSE MATURATION-1 DASM1; SELF-AVOIDANCE; IMMUNOGLOBULIN SUPERFAMILY; SENSORY NEURONS; IG SUPERFAMILY; REQUIRE DSCAM; FAMILY-MEMBER; AXON GUIDANCE; CNS MIDLINE; ARBORIZATION	Background: Dendritic morphology largely determines patterns of synaptic connectivity and electrochemical properties of a neuron. Neurons display a myriad diversity of dendritic geometries which serve as a basis for functional classification. Several types of molecules have recently been identified which regulate dendrite morphology by acting at the levels of transcriptional regulation, direct interactions with the cytoskeleton and organelles, and cell surface interactions. Although there has been substantial progress in understanding the molecular mechanisms of dendrite morphogenesis, the specification of class-specific dendritic arbors remains largely unexplained. Furthermore, the presence of numerous regulators suggests that they must work in concert. However, presently, few genetic pathways regulating dendrite development have been defined. Methodology/Principal Findings: The Drosophila gene turtle belongs to an evolutionarily conserved class of immunoglobulin superfamily members found in the nervous systems of diverse organisms. We demonstrate that Turtle is differentially expressed in Drosophila da neurons. Moreover, MARCM analyses reveal Turtle acts cell autonomously to exert class specific effects on dendritic growth and/or branching in da neuron subclasses. Using transgenic overexpression of different Turtle isoforms, we find context-dependent, isoform-specific effects on mediating dendritic branching in class II, III and IV da neurons. Finally, we demonstrate via chromatin immunoprecipitation, qPCR, and immunohistochemistry analyses that Turtle expression is positively regulated by the Cut homeodomain transcription factor and via genetic interaction studies that Turtle is downstream effector of Cut-mediated regulation of da neuron dendrite morphology. Conclusions/Significance: Our findings reveal that Turtle proteins differentially regulate the acquisition of class-specific dendrite morphologies. In addition, we have established a transcriptional regulatory interaction between Cut and Turtle, representing a novel pathway for mediating class specific dendrite development.	[Sulkowski, Mikolaj J.; Iyer, Srividya Chandramouli; Kurosawa, Mathieu S.; Iyer, Eswar Prasad R.; Cox, Daniel N.] George Mason Univ, Sch Syst Biol, Manassas, VA USA; [Sulkowski, Mikolaj J.; Iyer, Srividya Chandramouli; Kurosawa, Mathieu S.; Iyer, Eswar Prasad R.; Cox, Daniel N.] George Mason Univ, Krasnow Inst Adv Study, Fairfax, VA 22030 USA	George Mason University; George Mason University	Sulkowski, MJ (corresponding author), George Mason Univ, Sch Syst Biol, Manassas, VA USA.	dcox5@gmu.edu	Cox, Daniel N/H-3036-2013; Iyer, Eswar/E-8443-2017	Cox, Daniel/0000-0001-9191-9212	National Institutes of Health [MH086928]; NATIONAL INSTITUTE OF MENTAL HEALTH [R15MH086928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by National Institutes of Health grant MH086928. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Anzi B, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-31; Ascoli GA, 2000, NEUROCOMPUTING, V32, P1003, DOI 10.1016/S0925-2312(00)00272-1; Barclay AN, 2003, SEMIN IMMUNOL, V15, P215, DOI 10.1016/S1044-5323(03)00047-2; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bodily KD, 2001, J NEUROSCI, V21, P3113, DOI 10.1523/JNEUROSCI.21-09-03113.2001; Brierley DJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000199; Brummendorf T, 2001, CURR OPIN CELL BIOL, V13, P611, DOI 10.1016/S0955-0674(00)00259-3; CAMPUZANO S, 1992, TRENDS GENET, V8, P202, DOI 10.1016/0168-9525(92)90234-U; Corty MM, 2009, DEVELOPMENT, V136, P1049, DOI 10.1242/dev.014423; Crozatier M, 2008, DEV BIOL, V315, P232, DOI 10.1016/j.ydbio.2007.12.030; Cubelos B, 2010, NEURON, V66, P523, DOI 10.1016/j.neuron.2010.04.038; Dimitrova S, 2008, DEV BIOL, V324, P18, DOI 10.1016/j.ydbio.2008.08.028; Ferguson K, 2009, J NEUROSCI, V29, P14151, DOI 10.1523/JNEUROSCI.2497-09.2009; Fuerst PG, 2008, NATURE, V451, P470, DOI 10.1038/nature06514; Furrer MP, 2007, DEVELOPMENT, V134, P3795, DOI 10.1242/dev.02882; Furrer MP, 2003, NAT NEUROSCI, V6, P223, DOI 10.1038/nn1017; Godenschwege TA, 2002, J NEUROSCI, V22, P3117, DOI 10.1523/JNEUROSCI.22-08-03117.2002; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Hattori Y, 2007, GENES CELLS, V12, P1011, DOI 10.1111/j.1365-2443.2007.01107.x; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Iyer E. P. R., 2009, JOVE-J VIS EXP, V34, P1599, DOI DOI 10.3791/1599; JAN YN, 1993, P NATL ACAD SCI USA, V90, P8305, DOI 10.1073/pnas.90.18.8305; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Jinushi-Nakao S, 2007, NEURON, V56, P963, DOI 10.1016/j.neuron.2007.10.031; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee WCA, 2006, PLOS BIOL, V4, P271, DOI 10.1371/journal.pbio.0040029; Long H, 2009, DEVELOPMENT, V136, P3475, DOI 10.1242/dev.040220; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Mishra A, 2008, MOL CELL BIOL, V28, P2782, DOI 10.1128/MCB.02102-07; Rose PK, 2007, ARCH ITAL BIOL, V145, P175; Segev I, 2000, SCIENCE, V290, P744, DOI 10.1126/science.290.5492.744; Seto H, 2006, GENES CELLS, V11, P499, DOI 10.1111/j.1365-2443.2006.00956.x; Shi SH, 2004, P NATL ACAD SCI USA, V101, P13346, DOI 10.1073/pnas.0405371101; Shi SH, 2004, P NATL ACAD SCI USA, V101, P13341, DOI 10.1073/pnas.0405370101; Shoji-Kasai Y, 2007, J CELL SCI, V120, P3830, DOI 10.1242/jcs.012450; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Vetter P, 2001, J NEUROPHYSIOL, V85, P926, DOI 10.1152/jn.2001.85.2.926; Vogel C, 2003, DEVELOPMENT, V130, P6317, DOI 10.1242/dev.00848; Williams DW, 2005, J NEUROBIOL, V64, P24, DOI 10.1002/neu.20151; Williams SR, 2003, TRENDS NEUROSCI, V26, P147, DOI 10.1016/S0166-2236(03)00035-3; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976	45	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22611	10.1371/journal.pone.0022611	http://dx.doi.org/10.1371/journal.pone.0022611			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811639	gold, Green Published, Green Submitted			2022-12-25	WOS:000292956800076
J	Noh, M; Smith, JL; Huh, YH; Sherley, JL				Noh, Minsoo; Smith, Janet L.; Huh, Yang Hoon; Sherley, James L.			A Resource for Discovering Specific and Universal Biomarkers for Distributed Stem Cells	PLOS ONE			English	Article							SELF-RENEWAL; TRANSCRIPTIONAL PROGRAM; HAIR FOLLICLE; CANCER CELLS; MOUSE MODEL; EXPRESSION; GENES; LGR5; EXPANSION; APOPTOSIS	Specific and universal biomarkers for distributed stem cells (DSCs) have been elusive. A major barrier to discovery of such ideal DSC biomarkers is difficulty in obtaining DSCs in sufficient quantity and purity. To solve this problem, we used cell lines genetically engineered for conditional asymmetric self-renewal, the defining DSC property. In gene microarray analyses, we identified 85 genes whose expression is tightly asymmetric self-renewal associated (ASRA). The ASRA gene signature prescribed DSCs to undergo asymmetric self-renewal to a greater extent than committed progenitor cells, embryonic stem cells, or induced pluripotent stem cells. This delineation has several significant implications. These include: 1) providing experimental evidence that DSCs in vivo undergo asymmetric self-renewal as individual cells; 2) providing an explanation why earlier attempts to define a common gene expression signature for DSCs were unsuccessful; and 3) predicting that some ASRA proteins may be ideal biomarkers for DSCs. Indeed, two ASRA proteins, CXCR6 and BTG2, and two other related self-renewal pattern associated (SRPA) proteins identified in this gene resource, LGR5 and H2A. Z, display unique asymmetric patterns of expression that have a high potential for universal and specific DSC identification.	[Noh, Minsoo] Ajou Univ, Sch Pharm, Suwon 441749, South Korea; [Smith, Janet L.; Huh, Yang Hoon; Sherley, James L.] Boston Biomed Res Inst, Adult Stem Cell Technol Ctr, Program Regenerat Biol, Watertown, MA USA; [Smith, Janet L.; Huh, Yang Hoon; Sherley, James L.] Boston Biomed Res Inst, Adult Stem Cell Technol Ctr, Program Canc Biol, Watertown, MA USA	Ajou University; Boston Biomedical Research Institute; Boston Biomedical Research Institute	Noh, M (corresponding author), Ajou Univ, Sch Pharm, Suwon 441749, South Korea.	sherleyj@bbri.org		NOH, MINSOO/0000-0002-4020-5372	NIH-NHGRI [PSO HG 003170]; NIH-NIEHS [689471]; NIH-NIGMS [5DP1OD000805]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003170] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000805] Funding Source: NIH RePORTER	NIH-NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH-NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH-NHGRI grant #PSO HG 003170, NIH-NIEHS grant #689471, and NIH-NIGMS Director's Pioneer Award #5DP1OD000805. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, GASTROENTEROLOGY, V138, P1681, DOI 10.1053/j.gastro.2010.03.002; Becker L, 2008, THESCIENTIFICWORLDJO, V8, P1168, DOI 10.1100/tsw.2008.148; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Blackett N, 1999, BLOOD, V93, P3148; Boiko AD, 2006, GENE DEV, V20, P236, DOI 10.1101/gad.1372606; Boivin B, 2003, J BIOL CHEM, V278, P29153, DOI 10.1074/jbc.M301738200; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Capuco AV, 2009, EXP BIOL MED, V234, P475, DOI 10.3181/0811-RM-320; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Culhane AC, 2005, BIOINFORMATICS, V21, P2789, DOI 10.1093/bioinformatics/bti394; Culhane AC, 2002, BIOINFORMATICS, V18, P1600, DOI 10.1093/bioinformatics/18.12.1600; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Darzynkiewicz Z, 1996, CYTOMETRY, V25, P1; Enver T, 1998, BLOOD, V92, P348, DOI 10.1182/blood.V92.2.348.Con3_348_351; Fortunel NO, 2003, SCIENCE, V302, P393; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; Harris MA, 2008, CANCER RES, V68, P10051, DOI 10.1158/0008-5472.CAN-08-0786; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Huang S, 1999, BLOOD, V94, P2595, DOI 10.1182/blood.V94.8.2595.420k37_2595_2604; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Kannan K, 2001, ONCOGENE, V20, P3449, DOI 10.1038/sj.onc.1204446; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Knudson A G, 1992, Semin Cancer Biol, V3, P99; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; LAJTHA LG, 1979, DIFFERENTIATION, V14, P23, DOI 10.1111/j.1432-0436.1979.tb01007.x; Lee HS, 2003, BIOTECHNOL BIOENG, V83, P760, DOI 10.1002/bit.10727; Liu Y, 1998, J CELL PHYSIOL, V177, P364, DOI 10.1002/(SICI)1097-4652(199811)177:2<364::AID-JCP18>3.0.CO;2-9; Liu YA, 1998, MOL BIOL CELL, V9, P15, DOI 10.1091/mbc.9.1.15; Loeffler Markus, 1997, P1, DOI 10.1016/B978-012563455-7/50002-7; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Martinez-Climent Jose A, 2006, Clin Transl Oncol, V8, P647, DOI 10.1007/s12094-006-0035-7; MATIOLI G, 1970, EUR J CLIN BIOL RES, V15, P20; Merok JR, 2002, CANCER RES, V62, P6791; MEROK JR, 2001, J BIOMED BIOTECHNOL, V1, P24; Mirza A, 2003, ONCOGENE, V22, P3645, DOI 10.1038/sj.onc.1206477; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; NOH M, 2006, THESIS MIT CAMBRIDGE; Pare JF, 2006, CURR TOP DEV BIOL, V73, P141, DOI 10.1016/S0070-2153(05)73005-2; Pine SR, 2010, P NATL ACAD SCI USA, V107, P2195, DOI 10.1073/pnas.0909390107; Quyn AJ, 2010, CELL STEM CELL, V6, P175, DOI 10.1016/j.stem.2009.12.007; Rambhatla L, 2005, CANCER RES, V65, P3155, DOI 10.1158/0008-5472.CAN-04-3161; Rambhatla L., 2001, J BIOMED BIOTECHNOL, V1, P28, DOI DOI 10.1155/S1110724301000079; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Sampath P, 2008, CELL STEM CELL, V2, P448, DOI 10.1016/j.stem.2008.03.013; Sax JK, 2003, CANCER BIOL THER, V2, P416, DOI 10.4161/cbt.2.4.477; Sherley J.L., 2010, U.S. Patent, Patent No. [7,824,912 B2, 7824912, 7,824,912]; Sherley James L., 2005, P21, DOI 10.1142/9781860949296_0002; Sherley James L, 2008, Breast Dis, V29, P37; SHERLEY JL, 1991, J BIOL CHEM, V266, P24815; SHERLEY JL, 1995, P NATL ACAD SCI USA, V92, P136, DOI 10.1073/pnas.92.1.136; SHERLEY JL, 1995, CELL PROLIFERAT, V28, P137, DOI 10.1111/j.1365-2184.1995.tb00062.x; SHERLEY JL, 2010, Patent No. 7655465; SHERLEY JL, 2010, Patent No. 7645610; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Spurgers KB, 2004, ONCOGENE, V23, P1712, DOI 10.1038/sj.onc.1207293; Taghizadeh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015183; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Watanabe G, 2009, CANCER SCI, V100, P2368, DOI 10.1111/j.1349-7006.2009.01316.x; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	66	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22077	10.1371/journal.pone.0022077	http://dx.doi.org/10.1371/journal.pone.0022077			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21818293	Green Published, gold, Green Submitted			2022-12-25	WOS:000292929500036
J	Zheng, J; Tian, F; Cui, SH; Song, JZ; Zhao, SH; Brown, EW; Meng, JH				Zheng, Jie; Tian, Fei; Cui, Shenghui; Song, Jiuzhou; Zhao, Shaohua; Brown, Eric W.; Meng, Jianghong			Differential Gene Expression by RamA in Ciprofloxacin-Resistant Salmonella Typhimurium	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; MULTIPLE-ANTIBIOTIC-RESISTANCE; MEDIATED MULTIDRUG-RESISTANCE; OXIDATIVE STRESS GENES; TOLC EFFLUX PUMP; ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; FLUOROQUINOLONE RESISTANCE; TRANSCRIPTIONAL REGULATOR; ENTEROBACTER-CLOACAE	Overexpression of ramA has been implicated in resistance to multiple drugs in several enterobacterial pathogens. In the present study, Salmonella Typhimurium strain LTL with constitutive expression of ramA was compared to its ramA-deletion mutant by employing both DNA microarrays and phenotype microarrays (PM). The mutant strain with the disruption of ramA showed differential expression of at least 33 genes involved in 11 functional groups. The study confirmed at the transcriptional level that the constitutive expression of ramA was directly associated with increased expression of multidrug efflux pump AcrAB-TolC and decreased expression of porin protein OmpF, thereby conferring multiple drug resistance phenotype. Compared to the parent strain constitutively expressing ramA, the ramA mutant had increased susceptibility to over 70 antimicrobials and toxic compounds. The PM analysis also uncovered that the ramA mutant was better in utilization of 10 carbon sources and 5 phosphorus sources. This study suggested that the constitutive expression of ramA locus regulate not only multidrug efflux pump and accessory genes but also genes involved in carbon metabolic pathways.	[Zheng, Jie; Meng, Jianghong] Univ Maryland, Joint Inst Food Safety & Appl Nutr, College Pk, MD 20742 USA; [Zheng, Jie; Meng, Jianghong] Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA; [Tian, Fei; Song, Jiuzhou] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Cui, Shenghui] State Food & Drug Adm, Beijing, Peoples R China; [Zhao, Shaohua] Univ Maryland, US FDA, Ctr Vet Med, College Pk, MD 20742 USA; [Zheng, Jie; Brown, Eric W.] Univ Maryland, Ctr Food Safety & Appl Nutr, US FDA, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; US Food & Drug Administration (FDA); University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; US Food & Drug Administration (FDA); University System of Maryland; University of Maryland College Park; US Food & Drug Administration (FDA)	Zheng, J (corresponding author), Univ Maryland, Joint Inst Food Safety & Appl Nutr, College Pk, MD 20742 USA.	jmeng@umd.edu	Song, Jiuzhou/AAD-6440-2020		Joint Institute for Food Safety & Applied Nutrition (JIFSAN), University of Maryland	Joint Institute for Food Safety & Applied Nutrition (JIFSAN), University of Maryland	This study was supported in part by the Joint Institute for Food Safety & Applied Nutrition (JIFSAN), University of Maryland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abouzeed YM, 2008, ANTIMICROB AGENTS CH, V52, P2428, DOI 10.1128/AAC.00084-08; ALEIXANDRE V, 1989, MOL GEN GENET, V219, P306, DOI 10.1007/BF00261192; ARIZA RR, 1994, J BACTERIOL, V176, P143, DOI 10.1128/JB.176.1.143-148.1994; Bagel S, 1999, ANTIMICROB AGENTS CH, V43, P868, DOI 10.1128/AAC.43.4.868; Bailey AM, 2008, ANTIMICROB AGENTS CH, V52, P3604, DOI 10.1128/AAC.00661-08; Bailey AM, 2010, J BACTERIOL, V192, P1607, DOI 10.1128/JB.01517-09; Barbosa TM, 2000, J BACTERIOL, V182, P3467, DOI 10.1128/JB.182.12.3467-3474.2000; Baucheron S, 2004, ANTIMICROB AGENTS CH, V48, P3729, DOI 10.1128/AAC.48.10.3729-3735.2004; Bearson BL, 2008, MICROB PATHOGENESIS, V44, P271, DOI 10.1016/j.micpath.2007.10.001; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Botteldoorn N, 2006, J MICROBIOL METH, V66, P125, DOI 10.1016/j.mimet.2005.11.003; Buckley AM, 2006, CELL MICROBIOL, V8, P847, DOI 10.1111/j.1462-5822.2005.00671.x; Chollet R, 2004, ANTIMICROB AGENTS CH, V48, P2518, DOI 10.1128/AAC.48.7.2518-2523.2004; *CLSI NCCLS, 2002, M31A2 CLSI NCCLS; COHEN SP, 1988, J BACTERIOL, V170, P5416, DOI 10.1128/jb.170.12.5416-5422.1988; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Delihas N, 1997, Nucleic Acids Symp Ser, P33; Feuerriegel S, 2008, MICROB DRUG RESIST, V14, P259, DOI 10.1089/mdr.2008.0846; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; GEORGE AM, 1995, MICROBIOL-UK, V141, P1909, DOI 10.1099/13500872-141-8-1909; GREENBERG JT, 1991, J BACTERIOL, V173, P4433, DOI 10.1128/JB.173.14.4433-4439.1991; HACHLER H, 1991, J BACTERIOL, V173, P5532; Hidalgo E, 1997, CELL, V88, P121, DOI 10.1016/S0092-8674(00)81864-4; Keeney D, 2007, MICROB DRUG RESIST, V13, P1, DOI 10.1089/mdr.2006.9990; KOMATSU T, 1990, J BACTERIOL, V172, P4082, DOI 10.1128/jb.172.7.4082-4089.1990; LEVIN RM, 1976, MOL PHARMACOL, V12, P581; Liochev SI, 1999, P NATL ACAD SCI USA, V96, P3537, DOI 10.1073/pnas.96.7.3537; Ma D, 1996, MOL MICROBIOL, V19, P101, DOI 10.1046/j.1365-2958.1996.357881.x; MA D, 1993, J BACTERIOL, V175, P6299, DOI 10.1128/JB.175.19.6299-6313.1993; Michan C, 2002, J BACTERIOL, V184, P4733, DOI 10.1128/JB.184.17.4733-4738.2002; Miller PF, 1996, MOL MICROBIOL, V21, P441, DOI 10.1111/j.1365-2958.1996.tb02553.x; Miron M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-333; Nikaido E, 2008, J BIOL CHEM, V283, P24245, DOI 10.1074/jbc.M804544200; Nishino K, 2006, MOL MICROBIOL, V59, P126, DOI 10.1111/j.1365-2958.2005.04940.x; Nishino K, 2003, ANTIMICROB AGENTS CH, V47, P3030, DOI 10.1128/AAC.47.9.3030-3033.2003; O'Regan E, 2009, ANTIMICROB AGENTS CH, V53, P1080, DOI 10.1128/AAC.01005-08; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Olliver A, 2004, FEMS MICROBIOL LETT, V238, P267, DOI 10.1016/j.femsle.2004.07.046; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Pomposiello PJ, 2000, J BACTERIOL, V182, P23, DOI 10.1128/JB.182.1.23-29.2000; Ricci V, 2009, J ANTIMICROB CHEMOTH, V64, P654, DOI 10.1093/jac/dkp234; Ricci V, 2009, J ANTIMICROB CHEMOTH, V63, P909, DOI 10.1093/jac/dkp054; Ruzin A, 2008, ANTIMICROB AGENTS CH, V52, P3430, DOI 10.1128/AAC.00591-08; Schneiders T, 2006, J BIOL CHEM, V281, P10049, DOI 10.1074/jbc.M512097200; Schneiders T, 2003, ANTIMICROB AGENTS CH, V47, P2831, DOI 10.1128/AAC.47.9.2831-2837.2003; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Spory A, 2002, J BACTERIOL, V184, P3549, DOI 10.1128/JB.184.13.3549-3559.2002; Sulavik MC, 2001, ANTIMICROB AGENTS CH, V45, P1126, DOI 10.1128/AAC.45.4.1126-1136.2001; van der Straaten T, 2004, INFECT IMMUN, V72, P996, DOI 10.1128/IAI.72.2.996-1003.2004; van der Straaten T, 2004, ANTIMICROB AGENTS CH, V48, P2292, DOI 10.1128/AAC.48.6.2292-2294.2004; Webber MA, 2009, J BACTERIOL, V191, P4276, DOI 10.1128/JB.00363-09; White DG, 1997, J BACTERIOL, V179, P6122, DOI 10.1128/jb.179.19.6122-6126.1997; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yassien MA, 2002, ANTIMICROB AGENTS CH, V46, P360, DOI 10.1128/AAC.46.2.360-366.2002; Zheng J, 2009, J ANTIMICROB CHEMOTH, V63, P95, DOI 10.1093/jac/dkn448; Zhou L, 2003, J BACTERIOL, V185, P4956, DOI 10.1128/JB.185.16.4956-4972.2003	58	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22161	10.1371/journal.pone.0022161	http://dx.doi.org/10.1371/journal.pone.0022161			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21811569	gold, Green Published, Green Submitted			2022-12-25	WOS:000292929500043
J	Jennewein, C; Karl, S; Baumann, B; Micheau, O; Debatin, KM; Fulda, S				Jennewein, C.; Karl, S.; Baumann, B.; Micheau, O.; Debatin, K-M; Fulda, S.			Identification of a novel pro-apoptotic role of NF-kappa B in the regulation of TRAIL- and CD95-mediated apoptosis of glioblastoma cells	ONCOGENE			English	Article						TRAIL; apoptosis; NF-kappa B; glioblastoma; CD95	CANCER-THERAPY; INDUCTION; SENSITIZATION; CONTRIBUTES; EXPRESSION	We recently reported that nuclear factor-kappa B (NF-kappa B) promotes DNA damage-triggered apoptosis in glioblastoma, the most common brain tumor. In the present study, we investigated the role of NF-kappa B in death receptor-mediated apoptosis. Here, we identify a novel pro-apopotic function of NF-kappa B in TRAIL- and CD95-induced apoptosis. Inhibition of NF-kappa B by overexpression of the dominant-negative I kappa B alpha-superrepressor (I kappa B alpha-SR) significantly decreases tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)- or CD95-induced apoptosis. Vice versa, activation of NF-kappa B via overexpression of constitutively active I kappa B kinase complex (IKK)beta (IKK-EE) significantly increases TRAIL-mediated apoptosis. Intriguingly, NF-kappa B inhibition reduces the recruitment of Fas-associated death domain and caspase-8 and formation of the death-inducing signaling complex (DISC) upon stimulation of TRAIL receptors or CD95. This results in reduced TRAIL-mediated activation of caspases, loss of mitochondrial potential and cytochrome c release in I kappa B alpha-SR-expressing cells. In comparison, NF-kappa B inhibition strongly enhances TNF-alpha-mediated apoptosis. Comparative studies revealed that TNF-alpha rapidly stimulates transcriptional activation and upregulation of anti-apoptotic proteins, whereas TRAIL causes apoptosis before transcriptional activation. Thus, this study demonstrates for the first time that NF-kappa B exerts a pro-apoptotic role in TRAIL- and CD95-induced apoptosis in glioblastoma cells by facilitating DISC formation. Oncogene (2012) 31, 1468-1474; doi:10.1038/onc.2011.333; published online 8 August 2011	[Fulda, S.] Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, D-60528 Frankfurt, Hesse, Germany; [Jennewein, C.; Karl, S.; Debatin, K-M; Fulda, S.] Univ Childrens Hosp, Ulm, Germany; [Baumann, B.] Univ Ulm, Inst Physiol Chem, Ulm, Germany; [Micheau, O.] INSERM, U866, Dijon, France	Goethe University Frankfurt; Ulm University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ulm University; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne	Fulda, S (corresponding author), Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, Komturstr 3A, D-60528 Frankfurt, Hesse, Germany.	simone.fulda@kgu.de	; micheau, olivier/C-3574-2011; Debatin, Klaus-Michael/J-9704-2014	Fulda, Simone/0000-0002-0459-6417; micheau, olivier/0000-0001-8499-7984; Debatin, Klaus-Michael/0000-0002-8397-1886	Deutsche Forschungsgemeinschaft; European Community (ApopTrain, APO-SYS); International Graduate School of Molecular Medicine Ulm University;  [IAP6/18]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Community (ApopTrain, APO-SYS)(European CommissionEuropean Commission Joint Research Centre); International Graduate School of Molecular Medicine Ulm University; 	We thank R Marienfeld (Ulm, Germany) for providing NEMO knockout mouse embryonic fibroblasts. This work has been partially supported by grants from the Deutsche Forschungsgemeinschaft, European Community (ApopTrain, APO-SYS) and IAP6/18 (to SF), and by a scholarship of the International Graduate School of Molecular Medicine Ulm University (to CJ).	Ammann JU, 2009, INT J CANCER, V124, P1301, DOI 10.1002/ijc.24068; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; Doi TS, 1999, P NATL ACAD SCI USA, V96, P2994, DOI 10.1073/pnas.96.6.2994; Farhana L, 2005, CANCER RES, V65, P4909, DOI 10.1158/0008-5472.CAN-04-4124; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Humphreys RC, 2008, ADV EXP MED BIOL, V615, P127, DOI 10.1007/978-1-4020-6554-5_7; Kang S, 2010, BIOCHEM BIOPH RES CO, V396, P731, DOI 10.1016/j.bbrc.2010.05.004; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karl S, 2009, J CELL MOL MED, V13, P4239, DOI 10.1111/j.1582-4934.2009.00888.x; Kohlhaas SL, 2007, J BIOL CHEM, V282, P12831, DOI 10.1074/jbc.M700438200; Mader I, 2010, FASEB J, V24, P1997, DOI 10.1096/fj.09-142943; Mattson MP, 2005, NEUROCHEM RES, V30, P883, DOI 10.1007/s11064-005-6961-x; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Pennarun B, 2010, BBA-REV CANCER, V1805, P123, DOI 10.1016/j.bbcan.2009.11.004; Plantivaux A, 2009, ANN NY ACAD SCI, V1171, P38, DOI 10.1111/j.1749-6632.2009.04725.x; Poppelmann B, 2005, J BIOL CHEM, V280, P15635, DOI 10.1074/jbc.M413006200; Radhakrishnan SK, 2006, BBA-REV CANCER, V1766, P53, DOI 10.1016/j.bbcan.2006.02.001; Ravi R, 2001, NAT CELL BIOL, V3, P409, DOI 10.1038/35070096; Shou Y, 2002, J NEUROCHEM, V81, P842, DOI 10.1046/j.1471-4159.2002.00880.x; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; Zhao XY, 2011, J NEURO-ONCOL, V102, P367, DOI 10.1007/s11060-010-0346-y	23	46	48	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2012	31	11					1468	1474		10.1038/onc.2011.333	http://dx.doi.org/10.1038/onc.2011.333			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	912FL	21822306				2022-12-25	WOS:000301780000013
J	Lowery, J; Szul, T; Seetharaman, J; Jian, XY; Su, M; Forouhar, F; Xiao, R; Acton, TB; Montelione, GT; Lin, HL; Wright, JW; Lee, E; Holloway, ZG; Randazzo, PA; Tong, L; Sztul, E				Lowery, Jason; Szul, Tomasz; Seetharaman, Jayaraman; Jian, Xiaoying; Su, Min; Forouhar, Farhad; Xiao, Rong; Acton, Thomas B.; Montelione, Gaetano T.; Lin, Helen; Wright, John W.; Lee, Eunjoo; Holloway, Zoe G.; Randazzo, Paul A.; Tong, Liang; Sztul, Elizabeth			Novel C-terminal Motif within Sec7 Domain of Guanine Nucleotide Exchange Factors Regulates ADP-ribosylation Factor (ARF) Binding and Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREFELDIN-A; PRODUCTION PLATFORM; STRUCTURAL BASIS; PROTEIN-1 BIG1; FACTOR GBF1; GOLGI; DYNAMICS; INTERFACE; RESIDUES; REVEALS	ADP-ribosylation factors (ARFs) and their activating guanine nucleotide exchange factors (GEFs) play key roles in membrane traffic and signaling. All ARF GEFs share a similar to 200-residue Sec7 domain (Sec7d) that alone catalyzes the GDP to GTP exchange that activates ARF. We determined the crystal structure of human BIG2 Sec7d. A C-terminal loop immediately following helix J (loop>J) was predicted to form contacts with helix H and the switch I region of the cognate ARF, suggesting that loop>J may participate in the catalytic reaction. Indeed, we identified multiple alanine substitutions within loop>J of the full length and/or Sec7d of two large brefeldin A-sensitive GEFs (GBF1 and BIG2) and one small brefeldin A-resistant GEF (ARNO) that abrogated binding of ARF and a single alanine substitution that allowed ARF binding but inhibited GDP to GTP exchange. Loop>J sequences are highly conserved, suggesting that loop>J plays a crucial role in the catalytic activity of all ARF GEFs. Using GEF mutants unable to bind ARF, we showed that GEFs associate with membranes independently of ARF and catalyze ARF activation in vivo only when membrane-associated. Our structural, cell biological, and biochemical findings identify loop>J as a key regulatory motif essential for ARF binding and GDP to GTP exchange by GEFs and provide evidence for the requirement of membrane association during GEF activity.	[Lowery, Jason; Szul, Tomasz; Lin, Helen; Wright, John W.; Lee, Eunjoo; Sztul, Elizabeth] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Seetharaman, Jayaraman; Su, Min; Forouhar, Farhad; Tong, Liang] Columbia Univ, NE Struct Genom Consortium, Dept Biol Sci, New York, NY 10027 USA; [Xiao, Rong; Acton, Thomas B.; Montelione, Gaetano T.] Rutgers State Univ, Dept Mol Biol & Biochem, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Xiao, Rong; Acton, Thomas B.; Montelione, Gaetano T.] NE Struct Genom Consortium, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA; [Jian, Xiaoying; Randazzo, Paul A.] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Holloway, Zoe G.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	University of Alabama System; University of Alabama Birmingham; Columbia University; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Oxford; Wellcome Centre for Human Genetics	Sztul, E (corresponding author), Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA.	esztul@uab.edu		Montelione, Gaetano/0000-0002-9440-3059; Tong, Liang/0000-0002-0563-6468	National Science Foundation [NSF0744471]; NATIONAL CANCER INSTITUTE [ZIABC007365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074958, U54GM094597] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Award NSF0744471 (to E. S.).	Acton TB, 2005, METHOD ENZYMOL, V394, P210, DOI 10.1016/S0076-6879(05)94008-1; Amor JC, 2005, J BIOL CHEM, V280, P1392, DOI 10.1074/jbc.M410820200; Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bui QT, 2009, MOL GENET GENOMICS, V282, P329, DOI 10.1007/s00438-009-0473-3; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; Cherfils J, 1998, NATURE, V392, P101, DOI 10.1038/32210; Citterio C, 2006, P NATL ACAD SCI USA, V103, P2683, DOI 10.1073/pnas.0510571103; Claude A, 1999, J CELL BIOL, V146, P71, DOI 10.1083/jcb.146.1.71; DiNitto JP, 2007, MOL CELL, V28, P569, DOI 10.1016/j.molcel.2007.09.017; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcia-Mata R, 2003, MOL BIOL CELL, V14, P2250, DOI 10.1091/mbc.E02-11-0730; Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Honda A, 2005, J CELL BIOL, V168, P1039, DOI 10.1083/jcb.200409138; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Jian XY, 2009, J BIOL CHEM, V284, P1652, DOI 10.1074/jbc.M804218200; Kuroda F, 2007, P NATL ACAD SCI USA, V104, P3201, DOI 10.1073/pnas.0611696104; Miyamoto T, 2008, J BIOL CHEM, V283, P4430, DOI 10.1074/jbc.M708296200; Monetta P, 2007, MOL BIOL CELL, V18, P2400, DOI 10.1091/mbc.E06-11-1005; Morohashi Y, 2010, BIOCHEM J, V427, P401, DOI 10.1042/BJ20091681; Mossessova E, 2003, MOL CELL, V12, P1403, DOI 10.1016/S1097-2765(03)00475-1; Mossessova E, 1998, CELL, V92, P415, DOI 10.1016/S0092-8674(00)80933-2; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; RANDAZZO PA, 1995, METHOD ENZYMOL, V257, P128; Robineau S, 2000, P NATL ACAD SCI USA, V97, P9913, DOI 10.1073/pnas.170290597; Sciaky N, 1997, J CELL BIOL, V139, P1137, DOI 10.1083/jcb.139.5.1137; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shin HW, 2004, MOL BIOL CELL, V15, P5283, DOI 10.1091/mbc.E04-05-0388; Shinotsuka C, 2002, BIOCHEM BIOPH RES CO, V294, P254, DOI 10.1016/S0006-291X(02)00456-4; Szul T, 2005, TRAFFIC, V6, P374, DOI 10.1111/j.1600-0854.2005.00282.x; Szul T, 2007, J CELL SCI, V120, P3929, DOI 10.1242/jcs.010769; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Togawa A, 1999, J BIOL CHEM, V274, P12308, DOI 10.1074/jbc.274.18.12308; Xiao R, 2010, J STRUCT BIOL, V172, P21, DOI 10.1016/j.jsb.2010.07.011; Zhao XH, 2006, J CELL SCI, V119, P3743, DOI 10.1242/jcs.03173	38	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36898	36906		10.1074/jbc.M111.230631	http://dx.doi.org/10.1074/jbc.M111.230631			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21828055	Green Published, hybrid			2022-12-25	WOS:000296538300069
J	Hast, MA; Nichols, CB; Armstrong, SM; Kelly, SM; Hellinga, HW; Alspaugh, JA; Beese, LS				Hast, Michael A.; Nichols, Connie B.; Armstrong, Stephanie M.; Kelly, Shannon M.; Hellinga, Homme W.; Alspaugh, J. Andrew; Beese, Lorena S.			Structures of Cryptococcus neoformans Protein Farnesyltransferase Reveal Strategies for Developing Inhibitors That Target Fungal Pathogens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFERASE INHIBITORS; GERANYLGERANYLTRANSFERASE-I; CRYSTALLOGRAPHIC ANALYSIS; ANGSTROM RESOLUTION; MALARIA PARASITES; CRYSTAL-STRUCTURE; DIFFRACTION DATA; N-RAS; FARNESYL; BINDING	Cryptococcus neoformans is a fungal pathogen that causes life-threatening infections in immunocompromised individuals, including AIDS patients and transplant recipients. Few antifungals can treat C. neoformans infections, and drug resistance is increasing. Protein farnesyltransferase (FTase) catalyzes post-translational lipidation of key signal transduction proteins and is essential in C. neoformans. We present a multidisciplinary study validating C. neoformans FTase (CnFTase) as a drug target, showing that several anticancer FTase inhibitors with disparate scaffolds can inhibit C. neoformans and suggesting structure-based strategies for further optimization of these leads. Structural studies are an essential element for species-specific inhibitor development strategies by revealing similarities and differences between pathogen and host orthologs that can be exploited. We, therefore, present eight crystal structures of CnFTase that define the enzymatic reaction cycle, basis of ligand selection, and structurally divergent regions of the active site. Crystal structures of clinically important anticancer FTase inhibitors in complex with CnFTase reveal opportunities for optimization of selectivity for the fungal enzyme by modifying functional groups that interact with structurally diverse regions. A substrate-induced conformational change in CnFTase is observed as part of the reaction cycle, a feature that is mechanistically distinct from human FTase. Our combined structural and functional studies provide a framework for developing FTase inhibitors to treat invasive fungal infections.	[Hast, Michael A.; Armstrong, Stephanie M.; Kelly, Shannon M.; Hellinga, Homme W.; Beese, Lorena S.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Nichols, Connie B.; Alspaugh, J. Andrew] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Duke University	Beese, LS (corresponding author), Duke Univ, Med Ctr, Dept Biochem, 134 Nanaline Duke Bldg,Box 3711,Res Dr, Durham, NC 27710 USA.	lb12@duke.edu	Alspaugh, Andrew/AAB-1664-2019	Alspaugh, Andrew/0000-0003-3009-627X	National Institutes of Health [GM052382, AI050128]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; Department of Energy (DOE) [DE-AC02-05CH11231]; United States Department of Energy; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050128, R21AI050128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052382, R37GM052382] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy (DOE)(United States Department of Energy (DOE)); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM052382 (to L. S. B.) and AI050128 (to J. A. A.).; We thank the laboratory of Professor Andrew D. Hamilton for providing the ethylenediamine inhibitors used in this study. Diffraction data were collected Southeast Regional Collaborative Access Team (SER-CAT) 22-ID beamline at the Advanced Photon Source (Argonne National Laboratory) or at SIBYLS beamline 12.3.1 at the Advanced Light Source (Lawrence Berkeley National Laboratory). Use of the Advanced Photon Source was supported in part by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract W-31-109-Eng-38. Use of the SIBYLS beamline at the Advanced Light Source, Lawrence Berkeley National Laboratory, was supported in part by Department of Energy (DOE) program Integrated Diffraction Analysis Technologies and DOE program Molecular Assemblies Genes and Genomics Integrated Efficiently (MAGGIE) under Contract DE-AC02-05CH11231 with the United States Department of Energy.	Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Alspaugh JA, 2000, MOL MICROBIOL, V36, P352, DOI 10.1046/j.1365-2958.2000.01852.x; Basso AD, 2006, J LIPID RES, V47, P15, DOI 10.1194/jlr.R500012-JLR200; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; CHANG YC, 1994, MOL CELL BIOL, V14, P4912, DOI 10.1128/MCB.14.7.4912; DeGraw AJ, 2008, CHEM BIOL DRUG DES, V72, P171, DOI 10.1111/j.1747-0285.2008.00698.x; Dursina B, 2006, J AM CHEM SOC, V128, P2822, DOI 10.1021/ja052196e; Eastman RT, 2006, J LIPID RES, V47, P233, DOI 10.1194/jlr.R500016-JLR200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; FURFINE ES, 1995, BIOCHEMISTRY-US, V34, P6857, DOI 10.1021/bi00020a032; Gelb MH, 2003, MOL BIOCHEM PARASIT, V126, P155, DOI 10.1016/S0166-6851(02)00282-7; Glenn MP, 2006, J MED CHEM, V49, P5710, DOI 10.1021/jm060081v; Glenn MR, 2005, ANGEW CHEM INT EDIT, V44, P4903, DOI 10.1002/anie.200500674; HARA M, 1993, P NATL ACAD SCI USA, V90, P2281, DOI 10.1073/pnas.90.6.2281; Hardy JA, 2004, CURR OPIN STRUC BIOL, V14, P706, DOI 10.1016/j.sbi.2004.10.009; Hast MA, 2009, CHEM BIOL, V16, P181, DOI 10.1016/j.chembiol.2009.01.014; HE B, 1991, P NATL ACAD SCI USA, V88, P11373, DOI 10.1073/pnas.88.24.11373; Hougland JL, 2010, J MOL BIOL, V395, P176, DOI 10.1016/j.jmb.2009.10.038; Ito T, 1996, JPN J CANCER RES, V87, P113, DOI 10.1111/j.1349-7006.1996.tb03146.x; Jessup CJ, 1998, J CLIN MICROBIOL, V36, P2874, DOI 10.1128/JCM.36.10.2874-2876.1998; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Long SB, 2000, STRUCTURE, V8, P209, DOI 10.1016/S0969-2126(00)00096-4; Long SB, 1998, BIOCHEMISTRY-US, V37, P9612, DOI 10.1021/bi980708e; Long SB, 2002, NATURE, V419, P645, DOI 10.1038/nature00986; Long SB, 2001, P NATL ACAD SCI USA, V98, P12948, DOI 10.1073/pnas.241407898; Mangues R, 1998, CANCER RES, V58, P1253; Mijimolle N, 2005, CANCER CELL, V7, P313, DOI 10.1016/j.ccr.2005.03.004; MITCHELL TG, 1995, CLIN MICROBIOL REV, V8, P515, DOI 10.1128/CMR.8.4.515; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nallan L, 2005, J MED CHEM, V48, P3704, DOI 10.1021/jm0491039; Nichols CB, 2009, EUKARYOT CELL, V8, P181, DOI 10.1128/EC.00351-08; Norman Peter, 2002, Curr Opin Investig Drugs, V3, P313; O'Meara TR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000776; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Park HW, 1997, SCIENCE, V275, P1800, DOI 10.1126/science.275.5307.1800; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; PFALLER MA, 1995, J CLIN MICROBIOL, V33, P1104, DOI 10.1128/JCM.33.5.1104-1107.1995; Pickett JS, 2003, J BIOL CHEM, V278, P51243, DOI 10.1074/jbc.M309226200; Pickett JS, 2003, BIOCHEMISTRY-US, V42, P9741, DOI 10.1021/bi0346852; Reid TS, 2004, BIOCHEMISTRY-US, V43, P6877, DOI 10.1021/bi049723b; Reid TS, 2004, J MOL BIOL, V343, P417, DOI 10.1016/j.jmb.2004.08.056; Reid TS, 2004, BIOCHEMISTRY-US, V43, P9000, DOI 10.1021/bi049280b; Rex JH, 2001, CLIN MICROBIOL REV, V14, P643, DOI 10.1128/CMR.14.4.643-658.2001; Saderholm MJ, 2000, BIOCHEMISTRY-US, V39, P12398, DOI 10.1021/bi0011781; Singh N, 2000, Transpl Infect Dis, V2, P101, DOI 10.1034/j.1399-3062.2000.020302.x; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Strickland CL, 1999, J MED CHEM, V42, P2125, DOI 10.1021/jm990030g; Taylor JS, 2003, EMBO J, V22, P5963, DOI 10.1093/emboj/cdg571; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; TRUEBLOOD CE, 1993, MOL CELL BIOL, V13, P4260, DOI 10.1128/MCB.13.7.4260; Vallim MA, 2004, MICROBIOL-SGM, V150, P1925, DOI 10.1099/mic.0.27030-0; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; Yang Y, 2010, BIOCHEMISTRY-US, V49, P9658, DOI 10.1021/bi1008358; Zaragoza O, 2008, CELL MICROBIOL, V10, P2043, DOI 10.1111/j.1462-5822.2008.01186.x	57	38	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35149	35162		10.1074/jbc.M111.250506	http://dx.doi.org/10.1074/jbc.M111.250506			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21816822	hybrid, Green Published			2022-12-25	WOS:000295406300068
J	Davrazou, F; Dong, E; Murphy, EJ; Johnson, HT; Jones, DNM				Davrazou, Foteini; Dong, Emily; Murphy, Emma J.; Johnson, Hannah T.; Jones, David N. M.			New Insights into the Mechanism of Odorant Detection by the Malaria-transmitting Mosquito Anopheles gambiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHEROMONE-BINDING-PROTEIN; ANTHERAEA-POLYPHEMUS; NMR STRUCTURE; HUMAN SWEAT; STRUCTURAL BASIS; MOTH; PH; IDENTIFICATION; ACTIVATION; RECEPTOR	Anopheles gambiae mosquitoes that transmit Plasmodium falciparum malaria use a series of olfactory cues present in human sweat to locate their hosts for a blood meal. Recognition of these odor cues occurs through the interplay of odorant receptors and odorant-binding proteins (OBPs) that bind to odorant molecules and transport and present them to the receptors. Recent studies have implicated potential heterodimeric interactions between two OBPs, OBP1 and OBP4, as important for perception of indole by the mosquito (Biessmann, H., Andronopoulou, E., Biessmann, M. R., Douris, V., Dimitratos, S. D., Eliopoulos, E., Guerin, P. M., Iatrou, K., Justice, R. W., Krober, T., Marinotti, O., Tsitoura, P., Woods, D. F., and Walter, M. F. (2010) PLoS ONE 5, e9471; Qiao, H., He, X., Schymura, D., Ban, L., Field, L., Dani, F. R., Michelucci, E., Caputo, B., della Torre, A., Iatrou, K., Zhou, J. J., Krieger, J., and Pelosi, P. (2011) Cell. Mol. Life Sci. 68, 1799-1813). Here we present the 2.0 angstrom crystal structure of the OBP4-indole complex, which adopts a classical odorant-binding protein fold, with indole bound at one end of a central hydrophobic cavity. Solution-based NMR studies reveal that OBP4 exists in a molten globule state and binding of indole induces a dramatic conformational shift to a well ordered structure, and this leads to the formation of the binding site for OBP1. Analysis of the OBP4-OBP1 interaction reveals a network of contacts between residues in the OBP1 binding site and the core of the protein and suggests how the interaction of the two proteins can alter the binding affinity for ligands. These studies provide evidence that conformational ordering plays a key role in regulating heteromeric interactions between OBPs.	[Davrazou, Foteini; Dong, Emily; Murphy, Emma J.; Johnson, Hannah T.; Jones, David N. M.] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA; [Jones, David N. M.] Univ Colorado, Sch Med, Program Struct Biol & Biophys, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Jones, DNM (corresponding author), Univ Colorado, Sch Med, Dept Pharmacol, 12801 E 17th Ave, Aurora, CO 80045 USA.	david.jones@ucdenver.edu	Jones, David N/C-5764-2013	Murphy, Emma/0000-0003-4551-8068	Program in Structural Biology and Biophysics; University of Colorado Cancer Center; National Institutes of Health (NIH) [IH P30-CA046934, P41-GM068928, DC008834]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM068928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008834] Funding Source: NIH RePORTER	Program in Structural Biology and Biophysics; University of Colorado Cancer Center; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Dr. Jay Nix for assistance in x-ray data collection, Patrick Jones, Jason Pitts, and Dr. Larry Zwiebel for An. gambiae cDNA libraries, and Dr. Geoff Armstrong for assistance with the 900 MHz NMR spectrometers. The x-ray crystallography and NMR facilities at University of Colorado School of Medicine are supported by the Program in Structural Biology and Biophysics and the University of Colorado Cancer Center Support Grant (National Institutes of Health IH P30-CA046934). Operation of the 900 MHz NMR spectrometer was supported by NIH Grant P41-GM068928.; This work was supported, in whole or in part, by National Institutes of Health Grant DC008834 (to D. N. M. J.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andronopoulou E, 2006, INSECT MOL BIOL, V15, P797, DOI 10.1111/j.1365-2583.2006.00685.x; Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Bette S, 2002, INSECT BIOCHEM MOLEC, V32, P241, DOI 10.1016/S0965-1748(01)00171-0; Biessmann H, 2005, INSECT MOL BIOL, V14, P575, DOI 10.1111/j.1365-2583.2005.00590.x; Biessmann H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009471; Braks MAH, 1999, PARASITOL TODAY, V15, P409, DOI 10.1016/S0169-4758(99)01514-8; Braks MAH, 1999, J CHEM ECOL, V25, P663, DOI 10.1023/A:1020970307748; Bucci BK, 2006, BIOCHEMISTRY-US, V45, P1693, DOI 10.1021/bi0516576; Campanacci V, 2001, J BIOL CHEM, V276, P20078, DOI 10.1074/jbc.M100713200; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; Cork A, 1996, MED VET ENTOMOL, V10, P269, DOI 10.1111/j.1365-2915.1996.tb00742.x; Damberger F, 2000, PROTEIN SCI, V9, P1038, DOI 10.1110/ps.9.5.1038; Damberger FF, 2007, J MOL BIOL, V373, P811, DOI 10.1016/j.jmb.2007.07.078; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Gillies M.T., 1987, PUBL S AFR I MED RES, V55, P1; Grosse-Wilde E, 2006, CHEM SENSES, V31, P547, DOI 10.1093/chemse/bjj059; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Honson N, 2003, CHEM SENSES, V28, P479, DOI 10.1093/chemse/28.6.479; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; Jin X, 2008, P NATL ACAD SCI USA, V105, P10996, DOI 10.1073/pnas.0803309105; Justice RW, 2003, INSECT MOL BIOL, V12, P581, DOI 10.1046/j.1365-2583.2003.00443.x; KLEIN U, 1987, INSECT BIOCHEM, V17, P1193, DOI 10.1016/0020-1790(87)90093-X; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kruse SW, 2003, NAT STRUCT BIOL, V10, P694, DOI 10.1038/nsb960; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Lee D, 2002, FEBS LETT, V531, P314, DOI 10.1016/S0014-5793(02)03548-2; Leite NR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008006; Lescop E, 2009, BIOCHEMISTRY-US, V48, P2431, DOI 10.1021/bi802300k; Mao Y, 2010, P NATL ACAD SCI USA, V107, P19102, DOI 10.1073/pnas.1012274107; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Meijerink J, 2000, J CHEM ECOL, V26, P1367, DOI 10.1023/A:1005475422978; Mohanty S, 2004, J MOL BIOL, V337, P443, DOI 10.1016/j.jmb.2004.01.009; Mohl Claudia, 2002, Invertebrate Neuroscience, V4, P165, DOI 10.1007/s10158-002-0018-5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Pesenti ME, 2009, J MOL BIOL, V390, P981, DOI 10.1016/j.jmb.2009.05.067; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Qiao HL, 2011, CELL MOL LIFE SCI, V68, P1799, DOI 10.1007/s00018-010-0539-8; Ronderos DS, 2009, FLY, V3, P290, DOI 10.4161/fly.9801; Ronderos DS, 2010, J NEUROSCI, V30, P2595, DOI 10.1523/JNEUROSCI.4819-09.2010; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shanbhag SR, 2005, ARTHROPOD STRUCT DEV, V34, P153, DOI 10.1016/j.asd.2005.01.003; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Thode AB, 2008, J MOL BIOL, V376, P1360, DOI 10.1016/j.jmb.2007.12.063; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Vogt Richard G., 2003, P391, DOI 10.1016/B978-012107151-6/50016-5; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wogulis M, 2006, BIOCHEM BIOPH RES CO, V339, P157, DOI 10.1016/j.bbrc.2005.10.191; Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Xu PX, 2003, INSECT MOL BIOL, V12, P549, DOI 10.1046/j.1365-2583.2003.00440.x; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Zubkov S, 2005, J MOL BIOL, V354, P1081, DOI 10.1016/j.jmb.2005.10.015	63	24	25	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34175	34183		10.1074/jbc.M111.274712	http://dx.doi.org/10.1074/jbc.M111.274712			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21816826	Green Published, hybrid			2022-12-25	WOS:000295159200048
J	Tang, YY; Wells, JA; Arkin, MR				Tang, Yinyan; Wells, James A.; Arkin, Michelle R.			Structural and Enzymatic Insights into Caspase-2 Protein Substrate Recognition and Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION; MECHANISM; SPECIFICITIES; APOPTOSIS; FAMILY; SITE	Caspase-2, the most evolutionarily conserved member in the human caspase family, may play important roles in stress-induced apoptosis, cell cycle regulation, and tumor suppression. In biochemical assays, caspase-2 uniquely prefers a pentapeptide (such as VDVAD) rather than a tetrapeptide, as required for efficient cleavage by other caspases. We investigated the molecular basis for pentapeptide specificity using peptide analog inhibitors and substrates that vary at the P5 position. We determined the crystal structures of apo caspase-2, caspase-2 in complex with peptide inhibitors VDVAD-CHO, ADVAD-CHO, and DVAD-CHO, and a T380A mutant of caspase-2 in complex with VDVAD-CHO. Two residues, Thr-380 and Tyr-420, are identified to be critical for the P5 residue recognition; mutation of the two residues reduces the catalytic efficiency by about 4- and 40-fold, respectively. The structures also provide a series of snapshots of caspase-2 in different catalytic states, shedding light on the mechanism of capase-2 activation, substrate binding, and catalysis. By comparing the apo and inhibited caspase-2 structures, we propose that the disruption of a non-conserved salt bridge between Glu-217 and the invariant Arg-378 is important for the activation of caspase-2. These findings broaden our understanding of caspase-2 substrate specificity and catalysis.	[Tang, Yinyan; Wells, James A.; Arkin, Michelle R.] Univ Calif San Francisco, Dept Pharmaceut Chem, Small Mol Discovery Ctr, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Arkin, MR (corresponding author), 1700 4th St,MC 2552, San Francisco, CA 94158 USA.	michelle.arkin@ucsf.edu	Wells, Jim A/O-9854-2016; arkin, michelle/AAN-4298-2021; Arkin, Michelle/AAO-2009-2021	arkin, michelle/0000-0002-9366-6770; 	CHDI Foundation	CHDI Foundation	This work was supported by a grant from the CHDI Foundation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agniswamy J, 2009, APOPTOSIS, V14, P1135, DOI 10.1007/s10495-009-0388-9; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baliga BC, 2004, CELL DEATH DIFFER, V11, P1234, DOI 10.1038/sj.cdd.4401492; Benkova B, 2009, ANAL BIOCHEM, V394, P68, DOI 10.1016/j.ab.2009.07.012; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Bouchier-Hayes L, 2010, J CELL MOL MED, V14, P1212, DOI 10.1111/j.1582-4934.2010.01037.x; Crawford ED, 2011, ANNU REV BIOCHEM, V80, P1055, DOI 10.1146/annurev-biochem-061809-121639; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fang B, 2006, J MOL BIOL, V360, P654, DOI 10.1016/j.jmb.2006.05.041; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Krumschnabel G, 2009, CELL DEATH DIFFER, V16, P195, DOI 10.1038/cdd.2008.170; Kumar S, 2009, NAT REV CANCER, V9, P897, DOI 10.1038/nrc2745; Lamkanfi M, 2002, CELL DEATH DIFFER, V9, P358, DOI 10.1038/sj.cdd.4400989; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Noble JE, 2009, METHOD ENZYMOL, V463, P73, DOI 10.1016/S0076-6879(09)63008-1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Romanowski MJ, 2004, STRUCTURE, V12, P1361, DOI 10.1016/j.str.2004.05.010; Schweizer A, 2003, J BIOL CHEM, V278, P42441, DOI 10.1074/jbc.M304895200; Shi YG, 2004, PROTEIN SCI, V13, P1979, DOI 10.1110/ps.04789804; Shimohama S, 1999, BIOCHEM BIOPH RES CO, V256, P381, DOI 10.1006/bbrc.1999.0344; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Vakifahmetoglu-Norberg H, 2010, TRENDS CELL BIOL, V20, P150, DOI 10.1016/j.tcb.2009.12.006; Witkowski WA, 2009, PROTEIN SCI, V18, P1459, DOI 10.1002/pro.151; Wolan DW, 2009, SCIENCE, V326, P853, DOI 10.1126/science.1177585	31	24	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34147	34154		10.1074/jbc.M111.247627	http://dx.doi.org/10.1074/jbc.M111.247627			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21828056	Green Published, hybrid			2022-12-25	WOS:000295159200045
J	Barbosa, RR; Silva, SP; Silva, SL; Melo, AC; Pedro, E; Barbosa, MP; Pereira-Santos, MC; Victorino, RMM; Sousa, AE				Barbosa, Rita R.; Silva, Sara P.; Silva, Susana L.; Melo, Alcinda Campos; Pedro, Elisa; Barbosa, Manuel P.; Conceicao Pereira-Santos, M.; Victorino, Rui M. M.; Sousa, Ana E.			Primary B-Cell Deficiencies Reveal a Link between Human IL-17-Producing CD4 T-Cell Homeostasis and B-Cell Differentiation	PLOS ONE			English	Article							COMMON VARIABLE IMMUNODEFICIENCY; TRANSLATIONAL MINIREVIEW SERIES; HELPER MEMORY CELLS; TH17 CELLS; ICOS DEFICIENCY; T-H-17 CELLS; IL-21; BAFF; EXPRESSION; GENERATION	IL-17 is a pro-inflammatory cytokine implicated in autoimmune and inflammatory conditions. The development/survival of IL-17-producing CD4 T cells (Th17) share critical cues with B-cell differentiation and the circulating follicular T helper subset was recently shown to be enriched in Th17 cells able to help B-cell differentiation. We investigated a putative link between Th17-cell homeostasis and B cells by studying the Th17-cell compartment in primary B-cell immunodeficiencies. Common Variable Immunodeficiency Disorders (CVID), defined by defects in B-cell differentiation into plasma and memory B cells, are frequently associated with autoimmune and inflammatory manifestations but we found no relationship between these and Th17-cell frequency. In fact, CVID patients showed a decrease in Th17-cell frequency in parallel with the expansion of activated non-differentiated B cells (CD21(low)CD38(low)). Moreover, Congenital Agammaglobulinemia patients, lacking B cells due to impaired early B-cell development, had a severe reduction of circulating Th17 cells. Finally, we found a direct correlation in healthy individuals between circulating Th17-cell frequency and both switched-memory B cells and serum BAFF levels, a crucial cytokine for B-cell survival. Overall, our data support a relationship between Th17-cell homeostasis and B-cell maturation, with implications for the understanding of the pathogenesis of inflammatory/autoimmune diseases and the physiology of B-cell depleting therapies.	[Barbosa, Rita R.; Silva, Sara P.; Silva, Susana L.; Melo, Alcinda Campos; Conceicao Pereira-Santos, M.; Victorino, Rui M. M.; Sousa, Ana E.] Univ Lisbon, Fac Med, Inst Med Mol, Lisbon, Portugal; [Silva, Sara P.; Silva, Susana L.; Pedro, Elisa; Barbosa, Manuel P.; Victorino, Rui M. M.] Ctr Hosp Lisboa Norte, Hosp Santa Maria, Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa; Hospital Santa Maria	Barbosa, RR (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, Lisbon, Portugal.	asousa@fm.ul.pt	Sousa, Ana E./L-2642-2014; Silva, Sara/GXM-8709-2022; Silva, Susana/L-1833-2014; Victorino, Rui/N-7948-2013	Sousa, Ana E./0000-0002-4618-9799; Santos, M. Conceicao/0000-0003-0689-7317; Victorino, Rui/0000-0001-7567-1704; Barbosa, Manuel Augusto de Castro Pereira/0000-0002-4662-1369	"Fundacao para a Ciencia e a Tecnologia" (FCT); "Programa Operacional Ciencia e Inovacao" [POCI2010]	"Fundacao para a Ciencia e a Tecnologia" (FCT)(Portuguese Foundation for Science and Technology); "Programa Operacional Ciencia e Inovacao"	This work was supported by grants from "Fundacao para a Ciencia e a Tecnologia" (FCT) and by "Programa Operacional Ciencia e Inovacao 2010" (POCI2010) (R. M. M. V. and A. E. S.). R. R. B. received a PhD scholarship from FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Boileau J, 2011, J AUTOIMMUN, V36, P25, DOI 10.1016/j.jaut.2010.10.002; Bossaller L, 2006, J IMMUNOL, V177, P4927, DOI 10.4049/jimmunol.177.7.4927; Brandtzaeg P, 2009, SCAND J IMMUNOL, V70, P505, DOI 10.1111/j.1365-3083.2009.02319.x; Chapel H, 2008, BLOOD, V112, P277, DOI 10.1182/blood-2007-11-124545; Conley ME, 2009, CURR OPIN IMMUNOL, V21, P466, DOI 10.1016/j.coi.2009.07.003; Crome SQ, 2010, CLIN EXP IMMUNOL, V159, P109, DOI 10.1111/j.1365-2249.2009.04037.x; Deteix C, 2010, J IMMUNOL, V184, P5344, DOI 10.4049/jimmunol.0902999; Dong C, 2001, J IMMUNOL, V166, P3659, DOI 10.4049/jimmunol.166.6.3659; Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; FORSTER R, 1994, BLOOD, V84, P830; Giovannetti A, 2007, J IMMUNOL, V178, P3932, DOI 10.4049/jimmunol.178.6.3932; HILBERT DM, 1989, J IMMUNOL, V143, P4019; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Iezzi G, 2009, P NATL ACAD SCI USA, V106, P876, DOI 10.1073/pnas.0810769106; Jin R, 2008, INT J MOL MED, V21, P233; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Knight AK, 2007, CLIN IMMUNOL, V124, P182, DOI 10.1016/j.clim.2007.04.012; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lam QLK, 2008, P NATL ACAD SCI USA, V105, P14993, DOI 10.1073/pnas.0806044105; Levesque MC, 2009, CLIN EXP IMMUNOL, V157, P198, DOI 10.1111/j.1365-2249.2009.03979.x; Lopes-da-Silva S, 2008, J CLIN IMMUNOL, V28, pS46, DOI 10.1007/s10875-008-9172-9; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Maddur MS, 2011, J ALLERGY CLIN IMMUN, V127, P823, DOI 10.1016/j.jaci.2010.12.1102; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Mannon PJ, 2006, GASTROENTEROLOGY, V131, P748, DOI 10.1053/j.gastro.2006.06.022; Martini H, 2011, CLIN EXP IMMUNOL, V164, P381, DOI 10.1111/j.1365-2249.2011.04377.x; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Moir S, 2001, P NATL ACAD SCI USA, V98, P10362, DOI 10.1073/pnas.181347898; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Rakhmanov M, 2009, P NATL ACAD SCI USA, V106, P13451, DOI 10.1073/pnas.0901984106; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sousa AE, 2001, J INFECT DIS, V184, P552, DOI 10.1086/322804; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Taubenheim N, 2005, J IMMUNOL, V175, P5498, DOI 10.4049/jimmunol.175.8.5498; Thaunat O, 2010, BLOOD, V116, P515, DOI 10.1182/blood-2010-01-266668; Townsend MJ, 2010, IMMUNOL REV, V237, P264, DOI 10.1111/j.1600-065X.2010.00945.x; van de Veerdonk FL, 2011, ARTHRITIS RHEUM-US, V63, P1507, DOI 10.1002/art.30314; Warnatz K, 2006, BLOOD, V107, P3045, DOI 10.1182/blood-2005-07-2955; Wehr C, 2008, BLOOD, V111, P77, DOI 10.1182/blood-2007-06-091744; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021	49	55	56	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22848	10.1371/journal.pone.0022848	http://dx.doi.org/10.1371/journal.pone.0022848			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826211	Green Published, gold, Green Submitted			2022-12-25	WOS:000293558900037
J	Giannone, RJ; Huber, H; Karpinets, T; Heimerl, T; Kuper, U; Rachel, R; Keller, M; Hettich, RL; Podar, M				Giannone, Richard J.; Huber, Harald; Karpinets, Tatiana; Heimerl, Thomas; Kueper, Ulf; Rachel, Reinhard; Keller, Martin; Hettich, Robert L.; Podar, Mircea			Proteomic Characterization of Cellular and Molecular Processes that Enable the Nanoarchaeum equitans-Ignicoccus hospitalis Relationship	PLOS ONE			English	Article							SET ENRICHMENT ANALYSIS; OUTER-MEMBRANE; PROTEIN; INSIGHTS; GENOME; EVOLUTION; PEPTIDES; DATABASE; PATHWAY; ARCHAEA	Nanoarchaeum equitans, the only cultured representative of the Nanoarchaeota, is dependent on direct physical contact with its host, the hyperthermophile Ignicoccus hospitalis. The molecular mechanisms that enable this relationship are unknown. Using whole-cell proteomics, differences in the relative abundance of >75% of predicted protein-coding genes from both Archaea were measured to identify the specific response of I. hospitalis to the presence of N. equitans on its surface. A purified N. equitans sample was also analyzed for evidence of interspecies protein transfer. The depth of cellular proteome coverage achieved here is amongst the highest reported for any organism. Based on changes in the proteome under the specific conditions of this study, I. hospitalis reacts to N. equitans by curtailing genetic information processing (replication, transcription) in lieu of intensifying its energetic, protein processing and cellular membrane functions. We found no evidence of significant Ignicoccus biosynthetic enzymes being transported to N. equitans. These results suggest that, under laboratory conditions, N. equitans diverts some of its host's metabolism and cell cycle control to compensate for its own metabolic shortcomings, thus appearing to be entirely dependent on small, transferable metabolites and energetic precursors from I. hospitalis.	[Giannone, Richard J.; Hettich, Robert L.] Oak Ridge Natl Lab, Div Chem Sci, Oak Ridge, TN 37831 USA; [Huber, Harald; Heimerl, Thomas; Kueper, Ulf; Rachel, Reinhard] Univ Regensburg, Lehrstuhl Mikrobiol, D-8400 Regensburg, Germany; [Huber, Harald; Heimerl, Thomas; Kueper, Ulf; Rachel, Reinhard] Univ Regensburg, Archaeenzentrum, Regensburg, Germany; [Karpinets, Tatiana; Keller, Martin; Podar, Mircea] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA; [Podar, Mircea] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Regensburg; University of Regensburg; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville	Giannone, RJ (corresponding author), Oak Ridge Natl Lab, Div Chem Sci, Oak Ridge, TN 37831 USA.	podarm@ornl.gov	Hettich, Robert L/N-1458-2016; Giannone, Richard/ABC-8247-2020; Keller, Martin/C-4416-2012; Podar, Mircea/B-7299-2012	Hettich, Robert L/0000-0001-7708-786X; Giannone, Richard/0000-0001-8551-0138; Podar, Mircea/0000-0003-2776-0205	U.S. Department of Energy Office of Science, Biological and Environmental Research; ORNL; U.S. Department of Energy [DE-AC05-00OR22725]; Deutsche Forschungsgemeinschaft	U.S. Department of Energy Office of Science, Biological and Environmental Research(United States Department of Energy (DOE)); ORNL; U.S. Department of Energy(United States Department of Energy (DOE)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	RJG, TK, MK, RLH and MP were sponsored by the U.S. Department of Energy Office of Science, Biological and Environmental Research programs at Oak Ridge National Laboratory (ORNL) and by the Laboratory Directed Research and Development Program of ORNL. ORNL is managed by UT-Battelle, LLC, for the U.S. Department of Energy under contract DE-AC05-00OR22725. HH, TH, UK and RR were supported by funding from the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens CH, 2010, NAT REV MOL CELL BIO, V11, P789, DOI 10.1038/nrm2973; Bagos PG, 2009, PROTEIN ENG DES SEL, V22, P27, DOI 10.1093/protein/gzn064; Burghardt T, 2008, ARCH MICROBIOL, V190, P379, DOI 10.1007/s00203-008-0399-x; Burghardt T, 2007, MOL MICROBIOL, V63, P166, DOI 10.1111/j.1365-2958.2006.05509.x; Burghardt T, 2009, BIOCHEM SOC T, V37, P127, DOI 10.1042/BST0370127; CAMPANARO S, 2010, ENV MICROBIOL; Caspi R, 2010, NUCLEIC ACIDS RES, V38, pD473, DOI 10.1093/nar/gkp875; Cha SW, 2010, MOL CELL PROTEOMICS, V9, P2529, DOI 10.1074/mcp.M110.000398; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Florens L, 2006, METHODS, V40, P303, DOI 10.1016/j.ymeth.2006.07.028; Forchhammer K, 2008, TRENDS MICROBIOL, V16, P65, DOI 10.1016/j.tim.2007.11.004; Gstaiger M, 2009, NAT REV GENET, V10, P617, DOI 10.1038/nrg2633; Huber H, 2002, NATURE, V417, P63, DOI 10.1038/417063a; Jahn U, 2004, ARCH MICROBIOL, V182, P404, DOI 10.1007/s00203-004-0725-x; Jahn U, 2008, J BACTERIOL, V190, P1743, DOI 10.1128/JB.01731-07; Jahn U, 2007, J BACTERIOL, V189, P4108, DOI 10.1128/JB.00047-07; Junglas B, 2008, ARCH MICROBIOL; Koonin EV, 2009, INT J BIOCHEM CELL B, V41, P298, DOI 10.1016/j.biocel.2008.09.015; Koonin EV, 2000, CURR BIOL, V10, pR774, DOI 10.1016/S0960-9822(00)00774-0; Kuper U, 2010, P NATL ACAD SCI USA, V107, P3152, DOI 10.1073/pnas.0911711107; Lewalter K, 2006, BBA-BIOENERGETICS, V1757, P437, DOI 10.1016/j.bbabio.2006.04.027; Makarova KS, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-33; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Mavromatis K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007979; McDonald WH, 2002, INT J MASS SPECTROM, V219, P245, DOI 10.1016/S1387-3806(02)00563-8; Muller DW, 2009, J BACTERIOL, V191, P6465, DOI 10.1128/JB.00858-09; Paley SM, 2006, NUCLEIC ACIDS RES, V34, P3771, DOI 10.1093/nar/gkl334; Paper W, 2007, INT J SYST EVOL MICR, V57, P803, DOI 10.1099/ijs.0.64721-0; Pedone E, 2004, FRONT BIOSCI-LANDMRK, V9, P2909, DOI 10.2741/1447; Podar M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r158; Qiu Y, 2010, GENOME RES, V20, P1304, DOI 10.1101/gr.107540.110; Rachel Reinhard, 2002, Archaea, V1, P9, DOI 10.1155/2002/307480; Ramos-Vera WH, 2011, J BACTERIOL, V193, P1201, DOI 10.1128/JB.01156-10; Strand KR, 2010, ARCH MICROBIOL, V192, P447, DOI 10.1007/s00203-010-0570-z; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun N, 2010, J PROTEOME RES, V9, P4839, DOI 10.1021/pr100567u; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tebbe A, 2009, PROTEOMICS, V9, P3843, DOI 10.1002/pmic.200800944; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Waters E, 2003, P NATL ACAD SCI USA, V100, P12984, DOI 10.1073/pnas.1735403100; Williams TJ, 2010, J PROTEOME RES, V9, P640, DOI 10.1021/pr900509n; Xia Q, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-149; Zybailov B, 2005, ANAL CHEM, V77, P6218, DOI 10.1021/ac050846r; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	44	43	43	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22942	10.1371/journal.pone.0022942	http://dx.doi.org/10.1371/journal.pone.0022942			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826220	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000293558900046
J	Nakayama, M; Sato, H; Okuda, T; Fujisawa, N; Kono, N; Arai, H; Suzuki, E; Umeda, M; Ishikawa, HO; Matsuno, K				Nakayama, Minoru; Sato, Hiroyasu; Okuda, Takayuki; Fujisawa, Nao; Kono, Nozomu; Arai, Hiroyuki; Suzuki, Emiko; Umeda, Masato; Ishikawa, Hiroyuki O.; Matsuno, Kenji			Drosophila Carrying Pex3 or Pex16 Mutations Are Models of Zellweger Syndrome That Reflect Its Symptoms Associated with the Absence of Peroxisomes	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; Y-CHROMOSOME; NEURONAL MIGRATION; IMPORT RECEPTOR; GENE-EXPRESSION; WILD-TYPE; MELANOGASTER; BIOGENESIS; SPERMATOGENESIS	The peroxisome biogenesis disorders (PBDs) are currently difficult-to-treat multiple-organ dysfunction disorders that result from the defective biogenesis of peroxisomes. Genes encoding Peroxins, which are required for peroxisome biogenesis or functions, are known causative genes of PBDs. The human peroxin genes PEX3 or PEX16 are required for peroxisomal membrane protein targeting, and their mutations cause Zellweger syndrome, a class of PBDs. Lack of understanding about the pathogenesis of Zellweger syndrome has hindered the development of effective treatments. Here, we developed potential Drosophila models for Zellweger syndrome, in which the Drosophila pex3 or pex16 gene was disrupted. As found in Zellweger syndrome patients, peroxisomes were not observed in the homozygous Drosophila pex3 mutant, which was larval lethal. However, the pex16 homozygote lacking its maternal contribution was viable and still maintained a small number of peroxisome-like granules, even though PEX16 is essential for the biosynthesis of peroxisomes in humans. These results suggest that the requirements for pex3 and pex16 in peroxisome biosynthesis in Drosophila are different, and the role of PEX16 orthologs may have diverged between mammals and Drosophila. The phenotypes of our Zellweger syndrome model flies, such as larval lethality in pex3, and reduced size, shortened longevity, locomotion defects, and abnormal lipid metabolisms in pex16, were reminiscent of symptoms of this disorder, although the Drosophila pex16 mutant does not recapitulate the infant death of Zellweger syndrome. Furthermore, pex16 mutants showed male-specific sterility that resulted from the arrest of spermatocyte maturation. pex16 expressed in somatic cyst cells but not germline cells had an essential role in the maturation of male germline cells, suggesting that peroxisome-dependent signals in somatic cyst cells could contribute to the progression of male germ-cell maturation. These potential Drosophila models for Zellweger syndrome should contribute to our understanding of its pathology.	[Nakayama, Minoru; Ishikawa, Hiroyuki O.; Matsuno, Kenji] Tokyo Univ Sci, Genome & Drug Res Ctr, Chiba, Japan; [Nakayama, Minoru; Sato, Hiroyasu; Okuda, Takayuki; Fujisawa, Nao; Matsuno, Kenji] Tokyo Univ Sci, Dept Biol Sci & Technol, Chiba, Japan; [Nakayama, Minoru; Matsuno, Kenji] Tokyo Univ Sci, Res Inst Sci & Technol, Chiba, Japan; [Kono, Nozomu; Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo, Japan; [Suzuki, Emiko] Grad Univ Adv Studies, Struct Biol Ctr, Natl Inst Genet, Shizuoka, Japan; [Suzuki, Emiko] Grad Univ Adv Studies, Dept Genet, Shizuoka, Japan; [Umeda, Masato] Kyoto Univ, Inst Chem Res, Kyoto 606, Japan	Tokyo University of Science; Tokyo University of Science; Tokyo University of Science; University of Tokyo; Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Kyoto University	Nakayama, M (corresponding author), Tokyo Univ Sci, Genome & Drug Res Ctr, Chiba, Japan.	matsuno@rs.noda.tus.ac.jp	KONO, nozomu/AAM-3178-2020	Suzuki, Emiko/0000-0002-4005-0542	National Institute of Genetics [2006-A78, 2007-A51]; Grants-in-Aid for Scientific Research [23227004, 23770139] Funding Source: KAKEN	National Institute of Genetics; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the National Institute of Genetics Cooperative Research Program (2006-A78, 2007-A51). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asheuer M, 2005, HUM MOL GENET, V14, P1293, DOI 10.1093/hmg/ddi140; Baes M, 1997, NAT GENET, V17, P49, DOI 10.1038/ng0997-49; BEARD ME, 1987, P NATL ACAD SCI USA, V84, P7433, DOI 10.1073/pnas.84.21.7433; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BONACCORSI S, 1988, GENETICS, V120, P1015; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRINK NG, 1968, MUTAT RES, V5, P192, DOI 10.1016/0027-5107(68)90093-6; Brites P, 2003, HUM MOL GENET, V12, P2255, DOI 10.1093/hmg/ddg236; Chen HY, 2010, HUM MOL GENET, V19, P494, DOI 10.1093/hmg/ddp518; Cherbas L, 2003, DEVELOPMENT, V130, P271, DOI 10.1242/dev.00205; Diagana TT, 2002, J NEUROSCI, V22, P428, DOI 10.1523/JNEUROSCI.22-02-00428.2002; DIMMICK JE, 1997, ORGANELLE DIS CLIN F, P211; Eitzen GA, 1997, J CELL BIOL, V137, P1265, DOI 10.1083/jcb.137.6.1265; Faust PL, 1997, J CELL BIOL, V139, P1293, DOI 10.1083/jcb.139.5.1293; Fujiki Y, 2006, BBA-MOL CELL RES, V1763, P1639, DOI 10.1016/j.bbamcr.2006.08.030; GANETZKY B, 1978, EXP GERONTOL, V13, P189, DOI 10.1016/0531-5565(78)90012-8; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; GRAHAM RC, 1966, J HISTOCHEM CYTOCHEM, V14, P291, DOI 10.1177/14.4.291; Hakeda S, 2000, J CELL BIOL, V148, P101, DOI 10.1083/jcb.148.1.101; HARDY RW, 1981, CHROMOSOMA, V83, P593, DOI 10.1007/BF00328522; Heiland I, 2005, FEBS J, V272, P2362, DOI 10.1111/j.1742-4658.2005.04690.x; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; Honsho M, 1998, AM J HUM GENET, V63, P1622, DOI 10.1086/302161; Hozumi S, 2006, NATURE, V440, P798, DOI 10.1038/nature04625; Jones JM, 2004, J CELL BIOL, V164, P57, DOI 10.1083/jcb.200304111; Karnik SK, 2005, PLANT PHYSIOL, V138, P1967, DOI [10.1104/pp.105.061291, 10.1104/PP.105.061291]; Kiel JAKW, 2006, TRAFFIC, V7, P1291, DOI 10.1111/j.1600-0854.2006.00479.x; Kim PK, 2006, J CELL BIOL, V173, P521, DOI 10.1083/jcb.200601036; KOANA T, 1978, J EMBRYOL EXP MORPH, V45, P123; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; LAZAROW PB, 1994, METABOLIC BASIS INHE, P2287; LEBOURG E, 1992, GERONTOLOGY, V38, P59; Matsuno K, 2002, DEVELOPMENT, V129, P1049; Matsuzaki T, 2008, J CELL BIOL, V183, P1275, DOI 10.1083/jcb.200806062; Maxwell M, 2003, MOL CELL BIOL, V23, P5947, DOI 10.1128/MCB.23.16.5947-5957.2003; Moser HW, 1999, MOL GENET METAB, V68, P316, DOI 10.1006/mgme.1999.2926; Moser HW, 1991, TECHNIQUES DIAGNOSTI, P177; Motley AM, 2007, J CELL BIOL, V178, P399, DOI 10.1083/jcb.200702167; Mullen RT, 1999, PLANT CELL, V11, P2167, DOI 10.1105/tpc.11.11.2167; OLIVIERI G, 1965, MUTAT RES, V2, P366, DOI 10.1016/0027-5107(65)90072-2; PISANO C, 1993, GENETICS, V133, P569; Platta HW, 2009, MOL CELL BIOL, V29, P5505, DOI 10.1128/MCB.00388-09; REAUME AG, 1991, GENETICS, V129, P1099; SAUMWEBER H, 1980, CHROMOSOMA, V80, P253, DOI 10.1007/BF00292684; Schliebs W, 2004, CURR BIOL, V14, pR397, DOI 10.1016/j.cub.2004.05.017; Schulz C, 2004, GENETICS, V167, P707, DOI 10.1534/genetics.103.023184; Shimozawa N, 2007, J INHERIT METAB DIS, V30, P193, DOI 10.1007/s10545-007-0516-z; Shimozawa N, 2000, HUM MOL GENET, V9, P1995, DOI 10.1093/hmg/9.13.1995; Steinberg SJ, 2006, BBA-MOL CELL RES, V1763, P1733, DOI 10.1016/j.bbamcr.2006.09.010; Subramani S, 2000, ANNU REV BIOCHEM, V69, P399, DOI 10.1146/annurev.biochem.69.1.399; SUZUKI E, 1994, J ELECTRON MICROSC, V43, P183; Tates AD, 1971, THESIS RIJKSUNIVERSI; Titorenko VI, 1998, TRENDS BIOCHEM SCI, V23, P231, DOI 10.1016/S0968-0004(98)01226-2; Titorenko VI, 2006, J CELL BIOL, V174, P11, DOI 10.1083/jcb.200604036; Toba G, 1999, GENETICS, V151, P725; Van Doren M, 1998, CURR BIOL, V8, P243; Wanders RJA, 1998, MOL ASPECTS MED, V19, P71, DOI 10.1016/S0098-2997(98)00003-X	57	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22984	10.1371/journal.pone.0022984	http://dx.doi.org/10.1371/journal.pone.0022984			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826223	Green Published, Green Submitted, gold			2022-12-25	WOS:000293558900049
J	Pena-Gomez, C; Vidal-Pineiro, D; Clemente, IC; Pascual-Leone, A; Bartres-Faz, D				Pena-Gomez, Cleofe; Vidal-Pineiro, Didac; Clemente, Immaculada C.; Pascual-Leone, Alvaro; Bartres-Faz, David			Down-Regulation of Negative Emotional Processing by Transcranial Direct Current Stimulation: Effects of Personality Characteristics	PLOS ONE			English	Article							NONINVASIVE BRAIN-STIMULATION; HUMAN MOTOR CORTEX; PREFRONTAL CORTEX; INDIVIDUAL-DIFFERENCES; DC-STIMULATION; MAGNETIC STIMULATION; STOCHASTIC RESONANCE; FMRI; EXCITABILITY; MECHANISMS	Evidence from neuroimaging and electrophysiological studies indicates that the left dorsolateral prefrontal cortex (DLPFC) is a core region in emotional processing, particularly during down-regulation of negative emotional conditions. However, emotional regulation is a process subject to major inter-individual differences, some of which may be explained by personality traits. In the present study we used transcranial direct current stimulation (tDCS) over the left DLPFC to investigate whether transiently increasing the activity of this region resulted in changes in the ratings of positive, neutral and negative emotional pictures. Results revealed that anodal, but not cathodal, tDCS reduced the perceived degree of emotional valence for negative stimuli, possibly due to an enhancement of cognitive control of emotional expression. We also aimed to determine whether personality traits (extraversion and neuroticism) might condition the impact of tDCS. We found that individuals with higher scores on the introversion personality dimension were more permeable than extraverts to the modulatory effects of the stimulation. The present study underlines the role of the left DLPFC in emotional regulation, and stresses the importance of considering individual personality characteristics as a relevant variable, although replication is needed given the limited sample size of our study.	[Pena-Gomez, Cleofe; Vidal-Pineiro, Didac; Bartres-Faz, David] Univ Barcelona, Fac Med, Dept Psiquiatria & Psicobiol Clin, Barcelona 7, Spain; [Clemente, Immaculada C.] Univ Barcelona, Fac Psicol, Dept Psiquiatria & Psicobiol Clin, Barcelona 7, Spain; [Pascual-Leone, Alvaro] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Berenson Allen Ctr Noninvas Brain Stimulat, Boston, MA 02215 USA; [Pascual-Leone, Alvaro] Inst Univ Neurorehabil Guttmann UAB, Badalona, Spain; [Bartres-Faz, David] Inst Nvestigac Biomed August Pi & Sunyer, Barcelona, Spain	University of Barcelona; University of Barcelona; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Pena-Gomez, C (corresponding author), Univ Barcelona, Fac Med, Dept Psiquiatria & Psicobiol Clin, Barcelona 7, Spain.	dbartres@ub.edu	Clemente, I Concepcion/H-5399-2013; Pascual-Leone, Alvaro/G-6566-2011; Pascual-Leone, Alvaro/AAC-5101-2019; Vidal-Piñeiro, Didac/O-5012-2016; Bartres-Faz, David/C-8997-2011	Clemente, I Concepcion/0000-0003-0728-0925; Pascual-Leone, Alvaro/0000-0001-8975-0382; Vidal-Piñeiro, Didac/0000-0001-9997-9156; Bartres-Faz, David/0000-0001-6020-4118	Spanish Ministerio de Educacion y Ciencia [SAF2007-66270]; Spanish Ministerio de Ciencia e Innovacion [SAF2009-07489]; National Institutes of Health [K24 RR018875, RO1-NS 20068, R01-EB 005047]; Harvard Clinical and Translational Science Center, from the National Center for Research Resources [UL1 RR025758]; NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR018875, UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005047] Funding Source: NIH RePORTER	Spanish Ministerio de Educacion y Ciencia(Spanish Government); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Clinical and Translational Science Center, from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Partially funded by a Spanish Ministerio de Educacion y Ciencia research grant (SAF2007-66270) and the Spanish Ministerio de Ciencia e Innovacion (SAF2009-07489). AP-L was supported in part by grants from the National Institutes of Health (K24 RR018875, RO1-NS 20068, R01-EB 005047), and Grant Number UL1 RR025758 - Harvard Clinical and Translational Science Center, from the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amstadter A, 2008, J ANXIETY DISORD, V22, P211, DOI 10.1016/j.janxdis.2007.02.004; Amting JM, 2010, J NEUROSCI, V30, P10039, DOI 10.1523/JNEUROSCI.6434-09.2010; BAXTER LR, 1989, ARCH GEN PSYCHIAT, V46, P243; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; BECK AT, 1996, ANUAL BECK DEPRESSIO; Bestmann S, 2008, CEREB CORTEX, V18, P1281, DOI 10.1093/cercor/bhm159; Blair KS, 2007, NEUROIMAGE, V35, P430, DOI 10.1016/j.neuroimage.2006.11.048; Boggio PS, 2009, J NEUROL NEUROSUR PS, V80, P444, DOI 10.1136/jnnp.2007.141853; Boggio PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004959; Boggio PS, 2009, NEUROPSYCHOLOGIA, V47, P212, DOI 10.1016/j.neuropsychologia.2008.07.022; Canli T, 2001, BEHAV NEUROSCI, V115, P33, DOI 10.1037//0735-7044.115.1.33; Canli T, 2002, SCIENCE, V296, P2191, DOI 10.1126/science.1068749; Canli T, 1998, NEUROREPORT, V9, P3233, DOI 10.1097/00001756-199810050-00019; Caspi A, 2005, ANNU REV PSYCHOL, V56, P453, DOI 10.1146/annurev.psych.55.090902.141913; Costa P.T., 2008, SAGE HDB PERSONALITY, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9, 10.4135/9781849200479.N9]; COSTA PT, 1980, J PERS SOC PSYCHOL, V38, P668, DOI 10.1037/0022-3514.38.4.668; COSTA PT, 1991, NEO 5 FACTOR INVENTO; Cremers HR, 2010, NEUROIMAGE, V49, P963, DOI 10.1016/j.neuroimage.2009.08.023; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; DAVIDSON RJ, 2007, HDB EMOTION REGULATI, P47; Dolcos F, 2004, NEUROIMAGE, V23, P64, DOI 10.1016/j.neuroimage.2004.05.015; DRABANT EM, 2010, NEUROIMAGE; Eisenberger NI, 2005, COGN AFFECT BEHAV NE, V5, P169, DOI 10.3758/CABN.5.2.169; Eysenck H.J., 1967, BIOL BASIS PERSONALI; Eysenck HJ., 1993, MANUAL EYSENCK PERSO, DOI 10.1037/t05461-000; Eysenck HJ, 1981, MODEL PERSONALITY, p1~37, DOI DOI 10.1007/978-3-642-67783-0_1; Floel A, 2008, J COGNITIVE NEUROSCI, V20, P1415, DOI 10.1162/jocn.2008.20098; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; George MS, 2010, EXPERT REV NEUROTHER, V10, P1761, DOI [10.1586/ern.10.95, 10.1586/ERN.10.95]; Gross J.J., 1998, REV GEN PSYCHOL, V2, P271, DOI [10.1037/1089-2680.2.3.271, DOI 10.1037/1089-2680.2.3.271]; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Hofman D, 2009, PSYCHOPHYSIOLOGY, V46, P1054, DOI 10.1111/j.1469-8986.2009.00849.x; Jackson DC, 2000, PSYCHOPHYSIOLOGY, V37, pS50; Jackson DC, 2003, PSYCHOL SCI, V14, P612, DOI 10.1046/j.0956-7976.2003.psci_1473.x; John OP, 2004, J PERS, V72, P1301, DOI 10.1111/j.1467-6494.2004.00298.x; Kim SH, 2007, J COGNITIVE NEUROSCI, V19, P776, DOI 10.1162/jocn.2007.19.5.776; Kincses TZ, 2004, NEUROPSYCHOLOGIA, V42, P113, DOI 10.1016/S0028-3932(03)00124-6; Koenigsberg HW, 2009, BIOL PSYCHIAT, V66, P854, DOI 10.1016/j.biopsych.2009.06.010; Kumari V, 2004, J NEUROSCI, V24, P10636, DOI 10.1523/JNEUROSCI.3206-04.2004; Kwon YH, 2008, NEUROSCI LETT, V435, P56, DOI 10.1016/j.neulet.2008.02.012; Lang N, 2005, EUR J NEUROSCI, V22, P495, DOI 10.1111/j.1460-9568.2005.04233.x; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; LANG PJ, 2001, A5 U FLOR; LARBAR KS, 2006, NAT REV NEUROSCI, V7, P54; Liebetanz D, 2002, BRAIN, V125, P2238, DOI 10.1093/brain/awf238; McCrae RR, 2004, PERS INDIV DIFFER, V36, P587, DOI 10.1016/S0191-8869(03)00118-1; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mogg K, 2007, BIOL PSYCHOL, V76, P163, DOI 10.1016/j.biopsycho.2007.07.005; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2003, J PHYSIOL-LONDON, V553, P293, DOI 10.1113/jphysiol.2003.049916; NOLENHOEKSEMA S, 1994, J PERS SOC PSYCHOL, V67, P92, DOI 10.1037/0022-3514.67.1.92; Ochsner KN, 2009, J COGNITIVE NEUROSCI, V21, P1841, DOI 10.1162/jocn.2009.21129; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; PENAGOMEZ C, 2010, HUM BRAIN MAPP C; POLANIA R, 2010, HUM BRAIN MAPP  0606; Ray RD, 2005, COGN AFFECT BEHAV NE, V5, P156, DOI 10.3758/CABN.5.2.156; Sabatinelli D, 2005, NEUROIMAGE, V24, P1265, DOI 10.1016/j.neuroimage.2004.12.015; Schwarzkopf DS, 2011, J NEUROSCI, V31, P3143, DOI 10.1523/JNEUROSCI.4863-10.2011; Silvanto J, 2008, J NEUROPHYSIOL, V99, P2725, DOI 10.1152/jn.01392.2007; Silvanto J, 2008, TRENDS COGN SCI, V12, P447, DOI 10.1016/j.tics.2008.09.004; Sotres-Bayon F, 2010, CURR OPIN NEUROBIOL, V20, P231, DOI 10.1016/j.conb.2010.02.005; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Stahl J, 2004, BRAIN COGNITION, V56, P293, DOI 10.1016/j.bandc.2004.07.004; Stocks NG, 2000, PHYS REV LETT, V84, P2310, DOI 10.1103/PhysRevLett.84.2310; Suslow T, 2010, NEUROSCIENCE, V167, P111, DOI 10.1016/j.neuroscience.2010.01.038; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Zaghi S, 2010, NEUROSCIENTIST, V16, P285, DOI 10.1177/1073858409336227	73	102	107	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22812	10.1371/journal.pone.0022812	http://dx.doi.org/10.1371/journal.pone.0022812			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829522	gold, Green Published, Green Submitted			2022-12-25	WOS:000293286500033
J	Higo, S; Hojo, Y; Ishii, H; Komatsuzaki, Y; Ooishi, Y; Murakami, G; Mukai, H; Yamazaki, T; Nakahara, D; Barron, A; Kimoto, T; Kawato, S				Higo, Shimpei; Hojo, Yasushi; Ishii, Hirotaka; Komatsuzaki, Yoshimasa; Ooishi, Yuuki; Murakami, Gen; Mukai, Hideo; Yamazaki, Takeshi; Nakahara, Daiichiro; Barron, Anna; Kimoto, Tetsuya; Kawato, Suguru			Endogenous Synthesis of Corticosteroids in the Hippocampus	PLOS ONE			English	Article							MALE-RAT HIPPOCAMPUS; CENTRAL-NERVOUS-SYSTEM; 3-BETA-HYDROXYSTEROID DEHYDROGENASE; PYRAMIDAL NEURONS; MESSENGER-RNA; STEROIDOGENIC ENZYMES; SYNAPTIC PLASTICITY; GENE-EXPRESSION; ADRENAL-CORTEX; BRAIN	Background: Brain synthesis of steroids including sex-steroids is attracting much attention. The endogenous synthesis of corticosteroids in the hippocampus, however, has been doubted because of the inability to detect deoxycorticosterone (DOC) synthase, cytochrome P450(c21). Methodology/Principal Findings: The expression of P450(c21) was demonstrated using mRNA analysis and immmunogold electron microscopic analysis in the adult male rat hippocampus. DOC production from progesterone (PROG) was demonstrated by metabolism analysis of (3)H-steroids. All the enzymes required for corticosteroid synthesis including P450(c21), P450(2D4), P450(11 beta 1) and 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) were localized in the hippocampal principal neurons as shown via in situ hybridization and immunoelectron microscopic analysis. Accurate corticosteroid concentrations in rat hippocampus were determined by liquid chromatography-tandem mass spectrometry. In adrenalectomized rats, net hippocampus-synthesized corticosterone (CORT) and DOC were determined to 6.9 and 5.8 nM, respectively. Enhanced spinogenesis was observed in the hippocampus following application of low nanomolar (10 nM) doses of CORT for 1 h. Conclusions/Significance: These results imply the complete pathway of corticosteroid synthesis of 'pregnenolone -> PROG -> DOC -> CORT' in the hippocampal neurons. Both P450(c21) and P450(2D4) can catalyze conversion of PROG to DOC. The low nanomolar level of CORT synthesized in hippocampal neurons may play a role in modulation of synaptic plasticity, in contrast to the stress effects by micromolar CORT from adrenal glands.	[Higo, Shimpei; Hojo, Yasushi; Ishii, Hirotaka; Komatsuzaki, Yoshimasa; Ooishi, Yuuki; Murakami, Gen; Mukai, Hideo; Barron, Anna; Kimoto, Tetsuya; Kawato, Suguru] Univ Tokyo, Dept Biophys & Life Sci, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan; [Hojo, Yasushi; Mukai, Hideo; Kawato, Suguru] Univ Tokyo, Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol Project, Meguro Ku, Tokyo, Japan; [Hojo, Yasushi; Murakami, Gen; Mukai, Hideo; Kawato, Suguru] Univ Tokyo, Japan Sci & Technol Agcy, Bioinformat Project, Meguro Ku, Tokyo, Japan; [Komatsuzaki, Yoshimasa] Nihon Univ, Coll Sci & Technol, Dept Phys, Chiyoda Ku, Tokyo 101, Japan; [Yamazaki, Takeshi] Hiroshima Univ, Lab Mol Brain Sci, Grad Sch Integrated Arts & Sci, Higashihiroshima 724, Japan; [Nakahara, Daiichiro] Hamamatsu Univ Sch Med, Dept Psychol, Hamamatsu, Shizuoka 4313192, Japan	University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo; Nihon University; Hiroshima University; Hamamatsu University School of Medicine	Higo, S (corresponding author), Univ Tokyo, Dept Biophys & Life Sci, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan.	kawato@bio.c.u-tokyo.ac.jp	Barron, Anna/AAT-7789-2020; Barron, Anna/C-6830-2011; Ishii, Hirotaka/ABB-1564-2020; Hojo, Yasushi/D-2964-2011	Barron, Anna/0000-0002-4715-9364; Ishii, Hirotaka/0000-0003-2044-316X; 	Japan Science and Technology Agency	Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by the Core Research for Evolutional Science and Technology Project of Japan Science and Technology Agency, and the Bioinformatics Project of Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MM, 2002, J NEUROSCI, V22, P3608; Beyenburg S, 2001, NEUROSCI LETT, V308, P111, DOI 10.1016/S0304-3940(01)01991-7; Breuner CW, 2002, J ENDOCRINOL, V175, P99, DOI 10.1677/joe.0.1750099; Davies E, 2003, CLIN EXP PHARMACOL P, V30, P437, DOI 10.1046/j.1440-1681.2003.03867.x; DIAMOND DM, 1992, HIPPOCAMPUS, V2, P421, DOI 10.1002/hipo.450020409; Do Rego JL, 2009, FRONT NEUROENDOCRIN, V30, P259, DOI 10.1016/j.yfrne.2009.05.006; DOODY KM, 1990, ENDOCRINOLOGY, V126, P2487, DOI 10.1210/endo-126-5-2487; Furukawa A, 1998, J NEUROCHEM, V71, P2231; Gago N, 2001, GLIA, V36, P295, DOI 10.1002/glia.1117; Gomez-Sanchez EP, 2005, AM J PHYSIOL-ENDOC M, V288, pE342, DOI 10.1152/ajpendo.00355.2004; GomezSanchez CE, 1996, ENDOCR RES, V22, P463, DOI 10.1080/07435809609043732; GomezSanchez CE, 1997, ENDOCRINOLOGY, V138, P3369, DOI 10.1210/en.138.8.3369; Guennoun R, 1997, EUR J NEUROSCI, V9, P2236, DOI 10.1111/j.1460-9568.1997.tb01642.x; Hassan AHS, 1996, EXP NEUROL, V140, P43, DOI 10.1006/exnr.1996.0113; Higo S, 2009, BIOCHEM BIOPH RES CO, V385, P62, DOI 10.1016/j.bbrc.2009.05.005; Hiroi T, 2001, ENDOCRINOLOGY, V142, P3901, DOI 10.1210/en.142.9.3901; Hojo Y, 2004, P NATL ACAD SCI USA, V101, P865, DOI 10.1073/pnas.2630225100; Hojo Y, 2008, MOL CELL ENDOCRINOL, V290, P31, DOI 10.1016/j.mce.2008.04.017; Hojo Y, 2009, ENDOCRINOLOGY, V150, P5106, DOI 10.1210/en.2009-0305; Ibanez C, 2003, ENDOCRINOLOGY, V144, P2902, DOI 10.1210/en.2002-0073; Ishida A, 2005, CELL METAB, V2, P297, DOI 10.1016/j.cmet.2005.09.009; Kawato S, 2002, METHOD ENZYMOL, V357, P241; Kimoto T, 2001, ENDOCRINOLOGY, V142, P3578, DOI 10.1210/en.142.8.3578; Kimoto T, 2010, ENDOCRINOLOGY, V151, P5795, DOI 10.1210/en.2010-0581; Kishimoto W, 2004, ENDOCRINOLOGY, V145, P699, DOI 10.1210/en.2003-1109; Komatsuzaki Y, 2005, BIOCHEM BIOPH RES CO, V335, P1002, DOI 10.1016/j.bbrc.2005.07.173; MacKenzie SM, 2000, J MOL ENDOCRINOL, V24, P321, DOI 10.1677/jme.0.0240321; MCEWEN BS, 1986, PHYSIOL REV, V66, P1121, DOI 10.1152/physrev.1986.66.4.1121; Mukai H, 2011, CEREBRAL CO IN PRESS; Mukai H, 2006, NEUROENDOCRINOLOGY, V84, P255, DOI 10.1159/000097747; Mukai H, 2010, BBA-GEN SUBJECTS, V1800, P1030, DOI 10.1016/j.bbagen.2009.11.002; Nakahara D, 2003, P NATL ACAD SCI USA, V100, P9584, DOI 10.1073/pnas.1631069100; OGISHIMA T, 1992, ENDOCRINOLOGY, V130, P2971, DOI 10.1210/en.130.5.2971; Pelletier G, 2004, MOL BRAIN RES, V125, P143, DOI 10.1016/j.molbrainres.2004.02.020; REIHELD CT, 1984, BRAIN RES BULL, V12, P349, DOI 10.1016/0361-9230(84)90102-3; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; Revest JM, 2005, NAT NEUROSCI, V8, P664, DOI 10.1038/nn1441; SAPOLSKY RM, 1985, J NEUROSCI, V5, P1222; Shinohara Y, 2008, P NATL ACAD SCI USA, V105, P19498, DOI 10.1073/pnas.0807461105; SHINZAWA K, 1988, J ENDOCRINOL, V119, P191, DOI 10.1677/joe.0.1190191; STAPLETON G, 1995, J BIOL CHEM, V270, P29739, DOI 10.1074/jbc.270.50.29739; STROMSTEDT M, 1995, MOL BRAIN RES, V34, P75, DOI 10.1016/0169-328X(95)00140-N; Tsurugizawa T, 2005, BIOCHEM BIOPH RES CO, V337, P1345, DOI 10.1016/j.bbrc.2005.09.188; Windle RJ, 1997, ENDOCRINOLOGY, V138, P3741, DOI 10.1210/en.138.9.3741; WOOLLEY CS, 1990, BRAIN RES, V531, P225, DOI 10.1016/0006-8993(90)90778-A; Ye P, 2008, J ENDOCRINOL, V196, P305, DOI 10.1677/JOE-07-0439	46	20	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e21631	10.1371/journal.pone.0021631	http://dx.doi.org/10.1371/journal.pone.0021631			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829438	gold, Green Published, Green Submitted			2022-12-25	WOS:000293284600006
J	Gharahkhani, P; O'Leary, CA; Kyaw-Tanner, M; Sturm, RA; Duffy, DL				Gharahkhani, Puya; O'Leary, Caroline A.; Kyaw-Tanner, Myat; Sturm, Richard A.; Duffy, David L.			A Non-Synonymous Mutation in the Canine Pkd1 Gene Is Associated with Autosomal Dominant Polycystic Kidney Disease in Bull Terriers	PLOS ONE			English	Article							FOCAL ADHESION KINASE; DUPLICATED REGION; EXPRESSION; MIGRATION; DEFECTS; PRODUCT; CALCIUM; PROTEIN; CELLS; LIVER	Polycystic Kidney Disease is an autosomal dominant disease common in some lines of Bull Terriers (BTPKD). The disease is linked to the canine orthologue of human PKD1 gene, Pkd1, located on CFA06, but no disease-associated mutation has been reported. This study sequenced genomic DNA from two Bull Terriers with BTPKD and two without the disease. A non-synonymous G>A transition mutation in exon 29 of Pkd1 was identified. A TaqMan (R) SNP Genotyping Assay was designed and demonstrated the heterozygous detection of the mutation in 47 Bull Terriers with BTPKD, but not in 102 Bull Terriers over one year of age and without BTPKD. This missense mutation replaces a glutamic acid residue with a lysine residue in the predicted protein, Polycystin 1. This region of Polycystin 1 is highly conserved between species, and is located in the first cytoplasmic loop of the predicted protein structure, close to the PLAT domain and the second transmembrane region. Thus, this change could alter Polycystin 1 binding or localization. Analytic programs PolyPhen 2, Align GVGD and SIFT predict this mutation to be pathogenic. Thus, BTPKD is associated with a missense mutation in Pkd1, and the application of this mutation specific assay could reduce disease transmission by allowing diagnosis of disease in young animals prior to breeding.	[Gharahkhani, Puya; Kyaw-Tanner, Myat] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia; [O'Leary, Caroline A.] Univ Queensland, Ctr Compan Anim Hlth, Brisbane, Qld, Australia; [Sturm, Richard A.] Univ Queensland, Melanogenix Grp, Inst Mol Biosci, Brisbane, Qld, Australia; [Duffy, David L.] Queensland Inst Med Res, Epidemiol Grp, Brisbane, Qld 4006, Australia	University of Queensland; University of Queensland; University of Queensland; QIMR Berghofer Medical Research Institute	Gharahkhani, P (corresponding author), Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia.	c.oleary@uq.edu.au	Sturm, Richard A/C-9943-2009; Gharahkhani, Puya/AAA-6912-2020; Duffy, David L/B-7392-2013	Sturm, Richard A/0000-0003-1301-0294; Gharahkhani, Puya/0000-0002-4203-5952; Duffy, David L/0000-0001-7227-632X	John and Mary Kibble Trust; Australian Companion Animal Health Foundation	John and Mary Kibble Trust; Australian Companion Animal Health Foundation	This study was funded by The John and Mary Kibble Trust Fund (http://www.anz.com/resources/c/d/cdc6a8004e4a39bea473af93c5571dd1/PB-Kibble-Biography.pdf?CACHEID = 33cdf5804e472d66997fbd6672659df2), and Australian Companion Animal Health Foundation (http://www.ava.com.au/about-us/trusts-and-foundations-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal AR, 2000, GENET TEST, V4, P365, DOI 10.1089/109065700750065108; Angers-Loustau A, 1999, J CELL BIOL, V144, P1019, DOI 10.1083/jcb.144.5.1019; Beck C, 2001, AUST VET J, V79, P181, DOI 10.1111/j.1751-0813.2001.tb14573.x; Brasier JL, 1997, J CLIN INVEST, V99, P194, DOI 10.1172/JCI119147; BURROWS AK, 1994, J SMALL ANIM PRACT, V35, P364, DOI 10.1111/j.1748-5827.1994.tb01719.x; Cary LA, 1998, J CELL BIOL, V140, P211, DOI 10.1083/jcb.140.1.211; Chauvet V, 2002, AM J PATHOL, V160, P973, DOI 10.1016/S0002-9440(10)64919-X; COWLEY BD, 1993, KIDNEY INT, V43, P522, DOI 10.1038/ki.1993.79; DALGAARD O. Z., 1957, ACTA MED SCAND SUPPL, V158, P1; Dannemann N, 2010, INT J CANCER, V127, P239, DOI 10.1002/ijc.25012; ELLES RG, 1994, J MED GENET, V31, P115, DOI 10.1136/jmg.31.2.115; Geng L, 1997, AM J PHYSIOL-RENAL, V272, pF451, DOI 10.1152/ajprenal.1997.272.4.F451; Geng L, 2000, BBA-MOL BASIS DIS, V1535, P21, DOI 10.1016/S0925-4439(00)00079-X; Gilmore AP, 1996, MOL BIOL CELL, V7, P1209, DOI 10.1091/mbc.7.8.1209; Hanks SK, 1997, BIOESSAYS, V19, P137, DOI 10.1002/bies.950190208; HUGNET C, 2007, POLYCYSTIC KIDNEY DI, P57; Lantinga-van Leeuwen IS, 2004, HUM MOL GENET, V13, P3069, DOI 10.1093/hmg/ddh336; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Lu WN, 1997, NAT GENET, V17, P179, DOI 10.1038/ng1097-179; Lu WN, 2001, HUM MOL GENET, V10, P2385, DOI 10.1093/hmg/10.21.2385; Lyons LA, 2004, J AM SOC NEPHROL, V15, P2548, DOI 10.1097/01.ASN.0000141776.38527.BB; Ma L, 2009, J BIOL CHEM, V284, P32942, DOI 10.1074/jbc.M109.021832; McAloose D, 1998, VET PATHOL, V35, P77, DOI 10.1177/030098589803500110; MCKENNA SC, 1980, VET PATHOL, V17, P436, DOI 10.1177/030098588001700405; Mellersh CS, 2000, MAMM GENOME, V11, P120, DOI 10.1007/s003350010024; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; O'Leary CA, 2009, ANIM GENET, V40, P543, DOI 10.1111/j.1365-2052.2009.01863.x; O'Leary CA, 2004, J SMALL ANIM PRACT, V45, P563, DOI 10.1111/j.1748-5827.2004.tb00205.x; O'Leary CA, 2003, ANIM GENET, V34, P358, DOI 10.1046/j.1365-2052.2003.01013.x; O'Leary CA, 1999, AUST VET J, V77, P361, DOI 10.1111/j.1751-0813.1999.tb10304.x; Palsson R, 1996, MOL MED, V2, P702, DOI 10.1007/BF03401654; Peltola P, 2005, J MOL MED, V83, P638, DOI 10.1007/s00109-005-0644-6; Perrichot R, 2000, EUR J HUM GENET, V8, P353, DOI 10.1038/sj.ejhg.5200459; Pritchard L, 2000, HUM MOL GENET, V9, P2617, DOI 10.1093/hmg/9.18.2617; Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6; RAVINE D, 1994, LANCET, V343, P824, DOI 10.1016/S0140-6736(94)92026-5; Rossetti S, 2002, KIDNEY INT, V61, P1588, DOI 10.1046/j.1523-1755.2002.00326.x; Rossetti S, 2001, AM J HUM GENET, V68, P46, DOI 10.1086/316939; Rossetti S, 2007, J AM SOC NEPHROL, V18, P2143, DOI 10.1681/ASN.2006121387; Rossetti S, 2009, KIDNEY INT, V75, P848, DOI 10.1038/ki.2008.686; Strachan T., 2004, HUM MOL GENET, V3; Szczesna-Cordary D, 2007, FASEB J, V21, P3974, DOI 10.1096/fj.07-8630com; Tavtigian SV, 2008, HUM MUTAT, V29, P1342, DOI 10.1002/humu.20896; Wilson PD, 2001, J AM SOC NEPHROL, V12, P834, DOI 10.1681/ASN.V124834; Wilson PD, 1999, LAB INVEST, V79, P1311; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119	46	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22455	10.1371/journal.pone.0022455	http://dx.doi.org/10.1371/journal.pone.0022455			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818326	gold, Green Published			2022-12-25	WOS:000293282700031
J	LaFerriere, H; Ostrowski, D; Guarnieri, DJ; Zars, T				LaFerriere, Holly; Ostrowski, Daniela; Guarnieri, Douglas J.; Zars, Troy			The arouser EPS8L3 Gene Is Critical for Normal Memory in Drosophila	PLOS ONE			English	Article							ETHANOL SENSITIVITY; TERM-MEMORY; DISSOCIATION; EXPRESSION; PARADIGM; OPERANT	The genetic mechanisms that influence memory formation and sensitivity to the effects of ethanol on behavior in Drosophila have some common elements. So far, these have centered on the cAMP/PKA signaling pathway, synapsin and fas2-dependent processes, pumilio-dependent regulators of translation, and a few other genes. However, there are several genes that are important for one or the other behaviors, suggesting that there is an incomplete overlap in the mechanisms that support memory and ethanol sensitive behaviors. The basis for this overlap is far from understood. We therefore examined memory in arouser (aru) mutant flies, which have recently been identified as having ethanol sensitivity deficits. The aru mutant flies showed memory deficits in both short-term place memory and olfactory memory tests. Flies with a revertant aru allele had wild-type levels of memory performance, arguing that the aru gene, encoding an EPS8L3 product, has a role in Drosophila memory formation. Furthermore, and interestingly, flies with the aru(8-128) insertion allele had deficits in only one of two genetic backgrounds in place and olfactory memory tests. Flies with an aru imprecise excision allele had deficits in tests of olfactory memory. Quantitative measurements of aru EPS8L3 mRNA expression levels correlate decreased expression with deficits in olfactory memory while over expression is correlated with place memory deficits. Thus, mutations of the aru EPS8L3 gene interact with the alleles of a particular genetic background to regulate arouser expression and reveals a role of this gene in memory.	[LaFerriere, Holly; Ostrowski, Daniela; Zars, Troy] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Guarnieri, Douglas J.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	University of Missouri System; University of Missouri Columbia; University of California System; University of California San Francisco	LaFerriere, H (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	zarst@missouri.edu		Zars, Troy/0000-0003-4114-9322	National Science Foundation [IOS 0613708]; MU Research Board	National Science Foundation(National Science Foundation (NSF)); MU Research Board	This study was supported by grants from the National Science Foundation (IOS 0613708) and the MU Research Board. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger KH, 2008, ALCOHOL CLIN EXP RES, V32, P895, DOI 10.1111/j.1530-0277.2008.00659.x; Cheng YZ, 2001, CELL, V105, P757, DOI 10.1016/S0092-8674(01)00386-5; DALBY B, 1995, GENETICS, V139, P757; deBelle JS, 1996, P NATL ACAD SCI USA, V93, P9875, DOI 10.1073/pnas.93.18.9875; Diegelmann S, 2006, LEARN MEMORY, V13, P72, DOI 10.1101/lm.45506; Eddison M, 2011, NEURON, V70, P979, DOI 10.1016/j.neuron.2011.03.030; Galili DS, 2011, J NEUROSCI, V31, P7240, DOI 10.1523/JNEUROSCI.6667-10.2011; Gioia A, 2009, J COMP PHYSIOL A, V195, P777, DOI 10.1007/s00359-009-0455-2; Godenschwege TA, 2004, EUR J NEUROSCI, V20, P611, DOI 10.1111/j.1460-9568.2004.03527.x; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Knapek S, 2010, LEARN MEMORY, V17, P76, DOI 10.1101/lm.1661810; LAFAVE MC, 2011, GENETICS; LaFerriere H, 2008, GENETICS, V178, P1895, DOI 10.1534/genetics.107.084582; McGuire SE, 2005, PROG NEUROBIOL, V76, P328, DOI 10.1016/j.pneurobio.2005.09.003; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; Offenhauser N, 2006, CELL, V127, P213, DOI 10.1016/j.cell.2006.09.011; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Putz G, 2004, J NEUROSCI, V24, P9745, DOI 10.1523/JNEUROSCI.3211-04.2004; Putz G, 2002, LEARN MEMORY, V9, P349, DOI 10.1101/lm.50402; Sitaraman D, 2008, P NATL ACAD SCI USA, V105, P5579, DOI 10.1073/pnas.0710168105; Sitaraman D, 2007, J COMP PHYSIOL A, V193, P903, DOI 10.1007/s00359-007-0243-9; Sitaraman D, 2010, J COMP PHYSIOL A, V196, P299, DOI 10.1007/s00359-010-0517-5; Tanimoto H, 2004, NATURE, V430, P983, DOI 10.1038/430983a; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Wustmann G, 1996, J COMP PHYSIOL A, V179, P429, DOI 10.1007/BF00194996; Zars M, 2006, J COMP PHYSIOL A, V192, P727, DOI 10.1007/s00359-006-0109-6; Zars M, 2009, NATURWISSENSCHAFTEN, V96, P927, DOI 10.1007/s00114-009-0550-9; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672; Zars T, 2000, LEARN MEMORY, V7, P18, DOI 10.1101/lm.7.1.18; Zars T, 2001, J COMP PHYSIOL A, V187, P235, DOI 10.1007/s003590100194; Zars T, 2010, LEARN MEMORY, V17, P246, DOI 10.1101/lm.1706110; Zars T, 2010, NEURON, V65, P442, DOI 10.1016/j.neuron.2010.02.009; Zars T, 2009, J NEUROGENET, V23, P104, DOI 10.1080/01677060802441364	33	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22867	10.1371/journal.pone.0022867	http://dx.doi.org/10.1371/journal.pone.0022867			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818402	gold, Green Published, Green Submitted			2022-12-25	WOS:000293282700086
J	Pietrella, D; Rachini, A; Pines, M; Pandey, N; Mosci, P; Bistoni, F; d'Enfert, C; Vecchiarelli, A				Pietrella, Donatella; Rachini, Anna; Pines, Mark; Pandey, Neelam; Mosci, Paolo; Bistoni, Francesco; d'Enfert, Cristophe; Vecchiarelli, Anna			Th17 Cells and IL-17 in Protective Immunity to Vaginal Candidiasis	PLOS ONE			English	Article							HOST-DEFENSE; T-CELLS; PHENOTYPICALLY DISTINCT; HALOFUGINONE; BETA; VAGINITIS; RECEPTOR; THERAPY; INTERLEUKIN-17; LYMPHOCYTES	Background: Th17 cells play a major role in coordinating the host defence in oropharyngeal candidiasis. In this study we investigated the involvement of the Th17 response in an animal model of vulvovaginal candidiasis (VVC). Methods: To monitor the course of infection we exploited a new in vivo imaging technique. Results: i) The progression of VVC leads to a strong influx of neutrophils in the vagina soon after the challenge which persisted despite the resolution of infection; ii) IL-17, produced by vaginal cells, particularly CD4 T cells, was detected in the vaginal wash during the infection, reaching a maximum 14 days after the challenge; iii) The amount and kinetics of IL-23 in vaginal fluids were comparable to those in vaginal cells; iv) The inhibition of Th17 differentiation led to significant inhibition of IL-17 production with consequent exacerbation of infection; v) An increased production of bdefensin 2 was manifested in cells of infected mice. This production was strongly reduced when Th17 differentiation was inhibited and was increased by rIL-17 treatment. Conclusions: These results imply that IL-17 and Th17, along with innate antimicrobial factors, have a role in the immune response to vaginal candidiasis.	[Pietrella, Donatella; Rachini, Anna; Pandey, Neelam; Bistoni, Francesco; Vecchiarelli, Anna] Univ Perugia, Dept Expt Med & Biochem Sci, Microbiol Sect, I-06100 Perugia, Italy; [Pines, Mark] Agr Res Org, Volcani Ctr, Inst Anim Sci, IL-50250 Bet Dagan, Israel; [Mosci, Paolo] Univ Perugia, Internal Med Sect, Dept Vet Pathol, I-06100 Perugia, Italy; [Mosci, Paolo] Univ Perugia, Diagnost & Vet Clin, I-06100 Perugia, Italy; [d'Enfert, Cristophe] Inst Pasteur, Unite Biol & Pathogenicite Fong, Paris, France; [d'Enfert, Cristophe] INRA, USC2019, Paris, France	University of Perugia; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; University of Perugia; University of Perugia; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; INRAE	Pietrella, D (corresponding author), Univ Perugia, Dept Expt Med & Biochem Sci, Microbiol Sect, I-06100 Perugia, Italy.	vecchiar@unipg.it		Vecchiarelli, Anna/0000-0002-3185-6720; mosci, paolo/0000-0002-1934-9662; d'Enfert, Christophe/0000-0002-6235-3886; Pietrella, Donatella/0000-0003-1572-4290	European Commission [PITN-GA-2008-214004]; Fondazione Cassa Risparmio Perugia [2009.010.0492]	European Commission(European CommissionEuropean Commission Joint Research Centre); Fondazione Cassa Risparmio Perugia(Fondazione Cassa Risparmio Perugia)	This study was funded by the European Commission (FINSysB Marie Curie Initial Training 16 Network, PITN-GA-2008-214004) and by a grant from Fondazione Cassa Risparmio Perugia 2009.010.0492. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Auja SJ, 2007, SEMIN IMMUNOL, V19, P377, DOI 10.1016/j.smim.2007.10.009; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Cassone A, 2007, INFECT IMMUN, V75, P4675, DOI 10.1128/IAI.00083-07; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; De Bernardis F, 2006, INFECT IMMUN, V74, P4282, DOI 10.1128/IAI.01714-05; Elkin M, 2000, FASEB J, V14, P2477, DOI 10.1096/fj.00-0292com; Enjalbert B, 2009, INFECT IMMUN, V77, P4847, DOI 10.1128/IAI.00223-09; Fantini MC, 2007, INFLAMM BOWEL DIS, V13, P1419, DOI 10.1002/ibd.20212; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Fidel PL, 2007, AM J REPROD IMMUNOL, V57, P2, DOI 10.1111/j.1600-0897.2006.00450.x; Fidel Paul L Jr, 2005, Curr Opin Infect Dis, V18, P107; Fidel PL, 1996, INFECT IMMUN, V64, P3793, DOI 10.1128/IAI.64.9.3793-3799.1996; Fidel PL, 2004, TRENDS MICROBIOL, V12, P220, DOI 10.1016/j.tim.2004.03.006; Fidel PL, 1996, CLIN MICROBIOL REV, V9, P335, DOI 10.1128/CMR.9.3.335; Fidel PL, 1999, INFECT IMMUN, V67, P3135, DOI 10.1128/IAI.67.6.3135-3140.1999; Ganz T, 2002, SCIENCE, V298, P977, DOI 10.1126/science.1078708; Ganz T, 1999, SCIENCE, V286, P420, DOI 10.1126/science.286.5439.420; Godinez I, 2008, INFECT IMMUN, V76, P2008, DOI 10.1128/IAI.01691-07; Gupta SM, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/534532; Han JH, 2010, CYTOKINE, V49, P209, DOI 10.1016/j.cyto.2009.09.005; Happel KI, 2003, J IMMUNOL, V170, P4432, DOI 10.4049/jimmunol.170.9.4432; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; IBRAGHIMOV AR, 1995, INT IMMUNOL, V7, P1763, DOI 10.1093/intimm/7.11.1763; Ildgruben AK, 2003, OBSTET GYNECOL, V102, P571, DOI 10.1016/S0029-7844(03)00618-5; Iwakura Y, 2006, J CLIN INVEST, V116, P1218, DOI 10.1172/JCI28508; Levitz SM, 2009, CELL HOST MICROBE, V5, P311, DOI 10.1016/j.chom.2009.04.004; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Magliani W, 2002, TRENDS MOL MED, V8, P121, DOI 10.1016/S1471-4914(01)02268-7; Matsuzaki G, 2007, MICROBIOL IMMUNOL, V51, P1139, DOI 10.1111/j.1348-0421.2007.tb04008.x; Miyahara Y, 2008, P NATL ACAD SCI USA, V105, P15505, DOI 10.1073/pnas.0710686105; Naglik JR, 2008, FEMS MICROBIOL LETT, V283, P129, DOI 10.1111/j.1574-6968.2008.01160.x; NANDI D, 1991, J IMMUNOL, V147, P1773; Nomanbhoy F, 2002, INFECT IMMUN, V70, P7081, DOI 10.1128/IAI.70.12.7081-7088.2002; Pietrella D, 2010, VACCINE, V28, P1717, DOI 10.1016/j.vaccine.2009.12.021; Pines M, 2000, DRUG DEVELOP RES, V50, P371, DOI 10.1002/1098-2299(200007/08)50:3/4<371::AID-DDR19>3.0.CO;2-R; Pines M, 2008, EXPERT OPIN DRUG DIS, V3, P11, DOI 10.1517/17460441.3.1.11; Pirofski LA, 2009, J EXP MED, V206, P269, DOI 10.1084/jem.20090093; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; Saavedra M, 1999, INFECT IMMUN, V67, P5820, DOI 10.1128/IAI.67.11.5820-5826.1999; Shen F, 2008, CYTOKINE, V41, P92, DOI 10.1016/j.cyto.2007.11.013; Sobel JD, 2007, LANCET, V369, P1961, DOI 10.1016/S0140-6736(07)60917-9; Sundrud MS, 2009, SCIENCE, V324, P1334, DOI 10.1126/science.1172638; Taylor BN, 2000, MED MYCOL, V38, P419, DOI 10.1080/714030969; Yano J, 2010, INFECT IMMUN, V78, P5126, DOI 10.1128/IAI.00388-10	47	87	95	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22770	10.1371/journal.pone.0022770	http://dx.doi.org/10.1371/journal.pone.0022770			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818387	Green Published, gold, Green Submitted			2022-12-25	WOS:000293282700074
J	Xia, HJ; Suda, S; Bindom, S; Feng, YM; Gurley, SB; Seth, D; Navar, LG; Lazartigues, E				Xia, Huijing; Suda, Sonia; Bindom, Sharell; Feng, Yumei; Gurley, Susan B.; Seth, Dale; Navar, L. Gabriel; Lazartigues, Eric			ACE2-Mediated Reduction of Oxidative Stress in the Central Nervous System Is Associated with Improvement of Autonomic Function	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; SPONTANEOUSLY HYPERTENSIVE-RATS; II INFUSED RATS; BLOOD-PRESSURE; SUPEROXIDE-PRODUCTION; NADPH OXIDASE; NITRIC-OXIDE; LIFE-SPAN; CARDIOVASCULAR REGULATION; SIGNALING PATHWAY	Oxidative stress in the central nervous system mediates the increase in sympathetic tone that precedes the development of hypertension. We hypothesized that by transforming Angiotensin-II (AngII) into Ang-(1-7), ACE2 might reduce AngII-mediated oxidative stress in the brain and prevent autonomic dysfunction. To test this hypothesis, a relationship between ACE2 and oxidative stress was first confirmed in a mouse neuroblastoma cell line (Neuro2A cells) treated with AngII and infected with Ad-hACE2. ACE2 overexpression resulted in a reduction of reactive oxygen species (ROS) formation. In vivo, ACE2 knockout (ACE2(-/y)) mice and non-transgenic (NT) littermates were infused with AngII (10 days) and infected with Ad-hACE2 in the paraventricular nucleus (PVN). Baseline blood pressure (BP), AngII and brain ROS levels were not different between young mice (12 weeks). However, cardiac sympathetic tone, brain NADPH oxidase and SOD activities were significantly increased in ACE2(-/y). Post infusion, plasma and brain AngII levels were also significantly higher in ACE2(-/y), although BP was similarly increased in both genotypes. ROS formation in the PVN and RVLM was significantly higher in ACE2(-/y) mice following AngII infusion. Similar phenotypes, i.e. increased oxidative stress, exacerbated dysautonomia and hypertension, were also observed on baseline in mature ACE2(-/y) mice (48 weeks). ACE2 gene therapy to the PVN reduced AngII-mediated increase in NADPH oxidase activity and normalized cardiac dysautonomia in ACE2(-/y) mice. Altogether, these data indicate that ACE2 gene deletion promotes age-dependent oxidative stress, autonomic dysfunction and hypertension, while PVN-targeted ACE2 gene therapy decreases ROS formation via NADPH oxidase inhibition and improves autonomic function. Accordingly, ACE2 could represent a new target for the treatment of hypertension-associated dysautonomia and oxidative stress.	[Xia, Huijing; Suda, Sonia; Bindom, Sharell; Feng, Yumei; Lazartigues, Eric] Louisiana State Univ, Dept Pharmacol & Expt Therapeut, Hlth Sci Ctr, New Orleans, LA 70112 USA; [Xia, Huijing; Suda, Sonia; Bindom, Sharell; Feng, Yumei; Lazartigues, Eric] Louisiana State Univ, Cardiovasc Ctr Excellence, Hlth Sci Ctr, New Orleans, LA USA; [Feng, Yumei; Seth, Dale; Navar, L. Gabriel] Tulane Univ, Sch Med, Dept Physiol Hypertens, New Orleans, LA 70112 USA; [Feng, Yumei; Seth, Dale; Navar, L. Gabriel] Tulane Univ, Sch Med, Renal Ctr Excellence, New Orleans, LA 70112 USA; [Gurley, Susan B.] Duke Univ, Sch Med, Dept Med, Div Nephrol, Durham, NC 27706 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Tulane University; Tulane University; Duke University	Xia, HJ (corresponding author), Louisiana State Univ, Dept Pharmacol & Expt Therapeut, Hlth Sci Ctr, New Orleans, LA 70112 USA.	elazar@lsuhsc.edu		Lazartigues, Eric/0000-0001-7290-0786	American Physiological Society; American Heart Association; NIH [NS052479, RR018766, HL093178, RR0117659]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018766] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093178] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103514] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS052479] Funding Source: NIH RePORTER	American Physiological Society; American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Postdoctoral Fellowships from the American Physiological Society to Dr. Huijing Xia, the American Heart Association to Dr. Yumei Feng, NIH grants NS052479, RR018766 and HL093178 to Dr. Eric Lazartigues and RR0117659 to Dr. LG. Navar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsham AM, 2003, J BIOL CHEM, V278, P29655, DOI 10.1074/jbc.M212770200; Benter IF, 2008, AM J NEPHROL, V28, P25, DOI 10.1159/000108758; Blagosklonny MV, 2008, CELL CYCLE, V7, P3344, DOI 10.4161/cc.7.21.6965; Chapleau MW, 2001, ANN NY ACAD SCI, V940, pXIII; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Davisson RL, 2003, AM J PHYSIOL-REG I, V285, pR498, DOI 10.1152/ajpregu.00190.2003; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Doobay MF, 2007, AM J PHYSIOL-REG I, V292, pR373, DOI 10.1152/ajpregu.00292.2006; Erdos B, 2006, J HYPERTENS, V24, P109, DOI 10.1097/01.hjh.0000198026.99600.59; Feng YM, 2008, CIRC RES, V102, P729, DOI 10.1161/CIRCRESAHA.107.169110; Feng YM, 2010, CIRC RES, V106, P373, DOI 10.1161/CIRCRESAHA.109.208645; Fujita M, 2007, HYPERTENSION, V50, P360, DOI 10.1161/HYPERTENSIONAHA.107.091009; Gallagher PE, 2008, AM J PHYSIOL-CELL PH, V295, pC1169, DOI 10.1152/ajpcell.00145.2008; Gallagher PE, 2008, AM J PHYSIOL-HEART C, V295, pH2373, DOI 10.1152/ajpheart.00426.2008; Gao L, 2004, CIRC RES, V95, P937, DOI 10.1161/01.RES.0000146676.04359.64; Gironacci MM, 2004, HYPERTENSION, V44, P783, DOI 10.1161/01.HYP.0000143850.73831.9d; Gurley SB, 2008, EXP PHYSIOL, V93, P538, DOI 10.1113/expphysiol.2007.040014; Gurley SB, 2006, J CLIN INVEST, V116, P2218, DOI 10.1172/JCI16980; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Gwathmey TM, 2010, HYPERTENSION, V55, P166, DOI 10.1161/HYPERTENSIONAHA.109.141622; Hafizi S, 2004, AM J PHYSIOL-HEART C, V287, pH1232, DOI 10.1152/ajpheart.00040.2004; Harrison DG, 2009, MED CLIN N AM, V93, P621, DOI 10.1016/j.mcna.2009.02.015; Hirooka Y, 2010, CIRC J, V74, P827, DOI 10.1253/circj.CJ-10-0153; Hitomi H, 2007, CURR OPIN CARDIOL, V22, P311, DOI 10.1097/HCO.0b013e3281532b53; Hsieh CC, 2010, AGING-US, V2, P582, DOI 10.18632/aging.100194; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kim-Mitsuyama S, 2005, STROKE, V36, P1077, DOI 10.1161/01.STR.0000163084.16505.e3; Kishi T, 2004, CIRCULATION, V109, P2357, DOI 10.1161/01.CIR.0000128695.49900.12; Kyaw M, 2004, ACTA PHARMACOL SIN, V25, P977; Li P, 1997, HYPERTENSION, V29, P394, DOI 10.1161/01.HYP.29.1.394; Lin ZY, 2008, EXP PHYSIOL, V93, P676, DOI 10.1113/expphysiol.2007.041657; Oudit GY, 2007, CARDIOVASC RES, V75, P29, DOI 10.1016/j.cardiores.2007.04.007; Pan YX, 2007, HYPERTENSION, V49, P519, DOI 10.1161/01.HYP.0000256955.74461.93; Polizio AH, 2007, PHARMACOL RES, V56, P86, DOI 10.1016/j.phrs.2007.04.004; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Sampaio WO, 2007, HYPERTENSION, V49, P185, DOI 10.1161/01.HYP.0000251865.35728.2f; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Vickers C, 2002, J BIOL CHEM, V277, P14838, DOI 10.1074/jbc.M200581200; Vinciguerra M, 2010, AGING-US, V2, P43; Wang G, 2004, J NEUROSCI, V24, P5516, DOI 10.1523/JNEUROSCI.1176-04.2004; Whitaker A, 2007, FASEB J, V21, pA889; Xia HJ, 2009, HYPERTENSION, V53, P210, DOI 10.1161/HYPERTENSIONAHA.108.123844; Yamamoto K, 2006, HYPERTENSION, V47, P718, DOI 10.1161/01.HYP.0000205833.89478.5b; Yamazato M, 2007, HYPERTENSION, V49, P926, DOI 10.1161/01.HYP.0000259942.38108.20; Yang RF, 2011, AM J PHYSIOL-CELL PH, V300, pC58, DOI 10.1152/ajpcell.00369.2010; Zhong JC, 2008, BRIT J PHARMACOL, V153, P66, DOI 10.1038/sj.bjp.0707482; Zimmerman MC, 2004, CIRC RES, V95, P532, DOI 10.1161/01.RES.0000139957.22530.b9; Zimmerman MC, 2004, CIRC RES, V95, P210, DOI 10.1161/01.RES.0000135483.12297.e4; Zou LX, 1998, AM J HYPERTENS, V11, P570, DOI 10.1016/S0895-7061(97)00410-X; Zou LX, 1996, HYPERTENSION, V27, P658, DOI 10.1161/01.HYP.27.3.658	52	72	81	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22682	10.1371/journal.pone.0022682	http://dx.doi.org/10.1371/journal.pone.0022682			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818366	Green Published, Green Submitted, gold			2022-12-25	WOS:000293282700059
J	Yang, Q; Xu, SQ; Li, XF; Wang, B; Wang, XP; Ma, DX; Yang, L; Peng, J; Hou, M				Yang, Qing; Xu, Shuqian; Li, Xiaofang; Wang, Bo; Wang, Xuping; Ma, Daoxin; Yang, Lei; Peng, Jun; Hou, Ming			Pathway of Toll-Like Receptor 7/B Cell Activating Factor/B Cell Activating Factor Receptor Plays a Role in Immune Thrombocytopenia In Vivo	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; B-CELLS; BAFF-R; RHEUMATOID-ARTHRITIS; MULTIPLE-SCLEROSIS; DENDRITIC CELLS; PURPURA ITP; TNF FAMILY; IFN-BETA; EXPRESSION	Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by anti-platelet autoantibody-mediated platelet destruction. Antigen-presenting cell (APC) dysfunction is considered to play crucial roles in ITP. However, how APC affects autoreactive B cells in ITP is still unknown. Using a mouse model of immune thrombocytopenia, we demonstrated an increase in levels of TLR7 in splenic mononuclear cells (SMCs). Using both TLR7 agonist and TLR7 silencing lentivirus, we found stimulation of TLR7 decreased platelet counts and increased levels of platelet-associated IgG (PAIgG) in ITP mice, which correlates TLR7 with platelet destruction by autoantibodies. Levels of serum BAFF increased significantly in ITP mice and stimulation of TLR7 promoted secretion of BAFF. Among the three BAFF receptors, only BAFF receptor (BAFF-R) increased in ITP mice. However, activation of TLR7 showed no effect on the expression of BAFF receptors. These findings indicate that upregulation of TLR7 may augment BAFF secretion by APC and through ligation of BAFF-R promote autoreactive B cell survival and thus anti-platelet autoantibody production. The pathway of TLR7/BAFF/BAFF-R provides us with an explanation of how activation of APC affects autoantibody production by B cells in ITP and thus might provide a reasonable therapeutic strategy for ITP.	[Yang, Qing] Shandong Univ, Dept Parasitol, Sch Med, Jinan 250100, Peoples R China; [Yang, Qing; Xu, Shuqian; Ma, Daoxin; Yang, Lei; Peng, Jun; Hou, Ming] Shandong Univ, Haematol Oncol Ctr, Qilu Hosp, Jinan 250100, Peoples R China; [Yang, Qing; Wang, Bo; Wang, Xuping] Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan 250100, Peoples R China; [Yang, Qing; Wang, Bo; Wang, Xuping] Shandong Univ, Chinese Minist Publ Hlth, Qilu Hosp, Jinan 250100, Peoples R China; [Li, Xiaofang] So Med Univ, Dept Hematol, Nanfang Hosp, Guangzhou, Peoples R China; [Wang, Bo] Shandong Univ, Qilu Hosp, Dept Tradit Chinese Med, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University; Southern Medical University - China; Shandong University	Yang, Q (corresponding author), Shandong Univ, Dept Parasitol, Sch Med, Jinan 250100, Peoples R China.	houming@medmail.com.cn		Xu, Shuqian/0000-0001-7071-8550	Tai Shan Scholar Foundation; National Natural Science Foundation of China [81070396, 81070408, 81070407, 81070411, 81021001]; 973 Program [2011 CB 503906]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China [200561]; Program for New Century Excellent Talents in University [NCET-07-0514]; Chinese Ministry of Education [109097]; Public Health Ministry of China; China Postdoctoral Science Foundation [20080431205]; Second China Postdoctoral Special Foundation [200902566]; Postdoctoral Innovation Program of Shandong Province, China [200803074]; Natural Science Foundation of Shandong Province [ZR2009CM001]; Clinical Medicine Center Foundation of Shandong Province; Leading Medical Professionals Foundation of Shandong Province; Outstanding Young Scientist Research Award Foundation of Shandong Province [2008BSO3009, BS2010YY039]; Independent Innovation Foundation of Shandong University [2009TS053]	Tai Shan Scholar Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Chinese Ministry of Education(Ministry of Education, China); Public Health Ministry of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Second China Postdoctoral Special Foundation; Postdoctoral Innovation Program of Shandong Province, China; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Clinical Medicine Center Foundation of Shandong Province; Leading Medical Professionals Foundation of Shandong Province; Outstanding Young Scientist Research Award Foundation of Shandong Province; Independent Innovation Foundation of Shandong University	This work was supported by grants from Tai Shan Scholar Foundation, National Natural Science Foundation of China (No. 81070396, No. 81070408, No. 81070407 and No. 81070411), 973 Program (No. 2011 CB 503906), Foundation for the Author of National Excellent Doctoral Dissertation of PR China (No. 200561), Program for New Century Excellent Talents in University (NCET-07-0514), Key Project of Chinese Ministry of Education (109097), Key Clinical Research Project of Public Health Ministry of China 2010-2012, the 43rd China Postdoctoral Science Foundation (20080431205), the Second China Postdoctoral Special Foundation (200902566), Postdoctoral Innovation Program of Shandong Province, China in 2008 (200803074), Natural Science Foundation of Shandong Province (ZR2009CM001), Clinical Medicine Center Foundation of Shandong Province, Leading Medical Professionals Foundation of Shandong Province, Outstanding Young Scientist Research Award Foundation of Shandong Province (2008BSO3009, BS2010YY039), Independent Innovation Foundation of Shandong University (No. 2009TS053) and State Program of National Natural Science Foundation of China for Innovative Research Group 2011-2013 (81021001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Al-Salleeh F, 2007, MICROBES INFECT, V9, P1384, DOI 10.1016/j.micinf.2007.07.001; Alsaleh G, 2007, ARTHRITIS RHEUM, V56, P3202, DOI 10.1002/art.22915; Carter RH, 2005, ARTHRITIS RHEUM-US, V52, P3943, DOI 10.1002/art.21489; Catani L, 2006, EXP HEMATOL, V34, P879, DOI 10.1016/j.exphem.2006.03.009; Groom JR, 2007, J EXP MED, V204, P1959, DOI 10.1084/jem.20062567; Kato A, 2006, J IMMUNOL, V177, P7164, DOI 10.4049/jimmunol.177.10.7164; Khan S, 2009, NAT REV RHEUMATOL, V5, P566, DOI 10.1038/nrrheum.2009.185; Kuwana M, 2009, J THROMB HAEMOST, V7, P322, DOI 10.1111/j.1538-7836.2008.03161.x; Li MC, 2009, CURR MOL MED, V9, P365, DOI 10.2174/156652409787847137; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsushita T, 2006, ARTHRITIS RHEUM-US, V54, P192, DOI 10.1002/art.21526; Moon EY, 2006, FREE RADICAL BIO MED, V40, P2103, DOI 10.1016/j.freeradbiomed.2006.02.007; Moransard M, 2010, GLIA, V58, P559, DOI 10.1002/glia.20945; Musaji A, 2004, EXP HEMATOL, V32, P87, DOI 10.1016/j.exphem.2003.09.024; Nakajima K, 2007, SCAND J RHEUMATOL, V36, P365, DOI 10.1080/03009740701286615; Pawar RD, 2007, J AM SOC NEPHROL, V18, P1721, DOI 10.1681/ASN.2006101162; Pawar RD, 2006, J AM SOC NEPHROL, V17, P141, DOI 10.1681/ASN.2005070714; Rolink AG, 2002, EUR J IMMUNOL, V32, P2004, DOI 10.1002/1521-4141(200207)32:7<2004::AID-IMMU2004>3.0.CO;2-5; Santiago-Raber ML, 2009, J AUTOIMMUN, V33, P231, DOI 10.1016/j.jaut.2009.10.001; Savarese E, 2008, ARTHRITIS RHEUM, V58, P1107, DOI 10.1002/art.23407; Sellam J, 2007, ANN RHEUM DIS, V66, P790, DOI 10.1136/ard.2006.065656; Shi CY, 2009, INT IMMUNOPHARMACOL, V9, P247, DOI 10.1016/j.intimp.2008.11.011; Sood R, 2006, PEDIATR BLOOD CANCER, V47, P675, DOI 10.1002/pbc.20981; Stasi R, 2008, THROMB HAEMOSTASIS, V99, P4, DOI 10.1160/TH07-08-0513; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Thangarajh M, 2007, SCAND J IMMUNOL, V65, P461, DOI 10.1111/j.1365-3083.2007.01921.x; Thangarajh M, 2004, J NEUROIMMUNOL, V152, P183, DOI 10.1016/j.jneuroim.2004.03.017; Treml JF, 2009, CELL BIOCHEM BIOPHYS, V53, P1, DOI 10.1007/s12013-008-9036-1; Treml LS, 2007, J IMMUNOL, V178, P7531, DOI 10.4049/jimmunol.178.12.7531; Warnatz K, 2009, P NATL ACAD SCI USA, V106, P13945, DOI 10.1073/pnas.0903543106; Zhang J, 2001, J IMMUNOL, V166, P6, DOI 10.4049/jimmunol.166.1.6; Zhou ZP, 2009, AUTOIMMUNITY, V42, P112, DOI 10.1080/08916930802397848	33	15	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22708	10.1371/journal.pone.0022708	http://dx.doi.org/10.1371/journal.pone.0022708			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818370	Green Published, gold, Green Submitted			2022-12-25	WOS:000293282700063
J	Beck, C; Neumann, H				Beck, Cornelia; Neumann, Heiko			Combining Feature Selection and Integration-A Neural Model for MT Motion Selectivity	PLOS ONE			English	Article							VISUAL AREA MT; RECEPTIVE-FIELD; DIRECTIONAL SELECTIVITY; PERCEIVED DIRECTION; NEURONAL RESPONSES; TEMPORAL DYNAMICS; CORTICAL-NEURONS; PATTERNS DEPENDS; APERTURE PROBLEM; V1	Background: The computation of pattern motion in visual area MT based on motion input from area V1 has been investigated in many experiments and models attempting to replicate the main mechanisms. Two different core conceptual approaches were developed to explain the findings. In integrationist models the key mechanism to achieve pattern selectivity is the nonlinear integration of V1 motion activity. In contrast, selectionist models focus on the motion computation at positions with 2D features. Methodology/Principal Findings: Recent experiments revealed that neither of the two concepts alone is sufficient to explain all experimental data and that most of the existing models cannot account for the complex behaviour found. MT pattern selectivity changes over time for stimuli like type II plaids from vector average to the direction computed with an intersection of constraint rule or by feature tracking. Also, the spatial arrangement of the stimulus within the receptive field of a MT cell plays a crucial role. We propose a recurrent neural model showing how feature integration and selection can be combined into one common architecture to explain these findings. The key features of the model are the computation of 1D and 2D motion in model area V1 subpopulations that are integrated in model MT cells using feedforward and feedback processing. Our results are also in line with findings concerning the solution of the aperture problem. Conclusion/Significance: We propose a new neural model for MT pattern computation and motion disambiguation that is based on a combination of feature selection and integration. The model can explain a range of recent neurophysiological findings including temporally dynamic behaviour.	[Beck, Cornelia; Neumann, Heiko] Univ Ulm, Inst Neural Informat Proc, Ulm, Germany	Ulm University	Beck, C (corresponding author), Univ Ulm, Inst Neural Informat Proc, Ulm, Germany.	cornelia.beck@uni-ulm.de			EU [027198, 215866]; German Research Foundation (DFG)	EU(European Commission); German Research Foundation (DFG)(German Research Foundation (DFG))	This research was supported in part by a grant from the EU to STREP-project no. 027198 Decisions-in-Motion, to ICT-project no. 215866 SEARISE, as well as the Transregional Collaborative Research, Center SFB/TRR62 "Companion Technology for Cognitive Technical Systems'' funded by the German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; ALLMAN J, 1985, PERCEPTION, V14, P105, DOI 10.1068/p140105; Andersen RA, 1997, NEURON, V18, P865, DOI 10.1016/S0896-6273(00)80326-8; ANSTIS S, 1990, AI AND THE EYE, P105; Bayerl P, 2004, NEURAL COMPUT, V16, P2041, DOI 10.1162/0899766041732404; BECK C, 2009, FRONTIERS COMPUTATIO, DOI DOI 10.3389/CONF.NEURO.10.2009.03.163; Beck C, 2010, J PHYSIOL-PARIS, V104, P61, DOI 10.1016/j.jphysparis.2009.11.005; Born RT, 2010, DYNAMICS OF VISUAL MOTION PROCESSING: NEURONAL, BEHAVIORAL, AND COMPUTATIONAL APPROACHES, P37, DOI 10.1007/978-1-4419-0781-3_2; Born RT, 2006, J NEUROPHYSIOL, V95, P284, DOI 10.1152/jn.01329.2005; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Born RT, 2002, PROG BRAIN RES, V140, P225; Bouecke JD, 2011, EURASIP J ADV SIG PR, DOI 10.1155/2011/781561; Carpenter G, 1981, J THEOR NEUROBIOL, V1, P1, DOI 10.1007/978-4-431-54880-5; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1118, DOI 10.1152/jn.1993.69.4.1118; DeAngelis GC, 2003, J NEUROPHYSIOL, V89, P1094, DOI 10.1152/jn.00717.2002; DERRINGTON A, 1991, VISION RES, V31, P139, DOI 10.1016/0042-6989(91)90081-F; DOBBINS A, 1989, VISION RES, V29, P1371, DOI 10.1016/0042-6989(89)90193-4; Duncan RO, 2000, J NEUROSCI, V20, P5885, DOI 10.1523/JNEUROSCI.20-15-05885.2000; Eifuku S, 1998, J NEUROPHYSIOL, V80, P282, DOI 10.1152/jn.1998.80.1.282; GROSSBERG S, 1985, PERCEPT PSYCHOPHYS, V38, P141, DOI 10.3758/BF03198851; Guo K, 2006, NEUROSCIENCE, V138, P1397, DOI 10.1016/j.neuroscience.2005.12.016; Guo K, 2004, EUR J NEUROSCI, V19, P1055, DOI 10.1111/j.1460-9568.2004.03212.x; Heitger F, 1998, IMAGE VISION COMPUT, V16, P407, DOI 10.1016/S0262-8856(97)00083-8; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; Huang X, 2008, J NEUROSCI, V28, P13889, DOI 10.1523/JNEUROSCI.1946-08.2008; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hupe JM, 2003, VISION RES, V43, P531, DOI 10.1016/S0042-6989(02)00593-X; Ito M, 2004, J NEUROSCI, V24, P3313, DOI 10.1523/JNEUROSCI.4364-03.2004; Koechlin E, 1999, BIOL CYBERN, V80, P25, DOI 10.1007/s004220050502; LAGAE L, 1989, BRAIN RES, V496, P361, DOI 10.1016/0006-8993(89)91089-5; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; Liden L, 1999, VISION RES, V39, P3301, DOI 10.1016/S0042-6989(99)00055-3; Loffler G, 1999, VISION RES, V39, P859, DOI 10.1016/S0042-6989(98)00194-1; LORENCEAU J, 1993, VISION RES, V33, P1207, DOI 10.1016/0042-6989(93)90209-F; MAJAJ NJ, 2007, J NEUROSCI, V27, P19; MARR D, 1981, PROC R SOC SER B-BIO, V211, P151, DOI 10.1098/rspb.1981.0001; Masland R. H., 2008, SENSES COMPREHENSIVE, P189, DOI [10.1016/B978-012370880-9.00309-1, DOI 10.1016/13978-012370880-9.00309-1]; Masson GS, 2002, J NEUROSCI, V22, P5149, DOI 10.1523/JNEUROSCI.22-12-05149.2002; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; MINGOLLA E, 1992, VISION RES, V32, P1015, DOI 10.1016/0042-6989(92)90003-2; Movshon A, 1985, PATTERN RECOGN, V54, P117; Movshon JA, 1996, J NEUROSCI, V16, P7733; NOEST AJ, 1993, SPATIAL VISION, V7, P125, DOI 10.1163/156856893X00324; NOWLAN SJ, 1994, J OPT SOC AM A, V11, P3177, DOI 10.1364/JOSAA.11.003177; Pack CC, 2004, J NEUROSCI, V24, P3268, DOI 10.1523/JNEUROSCI.4387-03.2004; Pack CC, 2003, NEURON, V39, P671, DOI 10.1016/S0896-6273(03)00439-2; Pack CC, 2001, NATURE, V409, P1040, DOI 10.1038/35059085; Pack CC, 2001, NATURE, V414, P905, DOI 10.1038/414905a; Perge JA, 2005, EUR J NEUROSCI, V22, P2049, DOI 10.1111/j.1460-9568.2005.04363.x; Perrone JA, 2008, J VISION, V8, DOI 10.1167/8.9.1; Raudies F, 2010, NEURAL NETWORKS, V23, P160, DOI 10.1016/j.neunet.2009.10.005; RODMAN HR, 1989, EXP BRAIN RES, V75, P53; RUBIN N, 1993, VISION RES, V33, P1385, DOI 10.1016/0042-6989(93)90045-X; Rust NC, 2006, NAT NEUROSCI, V9, P1421, DOI 10.1038/nn1786; SALIN PA, 1995, PHYSIOL REV, V75, P107, DOI 10.1152/physrev.1995.75.1.107; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Sceniak MP, 2001, J NEUROPHYSIOL, V85, P1873, DOI 10.1152/jn.2001.85.5.1873; Sillito AM, 2006, TRENDS NEUROSCI, V29, P307, DOI 10.1016/j.tins.2006.05.001; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; Skottun BC, 1999, VISION RES, V39, P2151, DOI 10.1016/S0042-6989(98)00299-5; Smith MA, 2005, NAT NEUROSCI, V8, P220, DOI 10.1038/nn1382; TANAKA K, 1986, J NEUROSCI, V6, P134; Tinsley CJ, 2003, J NEUROPHYSIOL, V90, P930, DOI 10.1152/jn.00708.2002; Tlapale E, 2010, VISION RES, V50, P1676, DOI 10.1016/j.visres.2010.05.022; Tsui JMG, 2010, J NEUROPHYSIOL, V103, P3123, DOI 10.1152/jn.00654.2009; VANDENBERG AV, 1993, EXP BRAIN RES, V96, P519, DOI 10.1007/BF00234120; VONDERHEYDT R, 1984, SCIENCE, V224, P1260, DOI 10.1126/science.6539501; Weidenbacher U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005909; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; WILSON HR, 1994, VISUAL NEUROSCI, V11, P1205, DOI 10.1017/S0952523800007008; Yazdanbakhsh A, 2006, NAT NEUROSCI, V9, P697, DOI 10.1038/nn1693; YO C, 1992, VISION RES, V32, P135, DOI 10.1016/0042-6989(92)90121-X; ZEKI SM, 1974, J PHYSIOL-LONDON, V236, P549, DOI 10.1113/jphysiol.1974.sp010452; ZETZSCHE C, 1990, VISION RES, V30, P1111, DOI 10.1016/0042-6989(90)90120-A	75	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e21254	10.1371/journal.pone.0021254	http://dx.doi.org/10.1371/journal.pone.0021254			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21814543	gold, Green Published			2022-12-25	WOS:000292956800002
J	Li, MS; Lau, TCK; Chan, SKP; Wong, CH; Ng, PKS; Sung, JJY; Chan, HLY; Tsui, SKW				Li, Man-Shan; Lau, Terrence Chi-Kong; Chan, Sophie Ka-Ping; Wong, Chi-Hang; Ng, Patrick Kwok-Shing; Sung, Joseph Jao-Yiu; Chan, Henry Lik-Yuen; Tsui, Stephen Kwok-Wing			The G1613A Mutation in the HBV Genome Affects HBeAg Expression and Viral Replication through Altered Core Promoter Activity	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; POSTTRANSCRIPTIONAL REGULATORY ELEMENT; TRACT-BINDING-PROTEIN; HEPATOCELLULAR-CARCINOMA; FULMINANT-HEPATITIS; NATURAL-HISTORY; SURFACE-ANTIGEN; PREGENOMIC RNA; ENHANCER-II; DNA LEVELS	Infection of hepatitis B virus (HBV) causes acute and chronic hepatitis and is closely associated with the development of cirrhosis and hepatocellular carcinoma (HCC). Previously, we demonstrated that the G1613A mutation in the HBV negative regulatory element (NRE) is a hotspot mutation in HCC patients. In this study, we further investigated the functional consequences of this mutation in the context of the full length HBV genome and its replication. We showed that the G1613A mutation significantly suppresses the secretion of e antigen (HBeAg) and enhances the synthesis of viral DNA, which is in consistence to our clinical result that the G1613A mutation associates with high viral load in chronic HBV carriers. To further investigate the molecular mechanism of the mutation, we performed the electrophoretic mobility shift assay with the recombinant RFX1 protein, a trans-activator that was shown to interact with the NRE of HBV. Intriguingly, RFX1 binds to the G1613A mutant with higher affinity than the wild-type sequence, indicating that the mutation possesses the transactivating effect to the core promoter via NRE. The trans-activating effect was further validated by the enhancement of the core promoter activity after overexpression of RFX1 in liver cell line. In summary, our results suggest the functional consequences of the hotspot G1613A mutation found in HBV. We also provide a possible molecular mechanism of this hotspot mutation to the increased viral load of HBV carriers, which increases the risk to HCC.	[Li, Man-Shan; Chan, Sophie Ka-Ping; Wong, Chi-Hang; Ng, Patrick Kwok-Shing; Tsui, Stephen Kwok-Wing] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Sung, Joseph Jao-Yiu; Chan, Henry Lik-Yuen] Chinese Univ Hong Kong, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Tsui, Stephen Kwok-Wing] Chinese Univ Hong Kong, Ctr Microbial Genom & Prote, Shatin, Hong Kong, Peoples R China; [Lau, Terrence Chi-Kong] City Univ Hong Kong, Dept Biol & Chem, Kowloon, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; City University of Hong Kong	Li, MS (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China.	kwtsui@cuhk.edu.hk	Lau, Terrence/ABB-7900-2021; Sung, Joseph J. Y./R-3203-2018; Chan, Henry Lik-Yuen/B-9636-2008; Wong, Chi Hang/ABE-8673-2021; Tsui, Stephen Kwok-Wing/E-4385-2015; Wong, Chi Hang/C-6909-2015	Lau, Terrence/0000-0002-7505-7306; Sung, Joseph J. Y./0000-0003-3125-5199; Chan, Henry Lik-Yuen/0000-0002-7790-1611; Wong, Chi Hang/0000-0003-4157-6287; Tsui, Stephen Kwok-Wing/0000-0003-0686-4259; Wong, Chi Hang/0000-0003-4157-6287	Health, Welfare and Food Bureau of the Hong Kong SAR Government [09080302]	Health, Welfare and Food Bureau of the Hong Kong SAR Government	This project team is supported by the Research Fund for the Control of Infectious Diseases (RFCID) (Ref: 09080302) from the Health, Welfare and Food Bureau of the Hong Kong SAR Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEASLEY RP, 1981, LANCET, V2, P1129; Buckwold VE, 1997, VIROLOGY, V227, P515, DOI 10.1006/viro.1996.8360; Chan HLY, 2008, J CLIN ONCOL, V26, P177, DOI 10.1200/JCO.2007.13.2043; Chan HLY, 2007, CLIN GASTROENTEROL H, V5, P1462, DOI 10.1016/j.cgh.2007.09.005; Chan HLY, 2005, J INFECT DIS, V191, P2022, DOI 10.1086/430324; Chan HLY, 2002, AM J GASTROENTEROL, V97, P406; CHEN M, 1995, VIROLOGY, V214, P198, DOI 10.1006/viro.1995.9940; Cheng Y, 2006, ANTIVIR RES, V69, P142, DOI 10.1016/j.antiviral.2005.11.005; Donello JE, 1996, J VIROL, V70, P4345, DOI 10.1128/JVI.70.7.4345-4351.1996; Ehlers I, 2004, J BIOL CHEM, V279, P43437, DOI 10.1074/jbc.M402227200; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; GERLACH KK, 1992, VIROLOGY, V189, P59, DOI 10.1016/0042-6822(92)90681-E; GUIDOTTI LG, 1995, J VIROL, V69, P6158, DOI 10.1128/JVI.69.10.6158-6169.1995; Gunther S, 1997, VIROLOGY, V238, P363, DOI 10.1006/viro.1997.8863; Heise T, 2006, NUCLEIC ACIDS RES, V34, P353, DOI 10.1093/nar/gkj440; HUANG JK, 1993, MOL CELL BIOL, V13, P7476, DOI 10.1128/MCB.13.12.7476; HUANG ZM, 1993, J VIROL, V67, P7032, DOI 10.1128/JVI.67.12.7032-7040.1993; Huang ZM, 1996, VIROLOGY, V217, P573, DOI 10.1006/viro.1996.0152; HUANG ZM, 1994, J VIROL, V68, P3193, DOI 10.1128/JVI.68.5.3193-3199.1994; HUANG ZM, 1995, MOL CELL BIOL, V15, P3864; JANG SK, 1990, GENE DEV, V4, P1560, DOI 10.1101/gad.4.9.1560; Kao JH, 2002, J GASTROEN HEPATOL, V17, P643, DOI 10.1046/j.1440-1746.2002.02737.x; Kramvis A, 1999, J VIRAL HEPATITIS, V6, P415, DOI 10.1046/j.1365-2893.1999.00189.x; Kumar M, 2008, GASTROENTEROLOGY, V134, P1376, DOI 10.1053/j.gastro.2008.02.075; Lai CL, 2003, LANCET, V362, P2089, DOI 10.1016/S0140-6736(03)15108-2; Li B, 2002, J BIOL CHEM, V277, P10306, DOI 10.1074/jbc.M109686200; LIANG TJ, 1991, NEW ENGL J MED, V324, P1705, DOI 10.1056/NEJM199106133242405; Lin LY, 2010, J MED VIROL, V82, P1494, DOI 10.1002/jmv.21863; Liu TT, 2008, WORLD J GASTROENTERO, V14, P3059, DOI 10.3748/wjg.14.3059; LO WY, 1994, J VIROL, V68, P1758, DOI 10.1128/JVI.68.3.1758-1764.1994; Mendy ME, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-23; Milich D, 2003, HEPATOLOGY, V38, P1075, DOI 10.1053/jhep.2003.50453; Moolla N, 2002, J VIRAL HEPATITIS, V9, P323, DOI 10.1046/j.1365-2893.2002.00381.x; Orito E, 2001, HEPATOLOGY, V34, P590, DOI 10.1053/jhep.2001.27221; Panjaworayan N, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-216; Park GT, 1997, DNA CELL BIOL, V16, P1459, DOI 10.1089/dna.1997.16.1459; REINHOLD W, 1995, MOL CELL BIOL, V15, P3041; ROSMORDUC O, 1995, HEPATOLOGY, V22, P10, DOI 10.1016/0270-9139(95)90346-1; Shinkai N, 2007, J CLIN MICROBIOL, V45, P3191, DOI 10.1128/JCM.00411-07; SIEGRIST CA, 1993, MOL CELL BIOL, V13, P6375, DOI 10.1128/MCB.13.10.6375; Sommer G, 2000, VIROLOGY, V271, P371, DOI 10.1006/viro.2000.0331; SU TS, 1989, J VIROL, V63, P4011, DOI 10.1128/JVI.63.9.4011-4018.1989; Sun CT, 2001, J BIOL CHEM, V276, P24059, DOI 10.1074/jbc.M101330200; Sung JJY, 2008, J VIROL, V82, P3604, DOI 10.1128/JVI.01197-07; Takahashi K, 1998, ARCH VIROL, V143, P2313, DOI 10.1007/s007050050463; TERAZAWA S, 1991, PEDIATR RES, V29, P5, DOI 10.1203/00006450-199101000-00002; TERRE S, 1991, J VIROL, V65, P5539; TUTTLEMAN JS, 1986, CELL, V47, P451, DOI 10.1016/0092-8674(86)90602-1; Wang YX, 2007, FEBS LETT, V581, P558, DOI 10.1016/j.febslet.2007.01.024; Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018; Wollerton MC, 2004, MOL CELL, V13, P91, DOI 10.1016/S1097-2765(03)00502-1; Wong VWS, 2010, J CLIN ONCOL, V28, P1660, DOI 10.1200/JCO.2009.26.2675; Wursthorn K, 2006, HEPATOLOGY, V44, P675, DOI 10.1002/hep.21282; Yu XM, 1997, J VIROL, V71, P9366, DOI 10.1128/JVI.71.12.9366-9374.1997; YUH CH, 1992, J VIROL, V66, P4073, DOI 10.1128/JVI.66.7.4073-4084.1992; Zacharakis G, 2008, J HEPATOL, V49, P884, DOI 10.1016/j.jhep.2008.06.009; Zang WQ, 1998, VIROLOGY, V248, P46, DOI 10.1006/viro.1998.9255; Zang WQ, 2001, J VIROL, V75, P10779, DOI 10.1128/JVI.75.22.10779-10786.2001	58	22	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e21856	10.1371/journal.pone.0021856	http://dx.doi.org/10.1371/journal.pone.0021856			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21814558	Green Submitted, gold, Green Published			2022-12-25	WOS:000292956800011
J	Song, A; Jung, WH; Jang, JH; Kim, E; Shim, G; Park, HY; Choi, CH; Kwon, JS				Song, Aram; Jung, Wi Hoon; Jang, Joon Hwan; Kim, Euitae; Shim, Geumsook; Park, Hye Yoon; Choi, Chi-Hoon; Kwon, Jun Soo			Disproportionate Alterations in the Anterior and Posterior Insular Cortices in Obsessive-Compulsive Disorder	PLOS ONE			English	Article							MATTER ABNORMALITIES; SYMPTOM DIMENSIONS; DECISION-MAKING; NEURAL RESPONSE; CORTEX; ACTIVATION; DISGUST; ANXIETY; SCHIZOPHRENIA; UNCERTAINTY	Background: Recent studies have reported that the insular cortex is involved in the pathophysiology of obsessive-compulsive disorder (OCD). However, specific morphometric abnormalities of the insular subregions remain unclear. In this study, we examined insular cortical volume to determine whether the volume of the anterior and posterior insular cortices of unmedicated OCD patients differed according to different symptom dimensions. Methods/Principal Findings: Using magnetic resonance imaging, we measured the gray matter volumes of the insular cortex and its subregions (anterior and posterior divisions) in 41 patients with OCD (31 drug-naive and 10 non-medicated) and 53 healthy controls. Volumetric measures of the insular cortex were compared according to different OC symptoms. Enlarged anterior and reduced posterior insular cortices were observed in OCD patients. The insular volumetric alterations were more significant in OCD patients with predominant checking rather than cleaning symptoms when compared with healthy controls. Conclusions/Significance: Our results suggest the presence of unbalanced anterior and posterior insular volumetric abnormalities in unmedicated OCD patients and emphasize the distinct role of the insular cortex in different OC symptoms. We propose that the insular morphometric alterations may influence the modulation of interoceptive processing, the insular functional role, in OCD patients with different symptoms.	[Song, Aram; Jung, Wi Hoon; Kwon, Jun Soo] Seoul Natl Univ, Coll Nat Sci, Interdisciplinary Program Neurosci, Seoul, South Korea; [Jang, Joon Hwan; Kim, Euitae; Shim, Geumsook; Park, Hye Yoon; Kwon, Jun Soo] Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Choi, Chi-Hoon] Natl Med Ctr, Dept Radiol, Seoul, South Korea; [Kwon, Jun Soo] Seoul Natl Univ, Coll Nat Sci, Brain & Cognit Sci World Class Univ Program, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); National Medical Center - Korea; Seoul National University (SNU)	Song, A (corresponding author), Seoul Natl Univ, Coll Nat Sci, Interdisciplinary Program Neurosci, Seoul, South Korea.	kwonjs@snu.ac.kr	Jung, Wi Hoon/J-4033-2019; Kwon, Jun Soo/J-2734-2012	Jung, Wi Hoon/0000-0002-8697-9584	Ministry of Education, Science and Technology [R31-2009-000-10089-0]; Ministry of Education, Science and Technology, Republic of Korea [2009K001270]	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by WCU (World Class University) program through the Korea Science and Engineering Foundation funded by the Ministry of Education, Science and Technology (R31-2009-000-10089-0) and a grant (2009K001270) from Brain Research Center of the 21st Century Frontier Research Program funded by the Ministry of Education, Science and Technology, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afif A, 2007, BRAIN STRUCT FUNCT, V212, P335, DOI 10.1007/s00429-007-0161-1; Allman JM, 2005, TRENDS COGN SCI, V9, P367, DOI 10.1016/j.tics.2005.06.008; ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Arce E, 2008, PSYCHOPHARMACOLOGY, V196, P661, DOI 10.1007/s00213-007-1004-8; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Berle D, 2006, PSYCHIATRY, V69, P228, DOI 10.1521/psyc.2006.69.3.228; Bloch MH, 2008, AM J PSYCHIAT, V165, P1532, DOI 10.1176/appi.ajp.2008.08020320; Corlett PR, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.012.2009; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Drzezga A, 2001, PAIN, V92, P295, DOI 10.1016/S0304-3959(01)00271-8; Gilbert AR, 2000, ARCH GEN PSYCHIAT, V57, P449, DOI 10.1001/archpsyc.57.5.449; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1012; Husted DS, 2006, PROG NEURO-PSYCHOPH, V30, P389, DOI 10.1016/j.pnpbp.2005.11.024; Jang JH, 2010, NEUROSCI LETT, V474, P158, DOI 10.1016/j.neulet.2010.03.031; Jones CL, 2010, J NEUROL NEUROSUR PS, V81, P611, DOI 10.1136/jnnp.2009.193672; Jung WH, 2009, EUR ARCH PSY CLIN N, V259, P46, DOI 10.1007/s00406-008-0833-8; Kasai K, 2003, ARCH GEN PSYCHIAT, V60, P1069, DOI 10.1001/archpsyc.60.11.1069; Kim JJ, 2001, BRIT J PSYCHIAT, V179, P330, DOI 10.1192/bjp.179.4.330; Kim JJ, 2003, SCHIZOPHR RES, V60, P191, DOI 10.1016/S0920-9964(02)00306-7; Kwon JS, 2009, EXPERT REV NEUROTHER, V9, P255, DOI 10.1586/14737175.9.2.255; Lawrence NS, 2007, BIOL PSYCHIAT, V61, P1072, DOI 10.1016/j.biopsych.2006.06.033; Lochner C, 2004, EUR NEUROPSYCHOPHARM, V14, P105, DOI 10.1016/S0924-977X(03)00063-4; Mancini F, 2001, PERS INDIV DIFFER, V31, P1173, DOI 10.1016/S0191-8869(00)00215-4; Mataix-Cols D, 2004, ARCH GEN PSYCHIAT, V61, P564, DOI 10.1001/archpsyc.61.6.564; Nagai M, 2007, EUR PSYCHIAT, V22, P387, DOI 10.1016/j.eurpsy.2007.02.006; Naidich TP, 2004, AM J NEURORADIOL, V25, P222; NISHIDA S, 2011, PROG NEUROP IN PRESS; Olausson H, 2002, NAT NEUROSCI, V5, P900, DOI 10.1038/nn896; PAUC R, 2009, CLIN CHIROPRACT, V12, P101; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Phillips ML, 2004, CNS SPECTRUMS, V9, P275, DOI 10.1017/S1092852900009214; Phillips ML, 2000, PSYCHOL MED, V30, P1037, DOI 10.1017/S0033291799002652; Pujol J, 2004, ARCH GEN PSYCHIAT, V61, P720, DOI 10.1001/archpsyc.61.7.720; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Rotge JY, 2010, NEUROPSYCHOPHARMACOL, V35, P686, DOI 10.1038/npp.2009.175; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; Simmons A, 2008, NEUROSCI LETT, V430, P92, DOI 10.1016/j.neulet.2007.10.030; Singer T, 2009, TRENDS COGN SCI, V13, P334, DOI 10.1016/j.tics.2009.05.001; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Stein MB, 2007, AM J PSYCHIAT, V164, P318, DOI 10.1176/appi.ajp.164.2.318; Thielscher A, 2007, J NEUROSCI, V27, P2908, DOI 10.1523/JNEUROSCI.3024-06.2007; Tolin DF, 2003, J ANXIETY DISORD, V17, P233, DOI 10.1016/S0887-6185(02)00182-2; Valente AA, 2005, BIOL PSYCHIAT, V58, P479, DOI 10.1016/j.biopsych.2005.04.021; van den Heuvel OA, 2009, BRAIN, V132, P853, DOI 10.1093/brain/awn267; WILLIAMS JB, 1998, STRUCTURED CLIN INTE; WILLIAMS JB, 1996, STRUCTURED CLIN INTE	51	32	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22361	10.1371/journal.pone.0022361	http://dx.doi.org/10.1371/journal.pone.0022361			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811591	gold, Green Published, Green Submitted			2022-12-25	WOS:000292956800046
J	Ataide, R; Mwapasa, V; Molyneux, ME; Meshnick, SR; Rogerson, SJ				Ataide, Ricardo; Mwapasa, Victor; Molyneux, Malcolm E.; Meshnick, Steven R.; Rogerson, Stephen J.			Antibodies That Induce Phagocytosis of Malaria Infected Erythrocytes: Effect of HIV Infection and Correlation with Clinical Outcomes	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; IN-VITRO; CHONDROITIN SULFATE; PREGNANCY; INHIBITION; ANTIGENS; ADHESION; IMMUNITY	HIV infection increases the burden of disease of malaria in pregnancy, in part by impairing the development of immunity. We measured total IgG and phagocytic antibodies against variant surface antigens of placental-type CS2 parasites in 187 secundigravidae (65% HIV infected). In women with placental malaria infection, phagocytic antibodies to CS2(VSA) were decreased in the presence of HIV (p = 0.011) and correlated positively with infant birth weight (coef = 3.57, p = 0.025), whereas total IgG to CS2(VSA) did not. Phagocytic antibodies to CS2(VSA) are valuable tools to study acquired immunity to malaria in the context of HIV co-infection. Secundigravidae may be an informative group for identification of correlates of immunity.	[Ataide, Ricardo; Rogerson, Stephen J.] Univ Melbourne, Dept Med RMH WH, PO Royal Melbourne Hosp, Melbourne, Vic, Australia; [Ataide, Ricardo] Univ Porto, Grad Program Areas Basic & Appl Biol GABBA, P-4100 Oporto, Portugal; [Mwapasa, Victor; Molyneux, Malcolm E.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Mwapasa, Victor] Univ Malawi, Coll Med, Dept Community Hlth, Blantyre, Malawi; [Molyneux, Malcolm E.] Univ Liverpool, Sch Trop Med, Liverpool L69 3BX, Merseyside, England; [Meshnick, Steven R.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA	Royal Melbourne Hospital; University of Melbourne; Universidade do Porto; University of Malawi; University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; University of North Carolina; University of North Carolina Chapel Hill	Ataide, R (corresponding author), Univ Melbourne, Dept Med RMH WH, PO Royal Melbourne Hosp, Melbourne, Vic, Australia.	ric.ataide@gmail.com	Ataide, Ricardo/B-7307-2017	Ataide, Ricardo/0000-0002-1014-0432; Rogerson, Stephen/0000-0003-4287-1982; Mwapasa, Victor/0000-0002-2748-8902	Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/32985/2006]; National Institutes of Health (NIH) [AI 49084]; National Health and Medical Research Council, Australia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049084] Funding Source: NIH RePORTER	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	RA is supported by Fundacao para a Ciencia e Tecnologia, Portugal, reference SFRH/BD/32985/2006. Patient recruitment was supported by a grant from National Institutes of Health (NIH) to SRM (NIH RO1 award number AI 49084). SJR is supported by the National Health and Medical Research Council, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken EH, 2010, J INFECT DIS, V201, P1316, DOI 10.1086/651578; Ataide R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010807; Aucan C, 2000, INFECT IMMUN, V68, P1252, DOI 10.1128/IAI.68.3.1252-1258.2000; Beeson JG, 2004, J INFECT DIS, V189, P540, DOI 10.1086/381186; BOUHAROUNTAYOUN H, 1992, MEM I OSWALDO CRUZ, V87, P229, DOI 10.1590/S0074-02761992000700038; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Duffy PE, 2003, INFECT IMMUN, V71, P6620, DOI 10.1128/IAI.71.11.6620-6623.2003; Jaworowski A, 2009, CLIN VACCINE IMMUNOL, V16, P312, DOI 10.1128/CVI.00356-08; Keen J, 2007, PLOS MED, V4, P912, DOI 10.1371/journal.pmed.0040181; Leoratti FMS, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-186; Mount AM, 2004, LANCET, V363, P1860, DOI 10.1016/S0140-6736(04)16354-X; Nasr A, 2007, SCAND J IMMUNOL, V66, P87, DOI 10.1111/j.1365-3083.2007.01947.x; Rogerson SJ, 2003, AM J TROP MED HYG, V68, P115, DOI 10.4269/ajtmh.2003.68.1.0680115; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Tebo AE, 2002, CLIN EXP IMMUNOL, V130, P300, DOI 10.1046/j.1365-2249.2002.01972.x; Tebo AE, 2001, EXP PARASITOL, V98, P20, DOI 10.1006/expr.2001.4619; van den Broek NR, 2000, AM J CLIN NUTR, V72, p247S, DOI 10.1093/ajcn/72.1.247S; Wilson DW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-152	18	36	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22491	10.1371/journal.pone.0022491	http://dx.doi.org/10.1371/journal.pone.0022491			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21811621	gold, Green Published			2022-12-25	WOS:000292929500073
J	Ruben, GJ; Kirkland, JG; MacDonough, T; Chen, M; Dubey, RN; Gartenberg, MR; Kamakaka, RT				Ruben, Giulia J.; Kirkland, Jacob G.; MacDonough, Tracy; Chen, Miao; Dubey, Rudra N.; Gartenberg, Marc R.; Kamakaka, Rohinton T.			Nucleoporin Mediated Nuclear Positioning and Silencing of HMR	PLOS ONE			English	Article							DOMAIN PROTEIN MPS3; MATING-TYPE LOCI; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL CONTROL; CHROMATIN-STRUCTURE; PORE ASSOCIATION; BUDDING YEAST; TELOMERE; COMPLEX; ORGANIZATION	The organization of chromatin domains in the nucleus is an important factor in gene regulation. In eukaryotic nuclei, transcriptionally silenced chromatin clusters at the nuclear periphery while transcriptionally poised chromatin resides in the nuclear interior. Recent studies suggest that nuclear pore proteins (NUPs) recruit loci to nuclear pores to aid in insulation of genes from silencing and during gene activation. We investigated the role of NUPs at a native yeast insulator and show that while NUPs localize to the native tDNA insulator adjacent to the silenced HMR domain, loss of pore proteins does not compromise insulation. Surprisingly we find that NUPs contribute to silencing at HMR and are able to restore silencing to a silencing-defective HMR allele when tethered to the locus. We show that the perinuclear positioning of heterochromatin is important for the NUP-mediated silencing effect and find that loss of NUPs result in decreased localization of HMR to the nuclear periphery. We also show that loss of telomeric tethering pathways does not eliminate NUP localization to HMR, suggesting that NUPs may mediate an independent pathway for HMR association with the nuclear periphery. We propose that localization of NUPs to the tDNA insulator at HMR helps maintain the intranuclear position of the silent locus, which in turn contributes to the fidelity of silencing at HMR.	[Ruben, Giulia J.; Kirkland, Jacob G.; MacDonough, Tracy; Kamakaka, Rohinton T.] Univ Calif Santa Cruz, Dept Mol Cell Dev Biol, Santa Cruz, CA 95064 USA; [Chen, Miao; Gartenberg, Marc R.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [Dubey, Rudra N.] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA	University of California System; University of California Santa Cruz; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick	Ruben, GJ (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell Dev Biol, Santa Cruz, CA 95064 USA.	rohinton@ucsc.edu	Kirkland, Jacob/AAY-5948-2020; Kamakaka, Rohinton/K-3140-2019	Kamakaka, Rohinton/0000-0003-1931-7000; Gartenberg, Marc/0000-0003-0713-7993; Kirkland, Jacob/0000-0001-5617-7065	NIH [GM078068, T32-GM008646, GM51402]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R55GM051402, R01GM078068, R01GM051402, T32GM008646] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the NIH (GM078068) to RTK, (T32-GM008646) to GR and (GM51402) to MRG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Brickner DG, 2007, PLOS BIOL, V5, P704, DOI 10.1371/journal.pbio.0050081; Brown CR, 2008, GENE DEV, V22, P627, DOI 10.1101/gad.1632708; Bupp JM, 2007, J CELL BIOL, V179, P845, DOI 10.1083/jcb.200706040; Bystricky K, 2009, MOL CELL BIOL, V29, P835, DOI 10.1128/MCB.01009-08; Casolari JM, 2005, GENE DEV, V19, P1188, DOI 10.1101/gad.1307205; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Deniaud E, 2009, CURR OPIN GENET DEV, V19, P187, DOI 10.1016/j.gde.2009.01.005; Denning D, 2001, J CELL BIOL, V154, P937, DOI 10.1083/jcb.200101007; Dhillon N, 2009, EMBO J, V28, P2583, DOI 10.1038/emboj.2009.198; Dieppois G, 2006, MOL CELL BIOL, V26, P7858, DOI 10.1128/MCB.00870-06; Dillon N, 2006, CHROMOSOME RES, V14, P117, DOI 10.1007/s10577-006-1027-8; Dilworth DJ, 2005, J CELL BIOL, V171, P955, DOI 10.1083/jcb.200509061; Donze D, 2001, EMBO J, V20, P520, DOI 10.1093/emboj/20.3.520; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Dorman ER, 2007, SEMIN CELL DEV BIOL, V18, P682, DOI 10.1016/j.semcdb.2007.08.009; Drubin DA, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-19; Fabre E, 1997, ANNU REV GENET, V31, P277, DOI 10.1146/annurev.genet.31.1.277; Feuerbach F, 2002, NAT CELL BIOL, V4, P214, DOI 10.1038/ncb756; Fox CA, 1997, SCIENCE, V276, P1547, DOI 10.1126/science.276.5318.1547; Galy V, 2000, NATURE, V403, P108, DOI 10.1038/47528; Gartenberg MR, 2004, CELL, V119, P955, DOI 10.1016/j.cell.2004.11.008; Gotta M, 1996, J CELL BIOL, V134, P1349, DOI 10.1083/jcb.134.6.1349; Hediger F, 2002, CURR BIOL, V12, P2076, DOI 10.1016/S0960-9822(02)01338-6; Hediger F, 2002, J STRUCT BIOL, V140, P79, DOI 10.1016/S1047-8477(02)00533-6; Ishii K, 2002, CELL, V109, P551, DOI 10.1016/S0092-8674(02)00756-0; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Laroche T, 2000, J STRUCT BIOL, V129, P159, DOI 10.1006/jsbi.2000.4240; Laroche T, 1998, CURR BIOL, V8, P653, DOI 10.1016/S0960-9822(98)70252-0; Lewis A, 2007, J CELL BIOL, V178, P813, DOI 10.1083/jcb.200702154; Madrid AS, 2006, J CELL BIOL, V173, P361, DOI 10.1083/jcb.200506199; Maillet L, 1996, GENE DEV, V10, P1796, DOI 10.1101/gad.10.14.1796; Nagai S, 2008, SCIENCE, V322, P597, DOI 10.1126/science.1162790; Oki M, 2005, MOL CELL, V19, P707, DOI 10.1016/j.molcel.2005.07.022; Oki M, 2004, MOL CELL BIOL, V24, P1956, DOI 10.1128/MCB.24.5.1956-1967.2004; Pascual-Garcia P, 2008, GENE DEV, V22, P2811, DOI 10.1101/gad.483308; Patterson EE, 2008, GENETICS, V180, P771, DOI 10.1534/genetics.108.091710; Raab JR, 2010, NAT REV GENET, V11, P439, DOI 10.1038/nrg2765; Rodriguez-Navarro S, 2004, CELL, V116, P75, DOI 10.1016/S0092-8674(03)01025-0; Rougemaille M, 2008, CELL, V135, P308, DOI 10.1016/j.cell.2008.08.005; RUSCHE LN, 2003, ANN REV BIOCH; Sabri N, 2002, MOL BIOL CELL, V13, P1765, DOI 10.1091/mbc.01-09-0436; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Schmid M, 2006, MOL CELL, V21, P379, DOI 10.1016/j.molcel.2005.12.012; Schober H, 2009, GENE DEV, V23, P928, DOI 10.1101/gad.1787509; Som I, 2005, EUKARYOT CELL, V4, P1725, DOI 10.1128/EC.4.10.1725-1735.2005; Taddei A, 2004, EMBO J, V23, P1301, DOI 10.1038/sj.emboj.7600144; Taddei A, 2004, BBA-GENE STRUCT EXPR, V1677, P120, DOI 10.1016/j.bbaexp.2003.11.014; TADDEI A, 2009, GENOME RES; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; Taddei Angela, 2005, V264, P140, DOI 10.1002/0470093765.ch10; Therizols P, 2006, J CELL BIOL, V172, P189, DOI 10.1083/jcb.200505159; THOMPSON JS, 1994, MOL CELL BIOL, V14, P446, DOI 10.1128/MCB.14.1.446; Valenzuela L, 2006, GENETICS, V172, P99, DOI 10.1534/genetics.105.050427; Valenzuela L, 2008, MOL CELL BIOL, V28, P1924, DOI 10.1128/MCB.01647-07; Valenzuela L, 2006, ANNU REV GENET, V40, P107, DOI 10.1146/annurev.genet.39.073003.113546; Valenzuela L, 2009, GENETICS, V183, P131, DOI 10.1534/genetics.109.106203; Van Leeuwen F, 2002, METHOD ENZYMOL, V350, P165, DOI 10.1016/S0076-6879(02)50962-9; Vandre CL, 2008, GENETICS, V180, P1407, DOI 10.1534/genetics.108.094490; West AG, 2004, MOL CELL, V16, P453, DOI 10.1016/j.molcel.2004.10.005	62	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e21923	10.1371/journal.pone.0021923	http://dx.doi.org/10.1371/journal.pone.0021923			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21818277	Green Submitted, Green Published, gold			2022-12-25	WOS:000292929500018
J	Gu, L; Zhang, H; He, J; Li, J; Huang, M; Zhou, M				Gu, L.; Zhang, H.; He, J.; Li, J.; Huang, M.; Zhou, M.			MDM2 regulates MYCN mRNA stabilization and translation in human neuroblastoma cells	ONCOGENE			English	Article						MYCN; MDM2; neuroblastoma	DIRECT TRANSCRIPTIONAL TARGET; RING FINGER DOMAIN; N-MYC; BINDING PROTEIN; IN-VIVO; EXPRESSION; P53; HUD; AMPLIFICATION; INDUCTION	The MYCN gene has a critical role in determining the clinical behavior of neuroblastoma. Although it is known that genomic amplification occurs in high-risk subsets, it remains unclear how MYCN expression is regulated in the pathogenesis of neuroblastomas. Here, we report that MYCN expression was regulated by the oncoprotein MDM2 at the post-transcriptional level and was associated with neuroblastoma cell growth. Increasing MDM2 by ectopic overexpression in the cytoplasm enhanced both mRNA and protein expression of MYCN. Mechanistic studies found that the C-terminal RING domain of the MDM2 protein bound to the MYCN mRNA's AREs within the 3 ' UTR and increased MYCN 3 ' UTR-mediated mRNA stability and translation. Conversely, MDM2 silencing by specific siRNA rendered the MYCN mRNA unstable and reduced the abundance of the MYCN protein in MYCN-amplified neuroblastoma cell lines. Importantly, this MDM2 silencing resulted in a remarkable inhibition of neuroblastoma cell growth and induction of cell death through a p53-independent pathway. Our results indicate that MDM2 has a p53-independent role in the regulation of both MYCN mRNA stabilization and its translation, suggesting that MDM2-mediated MYCN expression is one mechanism associated with growth of MYCN-associated neuroblastoma and disease progression. Oncogene (2012) 31, 1342-1353; doi:10.1038/onc.2011.343; published online 8 August 2011	[Zhou, M.] Emory Univ, Div Pediat Hematol Oncol, Sch Med, Dept Pediat,Aflac Canc Ctr, Atlanta, GA 30322 USA; Emory Univ, Blood Disorders Serv, Sch Med, Atlanta, GA 30322 USA	Emory University; Emory University	Zhou, M (corresponding author), Emory Univ, Div Pediat Hematol Oncol, Sch Med, Dept Pediat,Aflac Canc Ctr, 2015 Uppergate Dr, Atlanta, GA 30322 USA.	mzhou@emory.edu			National Institutes of Health [R01 CA123490, R01CA143107]; CURE; NATIONAL CANCER INSTITUTE [R01CA143107, R01CA123490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CURE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (R01 CA123490 and R01CA143107 to MZ) and CURE (MZ and LG).	Alt JR, 2003, EMBO J, V22, P1442, DOI 10.1093/emboj/cdg133; Anderson JJ, 2007, INT J ONCOL, V31, P545; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Candeias MM, 2008, NAT CELL BIOL, V10, P1098, DOI 10.1038/ncb1770; Carr J, 2006, CANCER RES, V66, P2138, DOI 10.1158/0008-5472.CAN-05-2623; Cattelani S, 2008, CLIN CANCER RES, V14, P3248, DOI 10.1158/1078-0432.CCR-07-4725; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chen LD, 2010, CANCER RES, V70, P1377, DOI 10.1158/0008-5472.CAN-09-2598; Chen ZW, 2009, NEOPLASIA, V11, P753, DOI 10.1593/neo.09466; Cobbold LC, 2008, MOL CELL BIOL, V28, P40, DOI 10.1128/MCB.01298-07; CORVI R, 1995, ONCOGENE, V10, P1081; Elenbaas B, 1996, MOL MED, V2, P439, DOI 10.1007/BF03401903; Fornaro M, 2007, ANN ANAT, V189, P223, DOI 10.1016/j.aanat.2006.11.004; Gu LB, 2009, CANCER CELL, V15, P363, DOI 10.1016/j.ccr.2009.03.002; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hogarty MD, 2003, CANCER LETT, V197, P173, DOI 10.1016/S0304-3835(03)00103-4; Horvilleur E, 2008, NUCLEIC ACIDS RES, V36, P4222, DOI 10.1093/nar/gkn394; Jones SN, 1998, P NATL ACAD SCI USA, V95, P15608, DOI 10.1073/pnas.95.26.15608; Lai ZH, 1998, BIOCHEMISTRY-US, V37, P17005, DOI 10.1021/bi980596r; Lazarova DL, 1999, ONCOGENE, V18, P2703, DOI 10.1038/sj.onc.1202621; Manohar CF, 2002, J BIOL CHEM, V277, P1967, DOI 10.1074/jbc.M106966200; Matthay KK, 2000, J CLIN ONCOL, V18, P3591, DOI 10.1200/JCO.2000.18.21.3591; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Meek DW, 2003, MOL CANCER RES, V1, P1017; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; NEGRONI A, 1991, CELL GROWTH DIFFER, V2, P511; Okamoto K, 2002, MOL CELL, V9, P761, DOI 10.1016/S1097-2765(02)00504-X; Peirce SK, 2009, INT J ONCOL, V34, P1395, DOI 10.3892/ijo_00000267; Poyurovsky MV, 2003, MOL CELL, V12, P875, DOI 10.1016/S1097-2765(03)00400-3; Ross RA, 1997, EUR J CANCER, V33, P2071, DOI 10.1016/S0959-8049(97)00331-6; SCHWEIGERER L, 1990, CANCER RES, V50, P4411; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Sivak LE, 1997, ONCOGENE, V15, P1937, DOI 10.1038/sj.onc.1201363; Slack A, 2005, P NATL ACAD SCI USA, V102, P731, DOI 10.1073/pnas.0405495102; Tang XX, 2006, CANCER RES, V66, P2826, DOI 10.1158/0008-5472.CAN-05-0854; Thompson J, 1997, CLIN CANCER RES, V3, P423; Wang XQ, 2001, NAT STRUCT BIOL, V8, P141, DOI 10.1038/84131; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Zhang Z, 2005, CURR CANCER DRUG TAR, V5, P9, DOI 10.2174/1568009053332618	39	46	47	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2012	31	11					1342	1353		10.1038/onc.2011.343	http://dx.doi.org/10.1038/onc.2011.343			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	912FL	21822304	Green Accepted			2022-12-25	WOS:000301780000002
J	Alejandro, EU; Lim, GE; Mehran, AE; Hu, XK; Taghizadeh, F; Pelipeychenko, D; Baccarini, M; Johnson, JD				Alejandro, Emilyn U.; Lim, Gareth E.; Mehran, Arya E.; Hu, Xiaoke; Taghizadeh, Farnaz; Pelipeychenko, Dmytro; Baccarini, Manuela; Johnson, James D.			Pancreatic beta-cell Raf-1 is required for glucose tolerance, insulin secretion, and insulin 2 transcription	FASEB JOURNAL			English	Article						knockout mouse models; diabetes; growth factor signaling	PROTEIN-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; GENE-TRANSCRIPTION; C-RAF-1 GENE; MICE LACKING; SYNAPSIN-I; APOPTOSIS; EXPRESSION; GROWTH; ACTIVATION	Regulation of glucose homeostasis by insulin depends on pancreatic beta-cell growth, survival, and function. Raf-1 kinase is a major downstream target of several growth factors that promote proliferation and survival of many cell types, including the pancreatic beta cells. We have previously reported that insulin protects beta cells from apoptosis and promotes proliferation by activating Raf-1 signaling in cultured human islets, mouse islets, and MIN6 cells. As Raf-1 activity is critical for basal apoptosis and insulin secretion in vitro, we hypothesized that Raf-1 may play an important role in glucose homeostasis in vivo. To test this hypothesis, we utilized the Cre-loxP recombination system to obtain a pancreatic beta-cell-specific ablation of Raf-1 kinase gene (RIPCre(+/+):Raf-1(flox/flox)) and a complete set of littermate controls (RIPCre(+/+):Raf-1(wt/wt)). RIPCre(+/+):Raf-1(flox/flox) mice were viable, and no effects on weight gain were observed. RIPCre(+/+):Raf-1(flox/flox) mice had increased fasting blood glucose levels and impaired glucose tolerance but normal insulin tolerance compared to littermate controls. Insulin secretion in vivo and in isolated islets was markedly impaired, but there was no apparent effect on the exocytosis machinery. However, islet insulin protein and insulin 2 mRNA, but not insulin 1 mRNA, were dramatically reduced in Raf-1-knockout mice. Analysis of insulin 2 knockout mice demonstrated that this reduction in mRNA was sufficient to impair in vivo insulin secretion. Our data further indicate that Raf-1 specifically and acutely regulates insulin 2 mRNA via negative action on Foxo1, which has been shown to selectively control the insulin 2 gene. This work provides the first direct evidence that Raf-1 signaling is essential for the regulation of basal insulin transcription and the supply of releasable insulin in vivo.-Alejandro, E. U., Lim, G. E., Mehran, A. E., Hu, X., Taghizadeh, F., Pelipeychenko, D., Baccarini, M., Johnson, J. D. Pancreatic beta-cell Raf-1 is required for glucose tolerance, insulin secretion, and insulin 2 transcription. FASEB J. 25, 3884-3895 (2011). www.fasebj.org	[Alejandro, Emilyn U.; Lim, Gareth E.; Mehran, Arya E.; Hu, Xiaoke; Taghizadeh, Farnaz; Pelipeychenko, Dmytro; Johnson, James D.] Univ British Columbia, Dept Cellular & Physiol Sci, Diabet Res Grp, Lab Mol Signalling Diabet, Vancouver, BC V6T 1Z3, Canada; [Alejandro, Emilyn U.; Lim, Gareth E.; Mehran, Arya E.; Hu, Xiaoke; Taghizadeh, Farnaz; Pelipeychenko, Dmytro; Johnson, James D.] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1Z3, Canada; [Baccarini, Manuela] Univ Vienna, Max F Perutz Labs, Vienna, Austria	University of British Columbia; University of British Columbia; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Johnson, JD (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Diabet Res Grp, Lab Mol Signalling Diabet, 5358 Life Sci Bldg,2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	jimjohn@interchange.ubc.ca	Baccarini, Manuela/B-6481-2014; Lim, Gareth/G-9143-2017	Baccarini, Manuela/0000-0002-3033-391X; Alejandro, Emilyn/0000-0002-7941-8439; Lim, Gareth/0000-0003-3850-3757	Juvenile Research Foundation (JDRF); Canadian Diabetes Association; Canadian Institutes for Health Research (CIHR); U.S. National Institutes of Health [F31DK079346]; University of British Columbia; Michael Smith Foundation for Health Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK079346] Funding Source: NIH RePORTER	Juvenile Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Canadian Diabetes Association; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of British Columbia; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Rong Liang for technical assistance. This work was supported by a regular research grant from the Juvenile Research Foundation (JDRF). J.D.J. was supported by salary awards from the JDRF, Canadian Diabetes Association, and the Canadian Institutes for Health Research (CIHR). E.U.A. was supported by scholarships from the U.S. National Institutes of Health (F31DK079346) and the University of British Columbia. G.E.L. was supported by fellowships from the CIHR and the Michael Smith Foundation for Health Research. E.U.A and G.E.L. performed the experiments, analyzed data, and wrote and edited the manuscript. F.T., A.E.M., X.H., and D.P. performed experiments and analyzed the data. M.B. contributed to discussion and edited the manuscript. J.D.J. conceived the study and wrote and edited the manuscript.	Alejandro EU, 2008, J BIOL CHEM, V283, P2407, DOI 10.1074/jbc.M703612200; Alejandro EU, 2010, ENDOCRINOLOGY, V151, P502, DOI 10.1210/en.2009-0678; Aspinwall CA, 1999, J BIOL CHEM, V274, P6360, DOI 10.1074/jbc.274.10.6360; Beith JL, 2008, ENDOCRINOLOGY, V149, P2251, DOI 10.1210/en.2007-1557; Bernal-Mizrachi E, 2001, J CLIN INVEST, V108, P1631, DOI 10.1172/JCI13785; Bernal-Mizrachi E, 2004, J CLIN INVEST, V114, P928, DOI 10.1172/JCI200420016; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; Dror V, 2007, DIABETOLOGIA, V50, P2504, DOI 10.1007/s00125-007-0835-5; Duan LL, 2010, P NATL ACAD SCI USA, V107, P22314, DOI 10.1073/pnas.1016630108; Ehrenreiter K, 2005, J CELL BIOL, V168, P955, DOI 10.1083/jcb.200409162; Elghazi L, 2007, DIABETES OBES METAB, V9, P147, DOI 10.1111/j.1463-1326.2007.00783.x; Fex M, 2007, J ENDOCRINOL, V194, P551, DOI 10.1677/JOE-07-0161; Fontes G, 2009, DIABETES, V58, P2048, DOI 10.2337/db08-0579; Galabova-Kovacs G, 2006, CELL CYCLE, V5, P1514, DOI 10.4161/cc.5.14.2981; Gu CY, 2010, CELL METAB, V11, P298, DOI 10.1016/j.cmet.2010.03.006; Hay CW, 2006, DIABETES, V55, P3201, DOI 10.2337/db06-0788; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Jeffrey KD, 2008, P NATL ACAD SCI USA, V105, P8452, DOI 10.1073/pnas.0711232105; Johnson JD, 2008, CELL CYCLE, V7, P1343, DOI 10.4161/cc.7.10.5865; Johnson JD, 2006, P NATL ACAD SCI USA, V103, P19575, DOI 10.1073/pnas.0604208103; Johnson JD, 2002, P NATL ACAD SCI USA, V99, P14566, DOI 10.1073/pnas.222099799; Kaneko K, 2010, CELL METAB, V12, P619, DOI 10.1016/j.cmet.2010.11.005; Khoo S, 2003, J BIOL CHEM, V278, P32969, DOI 10.1074/jbc.M301198200; Kowluru A, 2010, DIABETES, V59, P967, DOI 10.2337/db09-1334; Lawrence MC, 2005, J BIOL CHEM, V280, P26751, DOI 10.1074/jbc.M503158200; Lawrence MC, 2008, P NATL ACAD SCI USA, V105, P13315, DOI 10.1073/pnas.0806465105; Lee JY, 2006, J BIOL CHEM, V281, P2649, DOI 10.1074/jbc.M512373200; Leibiger IB, 1998, MOL CELL, V1, P933, DOI 10.1016/S1097-2765(00)80093-3; Leibiger IB, 2008, ANNU REV NUTR, V28, P233, DOI 10.1146/annurev.nutr.28.061807.155530; Leroux L, 2001, DIABETES, V50, pS150, DOI 10.2337/diabetes.50.2007.S150; Longuet C, 2005, ENDOCRINOLOGY, V146, P643, DOI 10.1210/en.2004-0841; Luciani DS, 2005, MOL CELL ENDOCRINOL, V241, P88, DOI 10.1016/j.mce.2005.06.006; Madadi G, 2008, BIOCHEM BIOPH RES CO, V376, P694, DOI 10.1016/j.bbrc.2008.09.054; Matsumoto K, 1999, J BIOL CHEM, V274, P2053, DOI 10.1074/jbc.274.4.2053; MEUR G, J BIOL CHEM, V286, P13647; Mikula M, 2001, EMBO J, V20, P1952, DOI 10.1093/emboj/20.8.1952; Montiel C, 2003, J NEUROSCI RES, V71, P353, DOI 10.1002/jnr.10499; Nelson JD, 2011, DIABETES, V60, P127, DOI 10.2337/db09-1806; Niault T, 2009, J CELL BIOL, V187, P335, DOI 10.1083/jcb.200906178; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Otani K, 2004, AM J PHYSIOL-ENDOC M, V286, pE41, DOI 10.1152/ajpendo.00533.2001; Sreenan SK, 2001, DIABETES, V50, P2013, DOI 10.2337/diabetes.50.9.2013; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Ueki K, 2006, NAT GENET, V38, P583, DOI 10.1038/ng1787; Wang HJ, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-66; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624; Yamaguchi O, 2004, J CLIN INVEST, V114, P937, DOI 10.1172/JCI200420317; Yokomaku D, 2003, MOL ENDOCRINOL, V17, P831, DOI 10.1210/me.2002-0314; Ziegler CG, 2008, ENDOCRINOLOGY, V149, P320, DOI 10.1210/en.2007-0645	52	31	31	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	NOV	2011	25	11					3884	3895		10.1096/fj.10-180349	http://dx.doi.org/10.1096/fj.10-180349			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	844BT	21817126	Green Published			2022-12-25	WOS:000296723100013
J	Schulze, T; Golfier, S; Tabeling, C; Rabel, K; Graler, MH; Witzenrath, M; Lipp, M				Schulze, Tobias; Golfier, Sven; Tabeling, Christoph; Raebel, Katrin; Graeler, Markus H.; Witzenrath, Martin; Lipp, Martin			Sphingosine-1-phospate receptor 4 (S1P(4)) deficiency profoundly affects dendritic cell function and T(H)17-cell differentiation in a murine model	FASEB JOURNAL			English	Article						G-protein-coupled receptor; T-cell polarization; animal model	PROTEIN-COUPLED RECEPTOR; CD4 T-CELLS; 1-PHOSPHATE RECEPTOR; AIRWAY HYPERRESPONSIVENESS; LYMPHOCYTE EGRESS; TRANSGENIC MICE; ALLERGIC-ASTHMA; CHEMOTAXIS; MIGRATION; RESPONSES	Although predominantly expressed on lymphocytic and hematopoietic cells, the role of sphingosine-1-phospate receptor 4 (S1P(4)) in immune homeo-stasis is still poorly understood. In this report, we used a S1P(4)-deficient murine model to characterize the biological role of S1P(4)-mediated S1P signaling in the immune system. S1p(4)(-/-) animals showed normal peripheral lymphocyte numbers and a regular architecture of secondary lymphoid organs. Interestingly, S1P4 only marginally affects T-cell function in vivo. In contrast, dendritic cell (DC) migration and cytokine secretion are profoundly affected by S1P(4) deficiency. Lack of S1P(4) expression on DCs significantly reduces T(H)17 differentiation of T-H cells. Furthermore, in various in vivo models of T(H)1- or T(H)2-dominated immune reactions, S1P(4) deficiency consistently increased the amplitude of T(H)2-dominated immune responses, while those depending on T(H)1-dominated mechanisms were diminished. Finally, S1p(4)(-/-) mice showed decreased pathology in a model of dextran sulfate sodium-induced colitis. In summary, for the first time, we show that S1P(4) signaling is involved in the regulation of DC function and T(H)17 T-cell differentiation. S1P(4)-mediated S1P signaling also modifies the course of various immune diseases in a murine model. We propose that S1P(4) may constitute an interesting target to influence the course of various autoimmune pathologies.-Schulze, T., Golfier, S., Tabeling, C., Rabel, K., Graler, M. H., Witzenrath, M., Lipp, M. Sphingosine-1-phospate receptor 4 (S1P(4)) deficiency profoundly affects dendritic cell function and T(H)17-cell differentiation in a murine model. FASEB J. 25, 4024-4036 (2011). www.fasebj.org	[Schulze, Tobias; Golfier, Sven; Raebel, Katrin; Graeler, Markus H.; Lipp, Martin] MDC, Max Delbruck Ctr Mol Med, Dept Tumor Genet & Immunogenet, D-13125 Berlin, Germany; [Tabeling, Christoph; Witzenrath, Martin] Charite, Dept Internal Med Infect Dis & Pulm Med, D-13353 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Lipp, M (corresponding author), MDC, Max Delbruck Ctr Mol Med, Dept Tumor Genet & Immunogenet, Robert Rossle Str 10, D-13125 Berlin, Germany.	mlipp@mdc-berlin.de	Gräler, Markus/ABH-1905-2021	Gräler, Markus/0000-0001-6650-7849; Tabeling, Christoph/0000-0001-9189-4318; Lipp, Martin/0000-0002-0087-2672	Deutsche Krebshilfe (German Cancer Aid) [FKZ 106952]	Deutsche Krebshilfe (German Cancer Aid)(Deutsche Krebshilfe)	The authors thank Gerd Mueller and Uta Hoepken for helpful discussions and critical reading of the manuscript. The authors are grateful to Jenny Grobe, Ulrike Keitel, and Heike Schwede for technical assistance. This work was supported by Deutsche Krebshilfe (German Cancer Aid) grant FKZ 106952.	Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Choi JW, 2008, BBA-MOL CELL BIOL L, V1781, P531, DOI 10.1016/j.bbalip.2008.03.004; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; Czeloth N, 2007, J IMMUNOL, V179, P5855, DOI 10.4049/jimmunol.179.9.5855; Dorsam G, 2003, J IMMUNOL, V171, P3500, DOI 10.4049/jimmunol.171.7.3500; Egger B, 2000, DIGESTION, V62, P240, DOI 10.1159/000007822; Fukata M, 2008, J IMMUNOL, V180, P1886, DOI 10.4049/jimmunol.180.3.1886; Girkontaite I, 2004, J EXP MED, V200, P1491, DOI 10.1084/jem.20041483; Goetzl EJ, 2004, J CLIN INVEST, V114, P1531, DOI 10.1172/JCI200423704; Golfier S, 2010, FASEB J, V24, P4701, DOI 10.1096/fj.09-141473; Gollmann G, 2008, INT IMMUNOL, V20, P911, DOI 10.1093/intimm/dxn050; Graeler M, 2002, J IMMUNOL, V169, P4084, DOI 10.4049/jimmunol.169.8.4084; Grahler MH, 2005, J IMMUNOL, V174, P1997; Graler MH, 1998, GENOMICS, V53, P164, DOI 10.1006/geno.1998.5491; Graler MH, 2003, J CELL BIOCHEM, V89, P507, DOI 10.1002/jcb.10537; Haberberger RV, 2009, J ALLERGY CLIN IMMUN, V124, P933, DOI 10.1016/j.jaci.2009.06.034; Held HD, 1999, BRIT J PHARMACOL, V126, P1191, DOI 10.1038/sj.bjp.0702394; Huang MC, 2007, J IMMUNOL, V178, P6806, DOI 10.4049/jimmunol.178.11.6806; Idzko M, 2002, FASEB J, V16, P625, DOI 10.1096/fj.01-0625fje; Idzko M, 2006, J CLIN INVEST, V116, P2935, DOI 10.1172/JCI28295; Jolly PS, 2004, J EXP MED, V199, P959, DOI 10.1084/jem.20030680; Kabashima K, 2006, J EXP MED, V203, P2683, DOI 10.1084/jem.20061289; Kohno T, 2003, GENES CELLS, V8, P685, DOI 10.1046/j.1365-2443.2003.00667.x; Kurashima Y, 2007, J IMMUNOL, V179, P1577, DOI 10.4049/jimmunol.179.3.1577; Kveberg L, 2002, EUR J IMMUNOL, V32, P1856, DOI 10.1002/1521-4141(200207)32:7<1856::AID-IMMU1856>3.0.CO;2-B; Lai WQ, 2008, J IMMUNOL, V180, P4323, DOI 10.4049/jimmunol.180.6.4323; Lan YY, 2008, TRANSPL IMMUNOL, V20, P88, DOI 10.1016/j.trim.2008.07.004; Liao JJ, 2007, J IMMUNOL, V178, P5425, DOI 10.4049/jimmunol.178.9.5425; Maeda Y, 2007, J IMMUNOL, V178, P3437, DOI 10.4049/jimmunol.178.6.3437; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Matsuyuki H, 2006, CELL MOL IMMUNOL, V3, P429; Muller H, 2005, EUR J IMMUNOL, V35, P533, DOI 10.1002/eji.200425556; Osorio F, 2008, EUR J IMMUNOL, V38, P3274, DOI 10.1002/eji.200838950; Pabst R, 2002, J ALLERGY CLIN IMMUN, V110, P209, DOI 10.1067/mai.2002.126836; Rahaman M, 2006, AM J RESP CELL MOL, V34, P233, DOI 10.1165/rcmb.2005-0126OC; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Roviezzo F, 2004, P NATL ACAD SCI USA, V101, P11170, DOI 10.1073/pnas.0401439101; Roviezzo F, 2007, AM J RESP CELL MOL, V36, P757, DOI 10.1165/rcmb.2006-0383OC; Roviezzo F, 2010, AM J RESP CELL MOL, V42, P572, DOI 10.1165/rcmb.2009-0108OC; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Skeritzian CA, 2007, PHARMACOL THERAPEUT, V115, P390, DOI 10.1016/j.pharmthera.2007.05.011; Sunyer J, 1996, EUR RESPIR J, V9, P1880, DOI 10.1183/09031936.96.09091880; Tang AM, 1996, J IMMUNOL, V157, P117; Wang WG, 2007, J IMMUNOL, V178, P4885, DOI 10.4049/jimmunol.178.8.4885; Wang WG, 2005, FASEB J, V19, P1731, DOI 10.1096/fj.05-3730fje; Witzenrath M, 2006, EUR RESPIR J, V28, P370, DOI 10.1183/09031936.06.00080105; Witzenrath M, 2006, AM J PHYSIOL-LUNG C, V291, pL466, DOI 10.1152/ajplung.00011.2005; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978	49	81	82	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2011	25	11					4024	4036		10.1096/fj.10-179028	http://dx.doi.org/10.1096/fj.10-179028			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	844BT	21825036				2022-12-25	WOS:000296723100026
J	Shinkyo, R; Xu, LB; Tallman, KA; Cheng, Q; Porter, NA; Guengerich, FP				Shinkyo, Raku; Xu, Libin; Tallman, Keri A.; Cheng, Qian; Porter, Ned A.; Guengerich, F. Peter			Conversion of 7-Dehydrocholesterol to 7-Ketocholesterol Is Catalyzed by Human Cytochrome P450 7A1 and Occurs by Direct Oxidation without an Epoxide Intermediate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEMLI-OPITZ SYNDROME; CHOLESTEROL AUTOXIDATION; BIOLOGICAL-ACTIVITIES; ESCHERICHIA-COLI; OXYSTEROLS; METABOLISM; PRODUCTS; MIGRATION; PLASMA; 4-BETA-HYDROXYCHOLESTEROL	7-Ketocholesterol is a bioactive sterol, a potent competitive inhibitor of cytochrome P450 7A1, and toxic in liver cells. Multiple origins of this compound have been identified, with cholesterol being the presumed precursor. Although routes for formation of the 7-keto compound from cholesterol have been established, we found that 7-dehydrocholesterol (the immediate precursor of cholesterol) is oxidized by P450 7A1 to 7-ketocholesterol (k(cat)/K-m = 3 x 10(4) M-1 s(-1)). P450 7A1 converted lathosterol (Delta(5)-dihydro-7-dehydrocholesterol) to a mixture of the 7-keto and 7 alpha,8 alpha-epoxide products (similar to 1:2 ratio), with the epoxide not rearranging to the ketone. The oxidation of 7-dehydrocholesterol occured with predominant formation of 7-ketocholesterol and with the 7 alpha,8 alpha-epoxide as only a minor product; the synthesized epoxide was stable in the presence of P450 7A1. The mechanism of 7-dehydrocholesterol oxidation to 7-ketocholesterol is proposed to involve a FeIII-O-C-C+ intermediate and a 7,8-hydride shift or an alternative closing to yield the epoxide (Liebler, D. C., and Guengerich, F. P. (1983) Biochemistry 22, 5482-5489). Accordingly, reaction of P450 7A1 with 7-[H-2(1)]dehydrocholesterol yielded complete migration of deuterium in the product 7-ketocholesterol. The finding that 7-dehydrocholesterol is a precursor of 7-ketocholesterol has relevance to an inborn error of metabolism known as Smith-Lemli-Opitz syndrome (SLOS) caused by defective cholesterol biosynthesis. Mutations within the gene encoding 7-dehydrocholesterol reductase, the last enzyme in the pathway, lead to the accumulation of 7-dehydrocholesterol in tissues and fluids of SLOS patients. Our findings suggest that 7-ketocholesterol levels may also be elevated in SLOS tissue and fluids as a result of P450 7A1 oxidation of 7-dehydrocholesterol.	[Shinkyo, Raku; Cheng, Qian; Porter, Ned A.; Guengerich, F. Peter] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Xu, Libin; Tallman, Keri A.; Porter, Ned A.] Vanderbilt Univ, Dept Chem, Sch Med, Nashville, TN 37232 USA; [Porter, Ned A.; Guengerich, F. Peter] Vanderbilt Univ, Ctr Mol Toxicol, Sch Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Cheng, Q (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu	Xu, Libin/J-3693-2019; Shinkyo, Raku/HIK-2997-2022	Xu, Libin/0000-0003-1021-5200; 	NICHD NIH HHS [R01 HD064727] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD064727] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BJORKHEM I, 1986, ANAL BIOCHEM, V154, P497, DOI 10.1016/0003-2697(86)90021-7; Bjorkhem I, 2009, MOL ASPECTS MED, V30, P171, DOI 10.1016/j.mam.2009.02.001; Bodin K, 2001, J BIOL CHEM, V276, P38685, DOI 10.1074/jbc.M105127200; Bodin K, 2002, J BIOL CHEM, V277, P31534, DOI 10.1074/jbc.M201712200; BREUER O, 1990, STEROIDS, V55, P185, DOI 10.1016/0039-128X(90)90109-O; BREUER O, 1993, EUR J BIOCHEM, V215, P705, DOI 10.1111/j.1432-1033.1993.tb18082.x; Brown AJ, 1999, ATHEROSCLEROSIS, V142, P1, DOI 10.1016/S0021-9150(98)00196-8; Brown AJ, 1997, J LIPID RES, V38, P1730; BROWN MS, 1974, J BIOL CHEM, V249, P7306; Chang YH, 1997, FREE RADICAL BIO MED, V23, P202, DOI 10.1016/S0891-5849(96)00626-0; de Sain-van der Velden MGM, 2008, J INHERIT METAB DIS, V31, pS387, DOI 10.1007/s10545-008-0963-1; DZELETOVIC S, 1995, ANAL BIOCHEM, V225, P73, DOI 10.1006/abio.1995.1110; GILLAM EMJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P123, DOI 10.1006/abbi.1993.1401; Gontscharow N. P., 1971, J STEROID BIOCHEM, V2, P389; GONTSCHAROW NP, 1975, ENDOKRINOLOGIE, V64, P213; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Guengerich F. P., 2007, PRINCIPLES METHODS T, P1981; Guengerich FP, 2005, ARCH BIOCHEM BIOPHYS, V440, P204, DOI 10.1016/j.abb.2005.06.019; GUROFF G, 1967, SCIENCE, V157, P1524, DOI 10.1126/science.157.3796.1524; Haas D, 2007, J INHERIT METAB DIS, V30, P375, DOI 10.1007/s10545-007-0537-7; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; HOLICK MF, 1977, BIOCHEM BIOPH RES CO, V76, P107, DOI 10.1016/0006-291X(77)91674-6; Hosea NA, 2000, BIOCHEMISTRY-US, V39, P5929, DOI 10.1021/bi992765t; HOWARD JA, 1968, J AM CHEM SOC, V90, P1056, DOI 10.1021/ja01006a037; HUGHES H, 1994, ARTERIOSCLER THROMB, V14, P1177, DOI 10.1161/01.ATV.14.7.1177; Javitt NB, 2008, STEROIDS, V73, P149, DOI 10.1016/j.steroids.2007.10.004; KEENEY DS, 1993, PHARMACOL THERAPEUT, V58, P301, DOI 10.1016/0163-7258(93)90026-A; Kelley RI, 2000, J MED GENET, V37, P321, DOI 10.1136/jmg.37.5.321; KELLEY RI, 1995, CLIN CHIM ACTA, V236, P45, DOI 10.1016/0009-8981(95)06038-4; Korade Z, 2010, J LIPID RES, V51, P3259, DOI 10.1194/jlr.M009365; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; LIEBLER DC, 1983, BIOCHEMISTRY-US, V22, P5482, DOI 10.1021/bi00293a005; MACLAUGHLIN J, 1985, J CLIN INVEST, V76, P1536, DOI 10.1172/JCI112134; MANSUY D, 1984, BIOCHEM BIOPH RES CO, V119, P319, DOI 10.1016/0006-291X(84)91654-1; Mast N, 2005, J LIPID RES, V46, P1561, DOI 10.1194/jlr.D500008-JLR200; MILLER RE, 1982, BIOCHEMISTRY-US, V21, P1090, DOI 10.1021/bi00534a041; Moreira EF, 2009, INVEST OPHTH VIS SCI, V50, P523, DOI 10.1167/iovs.08-2373; Murphy RC, 2008, J BIOL CHEM, V283, P15521, DOI 10.1074/jbc.R700049200; Parikh A, 1997, NAT BIOTECHNOL, V15, P784, DOI 10.1038/nbt0897-784; Porter FD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001417; Porter FD, 2011, J LIPID RES, V52, P6, DOI 10.1194/jlr.R009548; Rodriguez IR, 2009, PHOTOCHEM PHOTOBIOL, V85, P1116, DOI 10.1111/j.1751-1097.2009.00568.x; Schroepfer GJ, 2000, PHYSIOL REV, V80, P361, DOI 10.1152/physrev.2000.80.1.361; Shaw PM, 1997, ARCH BIOCHEM BIOPHYS, V348, P107, DOI 10.1006/abbi.1997.0378; Shinkyo R, 2011, J BIOL CHEM, V286, P18426, DOI 10.1074/jbc.M111.240457; Shinkyo R, 2011, J BIOL CHEM, V286, P4632, DOI 10.1074/jbc.M110.193409; Smith, 1981, CHOLESTEROL AUTOXIDA; SMITH LL, 1989, FREE RADICAL BIO MED, V7, P285, DOI 10.1016/0891-5849(89)90136-6; SMITH LL, 1987, CHEM PHYS LIPIDS, V44, P87, DOI 10.1016/0009-3084(87)90046-6; Song W, 1998, J BIOL CHEM, V273, P16223, DOI 10.1074/jbc.273.26.16223; STRANDVIK B, 1994, SCAND J CLIN LAB INV, V54, P1, DOI 10.3109/00365519409086503; TINT GS, 1995, J LIPID RES, V36, P89; TINT GS, 1994, NEW ENGL J MED, V330, P107, DOI 10.1056/NEJM199401133300205; Vejux A, 2008, BRAZ J MED BIOL RES, V41, P545, DOI 10.1590/S0100-879X2008000700001; Vejux A, 2009, MOL ASPECTS MED, V30, P153, DOI 10.1016/j.mam.2009.02.006; Xu L., 2011, J LIPID RES IN PRESS; Xu LB, 2011, J LIPID RES, V52, P1222, DOI 10.1194/jlr.M014498; Xu LB, 2010, J AM CHEM SOC, V132, P2222, DOI 10.1021/ja9080265; Xu LB, 2009, J AM CHEM SOC, V131, P13037, DOI 10.1021/ja9029076	59	74	74	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33021	33028		10.1074/jbc.M111.282434	http://dx.doi.org/10.1074/jbc.M111.282434			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21813643	hybrid, Green Published			2022-12-25	WOS:000294968800020
J	McGee, CE; Tsetsarkin, KA; Guy, B; Lang, J; Plante, K; Vanlandingham, DL; Higgs, S				McGee, Charles E.; Tsetsarkin, Konstantin A.; Guy, Bruno; Lang, Jean; Plante, Kenneth; Vanlandingham, Dana L.; Higgs, Stephen			Stability of Yellow Fever Virus under Recombinatory Pressure as Compared with Chikungunya Virus	PLOS ONE			English	Article							BORNE ENCEPHALITIS-VIRUS; HEPATITIS-C-VIRUS; CULTURED MOSQUITO CELLS; CENTRAL-NERVOUS-SYSTEM; DENGUE VIRUS; WEST-NILE; NATURAL-POPULATIONS; IN-VITRO; JAPANESE ENCEPHALITIS; FLAVIVIRUS VACCINES	Recombination is a mechanism whereby positive sense single stranded RNA viruses exchange segments of genetic information. Recent phylogenetic analyses of naturally occurring recombinant flaviviruses have raised concerns regarding the potential for the emergence of virulent recombinants either post-vaccination or following co-infection with two distinct wild-type viruses. To characterize the conditions and sequences that favor RNA arthropod-borne virus recombination we constructed yellow fever virus (YFV) 17D recombinant crosses containing complementary deletions in the envelope protein coding sequence. These constructs were designed to strongly favor recombination, and the detection conditions were optimized to achieve high sensitivity recovery of putative recombinants. Full length recombinant YFV 17D virus was never detected under any of the experimental conditions examined, despite achieving estimated YFV replicon co-infection levels of similar to 2.4 x 10(6) in BHK-21 (vertebrate) cells and similar to 1.05 x 10(5) in C(7)10 (arthropod) cells. Additionally YFV 17D superinfection resistance was observed in vertebrate and arthropod cells harboring a primary infection with wild-type YFV Asibi strain. Furthermore recombination potential was also evaluated using similarly designed chikungunya virus (CHIKV) replicons towards validation of this strategy for recombination detection. Non-homologus recombination was observed for CHIKV within the structural gene coding sequence resulting in an in-frame duplication of capsid and E3 gene. Based on these data, it is concluded that even in the unlikely event of a high level acute co-infection of two distinct YFV genomes in an arthropod or vertebrate host, the generation of viable flavivirus recombinants is extremely unlikely.	[McGee, Charles E.; Tsetsarkin, Konstantin A.; Plante, Kenneth; Vanlandingham, Dana L.; Higgs, Stephen] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [McGee, Charles E.] Univ N Carolina, Carolina Vaccine Inst, Chapel Hill, NC USA; [Guy, Bruno; Lang, Jean] Sanofi Pasteur, Marcy Letoile, France	University of Texas System; University of Texas Medical Branch Galveston; University of North Carolina; University of North Carolina Chapel Hill	McGee, CE (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.	cemcgee@email.unc.edu		Plante, Kenneth/0000-0002-7485-3167	Univesity of Texas Medical Branch Department of Pathology; Centers for Disease Control [(R36) PAR07-231]; NIH [T32 AI 07526]; UTMB; Sanofi-Pasteur; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007526] Funding Source: NIH RePORTER	Univesity of Texas Medical Branch Department of Pathology; Centers for Disease Control(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UTMB; Sanofi-Pasteur; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was in part supported by funds provided by the Univesity of Texas Medical Branch Department of Pathology. CEM was supported by Centers for Disease Control Grant for Public Health Research Dissertation (R36) PAR07-231 and NIH T32 AI 07526 Training Grant in Emerging and Tropical Infectious Diseases. KAT was supported by the Mclaughlin pre-doctoral fellowship UTMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study. The study was also supported by funds provided by Sanofi-Pasteur whose role was to support the experiments described in this study.	ABRAHAM R, 1993, J INFECT DIS, V168, P1105, DOI 10.1093/infdis/168.5.1105; BAKER JC, 1987, J AM VET MED ASSOC, V190, P1449; Barrett ADT, 2007, VACCINE, V25, P2758, DOI 10.1016/j.vaccine.2006.12.015; Becher P, 2001, J VIROL, V75, P6256, DOI 10.1128/JVI.75.14.6256-6264.2001; BOCHKOVA NG, 1981, VOP VIRUSOL+, P611; Bredenbeek PJ, 2003, J GEN VIROL, V84, P1261, DOI 10.1099/vir.0.18860-0; Carvalho SES, 2010, VIRUS GENES, V40, P60, DOI 10.1007/s11262-009-0428-0; Chen SP, 2008, ARCH VIROL, V153, P1175, DOI 10.1007/s00705-008-0090-1; Colina R, 2004, J GEN VIROL, V85, P31, DOI 10.1099/vir.0.19472-0; Cristina J, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-53; Cuervo NS, 2001, J VIROL, V75, P5740, DOI 10.1128/JVI.75.13.5740-5751.2001; de Silva A, 2004, LANCET, V364, P500, DOI 10.1016/S0140-6736(04)16802-5; DITTMAR D, 1982, J GEN VIROL, V59, P273, DOI 10.1099/0022-1317-59-2-273; FOKINA GI, 1982, ACTA VIROL, V26, P369; FURIONE M, 1993, VIROLOGY, V196, P199; GEORGESCU MM, 1994, J VIROL, V68, P8089, DOI 10.1128/JVI.68.12.8089-8101.1994; GOULD EA, 1985, J GEN VIROL, V66, P1369, DOI 10.1099/0022-1317-66-7-1369; Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013; Gubler Duane J, 2006, Novartis Found Symp, V277, P3, DOI 10.1002/0470058005.ch2; Guy B, 2010, VACCINE, V28, P632, DOI 10.1016/j.vaccine.2009.09.098; HASE T, 1987, ARCH VIROL, V92, P273, DOI 10.1007/BF01317484; Heinz FX, 2003, ADV VIRUS RES, V59, P63, DOI 10.1016/S0065-3527(03)59003-0; Higgs S., 1997, The molecular biology of insect disease vectors: a methods manual., P459; Holmes EC, 1999, MOL BIOL EVOL, V16, P405, DOI 10.1093/oxfordjournals.molbev.a026121; Hombach J, 2004, LANCET, V364, P498, DOI 10.1016/S0140-6736(04)16800-1; HOSKINS Meredith, 1935, American Journal of Tropical Medicine, V15, P675; IGARASHI A, 1979, NATURE, V280, P690, DOI 10.1038/280690a0; JOHNSON HN, 1970, AM J TROP MED HYG, V19, P537, DOI 10.4269/ajtmh.1970.19.537; Kageyama S, 2006, J MED VIROL, V78, P1423, DOI 10.1002/jmv.20714; Kalinina O, 2002, J VIROL, V76, P4034, DOI 10.1128/JVI.76.8.4034-4043.2002; KEW OM, 1981, J GEN VIROL, V56, P337, DOI 10.1099/0022-1317-56-2-337; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Kummerer BM, 2000, VET MICROBIOL, V77, P117, DOI 10.1016/S0378-1135(00)00268-6; Kurbanov F, 2008, J INFECT DIS, V198, P1448, DOI 10.1086/592757; Legrand-Abravanel F, 2007, J VIROL, V81, P4357, DOI 10.1128/JVI.02639-06; MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; MALENKO GV, 1982, ACTA VIROL, V26, P362; Mallet L, 1997, J MED VIROL, V52, P50; McElroy KL, 2005, J GEN VIROL, V86, P1747, DOI 10.1099/vir.0.80746-0; MCGEE CE, 2009, INFECT DISSEMINATION; Mcgee CE, 2008, J INFECT DIS, V197, P686, DOI 10.1086/527328; Mcgee CE, 2008, J INFECT DIS, V197, P693, DOI 10.1086/527329; MEYERS G, 1991, ARCH VIROL, P133; MEYERS G, 1992, VIROLOGY, V191, P368, DOI 10.1016/0042-6822(92)90199-Y; MEYERS G, 1991, VIROLOGY, V180, P602, DOI 10.1016/0042-6822(91)90074-L; MEYERS G, 1989, NATURE, V341, P491, DOI 10.1038/341491a0; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Monath TP, 2005, EXPERT REV VACCINES, V4, P553, DOI 10.1586/14760584.4.4.553; Monath TP, 2005, VACCINE, V23, P2956, DOI 10.1016/j.vaccine.2004.11.069; Moreau I, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-95; Moreno MP, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-87; Murphy BR, 2004, LANCET, V364, P499, DOI 10.1016/S0140-6736(04)16801-3; MURPHY BR, 2010, ANNU REV IMMUNOL; Murray K, 2010, J INFECT DIS, V201, P2, DOI 10.1086/648731; Noppornpanth S, 2006, J VIROL, V80, P7569, DOI 10.1128/JVI.00312-06; Nybakken GE, 2006, J VIROL, V80, P11467, DOI 10.1128/JVI.01125-06; Pepin KM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-28; Perez-Ramirez G, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-260; Petersen LR, 2005, J TRAVEL MED, V12, pS3; Petrakova O, 2005, J VIROL, V79, P7597, DOI 10.1128/JVI.79.12.7597-7608.2005; PHILIP CB, 1962, AM J TROP MED HYG, V11, P697, DOI 10.4269/ajtmh.1962.11.697; Pickett BE, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-165; POGODINA VV, 1983, ARCH VIROL, V75, P71, DOI 10.1007/BF01314128; POGODINA VV, 1981, ACTA VIROL, V25, P344; POGODINA VV, 1981, ACTA VIROL, V25, P337; POGODINA VV, 1981, ACTA VIROL, V25, P352; Pushko P, 1997, VIROLOGY, V239, P389, DOI 10.1006/viro.1997.8878; RAVI V, 1993, J MED VIROL, V40, P326, DOI 10.1002/jmv.1890400412; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; RIDPATH JF, 1995, VIROLOGY, V212, P259, DOI 10.1006/viro.1995.1480; SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHLESINGER S, 1994, ARCH VIROL, P213; Scholle F, 2004, J VIROL, V78, P11605, DOI 10.1128/JVI.78.21.11605-11614.2004; Seligman SJ, 2004, LANCET, V363, P2073, DOI 10.1016/S0140-6736(04)16459-3; Shustov AV, 2007, J VIROL, V81, P11737, DOI 10.1128/JVI.01112-07; Shustov AV, 2010, VIROLOGY, V400, P8, DOI 10.1016/j.virol.2009.12.015; Slavin HB, 1943, J BACTERIOL, V46, P113, DOI 10.1128/JB.46.2.113-116.1943; Smith DR, 2008, VIROLOGY, V372, P176, DOI 10.1016/j.virol.2007.10.011; Strauss JH, 1997, SEMIN VIROL, V8, P85, DOI 10.1006/smvy.1997.0115; STRAUSS JH, 2002, PLUS STRAND RNA DOUB, P57; Taucher C, 2010, J VIROL, V84, P599, DOI 10.1128/JVI.01063-09; Tesh RB, 2005, J INFECT DIS, V192, P287, DOI 10.1086/431153; Tolou HJG, 2001, J GEN VIROL, V82, P1283, DOI 10.1099/0022-1317-82-6-1283; TSETSARKIN K, 2009, ADAPTATION CHIKUNGUN; Tsetsarkin K, 2006, VECTOR-BORNE ZOONOT, V6, P325, DOI 10.1089/vbz.2006.6.325; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Twiddy SS, 2003, J GEN VIROL, V84, P429, DOI 10.1099/vir.0.18660-0; Viazov S, 2010, J MED VIROL, V82, P232, DOI 10.1002/jmv.21631; Weaver SC, 1997, J VIROL, V71, P613, DOI 10.1128/JVI.71.1.613-623.1997; WEISS BG, 1991, J VIROL, V65, P4017, DOI 10.1128/JVI.65.8.4017-4025.1991; Worobey M, 1999, P NATL ACAD SCI USA, V96, P7352, DOI 10.1073/pnas.96.13.7352; Zou G, 2009, J VIROL, V83, P11765, DOI 10.1128/JVI.01205-09	94	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e23247	10.1371/journal.pone.0023247	http://dx.doi.org/10.1371/journal.pone.0023247			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826243	Green Published, gold, Green Submitted			2022-12-25	WOS:000293558900069
J	Davis, DA; Chawla, NV				Davis, Darcy A.; Chawla, Nitesh V.			Exploring and Exploiting Disease Interactions from Multi-Relational Gene and Phenotype Networks	PLOS ONE			English	Article								The availability of electronic health care records is unlocking the potential for novel studies on understanding and modeling disease co-morbidities based on both phenotypic and genetic data. Moreover, the insurgence of increasingly reliable phenotypic data can aid further studies on investigating the potential genetic links among diseases. The goal is to create a feedback loop where computational tools guide and facilitate research, leading to improved biological knowledge and clinical standards, which in turn should generate better data. We build and analyze disease interaction networks based on data collected from previous genetic association studies and patient medical histories, spanning over 12 years, acquired from a regional hospital. By exploring both individual and combined interactions among these two levels of disease data, we provide novel insight into the interplay between genetics and clinical realities. Our results show a marked difference between the well defined structure of genetic relationships and the chaotic co-morbidity network, but also highlight clear interdependencies. We demonstrate the power of these dependencies by proposing a novel multi-relational link prediction method, showing that disease co-morbidity can enhance our currently limited knowledge of genetic association. Furthermore, our methods for integrated networks of diverse data are widely applicable and can provide novel advances for many problems in systems biology and personalized medicine.	[Davis, Darcy A.; Chawla, Nitesh V.] Univ Notre Dame, Dept Comp Sci & Engn, Interdisciplinary Ctr Network Sci & Applicat, Notre Dame, IN 46556 USA	University of Notre Dame	Davis, DA (corresponding author), Univ Notre Dame, Dept Comp Sci & Engn, Interdisciplinary Ctr Network Sci & Applicat, Notre Dame, IN 46556 USA.	nchawla@nd.edu	Chawla, Nitesh/F-2690-2016	Chawla, Nitesh/0000-0003-3932-5956; Davis, Darcy/0000-0003-0652-4406	National Science Foundation (NSF) [BCS-0826958]; Division Of Behavioral and Cognitive Sci [0826958] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	Research is supported in part by the National Science Foundation (NSF) Grant BCS-0826958. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic LA, 2003, SOC NETWORKS, V25, P211, DOI 10.1016/S0378-8733(03)00009-1; Baudot A, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-221; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; DAVIS D, 2009, DATA MIN KNOWL DISC, P388; Davis J., 2006, P 23 INT C MACH LEAR, P233, DOI [10.1145/1143844.1143874, DOI 10.1145/1143844.1143874]; DAVIS J, 1967, SOCIOLOGICAL THEORIE, V2; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; GETOOR, 2005, ACM SIGKDD EXPLORATI, V7, P3, DOI DOI 10.1145/1117454.1117456; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hidalgo CA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000353; HOLLAND PW, 1970, AM J SOCIOL, V76, P492, DOI 10.1086/224954; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; MENON AK, 2010, IEEE INT C DAT MIN; Miller K., 2009, ADV NEURAL INFORM PR, P1276; Moore JH, 2005, MOL GENET METAB, V84, P104, DOI 10.1016/j.ymgme.2004.10.006; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Park J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.16; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; Przulj N, 2004, BIOINFORMATICS, V20, P3508, DOI 10.1093/bioinformatics/bth436; Przulj N, 2007, BIOINFORMATICS, V23, pE177, DOI 10.1093/bioinformatics/btl301; Radivojac P, 2008, PROTEINS, V72, P1030, DOI 10.1002/prot.21989; SAARTSECHANSKY M, 2007, J MACHINE LEARNING R, V8, P9; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Troyanskaya OG, 2003, P NATL ACAD SCI USA, V100, P8348, DOI 10.1073/pnas.0832373100; Ucar D, 2009, BIOINFORMATICS, V25, pI137, DOI 10.1093/bioinformatics/btp213; VASQUEZ A, 2004, P NATL ACAD SCI, V101; Wasserman S., 1994, SOCIAL NETWORK ANAL; Zheleva E, 2010, LECT NOTES COMPUT SC, V5498, P97	30	53	53	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22670	10.1371/journal.pone.0022670	http://dx.doi.org/10.1371/journal.pone.0022670			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829475	gold, Green Submitted, Green Published			2022-12-25	WOS:000293286500016
J	Deshpande, NP; Kaakoush, NO; Mitchell, H; Janitz, K; Raftery, MJ; Li, SS; Wilkins, MR				Deshpande, Nandan P.; Kaakoush, Nadeem O.; Mitchell, Hazel; Janitz, Karolina; Raftery, Mark J.; Li, Simone S.; Wilkins, Marc R.			Sequencing and Validation of the Genome of a Campylobacter concisus Reveals Intra-Species Diversity	PLOS ONE			English	Article							CRYPTIC PLASMID; ESSENTIAL GENES; IDENTIFICATION; CHILDREN; DIARRHEA; VISUALIZATION; ANNOTATIONS; PREVALENCE; PROTEINS; DATABASE	Campylobacter concisus is an emerging pathogen of the human gastrointestinal tract. Its role in different diseases remains a subject of debate; this may be due to strain to strain genetic variation. Here, we sequence and analyze the genome of a C. concisus from a biopsy of a child with Crohn's disease (UNSWCD); the second such genome for this species. A 1.8 Mb genome was assembled with paired-end reads from a next-generation sequencer. This genome is smaller than the 2.1 Mb C. concisus reference BAA-1457. While 1593 genes were conserved across UNSWCD and BAA-1457, 138 genes from UNSWCD and 281 from BAA-1457 were unique when compared against the other. To further validate the genome assembly and annotation, comprehensive shotgun proteomics was performed. This confirmed 78% of open reading frames in UNSWCD and, importantly, provided evidence of expression for 217 proteins previously defined as 'hypothetical' in Campylobacter. Substantial functional differences were observed between the UNSWCD and the reference strain. Enrichment analysis revealed differences in membrane proteins, response to stimulus, molecular transport and electron carriers. Synteny maps for the 281 genes not present in UNSWCD identified seven functionally associated gene clusters. These included one associated with the CRISPR family and another which encoded multiple restriction endonucleases; these genes are all involved in resistance to phage attack. Many of the observed differences are consistent with UNSWCD having adapted to greater surface interaction with host cells, as opposed to BAA-1457 which may prefer a free-living environment.	[Deshpande, Nandan P.; Li, Simone S.; Wilkins, Marc R.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Syst Biol Initiat, Sydney, NSW, Australia; [Janitz, Karolina] Univ New S Wales, Ramaciotti Ctr Gene Funct Anal, Sydney, NSW, Australia; [Raftery, Mark J.] Univ New S Wales, Biol Mass Spectrometry Facil, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Deshpande, NP (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Syst Biol Initiat, Sydney, NSW, Australia.	marc.wilkins@unsw.edu.au	Kaakoush, Nadeem/ABG-9499-2020	Li, Simone S/0000-0002-0073-3656; Kaakoush, Nadeem Omar/0000-0003-4017-1077	University of New South Wales; NSW State Government; EIF Super Science Scheme; Australian Research Council; National Health and Medical Research Council, Australia	University of New South Wales; NSW State Government; EIF Super Science Scheme; Australian Research Council(Australian Research Council); National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	MRW and the Systems Biology Initiative acknowledge financial support from the University of New South Wales, the NSW State Government Science Leveraging Fund, the EIF Super Science Scheme, and the Australian Research Council. We acknowledge Federal government subsidies for genomic and proteomic analyses at the Ramaciotti Centre for Gene Function Analysis and the Bioanalytical Mass Spectrometry Facility at the University of New South Wales, respectively. NOK and HM acknowledge the the support of the National Health and Medical Research Council, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabenhus R, 2005, EUR J GASTROEN HEPAT, V17, P1019, DOI 10.1097/00042737-200510000-00003; Aabenhus R, 2002, SCAND J INFECT DIS, V34, P248, DOI 10.1080/00365540110080566; Aabenhus R, 2008, WORLD J GASTROENTERO, V14, P6954, DOI 10.3748/wjg.14.6954; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arthur JW, 2004, J PROTEOME RES, V3, P393, DOI 10.1021/pr034056e; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Engberg J, 2005, CLIN MICROBIOL INFEC, V11, P288, DOI 10.1111/j.1469-0691.2005.01111.x; Engberg J, 2000, J CLIN MICROBIOL, V38, P286; Farrer RA, 2009, FEMS MICROBIOL LETT, V291, P103, DOI 10.1111/j.1574-6968.2008.01441.x; Gatlin CL, 1998, ANAL BIOCHEM, V263, P93, DOI 10.1006/abio.1998.2809; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Ho E, 2008, J PROTEOME RES, V7, P104, DOI 10.1021/pr070274m; *I B, I B INT GEN VIEW IGV; *I WTS, I WTS PFAM 24 0; Istivan TS, 2004, J MED MICROBIOL, V53, P483, DOI 10.1099/jmm.0.45554-0; Ito T, 2007, BRIT J BIOMED SCI, V64, P70, DOI 10.1080/09674845.2007.11732759; Kaakoush NO, 2010, FEBS J, V277, P1606, DOI 10.1111/j.1742-4658.2010.07587.x; KAMMA JJ, 1994, J PERIODONTOL, V65, P1073, DOI 10.1902/jop.1994.65.11.1073; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Lastovica A. J., 2006, Clinical Microbiology Newsletter, V28, P49, DOI 10.1016/j.clinmicnews.2006.03.004; Lastovica AJ, 2000, J CLIN MICROBIOL, V38, P2798; LINDBLOM GB, 1995, SCAND J INFECT DIS, V27, P187, DOI 10.3109/00365549509019006; Maher M, 2003, J CLIN MICROBIOL, V41, P2980, DOI 10.1128/JCM.41.7.2980-2986.2003; Man SM, 2010, J INFECT DIS, V202, P1855, DOI 10.1086/657316; Man SM, 2010, INFLAMM BOWEL DIS, V16, P1008, DOI 10.1002/ibd.21157; Man SM, 2010, APPL ENVIRON MICROB, V76, P3071, DOI 10.1128/AEM.02551-09; Matsheka MI, 2002, FEMS MICROBIOL LETT, V211, P17, DOI 10.1016/S0378-1097(02)00667-5; MOORE LVH, 1987, J DENT RES, V66, P989, DOI 10.1177/00220345870660052401; Musmanno RA, 1998, MICROBIOLOGICA, V21, P15; Newell DG, 2005, EUR J GASTROEN HEPAT, V17, P1013, DOI 10.1097/00042737-200510000-00001; Ochman H, 2001, SCIENCE, V292, P1096, DOI 10.1126/science.1058543; Reinhardt JA, 2009, GENOME RES, V19, P294, DOI 10.1101/gr.083311.108; RUSSELL JWP, 1998, CAMPYLOBACTER HELICO; Schlenker C, 2009, BEST PRACT RES CL GA, V23, P89, DOI 10.1016/j.bpg.2008.11.014; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Studholme DJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-395; TANNER ACR, 1987, J PERIODONTAL RES, V22, P207, DOI 10.1111/j.1600-0765.1987.tb01568.x; VANDAMME P, 1989, J CLIN MICROBIOL, V27, P1775, DOI 10.1128/JCM.27.8.1775-1781.1989; VanEtterijck R, 1996, J CLIN MICROBIOL, V34, P2304, DOI 10.1128/JCM.34.9.2304-2306.1996; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; WATERMAN SR, 1993, GENE, V125, P11, DOI 10.1016/0378-1119(93)90739-P; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang L, 2009, J CLIN MICROBIOL, V47, P453, DOI 10.1128/JCM.01949-08; Zhang R, 2004, NUCLEIC ACIDS RES, V32, pD271, DOI 10.1093/nar/gkh024	49	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22170	10.1371/journal.pone.0022170	http://dx.doi.org/10.1371/journal.pone.0022170			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829448	Green Published, Green Submitted, gold			2022-12-25	WOS:000293286500006
J	Jiang, ZY; Lossie, AC; Applegate, TJ				Jiang, Zhengyu; Lossie, Amy C.; Applegate, Todd J.			Evolution of Trefoil Factor(s): Genetic and Spatio-Temporal Expression of Trefoil Factor 2 in the Chicken (Gallus Gallus Domesticus)	PLOS ONE			English	Article							SPASMOLYTIC POLYPEPTIDE PSP; FUNCTIONAL DIVERGENCE; PEPTIDES; FAMILY; MOUSE; LOCALIZATION; PROTEIN; TFF1	Trefoil factors are essential healing initiators participating in mucosal reconstitution and tissue morphogenesis, especially on the surfaces of the gastrointestinal tract. This family has been cloned and characterized predominantly from mammals and amphibians. Avian species ingest stone and grit to help digest food, which may expose their gut to severe physical conditions. To further the understanding of the function of the TFF gene family across species, we undertook this research to clone, sequence, and characterize the spatio-temporal expression patterns of chicken TFF2 (ChTFF2) cDNA. Bioinformatics analysis of the promoter region and deduced amino acid sequence demonstrated that ChTFF2 contained unique characteristics; specifically the chicken promoter has multiple start sites and the protein contains a series of Lys-Lys-Val repeats. Unlike mammals, where TFF2 is detected primarily in the stomach, and occasionally in the proximal duodenum, chicken TFF2 transcripts are found throughout the gastrointestinal tract, with major expression sites in the glandular and muscular stomach as well as evident expression in the colon, small intestine, cecal tonsil and crop. Temporal analysis of intestinal ChTFF2 transcripts by quantitative RT-PCR showed high levels in embryos and a trend of constant expression during embryonic and post-hatch development, with a reduction occurring around hatch. Phylogenetic analysis highlighted the conservation of TFF proteins and functional divergence of trefoil domains, which suggest a transitional role in the bird during evolution.	[Jiang, Zhengyu; Lossie, Amy C.; Applegate, Todd J.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Lossie, Amy C.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University Bloomington	Jiang, ZY (corresponding author), Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA.	applegt@purdue.edu	Lossie, Amy/D-2480-2009	Lossie, Amy/0000-0001-5078-7743; Applegate, Todd/0000-0002-2406-5058	Purdue University; Biomin Research Center, (Tulln, Austria)	Purdue University; Biomin Research Center, (Tulln, Austria)	This work was funded through state and federal funds appropriated to Purdue University, as well as through gift funds from Biomin Research Center, (Tulln, Austria). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-azzeh ED, 2000, BBA-GENE STRUCT EXPR, V1490, P324, DOI 10.1016/S0167-4781(00)00013-0; Babyatsky MW, 1996, GASTROENTEROLOGY, V110, P489, DOI 10.1053/gast.1996.v110.pm8566596; Beck S, 1999, DNA CELL BIOL, V18, P157, DOI 10.1089/104454999315547; Bulitta CJ, 2002, BIOCHEM BIOPH RES CO, V293, P366, DOI 10.1016/S0006-291X(02)00199-7; Campbell BG, 2008, RES VET SCI, V85, P68, DOI 10.1016/j.rvsc.2007.08.008; Gott P, 1996, EUR J HUM GENET, V4, P308; Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080; Gu X, 2003, GENETICA, V118, P133, DOI 10.1023/A:1024197424306; HAUSER F, 1991, J BIOL CHEM, V266, P21306; Hnia K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003854; JORGENSEN KH, 1982, REGUL PEPTIDES, V3, P207, DOI 10.1016/0167-0115(82)90126-4; JORNVALL H, 1983, BIOSCIENCE REP, V3, P225, DOI 10.1007/BF01122454; Karam SM, 2004, GUT, V53, P1408, DOI 10.1136/gut.2003.031963; Karcher DM, 2009, GROWTH HORM IGF RES, V19, P31, DOI 10.1016/j.ghir.2008.05.003; Kjellev S, 2009, CELL MOL LIFE SCI, V66, P1350, DOI 10.1007/s00018-008-8646-5; KOKAS E, 1967, COMP BIOCHEM PHYSIOL, V22, P81, DOI 10.1016/0010-406X(67)90169-7; Lefebvre O, 1996, SCIENCE, V274, P259, DOI 10.1126/science.274.5285.259; LEFEBVRE O, 1993, J CELL BIOL, P122; Lemercinier X, 2001, BIOCHEMISTRY-US, V40, P9552, DOI 10.1021/bi010184+; Lin J, 1999, BIOL NEONATE, V76, P92, DOI 10.1159/000014146; Madsen J, 2007, J HISTOCHEM CYTOCHEM, V55, P505, DOI 10.1369/jhc.6A7100.2007; Marchbank T, 2001, J BIOL CHEM, V276, P24088, DOI 10.1074/jbc.M101363200; Otto WR, 1999, ANAT EMBRYOL, V199, P499, DOI 10.1007/s004290050247; RASMUSSEN TN, 1992, HISTOCHEMISTRY, V98, P113, DOI 10.1007/BF00717002; Ribieras S, 2001, GENE, V266, P67, DOI 10.1016/S0378-1119(01)00380-8; Sands BE, 1996, ANNU REV PHYSIOL, V58, P253, DOI 10.1146/annurev.ph.58.030196.001345; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Thim L, 2005, CELL MOL LIFE SCI, V62, P2956, DOI 10.1007/s00018-005-5484-6; Thim L, 1997, CELL MOL LIFE SCI, V53, P888, DOI 10.1007/s000180050108; THIM L, 1982, REGUL PEPTIDES, V3, P221, DOI 10.1016/0167-0115(82)90127-6; THIM L, 1989, FEBS LETT, V250, P85, DOI 10.1016/0014-5793(89)80690-8; Tran CP, 1999, GUT, V44, P636, DOI 10.1136/gut.44.5.636; ULAGANATHAN M, 2001, J GASTROEN HEPATOL, P506; Vestergaard EM, 2008, EARLY HUM DEV, V84, P631, DOI 10.1016/j.earlhumdev.2008.04.001; Wong WM, 1999, GUT, V44, P890, DOI 10.1136/gut.44.6.890; YU G, 2010, BIOCH BIOPHYSICAL RE, P1; Zhang J, 2005, BIOCHEM BIOPH RES CO, V330, P1027, DOI 10.1016/j.bbrc.2005.03.077	37	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22691	10.1371/journal.pone.0022691	http://dx.doi.org/10.1371/journal.pone.0022691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829480	Green Published, Green Submitted, gold			2022-12-25	WOS:000293286500018
J	Zhang, YQ; Wang, SC; Li, D; Zhnag, JY; Gu, DH; Zhu, YP; He, FC				Zhang, Yanqiong; Wang, Shaochuang; Li, Dong; Zhnag, Jiyang; Gu, Dianhua; Zhu, Yunping; He, Fuchu			A Systems Biology-Based Classifier for Hepatocellular Carcinoma Diagnosis	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; FOCAL ADHESION KINASE; GENE-EXPRESSION; NETWORK; EGFR; SIGNATURES; SURVIVAL	Aim: The diagnosis of hepatocellular carcinoma (HCC) in the early stage is crucial to the application of curative treatments which are the only hope for increasing the life expectancy of patients. Recently, several large-scale studies have shed light on this problem through analysis of gene expression profiles to identify markers correlated with HCC progression. However, those marker sets shared few genes in common and were poorly validated using independent data. Therefore, we developed a systems biology based classifier by combining the differential gene expression with topological features of human protein interaction networks to enhance the ability of HCC diagnosis. Methods and Results: In the Oncomine platform, genes differentially expressed in HCC tissues relative to their corresponding normal tissues were filtered by a corrected Q value cut-off and Concept filters. The identified genes that are common to different microarray datasets were chosen as the candidate markers. Then, their networks were analyzed by GeneGO Meta-Core software and the hub genes were chosen. After that, an HCC diagnostic classifier was constructed by Partial Least Squares modeling based on the microarray gene expression data of the hub genes. Validations of diagnostic performance showed that this classifier had high predictive accuracy (85.88 similar to 92.71%)and area under ROC curve (approximating 1.0), and that the network topological features integrated into this classifier contribute greatly to improving the predictive performance. Furthermore, it has been demonstrated that this modeling strategy is not only applicable to HCC, but also to other cancers. Conclusion: Our analysis suggests that the systems biology-based classifier that combines the differential gene expression and topological features of human protein interaction network may enhance the diagnostic performance of HCC classifier.	[Zhang, Yanqiong; He, Fuchu] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China; [Zhang, Yanqiong; He, Fuchu] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhang, Yanqiong; Li, Dong; Zhu, Yunping; He, Fuchu] Beijing Inst Radiat Med, State Key Lab Prote, Beijing Proteome Res Ctr, Beijing, Peoples R China; [Wang, Shaochuang; Gu, Dianhua] Nanjing Med Univ, Affiliated Huaian Peoples Hosp 1, Dept Hepatobiliary & Pancreat Surg, Huaian, Jiangsu, Peoples R China; [Zhnag, Jiyang] Natl Univ Def Technol, Dept Automat Control, Coll Mechatron & Automat, Changsha, Hunan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Academy of Military Medical Sciences - China; Nanjing Medical University; National University of Defense Technology - China	Zhang, YQ (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China.	zhuyp@hupo.org.cn; hefc@nic.bmi.ac.cn			Chinese National Key Program of Basic Research [2010CB912700, 2011CB910601]; National ST Major Project [2008ZX10002-016, 2009ZX09301-002]	Chinese National Key Program of Basic Research; National ST Major Project	This work was funded by the Chinese National Key Program of Basic Research (2010CB912700, 2011CB910601), and National S&T Major Project (2008ZX10002-016, 2009ZX09301-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagi CM, 2009, CANCER BIOL THER, V8, P856, DOI 10.4161/cbt.8.9.8246; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Braren R, 2006, J CELL BIOL, V172, P151, DOI 10.1083/jcb.200506184; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chadha KS, 2006, ANN SURG ONCOL, V13, P933, DOI 10.1245/ASO.2006.07.011; Chen JC, 2006, BIOINFORMATICS, V22, P2283, DOI 10.1093/bioinformatics/btl370; Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023; Dinu I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-242; Eschrich S, 2009, INT J RADIAT ONCOL, V75, P497, DOI 10.1016/j.ijrobp.2009.05.056; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Gene Expression Omnibus, GENE EXPRESSION OMNI; Giannelli G, 2006, BIOCHEM PHARMACOL, V71, P479, DOI 10.1016/j.bcp.2005.11.005; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Hopfner M, 2004, J HEPATOL, V41, P1008, DOI 10.1016/j.jhep.2004.08.024; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Huether A, 2005, BIOCHEM PHARMACOL, V70, P1568, DOI 10.1016/j.bcp.2005.09.007; Ikoma J, 2002, HEPATO-GASTROENTEROL, V49, P235; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kannangai R, 2006, MODERN PATHOL, V19, P1456, DOI 10.1038/modpathol.3800665; Li Y, 2003, J CANCER RES CLIN, V129, P43, DOI 10.1007/s00432-002-0396-4; Liu CC, 2006, NUCLEIC ACIDS RES, V34, P4069, DOI 10.1093/nar/gkl583; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Lu X, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100138; Ludbrook J, 2008, INT J EPIDEMIOL, V37, P1430, DOI 10.1093/ije/dyn162; Normanno N, 2003, J CELL PHYSIOL, V194, P13, DOI 10.1002/jcp.10194; Peng X, 2004, CARDIOVASC RES, V64, P421, DOI 10.1016/j.cardiores.2004.07.012; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rioux P A, 1994, J Comput Biol, V1, P293, DOI 10.1089/cmb.1994.1.293; Sakamoto M, 2008, INTERVIROLOGY, V51, P42, DOI 10.1159/000122603; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Segal E, 2005, NAT GENET, V37, pS38, DOI 10.1038/ng1561; Sherman M, 2008, NEW ENGL J MED, V359, P2045, DOI 10.1056/NEJMe0807581; Song PM, 2008, WORLD J GASTROENTERO, V14, P5816, DOI 10.3748/wjg.14.5816; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; van Nimwegen MJ, 2007, BIOCHEM PHARMACOL, V73, P597, DOI 10.1016/j.bcp.2006.08.011; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; STANFORD MICROARRAY	38	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22426	10.1371/journal.pone.0022426	http://dx.doi.org/10.1371/journal.pone.0022426			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829460	Green Published, Green Submitted, gold			2022-12-25	WOS:000293284600012
J	Fu, YS; Shi, ZY; Wu, ML; Zhang, JL; Jia, L; Chen, XW				Fu, Yuanshuai; Shi, Zhiyi; Wu, Minglin; Zhang, Junling; Jia, Liang; Chen, Xiaowu			Identification and Differential Expression of MicroRNAs during Metamorphosis of the Japanese Flounder (Paralichthys olivaceus)	PLOS ONE			English	Article							NUCLEIC-ACID; RNA; LET-7; DROSOPHILA; REAL; CLASSIFICATION; SKELETAL; SEQUENCE; PCR	Background: MicroRNAs (miRNAs) are a class of endogenous small non-coding RNAs of 20-25 nucleotides that play a key role in diverse biological processes. Japanese flounder undergo dramatic metamorphosis in their early development. The metamorphosis is characterized by morphological transformation from a bilaterally symmetrical to an asymmetrical body shape concomitant with extensive morphological and physiological remodeling of organs. So far, only a few miRNAs have been identified in fish and there are very few reports about the Japanese flounder miRNA. Methodology/Principal Findings: Solexa sequencing technology was used to perform high throughput sequencing of the small RNA library from the metamorphic period of Japanese flounder. Subsequently, aligning these sequencing data with metazoan known miRNAs, we characterized 140 conserved miRNAs and 57 miRNA: miRNA* pairs from the small RNA library. Among these 57 miRNA: miRNA* pairs, twenty flounder miRNA precursors were amplified from genomic DNA. We also demonstrated evolutionary conservation of Japanese flounder miRNAs and miRNA* in the animal evolution process. Using miRNA microarrays, we identified 66 differentially expressed miRNAs at two metamorphic stages (17 and 29 days post hatching) of Japanese flounder. The results show that miRNAs might play a key role in regulating gene expression during Japanese flounder metamorphosis. Conclusions/Significance: We identified a large number of miRNAs during flounder metamorphosis, some of which are differentially expressed at two different metamorphic stages. The study provides an opportunity for further understanding of miRNA function in the regulation of flounder metamorphosis and gives us clues for further studies of the mechanisms of metamorphosis in Japanese flounder.	[Fu, Yuanshuai; Shi, Zhiyi; Wu, Minglin; Zhang, Junling; Jia, Liang; Chen, Xiaowu] Shanghai Ocean Univ, Key Lab Explorat & Utilizat Aquat Genet Resources, Minist Educ, Shanghai, Peoples R China	Shanghai Ocean University	Fu, YS (corresponding author), Shanghai Ocean Univ, Key Lab Explorat & Utilizat Aquat Genet Resources, Minist Educ, Shanghai, Peoples R China.	zyshi@shou.edu.cn			National Natural Science Foundation of China [30571420]; Shanghai Leading Academic Discipline Project [S30701]; Graduate Education Excellent Paper Trainee Program of Shanghai; Shanghai Ocean University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Graduate Education Excellent Paper Trainee Program of Shanghai; Shanghai Ocean University	This work was supported by the National Natural Science Foundation of China (30571420) (http://www.nsfc.gov.cn), the Shanghai Leading Academic Discipline Project (S30701), the Graduate Education Excellent Paper Trainee Program of Shanghai, and the Shanghai Ocean University Student Scientific and Technological Creativity Fund by Luo Zhao-yao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Caygill EE, 2008, CURR BIOL, V18, P943, DOI 10.1016/j.cub.2008.06.020; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Chen X, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r78; Gao XL, 2004, BIOPOLYMERS, V73, P579, DOI 10.1002/bip.20005; Gomez-Orte E, 2009, P NATL ACAD SCI USA, V106, P21678, DOI 10.1073/pnas.0907391106; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Heimberg AM, 2008, P NATL ACAD SCI USA, V105, P2946, DOI 10.1073/pnas.0712259105; Hertel J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-25; Inui Y, 1995, AQUACULTURE, V135, P87, DOI 10.1016/0044-8486(95)01017-3; Jiang P, 2007, NUCLEIC ACIDS RES, V35, pW339, DOI 10.1093/nar/gkm368; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Leaman D, 2005, CELL, V121, P1097, DOI 10.1016/j.cell.2005.04.016; Liang CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010698; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCarthy JJ, 2007, J APPL PHYSIOL, V102, P306, DOI 10.1152/japplphysiol.00932.2006; MINAMI T, 1982, B JPN SOC SCI FISH, V48, P1581; MITSUO N, 2010, FISHERIES SCI TOKYO, V76, P243; Ng KLS, 2007, BIOINFORMATICS, V23, P1321, DOI 10.1093/bioinformatics/btm026; Niwa R, 2007, CURR OPIN GENET DEV, V17, P145, DOI 10.1016/j.gde.2007.02.004; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pasquinelli AE, 2003, EVOL DEV, V5, P372, DOI 10.1046/j.1525-142X.2003.03044.x; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Salem M, 2010, MAR BIOTECHNOL, V12, P410, DOI 10.1007/s10126-009-9232-z; Schreiber AM, 2006, J EXP BIOL, V209, P610, DOI 10.1242/jeb.02056; Schyth BD, 2008, J FISH BIOL, V72, P1890, DOI 10.1111/j.1095-8649.2008.01819.x; Sempere LF, 2006, J EXP ZOOL PART B, V306B, P575, DOI 10.1002/jez.b.21118; Sonkoly E, 2010, J INVEST DERMATOL, V130, P124, DOI 10.1038/jid.2009.294; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; Telernan AA, 2006, GENE DEV, V20, P417, DOI 10.1101/gad.374406; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; Wang XW, 2005, BIOINFORMATICS, V21, P3610, DOI 10.1093/bioinformatics/bti562; Watanabe T, 2005, FEBS LETT, V579, P318, DOI 10.1016/j.febslet.2004.11.067; Wei YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r6; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xie CX, 2011, COMP FUNCT GENOM, DOI 10.1155/2011/256038; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Zhang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004677; Zhu Jie, 2005, Journal of Ocean University of China, V4, P145, DOI 10.1007/s11802-005-0008-4; Zhu Qi, 2007, V382, P287, DOI 10.1007/978-1-59745-304-2_19; Zhu Z, 2010, DOMEST ANIM ENDOCRIN, V38, P200, DOI 10.1016/j.domaniend.2009.10.004; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	50	100	136	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22957	10.1371/journal.pone.0022957	http://dx.doi.org/10.1371/journal.pone.0022957			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818405	Green Published, gold, Green Submitted			2022-12-25	WOS:000293282700089
J	Ramot, Y; Tiede, S; Biro, T; Abu Bakar, MH; Sugawara, K; Philpott, MP; Harrison, W; Pietila, M; Paus, R				Ramot, Yuval; Tiede, Stephan; Biro, Tamas; Abu Bakar, Mohd Hilmi; Sugawara, Koji; Philpott, Michael P.; Harrison, Wesley; Pietila, Marko; Paus, Ralf			Spermidine Promotes Human Hair Growth and Is a Novel Modulator of Human Epithelial Stem Cell Functions	PLOS ONE			English	Article							TRANSGENIC MICE; ORNITHINE-DECARBOXYLASE; POLYAMINE METABOLISM; FOLLICLE FUNCTION; BREAST-CANCER; EXPRESSION; CYCLE; DIFFERENTIATION; PATHOGENESIS; PAPILLOMAS	Background: Rapidly regenerating tissues need sufficient polyamine synthesis. Since the hair follicle (HF) is a highly proliferative mini-organ, polyamines may also be important for normal hair growth. However, the role of polyamines in human HF biology and their effect on HF epithelial stem cells in situ remains largely unknown. Methods and Findings: We have studied the effects of the prototypic polyamine, spermidine (0.1-1 mu M), on human scalp HFs and human HF epithelial stem cells in serum-free organ culture. Under these conditions, spermidine promoted hair shaft elongation and prolonged hair growth (anagen). Spermidine also upregulated expression of the epithelial stem cell-associated keratins K15 and K19, and dose-dependently modulated K15 promoter activity in situ and the colony forming efficiency, proliferation and K15 expression of isolated human K15-GFP+ cells in vitro. Inhibiting the rate-limiting enzyme of polyamine synthesis, ornithine decarboyxlase (ODC), downregulated intrafollicular K15 expression. In primary human epidermal keratinocytes, spermidine slightly promoted entry into the S/G2-M phases of the cell cycle. By microarray analysis of human HF mRNA extracts, spermidine upregulated several key target genes implicated e.g. in the control of cell adherence and migration (POP3), or endoplasmic reticulum and mitochondrial functions (SYVN1, NACA and SLC25A3). Excess spermidine may restrict further intrafollicular polyamine synthesis by inhibiting ODC gene and protein expression in the HF's companion layer in situ. Conclusions: These physiologically and clinically relevant data provide the first direct evidence that spermidine is a potent stimulator of human hair growth and a previously unknown modulator of human epithelial stem cell biology.	[Ramot, Yuval] Hadassah Hebrew Univ, Med Ctr, Dept Dermatol, Jerusalem, Israel; [Ramot, Yuval; Tiede, Stephan; Abu Bakar, Mohd Hilmi; Sugawara, Koji; Paus, Ralf] Univ Lubeck, Dept Dermatol, Lubeck, Germany; [Biro, Tamas] Univ Debrecen, Dept Physiol, Res Ctr Mol Med, Debrecen, Hungary; [Abu Bakar, Mohd Hilmi] Univ Sains Malaysia, Kelantan, Malaysia; [Philpott, Michael P.; Harrison, Wesley] Queen Mary Univ London, Ctr Cutaneous Res, Blizard Inst Cell & Mol Sci, Barts & London Sch Med & Dent, London, England; [Pietila, Marko] Univ Eastern Finland, Dept Biotechnol & Mol Med, AI Virtanen Inst Mol Sci, Bioctr Kuopio, Kuopio, Finland; [Paus, Ralf] Univ Manchester, Sch Translat Med, Manchester, Lancs, England	Hebrew University of Jerusalem; Hadassah University Medical Center; University of Lubeck; University of Debrecen; Universiti Sains Malaysia; University of London; Queen Mary University London; University of Eastern Finland; University of Manchester	Ramot, Y (corresponding author), Hadassah Hebrew Univ, Med Ctr, Dept Dermatol, Jerusalem, Israel.	ralf.paus@uk-sh.de	Paus, Ralf/F-6243-2011; Paus, Ralf/B-5279-2015	Tiede, Stephan/0000-0002-6045-3736; Philpott, Michael/0000-0002-1255-4612; Sugawara, Koji/0000-0003-1662-3272; Paus, Ralf/0000-0002-3492-9358	Giuliani S.p.A, Milano, Italy; Deutsche Forschungsgemeinschaft [DFG Pa 345/12-1]; Giuliani	Giuliani S.p.A, Milano, Italy; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Giuliani	This study was supported in part by a research grant from Giuliani S.p.A, Milano, Italy, to Ralf Paus. Additional funding comes from Deutsche Forschungsgemeinschaft (DFG Pa 345/12-1) to RP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; RP and MP have received academic research grants from Giuliani, and have served in a consultancy function for this company. The authors are neither employees of Giuliani Srl, Milano, nor do they have any direct financial interests in the products of this company. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	BALLAS SK, 1983, P NATL ACAD SCI-BIOL, V80, P1942, DOI 10.1073/pnas.80.7.1942; Bettuzzi S, 1999, FEBS LETT, V446, P18, DOI 10.1016/S0014-5793(99)00182-9; Bodo E, 2007, AM J PATHOL, V171, P1153, DOI 10.2353/ajpath.2007.061164; Childs AC, 2003, CELL MOL LIFE SCI, V60, P1394, DOI 10.1007/s00018-003-2332-4; Coleman CS, 2002, CARCINOGENESIS, V23, P359, DOI 10.1093/carcin/23.2.359; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; Davidson NE, 1999, ENDOCR-RELAT CANCER, V6, P69, DOI 10.1677/erc.0.0060069; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Fashe TM, 2010, AMINO ACIDS, V38, P583, DOI 10.1007/s00726-009-0421-x; Foitzik K, 2006, AM J PATHOL, V168, P748, DOI 10.2353/ajpath.2006.050468; GASPAR E, 2009, FASEB J, V24, P373; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Gingold-Belfer R, 2011, INT J MOL MED, V27, P25, DOI 10.3892/ijmm.2010.558; Gugliucci A, 2004, CLIN CHIM ACTA, V344, P23, DOI 10.1016/j.cccn.2004.02.022; Hamzavi I, 2007, J AM ACAD DERMATOL, V57, P54, DOI 10.1016/j.jaad.2006.09.025; Harries MJ, 2010, AM J PATHOL, V177, P2152, DOI 10.2353/ajpath.2010.100454; Hu X, 2005, CANCER RES, V65, P11026, DOI 10.1158/0008-5472.CAN-05-1339; Hynd PI, 1996, J INVEST DERMATOL, V106, P249, DOI 10.1111/1523-1747.ep12340634; Johnson DA, 2002, INVEST OPHTH VIS SCI, V43, P1228; Kaeberlein M, 2009, NAT CELL BIOL, V11, P1277, DOI 10.1038/ncb1109-1277; Kim M, 2010, CARCINOGENESIS, V31, P1685, DOI 10.1093/carcin/bgq144; Kloepper JE, 2008, EXP DERMATOL, V17, P592, DOI 10.1111/j.1600-0625.2008.00720.x; Kloepper JE, 2010, EXP DERMATOL, V19, P305, DOI 10.1111/j.1600-0625.2009.00939.x; Langbein L, 2005, INT REV CYTOL, V243, P1, DOI 10.1016/S0074-7696(05)43001-6; LIMAT A, 1989, J INVEST DERMATOL, V92, P758, DOI 10.1111/1523-1747.ep12722530; LIMAT A, 1986, J INVEST DERMATOL, V87, P485, DOI 10.1111/1523-1747.ep12455548; Liu YW, 2010, BIOCHEMISTRY-US, V49, P2890, DOI 10.1021/bi902050p; Mayr JA, 2007, AM J HUM GENET, V80, P478, DOI 10.1086/511788; MCCORMACK SA, 1993, AM J PHYSIOL, V264, pG367, DOI 10.1152/ajpgi.1993.264.2.G367; MEGOSH L, 1995, CANCER RES, V55, P4205; Mehnert M, 2010, BIOESSAYS, V32, P905, DOI 10.1002/bies.201000046; Moinard C, 2005, CLIN NUTR, V24, P184, DOI 10.1016/j.clnu.2004.11.001; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Nancarrow M J, 1999, Exp Dermatol, V8, P326; Nancarrow MJ, 1999, MECH DEVELOP, V84, P161, DOI 10.1016/S0925-4773(99)00064-7; Nasizadeh S, 2005, EXP CELL RES, V308, P254, DOI 10.1016/j.yexcr.2005.04.027; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; Oredsson SM, 2003, BIOCHEM SOC T, V31, P366, DOI 10.1042/BST0310366; PALES JL, 1984, SCAND J HAEMATOL, V32, P241; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Panteleyev AA, 2000, EXP DERMATOL, V9, P146, DOI 10.1034/j.1600-0625.2000.009002146.x; Paus R, 2004, DIFFERENTIATION, V72, P489, DOI 10.1111/j.1432-0436.2004.07209004.x; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; PAUS R, 2008, HAIR GROWTH DISORDER, P753; Paus R, 2011, PIGM CELL MELANOMA R, V24, P89, DOI 10.1111/j.1755-148X.2010.00808.x; PEGG AE, 1986, BIOCHEM J, V234, P249, DOI 10.1042/bj2340249; PEGG AE, 1982, AM J PHYSIOL, V243, pC212, DOI 10.1152/ajpcell.1982.243.5.C212; Pegg AE, 2008, AM J PHYSIOL-ENDOC M, V294, pE995, DOI 10.1152/ajpendo.90217.2008; Philpott M P, 1994, J Dermatol Sci, V7 Suppl, pS55, DOI 10.1016/0923-1811(94)90036-1; Pietila M, 2005, J INVEST DERMATOL, V124, P596, DOI 10.1111/j.0022-202X.2005.23636.x; Pietila M, 1997, J BIOL CHEM, V272, P18746, DOI 10.1074/jbc.272.30.18746; Pietila M, 2001, J INVEST DERMATOL, V116, P801, DOI 10.1046/j.1523-1747.2001.01330.x; Ramot Y, 2010, EXP DERMATOL, V19, P784, DOI 10.1111/j.1600-0625.2010.01111.x; Ramot Y, 2010, FASEB J, V24, P1768, DOI 10.1096/fj.09-146415; RHEINWALD JG, 1977, NATURE, V265, P421, DOI 10.1038/265421a0; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; Scorcioni F, 2001, BIOCHEM J, V354, P217, DOI 10.1042/0264-6021:3540217; Smith MK, 1998, CARCINOGENESIS, V19, P1409, DOI 10.1093/carcin/19.8.1409; Soler AP, 1996, J INVEST DERMATOL, V106, P1108, DOI 10.1111/1523-1747.ep12340155; Sugawara K, 2010, J DERMATOL SCI, V57, P155, DOI 10.1016/j.jdermsci.2009.12.004; Sugiura K, 2008, J CHROMATOGR A, V1205, P94, DOI 10.1016/j.chroma.2008.08.026; SUNDBERG JP, 1994, CANCER RES, V54, P1344; Suppola S, 1999, BIOCHEM J, V338, P311, DOI 10.1042/0264-6021:3380311; Thomas T, 2001, CELL MOL LIFE SCI, V58, P244, DOI 10.1007/PL00000852; Tiede S, 2010, EUR J CELL BIOL, V89, P769, DOI 10.1016/j.ejcb.2010.06.002; Tiede S, 2009, STEM CELLS, V27, P2793, DOI 10.1002/stem.213; Tjabringa GS, 2008, J CELL MOL MED, V12, P1710, DOI 10.1111/j.1582-4934.2008.00224.x; Vuohelainen S, 2010, J CELL MOL MED, V14, P1683, DOI 10.1111/j.1582-4934.2009.00808.x; Wolf JE, 2007, INT J DERMATOL, V46, P94, DOI 10.1111/j.1365-4632.2006.03079.x; Yamaguchi T, 2007, J BIOCHEM, V141, P747, DOI 10.1093/jb/mvm080	70	51	54	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22564	10.1371/journal.pone.0022564	http://dx.doi.org/10.1371/journal.pone.0022564			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818338	Green Published, Green Submitted, gold			2022-12-25	WOS:000293282700039
J	Sorio, C; Buffelli, M; Angiari, C; Ettorre, M; Johansson, J; Vezzalini, M; Viviani, L; Ricciardi, M; Verze, G; Assael, BM; Melotti, P				Sorio, Claudio; Buffelli, Mario; Angiari, Chiara; Ettorre, Michele; Johansson, Jan; Vezzalini, Marzia; Viviani, Laura; Ricciardi, Mario; Verze, Genny; Assael, Baroukh Maurice; Melotti, Paola			Defective CFTR Expression and Function Are Detectable in Blood Monocytes: Development of a New Blood Test for Cystic Fibrosis	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; NASAL POTENTIAL DIFFERENCE; CELL-LINE; SWEAT CHLORIDE; DIAGNOSIS; GENE; MACROPHAGES; GUIDELINES; TRANSPORT; MULTICENTER	Background: Evaluation of cystic fibrosis transmembrane conductance regulator (CFTR) functional activity to assess new therapies and define diagnosis of cystic fibrosis (CF) is cumbersome. It is known that leukocytes express detectable levels of CFTR but the molecule has not been characterized in these cells. In this study we aim at setting up and validating a blood test to evaluate CFTR expression and function in leukocytes. Description: Western blot, PCR, immunofluorescence and cell membrane depolarization analysis by single-cell fluorescence imaging, using the potential-sensitive DiSBAC(2)(3) probe were utilized. Expression of PKA phosphorylated, cell membrane-localized CFTR was detected in non-CF monocytes, being undetectable or present in truncated form in monocytes derived from CF patients presenting with nonsense mutations. CFTR agonist administration induced membrane depolarization in monocytes isolated from non-CF donors (31 subjects) and, to a lesser extent, obligate CFTR heterozygous carriers (HTZ: 15 subjects), but it failed in monocytes from CF patients (44 subjects). We propose an index, which values in CF patients are significantly (p < 0.001) lower than in the other two groups. Nasal Potential Difference, measured in selected subjects had concordant results with monocytes assay (Kappa statistic 0.93, 95% CI: 0.80-1.00). Results and Significance: CFTR is detectable and is functional in human monocytes. We also showed that CFTR-associated activity can be evaluated in 5 ml of peripheral blood and devise an index potentially applicable for diagnostic purposes and both basic and translational research: from drug development to evaluation of functional outcomes in clinical trials.	[Sorio, Claudio; Angiari, Chiara; Johansson, Jan; Vezzalini, Marzia; Ricciardi, Mario; Verze, Genny] Univ Verona, Dipartimento Patol & Diagnost, Sez Patol Gen, I-37100 Verona, Italy; [Buffelli, Mario; Angiari, Chiara; Ettorre, Michele; Johansson, Jan; Verze, Genny] Univ Verona, Dipartimento Sci Neurol Neuropsicol Morfol & Moto, Physiol Sect, I-37100 Verona, Italy; [Angiari, Chiara; Johansson, Jan; Verze, Genny; Assael, Baroukh Maurice; Melotti, Paola] Azienda Osped Univ Integrata Verona, Ctr Fibrosi Cist, Verona, Italy; [Viviani, Laura] Univ Milan, Dipartimento Med Lavoro Clin Lavoro L Devoto, Sez Stat Med & Biometria GA Maccacaro, Milan, Italy	University of Verona; University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Milan	Sorio, C (corresponding author), Univ Verona, Dipartimento Patol & Diagnost, Sez Patol Gen, I-37100 Verona, Italy.	claudio.sorio@univr.it; paola.melotti@ospedaleuniverona.it	Buffelli, Mario/C-6953-2018; Sorio, Claudio/F-2764-2018; Viviani, Laura/A-4787-2010; Melotti, Paola/J-6205-2018	Buffelli, Mario/0000-0002-3709-013X; Sorio, Claudio/0000-0003-2739-4014; Viviani, Laura/0000-0003-2419-8472; Melotti, Paola/0000-0002-5276-1595; Ricciardi, Mario/0000-0003-3694-8218; Vezzalini, Marzia/0000-0002-5476-0844	Italian Cystic Fibrosis Research Foundation-onlus [05/09]; Azienda Ospedaliera di Verona [548/93]; "Lega Italiana Fibrosi Cistica Associazione Veneta Onlus" Italy	Italian Cystic Fibrosis Research Foundation-onlus; Azienda Ospedaliera di Verona; "Lega Italiana Fibrosi Cistica Associazione Veneta Onlus" Italy	This study was supported by the Italian Cystic Fibrosis Research Foundation-onlus, FFC #05/09 adopted by Rotary Club Trentino Nord e Tomasi Gioielli, Associazione Trentina FC Onlus (Gruppo di Sostegno FFC) in ricordo di "Anita Furlini" (C. S.), Azienda Ospedaliera di Verona according to Legge 548/93 Finanziamento Ricerca Fibrosi Cistica 2004 (B. M. A.) and by a research grant issued to P. M. by "Lega Italiana Fibrosi Cistica Associazione Veneta Onlus" Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens RC, 2002, PEDIATR PULM, V33, P142, DOI 10.1002/ppul.10043; Blom G., 1958, STAT ESTIMATES TRANS; Bot AGM, 2002, IMMUNODETECTION CFTR; Boyle MP, 2003, CHEST, V124, P482, DOI 10.1378/chest.124.2.482; Bruscia E, 2002, GENE THER, V9, P683, DOI 10.1038/sj.gt.3301741; BRUSCIA EM, 2008, AM J RESP CELL MOL B; Caci E, 2008, BIOCHEM J, V413, P135, DOI 10.1042/BJ20080029; Chen JH, 2010, CELL, V143, P911, DOI 10.1016/j.cell.2010.11.029; Chiba-Falek O, 1998, GENOMICS, V53, P276, DOI 10.1006/geno.1998.5517; CICCHETTI DV, 1990, J CLIN EPIDEMIOL, V43, P551, DOI 10.1016/0895-4356(90)90159-M; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; De Boeck K, 2006, THORAX, V61, P627, DOI 10.1136/thx.2005.043539; De Jonge Hugo R, 2004, J Cyst Fibros, V3 Suppl 2, P159, DOI 10.1016/j.jcf.2004.05.034; Dequeker E, 2009, EUR J HUM GENET, V17, P51, DOI 10.1038/ejhg.2008.136; Derichs N, 2010, THORAX, V65, P594, DOI 10.1136/thx.2009.125088; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Donaldson SH, 2007, CHEST, V132, P1631, DOI 10.1378/chest.07-0288; Doring G, 2000, EUR RESPIR J, V16, P749, DOI 10.1034/j.1399-3003.2000.16d30.x; Farrell PM, 2008, J PEDIATR-US, V153, pS4, DOI 10.1016/j.jpeds.2008.05.005; Green A, 2007, ANN CLIN BIOCHEM, V44, P25, DOI 10.1258/000456307779596011; IWAMURA T, 1987, JPN J CANCER RES, V78, P54; Kerem E, 2008, LANCET, V372, P719, DOI 10.1016/S0140-6736(08)61168-X; MASON SJ, 1991, BRIT J PHARMACOL, V103, P1649, DOI 10.1111/j.1476-5381.1991.tb09842.x; MCDONALD TV, 1992, J BIOL CHEM, V267, P3242; Miller Rupert G., 1981, SIMULTANEOUS STAT IN, V2nd, DOI [DOI 10.1007/978-1-4613-8122-8, 10.1007/978-1-4613-8122-8_1]; Painter RG, 2006, BIOCHEMISTRY-US, V45, P10260, DOI 10.1021/bi060490t; RENIER M, 1995, HUM GENE THER, V6, P1275, DOI 10.1089/hum.1995.6.10-1275; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; SCHOUMACHER RA, 1990, P NATL ACAD SCI USA, V87, P4012, DOI 10.1073/pnas.87.10.4012; Schuler Daniel, 2004, J Cyst Fibros, V3 Suppl 2, P151, DOI 10.1016/j.jcf.2004.05.032; Sermet-Gaudelus I, 2010, AM J RESP CRIT CARE, V182, P929, DOI 10.1164/rccm.201003-0382OC; SORIO C, 1995, CANCER RES, V55, P4855; Sorio C, 2009, J LEUKOCYTE BIOL, V86, P465, DOI 10.1189/jlb.0309120; STEWART B, 1995, AM J RESP CRIT CARE, V151, P899; Stumpf A, 2006, CELL PHYSIOL BIOCHEM, V17, P29, DOI 10.1159/000091457; Warth JD, 1996, CARDIOVASC RES, V31, P615; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Wilschanski M, 2001, EUR RESPIR J, V17, P1208, DOI 10.1183/09031936.01.00092501; Wilschanski M, 2006, AM J RESP CRIT CARE, V174, P787, DOI 10.1164/rccm.200509-1377OC; Xie JX, 1996, BIOPHYS J, V71, P3148, DOI 10.1016/S0006-3495(96)79508-5; Yaakov Y, 2007, CHEST, V132, P1219, DOI 10.1378/chest.06-2975; YOSHIMURA K, 1991, NUCLEIC ACIDS RES, V19, P5417, DOI 10.1093/nar/19.19.5417; ZEITLIN PL, 1991, AM J RESP CELL MOL, V4, P313, DOI 10.1165/ajrcmb/4.4.313; Zhang Y, 2010, J IMMUNOL, V184, P5104, DOI 10.4049/jimmunol.0902851	44	48	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22212	10.1371/journal.pone.0022212	http://dx.doi.org/10.1371/journal.pone.0022212			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811577	gold, Green Published			2022-12-25	WOS:000292956800033
J	Yu, S; Yang, SL; Holsboer, F; Sousa, N; Almeida, OFX				Yu, Shuang; Yang, Silei; Holsboer, Florian; Sousa, Nuno; Almeida, Osborne F. X.			Glucocorticoid Regulation of Astrocytic Fate and Function	PLOS ONE			English	Article							CELL-DEATH; MAJOR DEPRESSION; PREFRONTAL CORTEX; CORTICOSTEROID RECEPTORS; CASPASE ACTIVATION; INDUCED APOPTOSIS; HUMAN HIPPOCAMPUS; PROGENITOR CELLS; PROTECTIVE ROLE; STEM-CELLS	Glial loss in the hippocampus has been suggested as a factor in the pathogenesis of stress-related brain disorders that are characterized by dysregulated glucocorticoid (GC) secretion. However, little is known about the regulation of astrocytic fate by GC. Here, we show that astrocytes derived from the rat hippocampus undergo growth inhibition and display moderate activation of caspase 3 after exposure to GC. Importantly, the latter event, observed both in situ and in primary astrocytic cultures is not followed by either early-or late-stage apoptosis, as monitored by stage I or stage II DNA fragmentation. Thus, unlike hippocampal granule neurons, astrocytes are resistant to GC-induced apoptosis; this resistance is due to lower production of reactive oxygen species (ROS) and a greater buffering capacity against the cytotoxic actions of ROS. We also show that GC influence hippocampal cell fate by inducing the expression of astrocyte-derived growth factors implicated in the control of neural precursor cell proliferation. Together, our results suggest that GC instigate a hitherto unknown dialog between astrocytes and neural progenitors, adding a new facet to understanding how GC influence the cytoarchitecture of the hippocampus.	[Yu, Shuang; Yang, Silei; Holsboer, Florian; Almeida, Osborne F. X.] Max Planck Inst Psychiat, Munich, Germany; [Sousa, Nuno] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal	Max Planck Society; Universidade do Minho	Yu, S (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	shuang@mpipsykl.mpg.de; osa@mpipsykl.mpg.de	Sousa, Nuno JC/N-9137-2017; Sousa, Nuno/C-2782-2009; Almeida, Osborne F.X. F/E-8402-2010	Sousa, Nuno JC/0000-0002-8755-5126; Almeida, Osborne F.X. F/0000-0001-7331-6928	Max Planck Society; Max Planck Institute of Psychiatry; German Academic Exchange Service (DAAD); Portuguese Rectors' Conference (CRUP); European Commission (CRESCENDO) [LSHM-CT-2005-01852]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Max Planck Institute of Psychiatry(Max Planck Society); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Portuguese Rectors' Conference (CRUP); European Commission (CRESCENDO)(European CommissionEuropean Commission Joint Research Centre)	S. Yu was supported by a fellowship from the Max Planck Society. This study was supported by the Max Planck Institute of Psychiatry and by grants from the German Academic Exchange Service (DAAD) and the Portuguese Rectors' Conference (CRUP), and an Integrated Project grant from the European Commission (CRESCENDO, Contract No. LSHM-CT-2005-01852). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acarin L, 2007, GLIA, V55, P954, DOI 10.1002/glia.20518; Almeida OFX, 2000, FASEB J, V14, P779, DOI 10.1096/fasebj.14.5.779; Banasr M, 2010, MOL PSYCHIATR, V15, P501, DOI 10.1038/mp.2008.106; Banasr M, 2008, BIOL PSYCHIAT, V64, P863, DOI 10.1016/j.biopsych.2008.06.008; BOHN MC, 1994, ANN NY ACAD SCI, V746, P243; Bowley MP, 2002, BIOL PSYCHIAT, V52, P404, DOI 10.1016/S0006-3223(02)01404-X; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Cabras S, 2010, INT J NEUROPSYCHOPH, V13, P603, DOI 10.1017/S1461145710000210; Cerqueira JJ, 2005, J NEUROSCI, V25, P7792, DOI 10.1523/JNEUROSCI.1598-05.2005; Cerqueira JJ, 2007, J NEUROSCI, V27, P2781, DOI 10.1523/JNEUROSCI.4372-06.2007; Collins JA, 1997, J HISTOCHEM CYTOCHEM, V45, P923, DOI 10.1177/002215549704500702; Crochemore C, 2005, MOL PSYCHIATR, V10, P790, DOI 10.1038/sj.mp.4001679; Crochemore C, 2002, FASEB J, V16, DOI 10.1096/fj.01-0577com; Czeh B, 2006, NEUROPSYCHOPHARMACOL, V31, P1616, DOI 10.1038/sj.npp.1300982; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Fellin T, 2009, J NEUROCHEM, V108, P533, DOI 10.1111/j.1471-4159.2008.05830.x; Fernando P, 2005, FASEB J, V19, P1671, DOI 10.1096/fj.04-2981fje; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Fernando P, 2007, FASEB J, V21, P8, DOI 10.1096/fj.06-5912hyp; Galderisi U, 2003, ONCOGENE, V22, P5208, DOI 10.1038/sj.onc.1206558; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Goel N, 2009, J NEUROENDOCRINOL, V21, P415, DOI 10.1111/j.1365-2826.2009.01843.x; GOTTSCHALL PE, 1991, AM J PHYSIOL, V261, pE362, DOI 10.1152/ajpendo.1991.261.3.E362; Hassan AHS, 1996, EXP NEUROL, V140, P43, DOI 10.1006/exnr.1996.0113; Haynes LE, 2003, NEUROSCIENCE, V120, P799, DOI 10.1016/S0306-4522(03)00167-2; Herbert J, 2006, J NEUROENDOCRINOL, V18, P393, DOI 10.1111/j.1365-2826.2006.01429.x; Leao P, 2007, SYNAPSE, V61, P40, DOI 10.1002/syn.20341; Lu J, 2005, DEVELOPMENT, V132, P3231, DOI 10.1242/dev.01893; Lu J, 2003, NEUROSCIENCE, V121, P123, DOI 10.1016/S0306-4522(03)00421-4; Lupien SJ, 1999, REV NEUROSCIENCE, V10, P117; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Marinelli M, 2002, EUR J NEUROSCI, V16, P387, DOI 10.1046/j.1460-9568.2002.02089.x; McIntosh LJ, 1996, EXP NEUROL, V141, P201, DOI 10.1006/exnr.1996.0154; Meyer U, 2010, PROG NEUROBIOL, V90, P285, DOI 10.1016/j.pneurobio.2009.10.018; Mirescu C, 2006, HIPPOCAMPUS, V16, P233, DOI 10.1002/hipo.20155; Miura M, 2004, J CLIN INVEST, V114, P1704, DOI 10.1172/JCI200420427; Muller MB, 2001, EUR J NEUROSCI, V14, P1603, DOI 10.1046/j.0953-816x.2001.01784.x; Nichols NR, 2001, BRAIN RES REV, V37, P273, DOI 10.1016/S0165-0173(01)00131-X; Nolte C, 2001, GLIA, V33, P72; OBERHAMMER F, 1993, EMBO J, V12, P3679, DOI 10.1002/j.1460-2075.1993.tb06042.x; Okuyama R, 2004, DEV CELL, V6, P551, DOI 10.1016/S1534-5807(04)00098-X; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Pego JM, 2008, EUR J NEUROSCI, V27, P1503, DOI 10.1111/j.1460-9568.2008.06112.x; Platel JC, 2010, NEURON, V65, P859, DOI 10.1016/j.neuron.2010.03.009; Rajkowska G, 1999, BIOL PSYCHIAT, V45, P1085, DOI 10.1016/S0006-3223(99)00041-4; Rohn TT, 2004, EXP CELL RES, V295, P215, DOI 10.1016/j.yexcr.2003.12.029; Roy NS, 2000, NAT MED, V6, P271; Samejima K, 2001, J BIOL CHEM, V276, P45427, DOI 10.1074/jbc.M108844200; Sandi C, 2004, NAT REV NEUROSCI, V5, P917, DOI 10.1038/nrn1555; Schubert MI, 2008, J PSYCHIATR RES, V42, P902, DOI 10.1016/j.jpsychires.2007.10.003; Sheline YI, 2000, BIOL PSYCHIAT, V48, P791, DOI 10.1016/S0006-3223(00)00994-X; Sionov RV, 2006, J EXP MED, V203, P189, DOI 10.1084/jem.20050433; Son GH, 2005, BIOCHEM BIOPH RES CO, V338, P1751, DOI 10.1016/j.bbrc.2005.10.152; Sousa N, 2008, BRAIN RES REV, V57, P561, DOI 10.1016/j.brainresrev.2007.06.007; Starkman MN, 2003, BIOL PSYCHIAT, V53, P233, DOI 10.1016/S0006-3223(02)01750-X; Stockmeier CA, 2004, BIOL PSYCHIAT, V56, P640, DOI 10.1016/j.biopsych.2004.08.022; Sundberg M, 2006, J NEUROSCI, V26, P5402, DOI 10.1523/JNEUROSCI.4906-05.2006; Vardimon L, 1999, J NEUROBIOL, V40, P513, DOI 10.1002/(SICI)1097-4695(19990915)40:4<513::AID-NEU8>3.0.CO;2-D; Wang S, 1998, NAT BIOTECHNOL, V16, P196, DOI 10.1038/nbt0298-196; Wennstrom M, 2006, BIOL PSYCHIAT, V59, P178, DOI 10.1016/j.biopsych.2005.08.032; Yu S, 2008, J STEROID BIOCHEM, V108, P300, DOI 10.1016/j.jsbmb.2007.09.014; Yu S, 2010, ANN NEUROL, V67, P21, DOI 10.1002/ana.21812; Zandy AJ, 2005, J BIOL CHEM, V280, P30263, DOI 10.1074/jbc.M504007200; Zermati Y, 2001, J EXP MED, V193, P247, DOI 10.1084/jem.193.2.247; Zschocke J, 2005, J BIOL CHEM, V280, P34924, DOI 10.1074/jbc.M502581200	66	31	31	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22419	10.1371/journal.pone.0022419	http://dx.doi.org/10.1371/journal.pone.0022419			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811605	Green Submitted, Green Published, gold			2022-12-25	WOS:000292956800054
J	Spijkers, LJA; van den Akker, RFP; Janssen, BJA; Debets, JJ; De Mey, JGR; Stroes, ESG; van den Born, BJH; Wijesinghe, DS; Chalfant, CE; MacAleese, L; Eijkel, GB; Heeren, RMA; Alewijnse, AE; Peters, SLM				Spijkers, Leon J. A.; van den Akker, Rob F. P.; Janssen, Ben J. A.; Debets, Jacques J.; De Mey, Jo G. R.; Stroes, Erik S. G.; van den Born, Bert-Jan H.; Wijesinghe, Dayanjan S.; Chalfant, Charles E.; MacAleese, Luke; Eijkel, Gert B.; Heeren, Ron M. A.; Alewijnse, Astrid E.; Peters, Stephan L. M.			Hypertension Is Associated with Marked Alterations in Sphingolipid Biology: A Potential Role for Ceramide	PLOS ONE			English	Article							ENDOTHELIUM-DEPENDENT CONTRACTIONS; VASCULAR SMOOTH-MUSCLE; PROTEIN-KINASE-C; SPHINGOSINE KINASE; EXPRESSION; ACETYLCHOLINE; 1-PHOSPHATE; SHR; ACTIVATION; INHIBITOR	Background: Hypertension is, amongst others, characterized by endothelial dysfunction and vascular remodeling. As sphingolipids have been implicated in both the regulation of vascular contractility and growth, we investigated whether sphingolipid biology is altered in hypertension and whether this is reflected in altered vascular function. Methods and Findings: In isolated carotid arteries from spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto (WKY) rats, shifting the ceramide/S1P ratio towards ceramide dominance by administration of a sphingosine kinase inhibitor (dimethylsphingosine) or exogenous application of sphingomyelinase, induced marked endothelium-dependent contractions in SHR vessels (DMS: 1.4 +/- 0.4 and SMase: 2.1 +/- 0.1 mN/mm; n = 10), that were virtually absent in WKY vessels (DMS: 0.0 +/- 0.0 and SMase: 0.6 +/- 0.1 mN/mm; n = 9, p<0.05). Imaging mass spectrometry and immunohistochemistry indicated that these contractions were most likely mediated by ceramide and dependent on iPLA(2), cyclooxygenase-1 and thromboxane synthase. Expression levels of these enzymes were higher in SHR vessels. In concurrence, infusion of dimethylsphingosine caused a marked rise in blood pressure in anesthetized SHR (42 +/- 4%; n = 7), but not in WKY (-12 +/- 10%; n = 6). Lipidomics analysis by mass spectrometry, revealed elevated levels of ceramide in arterial tissue of SHR compared to WKY (691 +/- 42 vs. 419 +/- 27 pmol, n = 3-5 respectively, p<0.05). These pronounced alterations in SHR sphingolipid biology are also reflected in increased plasma ceramide levels (513 +/- 19 pmol WKY vs. 645 +/- 25 pmol SHR, n = 6-12, p<0.05). Interestingly, we observed similar increases in ceramide levels (correlating with hypertension grade) in plasma from humans with essential hypertension (185 +/- 8 pmol vs. 252 +/- 23 pmol; n = 18 normotensive vs. n = 19 hypertensive patients, p<0.05). Conclusions: Hypertension is associated with marked alterations in vascular sphingolipid biology such as elevated ceramide levels and signaling, that contribute to increased vascular tone.	[Spijkers, Leon J. A.; van den Akker, Rob F. P.; Alewijnse, Astrid E.; Peters, Stephan L. M.] Univ Amsterdam, Acad Med Ctr, Dept Pharmacol & Pharmacotherapy, NL-1105 AZ Amsterdam, Netherlands; [Janssen, Ben J. A.; Debets, Jacques J.; De Mey, Jo G. R.] Maastricht Univ, Dept Pharmacol & Toxicol, Maastricht, Netherlands; [Wijesinghe, Dayanjan S.; Chalfant, Charles E.] Virginia Commonwealth Univ, Dept Biochem, Richmond, VA USA; [MacAleese, Luke; Eijkel, Gert B.; Heeren, Ron M. A.] FOM Inst Atom & Mol Phys, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University; Virginia Commonwealth University; AMOLF	Spijkers, LJA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pharmacol & Pharmacotherapy, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	s.l.peters@amc.uva.nl	, MacAleese/E-2131-2012; van den Born, Bert-Jan/E-4263-2017; Heeren, Ron/ABA-4858-2020	, MacAleese/0000-0001-8821-6049; Heeren, Ron/0000-0002-6533-7179; van den Born, Bert-Jan H. (BJH)/0000-0003-0943-4393; Eijkel, Gert/0000-0003-4538-299X; De Mey, Jo G. R./0000-0001-6274-8071	Veteran's Administration (VA); National Institutes of Health [HL072925, CA117950]; EC [NMP-26668]; NATIONAL CANCER INSTITUTE [R01CA117950, R01CA154314] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072925] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010641] Funding Source: NIH RePORTER	Veteran's Administration (VA)(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EC(European CommissionEuropean Commission Joint Research Centre); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was performed within the framework of Top Institute Pharma project T2-108. C. E. C. and D. S. W. acknowledge support by grants from the Veteran's Administration (VA Merit Review I to C. E. C. and a Research Career Scientist Award to C. E. C.), from the National Institutes of Health (HL072925 (C. E. C), CA117950 (C. E. C). R. M. A. H. and L. M. acknowledge funding through the EC Project for targeted delivery of nanomedicine MEDITRANS (FP VI 2006, EU IP NMP-26668). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba S, 2004, BIOL PHARM BULL, V27, P1174, DOI 10.1248/bpb.27.1174; Berry C, 2001, AM J PHYSIOL-HEART C, V281, pH2337, DOI 10.1152/ajpheart.2001.281.6.H2337; Bourbon NA, 2002, J BIOL CHEM, V277, P3286, DOI 10.1074/jbc.M110541200; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; DE PC, 2006, ARTERIOSCLER THROMB, V26, P99; DEMEY JG, 1982, CIRC RES, V51, P439, DOI 10.1161/01.RES.51.4.439; Edsall LC, 1998, BIOCHEMISTRY-US, V37, P12892, DOI 10.1021/bi980744d; Euchenhofer C, 1998, NEUROSCI LETT, V248, P25, DOI 10.1016/S0304-3940(98)00325-5; Feletou M, 2009, BRIT J PHARMACOL, V156, P563, DOI 10.1111/j.1476-5381.2008.00060.x; Fenger M, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-44; GE T, 1995, CIRC RES, V76, P1003, DOI 10.1161/01.RES.76.6.1003; Gluais P, 2005, BRIT J PHARMACOL, V146, P834, DOI 10.1038/sj.bjp.0706390; Gong NL, 2004, P NATL ACAD SCI USA, V101, P6490, DOI 10.1073/pnas.0308684101; Hammad SM, 2010, J LIPID RES, V51, P3074, DOI 10.1194/jlr.D008532; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hendriks-Balk MC, 2008, EUR J PHARMACOL, V600, P1, DOI 10.1016/j.ejphar.2008.09.041; Johns DG, 2001, J HYPERTENS, V19, P63, DOI 10.1097/00004872-200101000-00009; Mazurais D, 2002, J HISTOCHEM CYTOCHEM, V50, P661, DOI 10.1177/002215540205000507; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Mogami K, 2005, FEBS LETT, V579, P393, DOI 10.1016/j.febslet.2004.11.100; Mulders ACM, 2006, ARTERIOSCL THROM VAS, V26, P2043, DOI 10.1161/01.ATV.0000237569.95046.b9; Mulders ACM, 2009, BASIC RES CARDIOL, V104, P50, DOI 10.1007/s00395-008-0744-x; Pettus BJ, 2004, J BIOL CHEM, V279, P11320, DOI 10.1074/jbc.M309262200; Roviezzo F, 2006, FASEB J, V20, P340, DOI 10.1096/fj.05-4647fje; Singh DK, 2007, ARCH BIOCHEM BIOPHYS, V459, P280, DOI 10.1016/j.abb.2006.11.014; Spijkers LJA, 2010, MOL CELLS, V29, P105, DOI 10.1007/s10059-010-0042-y; TADDEI S, 1993, HYPERTENSION, V21, P929, DOI 10.1161/01.HYP.21.6.929; Tamama K, 2002, CURR OPIN LIPIDOL, V13, P489, DOI 10.1097/00041433-200210000-00004; Tang EHC, 2008, PHYSIOL GENOMICS, V32, P409, DOI 10.1152/physiolgenomics.00136.2007; Vanhoutte P M, 1995, Hypertens Res, V18, P87, DOI 10.1291/hypres.18.87; Vanhoutte PM, 2008, J PHYSIOL-LONDON, V586, P5295, DOI 10.1113/jphysiol.2008.161430; Wang H, 2008, MOL CANCER THER, V7, P2967, DOI 10.1158/1535-7163.MCT-08-0549; Wijesinghe DS, 2010, J LIPID RES, V51, P641, DOI 10.1194/jlr.D000430; Wong MSK, 2010, AM J PHYSIOL-HEART C, V298, pH1260, DOI 10.1152/ajpheart.01068.2009	34	114	122	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e21817	10.1371/journal.pone.0021817	http://dx.doi.org/10.1371/journal.pone.0021817			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21818267	Green Published, Green Submitted, gold			2022-12-25	WOS:000292929500010
J	Claperon, A; Guedj, N; Mergey, M; Vignjevic, D; Desbois-Mouthon, C; Boissan, M; Saubamea, B; Paradis, V; Housset, C; Fouassier, L				Claperon, A.; Guedj, N.; Mergey, M.; Vignjevic, D.; Desbois-Mouthon, C.; Boissan, M.; Saubamea, B.; Paradis, V.; Housset, C.; Fouassier, L.			Loss of EBP50 stimulates EGFR activity to induce EMT phenotypic features in biliary cancer cells	ONCOGENE			English	Article						NHERF-1; EGFR; biliary carcinoma; adherens junctions; cell motility	MOESIN-BINDING PHOSPHOPROTEIN-50; SCAFFOLD PROTEINS; TUMOR-SUPPRESSOR; NHE-RF; RECEPTOR; EXPRESSION; NHERF1/EBP50; CONTRIBUTES; MEMBRANE; INHIBITION	Scaffold proteins form multiprotein complexes that are central to the regulation of intracellular signaling. The scaffold protein ezrin-radixin-moesin-binding phosphoprotein 50 (EBP50) is highly expressed at the plasma membrane of normal biliary epithelial cells and binds epidermal growth factor receptor (EGFR), a tyrosine kinase receptor with oncogenic properties. This study investigated EBP50-EGFR interplay in biliary cancer. We report that in a collection of 106 cholangio-carcinomas, EBP50 was delocalized to the cytoplasm of tumor cells in 66% of the cases. Ectopic expression of EBP50 was correlated with the presence of satellite nodules and with the expression of EGFR, which was at the plasma membrane, implying a loss of interaction with EBP50 in these cases. In vitro, loss of interaction between EBP50 and EGFR was mimicked by EBP50 depletion using a small interfering RNA approach in human biliary carcinoma cells co-expressing the two proteins at their plasma membrane, and in which interaction between EBP50 and EGFR was validated. EBP50 depletion caused an increase in EGFR expression at their surface, and a sustained activation of the receptor and of its downstream effectors (extracellular signal-regulated kinase 1/2, signal transducer and activator of transcription 3) in both basal and EGF-stimulated conditions. Cells lacking EBP50 showed epithelial-to-mesenchymal transition-associated features, including reduction in E-cadherin and cytokeratin-19 expression, induction of S100A4 and of the E-cadherin transcriptional repressor, Slug, and loss of cell polarity. Accordingly, depletion of EBP50 induced the disruption of adherens junctional complexes, the development of lamellipodia structures and the subsequent acquisition of motility properties. All these phenotypic changes were prevented upon inhibition of EGFR tyrosine kinase by gefitinib. These findings indicate that loss of EBP50 at the plasma membrane in tumor cells may contribute to biliary carcinogenesis through EGFR activation. Oncogene (2012) 31, 1376-1388; doi:10.1038/onc.2011.334; published online 8 August 2011	[Fouassier, L.] INSERM, Fac Med Pierre & Marie Curie, UMRS 938, F-75571 Paris, France; [Claperon, A.; Mergey, M.; Desbois-Mouthon, C.; Boissan, M.; Housset, C.; Fouassier, L.] Univ Paris 06, Paris, France; [Guedj, N.; Paradis, V.] Hop Beaujon, INSERM, UMRS U773, Clichy, France; [Guedj, N.; Paradis, V.] Hop Beaujon, AP HP, Serv Pathol, Clichy, France; [Vignjevic, D.] Inst Curie, CNRS, UMR 144, F-75231 Paris, France; [Boissan, M.] Hop Tenon, AP HP, Serv Biochim & Hormonol, F-75970 Paris, France; [Saubamea, B.] Univ Paris 05, INSERM, CNRS, U705,UMR 8206,Fac Pharm, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Fouassier, L (corresponding author), INSERM, Fac Med Pierre & Marie Curie, UMRS 938, Site St Antoine,27 Rue Chaligny, F-75571 Paris, France.	laura.fouassier@inserm.fr	Fouassier, Laura/M-7556-2017; saubamea, bruno/H-6882-2017; Paradis, Valerie/X-9097-2019; Vignjevic, Danijela/L-9721-2017; Desbois-Mouthon, Christele/M-7076-2017; vignjevic, Danijela Matic/R-5160-2019	Fouassier, Laura/0000-0001-6377-5610; saubamea, bruno/0000-0002-6218-0460; Desbois-Mouthon, Christele/0000-0002-0772-1711; vignjevic, Danijela Matic/0000-0003-4250-703X; Paradis, Valerie/0000-0003-3142-3762; guedj, nathalie/0000-0002-1421-6297	Institut National du Cancer; Association pour la Recherche sur le Cancer; Fonds CSP	Institut National du Cancer(Institut National du Cancer (INCA) France); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Fonds CSP	We thank Yves Chretien, UMRS_938, for statistical analysis, Anne-Marie Faussat, IFR65, for flow cytometry experiments and the Nikon Imaging Center, Institut Curie-CNRS Paris, for time-lapse microscopy. Confocal imaging was performed at the Cellular and Molecular Imaging facility of the IFR71-IMTCE (Faculty of Pharmacy, Paris Descartes University, Paris, France). This work was supported by grants from the Institut National du Cancer, Association pour la Recherche sur le Cancer and Fonds CSP (to CH). LF dedicates this work to RB Doctor and JG Fitz.	Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Cardone RA, 2007, MOL BIOL CELL, V18, P1768, DOI 10.1091/mbc.E06-07-0617; Chen HM, 2009, CANCER RES, V69, P9228, DOI 10.1158/0008-5472.CAN-09-1950; Claperon A, 2007, ONCOGENE, V26, P3143, DOI 10.1038/sj.onc.1210408; Cortese MS, 2008, PROG BIOPHYS MOL BIO, V98, P85, DOI 10.1016/j.pbiomolbio.2008.05.007; Curto M, 2007, J CELL BIOL, V177, P893, DOI 10.1083/jcb.200703010; Dard N, 2006, BIOESSAYS, V28, P146, DOI 10.1002/bies.20351; Finzi L, 2009, J IMMUNOL, V182, P2269, DOI 10.4049/jimmunol.0801768; Fouassier L, 2001, HEPATOLOGY, V33, P166, DOI 10.1053/jhep.2001.21143; Fouassier L, 2009, AM J PATHOL, V174, P869, DOI 10.2353/ajpath.2009.080079; Georgescu MM, 2008, CURR MOL MED, V8, P459, DOI 10.2174/156652408785748031; Guedj N, 2009, J HEPATOL, V51, P93, DOI 10.1016/j.jhep.2009.03.017; Hayashi Y, 2010, NEOPLASIA, V12, P1013, DOI 10.1593/neo.10780; Henson ES, 2006, CELL SIGNAL, V18, P2089, DOI 10.1016/j.cellsig.2006.05.015; Hoque MT, 2008, CANCER RES, V68, P4802, DOI 10.1158/0008-5472.CAN-07-6778; KNUTH A, 1985, J HEPATOL, V1, P579, DOI 10.1016/S0168-8278(85)80002-7; Kreimann EL, 2007, ONCOGENE, V26, P5290, DOI 10.1038/sj.onc.1210336; Lambertini E, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-13; Lazar CS, 2004, MOL BIOL CELL, V15, P5470, DOI 10.1091/mbc.E04-03-0239; Lee CH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-64; Li M, 2010, J BIOL CHEM, V285, P19299, DOI 10.1074/jbc.M109.096081; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Masuda M, 2005, J BIOL CHEM, V280, P42164, DOI 10.1074/jbc.M507136200; Molina JR, 2010, CANCER RES, V70, P6697, DOI 10.1158/0008-5472.CAN-10-1271; Murthy A, 1998, J BIOL CHEM, V273, P1273, DOI 10.1074/jbc.273.3.1273; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Sebastian S, 2006, BBA-REV CANCER, V1766, P120, DOI 10.1016/j.bbcan.2006.06.001; Shibata T, 2003, HEPATOLOGY, V38, P178, DOI 10.1053/jhep.2003.50270; Song J, 2007, HISTOPATHOLOGY, V51, P40, DOI 10.1111/j.1365-2559.2007.02730.x; Stemmer-Rachamimov AO, 2001, AM J PATHOL, V158, P57, DOI 10.1016/S0002-9440(10)63944-2; Takahashi Y, 2006, EMBO J, V25, P910, DOI 10.1038/sj.emboj.7600979; Vondriska TM, 2004, J MOL CELL CARDIOL, V37, P391, DOI 10.1016/j.yjmcc.2004.04.021; WEINMAN EJ, 1993, J CLIN INVEST, V92, P1781, DOI 10.1172/JCI116767; Werneburg NW, 2003, AM J PHYSIOL-GASTR L, V285, pG31, DOI 10.1152/ajpgi.00536.2002; Yoon JH, 2004, J HEPATOL, V41, P808, DOI 10.1016/j.jhep.2004.07.016; Yoshikawa D, 2008, BRIT J CANCER, V98, P418, DOI 10.1038/sj.bjc.6604129	36	44	48	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2012	31	11					1376	1388		10.1038/onc.2011.334	http://dx.doi.org/10.1038/onc.2011.334			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	912FL	21822312				2022-12-25	WOS:000301780000005
J	Jouven, X; Escolano, S; Celermajer, D; Empana, JP; Bingham, A; Hermine, O; Desnos, M; Perier, MC; Marijon, E; Ducimetiere, P				Jouven, Xavier; Escolano, Sylvie; Celermajer, David; Empana, Jean-Philippe; Bingham, Annie; Hermine, Olivier; Desnos, Michel; Perier, Marie-Cecile; Marijon, Eloi; Ducimetiere, Pierre			Heart Rate and Risk of Cancer Death in Healthy Men	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; MIDDLE-AGED MEN; SUDDEN-DEATH; RATE INCREASE; FOLLOW-UP; PROGNOSTIC VALUE; RATE RECOVERY; MORTALITY; EXERCISE; PREDICTOR	Background: Data from several previous studies examining heart-rate and cardiovascular risk have hinted at a possible relationship between heart-rate and non-cardiac mortality. We thus systematically examined the predictive value of heart-rate variables on the subsequent risk of death from cancer. Methods: In the Paris Prospective Study I, 6101 asymptomatic French working men aged 42 to 53 years, free of clinically detectable cardiovascular disease and cancer, underwent a standardized graded exercise test between 1967 and 1972. Resting heart-rate, heart-rate increase during exercise, and decrease during recovery were measured. Change in resting heart-rate over 5 years was also available in 5139 men. Mortality including 758 cancer deaths was assessed over the 25 years of follow-up. Findings: There were strong, graded and significant relationships between all heart-rate parameters and subsequent cancer deaths. After adjustment for age and tobacco consumption and, compared with the lowest quartile, those with the highest quartile for resting heart-rate had a relative risk of 2.4 for cancer deaths (95% confidence interval: 1.9-2.9, p < 0.0001) This was similar after adjustment for traditional cardiovascular risk factors and was observed for the commonest malignancies (respiratory and gastrointestinal). Similarly, significant relationships with cancer death were observed between poor heart rate increase during exercise, poor decrease during recovery and greater heart-rate increase over time (p < 0.0001 for all). Interpretation: Resting and exercise heart rate had consistent, graded and highly significant associations with subsequent cancer mortality in men.	[Jouven, Xavier; Escolano, Sylvie; Empana, Jean-Philippe; Bingham, Annie; Perier, Marie-Cecile; Marijon, Eloi] Univ Paris 05, INSERM, PARCC, UMR S970, Paris, France; [Celermajer, David] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Hermine, Olivier] Univ Paris 05, Hop Necker Enfants Malades, AP HP, CNRS,Dept Adult Hematol,UMR 8147, Paris, France; [Desnos, Michel] Univ Paris 05, Dept Cardiol, HEGP, AP HP, Paris, France; [Ducimetiere, Pierre] Univ Paris 11, INSERM, IFR 69, Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Sydney; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Jouven, X (corresponding author), Univ Paris 05, INSERM, PARCC, UMR S970, Paris, France.	xavier.jouven@inserm.fr	Empana, Jean-Philippe/AAF-6923-2021; Hermine, Olivier/Q-7072-2018	Empana, Jean-Philippe/0000-0002-1469-7772; escolano, sylvie/0000-0003-0864-4321; Celermajer, David/0000-0001-7640-0439; Hermine, Olivier/0000-0003-2574-3874	INSERM, the city of Paris; French Ministry of Health	INSERM, the city of Paris(Institut National de la Sante et de la Recherche Medicale (Inserm)); French Ministry of Health	This study was funded by INSERM, the city of Paris, and the French Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTHONY J, 2003, CHEST, V123, pS29; Benetos A, 1999, HYPERTENSION, V33, P44, DOI 10.1161/01.HYP.33.1.44; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; Diaz A, 2005, EUR HEART J, V26, P967, DOI 10.1093/eurheartj/ehi190; DUCIMETIERE P, 1980, LANCET, V1, P1346; DYER AR, 1980, AM J EPIDEMIOL, V112, P736, DOI 10.1093/oxfordjournals.aje.a113046; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Falcone C, 2005, CIRCULATION, V112, P1959, DOI 10.1161/CIRCULATIONAHA.105.545111; Fox K, 2007, J AM COLL CARDIOL, V50, P823, DOI 10.1016/j.jacc.2007.04.079; GILLUM RF, 1991, AM HEART J, V121, P172, DOI 10.1016/0002-8703(91)90970-S; Greenland P, 1999, AM J EPIDEMIOL, V149, P853; Hsia J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b219; Jouven X, 2005, NEW ENGL J MED, V352, P1951, DOI 10.1056/NEJMoa043012; Jouven X, 1999, CIRCULATION, V99, P1978, DOI 10.1161/01.CIR.99.15.1978; Jouven X, 2001, CARDIOVASC RES, V50, P373, DOI 10.1016/S0008-6363(01)00230-9; Jouven X, 2009, EUR HEART J, V30, P1703, DOI 10.1093/eurheartj/ehp160; Jouven X, 2009, AM J CARDIOL, V103, P279, DOI 10.1016/j.amjcard.2008.08.071; KANNEL WB, 1987, AM HEART J, V113, P1489, DOI 10.1016/0002-8703(87)90666-1; Kristal-Boneh E, 2000, EUR HEART J, V21, P116, DOI 10.1053/euhj.1999.1741; Lauer MS, 1996, CIRCULATION, V93, P1520, DOI 10.1161/01.CIR.93.8.1520; Lauer MS, 1999, JAMA-J AM MED ASSOC, V281, P524, DOI 10.1001/jama.281.6.524; Leeper NJ, 2007, CIRCULATION, V115, P468, DOI 10.1161/CIRCULATIONAHA.106.666388; Palatini P, 2006, DRUGS, V66, P133, DOI 10.2165/00003495-200666020-00001; PERSKY V, 1981, AM J EPIDEMIOL, V114, P477, DOI 10.1093/oxfordjournals.aje.a113213; SCHWARTZ PJ, 1988, CIRCULATION, V78, P969, DOI 10.1161/01.CIR.78.4.969; SHAPER AG, 1993, BRIT HEART J, V70, P49; Thomas F, 2001, J CLIN EPIDEMIOL, V54, P735, DOI 10.1016/S0895-4356(00)00353-X; Tverdal A, 2008, EUR HEART J, V29, P2772, DOI 10.1093/eurheartj/ehn435; Vivekananthan DP, 2003, J AM COLL CARDIOL, V42, P831, DOI 10.1016/S0735-1097(03)00833-7; *WHO, 1967, INT CLASS DIS MAN IN, V1, P3	31	41	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e21310	10.1371/journal.pone.0021310	http://dx.doi.org/10.1371/journal.pone.0021310			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826196	Green Submitted, Green Published, gold			2022-12-25	WOS:000293558900005
J	Shevchenko, AI; Malakhova, AA; Elisaphenko, EA; Mazurok, NA; Nesterova, TB; Brockdorff, N; Zakian, SM				Shevchenko, Alexander I.; Malakhova, Anastasia A.; Elisaphenko, Eugeny A.; Mazurok, Nina A.; Nesterova, Tatyana B.; Brockdorff, Neil; Zakian, Suren M.			Variability of Sequence Surrounding the Xist Gene in Rodents Suggests Taxon-Specific Regulation of X Chromosome Inactivation	PLOS ONE			English	Article							DOSAGE COMPENSATION; CHROMATIN-STRUCTURE; MOUSE DEVELOPMENT; TANDEM REPEATS; DNA-SEQUENCES; TSIX; REGION; LOCUS; MICE; RNA	One of the two X chromosomes in female mammalian cells is subject to inactivation (XCI) initiated by the Xist gene. In this study, we examined in rodents (voles and rat) the conservation of the microsatellite region DXPas34, the Tsix gene (antisense counterpart of Xist), and enhancer Xite that have been shown to flank Xist and regulate XCI in mouse. We have found that mouse regions of the Tsix gene major promoter and minisatellite repeat DXPas34 are conserved among rodents. We have also shown that in voles and rat the region homologous to the mouse Tsix major promoter, initiates antisense to Xist transcription and terminates around the Xist gene start site as is observed with mouse Tsix. A conservation of Tsix expression pattern in voles, rat and mice suggests a crucial role of the antisense transcription in regulation of Xist and XIC in rodents. Most surprisingly, we have found that voles lack the regions homologous to the regulatory element Xite, which is instead replaced with the Slc7a3 gene that is unassociated with the X-inactivation centre in any other eutherians studied. Furthermore, we have not identified any transcription that could have the same functions as murine Xite in voles. Overall, our data show that not all the functional elements surrounding Xist in mice are well conserved even within rodents, thereby suggesting that the regulation of XCI may be at least partially taxon-specific.	[Shevchenko, Alexander I.; Malakhova, Anastasia A.; Elisaphenko, Eugeny A.; Mazurok, Nina A.; Zakian, Suren M.] Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia; [Shevchenko, Alexander I.; Malakhova, Anastasia A.; Elisaphenko, Eugeny A.; Mazurok, Nina A.; Zakian, Suren M.] Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, Novosibirsk 630090, Russia; [Nesterova, Tatyana B.; Brockdorff, Neil] Univ Oxford, Dept Biochem, Oxford OX1 2JD, England; [Zakian, Suren M.] Russian Acad Sci, Res Ctr Clin & Expt Med, Siberian Branch, Novosibirsk 630090, Russia	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; University of Oxford; Russian Academy of Sciences	Shevchenko, AI (corresponding author), Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia.	zakian@bionet.nsc.ru	Elisafenko, Eugeny/AAD-5901-2020; Malakhova, Anastasia A/R-2640-2017; Shevchenko, Alexander I./T-3400-2018; Elisaphenko, Eugeny/V-5115-2018; Zakian, Suren/J-2196-2018	Elisafenko, Eugeny/0000-0002-3204-8178; Malakhova, Anastasia A/0000-0003-1916-1333; Brockdorff, Neil/0000-0003-4838-2653; Nesterova, Tatyana/0000-0001-7740-4386; Zakian, Suren/0000-0003-2448-6511	Russian Foundation for Basic Research [11-04-00799-a, 11-04-00847a]; Russian Academy of Sciences; Wellcome Trust [081385]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences(Russian Academy of Sciences); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Russian Foundation for Basic Research (grant no. 11-04-00799-a and 11-04-00847a, http://www.rfbr.ru/rffi/eng/about), the Program of the Russian Academy of Sciences "Molecular and Cellular Biology" (http://www.ras.ru/) and the Wellcome Trust (grant no. 081385, http://www.wellcome.ac.uk/funding/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Boumil RM, 2006, MOL CELL BIOL, V26, P2109, DOI 10.1128/MCB.26.6.2109-2117.2006; CATZEFLIS FM, 1989, J MOL EVOL, V29, P223, DOI 10.1007/BF02100206; Chao W, 2002, SCIENCE, V295, P345, DOI 10.1126/science.1065982; Chow JC, 2003, GENOMICS, V82, P309, DOI 10.1016/S0888-7543(03)00170-8; Chureau C, 2002, GENOME RES, V12, P894, DOI 10.1101/gr.152902; CHUREAU C, HUM MOL GENET, V20, P705; Clerc P, 2003, SEMIN CELL DEV BIOL, V14, P85, DOI 10.1016/S1084-9521(02)00140-4; Clerc P, 1998, NAT GENET, V19, P249, DOI 10.1038/924; Cohen DE, 2007, DEV CELL, V12, P57, DOI 10.1016/j.devcel.2006.11.014; COURTIER B, 1995, P NATL ACAD SCI USA, V92, P3531, DOI 10.1073/pnas.92.8.3531; Debrand E, 1999, MOL CELL BIOL, V19, P8513; DEMENTYEVA EV, CHROMOSOMA, V119, P541; Elisaphenko EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002521; Hore TA, 2007, CHROMOSOME RES, V15, P147, DOI 10.1007/s10577-007-1119-0; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; JAEGER JJ, 1985, REV PALEOBIOL, P1; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Johnston CM, 2002, GENOMICS, V80, P236, DOI 10.1006/geno.2002.6819; KAY GF, 1993, CELL, V72, P171, DOI 10.1016/0092-8674(93)90658-D; Lee JT, 2005, SCIENCE, V309, P768, DOI 10.1126/science.1113673; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Migeon BR, 2002, AM J HUM GENET, V71, P286, DOI 10.1086/341605; Migeon BR, 2001, AM J HUM GENET, V69, P951, DOI 10.1086/324022; Morey C, 2004, EMBO J, V23, P594, DOI 10.1038/sj.emboj.7600071; Morey C, 2001, HUM MOL GENET, V10, P1403, DOI 10.1093/hmg/10.13.1403; Navarro P, 2005, GENE DEV, V19, P1474, DOI 10.1101/gad.341105; Navarro P, 2006, GENE DEV, V20, P2787, DOI 10.1101/gad.389006; Nesterova TB, 2003, GENE DEV, V17, P2177, DOI 10.1101/gad.271203; Nesterova TB, 1998, CHROMOSOME RES, V6, P41, DOI 10.1023/A:1009266324602; Nesterova TB, 2001, GENOME RES, V11, P833, DOI 10.1101/gr.174901; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Prissette M, 2001, HUM MOL GENET, V10, P31, DOI 10.1093/hmg/10.1.31; RASTAN S, 1990, GENET RES, V56, P99, DOI 10.1017/S0016672300035163; Sado T, 2005, DEV CELL, V9, P159, DOI 10.1016/j.devcel.2005.05.015; Sado T, 2001, DEVELOPMENT, V128, P1275; Sado T, 2006, DEVELOPMENT, V133, P4925, DOI 10.1242/dev.02670; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Shibata S, 2003, HUM MOL GENET, V12, P125, DOI 10.1093/hmg/ddg010; Tian D, 2010, CELL, V143, P390, DOI 10.1016/j.cell.2010.09.049; Tsai CL, 2008, DEV BIOL, V319, P416, DOI 10.1016/j.ydbio.2008.04.010; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Xu CS, 2005, WORLD J GASTROENTERO, V11, P2932, DOI 10.3748/wjg.v11.i19.2932; Xu CS, 2004, WORLD J GASTROENTERO, V10, P2680, DOI 10.3748/wjg.v10.i18.2680; Xu CSA, 2005, WORLD J GASTROENTERO, V11, P2296, DOI 10.3748/wjg.v11.i15.2296; Yen ZC, 2007, GENOMICS, V90, P453, DOI 10.1016/j.ygeno.2007.07.002; ZAKIAN SM, 1991, GENET RES, V58, P105, DOI 10.1017/S0016672300029748; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	54	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22771	10.1371/journal.pone.0022771	http://dx.doi.org/10.1371/journal.pone.0022771			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826206	Green Published, gold, Green Submitted			2022-12-25	WOS:000293558900032
J	Chakravorty, A; Awad, MM; Hiscox, TJ; Cheung, JK; Carter, GP; Choo, JM; Lyras, D; Rood, JI				Chakravorty, Anjana; Awad, Milena M.; Hiscox, Thomas J.; Cheung, Jackie K.; Carter, Glen P.; Choo, Jocelyn M.; Lyras, Dena; Rood, Julian I.			The Cysteine Protease alpha-Clostripain is Not Essential for the Pathogenesis of Clostridium perfringens-Mediated Myonecrosis	PLOS ONE			English	Article							PORPHYROMONAS-GINGIVALIS; THETA-TOXIN; STREPTOCOCCUS-PYOGENES; ACTIVATED RECEPTORS; VIRR/VIRS SYSTEM; EPITHELIAL-CELLS; PHOSPHOLIPASE-C; VIRULENCE GENES; GAS-GANGRENE; CONSTRUCTION	Clostridium perfringens is the causative agent of clostridial myonecrosis or gas gangrene and produces many different extracellular toxins and enzymes, including the cysteine protease alpha-clostripain. Mutation of the alpha-clostripain structural gene, ccp, alters the turnover of secreted extracellular proteins in C. perfringens, but the role of alpha-clostripain in disease pathogenesis is not known. We insertionally inactivated the ccp gene C. perfringens strain 13 using TargeTron technology, constructing a strain that was no longer proteolytic on skim milk agar. Quantitative protease assays confirmed the absence of extracellular protease activity, which was restored by complementation with the wild-type ccp gene. The role of alpha-clostripain in virulence was assessed by analysing the isogenic wild-type, mutant and complemented strains in a mouse myonecrosis model. The results showed that although alpha-clostripain was the major extracellular protease, mutation of the ccp gene did not alter either the progression or the development of disease. These results do not rule out the possibility that this extracellular enzyme may still have a role in the early stages of the disease process.	[Chakravorty, Anjana; Awad, Milena M.; Hiscox, Thomas J.; Cheung, Jackie K.; Carter, Glen P.; Choo, Jocelyn M.; Lyras, Dena; Rood, Julian I.] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia	Monash University	Chakravorty, A (corresponding author), Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia.	julian.rood@monash.edu	Rood, Julian I/A-4858-2008	Rood, Julian I/0000-0003-2126-7209; Hiscox, Thomas/0000-0003-2182-2874; Awad, Milena/0000-0002-9275-3979; Carter, Glen/0000-0002-7306-9362; Lyras, Dena/0000-0003-2345-9271	Australian National Health and Medical Research Council	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by a grant from the Australian National Health and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AWAD MM, 1995, MOL MICROBIOL, V15, P191, DOI 10.1111/j.1365-2958.1995.tb02234.x; Awad MM, 2000, MICROB PATHOGENESIS, V28, P107, DOI 10.1006/mpat.1999.0328; Awad MM, 2001, INFECT IMMUN, V69, P7904, DOI 10.1128/IAI.69.12.7904-7910.2001; Awad MM, 1997, MICROB PATHOGENESIS, V22, P275, DOI 10.1006/mpat.1996.0115; Baba A, 2002, BIOL CHEM, V383, P1223, DOI 10.1515/BC.2002.135; Banbula A, 1999, BIOCHEM BIOPH RES CO, V261, P598, DOI 10.1006/bbrc.1999.1075; Bannam TL, 1999, MICROBIOL-SGM, V145, P2947, DOI 10.1099/00221287-145-10-2947; Bryant AE, 2006, J MED MICROBIOL, V55, P495, DOI 10.1099/jmm.0.46390-0; Bryant AE, 2003, J INFECT DIS, V187, P408, DOI 10.1086/367964; Bryant AE, 2003, CLIN MICROBIOL REV, V16, P451, DOI 10.1128/CMR.16.3.451-462.2003; Bryant AE, 2000, J INFECT DIS, V182, P799, DOI 10.1086/315756; Calkins CC, 1998, J BIOL CHEM, V273, P6611, DOI 10.1074/jbc.273.12.6611; Cheung JK, 2010, INFECT IMMUN, V78, P3064, DOI 10.1128/IAI.00123-10; Chiarezza M, 2009, INFECT IMMUN, V77, P4421, DOI 10.1128/IAI.00548-09; Collin M, 2002, INFECT IMMUN, V70, P6646, DOI 10.1128/IAI.70.12.6646-6651.2002; Collin M, 2001, INFECT IMMUN, V69, P7187, DOI 10.1128/IAI.69.11.7187-7189.2001; DARGATZ H, 1993, MOL GEN GENET, V240, P140, DOI 10.1007/BF00276893; Ellemor DM, 1999, INFECT IMMUN, V67, P4902, DOI 10.1128/IAI.67.9.4902-4907.1999; GILLES AM, 1979, J BIOL CHEM, V254, P1462; GILLES AM, 1984, FEBS LETT, V173, P58, DOI 10.1016/0014-5793(84)81017-0; GILLES AM, 1984, EUR J BIOCHEM, V145, P469, DOI 10.1111/j.1432-1033.1984.tb08579.x; Hickey MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000045; Jozwiak J, 2005, FEMS IMMUNOL MED MIC, V45, P137, DOI 10.1016/j.femsim.2005.03.005; Kennedy CL, 2009, MICROBES INFECT, V11, P413, DOI 10.1016/j.micinf.2009.01.002; Kennedy CL, 2009, INFECT IMMUN, V77, P943, DOI 10.1128/IAI.01267-08; Kida Y, 2011, INFECT IMMUN, V79, P211, DOI 10.1128/IAI.01053-10; Labrou NE, 2004, EUR J BIOCHEM, V271, P983, DOI 10.1111/j.1432-1033.2004.04000.x; Lourbakos A, 2001, BLOOD, V97, P3790, DOI 10.1182/blood.V97.12.3790; Lourbakos A, 2001, INFECT IMMUN, V69, P5121, DOI 10.1128/IAI.69.8.5121-5130.2001; LYRISTIS M, 1994, MOL MICROBIOL, V12, P761, DOI 10.1111/j.1365-2958.1994.tb01063.x; Manabe S, 2010, MICROBIOL-SGM, V156, P561, DOI 10.1099/mic.0.031609-0; Morelle G, 1989, FOCUS, V11, P7; O'Connor JR, 2006, MOL MICROBIOL, V61, P1335, DOI 10.1111/j.1365-2958.2006.05315.x; Okumura K, 2008, J BACTERIOL, V190, P7719, DOI 10.1128/JB.01573-07; Payne Shelley M., 1993, Trends in Microbiology, V1, P66, DOI 10.1016/0966-842X(93)90036-Q; ROBERTS I, 1986, APPL ENVIRON MICROB, V52, P197, DOI 10.1128/AEM.52.1.197-199.1986; ROOD JI, 1978, ANTIMICROB AGENTS CH, V13, P871, DOI 10.1128/AAC.13.5.871; Rood JI, 1998, ANNU REV MICROBIOL, V52, P333, DOI 10.1146/annurev.micro.52.1.333; Sambrook J, 2001, MOL CLONING LAB MANU; SCOTT PT, 1989, GENE, V82, P327, DOI 10.1016/0378-1119(89)90059-0; Shimizu T, 2002, J BACTERIOL, V184, P2587, DOI 10.1128/JB.184.10.2587-2594.2002; Shimizu T, 2001, MICROBIOL IMMUNOL, V45, P179, DOI 10.1111/j.1348-0421.2001.tb01278.x; Sijwali PS, 2001, BIOCHEM J, V360, P481, DOI 10.1042/0264-6021:3600481; Sijwali PS, 2001, PROTEIN EXPRES PURIF, V22, P128, DOI 10.1006/prep.2001.1416; SLOAN J, 1992, PLASMID, V27, P207, DOI 10.1016/0147-619X(92)90023-4; Stathopoulou PG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-107; Stevens DL, 1997, CLIN INFECT DIS, V25, pS160, DOI 10.1086/516249; STEVENS DL, 1987, J INFECT DIS, V156, P324, DOI 10.1093/infdis/156.2.324; TAKEYAMA M, 1986, ACTA PATHOL JAPON, V36, P757; Tamai E, 2008, APPL MICROBIOL BIOT, V80, P627, DOI 10.1007/s00253-008-1592-1; Tanaka H, 2008, APPL MICROBIOL BIOT, V77, P1063, DOI 10.1007/s00253-007-1245-9; Tanaka H, 2011, PROTEIN EXPRES PURIF, V76, P83, DOI 10.1016/j.pep.2010.10.002; Tanaka T, 2008, CHEMBIOCHEM, V9, P802, DOI 10.1002/cbic.200700614; Terao Y, 2008, J BIOL CHEM, V283, P6253, DOI 10.1074/jbc.M704821200; Tokuda M, 1998, INFECT IMMUN, V66, P5232, DOI 10.1128/IAI.66.11.5232-5237.1998; Tokuda M, 1996, INFECT IMMUN, V64, P4067, DOI 10.1128/IAI.64.10.4067-4073.1996	56	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22762	10.1371/journal.pone.0022762	http://dx.doi.org/10.1371/journal.pone.0022762			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829506	gold, Green Published			2022-12-25	WOS:000293286500026
J	Miyamoto, T; Yokoyama, M; Kono, K; Shioda, T; Sato, H; Nakayama, EE				Miyamoto, Tadashi; Yokoyama, Masaru; Kono, Ken; Shioda, Tatsuo; Sato, Hironori; Nakayama, Emi E.			A Single Amino Acid of Human Immunodeficiency Virus Type 2 Capsid Protein Affects Conformation of Two External Loops and Viral Sensitivity to TRIM5 alpha	PLOS ONE			English	Article							SPRY B30.2 DOMAIN; SIMIAN IMMUNODEFICIENCY; RETROVIRUS RESTRICTION; CYNOMOLGUS MONKEY; RHESUS-MONKEY; SPECIFICITY; INFECTION; REPLICATION; DETERMINES; CONTRIBUTE	We previously reported that human immunodeficiency virus type 2 (HIV-2) carrying alanine or glutamine but not proline at position 120 of the capsid protein (CA) could grow in the presence of anti-viral factor TRIM5 alpha of cynomolgus monkey (CM). To elucidate details of the interaction between the CA and TRIM5 alpha, we generated mutant HIV-2 viruses, each carrying one of the remaining 17 possible amino acid residues, and examined their sensitivity to CM TRIM5 alpha-mediated restriction. Results showed that hydrophobic residues or those with ring structures were associated with sensitivity, while those with small side chains or amide groups conferred resistance. Molecular dynamics simulation study revealed a structural basis for the differential TRIM5 alpha sensitivities. The mutations at position 120 in the loop between helices 6 and 7 (L6/7) affected conformation of the neighboring loop between helices 4 and 5 (L4/5), and sensitive viruses had a common L4/5 conformation. In addition, the common L4/5 structures of the sensitive viruses were associated with a decreased probability of hydrogen bond formation between the 97th aspartic acid in L4/5 and the 119th arginine in L6/7. When we introduced aspartic acid-to-alanine substitution at position 97 (D97A) of the resistant virus carrying glutamine at position 120 to disrupt hydrogen bond formation, the resultant virus became moderately sensitive. Interestingly, the virus carrying glutamic acid at position 120 showed resistance, while its predicted L4/5 conformation was similar to those of sensitive viruses. The D97A substitution failed to alter the resistance of this particular virus, indicating that the 120th amino acid residue itself is also involved in sensitivity regardless of the L4/5 conformation. These results suggested that a hydrogen bond between the L4/5 and L6/7 modulates the overall structure of the exposed surface of the CA, but the amino acid residue at position 120 is also directly involved in CM TRIM5 alpha recognition.	[Miyamoto, Tadashi; Kono, Ken; Shioda, Tatsuo; Nakayama, Emi E.] Osaka Univ, Dept Viral Infect, Microbial Dis Res Inst, Osaka, Japan; [Yokoyama, Masaru; Sato, Hironori] Natl Inst Infect Dis, Pathogen Genom Ctr, Tokyo, Japan; [Kono, Ken] Japan Soc Promot Sci, Tokyo, Japan	Osaka University; National Institute of Infectious Diseases (NIID); Japan Society for the Promotion of Science	Miyamoto, T (corresponding author), Osaka Univ, Dept Viral Infect, Microbial Dis Res Inst, Osaka, Japan.	emien@biken.osaka-u.ac.jp			Health Science Foundation; Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labour and Welfare, Japan; Grants-in-Aid for Scientific Research [23390111] Funding Source: KAKEN	Health Science Foundation; Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Health Science Foundation, the Ministry of Education, Culture, Sports, Science, and Technology, and the Ministry of Health, Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2006, J VIROL, V80, P9754, DOI 10.1128/JVI.01052-06; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Case D.A., 2006, AMBER, V9; Dodson GG, 2008, EMBO REP, V9, P144, DOI 10.1038/sj.embor.7401160; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Hatziioannou T, 2004, P NATL ACAD SCI USA, V101, P10774, DOI 10.1073/pnas.0402361101; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Kono K, 2008, VIROLOGY, V373, P447, DOI 10.1016/j.virol.2007.12.022; Kono K, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-72; Kono K, 2009, VIROLOGY, V388, P160, DOI 10.1016/j.virol.2009.03.004; Kuroishi A, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-70; Maegawa H, 2010, VIROLOGY, V399, P212, DOI 10.1016/j.virol.2010.01.003; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Nakayama EE, 2005, J VIROL, V79, P8870, DOI 10.1128/JVI.79.14.8870-8877.2005; Ohkura S, 2006, J VIROL, V80, P8554, DOI 10.1128/JVI.00688-06; Onyango CO, 2010, VACCINE, V28, pB60, DOI 10.1016/j.vaccine.2009.08.060; Perez-Caballero D, 2005, J VIROL, V79, P8969, DOI 10.1128/JVI.79.14.8969-8978.2005; Perron MJ, 2006, J VIROL, V80, P5631, DOI 10.1128/JVI.00219-06; Price AJ, 2009, NAT STRUCT MOL BIOL, V16, P1036, DOI 10.1038/nsmb.1667; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Rold CJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000074; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Sebastian S, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-40; Shirakawa K, 2008, NAT STRUCT MOL BIOL, V15, P1184, DOI 10.1038/nsmb.1497; Song H, 2007, J VIROL, V81, P7280, DOI 10.1128/JVI.00406-07; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2005, J VIROL, V79, P3139, DOI 10.1128/JVI.79.5.3139-3145.2005; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Wu XL, 2006, P NATL ACAD SCI USA, V103, P7465, DOI 10.1073/pnas.0510483103; Yap MW, 2005, CURR BIOL, V15, P73, DOI 10.1016/j.cub.2004.12.042; Ylinen LMJ, 2005, J VIROL, V79, P11580, DOI 10.1128/JVI.79.18.11580-11587.2005	32	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22779	10.1371/journal.pone.0022779	http://dx.doi.org/10.1371/journal.pone.0022779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829511	Green Published, gold, Green Submitted			2022-12-25	WOS:000293284600045
J	Shin, YJ; Hencey, B; Lipkin, SM; Shen, XL				Shin, Yong-Jun; Hencey, Brandon; Lipkin, Steven M.; Shen, Xiling			Frequency Domain Analysis Reveals External Periodic Fluctuations Can Generate Sustained p53 Oscillation	PLOS ONE			English	Article							P53-MDM2 FEEDBACK LOOP; EXPRESSION; NOISE; MDM2; NETWORKS; COMPLEX; CELLS	p53 is a well-known tumor suppressor protein that regulates many pathways, such as ones involved in cell cycle and apoptosis. The p53 levels are known to oscillate without damping after DNA damage, which has been a focus of many recent studies. A negative feedback loop involving p53 and MDM2 has been reported to be responsible for this oscillatory behavior, but questions remain as how the dynamics of this loop alter in order to initiate and maintain the sustained or undamped p53 oscillation. Our frequency domain analysis suggests that the sustained p53 oscillation is not completely dictated by the negative feedback loop; instead, it is likely to be also modulated by periodic DNA repair-related fluctuations that are triggered by DNA damage. According to our analysis, the p53-MDM2 feedback mechanism exhibits adaptability in different cellular contexts. It normally filters noise and fluctuations exerted on p53, but upon DNA damage, it stops performing the filtering function so that DNA repair-related oscillatory signals can modulate the p53 oscillation. Furthermore, it is shown that the p53-MDM2 feedback loop increases its damping ratio allowing p53 to oscillate at a frequency more synchronized with the other cellular efforts to repair the damaged DNA, while suppressing its inherent oscillation-generating capability. Our analysis suggests that the overexpression of MDM2, observed in many types of cancer, can disrupt the operation of this adaptive mechanism by making it less responsive to the modulating signals after DNA damage occurs.	[Shin, Yong-Jun; Hencey, Brandon; Shen, Xiling] Cornell Univ, Ithaca, NY 14853 USA; [Lipkin, Steven M.] Weill Cornell Coll Med, Dept Med, New York, NY USA	Cornell University; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Shin, YJ (corresponding author), Cornell Univ, Ithaca, NY 14853 USA.	xs66@cornell.edu		Hencey, Brandon/0000-0001-9240-7999				Alon U., 2007, INTRO SYSTEMS BIOL; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Bond GL, 2005, CURR CANCER DRUG TAR, V5, P3, DOI 10.2174/1568009053332627; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Dublanche Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100081; Dunlop MJ, 2008, NAT GENET, V40, P1493, DOI 10.1038/ng.281; Geva-Zatorsky N, 2010, P NATL ACAD SCI USA, V107, P13550, DOI 10.1073/pnas.1001107107; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Nise N. S., 1994, CONTROL SYSTEMS ENG; Piette J, 1997, ONCOGENE, V15, P1001, DOI 10.1038/sj.onc.1201432; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Shin YJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012785; Simpson ML, 2003, P NATL ACAD SCI USA, V100, P4551, DOI 10.1073/pnas.0736140100; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Tiana G, 2007, PHYS BIOL, V4, pR1, DOI 10.1088/1478-3975/4/2/R01; Toledo F, 2007, INT J BIOCHEM CELL B, V39, P1476, DOI 10.1016/j.biocel.2007.03.022; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675	22	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22852	10.1371/journal.pone.0022852	http://dx.doi.org/10.1371/journal.pone.0022852			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829536	gold, Green Published, Green Submitted			2022-12-25	WOS:000293284600058
J	Akiyama, T; Carstens, MI; Carstens, E				Akiyama, Tasuku; Carstens, Mirela Iodi; Carstens, Earl			Transmitters and Pathways Mediating Inhibition of Spinal Itch-Signaling Neurons by Scratching and Other Counterstimuli	PLOS ONE			English	Article							DORSAL-HORN NEURONS; HISTAMINE-INDUCED ITCH; DRY SKIN; PAR-2 AGONIST; ACTIVATED RECEPTORS; SENSORY NEURONS; FOS EXPRESSION; POTENTIAL ROLE; PAIN; MOUSE	Scratching relieves itch, but the underlying neural mechanisms are poorly understood. We presently investigated a role for the inhibitory neurotransmitters GABA and glycine in scratch-evoked inhibition of spinal itch-signaling neurons in a mouse model of chronic dry skin itch. Superficial dorsal horn neurons ipsilateral to hindpaw dry skin treatment exhibited a high level of spontaneous firing that was significantly attenuated by cutaneous scratching, pinch and noxious heat. Scratch-evoked inhibition was nearly abolished by spinal delivery of the glycine antagonist, strychnine, and was markedly attenuated by respective GABAA and GABAB antagonists bicuculline and saclofen. Scratch-evoked inhibition was also significantly attenuated (but not abolished) by interruption of the upper cervical spinal cord, indicating the involvement of both segmental and suprasegmental circuits that engage glycine- and GABA-mediated inhibition of spinal itch-signaling neurons by noxious counterstimuli.	[Akiyama, Tasuku; Carstens, Mirela Iodi; Carstens, Earl] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA	University of California System; University of California Davis	Akiyama, T (corresponding author), Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA.	eecarstens@ucdavis.edu	Akiyama, Tasuku/AFN-8329-2022	Akiyama, Tasuku/0000-0001-7155-4228	National Institutes of Health [DE013685, AR057194]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057194] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013685] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work is supported by grants from the National Institutes of Health DE013685 and AR057194. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2011, J NEUROPHYSIOL, V105, P2811, DOI 10.1152/jn.01124.2010; Akiyama T, 2010, NEUROSCI LETT, V484, P62, DOI 10.1016/j.neulet.2010.08.020; Akiyama T, 2009, J NEUROPHYSIOL, V102, P2176, DOI 10.1152/jn.00463.2009; Akiyama T, 2009, J PHARMACOL EXP THER, V329, P945, DOI 10.1124/jpet.109.152256; Akiyama T, 2009, J NEUROSCI, V29, P6691, DOI 10.1523/JNEUROSCI.6103-08.2009; Bickford RG, 1938, CLIN SCI, V3, P377; BROMM B, 1995, NEUROSCI LETT, V187, P157, DOI 10.1016/0304-3940(95)11362-Z; CARSTENS E, 2009, CURRENT TOPICS PAIN, P79; Carstens EE, 2010, NEUROREPORT, V21, P303, DOI 10.1097/WNR.0b013e328337310a; Chery N, 1999, J NEUROSCI, V19, P7342, DOI 10.1523/JNEUROSCI.19-17-07342.1999; Davidson S, 2009, NAT NEUROSCI, V12, P544, DOI 10.1038/nn.2292; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Dussor G, 2009, BRAIN RES REV, V60, P24, DOI 10.1016/j.brainresrev.2008.12.013; FRUHSTORFER H, 1986, PAIN, V24, P259, DOI 10.1016/0304-3959(86)90048-5; Gotoh Y, 2011, J PHARMACOL SCI, V115, P417, DOI 10.1254/jphs.10305SC; HALKIERSORENSEN L, 1989, CONTACT DERMATITIS, V21, P179, DOI 10.1111/j.1600-0536.1989.tb04732.x; Jinks SL, 1998, J NEUROPHYSIOL, V79, P1613; Johanek LM, 2008, J NEUROSCI, V28, P7659, DOI 10.1523/JNEUROSCI.1760-08.2008; Lagerstrom MC, 2010, NEURON, V68, P529, DOI 10.1016/j.neuron.2010.09.016; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Liu Y, 2010, NEURON, V68, P543, DOI 10.1016/j.neuron.2010.09.008; Lomber SG, 1999, J NEUROSCI METH, V86, P179, DOI 10.1016/S0165-0270(98)00165-4; MELTON FM, 1950, J INVEST DERMATOL, V15, P325, DOI 10.1038/jid.1950.106; Miyamoto T, 2002, JPN J PHARMACOL, V88, P285, DOI 10.1254/jjp.88.285; MURRAY FS, 1975, J COMP PHYSIOL PSYCH, V89, P819, DOI 10.1037/h0077028; Namer B, 2008, J NEUROPHYSIOL, V100, P2062, DOI 10.1152/jn.90482.2008; Narikawa K, 2000, J NEUROPHYSIOL, V84, P2171, DOI 10.1152/jn.2000.84.4.2171; Nojima H, 2004, NEUROSCI LETT, V361, P79, DOI 10.1016/j.neulet.2003.12.013; Ossipov MH, 2010, J CLIN INVEST, V120, P3779, DOI 10.1172/JCI43766; Reddy VB, 2008, J NEUROSCI, V28, P4331, DOI 10.1523/JNEUROSCI.0716-08.2008; Ross SE, 2010, NEURON, V65, P886, DOI 10.1016/j.neuron.2010.02.025; Schmelz M, 1997, J NEUROSCI, V17, P8003; SIMONE DA, 1991, SOMATOSENS MOT RES, V8, P271, DOI 10.3109/08990229109144750; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Tsujii K, 2008, J PHARMACOL SCI, V108, P385, DOI 10.1254/jphs.08200SC; Ward L, 1996, PAIN, V64, P129, DOI 10.1016/0304-3959(95)00080-1; White J., 1969, PAIN NEUROSURGEON 40; Yamaguchi T, 1999, NEUROSCI RES, V35, P77, DOI 10.1016/S0168-0102(99)00070-X; Zeilhofer HU, 2005, CELL MOL LIFE SCI, V62, P2027, DOI 10.1007/s00018-005-5107-2	40	86	89	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22665	10.1371/journal.pone.0022665	http://dx.doi.org/10.1371/journal.pone.0022665			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818363	Green Published, Green Submitted, gold			2022-12-25	WOS:000293282700058
J	Chu, CP; Bing, YH; Liu, QR; Qiu, DL				Chu, Chun-Ping; Bing, Yan-Hua; Liu, Quan-Ri; Qiu, De-Lai			Synaptic Responses Evoked by Tactile Stimuli in Purkinje Cells in Mouse Cerebellar Cortex Crus II In Vivo	PLOS ONE			English	Article							CLIMBING FIBER RESPONSES; GRANULE CELL; MOSSY-FIBER; SYNCHRONIZED ACTIVITY; SOMATOSENSORY CORTEX; CUTANEOUS AFFERENTS; LATERAL HEMISPHERES; RAT CEREBELLUM; INHIBITION; GOLGI	Background: Sensory stimuli evoke responses in cerebellar Purkinje cells (PCs) via the mossy fiber-granule cell pathway. However, the properties of synaptic responses evoked by tactile stimulation in cerebellar PCs are unknown. The present study investigated the synaptic responses of PCs in response to an air-puff stimulation on the ipsilateral whisker pad in urethane-anesthetized mice. Methods and Main Results: Thirty-three PCs were recorded from 48 urethane-anesthetized adult (6-8-week-old) HA/ICR mice by somatic or dendritic patch-clamp recording and pharmacological methods. Tactile stimulation to the ipsilateral whisker pad was delivered by an air-puff through a 12-gauge stainless steel tube connected with a pressurized injection system. Under current-clamp conditions (I = 0), the air-puff stimulation evoked strong inhibitory postsynaptic potentials (IPSPs) in the somata of PCs. Application of SR95531, a specific GABA(A) receptor antagonist, blocked IPSPs and revealed stimulation-evoked simple spike firing. Under voltage-clamp conditions, tactile stimulation evoked a sequence of transient inward currents followed by strong outward currents in the somata and dendrites in PCs. Application of SR95531 blocked outward currents and revealed excitatory postsynaptic currents (EPSCs) in somata and a temporal summation of parallel fiber EPSCs in PC dendrites. We also demonstrated that PCs respond to both the onset and offset of the air-puff stimulation. Conclusions: These findings indicated that tactile stimulation induced asynchronous parallel fiber excitatory inputs onto the dendrites of PCs, and failed to evoke strong EPSCs and spike firing in PCs, but induced the rapid activation of strong GABA(A) receptor-mediated inhibitory postsynaptic currents in the somata and dendrites of PCs in the cerebellar cortex Crus II in urethane-anesthetized mice.	[Chu, Chun-Ping; Bing, Yan-Hua; Liu, Quan-Ri; Qiu, De-Lai] Yanbian Univ, Cellular Funct Res Ctr, Yanji, Jilin Province, Peoples R China; [Bing, Yan-Hua; Liu, Quan-Ri; Qiu, De-Lai] Yanbian Univ, Coll Basic Med, Dept Physiol & Pathophysiol, Yanji, Jilin Province, Peoples R China; [Chu, Chun-Ping] Yanbian Univ, Funct Expt Ctr, Coll Basic Med, Yanji, Jilin Province, Peoples R China	Yanbian University; Yanbian University; Yanbian University	Chu, CP (corresponding author), Yanbian Univ, Cellular Funct Res Ctr, Yanji, Jilin Province, Peoples R China.	dlqiu@ybu.edu.cn			National Natural Science Foundation of China [31060138]; Leading Academic Discipline Program, 211 Project for Yanbian University, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Leading Academic Discipline Program, 211 Project for Yanbian University, China	This work was partially supported by National Natural Science Foundation of China (31060138). This study was also supported by Leading Academic Discipline Program, 211 Project for Yanbian University, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG DM, 1980, J PHYSIOL-LONDON, V309, P357, DOI 10.1113/jphysiol.1980.sp013513; BARBOUR B, 1993, NEURON, V11, P759, DOI 10.1016/0896-6273(93)90085-6; Barmack NH, 2008, J NEUROSCI, V28, P1140, DOI 10.1523/JNEUROSCI.3942-07.2008; Bower JM, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00027; BOWER JM, 1983, J NEUROPHYSIOL, V49, P745, DOI 10.1152/jn.1983.49.3.745; Brown IE, 2001, J COMP NEUROL, V429, P59, DOI 10.1002/1096-9861(20000101)429:1<59::AID-CNE5>3.0.CO;2-3; Brown IE, 2002, J NEUROSCI, V22, P6819; Chu CP, 2011, NEUROSCI LETT, V487, P182, DOI 10.1016/j.neulet.2010.10.018; Cohen D, 1998, P NATL ACAD SCI USA, V95, P15032, DOI 10.1073/pnas.95.25.15032; Cohen D, 2000, J NEUROPHYSIOL, V83, P1932, DOI 10.1152/jn.2000.83.4.1932; COOK JR, 1976, EXP BRAIN RES, V26, P193; Dieudonne S, 1998, J PHYSIOL-LONDON, V510, P845, DOI 10.1111/j.1469-7793.1998.845bj.x; Dunbar RL, 2004, NEUROSCIENCE, V126, P213, DOI 10.1016/j.neuroscience.2004.02.020; ECCLES JC, 1971, EXP BRAIN RES, V13, P54, DOI 10.1007/BF00236430; ECCLES JC, 1972, EXP BRAIN RES, V15, P261, DOI 10.1007/BF00235911; Eccles JC, 1967, CEREBELLUM NEURONAL; Gao WC, 2003, J NEUROSCI, V23, P1859; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Holtzman T, 2006, J PHYSIOL-LONDON, V574, P491, DOI 10.1113/jphysiol.2006.108282; Huang ZJ, 2007, NAT REV NEUROSCI, V8, P673, DOI 10.1038/nrn2188; JAEGER D, 1994, EXP BRAIN RES, V100, P200; Kolb FP, 1997, NEUROSCIENCE, V81, P1155, DOI 10.1016/S0306-4522(97)00255-8; LLANO I, 1993, J PHYSIOL-LONDON, V468, P177, DOI 10.1113/jphysiol.1993.sp019766; Lu H, 2005, J NEUROPHYSIOL, V94, P1849, DOI 10.1152/jn.01275.2004; Mann-Metzer P, 1999, J NEUROSCI, V19, P3298; MEEK J, 1992, NEUROSCIENCE, V48, P249, DOI 10.1016/0306-4522(92)90489-O; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Morissette J, 1996, EXP BRAIN RES, V109, P240; NAPPER RM, 1998, J COMP NEUROL, V274, P168; Palay S.L., 1974, CEREBELLAR CORTEX; Qiu DL, 2008, NEUROSIGNALS, V16, P289, DOI 10.1159/000123039; Rancz EA, 2007, NATURE, V450, P1245, DOI 10.1038/nature05995; Santamaria F, 2007, J NEUROPHYSIOL, V97, P248, DOI 10.1152/jn.01098.2005; SHAMBES GM, 1978, BRAIN RES, V157, P123, DOI 10.1016/0006-8993(78)91000-4; Sultan F, 1998, J COMP NEUROL, V393, P353; Tahon K, 2005, NEUROSCI LETT, V390, P156, DOI 10.1016/j.neulet.2005.08.018; Tahon K, 2011, J NEUROPHYSIOL, V105, P1327, DOI 10.1152/jn.00317.2010	37	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e22752	10.1371/journal.pone.0022752	http://dx.doi.org/10.1371/journal.pone.0022752			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21818384	Green Submitted, gold, Green Published			2022-12-25	WOS:000293175100048
J	Muller, MJ; Langemann, D; Gehrke, I; Later, W; Heller, M; Gluer, CC; Heymsfield, SB; Bosy-Westphal, A				Mueller, Manfred J.; Langemann, Dirk; Gehrke, Isabel; Later, Wiebke; Heller, Martin; Glueer, Claus C.; Heymsfield, Steven B.; Bosy-Westphal, Anja			Effect of Constitution on Mass of Individual Organs and Their Association with Metabolic Rate in Humans-A Detailed View on Allometric Scaling	PLOS ONE			English	Article							RESTING ENERGY-EXPENDITURE; FAT-FREE MASS; BODY-MASS; TISSUE MASS; THERMOGENESIS; WEIGHT; LAW; AGE	Resting energy expenditure (REE)-power relationships result from multiple underlying factors including weight and height. In addition, detailed body composition, including fat free mass (FFM) and its components, skeletal muscle mass and internal organs with high metabolic rates (i.e. brain, heart, liver, kidneys), are major determinants of REE. Since the mass of individual organs scales to height as well as to weight (and, thus, to constitution), the variance in these associations may also add to the variance in REE. Here we address body composition (measured by magnetic resonance imaging) and REE (assessed by indirect calorimetry) in a group of 330 healthy volunteers differing with respect to age (17-78 years), sex (61% female) and BMI (15.9-47.8 kg/m(2)). Using three dimensional data interpolation we found that the inter-individual variance related to scaling of organ mass to height and weight and, thus, the constitution-related variances in either FFM (model 1) or kidneys, muscle, brain and liver (model 2) explained up to 43% of the inter-individual variance in REE. These data are the first evidence that constitution adds to the complexity of REE. Since organs scale differently as weight as well as height the "fit" of organ masses within constitution should be considered as a further trait.	[Mueller, Manfred J.; Gehrke, Isabel; Later, Wiebke; Bosy-Westphal, Anja] Univ Kiel, Inst Humanernahrung & Lebensmittelkunde, D-2300 Kiel, Germany; [Langemann, Dirk] Tech Univ Carolo Wilhelmina Braunschweig, Inst Computat Math, Braunschweig, Germany; [Heller, Martin; Glueer, Claus C.] Univ Klinikum Schleswig Holstein, Klin Diagnost Radiol, Kiel, Germany; [Heymsfield, Steven B.] Pennington Biomed Res Ctr, Baton Rouge, LA USA	University of Kiel; Braunschweig University of Technology; University of Kiel; Schleswig Holstein University Hospital; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Muller, MJ (corresponding author), Univ Kiel, Inst Humanernahrung & Lebensmittelkunde, D-2300 Kiel, Germany.	mmueller@nutrfoodsc.uni-kiel.de	Glüer, Claus-Christian/C-9752-2010; Heymsfield, Steven B/N-1968-2017	Glüer, Claus-Christian/0000-0003-3539-8955; Heymsfield, Steven B/0000-0003-1127-9425	DFG [Mu 8-3]; BMBF Competent Network of Obesity (CNO)	DFG(German Research Foundation (DFG)); BMBF Competent Network of Obesity (CNO)(Federal Ministry of Education & Research (BMBF))	This study was fundedby DFG Mu 8-3, BMBF Competent Network of Obesity (CNO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Bader N, 2005, BRIT J NUTR, V94, P843, DOI 10.1079/BJN20051551; Bosy-Westphal A, 2004, INT J OBESITY, V28, P72, DOI 10.1038/sj.ijo.0802526; Bosy-Westphal A, 2003, J NUTR, V133, P2356, DOI 10.1093/jn/133.7.2356; Bosy-Westphal A, 2008, AM J CLIN NUTR, V87, P1695, DOI 10.1093/ajcn/87.6.1695; BRUNDIN T, 1987, CLIN PHYSIOL, V7, P481, DOI 10.1111/j.1475-097X.1987.tb00190.x; BRUNDIN T, 1991, AM J PHYSIOL, V260, pE232, DOI 10.1152/ajpendo.1991.260.2.E232; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Duck F.A., 1990, MED PHYS, V18; ELIA M, 1992, ENERGY METABOLISM, P19; Gallagher D, 1998, AM J PHYSIOL-ENDOC M, V275, pE249, DOI 10.1152/ajpendo.1998.275.2.E249; Gallagher D, 2000, ANN NY ACAD SCI, V904, P449; Gallagher D, 1996, METABOLISM, V45, P992, DOI 10.1016/S0026-0495(96)90269-3; Glazier DS, 2005, BIOL REV, V80, P611, DOI 10.1017/S1464793105006834; Heymsfield SB, 2007, J APPL PHYSIOL, V103, P1543, DOI 10.1152/japplphysiol.00461.2007; Heymsfield SB, 2007, AM J CLIN NUTR, V86, P82, DOI 10.1093/ajcn/86.1.82; Heymsfield SB, 2009, J APPL PHYSIOL, V106, P40, DOI 10.1152/japplphysiol.91123.2008; Hsu A, 2003, AM J CLIN NUTR, V77, P1506, DOI 10.1093/ajcn/77.6.1506; Illner K, 2000, AM J PHYSIOL-ENDOC M, V278, pE308, DOI 10.1152/ajpendo.2000.278.2.E308; Kim J, 2002, AM J CLIN NUTR, V76, P378, DOI 10.1093/ajcn/76.2.378; KLEIBER MAX, 1932, HILGARDIA, V6, P315; Later W, 2008, AM J CLIN NUTR, V88, P1004, DOI 10.1093/ajcn/88.4.1004; LEE P, 2010, AM J PHYSIOL, V299, pE60, DOI DOI 10.1152/AJPENDO.00298.2010; Livshits G, 2007, J CLIN ENDOCR METAB, V92, P3171, DOI 10.1210/jc.2007-0418; Rice T, 1996, OBES RES, V4, P441, DOI 10.1002/j.1550-8528.1996.tb00252.x; Rosenbaum M, 2010, INT J OBESITY, V34, pS47, DOI 10.1038/ijo.2010.184; ROTHWELL NJ, 1983, CLIN SCI, V64, P19, DOI 10.1042/cs0640019; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Walley AJ, 2009, NAT REV GENET, V10, P431, DOI 10.1038/nrg2594; Wang ZM, 2010, AM J CLIN NUTR, V92, P1369, DOI 10.3945/ajcn.2010.29885; Wang ZM, 2001, J NUTR, V131, P2967, DOI 10.1093/jn/131.11.2967; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363	32	44	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e22732	10.1371/journal.pone.0022732	http://dx.doi.org/10.1371/journal.pone.0022732			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21818376	gold, Green Published, Green Submitted			2022-12-25	WOS:000293175100045
J	Wendt, H; Hillmer, A; Reimers, K; Kuhbier, JW; Schafer-Nolte, F; Allmeling, C; Kasper, C; Vogt, PM				Wendt, Hanna; Hillmer, Anja; Reimers, Kerstin; Kuhbier, Joern W.; Schaefer-Nolte, Franziska; Allmeling, Christina; Kasper, Cornelia; Vogt, Peter M.			Artificial Skin - Culturing of Different Skin Cell Lines for Generating an Artificial Skin Substitute on Cross-Weaved Spider Silk Fibres	PLOS ONE			English	Article							NEPHILA-CLAVIPES ARANEAE; DRAGLINE SILK; ESCHERICHIA-COLI; BOMBYX-MORI; IN-VIVO; BIOMATERIALS; SCAFFOLDS; PROTEIN; WEB; DEGRADATION	Background: In the field of Plastic Reconstructive Surgery the development of new innovative matrices for skin repair is in urgent need. The ideal biomaterial should promote attachment, proliferation and growth of cells. Additionally, it should degrade in an appropriate time period without releasing harmful substances, but not exert a pathological immune response. Spider dragline silk from Nephila spp meets these demands to a large extent. Methodology/Principal Findings: Native spider dragline silk, harvested directly out of Nephila spp spiders, was woven on steel frames. Constructs were sterilized and seeded with fibroblasts. After two weeks of cultivating single fibroblasts, keratinocytes were added to generate a bilayered skin model, consisting of dermis and epidermis equivalents. For the next three weeks, constructs in co-culture were lifted on an originally designed setup for air/liquid interface cultivation. After the culturing period, constructs were embedded in paraffin with an especially developed program for spidersilk to avoid supercontraction. Paraffin cross-sections were stained in Haematoxylin & Eosin (H&E) for microscopic analyses. Conclusion/Significance: Native spider dragline silk woven on steel frames provides a suitable matrix for 3 dimensional skin cell culturing. Both fibroblasts and keratinocytes cell lines adhere to the spider silk fibres and proliferate. Guided by the spider silk fibres, they sprout into the meshes and reach confluence in at most one week. A well-balanced, bilayered cocultivation in two continuously separated strata can be achieved by serum reduction, changing the medium conditions and the cultivation period at the air/liquid interphase. Therefore spider silk appears to be a promising biomaterial for the enhancement of skin regeneration.	[Wendt, Hanna; Hillmer, Anja; Reimers, Kerstin; Kuhbier, Joern W.; Schaefer-Nolte, Franziska; Allmeling, Christina; Vogt, Peter M.] Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, D-3000 Hannover, Germany; [Kasper, Cornelia] Leibniz Univ Hannover, Inst Tech Chem, D-3000 Hannover, Germany	Hannover Medical School; Leibniz University Hannover	Wendt, H (corresponding author), Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, D-3000 Hannover, Germany.	HannaFW@web.de	Vogt, Peter M./AAL-1332-2020; Kasper, Cornelia/AAC-1924-2022	kasper, cornelia/0000-0003-2607-4326	StrucMed of Hannover Medical School	StrucMed of Hannover Medical School	The study was funded in part by the student support program StrucMed of Hannover Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Agapov II, 2009, DOKL BIOCHEM BIOPHYS, V426, P127, DOI 10.1134/S1607672909030016; Agnarsson I, 2008, J EXP ZOOL PART A, V309A, P494, DOI 10.1002/jez.480; Agnarsson I, 2009, ZOOLOGY, V112, P325, DOI 10.1016/j.zool.2008.11.003; Allmeling C, 2008, CELL PROLIFERAT, V41, P408, DOI 10.1111/j.1365-2184.2008.00534.x; Allmeling C, 2006, J CELL MOL MED, V10, P770, DOI 10.1111/j.1582-4934.2006.tb00436.x; Blackledge TA, 2009, J EXP BIOL, V212, P1980, DOI 10.1242/jeb.028944; Bogush VG, 2009, J NEUROIMMUNE PHARM, V4, P17, DOI 10.1007/s11481-008-9129-z; Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514; Cunniff P.M., 1994, POLYM ADVAN TECHNOL, V5, P401; Curran MP, 2002, BIODRUGS, V16, P439, DOI 10.2165/00063030-200216060-00005; Dai DY, 2007, STROKE, V38, P170, DOI 10.1161/01.STR.0000252128.83405.71; Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883; FANGMANN J, 1992, J EXP MED, V175, P1521, DOI 10.1084/jem.175.6.1521; Gellynck K, 2008, J MATER SCI-MATER M, V19, P3399, DOI 10.1007/s10856-008-3474-6; Gentzkow GD, 1996, DIABETES CARE, V19, P350, DOI 10.2337/diacare.19.4.350; Griffith LG, 2002, ANN NY ACAD SCI, V961, P83, DOI 10.1111/j.1749-6632.2002.tb03056.x; Hakimi O, 2010, J BIOMED MATER RES A, V92A, P1366, DOI 10.1002/jbm.a.32462; Hardy JG, 2009, BIOCHEM SOC T, V37, P677, DOI 10.1042/BST0370677; Higgins L, 2006, J ARACHNOL, V34, P374, DOI 10.1636/T04-53.1; Hinman MB, 2000, TRENDS BIOTECHNOL, V18, P374, DOI 10.1016/S0167-7799(00)01481-5; Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020; Hu SS, 2006, WOUND REPAIR REGEN, V14, P427, DOI 10.1111/j.1743-6109.2006.00148.x; Ko FK, 2004, BIOMACROMOLECULES, V5, P780, DOI 10.1021/bm0345099; Kubik S, 2002, ANGEW CHEM INT EDIT, V41, P2721, DOI 10.1002/1521-3773(20020802)41:15&lt;2721::AID-ANIE2721&gt;3.0.CO;2-3; Kuhbier JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012032; LOMBARDI SJ, 1990, J ARACHNOL, V18, P297; Lou RB, 2009, HAND CLIN, V25, P497, DOI 10.1016/j.hcl.2009.06.002; MacIntosh AC, 2008, J TISSUE ENG REGEN M, V2, P71, DOI 10.1002/term.68; Madison KC, 2003, J INVEST DERMATOL, V121, P231, DOI 10.1046/j.1523-1747.2003.12359.x; MANGOLDT VF, 1895, DEUT MED WOCHENSCHR, P789; Mann R, 1996, WESTERN J MED, V165, P215; Metcalfe AD, 2007, J R SOC INTERFACE, V4, P413, DOI 10.1098/rsif.2006.0179; MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008; Monstrey S, 1999, ANN PLAS SURG, V43, P268, DOI 10.1097/00000637-199909000-00008; NEWMAN J, 1995, INT J DERMATOL, V34, P290, DOI 10.1111/j.1365-4362.1995.tb01600.x; Nova A, 2010, NANO LETT, V10, P2626, DOI 10.1021/nl101341w; OSANAI M, 1984, EXP GERONTOL, V19, P37, DOI 10.1016/0531-5565(84)90030-5; Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3; PHILLIPS TJ, 1994, J INVEST DERMATOL S, V102, P38; Rios CN, 2009, TISSUE ENG PT A, V15, P2717, DOI [10.1089/ten.tea.2008.0360, 10.1089/ten.TEA.2008.0360]; Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R; SCHILDKNECHT H, 1972, NATURWISSENSCHAFTEN, V59, P98, DOI 10.1007/BF00591781; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Sponner A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000998; Supp DM, 2005, CLIN DERMATOL, V23, P403, DOI 10.1016/j.clindermatol.2004.07.023; Tan JL, 2004, TISSUE ENG, V10, P865, DOI 10.1089/1076327041348365; Vollrath F, 2002, IN VIVO, V16, P229; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000; Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002; Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050; Wen HX, 2010, MOL BIOL REP, V37, P1815, DOI 10.1007/s11033-009-9615-2; WORK RW, 1982, J ARACHNOL, V10, P1; Xia XX, 2010, P NATL ACAD SCI USA, V107, P14059, DOI 10.1073/pnas.1003366107; XIAO J, 1992, BURNS, V18, P401, DOI 10.1016/0305-4179(92)90040-2; Zhou SB, 2008, J PHYS CHEM B, V112, P11209, DOI 10.1021/jp800913k	55	77	82	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e21833	10.1371/journal.pone.0021833	http://dx.doi.org/10.1371/journal.pone.0021833			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21814557	gold, Green Published, Green Submitted			2022-12-25	WOS:000293175100010
J	Carlring, J; De Leenheer, E; Heath, AW				Carlring, Jennifer; De Leenheer, Evy; Heath, Andrew William			A Novel Redox Method for Rapid Production of Functional Bi-Specific Antibodies For Use in Early Pilot Studies	PLOS ONE			English	Article							BISPECIFIC ANTIBODIES; MONOCLONAL-ANTIBODIES; CELLS; LYMPHOMA; ANTIGENS; RECEPTOR; SINGLE	We demonstrate here a rapid alternative method for the production of functional bi-specific antibodies using the mild reducing agent 2-mercaptoethanesulfonic acid sodium salt (MESNA). Following reduction of a mixture of two monoclonal antibodies with MESNA to break inter heavy chain bonds, this solution is dialysed under oxidising conditions and antibodies are allowed to reform. During this reaction a mixture of antibodies is formed, including parental antibodies and bi-specific antibody. Bi-specific antibodies are purified over two sequential affinity columns. Following purification, bi-specificity of antibodies is determined in enzyme-linked immunosorbent assays and by flow cytometry. Using this redox method we have been successful in producing hybrid and same-species bi-specific antibodies in a time frame of 6-10 working days, making this production method a time saving alternative to the time-consuming traditional heterohybridoma technology for the production of bi-specific antibodies for use in early pilot studies. The use of both rat and mouse IgG antibodies forming a rat/mouse bi-specific antibody as well as producing a pure mouse bi-specific antibody and a pure rat bi-specific antibody demonstrates the flexibility of this production method.	[Carlring, Jennifer; De Leenheer, Evy; Heath, Andrew William] Univ Sheffield, Sch Med & Biomed Sci, Dept Infect & Immun, Acad Unit Immunol & Infect Dis, Sheffield, S Yorkshire, England	University of Sheffield	Carlring, J (corresponding author), Univ Sheffield, Sch Med & Biomed Sci, Dept Infect & Immun, Acad Unit Immunol & Infect Dis, Sheffield, S Yorkshire, England.	j.u.carlring-wright@shef.ac.uk			Yorkshire Cancer Research [S286]; HEIF	Yorkshire Cancer Research; HEIF	J. Carlring was sponsored by Yorkshire Cancer Research S286 (http://www.yorkshirecancerresearch.org.uk) and E. De Leenheer was supported by the HEIF Proof of Concept Fund administered by the University of Sheffield, UK. The funders had no role in study design, data collection and analysis, desision to publish, or preparation of the manuscript.	Bargou R, 2008, SCIENCE, V321, P974, DOI 10.1126/science.1158545; Barr TA, 2005, VACCINE, V23, P3477, DOI 10.1016/j.vaccine.2004.12.025; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Cochlovius B, 2000, CANCER RES, V60, P4336; Graziano Robert F., 2004, V283, P71; IEMIJ R, 1999, J IMMUNOTHER, V22, P514; IER G, 1975, NATURE, V256, P495; KIM KJ, 1979, J IMMUNOL, V122, P549; LEDBETTER JA, 1994, CIRC SHOCK, V44, P67; Lu D, 2005, J BIOL CHEM, V280, P19665, DOI 10.1074/jbc.M500815200; Menard S, 1989, Int J Biol Markers, V4, P131; MULLINK H, 1987, J IMMUNOL METHODS, V99, P199, DOI 10.1016/0022-1759(87)90128-1; Orcutt KD, 2010, PROTEIN ENG DES SEL, V23, P221, DOI 10.1093/protein/gzp077; Randall TD, 1998, IMMUNITY, V8, P733, DOI 10.1016/S1074-7613(00)80578-6; Segal DM, 1999, CURR OPIN IMMUNOL, V11, P558, DOI 10.1016/S0952-7915(99)00015-1; Shen JQ, 2006, J BIOL CHEM, V281, P10706, DOI 10.1074/jbc.M513415200; SURESH MR, 1986, METHOD ENZYMOL, V121, P210; VELAZQUEZ A, 1995, AM J CLIN NUTR, V61, P385, DOI 10.1093/ajcn/61.2.385; Wu CB, 2007, NAT BIOTECHNOL, V25, P1290, DOI 10.1038/nbt1345	19	9	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22533	10.1371/journal.pone.0022533	http://dx.doi.org/10.1371/journal.pone.0022533			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811628	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000292956800066
J	Foster, EL; Simpson, EL; Fredrikson, LJ; Lee, JJ; Lee, NA; Fryer, AD; Jacoby, DB				Foster, Erin L.; Simpson, Eric L.; Fredrikson, Lorna J.; Lee, James J.; Lee, Nancy A.; Fryer, Allison D.; Jacoby, David B.			Eosinophils Increase Neuron Branching in Human and Murine Skin and In Vitro	PLOS ONE			English	Article							MAJOR BASIC-PROTEIN; NERVE GROWTH-FACTOR; HUMAN PERIPHERAL EOSINOPHILS; ATOPIC-DERMATITIS; MAST-CELLS; CATIONIC PROTEIN; NON-ALLERGICS; RECEPTOR; EXPRESSION; EOTAXIN	Cutaneous nerves are increased in atopic dermatitis, and itch is a prominent symptom. We studied the functional interactions between eosinophils and nerves in human and mouse skin and in culture. We demonstrated that human atopic dermatitis skin has eosinophil granule proteins present in the same region as increased nerves. Transgenic mice in which interleukin-5 (IL-5) expression is driven by a keratin-14 (K14) promoter had many eosinophils in the epidermis, and the number of nerves was also significantly increased in the epidermis. In co-cultures, eosinophils dramatically increased branching of sensory neurons isolated from the dorsal root ganglia (DRG) of mice. This effect did not occur in DRG neurons co-cultured with mast cells or with dead eosinophils. Physical contact of the eosinophils with the neurons was not required, and the effect was not blocked by an antibody to nerve growth factor. DRG neurons express eotaxin-1, ICAM-1 and VCAM-1, which may be important in the recruitment, binding, and activation of eosinophils in the region of cutaneous nerves. These data indicate a pathophysiological role for eosinophils in cutaneous nerve growth in atopic dermatitis, and suggest they may present a therapeutic target in atopic dermatitis and other eosinophilic skin conditions with neuronal symptoms such as itch.	[Foster, Erin L.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA; [Simpson, Eric L.] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA; [Fredrikson, Lorna J.; Lee, James J.; Lee, Nancy A.] Mayo Clin, Dept Biochem, Scottsdale, AZ USA; [Fryer, Allison D.; Jacoby, David B.] Oregon Hlth & Sci Univ, Dept Med, Div Pulm & Crit Care, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Mayo Clinic; Mayo Clinic Phoenix; Oregon Health & Science University	Foster, EL (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA.	jacobyd@ohsu.edu	Fryer, Allison/F-2420-2014	Fryer, Allison/0000-0003-1712-9831; Jacoby, David/0000-0003-2195-9512	NIH [T32AI007472, HL61013, HL71795, AI75064, HL55543, ES14601, HL065228, RR109709, HL058723]; OHSU Tartar Fellowship; Mayo Foundation for Medical Education and Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055543, R01HL058723, R01HL061013, R01HL071795, R56HL058723, R01HL065228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI075064, T32AI007472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014601] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OHSU Tartar Fellowship; Mayo Foundation for Medical Education and Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH T32AI007472 (DBJ) and an OHSU Tartar Fellowship to E. F., and the Mayo Foundation for Medical Education and Research, as well as NIH HL61013 (DBJ), HL71795 (DBJ), AI75064 (DBJ), HL55543 (ADF), ES14601 (ADF), HL065228 (JJL), RR109709 (JJL), and HL058723 (NAL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew D, 1999, J NEUROPHYSIOL, V82, P2649, DOI 10.1152/jn.1999.82.5.2649; ARIZONO N, 1990, LAB INVEST, V62, P626; Benarafa C, 2002, VET REC, V151, P691; BYROM NA, 1979, BRIT J DERMATOL, V100, P491, DOI 10.1111/j.1365-2133.1979.tb05574.x; COSTA JJ, 1993, J CLIN INVEST, V91, P2673, DOI 10.1172/JCI116506; Costello RW, 1997, AM J PHYSIOL-LUNG C, V273, pL93, DOI 10.1152/ajplung.1997.273.1.L93; Damsgaard TE, 1997, ARCH DERMATOL RES, V289, P256, DOI 10.1007/s004030050189; DELREE P, 1989, J NEUROSCI RES, V23, P198, DOI 10.1002/jnr.490230210; Evans CM, 1997, J CLIN INVEST, V100, P2254, DOI 10.1172/JCI119763; Fryer AD, 2006, J CLIN INVEST, V116, P228, DOI 10.1172/JCI25423; Gu QH, 2009, AM J PHYSIOL-LUNG C, V296, pL453, DOI 10.1152/ajplung.90467.2008; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Ikoma A, 2004, NEUROLOGY, V62, P212, DOI 10.1212/WNL.62.2.212; Jarvikallio A, 1997, BRIT J DERMATOL, V136, P871, DOI 10.1046/j.1365-2133.1997.01831.x; Johansson O, 2000, ARCH DERMATOL RES, V292, P371, DOI 10.1007/s004030000142; KAGI MK, 1992, DERMATOLOGY, V185, P88, DOI 10.1159/000247419; Kiehl P, 2001, BRIT J DERMATOL, V145, P720, DOI 10.1046/j.1365-2133.2001.04456.x; Kingham PJ, 2003, AM J PHYSIOL-LUNG C, V285, pL915, DOI 10.1152/ajplung.00094.2003; Kitaura M, 1996, J BIOL CHEM, V271, P7725, DOI 10.1074/jbc.271.13.7725; Kobayashi H, 2002, BLOOD, V99, P2214, DOI 10.1182/blood.V99.6.2214; Lauria G, 1999, J NEUROL SCI, V164, P172, DOI 10.1016/S0022-510X(99)00063-5; Lee NA, 1997, J IMMUNOL, V158, P1332; LEIFERMAN KM, 1985, NEW ENGL J MED, V313, P282, DOI 10.1056/NEJM198508013130502; Namer B, 2008, J NEUROPHYSIOL, V100, P2062, DOI 10.1152/jn.90482.2008; Noga O, 2005, REGUL PEPTIDES, V132, P74, DOI 10.1016/j.regpep.2005.09.023; Noga O, 2003, CLIN EXP ALLERGY, V33, P649, DOI 10.1046/j.1365-2222.2003.01586.x; Paus R, 2006, J CLIN INVEST, V116, P1174, DOI 10.1172/JCI28553; PINCELLI C, 1994, J INVEST DERMATOL, V103, P13, DOI 10.1111/1523-1747.ep12388914; Ponath PD, 1996, J CLIN INVEST, V97, P604, DOI 10.1172/JCI118456; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Sawatzky DA, 2002, AM J PHYSIOL-LUNG C, V282, pL1279, DOI 10.1152/ajplung.00279.2001; Schmelz M, 1997, J NEUROSCI, V17, P8003; SOTELO JR, 1991, NEUROSCI LETT, V129, P91, DOI 10.1016/0304-3940(91)90727-B; Sugiura H, 1997, ARCH DERMATOL RES, V289, P125, DOI 10.1007/s004030050167; Taniuchi S, 2001, J DERMATOL SCI, V26, P79, DOI 10.1016/S0923-1811(00)00151-1; TOBIN D, 1992, J ALLERGY CLIN IMMUN, V90, P613, DOI 10.1016/0091-6749(92)90134-N; UNDEM BJ, 1990, J AUTONOM NERV SYST, V30, P75, DOI 10.1016/0165-1838(90)90164-E; VASSAR R, 1989, P NATL ACAD SCI USA, V86, P1563, DOI 10.1073/pnas.86.5.1563; WELLER PF, 1993, J IMMUNOL, V150, P2554	40	57	60	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22029	10.1371/journal.pone.0022029	http://dx.doi.org/10.1371/journal.pone.0022029			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811556	Green Submitted, Green Published, gold			2022-12-25	WOS:000292956800019
J	Catania, KC; Leitch, DB; Gauthier, D				Catania, Kenneth C.; Leitch, Duncan B.; Gauthier, Danielle			A Star in the Brainstem Reveals the First Step of Cortical Magnification	PLOS ONE			English	Article							ARCHITECTONIC VIBRISSAL REPRESENTATIONS; PRINCIPAL SENSORY NUCLEUS; GANGLION-CELL DENSITY; TRIGEMINAL COMPLEX; CEREBRAL-CORTEX; NOSED MOLE; STRUCTURAL ORGANIZATION; SOMATOSENSORY CORTEX; STRIATE CORTEX; RAT THALAMUS	A fundamental question in the neurosciences is how central nervous system (CNS) space is allocated to different sensory inputs. Yet it is difficult to measure innervation density and corresponding representational areas in the CNS of most species. These measurements can be made in star-nosed moles (Condylura cristata) because the cortical representation of nasal rays is visible in flattened sections and afferents from each ray can be counted. Here we used electrophysiological recordings combined with sections of the brainstem to identify a large, visible star representation in the principal sensory nucleus (PrV). PrV was greatly expanded and bulged out of the brainstem rostrally to partially invade the trigeminal nerve. The star representation was a distinct PrV subnucleus containing 11 modules, each representing one of the nasal rays. The 11 PrV ray representations were reconstructed to obtain volumes and the largest module corresponded to ray 11, the mole's tactile fovea. These measures were compared to fiber counts and primary cortical areas from a previous investigation. PrV ray volumes were closely correlated with the number of afferents from each ray, but afferents from the behaviorally most important, 11(th) ray were preferentially over-represented. This over-representation at the brainstem level was much less than at the cortical level. Our results indicate that PrV provides the first step in magnifying CNS representations of important afferents, but additional magnification occurs at higher levels. The early development of the 11(th), foveal appendage could provide a mechanism for the most important afferents to capture the most CNS space.	[Catania, Kenneth C.; Leitch, Duncan B.; Gauthier, Danielle] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Catania, KC (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	ken.catania@vanderbilt.edu	Leitch, Duncan/AAU-6744-2020	Leitch, Duncan/0000-0002-8513-888X	National Science Foundation [0844743]; MacArthur Foundation	National Science Foundation(National Science Foundation (NSF)); MacArthur Foundation	Supported by National Science Foundation (Award # 0844743) and the MacArthur Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian ED, 1943, BRAIN, V66, P89, DOI 10.1093/brain/66.2.89; Ashwell KWS, 2006, J CHEM NEUROANAT, V31, P81, DOI 10.1016/j.jchemneu.2005.08.007; AZZOPARDI P, 1993, NATURE, V361, P719, DOI 10.1038/361719a0; BATES CA, 1985, J COMP NEUROL, V240, P265, DOI 10.1002/cne.902400305; BELFORD GR, 1979, J COMP NEUROL, V183, P305, DOI 10.1002/cne.901830207; CARROLL EW, 1984, J COMP NEUROL, V222, P1, DOI 10.1002/cne.902220102; Catania KC, 1999, J COMP NEUROL, V410, P55; CATANIA KC, 1995, J COMP NEUROL, V351, P549, DOI 10.1002/cne.903510406; Catania KC, 2004, BRAIN BEHAV EVOLUT, V63, P1, DOI 10.1159/000073755; Catania KC, 1997, J COMP NEUROL, V387, P215; Catania KC, 2001, NAT NEUROSCI, V4, P353, DOI 10.1038/85992; DANIEL PM, 1961, J PHYSIOL-LONDON, V159, P203, DOI 10.1113/jphysiol.1961.sp006803; DRASDO N, 1977, NATURE, V266, P554, DOI 10.1038/266554a0; Erzurumlu RS, 2010, NAT REV NEUROSCI, V11, P252, DOI 10.1038/nrn2804; ERZURUMLU RS, 1983, J COMP NEUROL, V213, P365, DOI 10.1002/cne.902130402; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Gutierrez-Ibanez C, 2009, BRAIN BEHAV EVOLUT, V74, P280, DOI 10.1159/000270904; Haidarliu S, 2001, J COMP NEUROL, V429, P372, DOI 10.1002/1096-9861(20010115)429:3<372::AID-CNE2>3.0.CO;2-3; JACQUIN MF, 1993, J NEUROPHYSIOL, V70, P1911, DOI 10.1152/jn.1993.70.5.1911; Jacquin MF, 1996, EUR J NEUROSCI, V8, P1641, DOI 10.1111/j.1460-9568.1996.tb01308.x; KEMPLAY S, 1989, NEUROSCIENCE, V32, P153, DOI 10.1016/0306-4522(89)90115-2; KILLACKEY HP, 1995, TRENDS NEUROSCI, V18, P402, DOI 10.1016/0166-2236(95)93937-S; KILLACKEY HP, 1985, DEV BRAIN RES, V22, P141, DOI 10.1016/0165-3806(85)90077-X; LAND PW, 1995, J COMP NEUROL, V355, P573, DOI 10.1002/cne.903550407; MA PM, 1993, J COMP NEUROL, V327, P376, DOI 10.1002/cne.903270306; MA PM, 1991, J COMP NEUROL, V309, P161, DOI 10.1002/cne.903090202; MALPELI JG, 1975, J COMP NEUROL, V161, P569, DOI 10.1002/cne.901610407; MYERSON J, 1977, SCIENCE, V198, P855, DOI 10.1126/science.411172; Penfield W, 1950, CEREBRAL CORTEX MAN; PERRY VH, 1985, VISION RES, V25, P1795, DOI 10.1016/0042-6989(85)90004-5; SILVEIRA LCL, 1989, VISION RES, V29, P1471, DOI 10.1016/0042-6989(89)90131-4; SUGA N, 1976, SCIENCE, V194, P542, DOI 10.1126/science.973140; SUR M, 1980, J NEUROPHYSIOL, V44, P295, DOI 10.1152/jn.1980.44.2.295; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; VANDERLOOS H, 1976, NEUROSCI LETT, V2, P1, DOI 10.1016/0304-3940(76)90036-7; WAITE PME, 2003, RAT NERVOUS SYSTEM, P815; WASSLE H, 1989, NATURE, V341, P643, DOI 10.1038/341643a0; WASSLE H, 1990, VISION RES, V30, P1897, DOI 10.1016/0042-6989(90)90166-I; WELKER E, 1986, J NEUROSCI, V6, P3355; Woolsey CN, 1942, B JOHNS HOPKINS HOSP, V70, P399; WOOLSEY TA, 1975, J COMP NEUROL, V164, P79, DOI 10.1002/cne.901640107; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X	42	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22406	10.1371/journal.pone.0022406	http://dx.doi.org/10.1371/journal.pone.0022406			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21811600	Green Published, gold			2022-12-25	WOS:000292929500059
J	Guo, HX; Zhang, HZ; Li, YC; Ren, JP; Wang, X; Niu, HB; Yin, J				Guo, Hongxiang; Zhang, Huizhen; Li, Yongchun; Ren, Jiangping; Wang, Xiang; Niu, Hongbin; Yin, Jun			Identification of Changes in Wheat (Triticum aestivum L.) Seeds Proteome in Response to Anti-trx s Gene	PLOS ONE			English	Article							THIOREDOXIN-H; CROSS-LINKING; PROTEINS; BARLEY; EXPRESSION; GRAIN; DEHYDROGENASE; GERMINATION; SUBUNIT; TOMATO	Background: Thioredoxin h (trx h) is closely related to germination of cereal seeds. The cDNA sequences of the thioredoxin s (trx s) gene from Phalaris coerulescens and the thioredoxin h (trx h) gene from wheat are highly homologous, and their expression products have similar biological functions. Transgenic wheat had been formed after the antisense trx s was transferred into wheat, and it had been certified that the expression of trx h decreased in transgenic wheat, and transgenic wheat has high resistance to pre-harvest sprouting. Methodology/Principal Findings: Through analyzing the differential proteome of wheat seeds between transgenic wheat and wild type wheat, the mechanism of transgenic wheat seeds having high resistance to pre-harvest sprouting was studied in the present work. There were 36 differential proteins which had been identified by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF-MS). All these differential proteins are involved in regulation of carbohydrates, esters, nucleic acid, proteins and energy metabolism, and biological stress. The quantitative real time PCR results of some differential proteins, such as trx h, heat shock protein 70, alpha-amylase, beta-amylase, glucose-6-phosphate isomerase, 14-3-3 protein, S3-RNase, glyceraldehyde-3-phosphate dehydrogenase, and WRKY transcription factor 6, represented good correlation between transcripts and proteins. The biological functions of many differential proteins are consistent with the proposed role of trx h in wheat seeds. Conclusions/Significance: A possible model for the role of trx h in wheat seeds germination was proposed in this paper. These results will not only play an important role in clarifying the mechanism that transgenic wheat has high resistance to pre-harvest sprouting, but also provide further evidence for the role of trx h in germination of wheat seeds.	[Guo, Hongxiang; Li, Yongchun; Ren, Jiangping; Wang, Xiang; Niu, Hongbin; Yin, Jun] Henan Agr Univ, Natl Engn Res Ctr Wheat, Zhengzhou, Peoples R China; [Guo, Hongxiang] Henan Agr Univ, Coll Life Sci, Zhengzhou, Peoples R China; [Zhang, Huizhen] Zhengzhou Univ, Coll Publ Hlth, Zhengzhou, Peoples R China	Henan Agricultural University; Henan Agricultural University; Zhengzhou University	Guo, HX (corresponding author), Henan Agr Univ, Natl Engn Res Ctr Wheat, Zhengzhou, Peoples R China.	xmzxyj@126.com	Zhang, Hui/HHN-8494-2022; zhang, hui/GXH-6098-2022		National S&T Major Project of Breeding Transgenic New Biological Variety [2009ZX08012-023B, 2008ZX08002-002, 2009ZX08002-009B]	National S&T Major Project of Breeding Transgenic New Biological Variety	This work was financially supported by the National S&T Major Project of Breeding Transgenic New Biological Variety (2009ZX08012-023B, 2008ZX08002-002, 2009ZX08002-009B). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHARI A, 1981, PHILOS T ROY SOC B, V293, P145, DOI 10.1098/rstb.1981.0068; ARIS JP, 1983, J BIOL CHEM, V258, P4599; Bailly C, 2002, SEED SCI RES, V12, P47, DOI 10.1079/SSR200197; Ben Larbi Nadia, 2009, V517, P105, DOI 10.1007/978-1-59745-541-1_8; BERTRAND S, 1985, NUCLEIC ACIDS RES, V15, P3005; Besse I, 1996, P NATL ACAD SCI USA, V93, P3169, DOI 10.1073/pnas.93.8.3169; BROWN AHD, 1978, GENETICA, V49, P97, DOI 10.1007/BF00120555; Ceroni A, 2006, NUCLEIC ACIDS RES, V34, pW177, DOI 10.1093/nar/gkl266; CHING TM, 1978, PLANT PHYSIOL, V62, P866, DOI 10.1104/pp.62.6.866; Cooley MB, 1999, PLANT PHYSIOL, V121, P1339, DOI 10.1104/pp.121.4.1339; DAMERVAL C, 1986, ELECTROPHORESIS, V7, P52, DOI 10.1002/elps.1150070108; Di Carli M, 2010, J PROTEOME RES, V9, P5684, DOI 10.1021/pr100487x; Fulgosi H, 2002, PLANT MOL BIOL, V50, P1019, DOI 10.1023/A:1021295604109; GAUTIER MF, 1994, PLANT MOL BIOL, V25, P43, DOI 10.1007/BF00024197; Gonzalez MC, 1998, PLANT PHYSIOL, V116, P1249, DOI 10.1104/pp.116.4.1249; [郭红祥 GUO HongXiang], 2008, [植物生理学通讯, Plant Physiology Communications], V44, P651; Guo HongXiang, 2007, Acta Agronomica Sinica, V33, P885; [郭红祥 GUO HongXiang], 2007, [植物生理学通讯, Plant Physiology Communications], V43, P273; Ishiwatari Y, 1998, PLANTA, V205, P12, DOI 10.1007/s004250050291; JIAO JA, 1993, PLANT PHYSIOL BIOCH, V31, P799; JUAREZDIAZ JA, 2005, NOVEL THIOREDOXIN H, P1; KARLIE AN, 2010, PROTEOMICS, V10, P828; KOBREHEL K, 1992, PLANT PHYSIOL, V99, P919, DOI 10.1104/pp.99.3.919; Kochkina VM, 2004, BIOCHEMISTRY-MOSCOW+, V69, P897, DOI 10.1023/B:BIRY.0000040222.03147.01; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI XM, 1994, PLANT CELL, V6, P1923, DOI 10.1105/tpc.6.12.1923; LI XM, 1995, PLANT J, V8, P133, DOI 10.1046/j.1365-313X.1995.08010133.x; Liu Lei, 2004, Acta Agronomica Sinica, V30, P801; Marx C, 2003, PLANTA, V216, P454, DOI 10.1007/s00425-002-0857-7; Meyer Y, 2005, PHOTOSYNTH RES, V86, P419, DOI 10.1007/s11120-005-5220-y; Miflin BJ, 2002, J EXP BOT, V53, P979, DOI 10.1093/jexbot/53.370.979; Montrichard F, 2003, PLANT PHYSIOL, V132, P1707, DOI 10.1104/pp.102.019562; OLEINIKOV AV, 1993, P NATL ACAD SCI USA, V90, P9828, DOI 10.1073/pnas.90.21.9828; Oofusa K, 2004, SEIKAGAKU, V76, P1283; Payan F, 2004, J BIOL CHEM, V279, P36029, DOI 10.1074/jbc.M404225200; Ren Jiang-Ping, 2007, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V33, P325; Ren JiangPing, 2007, Journal of Triticeae Crops, V27, P893; ROSENKRANDS I, 1994, FEBS LETT, V343, P75, DOI 10.1016/0014-5793(94)80610-1; Sparla F, 2002, J BIOL CHEM, V277, P44946, DOI 10.1074/jbc.M206873200; Ulker B, 2004, CURR OPIN PLANT BIOL, V7, P491, DOI 10.1016/j.pbi.2004.07.012; van den Wijngaard PWJ, 2005, PLANT J, V41, P43, DOI 10.1111/j.1365-313X.2004.02273.x; Wong JH, 2003, FEBS LETT, V547, P151, DOI 10.1016/S0014-5793(03)00696-3; Wong JH, 2002, P NATL ACAD SCI USA, V99, P16325, DOI 10.1073/pnas.212641999; Yin J., 2009, ACTA AGR JIANGXI, V21, P1; ZHOU L, 2010, PLOS ONE, V6; Zhou Su-Mei, 2006, Sheng Wu Gong Cheng Xue Bao, V22, P438	46	23	25	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22255	10.1371/journal.pone.0022255	http://dx.doi.org/10.1371/journal.pone.0022255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21811579	Green Submitted, gold, Green Published			2022-12-25	WOS:000292929500047
J	Reynolds, F; Panneer, N; Tutino, CM; Wu, M; Skrabal, WR; Moskaluk, C; Kelly, KA				Reynolds, Fred; Panneer, Nivedha; Tutino, Christopher M.; Wu, Michael; Skrabal, William R.; Moskaluk, Christopher; Kelly, Kimberly A.			A Functional Proteomic Method for Biomarker Discovery	PLOS ONE			English	Article							PANCREATIC DUCTAL ADENOCARCINOMA; EPITHELIAL-MESENCHYMAL TRANSITION; ANNEXIN-II; CELL-SURFACE; CANCER CELLS; MEMBRANE-PROTEINS; PLASMINOGEN RECEPTOR; M2-PYRUVATE KINASE; MASS-SPECTROMETRY; APOPTOTIC CELLS	The sequencing of the human genome holds out the hope for personalized medicine, but it is clear that analysis of DNA or RNA content alone is not sufficient to understand most disease processes. Proteomic strategies that allow unbiased identification of proteins and their post-transcriptional and -translation modifications are an essential complement to genomic strategies. However, the enormity of the proteome and limitations in proteomic methods make it difficult to determine the targets that are particularly relevant to human disease. Methods are therefore needed that allow rational identification of targets based on function and relevance to disease. Screening methodologies such as phage display, SELEX, and small-molecule combinatorial chemistry have been widely used to discover specific ligands for cells or tissues of interest, such as tumors. Those ligands can be used in turn as affinity probes to identify their cognate molecular targets when they are not known in advance. Here we report an easy, robust and generally applicable approach in which phage particles bearing cell-or tissue-specific peptides serve directly as the affinity probes for their molecular targets. For proof of principle, the method successfully identified molecular binding partners, three of them novel, for 15 peptides specific for pancreatic cancer.	[Reynolds, Fred; Panneer, Nivedha; Tutino, Christopher M.; Wu, Michael; Skrabal, William R.; Kelly, Kimberly A.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22903 USA; [Reynolds, Fred; Kelly, Kimberly A.] Univ Virginia, Cardiovasc Res Ctr, Charlottesville, VA USA; [Moskaluk, Christopher] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; [Moskaluk, Christopher] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Reynolds, F (corresponding author), Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22903 USA.	kak3x@virginia.edu			NIH NCI [RO1CA13707]; NIH NIBIB [RO1EB010023]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB010023] Funding Source: NIH RePORTER	NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded by NIH NCI RO1CA13707 and NIH NIBIB RO1EB010023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloysius MM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-327; Bausch D, 2009, J GASTROINTEST SURG, V13, P1948, DOI 10.1007/s11605-009-1001-9; Brix K, 1998, J CLIN INVEST, V102, P283, DOI 10.1172/JCI1614; Chen R, 2005, GASTROENTEROLOGY, V129, P1187, DOI 10.1053/j.gastro.2005.08.001; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Das R, 2007, BLOOD, V110, P3763, DOI 10.1182/blood-2007-03-079392; Davis RG, 1995, J IMMUNOL METHODS, V188, P91, DOI 10.1016/0022-1759(95)00207-3; Diaz VM, 2004, GUT, V53, P993, DOI 10.1136/gut.2003.026831; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Esposito I, 2006, J PATHOL, V208, P673, DOI 10.1002/path.1935; Fan G, 2005, AM J CLIN PATHOL, V124, P920, DOI 10.1309/UEDXPHAAP740B61D; Furnrohr BG, 2007, AUTOIMMUNITY, V40, P322, DOI 10.1080/08916930701356457; Geuijen CAW, 2005, EUR J CANCER, V41, P178, DOI 10.1016/j.ejca.2004.10.008; Geuijen Cecile A. W., 2009, V528, P141, DOI 10.1007/978-1-60327-310-7_11; Gong XG, 2010, BIOL PHARM BULL, V33, P1261, DOI 10.1248/bpb.33.1261; Goshe MB, 2003, J PROTEOME RES, V2, P153, DOI 10.1021/pr0255607; Hagmann W, 2010, NEOPLASIA, V12, P740, DOI 10.1593/neo.10576; Han Haibo, 2009, Clinical Oncology and Cancer Research, V6, P313, DOI 10.1007/s11805-009-0313-6; Hardt PD, 2000, ANTICANCER RES, V20, P4965; Hariton-Gazal E, 2003, J CELL SCI, V116, P4577, DOI 10.1242/jcs.00757; Hastie C, 2008, J BIOL CHEM, V283, P12595, DOI 10.1074/jbc.M800189200; Hayes MJ, 2004, TRAFFIC, V5, P571, DOI 10.1111/j.1600-0854.2004.00210.x; Herren T, 2006, BIOCHEMISTRY-US, V45, P9463, DOI 10.1021/bi060756w; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Jancik S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/150960; Javle MM, 2007, ANN SURG ONCOL, V14, P3527, DOI 10.1245/s10434-007-9540-3; Joergensen MT, 2010, ANTICANCER RES, V30, P587; Kaouass M, 2006, J CONTROL RELEASE, V113, P245, DOI 10.1016/j.jconrel.2006.04.013; Kelly KA, 2008, PLOS MED, V5, P657, DOI 10.1371/journal.pmed.0050085; Kesavan K, 2010, J BIOL CHEM, V285, P4366, DOI 10.1074/jbc.M109.066092; Klepsch F, 2010, CURR PHARM DESIGN, V16, P1742, DOI 10.2174/138161210791163992; KUMBLE KD, 1991, J CELL SCI, V99, P751; Leffler J, 2010, J BIOL CHEM, V285, P3766, DOI 10.1074/jbc.M109.045427; Liu YX, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-16; Massey-Harroche D, 1998, J CELL SCI, V111, P3007; MECHERI S, 1993, MOL IMMUNOL, V30, P549, DOI 10.1016/0161-5890(93)90029-B; Mishra B, 2010, J NEUROSCI, V30, P12400, DOI 10.1523/JNEUROSCI.6407-09.2010; MOTTET N, 2007, AACR M; Nakajima S, 2004, CLIN CANCER RES, V10, P4125, DOI 10.1158/1078-0432.CCR-0578-03; Nedjadi T, 2009, BRIT J CANCER, V101, P1145, DOI 10.1038/sj.bjc.6605289; Novotny I, 2008, HEPATO-GASTROENTEROL, V55, P1475; Paciucci R, 1998, ONCOGENE, V16, P625, DOI 10.1038/sj.onc.1201564; Parseghian MH, 2006, BIOCHEM CELL BIOL, V84, P589, DOI 10.1139/O06-082; Qian C, 2010, J BIOL CHEM, V285, P9367, DOI 10.1074/jbc.M109.059857; Qiu HB, 2008, J PROTEOME RES, V7, P1904, DOI 10.1021/pr700651b; Radic M, 2004, J IMMUNOL, V172, P6692, DOI 10.4049/jimmunol.172.11.6692; Rajotte D, 1999, J BIOL CHEM, V274, P11593, DOI 10.1074/jbc.274.17.11593; Roda O, 2006, PROTEOMICS, V6, pS36, DOI 10.1002/pmic.200500376; Rosenbluh J, 2004, BBA-BIOMEMBRANES, V1664, P230, DOI 10.1016/j.bbamem.2004.06.003; SCHUSSLER MH, 1992, AM J PATHOL, V140, P559; Singh D, 1996, NUCLEIC ACIDS RES, V24, P3113, DOI 10.1093/nar/24.15.3113; Singh P, 2007, CANCER LETT, V252, P19, DOI 10.1016/j.canlet.2006.11.012; Takano S, 2008, ANN SURG ONCOL, V15, P3157, DOI 10.1245/s10434-008-0061-5; Tian R, 2008, DIGEST DIS SCI, V53, P65, DOI 10.1007/s10620-007-9823-3; Tsao R, 2009, RES DEV DISABIL, V30, P426, DOI 10.1016/j.ridd.2008.10.009; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Watson K, 1999, J BIOL CHEM, V274, P21707, DOI 10.1074/jbc.274.31.21707; WATSON K, 1995, BIOCHEM PHARMACOL, V50, P299, DOI 10.1016/0006-2952(95)00142-M; Weeks ME, 2008, PROTEOM CLIN APPL, V2, P1047, DOI 10.1002/prca.200780164; ZOLLO M, 1994, BIOTECHNIQUES, V16, P370	60	13	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22471	10.1371/journal.pone.0022471	http://dx.doi.org/10.1371/journal.pone.0022471			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21811618	Green Published, Green Submitted, gold			2022-12-25	WOS:000292929500070
J	Sanz, J; Navarro, J; Arbues, A; Martin, C; Marijuan, PC; Moreno, Y				Sanz, Joaquin; Navarro, Jorge; Arbues, Ainhoa; Martin, Carlos; Marijuan, Pedro C.; Moreno, Yamir			The Transcriptional Regulatory Network of Mycobacterium tuberculosis	PLOS ONE			English	Article							COMPLEX NETWORKS; ESCHERICHIA-COLI; BIOLOGY; MOTIFS; EXPRESSION; VACCINES; OPERON; STRAIN; PHOP	Under the perspectives of network science and systems biology, the characterization of transcriptional regulatory (TR) networks beyond the context of model organisms offers a versatile tool whose potential remains yet mainly unexplored. In this work, we present an updated version of the TR network of Mycobacterium tuberculosis (M.tb), which incorporates newly characterized transcriptional regulations coming from 31 recent, different experimental works available in the literature. As a result of the incorporation of these data, the new network doubles the size of previous data collections, incorporating more than a third of the entire genome of the bacterium. We also present an exhaustive topological analysis of the new assembled network, focusing on the statistical characterization of motifs significances and the comparison with other model organisms. The expanded M. tb transcriptional regulatory network, considering its volume and completeness, constitutes an important resource for diverse tasks such as dynamic modeling of gene expression and signaling processes, computational reliability determination or protein function prediction, being the latter of particular relevance, given that the function of only a small percent of the proteins of M. tb is known.	[Sanz, Joaquin; Moreno, Yamir] Univ Zaragoza, Inst Biocomp & Fis Sistemas Complejos, Zaragoza, Spain; [Sanz, Joaquin] Univ Zaragoza, Dept Fs Mat Condensada, Zaragoza, Spain; [Navarro, Jorge; Marijuan, Pedro C.] Inst Aragones Ciencias Salud, Grp Bioinformac, Zaragoza, Spain; [Arbues, Ainhoa; Martin, Carlos] Univ Zaragoza, Fac Med, Dept Microbiol, Grp Genet Micobacterias, Zaragoza, Spain; [Arbues, Ainhoa; Martin, Carlos] Univ Zaragoza, Fac Med, Ctr Invest Biomed Red Enfermedades Resp, Zaragoza, Spain; [Moreno, Yamir] Univ Zaragoza, Dept Fis Teor, E-50009 Zaragoza, Spain	University of Zaragoza; University of Zaragoza; University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Zaragoza; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - UAM - Institut de Fisica Teorica (IFT); University of Zaragoza	Sanz, J (corresponding author), Univ Zaragoza, Inst Biocomp & Fis Sistemas Complejos, Zaragoza, Spain.	yamir.moreno@gmail.com	Martin, Carlos/A-7283-2008; Navarro-Lopez, Jorge/ABF-6236-2020; Sanz, Joaquín/AAA-4010-2019; Moreno, Yamir/A-1076-2009	Martin, Carlos/0000-0003-2993-5478; Navarro-Lopez, Jorge/0000-0001-6148-0667; Sanz, Joaquín/0000-0002-2980-9685; Moreno, Yamir/0000-0002-0895-1893	Government of Aragon (DGA, Spain) [PI038/08]; MICINN [FIS2008-01240, FIS2009-13364-C02-01]	Government of Aragon (DGA, Spain)(Gobierno de Aragon); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission)	This work was mainly supported by the Government of Aragon (DGA, Spain) through the project PI038/08. The authors also acknowledge partial support by MICINN through Grants FIS2008-01240 and FIS2009-13364-C02-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Balazsi G, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.63; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Dannenberg Arthur M. Jr., 1994, P459; Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994; Gomez-Gardenes J, 2006, CHAOS, V16, DOI 10.1063/1.2146115; Gonzalo-Asensio J, 2008, J BACTERIOL, V190, P7068, DOI 10.1128/JB.00712-08; Gonzalo-Asensio J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003496; Guimera R, 2009, P NATL ACAD SCI USA, V106, P22073, DOI 10.1073/pnas.0908366106; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; Martin C, 2006, VACCINE, V24, P3408, DOI 10.1016/j.vaccine.2006.03.017; Martin C, 2006, CURR OPIN PULM MED, V12, P186, DOI 10.1097/01.mcp.0000219267.27439.1b; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Milo R., 2003, UNIFORM GENERATION R; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Roback P, 2007, NUCLEIC ACIDS RES, V35, P5085, DOI 10.1093/nar/gkm518; Ronen M, 2002, P NATL ACAD SCI USA, V99, P10555, DOI 10.1073/pnas.152046799; Rosenfeld N, 2003, J MOL BIOL, V329, P645, DOI 10.1016/S0022-2836(03)00506-0; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; *WHO, 2000, WHOCDSTB20002751179; Young D, 2006, CELL, V124, P683, DOI 10.1016/j.cell.2006.02.013; Young D, 2008, NAT REV MICROBIOL, V6, P520, DOI 10.1038/nrmicro1919; Zaslaver A, 2004, NAT GENET, V36, P486, DOI 10.1038/ng1348	33	41	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22178	10.1371/journal.pone.0022178	http://dx.doi.org/10.1371/journal.pone.0022178			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21818301	Green Published, Green Submitted, gold			2022-12-25	WOS:000292929500045
J	Mierke, CT; Bretz, N; Altevogt, P				Mierke, Claudia Tanja; Bretz, Niko; Altevogt, Peter			Contractile Forces Contribute to Increased Glycosylphosphatidylinositol-anchored Receptor CD24-facilitated Cancer Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDEPENDENT PROGNOSTIC MARKER; BREAST-CARCINOMA CELLS; CD24 EXPRESSION; TUMOR-CELLS; EXTRACELLULAR-MATRIX; ADHESION; METASTASIS; MIGRATION; BINDING; INTEGRINS	The malignancy of a tumor depends on the capability of cancer cells to metastasize. The process of metastasis involves cell invasion through connective tissue and transmigration through endothelial monolayers. The expression of the glycosylphosphatidylinositol- anchored receptor CD24 is increased in several tumor types and is consistently associated with increased metastasis formation in patients. Furthermore, the localization of beta 1-integrins in lipid rafts depends on CD24. Cell invasion is a fundamental biomechanical process and usually requires cell adhesion to the extracellular matrix (ECM) mainly through beta 1 heterodimeric integrin receptors. Here, we studied the invasion of A125 human lung cancer cells with different CD24 expression levels in three-dimensional ECMs. We hypothesized that CD24 expression increases cancer cell invasion through increased contractile forces. To analyze this, A125 cells (CD24 negative) were stably transfected with CD24 and sorted for high and low CD24 expression. The invasiveness of theCD24(high) andCD24(low) transfectants was determined in three-dimensional ECMs. The percentage of invasive cells and their invasion depth was increased in CD24(high) cells compared with CD24(low) cells. Knockdown of CD24 and of the beta 1-integrin subunit in CD24(high) cells decreased their invasiveness, indicating that the increased invasiveness is CD24 and beta 1-integrin subunit-dependent. Fourier transform traction microscopy revealed that the CD24(high) cells generated 5-fold higher contractile forces compared with CD24(low) cells. To analyze whether contractile forces are essential for CD24-facilitated cell invasion, we performed invasion assays in the presence of myosin light chain kinase inhibitor ML-7 as well as Rho kinase inhibitor Y27632. Cell invasiveness was reduced after addition of ML-7 and Y27632 in CD24(high) cells but not in CD24(neg) cells. Moreover, after addition of lysophosphatidic acid or calyculin A, an increase in pre-stress in CD24(neg) cells was observed, which enhanced cellular invasiveness. In addition, inhibition of the Src kinase or STAT3 strongly reduced the invasiveness of CD24(high) cells, slightly reduced that of CD24(low) cells, and did not alter the invasiveness of CD24(neg) cells. Taken together, these results suggest that CD24 enhances cell invasion through increased generation or transmission of contractile forces.	[Mierke, Claudia Tanja] Univ Leipzig, Fac Phys & Earth Sci, Inst Expt Phys 1, Soft Matter Phys Div, D-04103 Leipzig, Germany; [Bretz, Niko; Altevogt, Peter] German Canc Res Ctr, Tumor Immunol Programm, D-69120 Heidelberg, Germany	Leipzig University; Helmholtz Association; German Cancer Research Center (DKFZ)	Mierke, CT (corresponding author), Univ Leipzig, Fac Phys & Earth Sci, Inst Expt Phys 1, Soft Matter Phys Div, Linnestr 5, D-04103 Leipzig, Germany.	claudia.mierke@t-online.de	Mierke, Claudia Tanja/L-5293-2018	Mierke, Claudia Tanja/0000-0002-6622-335X	Deutsche Krebshilfe [109432]	Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by Deutsche Krebshilfe Grant 109432.	Agrawal S, 2007, J GASTROINTEST SURG, V11, P445, DOI 10.1007/s11605-007-0091-5; Aigner S, 1998, FASEB J, V12, P1241, DOI 10.1096/fasebj.12.12.1241; Al-Mehdi AB, 2000, NAT MED, V6, P100, DOI 10.1038/71429; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Bauer K, 2007, INT J CANCER, V121, P1910, DOI 10.1002/ijc.22879; Baumann P, 2005, CANCER RES, V65, P10783, DOI 10.1158/0008-5472.CAN-05-0619; Bloom RJ, 2008, BIOPHYS J, V95, P4077, DOI 10.1529/biophysj.108.132738; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Chou YY, 2007, ANN SURG ONCOL, V14, P2748, DOI 10.1245/s10434-007-9501-x; DAMSKY CH, 1985, J CELL BIOL, V100, P1528, DOI 10.1083/jcb.100.5.1528; ELSON EL, 1988, ANNU REV BIOPHYS BIO, V17, P397; Fabry B, 2003, RESP PHYSIOL NEUROBI, V137, P109, DOI 10.1016/S1569-9048(03)00141-1; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Fredberg JJ, 1996, J APPL PHYSIOL, V81, P2703, DOI 10.1152/jappl.1996.81.6.2703; Friedl P, 2000, CELL MOL LIFE SCI, V57, P41, DOI 10.1007/s000180050498; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Fukushima T, 2007, J BIOL CHEM, V282, P18634, DOI 10.1074/jbc.M609567200; Gallant ND, 2005, MOL BIOL CELL, V16, P4329, DOI 10.1091/mbc.E05-02-0170; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Giancotti FG, 2000, NAT CELL BIOL, V2, pE13, DOI 10.1038/71397; Giannone G, 2006, TRENDS CELL BIOL, V16, P213, DOI 10.1016/j.tcb.2006.02.005; Guan JL, 2004, SCIENCE, V303, P773, DOI 10.1126/science.1094376; HEMLER ME, 1987, J BIOL CHEM, V262, P3300; HILDEBRANDT J, 1969, B MATH BIOPHYS, V31, P651, DOI 10.1007/BF02477779; Horwitz AF, 1997, SCI AM, V276, P68, DOI 10.1038/scientificamerican0597-68; Huveneers S, 2008, J CELL SCI, V121, P2452, DOI 10.1242/jcs.033001; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Inutsuka A, 2009, BIOCHEM BIOPH RES CO, V390, P1160, DOI 10.1016/j.bbrc.2009.10.108; JACKSON D, 1992, CANCER RES, V52, P5264; Jacob J, 2004, PANCREATOLOGY, V4, P454, DOI 10.1159/000079824; Kasza KE, 2009, BIOPHYS J, V96, P4326, DOI 10.1016/j.bpj.2009.02.035; Kollmannsberger P, 2011, SOFT MATTER, V7, P3127, DOI 10.1039/c0sm00833h; Kollmannsberger P, 2009, SOFT MATTER, V5, P1771, DOI 10.1039/b820228a; Kristiansen G, 2003, CLIN CANCER RES, V9, P4906; Kristiansen G, 2002, AM J PATHOL, V161, P1215, DOI 10.1016/S0002-9440(10)64398-2; Langley RR, 2007, ENDOCR REV, V28, P297, DOI 10.1210/er.2006-0027; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; Loftus JC, 1997, J CLIN INVEST, V99, P2302, DOI 10.1172/JCI119408; McNulty AL, 2009, CLIN ORTHOP RELAT R, V467, P1557, DOI 10.1007/s11999-008-0596-6; Metzner C, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194105; Mickel W, 2008, BIOPHYS J, V95, P6072, DOI 10.1529/biophysj.108.135939; Mierke CT, 2008, EUR J CELL BIOL, V87, P669, DOI 10.1016/j.ejcb.2008.01.002; Mierke CT, 2008, BIOPHYS J, V94, P2832, DOI 10.1529/biophysj.107.113613; Mierke CT, 2008, BIOPHYS J, V94, P661, DOI 10.1529/biophysj.107.108472; Mierke CT, 2011, J CELL SCI, V124, P369, DOI 10.1242/jcs.071985; Mierke CT, 2008, J BIOPHYS, V2008; Mijailovich SM, 2002, J APPL PHYSIOL, V93, P1429, DOI 10.1152/japplphysiol.00255.2002; NEFF NT, 1982, J CELL BIOL, V95, P654, DOI 10.1083/jcb.95.2.654; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Riedle S, 2009, BIOCHEM J, V420, P391, DOI 10.1042/BJ20081625; Rosel D, 2008, MOL CANCER RES, V6, P1410, DOI 10.1158/1541-7786.MCR-07-2174; Runz S, 2008, BIOCHEM BIOPH RES CO, V365, P35, DOI 10.1016/j.bbrc.2007.10.139; Sagiv E, 2006, GASTROENTEROLOGY, V131, P630, DOI 10.1053/j.gastro.2006.04.028; Schabath H, 2006, J CELL SCI, V119, P314, DOI 10.1242/jcs.02741; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wei Y, 2005, J CELL BIOL, V168, P501, DOI 10.1083/jcb.200404112; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Yang XR, 2009, CLIN CANCER RES, V15, P5518, DOI 10.1158/1078-0432.CCR-09-0151; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	66	55	57	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34858	34871		10.1074/jbc.M111.245183	http://dx.doi.org/10.1074/jbc.M111.245183			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21828044	hybrid, Green Published			2022-12-25	WOS:000295406300040
J	Hwangbo, C; Park, J; Lee, JH				Hwangbo, Cheol; Park, Juhee; Lee, Jeong-Hyung			mda-9/Syntenin Protein Positively Regulates the Activation of Akt Protein by Facilitating Integrin-linked Kinase Adaptor Function during Adhesion to Type I Collagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-MELANOMA CELLS; CH-ILKBP; FOCAL ADHESIONS; CANCER-CELLS; HUMAN BREAST; PDZ DOMAINS; LOCALIZATION; SYNTENIN; BINDING; PINCH	The integrin-linked kinase (ILK)-PINCH1-alpha-parvin (IPP) complex functions as a signaling platform for integrins that modulates various cellular processes. ILK functions as a central adaptor for the assembly of IPP complex. We report here that mda-9/syntenin, a positive regulator of cancer metastasis, regulates the activation of Akt (also known as protein kinase B) by facilitating ILK adaptor function during adhesion to type I collagen (COL-I) in human breast cancer cells. COL-I stimulation induced the phosphorylation and plasma membrane translocation of Akt. Inhibition of mda-9/syntenin or expression of mutant ILK (E359K) significantly blocked the translocation of both ILK and Akt to the plasma membrane. mda-9/syntenin associated with ILK, and this association was increased at the plasma membrane by COL-I stimulation. Knockdown of mda-9/syntenin impaired COL-I-induced association of ILK with Akt and plasma membrane targeting of ILK-Akt complex. These results demonstrated that mda-9/syntenin regulates the activation of Akt by controlling the plasma membrane targeting of Akt via a mechanism that facilitates the association of Akt with ILK at the plasma membrane during adhesion to COL-I. On a striking note, inhibition of mda-9/syntenin impaired COL-I-induced plasma membrane translocation of the IPP complex and assembly of integrin beta 1-IPP signaling complexes. Thus, our study defines the role of mda-9/syntenin in ILK adaptor function and describes a new mechanism of mda-9/syntenin for regulation of cell migration.	[Lee, Jeong-Hyung] Kangwon Natl Univ, Dept Biochem, Coll Nat Sci, Chunchon 200701, South Korea; Kangwon Natl Univ, Med & Biomat Res Ctr, Chunchon 200701, South Korea	Kangwon National University; Kangwon National University	Lee, JH (corresponding author), Kangwon Natl Univ, Dept Biochem, Coll Nat Sci, Chunchon 200701, South Korea.	jhlee36@kangwon.ac.kr			National Research Foundation of Korea [2009-0073826, 2010-0007366]; Regional Research Core Research Program/Medical and Biomaterials Research Center; Ministry of Education, Science, and Technology	National Research Foundation of Korea(National Research Foundation of Korea); Regional Research Core Research Program/Medical and Biomaterials Research Center; Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Basic Science Research Program Grants 2009-0073826 and 2010-0007366 through the National Research Foundation of Korea and the Regional Research Core Research Program/Medical and Biomaterials Research Center funded by the Ministry of Education, Science, and Technology.	Attwell S, 2003, MOL BIOL CELL, V14, P4813, DOI 10.1091/mbc.E03-05-0308; Beekman JM, 2008, J CELL SCI, V121, P1349, DOI 10.1242/jcs.026401; Boukerche H, 2005, CANCER RES, V65, P10901, DOI 10.1158/0008-5472.CAN-05-1614; Boukerche H, 2008, P NATL ACAD SCI USA, V105, P15914, DOI 10.1073/pnas.0808171105; Boukerche H, 2007, CANCER RES, V67, P1812, DOI 10.1158/0008-5472.CAN-06-3875; Chiswell BP, 2008, P NATL ACAD SCI USA, V105, P20677, DOI 10.1073/pnas.0811415106; Dai DL, 2003, CLIN CANCER RES, V9, P4409; Dash R, 2010, ONCOGENE, V29, P4412, DOI 10.1038/onc.2010.194; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Deng JT, 2001, J BIOL CHEM, V276, P16365, DOI 10.1074/jbc.M011634200; Filippa N, 2000, MOL CELL BIOL, V20, P5712, DOI 10.1128/MCB.20.15.5712-5721.2000; Fukuda K, 2011, J BIOL CHEM, V286, P21886, DOI 10.1074/jbc.M111.240093; Fukuda K, 2009, MOL CELL, V36, P819, DOI 10.1016/j.molcel.2009.11.028; Fukuda T, 2003, J CELL BIOL, V160, P1001, DOI 10.1083/jcb.200212113; Grembecka J, 2006, BIOCHEMISTRY-US, V45, P3674, DOI 10.1021/bi052225y; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Hwangbo C, 2010, CANCER RES, V70, P1645, DOI 10.1158/0008-5472.CAN-09-2447; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Kang BS, 2003, STRUCTURE, V11, P459, DOI 10.1016/S0969-2126(03)00052-2; Kim KK, 2008, CARCINOGENESIS, V29, P704, DOI 10.1093/carcin/bgn031; Koo TH, 2002, ONCOGENE, V21, P4080, DOI 10.1038/sj.onc.1205514; Koroll M, 2001, J BIOL CHEM, V276, P10646, DOI 10.1074/jbc.M010647200; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Li FG, 1999, J CELL SCI, V112, P4589; Ling L, 2000, J BIOL CHEM, V275, P23852, DOI 10.1074/jbc.M001095200; Maydan M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012356; McDonald PC, 2008, J CELL SCI, V121, P3121, DOI 10.1242/jcs.017996; Meerschaert K, 2007, EXP CELL RES, V313, P1790, DOI 10.1016/j.yexcr.2007.03.014; Nho RS, 2005, J BIOL CHEM, V280, P26630, DOI 10.1074/jbc.M411798200; Nikolopoulos SN, 2002, J BIOL CHEM, V277, P1568, DOI 10.1074/jbc.M108612200; Papachristou DJ, 2008, EUR J CANCER, V44, P2518, DOI 10.1016/j.ejca.2008.07.021; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Restuccia DF, 2009, SCIENCE, V325, P1083, DOI 10.1126/science.1179972; Sarkar D, 2008, CANCER RES, V68, P3087, DOI 10.1158/0008-5472.CAN-07-6210; SCHALLER MD, 1994, CURR OPIN CELL BIOL, V6, P705, DOI 10.1016/0955-0674(94)90097-3; Tan C, 2004, CANCER CELL, V5, P79, DOI 10.1016/S1535-6108(03)00281-2; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Wickstrom SA, 2010, EMBO J, V29, P281, DOI 10.1038/emboj.2009.376; Yamaji S, 2001, J CELL BIOL, V153, P1251, DOI 10.1083/jcb.153.6.1251; Zhang YJ, 2002, J CELL SCI, V115, P4777, DOI 10.1242/jcs.00166	44	20	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33601	33612		10.1074/jbc.M110.206789	http://dx.doi.org/10.1074/jbc.M110.206789			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21828040	hybrid, Green Published			2022-12-25	WOS:000294968800076
J	Haeussler, DJ; Evangelista, AM; Burgoyne, JR; Cohen, RA; Bachschmid, MM; Pimental, DR				Haeussler, Dagmar J.; Evangelista, Alicia M.; Burgoyne, Joseph R.; Cohen, Richard A.; Bachschmid, Markus M.; Pimental, David R.			Checkpoints in Adenoviral Production: Cross-Contamination and E1A	PLOS ONE			English	Article								Adenoviruses are widely used for overexpressing proteins in primary mammalian cells. Incorporation of the early viral gene, E1A, or viral cross-contamination can occur during amplification, and identification of these products is crucial as the transcription of unwanted genetic material can impact cell function and compromise data interpretation. Here we report methods for evaluation of contaminating adenovirus and E1 viral DNA.	[Haeussler, Dagmar J.; Evangelista, Alicia M.; Burgoyne, Joseph R.; Cohen, Richard A.; Bachschmid, Markus M.] Boston Univ, Med Ctr, Vasc Biol Sect, Boston, MA 02118 USA; [Pimental, David R.] Boston Univ, Med Ctr, Myocardial Biol Unit, Boston, MA USA	Boston University; Boston University	Haeussler, DJ (corresponding author), Boston Univ, Med Ctr, Vasc Biol Sect, Boston, MA 02118 USA.	bach@bu.edu		Bachschmid, Markus Michael/0000-0002-0748-5528; Burgoyne, Joseph/0000-0001-7325-7382; Pimentel, David/0000-0002-0537-7195; /0000-0002-1070-6408	National Institutes of Health [HL031607-28, PO1 HL 068758, R37 HL104017, HL007501-26, K08HL071563]; Wellcome Trust [085483/Z/08/Z]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031607, K08HL071563, R37HL104017, T32HL007501, P01HL068758] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (HL031607-28 to R. A. C., PO1 HL 068758 and R37 HL104017 to D.J.H., J.R.B., and M. M. B., and HL007501-26 to A. E., and K08HL071563 to D. P.) and its contents are solely the responsibility of the authors and do not necessarily represent the official views of the awarding offices. This work was also supported by a Sir Henry Wellcome postdoctoral fellowship from The Wellcome Trust (Sponsor Reference 085483/Z/08/Z; to J.R.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2004, J BIOL CHEM, V279, P29857, DOI 10.1074/jbc.M313320200; GINSBERG HS, 1989, P NATL ACAD SCI USA, V86, P3823, DOI 10.1073/pnas.86.10.3823; Kuwano K, 1997, EUR RESPIR J, V10, P1445, DOI 10.1183/09031936.97.10071445; Lavine JA, 2010, MOL ENDOCRINOL, V24, P464, DOI 10.1210/me.2009-0384; LILY W, 1987, NATURE, V326, P512, DOI 10.1038/326512a0; LOCHMULLER H, 1994, HUM GENE THER, V5, P1485, DOI 10.1089/hum.1994.5.12-1485; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; NEVINS JR, 1986, CRIT REV BIOCHEM MOL, V19, P307, DOI 10.3109/10409238609082543; Schaack J, 2004, P NATL ACAD SCI USA, V101, P3124, DOI 10.1073/pnas.0303709101	9	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e23160	10.1371/journal.pone.0023160	http://dx.doi.org/10.1371/journal.pone.0023160			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826235	Green Published, gold, Green Submitted			2022-12-25	WOS:000293558900061
J	Heard, M; Smith, KF; Ripp, K				Heard, Matthew; Smith, Katherine F.; Ripp, Kelsey			Examining the Evidence for Chytridiomycosis in Threatened Amphibian Species	PLOS ONE			English	Article							WILD FROGS; EXTINCTION; DECLINES; CONSERVATION; DISEASE; BIODIVERSITY; IMPACT	Extinction risks are increasing for amphibians due to rising threats and minimal conservation efforts. Nearly one quarter of all threatened/extinct amphibians in the IUCN Red List is purportedly at risk from the disease chytridiomycosis. However, a closer look at the data reveals that Batrachochytrium dendrobatidis (the causal agent) has been identified and confirmed to cause clinical disease in only 14% of these species. Primary literature surveys confirm these findings; ruling out major discrepancies between Red List assessments and real-time science. Despite widespread interest in chytridiomycosis, little progress has been made between assessment years to acquire evidence for the role of chytridiomycosis in species-specific amphibian declines. Instead, assessment teams invoke the precautionary principle when listing chytridiomycosis as a threat. Precaution is valuable when dealing with the world's most threatened taxa, however scientific research is needed to distinguish between real and predicted threats in order to better prioritize conservation efforts. Fast paced, cost effective, in situ research to confirm or rule out chytridiomycosis in species currently hypothesized to be threatened by the disease would be a step in the right direction. Ultimately, determining the manner in which amphibian conservation resources are utilized is a conversation for the greater conservation community that we hope to stimulate here.	[Heard, Matthew; Smith, Katherine F.; Ripp, Kelsey] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA	Brown University	Heard, M (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	matthew_heard@brown.edu			Brown University Environmental Change Initiative Conservation Medicine Working Group	Brown University Environmental Change Initiative Conservation Medicine Working Group	This work was supported by a Brown University Environmental Change Initiative Conservation Medicine Working Group Grant (2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Brooks TM, 2009, CONSERV BIOL, V23, P1448, DOI 10.1111/j.1523-1739.2009.01334.x; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; Cooney R., 2004, PRECAUTIONARY PRINCI; Costa LP, 2005, CONSERV BIOL, V19, P672, DOI 10.1111/j.1523-1739.2005.00666.x; Daszak P, 2004, HERPETOL J, V14, P201; Daszak P, 1999, EMERG INFECT DIS, V5, P735, DOI 10.3201/eid0506.990601; GASCON C, 2007, AMPH CONS ACT PLAN; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; Hayward MW, 2009, CONSERV BIOL, V23, P1568, DOI 10.1111/j.1523-1739.2009.01260.x; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Howald G, 2007, CONSERV BIOL, V21, P1258, DOI 10.1111/j.1523-1739.2007.00755.x; IUCN, 2019, IUCN RED LIST THREAT; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Kriger KM, 2006, DIS AQUAT ORGAN, V71, P141, DOI 10.3354/dao071141; Kriger KM, 2009, ECOHEALTH, V6, P6, DOI 10.1007/s10393-009-0228-y; Lannoo M, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P1; Lips KR, 2003, J HERPETOL, V37, P215, DOI 10.1670/0022-1511(2003)037[0215:CIWFFS]2.0.CO;2; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Mendelson JR, 2006, SCIENCE, V313, P48, DOI 10.1126/science.1128396; Nogales M, 2004, CONSERV BIOL, V18, P310, DOI 10.1111/j.1523-1739.2004.00442.x; Puschendorf R, 2006, BIOL CONSERV, V132, P136, DOI 10.1016/j.biocon.2006.03.010; Ruiz A, 2008, ECOHEALTH, V5, P27, DOI 10.1007/s10393-008-0159-z; Schloegel LM, 2006, ECOHEALTH, V3, P35, DOI 10.1007/s10393-005-0012-6; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Smith KF, 2006, CONSERV BIOL, V20, P1349, DOI 10.1111/j.1523-1739.2006.00524.x; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399	32	12	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e23150	10.1371/journal.pone.0023150	http://dx.doi.org/10.1371/journal.pone.0023150			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21826233	Green Published, Green Submitted, gold			2022-12-25	WOS:000293558900059
J	Janku, F; Lee, JJ; Tsimberidou, AM; Hong, DS; Naing, A; Falchook, GS; Fu, SQ; Luthra, R; Garrido-Laguna, I; Kurzrock, R				Janku, Filip; Lee, J. Jack; Tsimberidou, Apostolia M.; Hong, David S.; Naing, Aung; Falchook, Gerald S.; Fu, Siqing; Luthra, Rajyalakshmi; Garrido-Laguna, Ignacio; Kurzrock, Razelle			PIK3CA Mutations Frequently Coexist with RAS and BRAF Mutations in Patients with Advanced Cancers	PLOS ONE			English	Article							CELL LUNG-CANCER; ACTIVATING MUTATIONS; COLORECTAL-CANCER; KRAS MUTATIONS; INHIBITOR; EFFICACY; GENE; NRAS; PREVALENCE; PROGNOSIS	Background: Oncogenic mutations of PIK3CA, RAS (KRAS, NRAS), and BRAF have been identified in various malignancies, and activate the PI3K/AKT/mTOR and RAS/RAF/MEK pathways, respectively. Both pathways are critical drivers of tumorigenesis. Methods: Tumor tissues from 504 patients with diverse cancers referred to the Clinical Center for Targeted Therapy at MD Anderson Cancer Center starting in October 2008 were analyzed for PIK3CA, RAS (KRAS, NRAS), and BRAF mutations using polymerase chain reaction-based DNA sequencing. Results: PIK3CA mutations were found in 54 (11%) of 504 patients tested; KRAS in 69 (19%) of 367; NRAS in 19 (8%) of 225; and BRAF in 31 (9%) of 361 patients. PIK3CA mutations were most frequent in squamous cervical (5/14, 36%), uterine (7/28, 25%), breast (6/29, 21%), and colorectal cancers (18/105, 17%); KRAS in pancreatic (5/9, 56%), colorectal (49/97, 51%), and uterine cancers (3/20, 15%); NRAS in melanoma (12/40, 30%), and uterine cancer (2/11, 18%); BRAF in melanoma (23/52, 44%), and colorectal cancer (5/88, 6%). Regardless of histology, KRAS mutations were found in 38% of patients with PIK3CA mutations compared to 16% of patients with wild-type (wt) PIK3CA (p = 0.001). In total, RAS (KRAS, NRAS) or BRAF mutations were found in 47% of patients with PIK3CA mutations vs. 24% of patients wtPIK3CA (p = 0.001). PIK3CA mutations were found in 28% of patients with KRAS mutations compared to 10% with wtKRAS (p = 0.001) and in 20% of patients with RAS (KRAS, NRAS) or BRAF mutations compared to 8% with wtRAS (KRAS, NRAS) or wtBRAF (p = 0.001). Conclusions: PIK3CA, RAS (KRAS, NRAS), and BRAF mutations are frequent in diverse tumors. In a wide variety of tumors, PIK3CA mutations coexist with RAS (KRAS, NRAS) and BRAF mutations.	[Janku, Filip; Tsimberidou, Apostolia M.; Hong, David S.; Naing, Aung; Falchook, Gerald S.; Fu, Siqing; Garrido-Laguna, Ignacio; Kurzrock, Razelle] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USA; [Lee, J. Jack] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Luthra, Rajyalakshmi] Univ Texas MD Anderson Canc Ctr, Mol Diagnost Lab, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Janku, F (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USA.	rkurzroc@mdanderson.org	Garrido-Laguna, Ignacio/ABD-1875-2020; Kurzrock, Razelle/AAU-9782-2020; Lee, Jack/P-7331-2019; Center, Univ of Texas-M D Anderson Cancer/AAE-8182-2019; Janku, Filip/ABB-9136-2020	Garrido-Laguna, Ignacio/0000-0003-2273-9028; Lee, Jack/0000-0002-4584-929X; Center, Univ of Texas-M D Anderson Cancer/0000-0001-5469-9214; Tsimberidou, Apostolia M./0000-0003-2713-233X; Fu, Siqing/0000-0002-1933-0419; Naing, Aung/0000-0002-4803-8513	National Center for Research Resources, a component of the NIH Roadmap for Medical Research [RR024148]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER	National Center for Research Resources, a component of the NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported in part by Grant Number RR024148 from the National Center for Research Resources, a component of the NIH Roadmap for Medical Research (http://nihroadmap.nih.gov/clinicalresearch/overview-translational.asp). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Bacher U, 2006, BLOOD, V107, P3847, DOI 10.1182/blood-2005-08-3522; Benvenuti S, 2008, HUM MUTAT, V29, P284, DOI 10.1002/humu.20648; Braiteh F, 2007, MOL CANCER THER, V6, P1175, DOI 10.1158/1535-7163.MCT-06-0674; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Devitt BA, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.8500; Di Nicolantonio F, 2010, J CLIN INVEST, V120, P2858, DOI 10.1172/JCI37539; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Ellerhorst JA, 2011, CLIN CANCER RES, V17, P229, DOI 10.1158/1078-0432.CCR-10-2276; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Hayes MP, 2006, CLIN CANCER RES, V12, P5932, DOI 10.1158/1078-0432.CCR-06-1375; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Ihle NT, 2009, CANCER RES, V69, P143, DOI 10.1158/0008-5472.CAN-07-6656; IHLE NT, 2011, AACR SPEC C TARG PI3; Janku F, 2010, J CLIN ONCOL, V1, p28(31); Janku F, 2011, MOL CANCER THER, V10, P558, DOI 10.1158/1535-7163.MCT-10-0994; Janku F, 2010, NAT REV CLIN ONCOL, V7, P401, DOI 10.1038/nrclinonc.2010.64; Kebebew E, 2007, ANN SURG, V246, P466, DOI 10.1097/SLA.0b013e318148563d; Kefford R, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.8503; Kuo KT, 2009, AM J PATHOL, V174, P1597, DOI 10.2353/ajpath.2009.081000; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Miyake T, 2008, CANCER LETT, V261, P120, DOI 10.1016/j.canlet.2007.11.004; Nosho K, 2008, NEOPLASIA, V10, P534, DOI 10.1593/neo.08336; Nucera C, 2010, ONCOTARGET, V1, P751; O'Byrne KJ, 2009, J CLIN ONCOL, V27; Ogino S, 2009, J CLIN ONCOL, V27, P1477, DOI 10.1200/JCO.2008.18.6544; Peyssonnaux C, 2001, BIOL CELL, V93, P53, DOI 10.1016/S0248-4900(01)01125-X; Prenen H, 2009, CLIN CANCER RES, V15, P3184, DOI 10.1158/1078-0432.CCR-08-2961; Sacco A, 2010, ONCOTARGET, V1, P578; Saldanha G, 2006, CLIN CANCER RES, V12, P4499, DOI 10.1158/1078-0432.CCR-05-2447; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sartore-Bianchi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007287; Schmidt-Kittler O, 2010, ONCOTARGET, V1, P339; Shi J, 2010, ONCOTARGET, V1, P9, DOI 10.18632/oncotarget.104; Stewart DJ, 2009, J CLIN ONCOL, V27, P328, DOI 10.1200/JCO.2008.18.9621; Tol J, 2009, NEW ENGL J MED, V361, P98, DOI 10.1056/NEJMc0904160; Velho S, 2005, EUR J CANCER, V41, P1649, DOI 10.1016/j.ejca.2005.04.022; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Xing MZ, 2005, J CLIN ENDOCR METAB, V90, P6373, DOI 10.1210/jc.2005-0987; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Zuo Z, 2009, MODERN PATHOL, V22, P1023, DOI 10.1038/modpathol.2009.59	48	152	155	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22769	10.1371/journal.pone.0022769	http://dx.doi.org/10.1371/journal.pone.0022769			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829508	Green Published, gold, Green Submitted			2022-12-25	WOS:000293286500027
J	Wang, RYR; Han, Y; Krassovsky, K; Sheffler, W; Tyka, M; Baker, D				Wang, Ray Yu-Ruei; Han, Yan; Krassovsky, Kristina; Sheffler, William; Tyka, Michael; Baker, David			Modeling Disordered Regions in Proteins Using Rosetta	PLOS ONE			English	Article							PREDICTION	Protein structure prediction methods such as Rosetta search for the lowest energy conformation of the polypeptide chain. However, the experimentally observed native state is at a minimum of the free energy, rather than the energy. The neglect of the missing configurational entropy contribution to the free energy can be partially justified by the assumption that the entropies of alternative folded states, while very much less than unfolded states, are not too different from one another, and hence can be to a first approximation neglected when searching for the lowest free energy state. The shortcomings of current structure prediction methods may be due in part to the breakdown of this assumption. Particularly problematic are proteins with significant disordered regions which do not populate single low energy conformations even in the native state. We describe two approaches within the Rosetta structure modeling methodology for treating such regions. The first does not require advance knowledge of the regions likely to be disordered; instead these are identified by minimizing a simple free energy function used previously to model protein folding landscapes and transition states. In this model, residues can be either completely ordered or completely disordered; they are considered disordered if the gain in entropy outweighs the loss of favorable energetic interactions with the rest of the protein chain. The second approach requires identification in advance of the disordered regions either from sequence alone using for example the DISOPRED server or from experimental data such as NMR chemical shifts. During Rosetta structure prediction calculations the disordered regions make only unfavorable repulsive contributions to the total energy. We find that the second approach has greater practical utility and illustrate this with examples from de novo structure prediction, NMR structure calculation, and comparative modeling.	[Wang, Ray Yu-Ruei; Han, Yan; Baker, David] Univ Washington, Grad Program Biomol Struct & Design, Seattle, WA 98195 USA; [Wang, Ray Yu-Ruei; Han, Yan; Sheffler, William; Tyka, Michael; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Han, Yan; Krassovsky, Kristina] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; [Krassovsky, Kristina; Baker, David] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Wang, RYR (corresponding author), Univ Washington, Grad Program Biomol Struct & Design, Seattle, WA 98195 USA.	dabaker@u.washington.edu	Han, Yan/ABC-1031-2020	Han, Yan/0000-0002-1207-7756; Tyka, Michael/0000-0003-0108-6558	National Institutes of Health [P41RR002250]; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092802] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grant P41RR002250 and the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm E, 1999, P NATL ACAD SCI USA, V96, P11305, DOI 10.1073/pnas.96.20.11305; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2009, J BIOMOL NMR, V43, P63, DOI 10.1007/s10858-008-9288-5; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Zemla A, 1999, PROTEINS, V34, P220, DOI 10.1002/(SICI)1097-0134(19990201)34:2<220::AID-PROT7>3.0.CO;2-K	11	88	91	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22060	10.1371/journal.pone.0022060	http://dx.doi.org/10.1371/journal.pone.0022060			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829444	Green Published, Green Submitted			2022-12-25	WOS:000293286500004
J	Yang, SC; Liu, F; Wang, QJ; Rosenberg, SA; Morgan, RA				Yang, Shicheng; Liu, Fang; Wang, Qiong J.; Rosenberg, Steven A.; Morgan, Richard A.			The Shedding of CD62L (L-Selectin) Regulates the Acquisition of Lytic Activity in Human Tumor Reactive T Lymphocytes	PLOS ONE			English	Article							CENTRAL MEMORY; CELL SUBSETS; SECRETORY LYSOSOMES; EFFECTOR FUNCTION; GENE-EXPRESSION; CD8+T CELLS; RECEPTOR; ADHESION; ANTIGEN; IDENTIFICATION	CD62L/L-selectin is a marker found on naive T cells and further distinguishes central memory (Tcm, CD62L+) from effector memory (Tem, CD62L-) T cells. The regulation of CD62L plays a pivotal role in controlling the traffic of T lymphocytes to and from peripheral lymph nodes. CD62L is shed from the cell membrane following T cell activation, however, the physiological significance of this event remains to be elucidated. In this study, we utilized in vitro generated anti-tumor antigen T cells and melanoma lines as a model to evaluate the dynamics of CD62L shedding and expression of CD107a as a marker of lytic activity. Upon encounter, with matched tumor lines, antigen reactive T cells rapidly lose CD62L expression and this was associated with the acquisition of CD107a. By CD62L ELISA, we confirmed that this transition was mediated by the shedding of CD62L when T cells encountered specific tumor antigen. The introduction of a shedding resistant mutant of CD62L into the tumor antigen-reactive T cell line JKF6 impaired CD107a acquisition following antigen recognition and this was correlated with decreased lytic activity as measured by Cr-51 release assays. The linkage of the shedding of CD62L from the surface of anti-tumor T cells and acquisition of lytic activity, suggests a new function for CD62L in T cell effector functions and anti-tumor activity.	[Yang, Shicheng; Liu, Fang; Wang, Qiong J.; Rosenberg, Steven A.; Morgan, Richard A.] NCI, Surg Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Yang, SC (corresponding author), NCI, Surg Branch, Ctr Canc Res, NIH, Bldg 10, Bethesda, MD 20892 USA.	rmorgan@mail.nih.gov			Center for Cancer Research, National Cancer Institute; National Institutes of Health, Bethesda, Maryland, United States of America; NATIONAL CANCER INSTITUTE [ZIABC010984] Funding Source: NIH RePORTER	Center for Cancer Research, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, Bethesda, Maryland, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Intramural Research Program of the Center for Cancer Research, National Cancer Institute, and the National Institutes of Health, Bethesda, Maryland, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas E, 2009, CELL IMMUNOL, V254, P149, DOI 10.1016/j.cellimm.2008.08.007; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; Baars PA, 2005, EUR J IMMUNOL, V35, P3131, DOI 10.1002/eji.200425770; Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Campbell JJ, 1998, J CELL BIOL, V141, P1053, DOI 10.1083/jcb.141.4.1053; Chao CC, 1997, J IMMUNOL, V159, P1686; CHEN AJ, 1995, J EXP MED, V182, P519, DOI 10.1084/jem.182.2.519; de Bree GJ, 2005, J EXP MED, V202, P1433, DOI 10.1084/jem.20051365; de Saint Basile G, 2010, NAT REV IMMUNOL, V10, P568, DOI 10.1038/nri2803; Diaz-Rodriguez E, 2000, BIOCHEM J, V346, P359, DOI 10.1042/0264-6021:3460359; Dwir O, 2001, J CELL BIOL, V155, P145, DOI 10.1083/jcb.200103042; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Galkina E, 2003, J EXP MED, V198, P1323, DOI 10.1084/jem.20030485; Garton KJ, 2006, J LEUKOCYTE BIOL, V79, P1105, DOI 10.1189/jlb.0106038; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Ivetic A, 2004, BIOCHEM SOC T, V32, P1118, DOI 10.1042/BST0321118; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; JONES S, 2009, HUM GENE THER; Jones S, 2009, HUM GENE THER, V20, P630, DOI 10.1089/hum.2008.048; KAHN J, 1994, J CELL BIOL, V125, P461, DOI 10.1083/jcb.125.2.461; Kannan K, 1996, CELL IMMUNOL, V171, P10, DOI 10.1006/cimm.1996.0167; Killock DJ, 2009, J BIOL CHEM, V284, P8824, DOI 10.1074/jbc.M806983200; KISHIMOTO TK, 1989, SCIENCE, V245, P1238, DOI 10.1126/science.2551036; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Lefrancois L, 2006, IMMUNOL REV, V211, P93, DOI 10.1111/j.0105-2896.2006.00393.x; Lettau M, 2007, IMMUNOL LETT, V108, P10, DOI 10.1016/j.imlet.2006.10.001; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Mora JR, 2006, TRENDS IMMUNOL, V27, P235, DOI 10.1016/j.it.2006.03.007; PAVALKO FM, 1995, J CELL BIOL, V129, P1155, DOI 10.1083/jcb.129.4.1155; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Richards H, 2008, J IMMUNOL, V180, P198, DOI 10.4049/jimmunol.180.1.198; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schambach A, 2006, GENE THER, V13, P641, DOI 10.1038/sj.gt.3302698; Tomiyama H, 2004, EUR J IMMUNOL, V34, P999, DOI 10.1002/eji.200324478; TOPALIAN SL, 1989, J IMMUNOL, V142, P3714; Unsoeld H, 2005, J VIROL, V79, P4510, DOI 10.1128/JVI.79.7.4510-4513.2005; Wang Y, 2010, J IMMUNOL, V184, P4447, DOI 10.4049/jimmunol.0902925; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Yang S, 2008, GENE THER, V15, P1411, DOI 10.1038/gt.2008.90; Yang SC, 2010, J IMMUNOTHER, V33, P648, DOI 10.1097/CJI.0b013e3181e311cb; Yang S, 2008, J IMMUNOTHER, V31, P830, DOI 10.1097/CJI.0b013e31818817c5	49	64	69	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22560	10.1371/journal.pone.0022560	http://dx.doi.org/10.1371/journal.pone.0022560			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829468	Green Published, gold, Green Submitted			2022-12-25	WOS:000293284600018
J	Cea, M; Soncini, D; Fruscione, F; Raffaghello, L; Garuti, A; Emionite, L; Moran, E; Magnone, M; Zoppoli, G; Reverberi, D; Caffa, I; Salis, A; Cagnetta, A; Bergamaschi, M; Casciaro, S; Pierri, I; Damonte, G; Ansaldi, F; Gobbi, M; Pistoia, V; Ballestrero, A; Patrone, F; Bruzzone, S; Nencioni, A				Cea, Michele; Soncini, Debora; Fruscione, Floriana; Raffaghello, Lizzia; Garuti, Anna; Emionite, Laura; Moran, Eva; Magnone, Mirko; Zoppoli, Gabriele; Reverberi, Daniele; Caffa, Irene; Salis, Annalisa; Cagnetta, Antonia; Bergamaschi, Micaela; Casciaro, Salvatore; Pierri, Ivana; Damonte, Gianluca; Ansaldi, Filippo; Gobbi, Marco; Pistoia, Vito; Ballestrero, Alberto; Patrone, Franco; Bruzzone, Santina; Nencioni, Alessio			Synergistic Interactions between HDAC and Sirtuin Inhibitors in Human Leukemia Cells	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; ACUTE MYELOID-LEUKEMIA; CHRONIC LYMPHOCYTIC-LEUKEMIA; MYELODYSPLASTIC SYNDROMES; HEMATOLOGIC MALIGNANCIES; BIOSYNTHESIS INHIBITOR; ANTITUMOR-ACTIVITY; MELANOMA-CELLS; APOPTOSIS; P53	Aberrant histone deacetylase (HDAC) activity is frequent in human leukemias. However, while classical, NAD(+)-independent HDACs are an established therapeutic target, the relevance of NAD(+)-dependent HDACs (sirtuins) in leukemia treatment remains unclear. Here, we assessed the antileukemic activity of sirtuin inhibitors and of the NAD(+)-lowering drug FK866, alone and in combination with traditional HDAC inhibitors. Primary leukemia cells, leukemia cell lines, healthy leukocytes and hematopoietic progenitors were treated with sirtuin inhibitors (sirtinol, cambinol, EX527) and with FK866, with or without addition of the HDAC inhibitors valproic acid, sodium butyrate, and vorinostat. Cell death was quantified by propidium iodide cell staining and subsequent flow-cytometry. Apoptosis induction wasmonitored by cell staining with FITC-Annexin-V/propidium iodide or with TMRE followed by flow-cytometric analysis, and by measuring caspase3/7 activity. Intracellular Bax was detected by flow-cytometry and western blotting. Cellular NAD(+) levels were measured by enzymatic cycling assays. Bax was overexpressed by retroviral transduction. Bax and SIRT1 were silenced by RNA-interference. Sirtuin inhibitors and FK866 synergistically enhanced HDAC inhibitor activity in leukemia cells, but not in healthy leukocytes and hematopoietic progenitors. In leukemia cells, HDAC inhibitors were found to induce upregulation of Bax, a pro-apoptotic Bcl2 family-member whose translocation to mitochondria is normally prevented by SIRT1. As a result, leukemia cells become sensitized to sirtuin inhibitor-induced apoptosis. In conclusion, NAD(+)-independent HDACs and sirtuins cooperate in leukemia cells to avoid apoptosis. Combining sirtuin with HDAC inhibitors results in synergistic antileukemic activity that could be therapeutically exploited.	[Cea, Michele; Soncini, Debora; Garuti, Anna; Moran, Eva; Zoppoli, Gabriele; Caffa, Irene; Casciaro, Salvatore; Ballestrero, Alberto; Patrone, Franco; Nencioni, Alessio] Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy; [Cea, Michele; Cagnetta, Antonia] Harvard Univ, Sch Med, Jerome Lipper Multiple Myeloma Ctr, Dana Farber Canc Inst,Boston Novartis Inst BioMed, Cambridge, MA 02138 USA; [Fruscione, Floriana] ABC, Genoa, Italy; [Raffaghello, Lizzia; Pistoia, Vito] IRCCS G Gaslini, Lab Oncol, Genoa, Italy; [Emionite, Laura] Natl Canc Inst, Anim Facil, Genoa, Italy; [Magnone, Mirko; Salis, Annalisa; Damonte, Gianluca; Bruzzone, Santina] Univ Genoa, Biochem Sect, Dept Expt Med, Genoa, Italy; [Reverberi, Daniele] Natl Canc Inst, Med Oncol Div C, Genoa, Italy; [Cagnetta, Antonia; Bergamaschi, Micaela; Pierri, Ivana; Gobbi, Marco] San Martino Hosp, Dept Hematol & Oncol, Genoa, Italy; [Ansaldi, Filippo] Univ Genoa, Dept Hlth Sci, Genoa, Italy	University of Genoa; Harvard University; Dana-Farber Cancer Institute; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; University of Genoa; IRCCS AOU San Martino IST; University of Genoa	Cea, M (corresponding author), Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy.	A.Nencioni@gmx.net	cea, Michele/K-3863-2018; Nencioni, Alessio/K-3692-2018; Emionite, Laura/AAB-3120-2020; Soncini, Debora/AAB-2230-2019; fruscione, floriana/AAA-8747-2020; Zoppoli, Gabriele/B-6935-2016; BALLESTRERO, ALBERTO/K-7546-2016; Salis, Annalisa/R-9241-2018; Caffa, Irene/J-9835-2016; Zoppoli, Gabriele/B-6935-2016	cea, Michele/0000-0002-1530-6729; Emionite, Laura/0000-0002-5199-6384; Soncini, Debora/0000-0001-5156-498X; Zoppoli, Gabriele/0000-0003-3890-5588; Raffaghello, Lizzia/0000-0003-2357-0607; BALLESTRERO, ALBERTO/0000-0002-2601-7711; NENCIONI, ALESSIO/0000-0001-5068-8884; Salis, Annalisa/0000-0002-3082-2908; fruscione, floriana/0000-0002-4054-645X; CAGNETTA, ANTONIA/0000-0003-1973-3768; Caffa, Irene/0000-0003-1111-9915; Zoppoli, Gabriele/0000-0002-1619-1708	Associazione Italiana per la Ricerca sul Cancro (AIRC); Associazione Italiana contro le Leucemie-Linfomi e Mieloma; University of Genoa	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana contro le Leucemie-Linfomi e Mieloma; University of Genoa	This work was supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC, AN and LR), the Associazione Italiana contro le Leucemie-Linfomi e Mieloma, and by the University of Genoa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audrito V., 2011, CANC RES; Bouzar AB, 2009, BRIT J HAEMATOL, V144, P41, DOI 10.1111/j.1365-2141.2008.07426.x; Bradbury C, 2005, LEUKEMIA, V19, P1751, DOI 10.1038/sj.leu.2403910; Bruzzone S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007897; Byrd JC, 2005, BLOOD, V105, P959, DOI 10.1182/blood-2004-05-1693; Cea M, 2009, BLOOD, V113, P6035, DOI 10.1182/blood-2009-03-209213; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Drummond DC, 2005, ANNU REV PHARMACOL, V45, P495, DOI 10.1146/annurev.pharmtox.45.120403.095825; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Garcia-Manero G, 2008, BLOOD, V112, P981, DOI 10.1182/blood-2007-10-115873; Garcia-Manero G, 2008, BLOOD, V111, P1060, DOI 10.1182/blood-2007-06-098061; Gillespie S, 2006, APOPTOSIS, V11, P2251, DOI 10.1007/s10495-006-0283-6; Gore SD, 2002, CLIN CANCER RES, V8, P963; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; Hasmann M, 2003, CANCER RES, V63, P7436; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Holen K, 2008, INVEST NEW DRUG, V26, P45, DOI 10.1007/s10637-007-9083-2; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Imai S, 2009, CELL BIOCHEM BIOPHYS, V53, P65, DOI 10.1007/s12013-008-9041-4; Joung KE, 2006, CANCER RES, V66, P5394, DOI 10.1158/0008-5472.CAN-05-3835; Kelly WK, 2003, CLIN CANCER RES, V9, P3578; Kuendgen A, 2007, CANCER-AM CANCER SOC, V110, P943, DOI 10.1002/cncr.22891; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Lee SM, 2007, J PHARMACOL EXP THER, V322, P1084, DOI 10.1124/jpet.107.124461; Liu T, 2009, CANCER RES, V69, P1702, DOI 10.1158/0008-5472.CAN-08-3365; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Nahimana A, 2009, BLOOD, V113, P3276, DOI 10.1182/blood-2008-08-173369; Odenike OM, 2008, CLIN CANCER RES, V14, P7095, DOI 10.1158/1078-0432.CCR-08-1007; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Skokowa J, 2009, NAT MED, V15, P151, DOI 10.1038/nm.1913; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Takayama K, 2009, ARTHRITIS RHEUM-US, V60, P2731, DOI 10.1002/art.24864; Van Gool F, 2009, NAT MED, V15, P206, DOI 10.1038/nm.1906; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; VONHEIDEMAN A, 2009, CANC CHEMOTHER PHARM; Wampfler J, 2009, BRIT J HAEMATOL, V146, P337, DOI 10.1111/j.1365-2141.2009.07749.x; WANG B, 2010, ONCOGENE; Zhang XD, 2004, MOL CANCER THER, V3, P425	42	56	61	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22739	10.1371/journal.pone.0022739	http://dx.doi.org/10.1371/journal.pone.0022739			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818379	Green Submitted, gold, Green Published			2022-12-25	WOS:000293282700069
J	Ciocan, CM; Cubero-Leon, E; Minier, C; Rotchell, JM				Ciocan, Corina M.; Cubero-Leon, Elena; Minier, Christophe; Rotchell, Jeanette M.			Identification of Reproduction-Specific Genes Associated with Maturation and Estrogen Exposure in a Marine Bivalve Mytilus edulis	PLOS ONE			English	Article							OYSTER CRASSOSTREA-GIGAS; MESSENGER-RNA EXPRESSION; PATINOPECTEN-YESSOENSIS; SEROTONIN-RECEPTOR; SEX STEROIDS; VITELLOGENIN; PROTEIN; ESTRADIOL-17-BETA; METABOLISM; MUSSELS	Background: While it is established that vertebrate-like steroids, particularly estrogens (estradiol, estrone) and androgens (testosterone), are present in various tissues of molluscs, it is still unclear what role these play in reproductive endocrinology in such organisms. This is despite the significant commercial shellfishery interest in several bivalve species and their decline. Methodology/Principal Findings: Using suppression subtraction hybridisation of mussel gonad samples at two stages (early and mature) of gametogenesis and (in parallel) following controlled laboratory estrogen exposure, we isolate several differentially regulated genes including testis-specific kinases, vitelline lysin and envelope sequences. Conclusions: The differentially expressed mRNAs isolated provide evidence that mussels may be impacted by exogenous estrogen exposure.	[Ciocan, Corina M.; Cubero-Leon, Elena; Rotchell, Jeanette M.] Univ Sussex, Dept Biol & Environm Sci, Brighton, E Sussex, England; [Minier, Christophe] Univ Havre, Lab Ecotoxicol, Le Havre, France	University of Sussex; Universite de Reims Champagne-Ardenne; Universite Le Havre Normandie	Ciocan, CM (corresponding author), Univ Sussex, Dept Biol & Environm Sci, Brighton, E Sussex, England.	j.rotchell@hull.ac.uk		cubero leon, elena/0000-0003-1490-9162; Ciocan, Corina/0000-0002-4511-7398	European Regional Development Fund in the framework of the INTERREG IV A France (Channel) - England programme (DIESE) [4040]	European Regional Development Fund in the framework of the INTERREG IV A France (Channel) - England programme (DIESE)	This work was funded by the European Regional Development Fund in the framework of the INTERREG IV A France (Channel) - England programme (DIESE project number 4040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard JE, 2010, MOL BIOL EVOL, V27, P193, DOI 10.1093/molbev/msp221; Andral B, 2004, MAR POLLUT BULL, V49, P704, DOI 10.1016/j.marpolbul.2004.05.008; Arukwe A, 1997, ENVIRON HEALTH PERSP, V105, P418, DOI 10.2307/3433339; Bannister R, 2007, ENVIRON SCI TECHNOL, V41, P2643, DOI 10.1021/es062565m; Boutet I, 2008, GENE, V407, P130, DOI 10.1016/j.gene.2007.10.005; Ciocan CM, 2010, ENVIRON POLLUT, V158, P2977, DOI 10.1016/j.envpol.2010.05.025; Craft JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008875; Cubero-Leon E, 2010, AQUAT TOXICOL, V98, P178, DOI 10.1016/j.aquatox.2010.02.007; DELONGCAMP D, 1974, GEN COMP ENDOCR, V22, P116, DOI 10.1016/0016-6480(74)90093-8; Gagne F, 2011, COMP BIOCHEM PHYS C, V153, P99, DOI 10.1016/j.cbpc.2010.09.002; GOLDBERG ED, 1986, ENVIRON MONIT ASSESS, V7, P91, DOI 10.1007/BF00398031; Hines GA, 1996, INVERTEBR BIOL, V115, P113, DOI 10.2307/3227042; HYLLNER SJ, 1994, MOL REPROD DEV, V39, P166, DOI 10.1002/mrd.1080390208; Inoue K, 1995, BIOL BULL, V189, P370, DOI 10.2307/1542155; Janer G, 2007, ECOTOXICOLOGY, V16, P145, DOI 10.1007/s10646-006-0110-4; Kajiwara M, 2006, GEN COMP ENDOCR, V148, P315, DOI 10.1016/j.ygcen.2006.03.016; Kang N, 2008, CELL MOL IMMUNOL, V5, P279, DOI 10.1038/cmi.2008.34; Labadie P, 2007, STEROIDS, V72, P41, DOI 10.1016/j.steroids.2006.10.003; Langston WJ, 2007, MAR ECOL PROG SER, V333, P173, DOI 10.3354/meps333173; Larsson DGJ, 2002, GEN COMP ENDOCR, V125, P184, DOI 10.1006/gcen.2001.7740; Le Curieux-Belfond O, 2005, J EXP MAR BIOL ECOL, V325, P125, DOI 10.1016/j.jembe.2005.04.027; Le Curieux-Belfond O, 2001, J STEROID BIOCHEM, V78, P359, DOI 10.1016/S0960-0760(01)00109-1; Li Q, 1998, INVERTEBR REPROD DEV, V33, P87, DOI 10.1080/07924259.1998.9652345; Matsumoto T, 2007, GEN COMP ENDOCR, V151, P195, DOI 10.1016/j.ygcen.2007.01.016; Morcillo Y, 2000, ENVIRON POLLUT, V107, P47, DOI 10.1016/S0269-7491(99)00133-5; Osada M, 2004, COMP BIOCHEM PHYS B, V139, P123, DOI 10.1016/j.cbpc.2004.07.002; Osada M, 2003, J EXP ZOOL PART A, V299A, P172, DOI 10.1002/jez.a.10276; Osada M, 1998, J EXP ZOOL, V281, P124, DOI 10.1002/(SICI)1097-010X(19980601)281:2&lt;124::AID-JEZ6&gt;3.0.CO;2-Q; Peck MR, 2007, CHEMOSPHERE, V69, P1, DOI 10.1016/j.chemosphere.2007.04.082; Puinean AM, 2006, AQUAT TOXICOL, V79, P376, DOI 10.1016/j.aquatox.2006.07.006; REISHENRIQUES MA, 1990, COMP BIOCHEM PHYS B, V95, P303, DOI 10.1016/0305-0491(90)90080-D; Riffeser M, 2002, COMP BIOCHEM PHYS C, V132, P75, DOI 10.1016/S1532-0456(02)00048-0; Rittschof D, 2005, MAR POLLUT BULL, V50, P369, DOI 10.1016/j.marpolbul.2005.02.008; Sedik WF, 2010, MAR BIOL, V157, P639, DOI 10.1007/s00227-009-1349-0; Thornton JW, 2003, SCIENCE, V301, P1714, DOI 10.1126/science.1086185; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Viarengo A, 2007, COMP BIOCHEM PHYS C, V146, P281, DOI 10.1016/j.cbpc.2007.04.011; Wang CD, 2003, INVERTEBR REPROD DEV, V44, P89, DOI 10.1080/07924259.2003.9652559; Westerlund L, 2001, GEN COMP ENDOCR, V122, P78, DOI 10.1006/gcen.2001.7614; Zhu W, 2003, NEUROENDOCRINOL LETT, V24, P137	40	52	52	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22326	10.1371/journal.pone.0022326	http://dx.doi.org/10.1371/journal.pone.0022326			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21818309	gold, Green Published			2022-12-25	WOS:000293282700022
J	Talaei, F; Bouma, H; Van der Graaf, A; Strijkstra, A; Schmidt, M; Henning, R				Talaei, Fatemeh; Bouma, Hjalmar; Van der Graaf, Adrianus; Strijkstra, Arjen; Schmidt, Martina; Henning, Robert			Serotonin and Dopamine Protect from Hypothermia/Rewarming Damage through the CBS/H2S Pathway	PLOS ONE			English	Article							CYSTATHIONINE-BETA-SYNTHASE; RAT VAS-DEFERENS; HYDROGEN-SULFIDE; ISCHEMIA-REPERFUSION; REDOX REGULATION; MICE; H2S; INJURY; INHIBITION; KIDNEY	Biogenic amines have been demonstrated to protect cells from apoptotic cell death. Herein we show for the first time that serotonin and dopamine increase H2S production by the endogenous enzyme cystathionine-beta-synthase (CBS) and protect cells against hypothermia/rewarming induced reactive oxygen species (ROS) formation and apoptosis. Treatment with both compounds doubled CBS expression through mammalian target of rapamycin (mTOR) and increased H2S production in cultured rat smooth muscle cells. In addition, serotonin and dopamine treatment significantly reduced ROS formation. The beneficial effect of both compounds was minimized by inhibition of their re-uptake and by pharmacological inhibition of CBS or its down-regulation by siRNA. Exogenous administration of H2S and activation of CBS by Prydoxal 5'-phosphate also protected cells from hypothermic damage. Finally, serotonin and dopamine pretreatment of rat lung, kidney, liver and heart prior to 24 h of hypothermia at 3 degrees C followed by 30 min of rewarming at 37 degrees C upregulated the expression of CBS, strongly reduced caspase activity and maintained the physiological pH compared to untreated tissues. Thus, dopamine and serotonin protect cells against hypothermia/rewarming induced damage by increasing H2S production mediated through CBS. Our data identify a novel molecular link between biogenic amines and the H2S pathway, which may profoundly affect our understanding of the biological effects of monoamine neurotransmitters.	[Talaei, Fatemeh; Bouma, Hjalmar; Strijkstra, Arjen; Henning, Robert] Univ Groningen, Dept Clin Pharmacol FB20, Univ Med Ctr Groningen, Groningen, Netherlands; [Van der Graaf, Adrianus] Angteq BV, Groningen, Netherlands; [Strijkstra, Arjen] Univ Groningen, Dept Chronobiol, Groningen, Netherlands; [Schmidt, Martina] Univ Groningen, Dept Mol Pharmacol, Fac Pharm, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Talaei, F (corresponding author), Univ Groningen, Dept Clin Pharmacol FB20, Univ Med Ctr Groningen, Groningen, Netherlands.	F.Talaei@med.umcg.nl	Bouma, Hjalmar/F-9737-2015; Schmidt, Martina/C-5339-2018; Henning, Robert H/AAY-5222-2020	Bouma, Hjalmar/0000-0003-1032-321X; Schmidt, Martina/0000-0003-3075-0630; Henning, Robert/0000-0002-5135-4621	UMCG	UMCG	This work is supported by a PhD grant from UMCG to FT. AVdG was involved in designing the experiments, no additional financial contribution was received from Angteq B.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee R, 2005, ARCH BIOCHEM BIOPHYS, V433, P144, DOI 10.1016/j.abb.2004.08.037; Becker LB, 2004, CARDIOVASC RES, V61, P461, DOI 10.1016/j.cardiores.2003.10.025; Betten A, 2001, J LEUKOCYTE BIOL, V70, P65; Bianchi P, 2005, FASEB J, V19, P641, DOI 10.1096/fj.04-2518fje; Boutilier RG, 2001, J EXP BIOL, V204, P3171; Brinkkoetter PT, 2008, CELL PHYSIOL BIOCHEM, V22, P195, DOI 10.1159/000149797; BUSZA AL, 1992, TRANSPLANTATION, V54, P562, DOI 10.1097/00007890-199209000-00037; Calvert JW, 2010, ANTIOXID REDOX SIGN, V12, P1203, DOI 10.1089/ars.2009.2882; CELUCH SM, 1988, NEUROCHEM RES, V13, P967, DOI 10.1007/BF00970770; Dorweiler B, 2007, EUR J TRAUMA EMERG S, V33, P600, DOI 10.1007/s00068-007-7152-z; Drabek T, 2011, SHOCK, V35, P67, DOI 10.1097/SHK.0b013e3181e86f49; Eisenhofer G, 2001, PHARMACOL THERAPEUT, V91, P35, DOI 10.1016/S0163-7258(01)00144-9; Finkelstein JD, 1998, EUR J PEDIATR, V157, pS40, DOI 10.1007/PL00014300; Frank N, 2008, ARCH BIOCHEM BIOPHYS, V470, P64, DOI 10.1016/j.abb.2007.11.006; FUENMAYORT L, 1976, NEUROSCIENCE, V1, P197; GREEN RGF, 1995, BR J ANAESTHESIOL, V74, P591; Hamelet J, 2007, EXP MOL PATHOL, V83, P249, DOI 10.1016/j.yexmp.2007.04.005; Haouzi P, 2008, RESP PHYSIOL NEUROBI, V160, P109, DOI 10.1016/j.resp.2007.09.001; Hosoki R, 1997, BIOCHEM BIOPH RES CO, V237, P527, DOI 10.1006/bbrc.1997.6878; Janosik M, 2001, BIOCHEMISTRY-US, V40, P10625, DOI 10.1021/bi010711p; Kawabata A, 2007, PAIN, V132, P74, DOI 10.1016/j.pain.2007.01.026; LaBella FS, 2000, SEMIN CANCER BIOL, V10, P47, DOI 10.1006/scbi.2000.0307; Lin KH, 2002, NUCL MED BIOL, V29, P643, DOI 10.1016/S0969-8051(02)00323-2; Liu YL, 2006, AM J RESP CELL MOL, V34, P182, DOI 10.1165/rcmb.2005-0163OC; MUDD SH, 1985, AM J HUM GENET, V37, P1; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Osipov RM, 2009, J CARDIOVASC PHARM, V54, P287, DOI 10.1097/FJC.0b013e3181b2b72b; Ovechkin AV, 2006, AM J PHYSIOL-LUNG C, V291, pL905, DOI 10.1152/ajplung.00543.2005; Pena-Silva RA, 2009, AM J PHYSIOL-HEART C, V297, pH1354, DOI 10.1152/ajpheart.00570.2009; Peng YJ, 2010, P NATL ACAD SCI USA, V107, P10719, DOI 10.1073/pnas.1005866107; Qu K, 2008, NEUROCHEM INT, V52, P155, DOI 10.1016/j.neuint.2007.05.016; Racagni G, 2010, INT CLIN PSYCHOPHARM, V25, P117, DOI 10.1097/YIC.0b013e3283311acd; Rauen U, 2002, BIOL CHEM, V383, P477, DOI 10.1515/BC.2002.050; Robert K, 2003, J HISTOCHEM CYTOCHEM, V51, P363, DOI 10.1177/002215540305100311; Santini E, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000308; Schnuelle P, 2009, JAMA-J AM MED ASSOC, V302, P1067, DOI 10.1001/jama.2009.1310; SCHUFFWERNER P, 1995, EUR J CLIN INVEST, V25, P477, DOI 10.1111/j.1365-2362.1995.tb01733.x; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Sola A, 2003, TRANSPLANTATION, V75, P744, DOI 10.1097/01.TP.0000054683.72223.2D; STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Tang GH, 2005, MOL PHARMACOL, V68, P1757, DOI 10.1124/mol.105.017467; Taoka S, 1998, J BIOL CHEM, V273, P25179, DOI 10.1074/jbc.273.39.25179; Wang XM, 2006, PHYSIOLOGY, V21, P362, DOI 10.1152/physiol.00024.2006; WARENYCIA MW, 1989, ARCH TOXICOL, V63, P131, DOI 10.1007/BF00316435; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; Wolf RFE, 1996, TRANSPLANTATION, V61, P66, DOI 10.1097/00007890-199601150-00014; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yard B, 2004, AM J TRANSPLANT, V4, P22, DOI 10.1046/j.1600-6143.2003.00268.x; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	51	42	44	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22568	10.1371/journal.pone.0022568	http://dx.doi.org/10.1371/journal.pone.0022568			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21829469	Green Submitted, gold, Green Published			2022-12-25	WOS:000293282700040
J	Chauvet, C; Vanhoutteghem, A; Duhem, C; Saint-Auret, G; Bois-Joyeux, B; Djian, P; Staels, B; Danan, JL				Chauvet, Caroline; Vanhoutteghem, Amandine; Duhem, Christian; Saint-Auret, Gaelle; Bois-Joyeux, Brigitte; Djian, Philippe; Staels, Bart; Danan, Jean-Louis			Control of Gene Expression by the Retinoic Acid-Related Orphan Receptor Alpha in HepG2 Human Hepatoma Cells	PLOS ONE			English	Article							REV-ERB-ALPHA; HYPOXIA-INDUCIBLE FACTOR-1; ROR-ALPHA; NUCLEAR RECEPTORS; TRANSCRIPTIONAL REGULATION; HEPATOCELLULAR-CARCINOMA; STAGGERER MOUSE; TARGET GENE; IDENTIFICATION; DISEASE	Retinoic acid-related Orphan Receptor alpha (ROR alpha; NR1F1) is a widely distributed nuclear receptor involved in several (patho) physiological functions including lipid metabolism, inflammation, angiogenesis, and circadian rhythm. To better understand the role of this nuclear receptor in liver, we aimed at displaying genes controlled by ROR alpha in liver cells by generating HepG2 human hepatoma cells stably over-expressing ROR alpha. Genes whose expression was altered in these cells versus control cells were displayed using micro-arrays followed by qRT-PCR analysis. Expression of these genes was also altered in cells in which ROR alpha was transiently over-expressed after adenoviral infection. A number of the genes found were involved in known pathways controlled by ROR alpha, for instance LPA, NR1D2 and ADIPOQ in lipid metabolism, ADIPOQ and PLG in inflammation, PLG in fibrinolysis and NR1D2 and NR1D1 in circadian rhythm. This study also revealed that genes such as G6PC, involved in glucose homeostasis, and AGRP, involved in the control of body weight, are also controlled by ROR alpha. Lastly, SPARC, involved in cell growth and adhesion, and associated with liver carcinogenesis, was up-regulated by ROR alpha. SPARC was found to be a new putative ROR alpha target gene since it possesses, in its promoter, a functional RORE as evidenced by EMSAs and transfection experiments. Most of the other genes that we found regulated by ROR alpha also contained putative ROREs in their regulatory regions. Chromatin immunoprecipitation (ChIP) confirmed that the ROREs present in the SPARC, PLG, G6PC, NR1D2 and AGRP genes were occupied by ROR alpha in HepG2 cells. Therefore these genes must now be considered as direct ROR alpha targets. Our results open new routes on the roles of ROR alpha in glucose metabolism and carcinogenesis within cells of hepatic origin.	[Chauvet, Caroline] Univ Paris 05, INSERM, Lab Pharmacol Toxicol & Signalisat Cellulaire, Ctr Univ St Peres,UMR S747, Paris, France; [Chauvet, Caroline; Bois-Joyeux, Brigitte; Danan, Jean-Louis] Univ Paris 05, Ctr Necker, CNRS, FRE 3210, Paris, France; [Vanhoutteghem, Amandine; Djian, Philippe; Danan, Jean-Louis] Univ Paris 05, Ctr Univ St Peres, CNRS, FRE 3235, Paris, France; [Duhem, Christian; Staels, Bart] Univ Lille Nord France, Lille, France; [Duhem, Christian; Staels, Bart] INSERM, U1011, F-59045 Lille, France; [Duhem, Christian; Staels, Bart] UDSL, Lille, France; [Duhem, Christian; Staels, Bart] Inst Pasteur, Lille, France; [Saint-Auret, Gaelle] INSERM, Fac Med & Pharm, Rouen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Institut National de la Sante et de la Recherche Medicale (Inserm)	Chauvet, C (corresponding author), Univ Paris 05, INSERM, Lab Pharmacol Toxicol & Signalisat Cellulaire, Ctr Univ St Peres,UMR S747, Paris, France.	caroline.chauvet@parisdescartes.fr	Staels, Bart/N-9497-2016	Staels, Bart/0000-0002-3784-1503; Djian, Philippe/0000-0001-9586-0254; Duhem, Christian/0000-0003-0931-3815	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (INSERM); University Paris Descartes; Association pour la Recherche sur le Cancer [3511]; Region Nord Pas-de-Calais/FEDER; Association pour la Recherche sur le Cancer	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University Paris Descartes; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Region Nord Pas-de-Calais/FEDER(Region Hauts-de-FranceEuropean Commission); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by the Centre National de la Recherche Scientifique (CNRS), the Institut National de la Sante et de la Recherche Medicale (INSERM), the University Paris Descartes and grants from the Association pour la Recherche sur le Cancer [no. 3511] (to J.L.D.), from the Region Nord Pas-de-Calais/FEDER (to B.S.), and from the Association pour la Recherche sur le Cancer and the Ligue contre le cancer (to A.V. and P.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atorrasagasti C, 2010, INT J CANCER, V126, P2726, DOI 10.1002/ijc.24966; Auwerx J, 1999, CELL, V97, P161; BECKERANDRE M, 1993, BIOCHEM BIOPH RES CO, V194, P1371, DOI 10.1006/bbrc.1993.1976; Besnard S, 2001, CIRC RES, V89, P1209, DOI 10.1161/hh2401.101755; Bois-Joyeux B, 2000, DNA CELL BIOL, V19, P589, DOI 10.1089/104454900750019344; Camino AM, 2008, J GENE MED, V10, P993, DOI 10.1002/jgm.1228; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; Chauvet C, 2005, MOL ENDOCRINOL, V19, P2517, DOI 10.1210/me.2005-0153; Chauvet C, 2004, BIOCHEM J, V384, P79, DOI 10.1042/BJ20040709; Chopra AR, 2008, SCIENCE, V322, P1395, DOI 10.1126/science.1164847; Chou JY, 2008, HUM MUTAT, V29, P921, DOI 10.1002/humu.20772; Del Rosso M, 2008, FRONT BIOSCI-LANDMRK, V13, P4667, DOI 10.2741/3032; Delerive P, 2001, EMBO REP, V2, P42, DOI 10.1093/embo-reports/kve007; Delerive P, 2002, J BIOL CHEM, V277, P35013, DOI 10.1074/jbc.M202979200; Diez JJ, 2003, EUR J ENDOCRINOL, V148, P293, DOI 10.1530/eje.0.1480293; Djian P, 2000, J CELL BIOL, V151, P381, DOI 10.1083/jcb.151.2.381; Duez H, 2008, DIABETES VASC DIS RE, V5, P82, DOI 10.3132/dvdr.2008.0014; Duez H, 2009, FEBS LETT, V583, P2031, DOI 10.1016/j.febslet.2009.05.019; FRIZELL E, 1995, HEPATOLOGY, V21, P847, DOI 10.1002/hep.1840210335; Gawlas K, 2000, BBA-GENE STRUCT EXPR, V1494, P236, DOI 10.1016/S0167-4781(00)00237-2; Germain P, 2006, PHARMACOL REV, V58, P685, DOI 10.1124/pr.58.4.2; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; Giraud S, 2002, J BIOL CHEM, V277, P8004, DOI 10.1074/jbc.M111486200; Gold DA, 2007, BRAIN RES, V1140, P19, DOI 10.1016/j.brainres.2005.11.080; Hafner M, 1995, MATRIX BIOL, V14, P733, DOI 10.1016/S0945-053X(05)80016-2; Jetten AM, 2009, NUCL RECEPT SIGNAL, V7, pe003; Kallen J, 2004, J BIOL CHEM, V279, P14033, DOI 10.1074/jbc.M400302200; Kang HS, 2007, PHYSIOL GENOMICS, V31, P281, DOI 10.1152/physiolgenomics.00098.2007; Kim EJ, 2008, ARTERIOSCL THROM VAS, V28, P1796, DOI 10.1161/ATVBAHA.108.171546; KOPMELS B, 1992, J NEUROCHEM, V58, P192, DOI 10.1111/j.1471-4159.1992.tb09295.x; Kwaan Hau C., 2009, V148, P43, DOI 10.1007/978-0-387-79962-9_4; Lau CPY, 2006, J PATHOL, V210, P459, DOI 10.1002/path.2068; Lind U, 2005, BIOCHEM BIOPH RES CO, V330, P233, DOI 10.1016/j.bbrc.2005.02.151; Lippi G, 2007, CANCER TREAT REV, V33, P427, DOI 10.1016/j.ctrv.2007.02.006; Mamontova A, 1998, CIRCULATION, V98, P2738, DOI 10.1161/01.CIR.98.24.2738; Moh MC, 2003, J HEPATOL, V39, P580, DOI 10.1016/S0168-8278(03)00359-3; Rambaud J, 2009, MOL ENDOCRINOL, V23, P630, DOI 10.1210/me.2008-0395; Raspe E, 1999, J LIPID RES, V40, P2099; Raspe E, 2002, J LIPID RES, V43, P2172, DOI 10.1194/jlr.M200386-JLR200; Raspe E, 2002, J BIOL CHEM, V277, P49275, DOI 10.1074/jbc.M206215200; Raspe E, 2001, J BIOL CHEM, V276, P2865, DOI 10.1074/jbc.M004982200; Robinson-Rechavi M, 2003, J CELL SCI, V116, P585, DOI 10.1242/jcs.00247; SARDET C, 1995, P NATL ACAD SCI USA, V92, P2403, DOI 10.1073/pnas.92.6.2403; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Shibata R, 2009, CIRC J, V73, P608, DOI 10.1253/circj.CJ-09-0057; Sonoda J, 2008, FEBS LETT, V582, P2, DOI 10.1016/j.febslet.2007.11.016; Tai IT, 2008, DRUG RESIST UPDATE, V11, P231, DOI 10.1016/j.drup.2008.08.005; Van Schaftingen E, 2002, BIOCHEM J, V362, P513, DOI 10.1042/0264-6021:3620513; VuDac N, 1997, J BIOL CHEM, V272, P22401, DOI 10.1074/jbc.272.36.22401; Wang J, 2006, J BIOL CHEM, V281, P33842, DOI 10.1074/jbc.M607873200; WIESENBERG I, 1995, NUCLEIC ACIDS RES, V23, P327, DOI 10.1093/nar/23.3.327; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179	52	24	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e22545	10.1371/journal.pone.0022545	http://dx.doi.org/10.1371/journal.pone.0022545			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21818335	Green Submitted, gold, Green Published			2022-12-25	WOS:000293175100032
J	Hottes, TS; Skowronski, DM; Hiebert, B; Janjua, NZ; Roos, LL; Van Caeseele, P; Law, BJ; De Serres, G				Hottes, Travis S.; Skowronski, Danuta M.; Hiebert, Brett; Janjua, Naveed Z.; Roos, Leslie L.; Van Caeseele, Paul; Law, Barbara J.; De Serres, Gaston			Influenza Vaccine Effectiveness in the Elderly Based on Administrative Databases: Change in Immunization Habit as a Marker for Bias	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; PREVENTING HOSPITALIZATION; INSTRUMENTAL VARIABLES; CLINICAL EFFECTIVENESS; COST-EFFECTIVENESS; PROPENSITY SCORE; MORTALITY; EFFICACY; PEOPLE; RISK	Background: Administrative databases provide efficient methods to estimate influenza vaccine effectiveness (IVE) against severe outcomes in the elderly but are prone to intractable bias. This study returns to one of the linked population databases by which IVE against hospitalization and death in the elderly was first assessed. We explore IVE across six more recent influenza seasons, including periods before, during, and after peak activity to identify potential markers for bias. Methods and Findings: Acute respiratory hospitalization and all-cause mortality were compared between immunized/nonimmunized community-dwelling seniors >= 65years through administrative databases in Manitoba, Canada between 2000-01 and 2005-06. IVE was compared during pre-season/influenza/post-season periods through logistic regression with multivariable adjustment (age/sex/income/residence/prior influenza or pneumococcal immunization/medical visits/comorbidity), stratification based on prior influenza immunization history, and propensity scores. Analysis during pre-season periods assessed baseline differences between immunized and unimmunized groups. The study population included,140,000 seniors, of whom 50-60% were immunized annually. Adjustment for key covariates and use of propensity scores consistently increased IVE. Estimates were paradoxically higher pre-season and for all-cause mortality vs. acute respiratory hospitalization. Stratified analysis showed that those twice consecutively and currently immunized were always at significantly lower hospitalization/mortality risk with odds ratios (OR) of 0.60 [95% CI0.48-0.75] and 0.58 [0.53-0.64] pre-season and 0.77 [0.69-0.86] and 0.71 [0.66-0.77] during influenza circulation, relative to the consistently unimmunized. Conversely, those forgoing immunization when twice previously immunized were always at significantly higher hospitalization/mortality risk with OR of 1.41 [1.14-1.73] and 2.45 [2.21-2.72] pre-season and 1.21 [1.03-1.43] and 1.78 [1.61-1.96] during influenza circulation. Conclusions: The most pronounced IVE estimates were paradoxically observed pre-season, indicating bias tending to overestimate vaccine protection. Change in immunization habit from that of the prior two years may be a marker for this bias in administrative data sets; however, no analytic technique explored could adjust for its influence. Improved methods to achieve valid interpretation of protection in the elderly are needed.	[Hottes, Travis S.; Skowronski, Danuta M.; Janjua, Naveed Z.] BC Ctr Dis Control, Epidemiol Serv, Vancouver, BC, Canada; [Skowronski, Danuta M.; Janjua, Naveed Z.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Hiebert, Brett; Roos, Leslie L.] Univ Manitoba, Dept Community Hlth Sci, Fac Med, Manitoba Ctr Hlth Policy, Winnipeg, MB R3T 2N2, Canada; [Van Caeseele, Paul] Manitoba Hlth, Cadham Prov Lab, Winnipeg, MB, Canada; [Law, Barbara J.] Publ Hlth Agcy Canada, Ctr Immunizat & Resp Infect Dis, Surveillance & Outbreak Response Div, Ottawa, ON, Canada; [De Serres, Gaston] Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada; [De Serres, Gaston] Univ Laval, Dept Social & Prevent Med, Quebec City, PQ, Canada	University of British Columbia; University of Manitoba; Public Health Agency of Canada; Institut national de sante publique du Quebec (INSPQ); Laval University	Hottes, TS (corresponding author), BC Ctr Dis Control, Epidemiol Serv, Vancouver, BC, Canada.	danuta.skowronski@bccdc.ca	Zafar, Naveed/A-2712-2008	Zafar, Naveed/0000-0001-5681-719X; Salway, Travis/0000-0002-5699-5444; Roos, Leslie L./0000-0002-4215-8346	Canadian Institutes of Health Research [PAN 83140]; GlaxoSmithKline; SanofiPasteur; Merck Frosst Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); GlaxoSmithKline(GlaxoSmithKline); SanofiPasteur; Merck Frosst Canada	This work was supported by the Canadian Institutes of Health Research (grant # PAN 83140) (http://www.cihr-irsc.gc.ca/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; In the 36 months prior to submission, GDS received research grants for unrelated projects from GlaxoSmithKline and SanofiPasteur, BJL received a research grant for an unrelated project from Merck Frosst Canada, and DMS was principal investigator on a clinical trial for which influenza vaccine was provided free by SanofiPasteur. No other authors have conflicts of interest to declare within 36 months of this submission. These competing interests do not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Baxter R, 2010, J INFECT DIS, V201, P186, DOI 10.1086/649568; Christenson B, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-52; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Eurich DT, 2008, AM J RESP CRIT CARE, V178, P527, DOI 10.1164/rccm.200802-282OC; FEDSON DS, 1993, JAMA-J AM MED ASSOC, V270, P1956, DOI 10.1001/jama.270.16.1956; Fireman B, 2009, AM J EPIDEMIOL, V170, P650, DOI 10.1093/aje/kwp173; Fleming DM, 1995, EPIDEMIOL INFECT, V115, P581, DOI 10.1017/S095026880005874X; FOSTER DA, 1992, AM J EPIDEMIOL, V136, P296, DOI 10.1093/oxfordjournals.aje.a116495; GOVAERT TME, 1994, JAMA-J AM MED ASSOC, V272, P1661, DOI 10.1001/jama.272.21.1661; Greenland S, 2000, INT J EPIDEMIOL, V29, P722, DOI 10.1093/ije/29.4.722; Groenwold RHH, 2010, VALUE HEALTH, V13, P132, DOI 10.1111/j.1524-4733.2009.00584.x; Hak E, 2005, ARCH INTERN MED, V165, P274, DOI 10.1001/archinte.165.3.274; Hak E, 2002, J EPIDEMIOL COMMUN H, V56, P951, DOI 10.1136/jech.56.12.951; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Jackson LA, 2006, INT J EPIDEMIOL, V35, P345, DOI 10.1093/ije/dyi275; Jackson ML, 2008, LANCET, V372, P398, DOI 10.1016/S0140-6736(08)61160-5; JEFFERSON T, 2010, COCHRANE DATABASE SY, V2; KWONG JC, 2007, STAT CANADA HLTH REP, V18, P1; LONG P H, 1964, Med Times, V92, P1203; Mangtani P, 2004, J INFECT DIS, V190, P1, DOI 10.1086/421274; MULLOOLY JP, 1994, ANN INTERN MED, V121, P947, DOI 10.7326/0003-4819-121-12-199412150-00008; Newgard CD, 2004, ACAD EMERG MED, V11, P953, DOI 10.1197/j.aem.2004.02.530; Nichol KL, 1999, VACCINE, V17, pS47, DOI 10.1016/S0264-410X(99)00105-X; Nichol KL, 2003, NEW ENGL J MED, V348, P1322, DOI 10.1056/NEJMoa025028; Nichol KL, 1999, ANN INTERN MED, V130, P397, DOI 10.7326/0003-4819-130-5-199903020-00003; Nichol KL, 1998, ARCH INTERN MED, V158, P1769, DOI 10.1001/archinte.158.16.1769; NICHOL KL, 1994, NEW ENGL J MED, V331, P778, DOI 10.1056/NEJM199409223311206; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Nordin J, 2001, J INFECT DIS, V184, P665, DOI 10.1086/323085; Ohmit SE, 1995, INT J EPIDEMIOL, V24, P1240, DOI 10.1093/ije/24.6.1240; ORENSTEIN WA, 1985, B WORLD HEALTH ORGAN, V63, P1055; Petrie JG, 2011, J INFECT DIS, V203, P1309, DOI 10.1093/infdis/jir015; Praditsuwan Rungnirand, 2005, Journal of the Medical Association of Thailand, V88, P256; PuigBarbera J, 1997, J EPIDEMIOL COMMUN H, V51, P526, DOI 10.1136/jech.51.5.526; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Rudenko LG, 2000, VACCINE, V19, P308, DOI 10.1016/S0264-410X(00)00153-5; Schade C P, 2000, W V Med J, V96, P444; Schneeweiss S, 2007, MED CARE, V45, pS131, DOI 10.1097/MLR.0b013e318070c08e; Shapiro Y, 2003, ISRAEL MED ASSOC J, V5, P706; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; Simonsen L, 2007, LANCET INFECT DIS, V7, P658, DOI 10.1016/S1473-3099(07)70236-0; Skowronski DM, 2009, J INFECT DIS, V199, P168, DOI 10.1086/595862; Spaude KA, 2007, ARCH INTERN MED, V167, P53, DOI 10.1001/archinte.167.1.53; *STAT CAN, 2002, 92378XIE STAT CAN; Sturmer T, 2006, J CLIN EPIDEMIOL, V59, P437, DOI 10.1016/j.jclinepi.2005.07.004; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Vila-Corcoles A, 2007, VACCINE, V25, P6699, DOI 10.1016/j.vaccine.2007.07.015; Voordouw BCG, 2003, ARCH INTERN MED, V163, P1089, DOI 10.1001/archinte.163.9.1089; Vu T, 2002, VACCINE, V20, P1831, DOI 10.1016/S0264-410X(02)00041-5; Wang ST, 2005, VACCINE, V23, P1973, DOI 10.1016/j.vaccine.2004.10.011	51	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e22618	10.1371/journal.pone.0022618	http://dx.doi.org/10.1371/journal.pone.0022618			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21818350	gold, Green Published			2022-12-25	WOS:000293175100036
J	Saakian, DB; Biebricher, CK; Hu, CK				Saakian, David B.; Biebricher, Christof K.; Hu, Chin-Kun			Lethal Mutants and Truncated Selection Together Solve a Paradox of the Origin of Life	PLOS ONE			English	Article							ERROR-THRESHOLD; FITNESS; EVOLUTION; MODEL; MUTAGENESIS; ROBUSTNESS; EPISTASIS; DESIGN	Background: Many attempts have been made to describe the origin of life, one of which is Eigen's cycle of autocatalytic reactions [Eigen M (1971) Naturwissenschaften 58, 465-523], in which primordial life molecules are replicated with limited accuracy through autocatalytic reactions. For successful evolution, the information carrier (either RNA or DNA or their precursor) must be transmitted to the next generation with a minimal number of misprints. In Eigen's theory, the maximum chain length that could be maintained is restricted to 100-1000 nucleotides, while for the most primitive genome the length is around 7000-20000. This is the famous error catastrophe paradox. How to solve this puzzle is an interesting and important problem in the theory of the origin of life. Methodology/Principal Findings: We use methods of statistical physics to solve this paradox by carefully analyzing the implications of neutral and lethal mutants, and truncated selection (i.e., when fitness is zero after a certain Hamming distance from the master sequence) for the critical chain length. While neutral mutants play an important role in evolution, they do not provide a solution to the paradox. We have found that lethal mutants and truncated selection together can solve the error catastrophe paradox. There is a principal difference between prebiotic molecule self-replication and proto-cell self-replication stages in the origin of life. Conclusions/Significance: We have applied methods of statistical physics to make an important breakthrough in the molecular theory of the origin of life. Our results will inspire further studies on the molecular theory of the origin of life and biological evolution.	[Saakian, David B.; Hu, Chin-Kun] Acad Sinica, Inst Phys, Taipei, Taiwan; [Saakian, David B.] Yerevan Phys Inst, Yerevan 375036, Armenia; [Saakian, David B.] Natl Taiwan Univ, Natl Ctr Theoret Sci, Div Phys, Taipei 10764, Taiwan; [Biebricher, Christof K.] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Hu, Chin-Kun] Beijing Normal Univ, Dept Phys, Beijing 100875, Peoples R China	Academia Sinica - Taiwan; Yerevan Physics Institute; National Taiwan University; Max Planck Society; Beijing Normal University	Saakian, DB (corresponding author), Acad Sinica, Inst Phys, Taipei, Taiwan.	huck@phys.sinica.edu.tw	Saakian, David B/T-7807-2018	Saakian, David B/0000-0003-3849-3878; Hu, Chin-Kun/0000-0002-3620-8319	NCTS (North);  [NSC 96-2911-M 001-003-MY3];  [NSC 98-2811-M-001-080];  [NSC 100-2923-M-001-003-MY3]	NCTS (North); ; ; 	This work was supported by grants NSC 96-2911-M 001-003-MY3, NSC 98-2811-M-001-080, NSC 100-2923-M-001-003-MY3 and NCTS (North). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avetisyan Z, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.051916; Baake E, 1997, PHYS REV LETT, V78, P559, DOI 10.1103/PhysRevLett.78.559; Bonnaz D, 1999, J THEOR BIOL, V197, P415, DOI 10.1006/jtbi.1998.0883; Budin I, 2010, ANNU REV BIOPHYS, V39, P245, DOI 10.1146/annurev.biophys.050708.133753; Bull JJ, 2007, J VIROL, V81, P2930, DOI 10.1128/JVI.01624-06; Bull JJ, 2008, GENETICS, V180, P1061, DOI 10.1534/genetics.108.091413; Claverie JM, 2010, TRENDS GENET, V26, P431, DOI 10.1016/j.tig.2010.07.003; de Duve C, 2011, PHILOS T R SOC A, V369, P620, DOI 10.1098/rsta.2010.0312; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; EIGEN M, 1989, ADV CHEM PHYS, V75, P149; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; Hermisson J, 2002, THEOR POPUL BIOL, V62, P9, DOI 10.1006/tpbi.2002.1582; Huynen MA, 1996, P NATL ACAD SCI USA, V93, P397, DOI 10.1073/pnas.93.1.397; Ichihashi N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004945; INOUE T, 1982, J MOL BIOL, V162, P201, DOI 10.1016/0022-2836(82)90169-3; Johnston WK, 2001, SCIENCE, V292, P1319, DOI 10.1126/science.1060786; Kauffman S.A., 1993, ORIGINS ORDER; Kirakosyan Z, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011904; KONDRASHOV AS, 1994, GENETICS, V136, P1469; Krakauer DC, 2002, P NATL ACAD SCI USA, V99, P1405, DOI 10.1073/pnas.032668599; Kun A, 2005, NAT GENET, V37, P1008, DOI 10.1038/ng1621; Lincoln TA, 2009, SCIENCE, V323, P1229, DOI 10.1126/science.1167856; Mansy SS, 2008, NATURE, V454, P122, DOI 10.1038/nature07018; Meierhenrich UJ, 2010, ANGEW CHEM INT EDIT, V49, P3738, DOI 10.1002/anie.200905465; Munoz E, 2009, J STAT PHYS, V135, P429, DOI 10.1007/s10955-009-9732-2; Ofria C, 2003, J THEOR BIOL, V222, P477, DOI 10.1016/S0022-5193(03)00062-6; Pande VS, 2000, REV MOD PHYS, V72, P259, DOI 10.1103/RevModPhys.72.259; Park JM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.058101; Peck JR, 2010, EVOLUTION, V64, P3300, DOI 10.1111/j.1558-5646.2010.01074.x; Powner MW, 2009, NATURE, V459, P239, DOI 10.1038/nature08013; Rajamani S, 2010, J AM CHEM SOC, V132, P5880, DOI 10.1021/ja100780p; Saakian D, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.021913; Saakian DB, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011902; Saakian DB, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.061913; Saakian DB, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.041905; Saakian DB, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.061907; Saakian DB, 2006, P NATL ACAD SCI USA, V103, P4935, DOI 10.1073/pnas.0504924103; Saakian DB, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.041913; Saakian DB, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.041908; Saakian DB, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.046121; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P15376, DOI 10.1073/pnas.0404125101; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P8396, DOI 10.1073/pnas.0400146101; Sato K, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.061909; Schrum JP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002212; Schueler-Furman O, 2005, SCIENCE, V310, P638, DOI 10.1126/science.1112160; Schuster H.G, 2001, COMPLEX ADAPTIVE SYS; Stanley H.E., 1971, INTRO PHASE TRANSITI; Summers J, 2006, J VIROL, V80, P20, DOI 10.1128/JVI.80.1.20-26.2006; Takeuchi N, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-9; Takeuchi N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-15; Tejero H, 2010, J THEOR BIOL, V262, P733, DOI 10.1016/j.jtbi.2009.10.011; van Nimwegen E, 1999, P NATL ACAD SCI USA, V96, P9716, DOI 10.1073/pnas.96.17.9716; Wilke CO, 2001, EVOLUTION, V55, P2412; Wolff A, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/3/036007; Zahnle K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004895; Zorn J, 2004, BIOPOLYMERS, V73, P340, DOI 10.1002/bip.10525	56	25	25	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e21904	10.1371/journal.pone.0021904	http://dx.doi.org/10.1371/journal.pone.0021904			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21814563	gold, Green Submitted, Green Published			2022-12-25	WOS:000293175100012
J	Salman-Dilgimen, A; Hardy, PO; Dresser, AR; Chaconas, G				Salman-Dilgimen, Aydan; Hardy, Pierre-Olivier; Dresser, Ashley R.; Chaconas, George			HrpA, a DEAH-Box RNA Helicase, Is Involved in Global Gene Regulation in the Lyme Disease Spirochete	PLOS ONE			English	Article							RESPONSE REGULATOR; BURGDORFERI; EXPRESSION; PROTEINS; GENOME; IDENTIFICATION; OPERON; FAMILY; REGION; OSPC	Spirochetes causing Lyme borreliosis are obligate parasites that can only be found in a tick vector or a vertebrate host. The ability to survive in these two disparate environments requires up and downregulation of specific genes by regulatory circuits that remain largely obscure. In this work on the Lyme spirochete, B. burgdorferi, we show that a disruption of the hrpA gene, which encodes a putative RNA helicase, results in a complete loss in the ability of the spirochetes to infect mice by needle inoculation. Studies of protein expression in culture by 2D gels revealed a change in the expression of 33 proteins in hrpA clones relative to the wild-type parent. Quantitative characterization of protein expression by iTRAQ analysis revealed a total of 187 differentially regulated proteins in an hrpA background: 90 downregulated and 97 upregulated. Forty-two of the 90 downregulated and 65 of the 97 upregulated proteins are not regulated under any conditions by the previously reported regulators in B. burgdorferi (bosR, rrp2, rpoN, rpoS or rrp1). Downregulated and upregulated proteins also fell into distinct functional categories. We conclude that HrpA is part of a new and distinct global regulatory pathway in B. burgdorferi gene expression. Because an HrpA orthologue is present in many bacteria, its participation in global regulation in B. burgdorferi may have relevance in other bacterial species where its function remains obscure. We believe this to be the first report of a role for an RNA helicase in a global regulatory pathway in bacteria. This finding is particularly timely with the recent growth of the field of RNA regulation of gene expression and the ability of RNA helicases to modulate RNA structure and function.	[Salman-Dilgimen, Aydan] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB, Canada	University of Calgary; University of Calgary	Salman-Dilgimen, A (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada.	chaconas@ucalgary.ca			Canadian Institutes of Health Research [MOP 53086]; Alberta Heritage Foundation for Medical Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	This work was supported by grant MOP 53086 from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) to GC, who also holds a Canada Research Chair in the Molecular Biology of Lyme Borreliosis (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx) and a Scientist Award from the Alberta Heritage Foundation for Medical Research (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal Kunal, 2006, Briefings in Functional Genomics & Proteomics, V5, P112, DOI 10.1093/bfgp/ell018; Alverson J, 2003, MOL MICROBIOL, V48, P1665, DOI 10.1046/j.1365-2958.2003.03537.x; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; Beaurepaire C, 2007, MOL MICROBIOL, V63, P443, DOI 10.1111/j.1365-2958.2006.05533.x; Beisel CL, 2010, FEMS MICROBIOL REV, V34, P866, DOI 10.1111/j.1574-6976.2010.00241.x; Boardman BK, 2008, INFECT IMMUN, V76, P3844, DOI 10.1128/IAI.00467-08; Bono JL, 2000, J BACTERIOL, V182, P2445, DOI 10.1128/JB.182.9.2445-2452.2000; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brewis IA, 2010, ADV PROTEIN CHEM STR, V80, P1, DOI [10.1016/S1876-1623(10)80001-X, 10.1016/B978-0-12-381264-3.00001-1]; Brooks CS, 2003, INFECT IMMUN, V71, P3371, DOI 10.1128/IAI.71.6.3371-3383.2003; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Cabello F., 2010, BORRELIA MOL BIOL HO, P189; Calmano MJ, 2007, MOL MICROBIOL, V65, P1193, DOI 10.1111/j.1365-2958.2007.05860.x; Caron MP, 2010, RNA BIOL, V7, P140, DOI 10.4161/rna.7.2.11056; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Dresser AR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000680; Elias AF, 2000, J BACTERIOL, V182, P2909, DOI 10.1128/JB.182.10.2909-2918.2000; Elias AF, 2003, J MOL MICROB BIOTECH, V6, P29, DOI 10.1159/000073406; Fisher MA, 2005, P NATL ACAD SCI USA, V102, P5162, DOI 10.1073/pnas.0408536102; Frohlich KS, 2009, CURR OPIN MICROBIOL, V12, P674, DOI 10.1016/j.mib.2009.09.009; Gripenland J, 2010, NAT REV MICROBIOL, V8, P857, DOI 10.1038/nrmicro2457; HEUKESHOVEN J, 1988, ELECTROPHORESIS, V9, P28, DOI 10.1002/elps.1150090106; Hubner A, 2001, P NATL ACAD SCI USA, V98, P12724, DOI 10.1073/pnas.231442498; Hyde JA, 2010, INFECT IMMUN, V78, P265, DOI 10.1128/IAI.01018-09; Hyde JA, 2009, MOL MICROBIOL, V74, P1344, DOI 10.1111/j.1365-2958.2009.06951.x; Jagessar KL, 2010, RNA, V16, P1386, DOI 10.1261/rna.2015610; Jain C, 2006, PROTEIN EXPRES PURIF, V46, P294, DOI 10.1016/j.pep.2005.07.017; Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008; Jost D, 2011, BMB REP, V44, P11, DOI 10.5483/BMBRep.2011.44.1.11; Koo JT, 2004, MOL MICROBIOL, V52, P1813, DOI 10.1111/j.1365-2958.2004.04099.x; Lin T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000679; Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468; Lioliou E, 2010, NEW BIOTECHNOL, V27, P222, DOI 10.1016/j.nbt.2010.03.002; Liu JM, 2010, CURR OPIN MICROBIOL, V13, P18, DOI 10.1016/j.mib.2009.11.004; Lybecker MC, 2007, MOL MICROBIOL, V64, P1075, DOI 10.1111/j.1365-2958.2007.05716.x; Lybecker MC, 2010, MOL MICROBIOL, V78, P622, DOI 10.1111/j.1365-2958.2010.07374.x; Margolis N, 1995, MOL BIOL REP, V21, P159, DOI 10.1007/BF00997238; Medrano MS, 2007, J BACTERIOL, V189, P2653, DOI 10.1128/JB.01760-06; Medrano MS, 2010, NUCLEIC ACIDS RES, V38, P414, DOI 10.1093/nar/gkp1027; Narasimhan S, 2002, J BACTERIOL, V184, P3122, DOI 10.1128/JB.184.11.3122-3125.2002; Norris S.J., 2010, BORRELIA MOL BIOL HO, P293; Ojaimi C, 2003, INFECT IMMUN, V71, P1689, DOI 10.1128/IAI.71.4.1689-1705.2003; Ouyang ZM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001272; Ouyang ZM, 2009, MOL MICROBIOL, V74, P1331, DOI 10.1111/j.1365-2958.2009.06945.x; Pal U., 2010, BORRELIA MOL BIOL HO, P279; Papenfort K, 2010, CELL HOST MICROBE, V8, P116, DOI 10.1016/j.chom.2010.06.008; Purser JE, 2000, P NATL ACAD SCI USA, V97, P13865, DOI 10.1073/pnas.97.25.13865; Revel AT, 2002, P NATL ACAD SCI USA, V99, P1562, DOI 10.1073/pnas.032667699; Rogers EA, 2009, MOL MICROBIOL, V71, P1551, DOI 10.1111/j.1365-2958.2009.06621.x; Samuels DS, 2009, MOL MICROBIOL, V74, P1295, DOI 10.1111/j.1365-2958.2009.06971.x; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SKARE JT, 2010, BORRELIA MOL BIOL HO, P67; Stanek G, 2011, CLIN MICROBIOL INFEC, V17, P69, DOI 10.1111/j.1469-0691.2010.03175.x; Stewart PE, 2001, MOL MICROBIOL, V39, P714, DOI 10.1046/j.1365-2958.2001.02256.x; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Thomason MK, 2010, ANNU REV GENET, V44, P167, DOI 10.1146/annurev-genet-102209-163523; Tokarz R, 2004, INFECT IMMUN, V72, P5419, DOI 10.1128/IAI.72.9.5419-5432.2004; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Yang XFF, 2003, P NATL ACAD SCI USA, V100, P11001, DOI 10.1073/pnas.1834315100; Zhiming OY, 2008, MICROBIOL-SGM, V154, P2641, DOI 10.1099/mic.0.2008/019992-0	60	31	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e22168	10.1371/journal.pone.0022168	http://dx.doi.org/10.1371/journal.pone.0022168			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21814569	gold, Green Published, Green Submitted			2022-12-25	WOS:000293175100016
J	Choi, MK; Moon, CH; Ko, MS; Lee, UH; Cho, WJ; Cha, SJ; Do, JW; Heo, GJ; Jeong, SG; Hahm, YS; Harmache, A; Bremont, M; Kurath, G; Park, JW				Choi, Myeong Kyu; Moon, Chang Hoon; Ko, Myoung Seok; Lee, Unn-Hwa; Cho, Wha Ja; Cha, Seung Ju; Do, Jeong Wan; Heo, Gang Joon; Jeong, Soo Geun; Hahm, Yoo Sik; Harmache, Abdallah; Bremont, Michel; Kurath, Gael; Park, Jeong Woo			A Nuclear Localization of the Infectious Haematopoietic Necrosis Virus NV Protein Is Necessary for Optimal Viral Growth	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; INFLUENZA-A VIRUS; TROUT ONCORHYNCHUS-MYKISS; NS1 PROTEIN; MATRIX PROTEIN; RAINBOW-TROUT; ALPHA/BETA INTERFERON; PHOSPHOPROTEIN-P; GENE-EXPRESSION; BETA-INTERFERON	The nonvirion (NV) protein of infectious hematopoietic necrosis virus (IHNV) has been previously reported to be essential for efficient growth and pathogenicity of IHNV. However, little is known about the mechanism by which the NV supports the viral growth. In this study, cellular localization of NV and its role in IHNV growth in host cells was investigated. Through transient transfection in RTG-2 cells of NV fused to green fluorescent protein (GFP), a nuclear localization of NV was demonstrated. Deletion analyses showed that the (32)EGDL(35) residues were essential for nuclear localization of NV protein, and fusion of these 4 amino acids to GFP directed its transport to the nucleus. We generated a recombinant IHNV, rIHNV-NV-Delta EGDL in which the (32)EGDL(35) was deleted from the NV. rIHNVs with wild-type NV (rIHNV-NV) or with the NV gene replaced with GFP (rIHNV-Delta NV-GFP) were used as controls. RTG-2 cells infected with rIHNV-Delta NV-GFP and rIHNV-NV-Delta EGDL yielded 12- and 5-fold less infectious virion, respectively, than wild type rIHNV-infected cells at 48 h post-infection (p.i.). While treatment with poly I: C at 24 h p.i. did not inhibit replication of wild-type rIHNVs, replication rates of rIHNV-Delta NV-GFP and rIHNV-NV-Delta EGDL were inhibited by poly I: C. In addition, both rIHNV-Delta NV and rIHNV-NV-Delta EGDL induced higher levels of expressions of both IFN1 and Mx1 than wild-type rIHNV. These data suggest that the IHNV NV may support the growth of IHNV through inhibition of the INF system and the amino acid residues of 32 EGDL 35 responsible for nuclear localization are important for the inhibitory activity of NV.	[Choi, Myeong Kyu; Moon, Chang Hoon; Ko, Myoung Seok; Lee, Unn-Hwa; Park, Jeong Woo] Univ Ulsan, Dept Biol Sci, Ulsan 680749, South Korea; [Cho, Wha Ja; Cha, Seung Ju] Univ Ulsan, Ulsan Univ Hosp, Coll Med, Biomed Res Ctr, Ulsan 680749, South Korea; [Do, Jeong Wan] Natl Fisheries Res & Dev Inst, S & W Sea Fisheries Res Inst, Yeosu, South Korea; [Heo, Gang Joon] Chungbuk Natl Univ, Coll Vet Med, Cheongju, South Korea; [Choi, Myeong Kyu; Jeong, Soo Geun; Hahm, Yoo Sik] Ulsan Inst Hlth & Environm, Ulsan, South Korea; [Harmache, Abdallah; Bremont, Michel] INRA CRJ, Unite Virol & Immunol Mol, Jouy En Josas, France; [Moon, Chang Hoon; Kurath, Gael] US Geol Survey, Western Fisheries Res Ctr, Seattle, WA USA	University of Ulsan; University of Ulsan; Ulsan University Hospital; Chungbuk National University; INRAE; United States Department of the Interior; United States Geological Survey	Choi, MK (corresponding author), Univ Ulsan, Dept Biol Sci, Ulsan 680749, South Korea.	jwpark@ulsan.ac.kr	HARMACHE, Abdallah/AAS-2586-2021; HARMACHE, ABDALLAH/E-7274-2011	Harmache, Abdallah/0000-0002-7377-7641	Korean government ( MEST) [2009-0060042, BRL-2009-0087350]	Korean government ( MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This project was partially supported by a Korea Science and Engineering Foundation (KOSEF) grant funded by the Korean government ( MEST), grant code: 2009-0060042 and BRL-2009-0087350, http://www.nrf.re.kr/html/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2003, J VIROL, V77, P4646, DOI 10.1128/JVI.77.8.4646-4657.2003; Alonso M, 2004, J VIROL, V78, P5875, DOI 10.1128/JVI.78.11.5875-5882.2004; AMMAYAPPAN A, 2010, MAR BIOTECHNOL NY; Batts W. N., 1989, Journal of Aquatic Animal Health, V1, P284, DOI 10.1577/1548-8667(1989)001&lt;0284:EDOIHN&gt;2.3.CO;2; Biacchesi S, 2000, J VIROL, V74, P11247, DOI 10.1128/JVI.74.23.11247-11253.2000; Biacchesi S, 2010, J VIROL, V84, P10038, DOI 10.1128/JVI.00343-10; BIRON CA, 2001, INTERFERONS OTHER CY, P321; BLACK BL, 1992, J VIROL, V66, P4058, DOI 10.1128/JVI.66.7.4058-4064.1992; BOOTLAND LM, 1999, INFECT HEMATOPOIETIC, P57; Brzozka K, 2005, J VIROL, V79, P7673, DOI 10.1128/JVI.79.12.7673-7681.2005; Brzozka K, 2006, J VIROL, V80, P2675, DOI 10.1128/JVI.80.6.2675-2683.2006; Chelbi-Alix MK, 2006, J INTERF CYTOK RES, V26, P271, DOI 10.1089/jir.2006.26.271; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Collet B, 2004, DEV COMP IMMUNOL, V28, P793, DOI 10.1016/j.dci.2003.12.005; Collet B, 2002, FISH SHELLFISH IMMUN, V12, P389, DOI 10.1006/fsim.2001.0405; Enninga J, 2002, SCIENCE, V295, P1523, DOI 10.1126/science.1067861; Faria PA, 2005, MOL CELL, V17, P93, DOI 10.1016/j.molcel.2004.11.023; FIELD AK, 1967, P NATL ACAD SCI USA, V58, P1004, DOI 10.1073/pnas.58.3.1004; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Glodowski DR, 2002, J BIOL CHEM, V277, P46864, DOI 10.1074/jbc.M208576200; GREENSPAN D, 1988, J VIROL, V62, P3020, DOI 10.1128/JVI.62.8.3020-3026.1988; Guo Z, 2007, AM J RESP CELL MOL, V36, P263, DOI 10.1165/rcmb.2006-0283RC; Gustin KE, 2002, J VIROL, V76, P8787, DOI 10.1128/JVI.76.17.8787-8796.2002; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; Hiscox JA, 2003, VIRUS RES, V95, P13, DOI 10.1016/S0168-1702(03)00160-6; KURATH G, 1985, J VIROL, V53, P469, DOI 10.1128/JVI.53.2.469-476.1985; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Li YZ, 1998, P NATL ACAD SCI USA, V95, P4864, DOI 10.1073/pnas.95.9.4864; Ludwig S, 2002, J VIROL, V76, P11166, DOI 10.1128/JVI.76.21.11166-11171.2002; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; MORZUNOV SP, 1995, VIRUS RES, V38, P175, DOI 10.1016/0168-1702(95)00056-V; Ooi EL, 2008, DEV COMP IMMUNOL, V32, P1211, DOI 10.1016/j.dci.2008.03.010; Opitz B, 2007, CELL MICROBIOL, V9, P930, DOI 10.1111/j.1462-5822.2006.00841.x; PARK MA, 1993, J FISH DIS, V16, P471, DOI 10.1111/j.1365-2761.1993.tb00880.x; Pasdeloup D, 2005, VIROLOGY, V334, P284, DOI 10.1016/j.virol.2005.02.005; Purcell MK, 2004, FISH SHELLFISH IMMUN, V17, P447, DOI 10.1016/j.fsi.2004.04.017; Rieder M, 2009, J INTERF CYTOK RES, V29, P499, DOI 10.1089/jir.2009.0068; Robertsen B, 2006, FISH SHELLFISH IMMUN, V20, P172, DOI 10.1016/j.fsi.2005.01.010; Robertsen B, 2008, FISH SHELLFISH IMMUN, V25, P351, DOI 10.1016/j.fsi.2008.02.004; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saint-Jean SR, 2006, VET IMMUNOL IMMUNOP, V110, P1, DOI 10.1016/j.vetimm.2005.08.023; Talon J, 2000, P NATL ACAD SCI USA, V97, P4309, DOI 10.1073/pnas.070525997; Thoulouze MI, 2004, J VIROL, V78, P4098, DOI 10.1128/JVI.78.8.4098-4107.2004; Trobridge GD, 1997, J VIROL, V71, P5304, DOI 10.1128/JVI.71.7.5304-5311.1997; Vidy A, 2005, J VIROL, V79, P14411, DOI 10.1128/JVI.79.22.14411-14420.2005; Vidy A, 2007, J VIROL, V81, P4255, DOI 10.1128/JVI.01930-06; von Kobbe C, 2000, MOL CELL, V6, P1243, DOI 10.1016/S1097-2765(00)00120-9; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; WOLF K, 1988, INFECT HEMATOPOIETIC, P83	51	54	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22362	10.1371/journal.pone.0022362	http://dx.doi.org/10.1371/journal.pone.0022362			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21814578	Green Submitted, gold, Green Published			2022-12-25	WOS:000292956800047
J	Cui, Y; Liu, B; Luo, SH; Zhen, XT; Fan, M; Liu, T; Zhu, WL; Park, M; Jiang, TZ; Jin, JS				Cui, Yue; Liu, Bing; Luo, Suhuai; Zhen, Xiantong; Fan, Ming; Liu, Tao; Zhu, Wanlin; Park, Mira; Jiang, Tianzi; Jin, Jesse S.		Alzheimers Dis Neuroimaging	Identification of Conversion from Mild Cognitive Impairment to Alzheimer's Disease Using Multivariate Predictors	PLOS ONE			English	Article							NEUROIMAGING INITIATIVE ADNI; CSF BIOMARKERS; PATTERN-CLASSIFICATION; FEATURE-SELECTION; BRAIN ATROPHY; MCI PATIENTS; BASE-LINE; DIAGNOSIS; MRI; SEGMENTATION	Prediction of conversion from mild cognitive impairment (MCI) to Alzheimer's disease (AD) is of major interest in AD research. A large number of potential predictors have been proposed, with most investigations tending to examine one or a set of related predictors. In this study, we simultaneously examined multiple features from different modalities of data, including structural magnetic resonance imaging (MRI) morphometry, cerebrospinal fluid (CSF) biomarkers and neuropsychological and functional measures (NMs), to explore an optimal set of predictors of conversion from MCI to AD in an Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort. After FreeSurfer-derived MRI feature extraction, CSF and NM feature collection, feature selection was employed to choose optimal subsets of features from each modality. Support vector machine (SVM) classifiers were then trained on normal control (NC) and AD participants. Testing was conducted on MCIc (MCI individuals who have converted to AD within 24 months) and MCInc (MCI individuals who have not converted to AD within 24 months) groups. Classification results demonstrated that NMs outperformed CSF and MRI features. The combination of selected NM, MRI and CSF features attained an accuracy of 67.13%, a sensitivity of 96.43%, a specificity of 48.28%, and an AUC (area under curve) of 0.796. Analysis of the predictive values of MCIc who converted at different follow-up evaluations showed that the predictive values were significantly different between individuals who converted within 12 months and after 12 months. This study establishes meaningful multivariate predictors composed of selected NM, MRI and CSF measures which may be useful and practical for clinical diagnosis.	[Cui, Yue; Luo, Suhuai; Liu, Tao; Park, Mira; Jin, Jesse S.] Univ Newcastle, Sch Design Commun & Informat Technol, Newcastle, NSW 2300, Australia; [Liu, Bing; Zhen, Xiantong; Fan, Ming; Jiang, Tianzi] Chinese Acad Sci, Inst Automat, LIAMA Ctr Computat Med, Natl Lab Pattern Recognit, Beijing, Peoples R China; [Liu, Tao; Zhu, Wanlin] Prince Wales Hosp, Inst Neuropsychiat, Sydney, NSW, Australia; [Liu, Tao; Zhu, Wanlin] Univ New S Wales, Sch Psychiat, Brain & Ageing Res Program, Sydney, NSW, Australia; [Jiang, Tianzi] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China	University of Newcastle; Chinese Academy of Sciences; Institute of Automation, CAS; University of New South Wales Sydney; University of Electronic Science & Technology of China	Cui, Y (corresponding author), Univ Newcastle, Sch Design Commun & Informat Technol, Newcastle, NSW 2300, Australia.	jiangtz@nlpr.ia.ac.cn; jesse.jin@newcastle.edu.au	Jiang, Tianzi/I-4256-2012; Park, Mira/ACM-8509-2022	Jiang, Tianzi/0000-0001-9531-291X; Park, Mira/0000-0003-0175-8692; Liu, Tao/0000-0002-7783-3073; Luo, Suhuai/0000-0002-6185-6035	National Key Basic Research and Development Program (973) [2011CBA00408]; Natural Science Foundation of China [60831004, 81000582]; National High Technology Research and Development Program of China (863 Program) [2009AA02Z302]; Beijing Nova Program [2010B061]; CSC; Alzheimer's Disease Neuroimaging Initiative (ADNI); National Institutes of Health [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; NIH [P30 AG010129, K01 AG030514]; Dana Foundation; NATIONAL INSTITUTE ON AGING [U19AG010483, P30AG010129, U01AG024904, K01AG030514] Funding Source: NIH RePORTER	National Key Basic Research and Development Program (973)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Beijing Nova Program(Beijing Municipal Science & Technology Commission); CSC; Alzheimer's Disease Neuroimaging Initiative (ADNI); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work received support from the National Key Basic Research and Development Program (973), Grant No. 2011CBA00408, the Natural Science Foundation of China, Grant Nos. 60831004 and 81000582, the National High Technology Research and Development Program of China (863 Program), Grant No. 2009AA02Z302, the Beijing Nova Program, Grant No. 2010B061, and a CSC-Newcastle Scholarship. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott, AstraZeneca AB, Bayer Schering Pharma AG, Bristol-Myers Squibb, Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare, GlaxoSmithKline, Innogenetics, Johnson and Johnson, Eli Lilly and Co., Medpace, Inc., Merck and Co., Inc., Novartis AG, Pfizer Inc., F. Hoffman-La Roche, Schering-Plough, Synarc, Inc., as well as non-profit partners the Alzheimer's Association and Alzheimer's Drug Discovery Foundation, with participation from the U.S. Food and Drug Administration. Private sector contributions to ADNI are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by NIH grants P30 AG010129, K01 AG030514, and the Dana Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backman L, 2005, NEUROPSYCHOLOGY, V19, P520, DOI 10.1037/0894-4105.19.4.520; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; CHAPMAN RM, NEUROBIOL A IN PRESS; Chapman RM, 2011, J CLIN EXP NEUROPSYC, V33, P187, DOI 10.1080/13803395.2010.499356; Clark CM, 2008, NEUROSIGNALS, V16, P11, DOI 10.1159/000109754; Costafreda SG, 2011, NEUROIMAGE, V56, P212, DOI 10.1016/j.neuroimage.2011.01.050; Cuingnet R, 2011, NEUROIMAGE, V56, P766, DOI 10.1016/j.neuroimage.2010.06.013; DAVATZIKOS C, NEUROBIOL A IN PRESS; Davatzikos C, 2008, NEUROBIOL AGING, V29, P514, DOI 10.1016/j.neurobiolaging.2006.11.010; Desikan RS, 2009, AM J NEURORADIOL, V30, P532, DOI 10.3174/ajnr.A1397; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Desikan RS, 2010, NEUROBIOL AGING, V31, P1364, DOI 10.1016/j.neurobiolaging.2010.04.023; deToledo-Morrell L, 2004, NEUROBIOL AGING, V25, P1197, DOI 10.1016/j.neurobiolaging.2003.12.007; Devanand DP, 2007, NEUROLOGY, V68, P828, DOI 10.1212/01.wnl.0000256697.20968.d7; Ding C, 2003, PROCEEDINGS OF THE 2003 IEEE BIOINFORMATICS CONFERENCE, P523, DOI 10.1109/CSB.2003.1227396; EWERS M, NEUROBIOL A IN PRESS; Fan Y, 2008, NEUROIMAGE, V41, P277, DOI 10.1016/j.neuroimage.2008.02.043; Fan Y, 2008, NEUROIMAGE, V39, P1731, DOI 10.1016/j.neuroimage.2007.10.031; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; Guyon Isabelle, 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Hsu C.W., 2003, PRACTICAL GUIDE SUPP; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jack CR, 2010, ALZHEIMERS DEMENT, V6, P212, DOI 10.1016/j.jalz.2010.03.004; Kaplan E, 1978, BOSTON NAMING TEST; Madevska-Bogdanova A, 2004, NEUROCOMPUTING, V62, P293, DOI 10.1016/j.neucom.2003.03.002; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; McEvoy LK, 2009, RADIOLOGY, V251, P195, DOI 10.1148/radiol.2511080924; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Minati L, 2009, AM J ALZHEIMERS DIS, V24, P95, DOI 10.1177/1533317508328602; Misra C, 2009, NEUROIMAGE, V44, P1415, DOI 10.1016/j.neuroimage.2008.10.031; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nestor PJ, 2004, NAT MED, V10, pS34, DOI 10.1038/nrn1433; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Perri R, 2007, NEUROPSYCHOLOGY, V21, P549, DOI 10.1037/0894-4105.21.5.549; Petersen RC, 2010, NEUROLOGY, V74, P201, DOI 10.1212/WNL.0b013e3181cb3e25; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Qiu AQ, 2009, NEUROIMAGE, V45, P656, DOI 10.1016/j.neuroimage.2009.01.013; Querbes O, 2009, BRAIN, V132, P2036, DOI 10.1093/brain/awp105; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rey A., 1964, EXAMEN CLIN PSYCHOL; Risacher SL, 2009, CURR ALZHEIMER RES, V6, P347, DOI 10.2174/156720509788929273; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; TUOKKO H, 1992, J AM GERIATR SOC, V40, P579, DOI 10.1111/j.1532-5415.1992.tb02106.x; Vemuri P, 2008, NEUROIMAGE, V39, P1186, DOI 10.1016/j.neuroimage.2007.09.073; Walhovd KB, 2010, AM J NEURORADIOL, V31, P347, DOI 10.3174/ajnr.A1809; Walhovd KB, 2010, NEUROBIOL AGING, V31, P1107, DOI 10.1016/j.neurobiolaging.2008.08.013; WECHSLER D, 1987, MANNUAL WECHSLER MEM; Zhang DQ, 2011, NEUROIMAGE, V55, P856, DOI 10.1016/j.neuroimage.2011.01.008	54	174	176	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e21896	10.1371/journal.pone.0021896	http://dx.doi.org/10.1371/journal.pone.0021896			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21814561	Green Published, gold, Green Submitted			2022-12-25	WOS:000292956800014
J	Du, M; Butchi, NB; Woods, T; Peterson, KE				Du, Min; Butchi, Niranjan B.; Woods, Tyson; Peterson, Karin E.			Poly-Thymidine Oligonucleotides Mediate Activation of Murine Glial Cells Primarily Through TLR7, Not TLR8	PLOS ONE			English	Article							SINGLE-STRANDED RNA; TOLL-LIKE RECEPTORS; CEREBROSPINAL-FLUID; IMMUNE-RESPONSES; DENDRITIC CELLS; INNATE IMMUNITY; RECOGNITION; BRAIN; TOLL-LIKE-RECEPTOR-8; EXPRESSION	The functional role of murine TLR8 in the inflammatory response of the central nervous system (CNS) remains unclear. Murine TLR8 does not appear to respond to human TLR7/8 agonists, due to a five amino acid deletion in the ectodomain. However, recent studies have suggested that murine TLR8 may be stimulated by alternate ligands, which include vaccinia virus DNA, phosphothioate oligodeoxynucleotides (ODNs) or the combination of phosphothioate poly-thymidine oligonucleotides (pT-ODNs) with TLR7/8 agonists. In the current study, we analyzed the ability of pT-ODNs to induce activation of murine glial cells in the presence or absence of TLR7/8 agonists. We found that TLR7/8 agonists induced the expression of glial cell activation markers and induced the production of multiple proinflammatory cytokines and chemokines in mixed glial cultures. In contrast, pT-ODNs alone induced only low level expression of two cytokines, CCL2 and CXCL10. The combination of pT-ODNs along with TLR7/8 agonists induced a synergistic response with substantially higher levels of proinflammatory cytokines and chemokines compared to CL075. This enhancement was not due to cellular uptake of the agonist, indicating that the pT-ODN enhancement of cytokine responses was due to effects on an intracellular process. Interestingly, this response was also not due to synergistic stimulation of both TLR7 and TLR8, as the loss of TLR7 abolished the activation of glial cells and cytokine production. Thus, pT-ODNs act in synergy with TLR7/8 agonists to induce strong TLR7-dependent cytokine production in glial cells, suggesting that the combination of pT-ODNs with TLR7 agonists may be a useful mechanism to induce pronounced glial activation in the CNS.	[Du, Min; Butchi, Niranjan B.; Woods, Tyson; Peterson, Karin E.] NIAID, Rocky Mt Labs, Persistent Viral Dis Lab, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Du, M (corresponding author), NIAID, Rocky Mt Labs, Persistent Viral Dis Lab, Hamilton, MT 59840 USA.	petersonka@niaid.nih.gov	Peterson, Karin/D-1492-2016	Peterson, Karin/0000-0003-4177-7249	National Institutes of Health; National Center for Research Resources [IP20RR020159]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the National Institutes of Health and by National Center for Research Resources Grant IP20RR020159. No additional external funding was received for this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asensio VC, 1997, J VIROL, V71, P7832, DOI 10.1128/JVI.71.10.7832-7840.1997; Bauer S, 2008, IMMUNOBIOLOGY, V213, P315, DOI 10.1016/j.imbio.2007.10.010; Butchi NB, 2008, J IMMUNOL, V180, P7604, DOI 10.4049/jimmunol.180.11.7604; Butchi NB, 2010, GLIA, V58, P650, DOI 10.1002/glia.20952; Demaria O, 2010, J CLIN INVEST, V120, P3651, DOI 10.1172/JCI42081; DICKSON DW, 1993, GLIA, V7, P75, DOI 10.1002/glia.440070113; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Gorden KB, 2005, J IMMUNOL, V174, P1259, DOI 10.4049/jimmunol.174.3.1259; Gorden KKB, 2006, J IMMUNOL, V177, P8164, DOI 10.4049/jimmunol.177.11.8164; Gorden KKB, 2006, J IMMUNOL, V177, P6584, DOI 10.4049/jimmunol.177.10.6584; Griffin DE, 2003, NAT REV IMMUNOL, V3, P493, DOI 10.1038/nri1105; Gurley C, 2008, PPAR RES, V2008, DOI 10.1155/2008/453120; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Jurk M, 2006, EUR J IMMUNOL, V36, P1815, DOI 10.1002/eji.200535806; Kelder W, 1998, ANN NEUROL, V44, P831, DOI 10.1002/ana.410440521; Kumagai Yutaro, 2008, Journal of Infection and Chemotherapy, V14, P86, DOI 10.1007/s10156-008-0596-1; Lee J, 2006, P NATL ACAD SCI USA, V103, P1828, DOI 10.1073/pnas.0510801103; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Lewis SD, 2008, J NEUROVIROL, V14, P492, DOI 10.1080/13550280802345723; Liu J, 2010, MOL IMMUNOL, V47, P1083, DOI 10.1016/j.molimm.2009.11.003; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Ma Y, 2007, CELL CYCLE, V6, P2859, DOI 10.4161/cc.6.23.5018; Ma YH, 2006, J CELL BIOL, V175, P209, DOI 10.1083/jcb.200606016; Marsh BJ, 2008, CURR OPIN PHARMACOL, V8, P8, DOI 10.1016/j.coph.2007.09.009; Martinez J, 2010, P NATL ACAD SCI USA, V107, P6442, DOI 10.1073/pnas.0913291107; McCoig C, 2004, PEDIATR INFECT DIS J, V23, P114, DOI 10.1097/01.inf.0000109247.67480.7a; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Mishra BB, 2006, J NEUROIMMUNOL, V181, P46, DOI 10.1016/j.jneuroim.2006.07.019; Pedras-Vasconcelos JA, 2006, J IMMUNOL, V176, P4940, DOI 10.4049/jimmunol.176.8.4940; Ranjith-Kumar CT, 2008, MOL CELL BIOL, V28, P4507, DOI 10.1128/MCB.00308-08; Ranjith-Kumar CT, 2009, J BIOL CHEM, V284, P1155, DOI 10.1074/jbc.M806219200; Rozen S, 2000, Methods Mol Biol, V132, P365; Town T, 2009, IMMUNITY, V30, P242, DOI 10.1016/j.immuni.2008.11.012; Yrlid U, 2006, EUR J IMMUNOL, V36, P2639, DOI 10.1002/eji.200636426	36	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22454	10.1371/journal.pone.0022454	http://dx.doi.org/10.1371/journal.pone.0022454			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811614	Green Published, gold			2022-12-25	WOS:000292956800059
J	da Costa, JDFB; Leal, MF; Silva, TCR; Andrade, EF; Rezende, AP; Muniz, JAPC; Lacreta, ACC; Assumpcao, PP; Calcagno, DQ; Demachki, S; Rabenhorst, SHB; Smith, MDC; Burbano, RR				Ferreira Borges da Costa, Joana de Fatima; Leal, Mariana Ferreira; Raiol Silva, Tanielly Cristina; Andrade Junior, Edilson Ferreira; Rezende, Alexandre Pingarilho; Pereira Carneiro Muniz, Jose Augusto; Cunha Lacreta Junior, Antonio Carlos; Assumpcao, Paulo Pimentel; Calcagno, Danielle Queiroz; Demachki, Samia; Barem Rabenhorst, Silvia Helena; Cardoso Smith, Marilia de Arruda; Burbano, Rommel Rodriguez			Experimental Gastric Carcinogenesis in Cebus apella Nonhuman Primates	PLOS ONE			English	Article							CONVENTIONAL CYTOGENETIC CHARACTERIZATION; IN-SITU HYBRIDIZATION; C-MYC AMPLIFICATION; NORTHERN BRAZIL; CHEMICAL CARCINOGENESIS; NUMERICAL ABERRATIONS; REACTIVE PROTEIN; ANIMAL-MODELS; CELL-LINE; CANCER	The evolution of gastric carcinogenesis remains largely unknown. We established two gastric carcinogenesis models in New-World nonhuman primates. In the first model, ACP03 gastric cancer cell line was inoculated in 18 animals. In the second model, we treated 6 animals with N-methyl-nitrosourea (MNU). Animals with gastric cancer were also treated with Canova immunomodulator. Clinical, hematologic, and biochemical, including C-reactive protein, folic acid, and homocysteine, analyses were performed in this study. MYC expression and copy number was also evaluated. We observed that all animals inoculated with ACP03 developed gastric cancer on the 9(th) day though on the 14(th) day presented total tumor remission. In the second model, all animals developed pre-neoplastic lesions and five died of drug intoxication before the development of cancer. The last surviving MNU-treated animal developed intestinal-type gastric adenocarcinoma observed by endoscopy on the 940(th) day. The level of C-reactive protein level and homocysteine concentration increased while the level of folic acid decreased with the presence of tumors in ACP03-inoculated animals and MNU treatment. ACP03 inoculation also led to anemia and leukocytosis. The hematologic and biochemical results corroborate those observed in patients with gastric cancer, supporting that our in vivo models are potentially useful to study this neoplasia. In cell line inoculated animals, we detected MYC immunoreactivity, mRNA overexpression, and amplification, as previously observed in vitro. In MNU-treated animals, mRNA expression and MYC copy number increased during the sequential steps of intestinal-type gastric carcinogenesis and immunoreactivity was only observed in intestinal metaplasia and gastric cancer. Thus, MYC deregulation supports the gastric carcinogenesis process. Canova immunomodulator restored several hematologic measurements and therefore, can be applied during/after chemotherapy to increase the tolerability and duration of anticancer treatments.	[Ferreira Borges da Costa, Joana de Fatima; Raiol Silva, Tanielly Cristina; Andrade Junior, Edilson Ferreira; Rezende, Alexandre Pingarilho; Burbano, Rommel Rodriguez] Fed Univ Para, Inst Ciencias Biol, Lab Citogenet Humana, BR-66059 Belem, Para, Brazil; [Leal, Mariana Ferreira; Calcagno, Danielle Queiroz; Cardoso Smith, Marilia de Arruda] Univ Fed Sao Paulo, Dept Morfol & Genet, Disciplina Genet, Sao Paulo, Brazil; [Pereira Carneiro Muniz, Jose Augusto] Minist Saude, Ctr Nacl Primatas, Ananindeua, Brazil; [Cunha Lacreta Junior, Antonio Carlos] Univ Fed Lavras, Dept Vet Med, Lavras, Brazil; [Assumpcao, Paulo Pimentel; Demachki, Samia] Fed Univ Para, Hosp Univ Joao de Barros Barreto, BR-66059 Belem, Para, Brazil; [Barem Rabenhorst, Silvia Helena] Univ Fed Ceara, Escola Med, Dept Patol & Med Forense, Genet Mol Lab, Fortaleza, Ceara, Brazil	Universidade Federal do Para; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Lavras; Universidade Federal do Para; Universidade Federal do Ceara	da Costa, JDFB (corresponding author), Fed Univ Para, Inst Ciencias Biol, Lab Citogenet Humana, BR-66059 Belem, Para, Brazil.	mariana.morf@epm.br	Leal, Mariana/C-4010-2012; de A. C. Smith, Marilia/C-4397-2012; Burbano, Rommel R/C-4149-2012	Leal, Mariana/0000-0003-4375-2563; de A. C. Smith, Marilia/0000-0002-1441-1033; Burbano, Rommel R/0000-0002-4872-234X; Lacreta Junior, Antonio Carlos Cunha/0000-0001-8575-5186; Lacreta Junior, Antonio Carlos/0000-0003-0072-1935; BAREM RABENHORST, SILVIA HELENA/0000-0002-5473-4048	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [550885/2007-2, 302774/2009-2, 301609/2007-1]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2007/02470-3, 2010/11174-1]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br) grant number 550885/2007-2, 302774/2009-2 to RRB and 301609/2007-1 to MdACS and by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (www.fapesp.br) grant number 2007/02470-3 to MFL and 2010/11174-1 to DQC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson John W, 2008, Hematology Am Soc Hematol Educ Program, P159, DOI 10.1182/asheducation-2008.1.159; ADAMSON RH, 1977, J NATL CANCER I, V59, P8; Assumpcao PP, 2006, CANCER GENET CYTOGEN, V169, P45, DOI 10.1016/j.cancergencyto.2006.03.019; Baiocchi M, 2010, CURR OPIN PHARMACOL, V10, P380, DOI 10.1016/j.coph.2010.05.002; Bergman PJ, 2009, TOP COMPANION ANIM M, V24, P130, DOI 10.1053/j.tcam.2009.06.001; Burbano RR, 2006, ANTICANCER RES, V26, P2909; Burbano RR, 2009, HOMEOPATHY, V98, P45, DOI 10.1016/j.homp.2008.11.011; Calcagno DQ, 2008, WORLD J GASTROENTERO, V14, P5962, DOI 10.3748/wjg.14.5962; Calcagno DQ, 2006, WORLD J GASTROENTERO, V12, P6207, DOI 10.3748/wjg.v12.i38.6207; Calcagno DQ, 2010, CANCER GENET CYTOGEN, V202, P63, DOI 10.1016/j.cancergencyto.2010.05.020; Calcagno DQ, 2009, ANTICANCER RES, V29, P2479; Calcagno DQ, 2005, ANTICANCER RES, V25, P4069; Cesar B, 2008, MICRON, V39, P461, DOI 10.1016/j.micron.2007.02.005; Chang Cheng-Chih, 2010, Chang Gung Med J, V33, P301; CORREA P, 1992, CANCER RES, V52, P6735; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; de Oliveira CC, 2006, J INFECTION, V52, P420, DOI 10.1016/j.jinf.2005.08.017; DUTHIE SJ, 2011, J INHERIT METAB DIS; Erlinger TP, 2004, JAMA-J AM MED ASSOC, V291, P585, DOI 10.1001/jama.291.5.585; Fenech M, 2007, FORUM NUTR, V60, P49, DOI 10.1159/000107067; Guimaraes AC, 2006, CLIN EXP MED, V6, P129, DOI 10.1007/s10238-006-0108-5; HOPMAN AHN, 1988, HISTOCHEMISTRY, V89, P307, DOI 10.1007/BF00500631; Kim DK, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-155; Kim YI, 2007, MOL NUTR FOOD RES, V51, P267, DOI 10.1002/mnfr.200600191; Kodama M, 2005, WORLD J GASTROENTERO, V11, P7063, DOI 10.3748/wjg.v11.i45.7063; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Leal MF, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/631268; Leal MF, 2009, CANCER GENET CYTOGEN, V195, P85, DOI 10.1016/j.cancergencyto.2009.04.020; Lentz SR, 1996, J CLIN INVEST, V98, P24, DOI 10.1172/JCI118771; Lima EM, 2004, BRAZ J MED BIOL RES, V37, P1831, DOI 10.1590/S0100-879X2004001200008; Liu H, 2009, GASTROENTEROLOGY, V137, P1367, DOI 10.1053/j.gastro.2009.07.041; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopes L, 2006, MICRON, V37, P277, DOI 10.1016/j.micron.2005.08.005; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pereira WKV, 2005, J INFECTION, V51, P157, DOI 10.1016/j.jinf.2004.09.009; Piemonte M. Da Rocha, 2002, Journal of Submicroscopic Cytology and Pathology, V34, P255; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; Prater MR, 2004, BIRTH DEFECTS RES A, V70, P862, DOI 10.1002/bdra.20082; PRICE CP, 1987, J IMMUNOL METHODS, V99, P205, DOI 10.1016/0022-1759(87)90129-3; Raiol LCC, 2008, CANCER GENET CYTOGEN, V181, P31, DOI 10.1016/j.cancergencyto.2007.10.011; Abud APR, 2006, CELL BIOL INT, V30, P808, DOI 10.1016/j.cellbi.2006.06.011; Ribeiro HF, 2010, BRAZ J MED BIOL RES, V43, P717, DOI 10.1590/S0100-879X2010007500068; Riviello MC, 2001, J MED PRIMATOL, V30, P308, DOI 10.1034/j.1600-0684.2001.300604.x; Sato D Y O, 2005, Homeopathy, V94, P26, DOI 10.1016/j.homp.2004.10.003; Smith MG, 2006, WORLD J GASTROENTERO, V12, P2979, DOI 10.3748/wjg.v12.i19.2979; Takayama S, 2008, P JPN ACAD A-MATH, V84, P176, DOI 10.2183/pjab/84.176; Takeno SS, 2009, CANCER GENET CYTOGEN, V190, P1, DOI 10.1016/j.cancergencyto.2008.09.007; THORGEIRSSON UP, 1994, REGUL TOXICOL PHARM, V19, P130, DOI 10.1006/rtph.1994.1013; Tsukamoto T, 2007, TOXICOL PATHOL, V35, P636, DOI 10.1080/01926230701420632; UWAGAWA S, 1991, JPN J CANCER RES, V82, P1397, DOI 10.1111/j.1349-7006.1991.tb01812.x; Wu LL, 2002, CLIN CHIM ACTA, V322, P21, DOI 10.1016/S0009-8981(02)00174-2; Zacho J, 2011, INT J CANCER, V128, P644, DOI 10.1002/ijc.25375	52	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e21988	10.1371/journal.pone.0021988	http://dx.doi.org/10.1371/journal.pone.0021988			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811552	gold, Green Published, Green Submitted			2022-12-25	WOS:000292956800017
J	Harris, G; Korchnak, A; Summers, P; Hapiak, V; Law, WJ; Stein, AM; Komuniecki, P; Komuniecki, R				Harris, Gareth; Korchnak, Amanda; Summers, Philip; Hapiak, Vera; Law, Wen Jing; Stein, Andrew M.; Komuniecki, Patricia; Komuniecki, Richard			Dissecting the Serotonergic Food Signal Stimulating Sensory-Mediated Aversive Behavior in C. elegans	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; LOCOMOTORY BEHAVIOR; NERVOUS-SYSTEM; GENE; MODULATION; NEURONS; EXPRESSION; DOPAMINE; CIRCUIT; PATHWAY	Nutritional state often modulates olfaction and in Caenorhabditis elegans food stimulates aversive responses mediated by the nociceptive ASH sensory neurons. In the present study, we have characterized the role of key serotonergic neurons that differentially modulate aversive behavior in response to changing nutritional status. The serotonergic NSM and ADF neurons play antagonistic roles in food stimulation. NSM 5-HT activates SER-5 on the ASHs and SER-1 on the RIA interneurons and stimulates aversive responses, suggesting that food-dependent serotonergic stimulation involves local changes in 5-HT levels mediated by extrasynaptic 5-HT receptors. In contrast, ADF 5-HT activates SER-1 on the octopaminergic RIC interneurons to inhibit food-stimulation, suggesting neuron-specific stimulatory and inhibitory roles for SER-1 signaling. Both the NSMs and ADFs express INS-1, an insulin-like peptide, that appears to cell autonomously inhibit serotonergic signaling. Food also modulates directional decisions after reversal is complete, through the same serotonergic neurons and receptors involved in the initiation of reversal, and the decision to continue forward or change direction after reversal is dictated entirely by nutritional state. These results highlight the complexity of the "food signal'' and serotonergic signaling in the modulation of sensory-mediated aversive behaviors.	[Harris, Gareth; Korchnak, Amanda; Summers, Philip; Hapiak, Vera; Law, Wen Jing; Stein, Andrew M.; Komuniecki, Patricia; Komuniecki, Richard] Univ Toledo, Dept Biol Sci, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Harris, G (corresponding author), Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.	rkomuni@uoft02.utoledo.edu			National Institutes of Health (NIH) [AI-145147]; Joan L. and Julius H. Jacobson Biomedical Professorship; NIH National Center for Research Resources	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joan L. and Julius H. Jacobson Biomedical Professorship; NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the National Institutes of Health (NIH) grant AI-145147 awarded to RWK and funds from the Joan L. and Julius H. Jacobson Biomedical Professorship. The present study is supported by the NIH National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; Aspock G, 2003, DEVELOPMENT, V130, P3369, DOI 10.1242/dev.00551; BRENNER S, 1974, GENETICS, V77, P71; Brockie PJ, 2001, J NEUROSCI, V21, P1510, DOI 10.1523/JNEUROSCI.21-05-01510.2001; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chalasani SH, 2010, NAT NEUROSCI, V13, P615, DOI 10.1038/nn.2526; Chang AJ, 2006, PLOS BIOL, V4, P1588, DOI 10.1371/journal.pbio.0040274; Chao MY, 2004, P NATL ACAD SCI USA, V101, P15512, DOI 10.1073/pnas.0403369101; Chase D. L., 2007, WORMBOOK ONLINE REV, P1, DOI [10.1895/wormbook.1.132.1, DOI 10.1895/WORMBOOK.1.132.1]; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; Dacks AM, 2008, J NEUROPHYSIOL, V99, P2077, DOI 10.1152/jn.01372.2007; DERNOVICI S, 2006, J NEUROBIOL, V67, P189; Esposito G, 2007, GENE, V395, P170, DOI 10.1016/j.gene.2007.03.002; Esposito G, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-138; Ezak MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009487; Ezcurra M, 2011, EMBO J, V30, P1110, DOI 10.1038/emboj.2011.22; GIACHETT.I, 1970, J PHYSIOL-PARIS, V62, P280; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Hapiak VM, 2009, GENETICS, V181, P153, DOI 10.1534/genetics.108.096891; Harris G, 2010, J NEUROSCI, V30, P7889, DOI 10.1523/JNEUROSCI.0497-10.2010; Harris GP, 2009, J NEUROSCI, V29, P1446, DOI 10.1523/JNEUROSCI.4585-08.2009; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Hokfelt T, 2000, NEUROPHARMACOLOGY, V39, P1337, DOI 10.1016/S0028-3908(00)00010-1; Hukema RK, 2008, LEARN MEMORY, V15, P829, DOI 10.1101/lm.994408; Julliard AK, 2007, BEHAV BRAIN RES, V183, P123, DOI 10.1016/j.bbr.2007.05.033; Kindt KS, 2002, CURR BIOL, V12, P1738, DOI 10.1016/S0960-9822(02)01199-5; KRAMER JM, 1990, MOL CELL BIOL, V10, P2081, DOI 10.1128/MCB.10.5.2081; Liang B, 2006, CELL METAB, V4, P429, DOI 10.1016/j.cmet.2006.11.004; Mello C, 1995, METHOD CELL BIOL, V48, P451; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; Petzold GC, 2009, NAT NEUROSCI, V12, P784, DOI 10.1038/nn.2335; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Prud'homme MJ, 2009, NEUROSCIENCE, V162, P1287, DOI 10.1016/j.neuroscience.2009.05.043; Ranganathan R, 2000, NATURE, V408, P470, DOI 10.1038/35044083; Ranganathan R, 2001, J NEUROSCI, V21, P5871, DOI 10.1523/JNEUROSCI.21-16-05871.2001; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Sagasti A, 1999, GENE DEV, V13, P1794, DOI 10.1101/gad.13.14.1794; Savigner A, 2009, J NEUROPHYSIOL, V101, P2898, DOI 10.1152/jn.91169.2008; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Sze JY, 2002, DEVELOPMENT, V129, P3901; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024; Torayama I, 2007, J NEUROSCI, V27, P741, DOI 10.1523/JNEUROSCI.4312-06.2007; Trudeau LE, 2004, J PSYCHIATR NEUROSCI, V29, P296; Tsalik EL, 2003, J NEUROBIOL, V56, P178, DOI 10.1002/neu.10245; Wakabayashi T, 2004, NEUROSCI RES, V50, P103, DOI 10.1016/j.neures.2004.06.005; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wragg RT, 2007, J NEUROSCI, V27, P13402, DOI 10.1523/JNEUROSCI.3495-07.2007; Wu Q, 2005, NAT NEUROSCI, V8, P1350, DOI 10.1038/nn1540; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	54	34	38	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e21897	10.1371/journal.pone.0021897	http://dx.doi.org/10.1371/journal.pone.0021897			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21814562	Green Published, gold, Green Submitted			2022-12-25	WOS:000292956800015
J	Rogoll, D; Schauber, J; Mheta, KK; Stich, A; Scheppach, W				Rogoll, Dorothee; Schauber, Juergen; Mheta, Koy K.; Stich, August; Scheppach, Wolfgang			Differential Cathelicidin Expression in Duodenal and Gastric Biopsies from Tanzanian and German Patients	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; HELICOBACTER-PYLORI; CROHNS-DISEASE; LL-37; TRANSCRIPTION; DEFENSINS; REGULATOR; MECHANISM; PEPTIDES; CELLS	Background: Epithelial surfaces such as the gastrointestinal mucosa depend on expression of antimicrobial peptides like cathelicidin for immune defence against pathogens. The mechanisms behind mucosal cathelicidin regulation are incompletely understood. Methods: Cathelicidin expression was analysed in duodenal, antral and corpus/fundic mucosal biopsies from African and German patients. Additionally, cathelicidin expression was correlated with Helicobacter pylori (HP) infection and the inflammatory status of the mucosa. Results: High cathelicidin transcript abundance was detected in duodenal biopsies from African subjects. On the contrary, cathelicidin mRNA expression was either undetectable or very low in tissue specimens from German patients. Also, in the antrum and corpus/fundus regions of the stomach significantly higher cathelicidin transcript levels were measured in Tanzanian compared to German patients. In gastric biopsies from African patients cathelicidin expression was increased in HP positive compared to HP negative subjects. Additionally, the inflammatory status measured by IL-8 expression correlated well with the HP infection status. Conclusions: A higher duodenal and gastric cathelicidin expression in African (compared with European) individuals may be due to upregulation by antigenic stimulation and may confer a higher resistance against enteric infections.	[Rogoll, Dorothee; Scheppach, Wolfgang] Univ Wurzburg, Dept Med 2, Wurzburg, Germany; [Schauber, Juergen] Univ Munich, Dept Dermatol, D-8000 Munich, Germany; [Mheta, Koy K.] Bugando Med Ctr, Mwanza, Tanzania; [Stich, August] Med Mission Hosp, Dept Trop Med, Wurzburg, Germany; [Scheppach, Wolfgang] Juliusspital Wuerzburg, Wurzburg, Germany	University of Wurzburg; University of Munich; University of Wurzburg	Rogoll, D (corresponding author), Univ Wurzburg, Dept Med 2, Wurzburg, Germany.	stuebs_d@medizin.uni-wuerzburg.de						Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Gudmundsson GH, 1999, J IMMUNOL METHODS, V232, P45, DOI 10.1016/S0022-1759(99)00152-0; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Hase K, 2003, GASTROENTEROLOGY, V125, P1613, DOI 10.1053/j.gastro.2003.08.028; Iimura M, 2005, J IMMUNOL, V174, P4901, DOI 10.4049/jimmunol.174.8.4901; Islam D, 2001, NAT MED, V7, P180, DOI 10.1038/84627; Johansson J, 1998, J BIOL CHEM, V273, P3718, DOI 10.1074/jbc.273.6.3718; Kelly P, 2006, J INFECT DIS, V193, P1464, DOI 10.1086/503747; LESZCZYNSKA K, 2009, BACTERIAL ACTIVITIES; Pflock M, 2007, J BACTERIOL, V189, P2339, DOI 10.1128/JB.01827-06; Raqib R, 2006, P NATL ACAD SCI USA, V103, P9178, DOI 10.1073/pnas.0602888103; Rosenberger CM, 2004, P NATL ACAD SCI USA, V101, P2422, DOI 10.1073/pnas.0304455101; Schauber J, 2004, MOL IMMUNOL, V41, P847, DOI 10.1016/j.molimm.2004.05.005; Schauber J, 2003, GUT, V52, P735, DOI 10.1136/gut.52.5.735; Schauber J, 2006, IMMUNOLOGY, V118, P509, DOI 10.1111/j.1365-2567.2006.02399.x; SCHEPPACH W, 1994, GUT, V35, pS35, DOI 10.1136/gut.35.1_Suppl.S35; Stolzenberg ED, 1997, P NATL ACAD SCI USA, V94, P8686, DOI 10.1073/pnas.94.16.8686; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Wehkamp J, 2003, INFLAMM BOWEL DIS, V9, P215, DOI 10.1097/00054725-200307000-00001	19	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22049	10.1371/journal.pone.0022049	http://dx.doi.org/10.1371/journal.pone.0022049			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21811558	Green Published, gold, Green Submitted			2022-12-25	WOS:000292929500033
J	Zhang, TY; Zhou, QX; Pignoni, F				Zhang, Tianyi; Zhou, Qingxiang; Pignoni, Francesca			Yki/YAP, Sd/TEAD and Hth/MEIS Control Tissue Specification in the Drosophila Eye Disc Epithelium	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PATHWAY; STEM-CELL PROLIFERATION; ORGAN SIZE; HIPPO PATHWAY; MORPHOGENETIC FURROW; TEAD/TEF FAMILY; GENETIC-CONTROL; ABSENT GENE; GROWTH; HOMOTHORAX	During animal development, accurate control of tissue specification and growth are critical to generate organisms of reproducible shape and size. The eye-antennal disc epithelium of Drosophila is a powerful model system to identify the signaling pathway and transcription factors that mediate and coordinate these processes. We show here that the Yorkie (Yki) pathway plays a major role in tissue specification within the developing fly eye disc epithelium at a time when organ primordia and regional identity domains are specified. RNAi-mediated inactivation of Yki, or its partner Scalloped (Sd), or increased activity of the upstream negative regulators of Yki cause a dramatic reorganization of the eye disc fate map leading to specification of the entire disc epithelium into retina. On the contrary, constitutive expression of Yki suppresses eye formation in a Sd-dependent fashion. We also show that knockdown of the transcription factor Homothorax (Hth), known to partner Yki in some developmental contexts, also induces an ectopic retina domain, that Yki and Scalloped regulate Hth expression, and that the gain-of-function activity of Yki is partially dependent on Hth. Our results support a critical role for Yki- and its partners Sd and Hth - in shaping the fate map of the eye epithelium independently of its universal role as a regulator of proliferation and survival.	[Zhang, Tianyi; Zhou, Qingxiang; Pignoni, Francesca] SUNY Upstate Med Univ, Dept Ophthalmol, Ctr Vis Res, Syracuse, NY USA; [Zhang, Tianyi; Zhou, Qingxiang; Pignoni, Francesca] SUNY Upstate Med Univ, SUNY Eye Inst, Syracuse, NY USA; [Pignoni, Francesca] SUNY Upstate Med Univ, Dept Biochem Mol Biol, Syracuse, NY USA; [Pignoni, Francesca] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Zhang, TY (corresponding author), SUNY Upstate Med Univ, Dept Ophthalmol, Ctr Vis Res, Syracuse, NY USA.	pignonif@upstate.edu			National Institutes of Health (NIH) [R01EY13167]; NATIONAL EYE INSTITUTE [R01EY013167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084947] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by the National Institutes of Health (NIH) grant R01EY13167 to FP, a Research to Prevent Blindness (RPB) Unrestricted Grant to the Department of Ophthalmology, SUNY Upstate Medical University, and the Lions District 20-Y1 of Central New York. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Atkins M, 2009, DEV DYNAM, V238, P2139, DOI 10.1002/dvdy.22034; Badouel C, 2009, CURR OPIN CELL BIOL, V21, P837, DOI 10.1016/j.ceb.2009.09.010; Baker NE, 2007, CURR OPIN GENET DEV, V17, P287, DOI 10.1016/j.gde.2007.05.005; Bessa J, 2005, DEVELOPMENT, V132, P5011, DOI 10.1242/dev.02082; Bessa J, 2002, GENE DEV, V16, P2415, DOI 10.1101/gad.1009002; BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; Bonini NM, 1997, DEVELOPMENT, V124, P4819; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brockmann A, 2011, DEV DYNAM, V240, P75, DOI 10.1002/dvdy.22494; Camargo FD, 2007, CURR BIOL, V17, P2094, DOI 10.1016/j.cub.2007.11.016; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Casares F, 1998, NATURE, V392, P723, DOI 10.1038/33706; Chanut F, 1997, DEVELOPMENT, V124, P559; Chen R, 1999, DEVELOPMENT, V126, P935; Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; Curtiss J, 2000, DEVELOPMENT, V127, P1325; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Emoto K, 2006, NATURE, V443, P210, DOI 10.1038/nature05090; Feng YQ, 2007, P NATL ACAD SCI USA, V104, P20362, DOI 10.1073/pnas.0706722105; Fernandez A, 2009, GENE DEV, V23, P2729, DOI 10.1101/gad.1824509; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Halder G, 1998, DEVELOPMENT, V125, P2181; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Hazelett DJ, 1998, DEVELOPMENT, V125, P3741; Ho LL, 2010, DEV BIOL, V337, P274, DOI 10.1016/j.ydbio.2009.10.042; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Ito K, 1997, DEVELOPMENT, V124, P761; Kango-Singh M, 2009, DEV DYNAM, V238, P1627, DOI 10.1002/dvdy.21996; Karpowicz P, 2010, DEVELOPMENT, V137, P4135, DOI 10.1242/dev.060483; Kenyon KL, 2003, DEV CELL, V5, P403, DOI 10.1016/S1534-5807(03)00243-0; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lopes CS, 2010, DEV BIOL, V339, P78, DOI 10.1016/j.ydbio.2009.12.020; MCGUIRE SE, 2004, SCI STKE ELECT RESOU; Mikeladze-Dvali T, 2005, CELL, V122, P775, DOI 10.1016/j.cell.2005.07.026; Newsome TP, 2000, DEVELOPMENT, V127, P851; Ni JQ, 2009, GENETICS, V182, P1089, DOI 10.1534/genetics.109.103630; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Pai CY, 1998, GENE DEV, V12, P435, DOI 10.1101/gad.12.3.435; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Pappu KS, 2004, INT J DEV BIOL, V48, P913, DOI 10.1387/ijdb.041875kp; Peng HW, 2009, GENE DEV, V23, P2307, DOI 10.1101/gad.1820009; Pichaud F, 2000, MECH DEVELOP, V96, P15, DOI 10.1016/S0925-4773(00)00372-5; Pignoni F, 1997, DEVELOPMENT, V124, P271; Reddy BVVG, 2008, DEVELOPMENT, V135, P2827, DOI 10.1242/dev.020974; Ren FF, 2010, P NATL ACAD SCI USA, V107, P21064, DOI 10.1073/pnas.1012759107; Shaw RL, 2010, DEVELOPMENT, V137, P4147, DOI 10.1242/dev.052506; Silver SJ, 2005, DEVELOPMENT, V132, P3, DOI 10.1242/dev.01539; Singh A, 2003, DEVELOPMENT, V130, P6351, DOI 10.1242/dev.00864; Staley BK, 2010, CURR BIOL, V20, P1580, DOI 10.1016/j.cub.2010.07.041; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Zecca M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000386; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	59	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22278	10.1371/journal.pone.0022278	http://dx.doi.org/10.1371/journal.pone.0022278			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794VN	21811580	Green Submitted, Green Published, gold			2022-12-25	WOS:000292929500049
J	Nicolas, MJ; Lopez-Azcarate, J; Valencia, M; Alegre, M; Perez-Alcazar, M; Iriarte, J; Artieda, J				Jesus Nicolas, Maria; Lopez-Azcarate, Jon; Valencia, Miguel; Alegre, Manuel; Perez-Alcazar, Marta; Iriarte, Jorge; Artieda, Julio			Ketamine-Induced Oscillations in the Motor Circuit of the Rat Basal Ganglia	PLOS ONE			English	Article							HIGH-FREQUENCY OSCILLATIONS; SUBTHALAMIC NUCLEUS; GAMMA-ACTIVITY; GREATER-THAN-200 HZ; SCHIZOPHRENIA; SYNCHRONY; PATHOPHYSIOLOGY; COHERENCY; RESPONSES; MOVEMENT	Oscillatory activity can be widely recorded in the cortex and basal ganglia. This activity may play a role not only in the physiology of movement, perception and cognition, but also in the pathophysiology of psychiatric and neurological diseases like schizophrenia or Parkinson's disease. Ketamine administration has been shown to cause an increase in gamma activity in cortical and subcortical structures, and an increase in 150 Hz oscillations in the nucleus accumbens in healthy rats, together with hyperlocomotion. We recorded local field potentials from motor cortex, caudate-putamen (CPU), substantia nigra pars reticulata (SNr) and subthalamic nucleus (STN) in 20 awake rats before and after the administration of ketamine at three different subanesthetic doses (10, 25 and 50 mg/Kg), and saline as control condition. Motor behavior was semiautomatically quantified by custom-made software specifically developed for this setting. Ketamine induced coherent oscillations in low gamma (similar to 50 Hz), high gamma (similar to 80 Hz) and high frequency (HFO, similar to 150 Hz) bands, with different behavior in the four structures studied. While oscillatory activity at these three peaks was widespread across all structures, interactions showed a different pattern for each frequency band. Imaginary coherence at 150 Hz was maximum between motor cortex and the different basal ganglia nuclei, while low gamma coherence connected motor cortex with CPU and high gamma coherence was more constrained to the basal ganglia nuclei. Power at three bands correlated with the motor activity of the animal, but only coherence values in the HFO and high gamma range correlated with movement. Interactions in the low gamma band did not show a direct relationship to movement. These results suggest that the motor effects of ketamine administration may be primarily mediated by the induction of coherent widespread high-frequency activity in the motor circuit of the basal ganglia, together with a frequency-specific pattern of connectivity among the structures analyzed.	[Jesus Nicolas, Maria; Lopez-Azcarate, Jon; Valencia, Miguel; Alegre, Manuel; Perez-Alcazar, Marta; Iriarte, Jorge; Artieda, Julio] Univ Navarra, CIMA, Neurosci Area, Neurophysiol Lab, E-31080 Pamplona, Spain; [Alegre, Manuel; Iriarte, Jorge; Artieda, Julio] Univ Navarra Clin, Clin Neurophysiol Sect, Pamplona, Spain	University of Navarra; University of Navarra	Nicolas, MJ (corresponding author), Univ Navarra, CIMA, Neurosci Area, Neurophysiol Lab, E-31080 Pamplona, Spain.	jartieda@unav.es	Alegre, Manuel/F-5379-2011; Artieda, Julio/L-4704-2014; Nicolás, María Jesús/ABF-9556-2021; Valencia, Miguel/C-3055-2009	Alegre, Manuel/0000-0003-4985-9724; Artieda, Julio/0000-0003-0987-0873; Valencia, Miguel/0000-0001-5617-5270; Nicolas, Maria Jesus/0000-0003-3714-3382	Fondo de Investigaciones Sanitarias (FIS) [070034]; UTE Proyecto CIMA; Spanish Ministry of Science and Innovation [JCI-2010-07876]	Fondo de Investigaciones Sanitarias (FIS)(Instituto de Salud Carlos III); UTE Proyecto CIMA; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work has been supported by a grant by the Fondo de Investigaciones Sanitarias (FIS 070034) and by the UTE Proyecto CIMA. Miguel Valencia Ustarroz acknowledges financial support from the Spanish Ministry of Science and Innovation, Juan de la Cierva Programme Ref. JCI-2010-07876. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler CM, 1999, AM J PSYCHIAT, V156, P1646, DOI 10.1176/ajp.156.10.1646; Adrian ED, 1935, J PHYSIOL-LONDON, V83; Alegre M, 2010, CLIN NEUROPHYSIOL, V121, P414, DOI 10.1016/j.clinph.2009.11.013; ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; Berke JD, 2009, EUR J NEUROSCI, V30, P848, DOI 10.1111/j.1460-9568.2009.06843.x; Brown P, 2003, MOVEMENT DISORD, V18, P357, DOI 10.1002/mds.10358; Brown P, 2001, J NEUROSCI, V21, P1033, DOI 10.1523/JNEUROSCI.21-03-01033.2001; Brown P, 2002, EXP NEUROL, V177, P581, DOI 10.1006/exnr.2002.7984; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Cassidy M, 2002, BRAIN, V125, P1235, DOI 10.1093/brain/awf135; Cheron G, 2005, NEUROSCIENCE, V130, P631, DOI 10.1016/j.neuroscience.2004.09.013; Cho RY, 2006, P NATL ACAD SCI USA, V103, P19878, DOI 10.1073/pnas.0609440103; Danish SF, 2007, BRAIN RES BULL, V74, P84, DOI 10.1016/j.brainresbull.2007.05.006; Ehrlichman RS, 2009, NEUROSCIENCE, V158, P705, DOI 10.1016/j.neuroscience.2008.10.031; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; FEIN G, 1988, ELECTROEN CLIN NEURO, V69, P581, DOI 10.1016/0013-4694(88)90171-X; Florian G, 1998, ELECTROEN CLIN NEURO, V106, P87, DOI 10.1016/S0013-4694(97)00105-3; Foffani G, 2003, BRAIN, V126, P2153, DOI 10.1093/brain/awg229; Gobbele R, 1998, EVOKED POTENTIAL, V108, P182, DOI 10.1016/S0168-5597(97)00100-7; Greenamyre JT, 2001, CLIN NEUROPHARMACOL, V24, P65, DOI 10.1097/00002826-200103000-00001; Gurtubay IG, 2006, EXP BRAIN RES, V175, P463, DOI 10.1007/s00221-006-0561-0; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Haig AR, 2000, CLIN NEUROPHYSIOL, V111, P1461, DOI 10.1016/S1388-2457(00)00347-3; Hakami T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006755; Hunt MJ, 2011, J PSYCHOPHARMACOL, V25, P808, DOI 10.1177/0269881110362126; Hunt MJ, 2006, BIOL PSYCHIAT, V60, P1206, DOI 10.1016/j.biopsych.2006.01.020; Jones MS, 1999, J NEUROPHYSIOL, V82, P1599, DOI 10.1152/jn.1999.82.3.1599; Kempf F, 2009, EUR J NEUROSCI, V29, P943, DOI 10.1111/j.1460-9568.2009.06655.x; Kissler J, 2000, CLIN NEUROPHYSIOL, V111, P2079, DOI 10.1016/S1388-2457(00)00425-9; KITA H, 1992, BRAIN RES, V589, P84, DOI 10.1016/0006-8993(92)91164-A; Lalo E, 2008, J NEUROSCI, V28, P3008, DOI 10.1523/JNEUROSCI.5295-07.2008; Lazarewicz MT, 2010, J COGNITIVE NEUROSCI, V22, P1452, DOI 10.1162/jocn.2009.21305; Levy R, 2000, J NEUROSCI, V20, P7766; Light GA, 2006, BIOL PSYCHIAT, V60, P1231, DOI 10.1016/j.biopsych.2006.03.055; Lopez-Azcarate J, 2010, J NEUROSCI, V30, P6667, DOI 10.1523/JNEUROSCI.5459-09.2010; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Nunez PL, 1999, CLIN NEUROPHYSIOL, V110, P469, DOI 10.1016/S1388-2457(98)00043-1; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; Olney JW, 1999, J PSYCHIAT RES, V33, P523, DOI 10.1016/S0022-3956(99)00029-1; PARENT A, 1995, BRAIN RES REV, V20, P128, DOI 10.1016/0165-0173(94)00008-D; Pinault D, 2008, BIOL PSYCHIAT, V63, P730, DOI 10.1016/j.biopsych.2007.10.006; Ravenscroft P, 2000, J ANAT, V196, P577, DOI 10.1046/j.1469-7580.2000.19640577.x; SARVAS J, 1987, PHYS MED BIOL, V32, P11, DOI 10.1088/0031-9155/32/1/004; Spencer KM, 2003, J NEUROSCI, V23, P7407; Stinstra JG, 1998, MED BIOL ENG COMPUT, V36, P711, DOI 10.1007/BF02518873; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Tiesinga P, 2009, NEURON, V63, P727, DOI 10.1016/j.neuron.2009.09.009; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Uhlhaas PJ, 2008, SCHIZOPHRENIA BULL, V34, P927, DOI 10.1093/schbul/sbn062; Williams D, 2002, BRAIN, V125, P1558, DOI 10.1093/brain/awf156	52	50	51	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e21814	10.1371/journal.pone.0021814	http://dx.doi.org/10.1371/journal.pone.0021814			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829443	Green Published, gold			2022-12-25	WOS:000293286500003
J	Kugler, KG; Mueller, LAJ; Graber, A; Dehmer, M				Kugler, Karl G.; Mueller, Laurin A. J.; Graber, Armin; Dehmer, Matthias			Integrative Network Biology: Graph Prototyping for Co-Expression Cancer Networks	PLOS ONE			English	Article							PROSTATE-CANCER; R/BIOCONDUCTOR PACKAGE; PATHWAYS; ARCHIVE; GENES	Network-based analysis has been proven useful in biologically-oriented areas, e. g., to explore the dynamics and complexity of biological networks. Investigating a set of networks allows deriving general knowledge about the underlying topological and functional properties. The integrative analysis of networks typically combines networks from different studies that investigate the same or similar research questions. In order to perform an integrative analysis it is often necessary to compare the properties of matching edges across the data set. This identification of common edges is often burdensome and computational intensive. Here, we present an approach that is different from inferring a new network based on common features. Instead, we select one network as a graph prototype, which then represents a set of comparable network objects, as it has the least average distance to all other networks in the same set. We demonstrate the usefulness of the graph prototyping approach on a set of prostate cancer networks and a set of corresponding benign networks. We further show that the distances within the cancer group and the benign group are statistically different depending on the utilized distance measure.	[Kugler, Karl G.; Mueller, Laurin A. J.; Graber, Armin; Dehmer, Matthias] UMIT, Inst Bioinformat & Translat Res, Hall In Tirol, Austria		Kugler, KG (corresponding author), UMIT, Inst Bioinformat & Translat Res, Hall In Tirol, Austria.	matthias.dehmer@umit.at	Kugler, Karl G/B-8406-2015	Kugler, Karl G/0000-0003-2342-7472	Tiroler Zukunftsstiftung (TZS); Tiroler Wissenschaftsfonds; COMET Center ONCOTYROL; Federal Ministry for Transport Innovation and Technology (BMVIT); Federal Ministry of Economics and Labour/the Federal Ministry of Economy, Family and Youth (BMWA/BMWFJ); Styrian Business Promotion Agency (SFG)	Tiroler Zukunftsstiftung (TZS); Tiroler Wissenschaftsfonds; COMET Center ONCOTYROL; Federal Ministry for Transport Innovation and Technology (BMVIT); Federal Ministry of Economics and Labour/the Federal Ministry of Economy, Family and Youth (BMWA/BMWFJ); Styrian Business Promotion Agency (SFG)	This project was supported by the Tiroler Zukunftsstiftung and the Tiroler Wissenschaftsfonds. This work was also funded by the COMET Center ONCOTYROL and funded by the Federal Ministry for Transport Innovation and Technology (BMVIT) and the Federal Ministry of Economics and Labour/the Federal Ministry of Economy, Family and Youth (BMWA/BMWFJ), the Tiroler Zukunftsstiftung (TZS) and the State of Styria represented by the Styrian Business Promotion Agency (SFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Altay G, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-132; Barabasi AL, 2003, SCI AM, V288, P60, DOI 10.1038/scientificamerican0503-60; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bonchev D, 1983, INFORM THEORETIC IND; Bunke H., 2001, Advances in Pattern Recognition - ICAPR 2001. Second International Conference. Proceedings (Lecture Notes in Computer Science Vol.2013), P1; Bunke H, 2000, INT C PATT RECOG, P117, DOI 10.1109/ICPR.2000.906030; BUNKE H, 1983, B EATCS, V20, P35; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Cootes AP, 2007, J MOL BIOL, V369, P1126, DOI 10.1016/j.jmb.2007.03.013; Cover TM, 1991, ELEMENTS INFORM THEO; Crawford ED, 2009, UROLOGY, V73, P4, DOI 10.1016/j.urology.2009.03.001; Dehmer M, 2007, TATRA MT MATH PUBL, V36, P39; Dehmer M, 2008, APPL MATH COMPUT, V196, P221, DOI 10.1016/j.amc.2007.05.058; Dehmer M, 2009, J CHEM INF MODEL, V49, P1655, DOI 10.1021/ci900060x; Dickinson PJ, 2004, PATTERN ANAL APPL, V7, P243, DOI [10.1007/s10044-044-0222-5, 10.1007/s10044-004-0222-5]; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Emmert-Streib F, 2005, DMIN '05: PROCEEDINGS OF THE 2005 INTERNATIONAL CONFERENCE ON DATA MINING, P200; Emmert-Streib F, 2007, J COMPUT BIOL, V14, P961, DOI 10.1089/cmb.2007.0041; Emmert-Streib F, 2008, ANALYSIS OF MICROARRAY DATA: A NETWORK-BASED APPROACH, P285, DOI 10.1002/9783527622818.ch10; Emmert-Streib F, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-76; Emmert-Streib F, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-35; EmmertStreib F, 2008, ANALYSIS OF MICROARRAY DATA: A NETWORK-BASED APPROACH, P1; EMMERTSTREIB F, 2011, NETWORKS SYSTEMS BIO; Erler JT, 2010, J PATHOL, V220, P290, DOI 10.1002/path.2646; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goble C, 2008, J BIOMED INFORM, V41, P687, DOI 10.1016/j.jbi.2008.01.008; Guzman-Vargas L, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-13; Jupiter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001717; KEPES F, 2008, BIOL NETWORKS COMPLE, P83; Kholodenko BN, 2009, FEBS LETT, V583, P4006, DOI 10.1016/j.febslet.2009.09.045; Kreeger PK, 2010, CARCINOGENESIS, V31, P2, DOI 10.1093/carcin/bgp261; Kuchaiev O, 2010, J R SOC INTERFACE, V7, P1341, DOI 10.1098/rsif.2010.0063; KUGLER KG, 2010, INT C BIOINF COMP BI, V1, P62; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Mehler A., 2005, LNCS; Meyer P., 2010, BIOCOMP, P700; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Michoel T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-49; Minnhagen P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001690; MOWSHOWITZ A, 1968, B MATH BIOPHYS, V30, P175, DOI 10.1007/BF02476948; MUELLER LA, 2010, INT C BIOINF COMP BI, V1, P55; Mueller LAJ, 2011, BIOINFORMATICS, V27, P140, DOI 10.1093/bioinformatics/btq606; Muller-Linow M, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-44; Opgen-Rhein R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-37; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Piruzian E, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-41; Przulj N, 2007, BIOINFORMATICS, V23, pE177, DOI 10.1093/bioinformatics/btl301; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Ruan JH, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-8; Schramm G, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-162; Semple C., 2003, GRADUATE SERIES MATH; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Skorobogatov VA, 1988, MATCH-COMMUN MATH CO, V23, P105; Sobik F, 1986, ZKI INFORM AKAD WISS, V4, P104; Sokolsky O, 2006, LECT NOTES COMPUT SC, V3920, P426; Strohman R, 2002, SCIENCE, V296, P701, DOI 10.1126/science.1070534; Tsavachidou D, 2009, JNCI-J NATL CANCER I, V101, P306, DOI 10.1093/jnci/djn512; Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608; Wang K, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000616; Wang L, 2009, CANCER RES, V69, P9490, DOI 10.1158/0008-5472.CAN-09-2183; Wang YP, 2010, CANCER RES, V70, P6448, DOI 10.1158/0008-5472.CAN-10-0021; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wiles AM, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-36; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	68	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e22843	10.1371/journal.pone.0022843	http://dx.doi.org/10.1371/journal.pone.0022843			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829532	Green Submitted, Green Published, gold			2022-12-25	WOS:000293286500037
J	Lee, SY; Yoon, J; Lee, HS; Hwang, YS; Cha, SW; Jeong, CH; Kim, JI; Park, JB; Lee, JY; Kim, S; Park, MJ; Dong, ZG; Kim, J				Lee, Sung-Young; Yoon, Jaeho; Lee, Hyun-Shik; Hwang, Yoo-Seok; Cha, Sang-Wook; Jeong, Chul-Ho; Kim, Jong-Il; Park, Jae-Bong; Lee, Jae-Yong; Kim, SungChan; Park, Mae Ja; Dong, Zigang; Kim, Jaebong			The Function of Heterodimeric AP-1 Comprised of c-Jun and c-Fos in Activin Mediated Spemann Organizer Gene Expression	PLOS ONE			English	Article							EARLY XENOPUS DEVELOPMENT; FIBROBLAST-GROWTH-FACTOR; MESODERM INDUCTION; CELL-PROLIFERATION; TGF-BETA; EMBRYOS; FGF; BMP-4; TUMORIGENESIS; SPECIFICATION	Background: Activator protein-1 (AP-1) is a mediator of BMP or FGF signaling during Xenopus embryogenesis. However, specific role of AP-1 in activin signaling has not been elucidated during vertebrate development. Methodology/Principal Findings: We provide new evidence showing that overexpression of heterodimeric AP-1 comprised of c-jun and c-fos (AP-1(c-Jun/c-Fos)) induces the expression of BMP-antagonizing organizer genes (noggin, chordin and goosecoid) that were normally expressed by high dose of activin. AP-1(c-Jun/c-Fos) enhanced the promoter activities of organizer genes but reduced that of PV.1, a BMP4-response gene. A loss of function study clearly demonstrated that AP-1(c-Jun/c-Fos) is required for the activin-induced organizer and neural gene expression. Moreover, physical interaction of AP-1(c-Jun/c-Fos) and Smad3 cooperatively enhanced the transcriptional activity of goosecoid via direct binding on this promoter. Interestingly, Smad3 mutants at c-Jun binding site failed in regulation of organizer genes, indicating that these physical interactions are specifically necessary for the expression of organizer genes. Conclusions/Significance: AP-1(c-Jun/c-Fos) plays a specific role in organizer gene expression in downstream of activin signal during early Xenopus embryogenesis.	[Lee, Sung-Young; Yoon, Jaeho; Lee, Hyun-Shik; Kim, Jong-Il; Park, Jae-Bong; Lee, Jae-Yong; Kim, SungChan; Kim, Jaebong] Hallym Univ, Coll Med, Dept Biochem, Chunchon, Kangwon Do, South Korea; [Lee, Sung-Young; Jeong, Chul-Ho; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Hwang, Yoo-Seok; Cha, Sang-Wook; Park, Mae Ja] Kyungpook Natl Univ, Sch Med, Dept Anat, Taegu, South Korea; [Lee, Hyun-Shik] Kyungpook Natl Univ, Coll Nat Sci, Sch Life Sci, Taegu, South Korea; [Jeong, Chul-Ho] Keimyung Univ, Coll Pharm, Taegu, South Korea	Hallym University; University of Minnesota System; Kyungpook National University; Kyungpook National University; Keimyung University	Lee, SY (corresponding author), Hallym Univ, Coll Med, Dept Biochem, Chunchon, Kangwon Do, South Korea.	jbkim@hallym.ac.kr	Lee, Hyun-Shik/G-3555-2011; Cha, Sang-Wook/D-3523-2016; KIM, JONG-IL/D-1019-2011; Kim, Jaebong/AAV-1986-2021	KIM, JONG-IL/0000-0002-7240-3744; Kim, Jaebong/0000-0003-1609-338X; Yoon, Jaeho/0000-0003-2730-8606	Ministry of Education, Science and Technology [KRF-2005-015-C00390, KRF-2005-070-C00115]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R13ES027302] Funding Source: NIH RePORTER	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (KRF-2005-015-C00390 and KRF-2005-070-C00115). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTABA AR, 1989, NATURE, V341, P33; AMAYA E, 1993, DEVELOPMENT, V118, P477; Ameyar M, 2003, BIOCHIMIE, V85, P747, DOI 10.1016/j.biochi.2003.09.006; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; ARIIZUMI T, 2009, CURR PROTOC STEM CEL, pCH1; CHO KWY, 1991, CELL, V67, P1111, DOI 10.1016/0092-8674(91)90288-A; CHRISTIAN JL, 1991, DEVELOPMENT, V111, P1045; Collart C, 2005, DEVELOPMENT, V132, P4575, DOI 10.1242/dev.02043; Dong ZG, 1996, J BIOL CHEM, V271, P9942, DOI 10.1074/jbc.271.17.9942; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Faure S, 2000, DEVELOPMENT, V127, P2917; GREEN JBA, 1990, NATURE, V347, P391, DOI 10.1038/347391a0; GREEN JBA, 1990, DEVELOPMENT, V108, P173; Grimm OH, 2002, NAT CELL BIOL, V4, P519, DOI 10.1038/ncb812; HEMMATIBRIVANLOU A, 1992, NATURE, V359, P609, DOI 10.1038/359609a0; Howell M, 2001, MECH DEVELOP, V104, P147, DOI 10.1016/S0925-4773(01)00365-3; ISAACS HV, 1992, DEVELOPMENT, V114, P711; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; KESSLER DS, 1994, SCIENCE, V266, P596, DOI 10.1126/science.7939714; Kim J, 1998, J BIOL CHEM, V273, P1542, DOI 10.1074/jbc.273.3.1542; Kim J, 1998, BIOCHEM BIOPH RES CO, V250, P516, DOI 10.1006/bbrc.1998.9280; KIMELMAN D, 1992, DEVELOPMENT, V116, P1; KIMELMAN D, 1987, CELL, V51, P869, DOI 10.1016/0092-8674(87)90110-3; Knochel S, 2000, MECH DEVELOP, V98, P29, DOI 10.1016/S0925-4773(00)00448-2; Messenger NJ, 2005, DEV CELL, V8, P599, DOI 10.1016/j.devcel.2005.03.001; Moore KB, 2004, DEV CELL, V6, P55, DOI 10.1016/S1534-5807(03)00395-2; Okabayashi K, 2003, CURR OPIN GENET DEV, V13, P502, DOI 10.1016/S0959-437X(03)00111-4; Qing J, 2000, J BIOL CHEM, V275, P38802, DOI 10.1074/jbc.M004731200; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; SLACK JMW, 1994, CURR BIOL, V4, P116, DOI 10.1016/S0960-9822(94)00027-8; SMITH JC, 1993, EMBO J, V12, P4463, DOI 10.1002/j.1460-2075.1993.tb06135.x; SMITH JC, 1983, J EMBRYOL EXP MORPH, V78, P299; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; Summerton J, 1997, ANTISENSE NUCLEIC A, V7, P187, DOI 10.1089/oli.1.1997.7.187; Tao QH, 1999, CELL RES, V9, P209, DOI 10.1038/sj.cr.7290019; VONDASSOW G, 1993, GENE DEV, V7, P355, DOI 10.1101/gad.7.3.355; Watabe T, 1995, GENE DEV, V9, P3038, DOI 10.1101/gad.9.24.3038; Weinstein M, 2000, CYTOKINE GROWTH F R, V11, P49, DOI 10.1016/S1359-6101(99)00028-3; Xu RH, 1996, P NATL ACAD SCI USA, V93, P834, DOI 10.1073/pnas.93.2.834	40	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e21796	10.1371/journal.pone.0021796	http://dx.doi.org/10.1371/journal.pone.0021796			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829441	Green Published, Green Submitted, gold			2022-12-25	WOS:000293286500002
J	Liang, Y				Liang, Yanhua			SHARPIN Negatively Associates with TRAF2-Mediated NF kappa B Activation	PLOS ONE			English	Article							CHRONIC PROLIFERATIVE DERMATITIS; PROTEIN UBIQUITINATION; IMMUNE-SYSTEM; SHANK FAMILY; MICE; APOPTOSIS; MOUSE; INFLAMMATION; MUTATIONS; DISEASE	NF kappa B is an inducible transcriptional factor controlled by two principal signaling cascades and plays pivotal roles in diverse physiological processes including inflammation, apoptosis, oncogenesis, immunity, and development. Activation of NF kappa B signaling was detected in skin of SHAPRIN-deficient mice and can be diminished by an NF kappa B inhibitor. However, in vitro studies demonstrated that SHARPIN activates NF kappa B signaling by forming a linear ubiquitin chain assembly complex with RNF31 (HOIP) and RBCK1 (HOIL1). The inconsistency between in vivo and in vitro findings about SHARPIN's function on NF kappa B activation could be partially due to SHARPIN's potential interactions with downstream molecules of NF kappa B pathway. In this study, 17 anti-flag immunoprecipitated proteins, including TRAF2, were identified by mass spectrum analysis among Sharpin-Flag transfected mouse fibroblasts, B lymphocytes, and BALB/c LN stroma 12 cells suggesting their interaction with SHARPIN. Interaction between SHARPIN and TRAF2 confirmed previous yeast two hybridization reports that SHARPIN was one TRAF2's partners. Furthermore, luciferase-based NF kappa B reporter assays demonstrated that SHARPIN negatively associates with NF kappa B activation, which can be partly compensated by over-expression of TRAF2. These data suggested that other than activating NF kappa B signaling by forming ubiquitin ligase complex with RNF31 and RBCK1, SHARPIN may also negatively associate with NF kappa B activation via interactions with other NF kappa B members, such as TRAF2.	Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA	Yale University	Liang, Y (corresponding author), Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA.	liangdoctor@163.com			Natural Science Foundation of China [30600358]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the Youth Funding of Natural Science Foundation of China (30600358). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa S, 1997, J BIOL CHEM, V272, P2042; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; Daigo Y, 2003, J GASTROEN HEPATOL, V18, P712, DOI 10.1046/j.1440-1746.2003.03046.x; DaSilva AJ, 1997, P NATL ACAD SCI USA, V94, P7493, DOI 10.1073/pnas.94.14.7493; Foo SY, 1999, TRENDS GENET, V15, P229; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; GIJBELS MJJ, 1995, ULTRASTRUCT PATHOL, V19, P107, DOI 10.3109/01913129509014610; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Groth A, 2000, J BIOL CHEM, V275, P27473; HOGENESCH H, 1993, AM J PATHOL, V143, P972; HogenEsch H, 1999, J IMMUNOL, V162, P3890; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Jung J, 2010, MOL CELL BIOCHEM, V340, P161, DOI 10.1007/s11010-010-0413-x; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Liang Y., 2011, PATHOLOG RES INT; LIANG Y, 2011, J DERMATOL SCI; Liang YH, 2011, J INVEST DERMATOL, V131, P141, DOI 10.1038/jid.2010.259; Lim S, 2001, MOL CELL NEUROSCI, V17, P385, DOI 10.1006/mcne.2000.0940; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Melo EO, 2005, GENET MOL RES, V4, P812; Norberg E, 2010, BIOCHEM BIOPH RES CO, V396, P95, DOI 10.1016/j.bbrc.2010.02.163; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Seymour R, 2006, VET PATHOL, V43, P401, DOI 10.1354/vp.43-4-401; Seymour RE, 2007, GENES IMMUN, V8, P416, DOI 10.1038/sj.gene.6364403; Sheng M, 2000, J CELL SCI, V113, P1851; Srivastava R, 2010, J BIOL CHEM, V285, P11100, DOI 10.1074/jbc.M109.068999; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Torres HIG, 1995, PATHOBIOLOGY, V63, P341; Xia TA, 2011, ENDOCRINE, V39, P104, DOI 10.1007/s12020-010-9418-1	34	10	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e21696	10.1371/journal.pone.0021696	http://dx.doi.org/10.1371/journal.pone.0021696			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829440	Green Published, Green Submitted, gold			2022-12-25	WOS:000293286500001
J	Srikanta, D; Yang, M; Williams, M; Doering, TL				Srikanta, Deepa; Yang, Meng; Williams, Matthew; Doering, Tamara L.			A Sensitive High-Throughput Assay for Evaluating Host-Pathogen Interactions in Cryptococcus neoformans Infection	PLOS ONE			English	Article							LEUKEMIA-CELL LINE; MACROPHAGE DIFFERENTIATION; INTRACELLULAR PARASITISM; CAENORHABDITIS-ELEGANS; QUANTITATIVE-ANALYSIS; MONONUCLEAR-CELLS; SCREENING ASSAYS; GENE-EXPRESSION; HIT SELECTION; PHAGOCYTOSIS	Background: Cryptococcus neoformans causes serious disease in immunocompromised individuals, leading to over 600,000 deaths per year worldwide. Part of this impact is due to the organism's ability to thwart what should be the mammalian hosts' first line of defense against cryptococcal infection: internalization by macrophages. Even when C. neoformans is engulfed by host phagocytes, it can survive and replicate within them rather than being destroyed; this ability is central in cryptococcal virulence. It is therefore critical to elucidate the interactions of this facultative intracellular pathogen with phagocytic cells of its mammalian host. Methodology/Principal Findings: To accurately assess initial interactions between human phagocytic cells and fungi, we have developed a method using high-throughput microscopy to efficiently distinguish adherent and engulfed cryptococci and quantitate each population. This method offers significant advantages over currently available means of assaying host-fungal cell interactions, and remains statistically robust when implemented in an automated fashion appropriate for screening. It was used to demonstrate the sensitivity of human phagocytes to subtle changes in the cryptococcal capsule, a major virulence factor of this pathogen. Conclusions/Significance: Our high-throughput method for characterizing interactions between C. neoformans and mammalian phagocytic cells offers a powerful tool for elucidating the relationship between these cell types during pathogenesis. This approach will be useful for screens of this organism and has potentially broad applications for investigating host-pathogen interactions.	[Srikanta, Deepa; Yang, Meng; Williams, Matthew; Doering, Tamara L.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Srikanta, D (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.	doering@borcim.wustl.edu			National Institutes of Health (NIH) [R21 AI082004, R01 AI078795, 5T32AI007172]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078795, R21AI082004, T32AI007172] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported by National Institutes of Health (NIH) grants R21 AI082004 and R01 AI078795 to TLD. DS is supported by NIH Training Grant 5T32AI007172. The funders (http://www.niaid.nih.gov/researchfunding/Pages/default.aspx) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez M, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-16; Alvarez M, 2006, CURR BIOL, V16, P2161, DOI 10.1016/j.cub.2006.09.061; Alvarez M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-51; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Bartlett Karen H, 2008, Curr Infect Dis Rep, V10, P58, DOI 10.1007/s11908-008-0011-1; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Boleti H, 2000, J MICROBIOL METH, V40, P265, DOI 10.1016/S0167-7012(00)00132-9; Bose I, 2003, EUKARYOT CELL, V2, P655, DOI 10.1128/EC.2.4.655-663.2003; BULMER GS, 1967, J BACTERIOL, V94, P1480, DOI 10.1128/JB.94.5.1480-1483.1967; Byrnes EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000850; Carruthers VB, 1999, CELL MICROBIOL, V1, P225, DOI 10.1046/j.1462-5822.1999.00023.x; CHAKA W, 1995, CLIN DIAGN LAB IMMUN, V2, P753, DOI 10.1128/CDLI.2.6.753-759.1995; Chayakulkeeree M, 2006, INFECT DIS CLIN N AM, V20, P507, DOI 10.1016/j.idc.2006.07.001; Cossart P, 2001, CURR OPIN IMMUNOL, V13, P96, DOI 10.1016/S0952-7915(00)00188-6; Cummings CA, 2000, EMERG INFECT DIS, V6, P513, DOI 10.3201/eid0605.000511; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Del Poeta M, 2004, EUKARYOT CELL, V3, P1067, DOI 10.1128/EC.3.5.1067-1075.2004; DIAMOND RD, 1973, INFECT IMMUN, V7, P231, DOI 10.1128/IAI.7.2.231-236.1973; DIAMOND RD, 1974, J IMMUNOL, V112, P2260; Doering TL, 2009, ANNU REV MICROBIOL, V63, P223, DOI 10.1146/annurev.micro.62.081307.162753; DROMER F, 1992, J MED VET MYCOL, V30, P395; Eisenman Helene C, 2007, Curr Infect Dis Rep, V9, P457, DOI 10.1007/s11908-007-0070-8; ELSINGHORST EA, 1994, METHOD ENZYMOL, V236, P405; FALKOW S, 1987, REV INFECT DIS, V9, pS450; Fan WH, 2005, EUKARYOT CELL, V4, P1420, DOI 10.1128/EC.4.8.1420-1433.2005; Feldmesser M, 2000, INFECT IMMUN, V68, P3642, DOI 10.1128/IAI.68.6.3642-3650.2000; Garcia-Hermoso D, 1999, J CLIN MICROBIOL, V37, P3204, DOI 10.1128/JCM.37.10.3204-3209.1999; Goldman DL, 2000, INFECT IMMUN, V68, P832, DOI 10.1128/IAI.68.2.832-838.2000; GRIFFIN FM, 1981, P NATL ACAD SCI-BIOL, V78, P3853, DOI 10.1073/pnas.78.6.3853; Hickman-Davis JM, 2001, AM J PHYSIOL-LUNG C, V281, pL517, DOI 10.1152/ajplung.2001.281.3.L517; Janbon G, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P27; Kohler S, 2002, P NATL ACAD SCI USA, V99, P15711, DOI 10.1073/pnas.232454299; KOZEL TR, 1988, REV INFECT DIS, V10, pS436; Kozel TR, 1996, CLIN MICROBIOL REV, V9, P34, DOI 10.1128/CMR.9.1.34; KOZEL TR, 1981, INFECT IMMUN, V31, P978, DOI 10.1128/IAI.31.3.978-984.1981; KOZEL TR, 1982, J IMMUNOL, V129, P1675; KOZEL TR, 1991, INFECT IMMUN, V59, P3101, DOI 10.1128/IAI.59.9.3101-3110.1991; Kurz CL, 2000, TRENDS MICROBIOL, V8, P142, DOI 10.1016/S0966-842X(99)01691-1; KWONCHUNG KJ, 1992, J MED VET MYCOL, V30, P133; Levitz SM, 1999, INFECT IMMUN, V67, P885, DOI 10.1128/IAI.67.2.885-890.1999; Ma HS, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-15; Ma HS, 2006, CURR BIOL, V16, P2156, DOI 10.1016/j.cub.2006.09.032; Ma HS, 2009, P NATL ACAD SCI USA, V106, P12980, DOI 10.1073/pnas.0902963106; MacGill TC, 2000, J IMMUNOL, V164, P4835, DOI 10.4049/jimmunol.164.9.4835; Mylonakis E, 2002, P NATL ACAD SCI USA, V99, P15675, DOI 10.1073/pnas.232568599; NILSSON K, 1974, INT J CANCER, V13, P808, DOI 10.1002/ijc.2910130609; Oliveira DL, 2010, INFECT IMMUN, V78, P1601, DOI 10.1128/IAI.01171-09; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Pierini LM, 2001, MOL MICROBIOL, V41, P105, DOI 10.1046/j.1365-2958.2001.02504.x; RALPH P, 1977, J IMMUNOL, V119, P950; Rogers PD, 2003, INFECT IMMUN, V71, P2087, DOI 10.1128/IAI.71.4.2087-2094.2003; Singh N, 2008, CLIN INFECT DIS, V47, P1321, DOI 10.1086/592690; SVEUM RJ, 1986, J IMMUNOL METHODS, V90, P257, DOI 10.1016/0022-1759(86)90083-9; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Tucker SC, 2002, P NATL ACAD SCI USA, V99, P3165, DOI 10.1073/pnas.052702799; Voelz K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015968; Voelz K, 2009, INFECT IMMUN, V77, P3450, DOI 10.1128/IAI.00297-09; Walenkamp AME, 2000, J MICROBIOL METH, V40, P39, DOI 10.1016/S0167-7012(99)00128-1; Zhang HY, 2005, P NATL ACAD SCI USA, V102, P2731, DOI 10.1073/pnas.0500023102; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang XD, 2007, J BIOMOL SCREEN, V12, P645, DOI 10.1177/1087057107300645; Zhang XD, 2007, J BIOMOL SCREEN, V12, P497, DOI 10.1177/1087057107300646	63	17	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e22773	10.1371/journal.pone.0022773	http://dx.doi.org/10.1371/journal.pone.0022773			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829509	gold, Green Published, Green Submitted			2022-12-25	WOS:000293284600043
J	Weiss, C; Herwig, A; Schutz-Bosbach, S				Weiss, Carmen; Herwig, Arvid; Schuetz-Bosbach, Simone			The Self in Social Interactions: Sensory Attenuation of Auditory Action Effects Is Stronger in Interactions with Others	PLOS ONE			English	Article							AWARENESS; ABNORMALITIES; PERCEPTION	The experience of oneself as an agent not only results from interactions with the inanimate environment, but often takes place in a social context. Interactions with other people have been suggested to play a key role in the construal of self-agency. Here, we investigated the influence of social interactions on sensory attenuation of action effects as a marker of pre-reflective self-agency. To this end, we compared the attenuation of the perceived loudness intensity of auditory action effects generated either by oneself or another person in either an individual, non-interactive or interactive action context. In line with previous research, the perceived loudness of self-generated sounds was attenuated compared to sounds generated by another person. Most importantly, this effect was strongly modulated by social interactions between self and other. Sensory attenuation of self-and other-generated sounds was increased in interactive as compared to the respective individual action contexts. This is the first experimental evidence suggesting that pre-reflective self-agency can extend to and is shaped by interactions between individuals.	[Weiss, Carmen; Schuetz-Bosbach, Simone] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Herwig, Arvid] Univ Bielefeld, Dept Psychol, Bielefeld, Germany	Max Planck Society; University of Bielefeld	Weiss, C (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	cweiss@cbs.mpg.de		Herwig, Arvid/0000-0002-5979-3004; Schutz-Bosbach, Simone/0000-0002-0937-9454	Max Planck Society; Volkswagen Foundation [Az. II/85 154]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Volkswagen Foundation(Volkswagen)	This work was supported by grants of Max Planck Society and Volkswagen Foundation (Az. II/85 154) to SS-B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken KJ, 1997, DEV PSYCHOPATHOL, V9, P653, DOI 10.1017/S0954579497001387; Blakemore SJ, 2002, TRENDS COGN SCI, V6, P237, DOI 10.1016/S1364-6613(02)01907-1; Blakemore SJ, 1999, J COGNITIVE NEUROSCI, V11, P551, DOI 10.1162/089892999563607; Cullen KE, 2004, CURR OPIN NEUROBIOL, V14, P698, DOI 10.1016/j.conb.2004.10.002; Frith CD, 2000, PHILOS T R SOC B, V355, P1771, DOI 10.1098/rstb.2000.0734; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Haggard P, 2009, CURR DIR PSYCHOL SCI, V18, P242, DOI 10.1111/j.1467-8721.2009.01644.x; Jeannerod M, 2003, BEHAV BRAIN RES, V142, P1, DOI 10.1016/S0166-4328(02)00384-4; Prinz W., 2008, EMBODIED COMMUNICATI, P111; Rochat P, 2010, NEUROPSYCHOLOGIA, V48, P738, DOI 10.1016/j.neuropsychologia.2009.11.021; Sato A, 2008, CONSCIOUS COGN, V17, P1219, DOI 10.1016/j.concog.2008.01.003; Shergill SS, 2003, SCIENCE, V301, P187, DOI 10.1126/science.1085327; SMITH A, 1759, GLASGOW EDITION WORK, P412; Synofzik M, 2009, CONSCIOUS COGN, V18, P1065, DOI 10.1016/j.concog.2009.07.007; Trevarthen C., 1993, PERCEIVED SELF ECOLO, P121, DOI [10.1017/CBO9780511664007.009, DOI 10.1017/CBO9780511664007.009]; Tsakiris M, 2003, EXP BRAIN RES, V149, P439, DOI 10.1007/s00221-003-1386-8; WEISS C, 2011, COGNITION IN PRESS; Wolpert DM, 2003, PHILOS T R SOC B, V358, P593, DOI 10.1098/rstb.2002.1238	18	44	44	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e22723	10.1371/journal.pone.0022723	http://dx.doi.org/10.1371/journal.pone.0022723			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	799JJ	21818373	Green Submitted, Green Published, gold			2022-12-25	WOS:000293282700066
J	Huber, S; Fieder, M				Huber, Susanne; Fieder, Martin			Educational Homogamy Lowers the Odds of Reproductive Failure	PLOS ONE			English	Article							MARITAL DISSOLUTION; MODERN SOCIETY; SUCCESS; PERSPECTIVE; SIMILARITY; MARRIAGES	Assortative mating based on education is a common phenomenon. We investigated whether it affected parameters of reproductive performance such as childlessness, offspring number and age at first marriage. On the basis of the US census from 1980 (n = 670,631 married US couples), we find that the proportion of childless individuals is usually minimal in women married to a husband of the same educational level. This holds particularly true in the highest and the lowest educated women. Educational homogamy is also associated with a lower average age at first marriage. No obvious effect of educational homogamy on a woman's average offspring number is found, where mean offspring number generally increases both with decreasing woman's and decreasing husband's educational attainment. We conclude that educational homogamy reduces the likelihood of reproductive failure.	[Huber, Susanne; Fieder, Martin] Univ Vienna, Dept Anthropol, Vienna, Austria; [Huber, Susanne] Univ Vet Med Vienna, Res Inst Wildlife Ecol, Vienna, Austria	University of Vienna; University of Veterinary Medicine Vienna	Huber, S (corresponding author), Univ Vienna, Dept Anthropol, Vienna, Austria.	susanne.huber@vetmeduni.ac.at						Bauer G, 2010, KOLNER Z SOZIOL SOZ, V62, P31, DOI 10.1007/s11577-010-0089-y; Becker Gary S., 1991, TREATISE FAMILY, DOI DOI 10.4159/9780674020665; BENTLER PM, 1978, J CONSULT CLIN PSYCH, V46, P1053, DOI 10.1037/0022-006X.46.5.1053; Bereczkei T, 1996, ETHOL SOCIOBIOL, V17, P17, DOI 10.1016/0162-3095(95)00104-2; BOUCHARD TJ, 1981, SCIENCE, V212, P1055, DOI 10.1126/science.7195071; BRYNIN M, 2008, 200832 ISER; Clarkwest A, 2007, J MARRIAGE FAM, V69, P639, DOI 10.1111/j.1741-3737.2007.00397.x; DRIBE M, 2010, ED ASSORTATIVE MATCH; EPSTEIN E, 1984, SOC BIOL, V31, P243; Fieder M, 2007, EVOL HUM BEHAV, V28, P392, DOI 10.1016/j.evolhumbehav.2007.05.004; HORNUNG CA, 1981, J MARRIAGE FAM, V43, P675, DOI 10.2307/351768; Kraft K., 2009, 4491 IZA; Lewis SK, 2000, DEMOGRAPHY, V37, P29, DOI 10.2307/2648094; Low BS, 2002, AM J HUM BIOL, V14, P149, DOI 10.1002/ajhb.10043; Lutz-Zois CJ, 2006, J SOC PERS RELAT, V23, P865, DOI 10.1177/0265407506068267; MARE RD, 1991, AM SOCIOL REV, V56, P15, DOI 10.2307/2095670; Mascie-taylor C G, 1986, Biol Soc, V3, P167; Mascie-Taylor C.G.N., 1988, HUMAN MATING PATTERN, P61; Nielsen HS, 2009, J HUM RESOUR, V44, P1066, DOI 10.1353/jhr.2009.0029; Penton-Voak IS, 1999, CURR PSYCHOL, V18, P104; Qian ZC, 1998, DEMOGRAPHY, V35, P279, DOI 10.2307/3004036; SCHWARTZ CR, 2010, ON LINE WORKING PAPE; Silventoinen K, 2003, AM J HUM BIOL, V15, P620, DOI 10.1002/ajhb.10183; Skirbekk V, 2004, DEMOGRAPHY, V41, P547, DOI 10.1353/dem.2004.0028; SPUHLER JN, 1982, SOC BIOL, V29, P53; THIESSEN D, 1980, ETHOL SOCIOBIOL, V1, P111, DOI 10.1016/0162-3095(80)90003-5; Tsou MW, 2011, BIOL LETTERS, V7, P562, DOI 10.1098/rsbl.2010.1208; WEISFELD GE, 1992, ETHOL SOCIOBIOL, V13, P125, DOI 10.1016/0162-3095(92)90022-V; Weiss Y, 1997, J LABOR ECON, V15, pS293, DOI 10.1086/209864	29	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e22330	10.1371/journal.pone.0022330	http://dx.doi.org/10.1371/journal.pone.0022330			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	798BE	21818310	Green Published, gold, Green Submitted			2022-12-25	WOS:000293175100020
J	Laiolo, P; Banuelos, MJ; Blanco-Fontao, B; Garcia, M; Gutierrez, G				Laiolo, Paola; Banuelos, Maria J.; Blanco-Fontao, Beatriz; Garcia, Monica; Gutierrez, Gloria			Mechanisms Underlying the Bioindicator Notion: Spatial Association between Individual Sexual Performance and Community Diversity	PLOS ONE			English	Article							CAPERCAILLIE TETRAO-UROGALLUS; CANTABRIAN CAPERCAILLIE; TOP PREDATORS; BIRD SONG; RED DEER; BIODIVERSITY; CONSERVATION; HABITAT; EVOLUTION; GROUSE	The bioindicator notion is an appealing concept that has received more support in applied than in basic ecology, mostly due to the difficulty in deriving general ecological rules applicable to all target organisms. However, recognizing the mechanisms that determine the association between a particular species and the well-being of many other species is important for understanding the functioning of ecosystems and the relationship among different biological levels. We examined here the processes at the individual level that cause an association between species performance and biodiversity value, by analyzing attributes that can be studied in a variety of animals with sexual reproduction, namely breeding site selection and condition-dependent sexual signals. Our study model was the Capercaillie, an indicator of forest functioning and diversity, and the associated bird community, used here as a surrogate of broader forest biodiversity. At a regional scale Capercaillie occurrence was not associated with the most diverse forest patches, but at the scale of male spring territories the sexual display grounds (arenas) were located in the oldest and less disturbed forest portions, which also hosted the richest local bird communities. Social mechanisms and conspecific cueing likely concurred with habitat-driven processes in determining the long-term persistence of traditional display grounds, which were appealing to many other species because of their structural composition. Characteristics of male vocal display that honestly advertize male quality (low frequencies and rapid song rates) were significantly correlated with high diversity values, resulting in a spatial association between individual and community performances. Costly or risky activities such as reproductive or social behaviors, which more than other attributes match gradients in habitat quality, are therefore contributing to functionally connect individuals with ecosystem health.	[Laiolo, Paola; Banuelos, Maria J.; Blanco-Fontao, Beatriz; Garcia, Monica; Gutierrez, Gloria] Univ Oviedo, Res Unit Biodivers CSIC UO PA, Oviedo, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Oviedo	Laiolo, P (corresponding author), Univ Oviedo, Res Unit Biodivers CSIC UO PA, Oviedo, Spain.	paola@ebd.csic.es	Laiolo, Paola/Q-3747-2019; Laiolo, Paola/B-6566-2014; /H-9916-2015	Laiolo, Paola/0000-0002-2009-6797; Laiolo, Paola/0000-0002-2009-6797; /0000-0002-8221-0487; Blanco Fontao, Beatriz/0000-0002-5492-2399	Spanish Ministry of Innovation and Science; FICYT [IB08-158, CGL2010-15990, CGL2008-02 749]	Spanish Ministry of Innovation and Science(Spanish Government); FICYT	This project was financially supported by the Spanish Ministry of Innovation and Science and FICYT, projects IB08-158, CGL2010-15990 (to MJB) and CGL2008-02 749 (to PL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JE, 1991, CONSERV BIOL, V5, P347, DOI 10.1111/j.1523-1739.1991.tb00148.x; [Anonymous], UROGALLO TETRAO UROG; Ballentine B, 2004, BEHAV ECOL, V15, P163, DOI 10.1093/beheco/arg090; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; Blanco-Fontao B, 2011, BIODIVERS CONSERV, V20, P1133, DOI 10.1007/s10531-011-0016-1; BROSE U, 2010, COMMUNITY ECOLOGY; Caro T. M, 2010, CONSERVATION PROXY I; Caro TM, 1999, CONSERV BIOL, V13, P805, DOI 10.1046/j.1523-1739.1999.98338.x; CLUTTONBROCK TH, 1979, BEHAVIOUR, V69, P145, DOI 10.1163/156853979X00449; Collins Sarah, 2004, P39, DOI 10.1016/B978-012473070-0/50005-0; de Greling C., 1971, Alauda, V39, P7; FUSANI L, 1994, BEHAVIOUR, V128, P301, DOI 10.1163/156853994X00307; GAUNT AS, 1987, BIRD RESPIRATION, V1, P71; GAVRIV V, 1964, BIRDS W PALEARCTIC I; Gibson RM, 1996, BEHAV ECOL SOCIOBIOL, V39, P55, DOI 10.1007/s002650050266; Gil D, 2002, TRENDS ECOL EVOL, V17, P133, DOI 10.1016/S0169-5347(02)02410-2; HANSEN AJ, 1991, BIOSCIENCE, V41, P382, DOI 10.2307/1311745; HJORTH L, 1970, VILTREVY, V7, P182; Johnson MTJ, 2007, TRENDS ECOL EVOL, V22, P250, DOI 10.1016/j.tree.2007.01.014; KREMEN C, 1992, ECOL APPL, V2, P203, DOI 10.2307/1941776; Kurki S, 2000, ECOLOGY, V81, P1985, DOI 10.1890/0012-9658(2000)081[1985:LFAFCE]2.0.CO;2; Laiolo P, 2008, ANIM CONSERV, V11, P433, DOI 10.1111/j.1469-1795.2008.00202.x; Laiolo P, 2005, J APPL ECOL, V42, P1183, DOI 10.1111/j.1365-2664.2005.01093.x; Laiolo P, 2004, BIODIVERS CONSERV, V13, P1925, DOI 10.1023/B:BIOC.0000035874.22210.8d; Laiolo P, 2004, ACTA OECOL, V25, P129, DOI 10.1016/j.actao.2003.12.003; Laiolo P, 2003, FOREST ECOL MANAG, V179, P441, DOI 10.1016/S0378-1127(02)00542-X; Laiolo P, 2011, P ROY SOC B-BIOL SCI, V278, P1072, DOI 10.1098/rspb.2010.1653; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Lieser M, 2005, J ORNITHOL, V146, P395, DOI 10.1007/s10336-005-0003-y; LOREAU M, 1994, AM NAT, V143, P508, DOI 10.1086/285616; LUMSDEN HARRY G., 1961, BRIT BIRDS, V54, P257; Martinez AM, 1993, THESIS LEON U; Morris DW, 2003, OECOLOGIA, V136, P1, DOI 10.1007/s00442-003-1241-4; MOSS D, 1978, J ANIM ECOL, V47, P521, DOI 10.2307/3798; MOSS R, 1980, BRIT BIRDS, V73, P440; Newton I, 1989, LIFETIME REPROD BIRD; ORING LW, 1982, AVIAN BIOL, V1, P1; Ozaki K, 2006, CONSERV BIOL, V20, P1507, DOI 10.1111/j.1523-1739.2006.00444.x; Pakkala T, 2003, WILDLIFE BIOL, V9, P309, DOI 10.2981/wlb.2003.019; Part T, 2001, P ROY SOC B-BIOL SCI, V268, P2267, DOI 10.1098/rspb.2001.1803; Quevedo M, 2006, BIOL CONSERV, V127, P190, DOI 10.1016/j.biocon.2005.07.019; R Development Core Team, 2009, R FDN STAT COMP; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; ROLSTAD J, 1987, OECOLOGIA, V72, P389, DOI 10.1007/BF00377569; Rolstad J, 2007, WILDLIFE BIOL, V13, P59, DOI 10.2981/0909-6396(2007)13[59:CTULFI]2.0.CO;2; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; ROTH P, 1975, Ornithologische Beobachter, V72, P101; RYAN MJ, 1985, AM NAT, V126, P87, DOI 10.1086/284398; Schulze CH, 2004, ECOL APPL, V14, P1321, DOI 10.1890/02-5409; Sergio F, 2005, NATURE, V436, P192, DOI 10.1038/436192a; Sergio F, 2005, ECOLOGY, V86, P340, DOI 10.1890/04-0137; Sergio F, 2003, BIOL CONSERV, V110, P101, DOI 10.1016/S0006-3207(02)00181-7; Sergio F, 2003, J ANIM ECOL, V72, P857, DOI 10.1046/j.1365-2656.2003.00758.x; Sergio F, 2006, J APPL ECOL, V43, P1049, DOI 10.1111/j.1365-2664.2006.01218.x; Sergio F, 2008, ANNU REV ECOL EVOL S, V39, P1, DOI 10.1146/annurev.ecolsys.39.110707.173545; Simberloff D, 1998, BIOL CONSERV, V83, P247, DOI 10.1016/S0006-3207(97)00081-5; Sirkia S, 2010, BIOL CONSERV, V143, P1540, DOI 10.1016/j.biocon.2010.03.038; STORCH I, 1994, BIOL CONSERV, V70, P237, DOI 10.1016/0006-3207(94)90168-6; Storch I, 2006, J ORNITHOL, V147, P653, DOI 10.1007/s10336-006-0101-5; Suter W, 2002, CONSERV BIOL, V16, P778, DOI 10.1046/j.1523-1739.2002.01129.x; VEHRENCAMP SL, 1989, ANIM BEHAV, V38, P885, DOI 10.1016/S0003-3472(89)80120-4; WEGGE P, 1986, BEHAV ECOL SOCIOBIOL, V19, P401, DOI 10.1007/BF00300542; Winkel W, 1997, J AVIAN BIOL, V28, P187, DOI 10.2307/3677313; WITTENBERGER JF, 1978, CONDOR, V80, P126, DOI 10.2307/1367912	65	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e22724	10.1371/journal.pone.0022724	http://dx.doi.org/10.1371/journal.pone.0022724			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21818374	Green Published, Green Submitted, gold			2022-12-25	WOS:000293175100043
J	Riemann, A; Schneider, B; Ihling, A; Nowak, M; Sauvant, C; Thews, O; Gekle, M				Riemann, Anne; Schneider, Bettina; Ihling, Angelika; Nowak, Martin; Sauvant, Christoph; Thews, Oliver; Gekle, Michael			Acidic Environment Leads to ROS-Induced MAPK Signaling in Cancer Cells	PLOS ONE			English	Article							P-GLYCOPROTEIN; MINERALOCORTICOID RECEPTOR; INTRACELLULAR PH; MICROENVIRONMENT; ACTIVATION; TUMORS; MITOCHONDRIA; ALDOSTERONE; METABOLISM; AUTOPHAGY	Tumor micromilieu often shows pronounced acidosis forcing cells to adapt their phenotype towards enhanced tumorigenesis induced by altered cellular signalling and transcriptional regulation. In the presents study mechanisms and potential consequences of the crosstalk between extra-and intracellular pH (pH(e), pH(i)) and mitogen-activated-protein-kinases (ERK1/2, p38) was analyzed. Data were obtained mainly in AT1 R-3327 prostate carcinoma cells, but the principle importance was confirmed in 5 other cell types. Extracellular acidosis leads to a rapid and sustained decrease of pH(i) in parallel to p38 phosphorylation in all cell types and to ERK1/2 phosphorylation in 3 of 6 cell types. Furthermore, p38 phosphorylation was elicited by sole intracellular lactacidosis at normal pH(e). Inhibition of ERK1/2 phosphorylation during acidosis led to necrotic cell death. No evidence for the involvement of the kinases c-SRC, PKC, PKA, PI3K or EGFR nor changes in cell volume in acidosis-induced MAPK activation was obtained. However, our data reveal that acidosis enhances the formation of reactive oxygen species (ROS), probably originating from mitochondria, which subsequently trigger MAPK phosphorylation. Scavenging of ROS prevented acidosis-induced MAPK phosphorylation whereas addition of H2O2 enhanced it. Finally, acidosis increased phosphorylation of the transcription factor CREB via p38, leading to increased transcriptional activity of a CRE-reporter even 24 h after switching the cells back to a normal environmental milieu. Thus, an acidic tumor microenvironment can induce a longer lasting p38-CREB-medited change in the transcriptional program, which may maintain the altered phenotype even when the cells leave the tumor environment.	[Riemann, Anne; Schneider, Bettina; Ihling, Angelika; Thews, Oliver; Gekle, Michael] Univ Halle Wittenberg, Julius Bernstein Inst Physiol, Halle, Germany; [Sauvant, Christoph] Univ Halle Wittenberg, Klin & Poliklin Anasthesie, Halle, Germany; [Nowak, Martin] Johannes Gutenberg Univ Mainz, Inst Physiol & Pathophysiol, D-6500 Mainz, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Johannes Gutenberg University of Mainz	Riemann, A (corresponding author), Univ Halle Wittenberg, Julius Bernstein Inst Physiol, Halle, Germany.	michael.gekle@medizin.uni-halle.de			Deutsche Krebshilfe [106774/106906]; BMBF [ProNet-T3 Ta-04]; Medical School, Universitat Halle-Wittenberg	Deutsche Krebshilfe(Deutsche Krebshilfe); BMBF(Federal Ministry of Education & Research (BMBF)); Medical School, Universitat Halle-Wittenberg	This study was supported by Deutsche Krebshilfe (Grants 106774/106906), the BMBF (ProNet-T3 Ta-04) and the Wilhelm-Roux program of the Medical School, Universitat Halle-Wittenberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGMEYER HU, 1974, METHODEN ENZYMATISCH, P1834; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Duchen MR, 1999, J PHYSIOL-LONDON, V516, P1, DOI 10.1111/j.1469-7793.1999.001aa.x; Elias AP, 2008, CANCER MICROENVIRON, V1, P131, DOI 10.1007/s12307-008-0013-4; Fu J, 2010, NEURO-ONCOLOGY, V12, P328, DOI 10.1093/neuonc/nop005; Gekle M, 2003, J PHYSIOL-LONDON, V552, P471, DOI 10.1113/jphysiol.2003.048074; GEKLE M, 1994, PFLUG ARCH EUR J PHY, V428, P157, DOI 10.1007/BF00374853; Gekle M, 2002, AM J PHYSIOL-RENAL, V283, pF549, DOI 10.1152/ajprenal.00206.2001; Gekle M, 1996, P NATL ACAD SCI USA, V93, P10500, DOI 10.1073/pnas.93.19.10500; Grossmann C, 2010, FASEB J, V24, P2010, DOI 10.1096/fj.09-146985; HENDERSON BW, 1987, CANCER RES, V47, P3110; Hsieh CC, 2006, FASEB J, V20, P259, DOI 10.1096/fj.05-4376com; Kennedy DJ, 2006, HYPERTENSION, V47, P488, DOI 10.1161/01.HYP.0000202594.82271.92; Kim DS, 2010, BIOL PHARM BULL, V33, P545, DOI 10.1248/bpb.33.545; Konerding MA, 1999, BRIT J CANCER, V80, P724, DOI 10.1038/sj.bjc.6690416; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Krug AW, 2003, J BIOL CHEM, V278, P43060, DOI 10.1074/jbc.M308134200; Laconi E, 2007, BIOESSAYS, V29, P738, DOI 10.1002/bies.20606; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Lang F, 2007, J AM COLL NUTR, V26, p613S, DOI 10.1080/07315724.2007.10719667; Lotz C, 2007, ONCOL REP, V17, P239; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Mijatovic T, 2007, BBA-REV CANCER, V1776, P32, DOI 10.1016/j.bbcan.2007.06.002; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Paget S, 1889, LANCET, V133, P571, DOI [DOI 10.1016/S0140-6736(00)49915-0, 10.1016/S0140-6736(00)49915-0]; Pfau A, 2007, MOL CELL ENDOCRINOL, V264, P35, DOI 10.1016/j.mce.2006.10.002; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; ROZENGURT E, 2007, J CELL PHYSL; Sarti P, 1999, FASEB J, V13, P191, DOI 10.1096/fasebj.13.1.191; Sauvant C, 2008, INT J CANCER, V123, P2532, DOI 10.1002/ijc.23818; TANNOCK IF, 1989, CANCER RES, V49, P4373; Thews O, 2006, NEOPLASIA, V8, P143, DOI 10.1593/neo.05697; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; VAUPEL P, 1989, CANCER RES, V49, P6449; WEINER ID, 1989, AM J PHYSIOL, V256, pF957, DOI 10.1152/ajprenal.1989.256.5.F957; Wohlfarth V, 2003, KIDNEY INT, V63, pS103, DOI 10.1046/j.1523-1755.63.s84.13.x; Xiao X, 2010, CURR CANCER DRUG TAR, V10, P384, DOI 10.2174/156800910791208535; ZHENG M, 2005, FASEB J, P109	40	98	99	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2011	6	7							e22445	10.1371/journal.pone.0022445	http://dx.doi.org/10.1371/journal.pone.0022445			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798BE	21818325	gold, Green Submitted, Green Published			2022-12-25	WOS:000293175100028
J	Amberbir, A; Medhin, G; Hanlon, C; Britton, J; Venn, A; Davey, G				Amberbir, Alemayehu; Medhin, Girmay; Hanlon, Charlotte; Britton, John; Venn, Andrea; Davey, Gail			Frequent Use of Paracetamol and Risk of Allergic Disease Among Women in an Ethiopian Population	PLOS ONE			English	Article							ACETAMINOPHEN USE; ASTHMA; CHILDREN; ASSOCIATION; INFECTION; CHILDHOOD; IBUPROFEN; EXPOSURE; ASPIRIN; WHEEZE	Introduction: The hypothesis that paracetamol might increase the risk of asthma and other allergic diseases have gained support from a range of independent studies. However, in studies based in developed countries, the possibility that paracetamol and asthma are associated through aspirin avoidance is difficult to exclude. Objectives: To explore this hypothesis among women in a developing country, where we have previously reported aspirin avoidance to be rare. Methods: In 2005/6 a population based cohort of 1065 pregnant women was established in Butajira, Ethiopia and baseline demographic data collected. At 3 years post birth, an interview-based questionnaire administered to 945 (94%) of these women collected data on asthma, eczema, and hay fever in the past 12 month, frequency of paracetamol use and potential confounders. Allergen skin tests to Dermatophagoides pteronyssinus and cockroach were also performed. The independent effects of paracetamol use on allergic outcomes were determined using multiple logistic regression analysis. Findings: The prevalence of asthma, eczema and hay fever was 1.7%, 0.9% and 3.8% respectively; of any one of these conditions 5.5%, and of allergen sensitization 7.8%. Paracetamol use in the past month was reported by 29%, and associations of borderline significance were seen for eczema (adjusted OR (95% CI) = 8.51 (1.68 to 43.19) for 1-3 tablets and 2.19 (0.36 to 13.38) for >= 4 tablets, compared to no tablets in the past month; overall p = 0.055) and for 'any allergic condition' (adjusted OR (95% CI) = 2.73 (1.22 to 6.11) for 1-3 tablets and 1.35 (0.67 to 2.70) for >= 4 tablets compared to 0 in the past month; overall p = 0.071). Conclusions: This study provides further cross-sectional evidence that paracetamol use increases the risk of allergic disease.	[Amberbir, Alemayehu; Davey, Gail] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia; [Amberbir, Alemayehu; Britton, John; Venn, Andrea] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England; [Medhin, Girmay] Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Hanlon, Charlotte] Univ Addis Ababa, Dept Psychiat, Addis Ababa, Ethiopia	Addis Ababa University; University of Nottingham; Addis Ababa University; Addis Ababa University	Amberbir, A (corresponding author), Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia.	alamwo1@yahoo.com	Hanlon, Charlotte/AAH-7769-2020; Britton, John R/G-9705-2011; Amberbir, Alemayehu/HGC-2647-2022	Hanlon, Charlotte/0000-0002-7937-3226; Davey, Gail/0000-0003-2796-7468; Medhin, Girmay/0000-0003-2146-4261	Asthma UK [07/036]; Wellcome Trust	Asthma UK; Wellcome Trust(Wellcome TrustEuropean Commission)	The study was funded by Asthma UK (grant 07/036) with additional funding from the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberbir A, 2011, AM J RESP CRIT CARE, V183, P165, DOI 10.1164/rccm.201006-0989OC; BARNES PJ, 1990, FREE RADICAL BIO MED, V9, P235, DOI 10.1016/0891-5849(90)90034-G; Barr RG, 2004, AM J RESP CRIT CARE, V169, P836, DOI 10.1164/rccm.200304-596OC; Beasley R, 2008, LANCET, V372, P1039, DOI 10.1016/S0140-6736(08)61445-2; BEASLEY RW, 2011, AM J RESP CRIT CARE; Belyhun Y, 2010, CLIN EXP ALLERGY, V40, P619, DOI 10.1111/j.1365-2222.2010.03479.x; BERHANE Y, 1999, ETHIOP J HLTH DEV S, V13; Davey G, 2005, J ALLERGY CLIN IMMUN, V116, P863, DOI 10.1016/j.jaci.2005.05.045; Denboba W, 2008, East Afr Med J, V85, P582; Duncan P, 2006, East Afr Med J, V83, P31; Eneli I, 2005, CHEST, V127, P604, DOI 10.1378/chest.127.2.604; Etminan M, 2009, CHEST, V136, P1316, DOI 10.1378/chest.09-0865; Farquhar H, 2010, CLIN EXP ALLERGY, V40, P32, DOI 10.1111/j.1365-2222.2009.03378.x; Hanlon C, 2009, TROP MED INT HEALTH, V14, P156, DOI 10.1111/j.1365-3156.2008.02198.x; Lesko SM, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e20; McKeever TM, 2005, AM J RESP CRIT CARE, V171, P966, DOI 10.1164/rccm.200409-1269OC; NASSINI R, 2010, FASEB J; Newson RB, 2000, EUR RESPIR J, V16, P817, DOI 10.1183/09031936.00.16581700; Peterson JD, 1998, P NATL ACAD SCI USA, V95, P3071, DOI 10.1073/pnas.95.6.3071; Scrivener S, 2001, LANCET, V358, P1493, DOI 10.1016/S0140-6736(01)06579-5; Shaheen S, 2008, EUR RESPIR J, V32, P1231, DOI 10.1183/09031936.00039208; Shaheen SO, 2005, CLIN EXP ALLERGY, V35, P18, DOI 10.1111/j.1365-2222.2005.02151.x; Shaheen SO, 2000, THORAX, V55, P266, DOI 10.1136/thorax.55.4.266; Shaheen SO, 2002, THORAX, V57, P958, DOI 10.1136/thorax.57.11.958; Varner AE, 1998, ANN ALLERG ASTHMA IM, V81, P347, DOI 10.1016/S1081-1206(10)63127-4	25	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2011	6	7							e22551	10.1371/journal.pone.0022551	http://dx.doi.org/10.1371/journal.pone.0022551			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FA	21811632	Green Published, Green Accepted, gold			2022-12-25	WOS:000292956800069
J	Roberts, ME; Goldstone, RL				Roberts, Michael E.; Goldstone, Robert L.			Adaptive Group Coordination and Role Differentiation	PLOS ONE			English	Article							DECISION-MAKING; KNOWLEDGE; GAMES; COOPERATION; PERFORMANCE; MINORITY; BEHAVIOR; FAILURE; HUMANS	Many real world situations (potluck dinners, academic departments, sports teams, corporate divisions, committees, seminar classes, etc.) involve actors adjusting their contributions in order to achieve a mutually satisfactory group goal, a win-win result. However, the majority of human group research has involved situations where groups perform poorly because task constraints promote either individual maximization behavior or diffusion of responsibility, and even successful tasks generally involve the propagation of one correct solution through a group. Here we introduce a group task that requires complementary actions among participants in order to reach a shared goal. Without communication, group members submit numbers in an attempt to collectively sum to a randomly selected target number. After receiving group feedback, members adjust their submitted numbers until the target number is reached. For all groups, performance improves with task experience, and group reactivity decreases over rounds. Our empirical results provide evidence for adaptive coordination in human groups, and as the coordination costs increase with group size, large groups adapt through spontaneous role differentiation and self-consistency among members. We suggest several agent-based models with different rules for agent reactions, and we show that the empirical results are best fit by a flexible, adaptive agent strategy in which agents decrease their reactions when the group feedback changes. The task offers a simple experimental platform for studying the general problem of group coordination while maximizing group returns, and we distinguish the task from several games in behavioral game theory.	[Roberts, Michael E.] Depauw Univ, Dept Psychol, Greencastle, IN 46135 USA; [Goldstone, Robert L.] Indiana Univ, Psychol & Brain Sci Dept, Bloomington, IN USA	DePauw University; Indiana University System; Indiana University Bloomington	Roberts, ME (corresponding author), Depauw Univ, Dept Psychol, Greencastle, IN 46135 USA.	michaelroberts@depauw.edu			National Science Foundation [0910218]; Department of Education [R305A1100060]	National Science Foundation(National Science Foundation (NSF)); Department of Education(US Department of Education)	This work was funded by National Science Foundation REESE grant 0910218 and Department of Education IES grant R305A1100060. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacharach M, 1997, GAME ECON BEHAV, V19, P1, DOI 10.1006/game.1997.0546; Bavalas A., 1952, CYBERNETICS T 8 C; BERRI DJ, 2006, WAGES WINS TAKING ME; Bottazzi G, 2003, PHYSICA A, V324, P124, DOI 10.1016/S0378-4371(02)01893-9; BREWER MB, 1986, J PERS SOC PSYCHOL, V50, P543, DOI 10.1037/0022-3514.50.3.543; Browning L, 2004, J THEOR BIOL, V229, P549, DOI 10.1016/j.jtbi.2004.04.032; CAMERER C, 1989, J POLIT ECON, V97, P1232, DOI 10.1086/261651; Camerer C, 2003, BEHAV GAME THEORY; Camerer CF, 2006, SCIENCE, V311, P47, DOI 10.1126/science.1110600; DARLEY JM, 1968, J PERS SOC PSYCHOL, V8, P377, DOI 10.1037/h0025589; Dawes CT, 2007, NATURE, V446, P794, DOI 10.1038/nature05651; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Goldstone RL, 2006, IEEE T SYST MAN CY A, V36, P611, DOI 10.1109/TSMCA.2005.855779; Guimera R, 2005, SCIENCE, V308, P697, DOI 10.1126/science.1106340; Helbing D, 2005, ADV COMPLEX SYST, V8, P87, DOI 10.1142/S0219525905000361; Helbing D, 2001, ENVIRON PLANN B, V28, P361, DOI 10.1068/b2697; Ho TH, 1998, AM ECON REV, V88, P947; Kearns M, 2006, SCIENCE, V313, P824, DOI 10.1126/science.1127207; KILPATRICK S, 1983, SCIENCE, V220, P671; Knuth D., 1997, ART COMPUTER PROGRAM, VThird; Lewis K, 2005, ORGAN SCI, V16, P581, DOI 10.1287/orsc.1050.0143; Lewis K, 2007, ORGAN BEHAV HUM DEC, V103, P159, DOI 10.1016/j.obhdp.2007.01.005; Maciejovsky B, 2007, J PERS SOC PSYCHOL, V92, P854, DOI 10.1037/0022-3514.92.5.854; Marsili M, 2001, PHYSICA A, V299, P93, DOI 10.1016/S0378-4371(01)00285-0; MEHTA J, 1994, AM ECON REV, V84, P658; Ostrom E., 1994, RULES GAMES COMMON P; Page SE, 2007, DIFFERENCE POWER DIV; Polzer JT, 2002, ADMIN SCI QUART, V47, P296, DOI 10.2307/3094807; Roberts ME, 2006, ADAPT BEHAV, V14, P291, DOI 10.1177/1059712306072336; Savit R, 1999, PHYS REV LETT, V82, P2203, DOI 10.1103/PhysRevLett.82.2203; STASSER G, 1992, J PERS SOC PSYCHOL, V63, P426, DOI 10.1037/0022-3514.63.3.426; STEWART DD, 1995, J PERS SOC PSYCHOL, V69, P619, DOI 10.1037/0022-3514.69.4.619; VANHUYCK JB, 1990, AM ECON REV, V80, P234; Weber RA, 2006, AM ECON REV, V96, P114, DOI 10.1257/000282806776157588; Weber RA, 2003, MANAGE SCI, V49, P400, DOI 10.1287/mnsc.49.4.400.14430; Wegner D. M., 1986, THEORIES GROUP BEHAV, P253; Young P, 1993, ECONOMETRICA, V61, P57, DOI DOI 10.2307/2951778	37	16	16	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2011	6	7							e22377	10.1371/journal.pone.0022377	http://dx.doi.org/10.1371/journal.pone.0022377			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	794VN	21811595	Green Submitted, Green Published, gold			2022-12-25	WOS:000292929500056
J	Parnell, G; McLean, A; Booth, D; Huang, S; Nalos, M; Tang, B				Parnell, Grant; McLean, Anthony; Booth, David; Huang, Stephen; Nalos, Marek; Tang, Benjamin			Aberrant Cell Cycle and Apoptotic Changes Characterise Severe Influenza A Infection - A Meta-Analysis of Genomic Signatures in Circulating Leukocytes	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX; VIRAL LOAD; IMMUNE; DEATH	Influenza A infection is a global disease that has been responsible for four pandemics over the last one hundred years. However, it remains poorly understood as to why some infected individuals succumb to life threatening complications whilst others recover and are relatively unaffected. Using gene-expression analysis of circulating leukocytes, here we show that the progression towards severe influenza A infection is characterised by an abnormal transcriptional reprogramming of cell cycle and apoptosis pathways. In severely infected humans, leukocyte gene-expression profiles display opposing cell cycle activities; an increased aberrant DNA replication in the G(1)/S phase yet delayed progression in the G(2)/M phase. In mild infection, cell cycle perturbations are fewer and are integrated with an efficient apoptotic program. Importantly, the loss of integration between cell cycle perturbations and apoptosis marks the transition from a mild viral illness to a severe, life threatening infection. Our findings suggest that circulating immune cells may play a significant role in the evolution of the host response. Further study may reveal alternative host response factors previously unrecognized in the current disease model of influenza.	[Parnell, Grant; McLean, Anthony; Huang, Stephen; Nalos, Marek; Tang, Benjamin] Univ Sydney, Nepean Hosp, Western Clin Sch, Dept Intens Care Med, Sydney, NSW 2006, Australia; [Booth, David] Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2006, Australia	Nepean Hospital; University of Sydney; University of Sydney; Westmead Institute for Medical Research	Parnell, G (corresponding author), Univ Sydney, Nepean Hosp, Western Clin Sch, Dept Intens Care Med, Sydney, NSW 2006, Australia.	gpar3109@uni.sydney.edu.au	Parnell, Grant/AAB-8155-2021; Huang, Stephen/O-6195-2019; Booth, David/A-7184-2012	Huang, Stephen/0000-0003-2518-0506; Booth, David/0000-0002-3801-0488; Parnell, Grant/0000-0002-2898-0253; Nalos, Marek/0000-0002-7977-9410	Nepean Institute of Critical Care Education and Research; Nepean Medical Research Foundation	Nepean Institute of Critical Care Education and Research; Nepean Medical Research Foundation	This work was supported by the Nepean Institute of Critical Care Education and Research and Nepean Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bermejo-Martin JF, 2009, CRIT CARE, V13, DOI 10.1186/cc8208; Castro A, 2005, ONCOGENE, V24, P314, DOI 10.1038/sj.onc.1207973; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Gandhi KS, 2010, HUM MOL GENET, V19, P2134, DOI 10.1093/hmg/ddq090; Heilman DW, 2005, CELL CYCLE, V4, P560; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Li IW, 2010, CHEST, V137, P759, DOI 10.1378/chest.09-3072; Ludwig S, 2006, CELL MICROBIOL, V8, P375, DOI 10.1111/j.1462-5822.2005.00678.x; MEUNIER I, 2009, CRIT CARE MED S, V38; Nagata K, 2008, REV MED VIROL, V18, P247, DOI 10.1002/rmv.575; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; To KKW, 2010, J MED VIROL, V82, P1, DOI 10.1002/jmv.21664; Turpin E, 2005, J VIROL, V79, P8802, DOI 10.1128/JVI.79.14.8802-8811.2005; *WHO, 2010, WHO INFL FACT SHEETS; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006	21	70	74	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17186	10.1371/journal.pone.0017186	http://dx.doi.org/10.1371/journal.pone.0017186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21826236	Green Published, Green Submitted, gold			2022-12-25	WOS:000288170000015
J	Johnson, CL; Runge, JA; Curtis, KA; Durbin, EG; Hare, JA; Incze, LS; Link, JS; Melvin, GD; O'Brien, TD; Van Guelpen, L				Johnson, Catherine L.; Runge, Jeffrey A.; Curtis, K. Alexandra; Durbin, Edward G.; Hare, Jonathan A.; Incze, Lewis S.; Link, Jason S.; Melvin, Gary D.; O'Brien, Todd D.; Van Guelpen, Lou			Biodiversity and Ecosystem Function in the Gulf of Maine: Pattern and Role of Zooplankton and Pelagic Nekton	PLOS ONE			English	Review							CONTINENTAL-SHELF ECOSYSTEM; NORTHWEST ATLANTIC-OCEAN; HERRING CLUPEA-HARENGUS; LONGFIN INSHORE SQUID; LARGE-SCALE PATTERNS; GEORGES-BANK; CALANUS-FINMARCHICUS; PREDATION MORTALITY; MARINE ECOSYSTEM; LOLIGO-PEALEII	This paper forms part of a broader overview of biodiversity of marine life in the Gulf of Maine area (GoMA), facilitated by the GoMA Census of Marine Life program. It synthesizes current data on species diversity of zooplankton and pelagic nekton, including compilation of observed species and descriptions of seasonal, regional and cross-shelf diversity patterns. Zooplankton diversity in the GoMA is characterized by spatial differences in community composition among the neritic environment, the coastal shelf, and deep offshore waters. Copepod diversity increased with depth on the Scotian Shelf. On the coastal shelf of the western Gulf of Maine, the number of higher-level taxonomic groups declined with distance from shore, reflecting more nearshore meroplankton. Copepod diversity increased in late summer, and interdecadal diversity shifts were observed, including a period of higher diversity in the 1990s. Changes in species diversity were greatest on interannual scales, intermediate on seasonal scales, and smallest across regions, in contrast to abundance patterns, suggesting that zooplankton diversity may be a more sensitive indicator of ecosystem response to interannual climate variation than zooplankton abundance. Local factors such as bathymetry, proximity of the coast, and advection probably drive zooplankton and pelagic nekton diversity patterns in the GoMA, while ocean-basin-scale diversity patterns probably contribute to the increase in diversity at the Scotian Shelf break, a zone of mixing between the cold-temperate community of the shelf and the warm-water community offshore. Pressing research needs include establishment of a comprehensive system for observing change in zooplankton and pelagic nekton diversity, enhanced observations of "underknown'' but important functional components of the ecosystem, population and metapopulation studies, and development of analytical modeling tools to enhance understanding of diversity patterns and drivers. Ultimately, sustained observations and modeling analysis of biodiversity must be effectively communicated to managers and incorporated into ecosystem approaches for management of GoMA living marine resources.	[Johnson, Catherine L.] Fisheries & Oceans Canada, Bedford Inst Oceanog, Dartmouth, NS B2Y 4A2, Canada; [Runge, Jeffrey A.] Univ Maine, Sch Marine Sci, Portland, ME USA; [Runge, Jeffrey A.] Gulf Maine Res Inst, Portland, ME USA; [Curtis, K. Alexandra] Acadia Univ, Acadia Ctr Estuarine Res, Wolfville, NS B0P 1X0, Canada; [Durbin, Edward G.] Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA; [Hare, Jonathan A.] NOAA, Natl Marine Fisheries Serv, NE Fisheries Sci Ctr, Narragansett, RI 02882 USA; [Incze, Lewis S.] Univ So Maine, Aquat Syst Grp, Portland, ME 04103 USA; [Link, Jason S.] Natl Marine Fisheries Serv, NE Fisheries Sci Ctr, Woods Hole, MA 02543 USA; [Melvin, Gary D.] Fisheries & Oceans Canada, St Andrews Biol Stn, St Andrews, NB, Canada; [O'Brien, Todd D.] Natl Marine Fisheries Serv, Marine Ecosyst Div, Off Sci Technol, Silver Spring, MD USA; [Van Guelpen, Lou] Huntsman Marine Sci Ctr, Atlantic Reference Ctr, St Andrews, NB, Canada	Bedford Institute of Oceanography; Fisheries & Oceans Canada; University of Maine System; University of Maine Orono; Gulf of Maine Research Institute; Acadia University; University of Rhode Island; National Oceanic Atmospheric Admin (NOAA) - USA; University of Maine System; University of Southern Maine; National Oceanic Atmospheric Admin (NOAA) - USA; Fisheries & Oceans Canada; National Oceanic Atmospheric Admin (NOAA) - USA	Johnson, CL (corresponding author), Fisheries & Oceans Canada, Bedford Inst Oceanog, POB 1006, Dartmouth, NS B2Y 4A2, Canada.	Catherine.Johnson@dfo-mpo.gc.ca		Link, Jason/0000-0003-2740-7161; Curtis, Katherine Alexandra/0000-0001-7284-944X; Johnson, Catherine/0000-0001-5291-3141; Gray, Nicola M/0000-0001-8497-394X	Alfred P. Sloan Foundation; National Science Foundation [OCE-0815336, 0733907, OISE-0502252]; Fisheries and Oceans Canada's Ecosystem Research Initiative in the Gulf of Maine	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); National Science Foundation(National Science Foundation (NSF)); Fisheries and Oceans Canada's Ecosystem Research Initiative in the Gulf of Maine	This work was supported by the Alfred P. Sloan Foundation through the Gulf of Maine Area Program of the Census of Marine Life (grant to L. Incze), by the National Science Foundation under awards OCE-0815336 and 0733907 to J. Runge and OISE-0502252 to C. Johnson, and by Fisheries and Oceans Canada's Ecosystem Research Initiative in the Gulf of Maine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMEIDA F, 1999, 9906 NE FISH SCI CTR; Angel MV, 1997, MARINE BIODIVERSITY-BOOK, P35, DOI 10.1017/CBO9780511752360.004; Auster PJ, 2009, MAR ECOL PROG SER, V382, P163, DOI 10.3354/meps07962; Azarovitz T.R., 1981, Canadian Special Publication of Fisheries and Aquatic Sciences, V58, P62; BAILEY KM, 1989, ADV MAR BIOL, V25, P1; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Beaugrand G, 2008, ECOL LETT, V11, P1157, DOI 10.1111/j.1461-0248.2008.01218.x; Beaugrand G, 2009, DEEP-SEA RES PT II, V56, P656, DOI 10.1016/j.dsr2.2008.12.022; Beaugrand G, 2009, GLOBAL CHANGE BIOL, V15, P1790, DOI 10.1111/j.1365-2486.2009.01848.x; BIGELOW HB, 1926, B US BUREAU FISHER 2, V40; Bonnet D, 2005, PROG OCEANOGR, V65, P1, DOI 10.1016/j.pocean.2005.02.002; BRADFORD J M, 1976, New Zealand Journal of Marine and Freshwater Research, V10, P159; Brodziak JKT, 2002, NE FISHERY SCI CTR R, P245; Bucklin A, 1996, DEEP-SEA RES PT II, V43, P1665, DOI 10.1016/S0967-0645(96)00059-8; Caudill CC, 2004, HYDROBIOLOGIA, V511, P91, DOI 10.1023/B:HYDR.0000014032.05680.9d; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; CHRISTENSEN V, 1992, ICLARM C P, V26, P14; CHURCHILL J, FISH OCEANO IN PRESS; Clarke A, 2006, P ROY SOC B-BIOL SCI, V273, P2257, DOI 10.1098/rspb.2006.3545; Coll M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003881; COWEN RK, 1993, B MAR SCI, V53, P567; COX J, 1979, ESTUAR COAST MAR SCI, V9, P509, DOI 10.1016/0302-3524(79)90076-8; Cushing D.H., 1982, CLIMATE FISHERIES; DABORN GR, 1984, CAN TECH REP FISH AQ, V1256, P135; Darbyson E, 2003, J FISH BIOL, V63, P1235, DOI 10.1046/j.1095-8649.2003.00247.x; Davis C.S., 1987, P256; Dawe EG, 2007, FISH OCEANOGR, V16, P303, DOI 10.1111/j.1365-2419.2007.00431.x; deYoung B, 2004, SCIENCE, V304, P1463, DOI 10.1126/science.1094858; Deyoung B, 2008, TRENDS ECOL EVOL, V23, P402, DOI 10.1016/j.tree.2008.03.008; DFO, 2003, STAT E SCOT SHELF EC; Duffy JE, 2006, MAR ECOL PROG SER, V311, P179, DOI 10.3354/meps311179; Durbin E, 2007, PROG OCEANOGR, V72, P249, DOI 10.1016/j.pocean.2007.01.008; Durbin EG, 2006, DEEP-SEA RES PT II, V53, P2537, DOI 10.1016/j.dsr2.2006.08.017; Durbin EG, 2003, MAR ECOL PROG SER, V254, P81, DOI 10.3354/meps254081; Ecosystem Assessment Program (EAP), 2009, 0911 EAP US DEP COMM; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Edwards SF, 2004, ECOL ECON, V49, P317, DOI 10.1016/j.ecolecon.2004.04.002; EVSEENKO SA, 1982, J NW ATL FISH SCI, P127; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; FROST BW, 1989, CAN J ZOOL, V67, P525, DOI 10.1139/z89-077; Fulton EA, 2004, ECOL MODEL, V174, P267, DOI 10.1016/j.ecolmodel.2003.09.027; Garrison LP, 2010, ICES J MAR SCI, V67, P856, DOI 10.1093/icesjms/fsq005; Gaston K. J., 2004, BIODIVERSITY INTRO; Gosselin F, 2006, J THEOR BIOL, V242, P591, DOI 10.1016/j.jtbi.2006.04.017; Gotelli NJ, 2004, ECOSIM NULL MODELS S; Grabe SA, 1996, J PLANKTON RES, V18, P881, DOI 10.1093/plankt/18.6.881; Greene CH, 2007, SCIENCE, V315, P1084, DOI 10.1126/science.1136495; HAMNER WM, 1975, LIMNOL OCEANOGR, V20, P907, DOI 10.4319/lo.1975.20.6.0907; Hare JA, 2001, FISH OCEANOGR, V10, P164, DOI 10.1046/j.1365-2419.2001.00168.x; Hartel KE, 2008, NORTHEAST NAT, V15, P317, DOI 10.1656/1092-6194-15.3.317; Hatun H, 2009, PROG OCEANOGR, V80, P149, DOI 10.1016/j.pocean.2009.03.001; Heath MR, 2007, FISH OCEANOGR, V16, P169, DOI 10.1111/j.1365-2419.2006.00423.x; Hillebrand H, 2004, MAR ECOL PROG SER, V273, P251, DOI 10.3354/meps273251; HOPKINS T L, 1981, Journal of Plankton Research, V3, P645, DOI 10.1093/plankt/3.4.645; HOYSGAARD S, 2009, GROUPWISE COMPUTATIO; Hunsicker ME, 2008, CAN J FISH AQUAT SCI, V65, P2524, DOI 10.1139/F08-154; Hunsicker ME, 2006, CAN J FISH AQUAT SCI, V63, P754, DOI 10.1139/f05-258; Huret M, 2007, MAR ECOL PROG SER, V347, P261, DOI 10.3354/meps06983; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Incze L, 2010, FISH OCEANOGR, V19, P1, DOI 10.1111/j.1365-2419.2009.00522.x; Ji RB, 2009, MAR ECOL PROG SER, V384, P187, DOI 10.3354/meps08032; Johnson CL, 2008, ICES J MAR SCI, V65, P339, DOI 10.1093/icesjms/fsm171; JOHNSON CL, ADV ECOSYST IN PRESS; Johnson WS, 2005, ZOOPLANKTON ATLANTIC; Jumars PA, 2007, OCEANOGR MAR BIOL, V45, P89, DOI 10.1201/9781420050943.ch3; Kane J, 1997, FISH B-NOAA, V95, P85; Kane J, 2008, J PLANKTON RES, V30, P619, DOI 10.1093/plankt/fbn026; Kane J, 2007, ICES J MAR SCI, V64, P909, DOI 10.1093/icesjms/fsm066; Kane J, 2009, J PLANKTON RES, V31, P249, DOI 10.1093/plankt/fbn119; Kelly NE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013832; Kindt R., 2005, WORLD; Kirby RR, 2008, LIMNOL OCEANOGR, V53, P1805, DOI 10.4319/lo.2008.53.5.1805; Krause AE, 2003, NATURE, V426, P282, DOI 10.1038/nature02115; Lande R, 1996, OIKOS, V76, P5, DOI 10.2307/3545743; LANGE AMT, 1980, MAR FISH REV, V42, P23; LEGARE JEH, 1960, J FISH RES BOARD CAN, V17, P409, DOI 10.1139/f60-030; LEGARE JEH, 1961, ZOOPLANKTON PASSAMAQ; Lemon J., 2009, PLOTRIX VARIOUS PLOT; LI WKW, PLOS ONE UNPUB; Lindley JA, 1997, J CRUSTACEAN BIOL, V17, P569, DOI 10.2307/1549361; Link J, 2002, MAR ECOL PROG SER, V230, P1, DOI 10.3354/meps230001; Link J., 2008, J NW ATLANTIC FISHER, V39, P83, DOI DOI 10.2960/J.V39.M582; Link J, 2008, J MARINE SYST, V74, P453, DOI 10.1016/j.jmarsys.2008.03.007; Link J, 2009, ECOL MODEL, V220, P351, DOI 10.1016/j.ecolmodel.2008.10.009; Link JS, 2007, ECOL APPL, V17, P2037, DOI 10.1890/06-1154.1; Link JS, 2006, MAR ECOL PROG SER, V320, P153, DOI 10.3354/meps320153; Link JS, 2009, N AM J FISH MANAGE, V29, P1567, DOI 10.1577/M08-233.1; Link JS, 2002, CAN J FISH AQUAT SCI, V59, P1429, DOI 10.1139/F02-115; LINK JS, FULTON EA NEUS ATLAN; Link JS, 2006, US DEP COMMERCE NE F, P166; LONGHURST AR, 1985, DEEP-SEA RES, V32, P1535, DOI 10.1016/0198-0149(85)90102-5; Mackas DL, 2010, J MARINE SYST, V79, P286, DOI 10.1016/j.jmarsys.2008.11.030; Mackas DL, 2004, DEEP-SEA RES PT II, V51, P875, DOI 10.1016/j.dsr2.2004.05.011; MACY WK, 1982, BIOL BULL, V162, P28, DOI 10.2307/1540967; Madin LP, 1996, DEEP-SEA RES PT II, V43, P1823, DOI 10.1016/S0967-0645(96)00038-0; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Manning CA, 2005, MAR ECOL PROG SER, V292, P233, DOI 10.3354/meps292233; Marcus NH, 1996, HYDROBIOLOGIA, V320, P141, DOI 10.1007/BF00016815; Mauchline J., 1998, ADV MARINE BIOL, V33; May R.M., 1975, P81; Mitchell M. R., 2002, ATLANTIC ZONAL MONIT; Moore J. A., 2003, Journal of Northwest Atlantic Fishery Science, V31, P363; Moore JA, 2003, NORTHEAST NAT, V10, P159, DOI 10.1656/1092-6194(2003)010[0159:AALODF]2.0.CO;2; MORGAN S, 1995, ECOLOGY MARINE INVER; Morgan Steven G., 1995, P157; Mountain D.G., 2004, J NW ATL FISH SCI, V34, P101; Moustahfid H, 2009, ICES J MAR SCI, V66, P445, DOI 10.1093/icesjms/fsn217; Moustahfid H, 2009, N AM J FISH MANAGE, V29, P1555, DOI 10.1577/M08-221.1; NEFC, 1988, NMFSFNEC52 NOAA; *NEFSC, 2007, 0716 NE FISH SCI CTR, P13; *NEFSC, 2006, 42 NE REG STOCK AS B; NICOL S, 1984, MAR ECOL PROG SER, V18, P241, DOI 10.3354/meps018241; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Oksanen J., 2009, VEGAN COMMUNITY ECOL; Olszewski TD, 2004, OIKOS, V104, P377, DOI 10.1111/j.0030-1299.2004.12519.x; Overholtz WJ, 2008, N AM J FISH MANAGE, V28, P247, DOI 10.1577/M06-267.1; Overholtz WJ, 2007, ICES J MAR SCI, V64, P83, DOI 10.1093/icesjms/fsl009; Overholtz WJ, 2002, FISH B-NOAA, V100, P593; Overholtz WJ, 2002, FISH RES, V57, P237, DOI 10.1016/S0165-7836(01)00359-9; PERCY JA, 1997, BAY FUND ISS SCI OV; Perry RI, 2004, ICES J MAR SCI, V61, P445, DOI 10.1016/j.icesjms.2004.03.022; Pershing AJ, 2005, ICES J MAR SCI, V62, P1511, DOI 10.1016/j.icesjms.2005.04.025; Pershing AJ, 2009, MAR ECOL PROG SER, V378, P227, DOI 10.3354/meps07828; Pershing AJ, 2009, MAR ECOL PROG SER, V378, P245, DOI 10.3354/meps07829; Pierrot-Bults AC, 1997, MARINE BIODIVERSITY-BOOK, P69, DOI 10.1017/CBO9780511752360.005; PODRAZHANSKAYA SG, 2009, NW ATLANTIC FISHERIE, V19, P79; Quattrini AM, 2005, FISH OCEANOGR, V14, P413, DOI 10.1111/j.1365-2419.2005.00344.x; R Development Core Team, 2009, R FDN STAT COMP; RAMP SR, 1985, J PHYS OCEANOGR, V15, P1790, DOI 10.1175/1520-0485(1985)015<1790:TDFTTN>2.0.CO;2; Razouls C, 2005, DIVERSITY GEOGRAPHIC; Record NR, 2010, J PLANKTON RES, V32, P1675, DOI 10.1093/plankt/fbq050; Richardson DE, 2010, ICES J MAR SCI, V67, P617, DOI 10.1093/icesjms/fsp276; ROGERS CA, 1976, IMPACT AUTUMN WINTER, P76; Rombouts I, 2009, P ROY SOC B-BIOL SCI, V276, P3053, DOI 10.1098/rspb.2009.0742; Royle J. A., 2008, HIERARCHICAL MODELIN; RUNGE J, 2010, PROG OCEANO IN PRESS; RUNGE J, 2005, GLOBAL COASTAL OCEAN, V13; RUNGE JA, ADV ECOSYST IN PRESS; Rutherford S, 1999, NATURE, V400, P749, DOI 10.1038/23449; SAMEOTO D, 1993, CAN J FISH AQUAT SCI, V50, P334, DOI 10.1139/f93-039; SAMEOTO DD, 1992, CAN J FISH AQUAT SCI, V49, P857, DOI 10.1139/f92-096; Saumweber WJ, 2006, DEEP-SEA RES PT II, V53, P2597, DOI 10.1016/j.dsr2.2006.08.003; SCHNEPPENHEIM R, 1986, POLAR BIOL, V6, P215, DOI 10.1007/BF00443398; SHERMAN K, 1983, FISH B-NOAA, V81, P855; SHERMAN K, 1968, SEASONAL AREAL DISTR, P1; SINCLAIR M, 1988, MARINE POPULATIONS A; SMITH PC, 1983, J PHYS OCEANOGR, V13, P1034, DOI 10.1175/1520-0485(1983)013<1034:TMASCO>2.0.CO;2; Staudinger MD, 2006, FISH B-NOAA, V104, P605; Steele JH, 2007, PROG OCEANOGR, V74, P423, DOI 10.1016/j.pocean.2007.05.003; Steele John H., 2008, GLOBEC International Newsletter, V14, P3; Stevick PT, 2008, MAR ECOL PROG SER, V363, P15, DOI 10.3354/meps07475; Townsend D.W., 2006, SEA, V14A, P119; TOWNSEND DW, 1984, MAR ECOL PROG SER, V15, P79, DOI 10.3354/meps015079; TREMBLAY MJ, 1983, CAN J FISH AQUAT SCI, V40, P598, DOI 10.1139/f83-079; TURNER JT, 1994, HYDROBIOLOGIA, V293, P405; TURNER JT, 1981, J BIOGEOGR, V8, P369, DOI 10.2307/2844757; Tyrrell MC, 2008, ICES J MAR SCI, V65, P1689, DOI 10.1093/icesjms/fsn185; UCHUPI E, 1968, US GEOL SURV PROF C, V529, pC1; VARPE O, ECOLOGY IN PRESS; Vidjak O, 2009, ACTA ADRIAT, V50, P45; Walters C, 2001, CAN J FISH AQUAT SCI, V58, P39, DOI 10.1139/cjfas-58-1-39; Weisse T, 2002, ESTUAR COAST SHELF S, V54, P423, DOI 10.1006/ecss.2000.0656; WIGLEY RL, 1971, FISH BULL NATL OC AT, V69, P717; Woodd-Walker RS, 2002, MAR ECOL PROG SER, V236, P189, DOI 10.3354/meps236189	164	90	94	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16491	10.1371/journal.pone.0016491	http://dx.doi.org/10.1371/journal.pone.0016491			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21818250	Green Submitted, gold, Green Published			2022-12-25	WOS:000286834300071
J	Wu, CL; Kandarian, SC; Jackman, RW				Wu, Chia-Ling; Kandarian, Susan C.; Jackman, Robert W.			Identification of Genes that Elicit Disuse Muscle Atrophy via the Transcription Factors p50 and Bcl-3	PLOS ONE			English	Article							NF-KAPPA-B; DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; ACTIVATION; EXPRESSION; PROTEIN; TARGET; INFLAMMATION; HOMODIMERS; ATROGIN-1	Skeletal muscle atrophy is a debilitating condition associated with weakness, fatigue, and reduced functional capacity. Nuclear factor-kappaB (NF-kappa B) transcription factors play a critical role in atrophy. Knockout of genes encoding p50 or the NF-kappa B co-transactivator, Bcl-3, abolish disuse atrophy and thus they are NF-kappa B factors required for disuse atrophy. We do not know however, the genes targeted by NF-kappa B that produce the atrophied phenotype. Here we identify the genes required to produce disuse atrophy using gene expression profiling in wild type compared to Nfkb1 (gene encodes p50) and Bcl-3 deficient mice. There were 185 and 240 genes upregulated in wild type mice due to unloading, that were not upregulated in Nfkb1(-/-) and Bcl-3(-/-) mice, respectively, and so these genes were considered direct or indirect targets of p50 and Bcl-3. All of the p50 gene targets were contained in the Bcl-3 gene target list. Most genes were involved with protein degradation, signaling, translation, transcription, and transport. To identify direct targets of p50 and Bcl-3 we performed chromatin immunoprecipitation of selected genes previously shown to have roles in atrophy. Trim63 (MuRF1), Fbxo32 (MAFbx), Ubc, Ctsl, Runx1, Tnfrsf12a (Tweak receptor), and Cxcl10 (IP-10) showed increased Bcl-3 binding to kappa B sites in unloaded muscle and thus were direct targets of Bcl-3. p50 binding to the same sites on these genes either did not change or increased, supporting the idea of p50: Bcl-3 binding complexes. p65 binding to kappa B sites showed decreased or no binding to these genes with unloading. Fbxo9, Psma6, Psmc4, Psmg4, Foxo3, Ankrd1 (CARP), and Eif4ebp1 did not show changes in p65, p50, or Bcl-3 binding to kB sites, and so were considered indirect targets of p50 and Bcl-3. This work represents the first study to use a global approach to identify genes required to produce the atrophied phenotype with disuse.	[Wu, Chia-Ling; Kandarian, Susan C.; Jackman, Robert W.] Boston Univ, Dept Hlth Sci, Boston, MA 02215 USA	Boston University	Wu, CL (corresponding author), Boston Univ, Dept Hlth Sci, Boston, MA 02215 USA.	rjackman@bu.edu		TSAO, PO-NIEN/0000-0002-6114-1769; WU, CHEN-CHI/0000-0002-5047-2204; HSIEH, WU-SHIUN/0000-0002-0609-3311; Lee, Chien-Nan/0000-0002-1725-0407; LIN, SHIN-YU/0000-0002-0753-2793; Wu, Chia-Ling/0000-0002-0595-9064	National Institutes of Health [R01 AR041705, R01 AR041705-15S1]; Boston University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041705] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by National Institutes of Health grants R01 AR041705 and R01 AR041705-15S1 to SK and a Boston University Dudley Allen Sargent grant to CW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2005, CANCER CELL, V8, P421, DOI 10.1016/j.ccr.2005.10.004; Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Andrews JL, 2010, P NATL ACAD SCI USA, V107, P19090, DOI 10.1073/pnas.1014523107; Bar-Shai M, 2008, FREE RADICAL BIO MED, V44, P202, DOI 10.1016/j.freeradbiomed.2007.03.019; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Caamano JH, 1996, MOL CELL BIOL, V16, P1342; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Dogra C, 2007, FASEB J, V21, P1857, DOI 10.1096/fj.06-7537com; Frenette J, 2000, AM J PATHOL, V156, P2103, DOI 10.1016/S0002-9440(10)65081-X; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heissmeyer V, 1999, EMBO J, V18, P4766, DOI 10.1093/emboj/18.17.4766; Hunter RB, 2004, J CLIN INVEST, V114, P1504, DOI 10.1172/JCI200421696; Hunter RB, 2002, FASEB J, V16, P529, DOI 10.1096/fj.01-0866com; Judge AR, 2007, AM J PHYSIOL-CELL PH, V292, pC372, DOI 10.1152/ajpcell.00293.2006; Kandarian SC, 2006, MUSCLE NERVE, V33, P155, DOI 10.1002/mus.20442; Koncarevic A, 2007, FASEB J, V21, P427, DOI 10.1096/fj.06-6665com; Kuehn H., 2008, CURR PROTOC BIOINFOR, DOI [DOI 10.1002/0471250953.BI0712S22, 10.1002/0471250953.bi0712s22]; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Mittal A, 2010, J CELL BIOL, V188, P833, DOI 10.1083/jcb.200909117; Mourkioti F, 2006, J CLIN INVEST, V116, P2945, DOI 10.1172/JCI28721; OHMORI Y, 1993, J BIOL CHEM, V268, P6677; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Peterson JM, 2008, INT REV IMMUNOL, V27, P375, DOI 10.1080/08830180802302389; RHOADS MG, 2010, EUR J CANC; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Salminen A, 2010, AGEING RES REV, V9, P298, DOI 10.1016/j.arr.2009.11.001; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; SCHULTE LM, 1993, AM J PHYSIOL, V264, pC1308, DOI 10.1152/ajpcell.1993.264.5.C1308; Stevenson EJ, 2003, J PHYSIOL-LONDON, V551, P33, DOI 10.1113/jphysiol.2003.044701; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tachibana Keisuke, 2005, Nucl Recept, V3, P3, DOI 10.1186/1478-1336-3-3; Taillandier D, 1996, BIOCHEM J, V316, P65, DOI 10.1042/bj3160065; Van Gammeren D, 2009, FASEB J, V23, P362, DOI 10.1096/fj.08-114249; Wang XX, 2005, GENE DEV, V19, P1715, DOI 10.1101/gad.1318305; Witt SH, 2005, J MOL BIOL, V350, P713, DOI 10.1016/j.jmb.2005.05.021; Yamazaki Y, 2010, BIOCHEM J, V427, P171, DOI 10.1042/BJ20091346	44	57	62	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16171	10.1371/journal.pone.0016171	http://dx.doi.org/10.1371/journal.pone.0016171			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21811586	gold, Green Published, Green Submitted			2022-12-25	WOS:000286515000025
